REFKEY	TITLE	TITLE2	AUTHORS	AUTHORS2	JOURNAL	VOLUME	YEAR	PAGES	JNUM	PMID
2	Expression of murine leukemia viruses in B-cell lymphomas of CWD/Agl mice.		Angel JM; Bedigian HG		J Virol	52	1984	691-4	J:24875	6092692
3	A new mouse tumor model system (RIF-1) for comparison of end-point studies.		Twentyman PR; Brown JM; Gray JW; Franko AJ; Scoles MA; Kallman RF		J Natl Cancer Inst	64	1980	595-604	J:46449	6928244
4	Tumorigenesis in strain DW-J mice and induction by prolactin of the group-specific antigen of endogenous C-type RNA tumor virus.		Chen HW; Meier H; Heiniger HJ; Huebner RJ		J Natl Cancer Inst	49	1972	1145-54	J:46465	4117317
5	Pathology image and annotation source		Sundberg J		Personal Communication		1997		J:94307	 
7	Biological and chemotherapeutic studies on primary mammary tumors in C3H and C3HO mice.		Gelzer J; Loustalot P		Int J Cancer	2	1967	179-187	J:46441	6039767
9	Influence of mammary tumor virus on the tumor-producing capabilities of nodule outgrowth free of mammary tumor virus.		Medina D; DeOme KB		J Natl Cancer Inst	40	1968	1303-1308	J:46443	4298252
10	Response of hyperplastic alveolar nodule outgrowth-line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination.		Medina D; DeOme KB		J Natl Cancer Inst	42	1969	303-310	J:46444	4303882
11	Carcinogen-induce mammary tumors from preneoplastic nodule outgrowths in BALB/c mice		Medina D; DeOme KB		Cancer Res	30	1970	1055-1059	J:46445	5504348
13	Heterogeneity of tumor cells from a single mouse mammary tumor.		Dexter DL; Kowalski HM; Blazar BA; Fligiel Z; Vogel R; Heppner GH		Cancer Res	38	1978	3174-81	J:46447	210930
14	Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.		Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P		Cancer Res	38	1978	3758-63	J:46448	698935
18	TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma.		Nanni P; de Giovanni C; Lollini PL; Nicoletti G; Prodi G		Clin Exp Metastasis	1	1983	373-80	J:46453	6546207
19	Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.		Sinn E; Muller W; Pattengale P; Tepler I; Wallace R; Leder P		Cell	49	1987	465-75	J:46454	3032456
20	Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.		Suda Y; Aizawa S; Hirai S; Inoue T; Furuta Y; Suzuki M; Hirohashi S; Ikawa Y		EMBO J	6	1987	4055-65	J:46455	2832150
21	Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: distinct effects in various tissues.		Tremblay PJ; Pothier F; Hoang T; Tremblay G; Brownstein S; Liszauer A; Jolicoeur P		Mol Cell Biol	9	1989	854-9	J:46456	2540427
23	Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene.		Nielsen LL; Discafani CM; Gurnani M; Tyler RD		Cancer Res	51	1991	3762-7	J:46458	2065330
25	Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.		Guy CT; Cardiff RD; Muller WJ		Mol Cell Biol	12	1992	954-61	J:46460	1312220
26	Evaluation of the wap-ras transgenic mouse as a model system for testing anticancer drugs.		Nielsen LL; Gurnani M; Tyler RD		Cancer Res	52	1992	3733-8	J:46461	1617645
27	Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo.		Medina D; Kittrell FS		Carcinogenesis	14	1993	25-8	J:46462	8425268
28	Development of a nude mouse model of ras-mediated neoplasia using WR21 cells from a transgenic mouse salivary tumor.		Nielsen LL; Gurnani M; Porter G; Trexler S; Emerson D; Tyler RD		In Vivo	8	1994	295-302	J:46463	7803707
29	In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background.		Nielsen LL; Gurnani M; Catino JJ; Tyler RD		Anticancer Res	15	1995	385-92	J:46464	7763010
31	Effect of ascorbic acid on incidence of spontaneous mammary tumors and UV-light-induced skin tumors in mice.		Pauling L		Am J Clin Nutr	54	1991	1252S-1255S	J:634	1962578
32	Effect of the amount of dietary fat on the development of mammary tumors in BALB/c-MTV mice.		Zevenbergen JL; Verschuren PM; Zaalberg J; van Stratum P; Vles RO		Nutr Cancer	17	1992	9-18	J:1469	1574447
33	Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.		Shackleford GM; MacArthur CA; Kwan HC; Varmus HE		Proc Natl Acad Sci U S A	90	1993	740-4	J:3728	8380647
34	Calories, parity, and prolactin influence mammary epithelial kinetics and differentiation and alter mouse mammary tumor risk.		Engelman RW; Day NK; Good RA		Cancer Res	53	1993	1188-94	J:4072	8382558
35	Characterization of mammary plaques in DDD mice congenic for Mtv-2 gene, DDD/1-Mtv-2/Mtv-2.		Matsuzawa A; Kaneko T; Takeda Y; Murakami A; Tsubura A		Jpn J Cancer Res	84	1993	48-54	J:4256	8383648
36	Regulation of endogenous murine mammary tumor virus expression in C57BL mouse lactating mammary glands: transcription of functional mRNA with a block at the translational level.		Vaidya AB; Taraschi NE; Tancin SL; Long CA		J Virol	46	1983	818-28	J:7071	6304344
37	A new locus (Mtv-4) for endogenous mammary tumor virus expression and early mammary tumor development in the SHN mouse strain.		Imai S; Tsubura Y; Hilgers J; Michalides R		J Natl Cancer Inst	71	1983	517-21	J:7178	6310199
38	Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription.		Schoenenberger CA; Andres AC; Groner B; van der Valk M; LeMeur M; Gerlinger P		EMBO J	7	1988	169-75	J:9143	2834201
39	Sequential process of blood-borne lung metastases of spontaneous mammary carcinoma in C3H mice.		Sugino T; Kawaguchi T; Suzuki T		Int J Cancer	55	1993	141-7	J:14583	7688351
40	Mammary tumour induction by pituitary grafting in male mice: an animal model for male breast cancer.		Nagasawa H; Morii S; Furuichi R; Iwai Y; Iwai M; Mori T; Goto Y		Lab Anim	27	1993	358-63	J:15288	8277709
41	Menhaden, coconut, and corn oils and mammary tumor incidence in BALB/c virgin female mice treated with DMBA.		Craig-Schmidt M; White MT; Teer P; Johnson J; Lane HW		Nutr Cancer	20	1993	99-106	J:15439	8233985
42	Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice.		Tsukamoto AS; Grosschedl R; Guzman RC; Parslow T; Varmus HE		Cell	55	1988	619-25	J:28473	3180222
44	Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans.		Bradlow HL; Hershcopf RJ; Martucci CP; Fishman J		Proc Natl Acad Sci U S A	82	1985	6295-9	J:37506	2994069
45	Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.		Takayama H; LaRochelle WJ; Sharp R; Otsuka T; Kriebel P; Anver M ; Aaronson SA ; Merlino G		Proc Natl Acad Sci U S A	94	1997	701-6	J:37771	9012848
47	Heart levels of adriamycin in normal and tumor-bearing mice.		Donelli MG; Martini A; Colombo T; Bossi A; Garattini S		Eur J Cancer	12	1976	913-23	J:38163	991900
50	Induction of invasive squamous cell carcinomas in the forestomach of (C3H x MSM)F1, MSM, and C3H mice by N-methyl-N-nitrosourea and mutational analysis of the H-ras and p53 genes.		Masui T; Tezuka N; Nakanishi H; Inada K; Miyashita N; Tatematsu M		Cancer Lett	111	1997	97-104	J:38729	9022133
52	Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice.		Qing WG; Conti CJ; LaBate M; Johnston D; Slaga TJ; MacLeod MC		Carcinogenesis	18	1997	553-9	J:39127	9067556
54	4-nitroquinoline-1-oxide (4NQO)-induced murine oral cavity carcinogenesis: A paradigm of human head and neck cancer.		Hendler FJ; Yuan B; Heniford BW; Hawkins BL; Oechsli MN; Lentsch EM; Hu LH; Menes JC; Alagar R; ShumSiu A; Ackermann DM				1996	79-87	J:39261	 
55	Induction of graft vs. tumor effect in a murine model of mammary adenocarcinoma.		Morecki S; Moshel Y; Gelfend Y; Pugatsch T; Slavin S		Int J Cancer	71	1997	59-63	J:39355	9096666
56	Dose-dependent induction of both pepsinogen-altered pyloric glands and adenocarcinomas in the glandular stomach of C3H mice treated with N-methyl-N-nitrosourea.		Yamamoto M; Furihata C; Fujimitsu Y; Imai T; Inada K; Nakanishi H ; Tatematsu M		Jpn J Cancer Res	88	1997	238-44	J:39579	9140107
57	Both K-ras and H-ras protooncogene mutations are associated with Harderian gland tumorigenesis in B6C3F1 mice exposed to isoprene for 26 weeks.		Hong HL; Devereux TR; Melnick RL; Eldridge SR; Greenwell A; Haseman J ; Boorman GA ; Sills RC		Carcinogenesis	18	1997	783-9	J:39817	9111215
59	p53 mutations in MeIQ-induced mouse forestomach tumors.		Makino H; Ushijima T; Onda M; Nagao M		Nippon Ika Daigaku Zasshi	64	1997	39-44	J:40110	9119951
62	Rare occurrence of ras and p53 gene mutations in mouse stomach tumors induced by N-methyl-N-nitrosourea.		Furihata C; Tatematsu M; Saito M; Ishida S; Nakanishi H; Inada K ; Tei H ; Hattori M ; Ito T ; Sakaki Y		Jpn J Cancer Res	88	1997	363-8	J:40723	9197527
71	A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.		Yuan B; Oechsli MN; Hendler FJ		Oncogene	15	1997	1161-70	J:42971	9294609
72	A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities.		Mueller A; Odze R; Jenkins TD; Shahsesfaei A; Nakagawa H; Inomoto T; Rustgi AK		Cancer Res	57	1997	5542-9	J:45230	9407965
73	Dose-dependent promoting effects of catechol on glandular stomach carcinogenesis in BALB/c mice initiated with N-methyl-N-nitrosourea		Kobayashi K; Shimizu N; Tsukamoto T; Inada K; Nakanishi H; Goto K; Mutai M; Tatematsu M		Jpn J Cancer Res	88	1997	1143-8	J:45381	9473731
77	Resistance of various inbred strains of mice to tumor homoiotransplants, and its relation to the H-2 allele which each carries				J Natl Cancer Inst	14	1953	485-491		
81	Two-way selection of a stock of Swiss albino mice for mammary tumorigenesis: establishment of two new strains (SHN and SLN).		Nagasawa H; Yanai R; Taniguchi H; Tokuzen R; Nakahara W		J Natl Cancer Inst	57	1976	425-30	J:25446	187774
83	Disease descriptions and incidences		Clapp NK				1973		J:49029	 
84	The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach.		Nakagawa H; Wang TC; Zukerberg L; Odze R; Togawa K; May GH; Wilson J; Rustgi AK		Oncogene	14	1997	1185-90	J:48597	9121767
91	Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas.				J Natl Cancer Inst	50	1973	347-62		
92	Establishment and characterization of BALB/c lymphoma lines with B cell properties.				J Immunol	122	1979	549-54		
98	Plasma gonadotropin levels during early stages of ovarian tumorigenesis in mice of the W x -W v genotype.		Murphy ED; Beamer WG		Cancer Res	33	1973	721-3	J:48589	4696472
99	Spontaneous malignant granulosa cell tumors in ovaries of young SWR mice.		Beamer WG; Hoppe PC; Whitten WK		Cancer Res	45	1985	5575-81	J:34553	4053032
100	Ovarian tumors not induced by irradiation and gonadotropins in hypogonadal (hpg) mice.		Tennent BJ; Beamer WG		Biol Reprod	34	1986	751-60	J:48591	3708055
101	Gonadotropin uptake in genetic and irradiation models of ovarian tumorigenesis.		Beamer WG; Tennent BJ		Biol Reprod	34	1986	761-70	J:48594	3085740
102	Gonadotropin, steroid, and thyroid hormone milieu of young SWR mice bearing spontaneous granulosa cell tumors.		Beamer WG		J Natl Cancer Inst	77	1986	1117-23	J:48593	3095581
103	Induction of ovarian granulosa cell tumors in SWXJ-9 mice with dehydroepiandrosterone.		Beamer WG; Shultz KL; Tennent BJ		Cancer Res	48	1988	2788-92	J:27621	2965969
104	Gene for ovarian granulosa cell tumor susceptibility, Gct, in SWXJ recombinant inbred strains of mice revealed by dehydroepiandrosterone.		Beamer WG; Tennent BJ; Shultz KL; Nadeau JH; Shultz LD; Skow LC		Cancer Res	48	1988	5092-5	J:9301	2970296
105	Epidermal growth factor receptors in spontaneous ovarian granulosa cell tumors of SWR-derived mice.		Tennent BJ; Beamer WG; Shultz LD; Adamson ED		Int J Cancer	44	1989	477-82	J:48592	2789196
106	Ovarian granulosa cell tumorigenesis in SWR-derived F1 hybrid mice: preneoplastic follicular abnormality and malignant disease progression.		Tennent BJ; Shultz KL; Sundberg JP; Beamer WG		Am J Obstet Gynecol	163	1990	625-34	J:48590	2386155
107	Genetic susceptibility for C19 androgen induction of ovarian granulosa cell tumorigenesis in SWXJ strains of mice.		Tennent BJ; Shultz KL; Beamer WG		Cancer Res	53	1993	1059-63	J:4202	8439952
108	Granulosa cell tumorigenesis in genetically hypogonadal-immunodeficient mice grafted with ovaries from tumor-susceptible donors.		Beamer WG; Shultz KL; Tennent BJ; Shultz LD		Cancer Res	53	1993	3741-6	J:14443	8339285
109	Comparison of chemical carcinogen skin tumor induction efficacy in inbred, mutant, and hybrid strains of mice: Morphologic variations of induced tumors and absence of a papillomavirus cocarcinogen.		Sundberg JP; Sundberg BA; Beamer WG		Mol Carcinog	20	1997	19-32	J:43880	9328433
110	Hormone synthesis and responsiveness of spontaneous granulosa cell tumors in (SWR x SWXJ-9) F1 mice.		Gocze PM; Beamer WG; de Jong FH; Freeman DA		Gynecol Oncol	65	1997	143-8	J:48782	9103404
111	Multigenic and imprinting control of ovarian granulosa cell tumorigenesis in mice.		Beamer WG; Shultz KL; Tennent BJ; Nadeau JH; Churchill GA; Eicher EM		Cancer Res	58	1998	3694-9	J:49710	9721880
112	Spontaneous Leydig cell tumors in inbred laboratory mice.		Mahler M; Sundberg JP		Lab Anim Sci	47	1997	148-52	J:45430	9150493
113	Lipomatous hamartomas and choristomas in inbred laboratory mice.		Adkison DL; Sundberg JP		Vet Pathol	28	1991	305-12	J:2714	1949510
114	Forestomach papillomas in flaky skin and steel-Dickie mutant mice.		Sundberg JP; Kenty GA; Beamer WG; Adkison DL		J Vet Diagn Invest	4	1992	312-7	J:2777	1325193
115	Coincidental development of forestomach papilloma and prepyloric ulcer in nontreated mutant mice of W/Wv and SI/SId genotypes.		Kitamura Y; Yokoyama M; Matsuda H; Shimada M		Cancer Res	40	1980	3392-7	J:6393	7000343
116	Induced ovarian and adrenal tumors		Hummel KP		J Natl Cancer Inst	15	1954	711-715	J:50501	13233920
117	Observations on the effect of thymectomy on spontaneous leukemias in mice of the high-leukemic strains, RIL and C58		Law LW; Miller JH		J Natl Cancer Inst	11	1950	253-62	J:2445	14795182
118	The R.I.L. strain of mice. Its relation to the leukemic AK strain and AKR substrains		Lynch CJ		J Natl Cancer Inst	15	1954	161-76	J:2451	13233875
119	Spontaneous tumors and pathologic lesions in SWR-J mice.		Rabstein LS; Peters RL; Spahn GJ		J Natl Cancer Inst	50	1973	751-8	J:25858	4732946
120	Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids.		Smith GS; Walford RL; Mickey MR		J Natl Cancer Inst	50	1973	1195-213	J:22620	4351393
121	Development of tumors, especially mammary tumors, in agent-free strain DBA/2eB mice		Deringer MK		J Natl Cancer Inst	28	1962	203-210	J:2414	13885590
122	High incidence of spontaneous hepatomas and the increase of this incidence with urethan in C3H, C3Hf, and C3He male mice		Heston WE; Vlahakis G; Deringer MK		J Natl Cancer Inst	24	1960	425-435	J:2433	14401531
123	SJL/J, a new inbred strain of mouse with a high, early incidence of reticulum-cell neoplasms		Murphy ED		Proc Am Assoc Cancer Res	4	1963	46 (Abstr.)	J:2463	 
124	Longevity and gross pathology at death in 22 inbred mouse strains.		Storer JB		J Gerontol	21	1966	404-9	J:22621	5944803
125	The effect of subcutaneous inoculation of 4-o-Tolylazo-o-Toluidine in strain HR mice		Deringer MK		J Natl Cancer Inst	17	1956	533-9	J:24688	13367821
126	Occurrence of tumors, particularly mammary tumors, in agent-free strain C3HeB mice		Deringer MK		J Natl Cancer Inst	22	1959	995-1002	J:24689	13655075
127	Strain DD, a new high mammary tumor strain, and comparison of DD with strain C3H		Heston WE; Vlahakis G; Tsubura Y		J Natl Cancer Inst	32	1964	237-51	J:24690	14114970
128	Genetic control by the hr-locus of susceptibility and resistance to leukemia.		Meier H; Myers DD; Huebner RJ		Proc Natl Acad Sci U S A	63	1969	759-66	J:24786	4310515
129	Spontaneous lesions in virgin and retired breeder BALB/c and C57BL/6 mice.		Frith CH; Highman B; Burger G; Sheldon WD		Lab Anim Sci	33	1983	273-86	J:27148	6876733
131	Age-related spontaneous uterine lesions in mice.		Malinin GI; Malinin IM		J Gerontol	27	1972	193-6	J:39983	5060720
132	Inheritance of susceptibility to spontaneous pulmonary tumors in mice		Heston WE		J Natl Cancer Inst	3	1942	79-82	J:50503	 
133	Ovarian tumors induced by a sterilizing steroid		Lipschutz A; Iglesias R; Salinas S		Nature	196	1962	946-948	J:50504	 
134	Neoplasms in the C3H strain and in F1 hybrid mice of two crosses following introduction of extracts and filtrates of leukemic tissues		Law LW; Dunn TB; Boyle PJ		J Natl Cancer Inst	16	1955	495-539	J:50505	13263918
135	Further observations on late somatic effects of radiomimetic chemicals and x-rays in mice		Conklin JW; Upton AC; Christenberry KW		Cancer Res	25	1965	20-28	J:50506	14254989
136	Spontaneous hepatocellular neoplasms and hepatic hemangiosarcomas in several strains of mice.		Frith CH; Wiley L		Lab Anim Sci	32	1982	157-62	J:50507	6281574
137	Characteristic Tumors		Murphy ED				1966	521-62	J:24830	 
138	Genetic and environmental influences on teratocarcinogenesis in mice		Stevens LC; Mackensen JA		J Natl Cancer Inst	27	1961	443-453	J:50508	 
139	Pituitary tumorigenesis in aging female C57BL/6J mice: a light and electron microscopic study.		Schechter JE; Felicio LS; Nelson JF; Finch CE		Anat Rec	199	1981	423-32	J:50509	7258686
140	Animal model of human disease: benign cystic and malignant ovarian teratoma.		Stevens LC		Am J Pathol	85	1976	809-13	J:50510	998739
141	Resistance to skin tumorigenesis by 3-methylcholanthrene in mice susceptible to leukemia.		Duran-Reynals ML; Cook C		J Natl Cancer Inst	52	1974	1001-3	J:50511	4363686
142	Occurrence of mammary tumors, reticular neoplasms, and pulmonary tumors in strain BALB-cAnDe breeding female mice.		Deringer MK		J Natl Cancer Inst	35	1965	1047-52	J:50512	5323146
143	Spontaneous pituitary tumorigenesis and plasma oestradiol in ageing female C57BL/6J mice.		Felicio LS; Nelson JF; Finch CE		Exp Gerontol	15	1980	139-43	J:24262	7190097
144	Primary harderian gland neoplasms in mice.		Sheldon WG; Curtis M; Kodell RL; Weed L		J Natl Cancer Inst	71	1983	61-8	J:48633	6575211
145	Effects of an Rb mutation in the mouse [see comments]		Jacks T; Fazeli A; Schmitt EM; Bronson RT; Goodell MA; Weinberg RA		Nature	359	1992	295-300	J:2511	1406933
146	Tumor spectrum analysis in p53-mutant mice.		Jacks T; Remington L; Williams BO; Schmitt EM; Halachmi S; Bronson RT; Weinberg RA		Curr Biol	4	1994	1-7	J:17728	7922305
147	Targeted disruption of p107: functional overlap between p107 and Rb.		Lee MH; Williams BO; Mulligan G; Mukai S; Bronson RT; Dyson N; Harlow E; Jacks T		Genes Dev	10	1996	1621-32	J:34058	8682293
148	Cooperative tumorigenic effects of germline mutations in Rb and p53.		Williams BO; Remington L; Albert DM; Mukai S; Bronson RT; Jacks T		Nat Genet	7	1994	480-4	J:19542	7951317
149	Retinoblastoma in transgenic mice.		Windle JJ; Albert DM; O'Brien JM; Marcus DM; Disteche CM; Bernards R; Mellon PL		Nature	343	1990	665-9	J:10320	1689463
150	Standardized Nomenclature for Inbred Strains of Mice: eighth listing.		Staats J		Cancer Res	45	1985	945-77	J:50296	3971387
151	Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10.		Sundberg JP; Erickson AA; Roop DR; Binder RL		Cancer Res	54	1994	1344-51	J:17018	7509717
152	Myoepitheliomas in inbred laboratory mice.		Sundberg JP; Hanson CA; Roop DR; Brown KS; Bedigian HG		Vet Pathol	28	1991	313-23	J:22767	1719689
153	Skeletal muscle rhabdomyosarcomas in inbred laboratory mice.		Sundberg JP; Adkison DL; Bedigian HG		Vet Pathol	28	1991	200-6	J:24311	1830433
154	Hemangiomas and hemangiosarcomas in inbred laboratory mice.		Booth CJ; Sundberg JP		Lab Anim Sci	45	1995	497-502	J:30363	8569146
155	Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.		Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ		Cancer Res	58	1998	4314-23	J:50210	9766659
156	Evidence that initiated keratinocytes clonally expand into multiple existing hair follicles during papilloma histogenesis in SENCAR mouse skin.		Binder RL; Gallagher PM; Johnson GR; Stockman SL; Smith BJ; Sundberg JP; Conti CJ		Mol Carcinog	20	1997	151-8	J:43952	9328446
157	Motif-primed polymerase chain reaction-based allelotype of sarcomas induced by 3-methylcholanthrene in interspecific hybrid mice.		Dudley ME; Sundberg JP; Roopenian DC		Oncogene	11	1995	517-24	J:28002	7630636
158	Frequency and histological appearance of adenomas in multiple intestinal neoplasia mice are unaffected by severe combined immunodeficiency (scid) mutation.		Dudley ME; Sundberg JP; Roopenian DC		Int J Cancer	65	1996	249-53	J:31690	8567125
160	Spontaneous vulvar carcinomas in 129/J mice.		Locklear J; Mahler J; Thigpen JE; Goelz MF; Forsythe D		Lab Anim Sci	45	1995	604-6	J:30090	8569168
161	Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.		Donehower LA; Harvey M; Slagle BL; McArthur MJ; Montgomery CA Jr; Butel JS; Bradley A		Nature	356	1992	215-21	J:1999	1552940
162	Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.		Donehower LA; Godley LA; Aldaz CM; Pyle R; Shi YP; Pinkel D; Gray J; Bradley A; Medina D; Varmus HE		Genes Dev	9	1995	882-95	J:24407	7705663
163	Effects of genetic background on tumorigenesis in p53-deficient mice.		Donehower LA; Harvey M; Vogel H; McArthur MJ; Montgomery CA Jr; Park SH; Thompson T; Ford RJ; Bradley A		Mol Carcinog	14	1995	16-22	J:29486	7546219
164	Pten is essential for embryonic development and tumour suppression.		Di Cristofano A; Pesce B; Cordon-Cardo C; Pandolfi PP		Nat Genet	19	1998	348-55	J:49532	9697695
166	Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.		He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G ; Pandolfi PP		Proc Natl Acad Sci U S A	94	1997	5302-7	J:40373	9144232
167	Bax suppresses tumorigenesis and stimulates apoptosis in vivo.		Yin C; Knudson CM; Korsmeyer SJ; Van Dyke T		Nature	385	1997	637-40	J:38331	9024662
168	Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors.		Sabourin CL; Wang QS; Ralston SL; Evans J; Coate J; Herzog CR; Jones SL; Weghorst CM; Kelloff GJ; Lubet RA; You M; Stoner GD		Exp Lung Res	24	1998	499-521	J:50428	9659580
169	Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.		Tober KL; Cannon RE; Spalding JW; Oberyszyn TM; Parrett ML; Rackoff AI; Oberyszyn AS; Tennant RW; Robertson FM		Biochem Biophys Res Commun	247	1998	644-53	J:48326	9647747
171	Photocarcinogenesis and susceptibility to UV radiation in the v-Ha-ras transgenic Tg.AC mouse.		Trempus CS; Mahler JF; Ananthaswamy HN; Loughlin SM; French JE; Tennant RW		J Invest Dermatol	111	1998	445-51	J:49862	9740239
172	Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.		Reitmair AH; Redston M; Cai JC; Chuang TC; Bjerknes M; Cheng H; Hay K; Gallinger S; Bapat B; Mak TW		Cancer Res	56	1996	3842-9	J:34940	8706033
175	Tumor induction and tissue atrophy in mice lacking E2F-1.		Yamasaki L; Jacks T; Bronson R; Goillot E; Harlow E; Dyson NJ		Cell	85	1996	537-48	J:33099	8653789
176	Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors.		McClatchey AI; Saotome I; Mercer K; Crowley D; Gusella JF; Bronson RT; Jacks T		Genes Dev	12	1998	1121-33	J:47282	9553042
177	Cooperative effects of INK4a and ras in melanoma susceptibility in vivo.		Chin L; Pomerantz J; Polsky D; Jacobson M; Cohen C; Cordon-Cardo C; Horner JW 2nd; DePinho RA		Genes Dev	11	1997	2822-34	J:44088	9353252
178	Telomere shortening and tumor formation by mouse cells lacking telomerase RNA [see comments]		Blasco MA; Lee HW; Hande MP; Samper E; Lansdorp PM; DePinho RA ; Greider CW		Cell	91	1997	25-34	J:43517	9335332
179	Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4.		Radany EH; Hong K; Kesharvarzi S; Lander ES; Bishop JM		Proc Natl Acad Sci U S A	94	1997	8664-9	J:42251	9238034
180	Targeted expression of MYCN causes neuroblastoma in transgenic mice.		Weiss WA; Aldape K; Mohapatra G; Feuerstein BG; Bishop JM		EMBO J	16	1997	2985-95	J:41126	9214616
181	Gene interaction and single gene effects in colon tumour susceptibility in mice [see comments]		van Wezel T; Stassen AP; Moen CJ; Hart AA; van der Valk MA; Demant P		Nat Genet	14	1996	468-70	J:36996	8944029
182	Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse.		Fijneman RJ; de Vries SS; Jansen RC; Demant P		Nat Genet	14	1996	465-7	J:36997	8944028
183	Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.		Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH		Cancer Res	56	1996	1775-85	J:33193	8620493
185	Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.		Kitsberg DI; Leder P		Oncogene	13	1996	2507-15	J:37679	9000125
186	A mouse model of human familial adenomatous polyposis.		Yang K; Edelmann W; Fan K; Lau K; Kolli VR; Fodde R; Khan PM; Kucherlapati R; Lipkin M		J Exp Zool	277	1997	245-54	J:38850	9062998
187	Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis.		Smits R; Kartheuser A; Jagmohan-Changur S; Leblanc V; Breukel C ; de Vries A ; van Kranen H ; van Krieken JH ; Williamson S ; Edelmann W ; Kucherlapati R ; KhanPM ; Fodde R		Carcinogenesis	18	1997	321-7	J:39174	9054624
188	DNA copy number changes associated with characteristic LOH in islet cell carcinomas of transgenic mice.		Shi YP; Naik P; Dietrich WF; Gray JW; Hanahan D; Pinkel D		Genes Chromosomes Cancer	19	1997	104-11	J:40588	9172001
189	Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene.		Shibata H; Toyama K; Shioya H; Ito M; Hirota M; Hasegawa S; Matsumoto H ; Takano H ; Akiyama T ; Toyoshima K ; Kanamaru R ; Kanegae Y ; Saito I ; Nakamura Y ; Shiba K ; Noda T		Science	278	1997	120-3	J:43301	9311916
191	Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice.		Wang YA; Elson A; Leder P		Proc Natl Acad Sci U S A	94	1997	14590-5	J:45078	9405657
193	c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.		Otsuka T; Takayama H; Sharp R; Celli G; LaRochelle WJ; Bottaro DP; Ellmore N; Vieira W; Owens JW; Anver M; Merlino G		Cancer Res	58	1998	5157-67	J:50947	9823327
194	High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.		Suzuki A; de la Pompa JL; Stambolic V; Elia AJ; Sasaki T; del Barco Barrantes I ; Ho A ; Wakeham A ; Itie A ; Khoo W ; Fukumoto M ; Mak TW		Curr Biol	8	1998	1169-78	J:50437	9799734
195	Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.		Jacks T; Shih TS; Schmitt EM; Bronson RT; Bernards A; Weinberg RA		Nat Genet	7	1994	353-61	J:18542	7920653
196	Kras-2 alleles, mutations, and lung tumor susceptibility in the mouse--an evaluation.		Fijneman RJ; Ophoff RA; Hart AA; Demant P		Oncogene	9	1994	1417-21	J:17850	8152802
197	Carcinogenicity study of outdoor airborne particulate matter in newborn male NMRI mice.		Heussen GA; van den Berg JH; Dreef-van der Meulen HC; Alink GM		Toxicol Lett	88	1996	23-8	J:37505	8920712
198	Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice.		Sakumi K; Shiraishi A; Shimizu S; Tsuzuki T; Ishikawa T; Sekiguchi M		Cancer Res	57	1997	2415-8	J:41434	9192819
199	Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung.		Prahalad AK; Ross JA; Nelson GB; Roop BC; King LC; Nesnow S ; Mass MJ		Carcinogenesis	18	1997	1955-63	J:44141	9364006
200	Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice.		Yang GY; Liu Z; Seril DN; Liao J; Ding W; Kim S; Bondoc F; Yang CS		Carcinogenesis	18	1997	2361-5	J:45292	9450482
201	Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene.		Lin L; Festing MF; Devereux TR; Crist KA; Christiansen SC; Wang Y; Yang A; Svenson K; Paigen B; Malkinson AM; You M		Exp Lung Res	24	1998	481-97	J:48996	9659579
202	Susceptibility to urethan-induced pulmonary adenomas between A/J and C57BL/6J mice: use of AXB and BXA recombinant inbred lines indicating a three-locus genetic model.		Malkinson AM; Nesbitt MN; Skamene E		J Natl Cancer Inst	75	1985	971-4	J:8075	3863994
203	Rb and p53 gene deletions in lung adenocarcinomas from irradiated and control mice.		Zhang Y; Woloschak GE		Radiat Res	148	1997	81-9	J:41467	9216621
204	Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice.		Yang G; Wang ZY; Kim S; Liao J; Seril DN; Chen X; Smith TJ ; Yang CS		Cancer Res	57	1997	1889-94	J:40425	9157981
205	Lung cancer response following inhaled radon in the A/J and C57BL/6J mouse.		Groch KM; Khan MA; Brooks AL; Saffer JD		Int J Radiat Biol	71	1997	301-8	J:39931	9134020
206	The carcinogenicity of environmental tobacco smoke.		Witschi H; Espiritu I; Peake JL; Wu K; Maronpot RR; Pinkerton KE		Carcinogenesis	18	1997	575-86	J:39409	9067559
207	Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.		Horio Y; Chen A; Rice P; Roth JA; Malkinson AM; Schrump DS		Mol Carcinog	17	1996	217-23	J:38027	8989915
208	Deletion and differential expression of p16INK4a in mouse lung tumors.		Belinsky SA; Swafford DS; Middleton SK; Kennedy CH; Tesfaigzi J		Carcinogenesis	18	1997	115-20	J:38603	9054597
209	Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas.		Lebel M; Webster M; Muller WJ; Royal A; Gauthier J; Mes-Masson AM		Cell Growth Differ	6	1995	1591-600	J:38873	9019164
210	Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors.		Leone-Kabler S; Wessner LL; McEntee MF; D'Agostino RB Jr; Miller MS		Carcinogenesis	18	1997	1163-8	J:41565	9214598
211	Similar incidence of K-ras mutations in lung carcinomas of FVB/N mice and FVB/N mice carrying a mutant p53 transgene.		Shafarenko M; Mahler J; Cochran C; Kisielewski A; Golding E; Wiseman R ; Goodrow T		Carcinogenesis	18	1997	1423-6	J:41667	9230291
212	Tumor progression and cellular differentiation of pulmonary adenocarcinomas in SV40 large T antigen transgenic mice.		Wikenheiser KA; Whitsett JA		Am J Respir Cell Mol Biol	16	1997	713-23	J:41560	9191473
213	Smad4 (homolog of human DPC4) and Smad2 (homolog of human JV18-1): candidates for murine lung tumor resistance and suppressor genes.		Devereux TR; Anna CH; Patel AC; White CM; Festing MF; You M		Carcinogenesis	18	1997	1751-5	J:43006	9328171
214	Genome wide search for genetic damage in p53 transgenic mouse lung tumours reveals consistent loss of chromosome 4.		Wu MC; Sundaresan M; Sundaresan V; Rabbitts P		Eur J Cancer	33	1997	1677-84	J:43698	9389933
218	Ki-ras mutation and cell proliferation of lung lesions induced by 1-nitropyrene in A/J mice.		Bai F; Nakanishi Y; Takayama K; Pei XH; Tokiwa H; Hara N		Mol Carcinog	22	1998	258-64	J:49725	9726818
219	Detection of codon 12 point mutations of the K-ras gene from mouse lung adenocarcinoma by 'enriched' PCR.		Zhang Y; Woloschak GE		Int J Radiat Biol	74	1998	43-51	J:49183	9687974
220	Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers.		Marsella JM; Liu BL; Vaslet CA; Kane AB		Environ Health Perspect	105 Suppl 5	1997	1069-72	J:44660	9400702
221	High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene.		Lavigueur A; Maltby V; Mock D; Rossant J; Pawson T; Bernstein A		Mol Cell Biol	9	1989	3982-91	J:19870	2476668
222	K-ras mutations in benzotrichloride-induced lung tumors of A/J mice.		You M; Wang Y; Nash B; Stoner GD		Carcinogenesis	14	1993	1247-9	J:13107	8508514
223	Oncogenic response of strain A/J mice to inhaled chemicals.		Adkins B Jr; Van Stee EW; Simmons JE; Eustis SL		J Toxicol Environ Health	17	1986	311-22	J:22707	3083111
224	Pulmonary adenomas in A/J mice treated with silica.		McNeill DA; Chrisp CE; Fisher GL		Drug Chem Toxicol	13	1990	87-92	J:22736	2165900
225	Tumorigenicity of nickel subsulfide in Strain A/J mice.		McNeill DA; Chrisp CE; Fisher GL		Drug Chem Toxicol	13	1990	71-86	J:22737	2379474
226	Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.		You M; Candrian U; Maronpot RR; Stoner GD; Anderson MW		Proc Natl Acad Sci U S A	86	1989	3070-4	J:22773	2654935
227	Neoplasms in strains of splenectomized mice after a single 7,12-dimethylbenz[alpha]anthracene treatment.		Akamatsu Y		J Natl Cancer Inst	55	1975	893-7	J:24687	171427
228	Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.		Foster BA; Gingrich JR; Kwon ED; Madias C; Greenberg NM		Cancer Res	57	1997	3325-30	J:42333	9269988
230	Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland.		Wennbo H; Kindblom J; Isaksson OG; Tornell J		Endocrinology	138	1997	4410-5	J:43355	9322957
231	Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice.		Perez-Stable C; Altman NH; Brown J; Harbison M; Cray C; Roos BA		Lab Invest	74	1996	363-73	J:52340	8780156
232	Prostate cancer progression, metastasis, and gene expression in transgenic mice.		Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA		Cancer Res	57	1997	900-6	J:38778	9041192
233	Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.		Maroulakou IG; Anver M; Garrett L; Green JE		Proc Natl Acad Sci U S A	91	1994	11236-40	J:52786	7972041
234	Development and characterization of a mouse prostate adenocarcinoma cell line: ductal formation determined by extracellular matrix.		Jorcyk CL; Liu ML; Shibata MA; Maroulakou IG; Komschlies KL; McPhaul MJ ; Resau JH ; Green JE		Prostate	34	1998	10-22	J:45372	9428383
235	Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth.		Schreiber-Agus N; Meng Y; Hoang T; Hou H Jr; Chen K; Greenberg R; Cordon-Cardo C; Lee HW; DePinho RA		Nature	393	1998	483-7	J:48236	9624006
236	Studies on the relation between tumor susceptibility and heredity. III. Spontaneous tumors of the lung in mice.		Lynch CJ		J Exp Med	43	1926	339-55	J:24654	 
238	Life span of specified-pathogen-free (MRC category 4) mice and rats.		Festing MF; Blackmore DK		Lab Anim	5	1971	179-92	J:22607	5166568
240	Inbred Strains of Mice No. 1		Staats J		Companion to Mouse News Lett No. 21		1959		J:55930	 
241	Inbred Strains of Mice No. 2		Staats J		Companion to Mouse News Lett No. 25		1961		J:55931	 
242	Inbred Strains of Mice No. 3		Staats J		Companion to Mouse News Lett No. 29		1963		J:55932	 
243	Inbred Strains of Mice No. 4		Staats J		Companion to Mouse News Lett No. 33		1965		J:54944	 
244	Inbred Strains of Mice No. 5		Staats J		Companion to Mouse News Lett No. 37		1967		J:55933	 
245	Inbred Strains of Mice No. 6		Staats J		Companion to Mouse News Lett No. 41		1969		J:55166	 
246	Inbred Strains of Mice No. 7		Staats J		Companion to Mouse News Lett No. 45		1971		J:55934	 
247	Inbred Strains of Mice No. 8		Staats J		Companion to Mouse News Lett No. 49		1973		J:55935	 
248	Influence of the H-2 and H-1 histocompatibility systems upon life span and spontaneous cancer incidences in congenic mice		Smith GS; Walford RL			XIV	1978	281-312	J:22760	 
249	Instability of characteristics in inbred strains of mice		Muhlbock O; van Ebbenhorst Tengbergen WP				1971	230-49	J:36410	 
250	Prevalence of murine C-type RNA virus group specific antigen in inbred strains of mice		Myers DD; Meier H; Huebner RJ		Life Sci	9	1970	1071-80	J:22741	 
251	Lifespan and aging patterns		Russell ES				1966	511-519	J:2470	 
252	Spontaneous cancer in mice		Hoag WG		Ann N Y Acad Sci	108	1963	805-831	J:2434	14081516
253	Genetics of Neoplasia		Heston WE				1963	247-68	J:23470	 
254	Genetics of N-methyl-N-nitrosourea induction of thymic lymphomas in AKR/J mice: assignment of a susceptibility gene to mouse chromosome 7.		Angel JM; Morizot DC; Richie ER		J Natl Cancer Inst	81	1989	1652-5	J:10061	2552132
255	Variations among sublines of inbred AKR mice.		Acton RT; Balankenhorn EP; Douglas TC; Owen RD; Hilgers J; Hoffman HA; Boyse EA		Nat New Biol	245	1973	8-10	J:5369	4353891
256	Observations on leukemia in AKR mice born from transferred ova and nursed by low leukemic mothers		Fekete E; Otis HK		Cancer Res	14	1954	445-47	J:2421	13172710
257	Prolongation of life with prevention of leukemia by thymectomy in mice		Furth J		J Gerontol	1	1946	46-54	J:2422	 
258	AL/N: A homozygous Robertsonian translocation mouse strain identical to TlWh.		White BJ; Tjio JH		Cytologia (Tokyo)	40	1975	249-52	J:26457	1157523
259	Susceptibility to Abelson or Moloney murine leukemia viruses.		Risser R; Kaehler D		Curr Top Microbiol Immunol	122	1985	162-8	J:24306	4042674
260	A comparative study of the biologic and molecular basis of murine mammary carcinoma: A model for human breast cancer		Schlom J; Michalides R; Kufe D; Hehlmann R; Spiegelman S; Bentvelzen P; Hgeman P		J Natl Cancer Inst	51	1973	541-51	J:24308	4797259
261	Mammary tumors, plaques, and hyperplastic alveolar nodules in various combinations of mouse inbred strains and the different lines of the mammary tumor virus.		Heston WE; Vlahakis G		Int J Cancer	7	1971	141-8	J:24674	4322934
262	RNA tumor-virus antigen expression in chemically induced tumors. Virus-genome-specified common antigens detected by complement fixation in mouse tumors induced by 3-methylcholanthrene.		Whitmire CE; Salerno RA; Rabstein LS; Huebner RJ; Turner HC		J Natl Cancer Inst	47	1971	1255-65	J:35684	4330465
263	Spontaneous neoplasms in germfree BALB/cPi mice.		Smith CS; Pilgrim HI		Proc Soc Exp Biol Med	138	1971	542-4	J:24310	4330234
264	The susceptibility of various strains of neonatal mice to the carcinogenic effects of 9,10-dimethyl-1,2-benzanthracene.		Flaks A		Eur J Cancer	4	1968	579-85	J:23487	5717955
265	Tumour incidence and tumour-free sublines in BR6 mice		Mundy J; Williams PC		Br J Cancer	15	1961	561-7	J:24879	14477198
266	Neoplasms and amyloidosis in strains of mice treated with 3-methylcholanthrene.		Akamatsu Y; Barton BP		J Natl Cancer Inst	52	1974	377-85	J:24686	4361176
267	Effect of host strain and H-2 type on spontaneous regression of murine leukemia.		Dietz M; Rich MA		Int J Cancer	10	1972	99-104	J:25401	4661563
268	C17-Icrc, a new inbred strain of mouse, useful for studies on environmental carcinogens. Short communication.		Ranadive KJ; Gothoskar SV; Fernandes G		Z Versuchstierkd	14	1972	48-9	J:27978	5029369
269	Incidence of spontaneous tumors in a colony of strain C3H mice		Andervont HB; McEleney WJ		Public Health Rep	52	1937	772-780	J:2394	 
270	Spontaneous tumors in a subline of strain C3H mice		Andervont HB; McEleney WJ		J Natl Cancer Inst	1	1941	737-744	J:2395	 
271	Attempts to alter incidence of leukemia and Mammary cancer in C3H/Fg mice		Fuchs PC		Anat Rec	142	1962	233	J:24576	 
272	Effects on C3H mouse mammary cancer of changing from a high fat to a low fat diet before, at, or after puberty.		Silverman J; Powers J; Stromberg P; Pultz JA; Kent S		Cancer Res	49	1989	3857-60	J:24603	2736528
274	On the oncological characteristics of C3HA mice		Maluguina LL; Prokofieva OG		Vopr Onkol	3	1957	201-7	J:27973	 
275	A new mouse strain susceptible to mammary cancer		Taylor A; McKenna GF		Tex Rep Biol Med	19	1961	706-7	J:24876	13919906
276	Differential susceptibility of four mouse strains to induction of multiple large-bowel neoplasms by 1,2-dimethylhydrazine.		Evans JT; Hauschka TS; Mittelman A		J Natl Cancer Inst	52	1974	999-1000	J:24721	4826576
277	Differences in response among mice of fifteen inbred strains to the subcutaneous injection of methylcholanthrene		Strong LC		Yale J Biol Med	25	1952	34-43	J:22766	13006401
278	Reticulum cell neoplasm, type B, or the Hodgkin's-like lesion of the mouse.		Dunn TB; Deringer MK		J Natl Cancer Inst	40	1968	771-821	J:2417	4869134
279	The genetics of non-epithelial tumor formation in mice		Little CC; Murray WS; Cloudman AM		Am J Cancer	36	1939	431-450	J:2448	 
280	The time factor in inhibition of lymphoid-tumor development by injection of marrow cell suspensions into irradiated C57BL mice		Kaplan HS; Moses LE; Brown MB; Nagareda CS; Hirsch BB		J Natl Cancer Inst	15	1955	975-9	J:26151	13233941
281	Tumours of the bone in C57BL/10J mice.		Wadsworth PF		Lab Anim	23	1989	324-7	J:24844	2811271
282	Relationships between aryl hydrocarbon hydroxylase inducibility and sensitivity to chemically induced subcutaneous sarcomas in various strains of mice.		Kouri RE; Salerno RA; Whitmire CE		J Natl Cancer Inst	50	1973	363-8	J:25838	4702110
283	Effect of pretreatment with beta-naphthoflavone on tumorigenesis by N-nitrosoethylurea in five mouse strains.		Anderson LM; Jones AB; Kovatch RM		Cancer Lett	52	1990	91-4	J:26439	2379139
284	[Age-related incidence of spontaneous tumors in SPF C57BL/6 and BDF1 mice]		Nakamura K; Kuramoto K; Shibasaki K; Shumiya S; Ohtsubo K		Jikken Dobutsu	41	1992	279-85	J:1341	1324182
285	Transplacental effects of 1-ethyl-1-nitrosourea in inbred strains of mice. 3. Association between infectious or subinfectious endogenous type-C RNA tumor virus expression and chemically induced tumorigenesis.		Diwan BA; Meier H; Huebner RJ		J Natl Cancer Inst	51	1973	1965-70	J:24831	4358152
286	Mouse leukemia. XIII. A maternal influence that lowers the incidence of spontaneous cases		MacDowell EC; Taylor MJ		Proc Soc Exp Biol Med	68	1948	571-577	J:2456	 
287	Effects of subcutaneous administration of chemical carcinogens on leukemia in C58 mice.		Whitmire CE		J Natl Cancer Inst	62	1979	555-9	J:32292	216841
288	Comparative molecular genetic analysis of lymphomas from six inbred mouse strains.		Mucenski ML; Bedigian HG; Shull MM; Copeland NG; Jenkins NA		J Virol	62	1988	839-46	J:25442	2828679
289	Production of the CBA strain of inbred mice: Long life associated with low tumour incidence		Strong LC		Br J Exp Pathol	17	1936	60-63	J:2482	 
290	The incidence, pathology and transplantation of hepatomas in CBA mice.		Sharp JG; Riches AC; Littlewood V; Thomas DB		J Pathol	119	1976	211-20	J:24717	182943
291	Identification of a high-frequency model for renal carcinoma by the induction of renal tumors in the mouse with a single dose of streptozotocin.		Hard GC		Cancer Res	45	1985	703-8	J:24857	3155646
292	Biochemical, pathological, and genetic aspects of a spontaneous mouse hepatoma.		Hancock RL; Dickie MM		J Natl Cancer Inst	43	1969	407-15	J:24685	4307863
293	The incidence of adrenal cortical carcinoma in gonadectomized female mice of the extreme dilution strain. 1. Observations on the adrenal cortex		Woolley GW; Little CC		Cancer Res	5	1945	193-202	J:2494	 
294	Mammary tumorigenesis in feral mice: identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors.		Gallahan D; Callahan R		J Virol	61	1987	66-74	J:20073	3023708
295	Histological changes following ovariectomy in mice. I. dba high tumor strain		Fekete E; Woolley G; Little CC		J Exp Med	74	1941	1-8	J:2418	 
296	Mammary tumor development in mice ovariectomized at birth		Woolley G; Fekete E; Little CC		Proc Natl Acad Sci U S A	25	1939	277-79	J:2492	16577897
297	Urethan-induced mammary tumorigenesis in a murine mammary tumor virus (MuMTV)-positive mouse strain: evidence for a keratinized nodule as an MuMTV-negative precursor lesion for squamous cell tumors.		Imai S; Tsubura Y; Hilgers J		J Natl Cancer Inst	73	1984	935-41	J:24723	6090751
298	Addendum II. Standardized nomenclature fo inbred strains of mice		Tajima Y				1966	123-8	J:27823	 
299	Hepatomas in GRS/A male mice treated with horse serum or horse anti-mouse antilymphocyte serum.		Den Engelse L; Misdorp W; Emmelot P		Eur J Cancer	12	1976	101-6	J:24630	177290
300	Development and genetic characteristics of the adenomatous stomach lesion in strain I mice		Andervont HB		Public Health Rep	54	1939	1851-5	J:24848	 
301	Pituitaries of spayed mice of different strains: cytology and gonadotrophin content.		Ranadive KJ; Karande KA		J Endocrinol	48	1970	449-56	J:24671	5480893
302	Tumours of the nervous system in mice treated neonatally with N-ethyl-N-nitrosourea.		Searle CE; Jones EL		Nature	240	1972	559-60	J:27901	4346710
303	Reticular cell hyperplasia and amyloidosis in a line of mice with low leukocyte counts.		Chai CK		Am J Pathol	85	1976	49-72	J:24582	970442
304	Ultrastructure of Ovarian Teratomas in LT mice		Damjanov I; Katic V; Stevens LC		Z Krebsforsch	83	1975	261-7	J:27979	 
305	A genetic analysis of the induction of tumors by methylcholanthrene.  With a note on the origin of the NH strain of mice.		Strong LC		Am J Cancer	39	1940	347-9	J:24585	 
306	Spontaneous granulosa cell tumours in mice of strains NZC-B1, NZO-B1, NZY-B1 and NZB-B1.		Bielschowsky M; D'Ath EF		Pathology	5	1973	303-10	J:27914	4780533
307	Malignant lymphomas arising in Peyer's patches and other organs of untreated NZO-Bl mice.		Rappaport H; Bielschowsky M; D'Ath EF; Goodall CM		Cancer Res	31	1971	2047-53	J:25462	4941087
308	Oncological and survival reference data for NZO-B1 inbred mice.		Goodall CM; Bielschowsky M; Forster DR; D'Ath EF		Lab Anim	7	1973	65-71	J:27172	4685756
309	The origins of some hitherto undescribed inbred mouse strains.		Hall WH; Simpson LO		Lab Anim	9	1975	139-42	J:25460	1142717
310	Characteristics of a new inbred strain of mice (PBA) with a high tumor incidence: preliminary report.		Bailey PC; Leach WB; Hartley MW		J Natl Cancer Inst	45	1970	59-73	J:25458	4194656
311	Methylcholanthrene-induced neoplasms in germ-free RFM mice.		Walburg HE Jr; Cosgrove GE		Int J Cancer	8	1971	338-43	J:25402	5289593
312	A new murine model of accelerated senescence.		Takeda T; Hosokawa M; Takeshita S; Irino M; Higuchi K; Matsushita T; Tomita Y; Yasuhira K; Hamamoto H; Shimizu K; Ishii M; Yamamuro T		Mech Ageing Dev	17	1981	183-94	J:28683	7311623
313	Senescence-accelerated mouse (SAM): a novel murine model of accelerated senescence.		Takeda T; Hosokawa M; Higuchi K		J Am Geriatr Soc	39	1991	911-9	J:21674	1885867
314	Establishment of the TAI and TAII strains of inbred mice and studies on their biological characteristics		Yi L; Bing-shui L; Hua L; Yuying Z; Jiayong L		Mouse News Lett	68	1983	85	J:24748	 
315	Primary and secondary heart tumors in mice maintained on various diets.		Szepsenwol J; Boschetti NV		Oncology	32	1975	58-72	J:25304	1219538
316	Role of the INK4a locus in tumor suppression and cell mortality.		Serrano M; Lee H; Chin L; Cordon-Cardo C; Beach D; DePinho RA		Cell	85	1996	27-37	J:53805	8620534
317	A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.		Garabedian EM; Humphrey PA; Gordon JI		Proc Natl Acad Sci U S A	95	1998	15382-7	J:51704	9860977
318	Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.		Prolla TA; Baker SM; Harris AC; Tsao JL; Yao X; Bronner CE; Zheng B ; Gordon M ; Reneker J ; Arnheim N ; Shibata D ; Bradley A ; Liskay RM		Nat Genet	18	1998	276-9	J:46382	9500552
319	Inhibitory effects of rebamipide on ENNG-induced duodenal carcinogenesis in mice: a possible strategy for chemoprevention of gastrointestinal cancers.		Yamane T; Nakatani H; Matsumoto H; Iwata Y; Kikuoka N; Takahashi T		Dig Dis Sci	43	1998	207S-211S	J:52691	9753252
320	The relationship between 1,2-dimethylhydrazine dose and the induction of colon tumours: tumour development in female SWR mice does not require a K-ras mutational event.		Jackson PE; Cooper DP; O'Connor PJ; Povey AC		Carcinogenesis	20	1999	509-13	J:53531	10190570
321	Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis.		Wang QS; Papanikolaou A; Sabourin CL; Rosenberg DW		Carcinogenesis	19	1998	2001-6	J:51245	9855016
322	Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice.		Fukutake M; Nakatsugi S; Isoi T; Takahashi M; Ohta T; Mamiya S; Taniguchi Y; Sato H; Fukuda K; Sugimura T; Wakabayashi K		Carcinogenesis	19	1998	1939-42	J:51244	9855006
323	Smad3 mutant mice develop metastatic colorectal cancer.		Zhu Y; Richardson JA; Parada LF; Graff JM		Cell	94	1998	703-14	J:49839	9753318
324	No direct correlation between mutant frequencies and cancer incidence induced by MeIQ in various organs of Big Blue mice.		Nagao M; Fujita H; Ochiai M; Wakabayashi K; Sofuni T; Matsushima T; Sugimura T; Ushijima T		Mutat Res	400	1998	251-7	J:49727	9685668
325	Longevity, stress response, and cancer in aging telomerase-deficient mice.		Rudolph KL; Chang S; Lee HW; Blasco M; Gottlieb GJ; Greider C; DePinho RA		Cell	96	1999	701-12	J:53350	10089885
326	Homeosis and intestinal tumours in Cdx2 mutant mice.		Chawengsaksophak K; James R; Hammond VE; Kontgen F; Beck F		Nature	386	1997	84-7	J:38772	9052785
327	Induction of aberrant crypts in murine colon with varying sensitivity to colon carcinogenesis.		Rosenberg DW; Liu Y		Cancer Lett	92	1995	209-14	J:28367	7600532
328	Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis.		Mahler M; Bristol IJ; Leiter EH; Workman AE; Birkenmeier EH; Elson CO; Sundberg JP		Am J Physiol	274	1998	G544-51	J:46553	9530156
329	Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis.		Kurimasa A; Ouyang H; Dong LJ; Wang S; Li X; Cordon-Cardo C; Chen DJ; Li GC		Proc Natl Acad Sci U S A	96	1999	1403-8	J:53765	9990036
330	Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.		Wilson CL; Heppner KJ; Labosky PA; Hogan BL; Matrisian LM		Proc Natl Acad Sci U S A	94	1997	1402-7	J:38609	9037065
331	Somatic genetic events linked to the Apc locus in intestinal adenomas of the Min mouse.		Luongo C; Dove WF		Genes Chromosomes Cancer	17	1996	194-8	J:37497	8946200
332	Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice.		Pierre F; Perrin P; Champ M; Bornet F; Meflah K; Menanteau J		Cancer Res	57	1997	225-8	J:38422	9000559
333	Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status.		Dove WF; Clipson L; Gould KA; Luongo C; Marshall DJ; Moser AR; Newton MA; Jacoby RF		Cancer Res	57	1997	812-4	J:38777	9041176
334	Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice.		Wasan HS; Novelli M; Bee J; Bodmer WF		Proc Natl Acad Sci U S A	94	1997	3308-13	J:39278	9096389
335	Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.		Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD		Cancer Res	57	1997	1638-43	J:40133	9134999
336	2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice.		Steffensen IL; Paulsen JE; Eide TJ; Alexander J		Carcinogenesis	18	1997	1049-54	J:40366	9163695
337	Somatic mutational mechanisms involved in intestinal tumor formation in Min mice.		Shoemaker AR; Luongo C; Moser AR; Marton LJ; Dove WF		Cancer Res	57	1997	1999-2006	J:40435	9157997
338	R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.		Wechter WJ; Kantoci D; Murray ED Jr; Quiggle DD; Leipold DD; Gibson KM ; McCracken JD		Cancer Res	57	1997	4316-24	J:43175	9331093
339	The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.		Mahmoud NN; Boolbol SK; Dannenberg AJ; Mestre JR; Bilinski RT; Martucci C; Newmark HL; Chadburn A; Bertagnolli MM		Carcinogenesis	19	1998	87-91	J:45638	9472698
340	Expression of the gut-enriched Kruppel-like factor gene during development and intestinal tumorigenesis.		Ton-That H; Kaestner KH; Shields JM; Mahatanankoon CS; Yang VW		FEBS Lett	419	1997	239-43	J:45361	9428642
341	A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse.		Paulsen JE; Elvsaas IK; Steffensen IL; Alexander J		Carcinogenesis	18	1997	1905-10	J:45978	9363998
342	Pathobiology of the senescence-accelerated mouse (SAM).		Takeda T; Matsushita T; Kurozumi M; Takemura K; Higuchi K; Hosokawa M		Exp Gerontol	32	1997	117-27	J:38979	9088909
343	Comparison of tumorigenesis between accelerated heavy ion and X-ray in B6C3F1 mice.		Watanabe H; Ogiu T; Nishimura M; Masaoka Y; Kurosumi M; Takahashi T; Oguri T; Shoji S; Katoh O		J Radiat Res (Tokyo)	39	1998	93-100	J:49720	9735597
344	Mouse model for malignant juvenile ovarian granulosa cell tumors.		Beamer WG; Shultz KL; Tennent BJ; Azumi N; Sundberg JP		Toxicol Pathol	26	1998	704-10	J:50568	9789961
345	Induction of ovarian tumors by heavy ion irradiation in B6C3F1 mice.		Watanabe H; Ogiu T; Nishizaki M; Fujimoto N; Kido S; Ishimura Y; Shiraki K; Kuramoto K; Hirata S; Shoji S; Katoh O		Oncol Rep	5	1998	1377-80	J:51451	9769371
346	Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction.		St. John MA; Tao W; Fei X; Fukumoto R; Carcangiu ML; Brownstein DG; Parlow AF; McGrath J; Xu T		Nat Genet	21	1999	182-6	J:52536	9988269
347	Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen.		Diwan BA; Anderson LM; Ward JM		Carcinogenesis	18	1997	2009-14	J:45982	9364013
348	Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.		Kananen K; Rilianawati; Paukku T; Markkula M; Rainio EM; Huhtanemi I		Endocrinology	138	1997	3521-31	J:42412	9231807
349	Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines.		Kananen K; Markkula M; Rainio E; Su JG; Hsueh AJ; Huhtaniemi IT		Mol Endocrinol	9	1995	616-27	J:25047	7565808
350	Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice.		Matzuk MM; Finegold MJ; Su JG; Hsueh AJ; Bradley A		Nature	360	1992	313-9	J:3315	1448148
351	Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.		Hanahan D		Nature	315	1985	115-22	J:50695	2986015
352	Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.		Bergers G; Javaherian K; Lo KM; Folkman J; Hanahan D		Science	284	1999	808-12	J:54512	10221914
353	Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells.		Perl AK; Dahl U; Wilgenbus P; Cremer H; Semb H; Christofori G		Nat Med	5	1999	286-91	J:53305	10086383
354	Festing's Listing of Inbred Strains of Mice and Rats		Festing MFW				1998			
355	Targeting T cells against brain tumors with a bispecific ligand-antibody conjugate.		Roy EJ; Cho BK; Rund LA; Patrick TA; Kranz DM		Int J Cancer	76	1998	761-6	J:47765	9610737
356	Bax-deficient mice with lymphoid hyperplasia and male germ cell death.		Knudson CM; Tung KS; Tourtellotte WG; Brown GA; Korsmeyer SJ		Science	270	1995	96-9	J:29253	7569956
357	p53-dependent apoptosis suppresses tumor growth and progression in vivo.		Symonds H; Krall L; Remington L; Saenz-Robles M; Lowe S; Jacks T; Van Dyke T		Cell	78	1994	703-11	J:55471	8069917
358	Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice.		Weissenberger J; Steinbach JP; Malin G; Spada S; Rulicke T; Aguzzi A		Oncogene	14	1997	2005-13	J:40335	9160879
359	Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.		Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A		Am J Pathol	154	1999	581-90	J:52816	10027415
360	Altered neural cell fates and medulloblastoma in mouse patched mutants.		Goodrich LV; Milenkovic L; Higgins KM; Scott MP		Science	277	1997	1109-13	J:42441	9262482
361	Failure of central nervous system myelination in MBP/c-myc transgenic mice: evidence for c-myc cytotoxicity.		Jensen NA; Pedersen KM; Celis JE; West MJ		Oncogene	16	1998	2123-9	J:47290	9572493
362	Studies on the pathology, especially brain lesions, induced by R7, a spontaneous mutant of Moloney murine sarcoma virus 124.		Yuen PH; Kwak YT		Am J Pathol	152	1998	1509-20	J:47992	9626055
364	Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus.		Uhrbom L; Hesselager G; Nister M; Westermark B		Cancer Res	58	1998	5275-9	J:51373	9850047
365	Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals.		Krynska B; Otte J; Franks R; Khalili K; Croul S		Oncogene	18	1999	39-46	J:52961	9926918
366	Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction.		Liao MJ; Yin C; Barlow C; Wynshaw-Boris A; van Dyke T		Mol Cell Biol	19	1999	3095-102	J:53932	10082576
367	Atm-deficient mice: a paradigm of ataxia telangiectasia.		Barlow C; Hirotsune S; Paylor R; Liyanage M; Eckhaus M; Collins F; Shiloh Y; Crawley JN; Ried T; Tagle D; Wynshaw-Boris A		Cell	86	1996	159-71	J:34193	8689683
368	IgH intronic enhancer element HE2 (mu B) functions as a cis-activator in choroid plexus cells at the cellular level as well as in transgenic mice.		Enjoji M; Iwaki T; Nawata H; Watanabe T		J Neurochem	64	1995	961-6	J:51727	7861178
369	Molecular phenotype of simian virus 40 large T antigen-induced primitive neuroectodermal tumors in four different lines of transgenic mice.		Fung KM; Chikaraishi DM; Suri C; Theuring F; Messing A; Albert DM; Lee VM; Trojanowski JQ		Lab Invest	70	1994	114-24	J:54625	7508007
370	Tissue-specific inactivation of p53 tumor suppression in the mouse.		Bowman T; Symonds H; Gu L; Yin C; Oren M; Van Dyke T		Genes Dev	10	1996	826-35	J:54288	8846919
371	Metastasizing neuroblastomas in mice transgenic for simian virus 40 large T (SV40T) under the olfactory marker protein gene promoter.		Servenius B; Vernachio J; Price J; Andersson LC; Peterson PA		Cancer Res	54	1994	5198-205	J:54269	7923140
372	Immortalization of neuroendocrine pinealocytes from transgenic mice by targeted tumorigenesis using the tryptophan hydroxylase promoter.		Son JH; Chung JH; Huh SO; Park DH; Peng C; Rosenblum MG; Chung YI; Joh TH		Brain Res Mol Brain Res	37	1996	32-40	J:54266	8738133
374	Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus.		Li S; Washburn KA; Moore R; Uno T; Teng C; Newbold RR; McLachlan JA ; Negishi M		Cancer Res	57	1997	4356-9	J:43174	9331098
375	Endocrine defects in mice carrying a null mutation for the progesterone receptor gene.		Chappell PE; Lydon JP; Conneely OM; O'Malley BW; Levine JE		Endocrinology	138	1997	4147-52	J:43352	9322923
376	Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.		Lydon JP; DeMayo FJ; Funk CR; Mani SK; Hughes AR; Montgomery CA Jr; Shyamala G; Conneely OM; O'Malley BW		Genes Dev	9	1995	2266-78	J:28980	7557380
377	Uterine carcinoma in mice treated neonatally with tamoxifen.		Newbold RR; Jefferson WN; Padilla-Burgos E; Bullock BC		Carcinogenesis	18	1997	2293-8	J:45290	9450472
378	Effects of tamoxifen on endometrial carcinogenesis in mice.		Niwa K; Morishita S; Hashimoto M; Itoh T; Fujimoto J; Mori H; Tamaya T		Jpn J Cancer Res	89	1998	502-9	J:48614	9685853
379	Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol.		Newbold RR; Hanson RB; Jefferson WN; Bullock BC; Haseman J; McLachlan JA		Carcinogenesis	19	1998	1655-63	J:50278	9771938
380	Apoptotic cell death in artificially induced deciduoma of pseudopregnant mice.		Hirabayashi H; Sato T; Kohno S; Tanaka M; Kobayashi S; Ohta Y; Iguchi T		Anat Rec	254	1999	205-13	J:52883	9972805
381	A murine renal cell carcinoma.		Murphy GP; Hrushesky WJ		J Natl Cancer Inst	50	1973	1013-25	J:53747	4703766
382	Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice.		Ansar S; Iqbal M; Athar M		Carcinogenesis	20	1999	599-606	J:54799	10223187
383	Development and progression of psoriasiform dermatitis and systemic lesions in the flaky skin (fsn) mouse mutant.		Sundberg JP; France M; Boggess D; Sundberg BA; Jenson AB; Beamer WG; Shultz LD		Pathobiology	65	1997	271-86	J:44913	9459497
384	N-methyl-N-nitrosourea concentration-dependent, rather than total intake-dependent, induction of adenocarcinomas in the glandular stomach of BALB/c mice.		Yamachika T; Nakanishi H; Inada K; Tsukamoto T; Shimizu N; Kobayashi K; Fukushima S; Tatematsu M		Jpn J Cancer Res	89	1998	385-91	J:47856	9617343
385	Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin.		Singh SV; Hu X; Srivastava SK; Singh M; Xia H; Orchard JL; Zaren HA		Carcinogenesis	19	1998	1357-60	J:50132	9744529
386	High incidence of esophageal cancer in esophageal achalasia by the oral administration of N-amyl-N-methylnitrosamine and its prevention by nicardipine hydrochloride in mice.		Kurooka M; Hongyo T; Nakajima H; Baskar R; Li LY; Fukuda K; Sutoh K; Miyata M; Matsuda H; Nomura T		Cancer Lett	127	1998	55-61	J:48901	9619858
387	Effect of photodynamic therapy using 5-aminolevulinic acid on 4-nitroquinoline-1-oxide-induced premalignant and malignant lesions of mouse tongue.		Ma G; Ikeda H; Inokuchi T; Sano K		Oral Oncol	35	1999	120-4	J:51425	10211320
388	Loss of function of Trp53, but not Apc, leads to the development of esophageal adenocarcinoma in mice with jejunoesophageal reflux.		Fein M; Peters JH; Baril N; McGarvey M; Chandrasoma P; Shibata D ; Laird PW ; Skinner KA		J Surg Res	83	1999	48-55	J:55225	10210642
390	Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.		Dunn SE; Kari FW; French J; Leininger JR; Travlos G; Wilson R ; Barrett JC		Cancer Res	57	1997	4667-72	J:43765	9354418
391	Genetic instability and p53 mutations in metastatic foci of mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.		Yamamoto S; Chen T; Murai T; Mori S; Morimura K; Oohara T; Makino S; Tatematsu M; Wanibuchi H; Fukushima S		Carcinogenesis	18	1997	1877-82	J:44140	9363994
392	Clonal analysis of urothelial carcinomas in C3H/HeN<-->BALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.		Yamamoto S; Tatematsu M; Yamamoto M; Fukami H; Fukushima S		Carcinogenesis	19	1998	855-60	J:47713	9635874
393	p16 gene overexpression in mouse bladder carcinomas.		Asamoto M; Hori T; Baba-Toriyama H; Sano M; Takahashi S; Tsuda H; Shirai T		Cancer Lett	127	1998	9-13	J:47839	9619852
394	High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.		Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H ; Yoshitake A ; Wanibuchi H ; Koide A ; Mori Y ; Fukushima S		Cancer Res	58	1998	3806-11	J:49595	9731488
395	Possible rare involvement of O6-methylguanine formation as a significant mutational factor in mouse urinary bladder carcinogenesis models.		Chen T; Yamamoto S; Kitano M; Murai T; Wanibuchi H; Matsukuma S ; Nakatsuru Y ; Ishikawa T ; Fukushima S		Teratog Carcinog Mutagen	18	1998	101-10	J:49732	9728794
396	The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.		Elkin M; Ayesh S; Schneider T; de Groot N; Hochberg A; Ariel I		Carcinogenesis	19	1998	2095-9	J:51847	9886562
397	Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.		Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR		Cancer Res	59	1999	3512-7	J:56305	10416618
398	Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice.		Kondo Y; Himeno S; Endo W; Mita M; Suzuki Y; Nemoto K; Akimoto M; Lazo JS; Imura N		Carcinogenesis	20	1999	1625-7	J:56770	10426817
399	v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid.		Leder A; Kuo A; Cardiff RD; Sinn E; Leder P		Proc Natl Acad Sci U S A	87	1990	9178-82	J:55016	2251261
400	Kinetics of wound-induced v-Ha-ras transgene expression and papilloma development in transgenic Tg.AC mice.		Cannon RE; Spalding JW; Trempus CS; Szczesniak CJ; Virgil KM; Humble MC; Tennant RW		Mol Carcinog	20	1997	108-14	J:44372	9328441
401	Hemizygous Tg.AC transgenic mouse as a potential alternative to the two-year mouse carcinogenicity bioassay: evaluation of husbandry and housing factors.		Holden HE; Stoll RE; Spalding JW; Tennant RW		J Appl Toxicol	18	1998	19-24	J:46478	9526830
402	Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.		Owens DM; Spalding JW; Tennant RW; Smart RC		Cancer Res	55	1995	3171-8	J:57352	7606738
403	Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice.		Hansen LA; Trempus CS; Mahler JF; Tennant RW		Carcinogenesis	17	1996	1825-33	J:55156	8824502
404	Lactation-induced WAP-SV40 Tag transgene expression in C57BL/6J mice leads to mammary carcinoma.		Husler MR; Kotopoulis KA; Sundberg JP; Tennent BJ; Kunig SV; Knowles BB		Transgenic Res	7	1998	253-63	J:53175	9859214
405	Precocious mammary gland development in P-cadherin-deficient mice.		Radice GL; Ferreira-Cornwell MC; Robinson SD; Rayburn H; Chodosh LA; Takeichi M; Hynes RO		J Cell Biol	139	1997	1025-32	J:44359	9362520
406	Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation [see comments]		Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L ; Wynshaw-Boris A ; Deng CX		Nat Genet	22	1999	37-43	J:54533	10319859
407	A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.		Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS		Cancer Res	59	1999	1869-76	J:54215	10213494
408	Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis.		Jones JM; Attardi L; Godley LA; Laucirica R; Medina D; Jacks T ; Varmus HE ; Donehower LA		Cell Growth Differ	8	1997	829-38	J:43335	9269892
409	Heterozygosity of p21WAF1/CIP1 enhances tumor cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer model.		Jones JM; Cui XS; Medina D; Donehower LA		Cell Growth Differ	10	1999	213-22	J:54464	10319991
411	A transgenic mouse model for mammary carcinogenesis.		Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM		Oncogene	16	1998	997-1007	J:46426	9519874
412	neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.		Li B; Rosen JM; McMenamin-Balano J; Muller WJ; Perkins AS		Mol Cell Biol	17	1997	3155-63	J:40336	9154814
413	Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands.		Jhappan C; Gallahan D; Stahle C; Chu E; Smith GH; Merlino G; Callahan R		Genes Dev	6	1992	345-55	J:11644	1372276
419	Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.		Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ		Proc Natl Acad Sci U S A	89	1992	10578-82	J:56332	1359541
420	Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy.		Thompson JA; Eades-Perner AM; Ditter M; Muller WJ; Zimmermann W		Int J Cancer	72	1997	197-202	J:41380	9212243
422	Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.		Muller WJ; Sinn E; Pattengale PK; Wallace R; Leder P		Cell	54	1988	105-15	J:48632	2898299
423	Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.		Lifsted T; Le Voyer T; Williams M; Muller W; Klein-Szanto A; Buetow KH ; Hunter KW		Int J Cancer	77	1998	640-4	J:48854	9679770
424	The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.		Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM		Cancer Res	58	1998	5500-6	J:51367	9850086
429	Mammary tumor formation in p53- and BRCA1-deficient mice.		Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH		Cell Growth Differ	10	1999	1-10	J:52011	9950212
430	Spontaneous lesions in aging FVB/N mice.		Mahler JF; Stokes W; Mann PC; Takaoka M; Maronpot RR		Toxicol Pathol	24	1996	710-6	J:38438	8994298
431	Consistent allelic loss on mouse chromosome 7 distal to tyrosinase in 4-nitroquinoline-1-oxide-induced oral cavity tumors with loss of heterozygosity at Ha-ras-1.		Yuan B; Hu LH; Lentsch EM; Shum-Siu A; Hendler FJ		Mol Carcinog	19	1997	8-16	J:41289	9180923
432	p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions.		Kalkuhl A; Troppmair J; Buchmann A; Stinchcombe S; Buenemann CL ; Rapp UR ; Kaestner K ; Schwarz M		Hepatology	27	1998	1081-8	J:47091	9537449
433	Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.		Fan CY; Pan J; Usuda N; Yeldandi AV; Rao MS; Reddy JK		J Biol Chem	273	1998	15639-45	J:48180	9624157
434	Three for the price of one knockout--a mouse model of a congenital peroxisomal disorder, steatohepatitis, and hepatocarcinogenesis.		Bass NM		Hepatology	29	1999	606-8	J:53006	9918944
435	Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression.		Bhaumik M; Harris T; Sundaram S; Johnson L; Guttenplan J; Rogler C; Stanley P		Cancer Res	58	1998	2881-7	J:48441	9661906
436	Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions.		Wastl UM; Rossmanith W; Lang MA; Camus-Randon AM; Grasl-Kraupp B; Bursch W; Schulte-Hermann R		Mol Carcinog	22	1998	229-34	J:49724	9726815
437	Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.		Onda H; Lueck A; Marks PW; Warren HB; Kwiatkowski DJ		J Clin Invest	104	1999	687-95	J:57631	10491404
438	Expression of an IL-1 receptor antagonist during mouse hepatocarcinogenesis demonstrated by differential display analysis.		Yamada Y; Karasaki H; Matsushima K; Lee GH; Ogawa K		Lab Invest	79	1999	1059-67	J:57642	10496524
439	Differential expression of c-jun and c-myc in N-nitroso diethylamine-induced hepatic oncogenesis in AKR mice.		Giri RK; Das BR		Cancer Lett	109	1996	121-7	J:38015	9020911
440	Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors [see comments]		Ushijima T; Morimura K; Hosoya Y; Okonogi H; Tatematsu M; Sugimura T ; Nagao M		Proc Natl Acad Sci U S A	94	1997	2284-9	J:39735	9122186
441	High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32.		Temme A; Buchmann A; Gabriel HD; Nelles E; Schwarz M; Willecke K		Curr Biol	7	1997	713-6	J:42938	9285723
442	Chronic toxicity studies of piperonyl butoxide in CD-1 mice: induction of hepatocellular carcinoma.		Takahashi O; Oishi S; Fujitani T; Tanaka T; Yoneyama M		Toxicology	124	1997	95-103	J:46037	9457999
443	Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene.		Gressani KM; Rollins LA; Leone-Kabler S; Cline JM; Miller MS		Carcinogenesis	19	1998	1045-52	J:48303	9667743
444	Tumorigenesis in F1 offspring mice following paternal 12.5 cGy 252Cf fission neutron irradiation.		Shoji S; Masaoka Y; Kurosumi M; Katoh O; Watanabe H		Oncol Rep	5	1998	1175-8	J:50313	9683830
445	Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice.		Shiota G; Harada K; Ishida M; Tomie Y; Okubo M; Katayama S; Ito H; Kawasaki H		Carcinogenesis	20	1999	59-63	J:52891	9934850
446	Tumor-promoting activities of hydroquinone and 1,1-dimethylhydrazine after initiation of newborn mice with 1-methyl-1-nitrosourea.		Tamura T; Shibutani M; Toyoda K; Shoda T; Takada K; Uneyama C; Takahashi M; Hirose M		Cancer Lett	143	1999	71-80	J:57141	10465340
447	Tumorigenicity and liver tumor ras-protooncogene mutations in CD-1 mice treated neonatally with 1- and 3-nitrobenzo[a]pyrene and their trans-7,8-dihydrodiol and aminobenzo[a]pyrene metabolites.		Von Tungeln LS; Xia Q; Bucci T; Heflich RH; Fu PP		Cancer Lett	137	1999	137-43	J:57209	10374834
448	Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice.		Christensen JG; Romach EH; Healy LN; Gonzales AJ; Anderson SP; Malarkey DE; Corton JC; Fox TR; Cattley RC; Goldsworthy TL		Carcinogenesis	20	1999	1583-90	J:57412	10426811
449	Methylcholanthrene-induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expression.		Engel AM; Svane IM; Mouritsen S; Rygaard J; Clausen J; Werdelin O		APMIS	104	1996	629-39	J:37948	8972687
450	p53 gene mutation and loss of heterozygosity of chromosome 11 in methylcholanthrene-induced mouse sarcomas.		Shimokado K; Watanabe H; Sumii M; Miyagawa K; Kamiya K; Dohi K ; Niwa O		Jpn J Cancer Res	89	1998	269-77	J:47139	9600120
451	Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome [see comments]		Hahn H; Wojnowski L; Zimmer AM; Hall J; Miller G; Zimmer A		Nat Med	4	1998	619-22	J:47421	9585239
452	Loss of one but not two mdm2 null alleles alters the tumour spectrum in p53 null mice.		McDonnell TJ; Montes de Oca Luna R; Cho S; Amelse LL; Chavez-Reyes A; Lozano G		J Pathol	188	1999	322-8	J:56319	10419603
453	Radiographic features of bone in several strains of laboratory mice and of their tumours induced by bone-seeking radionuclides.		Loutit JF; Corp MJ; Ardran GM		J Anat	122	1976	357-75	J:58169	1069700
454	Naturally occurring bone tumors in C57BL-Lcrf mice.		Franks LM; Rowlatt C; Chesterman FC		J Natl Cancer Inst	50	1973	431-8	J:41482	4121930
455	Osteosarcomas in BALB/c female mice.		Frith CH; Johnson BP; Highman B		Lab Anim Sci	32	1982	60-3	J:41414	6952039
456	Activation of H-ras is prevalent in 1,3-butadiene-induced and spontaneously occurring murine Harderian gland tumors.		Goodrow TL; Nichols WW; Storer RD; Anderson MW; Maronpot RR		Carcinogenesis	15	1994	2665-7	J:48630	7955123
457	Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA.		de Vries A; van Oostrom CT; Hofhuis FM; Dortant PM; Berg RJ; de Gruijl FR; Wester PW; van Kreijl CF; Capel PJ; van Steeg H; Verbeek SJ		Nature	377	1995	169-73	J:28710	7675086
458	Ultraviolet-B induced hyperplasia and squamous cell carcinomas in the cornea of XPA-deficient mice.		De Vries A; Gorgels TG; Berg RJ; Jansen GH; Van Steeg H		Exp Eye Res	67	1998	53-9	J:49319	9702178
459	p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone.		Duddy SK; Parker RF; Bleavins MR; Gough AW; Rowse PE; Gorospe S; Dethloff LA; de la Iglesia FA		Toxicol Appl Pharmacol	156	1999	106-12	J:55234	10198275
460	Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.		Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T		Nat Genet	18	1998	360-4	J:47108	9537419
463	Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis [see comments]		Lee EY; Chang CY; Hu N; Wang YC; Lai CC; Herrup K; Lee WH; Bradley A		Nature	359	1992	288-94	J:2516	1406932
464	Requirement for a functional Rb-1 gene in murine development [see comments]		Clarke AR; Maandag ER; van Roon M; van der Lugt NM; van der Valk M; Hooper ML; Berns A; te Riele H		Nature	359	1992	328-30	J:2498	1406937
468	A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.		Fodde R; Edelmann W; Yang K; van Leeuwen C; Carlson C; Renault B; Breukel C; Alt E; Lipkin M; Khan PM; Kucherlapati R		Proc Natl Acad Sci U S A	91	1994	8969-73	J:20443	8090754
470	A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.		Moser AR; Pitot HC; Dove WF		Science	247	1990	322-4	J:10209	2296722
471	Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.		Oshima M; Oshima H; Kitagawa K; Kobayashi M; Itakura C; Taketo M		Proc Natl Acad Sci U S A	92	1995	4482-6	J:25200	7753829
472	Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene [published erratum appears in Science 1992 May 22;256(5060):1114]		Su LK; Kinzler KW; Vogelstein B; Preisinger AC; Moser AR; Luongo C; Gould KA; Dove WF		Science	256	1992	668-70	J:830	1350108
473	Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development.		Smits R; Kielman MF; Breukel C; Zurcher C; Neufeld K; Jagmohan-Changur S; Hofland N; van Dijk J; White R; Edelmann W; Kucherlapati R; Khan PM; Fodde R		Genes Dev	13	1999	1309-21	J:55416	10346819
474	Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts.		Smits R; van der Houven van Oordt W; Luz A; Zurcher C; Jagmohan-Changur S ; Breukel C ; Khan PM ; Fodde R		Gastroenterology	114	1998	275-83	J:46025	9453487
475	Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.		Clarke AR; Cummings MC; Harrison DJ		Oncogene	11	1995	1913-20	J:29664	7478622
476	Thymocyte apoptosis induced by p53-dependent and independent pathways [see comments]		Clarke AR; Purdie CA; Harrison DJ; Morris RG; Bird CC; Hooper ML; Wyllie AH		Nature	362	1993	849-52	J:60008	8479523
477	Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis.		Yang K; Edelmann W; Fan K; Lau K; Leung D; Newmark H; Kucherlapati R; Lipkin M		Cancer Res	58	1998	5713-7	J:51518	9865728
478	Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis [see comments]		Cormier RT; Hong KH; Halberg RB; Hawkins TL; Richardson P; Mulherkar R ; Dove WF ; Lander ES		Nat Genet	17	1997	88-91	J:42722	9288104
479	Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice.		Gould KA; Dietrich WF; Borenstein N; Lander ES; Dove WF		Genetics	144	1996	1769-76	J:37224	8978062
480	A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice.		Shoemaker AR; Moser AR; Midgley CA; Clipson L; Newton MA; Dove WF		Proc Natl Acad Sci U S A	95	1998	10826-31	J:49809	9724789
481	Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene.		Harada N; Tamai Y; Ishikawa T; Sauer B; Takaku K; Oshima M; Taketo MM		EMBO J	18	1999	5931-42	J:58367	10545105
482	De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin.		Gat U; DasGupta R; Degenstein L; Fuchs E		Cell	95	1998	605-14	J:51296	9845363
483	Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice.		Oshima H; Oshima M; Kobayashi M; Tsutsumi M; Taketo MM		Cancer Res	57	1997	1644-9	J:40134	9135000
484	Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).		Oshima M; Dinchuk JE; Kargman SL; Oshima H; Hancock B; Kwong E; Trzaskos JM; Evans JF; Taketo MM		Cell	87	1996	803-9	J:36816	8945508
485	Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.		de Wind N; Dekker M; Berns A; Radman M; te Riele H		Cell	82	1995	321-30	J:27469	7628020
486	MSH2 deficient mice are viable and susceptible to lymphoid tumours.		Reitmair AH; Schmits R; Ewel A; Bapat B; Redston M; Mitri A; Waterhouse P; Mittrucker HW; Wakeham A; Liu B; Thomason A; Griesser H; Gallinger S; Ballhausen WG; Fishel R; Mak TW		Nat Genet	11	1995	64-70	J:28397	7550317
487	Mouse models for hereditary nonpolyposis colorectal cancer.		de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H		Cancer Res	58	1998	248-55	J:45433	9443401
488	Mammalian MutS homologue 5 is required for chromosome pairing in meiosis.		Edelmann W; Cohen PE; Kneitz B; Winand N; Lia M; Heyer J; Kolodner R; Pollard JW; Kucherlapati R		Nat Genet	21	1999	123-7	J:51921	9916805
489	Mutation in the mismatch repair gene Msh6 causes cancer susceptibility.		Edelmann W; Yang K; Umar A; Heyer J; Lau K; Fan K; Liedtke W ; Cohen PE ; Kane MF ; Lipford JR ; Yu N ; Crouse GF ; Pollard JW ; Kunkel T ; Lipkin M ; Kolodner R ; Kucherlapati R		Cell	91	1997	467-77	J:44428	9390556
490	HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.		de Wind N; Dekker M; Claij N; Jansen L; van Klink Y; Radman M; Riggins G; van der Valk M; van't Wout K; te Riele H		Nat Genet	23	1999	359-62	J:59561	10545954
491	The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression.		Edelmann W; Umar A; Yang K; Heyer J; Kucherlapati M; Lia M; Kneitz B; Avdievich E; Fan K; Wong E; Crouse G; Kunkel T; Lipkin M; Kolodner RD; Kucherlapati R		Cancer Res	60	2000	803-7	J:60604	10706084
492	Meiotic pachytene arrest in MLH1-deficient mice.		Edelmann W; Cohen PE; Kane M; Lau K; Morrow B; Bennett S; Umar A; Kunkel T; Cattoretti G; Chaganti R; Pollard JW; Kolodner RD; Kucherlapati R		Cell	85	1996	1125-34	J:33878	8674118
493	Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice.		Edelmann W; Yang K; Kuraguchi M; Heyer J; Lia M; Kneitz B; Fan K; Brown AM; Lipkin M; Kucherlapati R		Cancer Res	59	1999	1301-7	J:53451	10096563
494	Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over [see comments]		Baker SM; Plug AW; Prolla TA; Bronner CE; Harris AC; Yao X; Christie DM; Monell C; Arnheim N; Bradley A; Ashley T; Liskay RM		Nat Genet	13	1996	336-42	J:34291	8673133
495	Enhanced intestinal adenomatous polyp formation in Pms2-/-;Min mice.		Baker SM; Harris AC; Tsao JL; Flath TJ; Bronner CE; Gordon M ; Shibata D ; Liskay RM		Cancer Res	58	1998	1087-9	J:46419	9515784
497	The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo.		Sirard C; de la Pompa JL; Elia A; Itie A; Mirtsos C; Cheung A; Hahn S; Wakeham A; Schwartz L; Kern SE; Rossant J; Mak TW		Genes Dev	12	1998	107-19	J:45399	9420335
498	Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.		Takaku K; Oshima M; Miyoshi H; Matsui M; Seldin MF; Taketo MM		Cell	92	1998	645-56	J:46242	9506519
499	Loss of Apc+ in intestinal adenomas from Min mice.		Luongo C; Moser AR; Gledhill S; Dove WF		Cancer Res	54	1994	5947-52	J:21369	7954427
501	Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities.		Gowen LC; Johnson BL; Latour AM; Sulik KK; Koller BH		Nat Genet	12	1996	191-4	J:31571	8563759
502	Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.		Liu CY; Flesken-Nikitin A; Li S; Zeng Y; Lee WH		Genes Dev	10	1996	1835-43	J:34458	8698242
503	The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.		Hakem R; de la Pompa JL; Sirard C; Mo R; Woo M; Hakem A; Wakeham A; Potter J; Reitmair A; Billia F; Firpo E; Hui CC; Roberts J; Rossant J; Mak TW		Cell	85	1996	1009-23	J:33880	8674108
504	Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia.		Chen M; Tomkins DJ; Auerbach W; McKerlie C; Youssoufian H; Liu L; Gan O; Carreau M; Auerbach A; Groves T; Guidos CJ; Freedman MH; Cross J; Percy DH; Dick JE; Joyner AL; Buchwald M		Nat Genet	12	1996	448-51	J:32080	8630504
505	Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.		Whitney MA; Royle G; Low MJ; Kelly MA; Axthelm MK; Reifsteck C; Olson S; Braun RE; Heinrich MC; Rathbun RK; Bagby GC; Grompe M		Blood	88	1996	49-58	J:61512	8704201
506	Mouse models of tumor development in neurofibromatosis type 1.		Cichowski K; Shih TS; Schmitt E; Santiago S; Reilly K; McLaughlin ME; Bronson RT; Jacks T		Science	286	1999	2172-6	J:58876	10591652
507	Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues [published erratum appears in Genes Dev 1994 Nov 15;8(22):2792]		Brannan CI; Perkins AS; Vogel KS; Ratner N; Nordlund ML; Reid SW; Buchberg AM; Jenkins NA; Parada LF; Copeland NG		Genes Dev	8	1994	1019-29	J:18048	7926784
508	Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.		Engle SJ; Hoying JB; Boivin GP; Ormsby I; Gartside PS; Doetschman T		Cancer Res	59	1999	3379-86	J:62324	10416598
510	Mouse tumor model for neurofibromatosis type 1.		Vogel KS; Klesse LJ; Velasco-Miguel S; Meyers K; Rushing EJ; Parada LF		Science	286	1999	2176-9	J:58877	10591653
511	Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP.		Kung AL; Rebel VI; Bronson RT; Ch'ng LE; Sieff CA; Livingston DM; Yao TP		Genes Dev	14	2000	272-7	J:60630	10673499
512	Subcapsular cell hyperplasia and mast cell infiltration in the adrenal cortex of mice: comparative study in 7 inbred strains.		Kim JS; Kubota H; Kiuchi Y; Doi K; Saegusa J		Exp Anim	46	1997	303-6	J:44011	9353639
513	Role of androgens in testicular tumor development in inhibin-deficient mice.		Shou W; Woodruff TK; Matzuk MM		Endocrinology	138	1997	5000-5	J:43852	9348231
514	Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice.		Matzuk MM; Finegold MJ; Mather JP; Krummen L; Lu H; Bradley A		Proc Natl Acad Sci U S A	91	1994	8817-21	J:20450	8090730
515	Induction of thyroid tumours in (C57BL/6N x C3H/N)F1 mice by oral administration of kojic acid.		Fujimoto N; Watanabe H; Nakatani T; Roy G; Ito A		Food Chem Toxicol	36	1998	697-703	J:49684	9734720
516	RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer.		Coxon AB; Ward JM; Geradts J; Otterson GA; Zajac-Kaye M; Kaye FJ		Oncogene	17	1998	1625-8	J:50139	9794240
517	k-FGF protoncogene expression is associated with murine testicular teratogenesis, but is not involved during mouse testicular development.		de Anta JM; Monzo M; Peris B; Ruano D		Histol Histopathol	12	1997	33-41	J:39156	9046041
519	Identification of an inhibin receptor in gonadal tumors from inhibin alpha-subunit knockout mice.		Draper LB; Matzuk MM; Roberts VJ; Cox E; Weiss J; Mather JP; Woodruff TK		J Biol Chem	273	1998	398-403	J:45039	9417095
520	Characterization of the model for experimental testicular teratoma in 129/SvJ-mice.		Sundstrom J; Pelliniemi LJ; Kuopio T; Verajankorva E; Frojdman K; Harley V; Salminen E; Pollanen P		Br J Cancer	80	1999	149-60	J:54503	10389991
521	Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol.		Newbold RR; Hanson RB; Jefferson WN; Bullock BC; Haseman J; McLachlan JA		Carcinogenesis	21	2000	1355-63	J:62956	10874014
524	Activation of neu by missense point mutation in the transmembrane domain in schwannomas induced in C3H/HeNCr mice by transplacental exposure to N-nitrosoethylurea.		Buzard GS; Enomoto T; Anderson LM; Perantoni AO; Devor DE; Rice JM		J Cancer Res Clin Oncol	125	1999	653-9	J:58827	10592097
525	Genetic background alters the spectrum of tumors that develop in p53-deficient mice.		Harvey M; McArthur MJ; Montgomery CA Jr; Bradley A; Donehower LA		FASEB J	7	1993	938-43	J:59272	8344491
526	Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.		Giovannini M; Robanus-Maandag E; van der Valk M; Niwa-Kawakita M; Abramowski V; Goutebroze L; Woodruff JM; Berns A; Thomas G		Genes Dev	14	2000	1617-30	J:63264	10887156
527	Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.		Giovannini M; Robanus-Maandag E; Niwa-Kawakita M; van der Valk M; Woodruff JM; Goutebroze L; Merel P; Berns A; Thomas G		Genes Dev	13	1999	978-86	J:54466	10215625
528	Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1.		Roose J; Huls G; van Beest M; Moerer P; van der Horn K; Goldschmeding R; Logtenberg T; Clevers H		Science	285	1999	1923-6	J:57721	10489374
529	Lung adenoma structure among inbred strains of mice: the pulmonary adenoma histologic type (Pah) genes.		Thaete LG; Nesbitt MN; Malkinson AM		Cancer Lett	61	1991	15-20	J:796	1764694
530	ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias.		Moser AR; Mattes EM; Dove WF; Lindstrom MJ; Haag JD; Gould MN		Proc Natl Acad Sci U S A	90	1993	8977-81	J:15101	8415640
532	The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system.		Moser AR; Dove WF; Roth KA; Gordon JI		J Cell Biol	116	1992	1517-26	J:1879	1541640
533	Expression of guanylin is downregulated in mouse and human intestinal adenomas.		Steinbrecher KA; Tuohy TM; Heppner Goss K; Scott MC; Witte DP; Groden J; Cohen MB		Biochem Biophys Res Commun	273	2000	225-30	J:62891	10873591
536	Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis.		Norgaard P; Law B; Joseph H; Page DL; Shyr Y; Mays D; Pietenpol JA; Kohl NE; Oliff A; Coffey RJ Jr; Poulsen HS; Moses HL		Clin Cancer Res	5	1999	35-42	J:52053	9918200
537	Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.		Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL		Proc Natl Acad Sci U S A	97	2000	9609-14	J:64071	10931950
538	Synergistic interaction between hypergastrinemia and helicobacter infection in a mouse model of gastric cancer		Wang TC; Dangler CA; Chen D; Goldenring JR; Koh T; Raychowdhury R; Coffey RJ; Ito S; Varro A; Dockray GJ; Fox JG		Gastroenterology	118	2000	36-47	J:59575	10611152
540	Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects		Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T		Nat Genet	26	2000	109-13	J:64364	10973261
541	Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53.		Nozawa H; Oda E; Nakao K; Ishihara M; Ueda S; Yokochi T; Ogasawara K; Nakatsuru Y; Shimizu S; Ohira Y; Hioki K; Aizawa S; Ishikawa T; Katsuki M; Muto T; Taniguchi T; Tanaka N		Genes Dev	13	1999	1240-5	J:55418	10346812
543	Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice [see comments]		Artandi SE; Chang S; Lee SL; Alson S; Gottlieb GJ; Chin L; DePinho RA		Nature	406	2000	641-5	J:63843	10949306
544	Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.		Takaku K; Miyoshi H; Matsunaga A; Oshima M; Sasaki N; Taketo MM		Cancer Res	59	1999	6113-7	J:59214	10626800
545	Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.		Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM		Mol Carcinog	24	1999	177-87	J:56012	10204802
546	Colossal crypts bordering colon adenomas in Apc(Min) mice express full-length Apc.		Bjerknes M; Cheng H		Am J Pathol	154	1999	1831-4	J:55509	10362808
547	Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis.		Mahmoud NN; Dannenberg AJ; Bilinski RT; Mestre JR; Chadburn A; Churchill M; Martucci C; Bertagnolli MM		Carcinogenesis	20	1999	299-303	J:53701	10069468
548	Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.		Greenberg RA; Chin L; Femino A; Lee KH; Gottlieb GJ; Singer RH; Greider CW; DePinho RA		Cell	97	1999	515-25	J:54989	10338215
549	Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac.		Mahmoud NN; Bilinski RT; Churchill MR; Edelmann W; Kucherlapati R ; Bertagnolli MM		Cancer Res	59	1999	353-9	J:52043	9927046
550	Colonic hamartoma development by anomalous duplication in Cdx2 knockout mice.		Tamai Y; Nakajima R; Ishikawa T; Takaku K; Seldin MF; Taketo MM		Cancer Res	59	1999	2965-70	J:47050	10383162
551	Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.		Berg DJ; Davidson N; Kuhn R; Muller W; Menon S; Holland G; Thompson-Snipes L; Leach MW; Rennick D		J Clin Invest	98	1996	1010-20	J:35020	8770874
552	Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice		Shattuck-Brandt RL; Varilek GW; Radhika A; Yang F; Washington MK; DuBois RN		Gastroenterology	118	2000	337-45	J:60015	10648462
553	Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma.		Sasaki T; Irie-Sasaki J; Horie Y; Bachmaier K; Fata JE; Li M; Suzuki A; Bouchard D; Ho A; Redston M; Gallinger S; Khokha R; Mak TW; Hawkins PT; Stephens L; Scherer SW; Tsao M; Penninger JM		Nature	406	2000	897-902	J:64162	10972292
554	Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis.		Mahmoud NN; Carothers AM; Grunberger D; Bilinski RT; Churchill MR; Martucci C; Newmark HL; Bertagnolli MM		Carcinogenesis	21	2000	921-7	J:61979	10783313
555	Mlh1 deficiency enhances several phenotypes of Apc(Min)/+ mice.		Shoemaker AR; Haigis KM; Baker SM; Dudley S; Liskay RM; Dove WF		Oncogene	19	2000	2774-9	J:62824	10851078
556	Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.		Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI		Cancer Res	60	2000	3191-9	J:62926	10866310
557	Roles for Nkx3.1 in prostate development and cancer.		Bhatia-Gaur R; Donjacour AA; Sciavolino PJ; Kim M; Desai N; Young P; Norton CR; Gridley T; Cardiff RD; Cunha GR; Abate-Shen C; Shen MM		Genes Dev	13	1999	966-77	J:54465	10215624
559	Early castration reduces prostatic carcinogenesis in transgenic mice		Eng MH; Charles LG; Ross BD; Chrisp CE; Pienta KJ; Greenberg NM; Hsu CX; Sanda MG		Urology	54	1999	1112-9	J:59577	10604719
560	A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice.		Kawate H; Itoh R; Sakumi K; Nakabeppu Y; Tsuzuki T; Ide F; Ishikawa T; Noda T; Nawata H; Sekiguchi M		Carcinogenesis	21	2000	301-5	J:60616	10657972
561	High metastatic potential in mice inheriting a targeted p53 missense mutation		Liu G; McDonnell TJ; Montes De Oca Luna R; Kapoor M; Mims B; El-Naggar AK; Lozano G		Proc Natl Acad Sci U S A	97	2000	4174-9	J:61683	10760284
562	E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse		Wechter WJ; Leipold DD; Murray ED Jr; Quiggle D; McCracken JD; Barrios RS; Greenberg NM		Cancer Res	60	2000	2203-8	J:61729	10786685
564	Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.		Hurwitz AA; Foster BA; Kwon ED; Truong T; Choi EM; Greenberg NM; Burg MB; Allison JP		Cancer Res	60	2000	2444-8	J:62479	10811122
565	Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.		Liu Q; Guntuku S; Cui XS; Matsuoka S; Cortez D; Tamai K; Luo G; Carattini-Rivera S; DeMayo F; Bradley A; Donehower LA; Elledge SJ		Genes Dev	14	2000	1448-59	J:62919	10859164
566	Genomic instability-based transgenic models of prostate cancer.		Voelkel-Johnson C; Voeks DJ; Greenberg NM; Barrios R; Maggouta F; Kurtz DT; Schwartz DA; Keller GM; Papenbrock T; Clawson GA; Norris JS		Carcinogenesis	21	2000	1623-7	J:63563	10910968
567	Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development		Gao Y; Ferguson DO; Xie W; Manis JP; Sekiguchi J; Frank KM; Chaudhuri J; Horner J; DePinho RA; Alt FW		Nature	404	2000	897-900	J:61973	10786799
568	Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.		Deng C; Zhang P; Harper JW; Elledge SJ; Leder P		Cell	82	1995	675-84	J:28420	7664346
570	Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma [see comments]		Xu Y; Ashley T; Brainerd EE; Bronson RT; Meyn MS; Baltimore D		Genes Dev	10	1996	2411-22	J:35914	8843194
571	Pleiotropic defects in ataxia-telangiectasia protein-deficient mice.		Elson A; Wang Y; Daugherty CJ; Morton CC; Zhou F; Campos-Torres J; Leder P		Proc Natl Acad Sci U S A	93	1996	13084-9	J:36561	8917548
572	Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice		Xu X; Brodie SG; Yang X; Im YH; Parks WT; Chen L; Zhou YX; Weinstein M; Kim SJ; Deng CX		Oncogene	19	2000	1868-74	J:61772	10773876
573	Prostate cancer in a transgenic mouse.		Greenberg NM; DeMayo F; Finegold MJ; Medina D; Tilley WD; Aspinall JO; Cunha GR; Donjacour AA; Matusik RJ; Rosen JM		Proc Natl Acad Sci U S A	92	1995	3439-43	J:65303	7724580
574	Metastatic prostate cancer in a transgenic mouse.		Gingrich JR; Barrios RJ; Morton RA; Boyce BF; DeMayo FJ; Finegold MJ; Angelopoulou R; Rosen JM; Greenberg NM		Cancer Res	56	1996	4096-102	J:65304	8797572
575	Androgen-independent prostate cancer progression in the TRAMP model.		Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM		Cancer Res	57	1997	4687-91	J:65305	9354422
576	Basal cell carcinomas in mice overexpressing sonic hedgehog.		Oro AE; Higgins KM; Hu Z; Bonifas JM; Epstein EH Jr; Scott MP		Science	276	1997	817-21	J:40166	9115210
577	Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice.		Kobayashi T; Minowa O; Kuno J; Mitani H; Hino O; Noda T		Cancer Res	59	1999	1206-11	J:52464	10096549
578	Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.		Dranoff G; Crawford AD; Sadelain M; Ream B; Rashid A; Bronson RT; Dickersin GR; Bachurski CJ; Mark EL; Whitsett JA; Mulligan RC		Science	264	1994	713-6	J:17978	8171324
579	SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.		Palmiter RD; Chen HY; Messing A; Brinster RL		Nature	316	1985	457-60	J:53184	2991771
580	Surfactant protein C expression in urethane-induced murine pulmonary tumors.		Mason RJ; Kalina M; Nielsen LD; Malkinson AM; Shannon JM		Am J Pathol	156	2000	175-82	J:59352	10623665
581	Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.		Lantry LE; Zhang Z; Yao R; Crist KA; Wang Y; Ohkanda J; Hamilton AD; Sebti SM; Lubet RA; You M		Carcinogenesis	21	2000	113-6	J:59576	10607742
582	Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.		Wattenberg LW; Wiedmann TS; Estensen RD; Zimmerman CL; Galbraith AR; Steele VE; Kelloff GJ		Carcinogenesis	21	2000	179-82	J:60825	10657955
583	High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors.		Bauer AK; Dwyer-Nield LD; Malkinson AM		Carcinogenesis	21	2000	543-50	J:61782	10753183
585	Incidence and spectrum of spontaneous neoplasms in male and female CBA/J mice		Tillmann T; Kamino K; Mohr U		Exp Toxicol Pathol	52	2000	221-5	J:64648	10930122
586	A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.		Fero ML; Rivkin M; Tasch M; Porter P; Carow CE; Firpo E; Polyak K; Tsai LH; Broudy V; Perlmutter RM; Kaushansky K; Roberts JM		Cell	85	1996	733-44	J:33400	8646781
587	Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).		Kiyokawa H; Kineman RD; Manova-Todorova KO; Soares VC; Hoffman ES; Ono M; Khanam D; Hayday AC; Frohman LA; Koff A		Cell	85	1996	721-32	J:33401	8646780
588	Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.		Nakayama K; Ishida N; Shirane M; Inomata A; Inoue T; Shishido N; Horii I; Loh DY; Nakayama K		Cell	85	1996	707-20	J:33402	8646779
589	The murine gene p27Kip1 is haplo-insufficient for tumour suppression.		Fero ML; Randel E; Gurley KE; Roberts JM; Kemp CJ		Nature	396	1998	177-80	J:50966	9823898
590	Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.		Kamijo T; Zindy F; Roussel MF; Quelle DE; Downing JR; Ashmun RA; Grosveld G; Sherr CJ		Cell	91	1997	649-59	J:44427	9393858
591	Tumor spectrum in ARF-deficient mice.		Kamijo T; Bodner S; van de Kamp E; Randle DH; Sherr CJ		Cancer Res	59	1999	2217-22	J:54540	10232611
592	Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors.		Risma KA; Clay CM; Nett TM; Wagner T; Yun J; Nilson JH		Proc Natl Acad Sci U S A	92	1995	1322-6	J:55157	7877975
593	Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology.		Risma KA; Hirshfield AN; Nilson JH		Endocrinology	138	1997	3540-7	J:66175	9231809
594	Transgenic mice with chronically elevated luteinizing hormone are infertile due to anovulation, defects in uterine receptivity, and midgestation pregnancy failure.		Mann RJ; Keri RA; Nilson JH		Endocrinology	140	1999	2592-601	J:66176	10342846
595	Luteinizing hormone induction of ovarian tumors: oligogenic differences between mouse strains dictates tumor disposition.		Keri RA; Lozada KL; Abdul-Karim FW; Nadeau JH; Nilson JH		Proc Natl Acad Sci U S A	97	2000	383-7	J:59366	10618427
596	p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant To induce pre-B lymphoma In vivo		Zou X; Cong F; Coutts M; Cattoretti G; Goff SP; Calame K		Mol Cell Biol	20	2000	628-33	J:59574	10611241
597	Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.		Podsypanina K; Ellenson LH; Nemes A; Gu J; Tamura M; Yamada KM ; Cordon-Cardo C ; Catoretti G ; Fisher PE ; Parsons R		Proc Natl Acad Sci U S A	96	1999	1563-8	J:53065	9990064
598	Cancer predisposition caused by elevated mitotic recombination in bloom mice		Luo G; Santoro IM; McDaniel LD; Nishijima I; Mills M; Youssoufian H; Vogel H; Schultz RA; Bradley A		Nat Genet	26	2000	424-9	J:66261	11101838
599	Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice.		Gnarra JR; Ward JM; Porter FD; Wagner JR; Devor DE; Grinberg A ; Emmert-Buck MR ; Westphal H ; Klausner RD ; Linehan WM		Proc Natl Acad Sci U S A	94	1997	9102-7	J:42486	9256442
600	Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse.		Davis LM; Caspary WJ; Sakallah SA; Maronpot R; Wiseman R; Barrett JC; Elliott R; Hozier JC		Carcinogenesis	15	1994	1637-45	J:19777	8055644
601	Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas.		Fazeli A; Steen RG; Dickinson SL; Bautista D; Dietrich WF; Bronson RT ; Bresalier RS ; Lander ES ; Costa J ; Weinberg RA		Proc Natl Acad Sci U S A	94	1997	10199-204	J:42974	9294187
602	Bcl-2 accelerates multistep prostate carcinogenesis in vivo		Bruckheimer EM; Brisbay S; Johnson DJ; Gingrich JR; Greenberg N; McDonnell TJ		Oncogene	19	2000	5251-8	J:65876	11077442
603	The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo.		Bruckheimer EM; Cho S; Brisbay S; Johnson DJ; Gingrich JR; Greenberg N; McDonnell TJ		Oncogene	19	2000	2404-12	J:62297	10828882
604	Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.		Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H		Cancer Res	60	2000	5125-33	J:64783	11016639
605	Genetics of susceptibility to radiation-induced lymphomas, leukemias and lung tumors studied in recombinant congenic strains.		Szymanska H; Sitarz M; Krysiak E; Piskorowska J; Czarnomska A; Skurzak H; Hart AA; de Jong D; Demant P		Int J Cancer	83	1999	674-8	J:59527	10521806
606	STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma		Lee CK; Smith E; Gimeno R; Gertner R; Levy DE		J Immunol	164	2000	1286-92	J:59955	10640742
607	Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes.		Kawate H; Sakumi K; Tsuzuki T; Nakatsuru Y; Ishikawa T; Takahashi S; Takano H; Noda T; Sekiguchi M		Proc Natl Acad Sci U S A	95	1998	5116-20	J:47642	9560238
608	Pathologic progression of autochthonous prostate cancer in the TRAMP model.		Gingrich JR; Barrios RJ; Foster BA; Greenberg NM		Prostate Cancer Prostatic Dis	2	1999	70-75	J:66957	12496841
609	Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.		Haase VH; Glickman JN; Socolovsky M; Jaenisch R		Proc Natl Acad Sci U S A	98	2001	1583-8	J:67505	11171994
611	Effect of synthetic thymic and pineal peptides on biomarkers of ageing, survival and spontaneous tumour incidence in female CBA mice.		Anisimov VN; Khavinson VK; Mikhalski AI; Yashin AI		Mech Ageing Dev	122	2001	41-68	J:67515	11163623
613	Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398.		Rioux N; Castonguay A		Cancer Res	58	1998	5354-60	J:51371	9850065
614	Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.		Yao R; Rioux N; Castonguay A; You M		Exp Lung Res	26	2000	731-42	J:67462	11195467
618	Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas.		Herzog CR; Chen B; Wang Y; Schut HA; You M		Mol Carcinog	16	1996	83-90	J:34223	8645430
619	Detection of genetic alterations in mouse lung adenocarcinomas by two-dimensional gel electrophoresis.		Liu J; Gu P; Bergman G; Kelloff GJ; Boone CW; You M; Wang Y		Exp Lung Res	26	2000	651-8	J:67466	11195462
620	Pilot studies evaluating the lung tumor yield in cigarette smoke-exposed mice.		D'Agostini F; Balansky RM; Bennicelli C; Lubet RA; Kelloff GJ; De Flora S		Int J Oncol	18	2001	607-15	J:67488	11179494
621	Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene.		Holtschke T; Lohler J; Kanno Y; Fehr T; Giese N; Rosenbauer F; Lou J; Knobeloch KP; Gabriele L; Waring JF; Bachmann MF; Zinkernagel RM; Morse HC 3rd; Ozato K; Horak I		Cell	87	1996	307-17	J:36038	8861914
622	Somatic apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity		Smits R; Hofland N; Edelmann W; Geugien M; Jagmohan-Changur S; Albuquerque C; Breukel C; Kucherlapati R; Kielman MF; Fodde R		Genes Chromosomes Cancer	29	2000	229-39	J:64667	10992298
623	Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.		Johnson L; Mercer K; Greenbaum D; Bronson RT; Crowley D; Tuveson DA; Jacks T		Nature	410	2001	1111-6	J:68981	11323676
624	Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.		Di Cristofano A; De Acetis M; Koff A; Cordon-Cardo C; Pandolfi PP		Nat Genet	27	2001	222-4	J:67499	11175795
625	Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids.		You M; Wang Y; Stoner G; You L; Maronpot R; Reynolds SH; Anderson M		Proc Natl Acad Sci U S A	89	1992	5804-8	J:68954	1352876
626	ras mutations in 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumors in the CDF1 mouse.		Herzog CR; Schut HA; Maronpot RR; You M		Mol Carcinog	8	1993	202-7	J:16419	8216739
627	Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice.		DiGiovanni J; Kiguchi K; Frijhoff A; Wilker E; Bol DK; Beltran L; Moats S; Ramirez A; Jorcano J; Conti C		Proc Natl Acad Sci U S A	97	2000	3455-60	J:61189	10737798
628	ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.		Wang Y; Wang Y; Stoner G; You M		Cancer Res	53	1993	1620-4	J:4317	8453632
629	Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone.		Rumsby PC; Barrass NC; Phillimore HE; Evans JG		Carcinogenesis	12	1991	2331-6	J:1781	1747936
630	Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse.		Devereux TR; Anderson MW; Belinsky SA		Carcinogenesis	12	1991	299-303	J:25821	1995195
631	KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice.		Ryan J; Barker PE; Nesbitt MN; Ruddle FH		J Natl Cancer Inst	79	1987	1351-7	J:17778	2891865
633	Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice.		Malkinson AM; Beer DS		J Natl Cancer Inst	70	1983	931-6	J:7050	6573537
634	Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice.		Estensen RD; Wattenberg LW		Carcinogenesis	14	1993	1975-7	J:14838	8403228
635	Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse.		Belinsky SA; Devereux TR; Foley JF; Maronpot RR; Anderson MW		Cancer Res	52	1992	3164-73	J:1259	1591728
636	Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet.		Hecht SS; Morse MA; Amin S; Stoner GD; Jordan KG; Choi CI; Chung FL		Carcinogenesis	10	1989	1901-4	J:27317	2791206
637	Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains.		Devereux TR; Belinsky SA; Maronpot RR; White CM; Hegi ME; Patel AC; Foley JF; Greenwell A; Anderson MW		Mol Carcinog	8	1993	177-85	J:16464	8216736
638	The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility.		Chen B; Johanson L; Wiest JS; Anderson MW; You M		Proc Natl Acad Sci U S A	91	1994	1589-93	J:16946	8108449
639	Allele-specific activation and expression of the K-ras gene in hybrid mouse lung tumors induced by chemical carcinogens.		Chen B; You L; Wang Y; Stoner GD; You M		Carcinogenesis	15	1994	2031-5	J:20674	7923598
640	Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract.		Ohgaki H; Kusama K; Matsukura N; Morino K; Hasegawa H; Sato S; Takayama S; Sugimura T		Carcinogenesis	5	1984	921-4	J:69076	6733854
641	Bioassay of 29 alkylating chemicals by the pulmonary-tumor response in strain A mice		Shimkin MB; Weisburger JH; Weisburger EK; Gubareff N; Suntzeff V		J Natl Cancer Inst	36	1966	915-35	J:22757	 
642	High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL/6J x BALB/cJ) mice.		Massey TE; Devereux TR; Maronpot RR; Foley JF; Anderson MW		Carcinogenesis	16	1995	1065-9	J:25604	7767966
643	Inhibition of 7,12-dimethylbenz[a]anthracene-induced lung tumorigenesis in A/J mice by food restriction is reversed by adrenalectomy.		Pashko LL; Schwartz AG		Carcinogenesis	17	1996	209-12	J:31323	8625440
644	Impaired prostate tumorigenesis in Egr1-deficient mice.		Abdulkadir SA; Qu Z; Garabedian E; Song SK; Peters TJ; Svaren J; Carbone JM; Naughton CK; Catalona WJ; Ackerman JJ; Gordon JI; Humphrey PA; Milbrandt J		Nat Med	7	2001	101-7	J:67125	11135623
645	A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.		Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ		Cancer Res	61	2001	2239-49	J:68483	11280793
646	A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.		Holland EC; Hively WP; DePinho RA; Varmus HE		Genes Dev	12	1998	3675-85	J:52161	9851974
647	Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.		Holland EC; Celestino J; Dai C; Schaefer L; Sawaya RE; Fuller GN		Nat Genet	25	2000	55-7	J:61890	10802656
648	Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.		Holland EC; Li Y; Celestino J; Dai C; Schaefer L; Sawaya RA; Fuller GN		Am J Pathol	157	2000	1031-7	J:64389	10980141
655	Long-live euthymic BALB/c-nu mice. II: spontaneous tumors and other pathologies.		Anisimov VN; Zabezhinski MA; Rossolini G; Zaia A; Piantanelli A; Basso A; Piantanelli L		Mech Ageing Dev	122	2001	477-89	J:68465	11292513
656	Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice.		Moser AR; Hegge LF; Cardiff RD		Cancer Res	61	2001	3480-5	J:68915	11309311
663	Detection of differentially expressed genes in mouse lung adenocarcinomas.		Lin L; Wang Y; Bergman G; Kelloff GJ; Lubet RA; You M		Exp Lung Res	27	2001	217-29	J:68462	11293325
664	Defective gap junctional intercellular communication in lung cancer: loss of an important mediator of tissue homeostasis and phenotypic regulation.		Ruch RJ; Porter S; Koffler LD; Dwyer-Nield LD; Malkinson AM		Exp Lung Res	27	2001	231-43	J:68461	11293326
665	The effects of a binary mixture of benzo(a)pyrene and 7H-dibenzo(c,g)carbazole on lung tumors and K-ras oncogene mutations in strain A/J mice.		Gray DL; Warshawsky D; Xue W; Nines R; Wang Y; Yao R; Stoner GD		Exp Lung Res	27	2001	245-53	J:68460	11293327
667	K-ras mutations in mouse lung tumors of extreme age: independent of paternal preconceptional exposure to chromium(III) but significantly more frequent in carcinomas than adenomas.		McKenna IM; Ramakrishna G; Diwan BA; Shiao YH; Kasprzak KS; Powell DA; Anderson LM		Mutat Res	490	2001	57-65	J:67126	11152972
668	Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice.		Gunning WT; Kramer PM; Lubet RA; Steele VE; Pereira MA		Exp Lung Res	26	2000	757-72	J:67460	11195469
669	Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1		Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB		Mol Carcinog	29	2000	112-26	J:66204	11074608
670	Chemoprevention of lung tumorigenesis induced by a mixture of benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate		Prokopczyk B; Rosa JG; Desai D; Amin S; Sohn OS; Fiala ES; El-Bayoumy K		Cancer Lett	161	2000	35-46	J:66200	11078911
671	Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase		Shiraishi A; Sakumi K; Sekiguchi M		Carcinogenesis	21	2000	1879-83	J:65240	11023546
672	Failure of dietary lyophilized strawberries to inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-and benzo[a]pyrene-induced lung tumorigenesis in strain A/J mice		Carlton PS; Kresty LA; Stoner GD		Cancer Lett	159	2000	113-7	J:64662	10996721
673	Urban levels of air pollution modifies the progression of urethane-induced lung tumours in mice		Cury PM; Lichtenfels AJ; Reymao MS; Conceicao GM; Capelozzi VL; Saldiva PH		Pathol Res Pract	196	2000	627-33	J:64598	10997738
674	Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice.		Holland EC; Varmus HE		Proc Natl Acad Sci U S A	95	1998	1218-23	J:69971	9448312
675	Dual inactivation of RB and p53 pathways in RAS-induced melanomas.		Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L		Mol Cell Biol	21	2001	2144-53	J:67799	11238948
678	Tumor multiplicity, DNA adducts and K-ras mutation pattern of 5-methylchrysene in strain A/J mouse lung.		You L; Wang D; Galati AJ; Ross JA; Mass MJ; Nelson GB; Wilson KH; Amin S; Stoner JC; Nesnow S; Stoner GD		Carcinogenesis	15	1994	2613-8	J:21521	7955114
679	Histomorphology and ultrastructure of spontaneous pulmonary neoplasms in strain A mice.		Dixon D; Horton J; Haseman JK; Talley F; Greenwell A; Nettesheim P; Hook GE; Maronpot RR		Exp Lung Res	17	1991	131-55	J:27691	1646706
680	Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene.		Malkinson AM; Koski KM; Evans WA; Festing MF		Cancer Res	57	1997	2832-4	J:41834	9230183
682	Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone).		Malkinson AM; Koski KM; Dwyer-Nield LD; Rice PL; Rioux N; Castonguay A; Ahnen DJ; Thompson H; Pamukcu R; Piazza GA		Carcinogenesis	19	1998	1353-6	J:50133	9744528
683	Induction of benign and malignant pulmonary tumours in mice with benzo(a)pyrene.		Kim SH; Lee CS		Anticancer Res	16	1996	465-70	J:34127	8615655
684	Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea.		Wang ZY; Hong JY; Huang MT; Reuhl KR; Conney AH; Yang CS		Cancer Res	52	1992	1943-7	J:70503	1551122
685	Mutagenesis of the K-ras protooncogene in mouse lung tumors induced by N-ethyl-N-nitrosourea or N-nitrosodiethylamine.		You M; Wang Y; Lineen AM; Gunning WT; Stoner GD; Anderson MW		Carcinogenesis	13	1992	1583-6	J:70504	1394843
686	Lung tumors in mice: application to carcinogenesis bioassay.		Shimkin MB; Stoner GD		Adv Cancer Res	21	1975	1-58	J:23463	1108612
687	Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice.		Duperron C; Castonguay A		Carcinogenesis	18	1997	1001-6	J:40367	9163687
688	Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene.		Iwamoto T; Takahashi M; Ito M; Hamatani K; Ohbayashi M; Wajjwalku W; Isobe K; Nakashima I		EMBO J	10	1991	3167-75	J:70622	1915289
689	Proliferative lesions of the mouse lung: progression studies in strain A mice.		Foley JF; Anderson MW; Stoner GD; Gaul BW; Hardisty JF; Maronpot RR		Exp Lung Res	17	1991	157-68	J:27247	2050022
691	The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer.		Shibata MA; Jorcyk CL; Liu ML; Yoshidome K; Gold LG; Green JE		Toxicol Pathol	26	1998	177-82	J:46513	9502400
711	Lesions of aryl-hydrocarbon receptor-deficient mice.		Fernandez-Salguero PM; Ward JM; Sundberg JP; Gonzalez FJ		Vet Pathol	34	1997	605-14	J:44690	9396142
712	The uteroglobin promoter targets expression of the SV40 T antigen to a variety of secretory epithelial cells in transgenic mice.		Sandmoller A; Halter R; Gomez-La-Hoz E; Grone HJ; Suske G; Paul D; Beato M		Oncogene	9	1994	2805-15	J:71315	8084586
713	Expression of SV40 T antigen under control of rabbit uteroglobin promoter in transgenic mice.		DeMayo FJ; Finegold MJ; Hansen TN; Stanley LA; Smith B; Bullock DW		Am J Physiol	261	1991	L70-6	J:70786	1872417
714	Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.		Deane NG; Parker MA; Aramandla R; Diehl L; Lee WJ; Washington MK; Nanney LB; Shyr Y; Beauchamp RD		Cancer Res	61	2001	5389-95	J:70394	11454681
715	Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice.		Beck F; Chawengsaksophak K; Waring P; Playford RJ; Furness JB		Proc Natl Acad Sci U S A	96	1999	7318-23	J:56059	10377412
716	Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice.		Magdaleno SM; Wang G; Mireles VL; Ray MK; Finegold MJ; DeMayo FJ		Cell Growth Differ	8	1997	145-55	J:70785	9040936
717	Pulmonary carcinogenesis in transgenic mice.		Maronpot RR; Palmiter RD; Brinster RL; Sandgren EP		Exp Lung Res	17	1991	305-20	J:70784	2050033
718	Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice.		Wikenheiser KA; Clark JC; Linnoila RI; Stahlman MT; Whitsett JA		Cancer Res	52	1992	5342-52	J:70783	1394139
719	Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors.		Mitsumori K; Wakana S; Yamamoto S; Kodama Y; Yasuhara K; Nomura T; Hayashi Y; Maronpot RR		Mol Carcinog	20	1997	298-307	J:46044	9397190
720	Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes.		Saitoh A; Kimura M; Takahashi R; Yokoyama M; Nomura T; Izawa M; Sekiya T; Nishimura S; Katsuki M		Oncogene	5	1990	1195-200	J:64968	2202951
721	A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin.		Zhang Z; Liu Q; Lantry LE; Wang Y; Kelloff GJ; Anderson MW; Wiseman RW; Lubet RA; You M		Cancer Res	60	2000	901-7	J:61217	10706103
722	Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.		Rudolph KL; Millard M; Bosenberg MW; DePinho RA		Nat Genet	28	2001	155-9	J:69730	11381263
723	Essential role for oncogenic Ras in tumour maintenance.		Chin L; Tam A; Pomerantz J; Wong M; Holash J; Bardeesy N; Shen Q; O'Hagan R; Pantginis J; Zhou H; Horner JW nd; Cordon-Cardo C; Yancopoulos GD; DePinho RA		Nature	400	1999	468-72	J:71333	10440378
724	Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.		Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A		Nature	413	2001	83-6	J:71393	11544530
725	Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.		Sharpless NE; Bardeesy N; Lee KH; Carrasco D; Castrillon DH; Aguirre AJ; Wu EA; Horner JW; DePinho RA		Nature	413	2001	86-91	J:71394	11544531
726	The int-2 gene product acts as an epithelial growth factor in transgenic mice.		Muller WJ; Lee FS; Dickson C; Peters G; Pattengale P; Leder P		EMBO J	9	1990	907-13	J:71557	1690126
727	Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice.		Kwan H; Pecenka V; Tsukamoto A; Parslow TG; Guzman R; Lin TP; Muller WJ; Lee FS; Leder P; Varmus HE		Mol Cell Biol	12	1992	147-54	J:1811	1530875
728	Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.		Lin TP; Guzman RC; Osborn RC; Thordarson G; Nandi S		Cancer Res	52	1992	4413-9	J:2062	1386556
729	Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis.		MacArthur CA; Shankar DB; Shackleford GM		J Virol	69	1995	2501-7	J:23751	7884899
730	Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.		Kapoun AM; Shackleford GM		Oncogene	14	1997	2985-9	J:41162	9205106
732	Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation.		Broccoli D; Godley LA; Donehower LA; Varmus HE; de Lange T		Mol Cell Biol	16	1996	3765-72	J:71575	8668193
734	Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice.		Liu ML; Von Lintig FC; Liyanage M; Shibata MA; Jorcyk CL; Ried T; Boss GR; Green JE		Oncogene	17	1998	2403-11	J:50935	9811472
735	Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.		Matsui Y; Halter SA; Holt JT; Hogan BL; Coffey RJ		Cell	61	1990	1147-55	J:28453	2161707
736	Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis.		Rowse GJ; Ritland SR; Gendler SJ		Cancer Res	58	1998	2675-9	J:48749	9635596
737	Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.		Muller WJ; Arteaga CL; Muthuswamy SK; Siegel PM; Webster MA; Cardiff RD; Meise KS; Li F; Halter SA; Coffey RJ		Mol Cell Biol	16	1996	5726-36	J:35344	8816486
738	Spontaneous mammary carcinomas fail to induce an immune response in syngeneic FVBN202 neu transgenic mice.		Kurt RA; Whitaker R; Baher A; Seung S; Urba WJ		Int J Cancer	87	2000	688-94	J:64150	10925363
739	Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation.		Cheng AM; Saxton TM; Sakai R; Kulkarni S; Mbamalu G; Vogel W; Tortorice CG; Cardiff RD; Cross JC; Muller WJ; Pawson T		Cell	95	1998	793-803	J:51424	9865697
740	Reduced p53 dosage associated with mammary tumor metastases in C3(1)/TAG transgenic mice.		Maroulakou IG; Shibata MA; Jorcyk CL; Chen XX; Green JE		Mol Carcinog	20	1997	168-74	J:72307	9364206
741	Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage.		Shibata MA; Liu ML; Knudson MC; Shibata E; Yoshidome K; Bandey T ; Korsmeyer SJ ; Green JE		EMBO J	18	1999	2692-701	J:55778	10329616
742	DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway.		Frank KM; Sharpless NE; Gao Y; Sekiguchi JM; Ferguson DO; Zhu C; Manis JP; Horner J; DePinho RA; Alt FW		Mol Cell	5	2000	993-1002	J:63078	10911993
743	Requirement for Ku80 in growth and immunoglobulin V(D)J recombination.		Nussenzweig A; Chen C; da Costa Soares V; Sanchez M; Sokol K; Nussenzweig MC; Li GC		Nature	382	1996	551-5	J:72368	8700231
744	DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation.		Difilippantonio MJ; Zhu J; Chen HT; Meffre E; Nussenzweig MC; Max EE; Ried T; Nussenzweig A		Nature	404	2000	510-4	J:72312	10761921
745	Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias.		Honda H; Oda H; Suzuki T; Takahashi T; Witte ON; Ozawa K; Ishikawa T; Yazaki Y; Hirai H		Blood	91	1998	2067-75	J:46392	9490692
746	A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice.		Neznanov N; Man AK; Yamamoto H; Hauser CA; Cardiff RD; Oshima RG		Cancer Res	59	1999	4242-6	J:57272	10485465
747	Suppression of tumor growth and metastasis in Mgat5-deficient mice.		Granovsky M; Fata J; Pawling J; Muller WJ; Khokha R; Dennis JW		Nat Med	6	2000	306-12	J:60960	10700233
748	Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML		Honda H; Ushijima T; Wakazono K; Oda H; Tanaka Y; Aizawa Si; Ishikawa T; Yazaki Y; Hirai H		Blood	95	2000	1144-50	J:60817	10666183
749	Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.		Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ		Genes Dev	8	1994	23-32	J:72125	7507074
750	Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.		Ritland SR; Rowse GJ; Chang Y; Gendler SJ		Cancer Res	57	1997	3520-5	J:72134	9270023
751	PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas.		Trimble MS; Xin JH; Guy CT; Muller WJ; Hassell JA		Oncogene	8	1993	3037-42	J:72260	7692372
752	Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.		Kwabi-Addo B; Giri D; Schmidt K; Podsypanina K; Parsons R; Greenberg N; Ittmann M		Proc Natl Acad Sci U S A	98	2001	11563-8	J:71740	11553783
753	Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.		Stewart TA; Pattengale PK; Leder P		Cell	38	1984	627-37	J:29013	6488314
754	Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development.		Leder A; Pattengale PK; Kuo A; Stewart TA; Leder P		Cell	45	1986	485-95	J:72130	3011271
755	Transgenic oncogene mice. Tumor phenotype predicts genotype.		Cardiff RD; Sinn E; Muller W; Leder P		Am J Pathol	139	1991	495-501	J:72086	1887859
756	Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice.		Lucchini F; Sacco MG; Hu N; Villa A; Brown J; Cesano L; Mangiarini L; Rindi G; Kindl S; Sessa F; et al.		Cancer Lett	64	1992	203-9	J:72082	1322235
757	Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.		Boggio K; Nicoletti G; Di Carlo E; Cavallo F; Landuzzi L; Melani C; Giovarelli M; Rossi I; Nanni P; De Giovanni C; Bouchard P; Wolf S; Modesti A; Musiani P; Lollini PL; Colombo MP; Forni G		J Exp Med	188	1998	589-96	J:49500	9687535
758	Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.		Di Carlo E; Diodoro MG; Boggio K; Modesti A; Modesti M; Nanni P; Forni G; Musiani P		Lab Invest	79	1999	1261-9	J:58098	10532589
759	Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene.		Bouchard L; Lamarre L; Tremblay PJ; Jolicoeur P		Cell	57	1989	931-6	J:72129	2567634
760	Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice.		Cool M; Jolicoeur P		Cancer Res	59	1999	2438-44	J:71658	10344755
761	An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model.		Thomas H; Hanby AM; Smith RA; Hagger P; Patel K; Raikundalia B; Camplejohn RS; Balkwill FR		Br J Cancer	73	1996	65-72	J:72367	8554986
762	Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations.		Halter SA; Dempsey P; Matsui Y; Stokes MK; Graves-Deal R; Hogan BL; Coffey RJ		Am J Pathol	140	1992	1131-46	J:72085	1316084
763	Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice.		Lawler J; Miao WM; Duquette M; Bouck N; Bronson RT; Hynes RO		Am J Pathol	159	2001	1949-56	J:72391	11696456
764	Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicase.		Lebel M; Cardiff RD; Leder P		Cancer Res	61	2001	1816-9	J:68488	11280729
765	Tumor susceptibility of p21(Waf1/Cip1)-deficient mice.		Martin-Caballero J; Flores JM; Garcia-Palencia P; Serrano M		Cancer Res	61	2001	6234-8	J:70894	11507077
766	Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice [see comments]		Harvey M; McArthur MJ; Montgomery CA Jr; Butel JS; Bradley A; Donehower LA		Nat Genet	5	1993	225-9	J:15423	8275085
767	High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.		Stambolic V; Tsao MS; Macpherson D; Suzuki A; Chapman WB; Mak TW		Cancer Res	60	2000	3605-11	J:63478	10910075
768	Induction of osteosarcoma and acute myeloid leukaemia in CBA/H mice by the alpha-emitting nuclides, uranium-233, plutonium-239 and amercium-241.		Ellender M; Harrison JD; Pottinger H; Thomas JM		Int J Radiat Biol	77	2001	41-52	J:67447	11213349
770	CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.		Franklin DS; Godfrey VL; Lee H; Kovalev GI; Schoonhoven R; Chen-Kiang S; Su L; Xiong Y		Genes Dev	12	1998	2899-911	J:50053	9744866
771	Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis		Latres E; Malumbres M; Sotillo R; Martin J; Ortega S; Martin-Caballero J; Flores JM; Cordon-Cardo C; Barbacid M		EMBO J	19	2000	3496-506	J:63299	10880462
772	Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity		Franklin DS; Godfrey VL; O'Brien DA; Deng C; Xiong Y		Mol Cell Biol	20	2000	6147-58	J:63560	10913196
773	Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development.		Sturlan S; Oberhuber G; Beinhauer BG; Tichy B; Kappel S; Wang J; Rogy MA		Carcinogenesis	22	2001	665-71	J:68476	11285204
774	Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9.		Yang Y; Kuang Y; De Oca RM; Hays T; Moreau L; Lu N; Seed B; D'Andrea AD		Blood	98	2001	3435-40	J:72945	11719385
775	Source for unpublished tumor frequency		D'Andrea AD		Personal Communication		2001		J:94308	 
776	Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice.		Koomen M; Cheng NC; van de Vrugt HJ; Godthelp BC; van der Valk MA; Oostra AB; Zdzienicka MZ; Joenje H; Arwert F		Hum Mol Genet	11	2002	273-81	J:74737	11823446
780	p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.		Yang A; Walker N; Bronson R; Kaghad M; Oosterwegel M; Bonnin J; Vagner C; Bonnet H; Dikkes P; Sharpe A; McKeon F; Caput D		Nature	404	2000	99-103	J:60896	10716451
781	Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas.		Inoue K; Zindy F; Randle DH; Rehg JE; Sherr CJ		Genes Dev	15	2001	2934-9	J:72617	11711428
783	Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.		Coffey RJ Jr; Meise KS; Matsui Y; Hogan BL; Dempsey PJ; Halter SA		Cancer Res	54	1994	1678-83	J:72080	8137281
784	Mammary tumor suppression by transforming growth factor beta 1 transgene expression.		Pierce DF Jr; Gorska AE; Chytil A; Meise KS; Page DL; Coffey RJ Jr; Moses HL		Proc Natl Acad Sci U S A	92	1995	4254-8	J:71696	7753792
785	Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice.		Li Y, Podsypanina K, Liu X, Crane A, Tan LK, Parsons R, Varmus HE.		BMC Mol Biol	2	2001	2	J:67497	11178110
786	Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice : A model for Li-fraumeni syndrome		Kuperwasser C; Hurlbut GD; Kittrell FS; Dickinson ES; Laucirica R; Medina D; Naber SP; Jerry DJ		Am J Pathol	157	2000	2151-9	J:66136	11106587
787	TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas.		Jhappan C; Stahle C; Harkins RN; Fausto N; Smith GH; Merlino GT		Cell	61	1990	1137-46	J:28452	2350785
788	Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.		Takagi H; Sharp R; Hammermeister C; Goodrow T; Bradley MO; Fausto N; Merlino G		Cancer Res	52	1992	5171-7	J:2578	1394122
789	Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.		Jonkers J; Meuwissen R; van Der Gulden H; Peterse H; van Der Valk M; Berns A		Nat Genet	29	2001	418-25	J:73028	11694875
790	Thymic lymphomas in mice with a truncating mutation in Brca2.		Friedman LS; Thistlethwaite FC; Patel KJ; Yu VP; Lee H; Venkitaraman AR ; Abel KJ ; Carlton MB ; Hunter SM ; Colledge WH ; Evans MJ ; Ponder BA		Cancer Res	58	1998	1338-43	J:46812	9537225
791	Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.		Connor F; Bertwistle D; Mee PJ; Ross GM; Swift S; Grigorieva E; Tybulewicz VL; Ashworth A		Nat Genet	17	1997	423-30	J:44386	9398843
792	Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.		Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ		Genes Dev	14	2000	1797-809	J:63444	10898794
793	Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1.		Costa RM; Yang T; Huynh DP; Pulst SM; Viskochil DH; Silva AJ; Brannan CI		Nat Genet	27	2001	399-405	J:68489	11279521
795	Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.		Zhu Y; Romero MI; Ghosh P; Ye Z; Charnay P; Rushing EJ; Marth JD; Parada LF		Genes Dev	15	2001	859-76	J:68558	11297510
796	Tumorigenesis in mice carrying a truncating Brca1 mutation.		Ludwig T; Fisher P; Ganesan S; Efstratiadis A		Genes Dev	15	2001	1188-93	J:69187	11358863
797	Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase.		Tsuzuki T; Egashira A; Igarashi H; Iwakuma T; Nakatsuru Y; Tominaga Y; Kawate H; Nakao K; Nakamura K; Ide F; Kura S; Nakabeppu Y; Katsuki M; Ishikawa T; Sekiguchi M		Proc Natl Acad Sci U S A	98	2001	11456-61	J:71836	11572992
798	Pathology image and annotation source		Mikaelian I; Sundberg JP		Personal Communication		2002		J:94310	 
799	Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.		Tamano S; Merlino GT; Ward JM		Carcinogenesis	15	1994	1791-8	J:20676	7923571
800	Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.		Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB		Cell Growth Differ	6	1995	737-48	J:29599	7669729
801	Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.		Smith GH; Sharp R; Kordon EC; Jhappan C; Merlino G		Am J Pathol	147	1995	1081-96	J:72083	7573353
802	Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast.		Sandgren EP; Luetteke NC; Palmiter RD; Brinster RL; Lee DC		Cell	61	1990	1121-35	J:28451	1693546
803	Effect of calorie restriction on mortality kinetics in inbred strains of mice following 7,12-dimethylbenz[a]anthracene treatment.		Lipman RD		J Gerontol A Biol Sci Med Sci	57	2002	B153-7	J:75723	11909880
804	Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.		Jackson EL; Willis N; Mercer K; Bronson RT; Crowley D; Montoya R; Jacks T; Tuveson DA		Genes Dev	15	2001	3243-8	J:73445	11751630
810	Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance.		Hu N; Gutsmann A; Herbert DC; Bradley A; Lee WH; Lee EY		Oncogene	9	1994	1021-7	J:17434	8134105
811	Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.		Harvey M; Vogel H; Lee EY; Bradley A; Donehower LA		Cancer Res	55	1995	1146-51	J:23284	7867001
812	Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia.		Bardeesy N; Morgan J; Sinha M; Signoretti S; Srivastava S; Loda M; Merlino G; DePinho RA		Mol Cell Biol	22	2002	635-43	J:73973	11756558
814	A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.		Christofori G; Naik P; Hanahan D		Nature	369	1994	414-8	J:76997	7910953
815	Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer.		Li QL; Ito K; Sakakura C; Fukamachi H; Inoue K; Chi XZ; Lee KY; Nomura S; Lee CW; Han SB; Kim HM; Kim WJ; Yamamoto H; Yamashita N; Yano T; Ikeda T; Itohara S; Inazawa J; Abe T; Hagiwara A; Yamagishi H; Ooe A; Kaneda A; Sugimura T; Ushijima T; Bae SC; Ito	Y	Cell	109	2002	113-24	J:75869	11955451
816	Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene.		Meuwissen R; Linn SC; van der Valk M; Mooi WJ; Berns A		Oncogene	20	2001	6551-8	J:72206	11641780
817	Noninvasive Imaging of Spontaneous Retinoblastoma Pathway-dependent Tumors in Mice.		Vooijs M; Jonkers J; Lyons S; Berns A		Cancer Res	62	2002	1862-7	J:75763	11912166
818	p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.		Flores ER; Tsai KY; Crowley D; Sengupta S; Yang A; McKeon F; Jacks T		Nature	416	2002	560-4	J:77565	11932750
819	Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.		Marino S; Vooijs M; van Der Gulden H; Jonkers J; Berns A		Genes Dev	14	2000	994-1004	J:61961	10783170
833	Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours.		Malliri A; Van Der Kammen RA; Clark K; Van Der Valk M; Michiels F; Collard JG		Nature	417	2002	867-71	J:77148	12075356
835	Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication.		Nilsen H; Rosewell I; Robins P; Skjelbred CF; Andersen S; Slupphaug G; Daly G; Krokan HE; Lindahl T; Barnes DE		Mol Cell	5	2000	1059-65	J:63056	10912000
836	Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.		Kim MJ; Bhatia-Gaur R; Banach-Petrosky WA; Desai N; Wang Y; Hayward SW; Cunha GR; Cardiff RD; Shen MM; Abate-Shen C		Cancer Res	62	2002	2999-3004	J:77034	12036903
837	Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.		Eischen CM; Rehg JE; Korsmeyer SJ; Cleveland JL		Cancer Res	62	2002	2184-91	J:75877	11929842
843	Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice.		Miyoshi H; Nakau M; Ishikawa TO; Seldin MF; Oshima M; Taketo MM		Cancer Res	62	2002	2261-6	J:76202	11956081
845	Role of PML in cell growth and the retinoic acid pathway.		Wang ZG; Delva L; Gaboli M; Rivi R; Giorgio M; Cordon-Cardo C; Grosveld F; Pandolfi PP		Science	279	1998	1547-51	J:46381	9488655
849	Pathology of aging B6;129 mice.		Haines DC; Chattopadhyay S; Ward JM		Toxicol Pathol	29	2001	653-61	J:74387	11794381
852	Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice.		Ludwig T; Fisher P; Murty V; Efstratiadis A		Oncogene	20	2001	3937-48	J:70564	11494122
853	Black 6 substrain clarification		Turturro A		Personal Communication		2002		J:94311	 
854	Longevity, body weight, and neoplasia in ad libitum-fed and diet-restricted C57BL6 mice fed NIH-31 open formula diet.		Blackwell BN; Bucci TJ; Hart RW; Turturro A		Toxicol Pathol	23	1995	570-82	J:30114	8578100
855	Black 6 substrain clarification		Nadon N		Personal Communication		2002		J:94312	 
856										
861	Colorectal cancer in mice genetically deficient in the mucin Muc2.		Velcich A; Yang W; Heyer J; Fragale A; Nicholas C; Viani S; Kucherlapati R; Lipkin M; Yang K; Augenlicht L		Science	295	2002	1726-9	J:75047	11872843
862	INK4d-deficient mice are fertile despite testicular atrophy		Zindy F; van Deursen J; Grosveld G; Sherr CJ; Roussel MF		Mol Cell Biol	20	2000	372-8	J:58959	10594039
863	Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.		Sotillo R; Dubus P; Martin J; de la Cueva E; Ortega S; Malumbres M; Barbacid M		EMBO J	20	2001	6637-47	J:73034	11726500
864	PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.		Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC		Genes Dev	15	2001	1913-25	J:77287	11485986
865	Enhanced tumor formation in mice heterozygous for Blm mutation.		Goss KH; Risinger MA; Kordich JJ; Sanz MM; Straughen JE; Slovek LE; Capobianco AJ; German J; Boivin GP; Groden J		Science	297	2002	2051-3	J:79058	12242442
866	Unrepaired DNA Breaks in p53-Deficient Cells Lead to Oncogenic Gene Amplification Subsequent to Translocations.		Zhu C; Mills KD; Ferguson DO; Lee C; Manis J; Fleming J; Gao Y; Morton CC; Alt FW		Cell	109	2002	811-21	J:77972	12110179
867	Invasive melanoma in Cdk4-targeted mice.		Sotillo R; Garcia JF; Ortega S; Martin J; Dubus P; Barbacid M; Malumbres M		Proc Natl Acad Sci U S A	98	2001	13312-7	J:72579	11606789
868										
872	The circadian gene period2 plays an important role in tumor suppression and DNA damage response in vivo.		Fu L; Pelicano H; Liu J; Huang P; Lee C		Cell	111	2002	41	J:79456	12372299
873	VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.		Inoue M; Hager JH; Ferrara N; Gerber HP; Hanahan D		Cancer Cell	1	2002	193-202	J:77131	12086877
874										
875	Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis.		Christofori G; Naik P; Hanahan D		Mol Endocrinol	9	1995	1760-70	J:30063	8614412
876	Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis		Bergers G; Brekken R; McMahon G; Vu TH; Itoh T; Tamaki K; Tanzawa K; Thorpe P; Itohara S; Werb Z; Hanahan D		Nat Cell Biol	2	2000	737-44	J:65019	11025665
877	Hepatocellular carcinoma caused by loss of heterozygosity in lkb1 gene knockout mice.		Nakau M; Miyoshi H; Seldin MF; Imamura M; Oshima M; Taketo MM		Cancer Res	62	2002	4549-53	J:78502	12183403
878	Haploinsufficiency of snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice		Roberts CW; Galusha SA; McMenamin ME; Fletcher CD; Orkin SH		Proc Natl Acad Sci U S A	97	2000	13796-800	J:66417	11095756
879										
881	Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5.		Roberts CW; Leroux MM; Fleming MD; Orkin SH		Cancer Cell	2	2002	415-25	J:80224	12450796
883	Transformation of the microvascular system during multistage tumorigenesis.		Ryschich E; Schmidt J; Hammerling GJ; Klar E; Ganss R		Int J Cancer	97	2002	719-25	J:74304	11857345
885	Pathology image and annotation source		Mikaelian I; Sundberg JP		Personal Communication		2003		J:94313	 
886										
887	Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.		Pelengaris S; Khan M; Evan GI		Cell	109	2002	321-34	J:76473	12015982
888	Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis.		Gannon G; Mandriota SJ; Cui L; Baetens D; Pepper MS; Christofori G		Cancer Res	62	2002	603-8	J:73999	11809716
889	Reversible tumorigenesis by MYC in hematopoietic lineages.		Felsher DW; Bishop JM		Mol Cell	4	1999	199-207	J:59444	10488335
890	Sustained loss of a neoplastic phenotype by brief inactivation of MYC.		Jain M; Arvanitis C; Chu K; Dewey W; Leonhardt E; Trinh M; Sundberg CD; Bishop JM; Felsher DW		Science	297	2002	102-4	J:77751	12098700
891										
892										
893	Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.		Mandriota SJ; Jussila L; Jeltsch M; Compagni A; Baetens D; Prevo R; Banerji S; Huarte J; Montesano R; Jackson DG; Orci L; Alitalo K; Christofori G; Pepper MS		EMBO J	20	2001	672-82	J:67489	11179212
895	A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.		Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS		Proc Natl Acad Sci U S A	98	2001	1118-23	J:67128	11158604
896	Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice.		Wagner M; Luhrs H; Kloppel G; Adler G; Schmid RM		Gastroenterology	115	1998	1254-62	J:52757	9797382
897	A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease.		Wagner M; Greten FR; Weber CK; Koschnick S; Mattfeldt T; Deppert W; Kern H; Adler G; Schmid RM		Genes Dev	15	2001	286-93	J:67389	11159909
898	Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors.		Chen WY; Zeng X; Carter MG; Morrell CN; Chiu Yen RW; Esteller M; Watkins DN; Herman JG; Mankowski JL; Baylin SB		Nat Genet	33	2003	197-202	J:81448	12539045
899										
900	Pathology of mouse models of intestinal cancer: consensus report and recommendations.		Boivin GP; Washington K; Yang K; Ward JM; Pretlow TP; Russell R; Besselsen DG; Godfrey VL; Doetschman T; Dove WF; Pitot HC; Halberg RB; Itzkowitz SH; Groden J; Coffey RJ		Gastroenterology	124	2003	762-77	J:82108	12612914
901	Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin.		Romagnolo B; Berrebi D; Saadi-Keddoucci S; Porteu A; Pichard AL; Peuchmaur M; Vandewalle A; Kahn A; Perret C		Cancer Res	59	1999	3875-9	J:56895	10463573
902	Notch1 functions as a tumor suppressor in mouse skin.		Nicolas M; Wolfer A; Raj K; Kummer JA; Mill P; Van Noort M; Hui CC; Clevers H; Dotto GP; Radtke F		Nat Genet	33	2003	416-21	J:81943	12590261
903	Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype.		Spring K; Cross S; Li C; Watters D; Ben-Senior L; Waring P; Ahangari F; Lu SL; Chen P; Misko I; Paterson C; Kay G; Smorodinsky NI; Shiloh Y; Lavin MF		Cancer Res	61	2001	4561-8	J:69726	11389091
904	Neurofibromas in NF1: Schwann cell origin and role of tumor environment.		Zhu Y; Ghosh P; Charnay P; Burns DK; Parada LF		Science	296	2002	920-2	J:76359	11988578
905	Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation.		Xiao A; Wu H; Pandolfi PP; Louis DN; Van Dyke T		Cancer Cell	1	2002	157-68	J:77132	12086874
906	Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.		Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF		Nat Genet	32	2002	185-90	J:78527	12195425
907	Nf1 has an essential role in endothelial cells.		Gitler AD; Zhu Y; Ismat FA; Lu MM; Yamauchi Y; Parada LF; Epstein JA		Nat Genet	33	2003	75-9	J:80323	12469121
908	Keratinocyte-specific Pten Deficiency Results in Epidermal Hyperplasia, Accelerated Hair Follicle Morphogenesis and Tumor Formation.		Suzuki A; Itami S; Ohishi M; Hamada K; Inoue T; Komazawa N; Senoo H; Sasaki T; Takeda J; Manabe M; Mak TW; Nakano T		Cancer Res	63	2003	674-81	J:81529	12566313
909	In vivo evaluation of 5-[(18)F]fluoro-2'-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model.		Seitz U; Wagner M; Vogg AT; Glatting G; Neumaier B; Greten FR; Schmid RM; Reske SN		Cancer Res	61	2001	3853-7	J:69189	11358795
910	Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas.		Hodgson G; Hager JH; Volik S; Hariono S; Wernick M; Moore D; Albertson DG; Pinkel D; Collins C; Hanahan D; Gray JW		Nat Genet	29	2001	459-64	J:73027	11694878
911	Tumor incidence, pathology image and annotation source		Mikaelian I		Personal Communication		2003		J:94314	 
912	Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice.		Donoho G; Brenneman MA; Cui TX; Donoviel D; Vogel H; Goodwin EH; Chen DJ; Hasty P		Genes Chromosomes Cancer	36	2003	317-31	J:82434	12619154
913	Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene.		McAllister KA; Bennett LM; Houle CD; Ward T; Malphurs J; Collins NK; Cachafeiro C; Haseman J; Goulding EH; Bunch D; Eddy EM; Davis BJ; Wiseman RW		Cancer Res	62	2002	990-4	J:75026	11861370
914	Liver Tumor Development. c-Jun Antagonizes the Proapoptotic Activity of p53.		Eferl R; Ricci R; Kenner L; Zenz R; David JP; Rath M; Wagner EF		Cell	112	2003	181-92	J:81543	12553907
915	Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.		Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX		Nat Genet	28	2001	266-71	J:70271	11431698
916	Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.		Cao L; Li W; Kim S; Brodie SG; Deng CX		Genes Dev	17	2003	201-13	J:81559	12533509
920	Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.		Connolly DC; Bao R; Nikitin AY; Stephens KC; Poole TW; Hua X; Harris SS; Vanderhyden BC; Hamilton TC		Cancer Res	63	2003	1389-97	J:82550	12649204
921	Pathology image and annotation source		Nikitin AY		Personal Communication		2003		J:94315	 
923	Developmental anomalies and neoplasia in animals and cells deficient in the large zinc finger protein KRC.		Allen CE; Muthusamy N; Weisbrode SE; Hong JW; Wu LC		Genes Chromosomes Cancer	35	2002	287-98	J:79652	12378523
924	Pathology image source		Wu LC		Personal Communication		2003		J:94316	 
926	A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice.		Harvey M; Vogel H; Morris D; Bradley A; Bernstein A; Donehower LA		Nat Genet	9	1995	305-11	J:23262	7773294
927	CB6F1-rasH2 mouse: overview of available data.		Usui T; Mutai M; Hisada S; Takoaka M; Soper KA; McCullough B; Alden C		Toxicol Pathol	29 Suppl	2001	90-108	J:73015	11695565
928	Age-related uterine and ovarian hypertrophy in FSH receptor knockout and FSHbeta subunit knockout mice.		Abel MH; Huhtaniemi I; Pakarinen P; Kumar TR; Charlton HM		Reproduction	125	2003	165-73	J:81519	12578530
929	Pathology annotation source		Abel MH		Personal Communication		2003		J:94317	 
930	Tyr-TGFalpha transgenic mice develop ocular melanocytic lesions.		Sutton R; Gordon-Thomson C; Cree IA; Mason RS; Moore GP		Melanoma Res	12	2002	435-9	J:79664	12394184
931	Pathology image and annotation source		Gordon-Thomson C		Personal Communication		2003		J:94318	 
932	Pathology image source		Bassing CH		Personal Communication		2003		J:94319	 
933	Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.		Bassing CH; Suh H; Ferguson DO; Chua KF; Manis J; Eckersdorff M; Gleason M; Bronson R; Lee C; Alt FW		Cell	114	2003	359-70	J:84879	12914700
934	Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.		Houghtaling S; Timmers C; Noll M; Finegold MJ; Jones SN; Meyn MS; Grompe M		Genes Dev	17	2003	2021-35	J:84892	12893777
941	Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers.		Waalkes MP; Ward JM; Diwan BA		Carcinogenesis	25	2004	133-41	J:87703	14514661
942	Synergistic Role of Ku80 and Poly(ADP-ribose) Polymerase in Suppressing Chromosomal Aberrations and Liver Cancer Formation.		Tong WM; Cortes U; Hande MP; Ohgaki H; Cavalli LR; Lansdorp PM; Haddad BR; Wang ZQ		Cancer Res	62	2002	6990-6	J:80276	12460917
943	Histiocytic Sarcoma in C57BL/6J Female Mice is Associated with Liver Hematopoiesis: Review of 41 Cases.		Lacroix-Triki M; Lacoste-Collin L; Jozan S; Charlet JP; Caratero C; Courtade M		Toxicol Pathol	31	2003	304-9	J:84222	12746118
944	Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium.		Huang J; Powell WC; Khodavirdi AC; Wu J; Makita T; Cardiff RD; Cohen MB; Sucov HM; Roy-Burman P		Cancer Res	62	2002	4812-9	J:78553	12183441
945	Null Mutation of DNA Strand Break-Binding Molecule Poly(ADP-ribose) Polymerase Causes Medulloblastomas in p53(-/-) Mice.		Tong WM; Ohgaki H; Huang H; Granier C; Kleihues P; Wang ZQ		Am J Pathol	162	2003	343-52	J:80903	12507917
946	Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet.		Yang W; Bancroft L; Nicholas C; Lozonschi I; Augenlicht LH		Cancer Res	63	2003	4990-6	J:85140	12941825
947	Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice.		Evert M; Ott T; Temme A; Willecke K; Dombrowski F		Carcinogenesis	23	2002	697-703	J:76612	12016140
948	A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity.		Haigis KM; Dove WF		Nat Genet	33	2003	33-9	J:80330	12447373
949	Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors.		Nambiar PR; Girnun G; Lillo NA; Guda K; Whiteley HE; Rosenberg DW		Int J Oncol	22	2003	145-50	J:80268	12469197
950	Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice.		Zindy F; Nilsson LM; Nguyen L; Meunier C; Smeyne RJ; Rehg JE; Eberhart C; Sherr CJ; Roussel MF		Cancer Res	63	2003	5420-7	J:85515	14500377
953	Development of colonic adenocarcinomas in a mouse model of ulcerative colitis.		Shah SA; Simpson SJ; Brown LF; Comiskey M; de Jong YP; Allen D; Terhorst C		Inflamm Bowel Dis	4	1998	196-202	J:51450	9741021
954	Inhibition of Oncogenic K-ras Signaling by Aerosolized Gene Delivery in a Mouse Model of Human Lung Cancer.		Lee HY; Suh YA; Lee JI; Hassan KA; Mao L; Force T; Gilbert BE; Jacks T; Kurie JM		Clin Cancer Res	8	2002	2970-5	J:79065	12231543
955	Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences.		Williams BO; Schmitt EM; Remington L; Bronson RT; Albert DM; Weinberg RA; Jacks T		EMBO J	13	1994	4251-9	J:59268	7925270
956	ARF mutation accelerates pituitary tumor development in Rb+/- mice.		Tsai KY; MacPherson D; Rubinson DA; Nikitin AY; Bronson R; Mercer KL; Crowley D; Jacks T		Proc Natl Acad Sci U S A	99	2002	16865-70	J:81016	12486224
957	Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.		Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ		Oncogene	21	2002	8486-97	J:80271	12466968
958	Tumor incidence, pathology image and annotation source		Mikaelian I		Personal Communication		2004		J:94320	 
959	Pathology annotation source		Bronson RT		Personal Communication		2003		J:94321	 
960	Pathology image source		Dombrowski F		Personal Communication		2003		J:94322	 
961	Pathology annotation source		Evert M		Personal Communication		2003		J:94323	 
962	Pathology image source		Augenlicht LH		Personal Communication		2003		J:94324	 
963	Pathology image source		Yang WC		Personal Communication		2003		J:94325	 
964	Pathology annotation source		Ward J		Personal Communication		2003		J:94326	 
965	Pathology image source		Lacroix-Triki M		Personal Communication		2003		J:94327	 
966	Pathology image and annotation source		Tong WM		Personal Communication		2003		J:94328	 
967	2-Difluoromethylornithine and Dehydroepiandrosterone Inhibit Mammary Tumor Progression but not Mammary or Prostate Tumor Initiation in C3(1)/SV40 T/t-antigen Transgenic Mice.		Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R		Cancer Res	61	2001	7449-55	J:72279	11606379
969	Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice.		Sansom OJ; Stark LA; Dunlop MG; Clarke AR		Cancer Res	61	2001	7060-4	J:72233	11585736
970	Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency.		Gallagher RC; Hay T; Meniel V; Naughton C; Anderson TJ; Shibata H; Ito M; Clevers H; Noda T; Sansom OJ; Mason JO; Clarke AR		Oncogene	21	2002	6446-57	J:79068	12226748
971										
972	Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis.		Sharp R; Recio JA; Jhappan C; Otsuka T; Liu S; Yu Y; Liu W; Anver M; Navid F; Helman LJ; DePinho RA; Merlino G		Nat Med	8	2002	1276-80	J:79704	12368906
974	The Role of Ink4a/Arf in ErbB2 Mammary Gland Tumorigenesis.		D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG		Cancer Res	63	2003	3395-402	J:83972	12810676
975	Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.		Shibata MA; Ward JM; Devor DE; Liu ML; Green JE		Cancer Res	56	1996	4894-903	J:72324	8895741
976	Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.		You MJ; Castrillon DH; Bastian BC; O'Hagan RC; Bosenberg MW; Parsons R; Chin L; DePinho RA		Proc Natl Acad Sci U S A	99	2002	1455-60	J:74365	11818530
977	Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models.		Shibata MA; Kavanaugh C; Shibata E; Abe H; Nguyen P; Otsuki Y; Trepel JB; Green JE		Carcinogenesis	24	2003	453-9	J:82837	12663504
978	Genetic Interactions between the Wilms' Tumor 1 Gene and the p53 Gene.		Menke AL; Clarke AR; Leitch A; Ijpenberg A; Williamson KA; Spraggon L; Harrison DJ; Hastie ND		Cancer Res	62	2002	6615-20	J:80297	12438257
979	Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background.		Toft NJ; Curtis LJ; Sansom OJ; Leitch AL; Wyllie AH; te Riele H; Arends MJ; Clarke AR		Oncogene	21	2002	6299-306	J:79081	12214270
981	Telomere dysfunction provokes regional amplification and deletion in cancer genomes.		O'Hagan R; Chang S; Maser R; Mohan R; Artandi S; Chin L; DePinho R		Cancer Cell	2	2002	149-55	J:78479	12204535
982	Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.		Moore L; Venkatachalam S; Vogel H; Watt JC; Wu CL; Steinman H; Jones SN; Donehower LA		Oncogene	22	2003	7831-7	J:86658	14586409
983	Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice	 	Estensen RD; Jordan MM; Wiedmann TS; Galbraith AR; Steele VE; Wattenberg LW	 	Carcinogenesis	25	2004	197-201	J:86512	 
984	Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.		Meuwissen R; Linn SC; Linnoila RI; Zevenhoven J; Mooi WJ; Berns A		Cancer Cell	4	2003	181-9	J:86077	14522252
985										
986	Genetic interactions between Pten and p53 in radiation-induced lymphoma development.		Mao JH; Wu D; Perez-Losada J; Nagase H; DelRosario R; Balmain A		Oncogene	22	2003	8379-85	J:86813	14627978
987	Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.		Philipp-Staheli J; Kim KH; Payne SR; Gurley KE; Liggitt D; Longton G; Kemp CJ		Cancer Cell	1	2002	355-68	J:77135	12086850
988										
989										
991	A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.		Brown D; Kogan S; Lagasse E; Weissman I; Alcalay M; Pelicci PG ; Atwater S ; Bishop JM		Proc Natl Acad Sci U S A	94	1997	2551-6	J:39327	9122233
992	Unbalanced overexpression of the mutant allele in murine Patched mutants.		Calzada-Wack J; Kappler R; Schnitzbauer U; Richter T; Nathrath M; Rosemann M; Wagner SN; Hein R; Hahn H		Carcinogenesis	23	2002	727-33	J:77190	12016144
993	Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia.		Rane SG; Dubus P; Mettus RV; Galbreath EJ; Boden G; Reddy EP; Barbacid M		Nat Genet	22	1999	44-52	J:54534	10319860
995	Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin.		Vasioukhin V; Bauer C; Degenstein L; Wise B; Fuchs E		Cell	104	2001	605-17	J:67797	11239416
996	Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice.		Maandag EC; van der Valk M; Vlaar M; Feltkamp C; O'Brien J; van Roon M; van der Lugt N; Berns A; te Riele H		EMBO J	13	1994	4260-8	J:20542	7925271
998	Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage.		Passegue E; Jochum W; Schorpp-Kistner M; Mohle-Steinlein U; Wagner EF		Cell	104	2001	21-32	J:67298	11163237
999	Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice.		Luthra R; Kirma N; Jones J; Tekmal RR		J Steroid Biochem Mol Biol	86	2003	461-7	J:86740	14623545
1000	Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities.		Tekmal RR; Ramachandra N; Gubba S; Durgam VR; Mantione J; Toda K; Shizuta Y; Dillehay DL		Cancer Res	56	1996	3180-5	J:34063	8764102
1001	Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.		Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L		Oncogene	22	2003	5055-9	J:85075	12902988
1002	Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.		Ruggero D; Grisendi S; Piazza F; Rego E; Mari F; Rao PH; Cordon-Cardo C; Pandolfi PP		Science	299	2003	259-62	J:81054	12522253
1003	Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.		Lin EY; Jones JG; Li P; Zhu L; Whitney KD; Muller WJ; Pollard JW		Am J Pathol	163	2003	2113-26	J:86499	14578209
1004	Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.		Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC		Cancer Res	62	2002	5551-8	J:79689	12359767
1005	Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes.		Holland EC; Hively WP; Gallo V; Varmus HE		Genes Dev	12	1998	3644-9	J:51558	9851971
1006	MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials.		Koutcher JA; Hu X; Xu S; Gade TP; Leeds N; Zhou XJ; Zagzag D; Holland EC		Neoplasia	4	2002	480-5	J:79700	12407441
1007	c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice.		Rao G; Pedone CA; Coffin CM; Holland EC; Fults DW		Neoplasia	5	2003	198-204	J:85011	12869303
1009	p53 mutant mice that display early ageing-associated phenotypes.		Tyner SD; Venkatachalam S; Choi J; Jones S; Ghebranious N; Igelmann H; Lu X; Soron G; Cooper B; Brayton C; Hee Park S; Thompson T; Karsenty G; Bradley A; Donehower LA		Nature	415	2002	45-53	J:73757	11780111
1010	Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice.		Van Dyke TA; Finlay C; Miller D; Marks J; Lozano G; Levine AJ		J Virol	61	1987	2029-32	J:80228	3033329
1012	Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice.		Rudolph U; Finegold MJ; Rich SS; Harriman GR; Srinivasan Y; Brabet P; Boulay G; Bradley A; Birnbaumer L		Nat Genet	10	1995	143-50	J:24434	7663509
1014	Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.		Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX		Mol Endocrinol	17	2003	1880-92	J:85302	12819299
1015	Pathology image source		Roy-Burman P		Personal Communication		2003		J:94329	 
1016	Pathology annotation source		Khodavirdi AC		Personal Communication		2003		J:94330	 
1017	Pathology image source		Crosby K		Personal Communication		2003		J:94331	 
1018										
1028	Spontaneous aberrant crypt foci in Apc1638N mice with a mutant Apc allele.		Pretlow TP; Edelmann W; Kucherlapati R; Pretlow TG; Augenlicht LH		Am J Pathol	163	2003	1757-63	J:86500	14578176
1029	High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice.		Pazzaglia S; Mancuso M; Atkinson MJ; Tanori M; Rebessi S; Majo VD; Covelli V; Hahn H; Saran A		Oncogene	21	2002	7580-4	J:79666	12386820
1030	Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.		Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A		Cancer Res	61	2001	3826-36	J:69129	11325859
1031	The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched		Wetmore C; Eberhart DE; Curran T		Cancer Res	60	2000	2239-46	J:61727	10786690
1066	Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways.		Gallego MI; Bierie B; Hennighausen L		Oncogene	22	2003	8498-508	J:86776	14627990
1067	Pathology image source		Gallego MI		Personal Communication		2004		J:94332	 
1074	p53 Deficiency Accelerates Induction and Progression of Esophageal and Forestomach Tumors in Zinc-deficient Mice.		Fong LY; Ishii H; Nguyen VT; Vecchione A; Farber JL; Croce CM; Huebner K		Cancer Res	63	2003	186-95	J:81055	12517797
1076	Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice.		Aoki K; Tamai Y; Horiike S; Oshima M; Taketo MM		Nat Genet	35	2003	323-30	J:86737	14625550
1077	Sphingomyelin in the suppression of colon tumors: prevention versus intervention.		Lemonnier LA; Dillehay DL; Vespremi MJ; Abrams J; Brody E; Schmelz EM		Arch Biochem Biophys	419	2003	129-38	J:86487	14592456
1078	Genetic determinants of malignancy in a mouse model for oligodendroglioma.		Weiss WA; Burns MJ; Hackett C; Aldape K; Hill JR; Kuriyama H; Kuriyama N; Milshteyn N; Roberts T; Wendland MF; DePinho R; Israel MA		Cancer Res	63	2003	1589-95	J:82649	12670909
1079	Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice.		Kongkanuntn R; Bubb VJ; Sansom OJ; Wyllie AH; Harrison DJ; Clarke AR		Oncogene	18	1999	7219-25	J:59017	10602475
1080	The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development.		Bonhomme C; Duluc I; Martin E; Chawengsaksophak K; Chenard MP; Kedinger M; Beck F; Freund JN; Domon-Dell C		Gut	52	2003	1465-71	J:86091	12970140
1081	Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice.		Liu ES; Ye YN; Shin VY; Yuen ST; Leung SY; Wong BC; Cho CH		Carcinogenesis	24	2003	1407-13	J:84490	12807736
1082	Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression.		Ritland SR; Gendler SJ		Carcinogenesis	20	1999	51-8	J:52249	9934849
1083	Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.		Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ		Clin Cancer Res	5	1999	855-63	J:54378	10213222
1085	Inactivation of both APC alleles in human and mouse tumors.		Levy DB; Smith KJ; Beazer-Barclay Y; Hamilton SR; Vogelstein B; Kinzler KW		Cancer Res	54	1994	5953-8	J:21856	7954428
1086	Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.		Boolbol SK; Dannenberg AJ; Chadburn A; Martucci C; Guo XJ; Ramonetti JT; Abreu-Goris M; Newmark HL; Lipkin ML; DeCosse JJ; Bertagnolli MM		Cancer Res	56	1996	2556-60	J:33982	8653697
1088	Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos		Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA		Cancer Res	60	2000	1864-70	J:61461	10766173
1089	Adenoma-specific alterations of protein kinase C isozyme expression in Apc(MIN) mice		Klein IK; Ritland SR; Burgart LJ; Ziesmer SC; Roche PC; Gendler SJ; Karnes WE Jr		Cancer Res	60	2000	2077-80	J:61731	10786662
1090	Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea.		Qin X; Shibata D; Gerson SL		Carcinogenesis	21	2000	833-8	J:61787	10753224
1091	Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane.		Takahashi M; Nakatsugi S; Sugimura T; Wakabayashi K		Carcinogenesis	21	2000	1117-20	J:62880	10836998
1092	Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens.		Corpet DE; Parnaud G; Delverdier M; Peiffer G; Tache S		Cancer Res	60	2000	3160-4	J:62925	10866305
1093	Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.		Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR		Cancer Res	60	2000	5151-7	J:64784	11016642
1094	Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele.		Cormier RT; Dove WF		Cancer Res	60	2000	3965-70	J:63662	10919675
1095	The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.		Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA		Cancer Res	60	2000	5040-4	J:64781	11016626
1096	Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.		Chulada PC; Thompson MB; Mahler JF; Doyle CM; Gaul BW; Lee C; Tiano HF; Morham SG; Smithies O; Langenbach R		Cancer Res	60	2000	4705-8	J:64401	10987272
1097	Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in ApcMin mice but induces duodenal injury.		Ritland SR; Gendler SJ; Burgart LJ; Fry DW; Nelson JM; Bridges AJ; Andress L; Karnes WE Jr		Cancer Res	60	2000	4678-81	J:64399	10987266
1098	The effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice.		Wilson JW; Potten CS		Cancer Res	60	2000	4645-53	J:64010	10969819
1099	Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse		Song J; Medline A; Mason JB; Gallinger S; Kim YI		Cancer Res	60	2000	5434-40	J:65027	11034085
1100	Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency.		Kuraguchi M; Edelmann W; Yang K; Lipkin M; Kucherlapati R; Brown AM		Oncogene	19	2000	5755-63	J:67119	11126362
1101	(+)-Catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the min/+ mouse.		Weyant MJ; Carothers AM; Dannenberg AJ; Bertagnolli MM		Cancer Res	61	2001	118-25	J:67060	11196148
1102	p21(WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo.		Yang W; Velcich A; Mariadason J; Nicholas C; Corner G; Houston M; Edelmann W; Kucherlapati R; Holt PR; Augenlicht LH		Cancer Res	61	2001	6297-302	J:70893	11507085
1103	Suppression of intestinal polyps in msh2-deficient and non-msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.		Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S		Cancer Res	61	2001	6131-6	J:70902	11507063
1105	Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.		Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH Jr		Cancer Res	61	2001	6723-9	J:71590	11559543
1106	Molecular Genetics of Ulcerative Colitis-associated Colon Cancer in the Interleukin 2- and beta(2)-Microglobulin-deficient Mouse.		Sohn KJ; Shah SA; Reid S; Choi M; Carrier J; Comiskey M; Terhorst C; Kim YI		Cancer Res	61	2001	6912-7	J:71656	11559569
1107	Establishment of a Tcrb and Trp53 genes deficient mouse strain as an animal model for spontaneous colorectal cancer.		Funabashi H; Uchida K; Kado S; Matsuoka Y; Ohwaki M		Exp Anim	50	2001	41-7	J:68090	11326422
1108	Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal.		Yang WC; Mathew J; Velcich A; Edelmann W; Kucherlapati R; Lipkin M; Yang K; Augenlicht LH		Cancer Res	61	2001	565-9	J:67451	11212250
1109	Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.		Watson SA; Smith AM		Cancer Res	61	2001	625-31	J:67449	11212260
1110	1,2-Dimethylhydrazine-Induced Colon Carcinoma and Lymphoma in msh2(-/-) Mice.		Colussi C; Fiumicino S; Giuliani A; Rosini S; Musiani P; Macri C; Potten CS; Crescenzi M; Bignami M		J Natl Cancer Inst	93	2001	1534-40	J:72174	11604476
1111	Strain clarification		Rockwood S		Personal Communication		2004		J:97136	 
1112	Strain clarification		Merlino G		Personal Communication		2004		J:94333	 
1113	Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production.		Ahn B; Ohshima H		Cancer Res	61	2001	8357-60	J:73152	11731407
1114	Strain clarification		DePinho RA		Personal Communication		2004		J:94334	 
1131	Pathology annotation source		Summers BA		Personal Communication		2004		J:94335	 
1175	Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol.		Sohn OS; Fiala ES; Requeijo SP; Weisburger JH; Gonzalez FJ		Cancer Res	61	2001	8435-40	J:73155	11731424
1178	Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis.		Weyant MJ; Carothers AM; Mahmoud NN; Bradlow HL; Remotti H; Bilinski RT; Bertagnolli MM		Cancer Res	61	2001	2547-51	J:68469	11289129
1195	Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.		Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF		Cancer Res	61	2001	1733-40	J:68513	11245490
1198	The Distinct Spectra of Tumor-associated Apc Mutations in Mismatch Repair-deficient Apc(1638N) Mice Define the Roles of MSH3 and MSH6 in DNA Repair and Intestinal Tumorigenesis.		Kuraguchi M; Yang K; Wong E; Avdievich E; Fan K; Kolodner RD; Lipkin M; Brown AM; Kucherlapati R; Edelmann W		Cancer Res	61	2001	7934-42	J:73030	11691815
1199	Qualitative and Quantitative Relationship between Dysplastic Aberrant Crypt Foci and Tumorigenesis in the Min/+ Mouse Colon.		Erik Paulsen J; Steffensen IL; Loberg EM; Husoy T; Namork E; Alexander J		Cancer Res	61	2001	5010-5	J:70170	11431334
1204	Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice.		Kado S; Uchida K; Funabashi H; Iwata S; Nagata Y; Ando M; Onoue M; Matsuoka Y; Ohwaki M; Morotomi M		Cancer Res	61	2001	2395-8	J:68471	11289103
1205	Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis.		Jishage K; Nezu J; Kawase Y; Iwata T; Watanabe M; Miyoshi A; Ose A; Habu K; Kake T; Kamada N; Ueda O; Kinoshita M; Jenne DE; Shimane M; Suzuki H		Proc Natl Acad Sci U S A	99	2002	8903-8	J:77213	12060709
1206	Suppression of intestinal neoplasia by DNA hypomethylation.		Laird PW; Jackson-Grusby L; Fazeli A; Dickinson SL; Jung WE; Li E; Weinberg RA; Jaenisch R		Cell	81	1995	197-205	J:25691	7537636
1214	Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.		Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD		Cancer Res	61	2001	8803-10	J:73360	11751402
1215	One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene.		Andreassen A; Mollersen L; Vikse R; Steffensen IL; Mikalsen A; Paulsen JE; Alexander J		Mutat Res	517	2002	157-66	J:77184	12034317
1217	Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.		Rao DS; Hyun TS; Kumar PD; Mizukami IF; Rubin MA; Lucas PC; Sanda MG; Ross TS		J Clin Invest	110	2002	351-60	J:78515	12163454
1218	No effects of smad2 (madh2) null mutation on malignant progression of intestinal polyps in apc(delta716) knockout mice.		Takaku K; Wrana JL; Robertson EJ; Taketo MM		Cancer Res	62	2002	4558-61	J:78501	12183405
1220	1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse.		Huerta S; Irwin RW; Heber D; Go VL; Koeffler HP; Uskokovic MR; Harris DM		Cancer Res	62	2002	741-6	J:74361	11830528
1221	Complete Genetic Suppression of Polyp Formation and Reduction of CpG-Island Hypermethylation in Apc(Min/+) Dnmt1-Hypomorphic Mice.		Eads CA; Nickel AE; Laird PW		Cancer Res	62	2002	1296-9	J:75230	11888894
1222	Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.		Seno H; Oshima M; Ishikawa TO; Oshima H; Takaku K; Chiba T; Narumiya S; Taketo MM		Cancer Res	62	2002	506-11	J:74003	11809702
1223	Inhibition of colon tumor progression and angiogenesis by the ink4a/arf locus.		Gibson SL; Dai CY; Lee HW; DePinho RA; Gee MS; Lee WM; Furth EE; Brensinger C; Enders GH		Cancer Res	63	2003	742-6	J:81942	12591718
1224	Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis.		Takagi T; Nakano Y; Takekoshi S; Inagami T; Tamura M		Carcinogenesis	23	2002	1235-41	J:77740	12117783
1225	Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.		Mutoh M; Watanabe K; Kitamura T; Shoji Y; Takahashi M; Kawamori T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K		Cancer Res	62	2002	28-32	J:73944	11782353
1226	Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice.		Trasler J; Deng L; Melnyk S; Pogribny I; Hiou-Tim F; Sibani S; Oakes C; Li E; James SJ; Rozen R		Carcinogenesis	24	2003	39-45	J:81577	12538347
1227	Susceptibility of Msh2-deficient Mice to Inflammation-associated Colorectal Tumors.		Kohonen-Corish MR; Daniel JJ; te Riele H; Buffinton GD; Dahlstrom JE		Cancer Res	62	2002	2092-7	J:75751	11929830
1228	Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.		Bardeesy N; Sinha M; Hezel AF; Signoretti S; Hathaway NA; Sharpless NE; Loda M; Carrasco DR; DePinho RA		Nature	419	2002	162-7	J:78818	12226664
1229	Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts.		Steffensen IL; Schut HA; Paulsen JE; Andreassen A; Alexander J		Cancer Res	61	2001	8689-96	J:73361	11751386
1230	DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair.		Trinh BN; Long TI; Nickel AE; Shibata D; Laird PW		Mol Cell Biol	22	2002	2906-17	J:75745	11940649
1237	Use of transgenic mice reveals cell-specific transformation by a simian virus 40 T-antigen amino-terminal mutant.		Symonds HS; McCarthy SA; Chen J; Pipas JM; Van Dyke T		Mol Cell Biol	13	1993	3255-65	J:78681	8388535
1238	Pathology annotation source		Bronson RT		Personal Communication		2004		J:94336	 
1239	Pathology image source		Mercer K		Personal Communication		2004		J:94337	 
1254	Pathology image source		Burzenski L		Personal Communication		2004		J:97124	 
1255	Pathology annotation source		Lyons BL		Personal Communication		2004		J:97125	 
1257	The development of forestomach tumours in the mouse following exposure to 2-butoxyethanol by inhalation: studies on the mode of action and relevance to humans.		Green T; Toghill A; Lee R; Moore R; Foster J		Toxicology	180	2002	257	J:79665	12393295
1258	APC-dependent suppression of colon carcinogenesis by PPARgamma.		Girnun GD; Smith WM; Drori S; Sarraf P; Mueller E; Eng C; Nambiar P; Rosenberg DW; Bronson RT; Edelmann W; Kucherlapati R; Gonzalez FJ; Spiegelman BM		Proc Natl Acad Sci U S A	99	2002	13771-6	J:79682	12370429
1259	Diet, cancer and aging in DNA mismatch repair deficient mice.		Tsao JL; Dudley S; Kwok B; Nickel AE; Laird PW; Siegmund KD; Liskay RM; Shibata D		Carcinogenesis	23	2002	1807-10	J:80008	12419828
1260	The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus.		Koratkar R; Pequignot E; Hauck WW; Siracusa LD		Cancer Res	62	2002	5413-7	J:79690	12359746
1261	Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation.		Wong E; Yang K; Kuraguchi M; Werling U; Avdievich E; Fan K; Fazzari M; Jin B; Brown AM; Lipkin M; Edelmann W		Proc Natl Acad Sci U S A	99	2002	14937-42	J:80319	12417741
1262	PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.		Kim S; Domon-Dell C; Wang Q; Chung DH; Di Cristofano A; Pandolfi PP; Freund JN; Evers BM		Gastroenterology	123	2002	1163-78	J:79378	12360479
1263	Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene.		Hohenstein P; Molenaar L; Elsinga J; Morreau H; Van Der Klift H; Struijk A; Jagmohan-Changur S; Smits R; Van Kranen H; Van Ommen GJ; Cornelisse C; Devilee P; Fodde R		Genes Chromosomes Cancer	36	2003	273-82	J:81488	12557227
1264	Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction.		Wagenaar-Miller RA; Hanley G; Shattuck-Brandt R; DuBois RN; Bell RL; Matrisian LM; Morgan DW		Br J Cancer	88	2003	1445-52	J:83488	12778076
1265	Multistage gene expression profiling in a differentially susceptible mouse colon cancer model.		Guda K; Cui H; Garg S; Dong M; Nambiar PR; Achenie LE; Rosenberg DW		Cancer Lett	191	2003	17-25	J:81930	12609705
1266	Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility.		Papanikolaou A; Wang QS; Delker DA; Rosenberg DW		Cancer Lett	130	1998	29-34	J:49937	9751253
1267	Thrombospondin 1--a regulator of adenoma growth and carcinoma progression in the APC(Min/+) mouse model.		Gutierrez LS; Suckow M; Lawler J; Ploplis VA; Castellino FJ		Carcinogenesis	24	2003	199-207	J:79641	12584168
1268	Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.		Yang X; Letterio JJ; Lechleider RJ; Chen L; Hayman R; Gu H; Roberts AB; Deng C		EMBO J	18	1999	1280-91	J:53510	10064594
1269	p21Cip1 Nullizygosity increases tumor metastasis in irradiated mice.		Jackson RJ; Engelman RW; Coppola D; Cantor AB; Wharton W; Pledger WJ		Cancer Res	63	2003	3021-5	J:83967	12810620
1270	Pathology image source		Kemp CJ		Personal Communication		2004		J:97126	 
1271	Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis.		Takeda H; Sonoshita M; Oshima H; Sugihara K; Chulada PC; Langenbach R; Oshima M; Taketo MM		Cancer Res	63	2003	4872-7	J:85136	12941808
1272	The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice.		Mochida Y; Taguchi K; Taniguchi S; Tsuneyoshi M; Kuwano H; Tsuzuki T; Kuwano M; Wada M		Carcinogenesis	24	2003	1219-24	J:84491	12807720
1273	Cell Lineage-specific Effects Associated with Multiple Deficiencies of Tumor Susceptibility Genes in Msh2(-/-)Rb(+/-) Mice.		Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH		Cancer Res	62	2002	5134-8	J:79016	12234974
1274	High susceptibility of Scid mice to colon carcinogenesis induced by azoxymethane indicates a possible caretaker role for DNA-dependent protein kinase.		Ochiai M; Ubagai T; Kawamori T; Imai H; Sugimura T; Nakagama H		Carcinogenesis	22	2001	1551-5	J:84343	11532879
1275	High susceptibility of nullizygous p53 knockout mice to colorectal tumor induction by 1,2-dimethylhydrazine.		Sakai H; Tsukamoto T; Yamamoto M; Shirai N; Iidaka T; Hirata A; Yanai T; Masegi T; Donehower LA; Tatematsu M		J Cancer Res Clin Oncol	129	2003	335-40	J:84233	12743811
1276	Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice.		Yamada T; Mori Y; Hayashi R; Takada M; Ino Y; Naishiro Y; Kondo T; Hirohashi S		Cancer Res	63	2003	895-901	J:82288	12615699
1277	Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.		Gupta RA; Wang D; Katkuri S; Wang H; Dey SK; DuBois RN		Nat Med	10	2004	245-7	J:88127	14758356
1278	Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice.		Lefebvre AM; Chen I; Desreumaux P; Najib J; Fruchart JC; Geboes K; Briggs M; Heyman R; Auwerx J		Nat Med	4	1998	1053-7	J:49814	9734399
1279	Promotion of Colon Tumors in C57BL/6J-APC(min)/+ Mice by Thiazolidinedione PPARgamma Agonists and a Structurally Unrelated PPARgamma Agonist.		Pino MV; Kelley MF; Jayyosi Z		Toxicol Pathol	32	2004	58-63	J:88111	14713549
1280	Wnt inhibitory factor-1: a candidate for a new player in tumorigenesis of intestinal epithelial cells.		Cebrat M; Strzadala L; Kisielow P		Cancer Lett	206	2004	107-13	J:88778	15019166
1281	Simultaneous expression of COX-2 and mPGES-1 in mouse gastrointestinal hamartomas.		Takeda H; Miyoshi H; Tamai Y; Oshima M; Taketo MM		Br J Cancer	90	2004	701-4	J:88082	14760387
1282	Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice.		Ziegler CC; Rainwater L; Whelan J; McEntee MF		J Nutr	134	2004	5-10	J:88124	14704285
1283	Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin.		Barnes CJ; Lee M		Gastroenterology	114	1998	873-7	J:48008	9558273
1284	Activators of the nuclear receptor PPARgamma enhance colon polyp formation.		Saez E; Tontonoz P; Nelson MC; Alvarez JG; Ming UT; Baird SM; Thomazy VA; Evans RM		Nat Med	4	1998	1058-61	J:49813	9734400
1285	Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice.		Paulsen JE; Steffensen IL; Andreassen A; Vikse R; Alexander J		Carcinogenesis	20	1999	1277-82	J:56392	10383901
1286	The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse.		Sorensen IK; Kristiansen E; Mortensen A; Nicolaisen GM; Wijnands JA; van Kranen HJ; van Kreijl CF		Cancer Lett	130	1998	217-25	J:49938	9751277
1287	Effects of dietary fat and a vegetable-fruit mixture on the development of intestinal neoplasia in the ApcMin mouse.		van Kranen HJ; van Iersel PW; Rijnkels JM; Beems DB; Alink GM; van Kreijl CF		Carcinogenesis	19	1998	1597-601	J:49892	9771930
1288	NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice.		Williams JL; Kashfi K; Ouyang N; del Soldato P; Kopelovich L; Rigas B		Biochem Biophys Res Commun	313	2004	784-8	J:87459	14697260
1289	Cyclin D1 expression in the intestinal mucosa and tumors of Apc1638N mice.		Shinozaki H; Yang K; Fan K; Edelmann W; Kucherlapati R; Weinstein IB; Lipkin M		Anticancer Res	23	2003	2217-26	J:84994	12894495
1290	Adenomatous polyposis coli truncation mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumours of multiple intestinal neoplasia mice.		Mollersen L; Vikse R; Andreassen A; Steffensen IL; Mikalsen A; Paulsen JE; Alexander J		Mutat Res	557	2004	29-40	J:87470	14706516
1291	Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice.		Mollersen L; Paulsen JE; Olstorn HB; Knutsen HK; Alexander J		Carcinogenesis	25	2004	149-53	J:87705	14514656
1292	Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2- and beta(2)-microglobulin-deficient mice.		Carrier J; Medline A; Sohn KJ; Choi M; Martin R; Hwang SW; Kim YI		Cancer Epidemiol Biomarkers Prev	12	2003	1262-7	J:87528	14652292
1293	Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130.		Judd LM; Alderman BM; Howlett M; Shulkes A; Dow C; Moverley J; Grail D; Jenkins BJ; Ernst M; Giraud AS		Gastroenterology	126	2004	196-207	J:87206	14699500
1294	Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.		Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ		Physiol Genomics	15	2003	228-35	J:86113	13130079
1295	Effects of docosahexaenoic acid (DHA) on intestinal polyp development in Apc delta 716 knockout mice.		Oshima M; Takahashi M; Oshima H; Tsutsumi M; Yazawa K; Sugimura T; Nishimura S; Wakabayashi K; Taketo MM		Carcinogenesis	16	1995	2605-7	J:30492	7586174
1296	Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice		Nakatsugi S; Fukutake M; Takahashi M; Fukuda K; Isoi T; Taniguchi Y; Sugimura T; Wakabayashi K		Jpn J Cancer Res	88	1997	1117-20	J:45606	9473726
1297	Celecoxib and rofecoxib potentiate chronic colitis and premalignant changes in interleukin 10 knockout mice.		Hegazi RA; Mady HH; Melhem MF; Sepulveda AR; Mohi M; Kandil HM		Inflamm Bowel Dis	9	2003	230-6	J:85702	12902846
1298	Combined effects of prostaglandin E receptor subtype EP(1) and subtype EP(4) antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.		Kitamura T; Itoh M; Noda T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimura T; Wakabayashi K		Cancer Sci	94	2003	618-21	J:85027	12841871
1299	Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc(delta716) knockout mice.		Hioki K; Shivapurkar N; Oshima H; Alabaster O; Oshima M; Taketo MM		Carcinogenesis	18	1997	1863-5	J:44139	9363991
1300	Detection of spontaneous schwannomas by MRI in a transgenic murine model of neurofibromatosis type 2.		Messerli SM; Tang Y; Giovannini M; Bronson R; Weissleder R; Breakefield XO		Neoplasia	4	2002	501-9	J:79655	12407444
1301	Deficiency of Mbd2 suppresses intestinal tumorigenesis.		Sansom OJ; Berger J; Bishop SM; Hendrich B; Bird A; Clarke AR		Nat Genet	34	2003	145-7	J:83087	12730693
1302	Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.		Sterner-Kock A; Thorey IS; Koli K; Wempe F; Otte J; Bangsow T; Kuhlmeier K; Kirchner T; Jin S; Keski-Oja J; von Melchner H		Genes Dev	16	2002	2264-73	J:78819	12208849
1303	Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency.		Hollander MC; Kovalsky O; Salvador JM; Kim KE; Patterson AD; Haines DC; Fornace AJ		Cancer Res	61	2001	2487-91	J:68470	11289119
1304	Short-term carcinogenicity testing of a potent murine intestinal mutagen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), in Apc1638N transgenic mice.		Sorensen IK; Kristiansen E; Mortensen A; van Kranen H; van Kreijl C ; Fodde R ; Thorgeirsson SS		Carcinogenesis	18	1997	777-81	J:39818	9111214
1305	Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522.		Sasai H; Masaki M; Wakitani K		Carcinogenesis	21	2000	953-8	J:61978	10783317
1306	A new mouse model for evaluating the immunotherapy of human colorectal cancer.		Horig H; Wainstein A; Long L; Kahn D; Soni S; Marcus A; Edelmann W; Kucherlapati R; Kaufman HL		Cancer Res	61	2001	8520-6	J:73156	11731437
1307	Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression.		Kucherlapati M; Yang K; Kuraguchi M; Zhao J; Lia M; Heyer J; Kane MF; Fan K; Russell R; Brown AM; Kneitz B; Edelmann W; Kolodner RD; Lipkin M; Kucherlapati R		Proc Natl Acad Sci U S A	99	2002	9924-9	J:77962	12119409
1308	A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype.		Syder AJ; Karam SM; Mills JC; Ippolito JE; Ansari HR; Farook V; Gordon JI		Proc Natl Acad Sci U S A	101	2004	4471-6	J:89240	15070742
1309	Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.		Harman FS; Nicol CJ; Marin HE; Ward JM; Gonzalez FJ; Peters JM		Nat Med	10	2004	481-483	J:90217	15048110
1310	Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice.		Janssen KP; el-Marjou F; Pinto D; Sastre X; Rouillard D; Fouquet C; Soussi T; Louvard D; Robine S		Gastroenterology	123	2002	492-504	J:77986	12145803
1311	Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene.		Fazeli A; Dickinson SL; Hermiston ML; Tighe RV; Steen RG; Small CG; Stoeckli ET; Keino-Masu K; Masu M; Rayburn H; Simons J; Bronson RT; Gordon JI; Tessier-Lavigne M; Weinberg RA		Nature	386	1997	796-804	J:39765	9126737
1312	Immunisation against Helicobacter felis infection protects against the development of gastric MALT Lymphoma.		Sutton P; O'Rourke J; Wilson J; Dixon MF; Lee A		Vaccine	22	2004	2541-6	J:90784	15193379
1313	Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane.		Nozaki T; Fujihara H; Watanabe M; Tsutsumi M; Nakamoto K; Kusuoka O; Kamada N; Suzuki H; Nakagama H; Sugimura T; Masutani M		Cancer Sci	94	2003	497-500	J:84497	12824873
1314	Both suboptimal and elevated vitamin intake increase intestinal neoplasia and alter crypt fission in the ApcMin/+ mouse.		Bashir O; FitzGerald AJ; Goodlad RA		Carcinogenesis	25	2004	1507-15	J:91525	15016659
1315	Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.		Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW		Cancer Res	64	2004	3668-78	J:90258	15150127
1316	MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.		Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S		Cancer Res	56	1996	2922-6	J:75393	8674041
1317	Polyethylene glycol 8000 and colon carcinogenesis: inhibition in the F344 rat, promotion in the Min mouse.		Naigamwalla D; Chia MC; Tran TT; Medline A; Hay K; Gallinger S; Bruce WR		Cancer Res	60	2000	6856-8	J:66914	11156379
1319	Strain clarification		Weiss W		Personal Communication		2004		J:97133	 
1320	Pathology image source		Coffey RJ		Personal Communication		2004		J:97127	 
1321	Strain source		JAX Mice and Services		Personal Communication		2004		J:97135	 
1322	[Short-jaw changed to fetal muscular degeneration]		Gluecksohn-Waelsch S		Mouse News Lett	29	1963	14	J:169	 
1323	Pathology image source		Fancher K		Personal Communication		2004		J:97128	 
1324	An Msh2 point mutation uncouples DNA mismatch repair and apoptosis.		Lin DP; Wang Y; Scherer SJ; Clark AB; Yang K; Avdievich E; Jin B; Werling U; Parris T; Kurihara N; Umar A; Kucherlapati R; Lipkin M; Kunkel TA; Edelmann W		Cancer Res	64	2004	517-22	J:88092	14744764
1325	Strain clarification		Edelmann W		Personal Communication		2004		J:97129	 
1326	Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer.		Biswas S; Chytil A; Washington K; Romero-Gallo J; Gorska AE; Wirth PS; Gautam S; Moses HL; Grady WM		Cancer Res	64	2004	4687-92	J:91510	15256431
1327	Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer.		Han G; Foster BA; Mistry S; Buchanan G; Harris JM; Tilley WD; Greenberg NM		J Biol Chem	276	2001	11204-13	J:69752	11063747
1328	Strain clarification		Greenberg NM		Personal Communication		2004		J:97130	 
1329	Mice lacking a transcriptional corepressor Tob are predisposed to cancer.		Yoshida Y; Nakamura T; Komoda M; Satoh H; Suzuki T; Tsuzuku JK; Miyasaka T; Yoshida EH; Umemori H; Kunisaki RK; Tani K; Ishii S; Mori S; Suganuma M; Noda T; Yamamoto T		Genes Dev	17	2003	1201-6	J:83357	12756225
1330	Strain clarification		Yamamoto T		Personal Communication		2004		J:97131	 
1331	Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression.		Neumann CA; Krause DS; Carman CV; Das S; Dubey DP; Abraham JL; Bronson RT; Fujiwara Y; Orkin SH; Van Etten RA		Nature	424	2003	561-5	J:84677	12891360
1332	Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice.		Kleymenova E; Everitt JI; Pluta L; Portis M; Gnarra JR; Walker CL		Carcinogenesis	25	2004	309-15	J:88492	14604887
1345	Mouse embryos cloned from brain tumors.		Li L; Connelly MC; Wetmore C; Curran T; Morgan JI		Cancer Res	63	2003	2733-6	J:83607	12782575
1346	Strain clarification		Curran T		Personal Communication		2004		J:97132	 
1347	Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.		Pan H; Yin C; Dyson NJ; Harlow E; Yamasaki L; Van Dyke T		Mol Cell	2	1998	283-92	J:50084	9774967
1348	Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors.		Hackett CS; Hodgson JG; Law ME; Fridlyand J; Osoegawa K; de Jong PJ; Nowak NJ; Pinkel D; Albertson DG; Jain A; Jenkins R; Gray JW; Weiss WA		Cancer Res	63	2003	5266-73	J:85511	14500357
1350	Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.		Wetmore C; Eberhart DE; Curran T		Cancer Res	61	2001	513-6	J:67452	11212243
1351	Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model		Norris MD; Burkhart CA; Marshall GM; Weiss WA; Haber M		Med Pediatr Oncol	35	2000	585-9	J:66182	11107123
1352	Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1.		Weiner HL; Bakst R; Hurlbert MS; Ruggiero J; Ahn E; Lee WS; Stephen D; Zagzag D; Joyner AL; Turnbull DH		Cancer Res	62	2002	6385-9	J:80299	12438220
1354	The p53 heterozygous knockout mouse as a model for chemical carcinogenesis in vascular tissue		Carmichael NG; Debruyne EL; Bigot-Lasserre D		Environ Health Perspect	108	2000	61-5	J:60035	10620525
1355	DNA Ligase IV Suppresses Medulloblastoma Formation.		Lee Y; McKinnon PJ		Cancer Res	62	2002	6395-9	J:80298	12438222
1356	A molecular fingerprint for medulloblastoma.		Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ		Cancer Res	63	2003	5428-37	J:86085	14500378
1357	Strain clarification		McKinnon P		Personal Communication		2004		J:97134	 
1358	Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis.		Dumon-Jones V; Frappart PO; Tong WM; Sajithlal G; Hulla W; Schmid G; Herceg Z; Digweed M; Wang ZQ		Cancer Res	63	2003	7263-9	J:86563	14612522
1359	A mouse model of the aniridia-Wilms tumor deletion syndrome.		Glaser T; Lane J; Housman D		Science	250	1990	823-7	J:10820	2173141
1361	Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis.		Castonguay A; Rioux N; Duperron C; Jalbert G		Exp Lung Res	24	1998	605-15	J:52235	9659586
1362	High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading.		Goldsby RE; Hays LE; Chen X; Olmsted EA; Slayton WB; Spangrude GJ; Preston BD		Proc Natl Acad Sci U S A	99	2002	15560-5	J:80306	12429860
1363	A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice.		Moennikes O; Loeppen S; Buchmann A; Andersson P; Ittrich C; Poellinger L; Schwarz M		Cancer Res	64	2004	4707-10	J:91508	15256435
1364	Genetic Cooperation between the Werner Syndrome Protein and Poly(ADP-Ribose) Polymerase-1 in Preventing Chromatid Breaks, Complex Chromosomal Rearrangements, and Cancer in Mice.		Lebel M; Lavoie J; Gaudreault I; Bronsard M; Drouin R		Am J Pathol	162	2003	1559-69	J:83068	12707040
1365	Loss of p53 in craf-induced transgenic lung adenoma leads to tumor acceleration and phenotypic switch.		Fedorov LM; Papadopoulos T; Tyrsin OY; Twardzik T; Gotz R; Rapp UR		Cancer Res	63	2003	2268-77	J:83090	12727849
1367	A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression.		Zhang Z; Wang Y; Herzog CR; Liu G; Lee HW; DePinho RA; You M		Oncogene	21	2002	5960-6	J:78497	12185599
1391	A case of neighboring loci with similar effects		Dunn LC; Caspari E		Genetics	30	1945	543-68	J:242	17247179
1843	Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.		Piedrahita JA; Zhang SH; Hagaman JR; Oliver PM; Maeda N		Proc Natl Acad Sci U S A	89	1992	4471-5	J:1050	1584779
1915	Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.		Li E; Bestor TH; Jaenisch R		Cell	69	1992	915-26	J:1157	1606615
2412	RAG-1-deficient mice have no mature B and T lymphocytes.		Mombaerts P; Iacomini J; Johnson RS; Herrup K; Tonegawa S; Papaioannou VE		Cell	68	1992	869-77	J:1934	1547488
2413	RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.		Shinkai Y; Rathbun G; Lam KP; Oltz EM; Stewart V; Mendelsohn M; Charron J; Datta M; Young F; Stall AM; Alt FW		Cell	68	1992	855-67	J:1935	1547487
2993	Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.		Shull MM; Ormsby I; Kier AB; Pawlowski S; Diebold RJ; Yin M; Allen R; Sidman C; Proetzel G; Calvin D; Annunziata N; Doetschman T		Nature	359	1992	693-9	J:2892	1436033
4299	The T6 translocation in the mouse: its use in trisomy mapping, centromere localization, and cytological identification of linkage group 3.		Eicher EM; Green MC		Genetics	71	1972	621-32	J:5291	5055128
9745	A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice.		HogenEsch H; Gijbels MJ; Offerman E; van Hooft J; van Bekkum DW; Zurcher C		Am J Pathol	143	1993	972-82	J:14539	8362989
10135	Interleukin-10-deficient mice develop chronic enterocolitis [see comments]		Kuhn R; Lohler J; Rennick D; Rajewsky K; Muller W		Cell	75	1993	263-74	J:15222	8402911
10729	Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.		Lubahn DB; Moyer JS; Golding TS; Couse JF; Korach KS; Smithies O		Proc Natl Acad Sci U S A	90	1993	11162-6	J:16338	8248223
10789	Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium.		Masters BA; Kelly EJ; Quaife CJ; Brinster RL; Palmiter RD		Proc Natl Acad Sci U S A	91	1994	584-8	J:16487	8290567
10836	Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning.		Cremer H; Lange R; Christoph A; Plomann M; Vopper G; Roes J; Brown R; Baldwin S; Kraemer P; Scheff S; Barthels D; Rajewsky K; Wille W		Nature	367	1994	455-9	J:16590	8107803
12704	A 6.1 kb 5' upstream region of the mouse tryptophan hydroxylase gene directs expression of E. coli lacZ to major serotonergic brain regions and pineal gland in transgenic mice.		Huh SO; Park DH; Cho JY; Joh TH; Son JH		Brain Res Mol Brain Res	24	1994	145-52	J:19524	7968351
13195	Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice.		Stein PL; Vogel H; Soriano P		Genes Dev	8	1994	1999-2007	J:20346	7958873
13983	Creation of a large genomic deletion at the T-cell antigen receptor beta-subunit locus in mouse embryonic stem cells by gene targeting.		Mombaerts P; Clarke AR; Hooper ML; Tonegawa S		Proc Natl Acad Sci U S A	88	1991	3084-7	J:22591	1826563
14350	An HMG-box-containing T-cell factor required for thymocyte differentiation.		Verbeek S; Izon D; Hofhuis F; Robanus-Maandag E; te Riele H; van de Wetering M; Oosterwegel M; Wilson A; MacDonald HR; Clevers H		Nature	374	1995	70-4	J:23255	7870176
14858	Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.		Wang ZQ; Auer B; Stingl L; Berghammer H; Haidacher D; Schweiger M; Wagner EF		Genes Dev	9	1995	509-20	J:23942	7698643
16936	Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis.		Baker SM; Bronner CE; Zhang L; Plug AW; Robatzek M; Warren G; Elliott EA; Yu J; Ashley T; Arnheim N; Flavell RA; Liskay RM		Cell	82	1995	309-19	J:27389	7628019
18364	Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.		Morham SG; Langenbach R; Loftin CD; Tiano HF; Vouloumanos N; Jennette JC; Mahler JF; Kluckman KD; Ledford A; Lee CA; Smithies O.		Cell	83	1995	473-82	J:29510	8521477
18365	Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.		Langenbach R; Morham SG; Tiano HF; Loftin CD; Ghanayem BI; Chulada PC; Mahler JF; Lee CA; Goulding EH; Kluckman KD; Kim HS; Smithies O		Cell	83	1995	483-92	J:29511	8521478
18464	Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.		Laubach VE; Shesely EG; Smithies O; Sherman PA		Proc Natl Acad Sci U S A	92	1995	10688-92	J:29677	7479866
18566	Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.		Montes de Oca Luna R; Wagner DS; Lozano G		Nature	378	1995	203-6	J:29810	7477326
20505	The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice.		Schorpp M; Jager R; Schellander K; Schenkel J; Wagner EF; Weiher H; Angel P		Nucleic Acids Res	24	1996	1787-8	J:33045	8650001
20873	Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent.		Tsuzuki T; Sakumi K; Shiraishi A; Kawate H; Igarashi H; Iwakuma T; Tominaga Y; Zhang S; Shimizu S; Ishikawa T; Nakamura K; Nakao K; Katsuki M; Sekiguchi M.		Carcinogenesis	17	1996	1215-20	J:33696	8681434
22020	Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene.		Fan CY; Pan J; Chu R; Lee D; Kluckman KD; Usuda N; Singh I; Yeldandi AV; Rao MS; Maeda N; Reddy JK		J Biol Chem	271	1996	24698-710	J:35794	8798738
22195	Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice.		Nelles E; Butzler C; Jung D; Temme A; Gabriel HD; Dahl U; Traub O; Stumpel F; Jungermann K; Zielasek J; Toyka KV; Dermietzel R; Willecke K		Proc Natl Acad Sci U S A	93	1996	9565-70	J:36146	8790370
22262	De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells.		Lei H; Oh SP; Okano M; Juttermann R; Goss KA; Jaenisch R; Li E		Development	122	1996	3195-205	J:36234	8898232
22529	Enhanced proliferative potential in culture of cells from p53-deficient mice.		Tsukada T; Tomooka Y; Takai S; Ueda Y; Nishikawa S; Yagi T; Tokunaga T; Takeda N; Suda Y; Abe S; Matsuo I; Ikawa Y; Aizawa S.		Oncogene	8	1993	3313-22	J:36762	7504233
23259	Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility.		Kumar TR; Wang Y; Lu N; Matzuk MM		Nat Genet	15	1997	201-4	J:38099	9020850
24172	Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.		Schinkel AH; Mayer U; Wagenaar E; Mol CA; van Deemter L; Smit JJ ; van der Valk MA ; Voordouw AC ; Spits H ; van Tellingen O ; Zijlmans JM ; Fibbe WE ; Borst P		Proc Natl Acad Sci U S A	94	1997	4028-33	J:39804	9108099
25328	Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells.		de Murcia JM; Niedergang C; Trucco C; Ricoul M; Dutrillaux B ; Mark M ; Oliver FJ ; Masson M ; Dierich A ; LeMeur M ; Walztinger C ; Chambon P ; de Murcia G		Proc Natl Acad Sci U S A	94	1997	7303-7	J:41742	9207086
25332	Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development.		Tarutani M; Itami S; Okabe M; Ikawa M; Tezuka T; Yoshikawa K ; Kinoshita T ; Takeda J		Proc Natl Acad Sci U S A	94	1997	7400-5	J:41746	9207103
25569	Failure of parturition in mice lacking the prostaglandin F receptor.		Sugimoto Y; Yamasaki A; Segi E; Tsuboi K; Aze Y; Nishimura T ; Oida H ; Yoshida N ; Tanaka T ; Katsuyama M ; Hasumoto K ; Murata T ; Hirata M ; Ushikubi F ; Negishi M ; Ichikawa A ; Narumiya S		Science	277	1997	681-3	J:42113	9235889
25911	Dual roles of ATM in the cellular response to radiation and in cell growth control [see comments]		Xu Y; Baltimore D		Genes Dev	10	1996	2401-10	J:42324	8843193
27810	Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo.		Waldrip WR; Bikoff EK; Hoodless PA; Wrana JL; Robertson EJ		Cell	92	1998	797-808	J:46532	9529255
27996	The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice.		Yang X; Li C; Xu X; Deng C		Proc Natl Acad Sci U S A	95	1998	3667-72	J:46852	9520423
28229	MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.		Vu TH; Shipley JM; Bergers G; Berger JE; Helms JA; Hanahan D; Shapiro SD; Senior RM; Werb Z		Cell	93	1998	411-22	J:47297	9590175
28233	Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.		Yao TP; Oh SP; Fuchs M; Zhou ND; Ch'ng LE; Newsome D; Bronson RT ; Li E ; Livingston DM ; Eckner R		Cell	93	1998	361-72	J:47301	9590171
28396	Defective trophoblast function in mice with a targeted mutation of Ets2.		Yamamoto H; Flannery ML; Kupriyanov S; Pearce J; McKercher SR; Henkel GW; Maki RA; Werb Z; Oshima RG		Genes Dev	12	1998	1315-26	J:47620	9573048
28672	Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis.		Chen J; Kubalak SW; Chien KR		Development	125	1998	1943-9	J:48085	9550726
29073	Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse.		Vooijs M; van der Valk M; te Riele H; Berns A		Oncogene	17	1998	1-12	J:48860	9671308
29291	A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity.		Lebel M; Leder P		Proc Natl Acad Sci U S A	95	1998	13097-102	J:48424	9789047
30031	Role of CYP2E1 in the hepatotoxicity of acetaminophen.		Lee SS; Buters JT; Pineau T; Fernandez-Salguero P; Gonzalez FJ		J Biol Chem	271	1996	12063-7	J:48196	8662637
30317	Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV.		Frank KM; Sekiguchi JM; Seidl KJ; Swat W; Rathbun GA; Cheng HL; Davidson L; Kangaloo L; Alt FW		Nature	396	1998	173-7	J:50865	9823897
30817	Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice.		Barnes DE; Stamp G; Rosewell I; Denzel A; Lindahl T		Curr Biol	8	1998	1395-8	J:51608	9889105
30971	A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability.		Shen SX; Weaver Z; Xu X; Li C; Weinstein M; Chen L; Guan XY; Ried T; Deng CX		Oncogene	17	1998	3115-24	J:51834	9872327
31891	JunB is essential for mammalian placentation.		Schorpp-Kistner M; Wang ZQ; Angel P; Wagner EF		EMBO J	18	1999	934-48	J:53304	10022836
31925	Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes.		Masutani M; Suzuki H; Kamada N; Watanabe M; Ueda O; Nozaki T ; Jishage K ; Watanabe T ; Sugimoto T ; Nakagama H ; Ochiya T ; Sugimura T		Proc Natl Acad Sci U S A	96	1999	2301-4	J:53360	10051636
32607	p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.		Yang A; Schweitzer R; Sun D; Kaghad M; Walker N; Bronson RT; Tabin C; Sharpe A; Caput D; Crum C; McKeon F		Nature	398	1999	714-8	J:54637	10227294
33906	A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.		Yamauchi Y; Abe K; Mantani A; Hitoshi Y; Suzuki M; Osuzu F; Kuratani S; Yamamura K		Dev Biol	212	1999	191-203	J:56681	10419695
33965	The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin.		Vasioukhin V; Degenstein L; Wise B; Fuchs E		Proc Natl Acad Sci U S A	96	1999	8551-6	J:56822	10411913
34608	Genomic instability in Gadd45a-deficient mice.		Hollander MC; Sheikh MS; Bulavin DV; Lundgren K; Augeri-Henmueller L; Shehee R; Molinaro TA; Kim KE; Tolosa E; Ashwell JD; Rosenberg MP; Zhan Q; Fernandez-Salguero PM; Morgan WF; Deng CX; Fornace AJ Jr		Nat Genet	23	1999	176-84	J:57882	10508513
35320	Inducible gene knockouts in the small intestinal and colonic epithelium.		Saam JR; Gordon JI		J Biol Chem	274	1999	38071-82	J:59166	10608876
36013	Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration [see comments]		Sasaki T; Irie-Sasaki J; Jones RG; Oliveira-dos-Santos AJ; Stanford WL; Bolon B; Wakeham A; Itie A; Bouchard D; Kozieradzki I; Joza N; Mak TW; Ohashi PS; Suzuki A; Penninger JM		Science	287	2000	1040-6	J:60347	10669416
36133	Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome.		Carter MG; Johns MA; Zeng X; Zhou L; Zink MC; Mankowski JL; Donovan DM; Baylin SB		Hum Mol Genet	9	2000	413-9	J:60589	10655551
36235	Biosynthesis of major histocompatibility complex molecules and generation of T cells in Ii TAP1 double-mutant mice.		Tourne S; van Santen HM; van Roon M; Berns A; Benoist C; Mathis D; Ploegh H		Proc Natl Acad Sci U S A	93	1996	1464-9	J:60782	8643655
36383	Prostaglandin D2 as a mediator of allergic asthma.		Matsuoka T; Hirata M; Tanaka H; Takahashi Y; Murata T; Kabashima K; Sugimoto Y; Kobayashi T; Ushikubi F; Aze Y; Eguchi N; Urade Y; Yoshida N; Kimura K; Mizoguchi A; Honda Y; Nagai H; Narumiya S		Science	287	2000	2013-7	J:61023	10720327
36939	Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion		DiGiovanni J; Bol DK; Wilker E; Beltran L; Carbajal S; Moats S; Ramirez A; Jorcano J; Kiguchi K		Cancer Res	60	2000	1561-70	J:62011	10749124
37744	Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis.		Papanikolaou A; Wang QS; Papanikolaou D; Whiteley HE; Rosenberg DW		Carcinogenesis	21	2000	1567-72	J:63564	10910960
37870	Immune response in mice that lack the interferon-gamma receptor [see comments]		Huang S; Hendriks W; Althage A; Hemmi S; Bluethmann H; Kamijo R; Vilcek J; Zinkernagel RM; Aguet M		Science	259	1993	1742-5	J:63815	8456301
38121	Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.		Matsuyama T; Kimura T; Kitagawa M; Pfeffer K; Kawakami T; Watanabe N; Kundig TM; Amakawa R; Kishihara K; Wakeham A; et al		Cell	75	1993	83-97	J:64286	8402903
38635	A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis.		Gao Y; Sun Y; Frank KM; Dikkes P; Fujiwara Y; Seidl KJ; Sekiguchi JM; Rathbun GA; Swat W; Wang J; Bronson RT; Malynn BA; Bryans M; Zhu C; Chaudhuri J; Davidson L; Ferrini R; Stamato T; Orkin SH; Greenberg ME; Alt FW		Cell	95	1998	891-902	J:65218	9875844
38858	Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination.		Koller BH; Smithies O		Proc Natl Acad Sci U S A	86	1989	8932-5	J:65612	2682666
40342	Radiation-induced cell cycle arrest compromised by p21 deficiency.		Brugarolas J; Chandrasekaran C; Gordon JI; Beach D; Jacks T; Hannon GJ		Nature	377	1995	552-7	J:68068	7566157
41130	Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.		Indra AK; Warot X; Brocard J; Bornert JM; Xiao JH; Chambon P; Metzger D		Nucleic Acids Res	27	1999	4324-7	J:69324	10536138
41132	Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase.		Danielian PS; Muccino D; Rowitch DH; Michael SK; McMahon AP		Curr Biol	8	1998	1323-6	J:69326	9843687
41860	Efficient BLG-Cre mediated gene deletion in the mammary gland.		Selbert S; Bentley DJ; Melton DW; Rannie D; Lourenco P; Watson CJ; Clarke AR		Transgenic Res	7	1998	387-96	J:70554	9859227
41883	Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3.		Ushikubi F; Segi E; Sugimoto Y; Murata T; Matsuoka T; Kobayashi T; Hizaki H; Tuboi K; Katsuyama M; Ichikawa A; Tanaka T; Yoshida N; Narumiya S		Nature	395	1998	281-4	J:70534	9751056
42526	Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility.		Rudolph-Owen LA; Cannon P; Matrisian LM		Mol Biol Cell	9	1998	421-35	J:71574	9450965
42836	Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen.		Saenz Robles MT; Symonds H; Chen J; Van Dyke T		Mol Cell Biol	14	1994	2686-98	J:72121	8139568
43480	Desmoplakin is essential in epidermal sheet formation.		Vasioukhin V; Bowers E; Bauer C; Degenstein L; Fuchs E		Nat Cell Biol	3	2001	1076-85	J:73084	11781569
44791	A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.		Schwenk F; Baron U; Rajewsky K		Nucleic Acids Res	23	1995	5080-1	J:75204	8559668
45155	Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver.		Behrens A; Sibilia M; David JP; Mohle-Steinlein U; Tronche F; Schutz G; Wagner EF		EMBO J	21	2002	1782-90	J:75863	11927562
46276	A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors.		Andersson P; McGuire J; Rubio C; Gradin K; Whitelaw ML; Pettersson S; Hanberg A; Poellinger L		Proc Natl Acad Sci U S A	99	2002	9990-5	J:77977	12107286
46613	Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells.		Wang TC; Bonner-Weir S; Oates PS; Chulak M; Simon B; Merlino GT; Schmidt EV; Brand SJ		J Clin Invest	92	1993	1349-56	J:78615	8376589
47200	Gene replacement of the p53 gene with the lacZ gene in mouse embryonic stem cells and mice by using two steps of homologous recombination.		Gondo Y; Nakamura K; Nakao K; Sasaoka T; Ito K; Kimura M; Katsuki M		Biochem Biophys Res Commun	202	1994	830-7	J:79629	8048955
47487	Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice.		Onrust SV; Hartl PM; Rosen SD; Hanahan D		J Clin Invest	97	1996	54-64	J:80168	8550850
47676	Uniform cell-autonomous tumorigenesis of the choroid plexus by papovavirus large T antigens.		Chen JD; Van Dyke T		Mol Cell Biol	11	1991	5968-76	J:80498	1658622
47939	Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.		Hansen-Petrik MB; McEntee MF; Jull B; Shi H; Zemel MB; Whelan J		Cancer Res	62	2002	403-8	J:74005	11809688
48756	Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern.		Eades-Perner AM; van der Putten H; Hirth A; Thompson J; Neumaier M; von Kleist S; Zimmermann W		Cancer Res	54	1994	4169-76	J:82361	8033149
49721	Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs.		Bertolino P; Radovanovic I; Casse H; Aguzzi A; Wang ZQ; Zhang CX		Mech Dev	120	2003	549-60	J:83882	12782272
53363	Transgenic mice express the human phenylethanolamine N-methyltransferase gene in adrenal medulla and retina.		Baetge EE; Behringer RR; Messing A; Brinster RL; Palmiter RD		Proc Natl Acad Sci U S A	85	1988	3648-52	J:90322	2835776
53365	Metastatic hibernomas in transgenic mice expressing an alpha-amylase-SV40 T antigen hybrid gene.		Fox N; Crooke R; Hwang LH; Schibler U; Knowles BB; Solter D		Science	244	1989	460-3	J:90326	2785714
53366	Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus.		Huang AL; Ostrowski MC; Berard D; Hager GL		Cell	27	1981	245-55	J:90327	6277498
55019	The mPer2 gene encodes a functional component of the mammalian circadian clock.		Zheng B; Larkin DW; Albrecht U; Sun ZS; Sage M; Eichele G; Lee CC; Bradley A		Nature	400	1999	169-73	J:56167	10408444
55779	Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation.		Park HL; Bai C; Platt KA; Matise MP; Beeghly A; Hui CC; Nakashima M; Joyner AL		Development	127	2000	1593-605	J:60986	10725236
56145	Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.		Williamson R; Lee D; Hagaman J; Maeda N		Proc Natl Acad Sci U S A	89	1992	7134-8	J:2109	1496008
60143	Physiological consequences of loss of plasminogen activator gene function in mice.		Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC		Nature	368	1994	419-24	J:17427	8133887
60540	Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.		Schinkel AH; Smit JJ; van Tellingen O; Beijnen JH; Wagenaar E; van Deemter L; Mol CA; van der Valk MA; Robanus-Maandag EC; te Riele HP; Berns AJ; Borst P		Cell	77	1994	491-502	J:18554	7910522
62040	Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor [see comments]		Fernandez-Salguero P; Pineau T; Hilbert DM; McPhail T; Lee SS; Kimura S; Nebert DW; Rudikoff S; Ward JM; Gonzalez FJ		Science	268	1995	722-6	J:25048	7732381
63167	Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice.		Hein L; Barsh GS; Pratt RE; Dzau VJ; Kobilka BK		Nature	377	1995	744-7	J:29456	7477266
63305	Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.		Dinchuk JE; Car BD; Focht RJ; Johnston JJ; Jaffee BD; Covington MB; Contel NR; Eng VM; Collins RJ; Czerniak PM; Gorry SA; Trzaskos JM.		Nature	378	1995	406-9	J:29974	7477380
63615	Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.		Durbin JE; Hackenmiller R; Simon MC; Levy DE		Cell	84	1996	443-50	J:31325	8608598
64446	Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates.		Zhu C; Bogue MA; Lim DS; Hasty P; Roth DB		Cell	86	1996	379-89	J:34834	8756720
65642	Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells.		Zambrowicz BP; Imamoto A; Fiering S; Herzenberg LA; Kerr WG; Soriano P		Proc Natl Acad Sci U S A	94	1997	3789-94	J:39814	9108056
65696	Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting.		Schorle H; Holtschke T; Hunig T; Schimpl A; Horak I		Nature	352	1991	621-4	J:39989	1830926
65708	A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice.		Yoshioka M; Kayo T; Ikeda T; Koizumi A		Diabetes	46	1997	887-94	J:40063	9133560
65829	Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.		Ludwig T; Chapman DL; Papaioannou VE; Efstratiadis A		Genes Dev	11	1997	1226-41	J:40594	9171368
65831	The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation.		McClatchey AI; Saotome I; Ramesh V; Gusella JF; Jacks T		Genes Dev	11	1997	1253-65	J:40596	9171370
66198	Altered pain perception and inflammatory response in mice lacking prostacyclin receptor.		Murata T; Ushikubi F; Matsuoka T; Hirata M; Yamasaki A; Sugimoto Y ; Ichikawa A ; Aze Y ; Tanaka T ; Yoshida N ; Ueno A ; Oh-ishi S ; Narumiya S		Nature	388	1997	678-82	J:42275	9262402
67205	Selective disruption of genes transiently induced in differentiating mouse embryonic stem cells by using gene trap mutagenesis and site-specific recombination.		Thorey IS; Muth K; Russ AP; Otte J; Reffelmann A; von Melchner H		Mol Cell Biol	18	1998	3081-8	J:47007	9566926
67347	Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice.		Segi E; Sugimoto Y; Yamasaki A; Aze Y; Oida H; Nishimura T; Murata T; Matsuoka T; Ushikubi F; Hirose M; Tanaka T; Yoshida N; Narumiya S; Ichikawa A		Biochem Biophys Res Commun	246	1998	7-12	J:47618	9600059
68140	Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.		Postic C; Shiota M; Niswender KD; Jetton TL; Chen Y; Moates JM; Shelton KD; Lindner J; Cherrington AD; Magnuson MA		J Biol Chem	274	1999	305-15	J:51826	9867845
68346	VEGF is required for growth and survival in neonatal mice.		Gerber HP; Hillan KJ; Ryan AM; Kowalski J; Keller GA; Rangell L ; Wright BD ; Radtke F ; Aguet M ; Ferrara N		Development	126	1999	1149-59	J:52793	10021335
70245	The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction.		Abel MH; Wootton AN; Wilkins V; Huhtaniemi I; Knight PG; Charlton HM		Endocrinology	141	2000	1795-803	J:61909	10803590
70480	Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).		Peters JM; Lee SS; Li W; Ward JM; Gavrilova O; Everett C; Reitman ML; Hudson LD; Gonzalez FJ		Mol Cell Biol	20	2000	5119-28	J:63040	10866668
70762	Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice.		Linnoila RI; Zhao B; DeMayo JL; Nelkin BD; Baylin SB; DeMayo FJ; Ball DW		Cancer Res	60	2000	4005-9	J:64631	10945598
71312	Negative regulation of BMP/Smad signaling by Tob in osteoblasts.		Yoshida Y; Tanaka S; Umemori H; Minowa O; Usui M; Ikematsu N; Hosoda E; Imamura T; Kuno J; Yamashita T; Miyazono K; Noda M; Noda T; Yamamoto T		Cell	103	2000	1085-97	J:66504	11163184
71444	Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome.		Everett LA; Belyantseva IA; Noben-Trauth K; Cantos R; Chen A; Thakkar SI; Hoogstraten-Miller SL; Kachar B; Wu DK; Green ED		Hum Mol Genet	10	2001	153-61	J:67072	11152663
71488	Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.		Soriano P; Montgomery C; Geske R; Bradley A		Cell	64	1991	693-702	J:67040	1997203
71743	Cre-mediated gene deletion in the mammary gland.		Wagner KU; Wall RJ; St-Onge L; Gruss P; Wynshaw-Boris A; Garrett L; Li M; Furth PA; Hennighausen L		Nucleic Acids Res	25	1997	4323-30	J:67925	9336464
71745	Inducible gene targeting in mice.		Kuhn R; Schwenk F; Aguet M; Rajewsky K		Science	269	1995	1427-9	J:67927	7660125
71831	Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation.		Wu X; Wu J; Huang J; Powell WC; Zhang J; Matusik RJ; Sangiorgi FO; Maxson RE; Sucov HM; Roy-Burman P		Mech Dev	101	2001	61-9	J:68167	11231059
71878	Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development.		Hendrich B; Guy J; Ramsahoye B; Wilson VA; Bird A		Genes Dev	15	2001	710-23	J:68356	11274056
72148	Hepatocyte-specific expression of Cre recombinase.		Kellendonk C; Opherk C; Anlag K; Schutz G; Tronche F		Genesis	26	2000	151-3	J:69317	10686615
72150	Neural crest expression of Cre recombinase directed by the proximal Pax3 promoter in transgenic mice.		Li J; Chen F; Epstein JA		Genesis	26	2000	162-4	J:69319	10686619
72234	A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage.		Hohenstein P; Kielman MF; Breukel C; Bennett LM; Wiseman R; Krimpenfort P; Cornelisse C; van Ommen GJ; Devilee P; Fodde R		Oncogene	20	2001	2544-50	J:69602	11420664
72755	Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally.		Verbeek S; van Lohuizen M; van der Valk M; Domen J; Kraal G; Berns A		Mol Cell Biol	11	1991	1176-9	J:71550	1990273
72963	Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice.		Andres AC; Schonenberger CA; Groner B; Henninghausen L; LeMeur M; Gerlinger P		Proc Natl Acad Sci U S A	84	1987	1299-303	J:72262	3469670
74456	Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion.		Zhou YP; Pena JC; Roe MW; Mittal A; Levisetti M; Baldwin AC; Pugh W; Ostrega D; Ahmed N; Bindokas VP; Philipson LH; Hanahan D; Thompson CB; Polonsky KS		Am J Physiol Endocrinol Metab	278	2000	E340-51	J:78000	10662719
75090	Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein.		Kerkhoff E; Fedorov LM; Siefken R; Walter AO; Papadopoulos T; Rapp UR		Cell Growth Differ	11	2000	185-90	J:80895	10775035
75224	Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.		Akiyama TE; Sakai S; Lambert G; Nicol CJ; Matsusue K; Pimprale S; Lee YH; Ricote M; Glass CK; Brewer HB Jr; Gonzalez FJ		Mol Cell Biol	22	2002	2607-19	J:75777	11909955
76820	BUBR1 deficiency results in abnormal megakaryopoiesis.		Wang Q; Liu T; Fang Y; Xie S; Huang X; Mahmood R; Ramaswamy G; Sakamoto KM; Darzynkiewicz Z; Xu M; Dai W		Blood	103	2004	1278-85	J:88223	14576056
77650	Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.		Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Sorge JA; Putman DL; Short JM		Proc Natl Acad Sci U S A	88	1991	7958-62	J:82962	1832771
77728	Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development.		Takayama H; La Rochelle WJ; Anver M; Bockman DE; Merlin G		Proc Natl Acad Sci U S A	93	1996	5866-71	J:34022	8650184
77782	Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.		Lawler J; Sunday M; Thibert V; Duquette M; George EL; Rayburn H ; Hynes RO		J Clin Invest	101	1998	982-92	J:46182	9486968
78688	Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.		Kulkarni AB; Huh CG; Becker D; Geiser A; Lyght M; Flanders KC; Roberts AB; Sporn MB; Ward JM; Karlsson S		Proc Natl Acad Sci U S A	90	1993	770-4	J:50848	8421714
79025	The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.		Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA		Oncogene	23	2004	379-85	J:88365	14724566
80167	Enhanced O6-methylguanine-DNA methyltransferase activity in transgenic mice containing an integrated E. coli ada repair gene.		Matsukuma S; Nakatsuru Y; Nakagawa K; Utakoji T; Sugano H; Kataoka H; Sekiguchi M; Ishikawa T		Mutat Res	218	1989	197-206	J:90320	2530449
80168	Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen.		Theuring F; Gotz W; Balling R; Korf HW; Schulze F; Herken R; Gruss P		Oncogene	5	1990	225-32	J:90321	2157185
80618	Conditional inactivation of the TGF-beta type II receptor using Cre:Lox.		Chytil A; Magnuson MA; Wright CV; Moses HL		Genesis	32	2002	73-5	J:75073	11857781
80727	Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor.		Ichiki T; Labosky PA; Shiota C; Okuyama S; Imagawa Y; Fogo A; Niimura F; Ichikawa I; Hogan BL; Inagami T		Nature	377	1995	748-50	J:29457	7477267
81716	Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice.		Itoh T; Ikeda T; Gomi H; Nakao S; Suzuki T; Itohara S		J Biol Chem	272	1997	22389-92	J:42742	9278386
81866	Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice.		Garabedian EM; Roberts LJ; McNevin MS; Gordon JI		J Biol Chem	272	1997	23729-40	J:43025	9295317
82370	The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.		Adams JM; Harris AW; Pinkert CA; Corcoran LM; Alexander WS; Cory S; Palmiter RD; Brinster RL		Nature	318	1985	533-8	J:78177	3906410
82394	Analysis of Fgf8 gene function in vertebrate development.		Lewandoski M; Meyers EN; Martin GR		Cold Spring Harb Symp Quant Biol	62	1997	159-68	J:46833	9598348
82768	Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer [corrected and republished article originally printed in Lab Invest 1998 Mar;78(3):319-33]		Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ		Lab Invest	78	1998	i-xv	J:48623	9645768
84167	Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice.		Suri C; Fung BP; Tischler AS; Chikaraishi DM		J Neurosci	13	1993	1280-91	J:90323	7680068
85711	Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice.		Quesada CF; Kimata H; Mori M; Nishimura M; Tsuneyoshi T; Baba S		Jpn J Cancer Res	89	1998	392-6	J:47857	9617344
85958	Distinct negative regulatory mechanisms involved in the repression of human embryonic epsilon- and fetal G gamma-globin genes in transgenic mice.		Perez-Stable C		J Biol Chem	269	1994	33109-15	J:79828	7806539
85959	Relationship between susceptibility to induced pulmonary tumors and certain known genes in mice	 	Heston WE	 	J Natl Cancer Inst	2	1941	127-32		
85960	Relationship between susceptibility to induced pulmonary tumors and certain known genes in mice	 	Heston WE	 	J Natl Cancer Inst	2	1941	127-32		
85961	Relationship between susceptibility to induced pulmonary tumors and certain known genes in mice		Heston WE		J Natl Cancer Inst	2	1941	127-32	J:265	 
85962	Nonrandom chromosome changes in methylnitrosourea (MNU) induced mouse T-cell lymphomas.		Kaelbling M; Zhang YD; Dasgupta UB; Lilly F; Klinger HP		Ann Genet	34	1991	270-8	J:337	1809237
85963	[Mammary tumor incidence in A/Crgl/2 mice (now extinct)]		Barnawell EB		Personal Communication, to J. Staats, Jax	0	1960		J:551	 
85964	[Mammary tumor incidence in A/Crgl/3 mice (now extinct)]		Barnawell EB		Personal Communication, to J. Staats, JAX	0	1960		J:552	 
85965	Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.		Vorce RL; Goodman JI		J Toxicol Environ Health	34	1991	367-84	J:651	1658350
85966	Comparison of Ki-ras gene mutation among simultaneously occurring multiple urethan-induced lung tumors in individual mice.		Ohmori H; Abe T; Hirano H; Murakami T; Katoh T; Gotoh S; Kido M; Kuroiwa A; Nomura T; Higashi K		Carcinogenesis	13	1992	851-5	J:867	1586998
85967	Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice.		DiGiovanni J; Imamoto A; Naito M; Walker SE; Beltran L; Chenicek KJ; Skow L		Carcinogenesis	13	1992	525-31	J:951	1576703
85968	Rate of metastasis from C3H mouse mammary tumours.		Nias AH		Clin Exp Metastasis	10	1992	13-7	J:1048	1733642
85969	In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia.		Uckun FM; Chelstrom LM; Irvin JD; Finnegan D; Gunther R; Young J; Kuebelbeck V; Myers DE; Houston LL		Blood	79	1992	2649-61	J:1062	1375109
85970	p53 mutations in C57BL/6J murine thymic lymphomas induced by gamma-irradiation and N-methylnitrosourea.		Brathwaite O; Bayona W; Newcomb EW		Cancer Res	52	1992	3791-5	J:1285	1617648
85971	Observations on lymphomagenesis and lymphoma in AKR mice. A description of prelymphoma changes in the thymus and phenotypic diversity of lymphomas induced by SL3-3 virus.		Hays EF; Bristol G		Thymus	19	1992	219-34	J:1311	1385666
85972	Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.		Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ Jr; Conti CJ; Slaga TJ		Cancer Res	52	1992	3432-5	J:1312	1375869
85973	Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants.		Xu Y; Ho CT; Amin SG; Han C; Chung FL		Cancer Res	52	1992	3875-9	J:1418	1617663
85974	N-ras mutation in ultraviolet radiation-induced murine skin cancers.		Pierceall WE; Kripke ML; Ananthaswamy HN		Cancer Res	52	1992	3946-51	J:1419	1617670
85975	Differences in GTPase-activating protein activity between liver tumors and normal liver tissue in mice.		Muller O; Frech M; Gideon P; Wittinghofer A; Schwarz M		Oncogene	7	1992	1407-12	J:1498	1620552
85976	Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene.		Halmekyto M; Syrjanen K; Janne J; Alhonen L		Biochem Biophys Res Commun	187	1992	493-7	J:2154	1520339
85977	The Wnt gene family in tumorigenesis and in normal development.		Nusse R		J Steroid Biochem Mol Biol	43	1992	9-12	J:2249	1388050
85978	High frequency of myelomonocytic tumors in aging E mu L-myc transgenic mice.		Moroy T; Fisher PE; Lee G; Achacoso P; Wiener F; Alt FW		J Exp Med	175	1992	313-22	J:2279	1310099
85979	Disappearance of the mammary tumor agent from RIII mice		Andervont HB		Acta Union Int Contre Cancer	15	1959	124-27	J:2396	 
85980	Studies of the mammary-tumor agent of strain RIII mice		Andervont HB; Dunn TB		J Natl Cancer Inst	28	1962	159-185	J:2397	13861337
85981	A new strain of mice with a high incidence of mammary cancers and enlargement of the pituitary		Bielschowsky M; Bielschowsky F; Lindsay D		Br J Cancer	10	1956	688-699	J:2400	13426381
85982	Mouse leukemia. IX. The role of heredity in spontaneous cases		MacDowell EC; Richter MN		Arch Pathol	20	1935	709-24	J:2454	 
85983	Genetic aspects of mouse leukemia		MacDowell EC		Am J Cancer	26	1936	85-101	J:2455	 
85984	On the susceptibility to cancer development in the skin and in the mammary gland in two lines of inbred mice		Kreyberg L		Am J Cancer	24	1935	554-565	J:2441	 
85985	The establishment of the C3H inbred strain of mice for the study of spontaneous carcinoma of the mammary gland		Strong LC		Genetics	20	1935	586-591	J:2480	17246779
85986	Spontaneous mammary cancer in mice		Marsh MC		J Cancer Res	13	1929	313-339	J:2458	 
85987	Studies on mammary tumors in the O20 Amsterdam strain of mice		Muhlbock O; van Rijssel Th G		J Natl Cancer Inst	15	1954	73-93	J:2461	13233870
85988	Genetic segregation mammary cancer to no mammary cancer, in the mouse		Murray WS		Am J Cancer	34	1938	434-441	J:2465	 
85989	The effects of cortisone on the development of spontaneous leukemia in mice and on its induction by irradiation		Upton AC; Furth J		Blood	9	1954	686-695	J:2486	13172287
85990	Progressive atypia in spontaneous and N-nitrosodiethylamine-induced hepatocellular adenomas of C3H/HeNCr mice.		Jang JJ; Weghorst CM; Henneman JR; Devor DE; Ward JM		Carcinogenesis	13	1992	1541-7	J:2708	1394837
85991	Occurrence of tumours in the descendants of CBA male mice prenatally treated with diethylstilbestrol.		Turusov VS; Trukhanova LS; Parfenov YuD; Tomatis L		Int J Cancer	50	1992	131-5	J:2844	1728603
85992	The NZB mouse as a model for chronic lymphocytic leukemia.		Phillips JA; Mehta K; Fernandez C; Raveche ES		Cancer Res	52	1992	437-43	J:2829	1370214
85993	Absence of mutations in the functional parts of the p120-GAP gene in carcinogen-induced mouse liver tumors.		Muller O; Kress S; Schwarz M		Carcinogenesis	13	1992	1903-5	J:2893	1423850
85994	Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with	 N-nitrosodiethylamine.	Diwan BA; Lubet RA; Ward JM; Hrabie JA; Rice JM		Carcinogenesis	13	1992	1893-901	J:2894	1330346
85995	A study of tobacco carcinogenesis. XLVII. Bioassays of vinylpyridines for genotoxicity and for tumorigenicity in A/J mice.		Brunnemann KD; Rivenson A; Cheng SC; Saa V; Hoffmann D		Cancer Lett	65	1992	107-13	J:3016	1511414
85996	Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host.		Freund R; Dubensky T; Bronson R; Sotnikov A; Carroll J; Benjamin T		Virology	191	1992	724-31	J:3272	1333121
85997	Significance of strain and sex differences in the development of 252Cf neutron-induced liver tumors in mice.		Ito A; Takahashi T; Watanabe H; Ogundigie PO; Okamoto T		Jpn J Cancer Res	83	1992	1052-6	J:3277	1452457
85998	Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice.		Stanley LA; Devereux TR; Foley J; Lord PG; Maronpot RR; Orton TC; Anderson MW		Carcinogenesis	13	1992	2427-33	J:3531	1361883
85999	The A/J mouse lung as a model for developing new chemointervention strategies.		Belinsky SA; Stefanski SA; Anderson MW		Cancer Res	53	1993	410-6	J:3656	8417832
86000	An increase in disease latency is associated with a host-dependent selection for recombinant murine leukemia viruses with substitutions in the p15E (TM) gene.		Thomas CY; Coppola MA; Nuckols JD; Lawrenz-Smith SC; Massey AC		J Virol	67	1993	294-304	J:3689	8380077
86001	Telomere-like DNA polymorphisms associated with genetic predisposition to acute myeloid leukemia in irradiated CBA mice.		Silver A; Cox R		Proc Natl Acad Sci U S A	90	1993	1407-10	J:4005	8434000
86002	Spontaneous adenocarcinoma of the colon in a DDD mouse.		Madarame H; Sakurai H		Lab Anim Sci	43	1993	108-10	J:4096	8384674
86003	Histamine level and transglutaminase activity may provide indication of the development of spontaneous mammary tumor in C3H mice		Maslinski C; Kierska D		Agents Actions	Sp Iss C	1992	C384-C386	J:4144	 
86004	Susceptibility of AKXD recombinant inbred mouse strains to lymphomas.		Gilbert DJ; Neumann PE; Taylor BA; Jenkins NA; Copeland NG		J Virol	67	1993	2083-90	J:4179	8383230
86005	Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.		Murakami H; Sanderson ND; Nagy P; Marino PA; Merlino G; Thorgeirsson SS		Cancer Res	53	1993	1719-23	J:4527	8467484
86006	Comparison of 12-O-tetradecanoylphorbol-13-acetate and teleocidin for induction of epidermal hyperplasia, activation of epidermal PKC isozymes and skin tumor promotion in SENCAR and C57BL/6 mice.		Imamoto A; Wang XJ; Fujiki H; Walker SE; Beltran LM; DiGiovanni J		Carcinogenesis	14	1993	719-24	J:4602	8472338
86007	The inheritance of susceptibility to the Gross leukemia virus in mice.		Lilly F		Genetics	53	1966	529-39	J:5011	5919331
86008	Inheritance of susceptibility and resistance to Rauscher leukaemia virus.		Toth FD; Vaczi L; Balogh M		Acta Microbiol Acad Sci Hung	20	1973	183-9	J:5425	4798829
86009	Genetic analysis of mammary tumor induction and expression of mammary tumor virus antigen in hormone-treated ovariectomized GR mice.		van Nie R; Hilgers J		J Natl Cancer Inst	56	1976	27-32	J:5626	176379
86010	Effect of allelic substitutions at the hairless locus on endogenous ecotropic murine leukemia virus titers and leukemogenesis.		Heiniger HJ; Huebner RJ; Meier H		J Natl Cancer Inst	56	1976	1073-4	J:5726	186616
86011	Interactions between host and viral genomes in mouse leukemia.		Steeves R; Lilly F		Annu Rev Genet	11	1977	277-96	J:5913	202189
86012	Genetically dominant resistance in mice to 3-methylcholanthrene-induced lymphoma.		Mayer A; Lilly F; Duran-Reynals ML		Proc Natl Acad Sci U S A	77	1980	2960-3	J:6347	6930679
86013	Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.		Nusse R; Varmus HE		Cell	31	1982	99-109	J:6976	6297757
86014	A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testicular teratomas in 129/Sv-ter mice.		Noguchi T; Noguchi M		J Natl Cancer Inst	75	1985	385-92	J:7954	3860691
86015	Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors.		Mucenski ML; Taylor BA; Ihle JN; Hartley JW; Morse HC 3d; Jenkins NA; Copeland NG		Mol Cell Biol	8	1988	301-8	J:8988	2827004
86016	Specific chromosomal abnormalities characterize fibrosarcomas of bovine papillomavirus type 1 transgenic mice.		Lindgren V; Sippola-Thiele M; Skowronski J; Wetzel E; Howley PM; Hanahan D		Proc Natl Acad Sci U S A	86	1989	5025-9	J:9862	2544888
86017	The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors.		Peters G; Brookes S; Smith R; Placzek M; Dickson C		Proc Natl Acad Sci U S A	86	1989	5678-82	J:9935	2548184
86018	Oncogenicity of the ret transforming gene in MMTV/ret transgenic mice.		Iwamoto T; Takahashi M; Ito M; Hamaguchi M; Isobe K; Misawa N; Asai J; Yoshida T; Nakashima I		Oncogene	5	1990	535-42	J:10428	1691479
86019	Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain.		Roelink H; Wagenaar E; Lopes da Silva S; Nusse R		Proc Natl Acad Sci U S A	87	1990	4519-23	J:10554	2162045
86020	Evi-2, a common integration site involved in murine myeloid leukemogenesis.		Buchberg AM; Bedigian HG; Jenkins NA; Copeland NG		Mol Cell Biol	10	1990	4658-66	J:10694	2167436
86021	The tumour promoters dieldrin and phenobarbital increase the frequency of c-Ha-ras wild-type, but not of c-Ha-ras mutated focal liver lesions in male C3H/He mice.		Bauer-Hofmann R; Buchmann A; Mahr J; Kress S; Schwarz M		Carcinogenesis	13	1992	477-81	J:11642	1312398
86022	Induction of adenocarcinomas in the glandular stomach of BALB/c mice treated with N-methyl-N-nitrosourea.		Tatematsu M; Ogawa K; Hoshiya T; Shichino Y; Kato T; Imaida K; Ito N		Jpn J Cancer Res	83	1992	915-8	J:11864	1429199
86023	Expression of endogenous murine leukaemia viruses in AKR/J streaker mice.		Bedigian HG; Shultz LD; Meier H		Nature	279	1979	434-436	J:12015	16068183
86024	Sensitivity to tumor promotion of SENCAR and C57BL/6J mice correlates with oxidative events and DNA damage.		Wei L; Wei H; Frenkel K		Carcinogenesis	14	1993	841-7	J:12197	8389253
86025	Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters.		Wei H; Frenkel K		Carcinogenesis	14	1993	1195-201	J:13106	8508507
86026	Strain Differences in Neoplastic Response to DMBA-Induced Uterine Vascular Tumors in Mice		Tsubura A; Senzaki H; Oyaizu T; Fujita Y; Morii S		Int J Oncol	2	1993	927-930	J:13277	 
86027	Functional loss of tumour suppressor genes in multistage chemical carcinogenesis.		Balmain A; Kemp CJ; Burns PA; Stoler AB; Fowlis DJ; Akhurst RJ		Princess Takamatsu Symp	22	1991	97-108	J:14146	1844254
86028	SL/KH strain of mice: a model of spontaneous pre-B-lymphomas.		Shimada MO; Yamada Y; Nakakuki Y; Okamoto K; Fukumoto M; Honjo T; Hiai H		Leuk Res	17	1993	573-8	J:14362	8326739
86029	Lung tumors in strain A mice: application for studies in cancer chemoprevention.		Stoner GD; Adam-Rodwell G; Morse MA		J Cell Biochem Suppl	17F	1993	95-103	J:14713	8412213
86030	Expression of a retinoblastoma transgene results in dwarf mice.		Bignon YJ; Chen Y; Chang CY; Riley DJ; Windle JJ; Mellon PL; Lee WH		Genes Dev	7	1993	1654-62	J:15042	8370518
86031	Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.		Mock BA; Krall MM; Dosik JK		Proc Natl Acad Sci U S A	90	1993	9499-503	J:15235	8105477
86032	Myeloid leukaemia and osteosarcoma in CBA/H mice given 224Ra.		Humphreys ER; Isaacs KR; Raine TA; Saunders J; Stones VA; Wood DL		Int J Radiat Biol	64	1993	231-5	J:15436	8103548
86033	Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse.		Dietrich WF; Lander ES; Smith JS; Moser AR; Gould KA; Luongo C; Borenstein N; Dove W		Cell	75	1993	631-9	J:15703	8242739
86034	Characterization of somatically acquired ecotropic and mink cell focus-forming viruses in lymphomas of AKXD recombinant inbred mice.		Mucenski ML; Taylor BA; Copeland NG; Jenkins NA		J Virol	61	1987	2929-33	J:15726	3039180
86035	Spontaneous pleomorphic adenoma in the submandibular salivary gland of an aged male (C57BL/6N x C3H/HeN)F1 (B6C3F1) mouse.		Hagiwara A; Ogiso T; Shibata MA; Shirai T		Vet Pathol	30	1993	394-6	J:15783	8212467
86036	Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea.		Katiyar SK; Agarwal R; Mukhtar H		Cancer Res	53	1993	5409-12	J:15847	8221679
86037	Inhibition of chrysarobin skin tumor promotion in SENCAR mice by antioxidants.		Battalora MS; Kruszewski FH; DiGiovanni J		Carcinogenesis	14	1993	2507-12	J:16258	8269619
86038	Genetic predisposition to pre-B lymphomas in SL/Kh strain mice.		Yamada Y; Matsushiro H; Ogawa MS; Okamoto K; Nakakuki Y; Toyokuni S; Fukumoto M; Hiai H		Cancer Res	54	1994	403-7	J:16441	8275476
86039	Abnormal bone marrow B-cell differentiation in pre-B lymphoma-prone SL/Kh mice.		Okamoto K; Yamada Y; Ogawa MS; Toyokuni S; Nakakuki Y; Ikeda H; Yoshida O; Hiai H		Cancer Res	54	1994	399-402	J:16434	8275475
86040	H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.		Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T		Jpn J Cancer Res	84	1993	1273-8	J:16696	7507474
86041	Induction of glandular stomach cancers in C3H mice treated with N-methyl-N-nitrosourea in the drinking water.		Tatematsu M; Yamamoto M; Iwata H; Fukami H; Yuasa H; Tezuka N; Masui T; Nakanishi H		Jpn J Cancer Res	84	1993	1258-64	J:16699	8294216
86042	Inhibition of both stage I and stage II skin tumor promotion in SENCAR mice by a polyphenolic fraction isolated from green tea: inhibition depends on the duration of polyphenol treatment.		Katiyar SK; Agarwal R; Mukhtar H		Carcinogenesis	14	1993	2641-3	J:16700	8269639
86043	Intermittent 50 Hz magnetic field and skin tumor promotion in SENCAR mice.		Rannug A; Holmberg B; Ekstrom T; Mild KH; Gimenez-Conti I; Slaga TJ		Carcinogenesis	15	1994	153-7	J:16909	8313501
86044	Quantitative effects of the retinoblastoma gene on mouse development and tissue-specific tumorigenesis.		Chang CY; Riley DJ; Lee EY; Lee WH		Cell Growth Differ	4	1993	1057-64	J:16970	8117619
86045	Interactive effects of unleaded gasoline and estrogen on liver tumor promotion in female B6C3F1 mice.		Standeven AM; Wolf DC; Goldsworthy TL		Cancer Res	54	1994	1198-204	J:17019	8118806
86046	Experimental testicular germ cell tumorigenesis in mouse strains with and without spontaneous tumours differs from development of germ cell tumours of the adult human testis.		Walt H; Oosterhuis JW; Stevens LC		Int J Androl	16	1993	267-71	J:17071	8262659
86047	A mutation in the Ter gene causing increased susceptibility to testicular teratomas maps to mouse chromosome 18.		Asada Y; Varnum DS; Frankel WN; Nadeau JH		Nat Genet	6	1994	363-8	J:17491	8054975
86048	Promotional effects of azathioprine on peripheral B cell lymphomas in BALB/c mice induced by administration of 7,12-dimethylbenz[a]anthracene.		Fujiwara K; Yoshino T; Akagi T; Teramoto N; Hayashi K		J Cancer Res Clin Oncol	120	1994	319-24	J:17748	8138556
86049	Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7.		Bremner R; Balmain A		Cell	61	1990	407-17	J:17819	2185890
86050	Thymic lymphomas in interleukin 9 transgenic mice.		Renauld JC; van der Lugt N; Vink A; van Roon M; Godfraind C; Warnier G; Merz H; Feller A; Berns A; Van Snick J		Oncogene	9	1994	1327-32	J:17848	8152793
86051	Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomes.		Vaage J; Donovan D; Loftus T; Abra R; Working P; Huang A		Cancer	73	1994	2366-71	J:17834	8168041
86052	Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.		Kordon EC; Molinolo AA; Pasqualini CD; Charreau EH; Pazos P; Dran G; Lanari C		Breast Cancer Res Treat	28	1993	29-39	J:17948	8123867
86053	Metastasis-associated mts1 gene expression correlates with increased p53 detection in the B16 murine melanoma.		Parker C; Lakshmi MS; Piura B; Sherbet GV		DNA Cell Biol	13	1994	343-51	J:18168	7912076
86054	Dietary restriction from middle age attenuates age-associated lymphoma development and interleukin 6 dysregulation in C57BL/6 mice.		Volk MJ; Pugh TD; Kim M; Frith CH; Daynes RA; Ershler WB; Weindruch R		Cancer Res	54	1994	3054-61	J:18324	8187095
86055	Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse live tumors.		Ray JS; Harbison ML; McClain RM; Goodman JI		Mol Carcinog	9	1994	155-66	J:18365	7908202
86056	Renal cell tumors induced in CBA male mice by 1,2-dimethylhydrazine.		Turusov VS; Chemeris GYu		Toxicol Pathol	20	1992	570-5	J:21686	1364055
86057	The histology and development of hepatic nodules and carcinoma in C3H/He and C57BL/6 mice following chronic phenobarbitone administration.		Evans JG; Collins MA; Lake BG; Butler WH		Toxicol Pathol	20	1992	585-94	J:21685	1308624
86058	Ras mutations in methylclofenapate-induced B6C3F1 and C57BL/10J mouse liver tumours.		Stanley LA; Blackburn DR; Devereaux S; Foley J; Lord PG; Maronpot RR; Orton TC; Anderson MW		Carcinogenesis	15	1994	1125-31	J:19102	8020144
86059	Insertional mutation of int protooncogenes in the mammary tumors of a new strain of mice derived from the wild in China: normal- and tumor-tissue-specific expression of int-3 transcripts.		Sarkar NH; Haga S; Lehner AF; Zhao W; Imai S; Moriwaki K		Virology	203	1994	52-62	J:19445	8030284
86060	Chronic toxic and carcinogenic effects of cadmium chloride in male DBA/2NCr and NFS/NCr mice: strain-dependent association with tumors of the hematopoietic system, injection site, liver, and lung.		Waalkes MP; Rehm S		Fundam Appl Toxicol	23	1994	21-31	J:19844	7958559
86061	p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis.		Kemp CJ; Wheldon T; Balmain A		Nat Genet	8	1994	66-9	J:19978	7987394
86062	Skin-tumour-promoting activity of processed bidi tobacco in hairless S/RV Cri-ba mice.		Bagwe AN; Ramchandani AG; Bhisey RA		J Cancer Res Clin Oncol	120	1994	485-9	J:20121	8207047
86063	AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas.		Mucenski ML; Taylor BA; Jenkins NA; Copeland NG		Mol Cell Biol	6	1986	4236-43	J:20300	3025647
86064	Estrogen modification of 1,2-dimethylhydrazine carcinogenesis in C3HA mice [published erratum appears in Cancer Lett 1995 Mar 2;89(2):233]		Turusov VS; Morozova OV; Samoilov DV		Cancer Lett	83	1994	51-8	J:20376	8062234
86065	Effects of green tea and black tea on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation, DNA methylation, and lung tumorigenesis in A/J mice.		Shi ST; Wang ZY; Smith TJ; Hong JY; Chen WF; Ho CT; Yang CS		Cancer Res	54	1994	4641-7	J:20377	8062257
86066	SENCAR mouse skin tumors produced by promotion alone have A to G mutations in codon 61 of the c-rasHa gene.		Sutter C; Greenhalgh DA; Ueda M; Abhyankar S; Ngai P; Hennings H; Schweizer J; Yuspa SH; Strickland JE		Carcinogenesis	15	1994	1975-8	J:20675	7522983
86067	Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.		Glick AB; Lee MM; Darwiche N; Kulkarni AB; Karlsson S; Yuspa SH		Genes Dev	8	1994	2429-40	J:21131	7958907
86068	Tumours of the mammary gland.		Squartini F; Pingitore R		IARC Sci Publ		1994	47-100	J:21165	8082918
86069	Tumours of the Harderian gland.		Sheldon W		IARC Sci Publ		1994	101-13	J:21166	8082903
86070	Demonstration of a new mouse mammary tumor virus locus in the genome of the mammary tumor prone strain SHN mouse.		Koizumi A; Tsukada M; Wada Y; Kamiyama S		Biochem Biophys Res Commun	166	1990	336-41	J:21257	2154203
86071	Calorie intake during mammary development influences cancer risk: lasting inhibition of C3H/HeOu mammary tumorigenesis by peripubertal calorie restriction.		Engelman RW; Day NK; Good RA		Cancer Res	54	1994	5724-30	J:21248	7923222
86072	Different gene expression of mouse transforming growth factor alpha between pregnant mammary glands and mammary tumors in C3H/He mice.		Harigaya T; Tsunoda S; Mizuno M; Nagasawa H		Zoolog Sci	11	1994	625-7	J:21312	7765502
86073	Influence of sex and carcinogen treatment protocol on tumor latency and frequency of K-ras mutations in N-methyl-N-nitrosourea-induced lymphomas.		Romach E; Moore J; Rummel S; Richie E		Carcinogenesis	15	1994	2275-80	J:21317	7955066
86074	T lymphomagenesis is determined by a dominant host gene thymic lymphoma susceptible mouse-1 (TLSM-1) in mouse models.		Yamada Y; Shisa H; Matsushiro H; Kamoto T; Kobayashi Y; Kawarai A; Hiai H		J Exp Med	180	1994	2155-62	J:21741	7964490
86075	At least four genes and sex are associated with susceptibility to urethane-induced pulmonary adenomas in mice.		Festing MF; Yang A; Malkinson AM		Genet Res	64	1994	99-106	J:21801	7813906
86076	Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice.		Lee JM; Abrahamson JL; Kandel R; Donehower LA; Bernstein A		Oncogene	9	1994	3731-6	J:21840	7970733
86077	Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.		Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL; Leiter EH		J Immunol	154	1995	180-91	J:22026	7995938
86078	Susceptibility to tumors induced in mice by ethylnitrosourea is independent of retinoblastoma gene dosage.		Riley DJ; Lai CC; Chang CY; Jones D; Lee EY; Lee WH		Cancer Res	54	1994	6097-101	J:22053	7954454
86079	Transcription of multiple exogenous mouse mammary tumor viruses  in a single mammary tumor of an SHN mouse.		Koizumi A; Tsukada M; Sugawara K; Kusano T		Lab Anim Sci	44	1994	584-9	J:23002	7898031
86080	Morphological classification of mammary tumours in the mouse.		Ebbenhorst Tengbergen WJ		Pathol Eur	5	1970	260-72	J:23428	4320055
86081	Virus-like particles in chemically induced sarcomas in high- and low-leukemia strains of mice.		Liebelt RA; Suzuki S; Liebelt AG; Lane M		Cancer Res	30	1970	2438-48	J:23513	5475486
86082	Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms.		Schaffner DL; Barrios R; Shaker MR; Rajagopalan S; Huang SL; Tindall DJ; Young CY; Overbeek PA; Lebovitz RM; Lieberman MW		Lab Invest	72	1995	283-90	J:23947	7534850
86083	Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.		Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P		Proc Natl Acad Sci U S A	92	1995	2268-72	J:23957	7892260
86084	Complex Y chromosome aberrations are a recurrent secondary event in radiation-induced murine acute myeloid leukaemia.		Fennelly J; Crabtree G; Macdonald D; Lorimore S; Laval S; Proffitt J; Boyd Y; Wright E; Plumb M		Leukemia	9	1995	506-12	J:24136	7885048
86085	Elevation of peptidylproline hydroxylase activity and collagen synthesis in spontaneous primary mammary cancers of inbred mice.		Cutroneo KR; Guzman NA; Liebelt AG		Cancer Res	32	1972	2828-33	J:24559	4345409
86086	Phenotypic heterogeneity of spontaneous lymphomas of CWD mice.		Thomas CY; Buxton VK; Roberts JS; Boykin BJ; Innes D		Blood	73	1989	240-7	J:24566	2562923
86087	RNA tumor virus gs antigen and tumor induction by various doses of 3-methylcholanthrene in various strains of mice treated as weanlings.		Whitmire CE; Salerno RA		Cancer Res	32	1972	1129-32	J:24601	4337883
86088	Responsiveness of mouse mammary tumours to pregnancy.		Nie R van; Thung PJ		Eur J Cancer	1	1965	41-50	J:24632	5896138
86089	Litter seriation phenomena in fibrosarcoma susceptibility. A contribution to the subject of cancer susceptibility in relation to age		Strong LC		J Gerontol	6	1951	340-57	J:24649	14888869
86090	Mouse strain GR: A comparative study of its naturally occurring mammary tumor virus		Vlahakis G		J Natl Cancer Inst	59	1977	447-9	J:24682	 
86091	Differences in tumor incidence in two substrains of Claude BALB/c (BALB/cfCd) mice, emphasizing renal, mammary, pancreatic, and synovial tumors.		Sass B; Peters RL; Kelloff GJ		Lab Anim Sci	26	1976	736-41	J:24705	185454
86092	Friend murine leukemia virus resistance in Japanese wild mice: possible allelism with Fv-4 in FRG mice.		Suzuki S; Tsuji K; Moriwaki K		J Natl Cancer Inst	66	1981	729-31	J:24724	6939918
86093	Genetic and certain non-genetic factors with reference to Leukemia in the F strain of mice		Kirschbaum A		Proc Soc Exp Biol Med	55	1944	147-9	J:24781	 
86094	Genetic transmission of viruses that incite mammary tumor in mice.		Bentvelzen P; Daams JH; Hageman P; Calafat J		Proc Natl Acad Sci U S A	67	1970	377-84	J:24803	4318784
86095	Influence of heredity and environment upon number of tumor nodules occurring in lungs of mice		Lynch CJ		Proc Soc Exp Biol Med	43	1940	186-9	J:24802	 
86096	Strain C3H-A-vy-fB mice: ninety percent incidence of mammary tumors transmitted by either parent.		Vlahakis G; Heston WE; Smith GH		Science	170	1970	185-7	J:24819	4318540
86097	Mouse mammary tumors: alteration of incidence as apparent function of stress.		Riley V		Science	189	1975	465-7	J:24822	168638
86098	Studies on some possible causative factors of the spontaneous adenomatous lesion of the stomach in mice of strain I		Andervont HB		Public Health Rep	54	1939	2085-93	J:24847	 
86099	Mammary tumours in hybrid mice: The presence and transmission of the mammary tumour agent		Foulds L		Br J Cancer	3	1949	230-9	J:24877	 
86100	Attenuation of exogenous murine mammary tumor virus virulence in the C3H/HeJ mouse substrain bearing the Lps mutation.		Outzen HC; Corrow D; Shultz LD		J Natl Cancer Inst	75	1985	917-23	J:24864	2997536
86101	The variability of incidence of mammary carcinoma in inbred strains of mice		Bittner JJ		Cancer Res	1	1941	115-20	J:24866	 
86102	Effects of heterozygosity for the Rb-1t19neo allele in the mouse.		Harrison DJ; Hooper ML; Armstrong JF; Clarke AR		Oncogene	10	1995	1615-20	J:24928	7731716
86103	Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen.		Lukacher AE; Ma Y; Carroll JP; Abromson-Leeman SR; Laning JC; Dorf ME; Benjamin TL		J Exp Med	181	1995	1683-92	J:24958	7722447
86104	Effect of neutrons alone or combined with diethylnitrosamine on tumor induction in the livers of infant C57BL mice.		Maisin JR; Vankerkom J; De Saint-Georges L; Janowski M; Lambiet-Collier M; Mattelin G; Wambersie A		Radiat Res	142	1995	78-84	J:25035	7899562
86105	Life-span, T-cell responses, and incidence of lymphomas in congenic mice.		Salazar M; Leong T; Tu N; Gelman RS; Watson AL; Bronson R; Iglesias A; Mann M; Good RA; Yunis EJ		Proc Natl Acad Sci U S A	92	1995	3992-6	J:25059	7732019
86106	The genetic basis of susceptibility to lung tumors in mice [published erratum appears in Toxicology 1989 May 15;55(3):349]		Malkinson AM		Toxicology	54	1989	241-71	J:23874	2650016
86107	Novel integration sites at the distal 3' end of the c-myb locus in retrovirus-induced promonocytic leukemias.		Nazarov V; Wolff L		J Virol	69	1995	3885-8	J:25278	7745739
86108	Experimental studies on lymphomatosis of mice		Furth J; Seibold HR; Rathbone RR		Am J Cancer	19	1933	521-604	J:25354	 
86109	Sur quelques caracteres des souris appartenant a la nouvelle lignee cancereuse		Rudali G; Yourkovski N; Juliard L; Fautrel M		Bull Cancer (Paris)	43	1956	364-83	J:25332	 
86110	The genetic basis of susceptibility to leukemia induction in mice by 3-methylcholanthrene applied percutaneously.		Duran-Reynals ML; Lilly F; Bosch A; Blank KJ		J Exp Med	147	1978	459-69	J:25394	624906
86111	Growth of mammary tumors in a high and a low mammary tumor strains of mice established from the same basal stock of Swiss albino.		Nagasawa H; Tokuzen R; Nakahara LW		Gann	67	1976	913-5	J:25397	1021511
86112	Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during beta-cell tumorigenesis.		Christofori G; Naik P; Hanahan D		Nat Genet	10	1995	196-201	J:24904	7663515
86113	Lack of ecotropic virus involvement in induction of lymphomas in DBA/2J mice by 7,12-dimethylbenz(a)anthracene.		Mercer JA; Jenkins NA; Copeland NG		J Virol	64	1990	5199-203	J:25780	2168996
86114	Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents.		DiGiovanni J; Walker SC; Beltran L; Naito M; Eastin WC Jr		Cancer Res	51	1991	1398-405	J:25818	1900038
86115	Effects of type of dietary fat on phorbol ester-elicited tumor promotion and other events in mouse skin.		Leyton J; Lee ML; Locniskar M; Belury MA; Slaga TJ; Bechtel D; Fischer SM		Cancer Res	51	1991	907-15	J:25819	1899048
86116	Effect of subordinance, lack of social hierarchy, and restricted feeding on murine survival and virus leukemia.		Ebbesen P; Villadsen JA; Villadsen HD; Heller KE		Exp Gerontol	26	1991	479-86	J:25798	1756779
86117	Incidence of leukemia and nonlymphatic tumors in mice with glomerulosclerosis and allied disorders.		Yuhas JM; Clapp NK		J Natl Cancer Inst	48	1972	367-73	J:25843	4119884
86118	Spontaneous and induced tumors in strain ST mice		Deringer MK; Heston WE; Barrett MK		J Natl Cancer Inst	14	1953	375-80	J:25844	13097159
86119	Impaired immunological surveillance by 7,12-dimethylbenz(a)anthracene augments its skin tumorigenicity in C3H mice.		Elmets CA; Khan WA; Klemme JC; Mukhtar H		Biochem Biophys Res Commun	151	1988	148-52	J:26030	3126733
86120	Identification of 1-alkyl-2-acyl-3-(2',3'-diacylglycerol)glycerols, a new type of lipid class, in harderian gland tumors of mice.		Kasama K; Blank ML; Snyder F		J Biol Chem	264	1989	9453-61	J:26041	2722843
86121	Stimulation by caffeine of spontaneous mammary tumorigenesis in mice.		Nagasawa H; Konishi R		Eur J Cancer Clin Oncol	24	1988	803-5	J:25978	3383984
86122	Spontaneous tumors in aging (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice.		Tamano S; Hagiwara A; Shibata MA; Kurata Y; Fukushima S; Ito N		Toxicol Pathol	16	1988	321-6	J:26024	3194653
86123	Interleukin 6 is essential for in vivo development of B lineage neoplasms.		Hilbert DM; Kopf M; Mock BA; Kohler G; Rudikoff S		J Exp Med	182	1995	243-8	J:26249	7790819
86124	Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development.		Smith GH; Gallahan D; Diella F; Jhappan C; Merlino G; Callahan R		Cell Growth Differ	6	1995	563-77	J:26600	7544153
86125	Correlation between serum prolactin levels and hepatocellular tumorigenesis induced by 3'-methyl-4-dimethylaminoazobenzene in mice.		Yamamoto R; Iishi H; Tatsuta M; Yamamoto T; Koike K; Kanda Y; Miyake A; Tsuji M; Terada N		Br J Cancer	72	1995	17-21	J:26737	7599048
86126	Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.		Largaespada DA; Shaughnessy JD Jr; Jenkins NA; Copeland NG		J Virol	69	1995	5095-102	J:26865	7609078
86127	Proviral activation of the c-myb proto-oncogene is detectable in preleukemic mice infected neonatally with Moloney murine leukemia virus but not in resulting end stage T lymphomas.		Belli B; Wolff L; Nazarov V; Fan H		J Virol	69	1995	5138-41	J:26866	7609084
86128	Role of cytokines in termination of the B cell lymphoma dormant state in AKR mice.		Peled A; Tzehoval E; Haran-Ghera N		Leukemia	9	1995	1095-101	J:26850	7596176
86129	Animal models of medulloblastomas and related primitive neuroectodermal tumors. A review.		Fung KM; Trojanowski JQ		J Neuropathol Exp Neurol	54	1995	285-96	J:26937	7745427
86130	Investigation of lung tumour induction in BALB/cJ mice following paternal X-irradiation.		Cattanach BM; Patrick G; Papworth D; Goodhead DT; Hacker T; Cobb L; Whitehill E		Int J Radiat Biol	67	1995	607-15	J:26915	7775836
86131	The effect of body weight on tumor incidence and carcinogenicity testing in B6C3F1 mice and F344 rats.		Seilkop SK		Fundam Appl Toxicol	24	1995	247-59	J:26963	7737436
86132	The use of a mouse model in the study of Helicobacter sp.-associated gastric cancer.		Lee A		Eur J Gastroenterol Hepatol	6 Suppl 1	1994	S67-71	J:26966	7735939
86133	Growth, body weight, survival, and tumor trends in (C57BL/6 X C3H/HeN) F1 (B6C3F1) mice during a nine-year period.		Rao GN; Haseman JK; Grumbein S; Crawford DD; Eustis SL		Toxicol Pathol	18	1990	71-7	J:27047	2362989
86134	Molecular features of the H-2 class I and Qa antigens expressed on Gross virus induced AKR leukaemias.		Festenstein H		J Immunogenet	16	1989	329-33	J:27061	2700994
86135	Progression to development of lymphoma in the thymus of AKR mice treated neonatally with SL 3-3 virus.		Hays EF; Bristol GC; Lugo JP; Wang XF		Exp Hematol	17	1989	1116-21	J:27058	2511036
86136	Transfer, by selective breeding, of the pathogenic Mtv-2 endogenous provirus from the GR strain to a wild mouse line free of endogenous and exogenous mouse mammary tumor virus.		Morris DW; Young LJ; Gardner MB; Cardiff RD		J Virol	58	1986	247-52	J:27091	3009842
86137	N-methyl-N-nitrosourea-induced T-lymphomas of AKR/J mice contain somatically acquired ecotropic-like murine leukemia proviruses.		Richie ER; Angel JM; McEntire B		Virology	164	1988	211-9	J:27086	2834870
86138	Inhibition of the development of radiation-induced leukemia in mice by reduction of food intake.		Gross L; Dreyfuss Y		Proc Natl Acad Sci U S A	83	1986	7928-31	J:27116	3532125
86139	Glomerulonephritis associated with immune complex deposits and viral particles in spontaneous murine leukemia. An electron microscopic study with immunofluorescence.		Pascal RR; Koss MN; Kassel RL		Lab Invest	29	1973	159-65	J:27168	4353415
86140	Studies on DDD mouse with special reference to mammary gland tumors.		Matsuzawa A; Yamamoto T; Suzuki K		Jpn J Exp Med	40	1970	159-81	J:27169	4319726
86141	A new class of murine leukemia virus associated with development of spontaneous lymphomas.		Hartley JW; Wolford NK; Old LJ; Rowe WP		Proc Natl Acad Sci U S A	74	1977	789-92	J:27157	191826
86142	Distinctive infrared spectral features in liver tumor tissues of mice: evidence of structural modifications at the molecular level.		Wong PT; Cadrin M; French SW		Exp Mol Pathol	55	1991	269-84	J:27289	1748216
86143	Extra-thymic immature T cells: development in polyoma virus-induced murine salivary gland tumors.		Hoot GP; Kettman JR		Eur J Immunol	19	1989	1991-8	J:27602	2574678
86144	N-methylnitrosourea-induced Ki-ras codon 12 mutations: early events in mouse thymic lymphomas.		Newcomb EW; Bayona W; Pisharody S		Mol Carcinog	13	1995	89-95	J:27362	7605584
86145	BALB/c subline differences in susceptibility to plasmacytoma induction.		Potter M; Wax JS; Blankenhorn E		Curr Top Microbiol Immunol	122	1985	234-41	J:26481	3930153
86146	Physiology and regulation of biological rhythms in laboratory animals: an overview.		Wollnik F		Lab Anim	23	1989	107-25	J:26395	2651797
86147	Multiple skin tumors in mice following a single painting with 9:10 dimethyl-I:2 benzanthracene		Law LW		Am J Pathol	17	1941	827-31	J:26358	 
86148	Chromosomal and extrachromosomal influence in relation to the incidence of mammary tumors in mice		Murray WS; Little CC		Am J Cancer	37	1939	536-52	J:26448	 
86149	A comparative morphological study of the mammary gland in a high and a low tumor strain of mice		Fekete E		Am J Pathol	14	1938	557-78	J:26271	 
86150	Production of mammary carcinoma in mice by estrogens		Haagensen CD; Randall HT		Arch Pathol	33	1942	411-42	J:26295	 
86151	Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane.		Byrd LG; McDonald AH; Gold LG; Potter M		J Immunol	147	1991	3632-7	J:27571	1682379
86152	Radiation-induced myeloid leukemia in C3H/He mice and the effect of prednisolone acetate on leukemogenesis.		Seki M; Yoshida K; Nishimura M; Nemoto K		Radiat Res	127	1991	146-9	J:27576	1946997
86153	The endogenous mink cell focus-forming (MCF) gp70 linked to the Rmcf gene restricts MCF virus replication in vivo and provides partial resistance to erythroleukemia induced by Friend murine leukemia virus.		Buller RS; Sitbon M; Portis JL		J Exp Med	167	1988	1535-46	J:27618	2835418
86154	Morphologic characteristics of benign and malignant renal cell tumors in control and 2-acetylaminofluorene-treated BALB/c female mice.		Shinohara Y; Frith CH		Am J Pathol	100	1980	455-68	J:27630	7406020
86155	Genetic background and development of skin tumors.		Naito M; DiGiovanni J		Carcinog Compr Surv	11	1989	187-212	J:27657	2493334
86156	Spontaneous testicular teratomas in an inbred strain of mice		Stevens LC; Little CC		Proc Natl Acad Sci U S A	40	1954	1080-7	J:26336	16578442
86157	Hemoglobin levels in various degrees of susceptibility to spontaneous tumors		Strong LC		Am J Cancer	27	1936	500-9	J:26338	 
86158	Adrenal tumors, pituitary tumors, and other pathological changes in F1 hybrids of strain DE X strain DBA		Dickie MM; Lane PW		Cancer Res	16	1956	48-52	J:26340	13284729
86159	The results of a 'functional test' in a strain of mice (C57 Black) with a low breast tumor incidence		Little CC; Pearsons J		Am J Cancer	38	1940	224-33	J:26150	 
86160	The cancer producing properties of Azo compounds in mice		Law LW		Cancer Res	1	1941	397-401	J:26154	 
86161	Induction of lymphomatosis in mice following painting with 9:10 dimethyl-1:2 benzanthracene		Law LW; Lewisohn M		Proc Soc Exp Biol Med	43	1940	143-6	J:26171	 
86162	Further studies on the production of dibenzanthracene tumors in pure strain and stock mice		Andervont HB		Public Health Rep	50	1935	1211-17	J:26378	 
86163	The production of tumors in mice of strains C3H and Y by dibenzanthracene and methylcholanthrene and pulmonary tumors in mice		Andervont HB		Public Health Rep	53	1938	229-37	J:26379	 
86164	Pulmonary tumors in mice. VI. Time of appearance of tumors induced in strain A mice following injection of 1:2:5:6-dibenzanthracene or 20-methylcholanthrene		Andervont HB		Public Health Rep	54	1939	1512-19	J:26365	 
86165	Susceptibility of mice to spontaneous, induced, and transplantable tumors - A comparative study of eight strains		Andervont HB		Public Health Rep	53	1938	1647-65	J:26367	 
86166	Pulmonary tumors in mice. II. The influence of heredity upon lung tumors induced by the subcutaneous injection of a lard-dibenzanthracene solution		Andervont HB		Public Health Rep	52	1937	304-15	J:26368	 
86167	Dibenzanthracene tumors in mice. The production of subcutaneous and pulmonary tumors by 1:2:5:6-dibenzanthracene adsorbed on charcoal		Andervont HB; Lorenz E		Public Health Rep	52	1937	1931-40	J:26371	 
86168	Dibenzanthracene tumors in mice. The production of subcutaneous, pulmonary, and liver tumors by serum dispersions and lard solutions		Andervont HB; Lorenz E		Public Health Rep	52	1937	1-11	J:26372	 
86169	The incidence of induced subcutaneous and pulmonary tumors and spontaneous mammary tumors in hybrid mice		Andervont HB		Public Health Rep	53	1938	1665-71	J:26374	 
86170	Studies of the mammary tumor agent carried by wild house mice		Andervont HB; Dunn TB		Acta	12	1956	529-43	J:26375	 
86171	The occurrence of spontaneous and induced pulmonary and liver tumors in strain C3H mice		Andervont HB		Public Health Rep	54	1939	1158-69	J:26377	 
86172	Loss of spontaneous metastasizing potential in mouse mammary tumors.		Vaage J		Clin Exp Metastasis	7	1989	373-8	J:26451	2924453
86173	Iron as a synergist for hepatocellular carcinoma induced by polychlorinated biphenyls in Ah-responsive C57BL/10ScSn mice.		Smith AG; Francis JE; Carthew P		Carcinogenesis	11	1990	437-44	J:26441	2155720
86174	Effect of resiniferatoxin pretreatment on the inflammatory response to phorbol-12-myristate-13-acetate in mouse strains with different susceptibilities to phorbol ester tumor promotion.		Szallasi A; Blumberg PM		Carcinogenesis	11	1990	583-7	J:26442	2322999
86175	Incidence of spontaneous mammary carcinoma in the new strain of Indian laboratory mouse		Ranadive KJ; Kamat KA; Coutinho TG; Khanolkar VR		Indian J Med Res	49	1961	562-7	J:27831	 
86176	Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections.		Gangemi JD; Matter A; Poncioni B; Hochkeppel HK		J Interferon Res	9	1989	275-83	J:27869	2473142
86177	Amino acid-restricted diets in the treatment of mammary adenocarcinoma in mice.		Kamath SK; Conrad NC; Olson RE; Kohrs MB; Ghosh L		J Nutr	118	1988	1137-42	J:27912	3418421
86178	Specific growth factor activity identifies and predicts murine mammary tumor.		Ness JC; Morgan L; Outzen HC; Tapper D		J Surg Res	50	1991	6-14	J:27886	1987433
86179	Highlights of observations of the inbred ICRC mouse susceptible to spontaneous breast cancer and leukemia		Ranadive		Tex Rep Biol Med	29	1971	359 (Abstr.)	J:27950	 
86180	Immunoglobulin-producing tumors and myeloma proteins of mice.		Potter M		Physiol Rev	52	1972	631-719	J:27927	4555516
86181	The Emu-bcl-2 transgene enhances antigen-induced germinal center formation in both BALB/c and SJL mice but causes age-dependent germinal center hyperplasia only in the lymphoma-prone SJL strain.		Secord EA; Edington JM; Thorbecke GJ		Am J Pathol	147	1995	422-33	J:27999	7639335
86182	UV-induced skin cancer in a hairless mouse model.		de Gruijl FR; Forbes PD		Bioessays	17	1995	651-60	J:28129	7646487
86183	Analysis of loss of heterozygosity in murine hepatocellular tumors.		Manenti G; De Gregorio L; Gariboldi M; Dragani TA; Pierotti MA		Mol Carcinog	13	1995	191-200	J:28255	7619222
86184	Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.		Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ		Virology	211	1995	507-15	J:28300	7645254
86185	Biochemical changes during growth and regression of pregnancy-dependent mammary tumors of GR/A mice.		Goto Y; Nagasawa H; Sasaki T; Enami J; Iguchi T		Proc Soc Exp Biol Med	209	1995	343-53	J:28376	7638241
86186	H-ras oncogene mutation spectra in B6C3F1 and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells.		Watson MA; Devereux TR; Malarkey DE; Anderson MW; Maronpot RR		Carcinogenesis	16	1995	1705-10	J:28565	7634393
86187	ApcMin: a mouse model for intestinal and mammary tumorigenesis.		Moser AR; Luongo C; Gould KA; McNeley MK; Shoemaker AR; Dove WF		Eur J Cancer	31A	1995	1061-4	J:28572	7576992
86188	High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC.		Sands AT; Abuin A; Sanchez A; Conti CJ; Bradley A		Nature	377	1995	162-5	J:28708	7675084
86189	Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice.		Moskow JJ; Bullrich F; Huebner K; Daar IO; Buchberg AM		Mol Cell Biol	15	1995	5434-43	J:28792	7565694
86190	Trial of a new medium-term model using benzo(a)pyrene induced lung tumor in newborn mice.		Yun TK; Kim SH; Lee YS		Anticancer Res	15	1995	839-45	J:28862	7645968
86191	Relative biological effectiveness of tritium for induction of myeloid leukemia in CBA/H mice.		Johnson JR; Myers DK; Jackson JS; Dunford DW; Gragtmans NJ; Wyatt HM; Jones AR; Percy DH		Radiat Res	144	1995	82-9	J:29049	7568775
86192	Identification of a unique mouse mammary tumor virus in the BALB/cNIV mouse strain.		Puma JP; Fanning TG; Young LJ; Cardiff RD		J Virol	43	1982	158-65	J:29494	6286994
86193	A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas.		Stevens LC		J Natl Cancer Inst	50	1973	235-42	J:29502	4692863
86194	Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 [see comments]		Waterhouse P; Penninger JM; Timms E; Wakeham A; Shahinian A; Lee KP; Thompson CB; Griesser H; Mak TW		Science	270	1995	985-8	J:29652	7481803
86195	Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) [see comments]		Bates P; Fisher R; Ward A; Richardson L; Hill DJ; Graham CF		Br J Cancer	72	1995	1189-93	J:29662	7577466
86196	Promotion of N-nitrosodiethylamine-initiated hepatocellular tumors and hepatoblastomas by 2,3,7,8-tetrachlorodibenzo-p-dioxin or Aroclor 1254 in C57BL/6, DBA/2, and B6D2F1 mice.		Beebe LE; Fornwald LW; Diwan BA; Anver MR; Anderson LM		Cancer Res	55	1995	4875-80	J:29725	7585523
86197	Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.		de Vries TJ; Kitson JL; Silvers WK; Mintz B		Cancer Res	55	1995	4681-7	J:29728	7553649
86198	Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.		Linardopoulos S; Street AJ; Quelle DE; Parry D; Peters G; Sherr CJ; Balmain A		Cancer Res	55	1995	5168-72	J:29767	7585567
86199	Genetics of murine lung tumors.		Dragani TA; Manenti G; Pierotti MA		Adv Cancer Res	67	1995	83-112	J:29809	8571820
86200	Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.		Zornig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Moroy T		Oncogene	11	1995	2165-74	J:29892	7478538
86201	K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate.		Matzinger SA; Crist KA; Stoner GD; Anderson MW; Pereira MA; Steele VE; Kelloff GJ; Lubet RA; You M		Carcinogenesis	16	1995	2487-92	J:29998	7586156
86202	Effects of dietary n-3, n-6 and n-9 polyunsaturated fatty acids on benzo(a)pyrene-induced forestomach tumorigenesis in C57BL6J mice.		Silva RA; Munoz SE; Guzman CA; Evnard AR		Prostaglandins Leukot Essent Fatty Acids	53	1995	273-7	J:30098	8577781
86203	12-Lipoxygenase isoenzymes in mouse skin tumor development.		Krieg P; Kinzig A; Ress-Loschke M; Vogel S; Vanlandingham B; Stephan M; Lehmann WD; Marks F; Furstenberger G		Mol Carcinog	14	1995	118-29	J:30181	7576099
86204	The spontaneous incidence of lung tumors in relation to the incidence of mammary tumors in an inbred strain of albino mice (strain A)		Bittner JJ		Am J Cancer	27	1936	519-24	J:30360	 
86205	DNA pooling as a quick method for finding candidate linkages in multigenic trait analysis: an example involving susceptibility to germ cell tumors.		Collin GB; Asada Y; Varnum DS; Nadeau JH		Mamm Genome	7	1996	68-70	J:30812	8903734
86206	Second-site genetic analysis of multiple intestinal neoplasia		Dove W; Gould K; Katzung D; Luongo C; Moser A; Shoemaker A; Donehower L; Hong K; Dietrich W; Lander E		9th International Mouse Genome Conference		1995	27 (Abstr. 15)	J:30726	 
86207	The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.		Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P		Oncogene	11	1995	181-90	J:31124	7624126
86208	Establishment and characterization of transplantable tumor derived from a spontaneous malignant fibrous histiocytoma in the mouse.		Yamamoto H; Yamamoto I		Exp Anim	45	1996	45-54	J:31340	8689580
86209	Long-term effects on tumour incidence and survival from 241Am exposure of the BALB/c mouse in utero and during adulthood.		van den Heuvel R; Gerber GB; Leppens H; Vander Plaetse F; Schoeters GE		Int J Radiat Biol	68	1995	679-86	J:31404	8551111
86210	The effect of 'aging' of an inhibitor of spontaneous tumors in mice. II. Observations at aging from 101-1346 days.		Strong LC; Matsunaga H		J Surg Oncol	3	1971	369-78	J:31521	5097620
86211	Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia.		Largaespada DA; Brannan CI; Jenkins NA; Copeland NG		Nat Genet	12	1996	137-43	J:31568	8563750
86212	Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias [see comments]		Nakamura T; Largaespada DA; Shaughnessy JD Jr; Jenkins NA; Copeland NG		Nat Genet	12	1996	149-53	J:31569	8563752
86213	Multiple genes in the H-2 complex affect differently the number and growth rate of transplacentally induced lung tumours in mice.		Oomen LC; Demant P; Hart AA; Emmelot P		Int J Cancer	31	1983	447-54	J:31594	6832854
86214	Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome.		Katiyar SK; Agarwal R; Mukhtar H		Cancer Res	56	1996	1023-30	J:31623	8640756
86215	Peroxisome proliferation and microsomal enzyme induction by the hypolipidemic CI-924 in rats and mice: relationship to tumorgenicity.		Hofstra AH; King LM; Walker RM		Fundam Appl Toxicol	27	1995	277-86	J:31674	8529824
86216	Induction of thymic lymphoma in mice administered the dideoxynucleoside ddC.		Sanders VM; Elwell MR; Heath JE; Collins BJ; Dunnick JK; Rao GN; Prejean D; Lindamood C 3rd; Irwin RD		Fundam Appl Toxicol	27	1995	263-9	J:31675	8529822
86217	The establishment of the C3H Inbred Strain of mice for the study of spontaneous carcinoma of the mammary gland		Strong LC		CA Cancer J Clin	29	1979	54-62	J:31534	110402
86218	Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice.		Nesnow S; Ross JA; Stoner GD; Mass MJ		Toxicology	105	1995	403-13	J:32177	8571376
86219	Genetic and epigenetic resistance of SL/Ni mice to lymphomas.		Shisa H; Yamada Y; Kawarai A; Terada N; Kawai M; Matsushiro H; Hiai H		Jpn J Cancer Res	87	1996	258-62	J:32436	8613427
86220	The H-2 class II genes and the susceptibility to the development of pulmonary adenoma in mice.		Miyashita N; Moriwaki K; Migita S		Immunogenetics	29	1989	14-8	J:32504	2783252
86221	Endogenous mouse mammary tumor virus Mtv-17 is involved in Mtv-2-induced tumorigenesis in GR mice.		Golovkina TV; Prakash O; Ross SR		Virology	218	1996	14-22	J:33092	8615016
86222	E2F-1 functions in mice to promote apoptosis and suppress proliferation.		Field SJ; Tsai FY; Kuo F; Zubiaga AM; Kaelin WG Jr; Livingston DM; Orkin SH; Greenberg ME		Cell	85	1996	549-61	J:33100	8653790
86223	Comparison of mammary gland growth and some physiological parameters in a high mammary tumor strain of SHN mice and ICR, most popular and 'normal' mice.		Yasuda M; Tanaka M; Nagasawa H		Exp Anim	45	1996	141-8	J:33116	8726138
86224	Effects of two dietary fat levels and four dietary linoleic acid levels on mammary tumor development in Balb/c-MMTV mice under ad libitum feeding conditions.		Ritskes-Hoitinga J; Meijers M; Timmer WG; Wiersma A; Meijer GW; Weststrate JA		Nutr Cancer	25	1996	161-72	J:33196	8710685
86225	The mouse inhibin alpha-subunit promoter directs SV40 T-antigen to Leydig cells in transgenic mice [published erratum appears in Mol Cell Endocrinol 1996 Aug 30;122(1):109-10]		Kananen K; Markkula M; el-Hefnawy T; Zhang FP; Paukku T; Su JG; Hsueh AJ; Huhtaniemi I		Mol Cell Endocrinol	119	1996	135-46	J:33603	8807633
86226	On the shape of neutron dose-effect curves for radiogenic cancers and life shortening in mice.		Storer JB; Fry RJ		Radiat Environ Biophys	34	1995	21-7	J:33636	7604155
86227	Diminished expression of CYP1A1 in urethane-induced lung tumors in strain A/J mice: analysis by in situ hybridization and immunohistochemical methods.		Forkert PG; Jackson AC; Parkinson A; Chen S		Am J Respir Cell Mol Biol	14	1996	444-53	J:33777	8624249
86228	The influence of sex on life shortening and tumor induction in CBA/Cne mice exposed to X rays or fission neutrons.		Di Majo V; Coppola M; Rebessi S; Saran A; Pazzaglia S; Pariset L; Covelli V		Radiat Res	146	1996	81-7	J:33836	8677302
86229	Multigenic control of skin tumour development in mice.		Nagase H; Bryson S; Fee F; Balmain A			197	1996	156-168	J:34000	 
86230	Suppression by coffee cherry of the growth of spontaneous mammary tumours in SHN mice.		Nagasawa H; Yasuda M; Sakamoto S; Inatomi H		Anticancer Res	16	1996	151-3	J:34128	8615601
86231	Interleukin-6 is required for pristane-induced plasma cell hyperplasia in mice.		Dedera DA; Urashima M; Chauhan D; LeBrun DP; Bronson RT; Anderson KC		Br J Haematol	94	1996	53-6	J:34203	8757508
86232	Genetic determination of differential inflammatory reactivity and subcutaneous tumor susceptibility of AKR-J and C57BL-6J mice to 7,12-dimethylbenz- [a]anthracene.		Schmid FA; Elmer I; Tarnowski GS		Cancer Res	29	1969	1585-9	J:34134	5807232
86233	Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.		Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS		Am J Pathol	149	1996	407-28	J:34434	8701981
86234	Inhibition of neutrophil elastase suppresses the development of skin tumors in hairless mice.		Starcher B; O'Neal P; Granstein RD; Beissert S		J Invest Dermatol	107	1996	159-63	J:34446	8757756
86235	Development of inbred strains in the mouse and their use in cancer research		Heston WE				1949	1-23	J:34555	 
86236	Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice.		Nikitin AYu; Lee WH		Genes Dev	10	1996	1870-9	J:34766	8756345
86237	Prevention of murine radiogenic thymic lymphomas by tumor necrosis factor or by marrow grafting.		Humblet C; Greimers R; Delvenne P; Deman J; Boniver J; Defresne MP		J Natl Cancer Inst	88	1996	824-31	J:34853	8637049
86238	Two dominant host resistance genes to pre-B lymphoma in wild-derived inbred mouse strain MSM/Ms.		Pataer A; Kamoto T; Lu LM; Yamada Y; Hiai H		Cancer Res	56	1996	3716-20	J:34941	8706013
86239	Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice.		Martin DC; Ruther U; Sanchez-Sweatman OH; Orr FW; Khokha R		Oncogene	13	1996	569-76	J:34968	8760297
86240	TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice.		Cui W; Fowlis DJ; Bryson S; Duffie E; Ireland H; Balmain A; Akhurst RJ		Cell	86	1996	531-42	J:35024	8752208
86241	Inhibition of tumor promotion and hepatocellular growth by dietary restriction in mice.		Kolaja KL; Bunting KA; Klaunig JE		Carcinogenesis	17	1996	1657-64	J:35049	8761422
86242	Chromosomal abnormalities in neutron-induced acute myeloid leukemias in CBA/H mice.		Bouffler SD; Meijne EI; Huiskamp R; Cox R		Radiat Res	146	1996	349-52	J:35062	8752315
86243	Activation of K-ras in aflatoxin B1-induced lung tumors from AC3F1 (A/J x C3H/HeJ) mice.		Donnelly PJ; Devereux TR; Foley JF; Maronpot RR; Anderson MW; Massey TE		Carcinogenesis	17	1996	1735-40	J:35063	8761434
86244	Role of telomeric sequences in murine radiation-induced myeloid leukaemia.		Meijne EI; Silver AR; Bouffler SD; Morris DJ; van Kampen EW; Spanjer S; Huiskamp R; Cox R		Genes Chromosomes Cancer	16	1996	230-7	J:35174	8875236
86245	A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice.		Peng SL; Robert ME; Hayday AC; Craft J		J Exp Med	184	1996	1149-54	J:35237	9064331
86246	Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen.		Ewald D; Li M; Efrat S; Auer G; Wall RJ; Furth PA; Hennighausen L		Science	273	1996	1384-6	J:35417	8703072
86247	The influence of a water soluble fraction prepared from liver on the life span and development of leukemia in AKA mice		Arnesen K; Dedichen J		Acta Pathol Microbiol Scand	50	1960	347-9	J:35644	13684353
86248	Tumour incidence, growth, reproduction and longevity in female C3H mice fed polyunsaturated ruminant-derived foodstuffs.		Pennycuik PR; Fogerty AC; Willcox ME; Ferris MC; Baxter RI; Johnson AR		Aust J Biol Sci	32	1979	309-16	J:35662	574381
86249	Prolongation of the normal lifespan and inhibition of spontaneous cancer by antioxidants		Harman D		J Gerontol	16	1961	247-54	J:35666	13711616
86250	Carcinogenesis and aging. IV. Effect of low-molecular-weight factors of thymus, pineal gland and anterior hypothalamus on immunity, tumor incidence and life span of C3H/Sn mice.		Anisimov VN; Khavinson VK; Morozov VG		Mech Ageing Dev	19	1982	245-58	J:35650	6752596
86251	Late effects of X-radiation.  The influence of dose fractionation on life span, leukemia, and nephrosclerosis incidence in mice		Cole LJ; Nowell PC; Arnold JS		Radiat Res	12	1960	173-85	J:35656	13811124
86252	Benzo[b]fluoranthene: tumorigenicity in strain A/J mouse lungs, DNA adducts and mutations in the Ki-ras oncogene.		Mass MJ; Abu-Shakra A; Roop BC; Nelson G; Galati AJ; Stoner GD; Nesnow S; Ross JA		Carcinogenesis	17	1996	1701-4	J:35702	8761429
86253	Natural tumor incidence in a population of mice as a reference index		Newissen DJ		Fed Proc	30	1971	341 (Abstr.)	J:35679	 
86254	A genetic study of induced lung-tumours in mice		Falconer DS; Bloom JL		Br J Cancer	16	1962	665-85	J:35764	 
86255	Evidence for related antigens on sperm, tumor, and fetal cells in the mouse.		Goldberg EH; Tokuda S		Transplant Proc	9	1977	1363-5	J:35994	878010
86256	Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene.		Coppee F; Gerard AC; Denef JF; Ledent C; Vassart G; Dumont JE; Parmentier M		Oncogene	13	1996	1471-82	J:36009	8875985
86257	CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease.		Smith KG; Strasser A; Vaux DL		EMBO J	15	1996	5167-76	J:36055	8895561
86258	Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon.		Risio M; Lipkin M; Newmark H; Yang K; Rossini FP; Steele VE; Boone CW; Kelloff GJ		Cancer Res	56	1996	4910-6	J:36226	8895743
86259	Hodgkin's disease. SJL/J murine lymphoma.		Kumar RK		Am J Pathol	110	1983	393-6	J:35739	6829714
86260	Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene.		Ambartsumian NS; Grigorian MS; Larsen IF; Karlstrom O; Sidenius N; Rygaard J; Georgiev G; Lukanidin E		Oncogene	13	1996	1621-30	J:36642	8895507
86261	Chronic gastritis of the glandular stomach, adenomatous polyps of the duodenum, and calcareous pericarditis in strain DBA mice		Hare WV; Stewart HL		J Natl Cancer Inst	16	1956	889-911	J:36888	13286705
86262	Expression cloning and signal transduction pathway of P2U receptor in mammary tumor cells.		Enomoto K; Furuya K; Moore RC; Yamagishi S; Oka T; Maeno T		Biol Signals	5	1996	9-21	J:36938	8739319
86263	Active immunotherapy with transiently transfected cytokine-secreting tumor cells inhibits breast cancer metastases in tumor-bearing animals.		Coveney E; Clary B; Iacobucci M; Philip R; Lyerly K		Surgery	120	1996	265-72	J:36952	8751592
86264	Hepatotumorigenicity and peroxisome proliferation induced by the hypolipidemic CI-924 in a two-year study in male and female B6C3F1 mice.		Walker RM; Wojcinski ZW; Hofstra AH; King LM; Rogers JE; Baker KW; Chang PK; Smith GS		Toxicol Pathol	24	1996	265-72	J:36957	8736381
86265	The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.		Jones SN; Sands AT; Hancock AR; Vogel H; Donehower LA; Linke SP; Wahl GM; Bradley A		Proc Natl Acad Sci U S A	93	1996	14106-11	J:37047	8943068
86266	Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.		Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL		Cancer Res	56	1996	5391-6	J:37032	8968091
86267	Loss of intracisternal A-type retroviral particles in BL6 melanoma cells transfected with MHC class I genes.		Li M; Muller J; Rao V; Hearing V; Lueders K; Gorelik E		J Gen Virol	77	1996	2757-65	J:37200	8922469
86268	Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.		Sakata H; Takayama H; Sharp R; Rubin JS; Merlino G; LaRochelle WJ		Cell Growth Differ	7	1996	1513-23	J:37191	8930401
86269	Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis.		Valenzona HO; Pointer R; Ceredig R; Osmond DG		Exp Hematol	24	1996	1521-9	J:37108	8950236
86270	Lens-specific expression of PDGF-A in transgenic mice results in retinal astrocytic hamartomas.		Reneker LW; Overbeek PA		Invest Ophthalmol Vis Sci	37	1996	2455-66	J:37286	8933762
86271	Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression.		Aldaz CM; Liao QY; Paladugu A; Rehm S; Wang H		Mol Carcinog	17	1996	126-33	J:37488	8944072
86272	Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.		Santodonato L; Ferrantini M; Gabriele L; Proietti E; Venditti M; Musiani P; Modesti A; Modica A; Lupton SD; Belardelli F		Hum Gene Ther	7	1996	1-10	J:37602	8825863
86273	Expression of human Krev-1 gene in lungs of transgenic mice and subsequent reduction in multiplicity of ethyl carbamate-induced lung adenomas.		Damak S; Harnboonsong Y; George PM; Bullock DW		Mol Carcinog	17	1996	84-91	J:37603	8890957
86274	Loss of heterozygosity on chromosome 6 in dichloroacetic acid and trichloroacetic acid-induced liver tumors in female B6C3F1 mice.		Tao L; Li K; Kramer PM; Pereira MA		Cancer Lett	108	1996	257-61	J:37610	8973603
86275	Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53.		Hundley JE; Koester SK; Troyer DA; Hilsenbeck SG; Subler MA; Windle JJ		Mol Cell Biol	17	1997	723-31	J:37670	9001226
86276	Characterization of acidic actin in mouse sarcoma 180 cells.		Ueyama H; Kurokawa K; Sasaki I; Ueda K		Cell Struct Funct	12	1987	463-70	J:37727	3677181
86277	Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice.		Scheijen B; Jonkers J; Acton D; Berns A		J Virol	71	1997	9-16	J:37751	8985317
86278	Susceptibility of nude mice carrying the Fv-4 gene to Friend murine leukemia virus infection.		Higo K; Kubo Y; Iwatani Y; Ono T; Maeda M; Hiai H; Masuda T ; Kuribayashi K ; Zhang F ; Lamin TY ; Adachi A ; Ishimoto A		J Virol	71	1997	750-4	J:37778	8985411
86279	Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.		Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB		Cancer Res	54	1994	5607-13	J:37779	7923205
86280	Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene.		Lorico A; Rappa G; Srimatkandada S; Catapano CV; Fernandes DJ; Germino JF; Sartorelli AC		Cancer Res	55	1995	4352-60	J:37780	7671247
86281	Isolation of a novel Sry-related gene that is expressed in high-metastatic K-1735 murine melanoma cells.		Tani M; Shindo-Okada N; Hashimoto Y; Shiroishi T; Takenoshita S; Nagamachi Y; Yokota J		Genomics	39	1997	30-7	J:37842	9027483
86282	Id genes encoding inhibitors of transcription are expressed during in vitro astrocyte differentiation and in cell lines derived from astrocytic tumors.		Andres-Barquin PJ; Hernandez MC; Hayes TE; McKay RD; Israel MA		Cancer Res	57	1997	215-20	J:37870	9000557
86283	Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.		Faller DV; Weng H; Choi SY		Virology	227	1997	331-42	J:37874	9018132
86284	DNA tumor viruses and Src family tyrosine kinases, an intimate relationship.		Messerschmitt AS; Dunant N; Ballmer-Hofer K		Virology	227	1997	271-80	J:37875	9018126
86285	Evidence for the participation of interleukin-2 (IL-2) and IL-4 in the regulation of autonomous growth and tumorigenesis of transformed cells of lymphoid origin.		Hassuneh MR; Nagarkatti PS; Nagarkatti M		Blood	89	1997	610-20	J:37876	9002965
86286	Tumor necrosis factor-alpha- and interleukin-6-triggered mast cell development from mouse spleen cells.		Hu ZQ; Kobayashi K; Zenda N; Shimamura T		Blood	89	1997	526-33	J:37878	9002955
86287	Ectopic expression of the erythropoietin receptor in a murine interleukin-6-dependent plasmacytoma cell line (TEPC-2027) confers proliferative responsiveness to erythropoietin.		Feger F; Dubart A; Lacout C; Dusanter-Fourt I; Mayeux P; Vainchenker W ; Dumenil D		Blood	89	1997	435-45	J:37879	9002945
86288	Characteristics of androgen-independent growth of androgen-responsive Shionogi carcinoma 115 cells.		Tomioka S; Ichikawa T; Watabe Y; Suzuki H; Shimazaki J		Int J Urol	3	1996	286-91	J:37944	8844285
86289	The tissue distribution in BALB/c mice of C-14-labeled JM216, an orally active platinum antitumour compound.		Bates PI; Sharma HL; Murrer BA; McAuliffe CA		Cancer Chemother Pharmacol	39	1996	170-5	J:37954	8995517
86290	Activin and basic fibroblast growth factor regulate neurogenesis of murine embryonal carcinoma cells.		Ameerun RF; de Winter JP; van den Eijnden-van Raaij AJ; den Hertog J; de Laat SW; Tertoolen LG		Cell Growth Differ	7	1996	1679-88	J:37957	8959336
86291	Lifespan and lesions in genetically heterogeneous (four-way cross) mice: a new model for aging research.		Chrisp CE; Turke P; Luciano A; Swalwell S; Peterson J; Miller RA		Vet Pathol	33	1996	735-43	J:37980	8952040
86292	The mRNA expression of neurocan, a brain-specific chondroitin sulfate proteoglycan, in neoplastic mammary glands in mice.		Harigaya T; Ogawa H; Tsunoda S; Nagasawa H		Zoolog Sci	13	1996	665-8	J:37981	9004555
86293	Characterization of mutant HA-ras gene expression in transformed murine keratinocyte lines grown under in vitro and in vivo conditions.		Volpe JP; Conti CJ; Slaga TJ		Mol Carcinog	17	1996	202-6	J:38026	8989913
86294	Tumor suppressor gene mutations in mice.		Jacks T		Annu Rev Genet	30	1996	603-36	J:38036	8982467
86295	Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models.		Hanahan D; Christofori G; Naik P; Arbeit J		Eur J Cancer	32A	1996	2386-93	J:38120	9059326
86296	Spontaneous overexpression of the long form of the Bcl-X protein in a highly resistant P388 leukaemia.		Kuhl JS; Krajewski S; Duran GE; Reed JC; Sikic BI		Br J Cancer	75	1997	268-74	J:38249	9010037
86297	Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.		Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B		J Immunol	158	1997	1887-94	J:38250	9029130
86298	Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.		Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjold M; Collins VP; Dumanski JP; Rouleau GA.		Nat Genet	6	1994	180-4	J:38293	8162072
86299	Involvement of an octamer-like sequence within a crucial region of the androgen-dependent Slp enhancer.		Scarlett CO; Scheller A; Thompson E; Robins DM		DNA Cell Biol	16	1997	45-57	J:38277	9022044
86300	The murine L-plastin gene promoter: identification and comparison with the human L-plastin gene promoter.		Lin CS; Chang CH; Huynh T		DNA Cell Biol	16	1997	9-16	J:38279	9022040
86301	Spontaneous Rhabdomyosarcomas in (A/J x CBA/J) F1 mice		Davis JA; Miller GF; St Claire MF		Contemp Top Lab Anim Sci	38	1997	87-9	J:38282	12456193
86302	The mouse lymphoma L5178Y Tk+/- cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene.		Storer RD; Kraynak AR; McKelvey TW; Elia MC; Goodrow TL; DeLuca JG		Mutat Res	373	1997	157-65	J:38285	9042396
86303	Inhibition of gap junctional intercellular communication by barbiturates in long-term primary cultured rat hepatocytes is correlated with liver tumour promoting activity.		Ren P; Ruch RJ		Carcinogenesis	17	1996	2119-24	J:38312	8895477
86304	Imprinted genes in liver carcinogenesis.		De Souza AT; Yamada T; Mills JJ; Jirtle RL		FASEB J	11	1997	60-7	J:38313	9034167
86305	A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme.		Yamanaka S; Poksay KS; Arnold KS; Innerarity TL		Genes Dev	11	1997	321-33	J:38320	9030685
86306	Relative susceptibilities of XPA knockout mice and their heterozygous and wild-type littermates to UVB-induced skin cancer.		Berg RJ; de Vries A; van Steeg H; de Gruijl FR		Cancer Res	57	1997	581-4	J:38498	9044829
86307	Activation and biological properties of endogenous retroviruses in radiation osteosarcomagenesis.		Erfle V; Schmidt J; Strauss GP; Hehlmann R; Luz A		Leuk Res	10	1986	905-13	J:38421	3461225
86308	Endogenous murine leukemia viruses: frequency of radiation-activation and novel pathogenic effects of viral isolates.		Schmidt J; Luz A; Erfle V		Leuk Res	12	1988	393-403	J:38469	3379973
86309	Characterization of defective nucleotide excision repair in XPC mutant mice.		Cheo DL; Ruven HJ; Meira LB; Hammer RE; Burns DK; Tappe NJ; van Zeeland AA ; Mullenders LH ; Friedberg EC		Mutat Res	374	1997	1-9	J:38645	9067411
86310	H19 in normal development and neoplasia.		Looijenga LH; Verkerk AJ; De Groot N; Hochberg AA; Oosterhuis JW		Mol Reprod Dev	46	1997	419-39	J:38657	9041146
86311	DNA methylation and developmental genes in lymphomagenesis--more questions than answers?		Kay PH; Spagnolo DV; Taylor J; Ziman M		Leuk Lymphoma	24	1997	211-20	J:38741	9156651
86312	Induction of lung carcinogenesis in AKR-mice by N-nitrosodiethylamine/phenobarbitone, associated with high expression of c-myc and c-jun oncoproteins.		Giri RK; Baral RN; Das BR		Cancer Lett	112	1997	57-63	J:38725	9029169
86313	Selective hyperexpression of c-jun oncoprotein by glass fiber- and silica-transformed BALB/c-3T3 cells.		Gao H; Brick J; Ong S; Miller M; Whong WZ; Ong T		Cancer Lett	112	1997	65-9	J:38726	9029170
86314	Molecular mechanisms regulating TNF-alpha production by tumor-associated macrophages.		Dougherty ST; Eaves CJ; McBride WH; Dougherty GJ		Cancer Lett	111	1997	27-37	J:38727	9022125
86315	Induction of aberrant crypt foci in C57BL/6N mice by 2-amino-9H-pyrido[2,3-b]indole (A alphaC) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).		Okonogi H; Ushijima T; Shimizu H; Sugimura T; Nagao M		Cancer Lett	111	1997	105-9	J:38730	9022134
86316	Oxygen- and dioxin-regulated gene expression in mouse hepatoma cells.		Gassmann M; Kvietikova I; Rolfs A; Wenger RH		Kidney Int	51	1997	567-74	J:38769	9027741
86317	Induction of tumor necrosis factor in a murine tumor by systemic administration of a novel synthetic lipid A analogue, ONO-4007.		Ueda H; Yamazaki M		J Immunother	20	1997	65-9	J:38809	9101415
86318	Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100.		Zhai Y; Yang JC; Spiess P; Nishimura MI; Overwijk WW; Roberts B; Restifo NP; Rosenberg SA		J Immunother	20	1997	15-25	J:38811	9101410
86319	Additional organizational features of the murine folylpolyglutamate synthetase gene. Two remotely situated exons encoding an alternate 5' end and proximal open reading frame under the control of a second promoter.		Roy K; Mitsugi K; Sirotnak FM		J Biol Chem	272	1997	5587-93	J:38805	9038166
86320	The promoters for human and monkey poliovirus receptors. Requirements for basic and cell type-specific activity.		Solecki D; Schwarz S; Wimmer E; Lipp M; Bernhardt G		J Biol Chem	272	1997	5579-86	J:38806	9038165
86321	Regulation of RNA polymerases I and III by the retinoblastoma protein: a mechanism for growth control?		White RJ		Trends Biochem Sci	22	1997	77-80	J:38847	9066256
86322	Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor alpha, and estrogen receptor antagonist ICI 182,780.		Hilakivi-Clarke L; Cho E; Raygada M; Kenney N		J Cell Physiol	170	1997	279-89	J:38848	9066785
86323	The cat and mouse games that genes, viruses, and cells play.		Weinberg RA		Cell	88	1997	573-5	J:38839	9054495
86324	Chromosomal localization of acquired mouse mammary tumor proviral integration sites in T-cell lymphomas		Rajan L; Kozak CA; Dudley JP		Mamm Genome	9	1998	84-5	J:37959	9434954
86325	Differential adhesion of metastatic RAW117 large-cell lymphoma cells under static or hydrodynamic conditions: role of integrin alpha(v) beta3.		Yun Z; Smith TW; Menter DG; McIntire LV; Nicolson GL		Clin Exp Metastasis	15	1997	3-11	J:38871	9009100
86326	Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma.		Bloom MB; Perry-Lalley D; Robbins PF; Li Y; el-Gamil M; Rosenberg SA; Yang JC		J Exp Med	185	1997	453-9	J:38891	9053445
86327	APC mutation and the crypt cycle in murine and human intestine.		Bjerknes M; Cheng H; Hay K; Gallinger S		Am J Pathol	150	1997	833-9	J:38930	9060821
86328	Effect of restraint stress on immune system and experimental B16 melanoma metastasis in aged mice.		Kanno J; Wakikawa A; Utsuyama M; Hirokawa K		Mech Ageing Dev	93	1997	107-17	J:38991	9089575
86329	Th2-like response and antitumor effect of anti-interleukin-4 mAb in mice bearing renal cell carcinoma.		Takeuchi T; Ueki T; Sasaki Y; Kajiwara T; Li B; Moriyama N; Kawabe K		Cancer Immunol Immunother	43	1997	375-81	J:38994	9067410
86330	In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites.		Micallef MJ; Yoshida K; Kawai S; Hanaya T; Kohno K; Arai S; Tanimoto T ; Torigoe K ; Fujii M ; Ikeda M ; Kurimoto M		Cancer Immunol Immunother	43	1997	361-7	J:38995	9067408
86331	The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68.		Dubey P; Hendrickson RC; Meredith SC; Siegel CT; Shabanowitz J; Skipper JC; Engelhard VH; Hunt DF; Schreiber H		J Exp Med	185	1997	695-705	J:38999	9034148
86332	Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.		Yamada T; Kondoh N; Matsumoto M; Yoshida M; Maekawa A; Oikawa T		Blood	89	1997	1383-93	J:39031	9028962
86333	Allelic fusion of DNA topoisomerase II alpha and retinoic acid receptor alpha genes in adriamycin-resistant p388 murine leukemia revealed by fluorescence in situ hybridization.		Squire JA; McPherson JP; Beatty BG; Goldenberg GJ		Cytogenet Cell Genet	75	1996	164-6	J:39035	9040785
86334	mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.		Zhang M; Sheng S; Maass N; Sager R		Mol Med	3	1997	49-59	J:39071	9132279
86335	Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells.		Beauchemin N; Kunath T; Robitaille J; Chow B; Turbide C; Daniels E ; Veillette A		Oncogene	14	1997	783-90	J:39072	9047385
86336	Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.		Reiners JJ Jr; Singh KP		Carcinogenesis	18	1997	593-7	J:39126	9067561
86337	Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols.		Katiyar SK; Mohan RR; Agarwal R; Mukhtar H		Carcinogenesis	18	1997	497-502	J:39128	9067548
86338	N-(4-hydroxyphenyl)retinamide prevents development of T-lymphomas in AKR/J mice.		Chan LN; Zhang S; Cloyd M; Chan TS		Anticancer Res	17	1997	499-503	J:39149	9066702
86339	Apoptosis induced by gamma-irradiation, but not CD4 ligation, of peripheral T lymphocytes in vivo is p53-dependent.		Malcomson RD; Clarke AR; Peter A; Coutts SB; Howie SE; Harrison DJ		J Pathol	181	1997	166-71	J:39184	9120720
86340	Comparison of effect of tumor promoter treatments on DNA methylation status and gene expression in B6C3F1 and C57BL/6 mouse liver and in B6C3F1 mouse liver tumors.		Counts JL; McClain RM; Goodman JI		Mol Carcinog	18	1997	97-106	J:39186	9049185
86341	Uncoordinated regulation of mRNA expression of the three isoforms of transforming growth factor-beta in the mouse skin carcinogenesis model.		Rundhaug JE; Park J; Fischer SM		Mol Carcinog	18	1997	115-26	J:39187	9049187
86342	X-chromosome inactivation in hybrid embryonic carcinoma cells upon differentiation.		Park JG; Lee KH		Mol Cells	7	1997	115-9	J:39188	9085275
86343	Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.		Krajewski S; Krajewska M; Ehrmann J; Sikorska M; Lach B; Chatten J ; Reed JC		Am J Pathol	150	1997	805-14	J:39173	9060818
86344	Immortal, non-tumourigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase.		Said TK; Bonnette S; Medina D		Cell Prolif	29	1996	623-39	J:39199	9105418
86345	Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.		Malumbres M; Perez de Castro I; Santos J; Melendez B; Mangues R; Serrano M; Pellicer A; Fernandez-Piqueras J		Oncogene	14	1997	1361-70	J:39206	9178896
86346	Interleukin 2 exerts autocrine stimulation on murine T-cell leukaemia growth.		Waldner CI; Mongini C; Alvarez E; Sanchez Lockhart M; Gravisaco MJ ; Hajos SE		Br J Cancer	75	1997	946-50	J:39207	9083328
86347	Characterization of adrenocortical cell lines produced by genetically targeted tumorigenesis in transgenic mice.		Compagnone NA; Bair SR; Mellon SH		Steroids	62	1997	238-43	J:39193	9055383
86348	Cell cycle control with minimal participation of Cdk2 in a murine fibrosarcoma clone cultured in protein-free medium.		Dobashi Y; Chigira M; Shoji M; Wakata Y; Kitagawa M; Tamauchi H ; Akiyama T ; Kameya T		Biochem Biophys Res Commun	232	1997	622-5	J:39195	9126324
86349	Genetically modified tumour vaccines carrying inserted genes for immunoregulatory molecules.		Bubenik J		Folia Biol (Praha)	42	1996	295-304	J:39243	9158939
86350	Molecular evidence for the induction of large interstitial deletions on mouse chromosome 8 by ionizing radiation.		Turker MS; Pieretti M; Kumar S		Mutat Res	374	1997	201-8	J:39233	9100844
86351	Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines.		Nair SK; Boczkowski D; Snyder D; Gilboa E		Eur J Immunol	27	1997	589-97	J:39006	9079797
86352	Expression of the putative proto-oncogene His-1 in normal and neoplastic tissues.		Li J; Witte DP; Van Dyke T; Askew DS		Am J Pathol	150	1997	1297-305	J:39277	9094986
86353	Cloning and expression of angiotensin II type 2 (AT2) receptors from murine neuroblastoma N1E-115 cells: evidence for AT2 receptor heterogeneity.		Yee DK; He P; Yang XD; Reagan LP; Hines J; Siemens IR; Fluharty SJ		Brain Res Mol Brain Res	45	1997	108-16	J:39339	9105676
86354	An MMTV integration site maps near the distal end of mouse chromosome 11.		Rajan L; Dudley JP		Mamm Genome	8	1997	295-6	J:39309	9096121
86355	Glutathione S-transferases of female A/J mouse lung and their induction by anticarcinogenic organosulfides from garlic.		Hu X; Singh SV		Arch Biochem Biophys	340	1997	279-86	J:39653	9143332
86356	Localization of large-T oncoprotein during the embryonic and fetal development of transgenic mice.		Miosge N; Hesse D; Gotz W; Theuring F; Herken R		Teratology	54	1996	278-83	J:39358	9098921
86357	IL-2 gene delivery within an established murine tumor causes its regression without proliferation of preexisting antitumor-specific CTL.		Levraud JP; Duffour MT; Cordier L; Perricaudet M; Haddada H; Kourilsky P		J Immunol	158	1997	3335-43	J:39366	9120291
86358	Mouse cancer susceptibility		Gould KA		Trends Genet	13	1997	140	J:39385	 
86359	Chronic infection of Balb/c mice with murine herpesvirus 72 is associated with neoplasm development.		Mistrikova J; Rajcani J; Mrmusova M; Oravcova I		Acta Virol	40	1996	297-301	J:39402	9171459
86360	Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation.		Loric S; Maroteaux L; Kellermann O; Launay JM		Mol Pharmacol	47	1995	458-66	J:36934	7700243
86361	Genomic instability, as measured by microsatellite alterations, is not associated with liver tumor development in the genetically susceptible B6C3F1 mouse.		Fox TR; McMillen PJ; Maronpot RR; Goldsworthy TL		Toxicol Appl Pharmacol	143	1997	167-72	J:39429	9073604
86362	Role of Csk in neural differentiation of the embryonic carcinoma cell line P19.		Takayama Y; Nada S; Nagai K; Okada M		FEBS Lett	406	1997	11-6	J:39454	9109376
86363	Ganglioside biosynthetic gene expression in experimental mouse brain tumors.		Ecsedy JA; Manfredi MG; Yohe HC; Seyfried TN		Cancer Res	57	1997	1580-3	J:39625	9108463
86364	Characterization of a negative response DNA element in the upstream region of the cellular retinoic acid-binding protein-I gene of the mouse.		Chang L; Wei LN		J Biol Chem	272	1997	10144-50	J:39634	9092560
86365	Cytotoxic effect of cytokines on murine colon carcinoma cells involves TNF-mediated apoptosis.		Sveinbjornsson B; Rushfeldt C; Olsen R; Smedsrod B; Seljelid R		Biochem Biophys Res Commun	233	1997	270-5	J:39664	9144436
86366	Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.		Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM		Cancer Gene Ther	3	1996	373-84	J:39680	8988840
86367	Isolation and chemical characterization of polysaccharides from Iwatake, Gyrophora esculenta Miyoshi.		Sone Y; Isoda-Johmura M; Misaki A		Biosci Biotechnol Biochem	60	1996	213-5	J:39682	9063967
86368	Hepatitis C virus core and E2 protein expression in transgenic mice.		Pasquinelli C; Shoenberger JM; Chung J; Chang KM; Guidotti LG; Selby M; Berger K; Lesniewski R; Houghton M; Chisari FV		Hepatology	25	1997	719-27	J:39678	9049225
86369	Expression of a prolactin-like factor in preneoplastic and neoplastic mouse mammary gland and cells.		Jahnke GD; Trempus CS; Kari FW; DiAugustine RP		J Mol Endocrinol	17	1996	247-56	J:39685	8981231
86370	Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer [see comments]		Cao G; Kuriyama S; Du P; Sakamoto T; Kong X; Masui K; Qi Z		Gastroenterology	112	1997	501-10	J:39690	9024304
86371	Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis.		Tsuji H; Harada A; Mukaida N; Nakanuma Y; Bluethmann H; Kaneko S ; Yamakawa K ; Nakamura SI ; Kobayashi KI ; Matsushima K		Infect Immun	65	1997	1892-8	J:39779	9125577
86372	Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice.		Bol DK; Kiguchi K; Gimenez-Conti I; Rupp T; DiGiovanni J		Oncogene	14	1997	1725-34	J:39752	9135074
86373	CD8+ T cells activated during the course of murine acute myelogenous leukemia elicit therapeutic responses to late B7 vaccines after cytoreductive treatment.		Dunussi-Joannopoulos K; Krenger W; Weinstein HJ; Ferrara JL; Croop JM		Blood	89	1997	2915-24	J:39825	9108412
86374	TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in nonleukemogenic sublines.		Kasukabe T; Okabe-Kado J; Honma Y		Blood	89	1997	2975-85	J:39827	9108418
86375	Intensity of multigenerational carcinogenesis from diethylstilbestrol in mice.		Walker BE; Haven MI		Carcinogenesis	18	1997	791-3	J:39816	9111216
86376	Decoupling of DNA excision repair and RNA transcription in translocation breaksite regions of plasmacytoma-susceptible BALB/cAnPt mice.		Beecham EJ; Owens JD; Shaughnessy JD Jr; Huppi K; Bohr VA; Mushinski JF		Carcinogenesis	18	1997	687-94	J:39820	9111201
86377	Minisatellite rearrangements are increased in liver tumours induced by transplacental aflatoxin B1 treatment of hepatitis B virus transgenic mice, but not in spontaneously arising tumours.		Kaplanski C; Chisari FV; Wild CP		Carcinogenesis	18	1997	633-9	J:39821	9111192
86378	Png-1, a nervous system-specific zinc finger gene, identifies regions containing postmitotic neurons during mammalian embryonic development.		Weiner JA; Chun J		J Comp Neurol	381	1997	130-42	J:39863	9130664
86379	Immunopotentiating activity of Clostridium butyricum in mice.		Wang GR; Chen HY; Chen CH; Yeh MY; Mikami Y		Proc Natl Sci Counc Repub China B	20	1996	101-9	J:39868	9050255
86380	Tissue-specific expression of the K-ras allele from the A/J parent in (A/J x TSG-p53) F1 mice.		Matzinger SA; Chen B; Wang Y; Crist KA; Stoner GD; Kelloff GJ; Lubet RA; You M		Gene	188	1997	261-9	J:39845	9133601
86381	Substitution of just five nucleotides at and around the transcription start site of rat beta-actin promoter is sufficient to render the resulting transcript a subject for translational control.		Biberman Y; Meyuhas O		FEBS Lett	405	1997	333-6	J:39850	9108314
86382	The inhibitory effect of vitamin E on pulmonary polyamine biosynthesis, cell proliferation and carcinogenesis in mice.		Yano Y; Yano T; Uchida M; Murakami A; Ogita M; Ichikawa T; Otani S ; Hagiwara K		Biochim Biophys Acta	1356	1997	35-42	J:39917	9099989
86383	Downregulation of RAR alpha in mice by antisense transgene leads to a compensatory increase in RAR beta and RAR gamma and development of lymphoma.		Manshouri T; Yang Y; Lin H; Stass SA; Glassman AB; Keating MJ ; Albitar M		Blood	89	1997	2507-15	J:39918	9116296
86384	Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity.		Saxton ML; Longo DL; Wetzel HE; Tribble H; Alvord WG; Kwak LW; Leonard AS; Ullmann CD; Curti BD; Ochoa AC		Blood	89	1997	2529-36	J:39919	9116299
86385	Increased circulating colony-stimulating factor-1 (CSF-1) in SJL/J mice with radiation-induced acute myeloid leukemia (AML) is associated with autocrine regulation of AML cells by CSF-1.		Haran-Ghera N; Krautghamer R; Lapidot T; Peled A; Dominguez MG ; Stanley ER		Blood	89	1997	2537-45	J:39920	9116300
86386	Leucocyte interactions with the mouse cremaster muscle microcirculation in vivo in response to tumour-conditioned medium.		Brown NJ; Reed MW		Br J Cancer	75	1997	993-9	J:39924	9083334
86387	Preferential differentiation of P19 mouse embryonal carcinoma cells into smooth muscle cells. Use of retinoic acid and antisense against the central nervous system-specific POU transcription factor Brn-2.		Suzuki T; Kim HS; Kurabayashi M; Hamada H; Fujii H; Aikawa M; Watanabe M; Watanabe N; Sakomura Y; Yazaki Y; Nagai R		Circ Res	78	1996	395-404	J:39886	8593698
86388	Concurrent induction of CD4+ and CD8+ T cells during tumor growth with antitumor reactivity in adoptive immunotherapy.		Arca MJ; Krauss JC; Aruga A; Cameron MJ; Chang AE		J Immunother	20	1997	138-45	J:39937	9087386
86389	Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.		Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ		Mol Carcinog	18	1997	142-52	J:39939	9115584
86390	Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.		Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ		Mol Carcinog	18	1997	177-85	J:39940	9115588
86391	Differential induction of growth arrest inducible genes by selenium compounds.		Kaeck M; Lu J; Strange R; Ip C; Ganther HE; Thompson HJ		Biochem Pharmacol	53	1997	921-6	J:39952	9174104
86392	Transfection of the gene for B7-1 but not B7-2 can induce immunity to murine malignant mesothelioma.		Leong CC; Marley JV; Loh S; Milech N; Robinson BW; Garlepp MJ		Int J Cancer	71	1997	476-82	J:40035	9139887
86393	The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4).		Gallahan D; Callahan R		Oncogene	14	1997	1883-90	J:40039	9150355
86394	Expression of neural BC1 RNA: induction in murine tumours.		Chen W; Heierhorst J; Brosius J; Tiedge H		Eur J Cancer	33	1997	288-92	J:40084	9135502
86395	Specific recognition and rejection of the H-2-deficient cell line LR.4 by C57BL/6J mice.		Verastegui E; del Rio R; Ortega V; Alfaro G		Eur J Immunogenet	24	1997	93-103	J:40085	9104580
86396	The inhibitory effect of vitamin E on K-ras mutation at an early stage of lung carcinogenesis in mice.		Yano T; Uchida M; Yuasa M; Murakami A; Hagiwara K; Ichikawa T		Eur J Pharmacol	323	1997	99-102	J:40086	9105883
86397	Expression of the large I antigen forming beta-1,6-N-acetylglucosaminyltransferase in various tissues of adult mice.		Magnet AD; Fukuda M		Glycobiology	7	1997	285-95	J:40090	9134435
86398	Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.		Xian W; Rosenberg MP; DiGiovanni J		Oncogene	14	1997	1435-44	J:40094	9136987
86399	Paw preference, rotation, and dopamine function in Collins HI and LO mouse strains.		Nielsen DM; Visker KE; Cunningham MJ; Keller RW Jr; Glick SD ; Carlson JN		Physiol Behav	61	1997	525-35	J:40097	9108571
86400	Degradation of amyloid A precursor protein SAA by macrophage cell lines obtained from amyloid resistant and susceptible strains of mice.		Ham D; Caouras V; Radzioch D; Gervais F		Scand J Immunol	45	1997	354-60	J:40098	9105421
86401	DNA mismatch repair deficient mice in cancer research.		Prolla TA; Abuin A; Bradley A		Semin Cancer Biol	7	1996	241-7	J:40099	9110401
86402	Studies of neoplasia in the Min mouse.		Shoemaker AR; Gould KA; Luongo C; Moser AR; Dove WF		Biochim Biophys Acta	1332	1997	F25-48	J:40131	9141462
86403	Construction of recombinant vaccinia virus expressing GM-CSF and its use as tumor vaccine.		Qin HX; Chatterjee SK		Gene Ther	3	1996	59-66	J:40123	8929912
86404	Immunosuppressive activity of cloned natural killer (NK1.1+) T cells established from murine tumor-infiltrating lymphocytes.		Tamada K; Harada M; Abe K; Li T; Tada H; Onoe Y; Nomoto K		J Immunol	158	1997	4846-54	J:40201	9144500
86405	Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome.		Zhang P; Liegeois NJ; Wong C; Finegold M; Hou H; Thompson JC ; Silverman A ; Harper JW ; DePinho RA ; Elledge SJ		Nature	387	1997	151-8	J:40203	9144284
86406	Identification of four trp1 gene variants murine pancreatic beta-cells.		Sakura H; Ashcroft FM		Diabetologia	40	1997	528-32	J:40185	9165220
86407	Presence of c-Myc protein in murine myeloid leukaemia cells during growth and after irradiation.		Popovic-Hadzija M; Poljak-Blazi M; Pavelic K		Anticancer Res	17	1997	1089-92	J:40225	9137454
86408	Impact of schedule on leucovorin potentiation of fluorouracil antitumor activity in dietary folic acid deplete mice.		Raghunathan K; Schmitz JC; Priest DG		Biochem Pharmacol	53	1997	1197-202	J:40198	9175725
86409	MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer.		Callahan R		Breast Cancer Res Treat	39	1996	33-44	J:40249	8738604
86410	Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643.		Bojes HK; Germolec DR; Simeonova P; Bruccoleri A; Schoonhoven R ; Luster MI ; Thurman RG		Carcinogenesis	18	1997	669-74	J:40234	9111198
86411	Identification of a T cell-derived b cell growth factor distinct from interleukin 2.		Howard M; Farrar J; Hilfiker M; Johnson B; Takatsu K; Hamaoka T; Paul WE		J Exp Med	155	1982	914-23	J:39743	6977612
86412	Evidence for an uncommon microsatellite instability on mouse chromosomes 2 and 4 and its possible role in radiation leukemogenesis.		Rithidech KN; Dunn JJ; Gordon CR; Cronkite EP; Bond VP		Blood Cells Mol Dis	23	1997	99-109	J:40269	9215755
86413	Benzene-induced hematotoxicity and bone marrow compensation in B6C3F1 mice.		Farris GM; Robinson SN; Gaido KW; Wong BA; Wong VA; Hahn WP ; Shah RS		Fundam Appl Toxicol	36	1997	119-29	J:40276	9143481
86414	Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I.		Overturf K; al-Dhalimy M; Ou CN; Finegold M; Tanguay R; Lieber A ; Kay M ; Grompe M		Hum Gene Ther	8	1997	513-21	J:40279	9095403
86415	Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo.		Zhang L; Wikenheiser KA; Whitsett JA		Hum Gene Ther	8	1997	563-74	J:40280	9095408
86416	Characterization of retinoic acid-induced AP-1 activity in B16 mouse melanoma cells.		Desai SH; Niles RM		J Biol Chem	272	1997	12809-15	J:40315	9139741
86417	Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo.		He L; Mo H; Hadisusilo S; Qureshi AA; Elson CE		J Nutr	127	1997	668-74	J:40309	9164984
86418	Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: a projected basis for immunotherapy.		Le Fur N; Kelsall SR; Silvers WK; Mintz B		Proc Natl Acad Sci U S A	94	1997	5332-7	J:40371	9144237
86419	Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.		Park JA; Wang E; Kurt RA; Schluter SF; Hersh EM; Akporiaye ET		Cancer Gene Ther	4	1997	42-50	J:40411	9012450
86420	Transduction of murine and human tumors using recombinant adenovirus vectors.		Toloza EM; Hunt K; Miller AR; McBride W; Lau R; Swisher S; Rhoades K; Arthur J; Choi J; Chen L; Chang P; Chen A; Glaspy J; Economou JS		Ann Surg Oncol	4	1997	70-9	J:40416	8985520
86421	Transgenic mice carrying the human KRAS oncogene under the control of a thyroglobulin promoter: KRAS expression in thyroids analyzed by in situ hybridization.		Chiappetta G; Fabien N; Picone A; Califano D; Monaco C; de Franciscis V; Vecchio G; Santelli G		Oncol Res	8	1996	85-93	J:40417	8859779
86422	Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo.		Lieschke GJ; Rao PK; Gately MK; Mulligan RC		Nat Biotechnol	15	1997	35-40	J:40418	9035103
86423	Nitrotyrosine formation, apoptosis, and oxidative damage: relationships to nitric oxide production in SJL mice bearing the RcsX tumor.		Gal A; Tamir S; Kennedy LJ; Tannenbaum SR; Wogan GN		Cancer Res	57	1997	1823-8	J:40421	9157968
86424	Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.		Dark GG; Hill SA; Prise VE; Tozer GM; Pettit GR; Chaplin DJ		Cancer Res	57	1997	1829-34	J:40422	9157969
86425	In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.		Fink D; Zheng H; Nebel S; Norris PS; Aebi S; Lin TP; Nehme A ; Christen RD ; Haas M ; MacLeod CL ; Howell SB		Cancer Res	57	1997	1841-5	J:40423	9157971
86426	Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.		Suematsu S; Matsusaka T; Matsuda T; Ohno S; Miyazaki J; Yamamura K; Hirano T; Kishimoto T		Proc Natl Acad Sci U S A	89	1992	232-5	J:40405	1729694
86427	Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for self antigens.		Overwijk WW; Surman DR; Tsung K; Restifo NP		Methods	12	1997	117-23	J:40452	9184376
86428	Recombinant interleukin-2 acts as an adjuvant and helps to increase the efficacy of tumour vaccines.		Vondrys P; Simova J; Takacova S; Jandlova T; Bubenik J		Folia Biol (Praha)	43	1997	39-40	J:40453	9158948
86429	1alpha,25-dihydroxyvitamin D3 activates T cells of tumor bearers through protein phosphatase 2A.		Wiers KM; Lozano Y; Messingham KA; Metz RJ; Young MR		Cancer Immunol Immunother	44	1997	97-102	J:40455	9177471
86430	Interleukin-2 secretion by KHT sarcoma cells leads to loss of their vaccine potential.		Hsu SC; Glaves D; Sood AK		Cancer Immunol Immunother	44	1997	117-24	J:40456	9177474
86431	Markedly induced asialoGM1+CD8+ T cell production and enhancement of antimetastatic activity by interferon beta with folic or folinic acid.		Iigo M; Moriyama M; Suzuki I; Tsuda H		Cancer Immunol Immunother	44	1997	65-9	J:40457	9177466
86432	Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha.		Moro M; Pelagi M; Fulci G; Paganelli G; Dellabona P; Casorati G ; Siccardi AG ; Corti A		Cancer Res	57	1997	1922-8	J:40436	9157986
86433	Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.		Kirichenko AV; Rich TA; Newman RA; Travis EL		Cancer Res	57	1997	1929-33	J:40437	9157987
86434	Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.		Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO ; Pastan I ; Waldmann TA ; Paik CH ; Carrasquillo JA		Cancer Res	57	1997	1955-61	J:40438	9157991
86435	A newly identified membrane protein localized exclusively in intracellular organelles of neurons.		Kadota Y; Niiya A; Masaki R; Yamamoto A; Araki M; Taketani S		Brain Res Mol Brain Res	46	1997	265-73	J:40492	9191101
86436	Identification of the CD45-associated 116-kDa and 80-kDa proteins as the alpha- and beta-subunits of alpha-glucosidase II.		Arendt CW; Ostergaard HL		J Biol Chem	272	1997	13117-25	J:40482	9148925
86437	Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.		Dolcetti R; Giardini R; Doglioni C; Cariati R; Pomponi F; D'Orazi C ; Rao S ; Lazarovits AI ; Butcher EC ; Boiocchi M		Am J Pathol	150	1997	1595-605	J:40513	9137086
86438	Expression of LECAM-1 and LFA-1 on pre-B lymphoma cells but not on preneoplastic pre-B cells in SL/KH mice.		Lu LM; Ogawa M; Kamoto T; Yamada Y; Pataer A; Hiai H		Leuk Res	21	1997	337-42	J:40534	9150351
86439	Involvement of the transcriptional factor GATA-1 in regulation of expression of coproporphyrinogen oxidase in mouse erythroleukemia cells.		Tanabe A; Furukawa T; Ogawa Y; Yamamoto M; Hayashi N; Tokunaga R ; Taketani S		Biochem Biophys Res Commun	233	1997	729-36	J:40516	9168923
86440	Downregulation of Waf1, C2, C3, and major histocompatibility complex class I loci within an 18-cM region of chromosome 17 in adenovirus-transformed mouse cells.		Eyler YL; Siwarski DF; Huppi KE; Lewis AM Jr		Mol Carcinog	18	1997	213-20	J:40536	9142216
86441	Multiple pathways to cellular senescence: role of telomerase repressors.		Oshimura M; Barrett JC		Eur J Cancer	33	1997	710-5	J:40572	9282109
86442	Learned immunosuppression is associated with an increased risk of chemically-induced tumors.		Blom JM; Tamarkin L; Shiber JR; Nelson RJ		Neuroimmunomodulation	2	1995	92-9	J:40560	8521145
86443	Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specific receptors [see comments]		Preckel T; Grimm R; Martin S; Weltzien HU		J Exp Med	185	1997	1803-13	J:40612	9151706
86444	A new mouse gene, SRG3, related to the SWI3 of Saccharomyces cerevisiae, is required for apoptosis induced by glucocorticoids in a thymoma cell line.		Jeon SH; Kang MG; Kim YH; Jin YH; Lee C; Chung HY; Kwon H; Park SD ; Seong RH		J Exp Med	185	1997	1827-36	J:40613	9151708
86445	Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicity.		Lucas R; Echtenacher B; Sablon E; Juillard P; Magez S; Lou J ; Donati Y ; Bosman F ; Van de Voorde A ; Fransen L ; Mannel DN ; Grau GE ; de Baetselier P		Infect Immun	65	1997	2006-10	J:40578	9169725
86446	Recombinant and tissue-derived mouse BM-40 bind to several collagen types and have increased affinities after proteolytic activation.		Maurer P; Gohring W; Sasaki T; Mann K; Timpl R; Nischt R		Cell Mol Life Sci	53	1997	478-84	J:40586	9176569
86447	Tumour growth modifies intravascular polyamine transport by plasma lipoproteins in the mouse.		Catros-Quemener V; Leray G; Moulinoux JP; Havouis R; de Certaines JD ; Chapman J		Biochim Biophys Acta	1346	1997	30-7	J:40641	9187300
86448	Mechanisms of inhibition of amido phosphoribosyltransferase from mouse L1210 leukemia cells.		Schoettle SL; Crisp LB; Szabados E; Christopherson RI		Biochemistry	36	1997	6377-83	J:40642	9174353
86449	Activation of protein kinase C prevents induction of apoptosis by geranylgeraniol in human leukemia HL60 cells.		Masuda Y; Yoda M; Ohizumi H; Aiuchi T; Watabe M; Nakajo S; Nakaya K		Int J Cancer	71	1997	691-7	J:40672	9178828
86450	Retinal pigment epithelium abnormalities in mice with adenomatous polyposis coli gene disruption.		Marcus DM; Rustgi AK; Defoe D; Brooks SE; McCormick RS; Thompson TP ; Edelmann W ; Kucherlapati R ; Smith S		Arch Ophthalmol	115	1997	645-50	J:40678	9152133
86451	Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens.		Ananthaswamy HN; Loughlin SM; Cox P; Evans RL; Ullrich SE; Kripke ML		Nat Med	3	1997	510-4	J:40683	9142118
86452	IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer.		Gabrilovich DI; Cunningham HT; Carbone DP		J Immunother Emphasis Tumor Immunol	19	1996	414-8	J:40684	9041460
86453	Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis.		Brodt P; Fallavollita L; Bresalier RS; Meterissian S; Norton CR ; Wolitzky BA		Int J Cancer	71	1997	612-9	J:40671	9178816
86454	Clonal evolution of N-methylnitrosourea-induced C57BL/6J thymic lymphomas by analysis of multiple genetic alterations [see comments]		Newcomb EW		Leuk Res	21	1997	189-98	J:40699	9111162
86455	Acute leukaemia in chimeric mice by a bcr-ABLp190 fusion gene made by homologous recombination.		Castellanos A; Pintado B; Weruaga E; Arevalo R; Lopez A; Orfao A ; Sanchez-Garcia I		Int J Dev Biol	Suppl 1	1996	283S	J:40704	9087799
86456	Augmentation of production of TNF-alpha and anti-tumour activity by an amphotericin B preparation for clinical use in mice.		Okutomi T; Ubukata T; Yamaoka K; Abe S; Yamaguchi H		Br J Cancer	75	1997	1613-6	J:40787	9184176
86457	Treatment of subcutaneous tumor with adoptively transferred T cells.		Peng L; Shu S; Krauss JC		Cell Immunol	178	1997	24-32	J:40788	9184695
86458	Growth inhibition of transplantable mouse tumors by non-digestible carbohydrates.		Taper HS; Delzenne NM; Roberfroid MB		Int J Cancer	71	1997	1109-12	J:40812	9185718
86459	Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.		Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS		Cancer Res	57	1997	2089-95	J:40801	9187100
86460	Regulation of the ferrochelatase gene expression during differentiation of mouse erythroleukemia cells.		Furukawa T; Tokunaga R; Taketani S		Biochem Mol Biol Int	41	1997	1161-70	J:40835	9161711
86461	Expression of a defective mouse mammary tumor virus envelope glycoprotein precursor which binds stably to GRP78 within the lumen of the endoplasmic reticulum is associated with decreased glucocorticoid-induced apoptosis in mouse lymphoma cells.		Lam M; Stallcup M; Distelhorst CW		Cell Death Differ	4	1997	283-288	J:40836	16465242
86462	Sequential development of structural and functional alterations in T cells from tumor-bearing mice.		Correa MR; Ochoa AC; Ghosh P; Mizoguchi H; Harvey L; Longo DL		J Immunol	158	1997	5292-6	J:40842	9164948
86463	An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.		Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW		EMBO J	16	1997	2408-19	J:40868	9171354
86464	Targeted oncogenesis in the thyroid of transgenic mice.		Feunteun J; Michiels F; Rochefort P; Caillou B; Talbot M; Fournes B; Mercken L; Schlumberger M; Monier R		Horm Res	47	1997	137-9	J:40870	9167944
86465	Regulation of p53 stability by Mdm2.		Kubbutat MH; Jones SN; Vousden KH		Nature	387	1997	299-303	J:40879	9153396
86466	Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields.		Repacholi MH; Basten A; Gebski V; Noonan D; Finnie J; Harris AW		Radiat Res	147	1997	631-40	J:40881	9146709
86467	Mdm2 promotes the rapid degradation of p53.		Haupt Y; Maya R; Kazaz A; Oren M		Nature	387	1997	296-9	J:40878	9153395
86468	A secreted peptidase involved in T cell beta-endorphin metabolism.		Miller BC; Thiele D; Hersh LB; Cottam GL		Immunopharmacology	31	1996	151-61	J:40885	8861741
86469	A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815.		Belladonna ML; Fioretti MC; Bianchi R; Puccetti P; Grohmann U		Int J Immunopharmacol	18	1996	563-76	J:40886	9080250
86470	The use of two-dimensional gel electrophoresis in studies on the role of cytoskeletal plaque proteins as tumor suppressors.		Ben-Ze'ev A		Electrophoresis	17	1996	1752-63	J:40888	8982608
86471	Localized gene action controlling intestinal neoplasia in mice.		Gould KA; Dove WF		Proc Natl Acad Sci U S A	94	1997	5848-53	J:40923	9159163
86472	Cloning, sequencing and expression in MEL cells of a cDNA encoding the mouse ribosomal protein S5.		Vanegas N; Castaneda V; Santamaria D; Hernandez P; Schvartzman JB ; Krimer DB		Biochim Biophys Acta	1357	1997	1-4	J:40931	9202169
86473	Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes.		Bosse P; Bernex F; De Sepulveda P; Salaun P; Panthier JJ		Oncogene	14	1997	2661-70	J:40965	9178764
86474	Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma.		Ikeda H; Ohta N; Furukawa K; Miyazaki H; Wang L; Kuribayashi K; Old LJ; Shiku H		Proc Natl Acad Sci U S A	94	1997	6375-9	J:40973	9177225
86475	Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.		Hettinga JV; Lemstra W; Meijer C; Dam WA; Uges DR; Konings AW ; De Vries EG ; Kampinga HH		Br J Cancer	75	1997	1735-43	J:40979	9192975
86476	Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis.		Kurtz A; Wang HL; Darwiche N; Harris V; Wellstein A		Oncogene	14	1997	2671-81	J:40964	9178765
86477	Mini- and microsatellite mutations in radiation-induced acute myeloid leukaemia in the CBA/H mouse.		Fennelly J; Wright E; Plumb M		Leukemia	11	1997	807-10	J:40982	9177432
86478	Bcl-2 reduces lymphomagenesis in deltaV-TCRbeta transgenic mice.		Acton D; Jacobs H; Domen J; Berns A		Oncogene	14	1997	2497-501	J:40983	9191049
86479	Cloning and sequencing of a full-length cDNA of mouse N-acetylglucosamine (beta 1-4)galactosyltransferase.		Nakazawa K; Ando T; Kimura T; Narimatsu H		J Biochem (Tokyo)	104	1988	165-8	J:41033	3141392
86480	The mouse gene for hypoxia-inducible factor-1alpha--genomic organization, expression and characterization of an alternative first exon and 5' flanking sequence.		Wenger RH; Rolfs A; Kvietikova I; Spielmann P; Zimmermann DR ; Gassmann M		Eur J Biochem	246	1997	155-65	J:41006	9210478
86481	Post-transcriptional regulation of the abundance of mRNAs encoding alpha-tubulin and a 94,000-dalton protein in teratocarcinoma-derived stem cells versus differentiated cells.		Howe CC; Lugg DK; Overton GC		Mol Cell Biol	4	1984	2428-36	J:41039	6513923
86482	Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland.		Jackson D; Bresnick J; Rosewell I; Crafton T; Poulsom R; Stamp G ; Dickson C		J Cell Sci	110	1997	1261-8	J:41041	9202386
86483	Interaction between human cancer cells and cultured murine endothelial cells, and its relationship with metastatic potential.		Sato M; Narita T; Kimura N; Nakashio T; Hashimoto T; Manabe T; Kannagi R		Int J Oncol	10	1997	1173-1178	J:41143	 
86484	An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma.		Murata R; Nishimura Y; Hiraoka M		Int J Radiat Oncol Biol Phys	37	1997	1107-13	J:41144	9169820
86485	V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.		Aebersold DM; Banholzer R; Backenstoss V; Hirsch HH; Moroni C		Exp Hematol	25	1997	395-404	J:41141	9168061
86486	The Mtv29 gene encoding endogenous lymphoma superantigen in SJL mice, mapped to proximal chromosome 6.		Zhang DJ; D'Eustachio P; Thorbecke GJ		Immunogenetics	46	1997	163-6	J:41179	9162105
86487	Anti-cell death activity promotes pulmonary metastasis of melanoma cells.		Takaoka A; Adachi M; Okuda H; Sato S; Yawata A; Hinoda Y; Takayama S ; Reed JC ; Imai K		Oncogene	14	1997	2971-7	J:41163	9205104
86488	Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice.		Dupressoir A; Heidmann T		Oncogene	14	1997	2951-8	J:41164	9205102
86489	Charlotte Friend Memorial Lecture: murine leukemia virus (MuLV) tumorigenesis.		Hartley JW; Chattopadhyay SK; Morse HC 3rd; Fredrickson TN		Leukemia	11 Suppl 3	1997	147-8	J:41196	9209325
86490	To be or not to be a T-lymphomas, that is determined by a dominant gene Tlsm-1 in mouse models.		Hiai H; Yamada Y; Shisa H; Kamoto T; Abujiang P; Lu LM		Leukemia	11 Suppl 3	1997	193-4	J:41197	9209340
86491	MuLV-insertional mutagenesis of c-myb and Mml1 in a murine model for promonocytic leukemia.		Bies J; Koller R; Hoffman B; Amanullah A; Mock B; Wolff L		Leukemia	11 Suppl 3	1997	247-50	J:41204	9209355
86492	Fre-2, a locus closely linked to Fv-2, is rearranged in some erythroleukemias induced by Friend murine leukemia virus.		Eisel D; Veit M; Friedrich U; Pass M; Sels FT; Friedrich RW		Leukemia	11 Suppl 3	1997	155-9	J:41263	9209328
86493	Genetic control of immune responsiveness, aging and tumor incidence.		Doria G; Biozzi G; Mouton D; Covelli V		Mech Ageing Dev	96	1997	1-13	J:41237	9223107
86494	Altered gene expression in spontaneous hepatocellular carcinomas from male B6C3F1 mice.		Romach EH; Goldsworthy TL; Maronpot RR; Fox TR		Mol Carcinog	19	1997	31-8	J:41291	9180926
86495	Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice.		de Vries A; van Oostrom CT; Dortant PM; Beems RB; van Kreijl CF ; Capel PJ ; van Steeg H		Mol Carcinog	19	1997	46-53	J:41292	9180928
86496	Metastatic ability of MXT mouse mammary subpopulations correlates with clonal expression and/or membrane-association of gelatinase A.		Llorens A; Vinyals A; Alia P; Lopez-Barcons L; Gonzalez-Garrigues M ; Fabra A		Mol Carcinog	19	1997	54-66	J:41293	9180929
86497	cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.		Iwamoto T; Taniguchi M; Asai N; Ohkusu K; Nakashima I; Takahashi M		Oncogene	8	1993	1087-91	J:41301	8455936
86498	Chronic ultraviolet exposure-induced p53 gene alterations in Sencar mouse skin carcinogenesis model.		Tong Y; Smith MA; Tucker SB		J Toxicol Environ Health	51	1997	219-34	J:41280	9183379
86499	Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cell.		Chen Z; Plagemann PG		J Virol Methods	65	1997	227-36	J:41282	9186946
86500	Establishment of multipotential and antigen presenting cell lines derived from myeloid leukemias in GM-CSF transgenic mice.		Rasko JE; Metcalf D; Alexander B; Strasser A; Begley CG		Leukemia	11	1997	732-42	J:41283	9180300
86501	Pentoxifylline inhibits granzyme B and perforin expression following T-lymphocyte activation by anti-CD3 antibody.		Hoskin DW; Phu T; Makrigiannis AP		Int J Immunopharmacol	18	1996	623-31	J:41333	9089006
86502	N-ras mutations in radiation-induced murine leukemic cells.		Rithidech KN; Dunn JJ; Gordon CR; Cronkite EP; Bond VP		Blood Cells Mol Dis	22	1996	271-80	J:41337	9075579
86503	Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.		He Q; Lesley J; Hyman R; Ishihara K; Kincade PW		J Cell Biol	119	1992	1711-9	J:41342	1469058
86504	A mutant protein kinase C that can transform fibroblasts.		Megidish T; Mazurek N		Nature	342	1989	807-11	J:41343	2601739
86505	Retinoic acid resistance of the variant embryonal carcinoma cell line RAC65 is caused by expression of a truncated RAR alpha.		Kruyt FA; van der Veer LJ; Mader S; van den Brink CE; Feijen A; Jonk LJ; Kruijer W; van der Saag PT		Differentiation	49	1992	27-37	J:41344	1320576
86506	Terminology of developmental abnormalities in common laboratory mammals (version 1).		Wise LD; Beck SL; Beltrame D; Beyer BK; Chahoud I; Clark RL ; Clark R ; Druga AM ; Feuston MH ; Guittin P ; Henwood SM ; Kimmel CA ; Lindstrom P ; Palmer AK ; Petrere JA ; Solomon HM ; Yasuda M ; York RG		Teratology	55	1997	249-92	J:41345	9216042
86507	Effect of chemical structure and hydrophobicity on the pharmacokinetic properties of porphycenes in tumour-bearing mice.		Segalla A; Fedeli F; Reddi E; Jori G; Cross A		Int J Cancer	72	1997	329-36	J:41394	9219841
86508	Photodynamic activities and biodistribution of fluorinated zinc phthalocyanine derivatives in the murine EMT-6 tumour model.		Allemann E; Brasseur N; Kudrevich SV; La Madeleine C; van Lier JE		Int J Cancer	72	1997	289-94	J:41393	9219835
86509	Indomethacin is a potent inhibitor of pristane and plastic disc induced plasmacytomagenesis in a hypersusceptible BALB/c congenic strain.		Potter M; Wax J; Jones GM		Blood	90	1997	260-9	J:41409	9207461
86510	Radiation-induced DNA damage in tumors and normal tissues: IV. Influence of proliferation status and cell type on the formation of oxygen-dependent DNA damage in cultured cells [published erratum appears in Radiat Res 1997 Aug;148(2):202]		Miyagi Y; Zhang H; Wheeler KT		Radiat Res	148	1997	29-34	J:41466	9216615
86511	Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea.		Huang MT; Xie JG; Wang ZY; Ho CT; Lou YR; Wang CX; Hard GC ; Conney AH		Cancer Res	57	1997	2623-9	J:41487	9205068
86512	Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.		O'Brien TG; Megosh LC; Gilliard G; Soler AP		Cancer Res	57	1997	2630-7	J:41488	9205069
86513	Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.		Plautz GE; Touhalisky JE; Shu S		Cell Immunol	178	1997	101-7	J:41477	9225000
86514	Early steps in T cell development are affected by aging.		Thoman ML		Cell Immunol	178	1997	117-23	J:41478	9225002
86515	Potentiation of antitumor CTL response by GM-CSF involves a B7-dependent mechanism.		Mokyr MB; Kalinichenko TV; Gorelik L		Cell Immunol	178	1997	152-61	J:41479	9225006
86516	Assignment of HMAT1, the human homolog of the murine mammary transforming gene (MAT1) associated with tumorigenesis, to 1q21.1, a region frequently gained in human breast cancers.		Hwang S; Kuo WL; Cochran JF; Guzman RC; Tsukamoto T; Bandyopadhyay G ; Myambo K ; Collins CC		Genomics	42	1997	540-2	J:41511	9205133
86517	Effect of tissue factor deficiency on mouse and tumor development.		Toomey JR; Kratzer KE; Lasky NM; Broze GJ Jr		Proc Natl Acad Sci U S A	94	1997	6922-6	J:41500	9192667
86518	Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity.		Armstrong TD; Clements VK; Martin BK; Ting JPY; Ostrand-Rosenberg S		Proc Natl Acad Sci U S A	94	1997	6886-91	J:41501	9192661
86519			Casteels D; Poirier C; Guenet JL; Merregaert J		Mouse Genome	95	1997	488-91	J:41506	 
86520	Adoptive immunotherapy as an in vivo model to explore antitumor mechanisms induced by a recombinant anticancer vaccine.		Abrams SI; Hodge JW; McLaughlin JP; Steinberg SM; Kantor JA; Schlom J		J Immunother	20	1997	48-59	J:41536	9101413
86521	Genes in the RB pathway and their knockout in mice.		Lin SC; Skapek SX; Lee EY		Semin Cancer Biol	7	1996	279-89	J:41542	9110405
86522	Xpa knockout mice.		de Vries A; van Steeg H		Semin Cancer Biol	7	1996	229-40	J:41543	9110400
86523	Osteoclast formation during tumor osteolysis does not require proliferating osteoclast precursor cells.		Clohisy DR; Ramnaraine ML		J Orthop Res	15	1997	301-6	J:41527	9167635
86524	Photophysical and photobiological processes in the photodynamic therapy of tumours.		Ochsner M		J Photochem Photobiol B	39	1997	1-18	J:41583	9210318
86525	Chromosomal translocations deregulating c-myc are associated with normal immune responses.		Roschke V; Kopantzev E; Dertzbaugh M; Rudikoff S		Oncogene	14	1997	3011-6	J:41584	9223664
86526	Immortalization of neuro-endocrine cells from adrenal tumors arising in SV40 T-transgenic mice.		Cairns LA; Crotta S; Minuzzo M; Ricciardi-Castagnoli P; Pozzi L; Ottolenghi S		Oncogene	14	1997	3093-8	J:41585	9223673
86527	Macrophage function in mice with a mutation at the microphthalmia (mi) locus.		Rohan PJ; Stechschulte DJ; Li Y; Dileepan KN		Proc Soc Exp Biol Med	215	1997	269-74	J:41586	9207863
86528	Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor.		Lee CT; Wu S; Ciernik IF; Chen H; Nadaf-Rahrov S; Gabrilovich D ; Carbone DP		Hum Gene Ther	8	1997	187-93	J:41549	9017422
86529	Homeosis and polyposis: a tale from the mouse.		He TC; da Costa LT; Thiagalingam S		Bioessays	19	1997	551-5	J:41709	9230687
86530	The Min mouse: a genetic model for intestinal carcinogenesis.		Thompson MB		Toxicol Pathol	25	1997	329-32	J:41601	9210266
86531	Early skin response to fractionated doses of pions for determining therapeutic gain factors.		Ohizumi Y; Lam GK; Pickles T; Chaplin DJ		Tokai J Exp Clin Med	21	1996	69-75	J:41625	9239808
86532	Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1.		Tidswell M; Pachynski R; Wu SW; Qiu SQ; Dunham E; Cochran N ; Briskin MJ ; Kilshaw PJ ; Lazarovits AI ; Andrew DP ; Butcher EC ; Yednock TA ; Erle DJ		J Immunol	159	1997	1497-505	J:41630	9233649
86533	E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas.		Bain G; Engel I; Robanus Maandag EC; te Riele HP; Voland JR; Sharp LL ; Chun J ; Huey B ; Pinkel D ; Murre C		Mol Cell Biol	17	1997	4782-91	J:41658	9234734
86534	Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts.		Nagata Y; Furugen R; Hiasa A; Ikeda H; Ohta N; Furukawa K; Nakamura H; Furukawa K; Kanematsu T; Shiku H		J Immunol	159	1997	1336-43	J:41636	9233630
86535	Ig S gamma-specific DNA binding protein SNAP is related to the helix-loop-helix transcription factor E47.		Ma L; Hu B; Kenter AL		Int Immunol	9	1997	1021-9	J:41615	9237111
86536	Therapy with cultured T cells: principles revisited.		Cheever MA; Chen W		Immunol Rev	157	1997	177-94	J:41668	9255630
86537	Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family.		Oettgen P; Alani RM; Barcinski MA; Brown L; Akbarali Y; Boltax J ; Kunsch C ; Munger K ; Libermann TA		Mol Cell Biol	17	1997	4419-33	J:41660	9234700
86538	Synergistic effects of Actinobacillus suis cells in combination with 5-fluorouracil on mice bearing murine L1210 leukemia cells.		Watanabe T; Itoh S		Cancer Immunol Immunother	44	1997	216-20	J:41691	9222280
86539	Adoptive transfer of cytotoxic T lymphocytes induced by CD86-transfected tumor cells suppresses multi-organ metastases of C1300 neuroblastoma in mice.		Enomoto A; Kato K; Yagita H; Okumura K		Cancer Immunol Immunother	44	1997	204-10	J:41692	9222278
86540	The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation.		Murphy WJ; Longo DL		Immunol Rev	157	1997	167-76	J:41669	9255629
86541	Interferon-gamma-inducing factor gene transfection into Lewis lung carcinoma cells reduces tumorigenicity in vivo.		Fukumoto H; Nishio M; Nishio K; Heike Y; Arioka H; Kurokawa H ; Ishida T ; Fukuoka K ; Nomoto T ; Ohe Y ; Saijo N		Jpn J Cancer Res	88	1997	501-5	J:41674	9247607
86542	Protection by alpha G-rutin, a water-soluble antioxidant flavonoid, against renal damage in mice treated with ferric nitrilotriacetate.		Shimoi K; Shen B; Toyokuni S; Mochizuki R; Furugori M; Kinae N		Jpn J Cancer Res	88	1997	453-60	J:41675	9247601
86543	Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes.		Murakami A; Kuki W; Takahashi Y; Yonei H; Nakamura Y; Ohto Y ; Ohigashi H ; Koshimizu K		Jpn J Cancer Res	88	1997	443-52	J:41676	9247600
86544	Functional expression of the alpha 7 integrin receptor in differentiated smooth muscle cells.		Yao CC; Breuss J; Pytela R; Kramer RH		J Cell Sci	110	1997	1477-87	J:41678	9224765
86545	Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.		de Verdiere AC; Dubernet C; Nemati F; Soma E; Appel M; Ferte J ; Bernard S ; Puisieux F ; Couvreur P		Br J Cancer	76	1997	198-205	J:41704	9231919
86546	The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.		Robb L; Begley CG		Bioessays	19	1997	607-13	J:41706	9230693
86547	Transforming growth factor-beta: the breaking open of a black box.		Alevizopoulos A; Mermod N		Bioessays	19	1997	581-91	J:41708	9230691
86548	Peptide mapping of the murine DNA methyltransferase reveals a major phosphorylation site and the start of translation.		Glickman JF; Pavlovich JG; Reich NO		J Biol Chem	272	1997	17851-7	J:41720	9211941
86549	Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene in a mouse neuroendocrine tumor cell line.		Boylan MO; Jepeal LI; Jarboe LA; Wolfe MM		J Biol Chem	272	1997	17438-43	J:41729	9211887
86550	CD106 (VCAM-1) in testicular immunoregulation.		Sainio-Pollanen S; Sundstrom J; Erkkila S; Hanninen A; Vainiopaa M ; Martikainen M ; Salminen E ; Verajankorva E ; Antola H ; Nikula H ; Simell O ; Pollanen P		J Reprod Immunol	33	1997	221-38	J:41773	9255725
86551	Up-regulation of specific tyrosinase mRNAs in mouse melanomas with the c2j gene substituted for the wild-type tyrosinase allele: utilization in design of syngeneic immunotherapy models.		Le Fur N; Silvers WK; Kelsall SR; Mintz B		Proc Natl Acad Sci U S A	94	1997	7561-5	J:41755	9207131
86552	IkappaBalpha overexpression delays tumor formation in v-rel transgenic mice.		Carrasco D; Perez P; Lewin A; Bravo R		J Exp Med	186	1997	279-88	J:41756	9221757
86553	Variant mouse lymphoma cells with modified response to interferon demonstrate enhanced immunogenicity.		Mador N; Falk H; Bergel M; Panet A; Hochman J		Cancer Immunol Immunother	44	1997	249-56	J:41761	9247559
86554	Gene transfer of a hybrid interleukin-1 beta gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo.		Bjorkdahl O; Wingren AG; Hedhund G; Ohlsson L; Dohlsten M		Cancer Immunol Immunother	44	1997	273-81	J:41762	9247562
86555	Interleukin-4 is effective in restoring cytotoxic T cell activity that declines during in vivo progression of a murine B lymphoma.		Santra S; Ghosh SK		Cancer Immunol Immunother	44	1997	291-300	J:41763	9247564
86556	Proprotein-processing endoprotease furin controls growth of pancreatic beta-cells.		Kayo T; Sawada Y; Suda M; Konda Y; Izumi T; Tanaka S; Shibata H ; Takeuchi T		Diabetes	48	1997	1296-304	J:41797	9231654
86557	Tumour eradication with high-dose idarubicin-anti-Ly-2.1 with murine tumour necrosis factor-alpha in mice.		Pietersz GA; Bogdanovski M; Li W		Immunol Cell Biol	75	1997	253-8	J:41795	9243290
86558	Base transitions dominate the mutational spectrum of a transgenic reporter gene in MSH2 deficient mice.		Andrew SE; Reitmair AH; Fox J; Hsiao L; Francis A; McKinnon M ; Mak TW ; Jirik FR		Oncogene	15	1997	123-9	J:41865	9244348
86559	High sensitivity to hepato-tumorigenesis in hypocatalasemic C3H/C(s)b/Gen mice exposed to low doses of 252Cf fission neutrons and 60Co gamma-rays.		Yamada K; Ito A; Watanabe H; Takahashi T; Basaran NH; Gotoh T		Anticancer Res	17	1997	2041-7	J:41873	9216662
86560	Suppression of experimental lung colonization of mouse colon adenocarcinoma 26 in vivo by an anti-idiotype monoclonal antibody recognizing a platelet surface molecule.		Kato Y; Fujita N; Yano H; Tsuruo T		Cancer Res	57	1997	3040-5	J:41847	9230220
86561	Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.		Siim BG; Menke DR; Dorie MJ; Brown JM		Cancer Res	57	1997	2922-8	J:41848	9230202
86562	Genetic resistance to urethan-induced pulmonary adenomas in SMXA recombinant inbred mouse strains.		Pataer A; Nishimura M; Kamoto T; Ichioka K; Sato M; Hiai H		Cancer Res	57	1997	2904-8	J:41849	9230199
86563	Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.		Ribas A; Butterfield LH; McBride WH; Jilani SM; Bui LA; Vollmer CM ; Lau R ; Dissette VB ; Hu B ; Chen AY ; Glaspy JA ; Economou JS		Cancer Res	57	1997	2865-9	J:41850	9230191
86564	Calorie restriction induces a p53-independent delay of spontaneous carcinogenesis in p53-deficient and wild-type mice.		Hursting SD; Perkins SN; Brown CC; Haines DC; Phang JM		Cancer Res	57	1997	2843-6	J:41851	9230186
86565	Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor.		Grepin C; Nemer G; Nemer M		Development	124	1997	2387-95	J:41880	9199365
86566	CD8+ tumor-specific Tc cells primed in vivo or in vitro against the BALB/c plasmacytoma ADJ-PC-5 use the same TcR V beta families but display distinct TC1 or TC2 characteristics.		Becker C; Kolsch E; Pauels HG		Immunobiology	197	1997	16-30	J:41885	9241528
86567	Construction and characterization of a recombinant vaccinia virus expressing murine intercellular adhesion molecule-1: induction and potentiation of antitumor responses.		Uzendoski K; Kantor JA; Abrams SI; Schlom J; Hodge JW		Hum Gene Ther	8	1997	851-60	J:41912	9143911
86568	Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc.		Bronson R; Dawe C; Carroll J; Benjamin T		Proc Natl Acad Sci U S A	94	1997	7954-8	J:41947	9223294
86569	Evidence for serum response factor-mediated regulatory networks governing SM22alpha transcription in smooth, skeletal, and cardiac muscle cells.		Li L; Liu Z; Mercer B; Overbeek P; Olson EN		Dev Biol	187	1997	311-21	J:41935	9242426
86570	Involvement of T-cell subsets and natural killer (NK) cells in the growth suppression of murine fibrosarcoma cells transfected with interleukin-12 (IL-12) genes.		Schmitt M; Ikeda H; Nagata Y; Gu X; Wang L; Kuribayashi K; Shiku H		Int J Cancer	72	1997	505-11	J:41937	9247296
86571	Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status.		Akama TO; Okazaki Y; Ito M; Okuizumi H; Konno H; Muramatsu M ; Plass C ; Held WA ; Hayashizaki Y		Cancer Res	57	1997	3294-9	J:41971	9242463
86572	Melanocortin receptors, red hair, and skin cancer		Rees JL; Healy E		J Invest Dermatol Symp Proc	2	1997	94-8	J:42007	 
86573	Suppression of tumor growth with recombinant murine angiostatin.		Wu Z; O'Reilly MS; Folkman J; Shing Y		Biochem Biophys Res Commun	236	1997	651-4	J:42062	9245707
86574	atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity.		Westphal CH; Rowan S; Schmaltz C; Elson A; Fisher DE; Leder P		Nat Genet	16	1997	397-401	J:42055	9241281
86575	Differential induction of HNF-3 transcription factors during neuronal differentiation.		Jacob A; Budhiraja S; Reichel RR		Exp Cell Res	234	1997	277-84	J:42111	9260895
86576	CD28 is not required for rejection of unmanipulated syngeneic and autologous tumors.		Wen T; Kono K; Shahinian A; Kiessling R; Mak TW; Klein G		Eur J Immunol	27	1997	1988-93	J:42096	9295036
86577	Skin carcinogenicity of condensed asphalt roofing fumes and their fractions following dermal application to mice.		Sivak A; Niemeier R; Lynch D; Beltis K; Simon S; Salomon R; Latta R ; Belinky B ; Menzies K ; Lunsford A ; Cooper C ; Ross A ; Bruner R		Cancer Lett	117	1997	113-23	J:42188	9233840
86578	Development of a novel mouse tk+/- embryonic stem cell line for use in mutagenicity studies.		Dobrovolsky VN; Casciano DA; Heflich RH		Environ Mol Mutagen	28	1996	483-9	J:42191	8991081
86579	Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma.		Kuroda M; Urano M; Nishimura Y; Reynolds R		Int J Radiat Oncol Biol Phys	38	1997	411-7	J:42195	9226330
86580	Aspects of exposure to UVA tanning sources. Carcinogenic effect in mice and melanogenic effect in man and mice.		Bech-Thomsen N		Dan Med Bull	44	1997	242-56	J:42221	9233545
86581	A survey of genes expressed in mouse embryonal carcinoma F9 cells: characterization of expressed sequence tags matching no known genes.		Nomura M; Nishiguchi S; Motaleb MA; Takihara Y; Takagi T; Yasunaga T ; Shimada K		J Biochem (Tokyo)	122	1997	129-47	J:42198	9276681
86582	Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3.		Minamoto S; Ikegame K; Ueno K; Narazaki M; Naka T; Yamamoto H ; Matsumoto T ; Saito H ; Hosoe S ; Kishimoto T		Biochem Biophys Res Commun	237	1997	79-83	J:42258	9266833
86583	Ongoing Y-chromosome instability defines sub-clonal variants in radiation-induced leukaemias in the mouse.		Plumb M; Harper K; MacDonald D; Fennelly J; Lorimore S; Wright E		Int J Radiat Biol	72	1997	1-9	J:42229	9246189
86584	Demonstration of an E-box and its CNS-related binding factors for transcriptional regulation of the mouse type 1 inositol 1,4,5-trisphosphate receptor gene.		Konishi Y; Kobayashi Y; Kishimoto T; Makino Y; Miyawaki A; Furuichi T ; Okano H ; Mikoshiba K ; Tamura T		J Neurochem	69	1997	476-84	J:42230	9231705
86585	Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor.		Kadhim SA; Chin JL; Batislam E; Karlik SJ; Garcia B; Skamene E		J Urol	158	1997	646-52	J:42232	9224385
86586	Inhibition of WY-14,643 induced hepatic lesion growth in mice by rotenone.		Isenberg JS; Kolaja KL; Ayoubi SA; Watkins JB 3rd; Klaunig JE		Carcinogenesis	18	1997	1511-9	J:42337	9276624
86587	Effect of naturally occurring coumarins on the formation of epidermal DNA adducts and skin tumors induced by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in SENCAR mice.		Cai Y; Kleiner H; Johnston D; Dubowski A; Bostic S; Ivie W; DiGiovanni J		Carcinogenesis	18	1997	1521-7	J:42338	9276625
86588	Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells.		Sinha R; Medina D		Carcinogenesis	18	1997	1541-7	J:42340	9276628
86589	Upregulation of the elongation factor-1alpha gene by p53 in association with death of an erythroleukemic cell line.		Kato MV; Sato H; Nagayoshi M; Ikawa Y		Blood	90	1997	1373-8	J:42345	9269753
86590	Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.		Weinberg WC; Montano NE; Deng C		Oncogene	15	1997	685-90	J:42347	9264409
86591	Cis-elements required for the demethylation of the mouse M-lysozyme downstream enhancer.		Schmitz A; Short M; Ammerpohl O; Asbrand C; Nickel J; Renkawitz R		J Biol Chem	272	1997	20850-6	J:42350	9252411
86592	The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic beta-cells.		Macfarlane WM; Smith SB; James RF; Clifton AD; Doza YN; Cohen P ; Docherty K		J Biol Chem	272	1997	20936-44	J:42352	9252422
86593	Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors.		Ashkenas J; Penman M; Vasile E; Acton S; Freeman M; Krieger M		J Lipid Res	34	1993	983-1000	J:42396	8394868
86594	Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras.		Dlugosz AA; Hansen L; Cheng C; Alexander N; Denning MF; Threadgill DW ; Magnuson T ; Coffey RJ Jr ; Yuspa SH		Cancer Res	57	1997	3180-8	J:42403	9242447
86595	Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.		Aboagye EO; Maxwell RJ; Kelson AB; Tracy M; Lewis AD; Graham MA ; Horsman MR ; Griffiths JR ; Workman P		Cancer Res	57	1997	3314-8	J:42404	9242466
86596	Lack of evidence for the involvement of formaldehyde in the hepatocarcinogenicity of methyl tertiary-butyl ether in CD-1 mice.		Casanova M; Heck HA		Chem Biol Interact	105	1997	131-43	J:42405	9251725
86597	Regulation of hepatic CYP1A isozymes by piperonyl butoxide and acenaphthylene in the mouse.		Ryu DY; Levi PE; Hodgson E		Chem Biol Interact	105	1997	53-63	J:42406	9233375
86598	The murine Tcl1 oncogene: embryonic and lymphoid cell expression.		Narducci MG; Virgilio L; Engiles JB; Buchberg AM; Billips L; Facchiano A ; Croce CM ; Russo G ; Rothstein JL		Oncogene	15	1997	919-26	J:42464	9285687
86599	Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily.		Honda S; Morohashi K; Nomura M; Takeya H; Kitajima M; Omura T		J Biol Chem	268	1993	7494-502	J:42477	8463279
86600	Thymocyte development is normal in CTLA-4-deficient mice.		Chambers CA; Cado D; Truong T; Allison JP		Proc Natl Acad Sci U S A	94	1997	9296-301	J:42481	9256476
86601	Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels.		Metzger S; Goldschmidt N; Barash V; Peretz T; Drize O; Shilyansky J ; Shiloni E ; Chajek-Shaul T		Am J Physiol	273	1997	E262-7	J:42491	9277378
86602	Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo.		Chiang CS; Syljuasen RG; Hong JH; Wallis A; Dougherty GJ; McBride WH		Cancer Res	57	1997	3899-903	J:42731	9307268
86603	Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo.		Gollnick SO; Liu X; Owczarczak B; Musser DA; Henderson BW		Cancer Res	57	1997	3904-9	J:42732	9307269
86604	Analysis of tenascin mRNA expression in the murine mammary gland from embryogenesis to carcinogenesis: an in situ hybridization study.		Kalembey I; Yoshida T; Iriyama K; Sakakura T		Int J Dev Biol	41	1997	569-73	J:42541	9303344
86605	Viral oncolysis with host survival		Lindenmann J		Proc Soc Exp Biol Med	113	1963	85-91	J:42581	13930803
86606	Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells.		Boudjelal M; Taneja R; Matsubara S; Bouillet P; Dolle P; Chambon P		Genes Dev	11	1997	2052-65	J:42575	9284045
86607	Comparison of the biological properties of two anti-mucin-1 antibodies prepared for imaging and therapy.		Pietersz GA; Wenjun L; Krauer K; Baker T; Wreschner D; McKenzie IF		Cancer Immunol Immunother	44	1997	323-8	J:42582	9298934
86608	A nitric oxide-releasing reagent, S-nitroso-N-acetylpenicillamine, enhances the expression of superoxide dismutases mRNA in the murine macrophage cell line RAW264-7.		Sano H; Hirai M; Saito H; Nakashima I; Isobe KI		Immunology	92	1997	118-22	J:42629	9370933
86609	Transferrin mRNA level in the mouse mammary gland is regulated by pregnancy and extracellular matrix.		Chen LH; Bissell MJ		J Biol Chem	262	1987	17247-50	J:42621	3693348
86610	Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes.		Pericle F; Kirken RA; Bronte V; Sconocchia G; DaSilva L; Segal DM		J Immunol	159	1997	2580-5	J:42622	9300676
86611	Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines.		Fracasso PM; Slapak CA; Nair S; Modrak D; Draper MP; LeCerf JM ; Levy SB		Oncol Res	9	1997	183-91	J:42676	9268989
86612	Comparison of TRPs from murine and human malignant melanocytes.		Martinez-Esparza M; Jimenez-Cervantes C; Garcia-Borron JC; Lozano JA ; del Marmol V ; Ghanem G ; Solano F		Pigment Cell Res	10	1997	229-35	J:42677	9263330
86613	Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene.		Stewart M; Terry A; Hu M; O'Hara M; Blyth K; Baxter E; Cameron E ; Onions DE ; Neil JC		Proc Natl Acad Sci U S A	94	1997	8646-51	J:42678	9238031
86614	Mice carrying a truncated Apc gene have diminished gastric epithelial proliferation, gastric inflammation, and humoral immunity in response to Helicobacter felis infection.		Fox JG; Dangler CA; Whary MT; Edelman W; Kucherlapati R; Wang TC		Cancer Res	57	1997	3972-8	J:42733	9307281
86615	Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.		Weiskirch LM; Paterson Y		Immunol Rev	158	1997	159-69	J:42761	9314084
86616	Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase.		Rappa G; Lorico A; Liu MC; Kruh GD; Cory AH; Cory JG; Sartorelli AC		Biochem Pharmacol	54	1997	649-55	J:42803	9310341
86617	Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function.		Mittrucker HW; Matsuyama T; Grossman A; Kundig TM; Potter J ; Shahinian A ; Wakeham A ; Patterson B ; Ohashi PS ; Mak TW		Science	275	1997	540-3	J:42683	8999800
86618	An epitope on VLA-6 (alpha6beta1) integrin involved in migration but not adhesion is required for extravasation of murine melanoma B16F1 cells in liver.		Hangan D; Morris VL; Boeters L; von Ballestrem C; Uniyal S; Chan BM		Cancer Res	57	1997	3812-7	J:42809	9288792
86619	A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells.		Hoffmann J; Schirner M; Menrad A; Schneider MR		Cancer Res	57	1997	3847-51	J:42810	9288798
86620	Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?		Webster G; Onions DE; Neil JC; Cameron ER		Br J Cancer	76	1997	739-46	J:42875	9310239
86621	Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.		Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A		Oncogene	15	1997	1133-41	J:42922	9294606
86622	The activation domain of the enhancer binding protein p45NF-E2 interacts with TAFII130 and mediates long-range activation of the alpha- and beta-globin gene loci in an erythroid cell line.		Amrolia PJ; Ramamurthy L; Saluja D; Tanese N; Jane SM; Cunningham JM		Proc Natl Acad Sci U S A	94	1997	10051-6	J:42937	9294161
86623	Thymocytes in Thy-1-/- mice show augmented TCR signaling and impaired differentiation.		Hueber AO; Bernard AM; Battari CL; Marguet D; Massol P; Foa C; Brun N; Garcia S; Stewart C; Pierres M; He HT		Curr Biol	7	1997	705-8	J:42939	9285719
86624	Mutagenesis in the P53 gene.		Pfeifer GP; Holmquist GP		Biochim Biophys Acta	1333	1997	M1-8	J:42961	9294014
86625	Telomerase activity and metastasis: expansion of cells having higher telomerase activity within culture lines and tumor tissues.		Saito Y; Kosugi S; Suda T; Wakabayashi Y; Mishima Y; Hatakeyama K ; Kominami R		Jpn J Cancer Res	88	1997	732-7	J:43037	9330604
86626	Alternative splicing of the sodium channel SCN8A predicts a truncated two-domain protein in fetal brain and non-neuronal cells.		Plummer NW; McBurney MW; Meisler MH		J Biol Chem	272	1997	24008-15	J:43018	9295353
86627	Variable region gene segments of nine monoclonal antibodies specific to disialogangliosides (GD2, GD3) and their O-acetylated derivatives.		Cerato E; Birkle S; Portoukalian J; Mezazigh A; Chatal JF; Aubry J		Hybridoma	16	1997	307-16	J:43072	9309421
86628	Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation.		Aoki J; Koike S; Asou H; Ise I; Suwa H; Tanaka T; Miyasaka M ; Nomoto A		Exp Cell Res	235	1997	374-84	J:43078	9299162
86629	Role of interleukin-6 in the pathogenesis of murine plasmacytoma and human multiple myeloma [comment]		Pattengale PK		Am J Pathol	151	1997	647-9	J:43106	9284811
86630	DR-nm23 gene expression in neuroblastoma cells: relationship to integrin expression, adhesion characteristics, and differentiation.		Amendola R; Martinez R; Negroni A; Venturelli D; Tanno B; Calabretta B ; Raschella G		J Natl Cancer Inst	89	1997	1300-10	J:43119	9293921
86631	Massive mammary gland infection and pregnancy-dependent mammary tumor development in mice infected neonatally with mouse mammary tumor virus (SW) but not in mice infected as adults, despite a dramatic local response.		Papiernik M; Wache AC; Pontoux C; Nabarra B		Eur J Immunol	27	1997	2145-51	J:43166	9341752
86632	The absolute number of trans-rearrangements between the TCRG and TCRB loci is predictive of lymphoma risk: a severe combined immune deficiency (SCID) murine model.		Lista F; Bertness V; Guidos CJ; Danska JS; Kirsch IR		Cancer Res	57	1997	4408-13	J:43173	9331104
86633	Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression.		Manenti G; Gariboldi M; Fiorino A; Zanesi N; Pierotti MA; Dragani TA		Cancer Res	57	1997	4164-6	J:43176	9331067
86634	Galpha12 and Galpha13 mediate differentiation of P19 mouse embryonal carcinoma cells in response to retinoic acid.		Jho EH; Malbon CC		J Biol Chem	272	1997	24461-7	J:43154	9305907
86635	Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity.		Frost P; Ng CP; Belldegrun A; Bonavida B		Cell Immunol	180	1997	70-83	J:43159	9316641
86636	Genetic interaction between HAP1/REF-1 and p53 [letter]		Meira LB; Cheo DL; Hammer RE; Burns DK; Reis A; Friedberg EC		Nat Genet	17	1997	145	J:43195	9326930
86637	Correlation between Bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors.		Lee GH		Am J Pathol	151	1997	957-61	J:43188	9327729
86638	Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus.		Sipowicz MA; Chomarat P; Diwan BA; Anver MA; Awasthi YC; Ward JM; Rice JM; Kasprzak KS; Wild CP; Anderson LM		Am J Pathol	151	1997	933-41	J:43189	9327726
86639	Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway.		Endo F; Kubo S; Awata H; Kiwaki K; Katoh H; Kanegae Y; Saito I ; Miyazaki J ; Yamamoto T ; Jakobs C ; Hattori S ; Matsuda I		J Biol Chem	272	1997	24426-32	J:43207	9305902
86640	Comparison of tumor growth between hsp25- and hsp27-transfected murine L929 cells in nude mice.		Blackburn RV; Galoforo SS; Berns CM; Armour EP; McEachern D; Corry PM; Lee YJ		Int J Cancer	72	1997	871-7	J:43222	9311607
86641	High frequency of leukemic lymphomas with osteosarcomas but no myeloid leukemias in C3H mice after 239Pu citrate injection.		Oghiso Y; Yamada Y; Iida H		J Radiat Res (Tokyo)	38	1997	77-86	J:43224	9287460
86642	Studies of dual promoters of mouse kappa-opioid receptor gene.		Lu S; Loh HH; Wei LN		Mol Pharmacol	52	1997	415-20	J:43237	9281603
86643	Micronuclei containing whole chromosomes harbouring the selectable gene do not lead to mutagenesis.		Eckert I; Caspary WJ; Nusse M; Liechty M; Davis L; Stopper H		Mutagenesis	12	1997	379-82	J:43238	9379918
86644	Tying it all together: epigenetics, genetics, cell cycle, and cancer [see comments]		Baylin SB		Science	277	1997	1948-9	J:43241	9333948
86645	Meis2, a novel mouse Pbx-related homeobox gene induced by retinoic acid during differentiation of P19 embryonal carcinoma cells.		Oulad-Abdelghani M; Chazaud C; Bouillet P; Sapin V; Chambon P; Dolle P		Dev Dyn	210	1997	173-83	J:43263	9337137
86646	Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.		Tamura Y; Peng P; Liu K; Daou M; Srivastava PK		Science	278	1997	117-20	J:43302	9311915
86647	A short exposure to a high-glucose milieu stabilizes the acidic vacuolar apparatus of insulinoma cells in culture to ensuing oxidative stress.		Olejnicka BT; Ollinger K; Brunk UT		APMIS	105	1997	689-98	J:43314	9350212
86648	Parthenogenetic development of Mos-deficient mouse oocytes.		Hirao Y; Eppig JJ		Mol Reprod Dev	48	1997	391-6	J:43317	9322252
86649	Molecular cloning and nucleotide sequence of murine 2,3-bisphosphoglycerate mutase cDNA.		Le Boulch P; Joulin V; Garel MC; Rosa J; Cohen-Solal M		Biochem Biophys Res Commun	156	1988	874-81	J:43382	2847721
86650	Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.		Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M		Cancer Res	57	1997	4557-63	J:43452	9377569
86651	The Heidelberg classification of renal cell tumours [editorial]		Kovacs G; Akhtar M; Beckwith BJ; Bugert P; Cooper CS; Delahunt B ; Eble JN ; Fleming S ; Ljungberg B ; Medeiros LJ ; Moch H ; Reuter VE ; Ritz E ; Roos G ; Schmidt D ; Srigley JR ; Storkel S ; van den Berg E ; Zbar B		J Pathol	183	1997	131-3	J:43461	9390023
86652	Classification strategies for the grading of renal cell carcinomas, based on nuclear morphometry and densitometry.		Francois C; Decaestecker C; Petein M; van Ham P; Peltier A; Pasteels JL; Danguy A; Salmon I; van Velthoven R; Kiss R		J Pathol	183	1997	141-50	J:43462	9390025
86653	Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1.		Cox LS		J Pathol	183	1997	134-40	J:43463	9390024
86654	Induction of minisatellite mutation in NIH 3T3 cells by treatment with the tumor promoter okadaic acid.		Nakagama H; Kaneko S; Shima H; Inamori H; Fukuda H; Kominami R ; Sugimura T ; Nagao M		Proc Natl Acad Sci U S A	94	1997	10813-6	J:43490	9380716
86655	CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.		Blazar BR; Taylor PA; Boyer MW; Panoskaltsis-Mortari A; Allison JP ; Vallera DA		J Immunol	159	1997	3460-73	J:43543	9317145
86656	R7, a spontaneous mutant of Moloney murine sarcoma virus 124 with three direct repeats and an in-frame truncated gag-mos gene, induces brain lesions.		Yuen PH; Kwak YT		Virology	236	1997	213-8	J:43562	9299634
86657	The induction of immune responses to murine malignant mesothelioma by IL-2 gene transfer.		Leong CC; Marley JV; Loh S; Robinson BW; Garlepp MJ		Immunol Cell Biol	75	1997	356-9	J:43566	9315477
86658	Mutagenicity and cytotoxicity of reactive oxygen and nitrogen species in the MN-11 murine tumor cell line.		Sandhu JK; Birnboim HC		Mutat Res	379	1997	241-52	J:43596	9357553
86659	Influence of diet on mammary cancer in transgenic mice bearing an oncogene expressed in mammary tissue.		Rao GN; Ney E; Herbert RA		Breast Cancer Res Treat	45	1997	149-58	J:43631	9342440
86660	The sleep inducing factor oleamide is produced by mouse neuroblastoma cells.		Bisogno T; Sepe N; De Petrocellis L; Mechoulam R; Di Marzo V		Biochem Biophys Res Commun	239	1997	473-9	J:43681	9344854
86661	Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models.		Tuting T; Gambotto A; Baar J; Davis ID; Storkus WJ; Zavodny PJ; Narula S; Tahara H; Robbins PD; Lotze MT		Gene Ther	4	1997	1053-60	J:43643	9415311
86662	Regulation of the mouse cellular retinoic acid-binding protein-I gene by thyroid hormone and retinoids in transgenic mouse embryos and P19 cells.		Wei LN; Lee CH; Filipcik P; Chang L		J Endocrinol	155	1997	35-46	J:43644	9390004
86663	Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine.		Paul SR; Bennett F; Calvetti JA; Kelleher K; Wood CR; O'Hara RM Jr; Leary AC; Sibley B; Clark SC; Williams DA; Yang YC		Proc Natl Acad Sci U S A	87	1990	7512-6	J:38817	2145578
86664	Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host.		Soloway PD; Alexander CM; Werb Z; Jaenisch R		Oncogene	13	1996	2307-14	J:43744	8957071
86665	Adrenocorticotropic hormone regulates the activities of the orphan nuclear receptor Nur77 through modulation of phosphorylation.		Li Y; Lau LF		Endocrinology	138	1997	4138-46	J:43720	9322922
86666	Morphometric analysis of neointimal formation in murine cardiac grafts: III. Dissociation of intestitial fibrosis from neointimal formation.		Armstrong AT; Strauch AR; Starling RC; Sedmak DD; Orosz CG		Transplantation	64	1997	1198-202	J:43792	9355840
86667	SHP-1 is involved in neuronal differentiation of P19 embryonic carcinoma cells.		Mizuno K; Katagiri T; Maruyama E; Hasegawa K; Ogimoto M; Yakura H		FEBS Lett	417	1997	6-12	J:43778	9395064
86668	Matrix glycoprotein SC1/ECM2 augments B lymphopoiesis.		Oritani K; Kanakura Y; Aoyama K; Yokota T; Copeland NG; Gilbert DJ ; Jenkins NA ; Tomiyama Y ; Matsuzawa Y ; Kincade PW		Blood	90	1997	3404-13	J:43800	9345023
86669	Abnormal erythropoietin (Epo) gene expression in the murine erythroleukemia IW32 cells results from a rearrangement between the G-protein beta2 subunit gene and the Epo gene.		Chretien S; Duprez V; Maouche L; Gisselbrecht S; Mayeux P; Lacombe C		Oncogene	15	1997	1995-9	J:43802	9365246
86670	A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo.		Ashley DM; Sampson JH; Archer GE; Batra SK; Bigner DD; Hale LP		J Neuroimmunol	78	1997	34-46	J:43882	9307226
86671	Oncogenic changes in murine lymphoid tumors induced by in utero exposure to ionizing radiation.		Lumniczky K; Antal S; Unger E; Hidvegi EJ; Safrany G		Radiat Oncol Investig	5	1997	158-62	J:43883	9303076
86672	Role of H-ras gene in chronic liver damage in mice. By using transgenic mice carrying a human C-H-ras proto-oncogene without mutations.		Tsunematsu S; Saito H; Sato R; Morizane T; Ishii H		Biochem Mol Biol Int	42	1997	371-9	J:43885	9238536
86673	Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene-induced melanoma from TP-ras transgenic mice.		Gause PR; Lluria-Prevatt M; Keith WN; Balmain A; Linardopolous S ; Warneke J ; Powell MB		Mol Carcinog	20	1997	78-87	J:43879	9328438
86674	Roles of DNA repair methyltransferase in mutagenesis and carcinogenesis.		Sekiguchi M; Sakumi K		Jpn J Hum Genet	42	1997	389-99	J:43931	12503185
86675	Effect of low dietary calcium on bone metabolism in the SENCAR mouse.		Murray EJ; Murray SS; Grisanti M; Duarte ME; Urist MR		J Orthop Res	15	1997	585-92	J:43940	9379269
86676	The role of soluble growth factors in inducing transient growth and clonal extinction of stroma cell dependent erythroblastic leukemia cells.		Itoh K; Friel J; Laker C; Zeller W; Just U; Bittner S; Nibbs RJ; Harrison PR; Nishikawa SI; Mori KJ; Ostertag W		Leukemia	11	1997	1753-61	J:43942	9324297
86677	Tumor-targeted Salmonella as a novel anticancer vector.		Pawelek JM; Low KB; Bermudes D		Cancer Res	57	1997	4537-44	J:43920	9377566
86678	Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines.		Stoppacciaro A; Paglia P; Lombardi L; Parmiani G; Baroni C; Colombo MP		Eur J Immunol	27	1997	2375-82	J:43925	9341783
86679	The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4.		Mock BA; Hartley J; Le Tissier P; Wax JS; Potter M		Blood	90	1997	4092-8	J:43992	9354679
86680	Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.		Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM		J Immunol	159	1997	4665-75	J:43964	9366389
86681	New evidence for two MHC class II-restricted antigen presentation pathways by overexpression of a small G protein.		Briken V; Lankar D; Bonnerot C		J Immunol	159	1997	4653-8	J:43972	9366387
86682	Transcriptional regulation of the junB gene in B lymphocytes: role of protein kinase A and a membrane Ig-regulated protein phosphatase.		Amato SF; Nakajima K; Hirano T; Chiles TC		J Immunol	159	1997	4676-85	J:43973	9366390
86683	Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.		Hsing Y; Hostager BS; Bishop GA		J Immunol	159	1997	4898-906	J:43977	9366415
86684	Pas1 is a common lung cancer susceptibility locus in three mouse strains.		Manenti G; Gariboldi M; Fiorino A; Zedda AI; Pierotti MA; Dragani TA		Mamm Genome	8	1997	801-4	J:44025	9337390
86685	Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells.		Williams BA; Makrigiannis AP; Blay J; Hoskin DW		Int J Cancer	73	1997	416-23	J:44009	9359490
86686	Antitumor effects and pharmacological interaction of xiao-chai-hu-tang (sho-saiko-to) and interleukin 2 in murine renal cell carcinoma.		Huang Y; Marumo K; Murai M		Keio J Med	46	1997	132-7	J:44073	9339641
86687	The effect of NK cell activation by tumor cells on antigen-specific antibody responses.		Koh CY; Yuan D		J Immunol	159	1997	4745-52	J:44074	9366398
86688	Cloning and characterization of murine glial cell-derive neurotrophic factor inducible transcription factor (MGIF).		Yajima S; Lammers CH; Lee SH; Hara Y; Mizuno K; Mouradian MM		J Neurosci	17	1997	8657-66	J:44087	9348334
86689	Costimulation provided by DNA immunization enhances antitumor immunity.		Corr M; Tighe H; Lee D; Dudler J; Trieu M; Brinson DC; Carson DA		J Immunol	159	1997	4999-5004	J:44066	9366427
86690	Bioconjugation of tumor necrosis factor-alpha with the copolymer of divinyl ether and maleic anhydride increasing its antitumor potency.		Kaneda Y; Yamamoto Y; Tsunoda S; Kamada H; Tsutsumi Y; Hirano T; Mayumi T		Biochem Biophys Res Commun	239	1997	160-5	J:44136	9345288
86691	Down-regulation of major histocompatibility complex Q1b gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.		Dong L; Ma Q; Whitlock JP Jr		J Biol Chem	272	1997	29614-9	J:44174	9368027
86692	A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer.		Tymms MJ; Ng AY; Thomas RS; Schutte BC; Zhou J; Eyre HJ; Sutherland GR ; Seth A ; Rosenberg M ; Papas T ; Debouck C ; Kola I		Oncogene	15	1997	2449-62	J:44178	9395241
86693	T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice.		Wada H; Noguchi Y; Marino MW; Dunn AR; Old LJ		Proc Natl Acad Sci U S A	94	1997	12557-61	J:44186	9356488
86694	Developmental expression of H3.3A variant histone mRNA in mouse.		Lopez-Fernandez LA; Lopez-Alanon DM; Castaneda V; Krimer DB; del Mazo J		Int J Dev Biol	41	1997	699-703	J:44153	9415489
86695	Analysis and modulation of DNA repair in aging.		Walter CA; Grabowski DT; Street KA; Conrad CC; Richardson A		Mech Ageing Dev	98	1997	203-22	J:44154	9352490
86696	t-complex-associated embryonic surface antigen homologous to mLAMP-1. II. Expression and distribution analyses.		Acevedo-Schermerhorn C; Gray-Bablin J; Gama R; McCormick PJ		Exp Cell Res	236	1997	510-8	J:44197	9367636
86697	t-complex-associated embryonic surface antigen homologous to mLAMP-1. I. Biochemical and molecular analyses.		Gray-Bablin J; Acevedo-Schermerhorn C; Gama R; McCormick PJ		Exp Cell Res	236	1997	501-9	J:44198	9367635
86698	The high-mobility group protein T160 binds to both linear and cruciform DNA and mediates DNA bending as determined by ring closure.		Gariglio M; Ying GG; Hertel L; Gaboli M; Clerc RG; Landolfo S		Exp Cell Res	236	1997	472-81	J:44199	9367632
86699	Genome organization of human 48-kDa oligosaccharyltransferase (DDOST).		Yamagata T; Tsuru T; Momoi MY; Suwa K; Nozaki Y; Mukasa T; Ohashi H; Fukushima Y; Momoi T		Genomics	45	1997	535-40	J:44254	9367678
86700	Variability in gene expression and tumor formation within genetically homogeneous animal populations in bioassays.		Wolff GL		Fundam Appl Toxicol	29	1996	176-84	J:44233	8742313
86701	DAP kinase links the control of apoptosis to metastasis.		Inbal B; Cohen O; Polak-Charcon S; Kopolovic J; Vadai E; Eisenbach L; Kimchi A		Nature	390	1997	180-4	J:44238	9367156
86702	Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys [see comments]		Olivero OA; Anderson LM; Diwan BA; Haines DC; Harbaugh SW; Moskal TJ; Jones AB; Rice JM; Riggs CW; Logsdon D; Yuspa SH; Poirier MC		J Natl Cancer Inst	89	1997	1602-8	J:44243	9362158
86703	Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.		Lane TF; Leder P		Oncogene	15	1997	2133-44	J:44244	9393971
86704	Deletional remodeling of c-myc-deregulating chromosomal translocations.		Kovalchuk AL; Muller JR; Janz S		Oncogene	15	1997	2369-77	J:44245	9393881
86705	High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice.		Yan W; Young AZ; Soares VC; Kelley R; Benezra R; Zhuang Y		Mol Cell Biol	17	1997	7317-27	J:44278	9372963
86706	Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor alpha in mice.		Lasek W; Feleszko W; Golab J; Stoklosa T; Marczak M; Dabrowska A ; Malejczyk M ; Jakobisiak M		Cancer Immunol Immunother	45	1997	100-8	J:44326	9390201
86707	Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice.		Bugge TH; Kombrinck KW; Xiao Q; Holmback K; Daugherty CC; Witte DP; Degen JL		Blood	90	1997	4522-31	J:44314	9373263
86708	High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice.		Villeval JL; Cohen-Solal K; Tulliez M; Giraudier S; Guichard J; Burstein SA; Cramer EM; Vainchenker W; Wendling F		Blood	90	1997	4369-83	J:44316	9373248
86709	Growth retardation and leaky SCID phenotype of Ku70-deficient mice.		Gu Y; Seidl KJ; Rathbun GA; Zhu C; Manis JP; van der Stoep N; Davidson L; Cheng HL; Sekiguchi JM; Frank K; Stanhope-Baker P; Schlissel MS; Roth DB; Alt FW		Immunity	7	1997	653-65	J:44361	9390689
86710	Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells.		Grohmann U; Silla S; Belladonna ML; Bianchi R; Orabona C; Puccetti P; Fioretti MC		Cell Immunol	181	1997	109-19	J:44356	9398398
86711	Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin.		Puga A; Hoffer A; Zhou S; Bohm JM; Leikauf GD; Shertzer HG		Biochem Pharmacol	54	1997	1287-96	J:44780	9393671
86712	The tumor suppressor protein p16INK4a.		Serrano M		Exp Cell Res	237	1997	7-13	J:44752	9417860
86713	Immortalized mouse mammary cells in vivo do not exhibit increased telomerase activity.		Jiang C; Juo L; Said TK; Thompson H; Medina D		Carcinogenesis	18	1997	2085-91	J:44397	9395206
86714	Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II.		Utsugi T; Aoyagi K; Asao T; Okazaki S; Aoyagi Y; Sano M; Wierzba K; Yamada Y		Jpn J Cancer Res	88	1997	992-1002	J:44431	9414662
86715	Two distinct pituitary cell lines from mouse intermediate lobe tumors: a cell that produces prolactin-regulating factor and a melanotroph [seecomments]		Hnasko R; Khurana S; Shackleford N; Steinmetz R; Low MJ; Ben-Jonathan N		Endocrinology	138	1997	5589-96	J:44454	9389547
86716	Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800.		Sourla A; Luo S; Labrie C; Belanger A; Labrie F		Endocrinology	138	1997	5605-17	J:44455	9389549
86717	Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanoma.		Spanjaard RA; Lee PJ; Sarkar S; Goedegebuure PS; Eberlein TJ		Cancer Res	57	1997	5122-8	J:44498	9371513
86718	A mathematical model of the regulation of the G1 phase of Rb+/+ and Rb-/- mouse embryonic fibroblasts and an osteosarcoma cell line.		Obeyesekere MN; Knudsen ES; Wang JY; Zimmerman SO		Cell Prolif	30	1997	171-94	J:44528	9375029
86719	Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alpha.		Marr RA; Addison CL; Snider D; Muller WJ; Gauldie J; Graham FL		Gene Ther	4	1997	1181-8	J:44536	9425441
86720	Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.		Santodonato L; D'Agostino G; Santini SM; Carlei D; Musiani P; Modesti A; Signorelli P; Belardelli F; Ferrantini M		Gene Ther	4	1997	1246-55	J:44537	9425449
86721	Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies.		Zitzelsberger H; Lehmann L; Werner M; Bauchinger M		Histochem Cell Biol	108	1997	403-17	J:44509	9387933
86722	Antitumor activities of IL-12 and mechanisms of action.		Shurin MR; Esche C; Peron JM; Lotze MT			68	1997	153-174	J:44573	 
86723	Regression of established mouse leukemia by GM-CSF-transduced tumor vaccine: implications for cytotoxic T lymphocyte responses and tumor burdens.		Hsieh CL; Pang VF; Chen DS; Hwang LH		Hum Gene Ther	8	1997	1843-54	J:44541	9382951
86724	Association of a murine chromosome 9 locus (Psl1) with susceptibility to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.		Angel JM; Beltran L; Minda K; Rupp T; DiGiovanni J		Mol Carcinog	20	1997	162-7	J:44548	9364205
86725	Compartmentalization of the third component of complement (C3) in 3LL murine carcinoma cells, studied by immunogold labeling.		Morgante E; DiRenzo L; Longo A; Cunsolo MG; Lipari M; Pontieri GM; Russo MA		Recent Adv Microscopy Cells Tissues Organs		1997	135-139	J:44551	 
86726	Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis.		Serra R; Johnson M; Filvaroff EH; LaBorde J; Sheehan DM; Derynck R; Moses HL		J Cell Biol	139	1997	541-52	J:44579	9334355
86727	Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.		Song W; Kong HL; Carpenter H; Torii H; Granstein R; Rafii S; Moore MA; Crystal RG		J Exp Med	186	1997	1247-56	J:44581	9334364
86728	Polyclonal structure of intestinal adenomas in ApcMin/+ mice with concomitant loss of Apc+ from all tumor lineages.		Merritt AJ; Gould KA; Dove WF		Proc Natl Acad Sci U S A	94	1997	13927-31	J:44639	9391129
86729	Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor suppression.		Riley DJ; Liu CY; Lee WH		Mol Cell Biol	17	1997	7342-52	J:44677	9372965
86730	Inhibitory effect of black tea on the growth of established skin tumors in mice: effects on tumor size, apoptosis, mitosis and bromodeoxyuridine incorporation into DNA.		Lu YP; Lou YR; Xie JG; Yen P; Huang MT; Conney AH		Carcinogenesis	18	1997	2163-9	J:44656	9395217
86731	Intestinal and extra-intestinal tumor multiplicities in the Apc1638N mouse model after exposure to X-rays.		van der Houven van Oordt CW; Smits R; Williamson SL; Luz A; Khan PM; Fodde R; van der Eb AJ; Breuer ML		Carcinogenesis	18	1997	2197-203	J:44657	9395221
86732	Toxicity of divinylbenzene-55 for B6C3F1 mice in a two-week inhalation study.		Morgan DL; Mahler JF; Wilson RE; Moorman MP; Price HC Jr; O'connor RW		Fundam Appl Toxicol	39	1997	89-100	J:44662	9344621
86733	Regulatory role of CD8 in major histocompatibility complex-unrestricted tumoricidal activity of mouse T cells activated with anti-CD3 monoclonal antibody.		Stewart BH; Hoskin DW		Immunol Invest	26	1997	601-14	J:44664	9399103
86734	Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.		Jordan A; Scholz R; Wust P; Fahling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R		Int J Hyperthermia	13	1997	587-605	J:44667	9421741
86735	Subunit peptide cancer vaccines targeting activating mutations of the p21 ras proto-oncogene.		Triozzi PL; Stoner GD; Kaumaya PT		Biomed Pept Proteins Nucleic Acids	1	1995	185-92	J:44696	9346851
86736	Steroid hormone-dependent overexpression of cytochromes P450 2A in liver tumors of TGF alpha transgenic male mice.		Takagi H; Aida K; Sohara N; Mori M; Merlino G; Negishi M		J Gastroenterol	32	1997	708-11	J:44697	9350003
86737	p53: emergency brake and target for cancer therapy.		Wiman KG		Exp Cell Res	237	1997	14-8	J:44751	9417861
86738	The retinoblastoma protein pathway in cell cycle control and cancer.		Bartek J; Bartkova J; Lukas J		Exp Cell Res	237	1997	1-6	J:44753	9417859
86739	Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression.		Luan J; Shattuck-Brandt R; Haghnegahdar H; Owen JD; Strieter R; Burdick M; Nirodi C; Beauchamp D; Johnson KN; Richmond A		J Leukoc Biol	62	1997	588-97	J:44744	9365113
86740	Characterization of density-dependent regulation of the tyrosinase gene promoter: role of protein kinase C.		Mahalingam H; Watanabe A; Tachibana M; Niles RM		Exp Cell Res	237	1997	83-92	J:44750	9417870
86741	Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy.		Park JY; Elshami AA; Amin K; Rizk N; Kaiser LR; Albelda SM		Gene Ther	4	1997	909-17	J:44773	9349427
86742	Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance.		Smith KM; Olson DC; Hirose R; Hanahan D		Int Immunol	9	1997	1355-65	J:44775	9310839
86743	Role of T-cell subsets in acute and persistent E-55+ murine leukemia virus infection in susceptible progressor and resistant long-term nonprogressor mouse strains. Women and Infants Transmission Study.		Avidan N; Sieck TG; Blank KJ		Clin Immunol Immunopathol	85	1997	282-8	J:44787	9400628
86744	Gene transfer of Fas ligand induces tumor regression in vivo.		Arai H; Gordon D; Nabel EG; Nabel GJ		Proc Natl Acad Sci U S A	94	1997	13862-7	J:44640	9391118
86745	Emergence of different mechanisms of resistance in the evolution of multidrug resistance in murine erythroleukemia cell lines.		Modrak DE; Draper MP; Levy SB		Biochem Pharmacol	54	1997	1297-306	J:44781	9393672
86746	Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids.		Uda Y; Price KR; Williamson G; Rhodes MJ		Cancer Lett	120	1997	213-6	J:44783	9461039
86747	Inverse dose-rate effect for the induction of micronuclei in Lewis lung carcinoma after exposure to cobalt-60 gamma rays.		Widel M; Przybyszewski WM		Radiat Res	149	1998	98-102	J:44823	9421159
86748	Bispecific antibody treatment of murine B cell lymphoma.		De Jonge J; Heirman C; De Veerman M; Van Meirvenne S; Demanet C; Brissinck J; Thielemens K		Cancer Immunol Immunother	45	1997	162-5	J:44934	9435864
86749	Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function.		Yu Q; Toole BP; Stamenkovic I		J Exp Med	186	1997	1985-96	J:44875	9396767
86750	Trafficking of activated lymphocytes into the RENCA tumour microcirculation in vivo in mice.		Brown NJ; Ali S; Reed MW; Wiltrout R; Rees RC		Br J Cancer	76	1997	1572-8	J:44909	9413944
86751	The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model.		Nordsmark M; Maxwell RJ; Horsman MR; Bentzen SM; Overgaard J		Br J Cancer	76	1997	1432-9	J:44947	9400939
86752	Constitutive and inducible expression of megakaryocyte-specific genes in Friend erythroleukaemia cells.		Vannucchi AM; Linari S; Cellai C; Koury MJ; Paoletti F		Br J Haematol	99	1997	500-8	J:44948	9401056
86753	Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells.		Ramachandran C; You W; Krishan A		Anticancer Res	17	1997	3369-76	J:44940	9413174
86754	Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1		Felzmann T; Ramsey WJ; Blaese RM		Gene Ther	4	1997	1322-9	J:44960	9472556
86755	Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells.		Sharma S; Miller PW; Stolina M; Zhu L; Huang M; Paul RW; Dubinett SM		Gene Ther	4	1997	1361-70	J:44961	9472560
86756	Efficacy and mechanism of aluminium phthalocyanine and its sulphonated derivatives mediated photodynamic therapy on murine tumours.		Chan WS; Brasseur N; La Madeleine C; Ouellet R; van Lier JE		Eur J Cancer	33	1997	1855-9	J:44958	9470846
86757	CD44 in inflammation and metastasis.		Lesley J; Hyman R; English N; Catterall JB; Turner GA		Glycoconj J	14	1997	611-22	J:45002	9298694
86758	Analysis of a randomly assorted cDNA library from BW 5147 lymphoid cells. Frequency estimates based on computer aided concatenation matching of 2D gel polypeptide products.		Frey JR; Coleclough C; Kettman JR; Hofmann JP; Kuhn L; Lefkovits I		Mol Immunol	34	1997	753-63	J:45006	9444974
86759	Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger.		Wu J; Akaike T; Maeda H		Cancer Res	58	1998	159-65	J:45007	9426072
86760	Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope-expressing tumor.		Iwasaki A; Barber BH		Cancer Immunol Immunother	45	1998	273-9	J:45008	9439651
86761	Active antitumor immunotherapy, with or without B7-mediated costimulation, increases tumor progression in an immunogenic murine T cell lymphoma model.		Raes G; Van Ginderachter J; Liu YQ; Brys L; Thielemans K; De Baetselier P; Geldhof A		Cancer Immunol Immunother	45	1998	257-65	J:45009	9439649
86762	Inhibition of hepatocellular carcinoma development in hepatitis B virus transfected mice by low dietary casein.		Cheng Z; Hu J; King J; Jay G; Campbell TC		Hepatology	26	1997	1351-4	J:44992	9362383
86763	Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype.		Lee H; Li D; Prior T; Casto BC; Weghorst CM; Shuler CF; Milo GE		Cell Biol Toxicol	13	1997	419-34	J:44999	9352120
86764	Negative autoregulation of the organizer-specific homeobox gene goosecoid.		Danilov V; Blum M; Schweickert A; Campione M; Steinbeisser H		J Biol Chem	273	1998	627-35	J:45036	9417125
86765	Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells.		Bafetti LM; Young TN; Itoh Y; Stack MS		J Biol Chem	273	1998	143-9	J:45042	9417058
86766	Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells.		Geldhof AB; Moser M; Lespagnard L; Thielemans K; De Baetselier P		Blood	91	1998	196-206	J:45067	9414285
86767	Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.		Dunussi-Joannopoulos K; Dranoff G; Weinstein HJ; Ferrara JL; Bierer BE; Croop JM		Blood	91	1998	222-30	J:45068	9414288
86768	Gamma-globin gene promoter elements required for interaction with globin enhancers.		Langdon SD; Kaufman RE		Blood	91	1998	309-18	J:45069	9414299
86769	Inhibition of mouse mammary carcinoma development with doxorubicin in liposomes.		Vaage J; Working P; Uster P		Int J Cancer	75	1998	158-9	J:45099	9426705
86770	Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model.		Dias S; Thomas H; Balkwill F		Int J Cancer	75	1998	151-7	J:45100	9426704
86771	Increase in experimental pulmonary metastasis in mice by L-arginine under inhibition of nitric oxide production by NG-nitro-L-arginine methyl ester.		Yamamoto T; Terada N; Seiyama A; Nishizawa Y; Akedo H; Kosaka H		Int J Cancer	75	1998	140-4	J:45101	9426702
86772	Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in mice.		Ravindranath MH; Kelley MC; Jones RC; Amiri AA; Bauer PM; Morton DL		Int J Cancer	75	1998	117-24	J:45102	9426699
86773	p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: a third member of the p53 family?		Bian J; Sun Y		Proc Natl Acad Sci U S A	94	1997	14753-8	J:45082	9405685
86774	No female embryonic lethality in mice nullizygous for Msh2 and p53 [letter; comment]		Toft NJ; Arends MJ; Wyllie AH; Clarke AR		Nat Genet	18	1998	17	J:45115	9425892
86775	Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation.		Li G; Tron V; Ho V		J Invest Dermatol	110	1998	72-5	J:45109	9424091
86776	Overexpression of the neuron-specific molecule BM88 in mouse neuroblastoma cells: altered responsiveness to growth factors.		Gomez J; Boutou E; Hurel C; Mamalaki A; Kentroti S; Vernadakis A; Matsas R		J Neurosci Res	51	1998	119-28	J:45126	9452316
86777	Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice.		Freland S; Chambers BJ; Andersson M; Van Kaer L; Ljunggren HG		J Immunol	160	1998	572-9	J:45189	9551890
86778	Separation of function between the domains of toxic shock syndrome toxin-1.		Wahlsten JL; Ramakrishnan S		J Immunol	160	1998	854-9	J:45179	9551921
86779	Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.		Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapiere CM		Cancer Res	57	1997	5590-7	J:45232	9407972
86780	Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.		Wennbo H; Gebre-Medhin M; Gritli-Linde A; Ohlsson C; Isaksson OG; Tornell J		J Clin Invest	100	1997	2744-51	J:45260	9389738
86781	Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1.		Darby TG; Meissner JD; Ruhlmann A; Mueller WH; Scheibe RJ		Oncogene	15	1997	3067-82	J:45278	9444955
86782	Evaluation of p53 mutation in pancreatic acinar cell carcinomas of humans and transgenic mice.		Terhune PG; Memoli VA; Longnecker DS		Pancreas	16	1998	6-12	J:45279	9436856
86783	Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100		Schreurs MW; de Boer AJ; Schmidt A; Figdor CG; Adema GJ		Melanoma Res	7	1997	463-70	J:45267	9464618
86784	Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their early differentiated progeny.		Wilder PJ; Kelly D; Brigman K; Peterson CL; Nowling T; Gao QS; McComb RD; Capecchi MR; Rizzino A		Dev Biol	192	1997	614-29	J:45309	9441693
86785	cis-amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: In Vivo activity, toxicology, and pharmacokinetics in mice		Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR		Clin Cancer Res	3	1997	2063-2074	J:45318	9815598
86786	Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas.		Amoroso SR; Huang N; Roberts AB; Potter M; Letterio JJ		Proc Natl Acad Sci U S A	95	1998	189-94	J:45319	9419351
86787	Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiation.		Yamaguchi Y; Zon LI; Ackerman SJ; Yamamoto M; Suda T		Blood	91	1998	450-7	J:45321	9427697
86788	Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.		De Plaen E; Lurquin C; Van Pel A; Mariame B; Szikora JP; Wolfel T; Sibille C; Chomez P; Boon T		Proc Natl Acad Sci U S A	85	1988	2274-8	J:45342	3127830
86789	Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival.		Ghia P; Boussiotis VA; Schultze JL; Cardoso AA; Dorfman DM; Gribben JG; Freedman AS; Nadler LM		Blood	91	1998	244-51	J:45348	9414291
86790	Reactivation of the maternally imprinted IGF2 allele in TGFalpha induced hepatocellular carcinomas in mice.		Harris TM; Rogler LE; Rogler CE		Oncogene	16	1998	203-9	J:45382	9464538
86791	Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.		Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F		J Clin Invest	101	1998	429-41	J:45390	9435316
86792	Interleukin-6 does not mediate endotoxin-induced uveitis in mice: studies in gene deletion animals.		Rosenbaum JT; Kievit P; Han YB; Park JM; Planck SR		Invest Ophthalmol Vis Sci	39	1998	64-9	J:45408	9430546
86793	Identification of the lesion in the stimulatory GTP-binding protein of the uncoupled S49 lymphoma.		Rall T; Harris BA		FEBS Lett	224	1987	365-71	J:45409	2826231
86794	Rho proteins induce metastatic properties in vivo.		del Peso L; Hernandez-Alcoceba R; Embade N; Carnero A; Esteve P; Paje C; Lacal JC		Oncogene	15	1997	3047-57	J:45452	9444953
86795	Stochastic modelling of tumorigenesis in p53 deficient mice.		Mao JH; Lindsay KA; Balmain A; Wheldon TE		Br J Cancer	77	1998	243-52	J:45429	9460995
86796	Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.		Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB		Oncogene	16	1998	69-76	J:45467	9467944
86797	The catalytic domain of PKC-epsilon, in reciprocal PKC-delta and - epsilon chimeras, is responsible for conferring tumorgenicity to NIH3T3 cells, whereas both regulatory and catalytic domains of PKC-epsilon contribute to in vitro transformation.		Wang QJ; Acs P; Goodnight J; Blumberg PM; Mischak H; Mushinski JF		Oncogene	16	1998	53-60	J:45455	9467942
86798	Glycolipid sialyltransferases are enhanced during neural differentiation of mouse embryonic carcinoma cells, P19.		Osanai T; Watanabe Y; Sanai Y		Biochem Biophys Res Commun	241	1997	327-33	J:45460	9425271
86799	Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2.		El Sewedy T; Fornaro M; Alberti S		Int J Cancer	75	1998	324-30	J:45493	9462726
86800	Protection against cyclophosphamide-induced alopecia and inhibition of mammary tumor growth by topical 1,25-dihydroxyvitamin D3 in mice.		Chen G; Baechle A; Nevins TD; Oh S; Harmon C; Stacey DW		Int J Cancer	75	1998	303-9	J:45494	9462723
86801	An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types.		Nakhei H; Lingott A; Lemm I; Ryffel GU		Nucleic Acids Res	26	1998	497-504	J:45483	9421506
86802	A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within	the plasma membrane of tumor cells.	Roy K; Tolner B; Chiao JH; Sirotnak FM		J Biol Chem	273	1998	2526-31	J:45519	9446553
86803	Tracing the in vivo distribution and dynamics of cancer cells in mice by luminescence of aequorin- expressing transformants.		Yoshida R; Sanchez-Bueno A; Tsuji FI		Biochem Biophys Res Commun	242	1998	659-62	J:45501	9464273
86804	Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).		Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Loffler H; Schmitz N		Exp Hematol	26	1998	93-9	J:45522	9472798
86805	Modulators of intracellular Ca2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants of the B16 murine melanoma.		Parker C; Sherbet GV		Melanoma Res	2	1992	337-43	J:45527	1337998
86806	The Ca2+ channel blocker verapamil enhances melanogenesis without altering metastatic potential in the B16 murine melanoma.		Parker C; Sherbet GV		Melanoma Res	3	1993	347-50	J:45528	8292891
86807	Metastasis-associated mts1 gene expression is down-regulated by heat shock in variant cell lines of the B16 murine melanoma.		Cajone F; Debiasi S; Parker C; Lakshmi MS; Sherbet GV		Melanoma Res	4	1994	143-50	J:45529	7919958
86808	Paradoxical effect of GM-CSF gene transfer on the tumorigenicity and immunogenicity of murine tumors.		Wang J; Yang WK; Yang Y; Wei SJ; Yang DM; Whang-Peng J; Chen YM; Ting KL; Ting CC		Int J Cancer	75	1998	459-66	J:45535	9455809
86809	DeltaEF1, a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages.		Takagi T; Moribe H; Kondoh H; Higashi Y		Development	125	1998	21-31	J:45575	9389660
86810	Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complexes.		Wang W; Chi T; Xue Y; Zhou S; Kuo A; Crabtree GR		Proc Natl Acad Sci U S A	95	1998	492-8	J:45580	9435219
86811	Fc receptors are required in passive and active immunity to melanoma.		Clynes R; Takechi Y; Moroi Y; Houghton A; Ravetch JV		Proc Natl Acad Sci U S A	95	1998	652-6	J:45584	9435247
86812	Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.		Starkey CR; Lobelle-Rich PA; Granger S; Brightman BK; Fan H; Levy LS		J Virol	72	1998	1078-84	J:45618	9445002
86813	Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2.		Dai HY; Troseth GI; Gunleksrud M; Bruland T; Solberg LA; Aarset H; Kristiansen LI; Dalen A		J Virol	72	1998	1244-51	J:45619	9445024
86814	Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development.		de Vries A; Dolle ME; Broekhof JL; Muller JJ; Kroese ED; van Kreijl CF; Capel PJ; Vijg J; van Steeg H		Carcinogenesis	18	1997	2327-32	J:45598	9450477
86815	AOM-induced mouse colon tumors do not express full-length APC protein.		Maltzman T; Whittington J; Driggers L; Stephens J; Ahnen D		Carcinogenesis	18	1997	2435-9	J:45599	9450492
86816	Monoclonal and polyclonal development of digestive tract tumors in chimeric mice		Farber E		Jpn J Cancer Res	88	1997	1226-7	J:45607	9119735
86817	Heat shock modulates the expression of the metastasis associated gene MTS1 and proliferation of murine and human cancer cells.		Albertazzi E; Cajone F; Lakshmi MS; Sherbet GV		DNA Cell Biol	17	1998	1-7	J:45647	9468217
86818	A full-length Notch1 allele is dispensable for transformation associated with a provirally activated truncated Notch1 allele in Moloney MuLV-infected MMTV(D)/myc transgenic mice.		Girard L; Jolicoeur P		Oncogene	16	1998	517-22	J:45669	9484841
86819	Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.		Staveley-O'Carroll K; Sotomayor E; Montgomery J; Borrello I; Hwang L; Fein S; Pardoll D; Levitsky H		Proc Natl Acad Sci U S A	95	1998	1178-83	J:45658	9448305
86820	Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cells.		Hashimoto Y; Shindo-Okada N; Tani M; Nagamachi Y; Takeuchi K ; Shiroishi T ; Toma H ; Yokota J		J Exp Med	187	1998	289-96	J:45694	9449709
86821	Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.		Sehgal G; Hua J; Bernhard EJ; Sehgal I; Thompson TC; Muschel RJ		Am J Pathol	152	1998	591-6	J:45746	9466586
86822	Radioprotective and antileukemic effects of growth factors in regenerating hematopoietic tissue.		Svirnovski A; Sheleg S; Shimanskaya T; Bakkun A		Stem Cells	15 Suppl 2	1997	111-8	J:45735	9368293
86823	Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells.		Lamm GM; Christofori G		Cancer Res	58	1998	801-7	J:45771	9485038
86824	Strand specificity and absence of hot spots for p53 mutations in ultraviolet B-induced skin tumors of XPA-deficient mice.		Takeuchi S; Nakatsu Y; Nakane H; Murai H; Hirota S; Kitamura Y ; Okuyama A ; Tanaka K		Cancer Res	58	1998	641-6	J:45772	9485015
86825	Differences in latency and inducibility of mouse skin melanomas depending on the age and anatomic site of the skin.		Silvers WK; Mintz B		Cancer Res	58	1998	630-2	J:45773	9485013
86826	A test of the role of alpha5 integrin/fibronectin interactions in tumorigenesis.		Taverna D; Ullman-Cullere M; Rayburn H; Bronson RT; Hynes RO		Cancer Res	58	1998	848-53	J:45769	9485045
86827	herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells?		Bianchi L; Wible B; Arcangeli A; Taglialatela M; Morra F; Castaldo P; Crociani O; Rosati B; Faravelli L; Olivotto M; Wanke E		Cancer Res	58	1998	815-22	J:45770	9485040
86828	Cloning and expression of a human/mouse Polycomb group gene, ENX-2/Enx-2.		Ogawa M; Hiraoka Y; Taniguchi K; Aiso S		Biochim Biophys Acta	1395	1998	151-8	J:45792	9473645
86829	Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model		Cabanes A; Tzemach D; Goren D; Horowitz AT; Gabizon A		Clin Cancer Res	4	1998	499-505	J:45782	9516942
86830	Liver tumors induced in B6C3F1 mice by 7-chlorobenz[a]anthracene and 7-bromobenz [a]anthracene contain K-ras protooncogene mutations.		Xia Q; Yi P; Zhan DJ; Von Tungeln LS; Hart RW; Heflich RH; Fu PP		Cancer Lett	123	1998	21-5	J:45829	9461013
86831	Infrequent involvement of microsatellite instability in urinary bladder carcinomas of the NON/Shi mouse treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.		Chen T; Yamamoto S; Gen H; Murai T; Mori S; Oohara T; Makino S; Wanibuchi H; Fukushima S		Cancer Lett	123	1998	41-5	J:45830	9461016
86832	Helicobacter pylori promotes development of pepsinogen-altered pyloric glands, a preneoplastic lesion of glandular stomach of BALB/c mice pretreated with N-methyl-N-nitrosourea.		Shimizu N; Kaminishi M; Tatematsu M; Tsuji E; Yoshikawa A; Yamaguchi H; Aoki F; Oohara T		Cancer Lett	123	1998	63-9	J:45831	9461019
86833	Clonality of lymphomas at multiple sites in SJL mice.		Tang JC; Ho FC; Chan AC; Srivastava G		Lab Invest	78	1998	205-12	J:45935	9484718
86834	Expression of CD14 corrects the slow response to lipopolysaccharide in the 1B8 mutant of the B cell lymphoma 70Z/3.		Brophy VH; Sibley CH		Immunogenetics	47	1998	196-205	J:45968	9435337
86835	Embryonal carcinoma P19 cells produce erythropoietin constitutively but express lactate dehydrogenase in an oxygen-dependent manner.		Kambe T; Tada J; Chikuma M; Masuda S; Nagao M; Tsuchiya T; Ratcliffe PJ; Sasaki R		Blood	91	1998	1185-95	J:45973	9454748
86836	Inhibition of phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate-caused inflammatory responses in SENCAR mouse skin by black tea polyphenols.		Katiyar SK; Mukhtar H		Carcinogenesis	18	1997	1911-6	J:45979	9363999
86837	Studies of chemopreventive effects of budenoside on benzo[a]pyrene-induced neoplasia of the lung of female A/J mice.		Wattenberg LW; Estensen RD		Carcinogenesis	18	1997	2015-7	J:45983	9364014
86838	Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity.		Vizler C; Rosato A; Calderazzo F; Quintieri L; Fruscella P; Wainstok de Calmanovici R; Mantovani A; Vecchi A; Zanovello P; Collavo D		Br J Cancer	77	1998	656-62	J:45984	9484826
86839	Influence of local cytokines on tumor metastasis: Using cytokine gene-transfected tumor cells as experimental models.		Qin Z; Blankenstein T		Attempts to Understand Metastasis Formation III 213		1996	55-64	J:46017	 
86840	Structure and expression of the c-Myc/Pvt 1 megagene locus.		Siwarski D; Muller U; Andersson J; Notario V; Melchers F; Rolink A; Huppi K		Curr Top Microbiol Immunol	224	1997	67-72	J:46018	9308229
86841	A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay.		Culp SJ; Gaylor DW; Sheldon WG; Goldstein LS; Beland FA		Carcinogenesis	19	1998	117-24	J:46060	9472702
86842	Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.		Ossendorp F; Mengede E; Camps M; Filius R; Melief CJ		J Exp Med	187	1998	693-702	J:46077	9480979
86843	Mouse models for breast cancer susceptibility.		Bennett LM; Wiseman RW		Environ Toxicol Pharmacol	4	1997	283-288	J:46068	 
86844	Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.		Itoh T; Tanioka M; Yoshida H; Yoshioka T; Nishimoto H; Itohara S		Cancer Res	58	1998	1048-51	J:46091	9500469
86845	Retroviral transfer of CPP32beta gene into malignant gliomas in vitro and in vivo.		Kondo S; Tanaka Y; Kondo Y; Ishizaka Y; Hitomi M; Haqqi T; Liu J; Barnett GH; Alnemri ES; Barna BP		Cancer Res	58	1998	962-7	J:46092	9500457
86846	Quantitation of tumor foci in an experimental murine tumor model using computer-assisted video imaging.		Watts AM; Kennedy RC		Anal Biochem	256	1998	217-9	J:46148	9473280
86847	Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas.		Zhuang SM; Schippert A; Haugen-Strano A; Wiseman RW; Soderkvist P		Oncogene	16	1998	803-8	J:46150	9488045
86848	Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse.		Biozzi G; Ribeiro OG; Saran A; Araujo ML; Maria DA; De Franco M; Cabrera WK; Sant'anna OA; Massa S; Covelli V; Mouton D; Neveu T; Siqueira M; Ibanez OM		Carcinogenesis	19	1998	337-46	J:46129	9498286
86849	Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.		Zhang S; Ramsay ES; Mock BA		Proc Natl Acad Sci U S A	95	1998	2429-34	J:46172	9482902
86850	CD4+, but not CD8+, T cells from mammary tumor-bearing mice have a down- regulated production of IFN-gamma: role of phosphatidyl serine.		Cheng X; Lopez DM		J Immunol	160	1998	2735-41	J:46189	9510174
86851	Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells.		de Zoeten EF; Carr-Brendel V; Cohen EP		J Immunol	160	1998	2915-22	J:46191	9510195
86852	Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation.		Rodriguez-Villanueva J; Greenhalgh D; Wang XJ; Bundman D; Cho S; Delehedde M; Roop D; McDonnell TJ		Oncogene	16	1998	853-63	J:46236	9484776
86853	Development of heritable melanoma in transgenic mice.		Zhu H; Reuhl K; Zhang X; Botha R; Ryan K; Wei J; Chen S		J Invest Dermatol	110	1998	247-52	J:46264	9506443
86854	Regulation of NF-E2 activity in erythroleukemia cell differentiation.		Nagai T; Igarashi K; Akasaka J; Furuyama K; Fujita H; Hayashi N; Yamamoto M; Sassa S		J Biol Chem	273	1998	5358-65	J:46244	9478996
86855	Characterization of the mouse Cyp1B1 gene. Identification of an enhancer region that directs aryl hydrocarbon receptor-mediated constitutive and induced expression.		Zhang L; Savas U; Alexander DL; Jefcoate CR		J Biol Chem	273	1998	5174-83	J:46269	9478971
86856	An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15INK4b and p16INK4a tumor suppressor genes.		Malumbres M; Perez de Castro I; Santos J; Perez-Olle R; Fernandez-Piqueras J; Pellicer A		Mamm Genome	9	1998	183-5	J:46281	9501299
86857	Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors.		Noffz G; Qin Z; Kopf M; Blankenstein T		J Immunol	160	1998	345-50	J:46311	9551990
86858	Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice.		Contractor NV; Bassiri H; Reya T; Park AY; Baumgart DC; Wasik MA; Emerson SG; Carding SR		J Immunol	160	1998	385-94	J:46312	9551995
86859	Development of an experimental murine pulmonary metastasis model incorporating a viral encoded tumor specific antigen.		Watts AM; Shearer MH; Pass HI; Kennedy RC		J Virol Methods	69	1997	93-102	J:46315	9504755
86860	Ganglioside composition of a mouse brain tumor grown in the severe combined immunodeficiency (SCID) mouse.		Seyfried TN; el-Abbadi M; Ecsedy JA; Griffin ME; Yohe HC		Mol Chem Neuropathol	33	1998	27-37	J:46316	9493174
86861	Generation of a monoclonal antibody that induces apoptosis of hematopoietic cells.		Mio H; Satoh M; Yokokawa S; Nishio H; Suda T; Tamaoki T		Biochem Biophys Res Commun	243	1998	727-31	J:46294	9500976
86862	Alterations in cell cycle regulation in mouse skin tumors		Balasubramanian S; Ahmad N; Jeedigunta S; Mukhtar H		Biochem Biophys Res Commun	243	1998	744-8	J:46295	9500999
86863	Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines.		Christensen CR; Klingelhofer J; Tarabykina S; Hulgaard EF; Kramerov D; Lukanidin E		Cancer Res	58	1998	1238-44	J:46372	9515811
86864	Sequential expression of the MAD family of transcriptional repressors during differentiation and development.		Queva C; Hurlin PJ; Foley KP; Eisenman RN		Oncogene	16	1998	967-77	J:46374	9519870
86865	Interleukin-2: hope in cases of cisplatin-resistant tumours.		Bernsen MR; Van Der Velden AW; Everse LA; Dullens HF; Den Otter W; Heintz AP		Cancer Immunol Immunother	46	1998	41-7	J:46400	9520291
86866	Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A.		Shrayer DP; Kouttab N; Hearing VJ; Wanebo HJ		Cancer Immunol Immunother	46	1998	7-13	J:46401	9520286
86867	The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy.		Korbelik M; Naraparaju VR; Yamamoto N		Br J Cancer	77	1998	1009-14	J:46403	9528849
86868	A causal role for E-cadherin in the transition from adenoma to carcinoma.		Perl AK; Wilgenbus P; Dahl U; Semb H; Christofori G		Nature	392	1998	190-3	J:46388	9515965
86869	Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.		Rockwell SC; Kallman RF; Fajardo LF		J Natl Cancer Inst	49	1972	735-749	J:46446	4647494
86870	Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays.		Blazar BA; Laing CA; Miller FR; Heppner GH		J Natl Cancer Inst	65	1980	405-10	J:46450	6931258
86871	Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.		Hirst DG; Brown JM; Hazlehurst JL		Br J Cancer	46	1982	109-16	J:46451	7201845
86872	Properties of mouse mammary epithelial cell lines characterized by in vivo transplantation and in vitro immunocytochemical methods.		Medina D; Oborn CJ; Kittrell FS; Ullrich RL		J Natl Cancer Inst	76	1986	1143-56	J:46452	2423737
86873	Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.		Gorska AE; Joseph H; Derynck R; Moses HL; Serra R		Cell Growth Differ	9	1998	229-38	J:46432	9543389
86874	An androgen-dependent tumor derived from a hormone-independent spontaneous tumor of a female mouse.		Minesita T; Yamaguchi K		Steroids	4	1964	815-830	J:46466	 
86875	Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.		Aslakson CJ; Miller FR		Cancer Res	52	1992	1399-405	J:46459	1540948
86876	p53 Mutations in hairless SKH-hr1 mouse skin tumors induced by a solar simulator.		Ananthaswamy HN; Fourtanier A; Evans RL; Tison S; Medaisko C ; Ullrich SE ; Kripke ML		Photochem Photobiol	67	1998	227-32	J:46509	9487800
86877	Transcriptional activation of the mouse peripherin gene by leukemia inhibitory factor: involve-ment of STAT proteins.		Lecomte MJ; Basseville M; Landon F; Karpov V; Fauquet M		J Neurochem	70	1998	971-82	J:46481	9489716
86878	Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice.		Pazos P; Lanari C; Elizalde P; Montecchia F; Charreau EH; Molinolo AA		Carcinogenesis	19	1998	529-31	J:46524	9525291
86879	Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by black and green tea.		Landau JM; Wang ZY; Yang GY; Ding W; Yang CS		Carcinogenesis	19	1998	501-7	J:46525	9525286
86880	Coordinate regulation of complex T cell populations responding to bacterial infection.		Busch DH; Pilip IM; Vijh S; Pamer EG		Immunity	8	1998	353-62	J:46516	9529152
86881	Induction of forward mutations at the thymidine kinase locus of mouse lymphoma cells: evidence for electrophilic and non-electrophilic mechanisms.		Henry B; Grant SG; Klopman G; Rosenkranz HS		Mutat Res	397	1998	313-35	J:46543	9541657
86882	Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.		Pierce AM; Fisher SM; Conti CJ; Johnson DG		Oncogene	16	1998	1267-76	J:46535	9546428
86883	Autoregulation of the Stat3 gene through cooperation with a cAMP-responsive element-binding protein.		Ichiba M; Nakajima K; Yamanaka Y; Kiuchi N; Hirano T		J Biol Chem	273	1998	6132-8	J:46562	9497331
86884	Immunotherapy against murine leukemia.		de Vos S; Kohn DB; Cho SK; McBride WH; Said JW; Koeffler HP		Leukemia	12	1998	401-5	J:46617	9529135
86885	Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA).		Balzarini J; Hatse S; Naesens L; De Clercq E		Biochim Biophys Acta	1402	1998	29-38	J:46620	9551083
86886	Establishment, characterization, and chromosomal analysis of new leukemic cell lines derived from MT/p210bcr/abl transgenic mice.		Honda H; Ohno S; Takahashi T; Takatoku M; Yazaki Y; Hirai H		Exp Hematol	26	1998	188-97	J:46694	9502614
86887	Primordial germ cells, stem cells and testicular cancer.		Donovan PJ; de Miguel M; Cheng L; Resnick JL		APMIS	106	1998	134-41	J:46682	9524571
86888	Effects of nutrient deprivation and differentiation on the expression of growth-arrest genes (gas and gadd) in F9 embryonal carcinoma cells.		Fleming JV; Hay SM; Harries DN; Rees WD		Biochem J	330	1998	573-9	J:46732	9461558
86889	Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cells.		Tang DC; Jennelle RS; Shi Z; Garver RI Jr; Carbone DP; Loya F; Chang CH; Curiel DT		Hum Gene Ther	8	1997	2117-24	J:46714	9414259
86890	A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice.		Iakoubov LZ; Torchilin VP		Oncol Res	9	1997	439-46	J:46718	9436197
86891	Telomerase and cell proliferation in mouse skin papillomas.		Bednarek AK; Chu Y; Slaga TJ; Aldaz CM		Mol Carcinog	20	1997	329-31	J:46719	9433476
86892	Oral toxicity and carcinogenicity studies of sucrose acetate isobutyrate (SAIB) in the Fischer 344 rat and B6C3F1 mouse.		Mackenzie KM; Tisdel PJ; Hall RL; Boysen BG; Field WE; Chappel CI		Food Chem Toxicol	36	1998	111-20	J:46758	9519849
86893	Effect of macrophage colony-stimulating factor (M-CSF) on mouse immune responses in vivo.		Sakurai T; Wakimoto N; Yamada M; Shimamura S; Motoyoshi K		Immunopharmacol Immunotoxicol	20	1998	79-102	J:46759	9543701
86894	Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NFkappaB activation.		Wang JM; Chertov O; Proost P; Li JJ; Menton P; Xu L; Sozzani S; Mantovani A; Gong W; Schirrmacher V; Van Damme J; Oppenheim JJ		Int J Cancer	75	1998	900-7	J:46760	9506536
86895	Therapeutic effects on experimental metastatic tumor- bearing mice by vaccination with GM-CSF gene-modified and tumor antigen-pulsed macrophages.		Yu YZ; Cao ZT; Lei H; Zhang MH; Zhang WP; Zhu XJ; Ye TX; Wang JL		Sci China Ser C	41	1998	107-112	J:46782	 
86896	Targeted disruption of the beta1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity.		Stroeken PJ; van Rijthoven EA; van der Valk MA; Roos E		Cancer Res	58	1998	1569-77	J:46813	9537266
86897	In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model.		Kuppusamy P; Afeworki M; Shankar RA; Coffin D; Krishna MC; Hahn SM; Mitchell JB; Zweier JL		Cancer Res	58	1998	1562-8	J:46839	9537265
86898	Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice.		Feleszko W; Zagozdzon R; Golab J; Jakobisiak M		Eur J Cancer	34	1998	406-11	J:46823	9640231
86899	Beta2 integrin/ICAM-1 adhesion molecule interactions in cutaneous inflammation and tumor promotion.		Oberyszyn TM; Conti CJ; Ross MS; Oberyszyn AS; Tober KL; Rackoff AI; Robertson FM		Carcinogenesis	19	1998	445-55	J:46880	9525279
86900	Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein.		Carrasco D; Cheng J; Lewin A; Warr G; Yang H; Rizzo C; Rosas F; Snapper C; Bravo R		J Exp Med	187	1998	973-84	J:46911	9529314
86901	Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50.		Ishikawa H; Claudio E; Dambach D; Raventos-Suarez C; Ryan C; Bravo R		J Exp Med	187	1998	985-96	J:46912	9529315
86902	Cancer resistance genes in mice: models for the study of tumour modifiers.		Balmain A; Nagase H		Trends Genet	14	1998	139-44	J:46956	9594661
86903	Indirect radiation leukemogenesis in DBA/2 mice: increased expression of B2 repeats in FDC-P1 cells transformed by intracisternal A-particle transposition.		Blumenstein M; Hossfeld DK; Duhrsen U		Ann Hematol	76	1998	53-60	J:46980	9540758
86904	Lactogenic hormone-inducible phosphorylation and gamma-activated site-binding activities of Stat5b in primary rat Leydig cells and MA-10 mouse Leydig tumor cells.		Kanzaki M; Morris PL		Endocrinology	139	1998	1872-82	J:46994	9528973
86905	Polyamines regulate expression of the neoplastic phenotype in mouse skin.		Peralta Soler A; Gilliard G; Megosh L; George K; O'Brien TG		Cancer Res	58	1998	1654-9	J:47024	9563478
86906	UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells.		Okuda A; Fukushima A; Nishimoto M; Orimo A; Yamagishi T; Nabeshima Y; Kuro-o M; Nabeshima Yi; Boon K; Keaveney M; Stunnenberg HG; Muramatsu M		EMBO J	17	1998	2019-32	J:47012	9524124
86907	Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice.		Nogues N; Magnan E; De Grandis P; Butz M; Kineman RD; Kopchick JJ; Frohman LA		Mol Cell Endocrinol	137	1998	161-8	J:47018	9605518
86908	Enlargement of the ampullary gland and seminal vesicle, but not the prostate in int-2/Fgf-3 transgenic mice.		Donjacour AA; Thomson AA; Cunha GR		Differentiation	62	1998	227-37	J:47021	9566308
86909	Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases.		Orlow SJ; Silvers WK; Zhou BK; Mintz B		Cancer Res	58	1998	1521-3	J:47078	9537258
86910	Antigen presentation by B7-nonprofessional APC does not prevent responses to solid tumor cells.		Salvadori S; Moran T; Zier K		Cell Immunol	183	1998	52-9	J:47114	9578719
86911	Is mts1(S100A4) gene involved in the metastatic process modulated by gamma-interferon?		Chiaramonte R; Fasola S; Lollini PL; De Giovanni C; Comi P		Pathobiology	66	1998	38-40	J:47115	9577965
86912	The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice.		Ghebranious N; Sell S		Hepatology	27	1998	967-73	J:47088	9537435
86913	Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer.		Putzer BM; Bramson JL; Addison CL; Hitt M; Siegel PM; Muller WJ; Graham FL		Hum Gene Ther	9	1998	707-18	J:47092	9551618
86914	Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations.		Hsu YT; Youle RJ		J Biol Chem	273	1998	10777-83	J:47133	9553144
86915	p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.		Brugarolas J; Bronson RT; Jacks T		J Cell Biol	141	1998	503-14	J:47169	9548727
86916	Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice.		Pravtcheva DD; Wise TL		J Exp Zool	281	1998	43-57	J:47190	9571768
86917			Cao X		J Cancer Res Clin Oncol	124	1998	88-92	J:47191	9654191
86918	Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line.		Belkowski SM; Zhu J; Liu-Chen LY; Eisenstein TK; Adler MW; Rogers TJ		J Neuroimmunol	62	1995	113-7	J:47195	7499487
86919	Potent suppressive activity of nonpolyphenolic fraction of green tea (Camellia sinensis) against genotoxin-induced umu C gene expression in Salmonella typhimurium (TA 1535/pSK 1002), tumor promotor-dependent ornithine decarboxylase induction of BALB/c 3T3		Okai Y; Higashi-Okai K		Teratog Carcinog Mutagen	17	1997	305-12	J:47201	9485539
86920	Growth factor responses and protooncogene expression of murine mesothelial cell lines derived from asbestos-induced mesotheliomas.		Goodglick LA; Vaslet CA; Messier NJ; Kane AB		Toxicol Pathol	25	1997	565-73	J:47205	9437800
86921	The molecular genetics of endocrine tumours.		Learoyd DL; Twigg SM; Zedenius JV; Robinson BG		J Pediatr Endocrinol Metab	11	1998	195-228	J:47246	9642636
86922	Strain-dependent differences in the expression of the oncofetal protein p65 in mice susceptible and resistant to chemical carcinogenesis.		Szemraj J; Hanausek M; Walaszek Z; Adams AK			14	1998	475-485	J:47249	 
86923	Differential presentation of endogenously processed cytotoxic T lymphocyte epitopes by mouse hepatocarcinoma cell lines induced by SV40 large T antigen.		Lacabanne V; Viguier M; Romieu R; Kayibanda M; Connan F; Sermet S; Antoine B; Guillet JG; Choppin J		Int Immunol	10	1998	463-72	J:47276	9620602
86924	Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung.		Asai T; Ueda T; Itoh K; Yoshioka K; Aoki Y; Mori S; Yoshikawa H		Int J Cancer	76	1998	418-22	J:47352	9579581
86925	Secretion of urokinase and metalloproteinase-9 induced by staurosporine is dependent on a tyrosine kinase pathway in mammary tumor cells.		Aguirre Ghiso JA; Farias EF; Alonso DF; Bal de Kier Joffe E		Int J Cancer	76	1998	362-7	J:47353	9579573
86926	Anti-tumor effect of internal image bearing anti-idiotypic monoclonal antibody in relation to GM3 ganglioside.		Jinnohara T; Tsujisaki M; Sasaki S; Hinoda Y; Taniguchi M; Imai K		Int J Cancer	76	1998	345-53	J:47354	9579571
86927	Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.		Zitvogel L; Regnault A; Lozier A; Wolfers J; Flament C; Tenza D; Ricciardi-Castagnoli P; Raposo G; Amigorena S		Nat Med	4	1998	594-600	J:47414	9585234
86928	Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression.		Melcher A; Todryk S; Hardwick N; Ford M; Jacobson M; Vile RG		Nat Med	4	1998	581-7	J:47415	9585232
86929	Bcr/Abl associated leukemogenesis in bcr null mutant mice.		Voncken JW; Kaartinen V; Groffen J; Heisterkamp N		Oncogene	16	1998	2029-32	J:47417	9591787
86930	Altered gene expression in a clonal epidermal cell model of carcinogenesis identified by RNA differential display.		Liu Y; Kulesz-Martin MF		Carcinogenesis	19	1998	683-6	J:47423	9600355
86931	Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for beta-globin locus control region complex.		Igarashi K; Hoshino H; Muto A; Suwabe N; Nishikawa S; Nakauchi H; Yamamoto M		J Biol Chem	273	1998	11783-90	J:47446	9565602
86932	Somatic mutations that contribute to breast cancer.		Callahan R		Biochem Soc Symp	63	1998	211-21	J:47509	9513725
86933	Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice.		Sacco MG; Gribaldo L; Barbieri O; Turchi G; Zucchi I; Collotta A; Bagnasco L; Barone D; Montagna C; Villa A; Marafante E; Vezzoni P		Breast Cancer Res Treat	47	1998	171-80	J:47512	9497105
86934	Role of tumor suppressor genes in transplacental lung carcinogenesis.		Rollins LA; Leone-Kabler S; O'Sullivan MG; Miller MS		Mol Carcinog	21	1998	177-84	J:47515	9537649
86935	Differential modulation by dietary n-6 or n-9 unsaturated fatty acids on the development of two murine mammary gland tumors having different metastatic capabilities.		Munoz SE; Lopez CB; Valentich MA; Eynard AR		Cancer Lett	126	1998	149-55	J:47493	9585060
86936	Association of elevated mutagenesis in the spleen with genetic susceptibility to induced plasmacytoma development in mice.		Felix K; Kelliher K; Bornkamm GW; Janz S		Cancer Res	58	1998	1616-9	J:47542	9563470
86937	Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine.		Lee GH; Ooasa T; Osanai M		Cancer Res	58	1998	1665-9	J:47543	9563480
86938	Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR/ABL expression.		Klucher KM; Lopez DV; Daley GQ		Blood	91	1998	3927-34	J:47590	9573031
86939	Molecular cloning and expression of Ehf, a new member of the ets transcription factor/oncoprotein gene family.		Bochert MA; Kleinbaum LA; Sun LY; Burton FH		Biochem Biophys Res Commun	246	1998	176-81	J:47615	9600089
86940	Frequency of Ha-ras-1 gene mutations inversely correlated with furan dose in mouse liver tumors.		Johansson E; Reynolds S; Anderson M; Maronpot R		Mol Carcinog	18	1997	199-205	J:40535	9142214
86941	A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas.		Pena JC; Rudin CM; Thompson CB		Cancer Res	58	1998	2111-6	J:47630	9605754
86942	Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.		Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Sato H; Kondo E; Harada M; Koseki H; Nakayama T; Tanaka Y; Taniguchi M		Proc Natl Acad Sci U S A	95	1998	5690-3	J:47663	9576945
86943	Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice.		Ong ST; Hackbarth ML; Degenstein LC; Baunoch DA; Anastasi J; McKeithan TW		Oncogene	16	1998	2333-43	J:47695	9620550
86944	Identification of a novel type II activin receptor, type IIA-N, induced during the neural differentiation of murine P19 embryonal carcinoma cells.		Shoji H; Nakamura T; van den Eijnden-van Raaij AJ; Sugino H		Biochem Biophys Res Commun	246	1998	320-4	J:47707	9610356
86945	Induction of p53 and melanoma cell death is reciprocal with down-regulation of E2F, cyclin D1 and pRB.		Rieber M; Strasberg-Rieber M		Int J Cancer	76	1998	757-60	J:47766	9610736
86946	Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.		Selinsky CL; Boroughs KL; Halsey WA Jr; Howell MD		Immunology	94	1998	88-93	J:47757	9708191
86947	In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene.		Ohnishi T; Taki T; Hiraga S; Arita N; Morita T		Biochem Biophys Res Commun	245	1998	319-24	J:47793	9571148
86948	RAE28, BMI1, and M33 are members of heterogeneous multimeric mammalian Polycomb group complexes.		Hashimoto N; Brock HW; Nomura M; Kyba M; Hodgson J; Fujita Y; Takihara Y; Shimada K; Higashinakagawa T		Biochem Biophys Res Commun	245	1998	356-65	J:47794	9571155
86949	Morphological characteristics of spontaneous and 239- plutonium-induced lung tumors in the CBA mouse.		Brooks PN; Kellington JP		Inhal Toxicol	10	1998	321-356	J:47832	 
86950	Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389.		Lu H; Taya Y; Ikeda M; Levine AJ		Proc Natl Acad Sci U S A	95	1998	6399-402	J:47911	9600977
86951	Accumulation of IL-12-activated antitumor effector cells into lymph nodes of tumor-bearing mice.		Yahata T; Watanabe K; Ohta A; Ohmi Y; Sato N; Santa K; Abe N; Iwakabe K; Kaneko S; Suzuki N; Habu S; Yasuda S; Nishimura T		Immunol Lett	61	1998	127-33	J:47922	9657265
86952	Modulation of NK-target cell interaction by a monoclonal antibody to K562 cells.		Yoon SR; Cho DH; Pyun KH; Choi I		Immunol Lett	61	1998	145-9	J:47923	9657267
86953	Effect of mouse intestinal bacteria on incidence of colorectal tumors induced by 1,2-dimethylhydrazine injection in gnotobiotic transgenic mice harboring human prototype c-Ha-ras genes.		Narushima S; Itoh K; Mitsuoka T; Nakayama H; Itoh T; Hioki K; Nomura T		Exp Anim	47	1998	111-7	J:47894	9606421
86954	Requirement of the CD8+ or CD4+ T lymphocyte subsets for the rejection of lymphoma and fibrosarcoma grafts studied in gene knockout hosts.		Wen T; Trumper L; Fung-Leung W; Rahemtulla A; Klein E; Klein G; Mak TW		Immunol Lett	61	1998	187-90	J:47925	9657273
86955	Prostate-specific amplification of expanded polyglutamine expression: a novel approach for cancer gene therapy.		Segawa T; Takebayashi H; Kakehi Y; Yoshida O; Narumiya S; Kakizuka A		Cancer Res	58	1998	2282-7	J:47926	9622059
86956	Purification and characterization of a tumor lipid-mobilizing factor.		Todorov PT; McDevitt TM; Meyer DJ; Ueyama H; Ohkubo I; Tisdale MJ		Cancer Res	58	1998	2353-8	J:47927	9622074
86957	Tyrphostin 4-nitrobenzylidene malononitrile reduces chemotherapy toxicity without impairing efficacy.		Novogrodsky A; Weisspapir M; Patya M; Meshorer A; Vanichkin A		Cancer Res	58	1998	2397-403	J:47928	9622080
86958	Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.		Li C; Yu DF; Newman RA; Cabral F; Stephens LC; Hunter N; Milas L; Wallace S		Cancer Res	58	1998	2404-9	J:47929	9622081
86959	Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.		Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S		Cancer Res	58	1998	2417-25	J:47930	9622083
86960	Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.		Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T		Cancer Res	58	1998	2426-32	J:47931	9622084
86961	31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models.		Robinson SP; van den Boogaart A; Maxwell RJ; Griffiths JR; Hamilton E; Waterton JC		Br J Cancer	77	1998	1752-60	J:47979	9667643
86962	Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice.		Enno A; O'Rourke J; Braye S; Howlett R; Lee A		Am J Pathol	152	1998	1625-32	J:47990	9626066
86963	Idiotypic immunization induces immunity to mutated p53 and tumor rejection [see comments]		Ruiz PJ; Wolkowicz R; Waisman A; Hirschberg DL; Carmi P; Erez N; Garren H; Herkel J; Karpuj M; Steinman L; Rotter V; Cohen IR		Nat Med	4	1998	710-2	J:47991	9623981
86964	Inhibition of tumor growth by ribozyme-mediated suppression of aberran epidermal growth factor receptor gene expression [see comments]		Yamazaki H; Kijima H; Ohnishi Y; Abe Y; Oshika Y; Tsuchida T; Tokunaga T; Tsugu A; Ueyama Y; Tamaoki N; Nakamura M		J Natl Cancer Inst	90	1998	581-7	J:48014	9554440
86965	Antibody-IL-12 fusion proteins are effective in SCID mouse models of prostate and colon carcinoma metastases.		Gillies SD; Lan Y; Wesolowski JS; Qian X; Reisfeld RA; Holden S; Super M; Lo KM		J Immunol	160	1998	6195-203	J:48035	9637539
86966	Allelic loss analysis of gamma-ray-induced mouse thymic lymphomas: two candidate tumor suppressor gene loci on chromosomes 12 and 16.		Matsumoto Y; Kosugi S; Shinbo T; Chou D; Ohashi M; Wakabayashi Y ; Sakai K ; Okumoto M ; Mori N ; Aizawa S ; Niwa O ; Kominami R		Oncogene	16	1998	2747-54	J:48036	9652741
86967	Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.		McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB		Oncogene	16	1998	2755-66	J:48037	9652742
86968	Role of the IGF-I receptor in mutagenesis and tumor promotion.		Blakesley VA; Stannard BS; Kalebic T; Helman LJ; LeRoith D		J Endocrinol	152	1997	339-44	J:38832	9071953
86969	HIF-1 alpha is required for solid tumor formation and embryonic vascularization.		Ryan HE; Lo J; Johnson RS		EMBO J	17	1998	3005-15	J:48084	9606183
86970	Importance of the B7-2 molecule for low dose melphalan-induced acquisition of tumor-eradicating immunity by mice bearing a large MOPC-315 tumor.		Mokyr MB; Kalinichenko TV; Gorelik L; Bluestone JA		J Immunol	160	1998	1866-74	J:48103	9469448
86971	Isolation, purification, and characterization of a collagen-associated serpin, caspin, produced by murine colon adenocarcinoma cells.		Kozaki K; Miyaishi O; Koiwai O; Yasui Y; Kashiwai A; Nishikawa Y; Shimizu S; Saga S		J Biol Chem	273	1998	15125-30	J:48124	9614124
86972	Hepatocarcinogenesis (Z#2)/mutagenesis during initiation stage.		Nichols WS; Geller SA; Edmond VJ; Dycaico MJ; Sorge JA; Short JM		Mutat Res	398	1998	143-9	J:48107	9626974
86973	A novel response to dioxin. Induction of ecto-ATPase gene expression.		Gao L; Dong L; Whitlock JP Jr		J Biol Chem	273	1998	15358-65	J:48140	9624117
86974	Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.		Factor VM; Kiss A; Woitach JT; Wirth PJ; Thorgeirsson SS		J Biol Chem	273	1998	15846-53	J:48176	9624185
86975	Erythropoietin prevents the development of interleukin-12-induced anemia and thrombocytopenia but does not decrease its antitumor activity in mice [letter]		Golab J; Zagozdzon R; Stoklosa T; Jakobisiak M; Pojda Z; Machaj E		Blood	91	1998	4387-8	J:48207	9596689
86976	Epidermal cell adhesion and basement membrane alterations in experimental skin tumour development.		Makinen M; Jussila T; Stenback F		Anticancer Res	18	1998	877-84	J:48201	9615735
86977	Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.		Gaveriaux-Ruff C; Matthes HW; Peluso J; Kieffer BL		Proc Natl Acad Sci U S A	95	1998	6326-30	J:48241	9600964
86978	Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.		Newmaster RS; Mylin LM; Fu TM; Tevethia SS		Virology	244	1998	427-41	J:48244	9601511
86979	Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.		Kaplan DH; Shankaran V; Dighe AS; Stockert E; Aguet M; Old LJ; Schreiber RD		Proc Natl Acad Sci U S A	95	1998	7556-61	J:48269	9636188
86980	Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression.		Steeber DA; Campbell MA; Basit A; Ley K; Tedder TF		Proc Natl Acad Sci U S A	95	1998	7562-7	J:48271	9636189
86981	Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice.		Bugge TH; Lund LR; Kombrinck KK; Nielsen BS; Holmback K; Drew AF; Flick MJ; Witte DP; Dano K; Degen JL		Oncogene	16	1998	3097-104	J:48285	9671388
86982	High colony forming capacity of primary cultured hepatocytes as a dominant trait in hepatocarcinogenesis-susceptible and resistant mouse strains.		Yoshie M; Nishimori H; Lee GH; Ogawa K		Carcinogenesis	19	1998	1103-7	J:48304	9667750
86983	Multigenic control of skin tumor susceptibility in SENCARA/Pt mice.		Mock BA; Lowry DT; Rehman I; Padlan C; Yuspa SH; Hennings H		Carcinogenesis	19	1998	1109-15	J:48305	9667751
86984	Papillomas at high risk for malignant progression arising both early and late during two-stage carcinogenesis in SENCAR mice.		DuBowski A; Johnston DA; Rupp T; Beltran L; Conti CJ; DiGiovanni J		Carcinogenesis	19	1998	1141-7	J:48306	9667755
86985	Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.		Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W ; Moreau-Gachelin F		Oncogene	16	1998	2989-95	J:48392	9662331
86986	Initial levels of azoxymethane-induced DNA methyl adducts are not predictive of tumor susceptibility in inbred mice.		Papanikolaou A; Shank RC; Delker DA; Povey A; Cooper DP; Rosenberg DW		Toxicol Appl Pharmacol	150	1998	196-203	J:48393	9630469
86987	Selective inhibition of resistance to hemopoietic allografts but not rejection to a natural killer cell sensitive tumor in transgenic mice for granulocyte colony stimulating factor.		Kokai Y; Kimura H; Matsuura A; Fujimoto J		Artif Organs	20	1996	883-9	J:39686	8853800
86988	The evolution of B precursor leukemia in the Emu-ret mouse.		Wasserman R; Zeng XX; Hardy RR		Blood	92	1998	273-82	J:48500	9639527
86989	Tobacco smoke as a mouse lung carcinogen.		Witschi H		Exp Lung Res	24	1998	385-94	J:48991	9659572
86990	Mechanistic relationships between DNA adducts, oncogene mutations, and lung tumorigenesis in strain A mice.		Nesnow S; Ross JA; Mass MJ; Stoner GD		Exp Lung Res	24	1998	395-405	J:48992	9659573
86991	Use of quantitative trait loci to map murine lung tumor susceptibility genes.		Devereux TR; Kaplan NL		Exp Lung Res	24	1998	407-17	J:48993	9659574
86992	Genetics of quantitative and qualitative aspects of lung tumorigenesis in the mouse: multiple interacting Susceptibility to lung cancer (Sluc) genes with large effects.		Fijneman RJ; van der Valk MA; Demant P		Exp Lung Res	24	1998	419-36	J:48994	9659575
86993	Analysis of the Mom1 modifier of intestinal neoplasia in mice.		Gould KA; Dove WF		Exp Lung Res	24	1998	437-53	J:48995	9659576
86994	T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.		Bohm W; Thoma S; Leithauser F; Moller P; Schirmbeck R; Reimann J		J Immunol	161	1998	897-908	J:48548	9670968
86995	Tumor cells induce cytolytic T cells to a single immunodominant mutant peptide.		Dubey P; Meredith SC; Siegel CT; Schreiber H		J Immunother	21	1998	277-82	J:48557	9672849
86996	Loss of resistance to a highly immunogenic tumor with age corresponds to the decline of CD8 T cell activity.		Flood PM; Liu X; Alexander R; Schreiber H; Haque S		J Immunother	21	1998	307-16	J:48558	9672852
86997	Carcinogenicity of 1,3-butadiene in C57BL/6 x C3H F1 mice at low exposure concentrations.		Melnick RL; Huff J; Chou BJ; Miller RA		Cancer Res	50	1990	6592-9	J:48595	2208121
86998	Elastase I promoter directs expression of human growth hormone and SV40 T antigen genes to pancreatic acinar cells in transgenic mice.		Ornitz DM; Palmiter RD; Messing A; Hammer RE; Pinkert CA; Brinster RL		Cold Spring Harb Symp Quant Biol	50	1985	399-409	J:48596	3006998
86999	Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice.		Green N; Hiai H; Elder JH; Schwartz RS; Khiroya RH; Thomas CY; Tsichlis PN; Coffin JM		J Exp Med	152	1980	249-64	J:48631	7400758
87000	Workgroup 3: transgenic and reconstitution models of prostate cancer.		Green JE; Greenberg NM; Ashendel CL; Barrett JC; Boone C; Getzenberg RH; Henkin J; Matusik R; Janus TJ; Scher HI		Prostate	36	1998	59-63	J:48624	9650918
87001	UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element.		Miralles F; Parra M; Caelles C; Nagamine Y; Felez J; Munoz-Canoves P		Mol Cell Biol	18	1998	4537-47	J:48642	9671463
87002	Effect of green tea on p53 mutation distribution in ultraviolet B radiation-induced mouse skin tumors.		Liu Q; Wang Y; Crist KA; Wang ZY; Lou YR; Huang MT; Conney AH ; You M		Carcinogenesis	19	1998	1257-62	J:48644	9683186
87003	Targeted therapy with a novel enediyene antibiotic calicheamicin theta(I)1 effectively suppresses growth and dissemination of liver metastases in a syngeneic model of murine neuroblastoma.		Lode HN; Reisfeld RA; Handgretinger R; Nicolaou KC; Gaedicke G; Wrasidlo W		Cancer Res	58	1998	2925-8	J:48694	9679947
87004	Combined effects of angiostatin and ionizing radiation in antitumour therapy.		Mauceri HJ; Hanna NN; Beckett MA; Gorski DH; Staba MJ; Stellato KA; Bigelow K; Heimann R; Gately S; Dhanabal M; Soff GA; Sukhatme VP; Kufe DW; Weichselbaum RR		Nature	394	1998	287-91	J:48673	9685160
87005	Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia.		Gritti C; Dastot H; Soulier J; Janin A; Daniel MT; Madani A; Grimber G; Briand P; Sigaux F; Stern MH		Blood	92	1998	368-73	J:48742	9657733
87006	Estrogen-induced tumorigenesis in the pituitary gland of TGF-beta(+/-) knockout mice.		Shida N; Ikeda H; Yoshimoto T; Oshima M; Taketo MM; Miyoshi I		Biochim Biophys Acta	1407	1998	79-83	J:48743	9639680
87007	Expression of cyclin D1 in mouse B cell lymphomas of different histologic types and differentiation stages.		Qi CF; Chattopadhyay SK; Lander M; Kim Y; Fredrickson TN; Hartley JW; Morse HC 3rd		Leuk Res	22	1998	395-404	J:48762	9652725
87008	S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase.		Wei SJ; Chao Y; Hung YM; Lin WC; Yang DM; Shih YL; Ch'ang LY; Whang-Peng J; Yang WK		Exp Cell Res	241	1998	66-75	J:48751	9633514
87009	Antigen loss variants of a murine renal cell carcinoma: implications for tumor vaccination.		Kerkmann-Tucek A; Banat GA; Cochlovius B; Zoller M		Int J Cancer	77	1998	114-22	J:48753	9639402
87010	Antitumor vaccine effect of irradiated murine neuroblastoma cells producing interleukin-2 or granulocyte macrophage-colony stimulating factor.		Yoshida H; Enomoto H; Kawamura K; Takenaga K; Tanabe M; Ohnuma N; Sakiyama S; Tagawa M		Int J Oncol	13	1998	73-8	J:48754	9625805
87011	Synergistic anti-tumor effect of 13-cRA and IFN-alpha/beta in mouse renal cell carcinoma.		Taguchi I; Hara I; Gohji K; Arakawa S; Kamidono S		Int J Oncol	13	1998	145-9	J:48755	9625816
87012	Subcellular localization of enzyme activities in chemostat-grown murine myeloma cells.		Vriezen N; van Dijken JP		J Biotechnol	61	1998	43-56	J:48756	9650285
87013	A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma.		Kobayashi M; Kobayashi H; Pollard RB; Suzuki F		J Immunol	160	1998	5869-73	J:48759	9637498
87014	B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.		Lovmand J; Sorensen AB; Schmidt J; Ostergaard M; Luz A; Pedersen FS		J Virol	72	1998	5745-56	J:48761	9621033
87015	Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents [published erratum appears in Environ Health Perspect 1991 Nov;95:213]		Huff J; Cirvello J; Haseman J; Bucher J		Environ Health Perspect	93	1991	247-70	J:48776	1773796
87016	Detection of dibenzo[a,l]pyrene-induced H-ras codon 61 mutant genes in preneoplastic SENCAR mouse skin using a new PCR-RFLP method.		Chakravarti D; Mailander P; Franzen J; Higginbotham S; Cavalieri EL ; Rogan EG		Oncogene	16	1998	3203-10	J:48771	9671400
87017	Up-regulated expression of murine Mcl1/EAT, a bcl-2 related gene, in the early stage of differentiation of murine embryonal carcinoma cells and embryonic stem cells.		Okita H; Umezawa A; Suzuki A; Hata J		Biochim Biophys Acta	1398	1998	335-41	J:48814	9655929
87018	Identification of glutathione S-transferase p-1 as the class pi form dominantly expressed in mouse hepatic adenomas.		Ookawa K; Nakano H; Kakizaki I; Hatayama I; Kajihara-Kano H; Kimura J; Hayakari M; Takahata T; Satoh K; Tsuchida S		Jpn J Cancer Res	89	1998	641-8	J:48942	9703362
87019	Mammary tumor induction loci in GR and DBAf mice contain one provirus of the mouse mammary tumor virus.		Michalides R; van Nie R; Nusse R; Hynes NE; Groner B		Cell	23	1981	165-73	J:32351	6260372
87020	Laminin-alpha1-chain sequence Leu-Gln-Val-Gln-Leu-Ser-Ile-Arg (LQVQLSIR) enhances murine melanoma cell metastases.		Kim WH; Nomizu M; Song SY; Tanaka K; Kuratomi Y; Kleinman HK; Yamada Y		Int J Cancer	77	1998	632-9	J:48853	9679769
87021	Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.		Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR		Oncogene	17	1998	35-45	J:48861	9671312
87022	Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.		Amendt C; Schirmacher P; Weber H; Blessing M		Oncogene	17	1998	25-34	J:48862	9671311
87023	Antitumour activity of the novel immune modulator 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice lacking the interferon-gamma receptor.		Pang JH; Cao Z; Joseph WR; Baguley BC; Ching LM		Eur J Cancer	34	1998	1282-9	J:48872	9849492
87024	In vivo retargeting of T cell effector function by recombinant bispecific single chain Fv (anti-CD3 x anti-idiotype) induces long-term survival in the murine BCL1 lymphoma model.		De Jonge J; Heirman C; de Veerman M; Van Meirvenne S; Moser M; Leo O; Thielemans K		J Immunol	161	1998	1454-61	J:48881	9686611
87025	Ku70: a candidate tumor suppressor gene for murine T cell lymphoma.		Li GC; Ouyang H; Li X; Nagasawa H; Little JB; Chen DJ; Ling CC ; Fuks Z ; Cordon-Cardo C		Mol Cell	2	1998	1-8	J:48929	9702186
87026	B cells inhibit induction of T cell-dependent tumor immunity.		Qin Z; Richter G; Schuler T; Ibe S; Cao X; Blankenstein T		Nat Med	4	1998	627-30	J:48909	9585241
87027	Increased hepatic nicotinamide N-methyltransferase activity as a marker of cancer cachexia in mice bearing colon 26 adenocarcinoma.		Okamura A; Ohmura Y; Islam MM; Tagawa M; Horitsu K; Moriyama Y; Fujimura S		Jpn J Cancer Res	89	1998	649-56	J:48943	9703363
87028	Sequential T cell response involved in tumor rejection of sarcoma, Meth A, in syngeneic mice.		Jiao Y; Fujimoto S		Jpn J Cancer Res	89	1998	657-65	J:48944	9703364
87029	Cytotoxic mechanisms of FK317, a new class of bioreductive agent with potent antitumor activity.		Naoe Y; Inami M; Kawamura I; Nishigaki F; Tsujimoto S; Matsumoto S; Manda T; Shimomura K		Jpn J Cancer Res	89	1998	666-72	J:48945	9703365
87030	Both retinoic acid receptors alpha (RARalpha) and gamma (RARgamma) are able to initiate mouse upper-lip skin glandular metaplasia.		Blanchet S; Favier B; Chevalier G; Kastner P; Michaille JJ; Chambon P; Dhouailly D		J Invest Dermatol	111	1998	206-12	J:48946	9699718
87031	Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in a murine melanoma model.		Scott GA; Cassidy L		J Invest Dermatol	111	1998	243-50	J:48947	9699725
87032	Calorie restriction reduces ulcerative dermatitis and infection-related mortality in p53-deficient and wild-type mice.		Perkins SN; Hursting SD; Phang JM; Haines DC		J Invest Dermatol	111	1998	292-6	J:48948	9699732
87033	A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas.		Gu XG; Schmitt M; Hiasa A; Nagata Y; Ikeda H; Sasaki Y; Akiyoshi K; Sunamoto J; Nakamura H; Kuribayashi K; Shiku H		Cancer Res	58	1998	3385-90	J:48952	9699670
87034	The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells.		Pekarsky Y; Druck T; Cotticelli MG; Ohta M; Shou J; Mendrola J ; Montgomery JC ; Buchberg AM ; Siracusa LD ; Manenti G ; Fong LY ; Dragani TA ; Croce CM ; Huebner K		Cancer Res	58	1998	3401-8	J:48953	9699672
87035	Different modes of cell death induced by 5-fluoro-2'-deoxyuridine in two clones of the mouse mammary tumor FM3A cell line.		Kakutani T; Ebara Y; Kanja K; Hidaka M; Matsumoto Y; Nagano A; Wataya Y		Biochem Biophys Res Commun	247	1998	773-9	J:49016	9647769
87036	Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock.		Takahata S; Sogawa K; Kobayashi A; Ema M; Mimura J; Ozaki N; Fujii-Kuriyama Y		Biochem Biophys Res Commun	248	1998	789-94	J:49044	9704006
87037	Selective mutation of K-ras by N-ethylnitrosourea shifts from codon 12 to codon 61 during fetal mouse lung maturation.		Sithanandam G; Ramakrishna G; Diwan BA; Anderson LM		Oncogene	17	1998	493-502	J:49116	9696043
87038	Disease incidence and longevity are unaltered by dietary antioxidant supplementation initiated during middle age in C57BL/6 mice.		Lipman RD; Bronson RT; Wu D; Smith DE; Prior R; Cao G; Han SN; Martin KR; Meydani SN; Meydani M		Mech Ageing Dev	103	1998	269-84	J:49093	9723903
87039	Differential expression of Hox genes in multistage carcinogenesis of mouse skin.		Chang PY; Kozono T; Chida K; Kuroki T; Huh N		Biochem Biophys Res Commun	248	1998	749-52	J:49121	9703999
87040	Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cells.		Martinez-Esparza M; Jimenez-Cervantes C; Solano F; Lozano JA; Garcia-Borron JC		Eur J Biochem	255	1998	139-46	J:49181	9692912
87041	Inhibition of murine melanoma growth by granulocyte-macrophage colony stimulating factor gene transfection is not haplotype specific.		Botella R; Sarradet MD; Potter LE; Lawley M; Galloway TH; Ansel JC; Armstrong CA		Melanoma Res	8	1998	245-54	J:49186	9664146
87042	Allele-specific inactivation of the alpha4 integrin gene expression in fibrosarcoma cell lines and relevance for spontaneous metastasis.		Sato S; Tunashima K; Mafune Y; Ohtsuka H; Koide N; Endo Y; Saito Y; Asakura H; Kominami R		Oncogene	17	1998	105-13	J:49189	9671319
87043	Establishment and characterization of a murine cell-line derived from malignant fibrous histiocytoma of A/Jackson mouse.		Watanabe I; Kurosawa N; Nishihira T		Tohoku J Exp Med	184	1998	173-87	J:49192	9591335
87044	Transgenic mice as research tools in neurocarcinogenesis.		Rovigatti U; Afanasyeva T; Brandner S; Hainfellner JA; Kiess M; Maddalena A; Malin G; Rulicke T; Steinbach J; Weissenberger J; Aguzzi A		J Neurovirol	4	1998	159-74	J:49196	9584953
87045	Induction of T cell dependent acquired immunity in syngeneic mice by the combined expression of interleukin-4 and granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells.		Tasaki K; Gunji Y; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Kouzu T; Sakiyama S; Tagawa M		Anticancer Res	18	1998	1453-6	J:49176	9673355
87046	A dual hypoxic marker technique for measuring oxygenation change within individual tumors.		Iyer RV; Kim E; Schneider RF; Chapman JD		Br J Cancer	78	1998	163-9	J:49178	9683288
87047	Characterization of fatty acid synthase in cell lines derived from experimental mammary tumors.		Hennigar RA; Pochet M; Hunt DA; Lukacher AE; Venema VJ; Seal E; Marrero MB		Biochim Biophys Acta	1392	1998	85-100	J:49220	9593836
87048	Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions.		Davidson WF; Giese T; Fredrickson TN		J Exp Med	187	1998	1825-38	J:49221	9607923
87049	A role for SOX1 in neural determination.		Pevny LH; Sockanathan S; Placzek M; Lovell-Badge R		Development	125	1998	1967-78	J:49222	9550729
87050	Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK +/- (-)3.7.2C mouse lymphoma cells.		Harrington-Brock K; Doerr CL; Moore MM		Mutat Res	413	1998	265-76	J:49258	9651541
87051	Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice.		Xu Y; Yang EM; Brugarolas J; Jacks T; Baltimore D		Mol Cell Biol	18	1998	4385-90	J:49262	9632822
87052	IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes.		Yeh KY; McAdam AJ; Pulaski BA; Shastri N; Frelinger JG; Lord EM		J Immunol	160	1998	5773-80	J:49286	9637487
87053	The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site.		Yoneda Y; Yoshida R		J Immunol	160	1998	6012-7	J:49287	9637516
87054	Fas ligand-mediated lysis of self bystander targets by human papillomavirus-specific CD8+ cytotoxic T lymphocytes.		Smyth MJ; Krasovskis E; Johnstone RW		J Virol	72	1998	5948-54	J:49288	9621057
87055	Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinoma.		Hurwitz AA; Townsend SE; Yu TF; Wallin JA; Allison JP		Int J Cancer	77	1998	107-13	J:49289	9639401
87056	Induction of ectopic corticotropic tumor in mouse embryos by exo utero cell transplantation and its effects on the fetal adrenal gland.		Zhang H; Hatta T; Udagawa J; Moriyama K; Hashimoto R; Otani H		Endocrinology	139	1998	3306-15	J:49290	9645707
87057	Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.		Luo JC; Toyoda M; Shibuya M		Cancer Res	58	1998	2594-600	J:49291	9635584
87058	The INK4a/ARF tumor suppressor: one gene--two products--two pathways.		Chin L; Pomerantz J; DePinho RA		Trends Biochem Sci	23	1998	291-6	J:49292	9757829
87059	Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.		Overgaard J		Br J Cancer	41	1980	10-21	J:49299	7362770
87060	BMP4- and RA-induced apoptosis is mediated through the activation of retinoic acid receptor alpha and gamma in P19 embryonal carcinoma cells.		Glozak MA; Rogers MB		Exp Cell Res	242	1998	165-73	J:49318	9665814
87061	Tumour induction by methyl-nitroso-urea following preconceptional paternal contamination with plutonium-239.		Lord BI; Woolford LB; Wang L; Stones VA; McDonald D; Lorimore SA ; Papworth D ; Wright EG ; Scott D		Br J Cancer	78	1998	301-11	J:49306	9703275
87062	Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter.		Roy K; Chiao JH; Spengler BA; Tolner B; Yang CH; Biedler JL ; Sirotnak FM		Cancer Genet Cytogenet	105	1998	29-38	J:49307	9689927
87063	Tumor regression in mice following vaccination with human papillomavirus E7 recombinant protein in PROVAX.		Hariharan K; Braslawsky G; Barnett RS; Berquist LG; Huynh T; Hanna N; Black A		Int J Oncol	12	1998	1229-35	J:49348	9592179
87064	Class II-transfected tumor cells directly present endogenous antigen to CD4+ T cells in vitro and are APCs for tumor-encoded antigens in vivo.		Armstrong TD; Clements VK; Ostrand-Rosenberg S		J Immunother	21	1998	218-24	J:49349	9610914
87065	Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability.		Baross-Francis A; Andrew SE; Penney JE; Jirik FR		Proc Natl Acad Sci U S A	95	1998	8739-43	J:49341	9671748
87066	Infection of WHV/c-myc transgenic mice with Moloney murine leukaemia virus and proviral insertion near the syndecan-4 gene in an early liver tumour.		Renard CA; Transy C; Tiollais P; Buendia MA		Res Virol	149	1998	133-43	J:49344	9711537
87067	Mapping of a mouse mammary tumor virus integration site by retroviral LTR--arbitrary polymerase chain reaction.		Casper C; Leib-Mosch C; Salmons B; Gunzburg WH; Baumann G; Hofler H ; Erfle V ; Atkinson MJ		Virus Res	54	1998	207-15	J:49345	9696128
87068	Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice.		Sivanandham M; Shaw P; Bernik SF; Paoletti E; Wallack MK		Cancer Immunol Immunother	46	1998	261-7	J:49369	9690454
87069	Gamma-ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells.		Morel A; Fernandez N; de La Coste A; Haddada H; Viguier M; Polla BS; Antoine B; Kahn A		Cancer Immunol Immunother	46	1998	277-82	J:49370	9690456
87070	Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors.		Boxhorn HK; Smith JG; Chang YJ; Guerry D; Lee WM; Rodeck U; Turka LA; Eck SL		Cancer Immunol Immunother	46	1998	283-92	J:49371	9690457
87071	DNA double-strand breaks, p53, and apoptosis during lymphomagenesis in scid/scid mice.		Gurley KE; Vo K; Kemp CJ		Cancer Res	58	1998	3111-5	J:49372	9679979
87072	Chemopreventive effects of 2-(allylthio)pyrazine on hepatic lesion, mutagenesis and tumorigenesis induced by vinyl carbamate or vinyl carbamate epoxide.		Surh YJ; Kim SG; Park KK; Sohn Y; Lee JM; Kim ND; Miller JA		Carcinogenesis	19	1998	1263-7	J:49373	9683187
87073	Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone.		Blyth DI; Pedrick MS; Savage TJ; Bright H; Beesley JE; Sanjar S		Am J Respir Cell Mol Biol	19	1998	38-54	J:49364	9651179
87074	Generation of polyclonal rabbit antisera to mouse melanoma associated antigens using gene gun immunization.		Surman DR; Irvine KR; Shulman EP; Allweis TM; Rosenberg SA; Restifo NP		J Immunol Methods	214	1998	51-62	J:49384	9692858
87075	Inhibition of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma.		Fujioka T; Hasegawa M; Ishikura K; Matsushita Y; Sato M; Tanji S		J Urol	160	1998	247-51	J:49419	9628658
87076	Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.		Venkatachalam S; Shi YP; Jones SN; Vogel H; Bradley A; Pinkel D ; Donehower LA		EMBO J	17	1998	4657-67	J:49422	9707425
87077	Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo.		Robles AI; Rodriguez-Puebla ML; Glick AB; Trempus C; Hansen L; Sicinski P; Tennant RW; Weinberg RA; Yuspa SH; Conti CJ		Genes Dev	12	1998	2469-74	J:49440	9716400
87078	Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.		Packham G; White EL; Eischen CM; Yang H; Parganas E; Ihle JN; Grillot DA; Zambetti GP; Nunez G; Cleveland JL		Genes Dev	12	1998	2475-87	J:49441	9716401
87079	Lack of modulation of the galectin-3 and asialoglycoprotein receptor transcription in hepatocarcinoma of transgenic mice.		Hebert E; Monsigny M		Biol Cell	89	1997	467-73	J:49450	9561725
87080	Mouse mammary carcinoma cell line (BALB/c-MC) stimulates osteoclast formation from mouse bone marrow cells through cell-to-cell contact.		Ono K; Akatsu T; Murakami T; Wada S; Nishikawa M; Kugai N; Yamamoto M; Matsuura N; Nagata N		Bone	23	1998	27-32	J:49452	9662127
87081	A colon tumor model for anticancer agent evaluation.		Griswold DP; Corbett TH		Cancer	36	1975	2441-4	J:48908	1212662
87082	Strain differences in natural killer cell-mediated immunity among mice: a possible mechanism for the low natural killer cell activity of A/J mice.		Whyte AL; Miller SC		Immunobiology	199	1998	23-38	J:49525	9717665
87083	Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein.		Aberdam E; Bertolotto C; Sviderskaya EV; de Thillot V; Hemesath TJ; Fisher DE; Bennett DC; Ortonne JP; Ballotti R		J Biol Chem	273	1998	19560-5	J:49528	9677380
87084	Effect of dichloroacetic acid and trichloroacetic acid on DNA methylation in liver and tumors of female B6C3F1 mice.		Tao L; Kramer PM; Ge R; Pereira MA		Toxicol Sci	43	1998	139-44	J:49508	9710955
87085	Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.		Bajou K; Noel A; Gerard RD; Masson V; Brunner N; Holst-Hansen C; Skobe M; Fusenig NE; Carmeliet P; Collen D; Foidart JM		Nat Med	4	1998	923-8	J:49535	9701244
87086	A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4.		Santos J; Herranz M; Perez de Castro I; Pellicer A; Fernandez-Piqueras J		Oncogene	17	1998	925-9	J:49558	9780010
87087	Molecular mechanism of tumorigenesis in mice transgenic for the human T cell leukemia virus Tax gene.		Coscoy L; Gonzalez-Dunia D; Tangy F; Syan S; Brahic M; Ozden S		Virology	248	1998	332-41	J:49630	9721242
87088	Radioiodinated N-(alkylaminoalkyl)-substituted 4-methoxy-, 4-hydroxy-, and 4-aminobenzamides: biological investigations for the improvement of melanoma-imaging agents.		Mohammed A; Nicholl C; Titsch U; Eisenhut M		Nucl Med Biol	24	1997	373-80	J:42674	9290070
87089	Induction of mouse retinol binding protein gene expression by cyclic AMP in Hepa 1-6 cells.		Jessen KA; Satre MA		Arch Biochem Biophys	357	1998	126-30	J:49667	9721191
87090	Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas.		Cikes M; Friberg S Jr; Klein G		J Natl Cancer Inst	50	1973	347-62	J:49576	4573851
87091	Establishment and characterization of BALB/c lymphoma lines with B cell properties.		Kim KJ; Kanellopoulos-Langevin C; Merwin RM; Sachs DH; Asofsky R		J Immunol	122	1979	549-54	J:49362	310843
87092	Synergistic anti-tumor effects with co-expression of GM-CSF and IFN-gamma in murine tumors.		Yoon SJ; Heo DS; Kang JO; Lee SG; Kim CD; Sung MW; Kim NK		Int J Cancer	77	1998	907-12	J:49690	9714062
87093	Protection from lymphoma cell metastasis in ICAM-1 mutant mice: a posthoming event.		Aoudjit F; Potworowski EF; Springer TA; St-Pierre Y		J Immunol	161	1998	2333-8	J:49717	9725228
87094	p96, a MAPK-related protein, is consistently downregulated during mouse mammary carcinogenesis.		Schwahn DJ; Medina D		Oncogene	17	1998	1173-8	J:49730	9764828
87095	Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice.		DeMatos P; Abdel-Wahab Z; Vervaert C; Seigler HF		Cell Immunol	185	1998	65-74	J:49804	9636684
87096	TL antigen is not linked to radioinduced thymic lymphoma.		Boudreau R; St-Pierre Y; Beauchemin C; Potworowski EF		Cell Immunol	184	1998	161-7	J:49805	9630842
87097	Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.		Luzzi KJ; MacDonald IC; Schmidt EE; Kerkvliet N; Morris VL; Chambers AF; Groom AC		Am J Pathol	153	1998	865-73	J:49791	9736035
87098	Expression of hypoxia-inducible genes in tumor cells.		Kress S; Stein A; Maurer P; Weber B; Reichert J; Buchmann A; Huppert P; Schwarz M		J Cancer Res Clin Oncol	124	1998	315-20	J:49815	9692838
87099	Dissemination capacity of murine lymphoma cells is not dependent on efficient homing.		Jonas P; Holzmann B; Jablonski-Westrich D; Hamann A		Int J Cancer	77	1998	402-7	J:49818	9663603
87100	Infiltration patterns of short- and long-term cultured A-NK and T-LAK cells following adoptive immunotherapy.		Kjaergaard J; Hokland M; Nannmark U; Hokland P; Basse P		Scand J Immunol	47	1998	532-40	J:49810	9652820
87101	Variation in photodynamic efficacy during the cellular uptake of two phthalocyanine photosensitizers.		He J; Horng MF; Deahl JT; Oleinick NL; Evans HH		Photochem Photobiol	67	1998	720-8	J:49811	9648537
87102	Postadministration protective effect of magnesium-L-ascorbyl-phosphate on the development of UVB-induced cutaneous damage in mice.		Kobayashi S; Takehana M; Kanke M; Itoh S; Ogata E		Photochem Photobiol	67	1998	669-75	J:49812	9648533
87103	Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element.		Rechavi G; Givol D; Canaani E		Nature	300	1982	607-11	J:49661	6292737
87104	Metabolic cooperation between mouse mammary tumor subpopulations in three-dimensional collagen gel cultures.		Miller BE; McInerney D; Jackson D; Miller FR		Cancer Res	46	1986	89-93	J:47835	3940214
87105	Analysis of tumour cell composition in tumours composed of paired mixtures of mammary tumour cell lines.		Miller BE; Miller FR; Wilburn DJ; Heppner GH		Br J Cancer	56	1987	561-9	J:48764	3426919
87106	Macrophage involvement in the protective effect of pyran copolymer against the Madison lung carcinoma (M109).		Schultz RM; Papamatheakis JD; Luetzeler J; Ruiz P; Chirigos MA		Cancer Res	37	1977	358-64	J:48403	832262
87107	A unique tumor antigen produced by a single amino acid substitution.		Monach PA; Meredith SC; Siegel CT; Schreiber H		Immunity	2	1995	45-59	J:49488	7600302
87108	The nucleotide sequence of a cDNA clone encoding ribosomal protein S17 of Ehrlich ascites carcinoma cells.		Karasaki Y; Satoh Y; Ohji T; Tsukamoto S; Higashi K; Gotoh S; Mizusaki K		Biochem Genet	32	1994	409-14	J:49833	7748157
87109	Tumor induction of VEGF promoter activity in stromal cells.		Fukumura D; Xavier R; Sugiura T; Chen Y; Park EC; Lu N; Selig M; Nielsen G; Taksir T; Jain RK; Seed B		Cell	94	1998	715-25	J:49852	9753319
87110	The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice.		Bennoun M; Grimber G; Couton D; Seye A; Molina T; Briand P; Joulin V		Oncogene	17	1998	1253-9	J:49884	9771968
87111	A role for Indian hedgehog in extraembryonic endoderm differentiation in F9 cells and the early mouse embryo.		Becker S; Wang ZJ; Massey H; Arauz A; Labosky P; Hammerschmidt M ; St-Jacques B ; Bumcrot D ; McMahon A ; Grabel L		Dev Biol	187	1997	298-310	J:41978	9242425
87112	Exposure to 60 Hz magnetic fields and risk of lymphoma in PIM transgenic and TSG-p53 (p53 knockout) mice.		McCormick DL; Ryan BM; Findlay JC; Gauger JR; Johnson TR; Morrissey RL; Boorman GA		Carcinogenesis	19	1998	1649-53	J:49894	9771937
87113	Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a] anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice.		Huang MT; Lou YR; Xie JG; Ma W; Lu YP; Yen P; Zhu BT; Newmark H; Ho CT		Carcinogenesis	19	1998	1697-700	J:49895	9771944
87114	Metallothionein deficiency promotes mouse skin carcinogenesis induced by 7,12-dimethylbenz [a]anthracene.		Zhang B; Satoh M; Nishimura N; Suzuki JS; Sone H; Aoki Y; Tohyama C		Cancer Res	58	1998	4044-6	J:49890	9751606
87115	Lack of a co-promoting effect of a 60 Hz magnetic field on skin tumorigenesis in SENCAR mice.		Sasser LB; Anderson LE; Morris JE; Miller DL; Walborg EF Jr; Kavet R; Johnston DA; DiGiovanni J		Carcinogenesis	19	1998	1617-21	J:49893	9771933
87116	Analysis of ras gene mutational spectra in epidermal papillomas from K6/ODC transgenic mice.		Megosh L; Halpern M; Farkash E; O'Brien TG		Mol Carcinog	22	1998	145-9	J:49929	9688139
87117	The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted.		Brown K; Strathdee D; Bryson S; Lambie W; Balmain A		Curr Biol	8	1998	516-24	J:49922	9560338
87118	p53 mutations in cutaneous lesions induced in the hairless mouse by a solar ultraviolet light simulator.		Queille S; Seite S; Tison S; Medaisko C; Drougard C; Fourtanier A; Sarasin A; Daya-Grosjean L		Mol Carcinog	22	1998	167-74	J:49928	9688142
87119	APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.		Hahne M; Kataoka T; Schroter M; Hofmann K; Irmler M; Bodmer JL; Schneider P; Bornand T; Holler N; French LE; Sordat B; Rimoldi D; Tschopp J		J Exp Med	188	1998	1185-90	J:50020	9743536
87120	Tumor immunity and autoimmunity induced by immunization with homologous DNA.		Weber LW; Bowne WB; Wolchok JD; Srinivasan R; Qin J; Moroi Y; Clynes R; Song P; Lewis JJ; Houghton AN		J Clin Invest	102	1998	1258-64	J:50022	9739060
87121	The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope.		Theobald M; Ruppert T; Kuckelkorn U; Hernandez J; Haussler A; Ferreira EA; Liewer U; Biggs J; Levine AJ; Huber C; Koszinowski UH; Kloetzel PM; Sherman LA		J Exp Med	188	1998	1017-28	J:50027	9743520
87122	Inhibition of angiogenesis by interleukin 4.		Volpert OV; Fong T; Koch AE; Peterson JD; Waltenbaugh C; Tepper RI; Bouck NP		J Exp Med	188	1998	1039-46	J:50028	9743522
87123	Tau expression in model adenocarcinomas correlates with docetaxel sensitivity in tumour-bearing mice.		Veitia R; Bissery MC; Martinez C; Fellous A		Br J Cancer	78	1998	871-7	J:50056	9764577
87124	Reconstitution of IL6-inducible differentiation of a myeloid leukemia cell line by activated Stat factors.		Piekorz R; Schlierf B; Burger R; Hocke GM		Biochem Biophys Res Commun	250	1998	436-43	J:50047	9753648
87125	Association of v-Ha-ras transgene expression with development of erythroleukemia in Tg.AC transgenic mice.		Trempus CS; Ward S; Farris G; Malarkey D; Faircloth RS; Cannon RE; Mahler JF		Am J Pathol	153	1998	247-54	J:50073	9665485
87126	Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen.		Mandl S; Sigal LJ; Rock KL; Andino R		Proc Natl Acad Sci U S A	95	1998	8216-21	J:50074	9653167
87127	Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice.		Hasenkrug KJ; Brooks DM; Dittmer U		J Virol	72	1998	6559-64	J:50075	9658100
87128	Docosahexaenoic acid (DHA) alters the structure and composition of membranous vesicles exfoliated from the surface of a murine leukemia cell line.		Williams EE; Jenski LJ; Stillwell W		Biochim Biophys Acta	1371	1998	351-62	J:50076	9630720
87129	Forced expression of Id-1 in the adult mouse small intestinal epithelium is associated with development of adenomas.		Wice BM; Gordon JI		J Biol Chem	273	1998	25310-9	J:50065	9737997
87130	Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes.		Eue I; Kumar R; Dong Z; Killion JJ; Fidler IJ		J Immunother	21	1998	340-51	J:50088	9789196
87131	T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.		Nishimura MI; Custer MC; Schwarz SL; Parker LL; Mixon A; Clay TM; Yannelli JR; Rosenberg SA		J Immunother	21	1998	352-62	J:50089	9789197
87132	Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol.		Tandon M; Thomas PD; Shokravi M; Singh S; Samra S; Chang D; Jimbow K		Biochem Pharmacol	55	1998	2023-9	J:50077	9714323
87133	Local production of TGF beta1 inhibits cerebral edema, enhances TNF-alpha induced apoptosis and improves survival in a murine glioma model.		Ashley DM; Sampson JH; Archer GE; Hale LP; Bigner DD		J Neuroimmunol	86	1998	46-52	J:50078	9655471
87134	Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.		Kiguchi K; Beltran L; Rupp T; DiGiovanni J		Mol Carcinog	22	1998	73-83	J:50079	9655251
87135	A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.		Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M		Hepatology	28	1998	57-67	J:50080	9657097
87136	Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejection.		Bulfone-Paus S; von Bernuth H; Ruckert R; Wachtlin J; Ungureanu D; Notter M; Krause H; Pohl T; Paus R; Kunzendorf U		Cancer Res	58	1998	2707-10	J:50081	9661877
87137	The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor.		Tannenbaum CS; Tubbs R; Armstrong D; Finke JH; Bukowski RM; Hamilton TA		J Immunol	161	1998	927-32	J:50082	9670971
87138	Profiles of chemically-induced tumors in rodents: quantitative relationships.		Benigni R; Pino A		Mutat Res	421	1998	93-107	J:50083	9748520
87139	Characterization of genes which exhibit reduced expression during the retinoic acid-induced differentiation of F9 teratocarcinoma cells: involvement of cyclin D3 in RA-mediated growth arrest.		Faria TN; LaRosa GJ; Wilen E; Liao J; Gudas LJ		Mol Cell Endocrinol	143	1998	155-66	J:50125	9806360
87140	Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.		Smith MK; Trempus CS; Gilmour SK		Carcinogenesis	19	1998	1409-15	J:50136	9744537
87141	Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice.		Wei H; Bowen R; Zhang X; Lebwohl M		Carcinogenesis	19	1998	1509-14	J:50137	9744550
87142	Expression of T:G mismatch-specific thymidine-DNA glycosylase and DNA methyl transferase genes during development and tumorigenesis.		Niederreither K; Harbers M; Chambon P; Dolle P		Oncogene	17	1998	1577-85	J:50138	9794235
87143	The redox-sensitive human antioxidant responsive element induces gene expression under low oxygen conditions.		Waleh NS; Calaoagan J; Murphy BJ; Knapp AM; Sutherland RM; Laderoute KR		Carcinogenesis	19	1998	1333-7	J:50131	9744525
87144	Suppression of mouse skin tumor promotion and induction of apoptosis in HL-60 cells by Alpinia oxyphylla Miquel (Zingiberaceae).		Lee E; Park KK; Lee JM; Chun KS; Kang JY; Lee SS; Surh YJ		Carcinogenesis	19	1998	1377-81	J:50134	9744532
87145	Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents.		Rioux N; Castonguay A		Carcinogenesis	19	1998	1393-400	J:50135	9744535
87146	Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.		Kulwichit W; Edwards RH; Davenport EM; Baskar JF; Godfrey V; Raab-Traub N		Proc Natl Acad Sci U S A	95	1998	11963-8	J:50151	9751773
87147	Gender-related differences in susceptibility of A/J mouse to benzo[a]pyrene-induced pulmonary and forestomach tumorigenesis.		Singh SV; Benson PJ; Hu X; Pal A; Xia H; Srivastava SK; Awasthi S; Zaren HA; Orchard JL; Awasthi YC		Cancer Lett	128	1998	197-204	J:50154	9683283
87148	Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.		Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T		Cancer Immunol Immunother	47	1998	72-80	J:50166	9769115
87149	Calcium buffering capacity of neuronal cell cytosol measured by flash photolysis of calcium buffer NP-EGTA.		Fleet A; Ellis-Davies G; Bolsover S		Biochem Biophys Res Commun	250	1998	786-90	J:50176	9784424
87150	Activation of Fgf8 in S115 mouse mammary tumor cells is associated with genomic integration of mouse mammary tumor virus.		Valve EM; Tasanen MJ; Ruohola JK; Harkonen PL		Biochem Biophys Res Commun	250	1998	805-8	J:50177	9784427
87151	8-Methoxypsoralen potentiates the photocytotoxic effect of Photofrin II towards EMT-6 murine tumor cells.		Sousa C; Maziere C; Melo TS; Vincent-Fiquet O; Rogez JC; Santus R; Maziere JC		Cancer Lett	128	1998	177-82	J:50178	9683280
87152	Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells.		Burg MA; Grako KA; Stallcup WB		J Cell Physiol	177	1998	299-312	J:50195	9766527
87153	Molecular analysis of human pituitary adenoma with special reference to cell-cycle regulatory genes		Ikeda H; Yoshimoto T		Cancer J	11	1998	132-6	J:50183	 
87154	CD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb.		Krause DS; Mucenski ML; Lawler AM; May WS		Exp Hematol	26	1998	1086-92	J:50184	9766450
87155	Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.		Zeis M; Uharek L; Glass B; Vosskotter W; Dreger P; Schmitz N; Steinmann J		Exp Hematol	26	1998	1068-73	J:50185	9766447
87156	DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R2.		Marin JJ; Macias RI; Criado JJ; Bueno A; Monte MJ; Serrano MA		Int J Cancer	78	1998	346-52	J:50186	9766570
87157	IL-12 regulates VEGF and MMPs in a murine breast cancer model.		Dias S; Boyd R; Balkwill F		Int J Cancer	78	1998	361-5	J:50187	9766572
87158	Characterization and regulation of prolactin receptors in MA-10 Leydig cells.		Weiss-Messer E; Ber R; Amit T; Barkey RJ		Mol Cell Endocrinol	143	1998	53-64	J:50204	9806350
87159	IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production.		Grohmann U; Belladonna ML; Bianchi R; Orabona C; Ayroldi E; Fioretti MC; Puccetti P		Immunity	9	1998	315-23	J:50223	9768751
87160	The cytotoxic action of 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones and 1,3,5-triazine-4,6-(1 H,5 H)-diones in murine and human tumor cells.		Hall IH; Taylor K; Izydore RA; Coleman DE; Mitchell JA; Cummings R		Pharmazie	53	1998	398-405	J:50242	9675770
87161	Inhibitory effect of heliantriol C, a component of edible Chrysanthemum, on tumor promotion by 12-O-tetradecanoylphorbol-13-actetate in two-stage carcinogenesis in mouse skin		Yasukawa K; Akihisa T; Kasahara Y; Ukiya M; Kumaki K; Tamura T; Yamanouchi S; Takido M		Phytomedicine	5	1998	215-8	J:50243	 
87162	Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele.		Szikora JP; Van Pel A; Brichard V; Andre M; Van Baren N; Henry P; De Plaen E; Boon T		EMBO J	9	1990	1041-50	J:50234	2108859
87163	Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma.		Sharma D; Chelvi TP; Kaur J; Ralhan R		Melanoma Res	8	1998	240-4	J:50244	9664145
87164	The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL).		Peng B; Zhang M; Sun R; Lin YC; Chong SY; Lai H; Stein D; Raveche ES		Leuk Res	22	1998	509-16	J:50245	9678717
87165	Involvement of oxygen free radicals in ischaemia-reperfusion injury to murine tumours: role of nitric oxide.		Parkins CS; Holder AL; Dennis MF; Stratford MR; Chaplin DJ		Free Radic Res	28	1998	271-81	J:50246	9688213
87166	Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells: possible roles of interferon alpha, tumor necrosis factor alpha and transforming growth factor beta in Mn-SOD induction by	polysaccharide K.	Habelhah H; Okada F; Nakai K; Choi SK; Hamada J; Kobayashi M; Hosokawa M		Cancer Immunol Immunother	46	1998	338-44	J:50275	9756418
87167	Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.		Melani C; Figini M; Nicosia D; Luison E; Ramakrishna V; Casorati G; Parmiani G; Eshhar Z; Canevari S; Colombo MP		Cancer Res	58	1998	4146-54	J:50276	9751627
87168	Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumours of the skeleton.		Franchi A; Calzolari A; Zampi G		Virchows Arch	432	1998	515-9	J:50267	9672192
87169	Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation.		Picardo A; Karpoff HM; Ng B; Lee J; Brennan MF; Fong Y		Surgery	124	1998	57-64	J:50268	9663252
87170	Effect of pre-conceptional external or internal irradiation of N5 male mice and the risk of leukemia in their offspring.		Daher A; Varin M; Lamontagne Y; Oth D		Carcinogenesis	19	1998	1553-8	J:50277	9771924
87171	Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy.		Busetti A; Soncin M; Jori G; Kenney ME; Rodgers MA		Photochem Photobiol	68	1998	377-81	J:50300	9747592
87172	Inhibitory effect of Hesperidin on tumour initiation and promotion in mouse skin.		Berkarda B; Koyuncu H; Soybir G; Baykut F		Res Exp Med (Berl)	198	1998	93-9	J:50301	9782529
87173	Influence of diet restriction and tumor promoter dose on cell proliferation, oxidative DNA damage and rate of papilloma appearance in the mouse skin after initiation with DMBA and promotion with TPA.		Fischer WH; Lutz WK		Toxicol Lett	98	1998	59-69	J:50302	9776562
87174	Aspirin prevents tumors in a murine model of familial adenomatous polyposis.		Mahmoud NN; Dannenberg AJ; Mestre J; Bilinski RT; Churchill MR; Martucci C; Newmark H; Bertagnolli MM		Surgery	124	1998	225-31	J:50316	9706142
87175	Effect of the viable-yellow (A(vy)) agouti allele on skin tumorigenesis and humoral hypercalcemia in v-Ha-ras transgenic TGxAC mice.		Hansen LA; Malarkey DE; Wilkinson JE; Rosenberg M; Woychik RE; Tennant RW		Carcinogenesis	19	1998	1837-45	J:50361	9806167
87176	The effects of phenethyl isothiocyanate, N-acetylcysteine and green tea on tobacco smoke-induced lung tumors in strain A/J mice.		Witschi H; Espiritu I; Yu M; Willits NH		Carcinogenesis	19	1998	1789-94	J:50362	9806160
87177	Structural and functional characterization of the promoter region of the mouse c-Ki-ras gene.		Hoffman EK; Trusko SP; Freeman N; George DL		Mol Cell Biol	7	1987	2592-6	J:50353	3614201
87178	Mutations in the reduced folate carrier gene which confer dominant resistance to 5,10-dideazatetrahydrofolate.		Tse A; Brigle K; Taylor SM; Moran RG		J Biol Chem	273	1998	25953-60	J:50354	9748272
87179	Characterization of functional domains of an embryonic stem cell coactivator UTF1 which are conserved and essential for potentiation of ATF-2 activity.		Fukushima A; Okuda A; Nishimoto M; Seki N; Hori TA; Muramatsu M		J Biol Chem	273	1998	25840-9	J:50355	9748258
87180	The human WD repeat protein WAIT-1 specifically interacts with the cytoplasmic tails of beta7-integrins.		Rietzler M; Bittner M; Kolanus W; Schuster A; Holzmann B		J Biol Chem	273	1998	27459-66	J:50370	9765275
87181	Transgenic mouse model for skin malignant melanoma.		Kato M; Takahashi M; Akhand AA; Liu W; Dai Y; Shimizu S; Iwamoto T; Suzuki H; Nakashima I		Oncogene	17	1998	1885-8	J:50392	9778055
87182	Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression.		Llorens A; Rodrigo I; Lopez-Barcons L; Gonzalez-Garrigues M; Lozano E; Vinyals A; Quintanilla M; Cano A; Fabra A		Lab Invest	78	1998	1131-42	J:50422	9759657
87183	c-Fos degradation by the proteasome. An early, Bcl-2-regulated step in apoptosis.		He H; Qi XM; Grossmann J; Distelhorst CW		J Biol Chem	273	1998	25015-9	J:50419	9737957
87184	Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.		Coughlin CM; Salhany KE; Gee MS; LaTemple DC; Kotenko S; Ma X; Gri G; Wysocka M; Kim JE; Liu L; Liao F; Farber JM; Pestka S; Trinchieri G; Lee WM		Immunity	9	1998	25-34	J:50434	9697833
87185	High frequency of interactions between lung cancer susceptibility genes in the mouse: mapping of Sluc5 to Sluc14.		Fijneman RJ; Jansen RC; van der Valk MA; Demant P		Cancer Res	58	1998	4794-8	J:50525	9809979
87186	At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice.		Festing MF; Lin L; Devereux TR; Gao F; Yang A; Anna CH; White CM; Malkinson AM; You M		Genomics	53	1998	129-36	J:50533	9790761
87187	Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.		Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Lipari P; Malkowski M; Ferrari E; Nielsen L; Prioli N; Dell J; Sinha D; Syed J; Korfmacher WA; Nomeir AA; Lin CC; Wang L; Taveras AG; Doll RJ; Njoroge FG; Mallams AK; Remiszewski S; Catino JJ; Girijavallabhan VM	; Bishop WR; et al	Cancer Res	58	1998	4947-56	J:50611	9810004
87188	Identification of four genes in endothelial cells whose expression is affected by tumor cells and host immune status--a study in ex vivo-isolated endothelial cells.		Liliensiek B; Rocha M; Umansky V; Benner A; Lin J; Ziegler R; Nawroth PP; Schirrmacher V		Blood	92	1998	3394-404	J:50605	9787179
87189	FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells.		Hajitou A; Baramova EN; Bajou K; Noe V; Bruyneel E; Mareel M; Collette J; Foidart JM; Calberg-Bacq CM		Oncogene	17	1998	2059-71	J:50629	9798677
87190	Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.		Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD		Oncogene	17	1998	2073-85	J:50630	9798678
87191	Cancer-associated glycosphingolipid antigens: their structure, organization, and function.		Hakomori S		Acta Anat (Basel)	161	1998	79-90	J:50632	9780352
87192	Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine.		Zhang Z; Diwan BA; Anderson LM; Logsdon D; Olivero OA; Haines DC ; Rice JM ; Yuspa SH ; Poirier MC		Mol Carcinog	23	1998	45-51	J:50646	9766437
87193	Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.		Clark LS; Hart DW; Vojta PJ; Harrington-Brock K; Barrett JC; Moore MM ; Tindall KR		Mutagenesis	13	1998	427-34	J:50648	9800187
87194	Analysis of large and small colony L5178Y tk-/- mouse lymphoma mutants by loss of heterozygosity (LOH) and by whole chromosome 11 painting: detection of recombination.		Liechty MC; Scalzi JM; Sims KR; Crosby H Jr; Spencer DL; Davis LM ; Caspary WJ ; Hozier JC		Mutagenesis	13	1998	461-74	J:50649	9800191
87195	Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response.		Coleman M; Muller S; Quezada A; Mendiratta SK; Wang J; Thull NM; Bishop J; Matar M; Mester J; Pericle F		Hum Gene Ther	9	1998	2223-30	J:50683	9794206
87196	DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.		Carpentier AF; Rosenfeld MR; Delattre JY; Whalen RG; Posner JB; Dalmau J		Clin Cancer Res	4	1998	2819-24	J:50736	9829748
87197	On the correlation between the water diffusion coefficient and oxygen tension in RIF-1 tumors.		Helmer KG; Han S; Sotak CH		NMR Biomed	11	1998	120-30	J:50726	9699495
87198	The murine PKR tumor suppressor gene is rearranged in a lymphocytic leukemia.		Abraham N; Jaramillo ML; Duncan PI; Methot N; Icely PL; Stojdl DF; Barber GN; Bell JC		Exp Cell Res	244	1998	394-404	J:50753	9806790
87199	Mouse lymphoblasts lose their immunogenicity and susceptibility to specific cytotoxic T lymphocyte lysis during maintenance in culture.		Leshem B; Brass D		Immunology	95	1998	409-18	J:50740	9824505
87200	Antisense oligonucleotide specific for transforming growth factor-beta 1 inhibit both in vitro and in vivo growth of MBT-2 murine bladder cancer.		Tzai TS; Lin CI; Shiau AL; Wu CL		Anticancer Res	18	1998	1585-9	J:50741	9673374
87201	Augmentation of IL-2 activated natural killer cell adoptive immunotherapy with cyclophosphamide.		Goldfarb RH; Ohashi M; Brunson KW; Kirii Y; Kotera Y; Basse PH; Kitson RP		Anticancer Res	18	1998	1441-6	J:50742	9673353
87202	Immunohistochemical detection of CYP2E1 and 2-S-glutathionyl acetate in murine lung tumors: diminished formation of reactive intermediates of 1,1-dichloroethylene.		Forkert PG		Exp Lung Res	24	1998	455-61	J:50744	9659577
87203	Role of the cytosine DNA-methyltransferase and p16INK4a genes in the development of mouse lung tumors.		Belinsky SA		Exp Lung Res	24	1998	463-79	J:50745	9659578
87204	Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression.		Yang CS; Yang GY; Landau JM; Kim S; Liao J		Exp Lung Res	24	1998	629-39	J:50746	9659588
87205	An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum.		Smyth MJ; Kelly JM; Baxter AG; Korner H; Sedgwick JD		J Exp Med	188	1998	1611-9	J:50764	9802973
87206	Tumor-infiltrating macrophages influence the glycosphingolipid composition of murine brain tumors.		Ecsedy JA; Yohe HC; Bergeron AJ; Seyfried TN		J Lipid Res	39	1998	2218-27	J:50757	9799808
87207	Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice.		Brown MP; Topham DJ; Sangster MY; Zhao J; Flynn KJ; Surman SL; Woodland DL; Doherty PC; Farr AG; Pattengale PK; Brenner MK		Nat Med	4	1998	1253-60	J:50779	9809548
87208	combination therapy with fumagillin and vaccination with tumor-derived antigenic peptides in B16 melanoma-transplanted mice.		Tsuji F; Yamada K		Int J Immunopharmacol	20	1998	111-24	J:50782	9717086
87209	Radiation-induced tumorigenesis in preneoplastic mouse mammary glands in vivo: significance of p53 status and apoptosis.		Medina D; Stephens LC; Bonilla PJ; Hollmann CA; Schwahn D; Kuperwasser C; Jerry DJ; Butel JS; Meyn RE		Mol Carcinog	22	1998	199-207	J:50783	9688146
87210	Introduction to mouse lung tumorigenesis.		Stoner GD		Exp Lung Res	24	1998	375-83	J:50784	9659571
87211	Localization of prostaglandin-H synthase-1 and -2 in mouse skin: implications for cutaneous function.		Muller-Decker K; Scholz K; Neufang G; Marks F; Furstenberger G		Exp Cell Res	242	1998	84-91	J:50801	9665805
87212	Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry.		O'Hara JA; Goda F; Demidenko E; Swartz HM		Radiat Res	150	1998	549-56	J:50791	9806597
87213	Chronic, low-level (1.0 W/kg) exposure of mice prone to mammary cancer to 2450 MHz microwaves.		Frei MR; Jauchem JR; Dusch SJ; Merritt JH; Berger RE; Stedham MA		Radiat Res	150	1998	568-76	J:50792	9806599
87214	A differentially expressed prion gene mRNA is found in prion-infected mouse brains and in N2A cells but not in uninfected mice.		Schroder B; Groschup M; Hunsmann G; Bodemer W		Biochem Biophys Res Commun	251	1998	423-8	J:50814	9792790
87215	Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells.		Gladyshev VN; Factor VM; Housseau F; Hatfield DL		Biochem Biophys Res Commun	251	1998	488-93	J:50815	9792801
87216	Synergistic effects of colony-stimulating factor 1 and leukemia inhibitory factor in inducing early myeloid cell differentiation.		Aperlo C; Sevilla L; Guerin S; Pognonec P; Boulukos KE		Cell Growth Differ	9	1998	929-37	J:50883	9831245
87217	CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice.		Tempero RM; VanLith ML; Morikane K; Rowse GJ; Gendler SJ; Hollingsworth MA		J Immunol	161	1998	5500-6	J:50905	9820526
87218	The fetal origin of B-precursor leukemia in the E-mu-ret mouse.		Zeng XX; Zhang H; Hardy RR; Wasserman R		Blood	92	1998	3529-36	J:50955	9808544
87219	Stimulation of the Ca2+-mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A.		Schaefer A; Magocsi M; Fandrich A; Marquardt H		Biochem J	335	1998	505-11	J:50968	9794788
87220	Aberrant DNA methylation of genomic regions translocated in myeloid malignancies.		Litz CE; Etzell J		Leuk Lymphoma	30	1998	1-9	J:51003	9669671
87221	Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model.		Uchida N; Takeda Y; Hojo K; Maekawa R; Sugita K; Yoshioka T		Eur J Cancer	34	1998	1796-801	J:51016	9893671
87222	Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma.		Paglia P; Medina E; Arioli I; Guzman CA; Colombo MP		Blood	92	1998	3172-6	J:51007	9787153
87223	Comparison of expression of human globin genes transferred into mouse erythroleukemia cells and in transgenic mice.		Skarpidi E; Vassilopoulos G; Stamatoyannopoulos G; Li Q		Blood	92	1998	3416-21	J:51008	9787182
87224	Chromosomal localization and genomic characterization of the mouse melastatin gene (Mlsn1).		Hunter JJ; Shao J; Smutko JS; Dussault BJ; Nagle DL; Woolf EA; Holmgren LM; Moore KJ; Shyjan AW		Genomics	54	1998	116-23	J:51031	9806836
87225	Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.		Sharma B; Handler M; Eichstetter I; Whitelock JM; Nugent MA; Iozzo RV		J Clin Invest	102	1998	1599-608	J:51020	9788974
87226	The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily.		Madry C; Laabi Y; Callebaut I; Roussel J; Hatzoglou A; Le Coniat M ; Mornon JP ; Berger R ; Tsapis A		Int Immunol	10	1998	1693-702	J:51039	9846698
87227	Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene.		LeCouter JE; Kablar B; Hardy WR; Ying C; Megeney LA; May LL; Rudnicki MA		Mol Cell Biol	18	1998	7455-65	J:51060	9819431
87228	Establishment and characterization of osteoblast-like cell lines from retrovirus (RFB MuLV)-induced osteomas in mice.		Goralczyk R; Appold A; Luz A; Riemann S; Strauss PG; Erfle V; Schmidt J		Differentiation	63	1998	253-62	J:51090	9810704
87229	Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.		Pear WS; Miller JP; Xu L; Pui JC; Soffer B; Quackenbush RC; Pendergast AM; Bronson R; Aster JC; Scott ML; Baltimore D		Blood	92	1998	3780-92	J:51171	9808572
87230	Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.		Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A		Cancer Immunol Immunother	47	1998	143-8	J:51173	9829839
87231	The role of alcohol dehydrogenase in the metabolism of the colon carcinogen methylazoxymethanol.		Delker DA; McKnight SJ 3rd; Rosenberg DW		Toxicol Sci	45	1998	66-71	J:51208	9848112
87232	Telomerase activity in thymomas and mammary gland adenocarcinomas induced by polyoma virus in AKR mice.		Otero J; Sanjuan N		Medicina (B Aires)	58	1998	497-500	J:51196	9922483
87233	Wild-type egr1/Krox24 promotes and dominant-negative mutants inhibit, pluripotent differentiation of p19 embryonal carcinoma cells.		Lanoix J; Mullick A; He Y; Bravo R; Skup D		Oncogene	17	1998	2495-504	J:51202	9824160
87234	Inhibition of tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin/granulin precursor).		Zhang H; Serrero G		Proc Natl Acad Sci U S A	95	1998	14202-7	J:51235	9826678
87235	The mutationally activated Met receptor mediates motility and metastasis.		Jeffers M; Fiscella M; Webb CP; Anver M; Koochekpour S; Vande Woude GF		Proc Natl Acad Sci U S A	95	1998	14417-22	J:51237	9826715
87236	Hyperthermic modulation of SN-38-induced topoisomerase I DNA cross-linking and SN-38 cytotoxicity through altered topoisomerase I activity.		Katschinski DM; Robins HI		Int J Cancer	80	1999	104-9	J:51240	9935239
87237	Protein-kinase-Cmu expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture.		Rennecke J; Rehberger PA; Furstenberger G; Johannes FJ; Stohr M; Marks F; Richter KH		Int J Cancer	80	1999	98-103	J:51241	9935238
87238	Actinobacillus actinomycetemcomitans toxin induces both cell cycle arrest in the G2/M phase and apoptosis.		Ohguchi M; Ishisaki A; Okahashi N; Koide M; Koseki T; Yamato K; Noguchi T; Nishihara T		Infect Immun	66	1998	5980-7	J:51258	9826381
87239	Direct binding of Shc, Grb2, SHP-2 and p40 to the murine granulocyte colony-stimulating factor receptor.		Ward AC; Monkhouse JL; Hamilton JA; Csar XF		Biochim Biophys Acta	1448	1998	70-6	J:51250	9824671
87240	Modulation of agonist binding to recombinant human alpha2-adrenoceptors by sodium ions.		Pihlavisto M; Sjoholm B; Scheinin M; Wurster S		Biochim Biophys Acta	1448	1998	135-46	J:51252	9824686
87241	Proto-oncogene PML controls genes devoted to MHC class I antigen presentation.		Zheng P; Guo Y; Niu Q; Levy DE; Dyck JA; Lu S; Sheiman LA; Liu Y		Nature	396	1998	373-6	J:51294	9845074
87242	A series of spontaneous tumors in mice with observations on the influence of heredity on the frequency of their occurrence		Tyzzer EE		J Med Res	21	1909	479-518	J:51305	 
87243	Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.		Schmidt T; Karsunky H; Gau E; Zevnik B; Elsasser HP; Moroy T		Oncogene	17	1998	2661-7	J:51319	9840930
87244	Critical role for p27Kip1 in cell cycle arrest after androgen depletion in mouse mammary carcinoma cells (SC-3).		Menjo M; Kaneko Y; Ogata E; Ikeda K; Nakanishi M		Oncogene	17	1998	2619-27	J:51322	9840925
87245	Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.		Tsatsanis C; Patriotis C; Tsichlis PN		Oncogene	17	1998	2609-18	J:51323	9840924
87246	Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase-related protein 1/SV40 T antigen transgenic mice.		Penna D; Schmidt A; Beermann F		Oncogene	17	1998	2601-7	J:51324	9840923
87247	Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.		Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T		Exp Cell Res	245	1998	186-94	J:51354	9828115
87248	Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.		Germolec DR; Spalding J; Yu HS; Chen GS; Simeonova PP; Humble MC; Bruccoleri A; Boorman GA; Foley JF; Yoshida T; Luster MI		Am J Pathol	153	1998	1775-85	J:51350	9846968
87249	Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programs.		Phillips RM; Pearce J; Loadman PM; Bibby MC; Cooper PA; Swaine DJ; Double JA		Cancer Res	58	1998	5263-6	J:51374	9850044
87250	Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.		Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR		Cancer Res	58	1998	5447-52	J:51368	9850078
87251	EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells.		Muller M; Gounari F; Prifti S; Hacker HJ; Schirrmacher V; Khazaie K		Cancer Res	58	1998	5439-46	J:51369	9850077
87252	Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice.		Liu X; Turbyville T; Fritz A; Whitesell L		Cancer Res	58	1998	5432-8	J:51370	9850076
87253	Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice.		Mokyr MB; Kalinichenko T; Gorelik L; Bluestone JA		Cancer Res	58	1998	5301-4	J:51372	9850053
87254	Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants.		Wagner KU; Dierisseau P; Rucker EB 3rd; Robinson GW; Hennighausen L		Oncogene	17	1998	2761-70	J:51384	9840940
87255	The murine Hoxb1 3' RAIDR5 enhancer contains multiple regulatory elements.		Thompson JR; Huang DY; Gudas LJ		Cell Growth Differ	9	1998	969-81	J:51404	9869297
87256	Cell kinetics of mouse tumour subjected to photodynamic therapy - evaluation by proliferating cell nuclear antigen immunohistochemistry		Uehara M; Inokuchi T; Sano K; Sekine J; Ikeda H		Oral Oncol	35	1999	93-7	J:51413	10211316
87257	Separation of glycosphingolipid signaling domain from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling.		Iwabuchi K; Handa K; Hakomori S		J Biol Chem	273	1998	33766-73	J:51414	9837965
87258	c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells.		Rahimi N; Hung W; Tremblay E; Saulnier R; Elliott B		J Biol Chem	273	1998	33714-21	J:51417	9837958
87259	Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin.		Zagozdzon R; Golab J; Stoklosa T; Giermasz A; Nowicka D; Feleszko W; Lasek W; Jakobisiak M		Int J Cancer	77	1998	720-7	J:51426	9688305
87260	Recommendations for spacing of test chemical concentrations in the mouse lymphoma tk mutation assay (MLA) [see comments]		Kirkland DJ; Clements J		Mutat Res	415	1998	159-63	J:51427	9711272
87261	CTLs specific for bcr-abl joining region segment peptides fail to lyse leukemia cells expressing p210 bcr-abl protein.		Chen W; Qin H; Reese VA; Cheever MA		J Immunother	21	1998	257-68	J:51442	9672847
87262	The role of B7-CD28 co-stimulation in tumor rejection.		Yu X; Abe R; Hodes RJ		Int Immunol	10	1998	791-7	J:51443	9678760
87263	An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness.		Thompson KL; Rosenzweig BA; Sistare FD		Toxicol Pathol	26	1998	548-55	J:51446	9715514
87264	An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype.		Weaver JL; Contrera JF; Rosenzweig BA; Thompson KL; Faustino PJ; Strong JM; Ellison CD; Anderson LW; Prasanna HR; Long-Bradley PE; Lin KK; Zhang J; Sistare FD		Toxicol Pathol	26	1998	532-40	J:51447	9715512
87265	DNA repair, cell cycle progression and cell death following camptothecin treatment in two murine lymphoma L5178Y sublines.		Gradzka I; Skierski J; Szumiel I		Cell Biochem Funct	16	1998	239-52	J:51461	9857486
87266	Remodeling of hyperplastic pituitaries in hypothyroid alpha-subunit knockout mice after thyroxine and 17 beta- estradiol treatment: Role of apoptosis.		Kulig E; Camper SA; Kuecker S; Jin L; Lloyd RV		Endocr Pathol	9	1998	261-274	J:51465	12114718
87267	The effect of vitamin E acetate on ultraviolet-induced mouse skin carcinogenesis.		Berton TR; Conti CJ; Mitchell DL; Aldaz CM; Lubet RA; Fischer SM		Mol Carcinog	23	1998	175-84	J:51484	9833778
87268	The influence of rutin on the weight, metastasis and melanin content of B16 melanotic melanoma in C57BL/6 mice.		Drewa G; Schachtschabel DO; Palgan K; Grzanka A; Sujkowska R		Neoplasma	45	1998	266-71	J:51486	9890672
87269	The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors.		Horsman MR; Ehrnrooth E; Ladekarl M; Overgaard J		Int J Radiat Oncol Biol Phys	42	1998	895-8	J:51501	9845117
87270	Ultrastructure of murine tumour cell lines defective in MHC class I expression before and after interferon-gamma treatment.		Hosaka Y; Taguchi K; Iwamoto T; Kuroda K; Tsuruoka H; Xu H; Hamaoka T		J Electron Microsc (Tokyo)	47	1998	495-503	J:51504	9881456
87271	Sequence motifs in the integrin alpha 4 cytoplasmic tail required for regulation of in vivo expansion of murine lymphoma cells.		Bittner M; Gosslar U; Luz A; Holzmann B		J Immunol	161	1998	5978-86	J:51505	9834079
87272	Anti-metastatic and immunomodulating properties of the water extract from Celosia argentea seeds.		Hayakawa Y; Fujii H; Hase K; Ohnishi Y; Sakukawa R; Kadota S; Namba T; Saiki I		Biol Pharm Bull	21	1998	1154-9	J:51490	9853404
87273	Inhibition of polyposis in the small intestine of BALB/c mice by intestinal bacteria.		Ozaki A; Morishita Y; Oowada T; Itagaki S; Mizutani T		Cancer Lett	131	1998	153-6	J:51491	9851247
87274	Antitumour activity of diallyl sulfide on polycyclic aromatic hydrocarbon-induced mouse skin carcinogenesis.		Singh A; Shukla Y		Cancer Lett	131	1998	209-14	J:51492	9851255
87275	Tumor-growth inhibition with bispecific antibody fragments in a syngeneic mouse melanoma model: the role of targeted T-cell co-stimulation via CD28.		Grosse-Hovest L; Brandl M; Dohlsten M; Kalland T; Wilmanns W; Jung G		Int J Cancer	80	1999	138-44	J:51496	9935244
87276	Relationship of hypoxia to metallothionein expression in murine tumors.		Raleigh JA; Chou SC; Tables L; Suchindran S; Varia MA; Horsman MR		Int J Radiat Oncol Biol Phys	42	1998	727-30	J:51498	9845085
87277	The potentiation of radiation response in human colon carcinoma cells in vitro and murine lymphoma in vivo by AG337 (Thymitaq), a novel thymidylate synthase inhibitor.		Kim SH; Brown SL; Kim JH		Int J Radiat Oncol Biol Phys	42	1998	789-93	J:51499	9845097
87278	Immunosuppressant effect on Fas antigen expression and p53 of an experimental tumor.		Yokoyama I; Hayakawa A; Hayashi S; Kobayashi T; Negita T; Namii Y; Nagasaka T; Koike C; Tachi Y; Takagi H		Transplant Proc	30	1998	4196	J:51520	9865346
87279	Entry into mitosis without Cdc2 kinase activation.		Gowdy PM; Anderson HJ; Roberge M		J Cell Sci	111	1998	3401-10	J:51521	9788881
87280	FLT3-ligand administration inhibits liver metastases: role of NK cells.		Peron JM; Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR		J Immunol	161	1998	6164-70	J:51506	9834102
87281	Phenotypic effect correlating with loss of a novel tumor suppressor gene: towards cloning by complementation.		Cook WD; Alexander BJ		Leukemia	12	1998	1937-43	J:51509	9844923
87282	Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12.		Fallarino F; Uyttenhove C; Boon T; Gajewski TF		Int J Cancer	80	1999	324-33	J:51528	9935218
87283	Homologous recombination between p53 and its pseudogene in a radiation-induced mouse tumor.		Tanooka H; Ootsuyama A; Sasaki H		Cancer Res	58	1998	5649-51	J:51550	9865715
87284	Genetic control of natural killing and in vivo tumor elimination by the Chok locus.		Idris AH; Iizuka K; Smith HRC; Scalzo AA; Yokoyama WM		J Exp Med	188	1998	2243-56	J:51604	9858511
87285	Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas.		Elizalde PV; Lanari C; Molinolo AA; Guerra FK; Balana ME; Simian M; Iribarren AM; Charreau EH		J Steroid Biochem Mol Biol	67	1998	305-17	J:51628	9883987
87286	Molecular characterization of a newly identified heme-binding protein induced during differentiation of urine erythroleukemia cells.		Taketani S; Adachi Y; Kohno H; Ikehara S; Tokunaga R; Ishii T		J Biol Chem	273	1998	31388-94	J:51615	9813049
87287	High MHC class I expression correlates with slow growth in UV-induced skin carcinomas in hairless mice.		Svane IM; Engel AM; Thomsen NB; Wulf HC; Werdelin O		APMIS	106	1998	1101-7	J:51640	9890274
87288	Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.		Jones SN; Hancock AR; Vogel H; Donehower LA; Bradley A		Proc Natl Acad Sci U S A	95	1998	15608-12	J:51661	9861017
87289	The central role of CD4(+) T cells in the antitumor immune response.		Hung K; Hayashi R; Lafond-Walker A; Lowenstein C; Pardoll D; Levitsky H		J Exp Med	188	1998	2357-68	J:51677	9858522
87290	NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.		Melero I; Johnston JV; Shufford WW; Mittler RS; Chen L		Cell Immunol	190	1998	167-72	J:51679	9878117
87291	Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression.		Francia G; Mitchell SD; Moss SE; Hanby AM; Marshall JF; Hart IR		Cancer Res	56	1996	3855-8	J:51733	8752144
87292	Cerebellar cell lines established from a p53-deficient adult mouse.		Minakawa M; Sugimoto T; Aizawa S; Tomooka Y		Brain Res	813	1998	172-6	J:51763	9824692
87293	Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E- enriched liposomes.		Versluis AJ; Rensen PC; Rump ET; Van Berkel TJ; Bijsterbosch MK		Br J Cancer	78	1998	1607-14	J:51765	9862571
87294	Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice [published erratum appears in Cancer Chemother Pharmacol 1999;43(6):524]		Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA		Cancer Chemother Pharmacol	43	1999	1-7	J:51766	9923534
87295	Inversion of genetic predisposition to carcinogenesis in liver of two lines of mice selected for resistance (Car-R) or susceptibility (Car-S) to skin carcinogenesis.		Perin F; Perin-Roussel O; Taras-Valero D; Mouton D; Covelli V; Zajdela F		Cancer Lett	132	1998	81-90	J:51767	10397457
87296	Tumor growth and food intake in interleukin-6 gene knock-out mice.		Molotkov A; Satoh M; Tohyama C		Cancer Lett	132	1998	187-92	J:51769	10397473
87297	Pharmacological reactivity of neoplastic and non-neoplastic associated neovasculature to vasoconstrictors.		Andrade SP; Beraldo WT		Int J Exp Pathol	79	1998	425-32	J:51817	10319023
87298	CD44H participates in the intrahepatic growth of murine colon 26 adenocarcinoma cells.		Ogoshi T; Ishii S; Mizoi T; Harada N; Sato W; Saito K; Ogawa H; Inabe K; Shiiba K; Matsuno S		Jpn J Cancer Res	89	1998	1160-8	J:51820	9914785
87299	Electron microscopic and bioassay studies of milk from mice of high and low mammary-cancer and high and low leukemia strains.		Dmochowski L; Langford PL; Williams WC; Liebelt AG; Liebelt RA		J Natl Cancer Inst	40	1968	1339-58	J:51857	4298257
87300	Angiogenesis is an early event in the development of chemically induced skin tumors.		Bolontrade MF; Stern MC; Binder RL; Zenklusen JC; Gimenez-Conti IB; Conti CJ		Carcinogenesis	19	1998	2107-13	J:51848	9886564
87301	Insights into cancer from transgenic mouse models.		Macleod KF; Jacks T		J Pathol	187	1999	43-60	J:51881	10341706
87302	Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour.		Di Carlo E; Modesti A; Coletti A; Colombo MP; Giovarelli M; Forni G; Diodoro MG; Musiani P		J Pathol	186	1998	390-7	J:51900	10209488
87303	Genetic events and the role of TGF beta in epithelial tumour progression.		Akhurst RJ; Balmain A		J Pathol	187	1999	82-90	J:51882	10341708
87304	The p53 pathway.		Prives C; Hall PA		J Pathol	187	1999	112-26	J:51883	10341712
87305	Lymphoid hyperplasia in transgenic mice over-expressing a secreted form of the human interleukin-1beta gene product.		Bjorkdahl O; Akerblad P; Gjorloff-Wingren A; Leanderson T; Dohlsten M		Immunology	96	1999	128-37	J:51959	10233687
87306	Molecular mapping of chromosome 2 deletions in murine radiation-induced AML localizes a putative tumor suppressor gene to a 1.0 cM region homologous to human chromosome segment 11p11-12.		Silver A; Moody J; Dunford R; Clark D; Ganz S; Bulman R; Bouffler S; Finnon P; Meijne E; Huiskamp R; Cox R		Genes Chromosomes Cancer	24	1999	95-104	J:51944	9885975
87307	CMAP: a novel cystatin-like gene involved in liver metastasis.		Morita M; Yoshiuchi N; Arakawa H; Nishimura S		Cancer Res	59	1999	151-8	J:51977	9892200
87308	Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells.		Clifford JL; Menter DG; Wang M; Lotan R; Lippman SM		Cancer Res	59	1999	14-8	J:51979	9892176
87309	Mouse models in tumor suppression.		Ghebranious N; Donehower LA		Oncogene	17	1998	3385-400	J:52202	9917000
87310	Expression of the transmembrane glycoprotein CD44 and metastasis associated 18A2/MTS1 gene in B16 murine melanoma cells.		Lakshmi MS; Parker C; Sherbet GV		Anticancer Res	17	1997	3451-5	J:44941	9413186
87311	Induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen.		Tobery T; Siliciano RF		J Immunol	162	1999	639-42	J:52022	9916680
87312	Induction of B-cell lymphoma in BALB/c nude mice with an ecotropic, B-tropic helper virus present in the murine AIDS virus stock.		Tayar L; Higo K; Kubo Y; Wang Y; Lu LM; Zhang F; Iwatani Y; Wang L; Ono T; Maeda M; Sakai H; Ishimoto A		J Virol	73	1999	1640-4	J:52054	9882372
87313	A ret transgenic mouse model of thyroid carcinogenesis.		Capen C; Sagartz J		Lab Anim Sci	48	1998	580-3	J:52063	10090080
87314	Gene deletion explains both in vivo and in vitro generated chromosome 2 aberrations associated with murine myeloid leukemia.		Alexander BJ; Rasko JE; Morahan G; Cook WD		Leukemia	9	1995	2009-15	J:52091	8609710
87315	2F1 antigen, the mouse homolog of the rat mast cell function-associated antigen, is a lectin-like type II transmembrane receptor expressed by natural killer cells.		Hanke T; Corral L; Vance RE; Raulet DH		Eur J Immunol	28	1998	4409-17	J:52111	9862378
87316	Non-carcinogenicity of capsaicinoids in B6C3F1 mice.		Akagi A; Sano N; Uehara H; Minami T; Otsuka H; Izumi K		Food Chem Toxicol	36	1998	1065-71	J:52113	9862648
87317	The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection.		Brandle D; Bilsborough J; Rulicke T; Uyttenhove C; Boon T; Van den Eynde BJ		Eur J Immunol	28	1998	4010-9	J:52109	9862337
87318	Evaluation of the Emu-pim-1 transgenic mouse model for short-term carcinogenicity testing [see comments]		van Kreijl CF; van der Houven van Oordt CW; Kroese ED; Sorensen IK; Breuer ML; Storer RD		Toxicol Pathol	26	1998	750-6	J:52141	9864091
87319	Multiple genetic loci modify risk for retinoblastoma in transgenic mice.		Griep AE; Krawcek J; Lee D; Liem A; Albert DM; Carabeo R; Drinkwater N; McCall M; Sattler C; Lasudry JG; Lambert PF		Invest Ophthalmol Vis Sci	39	1998	2723-32	J:52121	9856783
87320	Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment.		Syed NA; Windle JJ; Darjatmoko SR; Lokken JM; Steeves RA; Chappell R; Wallow IH; Koop BA; Mangold G; Howes KA; Albert DM		Invest Ophthalmol Vis Sci	39	1998	2800-5	J:52122	9856795
87321	Downregulation of fibronectin transcription in highly metastatic adenocarcinoma cells.		Werbajh SE; Urtreger AJ; Puricelli LI; de Lustig ES; Bal de Kier Joffe E; Kornblihtt AR		FEBS Lett	440	1998	277-81	J:52158	9872386
87322	Effect of gold on survival of tumor-bearing mice.		Kamei H; Koide T; Kojima T; Hashimoto Y; Hasegawa M		Cancer Biother	13	1998	403-406	J:52149	 
87323	Beta 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis.		Drake DR 3rd; Lukacher AE		Virology	252	1998	275-84	J:52185	9875336
87324	Genetic instability in radiation-induced leukaemias: mouse models.		Plumb M; Cleary H; Wright E		Int J Radiat Biol	74	1998	711-20	J:52167	9881716
87325	Induction of lympho-haemopoietic malignancy: impact of preconception paternal irradiation.		Lord BI; Woolford LB; Wang L; McDonald D; Lorimore SA; Stones VA; Wright EG; Scott D		Int J Radiat Biol	74	1998	721-8	J:52168	9881717
87326	Transcriptional regulation of the Bmp2 gene. Retinoic acid induction in F9 embryonal carcinoma cells and Saccharomyces cerevisiae.		Heller LC; Li Y; Abrams KL; Rogers MB		J Biol Chem	274	1999	1394-400	J:52245	9880512
87327	Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions.		Levy-Strumpf N; Kimchi A		Oncogene	17	1998	3331-40	J:52232	9916995
87328	Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth.		Moody TW; Leyton J; Martinez A; Hong S; Malkinson A; Mulshine JL		Exp Lung Res	24	1998	617-28	J:52234	9659587
87329	Molecular comparison of human and mouse pulmonary adenocarcinomas.		Malkinson AM		Exp Lung Res	24	1998	541-55	J:52236	9659582
87330	Inhibition of NNK-induced lung tumorigenesis by modulators of NNK activation.		Morse MA		Exp Lung Res	24	1998	595-604	J:52237	9659585
87331	The Ras/Erk pathway induces primitive endoderm but prevents parietal endoderm differentiation of F9 embryonal carcinoma cells.		Verheijen MH; Wolthuis RM; Bos JL; Defize LH		J Biol Chem	274	1999	1487-94	J:52260	9880524
87332	Role of gap junctions in lung neoplasia.		Ruch RJ; Cesen-Cummings K; Malkinson AM		Exp Lung Res	24	1998	523-39	J:52264	9659581
87333	Molecular pathogenesis of transplacentally induced mouse lung tumors.		Miller MS; Leone-Kabler S; Rollins LA; Wessner LL; Fan M; Schaeffer DO; McEntee MF; O'Sullivan MG		Exp Lung Res	24	1998	557-77	J:52265	9659583
87334	Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor.		Dyall R; Vasovic LV; Clynes RA; Nikolic-Zugic J		Eur J Immunol	29	1999	30-7	J:52267	9933083
87335	Ectopic expression of RET results in microphthalmia and tumors in the retinal pigment epithelium.		Schmidt A; Tief K; Yavuzer U; Beermann F		Int J Cancer	80	1999	600-5	J:52284	9935163
87336	The role of stereoselectivity of chemosensitizers in the reversal of multidrug resistance of mouse lymphoma cells.		Szabo D; Molnar J		Anticancer Res	18	1998	3039-44	J:52386	9713506
87337	Potent suppressive activity of pheophytin a and b from the non-polyphenolic fraction of green tea (Camellia sinensis) against tumor promotion in mouse skin.		Higashi-Okai K; Otani S; Okai Y		Cancer Lett	129	1998	223-8	J:52513	9719465
87338	Activation of extracellular signal-regulated kinase in lung tissues of mice treated with carcinogen.		Yano T; Yano Y; Nagashima Y; Yuasa M; Yajima S; Horikawa S; Hagiwara K; Kishimoto M; Ichikawa T; Otani S		Life Sci	64	1999	229-36	J:52344	10027757
87339	Transgenic mouse models for gonadal tumorigenesis.		Rahman NA; Kananen Rilianawati K; Paukku T; Mikola M; Markkula M ; Hamalainen T ; Huhtaniemi IT		Mol Cell Endocrinol	145	1998	167-74	J:52348	9922114
87340	Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium.		Jenkins TD; Mueller A; Odze R; Shahsafaei A; Zukerberg LR; Kent R; Stoner GD; Rustgi AK		Oncogene	18	1999	59-66	J:52375	9926920
87341	Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.		Koga Y; Naraparaju VR; Yamamoto N		Proc Soc Exp Biol Med	220	1999	20-6	J:52392	9893164
87342	Adoptive-transfer therapy of tumors with the tumor-specific primary cytotoxic T cells induced in vitro with the B7.1-transduced MCA205 cell line.		Kim SJ; Sadelain M; Lee JS; Seong RH; Yun YS; Jang YJ; Chung HY		Cancer Immunol Immunother	47	1999	257-64	J:52399	10022469
87343	Organ-specific pancreatic tumor growth properties and tumor immunity.		Morikane K; Tempero RM; Sivinski CL; Nomoto M; Van Lith ML; Muto T; Hollingsworth MA		Cancer Immunol Immunother	47	1999	287-96	J:52400	10022473
87344	Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.		Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC 3rd		Lab Invest	79	1999	3-14	J:52415	9952106
87345	Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells.		Mallia CM; Aguirre V; McGary E; Tang Y; Scandurro AB; Liu C; Noguchi CT; Beckman BS		Exp Cell Res	246	1999	348-54	J:52444	9925750
87346	Lymphatic endothelial tumors induced by intraperitoneal injection of incomplete Freund's adjuvant.		Mancardi S; Stanta G; Dusetti N; Bestagno M; Jussila L; Zweyer M; Lunazzi G; Dumont D; Alitalo K; Burrone OR		Exp Cell Res	246	1999	368-75	J:52445	9925752
87347	Diminished CYP2E1 expression and formation of 2-S-glutathionyl acetate, a glutathione conjugate derived from 1,1-dichloroethylene epoxide, in murine lung tumors.		Forkert PG; Malkinson AM; Rice P; Moussa M		Drug Metab Dispos	27	1999	68-73	J:52490	9884311
87348	Tumors and DNA adducts in mice exposed to benzo[a]pyrene and coal tars: implications for risk assessment.		Goldstein LS; Weyand EH; Safe S; Steinberg M; Culp SJ; Gaylor DW; Beland FA; Rodriguez LV		Environ Health Perspect	106 Suppl 6	1998	1325-30	J:52491	9860888
87349	Lung tumorigenic interactions in strain A/J mice of five environmental polycyclic aromatic hydrocarbons.		Nesnow S; Mass MJ; Ross JA; Galati AJ; Lambert GR; Gennings C; Carter WH Jr; Stoner GD		Environ Health Perspect	106 Suppl 6	1998	1337-46	J:52492	9860890
87350	Analysis of intrahepatic invasion of hepatocellular carcinoma using fluorescent dye-labeled cells in mice.		Kuriyama S; Yamazaki M; Mitoro A; Tsujimoto T; Kikukawa M; Okuda H; Tsujinoue H; Nakatani T; Yoshiji H; Toyokawa Y; Nagao S; Fukui H		Anticancer Res	18	1998	4181-8	J:52482	9891465
87351	Lack of tumor promoting activity of capsaicin, a principal pungent ingredient of red pepper, in mouse skin carcinogenesis.		Park KK; Chun KS; Yook JI; Surh YJ		Anticancer Res	18	1998	4201-5	J:52483	9891468
87352	Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in mice.		Ben-Hur H; Ben-Meir A; Hagay Z; Ben-Meir A; Berman V; Schwartsburd B; Gurevich P; Sandler B; Tendler Y; Zinder O; Zusman I		Anticancer Res	18	1998	4237-41	J:52484	9891473
87353	Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin.		Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM		Photochem Photobiol	69	1999	61-70	J:52512	10063801
87354	The genetic background modifies the spontaneous and X-ray-induced tumor spectrum in the Apc1638N mouse model.		van der Houven van Oordt CW; Smits R; Schouten TG; Houwing-Duistermaat JJ; Williamson SL; Luz A; Meera Khan P; van der Eb AJ; Breuer ML; Fodde R		Genes Chromosomes Cancer	24	1999	191-8	J:52560	10451698
87355	Cyclic AMP analogs induce synthesis, processing, and secretion of prepro nociceptin/orphanin FQ-derived peptides by NS20Y neuroblastoma cells.		Sirianni MJ; Fujimoto KI; Nelson CS; Pellegrino MJ; Allen RG		DNA Cell Biol	18	1999	51-8	J:52570	10025508
87356	Antimetastatic effects of electrochemotherapy and of histoincompatible interleukin-2-secreting cells in the murine Lewis lung tumor.		Orlowski S; An D; Belehradek J Jr; Mir LM		Anticancer Drugs	9	1998	551-6	J:52153	9877244
87357	In vitro anti-multidrug resistance activities of acyclic and cyclic disulfonamides in murine leukemia cells.		Wakusawa S; Sawanishi H; Hayashi H		Anticancer Res	18	1998	2961-5	J:51757	9713492
87358	Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells.		Di Blasi P; Bernareggi A; Beggiolin G; Piazzoni L; Menta E; Formento ML		Anticancer Res	18	1998	3113-7	J:52353	9713519
87359	Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.		Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D		Anticancer Res	18	1998	2567-73	J:52320	9703911
87360	PKC-dependent modulation of IkB alpha-NFkB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells.		La Porta CA; Comolli R		Anticancer Res	18	1998	2591-7	J:52139	9703914
87361	Mutations in the p53 and scid genes Do not cooperate in lymphomagenesis in doubly heterozygous mice		Kosugi S; Miyazawa T; Chou D; Saito Y; Shinbo T; Matsuki A; Okano H; Miyaji C; Watanabe H; Hatakeyama K; Niwa O; Kominami R		Biochem Biophys Res Commun	255	1999	99-103	J:52589	10082662
87362	Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.		Cao X; Ju DW; Tao Q; Wang J; Wan T; Wang BM; Zhang W; Hamada H		Gene Ther	5	1998	1130-6	J:52493	10326037
87363	E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).		St. Croix B; Sheehan C; Rak JW; Florenes VA; Slingerland JM; Kerbel RS		J Cell Biol	142	1998	557-71	J:52476	9679152
87364	Mutual education between hematopoietic cells and bone marrow stromal cells through direct cell-to-cell contact: factors that determine the growth of bone marrow stroma-dependent leukemic (HB-1) cells.		Jiang H; Sugimoto K; Sawada H; Takashita E; Tohma M; Gonda H; Mori KJ		Blood	92	1998	834-41	J:52140	9680351
87365	Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice [published erratum appears in Cancer Lett 1998 Sep 25;131(2):23	1]	Park KK; Chun KS; Lee JM; Lee SS; Surh YJ		Cancer Lett	129	1998	139-44	J:50992	9719454
87366	Pulmonary fibrosis caused by N-methyl-N-nitrosourethane inhibits lung tumorigenesis by urethane in transgenic mice carrying the human prototype c-Ha-ras gene.		Mitsumori K; Yasuhara K; Mori I; Hayashi S; Shimo T; Onodera H; Nomura T; Hayashi Y		Cancer Lett	129	1998	181-90	J:52138	9719460
87367	Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.		Hall SJ; Sanford MA; Atkinson G; Chen SH		Cancer Res	58	1998	3221-5	J:52498	9699645
87368	Blood perfusion in a murine fibrosarcoma tumor model after direct current electrotherapy:  A study with Rb extraction technique		Jarm T; Cemazar M; Sersa G; Miklavcic D		Electro Magnetobiol	17	1998	273-82	J:52495	 
87369	Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice.		Li H; Lu H; Griscelli F; Opolon P; Sun LQ; Ragot T; Legrand Y; Belin D; Soria J; Soria C; Perricaudet M; Yeh P		Gene Ther	5	1998	1105-13	J:52494	10326034
87370	gp100/pmel 17 is a murine tumor rejection antigen: induction of self-reactive, tumoricidal T cells using high-affinity, altered peptide ligand.		Overwijk WW; Tsung A; Irvine KR; Parkhurst MR; Goletz TJ; Tsung K; Carroll MW; Liu C; Moss B; Rosenberg SA; Restifo NP		J Exp Med	188	1998	277-86	J:52608	9670040
87371	Immune pathogenesis of hepatocellular carcinoma.		Nakamoto Y; Guidotti LG; Kuhlen CV; Fowler P; Chisari FV		J Exp Med	188	1998	341-50	J:52609	9670046
87372	Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships.		Ohsumi K; Nakagawa R; Fukuda Y; Hatanaka T; Morinaga Y; Nihei Y; Ohishi K; Suga Y; Akiyama Y; Tsuji T		J Med Chem	41	1998	3022-32	J:52610	9685242
87373	Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model.		Smith JB; Wickstrom E		J Natl Cancer Inst	90	1998	1146-54	J:52611	9701364
87374	Use of Druckrey analysis to quantitatively evaluate the chemopreventive efficacy of N-difluoromethylornithine (DFMO), a prototype proliferation inhibitor.		Boone CW; Steele VE; Gaylor D; Kelloff GJ		Mutat Res	402	1998	173-7	J:52613	9675271
87375	Beta-casomorphin-5 stimulates neurite outgrowth in a mouse neuroblastoma cell line (Neuro-2a).		Sakaguchi M; Murayama K; Yabe K; Satoh M; Takeuchi M; Matsumura E		Neurosci Lett	251	1998	97-100	J:52614	9718983
87376	Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development.		Thomasset N; Lochter A; Sympson CJ; Lund LR; Williams DR; Behrendtsen O; Werb Z; Bissell MJ		Am J Pathol	153	1998	457-67	J:52615	9708806
87377	Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.		Schirmacher P; Peters M; Ciliberto G; Blessing M; Lotz J; Meyer zum Buschenfelde KH; Rose-John S		Am J Pathol	153	1998	639-48	J:52616	9708822
87378	Potential antitumor alpha-methylene-gamma-butyrolactone-bearing nucleic acid base. 3. Synthesis of 5'-methyl-5'-[(6-substituted-9H-purin-9-yl)methyl]-2'-oxo-3'-methylenetetrahydro-furans.		Kim JC; Kim SH; Kim JA; Choi SK; Park WW		Arch Pharm Res	21	1998	458-64	J:52617	9875476
87379	Granulocyte-macrophage colony-stimulating factor induces the differentiation of murine erythroleukaemia cells into dendritic cells.		Cao X; Zhao Y; Yu Y; Wang Y; Zhang M; Zhang W; Wang J		Immunology	95	1998	141-7	J:52678	9767469
87380	Spontaneous murine lung adenocarcinoma (P07): A new experimental model to study paraneoplastic syndromes of lung cancer.		Diament MJ; Garcia C; Stillitani I; Saavedra VM; Manzur T; Vauthay L; Klein S		Int J Mol Med	2	1998	45-50	J:52679	9854141
87381	The potentiation of the effect of radiation treatment by intratumoral delivery of cisplatin.		Yapp DT; Lloyd DK; Zhu J; Lehnert SM		Int J Radiat Oncol Biol Phys	42	1998	413-20	J:52734	9788424
87382	Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-/- mice.		Cheo DL; Burns DK; Meira LB; Houle JF; Friedberg EC		Cancer Res	59	1999	771-5	J:52823	10029060
87383	Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor.		Stripecke R; Skelton DC; Gruber T; Afar D; Pattengale PK; Witte ON; Kohn DB		Hum Gene Ther	9	1998	2049-62	J:52692	9759932
87384	Evaluation and validation issues in the development of transgenic mouse carcinogenicity bioassays.		Tennant RW		Environ Health Perspect	106 Suppl 2	1998	473-6	J:52632	9599694
87385	Upregulation of apoptosis with dietary restriction: implications for carcinogenesis and aging.		James SJ; Muskhelishvili L; Gaylor DW; Turturro A; Hart R		Environ Health Perspect	106 Suppl 1	1998	307-12	J:52634	9539024
87386	Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines.		Yannai S; Day AJ; Williamson G; Rhodes MJ		Food Chem Toxicol	36	1998	623-30	J:52635	9734712
87387	Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice.		Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Rossi I; Di Carlo E; Musiani P; Muller WJ; Nanni P		Int J Cancer	77	1998	937-41	J:52636	9714068
87388	cAMP-dependent phosphorylation and hexamethylene-bis-acetamide induced dephosphorylation of p19 in murine erythroleukemia cells.		Scheele JS		Mol Cell Biochem	185	1998	55-63	J:52638	9746212
87389	Radio-sensitive murine thymoma cell line 3SB: characterization of its apoptosis-resistant variants induced by repeated X-irradiation.		Hama-Inaba H; Wang B; Mori M; Matsushima T; Saitoh T; Takusagawa M; Yamada T; Muto M; Ohyama H		Mutat Res	403	1998	85-94	J:52640	9726009
87390	p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma.		Holmgren L; Jackson G; Arbiser J		Oncogene	17	1998	819-24	J:52641	9779998
87391	Lincomycin abrogates dexamethasone-enhanced melanogenesis in B16 melanoma cells.		Kim DG; Kim HY; Kim MY; Lee MY; You KR		Pigment Cell Res	11	1998	143-50	J:52627	9730321
87392	Delivery of cytotoxic drugs from carrier cells to tumour cells by apoptosis.		Ma J; Gallo JM		Apoptosis	3	1998	195-202	J:52629	14646500
87393	Thymic lymphomas are resistant to Nur77-mediated apoptosis.		Matuszyk J; Kobzdej M; Ziolo E; Kalas W; Kisielow P; Strzadala L		Biochem Biophys Res Commun	249	1998	279-82	J:52630	9705872
87394	Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.		Lash CJ; Li AE; Rutland M; Baguley BC; Zwi LJ; Wilson WR		Br J Cancer	78	1998	439-45	J:52631	9716024
87395	An IgG3-IL-2 fusion protein recognizing a murine B cell lymphoma exhibits effective tumor imaging and antitumor activity.		Penichet ML; Harvill ET; Morrison SL		J Interferon Cytokine Res	18	1998	597-607	J:52656	9726441
87396	Effect of the combination of a local OK-432 injection and hyperthermia on SCC VII tumors in mice.		Yamada T; Hayashi Y; Kaneko R; Tohnai I; Ueda M; Ito M		J Radiat Res (Tokyo)	39	1998	101-9	J:52658	9735598
87397	A comparison of UVB-carcinogenesis between nude mice and nude beige mice.		Ishigaki Y; Yasuda K; Hashimoto N; Hayakawa J; Hiai H; Nikaido O		J Radiat Res (Tokyo)	39	1998	119-27	J:52659	9735600
87398	Cytotoxicity of lipoic acid and dihydrolipoic acid against malignant murine leukaemia cells: a comparison with ascorbic acid and dehydroascorbic acid.		Roomi MW; House D; Tsao CS		Med Sci Res	26	1998	461-463	J:52661	 
87399	Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.		Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE		Oncogene	17	1998	1119-30	J:52662	9764822
87400	Direct association of YY-1 with c-Myc and the E-box binding protein in regulation of glycophorin gene expression.		Zhao JH; Inoue T; Shoji W; Nemoto Y; Obinata M		Oncogene	17	1998	1009-17	J:52663	9747880
87401	Effects of O6-benzylguanine on growth and differentiation of P19 embryonic carcinoma cells treated with alkylating agents.		Seeley MR; Faustman EM		Teratog Carcinog Mutagen	18	1998	111-22	J:52664	9728795
87402	The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.		Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR		Philos Trans R Soc Lond B Biol Sci	353	1998	915-23	J:52642	9684289
87403	Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin.		Ando H; Ryu A; Hashimoto A; Oka M; Ichihashi M		Arch Dermatol Res	290	1998	375-81	J:52643	9749992
87404	Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours.		Bhujwalla ZM; McCoy CL; Glickson JD; Gillies RJ; Stubbs M		Br J Cancer	78	1998	606-11	J:52645	9744499
87405	Leukemic predisposition of mice transplanted with gene-modified hematopoietic precursors expressing flt3 ligand.		Hawley TS; Fong AZ; Griesser H; Lyman SD; Hawley RG		Blood	92	1998	2003-11	J:52673	9731058
87406	Bb1-3, a transgenic hybrid cell line with erythroid and megakaryocytic differentiation potential that expresses high levels of human gamma-globin and human beta-globin.		Thomson AM; Roberts NA; Wood WG		Br J Haematol	102	1998	976-85	J:52675	9734648
87407	Assessment of the carcinogenic potential of polyglycerol polyricinoleate (PGPR) in rats and mice		Smith MR; Wilson R; Hepburn PA		Food Chem Toxicol	36	1998	747-54	J:52677	9737421
87408	The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells.		Grutz GG; Bucher K; Lavenir I; Larson T; Larson R; Rabbitts TH		EMBO J	17	1998	4594-605	J:52668	9707419
87409	Characterization of the specific response to serotonin of mouse tumour-feeding arterioles.		Laemmel E; Stucker O; Darmon PL; Vicaut E		Int J Radiat Biol	74	1998	379-86	J:52669	9737540
87410	Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia.		Burd R; Dziedzic TS; Xu Y; Caligiuri MA; Subjeck JR; Repasky EA		J Cell Physiol	177	1998	137-47	J:52670	9731754
87411	Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.		Cory AH; Cory JG		Biochem Biophys Res Commun	249	1998	687-91	J:52672	9731198
87412	Induction of DNA breakage in X-irradiated nucleoids selectively stripped of nuclear proteins in two mouse lymphoma cell lines differing in radiosensitivity.		Kruszewski M; Iwanenko T		Acta Biochim Pol	45	1998	701-4	J:52698	9918497
87413	Pharmacokinetics and tissue distribution of the imidazoacridinone C1311 in tumour-bearing mice.		Calabrese CR; Bibby MC; Double JA; Loadman PM		Cancer Chemother Pharmacol	42	1998	379-85	J:52699	9771952
87414	Chromosome breakpoints near CpG islands in double minutes.		Foureman P; Winfield JA; Hahn PJ		Gene	218	1998	121-8	J:52700	9751810
87415	The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice.		Kato M; Liu W; Yi H; Asai N; Hayakawa A; Kozaki K; Takahashi M; Nakashima I		J Invest Dermatol	111	1998	640-4	J:52701	9764846
87416	Proteinases reduce metastatic dissemination and increase survival time in C57Bl6 mice with the Lewis lung carcinoma.		Wald M; Olejar T; Pouckova P; Zadinova M		Life Sci	63	1998	PL237-43	J:52702	9808069
87417	Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2.		Muller-Decker K; Kopp-Schneider A; Marks F; Seibert K; Furstenberger G		Mol Carcinog	23	1998	36-44	J:52703	9766436
87418	NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity.		Mangues R; Corral T; Lu S; Symmans WF; Liu L; Pellicer A		Oncogene	17	1998	1705-16	J:52704	9796699
87419	Rabies virus replication induces Bax-related, caspase dependent apoptosis in mouse neuroblastoma cells.		Ubol S; Sukwattanapan C; Utaisincharoen P		Virus Res	56	1998	207-15	J:52705	9783470
87420	Immunomodulation and antitumor activities of aged garlic extract.		Kyo E; Uda N; Suzuki A; Kakimoto M; Ushijima M; Kasuga S; Itakura Y		Phytomedicine	5	1998	259-267	J:52695	 
87421	Crocin and crocetin derivatives inhibit skin tumour promotion in mice.		Konoshima T; Takasaki M; Tokuda H; Morimoto S; Tanaka H; Kawata E; Xuan LJ; Saito H; Sugiura M; Molnar J; Shoyama Y		Phytother Res	12	1998	400-404	J:52696	 
87422	Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis.		Alonso DF; Farina HG; Skilton G; Gabri MR; De Lorenzo MS; Gomez DE		Breast Cancer Res Treat	50	1998	83-93	J:52727	9802623
87423	Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer.		Webb MS; Logan P; Kanter PM; St.-Onge G; Gelmon K; Harasym T; Mayer LD; Bally MB		Cancer Chemother Pharmacol	42	1998	461-70	J:52728	9788572
87424	Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes.		Zhang Y; Talalay P		Cancer Res	58	1998	4632-9	J:52730	9788615
87425	Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes.		Ganss R; Hanahan D		Cancer Res	58	1998	4673-81	J:52731	9788621
87426	Decreased protein levels of the c-Cbl protooncogene in murine AIDS.		Trebak M; Lambert CA; Rahmouni S; Debrus S; Defresne MP; Regnier D; Boniver J; Moutschen M		Cell Immunol	188	1998	151-7	J:52732	9756645
87427	Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver.		Maione D; Di Carlo E; Li W; Musiani P; Modesti A; Peters M; Rose-John S; Della Rocca C; Tripodi M; Lazzaro D; Taub R; Savino R; Ciliberto G		EMBO J	17	1998	5588-97	J:52733	9755159
87428	Differential downstream functions of protein kinase Ceta and -theta in EL4 mouse thymoma cells.		Resnick MS; Kang BS; Luu D; Wickham JT; Sando JJ; Hahn CS		J Biol Chem	273	1998	27654-61	J:52735	9765301
87429	Pharmacokinetics, antifolate activity and tissue distribution of PT523 in SCC VII tumor-bearing mice [published erratum appears in Cancer Chemother Pharmacol 1999;43(6):522]		Wright JE; Pardo M; Tretyakov A; Alperin WL; Trites D; Rosowsky A		Cancer Chemother Pharmacol	42	1998	300-6	J:52707	9744775
87430	Regulation of mouse Ah receptor (Ahr) gene basal expression by members of the Sp family of transcription factors.		Fitzgerald CT; Nebert DW; Puga A		DNA Cell Biol	17	1998	811-22	J:52708	9778040
87431	Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment.		Kuriyama S; Sakamoto T; Kikukawa M; Nakatani T; Toyokawa Y; Tsujinoue H; Ikenaka K; Fukui H; Tsujii T		Gene Ther	5	1998	1299-305	J:52709	9930334
87432	Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression.		Kiyozuka Y; Asai A; Senzaki H; Uemura Y; Nakashima A; Morimoto J; Matsuzawa A; Tsubura A		Int J Mol Med	2	1998	437-444	J:52711	9857231
87433	Hepatocyte growth factor/scatter factor and hepatocytes are potent downregulators of tyrosinase expression in B16 melanoma cells.		Rusciano D; Lorenzoni P; Lin S; Burger MM		J Cell Biochem	71	1998	264-76	J:52712	9779824
87434	Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.		Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH		J Immunol	161	1998	3957-65	J:52713	9780164
87435	Role of cytokines in GVL (ESb lymphoma) and GVHD after adoptive transfer of allogeneic T lymphocytes in mice.		Gresser I; Greco G; Santini SM; Woodrow D; Mecchia M; Parlato S; Logozzi M; Venditti M; Maunoury MT; Belardelli F		J Interferon Cytokine Res	18	1998	667-79	J:52714	9781805
87436	Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation.		Ao Y; Park HY; Olaizola-Horn S; Gilchrest BA		Exp Cell Res	244	1998	117-24	J:52745	9770355
87437	Intracerebral bispecific ligand-antibody conjugate increases survival of animals bearing endogenously arising brain tumors.		Patrick TA; Kranz DM; Zachary JF; Roy EJ		Int J Cancer	78	1998	470-9	J:52746	9797136
87438	Differentiation of EL4 lymphoma cells by tumoral environment is associated with inappropriate expression of the large chondroitin sulfate proteoglycan PG-M and the tumor-associated antigen HTgp-175.		Rottiers P; Verfaillie T; Contreras R; Revets H; Desmedt M; Dooms H; Fiers W; Grooten J		Int J Cancer	78	1998	503-10	J:52747	9797141
87439	Characterization of the phosphoinositide-linked dopamine receptor in a mouse hippocampal-neuroblastoma hybrid cell line.		Jin LQ; Cai G; Wang HY; Smith C; Friedman E		J Neurochem	71	1998	1935-43	J:52748	9798918
87440	Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.		Kundu SD; Kim IY; Zelner D; Janulis L; Goodwin S; Engel JD; Lee C		J Urol	160	1998	1883-8	J:52736	9783979
87441	Differential inhibitory effect of OK-1035 on DNA repair in L5178Y murine lymphoma sublines with functional or defective repair of double strand breaks.		Kruszewski M; Wojewodzka M; Iwanenko T; Szumiel I; Okuyama A		Mutat Res	409	1998	31-6	J:52738	9806500
87442	Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice.		Weissig V; Whiteman KR; Torchilin VP		Pharm Res	15	1998	1552-6	J:52739	9794497
87443	Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells.		Kuzumaki T; Kobayashi T; Ishikawa K		Biochem Biophys Res Commun	251	1998	291-5	J:52740	9790949
87444	Natural forms of shed tumor gangliosides.		Kong Y; Li R; Ladisch S		Biochim Biophys Acta	1394	1998	43-56	J:52741	9767101
87445	Synergistic effect of Epstein-Barr virus and tumor promoters on induction of lymphoma and carcinoma in nude mice.		Liu Z; Liu Y; Zeng Y		J Cancer Res Clin Oncol	124	1998	541-8	J:52768	9829857
87446	Discordant effects of activator protein-1 transcription factor on gene regulation, invasion, and metastasis in spontaneous, radiation-induced, and fos-induced osteosarcomas.		Rupp B; Lorenz U; Schmidt J; Werenskiold AK		Mol Carcinog	23	1998	69-75	J:52769	9808160
87447	Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs.		Lim YS; Kang BY; Kim EJ; Kim SH; Hwang SY; Kim TS		Mol Cells	8	1998	629-36	J:52770	9856353
87448	Influence of an interferon inducer on bone marrow transplant reconstitution in irradiated, leukemic mice: elevated natural killer cell numbers and improved life span.		Currier NL; Miller SC		Nat Immun	16	1998	6-17	J:52771	9789120
87449	Effect of evening primrose and fish oils on two stage skin carcinogenesis in mice.		Ramesh G; Das UN		Prostaglandins Leukot Essent Fatty Acids	59	1998	155-61	J:52772	9844986
87450	Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia.		Zhang X; Ren R		Blood	92	1998	3829-40	J:52773	9808576
87451	Differential nitric oxide release and sensitivity to injury in different murine mammary tumor cell lines.		Eijan AM; Davel LE; Rueda HA; Rozenberg G; De Lustig ES; Jasnis MA		Int J Mol Med	2	1998	625-630	J:52776	9858663
87452	Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate.		Corbett TH; LoRusso P; Demchick L; Simpson C; Pugh S; White K; Kushner J; Polin L; Meyer J; Czarnecki J; Heilbrun L; Horwitz JP; Gross JL; Behrens CH; Harrison BA; McRipley RJ; Trainor G		Invest New Drugs	16	1998	129-39	J:52777	9848576
87453	Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model.		Souberbielle BE; Westby M; Ganz S; Kayaga J; Mendes R; Morrow WJ; Dalgleish AG		Gene Ther	5	1998	1447-54	J:52762	9930297
87454	High-resolution analysis of cytosine methylation in the 5long terminal repeat of retroviral vectors.		Wang L; Robbins PB; Carbonaro DA; Kohn DB		Hum Gene Ther	9	1998	2321-30	J:52764	9829531
87455	Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis.		Bergers G; Hanahan D; Coussens LM		Int J Dev Biol	42	1998	995-1002	J:52765	9853830
87456	Hepatocyte growth factor in transgenic mice.		Shiota G; Kawasaki H		Int J Exp Pathol	79	1998	267-77	J:52766	10193310
87457	Chromatin immunoselection defines a TAL-1 target gene.		Cohen-Kaminsky S; Maouche-Chretien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Romeo PH		EMBO J	17	1998	5151-60	J:52787	9724651
87458	Fas and Fas ligand interactions suppress melanoma lung metastasis.		Owen-Schaub LB; van Golen KL; Hill LL; Price JE		J Exp Med	188	1998	1717-23	J:52778	9802983
87459	Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.		Wang J; Saffold S; Cao X; Krauss J; Chen W		J Immunol	161	1998	5516-24	J:52780	9820528
87460	Genistein exerts estrogen-like effects in male mouse reproductive tract.		Strauss L; Makela S; Joshi S; Huhtaniemi I; Santti R		Mol Cell Endocrinol	144	1998	83-93	J:52781	9863629
87461	A model for spontaneous B-lineage lymphomas in IgHmu-HOX11 transgenic mice.		Hough MR; Reis MD; Singaraja R; Bryce DM; Kamel-Reid S; Dardick I; Breitman ML; Dube ID		Proc Natl Acad Sci U S A	95	1998	13853-8	J:52782	9811890
87462	Short-term biomarkers of tumor promotion in mouse skin treated with petroleum middle distillates.		Walborg EF Jr; DiGiovanni J; Conti CJ; Slaga TJ; Freeman JJ; Steup DR; Skisak CM		Toxicol Sci	45	1998	137-45	J:52783	9848120
87463	Lung tumor induction by inhalation exposure to molybdenum trioxide in rats and mice.		Chan PC; Herbert RA; Roycroft JH; Haseman JK; Grumbein SL; Miller RA; Chou BJ		Toxicol Sci	45	1998	58-65	J:52784	9848111
87464	Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site.		Halak BK; Maguire HC Jr; Lattime EC		Cancer Res	59	1999	911-7	J:52821	10029084
87465	Inhibitory effects of isopropyl-2-(1,3-dithietane-2-ylidene)-2- [N-(4-methylthiazol-2-yl)carbamoyl]acetate (YH439) on benzo[a]pyrene-induced skin carcinogenesis and micronucleated reticulocyte formation in mice.		Surh YJ; Kim SG; Liem A; Lee JW; Miller JA		Mutat Res	423	1999	149-53	J:52806	10029692
87466	H-2-controlled genetic susceptibility to pulmonary adenomas induced by urethane and 4-nitroquinoline 1-oxide in A/Wy congenic strains.		Miyashita N; Moriwaki K		Jpn J Cancer Res	78	1987	494-8	J:52845	3112061
87467	Transcriptional regulation by butyrate of mouse galectin-1 gene in embryonal carcinoma cells.		Lu Y; Lotan R		Biochim Biophys Acta	1444	1999	85-91	J:52825	9931450
87468	Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.		Bergman AM; Pinedo HM; Jongsma AP; Brouwer M; Ruiz van Haperen VW; Veerman G; Leyva A; Eriksson S; Peters GJ		Biochem Pharmacol	57	1999	397-406	J:52885	9933028
87469	Purification of a growth-suppressing factor for bovine artery endothelial cells from mouse lymphoma P388D1 cells.		Usui S; Matsunaga T; Ukai S; Kiho T; Hirano K		Biol Pharm Bull	22	1999	16-20	J:52886	9989655
87470	Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells.		Okada F; Nakai K; Kobayashi T; Shibata T; Tagami S; Kawakami Y; Kitazawa T; Kominami R; Yoshimura S; Suzuki K; Taniguchi N; Inanami O; Kuwabara M; Kishida H; Nakae D; Konishi Y; Moriuchi T; Hosokawa M		Br J Cancer	79	1999	377-85	J:52888	10027302
87471	238Pu alpha-particle-induced C3H10T1/2 transformants are less tumorigenic than the X-ray-induced equivalent.		Lehane MM; Bryant PE; Riches AC; Allen LA; Briscoe CV; Melville J; Mill AJ		Carcinogenesis	20	1999	35-40	J:52889	9934847
87472	Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.		Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T		Gene Ther	6	1999	91-7	J:52919	10341880
87473	Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice.		Nomura T; Yasuda K; Yamada T; Okamoto S; Mahato RI; Watanabe Y; Takakura Y; Hashida M		Gene Ther	6	1999	121-9	J:52920	10341884
87474	Suppression of spontaneous hepatocellular carcinoma development in C3H/HeNCrj mice by the lipophilic ascorbic acid, 2-O-octadecylascorbic acid (CV-3611).		Kushida H; Wakabayashi K; Suzuki M; Takahashi S; Imaida K; Sugimura T; Nagao M		Carcinogenesis	13	1992	913-5	J:1434	1318171
87475	Passively transferred anti-MUC1 antibodies cause neither autoimmune disorders nor immunity against transplanted tumors in MUC1 transgenic mice.		Tempero RM; Rowse GJ; Gendler SJ; Hollingsworth MA		Int J Cancer	80	1999	595-9	J:52927	9935162
87476	Interleukin-10 gene transfer activates interferon-gamma and the interferon-gamma-inducible genes Gbp-1/Mag-1 and Mig-1 in mammary tumors.		Sun H; Jackson MJ; Kundu N; Fulton AM		Int J Cancer	80	1999	624-9	J:52928	9935167
87477	Antitumor effect of electrochemotherapy on colorectal carcinoma in an orthotopic mouse model.		Kuriyama S; Kikukawa M; Mitoro A; Tsujinoue H; Nakatani T; Yamazaki M; Yoshiji H; Toyokawa Y; Yoshikawa M; Fukui H		Int J Oncol	14	1999	321-6	J:52931	9917509
87478	Inhibition of natural killer cell activity in mice treated with tobacco specific carcinogen NNK.		Goud SN; Kaplan AM		J Toxicol Environ Health	56	1999	131-44	J:52947	9972924
87479	WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts.		Hosono S; Luo X; Hyink DP; Schnapp LM; Wilson PD; Burrow CR; Reddy JC; Atweh GF; Licht JD		Oncogene	18	1999	417-27	J:52959	9927198
87480	Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.		Malumbres M; Perez de Castro I; Santos J; Fernandez Piqueras J; Pellicer A		Oncogene	18	1999	385-96	J:52958	9927195
87481	Analysis of effector cells in tumor-bearing mice pre-treated with active specific immunization followed by cyclophosphamide.		Li L; Okino T; Kan N; Yamasaki S; Ichinose Y; Sugie T; Kanaoka S; Imamura M		Biotherapy	11	1998	223-8	J:52998	9950097
87482	Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice.		Ebina T; Fujimiya Y		Biotherapy	11	1998	259-65	J:52999	9950102
87483	The role of p53 in tumour suppression: lessons from mouse models.		Attardi LD; Jacks T		Cell Mol Life Sci	55	1999	48-63	J:53055	10065151
87484	Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.		Lode HN; Moehler T; Xiang R; Jonczyk A; Gillies SD; Cheresh DA; Reisfeld RA		Proc Natl Acad Sci U S A	96	1999	1591-6	J:53062	9990069
87485	Low density lipoprotein (LDL)-mediated suppression of Lewis lung carcinoma in hypercholesterolemic LDL receptor-deficient mice.		Trieu VN; Uckun FM		Biochem Biophys Res Commun	255	1999	377-81	J:53068	10049716
87486	Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma.		Matsumoto T; Fujimoto-Ouchi K; Tamura S; Tanaka Y; Ishitsuka H		Br J Cancer	79	1999	764-9	J:53096	10070867
87487	RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice.		Khandelwal SR; Kavanagh BD; Lin PS; Truong QT; Lu J; Abraham DJ; Schmidt-Ullrich RK		Br J Cancer	79	1999	814-20	J:53097	10070874
87488	The adhesion of anti-CD3-activated mouse T cells to syngeneic colon adenocarcinoma cells is differentially regulated by protein tyrosine kinase-, protein kinase C-, and cAMP-dependent pathways in the effector cell.		MacKenzie WM; Hoskin DW; Blay J		Biochem Biophys Res Commun	255	1999	460-5	J:53117	10049731
87489	The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene.		Christofori G; Semb H		Trends Biochem Sci	24	1999	73-6	J:53102	10098402
87490	Chronic exercise increases macrophage-mediated tumor cytolysis in young and old mice.		Lu Q; Ceddia MA; Price EA; Ye SM; Woods JA		Am J Physiol	276	1999	R482-9	J:53126	9950928
87491	Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.		Watanabe H; Shimokado K; Asahara T; Dohi K; Niwa O		Jpn J Cancer Res	90	1999	40-7	J:53157	10076563
87492	pRb and E2f-1 in mouse development and tumorigenesis.		Macleod K		Curr Opin Genet Dev	9	1999	31-9	J:53158	10072353
87493	Inhibition of DNA synthesis by a farnesyltransferase inhibitor involves inhibition of the p70(s6k) pathway.		Law BK; Norgaard P; Gnudi L; Kahn BB; Poulson HS; Moses HL		J Biol Chem	274	1999	4743-8	J:51485	9988711
87494	Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse.		Balasubramanian S; Kim KH; Ahmad N; Mukhtar H		Oncogene	18	1999	1297-302	J:53213	10022811
87495	Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis.		Martin DC; Sanchez-Sweatman OH; Ho AT; Inderdeo DS; Tsao MS; Khokha R		Lab Invest	79	1999	225-34	J:53232	10068210
87496	Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation.		Colucci F; Soudais C; Rosmaraki E; Vanes L; Tybulewicz VL; Di Santo JP		J Immunol	162	1999	2761-5	J:53222	10072522
87497	Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state.		Farrar JD; Katz KH; Windsor J; Thrush G; Scheuermann RH; Uhr JW; Street NE		J Immunol	162	1999	2842-9	J:53224	10072532
87498	Molecular mechanisms of thyroid hormone-stimulated steroidogenesis in mouse leydig tumor cells. Involvement of the steroidogenic acute regulatory (StAR) protein.		Manna PR; Tena-Sempere M; Huhtaniemi IT		J Biol Chem	274	1999	5909-18	J:53257	10026215
87499	Influence of host microvascular environment on tumour vascular endothelium.		Kubitza M; Hickey L; Roberts WG		Int J Exp Pathol	80	1999	1-10	J:53299	10365081
87500	Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo.		Fields RC; Shimizu K; Mule JJ		Proc Natl Acad Sci U S A	95	1998	9482-7	J:53326	9689106
87501	Splenic marginal zone lymphomas of mice.		Fredrickson TN; Lennert K; Chattopadhyay SK; Morse HC 3rd; Hartley JW		Am J Pathol	154	1999	805-12	J:53351	10079258
87502	Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma.		Elchebly M; Wagner J; Kennedy TE; Lanctot C; Michaliszyn E; Itie A ; Drouin J ; Tremblay ML		Nat Genet	21	1999	330-3	J:53434	10080191
87503	Identification of a second major tumor-specific antigen recognized by CTLs on mouse mastocytoma P815.		Bilsborough J; Van Pel A; Uyttenhove C; Boon T; Van den Eynde BJ		J Immunol	162	1999	3534-40	J:53420	10092811
87504	Lysis of tumor cells by natural killer cells in mice is impeded by platelets.		Nieswandt B; Hafner M; Echtenacher B; Mannel DN		Cancer Res	59	1999	1295-300	J:53452	10096562
87505	Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.		Won J; Kim H; Park EJ; Hong Y; Kim SJ; Yun Y		Cancer Res	59	1999	1273-7	J:53453	10096559
87506	Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.		Lozonschi L; Sunamura M; Kobari M; Egawa S; Ding L; Matsuno S		Cancer Res	59	1999	1252-8	J:53454	10096556
87507	A mutational analysis of the Abetaz/Aalphad major histocompatibility complex class II molecule that restricts autoreactive T cells in (NZBxNZW)F1 mice. The critical influence of alanine at position 69 in the Aalphad chain.		Sai T; Mine M; Fukuoka M; Koarada S; Kimoto M		Immunology	96	1999	325-32	J:53444	10233712
87508	Use of a novel fibronectin receptor for liver infiltration by a mouse lymphoma cell line RL-male1.		Gazi MH; Ito M		Cancer Res	59	1999	1115-9	J:53479	10070971
87509	Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.		Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M		J Immunol	162	1999	3574-82	J:53458	10092816
87510	T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.		Marzo AL; Lake RA; Robinson BW; Scott B		Cancer Res	59	1999	1071-9	J:53480	10070965
87511	Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis.		Iozzo RV; Chakrani F; Perrotti D; McQuillan DJ; Skorski T; Calabretta B; Eichstetter I		Proc Natl Acad Sci U S A	96	1999	3092-7	J:53511	10077642
87512	Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin.		Cemazar M; Miklavcic D; Scancar J; Dolzan V; Golouh R; Sersa G		Br J Cancer	79	1999	1386-91	J:53529	10188880
87513	Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells.		Groisman IJ; Koshy R; Henkler F; Groopman JD; Alaoui-Jamali MA		Carcinogenesis	20	1999	479-83	J:53530	10190565
87514	Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.		Montecchia MF; Lamb C; Molinolo AA; Luthy IA; Pazos P; Charreau E; Vanzulli S; Lanari C		J Steroid Biochem Mol Biol	68	1999	11-21	J:53532	10215033
87515	Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.		Fernando GJ; Murray B; Zhou J; Frazer IH		Clin Exp Immunol	115	1999	397-403	J:53533	10193409
87516	Apoptotic changes precede mitochondrial dysfunction in red cell-type pyruvate kinase mutant mouse erythroleukemia cell lines.		Aisaki K; Kanno H; Oyaizu N; Hara Y; Miwa S; Ikawa Y		Jpn J Cancer Res	90	1999	171-9	J:53535	10189887
87517	Differential induction of apoptosis in B16 melanoma and EL-4 lymphoma cells by cytostatin and bactobolin.		Kawada M; Amemiya M; Ishizuka M; Takeuchi T		Jpn J Cancer Res	90	1999	219-25	J:53536	10189893
87518	Class II antigen processing defects in two H2d mouse cell lines are caused by point mutations in the H2-DMa gene.		Russell HI; York IA; Rock KL; Monaco JJ		Eur J Immunol	29	1999	905-11	J:53522	10092094
87519	THF-gamma 2-mediated reduction of pulmonary metastases and augmentation of immuno-competence in C57BL/6 mice bearing B16-melanoma.		Ophir R; Moalem G; Pecht M; Shashoua M; Rashid G; Ben-Efraim S; Trainin N; Burstein Y; Keisari Y		J Immunother	22	1999	103-13	J:53524	10093035
87520	Coinfusion of irradiated splenocytes with low titer tumor-infiltrating lymphocytes augments antitumor efficacy in adoptive immunotherapy.		Averbook BJ; Cleveland RP; Viscusi C; Papay R		J Immunother	22	1999	124-34	J:53525	10093037
87521	Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy.		Rakhmilevich AL; Timmins JG; Janssen K; Pohlmann EL; Sheehy MJ; Yang NS		J Immunother	22	1999	135-44	J:53526	10093038
87522	Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice.		Bibby MC; Thompson MJ; Rafferty JA; Margison GP; McElhinney RS		Br J Cancer	79	1999	1332-9	J:53527	10188873
87523	Hypoxia significantly reduces aminolaevulinic acid-induced protoporphyrin IX synthesis in EMT6 cells.		Georgakoudi I; Keng PC; Foster TH		Br J Cancer	79	1999	1372-7	J:53528	10188878
87524	Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.		Schreiber M; Muller WJ; Singh G; Graham FL		Oncogene	18	1999	1663-76	J:53547	10208428
87525	Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors.		Schmidt M; Maurer-Gebhard M; Groner B; Kohler G; Brochmann-Santos G; Wels W		Oncogene	18	1999	1711-21	J:53548	10208432
87526	Increased E1AF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression.		Habelhah H; Okada F; Kobayashi M; Nakai K; Choi S; Hamada J; Moriuchi T; Kaya M; Yoshida K; Fujinaga K; Hosokawa M		Oncogene	18	1999	1771-6	J:53549	10208438
87527	In vivo elimination of viral superantigen-activated CD4+ T cells: apoptosis occurs at a distance from the activation site.		Le Bon A; Wache AC; Papiernik M		Int Immunol	11	1999	373-82	J:53551	10221649
87528	A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.		Patek CE; Little MH; Fleming S; Miles C; Charlieu JP; Clarke AR ; Miyagawa K ; Christie S ; Doig J ; Harrison DJ ; Porteous DJ ; Brookes AJ ; Hooper ML ; Hastie ND		Proc Natl Acad Sci U S A	96	1999	2931-6	J:53585	10077614
87529	Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage: version 3.		Friedberg EC; Meira LB		Mutat Res	433	1999	69-87	J:53596	10102034
87530	Pharmacological characterization of beta2-adrenoceptor in PGT-beta mouse pineal gland tumour cells.		Suh BC; Chae HD; Chung JH; Kim KT		Br J Pharmacol	126	1999	399-406	J:53661	10077231
87531	B7-2 expressed on EL4 lymphoma suppresses antitumor immunity by an interleukin 4-dependent mechanism.		Stremmel C; Greenfield EA; Howard E; Freeman GJ; Kuchroo VK		J Exp Med	189	1999	919-30	J:53621	10075975
87532	Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.		Hull MA; Booth JK; Tisbury A; Scott N; Bonifer C; Markham AF; Coletta PL		Br J Cancer	79	1999	1399-405	J:53622	10188882
87533	Effect of plumbagin on the radiation induced cytogenetic and cell cycle changes in mouse Ehrlich ascites carcinoma in vivo.		Devi PU; Rao BS; Solomon FE		Indian J Exp Biol	36	1998	891-5	J:53639	9854429
87534	Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18.		Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M		Anticancer Res	18	1998	4267-74	J:53653	9891477
87535	Genotoxicity of iron compounds in Salmonella typhimurium and L5178Y mouse lymphoma cells.		Dunkel VC; San RH; Seifried HE; Whittaker P		Environ Mol Mutagen	33	1999	28-41	J:53675	10037321
87536	A PEA3 site flanked by SP1, SP4, and GATA sites positively regulates the differentiation-dependent expression of Brachyury in embryonal carcinoma P19 cells.		Yamaguchi H; Tanaka K; Kitagawa Y; Miki K		Biochem Biophys Res Commun	254	1999	542-7	J:53658	9920775
87537	Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency.		Fu YM; Yu ZX; Pelayo BA; Ferrans VJ; Meadows GG		Cancer Res	59	1999	758-65	J:53663	9973229
87538	Detection of differentially expressed gelatinase A in metastatic and non-metastatic subpopulations of tumor cells by target RNA arbitrarily primed polymerase chain reaction (TRAP-PCR).		Vinyals A; Alia P; Llorens A; Adrover M; Gonzalez-Garrigues M; Masramon L; Peinado MA; Fabra A		Clin Exp Metastasis	16	1998	603-11	J:53667	9932607
87539	Growth and dissemination of a newly-established murine B-cell lymphoma cell line is inhibited by multimeric YIGSR peptide.		Michigami T; Nomizu M; Yamada Y; Dunstan C; Williams PJ; Munday GR; Yoneda T		Clin Exp Metastasis	16	1998	645-54	J:53668	9932611
87540	Possible carcinogenic effects of X-rays in a transgenerational study with CBA mice.		Mohr U; Dasenbrock C; Tillmann T; Kohler M; Kamino K; Hagemann G ; Morawietz G ; Campo E ; Cazorla M ; Fernandez P ; Hernandez L ; Cardesa A ; Tomatis L		Carcinogenesis	20	1999	325-32	J:53702	10069472
87541	5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model.		Lantry LE; Zhang Z; Crist KA; Wang Y; Kelloff GJ; Lubet RA; You M		Carcinogenesis	20	1999	343-6	J:53703	10069475
87542	Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model.		Tseng YL; Hong RL; Tao MH; Chang FH		Int J Cancer	80	1999	723-30	J:53683	10048974
87543	Genetic dissection of murine susceptibilities to liver and lung tumors based on the two-stage concept of carcinogenesis.		Lee GH		Pathol Int	48	1998	925-33	J:53716	9952336
87544	The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice.		Ono K; Masunaga S; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M		Int J Radiat Oncol Biol Phys	43	1999	431-6	J:53710	10030272
87545	Binding partners for the myelin-associated glycoprotein of N2A neuroblastoma cells.		Strenge K; Schauer R; Kelm S		FEBS Lett	444	1999	59-64	J:53744	10037148
87546	Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.		Milan G; Zambon A; Cavinato M; Zanovello P; Rosato A; Collavo D		J Virol	73	1999	2280-7	J:53754	9971811
87547	Cytotoxicity of substituted alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 lymphoid leukemia cells.		Burnham BS; Gupton JT; Krumpe K; Webb T; Shuford J; Bowers B; Warren AE; Barnes C; Hall IH		Arch Pharm (Weinheim)	331	1998	337-41	J:53726	9881055
87548	Tumorigenicity of mouse BALB/c 3T3 fibroblast cells which express Epstein-Barr virus-encoded LMP1 and show normal growth phenotypes in vitro is correlated with loss of transforming growth factor-beta 1-mediated growth inhibition.		Takanashi M; Li J; Shirakata M; Mori S; Hirai K		Arch Virol	144	1999	241-57	J:53727	10470251
87549	Advantages of the CBA mouse in leukemogenesis research.		Rithidech KN; Cronkite EP; Bond VP		Blood Cells Mol Dis	25	1999	38-45	J:53730	10349512
87550	High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma.		Busetti A; Soncin M; Jori G; Rodgers MA		Br J Cancer	79	1999	821-4	J:53732	10070875
87551	A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha.		Horton HM; Anderson D; Hernandez P; Barnhart KM; Norman JA; Parker SE		Proc Natl Acad Sci U S A	96	1999	1553-8	J:53766	9990062
87552	Interactive effects of c-myc and transforming growth factor alpha transgenes on liver tumor development in simian virus 40 T antigen transgenic mice.		Enomoto A; Sandgren EP; Maronpot RR		Vet Pathol	35	1998	283-91	J:53769	9684972
87553	Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16.		Bubenik J; Simova J; Hajkova R; Sobota V; Jandlova T; Smahel M; Sobotkova E; Vonka V		Int J Oncol	14	1999	593-7	J:53784	10024696
87554	Synergistic effects of some pairs of antioxidants and related agents on mouse leukaemia L5178Y cell growth in-vitro.		Suzuki T; Ezure T; Ishida M		J Pharm Pharmacol	50	1998	1173-7	J:53786	9821666
87555	ATF-2-binding regulatory element is responsible for the Ly49A expression in murine T lymphoid line, EL-4.		Kubo S; Nagasawa R; Nishimura H; Shigemoto K; Maruyama N		Biochim Biophys Acta	1444	1999	191-200	J:53791	10023056
87556	Induction of autocrine factor inhibiting cell motility from murine B16-BL6 melanoma cells by alpha-melanocyte stimulating hormone.		Murata J; Ayukawa K; Ogasawara M; Watanabe H; Saiki I		Int J Cancer	80	1999	889-95	J:53783	10074923
87557	T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice.		Schuler T; Qin Z; Ibe S; Noben-Trauth N; Blankenstein T		J Exp Med	189	1999	803-10	J:53801	10049944
87558	Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas.		Buters JT; Sakai S; Richter T; Pineau T; Alexander DL; Savas U; Doehmer J; Ward JM; Jefcoate CR; Gonzalez FJ		Proc Natl Acad Sci U S A	96	1999	1977-82	J:53827	10051580
87559	Murine protein kinase CK2: gene and oncogene.		Xu X; Landesman-Bollag E; Channavajhala PL; Seldin DC		Mol Cell Biochem	191	1999	65-74	J:53821	10094394
87560	Regulation of UDP-N-acetylglucosamine:dolichyl-phosphate N-acetylglucosamine-1-phosphate transferase by retinoic acid in P19 cells.		Meissner JD; Naumann A; Mueller WH; Scheibe RJ		Biochem J	338	1999	561-8	J:53843	10024536
87561	Tumor promoting effect of N-nitroso-N-(2-hexanonyl)-3'-nitrotyramine (a nitrosated Maillard reaction product) in benzo(a)pyrene-initiated mouse skin carcinogenesis.		Tseng TH; Chang MC; Hsu JD; Lee MJ; Hsu CL; Lan KP; Wang CJ		Chem Biol Interact	115	1998	23-38	J:53847	9817073
87562	Can cellular phototoxicity be accurately predicted on the basis of sensitizer photophysics?		Aveline BM; Redmond RW		Photochem Photobiol	69	1999	306-16	J:53876	10089822
87563	Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.		Li YX; Papkoff J; Sarkar NH		Virology	255	1999	138-49	J:53878	10049829
87564	Expression of MDM2 during mammary tumorigenesis.		Pinkas J; Naber SP; Butel JS; Medina D; Jerry DJ		Int J Cancer	81	1999	292-8	J:53910	10188733
87565	Making the most of rodent tumour systems in cancer drug discovery.		Bibby MC		Br J Cancer	79	1999	1633-40	J:53942	10206270
87566	In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance.		Mistry P; Plumb J; Eccles S; Watson S; Dale I; Ryder H; Box G; Charlton P; Templeton D; Bevan PB		Br J Cancer	79	1999	1672-8	J:53943	10206276
87567	A novel class of lipophilic quinazoline-based folic acid analogues: cytotoxic agents with a folate-independent locus.		Skelton LA; Ormerod MG; Titley J; Kimbell R; Brunton LA; Jackman AL		Br J Cancer	79	1999	1692-701	J:53944	10206279
87568	Regulation of c-met expression in B16 murine melanoma cells by melanocyte stimulating hormone.		Rusciano D; Lorenzoni P; Burger MM		J Cell Sci	112	1999	623-30	J:53961	9973597
87569	WT1: what has the last decade told us?		Little M; Holmes G; Walsh P		Bioessays	21	1999	191-202	J:54043	10333728
87570	RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice.		Nikitin AY; Juarez-Perez MI; Li S; Huang L; Lee WH		Proc Natl Acad Sci U S A	96	1999	3916-21	J:54083	10097138
87571	Characterization of expression of the gene for human pterin carbinolamine dehydratase/ dimerization cofactor of HNF1.		Lei XD; Kaufman S		DNA Cell Biol	18	1999	243-52	J:54113	10098606
87572	Evaluation of three lines of immunodeficient mice for the study of spontaneous metastatic tumors.		Gallo-Hendrikx E; Percy D; Copps J; McKeown B; Quinton M; McMillan I; Croy BA; Wildeman AG		APMIS	107	1999	245-56	J:54114	10225324
87573	Seed versus soil: the importance of the target cell for transgenic models of human leukemias.		Westervelt P; Ley TJ		Blood	93	1999	2143-8	J:54116	10090920
87574	An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumorigenesis.		Herzig M; Novatchkova M; Christofori G		Biol Chem	380	1999	203-11	J:54150	10195427
87575	The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy.		Svechnikova IG; Korolenko TA; Stashko JuF; Kaledin VI; Nikolin VP; Nowicky JW		Drugs Exp Clin Res	24	1998	261-9	J:54153	10190085
87576	muFKBP38: a novel murine immunophilin homolog differentially expressed in Schwannoma cells and central nervous system neurons in vivo.		Pedersen KM; Finsen B; Celis JE; Jensen NA		Electrophoresis	20	1999	249-55	J:54154	10197430
87577	Murine plasmacytomas, carrier of the t(12;15) chromosomal translocation, develop from immature/mature B cells not from differentiated plasma cells.		Ohno S; Hayakawa J; Hashimoto N; Wiener F		Carcinogenesis	20	1999	529-38	J:54191	10223178
87578	Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice.		McEntee MF; Chiu CH; Whelan J		Carcinogenesis	20	1999	635-40	J:54192	10223192
87579	Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2.		Valk PJ; Vankan Y; Joosten M; Jenkins NA; Copeland NG; Lowenberg B; Delwel R		J Virol	73	1999	3595-602	J:54195	10196250
87580	Novel phenotype associated with in vivo activated CTL precursors.		Oughton JA; Kerkvliet NI		Clin Immunol	90	1999	323-33	J:54253	10075861
87581	The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell line.		Martin-Kleiner I; Bidlack JM		Int J Immunopharmacol	21	1999	133-40	J:54270	10230876
87582	Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2.		Mocchegiani E; Perissin L; Santarelli L; Tibaldi A; Zorzet S; Rapozzi V; Giacconi R; Bulian D; Giraldi T		Int J Immunopharmacol	21	1999	27-46	J:54271	10411280
87583	Murine dendritic cells transduced with an adenoviral vector expressing a defined tumor antigen can overcome anti-adenovirus neutralizing immunity and induce effective tumor regression.		Wan Y; Emtage P; Foley R; Carter R; Gauldie J		Int J Oncol	14	1999	771-6	J:54273	10087328
87584	Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen.		Giri U; Iqbal M; Athar M		Int J Oncol	14	1999	799-806	J:54274	10087332
87585	Role of endothelial factors in the specific response of mouse tumour-feeding arterioles to stimulation of 5-HT1 receptors.		Laemmel E; Stucker O; Vicaut E		Int J Radiat Biol	75	1999	365-71	J:54275	10203186
87586	cAMP-dependent induction of PDE5 expression in murine neuroblastoma cell differentiation.		Giordano D; Giorgi M; Sette C; Biagioni S; Augusti-Tocco G		FEBS Lett	446	1999	218-22	J:54264	10100844
87587	Differential effects of dietary Oenothera, Zizyphus mistol, and corn oils, and essential fatty acid deficiency on the progression of a murine mammary gland adenocarcinoma [see comments]		Munoz SE; Piegari M; Guzman CA; Eynard AR		Nutrition	15	1999	208-12	J:54294	10198915
87588	Vaccination with a recombinant vaccinia virus encoding a self antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.		Overwijk WW; Lee DS; Surman DR; Irvine KR; Touloukian CE; Chan CC; Carroll MW; Moss B; Rosenberg SA; Restifo NP		Proc Natl Acad Sci U S A	96	1999	2982-7	J:54298	10077623
87589	Antitumor effects of IL-6 on murine liver tumor cells in vivo.		Kang HS; Cho DH; Kim SS; Pyun KH; Choi I		J Biomed Sci	6	1999	142-4	J:54281	10087445
87590	Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.		Fayolle C; Ladant D; Karimova G; Ullmann A; Leclerc C		J Immunol	162	1999	4157-62	J:54284	10201941
87591	Inhibitory effect of green and black tea on tumor growth.		Conney AH; Lu Y; Lou Y; Xie J; Huang M		Proc Soc Exp Biol Med	220	1999	229-33	J:54301	10202394
87592	The prevention of lung cancer induced by a tobacco-specific carcinogen in rodents by green and black Tea.		Chung FL		Proc Soc Exp Biol Med	220	1999	244-8	J:54302	10202397
87593	Critical role of CD11a (LFA-1) in therapeutic efficacy of systemically transferred antitumor effector T cells.		Mukai S; Kagamu H; Shu S; Plautz GE		Cell Immunol	192	1999	122-32	J:54321	10087180
87594	Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength.		Fiszer-Maliszewska L; Den Otter W; Mordarski M		Cancer Immunol Immunother	47	1999	307-14	J:54327	10203060
87595	Rejection of tumors of the B cell lineage by idiotype-vaccinated mice.		Haimovich J; Kukulansky T; Weissman B; Hollander N		Cancer Immunol Immunother	47	1999	330-6	J:54328	10203063
87596	Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice.		Esserman LJ; Lopez T; Montes R; Bald LN; Fendly BM; Campbell MJ		Cancer Immunol Immunother	47	1999	337-42	J:54329	10203064
87597	Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis.		Watts AM; Shearer MH; Pass HI; Bright RK; Kennedy RC		Cancer Immunol Immunother	47	1999	343-51	J:54330	10203065
87598	Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.		Grunstein J; Roberts WG; Mathieu-Costello O; Hanahan D; Johnson RS		Cancer Res	59	1999	1592-8	J:54362	10197634
87599	Dietary intervention at middle age: caloric restriction but not dehydroepiandrosterone sulfate increases lifespan and lifetime cancer incidence in mice.		Pugh TD; Oberley TD; Weindruch R		Cancer Res	59	1999	1642-8	J:54363	10197641
87600	Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice.		Altavilla G; Trabanelli C; Merlin M; Caputo A; Lanfredi M; Barbanti-Brodano G; Corallini A		Am J Pathol	154	1999	1231-44	J:54341	10233861
87601	Establishment and characterization of a mouse strain (TLL) that spontaneously develops T-cell lymphomas/leukemia.		Eriksson B; Johansson AS; Roos G; Levan G; Holmberg D		Exp Hematol	27	1999	682-8	J:54380	10210326
87602	Effects of methylacetylenic putrescine, an ornithine decarboxylase inhibitor and potential novel anticancer agent, on human and mouse cancer cell lines.		Palyi I; Kremmer T; Kalnay A; Turi G; Mihalik R; Bencsik K; Boldizsar M		Anticancer Drugs	10	1999	103-11	J:54383	10194553
87603	Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models [see comments]		Emtage PC; Wan Y; Hitt M; Graham FL; Muller WJ; Zlotnik A; Gauldie J		Hum Gene Ther	10	1999	697-709	J:54403	10210138
87604	Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases.		Blezinger P; Freimark BD; Matar M; Wilson E; Singhal A; Min W; Nordstrom JL; Pericle F		Hum Gene Ther	10	1999	723-31	J:54404	10210140
87605	Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]: mechanism of the selective action investigated on mouse tumors.		Sava G; Clerici K; Capozzi I; Cocchietto M; Gagliardi R; Alessio E; Mestroni G; Perbellini A		Anticancer Drugs	10	1999	129-38	J:54384	10194556
87606	Cancer from the outside, aging from the inside: mouse models to study the consequences of defective nucleotide excision repair.		de Boer J; Hoeijmakers JH		Biochimie	81	1999	127-37	J:54389	10214917
87607	Electrical stimulation prolongs the survival days of leukemic mice treated with methotrexate.		Uemura N; Nakamura K; Ishii Y; Matsukubo S; Nyu S; Nakano S		Jpn J Pharmacol	79	1999	269-74	J:54411	10230853
87608	Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids.		Mo H; Elson CE		J Nutr	129	1999	804-13	J:54416	10203554
87609	Relationship between circadian rhythm of vinorelbine toxicity and efficacy in P388-bearing mice.		Filipski E; Amat S; Lemaigre G; Vincenti M; Breillout F; Levi FA		J Pharmacol Exp Ther	289	1999	231-5	J:54417	10087009
87610	Characterization of two infectious mouse mammary tumour viruses: superantigenicity and tumorigenicity.		Buggiano V; Goldman A; Nepomnaschy I; Bekinschtein P; Berguer P ; Lombardi G ; Deroche A ; Francisco MV ; Piazzon I		Scand J Immunol	49	1999	269-77	J:54429	10102644
87611	Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.		Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED		Int J Cancer	81	1999	588-91	J:54862	10225449
87612	Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without B-10- compound - Compared with that after gamma-ray irradiation.		Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M		Int J Radiat Oncol Biol Phys	44	1999	391-398	J:54863	10760435
87613	Isolation of 10 differentially expressed cDNAs in differentiated Neuro2a cells induced through controlled expression of the GD3 synthase gene.		Liu H; Nakagawa T; Kanematsu T; Uchida T; Tsuji S		J Neurochem	72	1999	1781-90	J:54635	10217254
87614	Expression of IGF system genes during T-antigen driven pituitary tumorigenesis.		Grewal A; Bradshaw SL; Schuller AG; Low MJ; Pintar JE		Horm Metab Res	31	1999	155-60	J:54673	10226797
87615	Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice.		Kuriyama S; Kikukawa M; Masui K; Okuda H; Nakatani T; Sakamoto T; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T		Int J Cancer	81	1999	592-7	J:54654	10225450
87616	Apolipoprotein(a), a link between atherosclerosis and tumor angiogenesis.		Trieu VN; Uckun FM		Biochem Biophys Res Commun	257	1999	714-8	J:54679	10208849
87617	The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity.		Ben-Porath I; Yanuka O; Benvenisty N		Mol Cell Biol	19	1999	3529-39	J:54715	10207076
87618	Accumulation of recombinant chromosomes and low fidelity of transmission of chromosome X DNA markers in gamma-ray-induced lymphomas lacking p53.		Koide N; Matsumoto Y; Kosugi S; Chou D; Sakai K; Hatakeyama K; Niwa O; Kominami R		Mol Carcinog	24	1999	57-63	J:54738	10029411
87619	Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell.		Gabrea A; Bergsagel PL; Chesi M; Shou Y; Kuehl WM		Mol Cell	3	1999	119-23	J:54752	10024885
87620	Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.		Prontera C; Mariani B; Rossi C; Poggi A; Rotilio D		Int J Cancer	81	1999	761-6	J:54504	10328230
87621	Dietary glycine inhibits the growth of B16 melanoma tumors in mice.		Rose ML; Madren J; Bunzendahl H; Thurman RG		Carcinogenesis	20	1999	793-8	J:54506	10334195
87622	Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months.		Williamson SL; Kartheuser A; Coaker J; Kooshkghazi MD; Fodde R ; Burn J ; Mathers JC		Carcinogenesis	20	1999	805-10	J:54507	10334197
87623	Multiple organ carcinogenicity of inhaled chloroprene (2-chloro-1,3-butadiene) in F344/N rats and B6C3F1 mice and comparison of dose-response with 1,3-butadiene in mice.		Melnick RL; Sills RC; Portier CJ; Roycroft JH; Chou BJ; Grumbein SL; Miller RA		Carcinogenesis	20	1999	867-78	J:54508	10334205
87624	Activation of lipoprotein lipase and inhibition of B16 melanoma-induced cachexia in mice by ponalrestat, an aldose reductase inhibitor.		Kawamura I; Yamamoto N; Sakai F; Yamazaki H; Naoe Y; Inami M; Manda T; Shimomura K		Anticancer Res	19	1999	341-8	J:54792	10226565
87625	Accelerated reoxygenation of a murine fibrosarcoma after carbon-ion radiation.		Ando K; Koike S; Ohira C; Chen YJ; Nojima K; Ando S; Ohbuchi T; Kobayashi N; Shimizu W; Urano M		Int J Radiat Biol	75	1999	505-12	J:54816	10331856
87626	Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49).		Gunther JH; Frambach M; Deinert I; Brandau S; Jocham D; Bohle A		J Urol	161	1999	1702-6	J:54825	10210443
87627	Mechanistically different acting tumor promoters induce consistent qualitative and quantitative changes in protein expression patterns of murine epidermis.		Schlatterer K; Krauter G; Schlatterer B; Hecker E; Chandra P		Anticancer Res	19	1999	385-95	J:54793	10226572
87628	Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice.		Ogawa K; Yamada Y; Kishibe K; Ishizaki K; Tokusashi Y		Cancer Res	59	1999	1830-3	J:54796	10213486
87629	S-adenosylmethionine synthetase is overexpressed in murine neuroblastoma cells resistant to nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase: a novel mechanism of drug resistance.		Dwivedi RS; Wang LJ; Mirkin BL		Cancer Res	59	1999	1852-6	J:54797	10213491
87630	Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.		Korbelik M; Dougherty GJ		Cancer Res	59	1999	1941-6	J:54798	10213504
87631	High frequency of codon 61 K-ras A-->T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene.		Sills RC; Hong HL; Melnick RL; Boorman GA; Devereux TR		Carcinogenesis	20	1999	657-62	J:54800	10223196
87632	Preliminary analysis of azoxymethane-induced colon tumorigenesis in mouse aggregation chimeras.		Wang QS; Walsh A; Goldsby JS; Papanikolaou A; Bolt AB; Rosenberg DW		Carcinogenesis	20	1999	691-7	J:54801	10223201
87633	LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.		Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H ; Fukushima S		Carcinogenesis	20	1999	715-8	J:54802	10223204
87634	Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis.		Feleszko W; Balkowiec EZ; Sieberth E; Marczak M; Dabrowska A; Giermasz A; Czajka A; Jakobisiak M		Int J Cancer	81	1999	560-7	J:54861	10225445
87635	The role of arachidonic acid on LH-stimulated steroidogenesis and steroidogenic acute regulatory protein accumulation in MA-10 mouse Leydig tumor cells.		Wang X; Walsh LP; Stocco DM		Endocrine	10	1999	7-12	J:54844	10403565
87636	Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia.		Petrik J; Pell JM; Arany E; McDonald TJ; Dean WL; Reik W; Hill DJ		Endocrinology	140	1999	2353-63	J:54848	10218989
87637	Inhibitory effects of tetragalloylglucose and digalloylhamamelose on adhesion and in vitro invasion of mouse lung carcinoma cells.		Saeki K; Shoji Y; Noro T; Miyase T; Nakamura Y; Funayama M; Isemura M		Planta Med	65	1999	227-9	J:54880	10232066
87638	Tumor suppressor genes in rodent lung carcinogenesis-mutation of p53 does not appear to be an early lesion in lung tumor pathogenesis.		Miller MS		Toxicol Appl Pharmacol	156	1999	70-7	J:54881	10101101
87639	Transcriptionally active and inactive mouse beta-globin gene loci are repaired at similar rates after ultraviolet irradiation.		Chakalova L; Russev G		Eur J Biochem	261	1999	667-73	J:54545	10215882
87640	Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.		Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH		Cancer Res	59	1999	2050-4	J:54537	10232585
87641	Mouse p73 gene maps to the distal part of chromosome 4 and might be involved in the progression of gamma-radiation-induced T-cell lymphomas.		Herranz M; Santos J; Salido E; Fernandez-Piqueras J; Serrano M		Cancer Res	59	1999	2068-71	J:54538	10232589
87642	The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.		Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM		Cancer Res	59	1999	2203-9	J:54539	10232609
87643	CD95 ligand expression enhances growth of murine renal cell carcinoma in vivo.		Nishimatsu H; Takeuchi T; Ueki T; Kajiwara T; Moriyama N; Ishida T; Li B; Kakizoe T; Kitamura T		Cancer Immunol Immunother	48	1999	56-61	J:54519	10235489
87644	Soybean isoflavones reduce experimental metastasis in mice.		Li D; Yee JA; McGuire MH; Murphy PA; Yan L		J Nutr	129	1999	1075-8	J:54542	10222402
87645	Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia.		Honda H; Inaba T; Suzuki T; Oda H; Ebihara Y; Tsuiji K; Nakahata T; Ishikawa T; Yazaki Y; Hirai H		Blood	93	1999	2780-90	J:54569	10216071
87646	Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes.		Lucas AD; Halliday GM		Immunology	97	1999	130-7	J:54609	10447724
87647	Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cells.		Storozynsky E; Woodward JG; Frelinger JG; Lord EM		Immunology	97	1999	138-49	J:54610	10447725
87648	Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element.		Rodrigo I; Cato AC; Cano A		Exp Cell Res	248	1999	358-71	J:54597	10222128
87649	The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.		van Dyk LF; Hess JL; Katz JD; Jacoby M; Speck SH; Virgin HW IV		J Virol	73	1999	5110-22	J:54947	10233974
87650	Intracisternal type A particle-mediated activation of the Notch4/int3 gene in a mouse mammary tumor: generation of truncated Notch4/int3 mRNAs by retroviral splicing events.		Lee JS; Haruna T; Ishimoto A; Honjo T; Yanagawa S		J Virol	73	1999	5166-71	J:54948	10233982
87651	p53-independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines.		He AW; Cory JG		Anticancer Res	19	1999	421-8	J:54954	10226577
87652	Stable expression of a recombinant sodium-dependent, pyrimidine-selective nucleoside transporter (CNT1) in a transport-deficient mouse leukemia cell line.		Crawford CR; Cass CE; Young JD; Belt JA		Biochem Cell Biol	76	1998	843-51	J:54940	10353719
87653	Tumor angiogenesis and endothelial cell modulatory factors [see comments]		Desai SB; Libutti SK		J Immunother	22	1999	186-211	J:54956	10335479
87654	p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.		Chin L; Artandi SE; Shen Q; Tam A; Lee SL; Gottlieb GJ; Greider CW; DePinho RA		Cell	97	1999	527-38	J:54988	10338216
87655	Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice.		Smith KS; Rhee JW; Naumovski L; Cleary ML		Mol Cell Biol	19	1999	4443-51	J:55022	10330184
87656	Effect of doxorubicin on wild-type and deoxyadenosine-resistant mouse leukemia L1210 cells.		He AW; Cory JG		Int J Oncol	14	1999	891-5	J:55008	10200338
87657	Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice.		Arbeit JM; Munger K; Howley PM; Hanahan D		J Virol	68	1994	4358-68	J:20125	7515971
87658	Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.		Coussens LM; Hanahan D; Arbeit JM		Am J Pathol	149	1996	1899-917	J:20130	8952526
87659	Combination gene therapy with CD86 and the MHC class II transactivator in the control of lung tumor growth.		Martin BK; Frelinger JG; Ting JP		J Immunol	162	1999	6663-70	J:55071	10352284
87660	Macrophage stimulation and antitumor effect of Ukrain.		Korolenko TA; Svechnikova IG; Filjushina EE; Kaledin VI; Vakulin GM; Usynin IF; Tsyrendordjiev DD		Drugs Exp Clin Res	24	1998	253-60	J:55074	10190084
87661	Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.		Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E		J Immunol	162	1999	6420-5	J:55068	10352255
87662	Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.		La E; Muga SJ; Locniskar MF; Fischer SM		Mol Carcinog	24	1999	276-86	J:55231	10326864
87663	Phytol is a novel tumor promoter on ICR mouse skin.		Kagoura M; Matsui C; Morohashi M		Jpn J Cancer Res	90	1999	377-84	J:55105	10363574
87664	Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells.		Itano N; Sawai T; Miyaishi O; Kimata K		Cancer Res	59	1999	2499-504	J:55099	10344764
87665	Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis, and increased germ cell tumorigenesis.		Hsu SY; Lai RJ; Finegold M; Hsueh AJ		Endocrinology	137	1996	4837-43	J:55158	8895354
87666	Expression in transgenic mice of the large T antigen of polyomavirus induces Sertoli cell tumours and allows the establishment of differentiated cell lines.		Paquis-Flucklinger V; Michiels JF; Vidal F; Alquier C; Pointis G; Bourdon V; Cuzin F; Rassoulzadegan M		Oncogene	8	1993	2087-94	J:55159	8393161
87667	Directed expression of an oncogene to Sertoli cells in transgenic mice using mullerian inhibiting substance regulatory sequences.		Peschon JJ; Behringer RR; Cate RL; Harwood KA; Idzerda RL; Brinster RL; Palmiter RD		Mol Endocrinol	6	1992	1403-11	J:55161	1331774
87668	Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.		Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ		Proc Natl Acad Sci U S A	96	1999	6318-23	J:55196	10339585
87669	Concurrent deregulation of gelsolin and cyclin D1 in the majority of human and rodent breast cancers.		Dong Y; Asch HL; Medina D; Ip C; Ip M; Guzman R; Asch BB		Int J Cancer	81	1999	930-8	J:55188	10362141
87670	Involvement of NO, H2O2 and TNF-alpha in the reduced antitumor activity of murine peritoneal macrophages by aflatoxin B1.		Moon EY; Rhee DK; Pyo S		Cancer Lett	136	1999	167-76	J:55214	10355746
87671	Tumour blood flow changes induced by application of electric pulses.		Sersa G; Cemazar M; Parkins CS; Chaplin DJ		Eur J Cancer	35	1999	672-7	J:55218	10492645
87672	Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells.		Lin HL; Liu TY; Lui WY; Chi CW		Cancer	85	1999	1937-42	J:55211	10223233
87673	Tumor-initiating activity of the (+)-(S,S)- and (-)-(R,R)- enantiomers of trans-11,12-di- hydroxy-11,12-dihydrodibenzo[a,l]pyrene in mouse skin.		Luch A; Friesel H; Seidel A; Platt KL		Cancer Lett	136	1999	119-28	J:55212	10355740
87674	Low antibody responsiveness is found to be associated with resistance to chemical skin tumorigenesis in several lines of Biozzi mice.		Ibanez OM; Mouton D; Ribeiro OG; Bouthillier Y; De Franco M; Cabrera WH; Siqueira M; Biozzi G		Cancer Lett	136	1999	153-8	J:55213	10355744
87675	Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53.		Shi Q; Huang S; Jiang W; Kutach LS; Ananthaswamy HN; Xie K		Cancer Res	59	1999	2072-5	J:55242	10232590
87676	Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis.		Zhu Z; Jiang W; Thompson HJ		Mol Carcinog	24	1999	241-5	J:55230	10326860
87677	Antitumor activity of killer cells stimulated with both interleukin-2 and interleukin-12 on mouse glioma cells.		Kikuchi T; Joki T; Abe T; Ohno T		J Immunother	22	1999	245-50	J:55261	10335484
87678	Transcriptional basis for the differences in inducible nitric oxide synthase (iNOS) expression between nonmetastatic and metastatic murine melanoma cell lines.		Gerecitano J; Perle MA; Vilcek J		J Interferon Cytokine Res	19	1999	393-405	J:55262	10334391
87679	Inhibition of solar simulator-induced p53 mutations and protection against skin cancer development in mice by sunscreens.		Ananthaswamy HN; Ullrich SE; Mascotto RE; Fourtanier A; Loughlin SM ; Khaskina P ; Bucana CD ; Kripke ML		J Invest Dermatol	112	1999	763-8	J:55263	10233769
87680	Cytokines (IFNs, TNF-alpha, IL-2 and IL-12) and animal models of cancer.		Burke F		Cytokines Cell Mol Ther	5	1999	51-61	J:55246	10390079
87681	Differential expression of mouse Disabled 2 gene in retinoic acid-treated F9 embryonal carcinoma cells and early mouse embryos.		Cho SY; Cho SY; Lee SH; Park SS		Mol Cells	9	1999	179-84	J:55266	10340473
87682	Interactive effects of psychosocial stressors and gender on mouse mammary tumor growth.		Kerr LR; Wilkinson DA; Emerman JT; Weinberg J		Physiol Behav	66	1999	277-84	J:55273	10336154
87683	Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors.		Raleigh JA; Chou SC; Arteel GE; Horsman MR		Radiat Res	151	1999	580-9	J:55274	10319731
87684	Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma.		Kanno H; Hattori S; Sato H; Murata H; Huang FH; Hayashi A; Suzuki N; Yamamoto I; Kawamoto S; Minami M; Miyatake S; Shuin T; Kaplitt MG		Cancer Gene Ther	6	1999	147-54	J:55302	10195881
87685	Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.		Hall SJ; Mutchnik SE; Yang G; Timme TL; Nasu Y; Bangma CH; Woo SL; Shaker M; Thompson TC		Cancer Gene Ther	6	1999	54-63	J:55304	10078964
87686	Immunogene therapy of murine fibrosarcoma using IL-15 gene with high translation efficiency.		Kimura K; Nishimura H; Hirose K; Matsuguchi T; Nimura Y; Yoshikai Y		Eur J Immunol	29	1999	1532-42	J:55318	10359107
87687	Enhanced adjuvant effect of granulocyte-macrophage colony-stimulating factor plus interleukin-12 compared with either alone in vaccine-induced tumor immunity.		Aruga A; Tanigawa K; Aruga E; Yu H; Chang AE		Cancer Gene Ther	6	1999	89-95	J:55306	10078968
87688	Dose-dependent induction of aberrant crypt foci in the colons but no neoplastic lesions in the livers of heterozygous p53-deficient mice treated with low dose 2-amino-3-methylimidazo [4,5-f]quinoline.		Morimura K; Salim EI; Yamamoto S; Wanibuchi H; Fukushima S		Cancer Lett	138	1999	81-5	J:55307	10378777
87689	Suppressive effects of alpha-Hederin on 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated murine Cyp1a-1 expression in the mouse hepatoma Hepa-1c1c7 cells.		Jeong HG; Lee SS		Cancer Lett	138	1999	131-7	J:55309	10378784
87690	Differences in metallothionein expression in transplantable mouse mammary tumor lines.		Yamamura Y; Sayama K; Takeda Y; Matsuzawa A; Iguchi T; Ohta Y		Cancer Lett	138	1999	167-74	J:55310	10378789
87691	Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.		Kamijo T; van de Kamp E; Chong MJ; Zindy F; Diehl JA; Sherr CJ; McKinnon PJ		Cancer Res	59	1999	2464-9	J:55311	10344759
87692	Reduced melanoma tumor formation in mice immunized with DNA expressing the melanoma-specific antigen gp100/pmel17.		Nawrath M; Pavlovic J; Dummet R; Schultz J; Strack B; Heinrich J; Moelling K		Leukemia	13 Suppl 1	1999	S48-51	J:55340	10232365
87693	Identification of murine CBF alpha1, a runt domain transcription factor, as a putative Myc collaborator in T cell lymphoma.		Neil J; Stewart M; Terry A; O'Hara M; Hu M; Blyth K; Baxter E; Onions D; Cameron E		Leukemia	13 Suppl 1	1999	S83-6	J:55341	10232373
87694	Alteration of proteolytic processing of c-Myb as a consequence of its truncation in murine myeloid leukemia.		Bies J; Nazarov V; Wolff L		Leukemia	13 Suppl 1	1999	S116-7	J:55342	10232384
87695	The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.		Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G		J Immunol	162	1999	6650-7	J:55334	10352282
87696	Perforin is a major contributor to NK cell control of tumor metastasis.		Smyth MJ; Thia KY; Cretney E; Kelly JM; Snook MB; Forbes CA; Scalzo AA		J Immunol	162	1999	6658-62	J:55335	10352283
87697	Treatment of breast cancer with fibroblasts transfected with DNA from breast cancer cells.		de Zoeten E; Carr-Brendel V; Markovic D; Taylor-Papadimitriou J; Cohen EP		J Immunol	162	1999	6934-41	J:55336	10352316
87698	In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.		Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG		Cancer Res	59	1999	2587-92	J:55365	10363978
87699	Inhibitory effects of TNF alpha on mouse tumor Leydig cells: possible role of ceramide in the mechanism of action.		Budnik LT; Jahner D; Mukhopadhyay AK		Mol Cell Endocrinol	150	1999	39-46	J:55366	10411298
87700	Testicular adenoma and seminal vesicle engorgement in polyomavirus large-T antigen transgenic mice.		Chalifour LE; Mes-Masson AM; Gomes ML; Wang NS		Mol Carcinog	5	1992	178-89	J:55367	1375029
87701	Chemopreventive action by an extract from Brassica compestris (var Sarason) on 7,12-dimethylbenz(a)anthracene induced skin papillomagenesis in mice.		Qiblawi S; Kumar A		Phytother Res	13	1999	261-3	J:55355	10353176
87702	Scheduling of gemcitabine and cisplatin in Lewis lung tumour bearing mice.		van Moorsel CJ; Pinedo HM; Veerman G; Vermorken JB; Postmus PE; Peters GJ		Eur J Cancer	35	1999	808-14	J:55381	10505043
87703	Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines.		Ooasa T; Karasaki H; Kanda H; Nomura K; Kitagawa T; Ogawa K		Mol Carcinog	23	1998	248-53	J:55383	9869454
87704	Establishment and further characterization of a line of transgenic mice showing testicular tumorigenesis at 100% incidence.		Kondoh G; Nishimune Y; Nishizawa Y; Hayasaka N; Matsumoto K; Hakura A		J Urol	152	1994	2151-4	J:55384	7966705
87705	IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo.		Matsushita T; Ando K; Kimura K; Ohnishi H; Imawari M; Muto Y; Moriwaki H		Int Immunol	11	1999	657-65	J:55372	10330271
87706	Functional differentiation signals mediated by distinct regions of the cytoplasmic domain of the granulocyte colony-stimulating factor receptor.		Koay DC; Sartorelli AC		Blood	93	1999	3774-84	J:55387	10339483
87707	Biochemical and genetic control of apoptosis: relevance to normal hematopoiesis and hematological malignancies.		Wickremasinghe RG; Hoffbrand AV		Blood	93	1999	3587-600	J:55388	10339463
87708	A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice.		Weaver ZA; McCormack SJ; Liyanage M; du Manoir S; Coleman A; Schrock E ; Dickson RB ; Ried T		Genes Chromosomes Cancer	25	1999	251-60	J:55530	10379871
87709	Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma.		Liao MJ; Van Dyke T		Genes Dev	13	1999	1246-50	J:55417	10346813
87710	An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma.		Chesney J; Metz C; Bacher M; Peng T; Meinhardt A; Bucala R		Mol Med	5	1999	181-91	J:55468	10404515
87711	Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice.		Maestroni GJ; Hertens E; Galli P		Cell Mol Life Sci	55	1999	663-7	J:55502	10357234
87712	Core-binding factor influences the disease specificity of Moloney murine leukemia virus.		Lewis AF; Stacy T; Green WR; Taddesse-Heath L; Hartley JW; Speck NA		J Virol	73	1999	5535-47	J:55549	10364302
87713	Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.		Schell TD; Mylin LM; Georgoff I; Teresky AK; Levine AJ; Tevethia SS		J Virol	73	1999	5981-93	J:55551	10364350
87714	Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis.		Coussens LM; Raymond WW; Bergers G; Laig-Webster M; Behrendtsen O; Werb Z; Caughey GH; Hanahan D		Genes Dev	13	1999	1382-97	J:55574	10364156
87715	MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells.		Neumark E; Anavi R; Witz IP; Ben-Baruch A		Immunol Lett	68	1999	141-6	J:55561	10397169
87716	Expression of surfactant protein mRNA in normal and neoplastic lung of B6C3F1 mice as demonstrated by in situ hybridization.		Pilling AM; Mifsud NA; Jones SA; Endersby-Wood HJ; Turton JA		Vet Pathol	36	1999	57-63	J:55606	9921757
87717	IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.		Yoshida R; Yoneda Y; Kuriyama M; Kubota T		J Immunol	163	1999	148-54	J:55646	10384111
87718	Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.		Wu GS; Burns TF; Zhan Y; Alnemri ES; El-Deiry WS		Cancer Res	59	1999	2770-5	J:55627	10383128
87719	Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.		Hermans IF; Ritchie DS; Daish A; Yang J; Kehry MR; Ronchese F		J Immunol	163	1999	77-81	J:55653	10384102
87720	Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.		Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gaken J; Souberbielle B; Farzaneh F		J Immunol	163	1999	62-70	J:55654	10384100
87721	Antagonism of p53-dependent apoptosis by mitogen signals.		Hong M; Lai MD; Lin YS; Lai MZ		Cancer Res	59	1999	2847-52	J:55687	10383145
87722	Optimizing syngeneic orthotopic murine bladder cancer (MB49).		Gunther JH; Jurczok A; Wulf T; Brandau S; Deinert I; Jocham D; Bohle A		Cancer Res	59	1999	2834-7	J:55688	10383142
87723	Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity.		Melcher A; Todryk S; Bateman A; Chong H; Lemoine NR; Vile RG		Cancer Res	59	1999	2802-5	J:55689	10383135
87724	Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells.		Horiguchi S; Petersson M; Nakazawa T; Kanda M; Zea AH; Ochoa AC; Kiessling R		Cancer Res	59	1999	2950-6	J:55681	10383160
87725	Differential effects of a stem cell factor-immunoglobulin fusion protein on malignant and normal hematopoietic cells.		Erben U; Thiel E; Notter M		Cancer Res	59	1999	2924-30	J:55683	10383156
87726	Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models.		Gasparri A; Moro M; Curnis F; Sacchi A; Pagano S; Veglia F; Casorati G; Siccardi AG; Dellabona P; Corti A		Cancer Res	59	1999	2917-23	J:55684	10383155
87727	NG2 proteoglycan-binding peptides target tumor neovasculature.		Burg MA; Pasqualini R; Arap W; Ruoslahti E; Stallcup WB		Cancer Res	59	1999	2869-74	J:55685	10383148
87728	Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.		Go C; Li P; Wang XJ		Cancer Res	59	1999	2861-8	J:55686	10383147
87729	HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo.		Gianasi E; Wasil M; Evagorou EG; Keddle A; Wilson G; Duncan R		Eur J Cancer	35	1999	994-1002	J:55716	10533484
87730	Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors.		Tunggal JK; Cowan DS; Shaikh H; Tannock IF		Clin Cancer Res	5	1999	1583-6	J:55706	10389947
87731	Jumping translocation breakpoint regions lead to amplification of rearranged Myc [letter]		Coleman AE; Kovalchuk AL; Janz S; Palini A; Ried T		Blood	93	1999	4442-4	J:55728	10391697
87732	Lecithinized ascorbic acid (PC-AS) effectively inhibits murine pulmonary metastasis.		Takenaga M; Igarashi R; Nakayama T; Mizushima Y		Anticancer Res	19	1999	1085-91	J:55755	10368658
87733	Characterization of biological features and chemosensitivity of a new experimental lung metastasis model originating from the MXT mouse mammary adenocarcinoma.		Farinelle S; Dedecker R; Malonne H; Werry J; Darro F; Kiss R		Anticancer Res	19	1999	1171-80	J:55757	10368671
87734	Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice.		Yan L; Yee JA; Li D; McGuire MH; Graef GL		Anticancer Res	19	1999	1337-42	J:55759	10368696
87735	Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.		Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS		Am J Pathol	154	1999	1693-700	J:55747	10362794
87736	Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine.		Sava G; Gagliardi R; Bergamo A; Alessio E; Mestroni G		Anticancer Res	19	1999	969-72	J:55752	10368640
87737	Effects of low dose catechol on glandular stomach carcinogenesis in BALB/c mice initiated with N-methyl-N-nitrosourea.		Kobayashi K; Inada K; Furihata C; Tsukamoto T; Ikehara Y; Yamamoto M; Tatematsu M		Cancer Lett	139	1999	167-72	J:55771	10395174
87738	Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.		Santibanez JF; Frontelo P; Iglesias M; Martinez J; Quintanilla M		J Cell Biochem	74	1999	61-73	J:55787	10381262
87739	Some biological aspects of skin carcinogenesis		Boutwell RK		Prog Exp Tumor Res	4	1964	207-250	J:56123	 
87740	Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer.		Talts JF; Wirl G; Dictor M; Muller WJ; Fassler R		J Cell Sci	112	1999	1855-64	J:56124	10341205
87741	Effects of streptococcal preparation OK-432 on cytokine induction in spleen and tumour tissues of mice bearing MH-134 tumour cells.		Nakatani S; Iwagaki H; Okabayashi T; Matsubara N; Isozaki H; Takakura N; Horimi T; Tanaka N		J Int Med Res	27	1999	27-37	J:55789	10417959
87742	The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells.		Longo WE; Grossmann EM; Erickson B; Panesar N; Mazuski JE; Kaminski DL		J Surg Res	84	1999	51-6	J:55793	10334889
87743	Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands.		Medina D; Smith GH		J Natl Cancer Inst	91	1999	967-9	J:55795	10359550
87744	Effect of lecithinized superoxide dismutase (PC-SOD) on experimental pulmonary metastasis in mice.		Takenaga M; Igarashi R; Ochiai A; Mizushima Y		Free Radic Biol Med	26	1999	1117-25	J:55781	10381181
87745	Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness.		Orucevic A; Bechberger J; Green AM; Shapiro RA; Billiar TR; Lala PK		Int J Cancer	81	1999	889-96	J:55784	10362135
87746	Uteroglobin: a novel cytokine?		Mukherjee AB; Kundu GC; Mantile-Selvaggi G; Yuan CJ; Mandal AK; Chattopadhyay S; Zheng F; Pattabiraman N; Zhang Z		Cell Mol Life Sci	55	1999	771-87	J:55819	10379362
87747	Inhibitory effects of roxithromycin on tumor angiogenesis, growth and metastasis of mouse B16 melanoma cells.		Yatsunami J; Tsuruta N; Fukuno Y; Kawashima M; Taniguchi S; Hayashi S		Clin Exp Metastasis	17	1999	119-24	J:55820	10411103
87748	Effects of immunization with tumor cells double transfected with interleukin-2 (IL-2) and interleukin-12 (IL-12) genes on artificial metastasis of colon26 cells in BALB/c mice.		Takada T; Kato K; Yagita H; Hamada H; Okumura K		Clin Exp Metastasis	17	1999	125-30	J:55821	10411104
87749	Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas.		Akimoto T; Kawabe S; Grothey A; Milas L		Clin Exp Metastasis	17	1999	171-6	J:55822	10411110
87750	Experimental metastasis is suppressed in MMP-9-deficient mice.		Itoh T; Tanioka M; Matsuda H; Nishimoto H; Yoshioka T; Suzuki R; Uehira M		Clin Exp Metastasis	17	1999	177-81	J:55823	10411111
87751	GPI1 stabilizes an enzyme essential in the first step of glycosylphosphatidylinositol biosynthesis.		Hong Y; Ohishi K; Watanabe R; Endo Y; Maeda Y; Kinoshita T		J Biol Chem	274	1999	18582-8	J:55851	10373468
87752	Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis.		Herzog CR; Noh S; Lantry LE; Guan KL; You M		Mol Carcinog	25	1999	92-8	J:55837	10365910
87753	Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice.		Cho JY; Sagartz JE; Capen CC; Mazzaferri EL; Jhiang SM		Oncogene	18	1999	3659-65	J:55883	10380889
87754	Cooperation of Myb and Myc proteins in T cell lymphomagenesis.		Davies J; Badiani P; Weston K		Oncogene	18	1999	3643-7	J:55885	10380886
87755	Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.		Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD		Mol Cell Biol	19	1999	5025-35	J:55891	10373552
87756	Enhancer-dependent transcriptional oscillations in mouse erythroleukemia cells.		Feng YQ; Alami R; Bouhassira EE		Mol Cell Biol	19	1999	4907-17	J:55919	10373540
87757	Catecholamines participate in the induction of ornithine decarboxylase gene expression in normal and hyperplastic mouse kidney.		Dudkowska M; Manteuffel-Cymborowska M; Chmurzynska W; Grzelakowska-Sztabert B		Biochim Biophys Acta	1454	1999	71-9	J:55943	10354516
87758	Anti-carcinogenic activity of Taraxacum plant. II.		Takasaki M; Konoshima T; Tokuda H; Masuda K; Arai Y; Shiojima K; Ageta H		Biol Pharm Bull	22	1999	606-10	J:55944	10408235
87759	Expression of neural cell adhesion molecules in the mouse anterior pituitary gland and pituitary tumor cells.		Yayoi Y; Takahashi S; Takeuchi S; Takeuchi M; Seki T; Arai Y		Biomed Res	19	1998	269-277	J:55947	 
87760	Potent suppressive effect of a Japanese edible seaweed, Enteromorpha prolifera (Sujiao-nori) on initiation and promotion phases of chemically induced mouse skin tumorigenesis.		Hiqashi-Okaj K; Otani S; Okai Y		Cancer Lett	140	1999	21-5	J:55950	10403537
87761	A diacetylenic spiroketal enol ether epoxide, AL-1, from Artemisia lactiflora inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion possibly by suppression of oxidative stress.		Nakamura Y; Kawamoto N; Ohto Y; Torikai K; Murakami A; Ohigashi H		Cancer Lett	140	1999	37-45	J:55951	10403539
87762	Expression pattern of the Tbr2 (Eomesodermin) gene during mouse and chick brain development.		Bulfone A; Martinez S; Marigo V; Campanella M; Basile A; Quaderi N; Gattuso C; Rubenstein JL; Ballabio A		Mech Dev	84	1999	133-8	J:55094	10473127
87763	The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals.		Song S; Pitot HC; Lambert PF		J Virol	73	1999	5887-93	J:55965	10364340
87764	Role of chloride and inhibitory action of inorganic nitrate on gonadotropin-stimulated steroidogenesis in mouse Leydig tumor cells.		Panesar NS		Metabolism	48	1999	693-700	J:55966	10381142
87765	Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis.		Stickeler E; Kittrell F; Medina D; Berget SM		Oncogene	18	1999	3574-82	J:55969	10380879
87766	Effect of the cisplatin-procaine complex DPR in combination with several anticancer agents on murine P388 leukemic cells in vitro and in vivo.		Pastrone I; Viale M; Cafaggi S; Mariggio MA; Parodi A; Esposito M		Invest New Drugs	16	1998	297-302	J:55960	10426661
87767	Ly-6A/E induction by interleukin-6 and interleukin-9 in T cells.		Demoulin JB; Maisin D; Renauld JC		Eur Cytokine Netw	10	1999	49-56	J:55985	10210773
87768	Estimation of mutation frequencies in normal mammalian cells and the development of cancer.		Turker MS		Semin Cancer Biol	8	1998	407-19	J:56011	10191175
87769	Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma.		Thomas GR; Chen Z; Oechsli MN; Hendler FJ; Van Waes C		Int J Cancer	82	1999	377-84	J:56062	10399955
87770	Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene.		Meyn MS		Clin Genet	55	1999	289-304	J:56074	10422797
87771	Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40.		Sotomayor EM; Borrello I; Tubb E; Rattis FM; Bien H; Lu Z; Fein S; Schoenberger S; Levitsky HI		Nat Med	5	1999	780-7	J:56067	10395323
87772	Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.		Moore RJ; Owens DM; Stamp G; Arnott C; Burke F; East N; Holdsworth H; Turner L; Rollins B; Pasparakis M; Kollias G; Balkwill F		Nat Med	5	1999	828-831	J:56068	10395330
87773	Overexpression of dominant negative mutant hepatocyte nuclear factor (HNF)-1alpha inhibits arginine-induced insulin secretion in MIN6 cells.		Tanizawa Y; Ohta Y; Nomiyama J; Matsuda K; Tanabe K; Inoue H; Matsutani A; Okuya S; Oka Y		Diabetologia	42	1999	887-91	J:56110	10440133
87774	Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression.		Kjaergaard J; Shu S		J Immunol	163	1999	751-9	J:56126	10395667
87775	Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.		Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL		J Immunol	163	1999	699-707	J:56127	10395660
87776	Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.		Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H		J Immunol	163	1999	583-9	J:56128	10395644
87777	Immune system development and function in prolactin receptor-deficient mice.		Bouchard B; Ormandy CJ; Di Santo JP; Kelly PA		J Immunol	163	1999	576-82	J:56163	10395643
87778	Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline.		Gude RP; Binda MM; Presas HL; Klein-Szanto AJ; Bonfil RD		J Biomed Sci	6	1999	133-41	J:54280	10087444
87779	Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1.		Shaughnessy JD Jr; Largaespada DA; Tian E; Fletcher CF; Cho BC ; Vyas P ; Jenkins NA ; Copeland NG		Oncogene	18	1999	2069-84	J:54295	10321731
87780	In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy.		Adams K; Rainbow AJ; Wilson BC; Singh G		J Photochem Photobiol B	49	1999	136-41	J:56203	10392463
87781	Angiogenesis and growth of murine colon carcinoma are dependent on infiltrating leukocytes.		Yoneda J; Killion JJ; Bucana CD; Fidler IJ		Cancer Biother Radiopharm	14	1999	221-30	J:56181	10850306
87782	Tannic acid raises survival rate of mice bearing syngeneic tumors.		Koide T; Kamei H; Hashimoto Y; Kojima T; Hasegawa M		Cancer Biother	14	1999	231-234	J:56182	 
87783	[Hepatitis virus and hepatocellular carcinoma]		Rosmorduc O; Paterlini P; Poupon R; Brechot C		Gastroenterol Clin Biol	23	1999	363-75	J:56190	10384341
87784	Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein.		Yu DY; Moon HB; Son JK; Jeong S; Yu SL; Yoon H; Han YM; Lee CS; Park JS; Lee CH; Hyun BH; Murakami S; Lee KK		J Hepatol	31	1999	123-32	J:56196	10424292
87785	Cloning of the cDNA encoding phenylalanyl tRNA synthetase regulatory alpha-subunit-like protein whose expression is down-regulated during differentiation.		Zhou X; Richon VM; Ngo L; Rifkind RA; Marks PA		Gene	233	1999	13-9	J:56249	10375616
87786	Induction of erythrocyte protein 4.2 gene expression during differentiation of murine erythroleukemia cells.		Karacay B; Chang LS		Genomics	59	1999	6-17	J:56279	10395794
87787	The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTL1 family members.		Webster MA; Martin-Soudant N; Nepveu A; Cardiff RD; Muller WJ		Oncogene	16	1998	1963-72	J:56288	9591780
87788	Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.		Allay E; Veigl M; Gerson SL		Oncogene	18	1999	3783-7	J:56290	10391687
87789	Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences.		March KL; Sandusky G; Fan L		Oncogene	18	1999	3773-82	J:56291	10391686
87790	Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene.		Efrat S; Fusco-DeMane D; Lemberg H; al Emran O; Wang X		Proc Natl Acad Sci U S A	92	1995	3576-80	J:56326	7724601
87791	The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.		Dong G; Chen Z; Kato T; Van Waes C		Cancer Res	59	1999	3495-504	J:56306	10416616
87792	Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.		de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G		Cancer Res	59	1999	3489-94	J:56307	10416615
87793	Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice.		Ching LM; Goldsmith D; Joseph WR; Korner H; Sedgwick JD; Baguley BC		Cancer Res	59	1999	3304-7	J:56308	10416582
87794	The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis.		Dobson CL; Warren AJ; Pannell R; Forster A; Lavenir I; Corral J; Smith AJ; Rabbitts TH		EMBO J	18	1999	3564-74	J:56340	10393173
87795	Down-regulation of phospholipase D during differentiation of mouse F9 teratocarcinoma cells.		Min DS; Shin KS; Kim EG; Kim SR; Yoon SH; Kim MS; Jo YH		FEBS Lett	454	1999	197-200	J:56344	10431806
87796	Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.		Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ		Mol Cell Biol	18	1998	2344-59	J:56327	9528804
87797	Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.		Witty JP; Lempka T; Coffey RJ Jr; Matrisian LM		Cancer Res	55	1995	1401-6	J:56328	7882342
87798	Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene.		Webster MA; Cardiff RD; Muller WJ		Proc Natl Acad Sci U S A	92	1995	7849-53	J:56331	7544006
87799	Intracisternal A-particle (IAP)-mediated leukemogenesis: Levels and stability of IAP mRNA in FDC-P1 cells exposed to the conditions of an irradiated environment		Blumenstein M; Tessmer U; Hossfeld DK; Duhrsen U		Cell Biol Int	22	1998	563-74	J:56375	10452824
87800	Increased resistance to apoptosis by bone marrow CD34(+)progenitor cells from tumor-bearing mice.		Young MR; Wright MA; Lathers DM; Messingham KA		Int J Cancer	82	1999	609-15	J:56376	10404079
87801	Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone.		Witschi H; Espiritu I; Uyeminami D		Carcinogenesis	20	1999	1375-8	J:56393	10383915
87802	Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF.		Xing C; Imagawa W		Carcinogenesis	20	1999	1201-8	J:56395	10383890
87803	Multiple deficiencies underlie NK cell inactivity in lymphotoxin-alpha gene-targeted mice.		Smyth MJ; Johnstone RW; Cretney E; Haynes NM; Sedgwick JD; Korner H ; Poulton LD ; Baxter AG		J Immunol	163	1999	1350-3	J:56397	10415034
87804	Butadiene diolepoxide- and diepoxybutane-derived DNA adducts at N7-guanine: a high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure.		Koivisto P; Kilpelainen I; Rasanen I; Adler ID; Pacchierotti F; Peltonen K		Carcinogenesis	20	1999	1253-9	J:56419	10383898
87805	Absence of correlation between telomerase activity and hepatic neoplasia in B6C3F1 mice.		King LM; Song J; Wojcinski ZW; Baker KW; Walker RM		Toxicol Lett	106	1999	247-54	J:56485	10403669
87806	Transgenic mice that develop pituitary tumors. A model for Cushing's disease.		Helseth A; Siegal GP; Haug E; Bautch VL		Am J Pathol	140	1992	1071-80	J:55528	1316082
87807	Characterization of a human genomic DNA fragment which rescues defective lipid-linked oligosaccharide synthesis in a mutant G258 cell line isolated from the FM3A mouse mammary carcinoma cell line.		Kataoka K; Takahashi T; Ayusawa D; Nishikawa Y		Somat Cell Mol Genet	24	1998	235-43	J:56483	10410677
87808	The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.		Sternlicht MD; Lochter A; Sympson CJ; Huey B; Rougier JP; Gray JW; Pinkel D; Bissell MJ; Werb Z		Cell	98	1999	137-46	J:56508	10428026
87809	Dbl expression driven by the neuron specific enolase promoter induces tumor formation in transgenic mice with a p53(+/-) genetic background.		Colucci-D'Amato GL; Santelli G; D'Alessio A; Chiappetta G; Mineo A; Manzo G; Vecchio G; de Franciscis V		Biochem Biophys Res Commun	216	1995	762-70	J:54268	7488191
87810	The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains.		Moennikes O; Buchmann A; Ott T; Willecke K; Schwarz M		Carcinogenesis	20	1999	1379-82	J:54431	10383916
87811	Antitumour immunity of Bacillus Calmette-Guerin and interferon alpha in murine bladder cancer.		Gan YH; Zhang Y; Khoo HE; Esuvaranathan K		Eur J Cancer	35	1999	1123-9	J:56525	10533458
87812	Involvement of fibronectin in the regulation of urokinase production and binding in murine mammary tumor cells.		Urtreger AJ; Aguirre Ghiso JA; Werbajh SE; Puricelli LI; Muro AF; Bal de Kier Joff E		Int J Cancer	82	1999	748-53	J:56527	10417775
87813	Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12.		Joki T; Kikuchi T; Akasaki Y; Saitoh S; Abe T; Ohno T		Int J Cancer	82	1999	714-20	J:56528	10417770
87814	Murine leukemia provirus-mediated activation of the Notch1 gene leads to induction of HES-1 in a mouse T lymphoma cell line, DL-3.		Lee JS; Ishimoto A; Honjo T; Yanagawa S		FEBS Lett	455	1999	276-80	J:56518	10437788
87815	Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.		Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI		Oncogene	18	1999	4120-30	J:56598	10435593
87816	Allelic loss mapping and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12.		Shinbo T; Matsuki A; Matsumoto Y; Kosugi S; Takahashi Y; Niwa O ; Kominami R		Oncogene	18	1999	4131-6	J:56599	10435594
87817	Loss of heterozygosity at the proximal-mid part of mouse chromosome 4 defines two novel tumor suppressor gene loci in T-cell lymphomas.		Melendez B; Santos J; Fernandez-Piqueras J		Oncogene	18	1999	4166-9	J:56600	10435599
87818	DNA vaccination against HuD antigen elicits antitumor activity in a small-cell lung cancer murine model.		Ohwada A; Nagaoka I; Takahashi F; Tominaga S; Fukuchi Y		Am J Respir Cell Mol Biol	21	1999	37-43	J:56567	10385591
87819	ICSAT overexpression is not sufficient to cause adult T-cell leukemia or multiple myeloma.		Saito T; Yamagata T; Takahashi T; Honda H; Hirai H		Biochem Biophys Res Commun	260	1999	329-31	J:56570	10403770
87820	Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.		Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL		Cancer Gene Ther	6	1999	358-66	J:56573	10419054
87821	The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.		Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y		Cell Death Differ	6	1999	599-608	J:56576	10453070
87822	Epidermal dysplasia and abnormal hair follicles in transgenic mice overexpressing homeobox gene MSX-2.		Jiang TX; Liu YH; Widelitz RB; Kundu RK; Maxson RE; Chuong CM		J Invest Dermatol	113	1999	230-7	J:56777	10469309
87823	Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium.		Shinohara H; Killion JJ; Bucana CD; Yano S; Fidler IJ		Clin Cancer Res	5	1999	2148-56	J:56853	10473099
87824	Dysregulated myelopoiesis in mice lacking Jak3.		Grossman WJ; Verbsky JW; Yang L; Berg LJ; Fields LE; Chaplin DD; Ratner L		Blood	94	1999	932-9	J:56629	10419884
87825	p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential.		Topley GI; Okuyama R; Gonzales JG; Conti C; Dotto GP		Proc Natl Acad Sci U S A	96	1999	9089-94	J:56634	10430900
87826	Stat3 as an oncogene [published erratum appears in Cell 1999 Oct 15;99(2):239]		Bromberg JF; Wrzeszczynska MH; Devgan G; Zhao Y; Pestell RG; Albanese C; Darnell JE Jr		Cell	98	1999	295-303	J:56637	10458605
87827	For better or worse? Telomerase inhibition and cancer.		de Lange T; Jacks T		Cell	98	1999	273-5	J:56638	10458601
87828	Anti-carcinogenic activity of Taraxacum plant. I.		Takasaki M; Konoshima T; Tokuda H; Masuda K; Arai Y; Shiojima K; Ageta H		Biol Pharm Bull	22	1999	602-5	J:56625	10408234
87829	A node between proliferation, apoptosis, and growth arrest.		Blagosklonny MV		Bioessays	21	1999	704-9	J:56662	10440867
87830	Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.		Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W		Immunology	97	1999	616-25	J:56703	10457215
87831	Expression of the death gene Bik/Nbk promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice.		Daniel PT; Pun KT; Ritschel S; Sturm I; Holler J; Dorken B; Brown R		Blood	94	1999	1100-7	J:56692	10419903
87832	Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction.		Bobe P; Benihoud K; Grandjon D; Opolon P; Pritchard LL; Huchet R		Blood	94	1999	1028-37	J:56693	10419895
87833	Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice.		Kimura Y; Okuda H		Jpn J Cancer Res	90	1999	765-74	J:56694	10470290
87834	DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4.		Zhang CC; Yang JM; Bash-Babula J; White E; Murphy M; Levine AJ; Hait WN		Cancer Res	59	1999	3663-70	J:56695	10446979
87835	Indomethacin suppresses the growth of colon 26, Meth-A and FM3A tumors in mice by reducing the prostaglandin E2 content and telomerase activity in tumor tissues.		Ogino M; Hisatomi H; Murata M; Hanazono M		Jpn J Cancer Res	90	1999	758-64	J:56696	10470289
87836	High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.		Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE		Cancer Res	59	1999	3634-40	J:56697	10446974
87837	Elevated mutant frequencies in lymphoid tissues persist throughout plasmacytoma development in BALB/c.lambdaLIZ mice.		Felix K; Kelliher KA; Bornkamm GW; Janz S		Cancer Res	59	1999	3621-6	J:56698	10446972
87838	Modulation of fluorouracil antitumor activity by folic acid in a murine model system.		Raghunathan K; Priest DG		Biochem Pharmacol	58	1999	835-9	J:56700	10449194
87839	Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.		Lee H; Trainer AH; Friedman LS; Thistlethwaite FC; Evans MJ; Ponder BA; Venkitaraman AR		Mol Cell	4	1999	1-10	J:56701	10445022
87840	Onset and dynamics of osteosclerosis in mice induced by Reilly-Finkel-Biskis (RFB) murine leukemia virus. Increase in bone mass precedes lymphomagenesis.		Schmidt J; Lumniczky K; Tzschaschel BD; Guenther HL; Luz A; Riemann S; Gimbel W; Erfle V; Erben RG		Am J Pathol	155	1999	557-70	J:56718	10433948
87841	IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.		Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL		J Clin Invest	104	1999	317-25	J:56720	10430613
87842			Deringer MK		J Natl Cancer Inst	12	1951	437-45	J:56775	14889254
87843	Accelerated development and aging of the immune system in p53-deficient mice.		Ohkusu-Tsukada K; Tsukada T; Isobe K		J Immunol	163	1999	1966-72	J:56755	10438933
87844	Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro.		Summerhayes IC; Franks LM		J Natl Cancer Inst	62	1979	1017-23	J:56454	107359
87845	m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.		Cretney E; Degli-Esposti MA; Densley EH; Farrell HE; Davis-Poynter NJ; Smyth MJ		J Exp Med	190	1999	435-44	J:56787	10430631
87846	Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.		Upadhyaya P; Kenney PM; Hochalter JB; Wang M; Hecht SS		Carcinogenesis	20	1999	1577-82	J:56788	10426810
87847	An in vitro model of the early genetic events in multistage carcinogenesis of malignant insulinoma.		Katic M; Hadzija M; Wrischer M; Pavelic K		Carcinogenesis	20	1999	1521-7	J:56789	10426801
87848	Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.		Elkin M; Reich R; Nagler A; Aingorn E; Pines M; de-Groot N; Hochberg A; Vlodavsky I		Clin Cancer Res	5	1999	1982-8	J:56854	10473075
87849	Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene.		Miyata M; Kudo G; Lee YH; Yang TJ; Gelboin HV; Fernandez-Salguero P; Kimura S; Gonzalez FJ		J Biol Chem	274	1999	23963-8	J:56886	10446164
87850	Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation.		Gutmann DH; Loehr A; Zhang Y; Kim J; Henkemeyer M; Cashen A		Oncogene	18	1999	4450-9	J:56902	10442636
87851	Interdependent action of RalGEF and Erk in Ras-induced primitive endoderm differentiation of F9 embryonal carcinoma cells.		Verheijen MH; Wolthuis RM; Defize LH; den Hertog J; Bos JL		Oncogene	18	1999	4435-9	J:56903	10442634
87852	Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12.		Nishioka Y; Hirao M; Robbins PD; Lotze MT; Tahara H		Cancer Res	59	1999	4035-41	J:56893	10463604
87853	An insulin-like growth factor-mediated, phosphatidylinositol 3' kinase-independent survival signaling pathway in beta tumor cells.		Burtscher I; Compagni A; Lamm GM; Christofori G		Cancer Res	59	1999	3923-6	J:56894	10463584
87854	Growth factor independence and BCR/ABL transformation: promise and pitfalls of murine model systems and assays.		Ghaffari S; Daley GQ; Lodish HF		Leukemia	13	1999	1200-6	J:56901	10450747
87855	Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies.		Lukas C; Jensen SK; Bartkova J; Lukas J; Bartek J		Hybridoma	18	1999	225-34	J:56941	10475236
87856	Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer.		Elson CE; Peffley DM; Hentosh P; Mo H		Proc Soc Exp Biol Med	221	1999	294-311	J:56963	10460692
87857	Ethanol decreases host resistance to pulmonary metastases in a mouse model: role of natural killer cells and the ethanol-induced stress response.		Wu WJ; Pruett SB		Int J Cancer	82	1999	886-92	J:56961	10446458
87858	Mushrooms, tumors, and immunity.		Borchers AT; Stern JS; Hackman RM; Keen CL; Gershwin ME		Proc Soc Exp Biol Med	221	1999	281-93	J:56962	10460691
87859	Induction of antitumor immunity using intercellular adhesion molecule 1 (ICAM-1) transfection in mouse glioma cells.		Kikuchi T; Joki T; Akasaki Y; Abe T; Ohno T		Cancer Lett	142	1999	201-6	J:56974	10463777
87860	Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.		Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ		Oncogene	18	1999	4689-98	J:57034	10467416
87861	Time-dependent effects of stressor application on metastasis of tumor cells in the lung and its regulation by an immunomodulator in mice.		Ishihara Y; Matsunaga K; Iijima H; Fujii T; Oguchi Y; Kagawa J		Psychoneuroendocrinology	24	1999	713-26	J:57009	10451907
87862	Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.		Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC		Oncogene	18	1999	4726-33	J:57035	10467420
87863	Interactions of apoptosis, proliferation and host age in the regression of the mouse mammary preneoplasia, TM3, carrying an unusual mutation in p53.		Bonnette SG; Kittrell FS; Stephens LC; Meyn RE; Medina D		Carcinogenesis	20	1999	1715-20	J:57288	10469615
87864	APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse.		Erdman SH; Ignatenko NA; Powell MB; Blohm-Mangone KA; Holubec H; Guillen-Rodriguez JM; Gerner EW		Carcinogenesis	20	1999	1709-13	J:57289	10469614
87865	Plasma membrane-resident glucocorticoid receptors in rodent lymphoma and human leukemia models.		Gametchu B; Chen F; Sackey F; Powell C; Watson CS		Steroids	64	1999	107-19	J:54376	10323679
87866	Signals transduced by CD3epsilon, but not by surface pre-TCR complexes, are able to induce maturation of an early thymic lymphoma in vitro.		Carleton M; Ruetsch NR; Berger MA; Rhodes M; Kaptik S; Wiest DL		J Immunol	163	1999	2576-85	J:57093	10452996
87867	Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout mice.		Ureta-Vidal A; Firat H; Perarnau B; Lemonnier FA		J Immunol	163	1999	2555-60	J:57095	10452993
87868	Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression.		Kalinichenko VV; Mokyr MB; Graf LH Jr; Cohen RL; Chambers DA		J Immunol	163	1999	2492-9	J:57098	10452985
87869	Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice.		Koshkina NV; Gilbert BE; Waldrep JC; Seryshev A; Knight V		Cancer Chemother Pharmacol	44	1999	187-92	J:57139	10453719
87870	Dietary zinc deficiency enhances esophageal cell proliferation and N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumor incidence in C57BL/6 mouse.		Fong LY; Magee PN		Cancer Lett	143	1999	63-9	J:57140	10465339
87871	Evaluation of the transgenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-term bioassay.		Dass SB; Bucci TJ; Heflich RH; Casciano DA		Cancer Lett	143	1999	81-5	J:57142	10465341
87872	Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.		Fischer SM; Lo HH; Gordon GB; Seibert K; Kelloff G; Lubet RA; Conti CJ		Mol Carcinog	25	1999	231-40	J:57157	10449029
87873	Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis.		Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; IshaiMichaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I		Nat Med	5	1999	793-802	J:57195	10395325
87874	Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.		Zhaoyou T; Qin L; Wang X; Zhou G; Liao Y; Weng Y; Jiang X; Lin Z; Liu K; Ye S		Chin Med J (Engl)	111	1998	313-8	J:57200	10374394
87875	Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity [see comments]		Biragyn A; Tani K; Grimm MC; Weeks S; Kwak LW		Nat Biotechnol	17	1999	253-8	J:57181	10096292
87876	Four new colon cancer susceptibility loci, Scc6 to Scc9 in the mouse.		van Wezel T; Ruivenkamp CA; Stassen AP; Moen CJ; Demant P		Cancer Res	59	1999	4216-8	J:57235	10485458
87877	Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone.		Jacob K; Webber M; Benayahu D; Kleinman HK		Cancer Res	59	1999	4453-7	J:57274	10485497
87878	Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3'-gallate as the most effective antioxidant constituent.		Zhao J; Wang J; Chen Y; Agarwal R		Carcinogenesis	20	1999	1737-45	J:57290	10469619
87879	Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas.		Perez de Castro IP; Malumbres M; Santos J; Pellicer A; Fernandez-Piqueras J		Carcinogenesis	20	1999	1675-82	J:57291	10469610
87880	Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis.		Qin X; Zhou H; Liu L; Gerson SL		Carcinogenesis	20	1999	1667-73	J:57292	10469609
87881	Induction of melanoma in TPras transgenic mice.		Broome Powell M; Gause PR; Hyman P; Gregus J; Lluria-Prevatt M; Nagle R; Bowden GT		Carcinogenesis	20	1999	1747-53	J:57280	10469620
87882	CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice.		Kimura S; Kawabe M; Ward JM; Morishima H; Kadlubar FF; Hammons GJ; Fernandez-Salguero P; Gonzalez FJ		Carcinogenesis	20	1999	1825-30	J:57281	10469630
87883	A multihit, multistage model of chemical carcinogenesis.		Owens DM; Wei S; Smart RC		Carcinogenesis	20	1999	1837-44	J:57282	10469632
87884	Induction of cyclin-dependent kinase inhibitors and G(1) prolongation by the chemopreventive agent N-acetylcysteine.		Liu M; Wikonkal NM; Brash DE		Carcinogenesis	20	1999	1869-72	J:57283	10469636
87885	Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.		Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH		Carcinogenesis	20	1999	1689-96	J:57287	10469612
87886	Gene therapy of B-cell lymphoma with cytokine gene-modified trioma cells.		Strehl J; Selmayr M; Kremer JP; Hultner L; Lindhofer H; Mocikat R		Int J Cancer	83	1999	113-20	J:57321	10449617
87887	Generation of anti-allogeneic cytotoxic T lymphocytes depends upon a signal, not delivered by tumor cells, that can be provided in trans in the presence of exogenous interleukin-2.		Zier KS; Salvadori S		Cancer Immunol Immunother	48	1999	247-52	J:57323	10478641
87888	The level of cell surface beta1,4-galactosyltransferase I influences the invasive potential of murine melanoma cells.		Johnson FM; Shur BD		J Cell Sci	112	1999	2785-95	J:57327	10413685
87889	High level antibody response to retrovirus-associated but not to melanocyte lineage-specific antigens in mice protected against B16 melanoma.		Sfondrini L; Morelli D; Bodini A; Colnaghi MI; Menard S; Balsari A		Int J Cancer	83	1999	107-12	J:57320	10449616
87890	Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.		Milas L; Kishi K; Hunter N; Mason K; Masferrer JL; Tofilon PJ		J Natl Cancer Inst	91	1999	1501-4	J:57347	10469752
87891	Tumor cells cotransduced with B7.1 and gamma-IFN induce effective rejection of established parental tumor.		Yang S; Vervaert CE; Seigler HF; Darrow TL		Gene Ther	6	1999	253-62	J:57377	10435110
87892	Immunological and molecular characterization of an aggressive murine lymphoma variant: modulation in vitro and in vivo.		Jurianz K; von Hoegen P; Schirrmacher V		Int J Oncol	15	1999	71-9	J:57383	10375596
87893	Target genes and target cells in carcinogenesis.		Frame S; Balmain A		Br J Cancer	80 Suppl 1	1999	28-33	J:57407	10466758
87894	Tumour vasculature as a target for cancer therapy.		Chaplin DJ; Dougherty GJ		Br J Cancer	80 Suppl 1	1999	57-64	J:57408	10466764
87895	Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice.		Arbeit JM; Riley RR; Huey B; Porter C; Kelloff G; Lubet R; Ward JM; Pinkel D		Cancer Res	59	1999	3610-20	J:57411	10446971
87896	Oxygen tension measurements of tumors growing in mice.		Adam MF; Dorie MJ; Brown JM		Int J Radiat Oncol Biol Phys	45	1999	171-80	J:57420	10477021
87897	Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.		Martiney MJ; Rulli K; Beaty R; Levy LS; Lenz J		J Virol	73	1999	7599-606	J:57431	10438850
87898	Differential expression of C-CAM cell adhesion molecule in prostate carcinogenesis in a transgenic mouse model [published erratum appears in J Urol 2000 Jan;163(1):253]		Pu YS; Luo W; Lu HH; Greenberg NM; Lin SH; Gingrich JR		J Urol	162	1999	892-6	J:57429	10458403
87899	Tandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias.		Granger SW; Bundy LM; Fan H		J Virol	73	1999	7175-84	J:57430	10438804
87900	Primary structure, gene expression and chromosomal mapping of rodent homologs of the MEN1 tumor suppressor gene.		Karges W; Maier S; Wissmann A; Dralle H; Dosch HM; Boehm BO		Biochim Biophys Acta	1446	1999	286-94	J:57456	10524203
87901	High levels of IL-4 and IL-10 mRNA and low levels of IL-2, IL-9 and IFN-gamma mRNA in MuLV-induced lymphomas.		Beaty RM; Rulli K; Bost KL; Pantginis J; Lenz J; Levy LS		Virology	261	1999	253-62	J:57483	10497110
87902	Turning on tumors to study cancer progression [news]		Berns A		Nat Med	5	1999	989-90	J:57506	10470069
87903	The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.		Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Sogaard M; Andersson J; Andersson U		Br J Cancer	81	1999	359-66	J:57541	10496366
87904	Ca2+-induced changes in energy metabolism and viability of melanoma cells.		Glass-Marmor L; Penso J; Beitner R		Br J Cancer	81	1999	219-24	J:57540	10496345
87905	Genetic dissection of X-linked interspecific hybrid placental dysplasia in congenic mouse strains.		Hemberger MC; Pearsall RS; Zechner U; Orth A; Otto S; Ruschendorf F; Fundele R; Elliott R		Genetics	153	1999	383-90	J:57551	10471720
87906	Beta-glucan, a 'specific' biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).		Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD		J Immunol	163	1999	3045-52	J:57602	10477568
87907	Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice.		Suganuma M; Okabe S; Marino MW; Sakai A; Sueoka E; Fujiki H		Cancer Res	59	1999	4516-8	J:57606	10493498
87908	Time course for early adaptive responses to ultraviolet B light in the epidermis of SKH-1 mice.		Lu YP; Lou YR; Yen P; Mitchell D; Huang MT; Conney AH		Cancer Res	59	1999	4591-602	J:57607	10493513
87909	Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo.		Nishimura T; Iwakabe K; Sekimoto M; Ohmi Y; Yahata T; Nakui M; Sato T; Habu S; Tashiro H; Sato M; Ohta A		J Exp Med	190	1999	617-27	J:57610	10477547
87910	IL-2 gene-modified tumour vaccines: monitoring of IL-2 levels in serum and peritoneal cavity of vaccinated mice.		Indrova M; Pajtasz-Piasecka E; Jandlova T; Simova J; Bubenik J; Radzikowski C		Folia Biol (Praha)	45	1999	7-11	J:53678	10732712
87911	[The study of correlation between the K-ras genotype and murine susceptibility to chemically induced lung neoplasms]		Timofeeva OA; Filipenko ML; Kaledin VI		Genetika	35	1999	1309-12	J:57706	10576066
87912	Deletion of Ku86 causes early onset of senescence in mice.		Vogel H; Lim DS; Karsenty G; Finegold M; Hasty P		Proc Natl Acad Sci U S A	96	1999	10770-5	J:57731	10485901
87913	Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.		Wong KS; Li YJ; Howard J; Ben-David Y		Oncogene	18	1999	5525-34	J:58012	10523829
87914	In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells.		Mahgoub N; Taylor BR; Gratiot M; Kohl NE; Gibbs JB; Jacks T; Shannon KM		Blood	94	1999	2469-76	J:57842	10498620
87915	The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia [letter]		Castilla LH; Garrett L; Adya N; Orlic D; Dutra A; Anderson S; Owens J; Eckhaus M; Bodine D; Liu PP		Nat Genet	23	1999	144-6	J:57880	10508507
87916	Skin tumorigenesis by initiators and promoters of different chemical structures in lines of mice selectively bred for resistance (Car-r) or susceptibility (Car-s) to two-stage skin carcinogenesis.		Saran A; Pazzaglia S; Rebessi S; Bouthillier Y; Pioli C; Covelli V; Mouton D; Doria G; Biozzi G		Int J Cancer	83	1999	335-40	J:57871	10495425
87917	Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancer.		Cefai D; Morrison BW; Sckell A; Favre L; Balli M; Leunig M; Gimmi CD		Int J Cancer	83	1999	393-400	J:57872	10495433
87918	Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression.		Maroulakou IG; Shibata MA; Anver M; Jorcyk CL; Liu Ml; Roche N; Roberts AB; Tsarfaty I; Reseau J; Ward J; Green JE		Oncogene	18	1999	5435-47	J:57996	10498897
87919	Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.		Johnsen AK; Templeton DJ; Sy M; Harding CV		J Immunol	163	1999	4224-31	J:57997	10510359
87920	T cell status influences colon tumor occurrence in min mice fed short chain fructo-oligosaccharides as a diet supplement.		Pierre F; Perrin P; Bassonga E; Bornet F; Meflah K; Menanteau J		Carcinogenesis	20	1999	1953-6	J:58033	10506110
87921	High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice.		Snibson KJ; Bhathal PS; Hardy CL; Brandon MR; Adams TE		Liver	19	1999	242-52	J:58071	10395045
87922	Histological and genetic changes in malignant transformation of gallbladder adenoma.		Watanabe H; Date K; Itoi T; Matsubayashi H; Yokoyama N; Yamano M; Ajioka Y; Nishikura K		Ann Oncol	10 Suppl 4	1999	136-9	J:58059	10436806
87923	Prenatal transmission and pathogenicity of endogenous ecotropic murine leukemia virus Akv.		Hesse I; Luz A; Kohleisen B; Erfle V; Schmidt J		Lab Anim Sci	49	1999	488-95	J:58213	10551449
87924	Rhabdomyosarcoma--working out the pathways.		Merlino G; Helman LJ		Oncogene	18	1999	5340-8	J:58240	10498887
87925	Mouse models of prostate cancer.		Sharma P; Schreiber-Agus N		Oncogene	18	1999	5349-55	J:58241	10498888
87926	Development of a flexible and specific gene delivery system for production of murine tumor models.		Fisher GH; Orsulic S; Holland E; Hively WP; Li Y; Lewis BC; Williams BO; Varmus HE		Oncogene	18	1999	5253-60	J:58243	10498877
87927	Acute promyelocytic leukemia: from treatment to genetics and back.		Kogan SC; Bishop JM		Oncogene	18	1999	5261-7	J:58244	10498878
87928	Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector.		Adams JM; Harris AW; Strasser A; Ogilvy S; Cory S		Oncogene	18	1999	5268-77	J:58245	10498879
87929	In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.		He LZ; Merghoub T; Pandolfi PP		Oncogene	18	1999	5278-92	J:58246	10498880
87930	Mammary gland development, reproductive history, and breast cancer risk.		Chodosh LA; D'Cruz CM; Gardner HP; Ha SI; Marquis ST; Rajan JV; Stairs DB; Wang JY; Wang M		Cancer Res	59	1999	1765-1771s; discussion 1771s-1	J:44157	10197594
87931	A bumper crop of cancer genes [news; comment]		DePinho RA; Jacks T		Nat Genet	23	1999	253-4	J:58264	10545932
87932	Leukaemia disease genes: large-scale cloning and pathway predictions [see comments]		Li J; Shen H; Himmel KL; Dupuy AJ; Largaespada DA; Nakamura T; Shaughnessy JD Jr; Jenkins NA; Copeland NG		Nat Genet	23	1999	348-53	J:58265	10610183
87933	Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.		Jacobs JJ; Scheijen B; Voncken JW; Kieboom K; Berns A; van Lohuizen M		Genes Dev	13	1999	2678-90	J:58291	10541554
87934	Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.		Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL		Genes Dev	13	1999	2658-69	J:58292	10541552
87935	INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.		Schmitt CA; McCurrach ME; de Stanchina E; Wallace-Brodeur RR; Lowe SW		Genes Dev	13	1999	2670-7	J:58293	10541553
87936	Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice.		Aszterbaum M; Epstein J; Oro A; Douglas V; LeBoit PE; Scott MP; Epstein EH Jr		Nat Med	5	1999	1285-91	J:58328	10545995
87937	Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice.		Asa SL; Kelly MA; Grandy DK; Low MJ		Endocrinology	140	1999	5348-55	J:58342	10537166
87938	B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).		Palomo C; Zou X; Nicholson IC; Butzler C; Bruggemann M		Cancer Res	59	1999	5625-8	J:58366	10554044
87939	Identification of a common site of provirus integration in radiation leukemia virus-induced T-cell lymphomas in mice.		Lambert J; Bergeron D; Kozak CA; Rassart E		Virology	264	1999	181-6	J:58403	10544143
87940	The role of lats in cell cycle regulation and tumorigenesis.		Turenchalk GS; St John MA; Tao W; Xu T		Biochim Biophys Acta	1424	1999	M9-M16	J:58428	10528150
87941	TCF transcription factors: molecular switches in carcinogenesis.		Roose J; Clevers H		Biochim Biophys Acta	1424	1999	M23-37	J:58430	10528152
87942	Many faces of ATM: eighth international workshop on ataxia-telangiectasia.		Halazonetis TD; Shiloh Y		Biochim Biophys Acta	1424	1999	R45-55	J:58431	10528155
87943	Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors.		Velupillai P; Yoshizawa I; Dey DC; Nahill SR; Carroll JP; Bronson RT; Benjamin TL		J Virol	73	1999	10079-85	J:58441	10559322
87944	Effectiveness of a simply designed tumor vaccine in prevention of malignant melanoma development.		Novakovic S; Ihan A; Jezersek B		Jpn J Cancer Res	90	1999	1130-8	J:58478	10595742
87945	Antitumor efficacy of hypothemycin, a new Ras-signaling inhibitor.		Tanaka H; Nishida K; Sugita K; Yoshioka T		Jpn J Cancer Res	90	1999	1139-45	J:58479	10595743
87946	Enhanced sonodynamic antitumor effect of ultrasound in the presence of nonsteroidal anti-inflammatory drugs.		Sakusabe N; Okada K; Sato K; Kamada S; Yoshida Y; Suzuki T		Jpn J Cancer Res	90	1999	1146-51	J:58480	10595744
87947	In vivo anti-tumor activity of a novel indolocarbazole compound, J-107088, on murine and human tumors transplanted into mice.		Arakawa H; Morita M; Kodera T; Okura A; Ohkubo M; Morishima H; Nishimura S		Jpn J Cancer Res	90	1999	1163-70	J:58481	10595746
87948	Generation of B lymphoma cell lines from knockout mice by transformation in vivo with an Emu-myc transgene.		Corcoran LM; Tawfilis S; Barlow LJ		J Immunol Methods	228	1999	131-8	J:58472	10556550
87949	The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.		Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J		EMBO J	18	1999	6362-9	J:58507	10562548
87950	c-Myc enhances protein synthesis and cell size during B lymphocyte development.		Iritani BM; Eisenman RN		Proc Natl Acad Sci U S A	96	1999	13180-5	J:58511	10557294
87951	Restricted immunoglobulin variable region (Ig V) gene expression accompanies secondary rearrangements of light chain Ig V genes in mouse plasmacytomas.		Diaw L; Siwarski D; Coleman A; Kim J; Jones GM; Dighiero G; Huppi K		J Exp Med	190	1999	1405-16	J:58492	10562316
87952	The p66shc adaptor protein controls oxidative stress response and life span in mammals [see comments]		Migliaccio E; Giorgio M; Mele S; Pelicci G; Reboldi P; Pandolfi PP; Lanfrancone L; Pelicci PG		Nature	402	1999	309-13	J:58535	10580504
87953	Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage.		Klungland A; Rosewell I; Hollenbach S; Larsen E; Daly G; Epe B; Seeberg E; Lindahl T; Barnes DE		Proc Natl Acad Sci U S A	96	1999	13300-5	J:58517	10557315
87954	Syncytiotrophoblastic giant cells in teratocarcinoma-like tumors derived from Parp-disrupted mouse embryonic stem cells.		Nozaki T; Masutani M; Watanabe M; Ochiya T; Hasegawa F; Nakagama H; Suzuki H; Sugimura T		Proc Natl Acad Sci U S A	96	1999	13345-50	J:58519	10557323
87955	Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA.		Oshikawa K; Shi F; Rakhmilevich AL; Sondel PM; Mahvi DM; Yang NS		Proc Natl Acad Sci U S A	96	1999	13351-6	J:58520	10557324
87956	Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.		Reddig PJ; Dreckschmidt NE; Ahrens H; Simsiman R; Tseng CP; Zou J; Oberley TD; Verma AK		Cancer Res	59	1999	5710-8	J:58557	10582689
87957	Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein.		Rauh MJ; Blackmore V; Andrechek ER; Tortorice CG; Daly R; Lai VK; Pawson T; Cardiff RD; Siegel PM; Muller WJ		Mol Cell Biol	19	1999	8169-79	J:58608	10567542
87958	Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas		Balana ME; Lupu R; Labriola L; Charreau EH; Elizalde PV		Oncogene	18	1999	6370-9	J:58616	10597237
87959	Activation of Hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia.		Hansen GM; Justice MJ		Oncogene	18	1999	6531-9	J:58689	10597256
87960	Immune evasion of tumor cells using membrane-bound complement regulatory proteins.		Gorter A; Meri S		Immunol Today	20	1999	576-82	J:58717	10562709
87961	Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model.		Furth PA; Bar-Peled U; Li M; Lewis A; Laucirica R; Jager R; Weiher H; Russell RG		Oncogene	18	1999	6589-96	J:58751	10597263
87962	Carcinogenesis in mice after injection of soluble plutonium citrate.		Oghiso Y; Yamada Y		Radiat Res	152	1999	S27-30	J:58818	10564931
87963	Allelic loss and promoter hypermethylation of the p15INK4b gene features in mouse radiation-induced lymphoid - but not myeloid - leukaemias.		Cleary HJ; Boulton E; Plumb M		Leukemia	13	1999	2049-52	J:58858	10602427
87964	Homozygous deletions and point mutations of the Ikaros gene in gamma-ray-induced mouse thymic lymphomas.		Okano H; Saito Y; Miyazawa T; Shinbo T; Chou D; Kosugi S; Takahashi Y; Odani S; Niwa O; Kominami R		Oncogene	18	1999	6677-83	J:58869	10597273
87965	Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation.		Beissert S; Bluestone JA; Mindt I; Voskort M; Metze D; Mehling A; Luger TA; Schwarz T; Grabbe S		J Immunol	163	1999	6725-31	J:58983	10586070
87966	Oppositely imprinted genes p57(Kip2) and igf2 interact in a mouse model for Beckwith-Wiedemann syndrome.		Caspary T; Cleary MA; Perlman EJ; Zhang P; Elledge SJ; Tilghman SM		Genes Dev	13	1999	3115-24	J:58998	10601037
87967	Glycoprotein glycosylation and cancer progression.		Dennis JW; Granovsky M; Warren CE		Biochim Biophys Acta	1473	1999	21-34	J:59033	10580127
87968	Myeloproliferative disorder and leukaemia in mice induced by different classes of constitutive mutants of the human IL-3/IL-5/GM-CSF receptor common beta subunit.		McCormack MP; Gonda TJ		Oncogene	18	1999	7190-9	J:59018	10602472
87969	Vaccines with interleukin-12-transduced acute myeloid leukemia cells elicit very potent therapeutic and long-lasting protective immunity.		Dunussi-Joannopoulos K; Runyon K; Erickson J; Schaub RG; Hawley RG; Leonard JP		Blood	94	1999	4263-73	J:59019	10590071
87970	Treatment of multidrug resistant (MDR1) murine leukemia with P-glycoprotein substrates accelerates the course of the disease.		Yang JM; Yang GY; Medina DJ; Vassil AD; Liao J; Hait WN		Biochem Biophys Res Commun	266	1999	167-73	J:59020	10581184
87971	Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis		Budunova IV; Perez P; Vaden VR; Spiegelman VS; Slaga TJ; Jorcano JL		Oncogene	18	1999	7423-31	J:59023	10602501
87972	Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice		Elson A		Oncogene	18	1999	7535-42	J:59024	10602512
87973	A subset of skin tumor modifier loci determines survival time of tumor-bearing mice		Nagase H; Mao JH; Balmain A		Proc Natl Acad Sci U S A	96	1999	15032-7	J:59049	10611333
87974	Difference in target organs in carcinogenesis with a heterocyclic amine, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, in different strains of mice.		Fujita H; Nagano K; Ochiai M; Ushijima T; Sugimura T; Nagao M; Matsushima T		Jpn J Cancer Res	90	1999	1203-6	J:59210	10622529
87975	Gastric hyperplasia in mice lacking the putative cdc42 effector IQGAP1		Li S; Wang Q; Chakladar A; Bronson RT; Bernards A		Mol Cell Biol	20	2000	697-701	J:59215	10611248
87976	Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells.		Uhrbom L; Hesselager G; Ostman A; Nister M; Westermark B		Int J Cancer	85	2000	398-406	J:59242	10652433
87977	Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice.		Hara A; Yoshimi N; Yamada Y; Matsunaga K; Kawabata K; Sugie S; Mori H		Br J Cancer	82	2000	467-71	J:59293	10646906
87978	Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus [see comments]		Stewart TH; Sage RD; Stewart AF; Cameron DW		Br J Cancer	82	2000	446-51	J:59294	10646903
87979	The hedgehog signalling pathway in tumorigenesis and development.		Wicking C; Smyth I; Bale A		Oncogene	18	1999	7844-51	J:59339	10630637
87980	Gli genes in development and cancer.		Matise MP; Joyner AL		Oncogene	18	1999	7852-9	J:59340	10630638
87981	The retinoblastoma gene family in differentiation and development.		Lipinski MM; Jacks T		Oncogene	18	1999	7873-82	J:59341	10630640
87982	The role of cyclooxygenases in inflammation, cancer, and development.		Williams CS; Mann M; DuBois RN		Oncogene	18	1999	7908-16	J:59342	10630643
87983	Susceptibility to urethane carcinogenesis of transgenic mice carrying a human prototype c-Ha-ras gene (rasH2 mice) and its modification by butylhydroxytoluene.		Umemura T; Kodama Y; Hioki K; Inoue T; Nomura T; Kurokawa Y		Cancer Lett	145	1999	101-6	J:59515	10530776
87984	Inhibitory effects of chlorophyllin on 7,12-dimethylbenz[a]anthracene-induced bacterial mutagenesis and mouse skin carcinogenesis.		Chung WY; Lee JM; Park MY; Yook JI; Kim J; Chung AS; Surh YJ; Park KK		Cancer Lett	145	1999	57-64	J:59516	10530770
87985	Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy		Kwon ED; Foster BA; Hurwitz AA; Madias C; Allison JP; Greenberg NM; Burg MB		Proc Natl Acad Sci U S A	96	1999	15074-9	J:59573	10611340
87986	Methylation and downregulated expression of mac25/insulin-like growth factor binding protein-7 is associated with liver tumorigenesis in SV40T/t antigen transgenic mice, screened by restriction landmark genomic scanning for methylation (RLGS-M).		Komatsu S; Okazaki Y; Tateno M; Kawai J; Konno H; Kusakabe M; Yoshiki A; Muramatsu M; Held WA; Hayashizaki Y		Biochem Biophys Res Commun	267	2000	109-17	J:59383	10623583
87987	The hallmarks of cancer.		Hanahan D; Weinberg RA		Cell	100	2000	57-70	J:59369	10647931
87988	Carcinogenicity and mutagenicity of heterocyclic amines in transgenic mouse models.		Thorgeirsson SS; Ryu DY; Weidner V; Synderwine EG		Cancer Lett	143	1999	245-7	J:59438	10503912
87989	Promotional effects of CO(2) laser and scalpel incision on 4-NQO-induced premalignant lesions of mouse tongue.		Ma G; Sano K; Ikeda H; Inokuchi T		Lasers Surg Med	25	1999	207-12	J:59439	10495296
87990	Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery.		David RM; Moore MR; Cifone MA; Finney DC; Guest D		Toxicol Sci	50	1999	195-205	J:59450	10478855
87991	Modulatory potential of clocimum oil on mouse skin papillomagenesis and the xenobiotic detoxication system.		Singh A; Singh SP; Bamezai R		Food Chem Toxicol	37	1999	663-70	J:59451	10478835
87992	The patched signaling pathway in tumorigenesis and development: lessons from animal models.		Hahn H; Wojnowski L; Miller G; Zimmer A		J Mol Med	77	1999	459-68	J:59453	10475061
87993	Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.		Watanabe K; Kawamori T; Nakatsugi S; Ohta T; Ohuchida S; Yamamoto H; Maruyama T; Kondo K; Ushikubi F; Narumiya S; Sugimura T; Wakabayashi K		Cancer Res	59	1999	5093-6	J:59509	10537280
87994	Compensatory lung growth after partial pneumonectomy enhances lung tumorigenesis induced by 3-methylcholanthrene.		Brown LM; Malkinson AM; Rannels DE; Rannels SR		Cancer Res	59	1999	5089-92	J:59510	10537279
87995	Tumor burden and clonality in multiple intestinal neoplasia mouse/normal mouse aggregation chimeras.		Novelli MR; Wasan H; Rosewell I; Bee J; Tomlinson IP; Wright NA; Bodmer WF		Proc Natl Acad Sci U S A	96	1999	12553-8	J:59511	10535960
87996	Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.		Forget MA; Desrosiers RR; Beliveau R		Can J Physiol Pharmacol	77	1999	465-80	J:59512	10535707
87997	Oxymetholone: III. Evaluation in the p53+/- transgenic mouse model [comment] [see comments]		Stoll RE; Holden HE; Barthel CH; Blanchard KT		Toxicol Pathol	27	1999	513-8	J:59521	10528630
87998	Oxymetholone: II. Evaluation in the Tg-AC transgenic mouse model for detection of carcinogens [comment] [see comments]		Holden HE; Stoll RE; Blanchard KT		Toxicol Pathol	27	1999	507-12	J:59522	10528629
87999	Noninsulin-dependent diabetes mellitus occurs in mice ectopically expressing the human Axl tyrosine kinase receptor.		Augustine KA; Rossi RM; Van G; Housman J; Stark K; Danilenko D; Varnum B; Medlock E		J Cell Physiol	181	1999	433-47	J:59523	10528229
88000	Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.		Duddy SK; Gorospe SM; Bleavins MR; de la Iglesia FA		Toxicol Appl Pharmacol	160	1999	133-40	J:59524	10527912
88001	Ferrochelatase, a novel target for photodynamic therapy of cancer.		Bhasin G; Kausar H; Athar M		Oncol Rep	6	1999	1439-42	J:59525	10523727
88002	Increased neoplasm development due to immunosuppressive treatment with FK-506 in BALB/C mice persistently infected with the mouse herpesvirus (MHV-72).		Mistrikova J; Mrmusova M; Durmanova V; Rajcani J		Viral Immunol	12	1999	237-47	J:59513	10532652
88003	Cancer biology: extracellular proteinases in malignancy.		Matrisian LM		Curr Biol	9	1999	R776-8	J:59514	10531025
88004	Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.		van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dolle ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H		Environ Mol Mutagen	34	1999	124-30	J:59517	10529736
88005	Protection against 12-O-tetradecanoylphorbol-13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline analogue of ellipticine.		Skarin T; Rozell BL; Bergman J; Toftgard R; Moller L		Chem Biol Interact	122	1999	89-106	J:59519	10528995
88006	Transponder-induced sarcoma in the heterozygous p53+/- mouse.		Blanchard KT; Barthel C; French JE; Holden HE; Moretz R; Pack FD; Tennant RW; Stoll RE		Toxicol Pathol	27	1999	519-27	J:59520	10528631
88007	N-3, n-6 and n-9 dietary fatty acids modulate the growth parameters of murine salivary gland tumors induced by dimethylbenzanthracene.		Actis AB; Lopez CB; Joekes S; Eynard AR		Prostaglandins Leukot Essent Fatty Acids	61	1999	259-65	J:59547	10574651
88008	Thymic hormones, cancer and behavioural adaptive responses.		Lempereur L; Cantarella G; Murabito P; Chiarenza A; Fiore L; Zappala G; Bernardini R		Ann Med	31 Suppl 2	1999	40-5	J:59548	10574154
88009	Mutational analysis of transgenic mouse B cell lymphomas: indication of a Trp53-independent pathway in tumor progression.		Samant SA; Sheppard RD		Leuk Res	23	1999	939-46	J:59549	10573140
88010	12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.		Wang XJ; Liefer KM; Greenhalgh DA; Roop DR		Mol Carcinog	26	1999	305-11	J:59550	10569807
88011	Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice.		Murphy KL; Kittrell FS; Gay JP; Jager R; Medina D; Rosen JM		Oncogene	18	1999	6597-604	J:59579	10597264
88012	Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin.		Gilmour SK; Birchler M; Smith MK; Rayca K; Mostochuk J		Cell Growth Differ	10	1999	739-48	J:59581	10593650
88013	Inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in benzo[a]pyrene-initiated CD-1 mouse skin by baicalein		Lee MJ; Wang CJ; Tsai YY; Hwang JM; Lin WL; Tseng TH; Chu CY		Nutr Cancer	34	1999	185-91	J:59583	10578486
88014	Toxicologic evaluation of flavor ingredients added to cigarette tobacco: skin painting bioassay of cigarette smoke condensate in SENCAR mice		Gaworski CL; Heck JD; Bennett MB; Wenk ML		Toxicology	139	1999	1-17	J:59571	10614684
88015	Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha.		Song SY; Gannon M; Washington MK; Scoggins CR; Meszoely IM; Goldenring JR; Marino CR; Sandgren EP; Coffey RJ Jr; Wright CV; Leach SD		Gastroenterology	117	1999	1416-26	J:59869	10579983
88016	Antitumorigenic actions of growth hormone-releasing hormone antagonists [comment]		Kineman RD		Proc Natl Acad Sci U S A	97	2000	532-4	J:59897	10639112
88017	Heritable lympho-epithelial thymoma resulting from a transgene insertional mutation.		Nakajima H; Nakajima HO; Soonpaa MH; Jing S; Field LJ		Oncogene	19	2000	32-8	J:59903	10644977
88018	Lessons from genetically engineered animal models. VII. Apoptosis in intestinal epithelium: lessons from transgenic and knockout mice.		Watson AJ; Pritchard DM		Am J Physiol Gastrointest Liver Physiol	278	2000	G1-5	J:59963	10644554
88019	Hair follicle apoptosis and Bcl-2.		Muller-Rover S; Rossiter H; Lindner G; Peters EM; Kupper TS; Paus R		J Investig Dermatol Symp Proc	4	1999	272-7	J:59943	10674380
88020	Organ-specific, carcinogen-induced increases in cell proliferation in p53-deficient mice.		Sukata T; Ozaki K; Uwagawa S; Seki T; Wanibuchi H; Yamamoto S; Okuno Y; Fukushima S		Cancer Res	60	2000	74-9	J:59949	10646856
88021	Influence of interferon-alpha2b (IFN-alpha2b) on the prevention of locally advanced bladder carcinoma in mice		Otto T; Bex A; Lummen G; Rubben H		Urol Res	27	1999	489-92	J:60013	10651139
88022	Barrett's esophagus and associated adenocarcinoma in a mouse surgical model		Xu X; LoCicero J 3rd; Macri E; Loda M; Ellis FH Jr		J Surg Res	88	2000	120-4	J:60016	10644476
88023	The tyrosinase related protein-1 (Tyrp1) promoter in transgenic experiments: targeted expression to the retinal pigment epithelium		Beermann F		Cell Mol Biol (Noisy-Le-Grand)	45	1999	961-8	J:60017	10644000
88024	A locus that influences susceptibility to 1, 2-dimethylhydrazine-induced colon tumors maps to the distal end of mouse chromosome 3.		Angel JM; Popova N; Lanko N; Turusov VS; DiGiovanni J		Mol Carcinog	27	2000	47-54	J:60018	10642436
88025	A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse		Trempus CS; Bishop WR; Njoroge FG; Doll RJ; Battalora MS; Mahler JF; Haseman JK; Tennant RW		Mol Carcinog	27	2000	24-33	J:60019	10642434
88026	Ozone carcinogenesis revisited.		Witschi H; Espiritu I; Pinkerton KE; Murphy K; Maronpot RR		Toxicol Sci	52	1999	162-7	J:60027	10630568
88027	Inhibition by whole-body hyperthermia with far-infrared rays of the growth of spontaneous mammary tumours in mice		Udagawa Y; Nagasawa H; Kiyokawa S		Anticancer Res	19	1999	4125-30	J:60028	10628363
88028	Inhibition of skin cancer by IP6 in vivo: initiation-promotion model.		Ishikawa T; Nakatsuru Y; Zarkovic M; Shamsuddin AM		Anticancer Res	19	1999	3749-52	J:60030	10625952
88029	Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositol.		Nishino H; Murakoshi M; Masuda M; Tokuda H; Satomi Y; Onozuka M; Yamaguchi S; Bu P; Tsuruta A; Nosaka K; Baba M; Takasuka N		Anticancer Res	19	1999	3663-4	J:60031	10625935
88030	Chemoprevention of pulmonary carcinogenesis by myo-inositol.		Wattenberg LW		Anticancer Res	19	1999	3659-61	J:60032	10625934
88031	Inhibition of chemical carcinogenesis by Psoralea corylifolia seeds		Latha PG; Panikkar KR		J Ethnopharmacol	68	1999	295-8	J:60033	10624891
88032	Overexpression of aromatase leads to development of testicular leydig cell tumors : an in vivo model for hormone-mediated TesticularCancer.		Fowler KA; Gill K; Kirma N; Dillehay DL; Tekmal RR		Am J Pathol	156	2000	347-53	J:60034	10623684
88033	Photoreceptor cell tumors in transgenic mice.		Howes KA; Lasudry JG; Albert DM; Windle JJ		Invest Ophthalmol Vis Sci	35	1994	342-51	J:60231	8112979
88034	Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.		Boggio K; Di Carlo E; Rovero S; Cavallo F; Quaglino E; Lollini PL; Nanni P; Nicoletti G; Wolf S; Musiani P; Forni G		Cancer Res	60	2000	359-64	J:60215	10667588
88035	Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model.		Menard S; Aiello P; Tagliabue E; Rumio C; Lollini PL; Colnaghi MI; Balsari A		Cancer Res	60	2000	273-5	J:60217	10667575
88036	Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma [see comments]		Yang TY; Chen SC; Leach MW; Manfra D; Homey B; Wiekowski M; Sullivan L; Jenh CH; Narula SK; Chensue SW; Lira SA		J Exp Med	191	2000	445-54	J:60254	10662790
88037	MDM2--master regulator of the p53 tumor suppressor protein.		Momand J; Wu HH; Dasgupta G		Gene	242	2000	15-29	J:60295	10721693
88038	Downregulation of the p53 tumor suppressor gene and upregulation of the bcl-2 gene in retinoic acid receptor alpha-deficient transgenic mice		Haidar MA; Manshouri T; Keating MJ; Kantarjian HM; Freireich EJ; Mehta K; Albitar M		Int J Oncol	16	2000	561-5	J:60478	10675490
88039	ATR disruption leads to chromosomal fragmentation and early embryonic lethality.		Brown EJ; Baltimore D		Genes Dev	14	2000	397-402	J:60768	10691732
88040	Mammalian DNA mismatch repair		Buermeyer AB; Deschenes SM; Baker SM; Liskay RM		Annu Rev Genet	33	1999	533-64	J:60788	10690417
88041	Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER mice.		Blyth K; Stewart M; Bell M; James C; Evan G; Neil JC; Cameron ER		Oncogene	19	2000	773-82	J:60583	10698495
88042	Accelerated appearance of multiple B cell lymphoma types in NFS/N mice congenic for ecotropic murine leukemia viruses.		Hartley JW; Chattopadhyay SK; Lander MR; Taddesse-Heath L; Naghashfar Z; Morse HC 3rd; Fredrickson TN		Lab Invest	80	2000	159-69	J:60584	10701686
88043	Altered surface expression and increased turnover of the alpha6beta4 integrin in an undifferentiated carcinoma.		Witkowski CM; Bowden GT; Nagle RB; Cress AE		Carcinogenesis	21	2000	325-30	J:60615	10657977
88044	Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene.		Frey S; Buchmann A; Bursch W; Schulte-Hermann R; Schwarz M		Carcinogenesis	21	2000	161-6	J:60617	10657952
88045	Expression analysis of the group IIA secretory phospholipase A(2) in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis.		Papanikolaou A; Wang QS; Mulherkar R; Bolt A; Rosenberg DW		Carcinogenesis	21	2000	133-8	J:60619	10657948
88046	Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis.		Chuang SE; Kuo ML; Hsu CH; Chen CR; Lin JK; Lai GM; Hsieh CY; Cheng AL		Carcinogenesis	21	2000	331-5	J:60614	10657978
88047	Signaling in leukemia: which messenger to kill? [comment]		Pear WS		J Clin Invest	105	2000	419-22	J:60674	10683370
88048	Basal cell carcinomas in mice overexpressing Gli2 in skin.		Grachtchouk M; Mo R; Yu S; Zhang X; Sasaki H; Hui CC; Dlugosz AA		Nat Genet	24	2000	216-7	J:60757	10700170
88049	Molecular pathology of cyclooxygenase-2 in neoplasia		Fosslien E		Ann Clin Lab Sci	30	2000	3-21	J:60801	10678579
88050	Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: A model for human AML		Cuenco GM; Nucifora G; Ren R		Proc Natl Acad Sci U S A	97	2000	1760-5	J:60802	10677531
88051	Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors		Willimsky G; Blankenstein T		Cancer Res	60	2000	685-92	J:60803	10676654
88052	Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion		Reddig PJ; Dreckschmidt NE; Zou J; Bourguignon SE; Oberley TD; Verma AK		Cancer Res	60	2000	595-602	J:60804	10676642
88053	Kaplan-Meier tumor probability as a starting point for dose-response modeling provides accurate lifetime risk estimates from rodent carcinogenicity studies		Ten Berge WF		Ann N Y Acad Sci	895	1999	112-24	J:60805	10676412
88054	Effects of nicotinamide on mouse skin tumor development and its mode of action		Gupta KP		Biomed Environ Sci	12	1999	177-87	J:60806	10674181
88055	Chemical hepatocarcinogenesis in transgenic mice overexpressing mature TGF beta-1 in liver		Schnur J; Nagy P; Sebestyen A; Schaff Z; Thorgeirsson SS		Eur J Cancer	35	1999	1842-5	J:60807	10674001
88056	The role of COX-2 in intestinal cancer		Williams C; Shattuck-Brandt RL; DuBois RN		Ann N Y Acad Sci	889	1999	72-83	J:60808	10668484
88057	Genetic factors in immunity and aging.		Doria G; Frasca D		Vaccine	18	2000	1591-5	J:60789	10689133
88058	Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable		Kogan SC; Hong Sh; Shultz DB; Privalsky ML; Bishop JM		Blood	95	2000	1541-50	J:60790	10688806
88059	Antitumor effects of bis(ethyl)polyamine analogs on mammary tumor development in FVB/NTgN (MMTVneu) transgenic mice.		Shah N; Antony T; Haddad S; Amenta P; Shirahata A; Thomas TJ; Thomas T		Cancer Lett	146	1999	15-23	J:60826	10656605
88060	Tumorigenicity of nitropolycyclic aromatic hydrocarbons in the neonatal B6C3F1 mouse bioassay and characterization of ras mutations in liver tumors from treated mice.		Von Tungeln LS; Xia Q; Herreno-Saenz D; Bucci TJ; Heflich RH; Fu PP		Cancer Lett	146	1999	1-7	J:60827	10656603
88061	Effects of simultaneous treatment with hydroxyapatite and coffee cherry, the residue left after the removal of coffee beans, on spontaneous mammary tumourigenesis and related parameters in SHN mice		Nagasawa H; Hirayama T; Inatomi H		In Vivo	13	1999	385-8	J:60828	10654190
88062	Effects of 100 mT time varying magnetic fields on the growth of tumors in mice.		de Seze R; Tuffet S; Moreau JM; Veyret B		Bioelectromagnetics	21	2000	107-11	J:60829	10653621
88063	Preventive effect of hesperidin against inflammation in CD-1 mouse skin caused by tumor promoter.		Koyuncu H; Berkarda B; Baykut F; Soybir G; Alatli C; Gul H; Altun M		Anticancer Res	19	1999	3237-41	J:60830	10652617
88064	The Brca1 and Brca2 proteins and tumor pathogenesis.		Ingvarsson S		Anticancer Res	19	1999	2853-61	J:60831	10652564
88065	Oncogenic activating mutations in the neu/erbB-2 oncogene are involved in the induction of mammary tumors		Chan R; Muller WJ; Siegel PM		Ann N Y Acad Sci	889	1999	45-51	J:60809	10668481
88066	Cellular mechanisms of risk and transformation		Augenlicht LH; Bordonaro M; Heerdt BG; Mariadason J; Velcich A		Ann N Y Acad Sci	889	1999	20-31	J:60810	10668479
88067	Preclinical mouse models for cancer chemoprevention studies		Lipkin M; Yang K; Edelmann W; Xue L; Fan K; Risio M; Newmark H; Kucherlapati R		Ann N Y Acad Sci	889	1999	14-9	J:60811	10668478
88068	Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens		Newbold RR; Liehr JG		Cancer Res	60	2000	235-7	J:60813	10667565
88069	Evidence that the epidermal targets of carcinogen action are found in the interfollicular epidermis of infundibulum as well as in the hair follicles		Morris RJ; Tryson KA; Wu KQ		Cancer Res	60	2000	226-9	J:60814	10667563
88070	Intestinal tumor load in the Min/+ mouse model is not correlated with eicosanoid biosynthesis		Whelan J; Chiu CH; McEntee MF		Adv Exp Med Biol	469	1999	607-15	J:60815	10667389
88071	Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene.		Dobson CL; Warren AJ; Pannell R; Forster A; Rabbitts TH		EMBO J	19	2000	843-51	J:60894	10698926
88072	FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor.		Newton K; Harris AW; Strasser A		EMBO J	19	2000	931-41	J:60895	10698935
88073	Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex.		Kero J; Poutanen M; Zhang FP; Rahman N; McNicol AM; Nilson JH; Keri RA; Huhtaniemi IT		J Clin Invest	105	2000	633-41	J:60969	10712435
88074	Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model.		Henderson WR Jr; Lu J; Poole KM; Dietsch GN; Chi EY		J Immunol	164	2000	3360-7	J:60977	10706731
88075	Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice.		Schmelz EM; Sullards MC; Dillehay DL; Merrill AH Jr		J Nutr	130	2000	522-7	J:61220	10702579
88076	TCR v(beta) repertoire restriction and lack of CDR3 conservation implicate TCR-superantigen interactions in promoting the clonal evolution of murine thymic lymphomas		Gomez G; Clarkin KZ; Kraig E; Infante AJ; Richie ER		Int Immunol	12	2000	263-70	J:61221	10700461
88077	The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.		Li S; Ilaria RL Jr; Million RP; Daley GQ; Van Etten RA		J Exp Med	189	1999	1399-412	J:54548	10224280
88078	In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model.		Wang C; Quevedo ME; Lannutti BJ; Gordon KB; Guo D; Sun W; Paller AS		J Invest Dermatol	112	1999	775-81	J:54601	10233771
88079	MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways [see comments]		Callahan R; Smith GH		Oncogene	19	2000	992-1001	J:61008	10713682
88080	Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer.		Li Y; Hively WP; Varmus HE		Oncogene	19	2000	1002-9	J:61009	10713683
88081	WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.		Li M; Lewis B; Capuco AV; Laucirica R; Furth PA		Oncogene	19	2000	1010-9	J:61010	10713684
88082	The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.		Green JE; Shibata MA; Yoshidome K; Liu ML; Jorcyk C; Anver MR; Wigginton J; Wiltrout R; Shibata E; Kaczmarczyk S; Wang W; Liu ZY; Calvo A; Couldrey C		Oncogene	19	2000	1020-7	J:61011	10713685
88083	A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland.		Schulze-Garg C; Lohler J; Gocht A; Deppert W		Oncogene	19	2000	1028-37	J:61012	10713686
88084	Mutant p53 and genomic instability in a transgenic mouse model of breast cancer [see comments]		Murphy KL; Rosen JM		Oncogene	19	2000	1045-51	J:61013	10713688
88085	A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.		Jerry DJ; Kittrell FS; Kuperwasser C; Laucirica R; Dickinson ES; Bonilla PJ; Butel JS; Medina D		Oncogene	19	2000	1052-8	J:61014	10713689
88086	Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.		Deng CX; Scott F		Oncogene	19	2000	1059-64	J:61015	10713690
88087	Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models [see comments]		Jamerson MH; Johnson MD; Dickson RB		Oncogene	19	2000	1065-71	J:61016	10713691
88088	Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.		Vomachka AJ; Pratt SL; Lockefeer JA; Horseman ND		Oncogene	19	2000	1077-84	J:61017	10713693
88089	Notch signaling in T cell development.		Deftos ML; Bevan MJ		Curr Opin Immunol	12	2000	166-72	J:61028	10712939
88090	Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis.		Jadeski LC; Hum KO; Chakraborty C; Lala PK		Int J Cancer	86	2000	30-9	J:61030	10728591
88091	Mouse models for breast cancer [comment]		Hennighausen L		Oncogene	19	2000	966-7	J:61033	10713679
88092	The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting [see comments]		Cardiff RD; Anver MR; Gusterson BA; Hennighausen L; Jensen RA; Merino MJ; Rehm S; Russo J; Tavassoli FA; Wakefield LM; Ward JM; Green JE		Oncogene	19	2000	968-88	J:61035	10713680
88093	Oxidative stress induced by L-buthionine-(S,R)-sulfoximine, a selective inhibitor of glutathione metabolism, abrogates mouse kidney mineralocorticoid receptor function		Piwien-Pilipuk G; Galigniana MD		Biochim Biophys Acta	1495	2000	263-80	J:61036	10699465
88094	Transforming growth factor alpha and mouse models of human breast cancer.		Humphreys RC; Hennighausen L		Oncogene	19	2000	1085-91	J:61018	10713694
88095	Transforming growth factor alpha- and c-myc-induced mammary carcinogenesis in transgenic mice [see comments]		Rose-Hellekant TA; Sandgren EP		Oncogene	19	2000	1092-6	J:61019	10713695
88096	Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors [see comments]		Bearss DJ; Subler MA; Hundley JE; Troyer DA; Salinas RA; Windle JJ		Oncogene	19	2000	1114-22	J:61021	10713698
88097	Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.		Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB		Oncogene	19	2000	1307-17	J:61095	10713672
88098	Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition.		Friedberg EC; Bond JP; Burns DK; Cheo DL; Greenblatt MS; Meira LB; Nahari D; Reis AM		Mutat Res	459	2000	99-108	J:61133	10725660
88099	Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice.		Zurawel RH; Allen C; Wechsler-Reya R; Scott MP; Raffel C		Genes Chromosomes Cancer	28	2000	77-81	J:61188	10738305
88100	Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.		Tekmal RR; Kirma N; Gill K; Fowler K		Endocr Relat Cancer	6	1999	307-14	J:61191	10731124
88101	Flipping the oncogene switch: illumination of tumor maintenance and regression		Chin L; DePinho RA		Trends Genet	16	2000	147-50	J:61192	10729826
88102	Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1.		Nilsson M; Unden AB; Krause D; Malmqwist U; Raza K; Zaphiropoulos PG; Toftgard R		Proc Natl Acad Sci U S A	97	2000	3438-43	J:61194	10725363
88103	Use of transgenic mice in identifying chemopreventive agents.		Alexander J		Toxicol Lett	112-113	2000	507-12	J:61196	10720773
88104	Cell surface complex of cathepsin B/annexin II tetramer in malignant progression.		Mai J; Waisman DM; Sloane BF		Biochim Biophys Acta	1477	2000	215-30	J:61163	10708859
88105	Are intestinal tumours in Apc+/-mice a suitable model of colorectal carcinoma in man?		Lojda Z; Havrankova E; Sovova V; Sloncova E; Fric P		Gen Physiol Biophys	18	1999	311-6	J:61219	10703747
88106	Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis.		Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R		Int J Cancer	85	2000	578-83	J:61222	10699933
88107	Assessing the potential carcinogenic activity of magnetic fields using animal models		McCann J; Kavet R; Rafferty CN		Environ Health Perspect	108 Suppl 1	2000	79-100	J:61224	10698725
88108	Responses of transgenic mouse lines p53(+/-) and Tg.AC to agents tested in conventional carcinogenicity bioassays.		Spalding JW; French JE; Stasiewicz S; Furedi-Machacek M; Conner F; Tice RR; Tennant RW		Toxicol Sci	53	2000	213-23	J:61225	10696769
88109	Serum lipid concentrations and mean life span are modulated by dietary polyunsaturated fatty acids in the senescence-accelerated mouse.		Umezawa M; Takeda T; Kogishi K; Higuchi K; Matushita T; Wang J; Chiba T; Hosokawa M		J Nutr	130	2000	221-7	J:61197	10720173
88110	Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene		Rao GN; Ney E; Herbert RA		Breast Cancer Res Treat	58	1999	241-54	J:61198	10718486
88111	Rodent carcinogenicity tests need be no longer than 18 months: an analysis based on 210 chemicals in the IARC monographs.		Davies TS; Lynch BS; Monro AM; Munro IC; Nestmann ER		Food Chem Toxicol	38	2000	219-35	J:61199	10717362
88112	Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers.		Halberg RB; Katzung DS; Hoff PD; Moser AR; Cole CE; Lubet RA; Donehower LA; Jacoby RF; Dove WF		Proc Natl Acad Sci U S A	97	2000	3461-6	J:61200	10716720
88113	Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice.		Borghesani PR; Alt FW; Bottaro A; Davidson L; Aksoy S; Rathbun GA; Roberts TM; Swat W; Segal RA; Gu Y		Proc Natl Acad Sci U S A	97	2000	3336-41	J:61201	10716718
88114	Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.		Andrechek ER; Hardy WR; Siegel PM; Rudnicki MA; Cardiff RD; Muller WJ		Proc Natl Acad Sci U S A	97	2000	3444-9	J:61202	10716706
88115	Inhibitory effect of euphol, a triterpene alcohol from the roots of Euphorbia kansui, on tumour promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin		Yasukawa K; Akihisa T; Yoshida ZY; Takido M		J Pharm Pharmacol	52	2000	119-24	J:61203	10716613
88116	Mammary gland oncogenes as indicators of pathways important in mammary gland development.		Dickson C; Creer A; Fantl V		Oncogene	19	2000	1097-101	J:61204	10713696
88117	The role of prolactin and growth hormone in breast cancer [see comments]		Wennbo H; Tornell J		Oncogene	19	2000	1072-6	J:61205	10713692
88118	Signal transduction in mammary tumorigenesis: a transgenic perspective [see comments]		Dankort DL; Muller WJ		Oncogene	19	2000	1038-44	J:61206	10713687
88119	Functions of mammalian Smad genes as revealed by targeted gene disruption in mice.		Weinstein M; Yang X; Deng C		Cytokine Growth Factor Rev	11	2000	49-58	J:61302	10708952
88120	Brachyury is a target gene of the Wnt/beta-catenin signaling pathway		Arnold SJ; Stappert J; Bauer A; Kispert A; Herrmann BG; Kemler R		Mech Dev	91	2000	249-58	J:61358	10704849
88121	Increased expression of intracisternal A-particle RNA in regenerated myeloid cells after X irradiation in C3H/He inbred mice.		Ishihara H; Tanaka I; Furuse M; Tsuneoka K		Radiat Res	153	2000	392-7	J:61491	10760998
88122	Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice.		Spalding JW; French JE; Tice RR; Furedi-Machacek M; Haseman JK; Tennant RW		Toxicol Sci	49	1999	241-54	J:59627	10416269
88123	Conditional expression of fibroblast growth factor-7 in the developing and mature lung.		Tichelaar JW; Lu W; Whitsett JA		J Biol Chem	275	2000	11858-64	J:61736	10766812
88124	p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation		Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD		Oncogene	19	2000	1875-84	J:61771	10773877
88125	Endocrine host responses during early and late phases of tumor development.		Besedovsky HO; Normann S; Schardt M; Del Rey A		Int J Cancer	86	2000	457-61	J:61803	10797255
88126	Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1,4-phenylene bis(methylene)selenocyanate.		Rao CV; Cooma I; Rodriguez JG; Simi B; El-Bayoumy K; Reddy BS		Carcinogenesis	21	2000	617-21	J:61783	10753194
88127	Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis.		Coghlan LG; Gimenez-Conti I; Kleiner HE; Fischer SM; Rundhaug JE; Conti CJ; Slaga TJ; DiGiovanni J		Carcinogenesis	21	2000	641-6	J:61784	10753198
88128	Characterization of the murine p19(ARF) promoter CpG island and its methylation pattern in primary lymphomas.		Melendez B; Malumbres M; de Castro IP; Santos J; Pellicer A; Fernandez-Piqueras J		Carcinogenesis	21	2000	817-21	J:61786	10753221
88129	Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo.		Borlado LR; Redondo C; Alvarez B; Jimenez C; Criado LM; Flores J; Marcos MA; Martinez-A C; Balomenos D; Carrera AC		FASEB J	14	2000	895-903	J:61807	10783143
88130	p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.		Park MS; Rosai J; Nguyen HT; Capodieci P; Cordon-Cardo C; Koff A		Proc Natl Acad Sci U S A	96	1999	6382-7	J:55197	10339596
88131	Muir-torre-like syndrome in fhit-deficient mice		Fong LY; Fidanza V; Zanesi N; Lock LF; Siracusa LD; Mancini R; Siprashvili Z; Ottey M; Martin SE; Druck T; McCue PA; Croce CM; Huebner K		Proc Natl Acad Sci U S A	97	2000	4742-7	J:61946	10758156
88132	G7c, a novel gene in the mouse and human major histocompatibility complex class III region, possibly controlling lung tumor susceptibility.		Snoek M; Albertella MR; van Kooij M; Wixon J; van Vugt H; de Groot K; Campbell RD		Immunogenetics	51	2000	383-6	J:61934	10803853
88133	Clonal diversification of primary BALB/c plasmacytomas harboring T(12;15) chromosomal translocations.		Kovalchuk AL; Mushinski EB; Janz S		Leukemia	14	2000	909-21	J:61955	10803525
88134	Expression of PGF(2alpha) receptor mRNA in normal, hyperplastic and neoplastic skin.		Muller K; Krieg P; Marks F; Furstenberger G		Carcinogenesis	21	2000	1063-6	J:61975	10783334
88135	Rapid induction of uterine tumors with p53 point mutations in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea.		Mitsumori K; Onodera H; Shimo T; Yasuhara K; Takagi H; Koujitani T; Hirose M; Maruyama C; Wakana S		Carcinogenesis	21	2000	1039-42	J:61976	10783330
88136	Chemoprevention of tobacco-smoke lung carcinogenesis in mice after cessation of smoke exposure.		Witschi H; Uyeminami D; Moran D; Espiritu I		Carcinogenesis	21	2000	977-82	J:61977	10783321
88137	(-)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice.		Mimoto J; Kiura K; Matsuo K; Yoshino T; Takata I; Ueoka H; Kataoka M; Harada M		Carcinogenesis	21	2000	915-9	J:61980	10783312
88138	Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice.		Salganik RI; Albright CD; Rodgers J; Kim J; Zeisel SH; Sivashinskiy MS; Van Dyke TA		Carcinogenesis	21	2000	909-14	J:61981	10783311
88139	p53 gene deletions in paraffin-preserved lymphoid tumors from irradiated mice.		Paunesku T; Zhang Y; Gemmell MA; Woloschak GE		Leuk Res	24	2000	511-7	J:61982	10781686
88140	Carcinogen dose-dependent variation in the transgene mutation spectrum in urethane-induced lung tumors in transgenic mice carrying the human prototype c-Ha-ras gene.		Mori I; Yasuhara K; Hayashi SM; Nonoyama T; Nomura T; Mitsumori K		Cancer Lett	153	2000	199-209	J:61983	10779650
88141	Potentiation of benzo[a]pyrene-induced pulmonary and forestomach tumorigenesis in mice by D,L-buthionine-S,R-sulfoximine-mediated tissue glutathione depletion.		Srivastava SK; Xia H; Pal A; Hu X; Guo J; Singh SV		Cancer Lett	153	2000	35-9	J:61984	10779627
88142	Biology of the adenomatous polyposis coli tumor suppressor.		Goss KH; Groden J		J Clin Oncol	18	2000	1967-79	J:61974	10784639
88143	Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression		Mussman JG; Horn HF; Carroll PE; Okuda M; Tarapore P; Donehower LA; Fukasawa K		Oncogene	19	2000	1635-46	J:62001	10763820
88144	Transgenic animal models of human papillomavirus-dependent disease (Review).		Eckert RL; Crish JF; Balasubramanian S; Rorke EA		Int J Oncol	16	2000	853-70	J:62002	10762621
88145	Susceptibility to polyoma virus tumorigenesis in X-linked immunodeficient (XID) and B-cell deficient (microMT) mice is not increased		Heidari S; Berke Z; Berglof A; Woldegiorgis A; Smith CI; Dalianis T		In Vivo	13	1999	439-44	J:62004	10757034
88146	Modulation of murine mammary tumor vasculature by dietary n-3 fatty acids in fish oil		Mukutmoni-Norris M; Hubbard NE; Erickson KL		Cancer Lett	150	2000	101-9	J:62005	10755393
88147	Delay of DNA-adduct repair and severe toxicity in xeroderma pigmentosum group A gene (XPA) deficient mice treated with 2-amino-1-methyl-6-phenyl-imidazo [4,5-b] pyridine (PhIP)		Imaida K; Ogawa K; Takahashi S; Ito T; Yamaguchi T; Totsuka Y; Wakabayashi K; Tanaka K; Ito N; Shirai T		Cancer Lett	150	2000	63-9	J:62006	10755388
88148	Effects of phenethyl isothiocyanate and benzyl isothiocyanate, individually and in combination, on lung tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone		Hecht SS; Kenney PM; Wang M; Trushin N; Upadhyaya P		Cancer Lett	150	2000	49-56	J:62007	10755386
88149	Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng		Keum YS; Park KK; Lee JM; Chun KS; Park JH; Lee SK; Kwon H; Surh YJ		Cancer Lett	150	2000	41-8	J:62008	10755385
88150	The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice.		Yamanaka K; Katsumata K; Ikuma K; Hasegawa A; Nakano M; Okada S		Cancer Lett	152	2000	79-85	J:62009	10754209
88151	Effects of dietary fat on benz-a-pyrene-induced forestomach tumorigenesis in mice chronically exposed to arsenic		Silva RA; Munoz SE; Perez CA; Eynard AR		Exp Toxicol Pathol	52	2000	11-6	J:61985	10779147
88152	Angiogenesis research. Cancer drugs found to work in new way [news]		Barinaga M		Science	288	2000	245	J:61986	10777399
88153	Further characterization of the Sho-saio-to-mediated anti-tumor effect on melanoma developed in RET-transgenic mice [letter]		Kato M; Isobe K; Dai Y; Liu W; Takahashi M; Nakashima I		J Invest Dermatol	114	2000	599-601	J:61987	10777360
88154	Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthrene-induced carcinogenesis in mice		Takagi A; Matsuzaki T; Sato M; Nomoto K; Morotomi M; Yokokura T		Med Microbiol Immunol (Berl)	188	1999	111-6	J:61988	10776840
88155	Lack of susceptibility of transgenic mice carrying the human c-Ha-ras proto-oncogene (rasH2 mice) to phenolphthalein in a 6-month carcinogenicity study.		Koujitani T; Yasuhara K; Usui T; Nomura T; Onodera H; Takagi H; Hirose M; Mitsumori K		Cancer Lett	152	2000	211-6	J:61989	10773414
88156	Anti-tumor-promoting effects of isoflavonoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis.		Ito C; Itoigawa M; Tan HT; Tokuda H; Yang Mou X; Mukainaka T; Ishikawa T; Nishino H; Furukawa H		Cancer Lett	152	2000	187-92	J:61990	10773411
88157	Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin.		Zhao J; Lahiri-Chatterjee M; Sharma Y; Agarwal R		Carcinogenesis	21	2000	811-6	J:62010	10753220
88158	Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.		Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H		Mol Carcinog	27	2000	298-307	J:62012	10747294
88159	Alteration of Egr-1 mRNA during multistage carcinogenesis in mouse skin.		Riggs PK; Rho O; DiGiovanni J		Mol Carcinog	27	2000	247-51	J:62013	10747287
88160	Analysis of ku80-mutant mice and cells with deficient levels of p53.		Lim DS; Vogel H; Willerford DM; Sands AT; Platt KA; Hasty P		Mol Cell Biol	20	2000	3772-80	J:62142	10805721
88161	Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.		Weiss WA; Godfrey T; Francisco C; Bishop JM		Cancer Res	60	2000	2483-7	J:62146	10811128
88162	Identification of metastasis-promoting sequences in the mouse laminin alpha 1 chain.		Kuratomi Y; Nomizu M; Nielsen PK; Tanaka K; Song SY; Kleinman HK; Yamada Y		Exp Cell Res	249	1999	386-95	J:55497	10366438
88163	The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice.		Shinagawa T; Dong HD; Xu M; Maekawa T; Ishii S		EMBO J	19	2000	2280-91	J:62174	10811619
88164	The INK4a/ARF locus in murine tumorigenesis.		Serrano M		Carcinogenesis	21	2000	865-9	J:62199	10783305
88165	Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas.		Schell TD; Knowles BB; Tevethia SS		Cancer Res	60	2000	3002-12	J:62541	10850449
88166	Restoration of thymic development in an Lck(-/-) thymoma overexpressing ZAP-70.		Ulivieri C; Majolini MB; Baldari CT		Mol Immunol	37	2000	85-90	J:62319	10781838
88167	Absence of PTEN/MMAC1 pseudogene in mice.		Kwabi-Addo B; Thompson TC; Ittmann M		DNA Cell Biol	19	2000	301-5	J:62322	10855797
88168	Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate.		Bull RJ		Environ Health Perspect	108 Suppl 2	2000	241-59	J:62438	10807555
88169	Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis.		Takasaki M; Konoshima T; Etoh H; Pal Singh I; Tokuda H; Nishino H		Cancer Lett	155	2000	61-5	J:62476	10814880
88170	Interlaboratory comparison of the CB6F1-Tg rasH2 rapid carcinogenicity testing model.		Maronpot RR; Mitsumori K; Mann P; Takaoka M; Yamamoto S; Usui T; Okamiya H; Nishikawa S; Nomura T		Toxicology	146	2000	149-59	J:62477	10814847
88171	Squamous epithelial proliferation induced by walleye dermal sarcoma retrovirus cyclin in transgenic mice		Lairmore MD; Stanley JR; Weber SA; Holzschu DL		Proc Natl Acad Sci U S A	97	2000	6114-9	J:62478	10811912
88172	Germline mutation and genome instability.		Olschwang S		Eur J Cancer Prev	9 Suppl 1	1999	S33-7	J:62480	10772416
88173	Dose-response analyses of the carcinogenic effects of trichloroethylene in experimental animals.		Rhomberg LR		Environ Health Perspect	108 Suppl 2	2000	343-58	J:62481	10807564
88174	Biologically based dose-response model for liver tumors induced by trichloroethylene.		Chen CW		Environ Health Perspect	108 Suppl 2	2000	335-42	J:62482	10807563
88175	Pulmonary toxicity and carcinogenicity of trichloroethylene: species differences and modes of action.		Green T		Environ Health Perspect	108 Suppl 2	2000	261-4	J:62483	10807556
88176	Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity		Joseph P; Long DJ; Klein-Szanto AJ; Jaiswal AK		Biochem Pharmacol	60	2000	207-14	J:62464	10825465
88177	The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues		Stepanova L; Finegold M; DeMayo F; Schmidt EV; Harper JW		Mol Cell Biol	20	2000	4462-73	J:62465	10825210
88178	Studies on the pathology, especially brain hemorrhage and angioendotheliomas, induced by two new mos-containing viruses		Lim KY; Ryan EA; Wong PK; Yuen PH		J Neurovirol	6	2000	106-20	J:62466	10822324
88179	Thymosinalpha1 is chemopreventive for lung adenoma formation in A/J mice.		Moody TW; Leyton J; Zia F; Tuthill C; Badamchian M; Goldstein AL		Cancer Lett	155	2000	121-7	J:62467	10822126
88180	Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland.		Rudolph-Owen LA; Matrisian LM		J Mammary Gland Biol Neoplasia	3	1998	177-89	J:62470	10819526
88181	Promotive effect of diethylstilbestrol on urethan-induced mouse lung tumorigenesis		Jiang YG; Chen JK; Wu ZL		Chemosphere	41	2000	187-90	J:62472	10819200
88182	Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation.		Brandt R; Eisenbrandt R; Leenders F; Zschiesche W; Binas B; Juergensen C; Theuring F		Oncogene	19	2000	2129-37	J:62474	10815804
88183	Formation and persistence of O(6)-methylguanine in the mouse colon following treatment with 1,2-dimethylhydrazine as measured by an O(6)-alkylguanine-DNA alkyltransferase inactivation assay.		Jackson PE; Cooper DP; Meyer TA; Wood M; Povey AC; Margison GP		Toxicol Lett	115	2000	205-12	J:62475	10814890
88184	Two distinct notch1 mutant alleles are involved in the induction of T-cell leukemia in c-myc transgenic mice		Hoemann CD; Beaulieu N; Girard L; Rebai N; Jolicoeur P		Mol Cell Biol	20	2000	3831-42	J:62484	10805726
88185	Glomerulonephritis with fibrillary deposition in a transgenic mouse carrying the human prototype c-Ha-ras gene (rasH2 mouse)		Kobayashi K; Sano F; Mutai M; Sugimoto J		Toxicol Pathol	28	2000	359-62	J:62485	10805155
88186	Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis		Lee GH		Toxicol Pathol	28	2000	215-25	J:62486	10805139
88187	Long-term ethanol consumption in ICR mice causes mammary tumor in females and liver fibrosis in males		Watabiki T; Okii Y; Tokiyasu T; Yoshimura S; Yoshida M; Akane A; Shikata N; Tsubura A		Alcohol Clin Exp Res	24	2000	117S-122S	J:62487	10803793
88188	Gastric mucosa-associated lymphoid tissue lymphoma: implications of animal models on pathogenic and therapeutic considerations--mouse models of gastric lymphoma		Lee A; O'Rourke J; Enno A		Recent Results Cancer Res	156	2000	42-51	J:62488	10802862
88189	Chemical constituents of mainly active component fractionated from the aqueous tea non-dialysates, an antitumor promoter.		Nakamura Y; Matsuda M; Honma T; Tomita I; Shibata N; Warashina T; Noro T; Hara Y		Basic Life Sci	66	1999	629-41	J:62489	10800467
88190	DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice.		Amici A; Smorlesi A; Noce G; Santoni G; Cappelletti P; Capparuccia L; Coppari R; Lucciarini R; Petrelli C; Provinciali M		Gene Ther	7	2000	703-6	J:62490	10800094
88191	Inhibitory effect of flavonoids from citrus plants on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors.		Iwase Y; Takemura Y; Ju-ichi M; Ito C; Furukawa H; Kawaii S; Yano M; Mou XY; Takayasu J; Tokuda H; Nishino H		Cancer Lett	154	2000	101-5	J:62491	10799745
88192	Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia		Peterson KE; Iwashiro M; Hasenkrug KJ; Chesebro B		J Virol	74	2000	5363-7	J:62492	10799615
88193	p53 transdominance but no gain of function in mouse brain tumor model.		Hegi ME; Klein MA; Ruedi D; Chene P; Hamou MF; Aguzzi A		Cancer Res	60	2000	3019-24	J:62542	10850451
88194	Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties.		Lesueur-Ginot L; Demarquay D; Kiss R; Kasprzyk PG; Dassonneville L; Bailly C; Camara J; Lavergne O; Bigg DC		Cancer Res	59	1999	2939-43	J:55682	10383158
88195	A transgenic mouse line that develops early-onset invasive gastric carcinoma provides a model for carcinoembryonic antigen-targeted tumor therapy.		Thompson J; Epting T; Schwarzkopf G; Singhofen A; Eades-Perner AM; van Der Putten H; Zimmermann W		Int J Cancer	86	2000	863-9	J:62581	10842202
88196	Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam.		Anna CH; Sills RC; Foley JF; Stockton PS; Ton TV; Devereux TR		Cancer Res	60	2000	2864-8	J:62606	10850429
88197	Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein.		Siegel CT; Schreiber K; Meredith SC; Beck-Engeser GB; Lancki DW; Lazarski CA; Fu YX; Rowley DA; Schreiber H		J Exp Med	191	2000	1945-56	J:62673	10839809
88198	Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation.		Behrens A; Jochum W; Sibilia M; Wagner EF		Oncogene	19	2000	2657-63	J:62687	10851065
88199	STATs in oncogenesis.		Bowman T; Garcia R; Turkson J; Jove R		Oncogene	19	2000	2474-88	J:62689	10851046
88200	Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.		Levy DE; Gilliland DG		Oncogene	19	2000	2505-10	J:62690	10851049
88201	The role of STATs in myeloid differentiation and leukemia.		Coffer PJ; Koenderman L; de Groot RP		Oncogene	19	2000	2511-22	J:62691	10851050
88202	Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice.		van Steeg H; Mullenders LH; Vijg J		Mutat Res	450	2000	167-80	J:62684	10838141
88203	Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.		Petiniot LK; Weaver Z; Barlow C; Shen R; Eckhaus M; Steinberg SM; Ried T; Wynshaw-Boris A; Hodes RJ		Proc Natl Acad Sci U S A	97	2000	6664-9	J:62720	10841564
88204	The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice.		Atit RP; Mitchell K; Nguyen L; Warshawsky D; Ratner N		J Invest Dermatol	114	2000	1093-100	J:62818	10844550
88205	Tumors arising in DNA mismatch repair-deficient mice show a wide variation in mutation frequency as assessed by a transgenic reporter gene.		Baross-Francis A; Milhausen MK; Andrew SE; Jevon G; Jirik FR		Carcinogenesis	21	2000	1259-62	J:62878	10837019
88206	Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.		Brasseur N; Ouellet R; La Madeleine C; van Lier JE		Br J Cancer	80	1999	1533-41	J:56130	10408394
88207	Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E.		Bortner DM; Rosenberg MP		Mol Cell Biol	17	1997	453-9	J:56329	8972226
88208	Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene.		Tzeng YJ; Guhl E; Graessmann M; Graessmann A		Oncogene	8	1993	1965-71	J:56330	8390039
88209	Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice.		Small JA; Khoury G; Jay G; Howley PM; Scangos GA		Proc Natl Acad Sci U S A	83	1986	8288-92	J:52103	2430282
88210	Lymph nodes and Peyer's patches of IL-6 transgenic BALB/c mice harbor T(12;15) translocated plasma cells that contain illegitimate exchanges between the immunoglobulin heavy-chain mu locus and c-myc		Kovalchuk AL; Kishimoto T; Janz S		Leukemia	14	2000	1127-35	J:62969	10865979
88211	Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment		Gulezian D; Jacobson-Ram D; McCullough CB; Olson H; Recio L; Robinson D; Storer R; Tennant R; Ward JM; Neumann DA		Toxicol Pathol	28	2000	482-99	J:62970	10862569
88212	Loss of heterozygosity in spontaneous and x-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of apc(+) and dpc4 in tumor development		Haines J; Dunford R; Moody J; Ellender M; Cox R; Silver A		Genes Chromosomes Cancer	28	2000	387-94	J:62971	10862047
88213	Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein		Zhang X; Lee C; Ng PY; Rubin M; Shabsigh A; Buttyan R		Prostate	43	2000	278-85	J:62972	10861747
88214	Resistance to friend murine leukemia virus infection conferred by the Fv-4 gene is recessive but appears dominant from the effect of the immune system		Zhang F; Ya LT; Iwatani Y; Higo K; Suzuki Y; Tanaka M; Nakahara T; Ono T; Sakai H; Kuribayashi K; Ishimoto A		J Virol	74	2000	6193-7	J:62974	10846105
88215	The effect of exposure to a commercial 2,4-D herbicide formulation during gestation on urethan-induced lung adenoma formation in CD-1 mice		Lee K; Johnson VJ; Blakley BR		Vet Hum Toxicol	42	2000	129-32	J:62977	10839313
88216	Comparative analysis of brain proteins from p53-deficient mice by two-dimensional electrophoresis		Araki N; Morimasa T; Sakai T; Tokuoh H; Yunoue S; Kamo M; Miyazaki K; Abe K; Saya H; Tsugita A		Electrophoresis	21	2000	1880-9	J:62963	10870973
88217	Proteomic analysis of the small intestine and colon epithelia of adenomatous polyposis coli gene-mutant mice by two-dimensional gel electrophoresis		Minowa T; Ohtsuka S; Sasai H; Kamada M		Electrophoresis	21	2000	1782-6	J:62964	10870965
88218	Proteomic analysis of colonic crypts from normal, multiple intestinal neoplasia and p53-null mice: a comparison with colonic polyps		Cole AR; Ji H; Simpson RJ		Electrophoresis	21	2000	1772-81	J:62965	10870964
88219	New evidence for an extra-hepatic role of N-acetylglucosaminyltransferase III in the progression of diethylnitrosamine-induced liver tumors in mice		Yang X; Bhaumik M; Bhattacharyya R; Gong S; Rogler CE; Stanley P		Cancer Res	60	2000	3313-9	J:62968	10866326
88220	Beef induces and rye bran prevents the formation of intestinal polyps in Apc(Min) mice: relation to beta-catenin and PKC isozymes.		Mutanen M; Pajari AM; Oikarinen SI		Carcinogenesis	21	2000	1167-73	J:62978	10837006
88221	Localisation and accumulation of a new carotenoporphyrin in two primary tumour models		van den Akker JT; Speelman OC; van Staveren HJ; Moore AL; Moore TA; Gust D; Star WM; Sterenborg HJ		J Photochem Photobiol B	54	2000	108-15	J:62979	10836539
88222	The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice.		Perez-Losada J; Pintado B; Gutierrez-Adan A; Flores T; Banares-Gonzalez B; del Campo JC; Martin-Martin JF; Battaner E; Sanchez-Garcia I		Oncogene	19	2000	2413-22	J:62980	10828883
88223	Prenatal toxicity and lack of carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) following transplacental exposure		Gressani KM; Leone-Kabler S; O'Sullivan MG; Townsend AJ; Miller MS		Toxicol Sci	55	2000	407-14	J:62981	10828274
88224	Evaluation of cytotoxicity, cell proliferation, and genotoxicity induced by p-cresidine in hetero- and nullizygous transgenic p53 mice		Delker DA; Yano BL; Gollapudi BB		Toxicol Sci	55	2000	361-9	J:62982	10828268
88225	Statistical analysis of skin tumor data from Tg.AC mouse bioassays		Dunson DB; Haseman JK; van Birgelen AP; Stasiewicz S; Tennant RW		Toxicol Sci	55	2000	293-302	J:62983	10828260
88226	Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation.		Rennick DM; Fort MM		Am J Physiol Gastrointest Liver Physiol	278	2000	G829-33	J:63032	10859210
88227	Chromosome instability contributes to loss of heterozygosity in mice lacking p53.		Shao C; Deng L; Henegariu O; Liang L; Stambrook PJ; Tischfield JA		Proc Natl Acad Sci U S A	97	2000	7405-10	J:63074	10861008
88228	Telomerase: not just black and white, but shades of gray.		Liu JP		Mol Cell Biol Res Commun	3	2000	129-35	J:63077	10860859
88229	Regulable expression of inhibin A in wild-type and inhibin alpha null mice		Pierson TM; Wang Y; DeMayo FJ; Matzuk MM; Tsai SY; Omalley BW		Mol Endocrinol	14	2000	1075-85	J:63159	10894156
88230	The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64		Cormier RT; Bilger A; Lillich AJ; Halberg RB; Hong KH; Gould KA; Borenstein N; Lander ES; Dove WF		Oncogene	19	2000	3182-92	J:63266	10918573
88231	Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.		Schroeder JA; Troyer KL; Lee DC		Oncogene	19	2000	3193-9	J:63267	10918574
88232	The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model.		Hasenkrug KJ; Dittmer U		Virology	272	2000	244-9	J:63295	10873767
88233	Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in notch3 transgenic mice		Bellavia D; Campese AF; Alesse E; Vacca A; Felli MP; Balestri A; Stoppacciaro A; Tiveron C; Tatangelo L; Giovarelli M; Gaetano C; Ruco L; Hoffman ES; Hayday AC; Lendahl U; Frati L; Gulino A; Screpanti I		EMBO J	19	2000	3337-48	J:63300	10880446
88234	Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.		Largaespada DA		Leukemia	14	2000	1174-84	J:63308	10914539
88235	DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in mice.		Neglia F; Orengo AM; Cilli M; Meazza R; Tomassetti A; Canevari S; Melani C; Colombo MP; Ferrini S		Cancer Gene Ther	6	1999	349-57	J:56572	10419053
88236	An anti-apoptotic role for the p53 family member, p73, during developmental neuron death [see comments]		Pozniak CD; Radinovic S; Yang A; McKeon F; Kaplan DR; Miller FD		Science	289	2000	304-6	J:63419	10894779
88237	The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development		Sibilia M; Fleischmann A; Behrens A; Stingl L; Carroll J; Watt FM; Schlessinger J; Wagner EF		Cell	102	2000	211-20	J:63426	10943841
88238	Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage.		Goding CR		Genes Dev	14	2000	1712-28	J:63442	10898786
88239	Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions.		Wardlaw SA; March TH; Belinsky SA		Carcinogenesis	21	2000	1371-7	J:63446	10874016
88240	The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors		Hansen LA; Woodson RL 2nd; Holbus S; Strain K; Lo YC; Yuspa SH		Cancer Res	60	2000	3328-32	J:63567	10910032
88241	Effects of combined treatment with coffee cherry and whole-body hyperthermia on the growth of spontaneous mammary tumours in SHN mice		Udagawa Y; Nagasawa H		In Vivo	14	2000	431-5	J:63570	10904877
88242	Androgen dependency of hepatocarcinogenesis in TGFalpha transgenic mice		Matsumoto T; Takagi H; Mori M		Liver	20	2000	228-33	J:63573	10902973
88243	The pineal gland and cancer. I. Pinealectomy corrects congenital hormonal dysfunctions and prolongs life of cancer-prone C3H/He mice		Bulian D; Pierpaoli W		J Neuroimmunol	108	2000	131-5	J:63575	10900346
88244	Establishment of human prostate carcinoma skeletal metastasis models.		Zhau HE; Li CL; Chung LW		Cancer	88	2000	2995-3001	J:63576	10898343
88245	Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.		Zhuang S; Soderkvist P		Mutat Res	452	2000	19-26	J:63577	10894886
88246	Cancer chemopreventive activity of an iridoid glycoside, 8-acetylharpagide, from Ajuga decumbens.		Konoshima T; Takasaki M; Tokuda H; Nishino H		Cancer Lett	157	2000	87-92	J:63578	10893446
88247	Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion		Dragan YP; Schrenk D		Food Addit Contam	17	2000	289-302	J:63561	10912243
88248	Pathology of small-cell lung cancer.		Junker K; Wiethege T; Muller KM		J Cancer Res Clin Oncol	126	2000	361-8	J:63615	10929757
88249	Correlation between bcl-2 overexpression and H-ras mutation in naturally occurring hepatocellular proliferative lesions of the B6C3F1 mouse		Iida M; Iwata H; Inoue H; Enomoto M; Horie N; Takeishi K		Toxicol Sci	56	2000	297-302	J:63562	10910987
88250	Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer		Carroll RE; Matkowskyj KA; Tretiakova MS; Battey JF; Benya RV		Cell Growth Differ	11	2000	385-93	J:63661	10939592
88251	Cooperative effects of Mycobacterium tuberculosis Ag38 gene transduction and interleukin 12 in vaccination against spontaneous tumor development in proto-neu transgenic mice.		Sfondrini L; Rodolfo M; Singh M; Colombo MP; Colnaghi MI; Menard S; Balsari A		Cancer Res	60	2000	3777-81	J:63663	10919650
88252	Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas		Marton I; Johnson SE; Damjanov I; Currier KS; Sundberg JP; Knowles BB		Transgenic Res	9	2000	115-25	J:63776	10951695
88253	Accommodating haploinsufficient tumor suppressor genes in Knudson's model.		Cook WD; McCaw BJ		Oncogene	19	2000	3434-8	J:63786	10918600
88254	Lung metastasis suppression of the bifunctional new radiosensitizer KIN-806.		Inomata T; Ogawa Y; Itoh S; Kariya S; Hamada N; Nishioka A; Yoshida S; Nagasawa H; Hori H; Inayama S		Int J Mol Med	4	1999	257-60	J:57152	10425275
88255	Preventive effects of Glycyrrhizae radix extract on estrogen-related endometrial carcinogenesis in mice.		Niwa K; Hashimoto M; Morishita S; Yokoyama Y; Mori H; Tamaya T		Jpn J Cancer Res	90	1999	726-32	J:57153	10470284
88256	Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII.		Go C; He W; Zhong L; Li P; Huang J; Brinkley BR; Wang XJ		Oncogene	19	2000	3623-31	J:63849	10951568
88257	Moloney murine leukemia virus-induced tumors show altered levels of proapoptotic and antiapoptotic proteins.		Bonzon C; Fan H		J Virol	74	2000	8151-8	J:63858	10933726
88258	Chromosomes 1 and 5 harbor plasmacytoma progressor genes in mice.		Coleman AE; Ried T; Janz S		Genes Chromosomes Cancer	29	2000	70-4	J:63888	10918396
88259	New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia.		Werner H; Le Roith D		Cell Mol Life Sci	57	2000	932-42	J:63860	10950308
88260	Wnt signaling and cancer.		Polakis P		Genes Dev	14	2000	1837-51	J:63871	10921899
88261	Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis		Barton D; HogenEsch H; Weih F		Eur J Immunol	30	2000	2323-32	J:63950	10940923
88262	Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma.		Krynska B; Del Valle L; Gordon J; Otte J; Croul S; Khalili K		Virology	274	2000	65-74	J:64008	10936089
88263	Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from atm-deficient mice		Liyanage M; Weaver Z; Barlow C; Coleman A; Pankratz DG; Anderson S; Wynshaw-Boris A; Ried T		Blood	96	2000	1940-6	J:64217	10961898
88264	A carboxy-terminal deletion mutant of notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice		Feldman BJ; Hampton T; Cleary ML		Blood	96	2000	1906-13	J:64218	10961893
88265	Targeting the ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?		Reuter CW; Morgan MA; Bergmann L		Blood	96	2000	1655-69	J:64223	10961860
88266	The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.		Chung DC		Gastroenterology	119	2000	854-65	J:64224	10982779
88267	Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver.		Adachi M; Suematsu S; Kondo T; Ogasawara J; Tanaka T; Yoshida N; Nagata S		Nat Genet	11	1995	294-300	J:64296	7581453
88268	Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis		Gonzalez-Suarez E; Samper E; Flores JM; Blasco MA		Nat Genet	26	2000	114-7	J:64363	10973262
88269	Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon.		Yang K; Lamprecht SA; Liu Y; Shinozaki H; Fan K; Leung D; Newmark H; Steele VE; Kelloff GJ; Lipkin M		Carcinogenesis	21	2000	1655-60	J:64370	10964096
88270	Radiation-associated loss of heterozygosity at the Znfn1a1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas.		Shimada Y; Nishimura M; Kakinuma S; Okumoto M; Shiroishi T; Clifton KH; Wakana S		Radiat Res	154	2000	293-300	J:64386	10956435
88271	Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.		Rodriguez-Puebla ML; LaCava M; Miliani De Marval PL; Jorcano JL; Richie ER; Conti CJ		Am J Pathol	157	2000	1039-50	J:64388	10980142
88272	A transactivation-deficient mouse model provides insights into trp53 regulation and function (Erratum: Nat Genet 2005;37(2):205)		Jimenez GS; Nister M; Stommel JM; Beeche M; Barcarse EA; Zhang XQ; O'Gorman S; Wahl GM		Nat Genet	26	2000	37-43	J:64367	10973245
88273	Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.		Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR		Carcinogenesis	21	2000	1691-700	J:64371	10964101
88274	Role of transforming growth factor-beta signaling in cancer		de Caestecker MP; Piek E; Roberts AB		J Natl Cancer Inst	92	2000	1388-402	J:64373	10974075
88275	Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model.		Rhoades KL; Hetherington CJ; Harakawa N; Yergeau DA; Zhou L; Liu LQ; Little MT; Tenen DG; Zhang DE		Blood	96	2000	2108-15	J:64482	10979955
88276	Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.		Kiguchi K; Bol D; Carbajal S; Beltran L; Moats S; Chan K; Jorcano J; DiGiovanni J		Oncogene	19	2000	4243-54	J:64524	10980598
88277	Patched target igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma		Hahn H; Wojnowski L; Specht K; Kappler R; Calzada-Wack J; Potter D; Zimmer A; Muller U; Samson E; Quintanilla-Martinez L		J Biol Chem	275	2000	28341-4	J:64528	10884376
88278	Genetics of mouse mammary tumor virus-induced mammary tumors: linkage of tumor induction to the gag gene.		Hook LM; Agafonova Y; Ross SR; Turner SJ; Golovkina TV		J Virol	74	2000	8876-83	J:64506	10982330
88279	Tumour resistance in mice lacking telomerase		Nasir J		Lancet	356	2000	917	J:64544	 
88280	Identification of notch1 as a frequent target for provirus insertional mutagenesis in T-cell lymphomas induced by leukemogenic mutants of mouse mammary tumor virus		Yanagawa S; Lee JS; Kakimi K; Matsuda Y; Honjo T; Ishimoto A		J Virol	74	2000	9786-91	J:64596	11000255
88281	Effects of astragali radix extract on carcinogenesis, cytokine production, and cytotoxicity in mice treated with a carcinogen, N-butyl-N'-butanolnitrosoamine		Kurashige S; Akuzawa Y; Endo F		Cancer Invest	17	1999	30-5	J:64597	10999046
88282	Age-related alterations in 32P-postlabeled DNA adducts in livers of mice infected with the tumorigenic bacterial pathogen, helicobacter hepaticus		Josyula S; Schut HA; Diwan BA; Anver MR; Anderson LM		Int J Oncol	17	2000	811-8	J:64599	10995896
88283	Induction of primary cutaneous melanomas in C3H mice by combined treatment with ultraviolet radiation, ethanol and aloe emodin		Strickland FM; Muller HK; Stephens LC; Bucana CD; Donawho CK; Sun Y; Pelley RP		Photochem Photobiol	72	2000	407-14	J:64600	10989613
88284	Early events in leukemogenesis in P190Bcr-abl transgenic mice		Salloukh HF; Vowles I; Heisterkamp N; Groffen J; Laneuville P		Oncogene	19	2000	4362-74	J:64601	10980612
88285	Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5		Sexl V; Piekorz R; Moriggl R; Rohrer J; Brown MP; Bunting KD; Rothammer K; Roussel MF; Ihle JN		Blood	96	2000	2277-83	J:64603	10979977
88286	Reduced oncogenicity of p190 Bcr/Abl F-actin-binding domain mutants		Heisterkamp N; Voncken JW; Senadheera D; Gonzalez-Gomez I; Reichert A; Haataja L; Reinikainen A; Pattengale PK; Groffen J		Blood	96	2000	2226-32	J:64604	10979970
88287	P27 in cell cycle control and cancer.		Moller MB		Leuk Lymphoma	39	2000	19-27	J:64605	10975380
88288	Phospholipid distribution in murine mammary adenocarcinomas induced by activated neu oncogene		Monteggia E; Colombo I; Guerra A; Berra B		Cancer Detect Prev	24	2000	207-11	J:64606	10975281
88289	Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma.		Smyth MJ; Thia KY; Street SE; MacGregor D; Godfrey DI; Trapani JA		J Exp Med	192	2000	755-60	J:64607	10974040
88290	Microsatellite DNA variants between the inbred SENCAR mouse strains.		Benavides F; Stern MC; Glasscock E; DiGiovanni J; Coghlan LG; Conti CJ		Mol Carcinog	28	2000	191-5	J:64608	10972988
88291	Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.		Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ		Cancer Res	60	2000	4475-84	J:64609	10969795
88292	Mammary gland development and tumorigenesis in estrogen receptor knockout mice.		Bocchinfuso WP; Korach KS		J Mammary Gland Biol Neoplasia	2	1997	323-34	J:64643	10935020
88293	Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas.		La Perle KM; Jhiang SM; Capen CC		Am J Pathol	157	2000	671-7	J:64644	10934169
88294	Mice without telomerase: what can they teach us about human cancer?		Artandi SE; DePinho RA		Nat Med	6	2000	852-5	J:64645	10932211
88295	Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology.		Wright WE; Shay JW		Nat Med	6	2000	849-51	J:64646	10932210
88296	1,2-Dimethylhydrazine carcinogenesis in CBA male mice prenatally treated with diethylstilbestrol		Turusov V; Trukhanova L; Samoilov D		Exp Toxicol Pathol	52	2000	241-5	J:64647	10930125
88297	Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice		Moore AB; He H; Yoshida A; Rico PJ; Haseman JK; Dixon D		Exp Toxicol Pathol	52	2000	195-200	J:64649	10930119
88298	Overexpression of Grb2 in inflammatory lesions and preneoplastic foci and tumors induced by N-nitrosodimethylamine in Helicobacter hepaticus-infected and -noninfected A/J mice		Diwan BA; Ramakrishna G; Anderson LM; Ramljak D		Toxicol Pathol	28	2000	548-54	J:64650	10930041
88299	Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years		Hong HH; Devereux TR; Melnick RL; Moomaw CR; Boorman GA; Sills RC		Toxicol Pathol	28	2000	529-34	J:64651	10930038
88300	Gamma-ray induced hepatocarcinogenesis in p53-deficient mice.		Kaizu H; Cho D; Matsuki A; Ohkoshi S; Nomoto M; Asakura H		Anticancer Res	20	2000	1545-50	J:64653	10928068
88301	Anti-promotion effect of chlorophyllin in DMBA-TPA-induced mouse skin carcinogenesis.		Kim J; Yook JI; Park KK; Jung SY; Hong JC; Kim KJ; Kim JA; Chung WY		Anticancer Res	20	2000	1493-8	J:64654	10928061
88302	The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis.		Weinstein EJ; Leder P		Cancer Res	60	2000	3856-61	J:64655	10919660
88303	Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice.		Noonan FP; Otsuka T; Bang S; Anver MR; Merlino G		Cancer Res	60	2000	3738-43	J:64656	10919643
88304	Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model.		Yokoyama Y; Green JE; Sukhatme VP; Ramakrishnan S		Cancer Res	60	2000	4362-5	J:64610	10969778
88305	Effect of Withania somnifera on 20-methylcholanthrene induced fibrosarcoma		Davis L; Kuttan G		J Exp Clin Cancer Res	19	2000	165-7	J:64611	10965813
88306	beta-Carotene fails to act as a tumor promoter, induces RAR expression, and prevents carcinoma formation in a two-stage model of skin carcinogenesis in male Sencar mice.		Ponnamperuma RM; Shimizu Y; Kirchhof SM; De Luca LM		Nutr Cancer	37	2000	82-8	J:64612	10965524
88307	Tannins protect against skin tumor promotion induced by ultraviolet-B radiation in hairless mice.		Gali-Muhtasib HU; Yamout SZ; Sidani MM		Nutr Cancer	37	2000	73-7	J:64613	10965522
88308	Telomeres, telomerase and cancer: an up-date.		Dhaene K; Van Marck E; Parwaresch R		Virchows Arch	437	2000	1-16	J:64614	10963374
88309	Metamorphosed fibroblasts and their relation to the histogenesis of malignant fibrous histiocytoma in experimental murine model		Osanai T; Yamakawa M; Suda A; Watanabe Y		Histol Histopathol	15	2000	697-705	J:64616	10963113
88310	Hepatocarcinogenesis in female mice with mosaic expression of connexin32.		Moennikes O; Buchmann A; Willecke K; Traub O; Schwarz M		Hepatology	32	2000	501-6	J:64617	10960441
88311	Ichthyotoxic phloroglucinol derivatives from Dryopteris fragrans and their anti-tumor promoting activity		Ito H; Muranaka T; Mori K; Jin ZX; Tokuda H; Nishino H; Yoshida T		Chem Pharm Bull (Tokyo)	48	2000	1190-5	J:64620	10959585
88312	The PEA3 group of ETS-related transcription factors. Role in breast cancer metastasis		de Launoit Y; Chotteau-Lelievre A; Beaudoin C; Coutte L; Netzer S; Brenner C; Huvent I; Baert JL		Adv Exp Med Biol	480	2000	107-16	J:64621	10959416
88313	Prevention of carcinogen-induced mouse skin papilloma by whole fruit aqueous extract of Momordica charantia		Ganguly C; De S; Das S		Eur J Cancer Prev	9	2000	283-8	J:64622	10958332
88314	Promutagenic etheno-DNA adducts in multistage mouse skin carcinogenesis: correlation with lipoxygenase-catalyzed arachidonic acid metabolism.		Nair J; Furstenberger G; Burger F; Marks F; Bartsch H		Chem Res Toxicol	13	2000	703-9	J:64623	10956057
88315	Antimutagenic and some other effects of conjugated linoleic acid.		Kritchevsky D		Br J Nutr	83	2000	459-65	J:64624	10953669
88316	Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.		Koh TJ; Bulitta CJ; Fleming JV; Dockray GJ; Varro A; Wang TC		J Clin Invest	106	2000	533-9	J:64625	10953028
88317	Oncogene inactivation in a mouse model.		Tanabe T; Kuwabara T; Warashina M; Tani K; Taira K; Asano S		Nature	406	2000	473-4	J:64626	10952298
88318	Inducible nitric oxide synthase mRNA is upregulated in skin tumors of v-ha-ras transgenic TG-AC mice treated with 12-o-tetradecanoylphorbol-13-acetate		Lee BM; Kim HS; Jeohn GH		Biol Pharm Bull	23	2000	826-9	J:64657	10919360
88319	Effect of etoposide on experimental testicular teratoma in 129/SvJ mice.		Sundstrom J; Pelliniemi LJ; Salminen E; Pollanen P; Abdelwahid E; Verajankorva E; Soderstrom KO		Virchows Arch	436	2000	608-16	J:64659	10917177
88320	Effects of oral administration of Pfaffia paniculata (Brazilian ginseng) on incidence of spontaneous leukemia in AKR/J mice		Watanabe T; Watanabe M; Watanabe Y; Hotta C		Cancer Detect Prev	24	2000	173-8	J:64660	10917139
88321	Antitumor-promoting effects of cyclic diarylheptanoids on epstein-barr virus activation and two-stage mouse skin carcinogenesis		Ishida J; Kozuka M; Wang H; Konoshima T; Tokuda H; Okuda M; Yang Mou X; Nishino H; Sakurai N; Lee K; Nagai M		Cancer Lett	159	2000	135-40	J:64661	10996724
88322	An epistatic interaction controls the latency of a transgene-induced mammary tumor.		Le Voyer T; Lu Z; Babb J; Lifsted T; Williams M; Hunter K		Mamm Genome	11	2000	883-9	J:64663	11003704
88323	MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis		Ganguli G; Abecassis J; Wasylyk B		EMBO J	19	2000	5135-47	J:64664	11013216
88324	Renal carcinogenesis induced by ferric nitrilotriacetate in mice, and protection from it by brazilian propolis and artepillin C		Kimoto T; Koya S; Hino K; Yamamoto Y; Nomura Y; Micallef MJ; Hanaya T; Arai S; Ikeda M; Kurimoto M		Pathol Int	50	2000	679-89	J:64665	11012980
88325	Chemopreventive activity of hydroksymatairesinol in adenomatous polyposis colimultiple intestinal neoplasia (Apc)(Min) mice		Oikannen SI; Pajari A; Mutanen M		Cancer Lett	159	2000	183-7	J:64666	10996730
88326	Teratocarcinomas induced by embryonic stem (ES) cells lacking vimentin: an approach to study the role of vimentin in tumorigenesis		Langa F; Kress C; Colucci-Guyon E; Khun H; Vandormael-Pournin S; Huerre M; Babinet C		J Cell Sci	113	2000	3463-72	J:64668	10984437
88327	Inadequate dietary copper increases tumorigenesis in the min mouse		Davis CD; Newman S		Cancer Lett	159	2000	57-62	J:64669	10974406
88328	Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia		Lavau C; Du C; Thirman M; Zeleznik-Le N		EMBO J	19	2000	4655-64	J:64670	10970858
88329	Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice		Baker M; Gamble J; Tooze R; Higgins D; Yang FT; O'Brien PC; Coleman N; Pingel S; Turner M; Alexander DR		EMBO J	19	2000	4644-54	J:64671	10970857
88330	Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors		Tao L; Yang S; Xie M; Kramer PM; Pereira MA		Cancer Lett	158	2000	185-93	J:64672	10960769
88331	Estrogens, BRCA1, and breast cancer.		Hilakivi-Clarke L		Cancer Res	60	2000	4993-5001	J:64778	11016617
88332	p53 is essential for chemotherapy-induced hair loss.		Botchkarev VA; Komarova EA; Siebenhaar F; Botchkareva NV; Komarov PG; Maurer M; Gilchrest BA; Gudkov AV		Cancer Res	60	2000	5002-6	J:64779	11016618
88333	Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice.		Murakami A; Nakamura Y; Torikai K; Tanaka T; Koshiba T; Koshimizu K; Kuwahara S; Takahashi Y; Ogawa K; Yano M; Tokuda H; Nishino H; Mimaki Y; Sashida Y; Kitanaka S; Ohigashi H		Cancer Res	60	2000	5059-66	J:64780	11016629
88334	Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.		Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M		Cancer Res	60	2000	5087-91	J:64782	11016633
88335	Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.		Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M		Cancer Res	60	2000	5254-60	J:64785	11016655
88336	Inhibitors of RAS signal transduction as antitumor agents		Garbay C; Liu W; Vidal M; Roques BP		Biochem Pharmacol	60	2000	1165-9	J:64787	11007954
88337	p53-independent functions of the p19(ARF) tumor suppressor.		Weber JD; Jeffers JR; Rehg JE; Randle DH; Lozano G; Roussel MF; Sherr CJ; Zambetti GP		Genes Dev	14	2000	2358-65	J:64876	10995391
88338	Development of high-grade lymphoma in Helicobacter pylori-infected C57BL/6 mice.		Wang X; Willen R; Andersson C; Wadstrom T		APMIS	108	2000	503-8	J:65547	11167546
88339	Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation.		Vassar R; Fuchs E		Genes Dev	5	1991	714-27	J:65045	1709129
88340	Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression		Diodoro MG; Di Carlo E; Zappacosta R; Iezzi M; Coletti A; Modesti A; D'Antuono T; Forni G; Musiani P		Int J Cancer	88	2000	329-35	J:65009	11054659
88341	E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice		Smits R; Ruiz P; Diaz-Cano S; Luz A; Jagmohan-Changur S; Breukel C; Birchmeier C; Birchmeier W; Fodde R		Gastroenterology	119	2000	1045-53	J:65142	11040191
88342	Progressive segregation of unmyelinated axons in peripheral nerves, myelin alterations in the CNS, and cyst formation in the kidneys of myelin and lymphocyte protein-overexpressing mice		Frank M; Atanasoski S; Sancho S; Magyar JP; Rulicke T; Schwab ME; Suter U		J Neurochem	75	2000	1927-39	J:65204	11032882
88343	p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis		Yamamoto M; Tsukamoto T; Sakai H; Shirai N; Ohgaki H; Furihata C; Donehower LA; Yoshida K; Tatematsu M		Carcinogenesis	21	2000	1891-7	J:65239	11023548
88344	Burkitt lymphoma in the mouse		Kovalchuk AL; Qi CF; Torrey TA; Taddesse-Heath L; Feigenbaum L; Park SS; Gerbitz A; Klobeck G; Hoertnagel K; Polack A; Bornkamm GW; Janz S; Morse HC 3rd		J Exp Med	192	2000	1183-90	J:65245	11034608
88345	Differential role of transcription-coupled repair in UVB-induced G2 arrest and apoptosis in mouse epidermis		van Oosten M; Rebel H; Friedberg EC; van Steeg H; van Der Horst GT; van Kranen HJ; Westerman A; van Zeeland AA; Mullenders LH; de Gruijl FR		Proc Natl Acad Sci U S A	97	2000	11268-73	J:65265	11005836
88346	Linking colorectal cancer to Wnt signaling		Bienz M; Clevers H		Cell	103	2000	311-20	J:65269	11057903
88347	TGFbeta signaling in growth control, cancer, and heritable disorders		Massague J; Blain SW; Lo RS		Cell	103	2000	295-309	J:65270	11057902
88348	P53 null mice: damaging the hypothesis?		Sansom OJ; Clarke AR		Mutat Res	452	2000	149-62	J:65273	11024475
88349	Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras		Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J		Cancer Res	60	2000	5688-95	J:65348	11059761
88350	The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice		Wijnhoven SW; Kool HJ; van Oostrom CT; Beems RB; Mullenders LH; van Zeeland AA; van der Horst GT; Vrieling H; van Steeg H		Cancer Res	60	2000	5681-7	J:65349	11059760
88351	Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome		Sacco MG; Ungari M; Cato EM; Villa A; Strina D; Notarangelo LD; Jonkers J; Zecca L; Facchetti F; Vezzoni P		Cancer Gene Ther	7	2000	1299-306	J:65351	11059686
88352	Kurosu, a traditional vinegar produced from unpolished rice, suppresses lipid peroxidation in vitro and in mouse skin		Nishidai S; Nakamura Y; Torikai K; Yamamoto M; Ishihara N; Mori H; Ohigashi H		Biosci Biotechnol Biochem	64	2000	1909-14	J:65352	11055395
88353	Loss of heterozygosity on chromosome 5 in vicinity of the telomere in gamma-radiation-induced thymic lymphomas in mice		Sitarz M; Wirth-Dzieciolowska E; Demant P		Neoplasma	47	2000	148-50	J:65353	11043836
88354	Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis		Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS		Oncogene	19	2000	5054-62	J:65354	11042693
88355	Exercise and tumor development in a mouse predisposed to multiple intestinal adenomas.		Colbert LH; Davis JM; Essig DA; Ghaffar A; Mayer EP		Med Sci Sports Exerc	32	2000	1704-8	J:65357	11039641
88356	Assessment of the carcinogenicity associated with oral exposures to hydrogen peroxide		DeSesso JM; Lavin AL; Hsia SM; Mavis RD		Food Chem Toxicol	38	2000	1021-41	J:65358	11038240
88357	Chronic hypersecretion of luteinizing hormone in transgenic mice disrupts both ovarian and pituitary function, with some effects modified by the genetic background		Nilson JH; Abbud RA; Keri RA; Quirk CC		Recent Prog Horm Res	55	2000	69-89; discussion 89-91	J:65359	11036934
88358	Microcystins (cyanobacterial toxins) in drinking water enhance the growth of aberrant crypt foci in the mouse colon		Humpage AR; Hardy SJ; Moore EJ; Froscio SM; Falconer IR		J Toxicol Environ Health A	61	2000	155-65	J:65360	11036504
88359	A mechanistic study of ovarian carcinogenesis induced by nitrofurazone using rasH2 mice		Takegawa K; Mitsumori K; Yasuhara K; Moriyasu M; Sakamori M; Onodera H; Hirose M; Nomura T		Toxicol Pathol	28	2000	649-55	J:65361	11026599
88360	Strain differences in carcinogenic and hematopoietic responses of mice after injection of plutonium citrate		Oghiso Y; Yamada Y		Radiat Res	154	2000	447-54	J:65362	11023609
88361	Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene		Altavilla G; Caputo A; Lanfredi M; Piola C; Barbanti-Brodano G; Corallini A		Am J Pathol	157	2000	1081-9	J:65363	11021811
88362	Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations.		Schrock E; Padilla-Nash H		Semin Hematol	37	2000	334-47	J:65343	11071356
88363	Centrosome-centriole abnormalities are markers for abnormal cell divisions and cancer in the transgenic adenocarcinoma mouse prostate (TRAMP) model.		Schatten H; Wiedemeier AM; Taylor M; Lubahn DB; Greenberg NM; Besch-Williford C; Rosenfeld CS; Day JK; Ripple M		Biol Cell	92	2000	331-40	J:65344	11071042
88364	Identification of genes potentially involved in LMO2-induced leukemogenesis		Davenport J; Neale GA; Goorha R		Leukemia	14	2000	1986-96	J:65345	11069036
88365	Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice		Louz D; van den Broek M; Verbakel S; Vankan Y; van Lom K; Joosten M; Meijer D; Lowenberg B; Delwel R		Leukemia	14	2000	1876-84	J:65346	11069022
88366	Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice		Lan L; Trempus C; Gilmour SK		Cancer Res	60	2000	5696-703	J:65347	11059762
88367	Collagenase induction promotes mouse tumorigenesis by two independent pathways		Colandrea TD; D'Armiento J; Kesari KV; Chada KK		Mol Carcinog	29	2000	8-16	J:65364	11020242
88368	Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.		van den Akker JT; de Bruijn HS; Beijersbergen van Henegouwen GM; Star WM; Sterenborg HJ		Photochem Photobiol	72	2000	399-406	J:65365	10989612
88369	What is the function of IGF-II in postnatal life? Answers from transgenic mouse models [see comments]		Wolf E; Hoeflich A; Lahm H		Growth Horm IGF Res	8	1998	185-93	J:65366	10984306
88370	Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice		Amling M; Neff L; Priemel M; Schilling AF; Rueger JM; Baron R		Bone	27	2000	603-10	J:65368	11062345
88371	Cyclobutane pyrimidine dimers form preferentially at the major p53 mutational hotspot in UVB-induced mouse skin tumors		You YH; Szabo PE; Pfeifer GP		Carcinogenesis	21	2000	2113-7	J:65369	11062176
88372	Protective effect of topically applied olive oil against photocarcinogenesis following UVB exposure of mice		Budiyanto A; Ahmed NU; Wu A; Bito T; Nikaido O; Osawa T; Ueda M; Ichihashi M		Carcinogenesis	21	2000	2085-90	J:65370	11062172
88373	Tumorigenicity of four optically active bay-region 3,4-diol 1, 2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine on mouse skin and in newborn mice		Chang RL; Wood AW; Kumar S; Lehr RE; Shirai N; Jerina DM; Conney AH		Carcinogenesis	21	2000	1997-2003	J:65371	11062160
88374	Role of the amino-terminal domain of simian virus 40 early region in inducing tumors in secretin-expressing cells in transgenic mice		Ratineau C; Ronco A; Leiter AB		Gastroenterology	119	2000	1305-11	J:65372	11054388
88375	Development of spontaneous hyperplastic skin lesions and chemically induced skin papillomas in transgenic mice expressing human papillomavirus type 16 E6/E7 genes		Kang J; Kim J; Lee S; Kim D; Kim H; Lee J; Seo J		Cancer Lett	160	2000	177-83	J:65373	11053647
88376	Modifying effects of ethinylestradiol but not methoxychlor on N-ethyl-N-nitrosourea-induced uterine carcinogenesis in heterozygous p53-deficient CBA mice		Mitsumori K; Shimo T; Onodera H; Takagi H; Yasuhara K; Tamura T; Aoki Y; Nagata O; Hirose M		Toxicol Sci	58	2000	43-9	J:65374	11053539
88377	Age-related retinal pigment epithelium and Bruch's membrane degeneration in senescence-accelerated mouse		Majji AB; Cao J; Chang KY; Hayashi A; Aggarwal S; Grebe RR; Eugene De Juan Jr		Invest Ophthalmol Vis Sci	41	2000	3936-42	J:65480	11053297
88378	MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis		Coussens LM; Tinkle CL; Hanahan D; Werb Z		Cell	103	2000	481-90	J:65699	11081634
88379	Diabetes and tumor formation in transgenic mice expressing reg I		Yamaoka T; Yoshino K; Yamada T; Idehara C; Hoque MO; Moritani M; Yoshimoto K; Hata Ji; Itakura M		Biochem Biophys Res Commun	278	2000	368-76	J:65746	11097844
88380	Expression of brca1 and splice variant Brca1Delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis		Mixon M; Kittrell F; Medina D		Oncogene	19	2000	5237-43	J:65877	11077440
88381	Two critical hits for promyelocytic leukemia.		He LZ; Bhaumik M; Tribioli C; Rego EM; Ivins S; Zelent A; Pandolfi PP		Mol Cell	6	2000	1131-41	J:65878	11106752
88382	Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.		Zimonjic DB; Pollock JL; Westervelt P; Popescu NC; Ley TJ		Proc Natl Acad Sci U S A	97	2000	13306-11	J:65883	11087871
88383	Induction of tolerance to immunogenic tumor antigens associated with lymphomagenesis in HOX11 transgenic mice.		Rosic-Kablar S; Chan K; Reis MD; Dube ID; Hough MR		Proc Natl Acad Sci U S A	97	2000	13300-5	J:65884	11069299
88384	ROSA26 mice carry a modifier of Min-induced mammary and intestinal tumor development.		Kohlhepp RL; Hegge LF; Nett JE; Moser AR		Mamm Genome	11	2000	1058-62	J:66060	11130972
88385	Allele-specific loss or imbalance of chromosomes 9, 15, and 16 in B-cell tumors from interspecific F1 hybrid mice carrying e&mgr;-c-myc or N-myc transgenes		Linardopoulos S; Silva S; Klein G; Balmain A		Int J Cancer	88	2000	920-7	J:66124	11093815
88386	Loss of fas-ligand expression in mouse keratinocytes during UV carcinogenesis		Ouhtit A; Gorny A; Muller HK; Hill LL; Owen-Schaub L; Ananthaswamy HN		Am J Pathol	157	2000	1975-81	J:66128	11106570
88387	Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression		Kupferman ME; Fini ME; Muller WJ; Weber R; Cheng Y; Muschel RJ		Am J Pathol	157	2000	1777-83	J:66129	11106549
88388	IL-12 treatment of endogenously arising murine brain tumors		Roy EJ; Gawlick U; Orr BA; Rund LA; Webb AG; Kranz DM		J Immunol	165	2000	7293-9	J:66104	11120864
88389	Mammary gland tumor in transgenic mice expressing targeted beta-casein/HPV16E6 fusion gene		Hwang DY; Chae KR; Shin DH; Jang IS; Hwang JH; Kim YJ; Cho JY; Kim BJ; Goo JS; Lim CJ; Kim CK; Cho YY; Paik SG; Kim YK; Cho JS		Int J Oncol	17	2000	1093-8	J:66201	11078793
88390	Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration		Thaller C; Shalev M; Frolov A; Eichele G; Thompson TC; Williams RH; Dillioglugil O; Kadmon D		J Clin Oncol	18	2000	3804-8	J:66202	11078493
88391	Elevated expression of hepatic proliferative markers during early hepatocarcinogenesis in hepatitis-B virus transgenic mice lacking mdr1a-encoded P-glycoprotein		Bao JJ; Lee BP; Stephens LC; Sahin AA; Van NT; Johnston DA; Ou CN; Kuo MT		Mol Carcinog	29	2000	103-11	J:66205	11074607
88392	Cooperation between Ha-ras and fos or transforming growth factor alpha overcomes a paradoxic tumor-inhibitory effect of p53 loss in transgenic mouse epidermis		Wang XJ; Greenhalgh DA; Donehower LA; Roop DR		Mol Carcinog	29	2000	67-75	J:66206	11074603
88393	Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic mice		Brunello AG; Weissenberger J; Kappeler A; Vallan C; Peters M; Rose-John S; Weis J		Am J Pathol	157	2000	1485-93	J:66207	11073809
88394	Web-based access to mouse models of human cancers: the mouse tumor biology (MTB) database		Bult CJ; Krupke DM; Naf D; Sundberg JP; Eppig JT		Nucleic Acids Res	29	2001	95-7	J:66208	11125059
88395	Ultraviolet radiation induces both full activation of ret kinase and malignant melanocytic tumor promotion in RFP-RET-transgenic mice.		Kato M; Liu W; Akhand AA; Hossain K; Takeda K; Takahashi M; Nakashima I		J Invest Dermatol	115	2000	1157-8	J:66209	11121157
88396	Protective effects of hemin and tetrakis(4-benzoic acid)porphyrin on bacterial mutagenesis and mouse skin carcinogenesis induced by 7, 12-dimethylbenz[a]anthracene		Chung W; Lee J; Lee W; Surh Y; Park K		Mutat Res	472	2000	139-45	J:66210	11113706
88397	Mapping of melanoma modifier loci in RET transgenic mice.		Dragani TA; Peissel B; Zanesi N; Aloisi A; Dai Y; Kato M; Suzuki H; Nakashima I		Jpn J Cancer Res	91	2000	1142-7	J:66211	11092979
88398	Protection against malignant progression of spontaneously developing liver tumors in transgenic mice expressing O(6)-methylguanine-DNA methyltransferase.		Qin X; Zhang S; Matsukuma S; Zarkovic M; Shimizu S; Ishikawa T; Nakatsuru Y		Jpn J Cancer Res	91	2000	1085-9	J:66212	11092970
88399	Complete Nucleotide Sequence of Mouse Mammary Tumor Virus from JYG Chinese Wild Mice: Absence of Bacterial Insertion Sequences in the Cloned Viral gag Gene.		Nishio M; Xu L; Sasaki M; Haga S; Okumoto M; Mori N; Sarkar NH; Acha-Orbea H; Enami J; Imai S		Breast Cancer	1	1994	89-94	J:66213	11091515
88400	Mouse Mammary Tumor Virus Proviral Integration in the DD/Tbr Mice.		Haga S; Imai S; Morimoto J; Okumoto M; Iwai M; Iwai Y; Hiroishi S; Mori N; Nagano K; Nishino T; Yamamoto H; Sarkar NH		Breast Cancer	1	1994	11-16	J:66214	11091502
88401	Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: a potential role for trans-RA-induced ZBP-89 in ODC inhibition.[In Proce	ss Citation]	Dawson MI; Park JH; Chen G; Chao W; Dousman L; Waleh N; Hobbs PD; Jong L; Toll L; Zhang X; Gu J; Agadir A; Merchant JL; Bai L; Verma AK; Thacher SM; Chandraratna RA; Shroot B; Hill DL		Int J Cancer	91	2001	8-21	J:66152	11149424
88402	Targeted disruption of the kvlqt1 gene causes deafness and gastric hyperplasia in mice		Lee MP; Ravenel JD; Hu RJ; Lustig LR; Tomaselli G; Berger RD; Brandenburg SA; Litzi TJ; Bunton TE; Limb C; Francis H; Gorelikow M; Gu H; Washington K; Argani P; Goldenring JR; Coffey RJ; Feinberg AP		J Clin Invest	106	2000	1447-55	J:66428	11120752
88403	Ductal growth is impeded in mammary glands of C-neu transgenic mice.		Mukherjee S; Louie SG; Campbell M; Esserman L; Shyamala G		Oncogene	19	2000	5982-7	J:66387	11146549
88404	Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.		Cui XS; Donehower LA		Oncogene	19	2000	5988-96	J:66388	11146550
88405	Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.		Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O		Oncogene	19	2000	6007-14	J:66389	11146552
88406	Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.		Perez-Losada J; Sanchez-Martin M; Rodriguez-Garcia MA; Perez-Mancera PA; Pintado B; Flores T; Battaner E; Sanchez-Garcia I		Oncogene	19	2000	6015-22	J:66390	11146553
88407	Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice.		Zhang M; Shi Y; Magit D; Furth PA; Sager R		Oncogene	19	2000	6053-8	J:66391	11146557
88408	Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice		Knight B; Yeoh GC; Husk KL; Ly T; Abraham LJ; Yu C; Rhim JA; Fausto N		J Exp Med	192	2000	1809-18	J:66448	11120777
88409	Somatic cell hybrids for high-density mapping of chromosome 2 breakpoints in radiation-induced myeloid leukemia cell lines from inbred mice.		Pazzaglia S; Pariset L; Rebessi S; Saran A; Coppola M; Covelli V; Moody J; Bouffler S; Cox R; Silver A		Mol Carcinog	27	2000	219-28	J:66467	10708484
88410	Hedgehog signalling in cancer.		Toftgard R		Cell Mol Life Sci	57	2000	1720-31	J:66500	11130178
88411	Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithe	lial apoptosis.	Wigginton JM; Park JW; Gruys ME; Young HA; Jorcyk CL; Back TC; Brunda MJ; Strieter RM; Ward J; Green JE; Wiltrout RH		J Immunol	166	2001	1156-68	J:66851	11145697
88412	Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.		el-Marjou A; Delouvee A; Thiery JP; Radvanyi F		Carcinogenesis	21	2000	2211-8	J:66876	11133810
88413	Candidate mutator genes in mismatch repair-deficient thymic lymphomas: no evidence of mutations in the DNA polymerase delta gene.		Campbell MR; Thang TY; Jirik FR; Andrew SE		Carcinogenesis	21	2000	2281-5	J:66877	11133819
88414	p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent.		Kemp CJ; Sun S; Gurley KE		Cancer Res	61	2001	327-32	J:67062	11196181
88415	Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity.		Tsutsumi M; Masutani M; Nozaki T; Kusuoka O; Tsujiuchi T; Nakagama H; Suzuki H; Konishi Y; Sugimura T		Carcinogenesis	22	2001	1-3	J:67068	11159733
88416	Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent. (Errata: Vol. 23(2):373)		French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW		Carcinogenesis	22	2001	99-106	J:67080	11159747
88417	Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.		Hulla JE; French JE; Dunnick JK		Carcinogenesis	22	2001	89-98	J:67081	11159746
88418	Effect of vilon on biological age and lifespan in mice.		Khavinson VK; Anisimov VN; Zavarzina NY; Zabezhinskii MA; Zimina OA; Popovich IG; Shtylik AV; Malinin VV; Morozov VG		Bull Exp Biol Med	130	2000	687-90	J:67115	11140587
88419	Novel approaches to chemoprevention of skin cancer.		Bickers DR; Athar M		J Dermatol	27	2000	691-5	J:67116	11138532
88420	Multiplex FISH and three-dimensional DNA imaging with near infrared femtosecond laser pulses.		Konig K; Riemann I; Fischer P; Halbhuber KJ		Histochem Cell Biol	114	2000	337-45	J:67118	11131098
88421	The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.		Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL		Oncogene	19	2000	5729-35	J:67120	11126359
88422	Diffuse large-cell and 'true' histiocytic lymphomas of mice.		Qi CF; Hori M; Taddesse-Heath L; Jenkins NA; Copeland NG; Shen H; Torrey TA; Hartley JW; Chattopadhyay SK; Fredrickson TN; Morse HC		Curr Top Microbiol Immunol	252	2000	301-5	J:67121	11125488
88423	Myeloma proteins that bind Hsp65 (GroEL) are polyreactive and are found in high incidence in pristine induced plasmacytomas.		Potter M; Jones G; Dubois W; Williams K; Mushinski E		Curr Top Microbiol Immunol	252	2000	265-71	J:67122	11125484
88424	Lessons learned from BRCA1 and BRCA2.		Zheng L; Li S; Boyer TG; Lee WH		Oncogene	19	2000	6159-75	J:67112	11156530
88425	Transgenic mouse models of human breast cancer.		Hutchinson JN; Muller WJ		Oncogene	19	2000	6130-7	J:67113	11156526
88426	Protective effects of sunscreening agents on photocarcinogenesis, photoaging, and DNA damage in XPA gene knockout mice.		Horiki S; Miyauchi-Hashimoto H; Tanaka K; Nikaido O; Horio T		Arch Dermatol Res	292	2000	511-8	J:67114	11142773
88427	Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model.		Portis T; Grossman WJ; Harding JC; Hess JL; Ratner L		J Virol	75	2001	2185-93	J:67285	11160722
88428	Bax accelerates tumorigenesis in p53-deficient mice.		Knudson CM; Johnson GM; Lin Y; Korsmeyer SJ		Cancer Res	61	2001	659-65	J:67325	11212265
88429	Identification of a novel member of the snail/Gfi-1 repressor family, mlt 1, which is methylated and silenced in liver tumors of SV40 T antigen transgenic mice.		Tateno M; Fukunishi Y; Komatsu S; Okazaki Y; Kawai J; Shibata K; Itoh M; Muramatsu M; Held WA; Hayashizaki Y		Cancer Res	61	2001	1144-53	J:67331	11221845
88430	Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity.		Rebel H; Mosnier LO; Berg RJ; Westerman-de Vries A; van Steeg H; van Kranen HJ; de Gruijl FR		Cancer Res	61	2001	977-83	J:67345	11221893
88431	From Bittner to Barr: a viral, diet and hormone breast cancer aetiology hypothesis.		Lawson JS; Tran D; Rawlinson WD		Breast Cancer Res	3	2001	81-5	J:67490	11250750
88432	Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.		Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ		Mol Cell Biol	21	2001	1540-51	J:67363	11238891
88433	Irradiation promotes V(D)J joining and RAG-dependent neoplastic transformation in SCID T-cell precursors.		Williams CJ; Grandal I; Vesprini DJ; Wojtyra U; Danska JS; Guidos CJ		Mol Cell Biol	21	2001	400-13	J:67368	11134329
88434	Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer-predisposed Ink4a/ARF knockout mice.		Lu Y; Lian H; Sharma P; Schreiber-Agus N; Russell RG; Chin L; van der Horst GT; Bregman DB		Mol Cell Biol	21	2001	1810-8	J:67340	11238917
88435	Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma.		Jansen AP; Verwiebe EG; Dreckschmidt NE; Wheeler DL; Oberley TD; Verma AK		Cancer Res	61	2001	808-12	J:67342	11221859
88436	Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.		Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD		Cancer Res	61	2001	970-6	J:67343	11221892
88437	Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.		Ha HY; Moon HB; Nam MS; Lee JW; Ryoo ZY; Lee TH; Lee KK; So BJ; Sato H; Seiki M; Yu DY		Cancer Res	61	2001	984-90	J:67346	11221894
88438	Role of lymphoid cells in age-related change of susceptibility to Friend leukemia virus-induced leukemia.		Yamaguchi S; Kitagawa M; Inoue M; Tejima Y; Kimura M; Aizawa S; Utsuyama M; Hirokawa K		Mech Ageing Dev	122	2001	219-32	J:67392	11166360
88439	The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.		Crawford HC; Fingleton B; Gustavson MD; Kurpios N; Wagenaar RA; Hassell JA; Matrisian LM		Mol Cell Biol	21	2001	1370-83	J:67388	11158322
88440	Alteration by phenobarbital of membrane-associated enzymes including gamma glutamyl transpeptidase in mouse liver neoplasms.		Williams GM; Ohmori T; Katayama S; Rice JM		Carcinogenesis	1	1980	813-8	J:67439	11219852
88441	Induction of mouse epidermal ornithine decarboxylase activity and skin tumors by 7,12-dimethylben.		Verma AK; Conrad EA; Boutwell RK		Carcinogenesis	1	1980	607-11	J:67440	11219836
88442	Tumorigenic action of N-n-butyl-N-formylhydrazine in mice.		Toth B; Nagel D; Patil K		Carcinogenesis	1	1980	589-93	J:67441	11219834
88443	Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21.		Shibata MA; Yoshidome K; Shibata E; Jorcyk CL; Green JE		Cancer Gene Ther	8	2001	23-35	J:67442	11219490
88444	Expression of a small heat shock protein 27 (HSP27) in mouse skin tumors induced by UVB-irradiation.		Kiriyama MT; Oka M; Takehana M; Kobayashi S		Biol Pharm Bull	24	2001	197-200	J:67443	11217093
88445	Cancer prevention studies in p53-deficient mice.		Hursting SD; Perkins SN; Donehower LA; Davis BJ		Toxicol Pathol	29	2001	137-41	J:67444	11215677
88446	Mammary tumor induction and premature ovarian failure in ApcMin mice are not enhanced by Brca2 deficiency.		Bennett LM; McAllister KA; Ward T; Malphurs J; Collins NK; Seely JC; Davis BJ; Wiseman RW		Toxicol Pathol	29	2001	117-25	J:67445	11215675
88447	Genetically engineered rodent models of mammary gland carcinogenesis: an overview.		Blackshear PE		Toxicol Pathol	29	2001	105-16	J:67446	11215674
88448	Role of the F-box protein Skp2 in lymphomagenesis.		Latres E; Chiarle R; Schulman BA; Pavletich NP; Pellicer A; Inghirami G; Pagano M		Proc Natl Acad Sci U S A	98	2001	2515-20	J:67474	11226270
88449	Expression of major capsid protein VP-1 in the absence of viral particles in thymomas induced by murine polyomavirus.		Sanjuan N; Porras A; Otero J; Perazzo S		J Virol	75	2001	2891-9	J:67475	11222714
88450	Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.		Li S; Gillessen S; Tomasson MH; Dranoff G; Gilliland DG; Van Etten RA		Blood	97	2001	1442-50	J:67476	11222392
88451	Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336.		Reichert A; Heisterkamp N; Daley GQ; Groffen J		Blood	97	2001	1399-403	J:67477	11222386
88452	Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.		Fehniger TA; Suzuki K; Ponnappan A; VanDeusen JB; Cooper MA; Florea SM; Freud AG; Robinson ML; Durbin J; Caligiuri MA		J Exp Med	193	2001	219-31	J:67478	11208862
88453	Effect of melatonin on two stage skin carcinogenesis in Swiss mice.		Kumar CA; Das UN		Med Sci Monit	6	2000	471-5	J:67480	11208355
88454	Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice.		Maruyama C; Tomisawa M; Wakana S; Yamazaki H; Kijima H; Suemizu H; Ohnishi Y; Urano K; Hioki K; Usui T; Nakamura M; Tsuchida T; Mitsumori K; Nomura T; Tamaoki N; Ueyama Y		Oncol Rep	8	2001	233-7	J:67482	11182032
88455	BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia.		Kogan SC; Brown DE; Shultz DB; Truong BT; Lallemand-Breitenbach V; Guillemin MC; Lagasse E; Weissman IL; Bishop JM		J Exp Med	193	2001	531-43	J:67483	11181704
88456	Role of promyelocytic leukemia (PML) protein in tumor suppression.		Rego EM; Wang ZG; Peruzzi D; He LZ; Cordon-Cardo C; Pandolfi PP		J Exp Med	193	2001	521-29	J:67484	11181703
88457	Heterozygosity for a mutation in Brca1 or Atm does not increase susceptibility to ENU-induced mammary tumors in Apc(Min)/+ mice.		Karabinis ME; Larson D; Barlow C; Wynshaw-Boris A; Moser AR		Carcinogenesis	22	2001	343-6	J:67485	11181458
88458	HMGI-C gene expression is not required for in vivo thyroid cell transformation.		Scala S; Portella G; Vitagliano D; Ledent C; Chiappetta G; Giancotti V; Dumont J; Fusco A		Carcinogenesis	22	2001	251-6	J:67486	11181445
88459	Bax gene disruption alters the epidermal response to ultraviolet irradiation and in vivo induced skin carcinogenesis.		Cho SH; Delehedde M; Rodriguez-Villanueva J; Brisbay S; McDonnell TJ		Int J Mol Med	7	2001	235-41	J:67487	11179500
88460	Susceptibility to radiation-induced leukaemia/lymphoma is genetically separable from sensitivity to radiation-induced genomic instability.		Boulton E; Cleary H; Papworth D; Plumb M		Int J Radiat Biol	77	2001	21-9	J:67448	11213347
88461	Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.		Vail ME; Pierce RH; Fausto N		Cancer Res	61	2001	594-601	J:67450	11212255
88462	129/Sv mice--a model system for studying germ cell biology and testicular cancer.		Jiang LI; Nadeau JH		Mamm Genome	12	2001	89-94	J:67453	11210194
88463	Dietary administration of tannic acid lowers plasminogen activator activity in the liver of C3H hepatoma bearing male mice.		Taitzoglou IA; Tsantarliotou MP; Nepka C; Zervos I; Maltezos E; Kouretas D; Kokolis NA		In Vivo	14	2000	767-71	J:67454	11204497
88464	Fluorescence imaging and spectroscopy of ethyl nile blue A in animal models of (pre)malignancies.		van Staveren HJ; Speelman OC; Witjes MJ; Cincotta L; Star WM		Photochem Photobiol	73	2001	32-8	J:67455	11202363
88465	MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells.		Michel LS; Liberal V; Chatterjee A; Kirchwegger R; Pasche B; Gerald W; Dobles M; Sorger PK; Murty VV; Benezra R		Nature	409	2001	355-9	J:67456	11201745
88466	Effect of melatonin and linolenic acid on mammary cancer in transgenic mice with c-neu breast cancer oncogene.		Rao GN; Ney E; Herbert RA		Breast Cancer Res Treat	64	2000	287-96	J:67457	11200779
88467	Gastrointestinal tumorigenesis in Smad4 (Dpc4) mutant mice.		Taketo MM; Takaku K		Hum Cell	13	2000	85-95	J:67459	11197776
88468	Successful and not so successful chemoprevention of tobacco smoke-induced lung tumors.		Witschi H		Exp Lung Res	26	2000	743-55	J:67461	11195468
88469	Low level expression of human papillomavirus type 16 (HPV16) E6 in squamous epithelium does not elicit E6 specific B- or T-helper immunological responses, or influence the outcome of immunisation with E6 protein.		Azoury-Ziadeh R; Herd K; Fernando GJ; Lambert P; Frazer IH; Tindle RW		Virus Res	73	2001	189-99	J:67504	11172923
88470	Biology of transforming growth factor beta in hepatocarcinogenesis.		Rossmanith W; Schulte-Hermann R		Microsc Res Tech	52	2001	430-6	J:67506	11170302
88471	Oral administration of dimethylvinyl chloride increases frequency of forestomach papillomas in Tg.AC mice.		Cannon RE; Graves S; Spalding JW; Trempus CS; Tennant RW		Mol Carcinog	29	2000	229-35	J:67507	11170261
88472	Analysis for loss of heterozygosity (LOH) of p53 allele in tumors derived from p53+/- and CD-1 mice following repeated subcutaneous injections of solutions containing antioxidants.		Youssef AF; Borellini F; Jacobson-Kram D; Fort FL		Environ Mol Mutagen	37	2001	27-30	J:67508	11170239
88473	Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence.		Johnsen AK; France J; Nagy N; Askew D; Abdul-Karim FW; Gerson SL; Sy MS; Harding CV		Int J Cancer	91	2001	366-72	J:67509	11169961
88474	Validity of mouse mammary tumour models for human breast cancer: comparative pathology.		Cardiff RD		Microsc Res Tech	52	2001	224-30	J:67510	11169869
88475	Protective immunity to UV radiation-induced skin tumours induced by skin grafts and epidermal cells.		Sluyter R; Yuen K; Halliday G		Immunol Cell Biol	79	2001	29-34	J:67511	11168620
88476	Protective role of medroxyprogesterone acetate on N-methyl-N-nitrosourea-induced lymphomas in BALB/c female mice.		Pazos P; Lanari C; Molinolo AA		Leuk Res	25	2001	165-7	J:67512	11166832
88477	Loss of heterozygosity in somatic cells of the mouse. An important step in cancer initiation?		Wijnhoven SW; Kool HJ; van Teijlingen CM; van Zeeland AA; Vrieling H		Mutat Res	473	2001	23-36	J:67513	11166024
88478	Mouse model for Burkitt's lymphoma will aid understanding and therapy.		Hillery A		Drug Discov Today	6	2001	3-4	J:67514	11165159
88479	Cancer chemopreventive activity of 3,5,6,7,8,3',4'-heptamethoxyflavone from the peel of citrus plants.		Iwase Y; Takemura Y; Ju-ichi M; Yano M; Ito C; Furukawa H; Mukainaka T; Kuchide M; Tokuda H; Nishino H		Cancer Lett	163	2001	7-9	J:67517	11163102
88480	Enhanced expression of the early retrotransposon in C3H mouse-derived myeloid leukemia cells.		Tanaka I; Ishihara H		Virology	280	2001	107-14	J:67518	11162824
88481	Metastases: the glycan connection.		Couldrey C; Green JE		Breast Cancer Res	2	2000	321-3	J:67492	11250723
88482	Tyrosine kinase signalling in breast cancer: Tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.		Andrechek ER; Muller WJ		Breast Cancer Res	2	2000	211-6	J:67493	11250712
88483	Tyrosine kinase signalling in breast cancer: Fibroblast growth factors and their receptors.		Dickson C; Spencer-Dene B; Dillon C; Fantl V		Breast Cancer Res	2	2000	191-6	J:67494	11250709
88484	Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models.		Wakefield LM; Yang Ya; Dukhanina O		Breast Cancer Res	2	2000	100-6	J:67495	11250699
88485	Killing the umpire: cooperative defects in mitotic checkpoint and BRCA2 genes on the road to transformation.		McKeon F		Breast Cancer Res	1	1999	8-10	J:67496	11250674
88486	c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.		D'Cruz CM; Gunther EJ; Boxer RB; Hartman JL; Sintasath L; Moody SE; Cox JD; Ha SI; Belka GK; Golant A; Cardiff RD; Chodosh LA		Nat Med	7	2001	235-9	J:67498	11175856
88487	Repeated exposure of C3H/HeJ mice to ultra-wideband electromagnetic pulses: lack of effects on mammary tumors.		Jauchem JR; Ryan KL; Frei MR; Dusch SJ; Lehnert HM; Kovatch RM		Radiat Res	155	2001	369-77	J:67500	11175673
88488	The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.		Salomon DS; Bianco C; Ebert AD; Khan NI; De Santis M; Normanno N; Wechselberger C; Seno M; Williams K; Sanicola M; Foley S; Gullick WJ; Persico G		Endocr Relat Cancer	7	2000	199-226	J:67502	11174844
88489	Genetic mapping and allelic loss analysis in mouse thymic lymphomas of helios and aiolos belonging to the ikaros gene family.		Xu H; Wakabayashi Y; Okano H; Saito Y; Miyazawa T; Kominami R		Jpn J Cancer Res	92	2001	36-41	J:67503	11173542
88490	Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3.		Tomasson MH; Williams IR; Li S; Kutok J; Cain D; Gillessen S; Dranoff G; Van Etten RA; Gilliland DG		Blood	97	2001	1435-41	J:67752	11222391
88491	Ectopeptidases in pathophysiology.		Antczak C; De Meester I; Bauvois B		Bioessays	23	2001	251-60	J:67754	11223882
88492	DNA mismatch repair and cancer.		Peltomaki P		Mutat Res	488	2001	77-85	J:67811	11223406
88493	Assignment of SND1, the gene encoding coactivator p100, to human chromosome 7q31.3 and rat chromosome 4q23 by in situ hybridization.		Lienard P; Riviere M; Van Vooren P; Szpirer C; Szpirer J		Cytogenet Cell Genet	90	2000	253-4	J:67878	11124528
88494	Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice.		Nagase H; Mao JH; de Koning JP; Minami T; Balmain A		Cancer Res	61	2001	1305-8	J:67849	11245425
88495	Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice.		Suganuma M; Ohkura Y; Okabe S; Fujiki H		J Cancer Res Clin Oncol	127	2001	69-72	J:67939	11206275
88496	Mouse models for sporadic cancer.		Meuwissen R; Jonkers J; Berns A		Exp Cell Res	264	2001	100-10	J:68006	11237526
88497	Wilms tumor and the wt1 gene.		Lee SB; Haber DA		Exp Cell Res	264	2001	74-99	J:68007	11237525
88498	Neurofibromin, a tumor suppressor in the nervous system.		Zhu Y; Parada LF		Exp Cell Res	264	2001	19-28	J:68008	11237520
88499	From the Cover: Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.		Ramos-Gomez M; Kwak MK; Dolan PM; Itoh K; Yamamoto M; Talalay P; Kensler TW		Proc Natl Acad Sci U S A	98	2001	3410-5	J:68072	11248092
88500	Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.		Lin EY; Nguyen AV; Russell RG; Pollard JW		J Exp Med	193	2001	727-40	J:68146	11257139
88501	Allelic loss mapping and physical delineation of a region harboring a thymic lymphoma suppressor gene on mouse chromosome 16.		Matsuki A; Kosugi-Okano H; Ochiai Y; Kosugi Si; Miyazawa T; Wakabayashi Yi; Hatakeyama K; Niwa O; Kominami R		Biochem Biophys Res Commun	282	2001	16-20	J:68193	11263964
88502	Ovarian Tumorigenesis in Mice Transgenic for Murine Inhibin alpha Subunit Promoter-Driven Simian Virus 40 T-Antigen: Ontogeny, Functional Characteristics, and Endocrine Effects.		Rahman NA; Huhtaniemi IT		Biol Reprod	64	2001	1122-30	J:68195	11259258
88503	Oncogene-induced liver neoplasia in transgenic mice.		Sandgren EP; Quaife CJ; Pinkert CA; Palmiter RD; Brinster RL		Oncogene	4	1989	715-24	J:68423	2543942
88504	Use of intercross outbred mice and single nucleotide polymorphisms to map skin cancer modifier loci.		Peissel B; Zaffaroni D; Pazzaglia S; Manenti G; Zanesi N; Zedda I; Rebessi S; Covelli V; Dragani TA; Saran A		Mamm Genome	12	2001	291-4	J:68404	11309660
88505	Chemoprevention of lung cancer by isothiocyanates and their conjugates in A/J mouse.		Chung EL		Exp Lung Res	27	2001	319-30	J:68459	11293331
88506	Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion.		Bauer AK; Dwyer-Nield LD; Keil K; Koski K; Malkinson AM		Exp Lung Res	27	2001	197-216	J:68463	11293324
88507	Genetic linkage of nuclear morphology of mouse lung tumors to the Kras-2 locus.		Tripodis N; Demant P		Exp Lung Res	27	2001	185-96	J:68464	11293323
88508	Up-regulation of MUC1 in mammary tumors generated in a double-transgenic mouse expressing human MUC1 cDNA, under the control of 1.4-kb 5' MUC1 promoter sequence and the middle T oncogene, expressed from the MMTV promoter.		Graham RA; Morris JR; Cohen EP; Taylor-Papadimitriou J		Int J Cancer	92	2001	382-7	J:68466	11291075
88509	Murine models for experimental therapy of pediatric solid tumors with poor prognosis.		Beltinger C; Debatin KM		Int J Cancer	92	2001	313-8	J:68467	11291063
88510	Angiogenesis and prostate cancer: identification of a molecular progression switch.		Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM		Cancer Res	61	2001	2736-43	J:68468	11289156
88511	Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes.		Ehrhardt A; Bartels T; Geick A; Klocke R; Paul D; Halter R		Br J Cancer	84	2001	813-8	J:68445	11259097
88512	Two-stage carcinogenesis in NMRI mice: intravaginal application of 7,12-dimethylbenz[a]anthracene as initiator followed by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter.		Goerttler K; Lohrke H; Hesse B		Carcinogenesis	1	1980	707-13	J:68497	11272124
88513	Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin.		Nakatani T; Roy G; Fujimoto N; Asahara T; Ito A		Jpn J Cancer Res	92	2001	249-56	J:68498	11267934
88514	Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse.		Buchholz F; Refaeli Y; Trumpp A; Bishop JM		EMBO Rep	1	2000	133-9	J:68499	11265752
88515	Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development.		Collins EC; Pannell R; Simpson EM; Forster A; Rabbitts TH		EMBO Rep	1	2000	127-32	J:68500	11265751
88516	The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression.		Klochendler-Yeivin A; Fiette L; Barra J; Muchardt C; Babinet C; Yaniv M		EMBO Rep	1	2000	500-6	J:68501	11263494
88517	Foreign body sarcoma: effects of foreign DNA, beta-carotene and paprika applied to the implant surface.		Lavelle SM; Iomhair MM		Technol Health Care	8	2000	357-61	J:68502	11258581
88518	Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia.		Pandolfi PP		Hum Mol Genet	10	2001	769-75	J:68503	11257111
88519	Unraveling human cancer in the mouse: recent refinements to modeling and analysis.		Resor L; Bowen TJ; Wynshaw-Boris A		Hum Mol Genet	10	2001	669-75	J:68504	11257098
88520	Mouse plasmacytoma: an experimental model of human multiple myeloma.		Gado K; Silva S; Paloczi K; Domjan G; Falus A		Haematologica	86	2001	227-36	J:68505	11255268
88521	The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice.		Heisterkamp N; Voncken JW; Senadheera D; Hemmeryckx B; Gonzalez-Gomez I; Reichert A; Pattengale PK; Groffen J		Int J Mol Med	7	2001	351-7	J:68506	11254872
88522	Gliomagenesis: genetic alterations and mouse models.		Holland EC		Nat Rev Genet	2	2001	120-9	J:68507	11253051
88523	The A beta 6w302 gene and molecular mechanisms of resistance to the spread of radiation-induced lymphoma in a mouse mutant, survivor-27.		Liu Y; Savinov AY; McMinimy DL; Kremlev SG; Chapoval AI; Egorov IK		Radiats Biol Radioecol	40	2000	500-5	J:68508	11252225
88524	Role of Fas ligand expression in promoting escape from immune rejection in a spontaneous tumor model.		Cefai D; Favre L; Wattendorf E; Marti A; Jaggi R; Gimmi CD		Int J Cancer	91	2001	529-37	J:68509	11251977
88525	Chromosome 11 loss from thymic lymphomas induced in heterozygous trp53 mice by phenolphthalein.		Hulla JE; French JE; Dunnick JK		Toxicol Sci	60	2001	264-70	J:68510	11248138
88526	Protection of mice against leukemia after vaccination with bone marrow-derived dendritic cells loaded with apoptotic leukemia cells.		Paczesny S; Beranger S; Salzmann JL; Klatzmann D; Colombo BM		Cancer Res	61	2001	2386-9	J:68472	11289101
88527	Encapsulation in cationic liposomes enhances antitumour efficacy and reduces the toxicity of etoposide, a topo-isomerase ii inhibitor.		Sengupta S; Tyagi P; Chandra S; Kochupillai V; Gupta SK		Pharmacology	62	2001	163-71	J:68473	11287818
88528	Effects of Motexafin gadolinium on tumor metabolism and radiation sensitivity.		Xu S; Zakian K; Thaler H; Matei C; Alfieri A; Chen Y; Koutcher JA		Int J Radiat Oncol Biol Phys	49	2001	1381-90	J:68474	11286846
88529	Deceleration of carcinogenic potential by adaptation with low dose gamma irradiation.		Bhattacharjee D; Ito A		In Vivo	15	2001	87-92	J:68475	11286136
88530	Intestinal toxicity and carcinogenic potential of the food mutagen 2-amino-1-methyl-6-phenylimidazo.		Klein JC; Beems RB; Zwart PE; Hamzink M; Zomer G; Steeg Hv; Kreijl CF		Carcinogenesis	22	2001	619-26	J:68477	11285198
88531	Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism.		Takagi A; Matsuzaki T; Sato M; Nomoto K; Morotomi M; Yokokura T		Carcinogenesis	22	2001	599-605	J:68478	11285195
88532	Free radical defenses in the liver and kidney of human growth hormone transgenic mice: possible mechanisms of early mortality.		Hauck SJ; Bartke A		J Gerontol A Biol Sci Med Sci	56	2001	B153-62	J:68479	11283186
88533	NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.		Smyth MJ; Crowe NY; Godfrey DI		Int Immunol	13	2001	459-63	J:68480	11282985
88534	The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis.		Sivagnanasundaram S; Islam I; Talbot I; Drummond F; Walters JR; Edwards YH		Br J Cancer	84	2001	218-25	J:68542	11161380
88535	Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.		Sigal A; Rotter V		Cancer Res	60	2000	6788-93	J:68543	11156366
88536	Mammary cancer in humans and mice: a tutorial for comparative pathology. The CD-ROM.		Cardiff RD; Wagner U; Henninghausen L		J Mammary Gland Biol Neoplasia	5	2000	243-4	J:68545	11149576
88537	The SH2 domain of bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype.		Zhang X; Wong R; Hao SX; Pear WS; Ren R		Blood	97	2001	277-87	J:68549	11133772
88538	Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.		Street SE; Cretney E; Smyth MJ		Blood	97	2001	192-7	J:68550	11133760
88539	The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma.		Barille S; Bataille R; Amiot M		Eur Cytokine Netw	11	2000	546-51	J:68551	11125296
88540	The biology of lung cancer including potential clinical applications.		Zochbauer-Muller S; Minna JD		Chest Surg Clin N Am	10	2000	691-708	J:68553	11091920
88541	Carcinogenicity and genotoxicity of ethylene oxide: new aspects and recent advances.		Thier R; Bolt HM		Crit Rev Toxicol	30	2000	595-608	J:68554	11055837
88542	Synthetic pineal peptide inhibits growth of spontaneous tumors and increases lifespan in mice.		Khavinson VK; Anisimov VN		Dokl Biol Sci	373	2000	361-3	J:68556	11013831
88543	Models of chronic myeloid leukemia.		Van Etten RA		Curr Oncol Rep	3	2001	228-37	J:68559	11296133
88544	Studies using structural analogs and inbred strain differences to support a role for quinone methide metabolites of butylated hydroxytoluene (BHT) in mouse lung tumor promotion.		Thompson JA; Carlson TJ; Sun Y; Dwyer-Nield LD; Malkinson AM		Toxicology	160	2001	197-205	J:68512	11246140
88545	Crkl enhances leukemogenesis in BCR/ABL P190 transgenic mice.		Hemmeryckx B; van Wijk A; Reichert A; Kaartinen V; de Jong R; Pattengale PK; Gonzalez-Gomez I; Groffen J; Heisterkamp N		Cancer Res	61	2001	1398-405	J:68514	11245441
88546	Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis.		Gokmen-Polar Y; Murray NR; Velasco MA; Gatalica Z; Fields AP		Cancer Res	61	2001	1375-81	J:68515	11245437
88547	Angiogenesis in transgenic models of multistep carcinogenesis.		D' Angelo MG; Afanasieva T; Aguzzi A		J Neurooncol	50	2000	89-98	J:68516	11245284
88548	Tephrosia purpurea alleviates phorbol ester-induced tumor promotion response in murine skin.		Saleem M; Ahmed Su; Alam A; Sultana S		Pharmacol Res	43	2001	135-44	J:68518	11243714
88549	Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.		Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A		Mol Carcinog	30	2001	111-8	J:68519	11241758
88550	Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.		Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ		Mol Cell Biol	21	2001	2203-12	J:68521	11238953
88551	Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (das) and related compounds from garlic.		Yang CS; Chhabra SK; Hong JY; Smith TJ		J Nutr	131	2001	1041S-5S	J:68522	11238812
88552	Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis.		Ross S; Spencer SD; Lasky LA; Koeppen H		Am J Pathol	158	2001	809-16	J:68524	11238029
88553	FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo.		Clark JC; Tichelaar JW; Wert SE; Itoh N; Perl AK; Stahlman MT; Whitsett JA		Am J Physiol Lung Cell Mol Physiol	280	2001	L705-15	J:68525	11238011
88554	Chemoprevention of lung cancer by lycopene.		Kim DJ; Takasuka N; Nishino H; Tsuda H		Biofactors	13	2000	95-102	J:68526	11237207
88555	Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid.		Huang MT; Badmaev V; Ding Y; Liu Y; Xie JG; Ho CT		Biofactors	13	2000	225-30	J:68527	11237186
88556	Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: fumonisin B(1) as an example.		Dragan YP; Bidlack WR; Cohen SM; Goldsworthy TL; Hard GC; Howard PC; Riley RT; Voss KA		Toxicol Sci	61	2001	6-17	J:68560	11294969
88557	The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells.		Li Z; Zhu YX; Plowright EE; Bergsagel PL; Chesi M; Patterson B; Hawley TS; Hawley RG; Stewart AK		Blood	97	2001	2413-9	J:68561	11290605
88558	Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse.		Battalora MS; Spalding JW; Szczesniak CJ; Cape JE; Morris RJ; Trempus CS; Bortner CD; Lee BM; Tennant RW		Carcinogenesis	22	2001	651-9	J:68562	11285202
88559	Xeroderma pigmentosum group A gene action as a protection factor against 4-nitroquinoline 1-oxide-induced tongue carcinogenesis.		Ide F; Oda H; Nakatsuru Y; Kusama K; Sakashita H; Tanaka K; Ishikawa T		Carcinogenesis	22	2001	567-72	J:68563	11285190
88560	Resistance to fulminant hepatitis and carcinogenesis conferred by overexpression of retinoblastoma protein in mouse liver.		Ichihara T; Komagata Y; Yang XL; Uezato T; Enomoto K; Koyama K; Miyazaki J; Sugiyama T; Miura N		Hepatology	33	2001	948-55	J:68564	11283859
88561	Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice.		Liu CH; Chang SH; Narko K; Trifan OC; Wu MT; Smith E; Haudenschild C; Lane TF; Hla T		J Biol Chem	276	2001	18563-9	J:68565	11278747
88562	The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation.		Forcet C; Ye X; Granger L; Corset V; Shin H; Bredesen DE; Mehlen P		Proc Natl Acad Sci U S A	98	2001	3416-21	J:68567	11248093
88563	Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin		Limtrakul P; Anuchapreeda S; Lipigorngoson S; Dunn FW		BMC Cancer	1	2001	1	J:68568	11231886
88564	High levels of ceruloplasmin in the serum of transgenic mice developing hepatocellular carcinoma.		Pousset D; Piller V; Bureaud N; Piller F		Eur J Biochem	268	2001	1491-9	J:68569	11231303
88565	Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice.		Kim D; Peng XC; Sun XH		Mol Cell Biol	19	1999	8240-53	J:58607	10567549
88566	Pituitary tumours.		Davis JR; Farrell WE; Clayton RN		Reproduction	121	2001	363-71	J:68691	11226062
88567	Elevated Cu/Zn-SOD exacerbates radiation sensitivity and hematopoietic abnormalities of Atm-deficient mice.		Peter Y; Rotman G; Lotem J; Elson A; Shiloh Y; Groner Y		EMBO J	20	2001	1538-46	J:68771	11285218
88568	Preventive effects of Juzen-taiho-to on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice.		Niwa K; Hashimoto M; Morishita S; Lian Z; Tagami K; Mori H; Tamaya T		Carcinogenesis	22	2001	587-91	J:68816	11285193
88569	A mutator phenotype in cancer.		Loeb LA		Cancer Res	61	2001	3230-9	J:68911	11309271
88570	Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.		Cadoret A; Ovejero C; Saadi-Kheddouci S; Souil E; Fabre M; Romagnolo B; Kahn A; Perret C		Cancer Res	61	2001	3245-9	J:68912	11309273
88571	Promotion of seminomatous tumors by targeted overexpression of glial cell line-derived neurotrophic factor in mouse testis.		Meng X; de Rooij DG; Westerdahl K; Saarma M; Sariola H		Cancer Res	61	2001	3267-71	J:68913	11309277
88572	Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.		Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M		Oncogene	20	2001	320-8	J:68918	11313961
88573	Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.		Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M		Oncogene	20	2001	295-302	J:68920	11313958
88574	Elevated mutant frequencies and increased C : G-->T : A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells.		Baross-Francis A; Makhani N; Liskay RM; Jirik FR		Oncogene	20	2001	619-25	J:68922	11313994
88575	Impairment of mammary lobular development induced by expression of TGFbeta1 under the control of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice.		Buggiano V; Schere-Levy C; Abe K; Vanzulli S; Piazzon I; Smith GH; Kordon EC		Int J Cancer	92	2001	568-76	J:68939	11304693
88576	Conditional liver-specific expression of simian virus 40 T antigen leads to regulatable development of hepatic neoplasm in transgenic mice.		Manickan E; Satoi J; Wang TC; Liang TJ		J Biol Chem	276	2001	13989-94	J:69003	11278564
88577	Disruption of ini1 leads to peri-implantation lethality and tumorigenesis in mice.		Guidi CJ; Sands AT; Zambrowicz BP; Turner TK; Demers DA; Webster W; Smith TW; Imbalzano AN; Jones SN		Mol Cell Biol	21	2001	3598-603	J:69009	11313485
88578	Facilitation of functional compartmentalization of bone marrow cells in leukemic mice by biological response modifiers: an immunotherapeutic approach.		Law S; Maiti D; Palit A; Majumder D; Basu K; Chaudhuri S; Chaudhuri S		Immunol Lett	76	2001	145-52	J:69041	11306141
88579	The retinoblastoma gene regulates somatic growth during mouse development.		Nikitin AYu; Shan B; Flesken-Nikitin A; Chang KH; Lee WH		Cancer Res	61	2001	3110-8	J:69037	11306495
88580	The occurrence of tumors of the forestomach in mice after parenteral administration of methylcholanthrene: A histopathologic and genetic analysis		Bagshaw MA; Strong LC		J Natl Cancer Inst	11	1950	141-175	J:69075	14784849
88581	Targeted Expression of bcl-2 to Murine Basal Epidermal Keratinocytes Results in Paradoxical Retardation of Ultraviolet- and Chemical-induced Tumorigenesis.		Rossiter H; Beissert S; Mayer C; Schon MP; Wienrich BG; Tschachler E; Kupper TS		Cancer Res	61	2001	3619-26	J:69132	11325830
88582	Effects of in vivo heregulin beta1 treatment in wild-type and ErbB gene-targeted mice depend on receptor levels and pregnancy.		O'Shea S; Johnson K; Clark R; Sliwkowski MX; Erickson SL		Am J Pathol	158	2001	1871-80	J:69103	11337386
88583	Ovarian expression of human insulin-like growth factor-I in transgenic mice results in cyst formation.		Dyck MK; Parlow AF; Senechal JF; Sirard MA; Pothier F		Mol Reprod Dev	59	2001	178-85	J:69144	11389552
88584	Deltan89beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland.		Imbert A; Eelkema R; Jordan S; Feiner H; Cowin P		J Cell Biol	153	2001	555-68	J:69210	11331306
88585	Abnormal ornithine decarboxylase activity in transgenic mice increases tumor formation and infertility.		Kilpelainen PT; Saarimies J; Kontusaari SI; Jarvinen MJ; Soler AP; Kallioinen MJ; Hietala OA		Int J Biochem Cell Biol	33	2001	507-20	J:69211	11331206
88586	A susceptibility locus for radiation lymphomagenesis on mouse chromosome 16.		Mori N; Okumoto M; Yamate J		J Radiat Res (Tokyo)	41	2000	367-72	J:69212	11329885
88587	Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice.		Collett GP; Robson CN; Mathers JC; Campbell FC		Carcinogenesis	22	2001	821-5	J:69213	11323404
88588	Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development.		Ohno J; Horio Y; Sekido Y; Hasegawa Y; Takahashi M; Nishizawa J; Saito H; Ishikawa F; Shimokata K		Carcinogenesis	22	2001	751-6	J:69214	11323394
88589	The role of nucleotide excision repair and loss of p53 in mutagenesis and carcinogenesis.		van Steeg H		Toxicol Lett	120	2001	209-19	J:69215	11323179
88590	New models for assessing carcinogenesis: an ongoing process.		Sills RC; French JE; Cunningham ML		Toxicol Lett	120	2001	187-98	J:69216	11323177
88591	Effects of coffee cherry, the residue left after removal of the beans from the coffee fruit, on mammary glands, automatic behavior and related parameters in mice.		Nagasawa H; Yada E; Udagawa Y; Inatomi H		Am J Chin Med	29	2001	119-27	J:69217	11321469
88592	Role of the newer p53 family proteins in malignancy.		Irwin MS; Kaelin WG		Apoptosis	6	2001	17-29	J:69218	11321038
88593	Overexpressed growth hormone (GH) synergistically promotes carcinogen-initiated liver tumour growth by promoting cellular proliferation in emerging hepatocellular neoplasms in female and male GH-transgenic mice.		Snibson KJ; Bhathal PS; Adams TE		Liver	21	2001	149-58	J:69219	11318985
88594	Pulmonary carcinogenesis induced by ferric nitrilotriacetate in mice and protection from it by Brazilian propolis and artepillin C.		Kimoto T; Koya-Miyata S; Hino K; Micallef MJ; Hanaya T; Arai S; Ikeda M; Kurimoto M		Virchows Arch	438	2001	259-70	J:69220	11315623
88595	Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis.		He W; Cao T; Smith DA; Myers TE; Wang XJ		Oncogene	20	2001	471-83	J:69221	11313978
88596	Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor).		Poon R; Smits R; Li C; Jagmohan-Changur S; Kong M; Cheon S; Yu C; Fodde R; Alman BA		Oncogene	20	2001	451-60	J:69222	11313976
88597	Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.		Brodie SG; Xu X; Li C; Kuo A; Leder P; Deng CX		Oncogene	20	2001	1445-54	J:69223	11313888
88598	Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice.		Rovero S; Boggio K; Carlo ED; Amici A; Quaglino E; Porcedda P; Musiani P; Forni G		Gene Ther	8	2001	447-52	J:69224	11313823
88599	Suppression of Skin Tumorigenesis in c-Jun NH(2)-Terminal Kinase-2-Deficient Mice.		Chen N; Nomura M; She QB; Ma WY; Bode AM; Wang L; Flavell RA; Dong Z		Cancer Res	61	2001	3908-12	J:69188	11358804
88600	Model mice for bcr/abl-positive leukemias.		Honda H; Hirai H		Blood Cells Mol Dis	27	2001	265-78	J:69190	11358387
88601	Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias.		Merghoub T; Gurrieri C; Piazza F; Pandolfi PP		Blood Cells Mol Dis	27	2001	231-48	J:69191	11358384
88602	Fatal leukemia in interleukin-15 transgenic mice.		Fehniger TA; Suzuki K; VanDeusen JB; Cooper MA; Freud AG; Caligiuri MA		Blood Cells Mol Dis	27	2001	223-30	J:69192	11358383
88603	Non-Hodgkin lymphomas of mice.		Hori M; Xiang S; Qi CF; Chattopadhyay SK; Fredrickson TN; Hartley JW; Kovalchuk AL; Bornkamm GW; Janz S; Copeland NG; Jenkins NA; Ward JM; Morse HC		Blood Cells Mol Dis	27	2001	217-22	J:69193	11358382
88604	Bcl-2 mediates chemoresistance in matched pairs of primary e&mgr;-myc lymphomas in vivo.		Schmitt CA; Lowe SW		Blood Cells Mol Dis	27	2001	206-16	J:69194	11358381
88605	Retroviral transduction models of ph(+) leukemia: advantages and limitations for modeling human hematological malignancies in mice.		Van Etten RA		Blood Cells Mol Dis	27	2001	201-5	J:69195	11358380
88606	Acute promyelocytic leukemia: a view from a mouse.		Kogan SC		Blood Cells Mol Dis	26	2000	620-5	J:69196	11358354
88607	Bioassay of mannitol and caprolactam and assessment of response to diethylnitrosamine in heterozygous p53-deficient (+/-) and wild type (+/+) mice.		Iatropoulos MJ; Jeffrey AM; Schluter G; Enzmann HG; Williams GM		Arch Toxicol	75	2001	52-8	J:69197	11357521
88608	Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.		Kitchin KT		Toxicol Appl Pharmacol	172	2001	249-61	J:69225	11312654
88609	Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.		Mittelman M; Neumann D; Peled A; Kanter P; Haran-Ghera N		Proc Natl Acad Sci U S A	98	2001	5181-6	J:69226	11309490
88610	Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression.		Dubey P; Wu H; Reiter RE; Witte ON		Cancer Res	61	2001	3256-61	J:69227	11309275
88611	Aberrant expression of cyclin D1 in pulmonary proliferative lesions induced by high doses of urethane in transgenic mice carrying the human prototype c-H-ras gene.		Mori I; Yasuhara K; Hayashi SM; Nonoyama T; Nomura T; Yanai T; Masegi T; Mitsumori K		J Vet Med Sci	63	2001	261-8	J:69228	11307925
88612	Brain tumor animal models: importance and progress.		Holland EC		Curr Opin Oncol	13	2001	143-7	J:69229	11307055
88613	A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia.		Cifaldi L; Quaglino E; Di Carlo E; Musiani P; Spadaro M; Lollini PL; Wolf S; Boggio K; Forni G; Cavallo F		Cancer Res	61	2001	2809-12	J:69230	11306448
88614	Effects of type and amount of dietary fat on mouse skin tumor promotion.		Lo HH; Locniskar MF; Bechtel D; Fischer SM		Nutr Cancer	22	1994	43-56	J:69231	11304909
88615	Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone.		Roy HK; Karolski WJ; Ratashak A		Int J Cancer	92	2001	609-15	J:69232	11304699
88616	Effects of 50 Hz magnetic fields on cancer induced by ionizing radiation in mice.		Heikkinen P; Kosma VM; Huuskonen H; Komulainen H; Kumlin T; Penttila I; Vaananen A; Juutilainen J		Int J Radiat Biol	77	2001	483-95	J:69233	11304440
88617	Characteristic association between K-ras gene mutation with loss of heterozygosity in X-ray-induced thymic lymphomas of the B6C3F1 mouse.		Shimada Y; Nishimura M; Kakinuma S; Takeuchi T; Ogiu T; Suzuki G; Nakata Y; Sasanuma S; Mita K; Sado T		Int J Radiat Biol	77	2001	465-73	J:69234	11304438
88618	Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice.		Di Carlo E; Rovero S; Boggio K; Quaglino E; Amici A; Smorlesi A; Forni G; Musiani P		Clin Cancer Res	7	2001	830s-837s	J:69235	11300480
88619	Current and future technologies for breast cancer imaging.		Basilion JP		Breast Cancer Res	3	2001	14-6	J:69236	11300100
88620	Effects of selenium supplementation on malignant lymphoproliferative pathologies associated with OF1 mouse ageing.		Wong HK; Riondel J; Ducros V; Ballester B; Mathieu J; Favier A		Anticancer Res	21	2001	393-402	J:69237	11299768
88621	Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer.		Berger F; Gambhir SS		Breast Cancer Res	3	2001	28-35	J:69238	11250742
88622	Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation.		Elenbaas B; Weinberg RA		Exp Cell Res	264	2001	169-84	J:69239	11237532
88623	The von Hippel-Lindau tumor suppressor gene.		Kondo K; Kaelin WG		Exp Cell Res	264	2001	117-25	J:69240	11237528
88624	B cell immunodeficiency fails to develop in cd4-deficient mice infected with bm5: murine aids as a multistep disease.		Harris DP; Koch S; Mullen LM; Swain SL		J Immunol	166	2001	6041-9	J:69348	11342621
88625	Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.		Imanishi Y; Hosokawa Y; Yoshimoto K; Schipani E; Mallya S; Papanikolaou A; Kifor O; Tokura T; Sablosky M; Ledgard F; Gronowicz G; Wang TC; Schmidt EV; Hall C; Brown EM; Bronson R; Arnold A		J Clin Invest	107	2001	1093-102	J:69423	11342573
88626	T cell-specific loss of pten leads to defects in central and peripheral tolerance.		Suzuki A; Yamaguchi MT; Ohteki T; Sasaki T; Kaisho T; Kimura Y; Yoshida R; Wakeham A; Higuchi T; Fukumoto M; Tsubata T; Ohashi PS; Koyasu S; Penninger JM; Nakano T; Mak TW		Immunity	14	2001	523-34	J:69471	11371355
88627	Absence of apparent phenotype in mice lacking cdc25c protein phosphatase.		Chen MS; Hurov J; White LS; Woodford-Thomas T; Piwnica-Worms H		Mol Cell Biol	21	2001	3853-61	J:69601	11359894
88628	Mammary gland involution is delayed by activated Akt in transgenic mice.		Schwertfeger KL; Richert MM; Anderson SM		Mol Endocrinol	15	2001	867-81	J:69612	11376107
88629	Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.		Strasser A; Harris AW; Bath ML; Cory S		Nature	348	1990	331-3	J:69571	2250704
88630	Diagnosing cancer in vivo.		Koenig F; Knittel J; Stepp H		Science	292	2001	1401-3	J:69650	11360991
88631	Inhibin and p27 interact to regulate gonadal tumorigenesis.		Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM		Mol Endocrinol	15	2001	985-96	J:69616	11376116
88632	Point mutations of K-ras and H-ras genes in forestomach neoplasms from control B6C3F1 mice and following exposure to 1,3-butadiene, isoprene or chloroprene for up to 2-years.		Sills RC; Hong HL; Boorman GA; Devereux TR; Melnick RL		Chem Biol Interact	135-136	2001	373-86	J:69717	11397402
88633	Metallothionein expression and apoptosis in pregnancy-dependent and -independent mouse mammary tumors.		Yamamura Y; Ohta Y; Iguchi T; Matsuzawa A		Anticancer Res	21	2001	1145-9	J:69718	11396154
88634	Oral shark cartilage does not abolish carcinogenesis but delays tumor progression in a murine model.		Barber R; Delahunt B; Grebe SK; Davis PF; Thornton A; Slim GC		Anticancer Res	21	2001	1065-9	J:69719	11396141
88635	Transplacental carcinogenic potential of the carbamate fungicide mancozeb.		Shukla Y; Arora A		J Environ Pathol Toxicol Oncol	20	2001	127-31	J:69721	11394711
88636	Preliminary results of interferon-alpha therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic mice.		Merle P; Chevallier M; Levy R; Maisonnas M; Terradillos O; Ahmed SNS; Trepo C; Buendia MA; Vitvitski-Trepo L		J Hepatol	34	2001	562-9	J:69722	11394656
88637	On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice.		Caballero F; Gerez E; Oliveri L; Falcoff N; Batlle A; Vazquez E		Int J Biochem Cell Biol	33	2001	681-90	J:69723	11390276
88638	Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung.		Malkinson AM		Lung Cancer	32	2001	265-79	J:69724	11390008
88639	Tailoring cancer vaccines to the elderly: the importance of suitable mouse models.		Gravekamp C		Mech Ageing Dev	122	2001	1087-105	J:69725	11389926
88640	Oxidative stress in the absence of inflammation in a mouse model for hepatitis c virus-associated hepatocarcinogenesis.		Moriya K; Nakagawa K; Santa T; Shintani Y; Fujie H; Miyoshi H; Tsutsumi T; Miyazawa T; Ishibashi K; Horie T; Imai K; Todoroki T; Kimura S; Koike K		Cancer Res	61	2001	4365-70	J:69727	11389061
88641	Uterine adenocarcinoma in mice treated neonatally with genistein.		Newbold RR; Banks EP; Bullock B; Jefferson WN		Cancer Res	61	2001	4325-8	J:69728	11389053
88642	Two inbred strains of mice with high and low mammary tumor potentials established from the same basal stock of Swiss albino (SHN and SLN): history of mammary tumorigenesis and reproduction after the 30th generation of full-sib mating.		Nagasawa H; Kusakawa S		Exp Anim	50	2001	167-71	J:69729	11381621
88643	Activation of the met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice.		Wang R; Ferrell LD; Faouzi S; Maher JJ; Bishop JM		J Cell Biol	153	2001	1023-34	J:69731	11381087
88644	The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.		Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A		Oncogene	20	2001	2325-32	J:69711	11402328
88645	In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy.		Ahmad N; Kalka K; Mukhtar H		Oncogene	20	2001	2314-7	J:69712	11402326
88646	Reducing mammary cancer risk through premature stem cell senescence.		Boulanger CA; Smith GH		Oncogene	20	2001	2264-72	J:69713	11402321
88647	Involvement of Transcription Factor HNF3gamma in the Effect of o-Aminoazotoluene on Glucocorticoid Induction of Tyrosine Aminotransferase in Mice Sensitive to its Hepatocarcinogenic Action.		Kropachev KY; Kaledin VI; Kobzev VF; Plisov SY; Levashova ZB; Merkulova TI		Mol Carcinog	31	2001	10-5	J:69714	11398193
88648	Topical and oral administration of the natural water-soluble antioxidant from spinach reduces the multiplicity of papillomas in the Tg.AC mouse model. (Erratum Toxicol Lett 2001 Sep 15; 123(2-3):237)		Nyska A; Lomnitski L; Spalding J; Dunson DB; Goldsworthy TL; Grossman S; Bergman M; Boorman G		Toxicol Lett	122	2001	33-44	J:69715	11397555
88649	Combined histiologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice.		Morse HC; Qi C; Chattopadhyay SK; Hori M; Taddesse-Heath L; Ozato K; Hartley JW; Taylor BA; Ward JM; Jenkins NA; Copeland NG; Fredrickson TN		Leuk Res	25	2001	719-33	J:69716	11397479
88650	Cancer. Improved mouse models.		Berns A		Nature	410	2001	1043-4	J:69748	11323655
88651	Role of the LTR region between the enhancer and promoter in mink cell focus-forming murine leukemia virus pathogenesis.		Yoshimura FK; Wang T		Virology	283	2001	121-31	J:69749	11312668
88652	The dual function steroid receptor coactivator/ubiquitin protein-ligase integrator E6-AP is overexpressed in mouse mammary tumorigenesis.		Sivaraman L; Nawaz Z; Medina D; Conneely OM; O'Malley BW		Breast Cancer Res Treat	62	2000	185-95	J:69751	11072783
88653	Avoiding tolerance against prostatic antigens with subdominant peptide epitopes.		Grossmann ME; Davila T; Celis T		J Immunother	24	2001	237-41	J:69753	11394501
88654	Squamous cell tumors in mice heterozygous for a null allele of Atp2a2, encoding the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 Ca2+ pump.		Liu LH; Boivin GP; Prasad V; Periasamy M; Shull GE		J Biol Chem	276	2001	26737-40	J:69754	11389134
88655	MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes.		Zhou P; Levy NB; Xie H; Qian L; Lee CY; Gascoyne RD; Craig RW		Blood	97	2001	3902-9	J:69755	11389033
88656	Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism.		Hawighorst T; Velasco P; Streit M; Hong YK; Kyriakides TR; Brown LF; Bornstein P; Detmar M		EMBO J	20	2001	2631-40	J:69756	11387198
88657	Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.		Gonzalez-Suarez E; Samper E; Ramirez A; Flores JM; Martin-Caballero J; Jorcano JL; Blasco MA		EMBO J	20	2001	2619-30	J:69757	11387197
88658	Tumorigenicity of racemic and optically pure bay region diol epoxides and other derivatives of the nitrogen heterocycle dibenz[a,h]acridine on mouse skin.		Kumar S; Chang RL; Wood AW; Xie JG; Huang MT; Cui XX; Kole PL; Sikka HC; Balani SK; Conney AH; Jerina DM		Carcinogenesis	22	2001	951-5	J:69758	11375904
88659	Hepatoblast-like cells populate the adult p53 knockout mouse liver: evidence for a hyperproliferative maturation-arrested stem cell compartment.		Dumble ML; Knight B; Quail EA; Yeoh GC		Cell Growth Differ	12	2001	223-31	J:69799	11373269
88660	Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.		Rego EM; He LZ; Warrell RP Jr; Wang ZG; Pandolfi PP		Proc Natl Acad Sci U S A	97	2000	10173-8	J:69841	10954752
88661	Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation.		Roy HK; Karoski WJ; Ratashak A; Smyrk TC		Br J Cancer	84	2001	1412-6	J:69899	11355956
88662	Mammary tumors in strains BL-LyDe and SWR-LyDe mice.		Deringer MK		J Natl Cancer Inst	45	1970	215-8	J:69927	4324608
88663	Lack of p53 accelerates hepatocarcinogenesis in transgenic mice constitutively overexpressing c-myc in the liver.		Klocke R; Bartels T; Jennings G; Brand K; Halter R; Strauss M; Paul D		FASEB J	15	2001	1404-6	J:69907	11387238
88664	Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1.		Liao C; Wang XY; Wei HQ; Li SQ; Merghoub T; Pandolfi PP; Wolgemuth DJ		Proc Natl Acad Sci U S A	98	2001	6853-8	J:69909	11381140
88665	Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin.		Neufang G; Furstenberger G; Heidt M; Marks F; Muller-Decker K		Proc Natl Acad Sci U S A	98	2001	7629-34	J:70039	11381142
88666	Influence of beta1 Integrins on Epidermal Squamous Cell Carcinoma Formation in a Transgenic Mouse Model: alpha3beta1, but not alpha2beta1, Suppresses Malignant Conversion.		Owens DM; Watt FM		Cancer Res	61	2001	5248-54	J:70167	11431366
88667	Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?		Yang S; Lin HZ; Hwang J; Chacko VP; Diehl AM		Cancer Res	61	2001	5016-23	J:70169	11431335
88668	Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat.		Lu YP; Lou YR; Lin Y; Shih WJ; Huang MT; Yang CS; Conney AH		Cancer Res	61	2001	5002-9	J:70171	11431333
88669	Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland.		McPherson SJ; Wang H; Jones ME; Pedersen J; Iismaa TP; Wreford N; Simpson ER; Risbridger GP		Endocrinology	142	2001	2458-67	J:70204	11356695
88670	Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway.		Baldassarre G; Fedele M; Battista S; Vecchione A; Klein-Szanto AJ; Santoro M; Waldmann TA; Azimi N; Croce CM; Fusco A		Proc Natl Acad Sci U S A	98	2001	7970-5	J:70261	11427729
88671	Quantitative analysis of mouse mammary tumor virus in milk in two sublines of RIII/AnOk mice with low and high mammary tumor incidence.		Takahashi M; Saga S; Nagayoshi S; Imai M; Tsutsui Y; Hoshino M		Gann	74	1983	69-76	J:70235	6301918
88672	Variations in Prkdc encoding the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) and susceptibility to radiation-induced apoptosis and lymphomagenesis.		Mori N; Matsumoto Y; Okumoto M; Suzuki N; Yamate J		Oncogene	20	2001	3609-19	J:70283	11439324
88673	Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice.		Conde C; Mark M; Oliver FJ; Huber A; de Murcia G; Menissier-de Murcia J		EMBO J	20	2001	3535-43	J:70350	11432840
88674	Effect of a complex environmental mixture from coal tar containing polycyclic aromatic hydrocarbons (PAH) on the tumor initiation, PAH-DNA binding and metabolic activation of carcinogenic PAH in mouse epidermis.		Marston CP; Pereira C; Ferguson J; Fischer K; Hedstrom O; Dashwood WM; Baird WM		Carcinogenesis	22	2001	1077-86	J:70352	11408352
88675	Gonadal tumors of mice double transgenic for inhibin-alpha promoter-driven simian virus 40 T-antigen and herpes simplex virus thymidine kinase are sensitive to ganciclovir treatment.		Mikola MK; Rahman NA; Paukku TH; Ahtiainen PM; Vaskivuo TE; Tapanainen JS; Poutanen M; Huhtaniemi IT		J Endocrinol	170	2001	79-90	J:70360	11431140
88676	Novel cell lines promote the discovery of genes involved in early heart development.		Brunskill EW; Witte DP; Yutzey KE; Potter SS		Dev Biol	235	2001	507-20	J:70363	11437454
88677	The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.		O'Neil J; Billa M; Oikemus S; Kelliher M		Oncogene	20	2001	3897-905	J:70381	11439353
88678	Bacterial infection promotes colon tumorigenesis in apcmin/+ mice.		Newman JV; Kosaka T; Sheppard BJ; Fox JG; Schauer DB		J Infect Dis	184	2001	227-30	J:70382	11424022
88679	Apoptosis Triggered by Myc-Induced Suppression of Bcl-X(L) or Bcl-2 Is Bypassed during Lymphomagenesis.		Eischen CM; Woo D; Roussel MF; Cleveland JL		Mol Cell Biol	21	2001	5063-70	J:70387	11438662
88680	Attempt to detect a mammary tumor-agent in strain C mice by estrogenic stimulation		Andervont HB		J Natl Cancer Inst	11	1950	73-81	J:70438	14784843
88681	Mzf1 controls cell proliferation and tumorigenesis.		Gaboli M; Kotsi PA; Gurrieri C; Cattoretti G; Ronchetti S; Cordon-Cardo C; Broxmeyer HE; Hromas R; Pandolfi PP		Genes Dev	15	2001	1625-30	J:70407	11445537
88682	Heredity of cancer, susceptibility in mice		Dobrovolskaia-Zavadskaia N		J Genet	27	1933	181-198	J:70525	 
88683	Fine chromosomal localization of the mouse Par2 gene that confers resistance against urethane-induction of pulmonary adenomas.		Lee GH; Matsushita H; Kitagawa T		Oncogene	20	2001	3979-85	J:70565	11494126
88684	T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity.		Drynan LF; Hamilton TL; Rabbitts TH		Oncogene	20	2001	4412-5	J:70546	11466623
88685	Expression profiling and identification of novel genes in hepatocellular carcinomas.		Graveel CR; Jatkoe T; Madore SJ; Holt AL; Farnham PJ		Oncogene	20	2001	2704-12	J:70641	11420682
88686	Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo.		Andreassen A; Vikse R; Steffensen IL; Paulsen JE; Alexander J		Mutagenesis	16	2001	309-15	J:70642	11420398
88687	Dysfunction of stat4 leads to accelerated incidence of chemical-induced thymic lymphomas in mice.		Zhang SS; Welte T; Fu XY		Exp Mol Pathol	70	2001	231-8	J:70643	11418001
88688	Cooperating Oncogenic Events in Murine Mammary Tumorigenesis: Assessment of ErbB2, Mutant p53, and Mouse Mammary Tumor Virus.		Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS		Exp Mol Pathol	70	2001	183-93	J:70644	11417997
88689	Tumor suppressor loss in pituitary tumors.		Alexander JM		Brain Pathol	11	2001	342-55	J:70645	11414476
88690	Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum.		Itoigawa M; Ito C; Tan HT; Kuchide M; Tokuda H; Nishino H; Furukawa H		Cancer Lett	169	2001	15-9	J:70646	11410320
88691	Chronic toxicity/oncogenicity study of styrene in cd-1 mice by inhalation exposure for 104 weeks.		Cruzan G; Cushman JR; Andrews LS; Granville GC; Johnson KA; Bevan C; Hardy CJ; Coombs DW; Mullins PA; Brown WR		J Appl Toxicol	21	2001	185-98	J:70647	11404830
88692	Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA-DNA adducts in mammary glands, and mammary tumorigenesis in Sencar mice.		Lin C; Lu Y; Lou Y; Ho C; Newmark HH; MacDonald C; Singletary KW; Huang M		Cancer Lett	168	2001	125-32	J:70648	11403916
88693	Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse.		Chang S; Khoo C; DePinho RA		Semin Cancer Biol	11	2001	227-39	J:70649	11407947
88694	The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.		Bardeesy N; Sharpless NE; DePinho RA; Merlino G		Semin Cancer Biol	11	2001	201-18	J:70650	11407945
88695	Enforced expression of gata-3 during t cell development inhibits maturation of cd8 single-positive cells and induces thymic lymphoma in transgenic mice.		Nawijn MC; Ferreira R; Dingjan GM; Kahre O; Drabek D; Karis A; Grosveld F; Hendriks RW		J Immunol	167	2001	715-23	J:70627	11441075
88696	Phenobarbitone - induced liver response in wild type and in p53 deficient mice.		Gould S; Sidaway J; Sansom N; Betton G; Orton T		Toxicol Lett	122	2001	131-40	J:70628	11439219
88697	Mutant and genetically modified mice as models for studying the relationship between aging and carcinogenesis.		Anisimov VN		Mech Ageing Dev	122	2001	1221-55	J:70629	11438116
88698	Reduced Blood Vessel Formation and Tumor Growth in alpha5-Integrin-negative Teratocarcinomas and Embryoid Bodies.		Taverna D; Hynes RO		Cancer Res	61	2001	5255-61	J:70630	11431367
88699	Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg-rasH2 mice.		Torii M; Itoh F; Yabuuchi K; Ohno K; Kominami G; Hirano K; Tasaki T; Nara H		J Toxicol Sci	26	2001	61-73	J:70632	11429969
88700	Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.		Wang D; Russell J; Xu H; Johnson DG		Mol Carcinog	31	2001	90-100	J:70633	11429786
88701	Ataxia telangiectasia gene mutations in leukaemia and lymphoma.		Boultwood J		J Clin Pathol	54	2001	512-6	J:70634	11429421
88702	NF1 mice: smaller brains but no tumours.		Hafezparast M		Trends Mol Med	7	2001	285	J:70635	11425624
88703	Anti-tumor Promoting Diterpenes from the Stem Bark of Thuja standishii (Cupressaceae).		Iwamoto M; Ohtsu H; Tokuda H; Nishino H; Matsunaga S; Tanaka R		Bioorg Med Chem	9	2001	1911-21	J:70636	11425594
88704	Protein kinase CK2 in mammary gland tumorigenesis.		Landesman-Bollag E; Romieu-Mourez R; Song DH; Sonenshein GE; Cardiff RD; Seldin DC		Oncogene	20	2001	3247-57	J:70637	11423974
88705	Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53-/- mice.		Powell Jr DJ; Russell JP; Li G; Kuo BA; Fidanza V; Huebner K; Rothstein JL		Oncogene	20	2001	3235-46	J:70638	11423973
88706	Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice.		Jatoi A; Cleary MP; Tee CM; Nguyen PL		Ann Nutr Metab	45	2001	116-20	J:70639	11423703
88707	Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice.		Sharfaei S; Viau G; Lui H; Bouffard D; Bissonnette R		Br J Dermatol	144	2001	1207-14	J:70640	11422043
88708	Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia.		Liu X; Alexander V; Vijayachandra K; Bhogte E; Diamond I; Glick A		Proc Natl Acad Sci U S A	98	2001	9139-44	J:70670	11481479
88709	A transgenic mouse model for lung adenocarcinoma.		Sandmoller A; Halter R; Suske G; Paul D; Beato M		Cell Growth Differ	6	1995	97-103	J:70787	7718490
88710	The developmental biology of brain tumors.		Wechsler-Reya R; Scott MP		Annu Rev Neurosci	24	2001	385-428	J:70889	11283316
88711	Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model.		Zhao Y; Xue Y; Oberley TD; Kiningham KK; Lin SM; Yen HC; Majima H; Hines J; St Clair D		Cancer Res	61	2001	6082-8	J:70895	11507057
88712	Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols.		Gupta S; Hastak K; Ahmad N; Lewin JS; Mukhtar H		Proc Natl Acad Sci U S A	98	2001	10350-5	J:70896	11504910
88713	Selective Inactivation of p53 Facilitates Mouse Epithelial Tumor Progression without Chromosomal Instability.		Lu X; Magrane G; Yin C; Louis DN; Gray J; Van Dyke T		Mol Cell Biol	21	2001	6017-30	J:70857	11486039
88714	Notch signaling in mammary gland tumorigenesis.		Callahan R; Raafat A		J Mammary Gland Biol Neoplasia	6	2001	23-36	J:70929	11467450
88715	Role of Ets transcription factors in mammary gland development and oncogenesis.		Shepherd T; Hassell JA		J Mammary Gland Biol Neoplasia	6	2001	129-40	J:70930	11467448
88716	Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse.		El-Abbadi M; Seyfried TN; Yates AJ; Orosz C; Lee MC		Br J Cancer	85	2001	285-92	J:70932	11461091
88717	Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice.		Danilovich N; Roy I; Sairam MR		Endocrinology	142	2001	3673-84	J:70933	11459817
88718	Gender-related differences in susceptibility, early virus dissemination and immunosuppression in mice infected with Friend murine leukaemia virus variant FIS-2.		Bruland T; Dai HY; Lavik LA; Kristiansen LI; Dalen A		J Gen Virol	82	2001	1821-7	J:70934	11457987
88719	trans-3,4-Dihydroxy-anti-1,2-epoxy-1,2,3,4-tetrahydrodi- benz.		Xue W; Schneider J; Mitchell K; Jaeger M; Nanayakkara V; Talaska G; Warshawsky D		Chem Res Toxicol	14	2001	871-8	J:70935	11453734
88720	Effect of isologous pineal transplants on tumorigenesis of autologous intrasplenic ovarian transplants in Swiss mice.		Chapekar T		Neuroendocrinol Lett	20	1999	305-309	J:70899	11460089
88721	Enhanced Formation of Azoxymethane-induced Colorectal Adenocarcinoma in gammadelta T Lymphocyte-deficient Mice.		Matsuda S; Kudoh S; Katayama S		Jpn J Cancer Res	92	2001	880-5	J:70900	11509121
88722	Induction of transplantable mouse renal cell cancers by streptozotocin: in vivo growth, metastases, and angiogenic phenotype.		Gruys ME; Back TC; Subleski J; Wiltrout TA; Lee JK; Schmidt L; Watanabe M; Stanyon R; Ward JM; Wigginton JM; Wiltrout RH		Cancer Res	61	2001	6255-63	J:70901	11507080
88723	Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis.		Feith DJ; Shantz LM; Pegg AE		Cancer Res	61	2001	6073-81	J:70903	11507056
88724	Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1.		Fujiki H; Suganuma M; Okabe S; Sueoka E; Sueoka N; Fujimoto N; Goto Y; Matsuyama S; Imai K; Nakachi K		Mutat Res	480-481	2001	299-304	J:70904	11506822
88725	Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer.		Trosko JE; Chang C		Mutat Res	480-481	2001	219-29	J:70905	11506816
88726	Independent contributions of gr-1+ leukocytes and fas/fasl interactions to induce apoptosis following interleukin-12 gene therapy in a metastatic model of prostate cancer.		Sanford MA; Yan Y; Canfield SE; Hassan W; Selleck WA; Atkinson G; Chen SH; Hall SJ		Hum Gene Ther	12	2001	1485-98	J:70906	11506692
88727	The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor.		Ambartsumian N; Klingelhofer J; Grigorian M; Christensen C; Kriajevska M; Tulchinsky E; Georgiev G; Berezin V; Bock E; Rygaard J; Cao R; Cao Y; Lukanidin E		Oncogene	20	2001	4685-95	J:70907	11498791
88728	Indomethacin reduces lung adenoma number in A/J mice.		Moody TW; Leyton J; Zakowicz H; Hida T; Kang Y; Jakowlew S; You L; Ozbun L; Zia H; Youngberg J; Malkinson A		Anticancer Res	21	2001	1749-55	J:70908	11497255
88729	Role of iron in lymphoma-induction by ATP.		Anghileri LJ; Plenat F; Thouvenot P		Oncol Rep	8	2001	1153-7	J:70909	11496334
88730	The tumor-preventing effect of a mixture of several lactic acid bacteria on 1,2-dimethylhydrazine-induced colon carcinogenesis in mice.		Fukui M; Fujino T; Tsutsui K; Maruyama T; Yoshimura H; Shinohara T; Fukui M; Nada O		Oncol Rep	8	2001	1073-8	J:70910	11496319
88731	Liposome encapsulated tumor-associated antigens elicited humoral and cellular immune responses in mice bearing tumor.		Alam A; Imliwati L; Rapthap C; Singh V		Indian J Exp Biol	39	2001	201-8	J:70911	11495277
88732	The contribution of NF-kappaB activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors.		Portis T; Harding JC; Ratner L		Blood	98	2001	1200-8	J:70912	11493471
88733			Cardiff RD		J Mammary Gland Biol Neoplasia	5	2000	421-37	J:70981	14973386
88734	The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.		Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA		Endocrinology	142	2001	3764-73	J:71046	11517152
88735	Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.		Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH		Cancer Res	61	2001	6577-82	J:71052	11522657
88736	p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice.		Suliman Y; Opitz OG; Avadhani A; Burns TC; El-Deiry W; Wong DT; Rustgi AK		Cancer Res	61	2001	6467-73	J:71053	11522642
88737	Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.		Sharma S; Stolina M; Zhu L; Lin Y; Batra R; Huang M; Strieter R; Dubinett SM		Cancer Res	61	2001	6406-12	J:71054	11522634
88738	scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.		Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD		Cancer Res	61	2001	6382-7	J:71055	11522630
88739	Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis.		Kanzler S; Meyer E; Lohse AW; Schirmacher P; Henninger J; Galle PR; Blessing M		Oncogene	20	2001	5015-24	J:71110	11526486
88740	Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus.		Gan DD; Reiss K; Carrill T; Del Valle L; Croul S; Giordano A; Fishman P; Khalili K		Oncogene	20	2001	4864-70	J:71111	11521197
88741	Genetic control of neuroadapted sindbis virus replication in female mice maps to chromosome 2 and associates with paralysis and mortality.		Thach DC; Kleeberger SR; Tucker PC; Griffin DE		J Virol	75	2001	8674-80	J:71216	11507212
88742			Devon RS		Clin Genet	60	2001	99-103	J:71298	 
88743	The tumor spectrum in FHIT-deficient mice.		Zanesi N; Fidanza V; Fong LY; Mancini R; Druck T; Valtieri M; Rudiger T; McCue PA; Croce CM; Huebner K		Proc Natl Acad Sci U S A	98	2001	10250-5	J:71303	11517343
88744	Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors.		Wilkinson RW; Ross EL; Poulsom R; Ilyas M; Straub J; Snary D; Bodmer WF; Mather SJ		Proc Natl Acad Sci U S A	98	2001	10256-60	J:71304	11517330
88745	An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.		Podsypanina K; Lee RT; Politis C; Hennessy I; Crane A; Puc J; Neshat M; Wang H; Yang L; Gibbons J; Frost P; Dreisbach V; Blenis J; Gaciong Z; Fisher P; Sawyers C; Hedrick-Ellenson L; Parsons R		Proc Natl Acad Sci U S A	98	2001	10320-5	J:71306	11504907
88746	Myc lacks E2F1's ability to suppress skin carcinogenesis.		Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG		Oncogene	20	2001	5341-9	J:71356	11536046
88747	Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.		Reese JS; Allay E; Gerson SL		Oncogene	20	2001	5258-63	J:71357	11536039
88748	Genetic loci controlling susceptibility to gamma-ray-induced thymic lymphoma.		Saito Y; Ochiai Y; Kodama Y; Tamura Y; Togashi T; Kosugi-Okano H; Miyazawa T; Wakabayashi Y; Hatakeyama K; Wakana S; Niwa O; Kominami R		Oncogene	20	2001	5243-7	J:71358	11526516
88749	beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.		Michaelson JS; Leder P		Oncogene	20	2001	5093-9	J:71361	11526497
88750	Reduced sensitivity to and ras mutation spectrum of N-ethyl-N-nitrosourea-induced thymic lymphomas in adult C.B-17 scid mice.		Nishimura M; Kakinuma S; Wakana S; Mukaigawara A; Mita K; Sado T; Ogiu T; Shimada Y		Mutat Res	486	2001	275-83	J:71401	11516930
88751	Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily.		Steele-Perkins G; Fang W; Yang XH; Van Gele M; Carling T; Gu J; Buyse IM; Fletcher JA; Liu J; Bronson R; Chadwick RB; de la Chapelle A; Zhang X; Speleman F; Huang S		Genes Dev	15	2001	2250-62	J:71406	11544182
88752	Glioma classification: a molecular reappraisal.		Louis DN; Holland EC; Cairncross JG		Am J Pathol	159	2001	779-86	J:71484	11549567
88753	Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage.		Kallay E; Pietschmann P; Toyokuni S; Bajna E; Hahn P; Mazzucco K; Bieglmayer C; Kato S; Cross HS		Carcinogenesis	22	2001	1429-35	J:71459	11532865
88754	Chromatin modifiers and tumor suppression.		Klochendler-Yeivin A; Yaniv M		Biochim Biophys Acta	1551	2001	M1-10	J:71499	11553416
88755	Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.		Liang TJ; Reid AE; Xavier R; Cardiff RD; Wang TC		J Clin Invest	97	1996	2872-7	J:71573	8675700
88756	Rhob is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells.		Liu AX; Rane N; Liu JP; Prendergast GC		Mol Cell Biol	21	2001	6906-12	J:71577	11564874
88757	Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcDelta716 knockout mice.		Sonoshita M; Takaku K; Sasaki N; Sugimoto Y; Ushikubi F; Narumiya S; Oshima M; Taketo MM		Nat Med	7	2001	1048-51	J:71543	11533709
88758	A new verdict for an old convict.		Pfeifer GP		Nat Genet	29	2001	3-4	J:71545	11528376
88759	Wildtype Kras2 can inhibit lung carcinogenesis in mice.		Zhang Z; Wang Y; Vikis HG; Johnson L; Liu G; Li J; Anderson MW; Sills RC; Hong HL; Devereux TR; Jacks T; Guan KL; You M		Nat Genet	29	2001	25-33	J:71546	11528387
88760	Heterozygous mice for the transforming growth factor-beta type ii receptor gene have increased susceptibility to hepatocellular carcinogenesis.		Im YH; Kim HT; Kim IY; Factor VM; Hahm KB; Anzano M; Jang JJ; Flanders K; Haines DC; Thorgeirsson SS; Sizeland A; Kim SJ		Cancer Res	61	2001	6665-8	J:71591	11559531
88761	Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).		Mentor-Marcel R; Lamartiniere CA; Eltoum IE; Greenberg NM; Elgavish A		Cancer Res	61	2001	6777-82	J:71655	11559550
88762	Selection for Loss of p53 Function in T-Cell Lymphomagenesis Is Alleviated by Moloney Murine Leukemia Virus Infection in myc Transgenic Mice.		Baxter EW; Blyth K; Cameron ER; Neil JC		J Virol	75	2001	9790-8	J:71657	11559812
88763	Epstein-barr virus encoded latent membrane protein-1 induces epithelial cell proliferation and sensitizes transgenic mice to chemical carcinogenesis.		Curran JA; Laverty FS; Campbell D; Macdiarmid J; Wilson JB		Cancer Res	61	2001	6730-8	J:71692	11559544
88764	Activated neu induces rapid tumor progression.		Guy CT; Cardiff RD; Muller WJ		J Biol Chem	271	1996	7673-8	J:71697	8631805
88765	Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis.		Humphreys RC; Hennighausen L		Cell Growth Differ	10	1999	685-94	J:71698	10547072
88766	Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin.		Milas L; Nishiguchi I; Hunter N; Murray D; Fleck R; Ito H; Travis E		Adv Space Res	12	1992	265-71	J:71726	11537017
88767	Protection by WR-2721 and WR-151327 against late effects of gamma rays and neutrons.		Grdina DJ; Garnes BA; Nagy B		Adv Space Res	12	1992	257-63	J:71727	11537016
88768	Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.		Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW		Mol Carcinog	31	2001	204-13	J:71728	11536370
88769	Retroviral integration at the epi1 locus cooperates with nf1 gene loss in the progression to acute myeloid leukemia.		Blaydes SM; Kogan SC; Truong BT; Gilbert DJ; Jenkins NA; Copeland NG; Largaespada DA; Brannan CI		J Virol	75	2001	9427-34	J:71729	11533205
88770	Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors.		Devanesan P; Santen RJ; Bocchinfuso WP; Korach KS; Rogan EG; Cavalieri E		Carcinogenesis	22	2001	1573-6	J:71730	11532882
88771	Effect of chloroform on dichloroacetic acid and trichloroacetic acid-induced hypomethylation and expression of the c-myc gene and on their promotion of liver and kidney tumors in mice.		Pereira MA; Kramer PM; Conran PB; Tao L		Carcinogenesis	22	2001	1511-9	J:71731	11532874
88772	Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice.		Martin KR; Trempus C; Saulnier M; Kari FW; Barrett JC; French JE		Carcinogenesis	22	2001	1373-8	J:71732	11532857
88773	Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis.		Badary OA; Gamal El-Din AM		Cancer Detect Prev	25	2001	362-8	J:71733	11531013
88774	AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.		Yuan Y; Zhou L; Miyamoto T; Iwasaki H; Harakawa N; Hetherington CJ; Burel SA; Lagasse E; Weissman IL; Akashi K; Zhang DE		Proc Natl Acad Sci U S A	98	2001	10398-403	J:71734	11526243
88775	Allelic loss on chromosome 4 (Lyr2/TLSR5) is associated with myeloid, B-lympho-myeloid, and lymphoid (B and T) mouse radiation-induced leukemias.		Cleary H; Boulton E; Plumb M		Blood	98	2001	1549-54	J:71735	11520806
88776	Pictures in Molecular Medicine: Three-dimensional visualization of intravascular tumor cells in mice.		Borsig L; Wong R; Feramisco J; Nadeau DR; Varki NM; Varki A		Trends Mol Med	7	2001	377	J:71736	11517000
88777	Malignant transformation of the esophageal mucosa is enhanced in p27 knockout mice.		Ellis FH Jr; Xu X; Kulke MH; Locicero J 3rd; Loda M		J Thorac Cardiovasc Surg	122	2001	809-14	J:71702	11581618
88778	Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis.		Rossman TG; Uddin AN; Burns FJ; Bosland MC		Toxicol Appl Pharmacol	176	2001	64-71	J:71703	11578149
88779	Assessment of murine lung tumour development: a comparison of two techniques.		John LC		Br J Biomed Sci	58	2001	159-63	J:71704	11575738
88780	Inducible and Reversible beta-Cell Autoimmunity and Hyperplasia in Transgenic Mice Expressing a Conditional Oncogene.		Berkovich I; Efrat S		Diabetes	50	2001	2260-7	J:71705	11574407
88781	Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors.		Donsante A; Vogler C; Muzyczka N; Crawford JM; Barker J; Flotte T; Campbell-Thompson M; Daly T; Sands MS		Gene Ther	8	2001	1343-6	J:71706	11571571
88782	Cancer chemopreventive agents, serratane-type triterpenoids from Picea jezoensis.		Tanaka R; Minami T; Tsujimoto K; Matsunaga S; Tokuda H; Nishino H; Terada Y; Yoshitake A		Cancer Lett	172	2001	119-26	J:71707	11566485
88783	Cancer chemopreventive activity of carotenoids in the fruits of red paprika Capsicum annuum L.		Maoka T; Mochida K; Kozuka M; Ito Y; Fujiwara Y; Hashimoto K; Enjo F; Ogata M; Nobukuni Y; Tokuda H; Nishino H		Cancer Lett	172	2001	103-9	J:71708	11566483
88784	Neonatal sunburn and melanoma in mice.		Noonan FP; Recio JA; Takayama H; Duray P; Anver MR; Rush WL; De Fabo EC; Merlino G		Nature	413	2001	271-2	J:71709	11565020
88785	Identification of a non-dividing subpopulation of mouse and human epidermal cells exhibiting high levels of persistent ultraviolet photodamage.		Mitchell DL; Volkmer B; Breitbart EW; Byrom M; Lowery MG; Greinert R		J Invest Dermatol	117	2001	590-5	J:71711	11564164
88786	Knockout mouse models and mammary tumorigenesis.		Deng CX; Brodie SG		Semin Cancer Biol	11	2001	387-94	J:71712	11562181
88787	Lack of effect of 94 GHz radio frequency radiation exposure in an animal model of skin carcinogenesis.		Mason PA; Walters TJ; DiGiovanni J; Beason CW; Jauchem JR; Dick EJ Jr; Mahajan K; Dusch SJ; Shields BA; Merritt JH; Murphy MR; Ryan KL		Carcinogenesis	22	2001	1701-8	J:71738	11577012
88788	Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), suppress H-ras mutations and aneuploidy in a murine skin carcinogenesis model.		Hanausek M; Ganesh P; Walaszek Z; Arntzen CJ; Slaga TJ; Gutterman JU		Proc Natl Acad Sci U S A	98	2001	11551-6	J:71739	11572997
88789	Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family		Sorensen AB; Lund AH; Ethelberg S; Copeland NG; Jenkins NA; Pedersen FS		J Virol	74	2000	2161-8	J:60319	10666245
88790	Role of the high mobility group A proteins in human lipomas.		Fedele M; Battista S; Manfioletti G; Croce CM; Giancotti V; Fusco A		Carcinogenesis	22	2001	1583-91	J:72093	11576996
88791	Comparative pathology of mammary tumorigenesis in transgenic mice.		Cardiff RD; Munn RJ		Cancer Lett	90	1995	13-9	J:72081	7720037
88792	Multiple tumor types appear in a transgenic mouse with the ras oncogene.		Cardiff RD; Leder A; Kuo A; Pattengale PK; Leder P		Am J Pathol	142	1993	1199-207	J:72084	8475993
88793	Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.		Muthuswamy SK; Siegel PM; Dankort DL; Webster MA; Muller WJ		Mol Cell Biol	14	1994	735-43	J:72122	7903421
88794	Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milk.		Tomasetto C; Wolf C; Rio MC; Mehtali M; LeMeur M; Gerlinger P; Chambon P; Lathe R		Mol Endocrinol	3	1989	1579-84	J:72123	2481815
88795	Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.		Lundgren K; Montes de Oca Luna R; McNeill YB; Emerick EP; Spencer B; Barfield CR; Lozano G; Rosenberg MP; Finlay CA		Genes Dev	11	1997	714-25	J:72124	9087426
88796	Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice.		Andres AC; van der Valk MA; Schonenberger CA; Fluckiger F; LeMeur M; Gerlinger P; Groner B		Genes Dev	2	1988	1486-95	J:72126	2463212
88797	Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.		Siegel PM; Dankort DL; Hardy WR; Muller WJ		Mol Cell Biol	14	1994	7068-77	J:72127	7935422
88798	Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.		Pierce DF Jr; Johnson MD; Matsui Y; Robinson SD; Gold LI; Purchio AF; Daniel CW; Hogan BL; Moses HL		Genes Dev	7	1993	2308-17	J:72128	8253379
88799	Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants.		Ornitz DM; Cardiff RD; Kuo A; Leder P		J Natl Cancer Inst	84	1992	887-92	J:72131	1317463
88800	Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene.		Mediavilla MD; Guezmez A; Ramos S; Kothari L; Garijo F; Sanchez Barcelo EJ		J Pineal Res	22	1997	86-94	J:72132	9181520
88801	The comparative pathology of human and mouse mammary glands.		Cardiff RD; Wellings SR		J Mammary Gland Biol Neoplasia	4	1999	105-22	J:72133	10219910
88802	Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology.		Chooi KF; Carter DA; Biswas S; Lightman SL; Ho MY; Murphy D		Cancer Res	54	1994	6434-40	J:72135	7987839
88803	p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.		Shibata MA; Maroulakou IG; Jorcyk CL; Gold LG; Ward JM; Green JE		Cancer Res	56	1996	2998-3003	J:72136	8674054
88804	Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer.		Muller WJ; Ho J; Siegel PM		Biochem Soc Symp	63	1998	149-57	J:72137	9513719
88805	Progressive changes in adherens junction structure during intestinal adenoma formation in apc mutant mice.		Carothers AM; Melstrom KA Jr; Mueller JD; Weyant MJ; Bertagnolli MM		J Biol Chem	276	2001	39094-102	J:72186	11483600
88806	Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma.		Kiguchi K; Carbajal S; Chan K; Beltran L; Ruffino L; Shen J; Matsumoto T; Yoshimi N; DiGiovanni J		Cancer Res	61	2001	6971-6	J:72232	11585718
88807	Dynamics of notch expression during murine prostate development and tumorigenesis.		Shou J; Ross S; Koeppen H; de Sauvage FJ; Gao WQ		Cancer Res	61	2001	7291-7	J:72234	11585768
88808	Chemoprevention of Basal Cell Carcinomas in the ptc1(+/-) Mouse - Green and Black Tea.		Hebert JL; Khugyani F; Athar M; Kopelovich L; Epstein EH Jr; Aszterbaum M		Skin Pharmacol Appl Skin Physiol	14	2001	358-62	J:72283	11598435
88809	Cancer chemopreventive activity of phenylpropanoid esters of sucrose, vanicoside B and lapathoside A, from Polygonum lapathifolium.		Takasaki M; Konoshima T; Kuroki S; Tokuda H; Nishino H		Cancer Lett	173	2001	133-8	J:72284	11597787
88810	Inhibitory effect of flavonoid derivatives on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors.		Iwase Y; Takemura Y; Ju-ichi M; Mukainaka T; Ichiishi E; Ito C; Furukawa H; Yano M; Tokuda H; Nishino H		Cancer Lett	173	2001	105-9	J:72285	11597783
88811	Spontaneous adenocarcinoma mouse models for immunotherapy.		Gendler SJ; Mukherjee P		Trends Mol Med	7	2001	471-5	J:72286	11597523
88812	p73 in apoptosis.		Stiewe T; Putzer BM		Apoptosis	6	2001	447-52	J:72287	11595834
88813	Alterations at the Ink4a locus in transplacentally induced murine lung tumors.		Mizesko MC; Grewe C; Grabner A; Miller MS		Cancer Lett	172	2001	59-66	J:72289	11595130
88814	MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.		Zhou H; Chen Wd; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL		Oncogene	20	2001	6009-17	J:72290	11593408
88815	Human papilloma virus 16 E7 oncogene does not cooperate with RET/PTC 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice.		Portella G; Borselli C; Santoro M; Gerbasio D; D'Armiento MR; Dumont JE; Ledent C; Rothstein JL; Vecchio G; Fusco A		Oncol Res	12	2000	347-54	J:72291	11589306
88816	Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis.		Schneider Y; Duranton B; Gosse F; Schleiffer R; Seiler N; Raul F		Nutr Cancer	39	2001	102-7	J:72292	11588890
88817	Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.		Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R		Cancer Res	61	2001	7101-9	J:72293	11585741
88818	BRCA1-associated tumorigenesis: what have we learned from knockout mice?		Brodie SG; Deng C		Trends Genet	17	2001	S18-22	J:72294	11585672
88819	Tumour biology. Weakening link to colorectal cancer?		Barbier M; Attoub S; Calvez R; Laffargue M; Jarry A; Mareel M; Altruda F; Gespach C; Wu D; Lu B; Hirsch E; Wymann MP		Nature	413	2001	796	J:72295	11677595
88820	Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase.		Zhou ZQ; Manguino D; Kewitt K; Intano GW; McMahan CA; Herbert DC; Hanes M; Reddick R; Ikeno Y; Walter CA		Proc Natl Acad Sci U S A	98	2001	12566-71	J:72296	11606727
88821	Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor.		Rodriguez-Manzaneque JC; Lane TF; Ortega MA; Hynes RO; Lawler J; Iruela-Arispe ML		Proc Natl Acad Sci U S A	98	2001	12485-90	J:72297	11606713
88822	Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene.		Portella G; Salvatore D; Botti G; Cerrato A; Zhang L; Mineo A; Chiappetta G; Santelli G; Pozzi L; Vecchio G; Fusco A; Santoro M		Oncogene	13	1996	2021-6	J:72261	8934550
88823	Mouse models for multistep tumorigenesis.		Wu X; Pandolfi PP		Trends Cell Biol	11	2001	S2-9	J:72266	11684435
88824	Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division.		Wang Z; Yu R; Melmed S		Mol Endocrinol	15	2001	1870-9	J:72267	11682618
88825	Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571.		Wolff NC; Ilaria RL Jr		Blood	98	2001	2808-16	J:72268	11675355
88826	Gain- and loss-of-function lyn mutant mice define a critical inhibitory role for lyn in the myeloid lineage.		Harder KW; Parsons LM; Armes J; Evans N; Kountouri N; Clark R; Quilici C; Grail D; Hodgson GS; Dunn AR; Hibbs ML		Immunity	15	2001	603-15	J:72269	11672542
88827	New TNF-alpha releasing inhibitors, geraniin and corilagin, in leaves of Acer nikoense, Megusurino-ki.		Okabe S; Suganuma M; Imayoshi Y; Taniguchi S; Yoshida T; Fujiki H		Biol Pharm Bull	24	2001	1145-8	J:72271	11642320
88828	Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras.		McKenna IM; Ramakrishna G; Diwan BA; Kang Y; Shiao YH; Wakefield LM; Powell DA; Anderson LM; Jakowlew SB		Toxicol Lett	123	2001	151-8	J:72273	11641043
88829	Chromosomal translocation master genes, mouse models and experimental therapeutics.		Rabbitts TH		Oncogene	20	2001	5763-77	J:72274	11607826
88830	Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.		Ayton PM; Cleary ML		Oncogene	20	2001	5695-707	J:72275	11607819
88831	Modeling Philadelphia chromosome positive leukemias.		Wong S; Witte ON		Oncogene	20	2001	5644-59	J:72276	11607816
88832	Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation.		Galvez AF; Chen N; Macasieb J; de Lumen BO		Cancer Res	61	2001	7473-8	J:72278	11606382
88833	Inducible Expression of Transforming Growth Factor beta1 in Papillomas Causes Rapid Metastasis.		Weeks BH; He W; Olson KL; Wang XJ		Cancer Res	61	2001	7435-43	J:72280	11606377
88834	Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis.		Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL		Mol Cell Biol	21	2001	7653-62	J:72281	11604501
88835	Butylhydroxytoluene (BHT) increases susceptibility of transgenic rasH2 mice to lung carcinogenesis.		Umemura T; Kodama Y; Hioki K; Inoue T; Nomura T; Kurokawa Y		J Cancer Res Clin Oncol	127	2001	583-90	J:72282	11599794
88836	Loss of the suv39h histone methyltransferases impairs Mammalian heterochromatin and genome stability.		Peters AH; O'Carroll D; Scherthan H; Mechtler K; Sauer S; Schofer C; Weipoltshammer K; Pagani M; Lachner M; Kohlmaier A; Opravil S; Doyle M; Sibilia M; Jenuwein T		Cell	107	2001	323-37	J:72503	11701123
88837	Expression of cyclins E1 and E2 during mouse development and in neoplasia.		Geng Y; Yu Q; Whoriskey W; Dick F; Tsai KY; Ford HL; Biswas DK; Pardee AB; Amati B; Jacks T; Richardson A; Dyson N; Sicinski P		Proc Natl Acad Sci U S A	98	2001	13138-43	J:72529	11687642
88838	Polyoma virus: old findings and new challenges.		Benjamin TL		Virology	289	2001	167-73	J:72624	11689038
88839	Biological consequences of the BCR/ABL fusion gene in humans and mice.		Gordon MY		J Clin Pathol	52	1999	719-22	J:60483	10674025
88840	A model of pulmonary adenocarcinoma in transgenic mice expressing the simian virus 40 T antigen driven by the rat Calbindin-D9K (CaBP9K) promoter.		Chailley-Heu B; Rambaud C; Barlier-Mur AM; Galateau-Salle F; Perret C; Capron F; Lacaze-Masmonteil T		J Pathol	195	2001	482-9	J:72686	11745681
88841	Mammary epithelial-specific expression of the integrin linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.		White DE; Cardiff RD; Dedhar S; Muller WJ		Oncogene	20	2001	7064-72	J:72669	11704830
88842	The ink4a/arf Tumor Suppressors Cooperate with p21cip1/waf in the Processes of Mouse Epidermal Differentiation, Senescence, and Carcinogenesis.		Paramio JM; Segrelles C; Ruiz S; Martin-Caballero J; Page A; Martinez J; Serrano M; Jorcano JL		J Biol Chem	276	2001	44203-11	J:72780	11551927
88843	Gonadal Pathologies in Transgenic Mice Expressing the Rat Inhibin alpha-Subunit.		McMullen ML; Cho BN; Yates CJ; Mayo KE		Endocrinology	142	2001	5005-14	J:72755	11606469
88844	A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice.		Newmark HL; Yang K; Lipkin M; Kopelovich L; Liu Y; Fan K; Shinozaki H		Carcinogenesis	22	2001	1871-5	J:72757	11698351
88845	The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility.		Bugni JM; Poole TM; Drinkwater NR		Carcinogenesis	22	2001	1853-62	J:72758	11698349
88846	Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.		Brodie SG; Xu X; Qiao W; Li WM; Cao L; Deng CX		Oncogene	20	2001	7514-23	J:72815	11709723
88847	The role of mutant apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis.		Cooper HS; Everley L; Chang WC; Pfeiffer G; Lee B; Murthy S; Clapper ML		Gastroenterology	121	2001	1407-16	J:72879	11729120
88848	Thyroid hormone-responsive pituitary hyperplasia independent of somatostatin receptor 2.		Brinkmeier ML; Stahl JH; Gordon DF; Ross BD; Sarapura VD; Dowding JM; Kendall SK; Lloyd RV; Ridgway EC; Camper SA		Mol Endocrinol	15	2001	2129-36	J:72988	11731614
88849	Total and structured water in cancer: an NMR experimental study of serum and tissues in DMBA-induced OF1 mice.		Pouliquen D; Foussard F; Tanguy G; Roux J; Malthiery Y		Cell Mol Biol (Noisy-le-grand)	47	2001	947-57	J:72992	11728105
88850	Effect of alpha-tocopherol on hepatocarcinogenesis in transforming growth factor-alpha (TGF-alpha) transgenic mice treated with diethylnitrosamine.		Kakizaki S; Takagi H; Fukusato T; Toyoda M; Horiguchi N; Sato K; Takayama H; Nagamine T; Mori M		Int J Vitam Nutr Res	71	2001	261-7	J:72993	11725690
88851	Effects of gold banded lily (Lilium auratum Lindl) or Chinese milk vetch (Astragalus sinicus L) on spontaneous mammary tumourigenesis in SHN mice.		Nagasawa H; Watanabe K; Yoshida M; Inatomi H		Anticancer Res	21	2001	2323-8	J:72994	11724289
88852	Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry.		Chaurand P; DaGue BB; Pearsall RS; Threadgill DW; Caprioli RM		Proteomics	1	2001	1320-6	J:72995	11721643
88853	Transgenic Polyoma middle-T mice model premalignant mammary disease.		Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL		Cancer Res	61	2001	8298-305	J:72996	11719463
88854	Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame.		Yang J; Luan J; Yu Y; Li C; DePinho RA; Chin L; Richmond A		Cancer Res	61	2001	8150-7	J:72997	11719444
88855	E2F1 and E2F2 Determine Thresholds for Antigen-Induced T-Cell Proliferation and Suppress Tumorigenesis.		Zhu JW; Field SJ; Gore L; Thompson M; Yang H; Fujiwara Y; Cardiff RD; Greenberg M; Orkin SH; DeGregori J		Mol Cell Biol	21	2001	8547-64	J:72952	11713289
88856	Diet and Cancer Prevention Studies in p53-Deficient Mice.		Hursting SD; Perkins SN; Phang JM; Barrett JC		J Nutr	131	2001	3092S-4S	J:73029	11694654
88857	Murine Leukemia Virus Proviral Insertions between the N-ras and unr Genes in B-Cell Lymphoma DNA Affect the Expression of N-ras Only.		Martin-Hernandez J; Sorensen AB; Pedersen FS		J Virol	75	2001	11907-12	J:73031	11689675
88858	Interleukin-4 Up-Regulates Mouse Mammary Tumor Virus Expression yet Is Not Required for In Vivo Virus Spread.		Czarneski J; Meyers J; Peng T; Abraham V; Mick R; Ross SR		J Virol	75	2001	11886-90	J:73032	11689671
88859	Inhibitory effect of mandarin juice rich in beta-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice.		Kohno H; Taima M; Sumida T; Azuma Y; Ogawa H; Tanaka T		Cancer Lett	174	2001	141-50	J:73033	11689289
88860	Camptothecin: A Promising Antiretroviral Drug.		Pantazis P		J Biomed Sci	3	1996	14-19	J:73035	11725078
88861	Recovery of Glycosylated gag Virus from Mice Infected with a Glycosylated gag-Negative Mutant of Moloney Murine Leukemia Virus.		Chun R; Fan H		J Biomed Sci	1	1994	218-223	J:73036	11725029
88862	Targeted expression of SV40 large tumour antigen (TAg) induces a transient enhancement of spermatocyte proliferation and apoptosis.		Tascou S; Nayernia K; Meinhardt A; Schweyer S; Engel W; Trappe R; Burfeind P		Mol Hum Reprod	7	2001	1123-31	J:73037	11719589
88863	ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.		Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F		EMBO J	20	2001	6327-36	J:73038	11707404
88864	Chronic effects in mice caused by oral administration of sublethal doses of azaspiracid, a new marine toxin isolated from mussels.		Ito E; Satake M; Ofuji K; Higashi M; Harigaya K; McMahon T; Yasumoto T		Toxicon	40	2002	193-203	J:73039	11689241
88865	The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.		Shepherd TG; Kockeritz L; Szrajber MR; Muller WJ; Hassell JA		Curr Biol	11	2001	1739-48	J:72998	11719215
88866	A mouse model for medulloblastoma and basal cell nevus syndrome.		Corcoran RB; Scott MP		J Neurooncol	53	2001	307-18	J:73000	11718263
88867	Modeling gliomagenesis with somatic cell gene transfer using retroviral vectors.		Uhrbom L; Holland EC		J Neurooncol	53	2001	297-305	J:73001	11718262
88868	Mouse astrocytoma models: embryonic stem cell mediated transgenesis.		Ding H; Guha A		J Neurooncol	53	2001	289-96	J:73002	11718261
88869	Development of colonic neoplasms and expressions of p53 and p21 proteins in experimental colitis of mice induced by dextran sulfate sodium.		Takesue F; Korenaga D; Yao T; Kabashima A; Sugimachi K		J Exp Clin Cancer Res	20	2001	413-8	J:73003	11718223
88870	IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesis.		Beissert S; Ruhlemann D; Mohammad T; Grabbe S; El-Ghorr A; Norval M; Morrison H; Granstein RD; Schwarz T		J Immunol	167	2001	6232-8	J:73004	11714785
88871	Immunohistochemical characterization of hepatoblastomas in B6C3F1 mice treated with diethylnitrosamine and sodium phenobarbital.		Sakairi T; Kobayashi K; Goto K; Okada M; Kusakabe M; Tsuchiya T; Sugimoto J; Sano F; Mutai M; Morohashi T		J Vet Med Sci	63	2001	1121-5	J:73005	11714029
88872	Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.		Robinson GW; Wagner KU; Hennighausen L		Oncogene	20	2001	7115-9	J:73006	11704837
88873	Animal models of tumor-suppressor genes.		Hakem R; Mak TW		Annu Rev Genet	35	2001	209-41	J:73007	11700283
88874	Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling.		Anderson SP; Dunn CS; Cattley RC; Corton JC		Carcinogenesis	22	2001	1843-51	J:73008	11698348
88875	Lack of promotion of 7,12-dimethylbenz[a]anthracene-initiated mouse skin carcinogenesis by 1.5 GHz electromagnetic near fields.		Imaida K; Kuzutani K; Wang J; Fujiwara O; Ogiso T; Kato K; Shirai T		Carcinogenesis	22	2001	1837-41	J:73009	11698347
88876	Building 'validated' mouse models of human cancer.		Hann B; Balmain A		Curr Opin Cell Biol	13	2001	778-84	J:73010	11698196
88877	Control of advanced choroid plexus tumors in SV40 T antigen transgenic mice following priming of donor CD8(+) T lymphocytes by the endogenous tumor antigen.		Schell TD; Tevethia SS		J Immunol	167	2001	6947-56	J:73092	11739514
88878	Polycomb-group genes as regulators of mammalian lymphopoiesis.		Raaphorst FM; Otte AP; Meijer CJ		Trends Immunol	22	2001	682-90	J:73208	11738999
88879	Photobiologic and photoimmunologic characteristics of XPA gene-deficient mice.		Horio T; Miyauchi-Hashimoto H; Kuwamoto K; Horiki S; Okamoto H; Tanaka K		J Investig Dermatol Symp Proc	6	2001	58-63	J:73192	11764287
88880	Expression of collagenase-3 (MMP-13) in c-fos-induced osteosarcomas and chondrosarcomas is restricted to a subset of cells of the osteo-/chondrogenic lineage.		Tuckermann JP; Vallon R; Gack S; Grigoriadis AE; Porte D; Lutz A; Wagner EF; Schmidt J; Angel P		Differentiation	69	2001	49-57	J:73313	11776394
88881	Effects of mobile phone radiation on x-ray-induced tumorigenesis in mice.		Heikkinen P; Kosma VM; Hongisto T; Huuskonen H; Hyysalo P; Komulainen H; Kumlin T; Lahtinen T; Lang S; Puranen L; Juutilainen J		Radiat Res	156	2001	775-85	J:73373	11741502
88882	Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice.		Shinagawa T; Nomura T; Colmenares C; Ohira M; Nakagawara A; Ishii S		Oncogene	20	2001	8100-8	J:73349	11781823
88883	Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes.		Carraresi L; Tripodi SA; Mulder LC; Bertini S; Nuti S; Schuerfeld K; Cintorino M; Bensi G; Rossini M; Mora M		Oncogene	20	2001	8148-53	J:73350	11781829
88884	Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene.		Xian J; Clark KJ; Fordham R; Pannell R; Rabbitts TH; Rabbitts PH		Proc Natl Acad Sci U S A	98	2001	15062-6	J:73485	11734623
88885	Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus.		Malstrom S; Tili E; Kappes D; Ceci JD; Tsichlis PN		Proc Natl Acad Sci U S A	98	2001	14967-72	J:73487	11752445
88886	Role of iron-dextran on 7,12-dimethylbenz(a) anthracene-initiated and croton oil-promoted cutaneous tumorigenesis in normal and pregnant mice.		Rezazadeh H; Nayebi AR; Athar M		Hum Exp Toxicol	20	2001	471-6	J:73530	11776409
88887	Development of cutaneous amelanotic melanoma in the absence of a functional tyrosinase.		Cohen-Solal KA; Reuhl KR; Ryan KB; Roberts KG; Chen S		Pigment Cell Res	14	2001	466-74	J:73531	11775059
88888	Genetic modeling of glioma formation in mice.		Begemann M; Fuller GN; Holland EC		Brain Pathol	12	2002	117-32	J:73532	11770894
88889	Chemomodulation of carcinogen metabolising enzymes, antioxidant profiles and skin and forestomach papillomagenesis by Spirulina platensis.		Dasgupta T; Banejee S; Yadav PK; Rao AR		Mol Cell Biochem	226	2001	27-38	J:73533	11768236
88890	Anti-tumor-Promoting activity of the diterpene from Excoecaria agallocha. II.		Konoshima T; Konishi T; Takasaki M; Yamazoe K; Tokuda H		Biol Pharm Bull	24	2001	1440-2	J:73534	11767120
88891	Effects of Helicobacter pylori and bile on N-methyl-N'-nitro-N'-nitrosoguanidine exposed antral mucosa of C57BU6 mice.		Loogna P; Franzen L; Sipponen P; Domellof L		Virchows Arch	439	2001	661-7	J:73535	11764387
88892	Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ER alpha KO, mice.		Day JK; Besch-Williford C; McMann TR; Hufford MG; Lubahn DB; MacDonald RS		Nutr Cancer	39	2001	226-32	J:73536	11759285
88893	Supplemental silk protein, sericin, suppresses colon tumorigenesis in 1,2-dimethylhydrazine-treated mice by reducing oxidative stress and cell proliferation.		Zhaorigetu S; Sasaki M; Watanabe H; Kato N		Biosci Biotechnol Biochem	65	2001	2181-6	J:73537	11758907
88894	Oviductural carcinoma in B6C3F1 female mice exosed to 0.5 ppm ozone.		Kim MY; Son JW; Cho MH; Choi CS; Chae CH; Lee MH		Vet Hum Toxicol	43	2001	370-2	J:73538	11757999
88895	Immunological prevention of spontaneous tumors: a new prospect?		Quaglino E; Rovero S; Cavallo F; Musiani P; Amici A; Nicoletti G; Nanni P; Forni G		Immunol Lett	80	2002	75-9	J:73541	11750037
88896	p53 and H-ras Mutations and Microsatellite Instability in Renal Pelvic Carcinomas of NON / Shi Mice Treated with N-Butyl-N-(4-hydroxybutyl)-nitrosamine: Different Genetic Alteration from Urinary Bladder Carcinoma.		Gen H; Yamamoto S; Morimura K; Min W; Mitsuhashi M; Murai T; Mori S; Hosono M; Oohara T; Makino S; Wanibuchi H; Fukushima S		Jpn J Cancer Res	92	2001	1278-83	J:73542	11749692
88897	Confirmation of the mapping of a 12-O-tetradecanoylphorbol-13-acetate promotion susceptibility locus, Psl1, to distal mouse chromosome 9.		Angel JM; Caballero M; DiGiovanni J		Mol Carcinog	32	2001	169-75	J:73582	11746828
88898	Coordinated genetic control of neoplastic and nonneoplastic diseases in mice.		Miller RA; Chrisp C; Jackson AU; Galecki AT; Burke DT		J Gerontol A Biol Sci Med Sci	57	2002	B3-8	J:73584	11773200
88899	Anticarcinogenic Effect of Panax ginseng C.A. Meyer and Identification of Active Compounds.		Yun TK; Lee YS; Lee YH; Kim SI; Yun HY		J Korean Med Sci	16 Suppl	2001	SS6-SS18	J:73543	11748383
88900	Cancer chemoprevention by ginseng in mouse liver and other organs.		Nishino H; Tokuda H; Ii T; Takemura M; Kuchide M; Kanazawa M; Mou XY; Bu P; Takayasu J; Onozuka M; Masuda M; Satomi Y; Konoshima T; Kishi N; Baba M; Okada Y; Okuyama T		J Korean Med Sci	16 Suppl	2001	S66-9	J:73544	11748379
88901	Promoter CpG methylation of Hox-a10 and Hox-a11 in mouse uterus not altered upon neonatal diethylstilbestrol exposure.		Li S; Ma L; Chiang T; Burow M; Newbold RR; Negishi M; Barrett JC; McLachlan JA		Mol Carcinog	32	2001	213-9	J:73546	11746833
88902	Comparison of Ha-ras mutational spectra of N-methyldibenzo[c,g]carbazole and 7H-dibenzo[c,g]carbazole-induced mouse skin tumors.		Mitchell KR; Warshawsky D		Mol Carcinog	32	2001	55-60	J:73547	11746817
88903	Polychlorinated biphenyls promote 1-nitropyrene-induced lung tumorigenesis without the induction of K-ras gene mutation in A/J mice.		Nakanishi Y; Bai F; Inoue K; Takayama K; Pei XH; Harada T; Izumi M; Kimotsuki K; Tokiwa H; Hara N		Teratog Carcinog Mutagen	21	2001	395-403	J:73548	11746253
88904	Is COX-2 inhibition a panacea for cancer prevention?		Vainio H		Int J Cancer	94	2001	613-4	J:73549	11745453
88905	Activins and inhibins in endocrine and other tumors.		Risbridger GP; Schmitt JF; Robertson DM		Endocr Rev	22	2001	836-58	J:73550	11739336
88906	A novel Notch ligand, Dll4, induces T-cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer.		Yan XQ; Sarmiento U; Sun Y; Huang G; Guo J; Juan T; Van G; Qi MY; Scully S; Senaldi G; Fletcher FA		Blood	98	2001	3793-9	J:73551	11739188
88907	Inhibitory effects of cinnamaldehyde on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung carcinogenesis in rasH2 mice.		Imai T; Yasuhara K; Tamura T; Takizawa T; Ueda M; Hirose M; Mitsumori K		Cancer Lett	175	2002	9-16	J:73552	11734331
88908	Oncogenic co-operation in beta-cell tumorigenesis.		Pelengaris S; Khan M		Endocr Relat Cancer	8	2001	307-14	J:73553	11733227
88909	Mouse model for astrocytoma.		O'Neill P		Trends Mol Med	7	2001	540	J:73554	11597515
88910	Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma.		Jiang Z; Zacksenhaus E		J Cell Biol	156	2002	185-98	J:73555	11777937
88911	Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias.		Miyoshi K; Shillingford JM; Le Provost F; Gounari F; Bronson R; von Boehmer H; Taketo MM; Cardiff RD; Hennighausen L; Khazaie K		Proc Natl Acad Sci U S A	99	2002	219-24	J:73556	11773619
88912	Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.		Barak Y; Liao D; He W; Ong ES; Nelson MC; Olefsky JM; Boland R; Evans RM		Proc Natl Acad Sci U S A	99	2002	303-8	J:73557	11756685
88913	CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.		Zhu S; Yoon K; Sterneck E; Johnson PF; Smart RC		Proc Natl Acad Sci U S A	99	2002	207-12	J:73558	11756662
88914	Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours.		Niemann C; Owens DM; Hulsken J; Birchmeier W; Watt FM		Development	129	2002	95-109	J:73649	11782404
88915	Uteroglobin promoter-targeted c-MYC expression in transgenic mice cause hyperplasia of Clara cells and malignant transformation of T-lymphoblasts and tubular epithelial cells.		Geick A; Redecker P; Ehrhardt A; Klocke R; Paul D; Halter R		Transgenic Res	10	2001	501-11	J:73674	11817538
88916	Pituitary adenomas in man and mouse: oncogenic potential of a truncated fibroblast growth factor receptor 4.		Low MJ		J Clin Invest	109	2002	15-6	J:73710	11781345
88917	Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.		Silverman KA; Koratkar R; Siracusa LD; Buchberg AM		Genome Res	12	2002	88-97	J:73854	11779834
88918	Technologically advanced cancer modeling in mice.		Tuveson DA; Jacks T		Curr Opin Genet Dev	12	2002	105-10	J:73857	11790563
88919	Genotype versus phenotype: conflicting results in mapping a lung tumor susceptibility locus to the G7c recombination interval in the mouse MHC class III region.		van Kooij M; de Groot K; van Vugt H; Aten J; Snoek M		Immunogenetics	53	2001	656-61	J:73829	11797099
88920	Antagonism of arachidonic acid is linked to the antitumorigenic effect of dietary eicosapentaenoic acid in Apc(Min/+) mice.		Petrik MB; McEntee MF; Chiu CH; Whelan J		J Nutr	130	2000	1153-8	J:61833	10801912
88921	Development of spontaneous uterine tumors in low molecular mass polypeptide-2 knockout mice.		Hayashi T; Faustman DL		Cancer Res	62	2002	24-7	J:73945	11782352
88922	Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 a	ctivity and induction of apoptosis.	Yang YM; Conaway CC; Chiao JW; Wang CX; Amin S; Whysner J; Dai W; Reinhardt J; Chung FL		Cancer Res	62	2002	2-7	J:73946	11782348
88923	Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.		Cretney E; Takeda K; Yagita H; Glaccum M; Peschon JJ; Smyth MJ		J Immunol	168	2002	1356-61	J:73948	11801676
88924	n-6 Polyunsaturated fatty acids increase skin but not cervical cancer in human papillomavirus 16 transgenic mice.		Qi M; Chen D; Liu K; Auborn KJ		Cancer Res	62	2002	433-6	J:74004	11809692
88925	Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control.		Choi J; Nannenga B; Demidov ON; Bulavin DV; Cooney A; Brayton C; Zhang Y; Mbawuike IN; Bradley A; Appella E; Donehower LA		Mol Cell Biol	22	2002	1094-105	J:74284	11809801
88926	Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors.		Lustig B; Jerchow B; Sachs M; Weiler S; Pietsch T; Karsten U; van de Wetering M; Clevers H; Schlag PM; Birchmeier W; Behrens J		Mol Cell Biol	22	2002	1184-93	J:74286	11809809
88927	Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase.		Munarini N; Jager R; Abderhalden S; Zuercher G; Rohrbach V; Loercher S; Pfanner-Meyer B; Andres AC; Ziemiecki A		J Cell Sci	115	2002	25-37	J:74291	11801721
88928	Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough.		Cavallaro U; Christofori G		Biochim Biophys Acta	1552	2001	39-45	J:74261	11781114
88929	Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis.		Tong WM; Cortes U; Wang ZQ		Biochim Biophys Acta	1552	2001	27-37	J:74262	11781113
88930	Glucagon replacement via micro-osmotic pump corrects hypoglycemia and alpha-cell hyperplasia in prohormone convertase 2 knockout mice.		Webb GC; Akbar MS; Zhao C; Swift HH; Steiner DF		Diabetes	51	2002	398-405	J:74302	11812747
88931	Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.		Cao Y; Prescott SM		J Cell Physiol	190	2002	279-86	J:74307	11857443
88932	Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice.		Davis CD; Zeng H; Finley JW		J Nutr	132	2002	307-9	J:74364	11823596
88933	Frequency and time trends of spontaneous tumors found in B6C3F1 mice oncogenicity studies over 10 years.		Eiben R		Exp Toxicol Pathol	53	2001	399-408	J:74367	11817110
88934	Comparative effect of dietary olive, safflower, and linseed oils on spontaneous liver tumorigenesis in C3H/He mice.		Thuy NT; He P; Takeuchi H		J Nutr Sci Vitaminol (Tokyo)	47	2001	363-6	J:74368	11814153
88935	Tlag2, an N-methyl-N-nitrosourea susceptibility locus, maps to mouse chromosome 4.		Angel JM; Richie ER		Mol Carcinog	33	2002	105-12	J:74369	11813303
88936	Spinosad insecticide: subchronic and chronic toxicity and lack of carcinogenicity in CD-1 mice.		Stebbins KE; Bond DM; Novilla MN; Reasor MJ		Toxicol Sci	65	2002	276-87	J:74370	11812932
88937	Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer.		Mizunuma H; Kanazawa K; Ogura S; Otsuka S; Nagai H		Oncology	62	2002	78-84	J:74372	11810047
88938	A new function of green tea: prevention of lifestyle-related diseases.		Sueoka N; Suganuma M; Sueoka E; Okabe S; Matsuyama S; Imai K; Nakachi K; Fujiki H		Ann N Y Acad Sci	928	2001	274-80	J:74375	11795518
88939	Health span and life span in transgenic mice with modulated DNA repair.		Walter CA; Zhou ZQ; Manguino D; Ikeno Y; Reddick R; Nelson J; Intano G; Herbert DC; McMahan CA; Hanes M		Ann N Y Acad Sci	928	2001	132-40	J:74376	11795504
88940	IL-6 transgenic mouse model for extraosseous plasmacytoma.		Kovalchuk AL; Kim JS; Park SS; Coleman AE; Ward JM; Morse HC rd; Kishimoto T; Potter M; Janz S		Proc Natl Acad Sci U S A	99	2002	1509-14	J:74377	11805288
88941	Anticarcinogenic effect of black tea on pulmonary tumors in Swiss albino mice.		Shukla Y; Taneja P		Cancer Lett	176	2002	137-41	J:74378	11804740
88942	The Polycomb-group gene eed regulates thymocyte differentiation and suppresses the development of carcinogen-induced T-cell lymphomas.		Richie ER; Schumacher A; Angel JM; Holloway M; Rinchik EM; Magnuson T		Oncogene	21	2002	299-306	J:74380	11803473
88943	Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu.		Montagna C; Andrechek ER; Padilla-Nash H; Muller WJ; Ried T		Oncogene	21	2002	890-8	J:74349	11840334
88944	Long-Term Therapy with NTBC and Tyrosine-Restricted Diet in a Murine Model of Hereditary Tyrosinemia Type I.		Al-Dhalimy M; Overturf K; Finegold M; Grompe M		Mol Genet Metab	75	2002	38-45	J:74405	11825062
88945	Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice.		Cao XY; Liu J; Lian ZR; Clayton M; Hu JL; Zhu MH; Fan DM; Feitelson M		World J Gastroenterol	7	2001	575-8	J:74406	11819834
88946	Inhibitory effects of RRR-alpha-tocopheryl succinate on benzo(a)pyrene (B(a)P)-induced forestomach carcinogenesis in female mice.		Wu K; Shan YJ; Zhao Y; Yu JW; Liu BH		World J Gastroenterol	7	2001	60-5	J:74407	11819734
88947	Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors.		Iordanescu I; Becker C; Zetter B; Dunning P; Taylor GA		Radiology	222	2002	460-7	J:74408	11818614
88948	Age-related mutation accumulation at a lacZ reporter locus in normal and tumor tissues of Trp53-deficient mice.		Giese H; Snyder WK; van Oostrom C; van Steeg H; Dolle ME; Vijg J		Mutat Res	514	2002	153-63	J:74409	11815254
88949	Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis.		Chakraborty A; Brantner A; Mukainaka T; Nobukuni Y; Kuchide M; Konoshima T; Tokuda H; Nishino H		Cancer Lett	177	2002	1-5	J:74410	11809524
88950	Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.		Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Kayagaki N; Yagita H; Okumura K		J Exp Med	195	2002	161-9	J:74411	11805143
88951	NTP summary report on the metabolism, disposition, and toxicity of 1,4-butanediol (CAS No. 110-63-4).		Irwin RD		Toxic Rep Ser	54	1996	1-28, A1-8, B1-5	J:74412	11803699
88952	Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.		Bowe DB; Kenney NJ; Adereth Y; Maroulakou IG		Oncogene	21	2002	291-8	J:74381	11803472
88953	Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.		Pozzi A; LeVine WF; Gardner HA		Oncogene	21	2002	272-81	J:74382	11803470
88954	Chemopreventive Effects of a Flavonoid Antioxidant Silymarin on N-Butyl-N-(4-hydroxybutyl)nitrosamine-induced Urinary Bladder Carcinogenesis in Male ICR Mice.		Vinh PQ; Sugie S; Tanaka T; Hara A; Yamada Y; Katayama M; Deguchi T; Mori H		Jpn J Cancer Res	93	2002	42-9	J:74383	11802807
88955	Final report on the safety assessment of trilaurin, triarachidin, tribehenin, tricaprin, tricaprylin, trierucin, triheptanoin, triheptylundecanoin, triisononanoin, triisopalmitin, triisostearin, trilinolein, trimyristin, trioctanoin, triolein, tripalmitin	, tripalmitolein, triricinolein, tristearin, triundecanoin, glyceryl triacetyl hydroxystearate, glyceryl triacetyl ricinoleate, and gl.	Johnson W Jr		Int J Toxicol	20 Suppl 4	2001	61-94	J:74385	11800053
88956	Targeting oncogenesis by introduction of a 5.2-kbp segment of the 5' regulatory region of the human thyrotropin beta-subunit gene.		Miyoshi I; Maki K; Kon Y; Yamashita T; Aoyama S; Hayashizaki Y; Kasai N		Endocr Res	27	2001	387-98	J:74386	11794463
88957	Functional roles of Akt signaling in mouse skin tumorigenesis.		Segrelles C; Ruiz S; Perez P; Murga C; Santos M; Budunova IV; Martinez J; Larcher F; Slaga TJ; Gutkind JS; Jorcano JL; Paramio JM		Oncogene	21	2002	53-64	J:74388	11791176
88958	SWI/SNF chromatin remodeling and cancer.		Klochendler-Yeivin A; Muchardt C; Yaniv M		Curr Opin Genet Dev	12	2002	73-9	J:74389	11790558
88959	The role of p53 and pRB in apoptosis and cancer.		Hickman ES; Moroni MC; Helin K		Curr Opin Genet Dev	12	2002	60-6	J:74390	11790556
88960	Cancer chemopreventive activity of flavanones on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis.		Itoigawa M; Ito C; Ju-ichi M; Nobukuni T; Ichiishi E; Tokuda H; Nishino H; Furukawa H		Cancer Lett	176	2002	25-9	J:74391	11790450
88961	Prevention of development of N,N'-dimethylhydrazine-induced colon tumors by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male ICR mice.		Lu H; Kyo E; Uesaka T; Katoh O; Watanabe H		Int J Mol Med	9	2002	113-7	J:74392	11786919
88962	Gradient of E2A activity in B-cell development.		Herblot S; Aplan PD; Hoang T		Mol Cell Biol	22	2002	886-900	J:74393	11784864
88963	Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.		Maggio-Price L; Shows D; Waggie K; Burich A; Zeng W; Escobar S; Morrissey P; Viney JL		Am J Pathol	160	2002	739-51	J:74501	11839595
88964	Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis.		Hiroyasu M; Ozeki M; Kohda H; Echizenya M; Tanaka T; Hiai H; Toyokuni S		Am J Pathol	160	2002	419-24	J:74502	11839561
88965	Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.		Roberts RB; Min L; Washington MK; Olsen SJ; Settle SH; Coffey RJ; Threadgill DW		Proc Natl Acad Sci U S A	99	2002	1521-6	J:74510	11818567
88966	Beta-catenin--a linchpin in colorectal carcinogenesis?		Wong NA; Pignatelli M		Am J Pathol	160	2002	389-401	J:74516	11839557
88967	Oxidative damage and cancer.		Oberley TD		Am J Pathol	160	2002	403-8	J:74517	11839558
88968	Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas.		Lee JC; Kim DC; Gee MS; Saunders HM; Sehgal CM; Feldman MD; Ross SR; Lee WM		Cancer Res	62	2002	747-55	J:74583	11830529
88969	High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORgamma.		Ueda E; Kurebayashi S; Sakaue M; Backlund M; Koller B; Jetten AM		Cancer Res	62	2002	901-9	J:74584	11830550
88970	The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice.		Hildt E; Munz B; Saher G; Reifenberg K; Hofschneider PH		EMBO J	21	2002	525-35	J:74732	11847101
88971	UVB radiation-induced cancer predisposition in Cockayne syndrome group A (Csa) mutant mice		van der Horst GT; Meira L; Gorgels TG; de Wit J; Velasco-Miguel S; Richardson JA; Kamp Y; Vreeswijk MP; Smit B; Bootsma D; Hoeijmakers JH; Friedberg EC		DNA Repair (Amst)	1	2002	143-57	J:74959	12509261
88972	Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice.		Silberg DG; Sullivan J; Kang E; Swain GP; Moffett J; Sund NJ; Sackett SD; Kaestner KH		Gastroenterology	122	2002	689-96	J:75016	11875002
88973	Leukemic predisposition of pSca-1/Cb2 transgenic mice.		Joosten M; Valk PJ; Jorda' MA; Vankan-Berkhoudt Y; Verbakel S; Van Den Broek M; Beijen A; Lowenberg B; Delwel R		Exp Hematol	30	2002	142-9	J:75020	11823049
88974	Intraocular teratoma in a mouse.		Smith RS; Miller JV; Sundberg JP		Comp Med	52	2002	68-72	J:75056	11900416
88975	Contributions of mouse biology to breast cancer research.		Cardiff RD		Comp Med	52	2002	12-31	J:75057	11900409
88976	Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.		Kim MJ; Cardiff RD; Desai N; Banach-Petrosky WA; Parsons R; Shen MM; Abate-Shen C		Proc Natl Acad Sci U S A	99	2002	2884-9	J:75085	11854455
88977	Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.		Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I		Proc Natl Acad Sci U S A	99	2002	3788-93	J:75270	11891328
88978	Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice.		Malkinson AM; Radcliffe RA; Bauer AK		Carcinogenesis	23	2002	411-7	J:75211	11895855
88979	Quantitative Trait Loci That Regulate Susceptibility to Both Butylated Hydroxytoluene-Induced Pulmonary Inflammation and Lung Tumor Promotion in CXB Recombinant Inbred Mice.		Malkinson A; Radcliffe R; Bauer A; Dwyer-Nield L; Kleeberger S		Chest	121	2002	82S	J:75212	11893704
88980	Bone tumorigenesis induced by alpha-particle radiation: mapping of genetic Loci influencing predisposition in mice.		Rosemann M; Lintrop M; Favor J; Atkinson MJ		Radiat Res	157	2002	426-34	J:75213	11893245
88981	Carcinogenicity test in B6C3F1 mice after parental and prenatal exposure to 50 Hz magnetic fields.		Otaka Y; Chida T; Yamagishi Y; Kitamura S		Bioelectromagnetics	23	2002	206-13	J:75214	11891750
88982	The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.		McKeller RN; Fowler JL; Cunningham JJ; Warner N; Smeyne RJ; Zindy F; Skapek SX		Proc Natl Acad Sci U S A	99	2002	3848-53	J:75215	11891301
88983	Pituitary Hyperplasia in Glycoprotein Hormone Alpha Subunit-, p18(INK4C)-, and p27(kip-1)-Null Mice : Analysis of Proteins Influencing p27(kip-1) Ubiquitin Degradation.		Lloyd RV; Ruebel KH; Zhang S; Jin L		Am J Pathol	160	2002	1171-9	J:75216	11891212
88984	Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors.		Morikawa S; Baluk P; Kaidoh T; Haskell A; Jain RK; McDonald DM		Am J Pathol	160	2002	985-1000	J:75217	11891196
88985	Thymic lymphomas arising in Msh2 deficient mice display a large increase in mutation frequency and an altered mutational spectrum.		Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG		Mutat Res	500	2002	67-74	J:75218	11890935
88986	Quantitation of the cancer process in C57BL/6J, B6C3F1 and C3H/HeJ mice.		Goldsworthy TL; Fransson-Steen R		Toxicol Pathol	30	2002	97-105	J:75219	11890483
88987	The Trp53 hemizygous mouse in pharmaceutical development: points to consider for pathologists.		Floyd E; Mann P; Long G; Ochoa R		Toxicol Pathol	30	2002	147-56	J:75222	11890468
88988	Targeted oncogene activation by site-specific recombination in transgenic mice.		Lakso M; Sauer B; Mosinger B Jr; Lee EJ; Manning RW; Yu SH; Mulder KL; Westphal H		Proc Natl Acad Sci U S A	89	1992	6232-6	J:75205	1631115
88989	Analysis of survival and cause of death statistics for mice under single and duration-of-life gamma irradiation.		Grahn D; Fry RJ; Lea RA		Life Sci Space Res	10	1972	175-86	J:75208	11898837
88990	Uv damage, DNA repair and skin carcinogenesis.		Cleaver JE; Crowley E		Front Biosci	7	2002	D1024-43	J:75209	11897551
88991	Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice.		Perez-Mancera PA; Perez-Losada J; Sanchez-Martin M; Rodriguez-Garcia MA; Flores T; Battaner E; Gutierrez-Adan A; Pintado B; Sanchez-Garcia I		Oncogene	21	2002	1679-84	J:75210	11896599
88992	Overexpression of a constitutively active form of c-src in skin epidermis increases sensitivity to tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.		Matsumoto T; Jiang J; Kiguchi K; Carbajal S; Rho O; Gimenez-Conti I; Beltran L; DiGiovanni J		Mol Carcinog	33	2002	146-55	J:75246	11870880
88993	Cytogenetic and cellular events during radiation-induced thymic lymphomagenesis in the p53 heterozygous (plus minus) B10 mouse.		Tanaka K; Watanabe K; Mori M; Kamisaku H; Tsuji H; Hirabayashi Y; Inoue T; Yoshida K; Aizawa S		Int J Radiat Biol	78	2002	165-72	J:75247	11869471
88994	Molecular mechanism of viral hepatocarcinogenesis.		Koike K; Tsutsumi T; Fujie H; Shintani Y; Kyoji M		Oncology	62 Suppl 1	2002	29-37	J:75248	11868782
88995	Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice.		Cavallo F; Carlo E D; Quaglin E; Jezzi M; Strasly M; Bussolino F; Colombo M P; Nanni P; Lollini P L; Musiani P; Forni G		J Biol Regul Homeost Agents	15	2001	351-8	J:75250	11860223
88996	Inhibition of myc-dependent breast tumor formation in transgenic mice.		Cui W; Gusterson BA; Clark AJ		Breast Cancer Res Treat	71	2002	9-20	J:75251	11859878
88997	Role of p73 in malignancy: tumor suppressor or oncogene?		Stiewe T; Putzer BM		Cell Death Differ	9	2002	237-45	J:75252	11859406
88998	The Tg rasH2 mouse in cancer hazard identification.		Morton D; Alden CL; Roth AJ; Usui T		Toxicol Pathol	30	2002	139-46	J:75223	11890467
88999	Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model.		Song SK; Qu Z; Garabedian EM; Gordon JI; Milbrandt J; Ackerman JJ		Cancer Res	62	2002	1555-8	J:75225	11888935
89000	A New Player in Oncogenesis: AUF1/hnRNPD Overexpression Leads to Tumorigenesis in Transgenic Mice.		Gouble A; Grazide S; Meggetto F; Mercier P; Delsol G; Morello D		Cancer Res	62	2002	1489-95	J:75226	11888925
89001	Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.		Raghow S; Hooshdaran MZ; Katiyar S; Steiner MS		Cancer Res	62	2002	1370-6	J:75227	11888907
89002	Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate.		She QB; Chen N; Bode AM; Flavell RA; Dong Z		Cancer Res	62	2002	1343-8	J:75228	11888903
89003	Loss of one allele of the p53 gene in the lens epithelial tumor in transgenic mice suppresses apoptosis induced by a topoisomerase I inhibitor (CPT-11).		Nakajima Y; Nakamura T; Enomoto T; Murata Y		Cancer Lett	179	2002	165-73	J:75232	11888671
89004	Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.		Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M		Oncogene	21	2002	1791-9	J:75265	11896611
89005	Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.		Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA		Oncogene	21	2002	1518-26	J:75266	11896580
89006	Mouse homologue of HOS (mHOS) is overexpressed in skin tumors and implicated in constitutive activation of NF-kappaB.		Bhatia N; Herter JR; Slaga TJ; Fuchs SY; Spiegelman VS		Oncogene	21	2002	1501-9	J:75267	11896578
89007	Lung tumors in A/J mice exposed to environmental tobacco smoke: estimated potency and implied human risk.		Bogen KT; Witschi H		Carcinogenesis	23	2002	511-9	J:75268	11895867
89008	Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis.		Singh RP; Tyagi AK; Zhao J; Agarwal R		Carcinogenesis	23	2002	499-510	J:75269	11895866
89009	The expression of keratin k10 in the Basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis.		Santos M; Paramio JM; Bravo A; Ramirez A; Jorcano JL		J Biol Chem	277	2002	19122-30	J:75271	11889133
89010	Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair.		Kang J; Bronson RT; Xu Y		EMBO J	21	2002	1447-55	J:75272	11889050
89011	Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.		Liu S; Liu W; Jakubczak JL; Erexson GL; Tindall KR; Chan R; Muller WJ; Adhya S; Garges S; Merlino G		Proc Natl Acad Sci U S A	99	2002	3770-5	J:75274	11867754
89012	ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.		Tamura T; Ozato K		J Interferon Cytokine Res	22	2002	145-52	J:75263	11846985
89013	Development of Hepatocellular Adenomas and Carcinomas Associated with Fibrosis in C57BL / 6J Male Mice Given a Choline-deficient, L-Amino Acid-defined Diet.		Denda A; Kitayama W; Kishida H; Murata N; Tsutsumi M; Tsujiuchi T; Nakae D; Konishi Y		Jpn J Cancer Res	93	2002	125-32	J:75253	11856475
89014	The gastrin receptor promotes pancreatic growth in transgenic mice.		Yen TW; Sandgren EP; Liggitt HD; Palmiter RD; Zhou W; Hinds TR; Grippo PJ; McDonald JM; Robinson LM; Bell RH Jr		Pancreas	24	2002	121-9	J:75255	11854616
89015	Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis.		Baba M; Asano R; Takigami I; Takahashi T; Ohmura M; Okada Y; Sugimoto H; Arika T; Nishino H; Okuyama T		Biol Pharm Bull	25	2002	247-50	J:75256	11853176
89016	Studies on cancer chemoprevention by traditional folk medicines XXIV. Inhibitory effect of a coumarin derivative, 7-isopentenyloxycoumarin, against tumor-promotion.		Baba M; Jin Y; Mizuno A; Suzuki H; Okada Y; Takasuka N; Tokuda H; Nishino H; Okuyama T		Biol Pharm Bull	25	2002	244-6	J:75257	11853175
89017	Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis.		Hackett JA; Greider CW		Oncogene	21	2002	619-26	J:75258	11850787
89018	Many ways to telomere dysfunction: in vivo studies using mouse models.		Goytisolo FA; Blasco MA		Oncogene	21	2002	584-91	J:75259	11850783
89019	Telomeres, aging and cancer: in search of a happy ending.		Kim Sh SH; Kaminker P; Campisi J		Oncogene	21	2002	503-11	J:75260	11850775
89020	Telomerase is not an oncogene.		Harley CB		Oncogene	21	2002	494-502	J:75261	11850774
89021	Growth stimulation of intestinal tumours in Apc(Min/+) mice by dietary L-methionine supplementation.		Paulsen JE; Alexander J		Anticancer Res	21	2001	3281-4	J:75262	11848484
89022	Clonal evolution and progression of 20-methylcholanthrene-induced squamous cell carcinoma of mouse epidermis as revealed by DNA instability and other malignancy markers.		Hirai K; Kumakiri M; Ueda K; Imamura Y; Noriki S; Nishi Y; Kato H; Fukuda M		Eur J Histochem	45	2001	319-32	J:75264	11846000
89023	Tumor-derived osteopontin is soluble, not matrix associated.		Rittling SR; Chen Y; Feng F; Wu Y		J Biol Chem	277	2002	9175-82	J:75339	11741994
89024	Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis.		Morrison C; Smith GC; Stingl L; Jackson SP; Wagner EF; Wang ZQ		Nat Genet	17	1997	479-82	J:75374	9398855
89025	Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene.		Purdie CA; Harrison DJ; Peter A; Dobbie L; White S; Howie SE; Salter DM; Bird CC; Wyllie AH; Hooper ML; et al.		Oncogene	9	1994	603-9	J:75382	8290271
89026	Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.		Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER		Oncogene	10	1995	1717-23	J:75383	7753548
89027	p53 transgenic mice: accelerated erythroleukemia induction by Friend virus.		Lavigueur A; Bernstein A		Oncogene	6	1991	2197-201	J:75384	1766668
89028	A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.		Yu D; Thomas-Tikhonenko A		Oncogene	21	2002	1922-7	J:75563	11896625
89029	Ectopic expression of FGF-3 results in abnormal prostate and Wolffian duct development.		Chua SS; Ma ZQ; Gong L; Lin SH; DeMayo FJ; Tsai SY		Oncogene	21	2002	1899-908	J:75564	11896623
89030	Aromatase overexpression transgenic mice model: cell type specific expression and use of letrozole to abrogate mammary hyperplasia without affecting normal physiology.		Mandava U; Kirma N; Tekmal RR		J Steroid Biochem Mol Biol	79	2001	27-34	J:75650	11850204
89031	Enhanced skin carcinogenesis in cyclin D1-conditional transgenic mice: cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation.		Yamamoto H; Ochiya T; Takeshita F; Toriyama-Baba H; Hirai K; Sasaki H; Sasaki H; Sakamoto H; Yoshida T; Saito I; Terada M		Cancer Res	62	2002	1641-7	J:75626	11912134
89032	Absence of fibroblast growth factor 2 does not prevent tumor formation originating from the RPE.		Foletti A; Ackermann J; Schmidt A; Hummler E; Beermann F		Oncogene	21	2002	1841-7	J:75629	11896616
89033	Protean PTEN: form and function.		Waite KA; Eng C		Am J Hum Genet	70	2002	829-44	J:75667	11875759
89034	Chromosome 14 alteration is associated with increased collagenase expression and the metastatic potential of murine melanomas.		Dave BJ; Singh R; Fidler IJ; Pathak S		Cancer Genet Cytogenet	92	1996	66-72	J:37943	8956875
89035	Induction of ovarian cancer by defined multiple genetic changes in a mouse model system.		Orsulic S; Li Y; Soslow RA; Vitale-Cross LA; Gutkind JS; Varmus HE		Cancer Cell	1	2002	53-62	J:75724	12086888
89036	Transgenic expression of FGF8 and FGF10 induces transdifferentiation of pancreatic islet cells into hepatocytes and exocrine cells.		Yamaoka T; Yoshino K; Yamada T; Yano M; Matsui T; Yamaguchi T; Moritani M; Hata J; Noji S; Itakura M		Biochem Biophys Res Commun	292	2002	138-43	J:75690	11890684
89037	The effect of subcutaneous tumour implantation in a murine lung tumour model.		John LC		Eur J Cardiothorac Surg	21	2002	616-20	J:75750	11932156
89038	Differential Effects of p21(WAF1/CIP1) Deficiency on MMTV-ras and MMTV-myc Mammary Tumor Properties.		Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ		Cancer Res	62	2002	2077-84	J:75752	11929828
89039	Lack of Tumorigenesis in the Mouse Liver after Adenovirus-mediated Expression of a Dominant Stable Mutant of beta-Catenin.		Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM		Cancer Res	62	2002	1971-7	J:75753	11929813
89040	Lack of mutation induction with exposure to 1.5 GHz electromagnetic near fields used for cellular phones in brains of Big Blue mice.		Takahashi S; Inaguma S; Cho YM; Imaida K; Wang J; Fujiwara O; Shirai T		Cancer Res	62	2002	1956-60	J:75754	11929810
89041	Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.		Le Beau MM; Bitts S; Davis EM; Kogan SC		Blood	99	2002	2985-91	J:75755	11929790
89042	MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo.		Fults D; Pedone C; Dai C; Holland EC		Neoplasia	4	2002	32-9	J:75757	11922389
89043	Environmental carcinogens and p53 tumor-suppressor gene interactions in a transgenic mouse model for mammary carcinogenesis.		Medina D; Ullrich R; Meyn R; Wiseman R; Donehower L		Environ Mol Mutagen	39	2002	178-83	J:75758	11921187
89044	Tumor formation in Brca1 conditional mutant mice.		Deng CX		Environ Mol Mutagen	39	2002	171-7	J:75759	11921186
89045	Effect of a homeopathic drug, Chelidonium, in amelioration of p-DAB induced hepatocarcinogenesis in mice.		Biswas S; Khuda-Bukhsh A		BMC Complement Altern Med	2	2002	4	J:75736	11943072
89046	RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.		Petiniot LK; Weaver Z; Vacchio M; Shen R; Wangsa D; Barlow C; Eckhaus M; Steinberg SM; Wynshaw-Boris A; Ried T; Hodes RJ		Mol Cell Biol	22	2002	3174-7	J:75737	11940674
89047	Tumor suppression by a severely truncated species of retinoblastoma protein.		Yang H; Williams BO; Hinds PW; Shih TS; Jacks T; Bronson RT; Livingston DM		Mol Cell Biol	22	2002	3103-10	J:75738	11940667
89048	Untimely ends and new beginnings in mouse cloning.		Perry AC; Wakayama T		Nat Genet	30	2002	243-4	J:75760	11919554
89049	Mutant laboratory mice with abnormalities in pigmentation: annotated tables.		Nakamura M; Tobin DJ; Richards-Smith B; Sundberg JP; Paus R		J Dermatol Sci	28	2002	1-33	J:75762	11916127
89050	Chronic toxicity of a mixture of chlorinated alkanes and alkenes in ICR mice.		Wang FI; Kuo ML; Shun CT; Ma YC; Wang JD; Ueng TH		J Toxicol Environ Health A	65	2002	279-91	J:75764	11911491
89051	Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo.		Cloud JE; Rogers C; Reza TL; Ziebold U; Stone JR; Picard MH; Caron AM; Bronson RT; Lees JA		Mol Cell Biol	22	2002	2663-72	J:75765	11909960
89052	Tlag1, a novel murine tumor susceptibility gene that regulates MNU-induced thymic lymphoma development.		Richie ER; Angel JM; Rinchik EM		Prog Clin Biol Res	395	1996	23-32	J:75850	8895981
89053	Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27(kip1) expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasia.		Ledford AW; Brantley JG; Kemeny G; Foreman TL; Quaggin SE; Igarashi P; Oberhaus SM; Rodova M; Calvet JP; Vanden Heuvel GB		Dev Biol	245	2002	157-71	J:76261	11969263
89054	Genetic and signal transduction analysis of nickel sulfide-induced sarcomas.		Govindarajan B; Klafter R; Miller MS; Mansur C; Mizesko M; Bai X; LaMontagne K; Arbiser JL		Mol Med	8	2002	1-8	J:76267	11984000
89055	Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice.		Hahm KB; Lee KM; Kim YB; Hong WS; Lee WH; Han SU; Kim MW; Ahn BO; Oh TY; Lee MH; Green J; Kim SJ		Aliment Pharmacol Ther	16 Suppl 2	2002	115-27	J:76268	11966532
89056	Effect of cholecystokinin-B gastrin receptor blockade on chemically induced colon carcinogenesis in mice: follow-up at 52 weeks.		Fontana MG; Moneghini D; Villanacci V; Donato F; Rindi G		Digestion	65	2002	35-40	J:76269	11961341
89057	Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation.		Shantz LM; Guo Y; Sawicki JA; Pegg AE; O'Brien TG		Carcinogenesis	23	2002	657-64	J:76270	11960919
89058	Cancer modifier alleles inhibiting lung tumorigenesis are common in inbred mouse strains.		Manenti G; Acevedo A; Galbiati F; Gianni Barrera R; Noci S; Salido E; Dragani TA		Int J Cancer	99	2002	555-9	J:76271	11992545
89059	Point mutations and deletions in the znfn1a1/ikaros gene in chemically induced murine lymphomas.		Karlsson A; Soderkvist P; Zhuang SM		Cancer Res	62	2002	2650-3	J:76199	11980663
89060	Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development.		Bol DK; Rowley RB; Ho CP; Pilz B; Dell J; Swerdel M; Kiguchi K; Muga S; Klein R; Fischer SM		Cancer Res	62	2002	2516-21	J:76200	11980643
89061	Absence of the CD44 gene prevents sarcoma metastasis.		Weber GF; Bronson RT; Ilagan J; Cantor H; Schmits R; Mak TW		Cancer Res	62	2002	2281-6	J:76201	11956084
89062	Enhanced spontaneous and aflatoxin-induced liver tumorigenesis in xeroderma pigmentosum group A gene-deficient mice.		Takahashi Y; Nakatsuru Y; Zhang S; Shimizu Y; Kume H; Tanaka K; Ide F; Ishikawa T		Carcinogenesis	23	2002	627-33	J:76206	11960916
89063	Food restriction inhibits the growth of intestinal polyps in multiple intestinal neoplasia mouse.		Kakuni M; Morimura K; Wanibuchi H; Ogawa M; Min W; Hayashi S; Fukushima S		Jpn J Cancer Res	93	2002	236-41	J:76214	11927003
89064	Truncated, Inactive N-Acetylglucosaminyltransferase III (GlcNAc-TIII) Induces Neurological and Other Traits Absent in Mice That Lack GlcNAc-TIII.		Bhattacharyya R; Bhaumik M; Raju TS; Stanley P		J Biol Chem	277	2002	26300-9	J:76272	11986323
89065	beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds.		Cheon SS; Cheah AY; Turley S; Nadesan P; Poon R; Clevers H; Alman BA		Proc Natl Acad Sci U S A	99	2002	6973-8	J:76273	11983872
89066	A comparison of the anticarcinogenic properties of four red wine polyphenols.		Soleas GJ; Grass L; Josephy PD; Goldberg DM; Diamandis EP		Clin Biochem	35	2002	119-24	J:76274	11983346
89067	Helicobacter pylori infection promotes gastric carcinogenesis in a mice model.		Han SU; Kim YB; Joo HJ; Hahm KB; Lee WH; Cho YK; Kim DY; Kim MW		J Gastroenterol Hepatol	17	2002	253-61	J:76275	11982694
89068	In vitro and in vivo effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemia.		Recher C; Chopin M; Raffoux E; Pierron G; Poupon J; Sigaux F; Dombret H; Stern MH		Br J Haematol	117	2002	343-50	J:76276	11972516
89069	Modelling the molecular circuitry of cancer.		Hahn WC; Weinberg RA		Nat Rev Cancer	2	2002	331-41	J:76300	12044009
89070	Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland.		Welm BE; Freeman KW; Chen M; Contreras A; Spencer DM; Rosen JM		J Cell Biol	157	2002	703-14	J:76468	12011115
89071	A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.		Schmitt CA; Fridman JS; Yang M; Lee S; Baranov E; Hoffman RM; Lowe SW		Cell	109	2002	335-46	J:76474	12015983
89072	Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.		Kalamarides M; Niwa-Kawakita M; Leblois H; Abramowski V; Perricaudet M; Janin A; Thomas G; Gutmann DH; Giovannini M		Genes Dev	16	2002	1060-5	J:76478	12000789
89073	Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.		Bichi R; Shinton SA; Martin ES; Koval A; Calin GA; Cesari R; Russo G; Hardy RR; Croce CM		Proc Natl Acad Sci U S A	99	2002	6955-60	J:76574	12011454
89074	Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility.		Cui Y; Miyoshi K; Claudio E; Siebenlist UK; Gonzalez FJ; Flaws J; Wagner KU; Hennighausen L		J Biol Chem	277	2002	17830-5	J:76553	11884400
89075	Modelling haematopoietic malignancies in the mouse and therapeutical implications.		Bernardi R; Grisendi S; Pandolfi PP		Oncogene	21	2002	3445-58	J:76750	12032781
89076	Transcription factor fusions in acute leukemia: variations on a theme.		Scandura JM; Boccuni P; Cammenga J; Nimer SD		Oncogene	21	2002	3422-44	J:76751	12032780
89077	p16(INK4a) and p53 deficiency cooperate in tumorigenesis.		Sharpless NE; Alson S; Chan S; Silver DP; Castrillon DH; DePinho RA		Cancer Res	62	2002	2761-5	J:76652	12019151
89078	Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.		Hewitt SC; Bocchinfuso WP; Zhai J; Harrell C; Koonce L; Clark J; Myers P; Korach KS		Cancer Res	62	2002	2798-805	J:76653	12019156
89079	Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.		Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK		Oncogene	21	2002	3620-30	J:76748	12032864
89080	Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice.		Murphy MA; Schnall RG; Venter DJ; Barnett L; Bertoncello I; Thien CB; Langdon WY; Bowtell DD		Mol Cell Biol	18	1998	4872-82	J:76895	9671496
89081	Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors.		Fahey JW; Haristoy X; Dolan PM; Kensler TW; Scholtus I; Stephenson KK; Talalay P; Lozniewski A		Proc Natl Acad Sci U S A	99	2002	7610-5	J:76861	12032331
89082	The impact of p53 loss on murine plasmacytoma development.		Mai S; Wiener F		Chromosome Res	10	2002	239-51	J:76914	12067213
89083	Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues.		He W; Li AG; Wang D; Han S; Zheng B; Goumans MJ; Ten Dijke P; Wang XJ		EMBO J	21	2002	2580-90	J:76938	12032071
89084	Pancreatic tumor pathogenesis reflects the causative genetic lesion.		Sandgren EP; Quaife CJ; Paulovich AG; Palmiter RD; Brinster RL		Proc Natl Acad Sci U S A	88	1991	93-7	J:76992	1986386
89085	Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.		Bottinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM		EMBO J	16	1997	2621-33	J:76993	9184209
89086	Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.		Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG		Cancer Res	62	2002	3276-81	J:77029	12036945
89087	Constitutive telomerase expression promotes mammary carcinomas in aging mice.		Artandi SE; Alson S; Tietze MK; Sharpless NE; Ye S; Greenberg RA; Castrillon DH; Horner JW; Weiler SR; Carrasco RD; DePinho RA		Proc Natl Acad Sci U S A	99	2002	8191-6	J:77106	12034875
89088	A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers.		Cozma D; Lukes L; Rouse J; Qiu TH; Liu ET; Hunter KW		Genome Res	12	2002	969-75	J:77063	12045150
89089	PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.		Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG		Proc Natl Acad Sci U S A	99	2002	8283-8	J:77118	12060771
89090	FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.		Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR		Cancer Res	58	1998	380-3	J:46059	9458075
89091	Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 k1 gene.		Prakash O; Tang ZY; Peng X; Coleman R; Gill J; Farr G; Samaniego F		J Natl Cancer Inst	94	2002	926-35	J:77152	12072546
89092	The genetic control of chemically and radiation-induced skin tumorigenesis: a study with carcinogenesis-susceptible and carcinogenesis-resistant mice.		Pazzaglia S; Mancuso M; Rebessi S; Di Majo V; Tanori M; Biozzi G; Covelli V; Saran A		Radiat Res	158	2002	78-83	J:77153	12071806
89093	Cytogenetic Analysis of Radiation-Induced Leukemia in Trp53-Deficient C3H/He Mice.		Ban N; Yoshida K; Aizawa S; Wada S; Kai M		Radiat Res	158	2002	69-77	J:77154	12071805
89094	Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.		Yang YA; Dukhanina O; Tang B; Mamura M; Letterio JJ; MacGregor J; Patel SC; Khozin S; Liu ZY; Green J; Anver MR; Merlino G; Wakefield LM		J Clin Invest	109	2002	1607-15	J:77155	12070308
89095	Deficiency of Either Cyclooxygenase (COX)-1 or COX-2 Alters Epidermal Differentiation and Reduces Mouse Skin Tumorigenesis.		Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R		Cancer Res	62	2002	3395-401	J:77156	12067981
89096	Low iron state is associated with reduced tumor promotion in a two-stage mouse skin carcinogenesis model.		Bhasin G; Kauser H; Athar M		Food Chem Toxicol	40	2002	1105-11	J:77157	12067571
89097	Development of tobacco smoke-induced lung tumors in mice fed Bowman-Birk protease inhibitor concentrate (BBIC).		Witschi H; Espiritu I		Cancer Lett	183	2002	141-6	J:77158	12065088
89098	Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice.		Seril DN; Liao J; Ho KL; Warsi A; Yang CS; Yang GY		Dig Dis Sci	47	2002	1266-78	J:77159	12064801
89099	A mouse model of hepatocellular carcinoma : ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.		Nicholes K; Guillet S; Tomlinson E; Hillan K; Wright B; Frantz GD; Pham TA; Dillard-Telm L; Tsai SP; Stephan JP; Stinson J; Stewart T; French DM		Am J Pathol	160	2002	2295-307	J:77160	12057932
89100	Celecoxib, a Cyclooxygenase 2 Inhibitor as a Potential Chemopreventive to UV-Induced Skin Cancer: A Study in the Hairless Mouse Model.		Orengo IF; Gerguis J; Phillips R; Guevara A; Lewis AT; Black HS		Arch Dermatol	138	2002	751-5	J:77161	12056955
89101	Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?		Blackburn AC; Jerry DJ		Breast Cancer Res	4	2002	101-11	J:77163	12052252
89102	Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice.		Mutoh H; Hakamata Y; Sato K; Eda A; Yanaka I; Honda S; Osawa H; Kaneko Y; Sugano K		Biochem Biophys Res Commun	294	2002	470-9	J:77164	12051735
89103	PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum.		Marino S; Krimpenfort P; Leung C; van der Korput HA; Trapman J; Camenisch I; Berns A; Brandner S		Development	129	2002	3513-22	J:77123	12091320
89104	Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene.		Le LQ; Kabarowski JH; Wong S; Nguyen K; Gambhir SS; Witte ON		Cancer Cell	1	2002	381-91	J:77134	12086852
89105	Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis.		Lopez T; Hanahan D		Cancer Cell	1	2002	339-53	J:77136	12086849
89106	Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A.		Martinez-Chantar ML; Corrales FJ; Martinez-Cruz LA; Garcia-Trevijano ER; Huang ZZ; Chen L; Kanel G; Avila MA; Mato JM; Lu SC		FASEB J	16	2002	1292-4	J:77214	12060674
89107	Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer.		Cao Z; Daniel D; Hanahan D		BMC Cancer	2	2002	11	J:77215	12019035
89108	Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.		Saavedra HI; Wu L; de Bruin A; Timmers C; Rosol TJ; Weinstein M; Robinson ML; Leone G		Cell Growth Differ	13	2002	215-25	J:77222	12065245
89109	Twenty-six-Week carcinogenicity study of chloroform in CB6F1 rasH2-transgenic mice.		Sehata S; Maejima T; Watanabe M; Ogata S; Makino T; Tanaka K; Manabe S; Takaoka M		Toxicol Pathol	30	2002	328-38	J:77165	12051550
89110	Gastric neuroendocrine tumors in a 2-year oncogenicity study with CD-1 mice.		Thoolen B; Koster H; van Kolfschoten A; de Haan M		Toxicol Pathol	30	2002	322-7	J:77166	12051549
89111	Effects of perillyl alcohol on melanoma in the TPras mouse model.		Lluria-Prevatt M; Morreale J; Gregus J; Alberts DS; Kaper F; Giaccia A; Powell MB		Cancer Epidemiol Biomarkers Prev	11	2002	573-9	J:77167	12050099
89112	Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.		Perkins S; Verschoyle RD; Hill K; Parveen I; Threadgill MD; Sharma RA; Williams ML; Steward WP; Gescher AJ		Cancer Epidemiol Biomarkers Prev	11	2002	535-40	J:77168	12050094
89113	Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation.		Suzui M; Okuno M; Tanaka T; Nakagama H; Moriwaki H		Cancer Lett	183	2002	31-41	J:77169	12049812
89114	E-cadherin is a survival factor for the lactating mouse mammary gland.		Boussadia O; Kutsch S; Hierholzer A; Delmas V; Kemler R		Mech Dev	115	2002	53-62	J:77170	12049767
89115	Inhibition of Methylcholanthrene-induced Carcinogenesis by an Interferon gamma Receptor-dependent Foreign Body Reaction.		Qin Z; Kim HJ; Hemme J; Blankenstein T		J Exp Med	195	2002	1479-90	J:77173	12045246
89116	Physical variables in experimental photocarcinogenesis and quantitative relationships between stages of tumor development.		De Gruijl FR; Van Der Leun JC		Front Biosci	7	2002	D1525-30	J:77174	12045015
89117	Animal models of ultraviolet radiation (uvr)-induced cutaneous melanoma.		Ley RD		Front Biosci	7	2002	D1531-4	J:77175	12045011
89118	Induction of epidermal proliferation and expressions of PKC and NF-kappaB by betel quid extracts in mouse: the role of lime-piper additives in betel quid.		Lee MJ; Hsu JD; Lin CL; Lin MH; Yuan SC; Wang CJ		Chem Biol Interact	140	2002	35-48	J:77176	12044559
89119	Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.		Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH		Oncogene	21	2002	4050-9	J:77179	12037687
89120	Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia.		Gounari F; Signoretti S; Bronson R; Klein L; Sellers WR; Kum J; Siermann A; Taketo MM; Boehmer HV; Khazaie K		Oncogene	21	2002	4099-107	J:77180	12037666
89121	The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice.		Million RP; Aster J; Gilliland DG; Van Etten RA		Blood	99	2002	4568-77	J:77182	12036890
89122	Induction of Intestinal Tumors and Lymphomas in C57BL / 6N Mice by a Food-borne Carcinogen, 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.		Ochiai M; Imai H; Sugimura T; Nagao M; Nakagama H		Jpn J Cancer Res	93	2002	478-83	J:77183	12036442
89123	Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice.		Balish E; Warner T		Am J Pathol	160	2002	2253-7	J:77373	12057927
89124	Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.		Ruivenkamp CA; van Wezel T; Zanon C; Stassen AP; Vlcek C; Csikos T; Klous AM; Tripodis N; Perrakis A; Boerrigter L; Groot PC; Lindeman J; Mooi WJ; Meijjer GA; Scholten G; Dauwerse H; Paces V; van Zandwijk N; van Ommen GJ; Demant P		Nat Genet	31	2002	295-300	J:77487	12089527
89125	Chemopreventive effects of emodin and cassiamin B in mouse skin carcinogenesis.		Koyama J; Morita I; Tagahara K; Nobukuni Y; Mukainaka T; Kuchide M; Tokuda H; Nishino H		Cancer Lett	182	2002	135-9	J:77172	12048158
89126	Intestinal adenomas can develop with a stable karyotype and stable microsatellites.		Haigis KM; Caya JG; Reichelderfer M; Dove WF		Proc Natl Acad Sci U S A	99	2002	8927-31	J:77346	12060718
89127	Dissecting p53 tumor suppressor functions in vivo.		Schmitt CA; Fridman JS; Yang M; Baranov E; Hoffman RM; Lowe SW		Cancer Cell	1	2002	289-98	J:77133	12086865
89128	Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.		Nambiar PR; Giardina C; Guda K; Aizu W; Raja R; Rosenberg DW		Cancer Res	62	2002	3667-74	J:77716	12097273
89129	Processing and proliferative effects of human progastrin in transgenic mice.		Wang TC; Koh TJ; Varro A; Cahill RJ; Dangler CA; Fox JG; Dockray GJ		J Clin Invest	98	1996	1918-29	J:77789	8878444
89130	Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice.		Kang Y; Ozbun LL; Angdisen J; Moody TW; Prentice M; Diwan BA; Jakowlew SB		Carcinogenesis	23	2002	1217-27	J:77757	12117781
89131	Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice.		Millar CB; Guy J; Sansom OJ; Selfridge J; MacDougall E; Hendrich B; Keightley PD; Bishop SM; Clarke AR; Bird A		Science	297	2002	403-5	J:77896	12130785
89132	Role of CXCL1 in tumorigenesis of melanoma.		Dhawan P; Richmond A		J Leukoc Biol	72	2002	9-18	J:77901	12101257
89133	Tumor promoting effect of phenolphthalein on development of lung tumors induced by N-ethyl-N-nitrosourea in transgenic mice carrying human prototype c-Ha-ras gene.		Imaoka M; Kashida Y; Watanabe T; Ueda M; Onodera H; Hirose M; Mitsumori K		J Vet Med Sci	64	2002	489-93	J:77951	12130832
89134	Diethylnitrosamine induces long-lasting re-expression of insulin-like growth factor II during early stages of liver carcinogenesis in mice.		Lahm H; Gittner K; Krebs O; Sprague L; Deml E; Oesterle D; Hoeflich A; Wanke R; Wolf E		Growth Horm IGF Res	12	2002	69-79	J:77952	12127304
89135	Contribution of dichloroacetate and trichloroacetate to liver tumor induction in mice by trichloroethylene.		Bull RJ; Orner GA; Cheng RS; Stillwell L; Stauber AJ; Sasser LB; Lingohr MK; Thrall BD		Toxicol Appl Pharmacol	182	2002	55-65	J:77953	12127263
89136	Adoptive immunotherapy prevents prostate cancer in a transgenic animal model.		Granziero L; Krajewski S; Farness P; Yuan L; Courtney MK; Jackson MR; Peterson PA; Vitiello A		Eur J Immunol	29	1999	1127-38	J:78025	10229079
89137	Reduction of Intestinal Neoplasia With Adenomatous Polyposis Coli Gene Replacement and COX-2 Inhibition Is Additive.		Lew JI; Guo Y; Kim RK; Vargish L; Michelassi F; Arenas RB		J Gastrointest Surg	6	2002	563-8	J:77954	12127122
89138	In vivo pharmacokinetics of 8-aminolevulinic acid-induced protoporphyrin IX during pre- and post-photodynamic therapy in 7,12-dimethylbenz(a)nthracene-treated skin carcinogenesis in Swiss mice: a comparison by three-compartment model.		Diagaradjane P; Madhuri S; Aruna P; Gupta PK; Ganesan S		Photochem Photobiol	76	2002	81-90	J:77955	12126311
89139	Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches.		An KP; Athar M; Tang X; Katiyar SK; Russo J; Beech J; Aszterbaum M; Kopelovich L; Epstein EH Jr; Mukhtar H; Bickers DR		Photochem Photobiol	76	2002	73-80	J:77956	12126310
89140	Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.		Cheng J; Huang H; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR		Cancer Res	62	2002	4157-63	J:77957	12124355
89141	Adenovirus-mediated Endostatin Delivery Results in Inhibition of Mammary Gland Tumor Growth in C3(1)/SV40 T-Antigen Transgenic Mice.		Calvo A; Feldman AL; Libutti SK; Green JE		Cancer Res	62	2002	3934-8	J:77958	12124322
89142	Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment.		McLaughlin ME; Jacks T		Cancer Cell	1	2002	408-10	J:77959	12124168
89143	TGF alpha transgenic mice. A model of pancreatic cancer development.		Greten FR; Wagner M; Weber CK; Zechner U; Adler G; Schmid RM		Pancreatology	1	2001	363-8	J:77961	12120215
89144	Inhibition of Rel/Nuclear Factor-kappaB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development.		Van Hogerlinden M; Auer G; Toftgard R		Oncogene	21	2002	4969-77	J:77963	12118375
89145	Role of yoghurt in the prevention of colon cancer.		Perdigon G; De Moreno De LeBlanc A; Valdez J; Rachid M		Eur J Clin Nutr	56 Suppl 3	2002	S65-8	J:77945	12142967
89146	Tumorigenicity of chloral hydrate, trichloroacetic acid, trichloroethanol, malondialdehyde, 4-hydroxy-2-nonenal, crotonaldehyde, and acrolein in the B6C3F(1) neonatal mouse.		Von Tungeln LS; Yi P; Bucci TJ; Samokyszyn VM; Chou MW; Kadlubar FF; Fu PP		Cancer Lett	185	2002	13-9	J:77946	12142074
89147	bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes.		Tsimbouri P; Drotar ME; Coy JL; Wilson JB		Oncogene	21	2002	5182-7	J:77947	12140768
89148	Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.		Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T		Oncogene	21	2002	5097-107	J:77948	12140760
89149	T cell subset patterns that predict resistance to spontaneous lymphoma, mammary adenocarcinoma, and fibrosarcoma in mice.		Miller RA; Chrisp C		J Immunol	169	2002	1619-25	J:77949	12133992
89150	Effects of the dietary phytoestrogens daidzein and genistein on the incidence of vulvar carcinomas in 129/J mice.		Thigpen JE; Locklear J; Haseman JK; Saunders H; Grant MF; Forsythe DB		Cancer Detect Prev	25	2001	527-32	J:77950	12132873
89151	Flt3 ligand expands dendritic cell numbers in normal and malignant murineprostate.		Moghaddami M; Swart B; Reynolds P; Diener K; Brown MP		Immunol Cell Biol	80	2002	370-81	J:77987	12121227
89152	Progressive appearance of pigmentation in amelanotic melanoma lesions.		Cohen-Solal KA; Crespo-Carbone SM; Namkoong J; Mackason KR; Roberts KG; Reuhl KR; Chen S		Pigment Cell Res	15	2002	282-9	J:77989	12100494
89153	Molecular profiling of angiogenesis markers.		Shih SC; Robinson GS; Perruzzi CA; Calvo A; Desai K; Green JE; Ali IU; Smith LE; Senger DR		Am J Pathol	161	2002	35-41	J:77978	12107087
89154	Cancer. Addiction to oncogenes--the Achilles heal of cancer.		Weinstein IB		Science	297	2002	63-4	J:77979	12098689
89155	Overexpression of parathyroid hormone-related protein causes hypercalcemia but not bone metastases in a murine model of mammary tumorigenesis.		Wysolmerski JJ; Dann PR; Zelazny E; Dunbar ME; Insogna KL; Guise TA; Perkins AS		J Bone Miner Res	17	2002	1164-70	J:77980	12096830
89156	Carcinogen-induced pancreatic lesions in the mouse: effect of Smad4 and Apc genotypes.		Cullingworth J; Hooper ML; Harrison DJ; Mason JO; Sirard C; Patek CE; Clarke AR		Oncogene	21	2002	4696-701	J:77981	12096346
89157	Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.		Vooijs M; te Riele H; van der Valk M; Berns A		Oncogene	21	2002	4635-45	J:77982	12096340
89158	A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice.		Tevethia MJ; Bonneau RH; Griffith JW; Mylin L		J Virol	71	1997	8157-66	J:78026	9343166
89159	The role of cyclooxygenase-2 (COX-2) in two different morphological stages of intestinal polyps in APC(Delta474) knockout mice.		Sunayama K; Konno H; Nakamura T; Kashiwabara H; Shoji T; Tsuneyoshi T; Nakamura S		Carcinogenesis	23	2002	1351-9	J:78064	12151354
89160	Chemoprevention by Lipoxygenase and Leukotriene Pathway Inhibitors of Vinyl Carbamate-induced Lung Tumors in Mice.		Gunning WT; Kramer PM; Steele VE; Pereira MA		Cancer Res	62	2002	4199-201	J:78112	12154018
89161	Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model.		Li H; Velasco-Miguel S; Vass WC; Parada LF; DeClue JE		Cancer Res	62	2002	4507-13	J:78113	12154062
89162	The N-ras Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene.		Diaz R; Ahn D; Lopez-Barcons L; Malumbres M; Perez De Castro I; Lue J; Ferrer-Miralles N; Mangues R; Tsong J; Garcia R; Perez-Soler R; Pellicer A		Cancer Res	62	2002	4514-8	J:78114	12154063
89163	Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway.		Arnott CH; Scott KA; Moore RJ; Hewer A; Phillips DH; Parker P; Balkwill FR; Owens DM		Oncogene	21	2002	4728-38	J:78099	12101411
89164	Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.		Tang B; Bottinger EP; Jakowlew SB; Bagnall KM; Mariano J; Anver MR; Letterio JJ; Wakefield LM		Nat Med	4	1998	802-7	J:78174	9662371
89165	A bcr-v-abl oncogene induces lymphomas in transgenic mice.		Hariharan IK; Harris AW; Crawford M; Abud H; Webb E; Cory S; Adams JM		Mol Cell Biol	9	1989	2798-805	J:78175	2789335
89166	N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.		Rosenbaum H; Webb E; Adams JM; Cory S; Harris AW		EMBO J	8	1989	749-55	J:78176	2785918
89167	HBx gene of hepatitis B virus induces liver cancer in transgenic mice.		Kim CM; Koike K; Saito I; Miyamura T; Jay G		Nature	351	1991	317-20	J:78178	2034275
89168	IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression.		Dildrop R; Ma A; Zimmerman K; Hsu E; Tesfaye A; DePinho R; Alt FW		EMBO J	8	1989	1121-8	J:78179	2501083
89169	Characterization of intraocular tumors arising in transgenic mice.		Anand R; Ma D; Alizadeh H; Comerford SA; Sambrook JF; Gething MJ; McLean IW; Niederkorn JY		Invest Ophthalmol Vis Sci	35	1994	3533-9	J:78183	8056529
89170	The genetics and pathology of mouse mammary cancer.		Hennighausen L		Semin Cancer Biol	11	2001	239-44	J:78290	11407948
89171	Autochthonous mouse models for prostate cancer: past, present and future.		Huss WJ; Maddison LA; Greenberg NM		Semin Cancer Biol	11	2001	245-60	J:78291	11407949
89172	Genetic dissection of melanoma pathways in the mouse.		Yang FC; Merlino G; Chin L		Semin Cancer Biol	11	2001	261-8	J:78292	11407950
89173	Two-year toxicity and carcinogenicity studies in B(6)C(3)F(1) mice with 5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent.		D'Cruz O; Erbeck D; Waurzyniak B; Uckun F		Toxicology	179	2002	61-77	J:78526	12204543
89174	Heterozygous PU.1 mutations are associated with acute myeloid leukemia.		Mueller BU; Pabst T; Osato M; Asou N; Johansen LM; Minden MD; Behre G; Hiddemann W; Ito Y; Tenen DG		Blood	100	2002	998-1007	J:78414	12130514
89175	Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland.		Li G; Robinson GW; Lesche R; Martinez-Diaz H; Jiang Z; Rozengurt N; Wagner KU; Wu DC; Lane TF; Liu X; Hennighausen L; Wu H		Development	129	2002	4159-70	J:78415	12163417
89176	Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.		Anisimov VN; Khavinson VK; Provinciali M; Alimova IN; Baturin DA; Popovich IG; Zabezhinski MA; Imyanitov EN; Mancini R; Franceschi C		Int J Cancer	101	2002	7-10	J:78418	12209581
89177	Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease.		Wu G; Tian X; Nishimura S; Markowitz GS; D'Agati V; Park JH; Yao L; Li L; Geng L; Zhao H; Edelmann W; Somlo S		Hum Mol Genet	11	2002	1845-54	J:78422	12140187
89178	Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.		Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A		Genes Dev	16	2002	2058-72	J:78467	12183361
89179	Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.		Rodriguez-Puebla ML; de Marval PL; LaCava M; Moons DS; Kiyokawa H; Conti CJ		Am J Pathol	161	2002	405-11	J:78458	12163365
89180	Prostatic intraepithelial neoplasia in genetically engineered mice.		Park JH; Walls JE; Galvez JJ; Kim M; Abate-Shen C; Shen MM; Cardiff RD		Am J Pathol	161	2002	727-35	J:78462	12163397
89181	Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification.		Difilippantonio MJ; Petersen S; Chen HT; Johnson R; Jasin M; Kanaar R; Ried T; Nussenzweig A		J Exp Med	196	2002	469-80	J:78496	12186839
89182	Lung Toxicity and Tumor Promotion by Hydroxylated Derivatives of 2,6-di-tert-Butyl-4-methylphenol (BHT) and 2-tert-Butyl-4-methyl-6-iso-propylphenol: Correlation with Quinone Methide Reactivity.		Kupfer R; Dwyer-Nield LD; Malkinson AM; Thompson JA		Chem Res Toxicol	15	2002	1106-12	J:78498	12184795
89183	Cyclin D1 Is Not an Essential Target of beta-Catenin Signaling During Intestinal Tumorigenesis, but It May Act as a Modifier of Disease Severity in Multiple Intestinal Neoplasia (Min) Mice.		Wilding J; Straub J; Bee J; Churchman M; Bodmer W; Dickson C; Tomlinson I; Ilyas M		Cancer Res	62	2002	4562-5	J:78500	12183406
89184	Inhibitory effect of stabilized analogues of glycoglycerolipids on Epstein-Barr virus activation and mouse skin tumor promotion.		Colombo D; Compostella F; Ronchetti F; Reza-Elahi S; Scala A; Toma L; Aoi W; Kuchide M; Takayasu J; Tokuda H; Nishino H		Cancer Lett	186	2002	37-41	J:78503	12183073
89185	Disturbed tooth eruption in osteopetrotic (op/op) mice: histopathogenesis of tooth malformation and odontomas.		Ida-Yonemochi H; Noda T; Shimokawa H; Saku T		J Oral Pathol Med	31	2002	361-73	J:78487	12201247
89186	F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4.		Kone J; Arroyo J; Savinelli T; Lin S; Boyd K; Wu Y; Nimmakayalu M; Copeland NG; Jenkins NA; Qumsiyeh M; Hu P; Prescott A; Wu H; Yang L; Roe B; Perkins AS		Leukemia	16	2002	1827-34	J:78488	12200699
89187	Ovarian Hyperstimulation by LH Leads to Mammary Gland Hyperplasia and Cancer Predisposition in Transgenic Mice.		Milliken EL; Ameduri RK; Landis MD; Behrooz A; Abdul-Karim FW; Keri RA		Endocrinology	143	2002	3671-80	J:78490	12193583
89188	Mouse models for generating P53 gene mutation spectra.		Zielinski B; Liu Z; Hollstein M; Hergenhahn M; Luo J		Toxicol Lett	134	2002	31-7	J:78492	12191858
89189	Promotion, but not progression, effects of tamoxifen on uterine carcinogenesis in mice initiated with N-ethyl-N'-nitro-N-nitrosoguanidine.		Takahashi M; Shimomoto T; Miyajima K; Iizuka S; Watanabe T; Yoshida M; Kurokawa Y; Maekawa A		Carcinogenesis	23	2002	1549-55	J:78493	12189200
89190	Induction of tumors in the colon and liver of the immunodeficient (SCID) mouse by 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ)-modulation by long-chain fatty acids.		Salim EI; Wanibuchi H; Morimura K; Murai T; Makino S; Nomura T; Fukushima S		Carcinogenesis	23	2002	1519-29	J:78494	12189196
89191	Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays.		Lemon WJ; Bernert H; Sun H; Wang Y; You M		J Med Genet	39	2002	644-55	J:78525	12205107
89192	Elevated susceptibility of the p53 knockout mouse esophagus to methyl-N-amylnitrosamine carcinogenesis.		Shirai N; Tsukamoto T; Yamamoto M; Iidaka T; Sakai H; Yanai T; Masegi T; Donehower LA; Tatematsu M		Carcinogenesis	23	2002	1541-7	J:78528	12189199
89193	High-throughput retroviral tagging to identify components of specific signaling pathways in cancer.		Mikkers H; Allen J; Knipscheer P; Romeyn L; Hart A; Vink E; Berns A		Nat Genet	32	2002	153-9	J:78530	12185366
89194	New genes involved in cancer identified by retroviral tagging.		Suzuki T; Shen H; Akagi K; Morse HC; Malley JD; Naiman DQ; Jenkins NA; Copeland NG		Nat Genet	32	2002	166-74	J:78531	12185365
89195	Hepatocellular kinetics and the expression of growth hormone (GH) in the livers and liver tumours of GH-transgenic mice.		Snibson KJ		Tissue Cell	34	2002	88-97	J:78532	12165243
89196	Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis.		Kapadia GJ; Azuine MA; Tokuda H; Takasaki M; Mukainaka T; Konoshima T; Nishino H		Pharmacol Res	45	2002	499-505	J:78533	12162952
89197	Modeling cancer in mice.		Jackson-Grusby L		Oncogene	21	2002	5504-14	J:78516	12154411
89198	A mouse lung tumor model of tobacco smoke carcinogenesis.		Witschi H; Espiritu I; Dance ST; Miller MS		Toxicol Sci	68	2002	322-30	J:78517	12151628
89199	Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis.		Hwang HC; Martins CP; Bronkhorst Y; Randel E; Berns A; Fero M; Clurman BE		Proc Natl Acad Sci U S A	99	2002	11293-8	J:78518	12151601
89200	Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer.		Tchou-Wong KM; Jiang Y; Yee H; LaRosa J; Lee TC; Pellicer A; Jagirdar J; Gordon T; Goldberg JD; Rom WN		Am J Respir Cell Mol Biol	27	2002	186-93	J:78519	12151310
89201	Amplifying mechanisms of lymphomagenesis.		Roth DB		Mol Cell	10	2002	1-2	J:78520	12150897
89202	Chemopreventive potential of cyclic diarylheptanoids.		Ishida J; Kozuka M; Tokuda H; Nishino H; Nagumo S; Lee KH; Nagai M		Bioorg Med Chem	10	2002	3361-5	J:78521	12150883
89203	Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.		Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH		Cancer Res	55	1995	4302-10	J:78732	7671240
89204	Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis.		Ginzinger DG; Godfrey TE; Nigro J; Moore DH nd; Suzuki S; Pallavicini MG; Gray JW; Jensen RH		Cancer Res	60	2000	5405-9	J:78859	11034080
89205	Characterization of Pheochromocytomas in a Mouse Strain with a Targeted Disruptive Mutation of the Neurofibromatosis Gene Nf1.		Tischler AS; Shih TS; Williams BO; Jacks T		Endocr Pathol	6	1995	323-335	J:78847	12114814
89206	A transgenic mouse prostate cancer model.		Gingrich JR; Greenberg NM		Toxicol Pathol	24	1996	502-4	J:78848	8864193
89207	A novel p53 mutational hotspot in skin tumors from UV-irradiated Xpc mutant mice alters transactivation functions.		Inga A; Nahari D; Velasco-Miguel S; Friedberg EC; Resnick MA		Oncogene	21	2002	5704-15	J:78919	12173040
89208	Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia.		Song Z; Wu X; Powell WC; Cardiff RD; Cohen MB; Tin RT; Matusik RJ; Miller GJ; Roy-Burman P		Cancer Res	62	2002	5096-105	J:78918	12208767
89209	High levels of progastrin significantly increase premalignant changes in colonic mucosa of mice in response to the chemical carcinogen, AOM		Singh P; Velasco M; Given R; Owlia A; Wargovich M; Wang TC		Gastroenterology		1998	A680 (Abstr)	J:78968	 
89210	Two novel tumor suppressor gene loci on chromosome 6q and 15q in human osteosarcoma identified through comparative study of allelic imbalances in mouse and man.		Nathrath MH; Kuosaite V; Rosemann M; Kremer M; Poremba C; Wakana S; Yanagi M; Nathrath WB; Hofler H; Imai K; Atkinson MJ		Oncogene	21	2002	5975-80	J:78944	12185601
89211	In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy.		Masson R; Lefebvre O; Noel A; Fahime ME; Chenard MP; Wendling C; Kebers F; LeMeur M; Dierich A; Foidart JM; Basset P; Rio MC		J Cell Biol	140	1998	1535-41	J:79012	9508784
89212	Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype.		Sheng H; Goich S; Wang A; Grachtchouk M; Lowe L; Mo R; Lin K; de Sauvage FJ; Sasaki H; Hui CC; Dlugosz AA		Cancer Res	62	2002	5308-16	J:79017	12235001
89213	Prevention of thymic lymphoma development in atm-/- mice by dexamethasone.		Yan M; Kuang X; Qiang W; Shen J; Claypool K; Lynn WS; Wong PK		Cancer Res	62	2002	5153-7	J:79018	12234978
89214	A new locus for resistance to gamma-radiation-induced thymic lymphoma identified using inter-specific consomic and inter-specific recombinant congenic strains of mice.		Santos J; Montagutelli X; Acevedo A; Lopez P; Vaquero C; Fernandez M; Arnau MR; Szatanik M; Salido E; Guenet JL; Fernandez-Piqueras J		Oncogene	21	2002	6680-3	J:79055	12242666
89215	Genetic interaction between the unstable v-Ha-RAS transgene (Tg.AC) and the murine Werner syndrome gene: transgene instability and tumorigenesis.		Leder A; Lebel M; Zhou F; Fontaine K; Bishop A; Leder P		Oncogene	21	2002	6657-68	J:79056	12242664
89216	Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmicroMyc transgenic mice.		Mikkers H; Allen J; Berns A		Oncogene	21	2002	6559-66	J:79057	12242653
89217	Biological and molecular characteristics of the premalignant mouse mammary gland.		Medina D		Biochim Biophys Acta	1603	2002	1-9	J:79059	12242106
89218	Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin.		Rulli SB; Kuorelahti A; Karaer O; Pelliniemi LJ; Poutanen M; Huhtaniemi I		Endocrinology	143	2002	4084-95	J:79060	12239120
89219	Generation of large homozygous chromosomal segments by mitotic recombination during lymphomagenesis in F1 hybrid mice.		Hong DP; Kubo K; Tsugawa N; Mori N; Umesako S; Song CW; Okumoto M		J Radiat Res (Tokyo)	43	2002	187-94	J:79061	12238333
89220	Putative tumor-suppressor gene regions responsible for radiation lymphomagenesis in F1 mice with different p53 status.		Hong DP; Mori N; Umesako S; Song CW; Park YG; Aizawa S; Okumoto M		J Radiat Res (Tokyo)	43	2002	175-85	J:79062	12238332
89221	Twenty-six week carcinogenicity study of ampicillin in CB6F1-TgrasH2 mice.		Adachi T; Kuwamura Y; Fujiwara T; Tanimoto N; Nishimura T; Koguchi A; Kobayashi K; Sasaki Y; Yamaguchi C; Honda T; Kawashima K; Yuasa H; Yamamura T; Inui T		J Toxicol Sci	27	2002	147-63	J:79063	12238139
89222	Withania somnifera root extract prevents DMBA-induced squamous cell carcinoma of skin in Swiss albino mice.		Prakash J; Gupta SK; Dinda AK		Nutr Cancer	42	2002	91-7	J:79064	12235655
89223	Use of mutant mice in photoimmunological and photocarcinogenic investigations.		Beissert S		Methods	28	2002	130-7	J:79066	12231197
89224	Effects of bitter melon (Momordica charantia l.) or ginger rhizome (Zingiber offifinale rosc) on spontaneous mammary tumorigenesis in SHN mice.		Nagasawa H; Watanabe K; Inatomi H		Am J Chin Med	30	2002	195-205	J:79067	12230008
89225	Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors.		Tao L; Li Y; Wang W; Kramer PM; Gunning WT; Lubet RA; Steele VE; Pereira MA		Mol Carcinog	35	2002	93-102	J:79053	12325039
89226	Dietary catechin delays tumor onset in a transgenic mouse model.		Ebeler SE; Brenneman CA; Kim GS; Jewell WT; Webb MR; Chacon-Rodriguez L; MacDonald EA; Cramer AC; Levi A; Ebeler JD; Islas-Trejo A; Kraus A; Hinrichs SH; Clifford AJ		Am J Clin Nutr	76	2002	865-72	J:79054	12324302
89227	Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.		Jacoby RF; Marshall DJ; Newton MA; Novakovic K; Tutsch K; Cole CE; Lubet RA; Kelloff GJ; Verma A; Moser AR; Dove WF		Cancer Res	56	1996	710-4	J:79095	8631000
89228	Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.		Brinster RL; Chen HY; Messing A; van Dyke T; Levine AJ; Palmiter RD		Cell	37	1984	367-79	J:79096	6327063
89229	Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo.		Chen YQ; Zhou YQ; Fisher JH; Wang MH		Oncogene	21	2002	6382-6	J:79080	12214279
89230	Age-associated alteration of lipid peroxidation and superoxide dismutase activity in CBA and AKR mice.		Sverko V; Balog T; Sobocanec S; Gavella M; Marotti T		Exp Gerontol	37	2002	1031-1039	J:79083	12213554
89231	Potential mouse tumor model for pre-clinical testing of mage-specific breast cancer vaccines.		Sypniewska RK; Hoflack L; Bearss DJ; Gravekamp C		Breast Cancer Res Treat	74	2002	221-33	J:79084	12211215
89232	Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice.		Sedger LM; Glaccum MB; Schuh JC; Kanaly ST; Williamson E; Kayagaki N; Yun T; Smolak P; Le T; Goodwin R; Gliniak B		Eur J Immunol	32	2002	2246-54	J:79085	12209637
89233	Preparation and biological evaluation of the new chlorin photosensitizer T3,4BCPC for detection and treatment of tumors.		Murugesan S; Shetty S; Srivastava T; Samuel A; Noronha O		J Photochem Photobiol B	68	2002	33	J:79087	12208034
89234	Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice.		Lu YP; Lou YR; Xie JG; Peng QY; Liao J; Yang CS; Huang MT; Conney AH		Proc Natl Acad Sci U S A	99	2002	12455-60	J:79088	12205293
89235	ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1.		Hulit J; Lee RJ; Russell RG; Pestell RG		Biochem Pharmacol	64	2002	827-36	J:79090	12213576
89236	The molecular and genetic basis of neurological tumours.		Zhu Y; Parada LF		Nat Rev Cancer	2	2002	616-26	J:79091	12154354
89237	Telomerase beyond telomeres.		Blasco MA		Nat Rev Cancer	2	2002	627-33	J:79092	12154355
89238	Connecting chromosomes, crisis, and cancer.		Maser RS; DePinho RA		Science	297	2002	565-9	J:79179	12142527
89239	The Bcl2 family: regulators of the cellular life-or-death switch.		Cory S; Adams JM		Nat Rev Cancer	2	2002	647-56	J:79249	12209154
89240	Strain Background Alters Mammary Gland Lesion Phenotype in Transforming Growth Factor-alpha Transgenic Mice.		Rose-Hellekant TA; Gilchrist K; Sandgren EP		Am J Pathol	161	2002	1439-47	J:79343	12368216
89241	Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production.		Kim MR; Manoukian R; Yeh R; Silbiger SM; Danilenko DM; Scully S; Sun J; DeRose ML; Stolina M; Chang D; Van GY; Clarkin K; Nguyen HQ; Yu YB; Jing S; Senaldi G; Elliott G; Medlock ES		Blood	100	2002	2330-40	J:79373	12239140
89242	RecQ helicases: at the heart of genetic stability.		Cobb JA; Bjergbaek L; Gasser SM		FEBS Lett	529	2002	43-8	J:79441	12354611
89243	Simple epithelium keratins are required for maintenance of hepatocyte integrity.		Loranger A; Duclos S; Grenier A; Price J; Wilson-Heiner M; Baribault H; Marceau N		Am J Pathol	151	1997	1673-83	J:44938	9403718
89244	NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.		Krane IM; Leder P		Oncogene	12	1996	1781-8	J:79534	8622899
89245	Linkage disequilibrium mapping of novel lung tumor susceptibility quantitative trait loci in mice.		Wang D; Lemon WJ; You M		Oncogene	21	2002	6858-65	J:79519	12360413
89246	Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years.		Devereux TR; Holliday W; Anna C; Ress N; Roycroft J; Sills RC		Carcinogenesis	23	2002	1737-43	J:79587	12376484
89247	The p53 network in lung carcinogenesis.		Robles AI; Linke SP; Harris CC		Oncogene	21	2002	6898-907	J:79597	12362272
89248	Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice.		Kisley LR; Barrett BS; Dwyer-Nield LD; Bauer AK; Thompson DC; Malkinson AM		Carcinogenesis	23	2002	1653-60	J:79585	12376474
89249	Oral administration of the citrus coumarin, isopimpinellin, blocks DNA adduct formation and skin tumor initiation by 7,12-dimethylbenz[a]anthracene in SENCAR mice.		Kleiner HE; Vulimiri SV; Starost MF; Reed MJ; DiGiovanni J		Carcinogenesis	23	2002	1667-75	J:79586	12376476
89250	Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.		van Lohuizen M; Verbeek S; Krimpenfort P; Domen J; Saris C; Radaszkiewicz T; Berns A		Cell	56	1989	673-82	J:79624	2537153
89251	Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES).		Newbold RR; Moore AB; Dixon D		Toxicol Pathol	30	2002	611-6	J:79675	12371671
89252	High oleic acid oil suppresses lung tumorigenesis in mice through the modulation of extracellular signal-regulated kinase cascade.		Yamaki T; Yano T; Satoh H; Endo T; Matsuyama C; Kumagai H; Miyahara M; Sakurai H; Pokorny J; Shin SJ; Hagiwara K		Lipids	37	2002	783-8	J:79674	12371749
89253	Comparative prevalence, multiplicity, and progression of spontaneous and vinyl carbamate-induced liver lesions in five strains of male mice.		Takahashi M; Dinse GE; Foley JF; Hardisty JF; Maronpot RR		Toxicol Pathol	30	2002	599-605	J:79676	12371669
89254	Apparent mesonephric duct (rete anlage) origin for cysts and proliferative epithelial lesions in the mouse ovary.		Long GG		Toxicol Pathol	30	2002	592-8	J:79677	12371668
89255	Hepatoblastomas in mice in the US National Toxicology Program (NTP) studies.		Turusov VS; Torii M; Sills RC; Willson GA; Herbert RA; Hailey JR; Haseman JK; Boorman GA		Toxicol Pathol	30	2002	580-91	J:79678	12371667
89256	Propylene glycol monomethyl ether (PGME): inhalation toxicity and carcinogenicity in Fischer 344 rats and B6C3F1 mice.		Spencer PJ; Crissman JW; Stott WT; Corley RA; Cieszlak FS; Schumann AM; Hardisty JF		Toxicol Pathol	30	2002	570-9	J:79679	12371666
89257	N-acetil-l-cysteine and 2-amino-2-thiiazoline N-acetyl-l-cysteinate as a possible cancer chemopreventive agents in murine models.		Simkeviciene V; Straukas J; Uleckiene S		Acta Biol Hung	53	2002	293-8	J:79680	12371608
89258	The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas.		Assimakopoulos D; Kolettas E; Patrikakos G; Evangelou A		Histol Histopathol	17	2002	1269-81	J:79681	12371152
89259	Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.		Schuff KG; Hentges ST; Kelly MA; Binart N; Kelly PA; Iuvone PM; Asa SL; Low MJ		J Clin Invest	110	2002	973-81	J:79683	12370275
89260	Modulating effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on skin carcinogenesis initiated by the weak inducer 7,12-dimethylbenz(a)anthracene.		Lesca P; Perrot N; Peryt B		Drug Metabol Drug Interact	11	1994	37-57	J:79684	12369593
89261	Soy isoflavones increase latency of spontaneous mammary tumors in mice.		Jin Z; MacDonald RS		J Nutr	132	2002	3186-90	J:79685	12368416
89262	c-myc: more than just a matter of life and death.		Pelengaris S; Khan M; Evan G		Nat Rev Cancer	2	2002	764-76	J:79686	12360279
89263	Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice.		Hamamoto T; Beppu H; Okada H; Kawabata M; Kitamura T; Miyazono K; Kato M		Cancer Res	62	2002	5955-61	J:79668	12384562
89264	Susceptibility to lymphoid neoplasia in immunodeficient strains of nonobese diabetic mice.		Chiu PP; Ivakine E; Mortin-Toth S; Danska JS		Cancer Res	62	2002	5828-34	J:79669	12384545
89265	Overexpression of Glutamine Synthetase Is Associated with beta-Catenin-Mutations in Mouse Liver Tumors during Promotion of Hepatocarcinogenesis by Phenobarbital.		Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M		Cancer Res	62	2002	5685-8	J:79670	12384525
89266	Application of inter-simple sequence repeat PCR to mouse models: Assessment of genetic alterations in carcinogenesis.		Benavides F; Zamisch M; Flores M; Campbell MR; Andrew SE; Angel JM; Licchesi J; Sternik G; Richie ER; Conti CJ		Genes Chromosomes Cancer	35	2002	299-310	J:79672	12378524
89267	Functional significance of the perforin/granzyme cell death pathway.		Trapani JA; Smyth MJ		Nat Rev Immunol	2	2002	735-47	J:79687	12360212
89268	Matrilysin (Matrix Metalloproteinase-7) Selects for Apoptosis-resistant Mammary Cells in Vivo.		Vargo-Gogola T; Fingleton B; Crawford HC; Matrisian LM		Cancer Res	62	2002	5559-63	J:79688	12359768
89269	Celecoxib, a Selective Cyclooxygenase 2 Inhibitor, Protects against Human Epidermal Growth Factor Receptor 2 (HER-2)/neu-induced Breast Cancer.		Howe LR; Subbaramaiah K; Patel J; Masferrer JL; Deora A; Hudis C; Thaler HT; Muller WJ; Du B; Brown AM; Dannenberg AJ		Cancer Res	62	2002	5405-7	J:79691	12359744
89270	Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in Apc(Min/+) mice.		Tucker J; Davis C; Kitchens M; Bunni M; Priest D; Spencer H; Berger F		Cancer Lett	187	2002	153	J:79692	12359363
89271	Allelic Losses in Mouse Skin Tumors Induced by gamma-Irradiation of p53 Heterozygotes.		Miyazawa T; Sato H; Hatakeyama K; Kitagawa T; Kominami R		Jpn J Cancer Res	93	2002	994-9	J:79693	12359052
89272	The pathogenesis of pituitary tumours.		Asa SL; Ezzat S		Nat Rev Cancer	2	2002	836-49	J:79695	12415254
89273	Bcl-2 Determines Susceptibility to Induction of Lung Cancer by Oncogenic CRaf.		Fedorov LM; Tyrsin OY; Papadopoulos T; Camarero G; Gotz R; Rapp UR		Cancer Res	62	2002	6297-303	J:79696	12414660
89274	Smad4 overexpression causes germ cell ablation and leydig cell hyperplasia in transgenic mice.		Narula A; Kilen S; Ma E; Kroeger J; Goldberg E; Woodruff TK		Am J Pathol	161	2002	1723-34	J:79698	12414519
89275	Developmental study of SV40 large T antigen expression in transgenic mice with choroid plexus neoplasia.		Messing A; Pinkert CA; Palmiter RD; Brinster RL		Oncogene Res	3	1988	87-97	J:79727	3060799
89276	Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).		Orner GA; Dashwood WM; Blum CA; Diaz GD; Li Q; Al-Fageeh M; Tebbutt N; Heath JK; Ernst M; Dashwood RH		Mutat Res	506-507	2002	121-7	J:79797	12351151
89277	Medulloblastoma growth inhibition by hedgehog pathway blockade.		Berman DM; Karhadkar SS; Hallahan AR; Pritchard JI; Eberhart CG; Watkins DN; Chen JK; Cooper MK; Taipale J; Olson JM; Beachy PA		Science	297	2002	1559-61	J:79798	12202832
89278	Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver.		Sargent LM; Zhou X; Keck CL; Sanderson ND; Zimonjic DB; Popescu NC; Thorgeirsson SS		Am J Pathol	154	1999	1047-55	J:79839	10233843
89279	Cancer immunoediting: from immunosurveillance to tumor escape.		Dunn GP; Bruce AT; Ikeda H; Old LJ; Schreiber RD		Nat Immunol	3	2002	991-8	J:80005	12407406
89280	Reduced cyclin D1 ubiquitination in UVB-induced murine squamous cell carcinomas.		Kim AL; Gautier J; Bickers DR; Athar M		Biochem Biophys Res Commun	298	2002	377-82	J:80029	12413951
89281	Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors.		Kenney AM; Cole MD; Rowitch DH		Development	130	2003	15-28	J:80019	12441288
89282	Timeline: Polyoma virus middle T antigen and its role in identifying cancer-related molecules.		Dilworth SM		Nat Rev Cancer	2	2002	951-6	J:80280	12459733
89283	The retinoblastoma tumour suppressor in development and cancer.		Classon M; Harlow E		Nat Rev Cancer	2	2002	910-7	J:80281	12459729
89284	A naturally occurring point substitution in Cdc25A, and not Fv2/Stk, is associated with altered cell-cycle status of early erythroid progenitor cells.		Melkun E; Pilione M; Paulson RF		Blood	100	2002	3804-11	J:80142	12411323
89285	Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps.		Sonoshita M; Takaku K; Oshima M; Sugihara K; Taketo MM		Cancer Res	62	2002	6846-9	J:80277	12460897
89286	Elimination of Colon Cancer in Germ-free Transforming Growth Factor Beta 1-deficient Mice.		Engle SJ; Ormsby I; Pawlowski S; Boivin GP; Croft J; Balish E; Doetschman T		Cancer Res	62	2002	6362-6	J:80209	12438215
89287	Carcinogenic induction directs the selection of allelic losses in mouse lung tumorigenesis.		Herzog CR; Devereux TR; Pittman B; You M		Cancer Res	62	2002	6424-9	J:80210	12438228
89288	Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.		Pan H; Griep AE		Genes Dev	8	1994	1285-99	J:80199	7926731
89289	Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis.		Ezzat S; Zheng L; Zhu XF; Wu GE; Asa SL		J Clin Invest	109	2002	69-78	J:80200	11781352
89290	Short chain Fatty acids and colon cancer.		Augenlicht LH; Mariadason JM; Wilson A; Arango D; Yang W; Heerdt BG; Velcich A		J Nutr	132	2002	3804S-8S	J:80269	12468628
89291	Timing of supplementation with the antioxidant N-acetyl-L-cysteine reduces tumor multiplicity in novel, cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) transgenic mice but has no impact on malignant progression.		Martin KR; Saulnier MJ; Kari FW; Barrett JC; French JE		Nutr Cancer	43	2002	59-66	J:80270	12467136
89292	Pim-1: A serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.		Wang Z; Bhattacharya N; Weaver M; Petersen K; Meyer M; Gapter L; Magnuson N		J Vet Sci	2	2001	167-79	J:80292	12441685
89293	Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice.		Hawighorst T; Oura H; Streit M; Janes L; Nguyen L; Brown LF; Oliver G; Jackson DG; Detmar M		Oncogene	21	2002	7945-56	J:80294	12439745
89294	A Mutant of Human Papillomavirus Type 16 E6 Deficient in Binding alpha-Helix Partners Displays Reduced Oncogenic Potential In Vivo.		Nguyen M; Song S; Liem A; Androphy E; Liu Y; Lambert PF		J Virol	76	2002	13039-48	J:80295	12438630
89295	Ink4a/Arf Deficiency Promotes Ultraviolet Radiation-induced Melanomagenesis.		Recio JA; Noonan FP; Takayama H; Anver MR; Duray P; Rush WL; Lindner G; De Fabo EC; DePinho RA; Merlino G		Cancer Res	62	2002	6724-30	J:80296	12438273
89296	Acceleration of Mouse Mammary Tumor Virus-Induced Murine Mammary Tumorigenesis by a p53(172H) Transgene: Influence of FVB Background on Tumor Latency and Identification of Novel Sites of Proviral Insertion.		Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS		Am J Pathol	161	2002	2241-53	J:80272	12466138
89297	The macrophage growth factor CSF-1 in mammary gland development and tumor progression.		Lin EY; Gouon-Evans V; Nguyen AV; Pollard JW		J Mammary Gland Biol Neoplasia	7	2002	147-62	J:80273	12465600
89298	PTEN regulation of neural development and CNS stem cells.		Li L; Liu F; Ross AH		J Cell Biochem	88	2003	24-8	J:80275	12461771
89299	Tumor Induction in Mouse Liver: Di-isononyl Phthalate Acts via Peroxisome Proliferation.		Kaufmann W; Deckardt K; McKee RH; Butala JH; Bahnemann R		Regul Toxicol Pharmacol	36	2002	175-83	J:80278	12460752
89300	Hemopoietic and Lymphoid Organs in AKR/JY Mice with Thymic Lymphoma.		Karpova GV; Fomina TI; Abramova EV; Bel'skaya NV; Trofimova ES; Perel'muter VM		Bull Exp Biol Med	134	2002	69-72	J:80279	12459873
89301	Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice.		Lin X; Gingrich JR; Bao W; Li J; Haroon ZA; Demark-Wahnefried W		Urology	60	2002	919-24	J:80307	12429338
89302	Dendritic cell-tumor cell fusion and staphylococcal enterotoxin B treatment in a pancreatic tumor model.		McConnell EJ; Pathangey LB; Madsen CS; Gendler SJ; Mukherjee P		J Surg Res	107	2002	196-202	J:80308	12429175
89303	Life span, cancer and non-cancer diseases in mouse exposed to a continuous very low dose of gamma-irradiation.		Courtade M; Billote C; Gasset G; Caratero A; Charlet JP; Pipy B; Caratero C		Int J Radiat Biol	78	2002	845-55	J:80309	12428925
89304	Epithalon inhibits tumor growth and expression of HER-2/neu oncogene in breast tumors in transgenic mice characterized by accelerated aging.		Anisimov VN; Khavinsov VKh; Alimova IN; Provintsiali M; Manchini R; Francheski K		Bull Exp Biol Med	133	2002	167-70	J:80310	12428286
89305	'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally.		Garcia-Cao I; Garcia-Cao M; Martin-Caballero J; Criado LM; Klatt P; Flores JM; Weill JC; Blasco MA; Serrano M		EMBO J	21	2002	6225-35	J:80311	12426394
89306	Arsenite cocarcinogenesis: an animal model derived from genetic toxicology studies.		Rossman TG; Uddin AN; Burns FJ; Bosland MC		Environ Health Perspect	110 Suppl 5	2002	749-52	J:80312	12426125
89307	Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.		Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW		Gene Ther	9	2002	1589-99	J:80313	12424611
89308	The Retinoid X Receptor-Selective Retinoid, LGD1069, Prevents the Development of Estrogen Receptor-Negative Mammary Tumors in Transgenic Mice.		Wu K; Zhang Y; Xu XC; Hill J; Celestino J; Kim HT; Mohsin SK; Hilsenbeck SG; Lamph WW; Bissonette R; Brown PH		Cancer Res	62	2002	6376-80	J:80300	12438218
89309	Microadenomatous lesions involving loss of apc heterozygosity in the colon of adult apc(min/+) mice.		Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H		Cancer Res	62	2002	6367-70	J:80301	12438216
89310	Ethanol Promotes Intestinal Tumorigenesis in the MIN Mouse.		Roy HK; Gulizia JM; Karolski WJ; Ratashak A; Sorrell MF; Tuma D		Cancer Epidemiol Biomarkers Prev	11	2002	1499-502	J:80302	12433735
89311	Visual Genotyping of a Coat Color Tagged p53 Mutant Mouse Line.		Zheng B; Vogel H; Donehower LA; Bradley A		Cancer Biol Ther	1	2002	433-5	J:80303	12432262
89312	Expression of peroxisome proliferator-activated receptor alpha, and PPARalpha regulated genes in spontaneously developed hepatocellular carcinomas in fatty acyl-CoA oxidase null mice.		Meyer K; Jia Y; Cao WQ; Kashireddy P; Ra MS		Int J Oncol	21	2002	1175-80	J:80305	12429965
89313	In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation.		Piva R; Liu J; Chiarle R; Podda A; Pagano M; Inghirami G		Mol Cell Biol	22	2002	8375-87	J:80320	12417738
89314	Characterization of a novel murine retrovirus mixture that facilitates hematopoiesis.		Hook LM; Jude BA; Ter-Grigorov VS; Hartley JW; Morse HC rd; Trainin Z; Toder V; Chervonsky AV; Golovkina TV		J Virol	76	2002	12112-22	J:80321	12414952
89315	New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.		Herlyn M; Padarathsingh M; Chin L; Hendrix M; Becker D; Nelson M; DeClerck Y; McCarthy J; Mohla S		Am J Pathol	161	2002	1949-57	J:80322	12414540
89316	Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity.		Greiner JW; Zeytin H; Anver MR; Schlom J		Cancer Res	62	2002	6944-51	J:80324	12460911
89317	Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis.		Kisley LR; Barrett BS; Bauer AK; Dwyer-Nield LD; Barthel B; Meyer AM; Thompson DC; Malkinson AM		Cancer Res	62	2002	6850-6	J:80325	12460898
89318	Expression of stabilized beta-catenin in differentiated neurons of transgenic mice does not result in tumor formation.		Kratz JE; Stearns D; Huso DL; Slunt HH; Price DL; Borchelt DR; Eberhart CG		BMC Cancer	2	2002	33	J:80326	12460454
89319	Epithalon decelerates aging and suppresses development of breast adenocarcinomas in transgenic her-2/neu mice.		Anisimov VN; Khavinson VKh; Alimova IN; Semchenko AV; Yashin AI		Bull Exp Biol Med	134	2002	187-90	J:80327	12459848
89320	Chemopreventive effect of Vitis vinifera extract on 12-O-tetradecanoyl-13-phorbol acetate-induced cutaneous oxidative stress and tumor promotion in murine skin.		Alam A; Khan N; Sharma S; Saleem M; Sultana S		Pharmacol Res	46	2002	557-64	J:80328	12457631
89321	Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9.		Gut MO; Parkkila S; Vernerova Z; Rohde E; Zavada J; Hocker M; Pastorek J; Karttunen T; Gibadulinova A; Zavadova Z; Knobeloch KP; Wiedenmann B; Svoboda J; Horak I; Pastorekova S		Gastroenterology	123	2002	1889-903	J:80329	12454846
89322	The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion.		Flemming A; Brummer T; Reth M; Jumaa H		Nat Immunol	4	2003	38-43	J:80332	12436112
89323	Mouse models to study the role of telomeres in cancer, aging and DNA repair.		Blasco MA		Eur J Cancer	38	2002	2222-8	J:80331	12441258
89324	Disruption of Dihydronicotinamide Riboside:Quinone Oxidoreductase 2 (NQO2) Leads to Myeloid Hyperplasia of Bone Marrow and Decreased Sensitivity to Menadione Toxicity.		Long DJ 2nd; Iskander K; Gaikwad A; Arin M; Roop DR; Knox R; Barrios R; Jaiswal AK		J Biol Chem	277	2002	46131-9	J:80549	12351651
89325	Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.		Pupa SM; Invernizzi AM; Forti S; Di Carlo E; Musiani P; Nanni P; Lollini PL; Meazza R; Ferrini S; Menard S		Gene Ther	8	2001	75-9	J:80581	11402305
89326	Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.		Iavnilovitch E; Groner B; Barash I		Mol Cancer Res	1	2002	32-47	J:80588	12496367
89327	A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo.		Zhang J; Thomas TZ; Kasper S; Matusik RJ		Endocrinology	141	2000	4698-710	J:80599	11108285
89328	Transgenic Mouse Models of Prostate Cancer		Matusik RJ; Masumori N; Thomas T; Case T; Paul M; Kasper S; Shappell SB				2001	401-25	J:80623	 
89329	Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.		Rilianawati; Paukku T; Kero J; Zhang FP; Rahman N; Kananen K; Huhtaniemi I		Mol Endocrinol	12	1998	801-9	J:80664	9626655
89330	GFP Expression in the Mammary Gland for Imaging of Mammary Tumor Cells in Transgenic Mice.		Ahmed F; Wyckoff J; Lin EY; Wang W; Wang Y; Hennighausen L; Miyazaki J; Jones J; Pollard JW; Condeelis JS; Segall JE		Cancer Res	62	2002	7166-9	J:80828	12499251
89331	Proviral Insertion Indicates a Dominant Oncogenic Role for Runx1/AML-1 in T-Cell Lymphoma.		Wotton S; Stewart M; Blyth K; Vaillant F; Kilbey A; Neil JC; Cameron ER		Cancer Res	62	2002	7181-5	J:80829	12499254
89332	Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice.		Foster BA; Evangelou A; Gingrich JR; Kaplan PJ; DeMayo F; Greenberg NM		Differentiation	70	2002	624-32	J:80821	12492503
89333	Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.		Ornitz DM; Hammer RE; Messing A; Palmiter RD; Brinster RL		Science	238	1987	188-93	J:80845	2821617
89334	Lung tumorigenesis associated with erb-B-2 and erb-B-3 overexpression in human erb-B-3 transgenic mice is enhanced by methylnitrosourea.		Zhou H; Liu L; Lee K; Qin X; Grasso AW; Kung HJ; Willis JE; Kern J; Wagner T; Gerson SL		Oncogene	21	2002	8732-40	J:80974	12483526
89335	Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis.		Zinser GM; Sundberg JP; Welsh J		Carcinogenesis	23	2002	2103-9	J:81031	12507934
89336	Gris1, a new common integration site in Graffi murine leukemia virus-induced leukemias: overexpression of a truncated cyclin D2 due to alternative splicing.		Denicourt C; Kozak CA; Rassart E		J Virol	77	2003	37-44	J:81019	12477808
89337	Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells.		West KA; Brognard J; Clark AS; Linnoila IR; Yang X; Swain SM; Harris C; Belinsky S; Dennis PA		J Clin Invest	111	2003	81-90	J:81064	12511591
89338	mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation.		Mendrysa SM; McElwee MK; Michalowski J; O'Leary KA; Young KM; Perry ME		Mol Cell Biol	23	2003	462-72	J:81065	12509446
89339	Pre-clinical applications of transgenic mouse mammary cancer models.		Kavanaugh CJ; Desai KV; Calvo A; Brown PH; Couldrey C; Lubet R; Green JE		Transgenic Res	11	2002	617-33	J:81067	12509137
89340	Inhibition of conjugated linoleic acid on mouse forestomach neoplasia induced by benzo (a) pyrene and chemopreventive mechanisms.		Chen BQ; Xue YB; Liu JR; Yang YM; Zheng YM; Wang XL; Liu RH		World J Gastroenterol	9	2003	44-9	J:81068	12508349
89341	Medulloblastoma in Mice Lacking p53 and PARP: All Roads Lead To Gli.		Eberhart CG		Am J Pathol	162	2003	7-10	J:81069	12507884
89342	Modeling human breast cancer metastasis in mice: maspin as a paradigm.		Shi HY; Zhang W; Liang R; Kittrell F; Templeton NS; Medina D; Zhang M		Histol Histopathol	18	2003	201-6	J:81070	12507299
89343	Lack of susceptibility of heterozygous p53-knockout CBA and CIEA mice to phenolphthalein in a 6-month carcinogenicity study.		Okamura M; Kashida Y; Watanabe T; Yasuhara K; Onodera H; Hirose M; Usui T; Tamaoki N; Mitsumori K		Toxicology	185	2003	17-22	J:81071	12505441
89344	Upregulation of FasL and apoptosis in thymic lymphomas in Atm knock-in mice.		Lavin MF; Spring K		Toxicology	181-182	2002	483-9	J:81072	12505357
89345	Evaluation on carcinogenicity of chemicals using transgenic mice.		Mitsumori K		Toxicology	181-182	2002	241-4	J:81073	12505318
89346	Progressive iron overload enhances chemically mediated tumor promotion in murine skin.		Bhasin G; Kausar H; Sarwar Alam M; Athar M		Arch Biochem Biophys	409	2003	262-73	J:81075	12504893
89347	Carcinogenic potential of o-nitrotoluene and p-nitrotoluene.		Dunnick JK; Burka LT; Mahler J; Sills R		Toxicology	183	2003	221-34	J:81076	12504353
89348	A 60 Hz magnetic field does not affect the incidence of squamous cell carcinomas in SENCAR mice.		McLean JR; Thansandote A; McNamee JP; Tryphonas L; Lecuyer D; Gajda G		Bioelectromagnetics	24	2003	75-81	J:81052	12524673
89349	Allelic Loss of p53 Gene Is Associated with Genesis and Maintenance, but not Invasion, of Mouse Carcinoma in Situ of the Bladder.		Cheng J; Huang H; Pak J; Shapiro E; Sun TT; Cordon-Cardo C; Waldman FM; Wu XR		Cancer Res	63	2003	179-85	J:81056	12517796
89350	Genetic Analysis of Three-dimensional Shape of Mouse Lung Tumors Reveals Eight Lung Tumor Shape-Determining (Ltsd) Loci That Are Associated with Tumor Heterogeneity and Symmetry.		Tripodis N; Demant P		Cancer Res	63	2003	125-31	J:81057	12517788
89351	A 2-Year Dose-Response Study of Lesion Sequences during Hepatocellular Carcinogenesis in the Male B6C3F(subscript)1(/subscript) Mouse Given the Drinking Water Chemical Dichloroacetic Acid.		Carter JH; Carter HW; Deddens JA; Hurst BM; George MH; DeAngelo AB		Environ Health Perspect	111	2003	53-64	J:81058	12515679
89352	FasL deficiency enhances the development of tumors in p53+/- mice.		Embree-Ku M; Boekelheide K		Toxicol Pathol	30	2002	705-13	J:81060	12512872
89353	Toxicity and carcinogenicity studies of chlorpromazine hydrochloride and p-cresidine in the p53 heterozygous mouse model.		Petruska JM; Frank DW; Freeman GB; Evans EW; MacDonald JS		Toxicol Pathol	30	2002	696-704	J:81061	12512871
89354	Comparative pathology of proliferative lesions of the urinary bladder.		Cohen SM		Toxicol Pathol	30	2002	663-71	J:81062	12512866
89355	Characteristics of the spectrum of proliferative lesions observed in the kidney and urinary bladder of Fischer 344 rats and B6C3F1 mice.		Wolf JC		Toxicol Pathol	30	2002	657-62	J:81063	12512865
89356	Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene.		Heidel SM; MacWilliams PS; Baird WM; Dashwood WM; Buters JT; Gonzalez FJ; Larsen MC; Czuprynski CJ; Jefcoate CR		Cancer Res	60	2000	3454-60	J:81113	10910056
89357	O-phenylphenol and its sodium and potassium salts: a toxicological assessment.		Bomhard EM; Brendler-Schwaab SY; Freyberger A; Herbold BA; Leser KH; Richter M		Crit Rev Toxicol	32	2002	551-625	J:81090	12487365
89358	Effects of conjugated linoleic acid on adenoma formation in the ApcMin mouse.		Rajakangas J; Turpeinen AM; Salminen I; Mutanen M		IARC Sci Publ	156	2002	405-6	J:81092	12484222
89359	Indigestible carbohydrates which reduce colon tumour incidence in Min mice may interfere with the local immune response.		Menanteau J; Pierre F; Bassonga E; Forest V; Bornet F; Perrin P; Meflah K		IARC Sci Publ	156	2002	391-2	J:81093	12484215
89360	The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.		Moynahan ME		Oncogene	21	2002	8994-9007	J:81094	12483515
89361	Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression.		Huss WJ; Barrios RJ; Foster BA; Greenberg NM		Prostate	54	2003	8-16	J:81095	12481250
89362	The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.		Gartel AL; Tyner AL		Mol Cancer Ther	1	2002	639-49	J:81096	12479224
89363	The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice.		Anisimov VN; Alimova IN; Baturin DA; Popovich IG; Zabezhinski MA; Manton KG; Semenchenko AV; Yashin AI		Int J Cancer	103	2003	300-5	J:81097	12471612
89364	Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: A sequential pathological evaluation.		Lakhtakia R; Kumar V; Reddi H; Mathur M; Dattagupta S; Panda SK		J Gastroenterol Hepatol	18	2003	80-91	J:81098	12519229
89365	Animal models of melanoma: an HGF/SF transgenic mouse model may facilitate experimental access to UV initiating events.		Noonan FP; Dudek J; Merlino G; De Fabo EC		Pigment Cell Res	16	2003	16-25	J:81099	12519121
89366	A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.		Sohal J; Phan VT; Chan PV; Davis EM; Patel B; Kelly LM; Abrams TJ; O'Farrell AM; Gilliland DG; Le Beau MM; Kogan SC		Blood	101	2003	3188-97	J:81100	12515727
89367	Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis.		Wu MX		Apoptosis	8	2003	11-18	J:81101	12510147
89368	Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas.		Jensen NA; Pedersen KM; Lihme F; Rask L; Nielsen JV; Rasmussen TE; Mitchelmore C		J Biol Chem	278	2003	8300-8	J:81102	12501251
89369	Androgens and growth factors in prostate cancer: a transgenic perspective.		Greenberg NM		Prostate Cancer Prostatic Dis	3	2000	224-228	J:81103	12497068
89370	Epidermal differentiation: transgenic/knockout mouse models reveal genes involved in stem cell fate decisions and commitment to differentiation.		Koster MI; Huntzinger KA; Roop DR		J Investig Dermatol Symp Proc	7	2002	41-5	J:81192	12518791
89371	Progress in cutaneous cancer research.		Dlugosz A; Merlino G; Yuspa SH		J Investig Dermatol Symp Proc	7	2002	17-26	J:81193	12518788
89372	The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model.		Ren R		Oncogene	21	2002	8629-42	J:81194	12476309
89373	Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory response.		Maria DA; Manenti G; Galbiati F; Ribeiro OG; Cabrera WH; Barrera RG; Pettinicchio A; Franco MD; Starobinas N; Siqueira M; Dragani TA; Ibanez OM		Oncogene	22	2003	426-32	J:81205	12545163
89374	Identification of Dss1 as a 12-O-Tetradecanoylphorbol-13-acetate-responsive Gene Expressed in Keratinocyte Progenitor Cells, with Possible Involvement in Early Skin Tumorigenesis.		Wei SJ; Trempus CS; Cannon RE; Bortner CD; Tennant RW		J Biol Chem	278	2003	1758-68	J:81214	12419822
89375	Targeted expression of the ras and myc oncogenes in transgenic mice		Groner B; Schonenberger CA; Andres AC		Trends Genet	3	1987	306-9	J:81262	 
89376	Gene silencing in phenomena related to DNA repair.		Mukai T; Sekiguchi M		Oncogene	21	2002	9033-42	J:81236	12483518
89377	Oxidative nucleotide damage: consequences and prevention.		Sekiguchi M; Tsuzuki T		Oncogene	21	2002	8895-904	J:81237	12483507
89378	Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.		Stewart M; Cameron E; Campbell M; McFarlane R; Toth S; Lang K; Onions D; Neil JC		Int J Cancer	53	1993	1023-30	J:81276	8473043
89379	Proapoptotic BID is required for myeloid homeostasis and tumor suppression.		Zinkel SS; Ong CC; Ferguson DO; Iwasaki H; Akashi K; Bronson RT; Kutok JL; Alt FW; Korsmeyer SJ		Genes Dev	17	2003	229-39	J:81329	12533511
89380	Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis.		Vassar R; Hutton ME; Fuchs E		Mol Cell Biol	12	1992	4643-53	J:81377	1406654
89381	Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skin carcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot.		Kapadia GJ; Azuine MA; Sridhar R; Okuda Y; Tsuruta A; Ichiishi E; Mukainake T; Takasaki M; Konoshima T; Nishino H; Tokuda H		Pharmacol Res	47	2003	141-8	J:81575	12543062
89382	Effect of targeted mutation in collagen V alpha 2 gene on development of cutaneous hyperplasia in tight skin mice.		Phelps RG; Murai C; Saito S; Hatakeyama A; Andrikopoulos K; Kasturi KN ; Bona CA		Mol Med	4	1998	356-60	J:48765	9642685
89383	Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene.		Mayo KE; Hammer RE; Swanson LW; Brinster RL; Rosenfeld MG; Evans RM		Mol Endocrinol	2	1988	606-12	J:81425	3137455
89384	Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas.		Dominey AM; Wang XJ; King LE Jr; Nanney LB; Gagne TA; Sellheyer K; Bundman DS; Longley MA; Rothnagel JA; Greenhalgh DA; et al.		Cell Growth Differ	4	1993	1071-82	J:81427	8117621
89385	Pancreatic cancer biology and genetics.		Bardeesy N; DePinho RA		Nat Rev Cancer	2	2002	897-909	J:81432	12459728
89386	Animal models of bone metastasis.		Rosol TJ; Tannehill-Gregg SH; LeRoy BE; Mandl S; Contag CH		Cancer	97	2003	748-57	J:81422	12548572
89387	Emergence of uterine pathology during accelerated biological aging in FSH receptor-haploinsufficient mice.		Danilovich N; Roy I; Sairam MR		Endocrinology	143	2002	3618-27	J:81460	12193578
89388	Vitamin E supplementation does not alter azoxymethane-induced colonic aberrant crypt foci formation in young or old mice.		Chung H; Wu D; Han SN; Gay R; Goldin B; Bronson RE; Mason JB; Smith DE; Meydani SN		J Nutr	133	2003	528-32	J:81483	12566495
89389	Anti-tumor Promoting Effect of Glycosides from Prunus persica Seeds.		Fukuda T; Ito H; Mukainaka T; Tokuda H; Nishino H; Yoshida T		Biol Pharm Bull	26	2003	271-3	J:81520	12576693
89390	Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells.		Xia J; Tanaka Y; Koido S; Liu C; Mukherjee P; Gendler SJ; Gong J		J Immunol	170	2003	1980-6	J:81521	12574367
89391	Mouse cancer models as a platform for performing preclinical therapeutic trials.		Weiss B; Shannon K		Curr Opin Genet Dev	13	2003	84-9	J:81522	12573440
89392	Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models.		Wetmore C		Curr Opin Genet Dev	13	2003	34-42	J:81523	12573433
89393	Neurofibromatosis 1: closing the GAP between mice and men.		Dasgupta B; Gutmann DH		Curr Opin Genet Dev	13	2003	20-7	J:81524	12573431
89394	Genomic approaches to identification of tumour-susceptibility genes using mouse models.		Mao JH; Balmain A		Curr Opin Genet Dev	13	2003	14-9	J:81525	12573430
89395	Antioxidant and antitumor effects of hydroxymatairesinol (HM-3000, HMR), a lignan isolated from the knots of spruce.		Kangas L; Saarinen N; Mutanen M; Ahotupa M; Hirsinummi R; Unkila M; Perala M; Soininen P; Laatikainen R; Korte H; Santti R		Eur J Cancer Prev	11 Suppl 2	2002	S48-57	J:81526	12570335
89396	Inhibitory effects of tea and caffeine on UV-induced carcinogenesis: relationship to enhanced apoptosis and decreased tissue fat.		Conney AH; Lu YP; Lou YR; Huang MT		Eur J Cancer Prev	11 Suppl 2	2002	S28-36	J:81527	12570332
89397	Mouse Wnt9b transforming activity, tissue-specific expression, and evolution.		Qian J; Jiang Z; Li M; Heaphy P; Liu YH; Shackleford GM		Genomics	81	2003	34-46	J:81512	12573259
89398	Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.		Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE		Oncogene	22	2003	412-25	J:81550	12545162
89399	p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development.		Carneiro C; Jiao MS; Hu M; Shaffer D; Park M; Pandolfi PP; Cordon-Cardo C; Koff A		Oncogene	22	2003	361-9	J:81551	12545157
89400	Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.		Wong KK; Maser RS; Bachoo RM; Menon J; Carrasco DR; Gu Y; Alt FW; DePinho RA		Nature	421	2003	643-8	J:81552	12540856
89401	Epididymal cribriform hyperplasia with nuclear atypia in p53 homozygous knockout mice on a mixed 129/Sv-FVB/N background.		La Perle KM; Blomme EA; Sagartz JE; Capen CC		Comp Med	52	2002	568-71	J:81553	12540173
89402	Unique Resistance of I/LnJ Mice to a Retrovirus Is Due to Sustained Interferon gamma-dependent Production of Virus-neutralizing Antibodies.		Purdy A; Case L; Duvall M; Overstrom-Coleman M; Monnier N; Chervonsky A; Golovkina T		J Exp Med	197	2003	233-43	J:81554	12538662
89403	Haploinsufficiency of p18(INK4c) Sensitizes Mice to Carcinogen-Induced Tumorigenesis.		Bai F; Pei XH; Godfrey VL; Xiong Y		Mol Cell Biol	23	2003	1269-77	J:81540	12556487
89404	Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice.		Bachelier R; Xu X; Wang X; Li W; Naramura M; Gu H; Deng CX		Oncogene	22	2003	528-37	J:81541	12555066
89405	Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice.		Lange K; Uckert W; Blankenstein T; Nadrowitz R; Bittner C; Renauld JC; Snick Jv J; Feller AC; Merz H		Oncogene	22	2003	517-27	J:81542	12555065
89406	A matrix metalloproteinase inhibitor, ONO-4817, retards the development of mammary tumor and the progression of uterine adenomyosis in mice.		Mori T; Nakahashi K; Kyokuwa M; Yamasaki S; Nagasawa H		Anticancer Res	22	2002	3985-8	J:81544	12553022
89407	The more an ulcerative colitis is repeated, the more the risk of colorectal carcinogenesis is increased in mice.		Mitamura T; Sakamoto S; Sassa S; Suzuiki S; Kudo H; Okayasu I		Anticancer Res	22	2002	3955-61	J:81545	12553018
89408	Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation.		Babu JR; Jeganathan KB; Baker DJ; Wu X; Kang-Decker N; Van Deursen JM		J Cell Biol	160	2003	341-53	J:81546	12551952
89409	CD4(+) CD25(+) Regulatory T Lymphocytes Inhibit Microbially Induced Colon Cancer in Rag2-Deficient Mice.		Erdman SE; Poutahidis T; Tomczak M; Rogers AB; Cormier K; Plank B; Horwitz BH; Fox JG		Am J Pathol	162	2003	691-702	J:81547	12547727
89410	Transforming Growth Factor-beta Mediates Intestinal Healing and Susceptibility to Injury in Vitro and in Vivo Through Epithelial Cells.		Beck PL; Rosenberg IM; Xavier RJ; Koh T; Wong JF; Podolsky DK		Am J Pathol	162	2003	597-608	J:81548	12547717
89411	Use of transgenic and mutant animal models in the study of heterocyclic amine-induced mutagenesis and carcinogenesis.		Dashwood RH		J Biochem Mol Biol	36	2003	35-42	J:81584	12542973
89412	Chemopreventive Effects of alpha-Santalol on Skin Tumor Development in CD-1 and SENCAR Mice.		Dwivedi C; Guan X; Harmsen WL; Voss AL; Goetz-Parten DE; Koopman EM; Johnson KM; Valluri HB; Matthees DP		Cancer Epidemiol Biomarkers Prev	12	2003	151-6	J:81570	12582025
89413	Effect of yogurt on the inhibition of an intestinal carcinoma by increasing cellular apoptosis.		Rachid MM; Gobbato NM; Valdez JC; Vitalone HH; Perdigon G		Int J Immunopathol Pharmacol	15	2002	209-216	J:81571	12575921
89414	Testicular cancer susceptibility in the 129.MOLF-Chr19 mouse strain: additive effects, gene interactions and epigenetic modifications.		Youngren KK; Nadeau JH; Matin A		Hum Mol Genet	12	2003	389-98	J:81573	12566386
89415	Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible?		Hahm KB; Song YJ; Oh TY; Lee JS; Surh YJ; Kim YB; Yoo BM; Kim JH; Han SU; Nahm KT; Kim MW; Kim DY; Cho SW		J Biochem Mol Biol	36	2003	82-94	J:81576	12542979
89416	Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria.		Libbrecht L; Meerman L; Kuipers F; Roskams T; Desmet V; Jansen P		J Pathol	199	2003	191-200	J:81608	12533832
89417	Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors.		Tam AS; Devereux TR; Patel AC; Foley JF; Maronpot RR; Massey TE		Carcinogenesis	24	2003	121-32	J:81624	12538357
89418	Inducible activation of ras and raf in adult epidermis.		Tarutani M; Cai T; Dajee M; Khavari PA		Cancer Res	63	2003	319-23	J:81660	12543782
89419	Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma.		Mueller A; O'Rourke J; Grimm J; Guillemin K; Dixon MF; Lee A; Falkow S		Proc Natl Acad Sci U S A	100	2003	1292-7	J:81840	12552104
89420	Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk.		Paez-Pereda M; Giacomini D; Refojo D; Nagashima AC; Hopfner U; Grubler Y; Chervin A; Goldberg V; Goya R; Hentges ST; Low MJ; Holsboer F; Stalla GK; Arzt E		Proc Natl Acad Sci U S A	100	2003	1034-9	J:81829	12552124
89421	Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model.		Kannan K; Sharpless NE; Xu J; O'Hagan RC; Bosenberg M; Chin L		Proc Natl Acad Sci U S A	100	2003	1221-5	J:81833	12538879
89422	Somatic recombination redux.		Tischfield JA; Shao C		Nat Genet	33	2003	5-6	J:81886	12509771
89423	Msh2 deficiency enhances somatic Apc and p53 mutations in Apc+/-Msh2-/- mice.		Sohn KJ; Choi M; Song J; Chan S; Medline A; Gallinger S; Kim YI		Carcinogenesis	24	2003	217-24	J:79407	12584170
89424	Minimal effects of dietary restriction on neuroendocrine carcinogenesis in Rb+/- mice.		Sharp ZD; Lee WH; Nikitin AY; Flesken-Nikitin A; Ikeno Y; Reddick R; Richardson AG; Nelson JF		Carcinogenesis	24	2003	179-83	J:79648	12584165
89425	Tumor initiating activity of Helicobacter pylori water extract on mouse skin carcinogenesis.		Ishikawa T; Yoshida N; Tokuda H; Ichiishi E; Kuchide M; Kokura S; Naito Y; Toyokuni S; Nishino H; Yoshikawa T		Cancer Lett	191	2003	41-7	J:81929	12609708
89426	Altered chemokine receptor sensitivity in FVBN202 rat neu transgenic mice.		Kurt RA; Bauck M; Harma S; Adler E; Vitiello P; Wisner KP; Tackitt S; Urba WJ		Breast Cancer Res Treat	77	2003	225-32	J:81932	12602922
89427	Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors.		Cleary MP; Phillips FC; Getzin SC; Jacobson TL; Jacobson MK; Christensen TA; Juneja SC; Grande JP; Maihle NJ		Breast Cancer Res Treat	77	2003	205-15	J:81933	12602920
89428	Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.		Gunther EJ; Moody SE; Belka GK; Hahn KT; Innocent N; Dugan KD; Cardiff RD; Chodosh LA		Genes Dev	17	2003	488-501	J:81934	12600942
89429	Low doses of radiation increase the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone, radiation-sensitive Trp53 heterozygous mice.		Mitchel RE; Jackson JS; Morrison DP; Carlisle SM		Radiat Res	159	2003	320-7	J:81935	12600234
89430	Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Kruppel-like zinc finger protein.		Warming S; Liu P; Suzuki T; Akagi K; Lindtner S; Pavlakis GN; Jenkins NA; Copeland NG		Blood	101	2003	1934-40	J:81926	12393497
89431	Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells.		Gil-Henn H; Elson A		J Biol Chem	278	2003	15579-86	J:77194	12598528
89432	Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice.		Salim EI; Wanibuchi H; Morimura K; Wei M; Mitsuhashi M; Yoshida K; Endo G; Fukushima S		Carcinogenesis	24	2003	335-42	J:78310	12584185
89433	CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicity.		Buters J; Quintanilla-Martinez L; Schober W; Soballa VJ; Hintermair J; Wolff T; Gonzalez FJ; Greim H		Carcinogenesis	24	2003	327-34	J:78489	12584184
89434	Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis.		Dong M; Guda K; Nambiar PR; Rezaie A; Belinsky GS; Lambeau G; Giardina C; Rosenberg DW		Carcinogenesis	24	2003	307-15	J:78600	12584182
89435	General keynote: expression of epidermal growth factor receptor family in transgenic mouse models of human breast cancer.		Muller WJ		Gynecol Oncol	88	2003	S43-6; discussion S52-5	J:81946	12586084
89436	Duplication of U3 sequences in the long terminal repeat of mink cell focus-inducing viruses generates redundancies of transcription factor binding sites important for the induction of thymomas.		DiFronzo NL; Frieder M; Loiler SA; Pham QN; Holland CA		J Virol	77	2003	3326-33	J:81947	12584358
89437	Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac.		Orner GA; Dashwood WM; Blum CA; Diaz GD; Li Q; Dashwood RH		Carcinogenesis	24	2003	263-7	J:81948	12584176
89438	Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice.		Waalkes MP; Ward JM; Liu J; Diwan BA		Toxicol Appl Pharmacol	186	2003	7-17	J:81949	12583988
89439	Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice.		Murillo G; Kosmeder JW nd; Pezzuto JM; Mehta RG		Int J Cancer	104	2003	7-11	J:82044	12532413
89440	Responses to antiangiogenesis treatment of spontaneous autochthonous tumors and their isografts.		Izumi Y; di Tomaso E; Hooper A; Huang P; Huber J; Hicklin DJ; Fukumura D; Jain RK; Suit HD		Cancer Res	63	2003	747-51	J:82046	12591719
89441	Classification of cancers by expression profiling.		Liu ET		Curr Opin Genet Dev	13	2003	97-103	J:82068	12573442
89442	Tumor suppression by Ink4a-Arf: progress and puzzles.		Lowe SW; Sherr CJ		Curr Opin Genet Dev	13	2003	77-83	J:82091	12573439
89443	Telomeres and cancer: a tale with many endings.		Blasco MA		Curr Opin Genet Dev	13	2003	70-6	J:82092	12573438
89444	DNA repair defects in colon cancer.		Jiricny J; Marra G		Curr Opin Genet Dev	13	2003	61-9	J:82093	12573437
89445	The core-binding factor leukemias: lessons learned from murine models.		Downing JR		Curr Opin Genet Dev	13	2003	48-54	J:82094	12573435
89446	NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.		Chiarle R; Gong JZ; Guasparri I; Pesci A; Cai J; Liu J; Simmons WJ; Dhall G; Howes J; Piva R; Inghirami G		Blood	101	2003	1919-27	J:82127	12424201
89447	Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas.		Wakabayashi Y; Inoue J; Takahashi Y; Matsuki A; Kosugi-Okano H; Shinbo T; Mishima Y; Niwa O; Kominami R		Biochem Biophys Res Commun	301	2003	598-603	J:82132	12565905
89448	The Role of Transcription Factor GATA-2 in Early Hematopoiesis.		Li Y; Wang M		Zhongguo Shi Yan Xue Ye Xue Za Zhi	8	2000	66-70	J:82161	12578722
89449	The multiple functions of tumour suppressors: it's all in APC.		Fodde R		Nat Cell Biol	5	2003	190-2	J:82182	12646874
89450	Characterisation and developmental expression of mouse Plu-1, a homologue of a human nuclear protein (PLU-1) which is specifically up-regulated in breast cancer.		Madsen B; Spencer-Dene B; Poulsom R; Hall D; Lu PJ; Scott K; Shaw AT; Burchell JM; Freemont P; Taylor-Papadimitriou J		Mech Dev	119 Suppl 1	2002	S239-46	J:82207	14516692
89451	Switching of melanocyte pigmentation associated with pituitary pars intermedia tumors in Rb+/- and p27-/- female mice with yellow pelage.		Smith AP; Henze M; Osborn KG; Lee JA; Bortner DM; Rosenberg MP; Reed SI		Comp Med	53	2003	75-80	J:82324	12625510
89452	Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma.		Moorehead RA; Sanchez OH; Baldwin RM; Khokha R		Oncogene	22	2003	853-7	J:82326	12584565
89453	Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.		Seshasayee D; Valdez P; Yan M; Dixit VM; Tumas D; Grewal IS		Immunity	18	2003	279-88	J:82331	12594954
89454	Transgene produces massive overexpression of human beta -glucuronidase in mice, lysosomal storage of enzyme, and strain-dependent tumors.		Vogler C; Galvin N; Levy B; Grubb J; Jiang J; Zhou XY; Sly WS		Proc Natl Acad Sci U S A	100	2003	2669-73	J:82393	12591953
89455	TSPY-LTA transgenic mice develop endocrine tumors of the pituitary and adrenal gland.		Tascou S; Trappe R; Nayernia K; Jarry H; Konig F; Schulz-Schaeffer W; Saeger W; Meinhardt A; Engel W; Schmidtke J; Burfeind P		Mol Cell Endocrinol	200	2003	9-18	J:82419	12644295
89456			Lu PY		Preclinica	1	2003	31-42	J:82449	 
89457	Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis.		Alt JR; Greiner TC; Cleveland JL; Eischen CM		EMBO J	22	2003	1442-50	J:82477	12628936
89458	MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.		Schroeder JA; Adriance MC; Thompson MC; Camenisch TD; Gendler SJ		Oncogene	22	2003	1324-32	J:82470	12618757
89459	Oestrogen receptor knockout mice: roles for oestrogen receptors alpha and beta in reproductive tissues.		Hewitt SC; Korach KS		Reproduction	125	2003	143-9	J:82473	12578528
89460	Vasopressin-SV40 T antigen expression in transgenic mice induces brain tumor and lymphoma.		Lee JW; Park JH; Kim KS; Lee EJ; Kim MO; Kim SH; Jeong SW; Kim CW; Lee HJ; Kang KS; Chang KT; Hyun BH; Ryoo ZY		Biochem Biophys Res Commun	302	2003	785-92	J:82565	12646238
89461	A study of regional gut endoderm potency by analysis of Cdx2 null mutant chimaeric mice.		Beck F; Chawengsaksophak K; Luckett J; Giblett S; Tucci J; Brown J; Poulsom R; Jeffery R; Wright NA		Dev Biol	255	2003	399-406	J:82634	12648499
89462	Hair cycle regulation of Hedgehog signal reception.		Oro AE; Higgins K		Dev Biol	255	2003	238-48	J:82653	12648487
89463	Low-penetrance genetic susceptibility and resistance loci implicated in the relative risk for radiation-induced acute myeloid leukemia in mice.		Boulton E; Cole C; Knight A; Cleary H; Snowden R; Plumb M		Blood	101	2003	2349-54	J:82643	12411293
89464	Phenotype-based identification of mouse chromosome instability mutants.		Shima N; Hartford SA; Duffy T; Wilson LA; Schimenti KJ; Schimenti JC		Genetics	163	2003	1031-40	J:82700	12663541
89465	Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors.		Maretto S; Cordenonsi M; Dupont S; Braghetta P; Broccoli V; Hassan AB; Volpin D; Bressan GM; Piccolo S		Proc Natl Acad Sci U S A	100	2003	3299-304	J:82727	12626757
89466	Roles of BRCA1 in DNA damage repair: a link between development and cancer.		Deng CX; Wang RH		Hum Mol Genet	12	2003	R113-23	J:82766	12668603
89467	A comparison of several lines of transgenic mice containing the SV40 early genes.		Van Dyke T; Finlay C; Levine AJ		Cold Spring Harb Symp Quant Biol	50	1985	671-8	J:82817	3007009
89468	Abnormal epidermal differentiation and impaired epithelial-mesenchymal tissue interactions in mice lacking the retinoblastoma relatives p107 and p130.		Ruiz S; Segrelles C; Bravo A; Santos M; Perez P; Leis H; Jorcano JL; Paramio JM		Development	130	2003	2341-53	J:82802	12702649
89469	Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice.		Ramos-Gomez M; Dolan PM; Itoh K; Yamamoto M; Kensler TW		Carcinogenesis	24	2003	461-7	J:82836	12663505
89470	Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.		Gotoh J; Obata M; Yoshie M; Kasai S; Ogawa K		Carcinogenesis	24	2003	435-42	J:82838	12663502
89471	Identification of two keratinocyte stem cell regulatory loci implicated in skin carcinogenesis.		Popova NV; Teti KA; Wu KQ; Morris RJ		Carcinogenesis	24	2003	417-25	J:82839	12663500
89472	Allelic imbalance at intragenic markers of Tbx18 is a hallmark of murine osteosarcoma.		Rosemann M; Kuosaite V; Nathrath M; Strom TM; Quintanilla-Martinez L; Richter T; Imai K; Atkinson MJ		Carcinogenesis	24	2003	371-6	J:82841	12663494
89473	Combined oral benzo[a]pyrene and inhalatory ozone exposure have no effect on lung tumor development in DNA repair-deficient Xpa mice.		Hoogervorst EM; de Vries A; Beems RB; van Oostrom CT; Wester PW; Vos JG; Bruins W; Roodbergen M; Cassee FR; Vijg J; van Schooten FJ; van Steeg H		Carcinogenesis	24	2003	613-9	J:82831	12663525
89474	Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations.		Yang K; Fan K; Kurihara N; Shinozaki H; Rigas B; Augenlicht L; Kopelovich L; Edelmann W; Kucherlapati R; Lipkin M		Carcinogenesis	24	2003	605-11	J:82832	12663524
89475	Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2.		Kimura S; Kawabe M; Yu A; Morishima H; Fernandez-Salguero P; Hammons GJ; Ward JM; Kadlubar FF; Gonzalez FJ		Carcinogenesis	24	2003	583-7	J:82833	12663521
89476	DNA repair protein MGMT protects against N-methyl-N-nitrosourea-induced conversion of benign into malignant tumors.		Becker K; Gregel C; Fricke C; Komitowski D; Dosch J; Kaina B		Carcinogenesis	24	2003	541-6	J:82834	12663516
89477	Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine.		Jackson PE; O'Connor PJ; Cooper DP; Margison GP; Povey AC		Carcinogenesis	24	2003	527-33	J:82835	12663514
89478	Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells.		Schlingemann J; Hess J; Wrobel G; Breitenbach U; Gebhardt C; Steinlein P; Kramer H; Furstenberger G; Hahn M; Angel P; Lichter P		Int J Cancer	104	2003	699-708	J:82870	12640676
89479	Mammary epithelial cells of PR-A transgenic mice exhibit distinct alterations in gene expression and growth potential associated with transformation.		Chou YC; Uehara N; Lowry JR; Shyamala G		Carcinogenesis	24	2003	403-9	J:82840	12663498
89480	Genetic control of susceptibility to spontaneous testicular germ cell tumors in mice.		Lam MY; Nadeau JH		APMIS	111	2003	184-90; discussion 191	J:82965	12752260
89481	Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice.		Dang TP; Eichenberger S; Gonzalez A; Olson S; Carbone DP		Oncogene	22	2003	1988-97	J:82990	12673204
89482	Expression of enhancing factor/phospholipase A2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis.		Mulherkar R; Kirtane BM; Ramchandani A; Mansukhani NP; Kannan S; Naresh KN		Oncogene	22	2003	1936-44	J:82991	12673199
89483	Constitutive Expression of AID Leads to Tumorigenesis.		Okazaki IM; Hiai H; Kakazu N; Yamada S; Muramatsu M; Kinoshita K; Honjo T		J Exp Med	197	2003	1173-81	J:83050	12732658
89484	The Runx genes as dominant oncogenes.		Cameron ER; Blyth K; Hanlon L; Kilbey A; Mackay N; Stewart M; Terry A; Vaillant F; Wotton S; Neil JC		Blood Cells Mol Dis	30	2003	194-200	J:83051	12732183
89485	Chemoprevention of mammary carcinogenesis in a transgenic mouse model by alpha-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity.		Li M; Ren S; Tilli MT; Flaws JA; Lubet R; Grubbs CJ; Furth PA		Oncogene	22	2003	2568-72	J:83052	12730671
89486	Differential expression of galectin-3 in pituitary tumors.		Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF Jr; Vidal S; Kovacs K; Raz A; Lloyd RV		Cancer Res	63	2003	2251-5	J:83053	12727847
89487	DNA Mismatch Repair Deficiency Stimulates N-Ethyl-N-nitrosourea-induced Mutagenesis and Lymphomagenesis.		Claij N; Van Der Wal A; Dekker M; Jansen L; Te Riele H		Cancer Res	63	2003	2062-6	J:83054	12727820
89488	Inhibitory effects of propolis granular A. P. C on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice.		Sugimoto Y; Iba Y; Kayasuga R; Kirino Y; Nishiga M; Alejandra Hossen M; Okihara K; Sugimoto H; Yamada H; Kamei C		Cancer Lett	193	2003	155-9	J:83069	12706872
89489	Cancer chemopreventive activity of acridone alkaloids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis.		Itoigawa M; Ito C; Wu TS; Enjo F; Tokuda H; Nishino H; Furukawa H		Cancer Lett	193	2003	133-8	J:83070	12706869
89490	Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F(1) mice.		Chou MW; Yan J; Nichols J; Xia Q; Beland FA; Chan PC; Fu PP		Cancer Lett	193	2003	119-25	J:83071	12706867
89491	High susceptibility of p53 knockout mice to esophageal and urinary bladder carcinogenesis induced by N, N-dibutylnitrosamine.		Nishikawa T; Salim EI; Morimura K; Kaneko M; Ogawa M; Kinoshita A; Osugi H; Kinoshita H; Fukushima S		Cancer Lett	194	2003	45-54	J:83072	12706858
89492	Role of biomodulators and involvement of protein tyrosine kinase on stem cell migration in normal and leukaemic mice.		Law S; Maiti D; Palit A; Chaudhuri S		Immunol Lett	86	2003	287-90	J:83073	12706533
89493	Investigation of ethyl alcohol and beta-carotene effect on two models of carcinogenesis.		Uleckiene S; Domkiene V		Acta Biol Hung	54	2003	89-93	J:83074	12705324
89494	Mouse models with modified p53 sequences to study cancer and ageing.		Clarke AR; Hollstein M		Cell Death Differ	10	2003	443-50	J:83061	12719721
89495	Loss of heterozygosity analysis of mouse pulmonary adenomas induced by coal tar.		Benavides F; Conti CJ; LaCava M; Flores M; Glasscock E; Sternik G; Gimenez-Conti IB; Johnston DA; Dunsford HA; Goldstein LS; Rodriguez LV		Environ Mol Mutagen	41	2003	300-8	J:83062	12717785
89496	The Mouse rasH2 / BHT Model as an in vivo Rapid Assay for Lung Carcinogens.		Umemura T; Kodama Y; Hioki K; Nomura T; Nishikawa A; Hirose M; Kurokawa Y		Jpn J Cancer Res	93	2002	861-6	J:83063	12716462
89497	Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.		Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW		Prostate	55	2003	308-16	J:83064	12712410
89498	Blue light inhibits the growth of skin tumors in the v-Ha-ras transgenic mouse.		Ohara M; Kawashima Y; Kitajima S; Mitsuoka C; Watanabe H		Cancer Sci	94	2003	205-9	J:83066	12708498
89499	Hepatocellular Tumor Induction in Heterozygous p53-Deficient CBA Mice by a 26-Week Dietary Administration of Kojic Acid.		Takizawa T; Mitsumori K; Tamura T; Nasu M; Ueda M; Imai T; Hirose M		Toxicol Sci	73	2003	287-93	J:83099	12700405
89500	Inhibition of foreign-body sarcoma by mammalian RNA?		Lavelle SM; Mhiclomhair M		Technol Health Care	11	2003	143-7	J:83100	12697954
89501	Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.		Nanni P; Nicoletti G; De Giovanni C; Landuzzi L; Di Carlo E; Iezzi M; Ricci C; Astolfi A; Croci S; Marangoni F; Musiani P; Forni G; Lollini PL		Int J Cancer	105	2003	384-9	J:83076	12704673
89502	Analysis of lung tumorigenesis in chimeric mice indicates the Pulmonary adenoma resistance 2 (Par2) locus to operate in the tumor-initiation stage in a cell-autonomous manner: detection of polymorphisms in the Poli gene as a candidate for Par2.		Lee GH; Nishimori H; Sasaki Y; Matsushita H; Kitagawa T; Tokino T		Oncogene	22	2003	2374-82	J:83077	12700672
89503	Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis.		Hicks SM; Vassallo JD; Dieter MZ; Lewis CL; Whiteley LO; Fix AS; Lehman-McKeeman LD		Toxicology	187	2003	217-28	J:83078	12699910
89504	Characterization of the toxicity, mutagenicity, and carcinogenicity of methacrylonitrile in F344 Rats and B6C3F1 mice.		Nyska A; Ghanayem BI		Arch Toxicol	77	2003	233-42	J:83079	12698239
89505	Effect of diet and housing on growth, body weight, survival and tumor incidences of B6C3F1 mice in chronic studies.		Rao GN; Crockett PW		Toxicol Pathol	31	2003	243-50	J:83080	12696586
89506	Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice.		Takaoka M; Sehata S; Maejima T; Imai T; Torii M; Satoh H; Toyosawa K; Tanakamaru ZY; Adachi T; Hisada S; Ueda M; Ogasawara H; Matsumoto M; Kobayashi K; Mutai M; Usui T		Toxicol Pathol	31	2003	191-9	J:83081	12696579
89507	NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.		Lallemand D; Curto M; Saotome I; Giovannini M; McClatchey AI		Genes Dev	17	2003	1090-100	J:83082	12695331
89508	Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.		Kaplan-Lefko PJ; Chen TM; Ittmann MM; Barrios RJ; Ayala GE; Huss WJ; Maddison LA; Foster BA; Greenberg NM		Prostate	55	2003	219-37	J:83083	12692788
89509	Acidic pH induces topoisomerase II-mediated DNA damage.		Xiao H; Li TK; Yang JM; Liu LF		Proc Natl Acad Sci U S A	100	2003	5205-10	J:83084	12692309
89510	Number of pregnancies and ovariectomy modify mammary carcinoma development in transgenic HER-2/neu female mice.		Anisimov VN; Popovich IG; Alimova IN; Zabezhinski MA; Semenchenko AV; Yashin AI		Cancer Lett	193	2003	49-55	J:83085	12691823
89511	Deficiencies of GM-CSF and interferon gamma link inflammation and cancer.		Enzler T; Gillessen S; Manis JP; Ferguson D; Fleming J; Alt FW; Mihm M; Dranoff G		J Exp Med	197	2003	1213-9	J:83086	12732663
89512	Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice.		Anisimov VN; Alimova IN; Baturin DA; Popovich IG; Zabezhinski MA; Rosenfeld SV; Manton KG; Semenchenko AV; Yashin AI		Exp Gerontol	38	2003	449-61	J:83124	12670632
89513	Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.		Pollock PM; Cohen-Solal K; Sood R; Namkoong J; Martino JJ; Koganti A; Zhu H; Robbins C; Makalowska I; Shin SS; Marin Y; Roberts KG; Yudt LM; Chen A; Cheng J; Incao A; Pinkett HW; Graham CL; Dunn K; Crespo-Carbone SM; Mackason KR; Ryan KB; Sinsimer D; Goyd	os J; Reuhl KR; Eckhaus M; Meltzer PS; Pavan WJ; Trent JM; Chen S	Nat Genet	34	2003	108-12	J:83183	12704387
89514	Increased susceptibility to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in transgenic mice overexpressing c-myc and epidermal growth factor in alveolar type II cells.		Ehrhardt A; Bartels T; Klocke R; Paul D; Halter R		J Cancer Res Clin Oncol	129	2003	71-5	J:83369	12669230
89515	Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.		Capozza F; Williams TM; Schubert W; McClain S; Bouzahzah B; Sotgia F; Lisanti MP		Am J Pathol	162	2003	2029-39	J:83485	12759258
89516	Age-related difference in susceptibility of Apc(Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcumin.		Perkins S; Clarke AR; Steward W; Gescher A		Br J Cancer	88	2003	1480-3	J:83487	12778080
89517	Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells.		Tourneur L; Mistou S; Michiels FM; Devauchelle V; Renia L; Feunteun J; Chiocchia G		Oncogene	22	2003	2795-804	J:83474	12743602
89518	Dysregulation of DNA Repair Pathways in a Transforming Growth Factor alpha/c-myc Transgenic Mouse Model of Accelerated Hepatocarcinogenesis.		Hironaka K; Factor VM; Calvisi DF; Conner EA; Thorgeirsson SS		Lab Invest	83	2003	643-54	J:83492	12746474
89519	Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice.		Beuschlein F; Looyenga BD; Bleasdale SE; Mutch C; Bavers DL; Parlow AF; Nilson JH; Hammer GD		Mol Cell Biol	23	2003	3951-64	J:83561	12748296
89520	Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia.		Tatematsu M; Tsukamoto T; Inada K		Cancer Sci	94	2003	135-41	J:83067	12708487
89521	The effect of delta-sleep-inducing peptide on the lifespan and incidence of spontaneous tumors in mice.		Popovich IG; Voitenkov BO; Anisimov VN; Zabezhinskii MA; Mikhaleva II; Ivanov VT		Dokl Biol Sci	388	2003	28-30	J:83075	12705123
89522	Alternative reading frame supports an alternative model for retinoblastoma.		Zacksenhaus E		Cell Cycle	2	2003	27-30	J:83101	12695682
89523	Development of Rhabdomyosarcoma in HER-2/neu Transgenic p53 Mutant Mice.		Nanni P; Nicoletti G; De Giovanni C; Croci S; Astolfi A; Landuzzi L; Di Carlo E; Iezzi M; Musiani P; Lollini PL		Cancer Res	63	2003	2728-32	J:83606	12782574
89524	Identification of Novel Genetic Loci Contributing to 12-O-Tetradecanoylphorbol-13-acetate Skin Tumor Promotion Susceptibility in DBA/2 and C57BL/6 Mice.		Angel JM; Caballero M; DiGiovanni J		Cancer Res	63	2003	2747-51	J:83608	12782578
89525	Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.		Kindblom J; Dillner K; Sahlin L; Robertson F; Ormandy C; Tornell J; Wennbo H		Endocrinology	144	2003	2269-78	J:83708	12746285
89526	The magnitude of hedgehog signaling activity defines skin tumor phenotype.		Grachtchouk V; Grachtchouk M; Lowe L; Johnson T; Wei L; Wang A; de Sauvage F; Dlugosz AA		EMBO J	22	2003	2741-51	J:83760	12773389
89527	High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.		Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I		Oncogene	22	2003	3269-78	J:83778	12761497
89528	Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.		Budunova IV; Kowalczyk D; Perez P; Yao YJ; Jorcano JL; Slaga TJ		Oncogene	22	2003	3279-87	J:83779	12761498
89529	Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.		Biggs PJ; Vogel H; Sage M; Martin LA; Donehower LA; Bradley A		Oncogene	22	2003	3288-96	J:83780	12761499
89530	Islet cell hyperplasia in transgenic mice overexpressing EAT/mcl-1, a bcl-2 related gene.		Matsushita K; Okita H; Suzuki A; Shimoda K; Fukuma M; Yamada T; Urano F; Honda T; Sano M; Iwanaga S; Ogawa S; Hata J; Umezawa A		Mol Cell Endocrinol	203	2003	105-16	J:83768	12782407
89531	Pituitary tumorigenesis targeted by the ovine follicle-stimulating hormone beta-subunit gene regulatory region in transgenic mice.		Pernasetti F; Spady TJ; Hall SB; Rosenberg SB; Givens ML; Anderson S; Paulus M; Miller WL; Mellon PL		Mol Cell Endocrinol	203	2003	169-83	J:83769	12782413
89532	Two-year follow-up of Helicobacter pylori infection in C57BL/6 and Balb/cA mice.		Wang X; Willen R; Svensson M; Ljungh A; Wadstrom T		APMIS	111	2003	514-22	J:83891	12780527
89533	Chromosomal instability and tumors promoted by DNA hypomethylation.		Eden A; Gaudet F; Waghmare A; Jaenisch R		Science	300	2003	455	J:83880	12702868
89534	Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.		Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK		Blood	101	2003	4529-38	J:83938	12543865
89535	Effect of delta-sleep inducing peptide-containing preparation Deltaran on biomarkers of aging, life span and spontaneous tumor incidence in female SHR mice.		Popovich IG; Voitenkov BO; Anisimov VN; Ivanov VT; Mikhaleva II; Zabezhinski MA; Alimova IN; Baturin DA; Zavarzina NY; Rosenfeld SV; Semenchenko AV; Yashin AI		Mech Ageing Dev	124	2003	721-31	J:83929	12782416
89536	Cooperation of cytokine signaling with chimeric transcription factors in leukemogenesis: PML-retinoic acid receptor alpha blocks growth factor-mediated differentiation.		Phan VT; Shultz DB; Truong BT; Blake TJ; Brown AL; Gonda TJ; Le Beau MM; Kogan SC		Mol Cell Biol	23	2003	4573-85	J:83955	12808098
89537	Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours.		Fleury-Feith J; Lecomte C; Renier A; Matrat M; Kheuang L; Abramowski V; Levy F; Janin A; Giovannini M; Jaurand MC		Oncogene	22	2003	3799-805	J:83974	12802287
89538	Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.		Wikonkal NM; Remenyik E; Knezevic D; Zhang W; Liu M; Zhao H; Berton TR; Johnson DG; Brash DE		Nat Cell Biol	5	2003	655-60	J:84051	12833065
89539	Genetically engineering a mouse.		Borowsky AD		Comp Med	53	2003	249-50	J:84082	12868566
89540	Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.		Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M		Oncogene	22	2003	3407-11	J:84194	12776191
89541	Relationship between oocyte apoptosis and ovarian tumours induced by high and low LET radiations in mice.		Nitta Y; Hoshi M		Int J Radiat Biol	79	2003	241-50	J:84195	12775448
89542	Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.		Hertervig E; Nilsson A; Nilbert M; Duan RD		Int J Colorectal Dis	18	2003	309-13	J:84197	12774245
89543	Intestinal polyp formation in the Apcmin mouse: effects of levels of dietary calcium and altered vitamin D homeostasis.		Huerta S; Irwin RW; Heber D; Go VL; Moatamed F; Huerta S; Ou C; Harris DM		Dig Dis Sci	48	2003	870-6	J:84198	12772782
89544	Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice.		Fischer SM; Conti CJ; Viner J; Aldaz CM; Lubet RA		Carcinogenesis	24	2003	945-52	J:84199	12771040
89545	A Comparative Immunohistochemical Study of Spontaneous and Chemically Induced Pheochromocytomas in B6C3F1 Mice.		Hill G; Pace V; Persohn E; Bresser C; Haseman J; Tischler A; Nyska A		Endocr Pathol	14	2003	81-92	J:84220	12746566
89546	Piroxicam-induced regression of intestinal adenomatous polyps in APC(delta474) mice.		Qiu ZF; Maruyama K; Sunayama K; Kashiwabara H; Shoji T; Nakamura T; Suzuki S; Konno H; Nakamura S		J Invest Surg	16	2003	71-81	J:84221	12746190
89547	Chemoprevention of Benzo(a)pyrene-induced Lung Tumors in Mice by the Farnesyltransferase Inhibitor R115777.		Gunning WT; Kramer PM; Lubet RA; Steele VE; End DW; Wouters W; Pereira MA		Clin Cancer Res	9	2003	1927-30	J:84223	12738751
89548	Murine models of colorectal cancer: studying the role of oncogenic K-ras.		Janssen KP		Cell Mol Life Sci	60	2003	495-506	J:84224	12737309
89549	Ras transgene expression in TG-AC mice treated with benzo[a]pyrene.		Lee BM; Kim HS; Kim IS; Ahn MY; Chun SA; Yoo SD; Park YA; Choi SM; Kim KB; Han SY; Park KL; Kwack SJ; Song HS; Lee KR; Bae HJ; Cho MH		Biol Pharm Bull	26	2003	733-5	J:84225	12736523
89550	Effect of Moderate Caloric Restriction and/or Weight Cycling on Mammary Tumor Incidence and Latency in MMTV-Neu Female Mice.		Pape-Ansorge KA; Grande JP; Christensen TA; Maihle NJ; Cleary MP		Nutr Cancer	44	2002	162-8	J:84226	12734063
89551	Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice.		Ress NB; Chou BJ; Renne RA; Dill JA; Miller RA; Roycroft JH; Hailey JR; Haseman JK; Bucher JR		Toxicol Sci	74	2003	287-96	J:84227	12773761
89552	Mouse Models of Metastatic Pancreatic Adenocarcinoma.		Xie K; Wang B; Shi Q; Abbruzzese J; Xiong Q; Le X		Int J Gastrointest Cancer	29	2001	25-36	J:84229	12754402
89553	Retinoids in chemoprevention of cancer.		Verma AK		J Biol Regul Homeost Agents	17	2003	92-7	J:84210	12757023
89554	Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis.		Tucker E; Buda A; Janghra B; Cpoad J; Moorghan M; Havler M; Dettmar P; Pignatelli M		Proc Nutr Soc	62	2003	229-36	J:84211	12756972
89555	Functional studies of the MEN1 gene.		Chandrasekharappa SC; Teh BT		J Intern Med	253	2003	606-15	J:84212	12755956
89556	Incorporation of the Food Mutagen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP) into Fur and Correlation with Intestinal Tumourigenesis in Min/+ Mice.		Steffensen IL; Janak K; Hegstad S; Andreassen A; Paulsen JE; Reistad R; Alexander J		Pharmacol Toxicol	92	2003	131-6	J:84213	12753428
89557	Growth regulatory factors and signalling proteins in testicular germ cell tumours.		Devouassoux-Shisheboran M; Mauduit C; Tabone E; Droz JP; Benahmed M		APMIS	111	2003	212-24; discussion 224	J:84214	12752264
89558	GDNF-induced seminomatous tumours in mouse--an experimental model for human seminomas?		Sariola H; Meng X		APMIS	111	2003	192-6; discussion 196	J:84215	12752262
89559	Counterpoint: from animal models to prevention of colon cancer. Criteria for proceeding from preclinical studies and choice of models for prevention studies.		Bruce WR		Cancer Epidemiol Biomarkers Prev	12	2003	401-4	J:84216	12750233
89560	Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.		Corpet DE; Pierre F		Cancer Epidemiol Biomarkers Prev	12	2003	391-400	J:84217	12750232
89561	PyV-mT-induced parotid gland hyperplasia as detected by altered lectin reactivity is not modulated by inducible nitric oxide deficiency.		Ellies LG		Arch Oral Biol	48	2003	415-22	J:84218	12749913
89562	Comparative susceptibilities of seven inbred strains of mice to qualified applications of 3, 4-benzpyrene		Poel WE; Stanton D; Peters E; Wade HO		Proc Am Assoc Cancer Res	2	1958	335	J:84245	 
89563	Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity.		Melani C; Chiodoni C; Forni G; Colombo MP		Blood	102	2003	2138-45	J:84231	12750171
89564	Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice.		Bashir O; Fitzgerald AJ; Berlanga-Acosta J; Playford RJ; Goodlad RA		Clin Sci (Lond)	105	2003	323-330	J:84232	12749762
89565	Loss of mitotic spindle checkpoint activity predisposes to chromosomal instability at early stages of fibrosarcoma development.		Gascoyne DM; Hixon ML; Gualberto A; Vivanco MD		Cell Cycle	2	2003	238-45	J:84234	12734433
89566	In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.		Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS		J Immunol	171	2003	697-707	J:84288	12847236
89567	Molecular characterization of Patched-associated rhabdomyosarcoma.		Kappler R; Calzada-Wack J; Schnitzbauer U; Koleva M; Herwig A; Piontek G; Graedler F; Adamski J; Heinzmann U; Schlegel J; Hemmerlein B; Quintanilla-Martinez L; Hahn H		J Pathol	200	2003	348-56	J:84283	12845631
89568	Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation.		Bierie B; Nozawa M; Renou JP; Shillingford JM; Morgan F; Oka T; Taketo MM; Cardiff RD; Miyoshi K; Wagner KU; Robinson GW; Hennighausen L		Oncogene	22	2003	3875-87	J:84340	12813461
89569	Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.		Flesken-Nikitin A; Choi KC; Eng JP; Shmidt EN; Nikitin AY		Cancer Res	63	2003	3459-63	J:84345	12839925
89570	Prevention of dual promoting effects of pentachlorophenol, an environmental pollutant, on diethylnitrosamine-induced hepato- and cholangiocarcinogenesis in mice by green tea infusion.		Umemura T; Kai S; Hasegawa R; Kanki K; Kitamura Y; Nishikawa A; Hirose M		Carcinogenesis	24	2003	1105-9	J:84334	12807750
89571	Outbred CD-1 mice carry the susceptibility allele at the pulmonary adenoma susceptibility 1 (Pas1) locus.		Manenti G; Galbiati F; Noci S; Dragani TA		Carcinogenesis	24	2003	1143-8	J:84368	12807761
89572	Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.		Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C		Carcinogenesis	24	2003	1123-32	J:84369	12807749
89573	Characterization of the FGF axis and identification of a novel FGFR1iiic isoform during prostate cancer progression in the TRAMP model.		Foster BA; Kaplan PJ; Greenberg NM		Prostate Cancer Prostatic Dis	2	1999	76-82	J:84412	12496842
89574	Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.		Siegel PM; Shu W; Cardiff RD; Muller WJ; Massague J		Proc Natl Acad Sci U S A	100	2003	8430-5	J:84434	12808151
89575	Development of pure prolactin receptor antagonists.		Bernichtein S; Kayser C; Dillner K; Moulin S; Kopchick JJ; Martial JA; Norstedt G; Isaksson O; Kelly PA; Goffin V		J Biol Chem	278	2003	35988-99	J:84484	12824168
89576	Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis.		Su T; Suzui M; Wang L; Lin CS; Xing WQ; Weinstein IB		Proc Natl Acad Sci U S A	100	2003	7824-9	J:84504	12810953
89577	Interferon-stimulated gene-15 (Isg15) expression is up-regulated in the mouse uterus in response to the implanting conceptus.		Austin KJ; Bany BM; Belden EL; Rempel LA; Cross JC; Hansen TR		Endocrinology	144	2003	3107-13	J:84506	12810567
89578	Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia.		Fox JG; Wang TC; Rogers AB; Poutahidis T; Ge Z; Taylor N; Dangler CA; Israel DA; Krishna U; Gaus K; Peek RM Jr		Gastroenterology	124	2003	1879-90	J:84507	12806621
89579	Advances in the therapy of chronic lymphocytic leukemia.		Johnson AJ; Mone AP; Abhyankar V; Byrd JC		Curr Opin Hematol	10	2003	297-305	J:84508	12799536
89580	Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model.		Majumder PK; Yeh JJ; George DJ; Febbo PG; Kum J; Xue Q; Bikoff R; Ma H; Kantoff PW; Golub TR; Loda M; Sellers WR		Proc Natl Acad Sci U S A	100	2003	7841-6	J:84509	12799464
89581	Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice.		Park JS; Rhyu JW; Kim CJ; Kim HS; Lee SY; Kwon YI; Namkoong SE; Sin HS; Um SJ		Gynecol Oncol	89	2003	360-8	J:84510	12798696
89582	Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology.		Mann RJ; Keri RA; Nilson JH		Recent Prog Horm Res	58	2003	343-75	J:84511	12795427
89583	c-Jun Regulates Eyelid Closure and Skin Tumor Development through EGFR Signaling.		Zenz R; Scheuch H; Martin P; Frank C; Eferl R; Kenner L; Sibilia M; Wagner EF		Dev Cell	4	2003	879-89	J:84512	12791272
89584	Stereospecific deuterium substitution attenuates the tumorigenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).		Jalas JR; McIntee EJ; Kenney PM; Upadhyaya P; Peterson LA; Hecht SS		Chem Res Toxicol	16	2003	794-806	J:84496	12807363
89585	Generation and Characterization of p53 Mutant Mice.		Dumble ML; Donehower LA; Lu X		Methods Mol Biol	234	2003	29-50	J:84498	12824523
89586	Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma.		Singh M; Kumar V		Rev Med Virol	13	2003	243-53	J:84502	12820186
89587	Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence.		Tilli MT; Furth PA		Breast Cancer Res	5	2003	202-5	J:84503	12817992
89588	Stromal cell involvement in cancer.		Almholt K; Johnsen M		Recent Results Cancer Res	162	2003	31-42	J:84513	12790319
89589	The INK4a/ARF locus and melanoma.		Sharpless E; Chin L		Oncogene	22	2003	3092-8	J:84514	12789286
89590	Fourteenth annual pezcoller symposium: the novel dichotomy of immune interactions with tumors.		Hanahan D; Lanzavecchia A; Mihich E		Cancer Res	63	2003	3005-8	J:84515	12782611
89591	Mouse models of human cancer consortium symposium on nervous system tumors.		Gutmann DH; Baker SJ; Giovannini M; Garbow J; Weiss W		Cancer Res	63	2003	3001-4	J:84516	12782610
89592	Radiation-induced-thymic lymphoma occurs in young, but not in old mice.		Utsuyama M; Hirokawa K		Exp Mol Pathol	74	2003	319-25	J:84517	12782021
89593	Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer.		Forster A; Pannell R; Drynan LF; McCormack M; Collins EC; Daser A; Rabbitts TH		Cancer Cell	3	2003	449-58	J:84518	12781363
89594	Transgenics at breaking-point.		Prosser H; Bradley A		Cancer Cell	3	2003	411-3	J:84519	12781356
89595	Combined cyclin D1 overexpression and zinc deficiency disrupts cell cycle and accelerates mouse forestomach carcinogenesis.		Fong LY; Mancini R; Nakagawa H; Rustgi AK; Huebner K		Cancer Res	63	2003	4244-52	J:84643	12874033
89596	Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.		Lozano J; Xing R; Cai Z; Jensen HL; Trempus C; Mark W; Cannon R; Kolesnick R		Cancer Res	63	2003	4232-8	J:84644	12874031
89597	Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis.		Fong LY; Feith DJ; Pegg AE		Cancer Res	63	2003	3945-54	J:84645	12873989
89598	Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases.		Abate-Shen C; Banach-Petrosky WA; Sun X; Economides KD; Desai N; Gregg JP; Borowsky AD; Cardiff RD; Shen MM		Cancer Res	63	2003	3886-90	J:84646	12873978
89599	Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis.		Inokuchi K; Dan K; Takatori M; Takahuji H; Uchida N; Inami M; Miyake K; Honda H; Hirai H; Shimada T		Blood	102	2003	320-3	J:84626	12623846
89600	Restriction of neuroblastoma to the prostate gland in transgenic mice.		Skalnik DG; Dorfman DM; Williams DA; Orkin SH		Mol Cell Biol	11	1991	4518-27	J:84499	1652058
89601	The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting.		Fingerle-Rowson G; Petrenko O; Metz CN; Forsthuber TG; Mitchell R; Huss R; Moll U; Muller W; Bucala R		Proc Natl Acad Sci U S A	100	2003	9354-9	J:84791	12878730
89602	Tumoricidal activity of lauryl gallate towards chemically induced skin tumours in mice.		Ortega E; Sadaba MC; Ortiz AI; Cespon C; Rocamora A; Escolano JM; Roy G; Villar LM; Gonzalez-Porque P		Br J Cancer	88	2003	940-3	J:84794	12644834
89603	Mouse Mammary Tumor Virus c-rel Transgenic Mice Develop Mammary Tumors.		Romieu-Mourez R; Kim DW; Shin SM; Demicco EG; Landesman-Bollag E; Seldin DC; Cardiff RD; Sonenshein GE		Mol Cell Biol	23	2003	5738-54	J:84797	12897145
89604	Clusterin as a biomarker in murine and human intestinal neoplasia.		Chen X; Halberg RB; Ehrhardt WM; Torrealba J; Dove WF		Proc Natl Acad Sci U S A	100	2003	9530-5	J:84784	12886021
89605	Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human.		Ewart-Toland A; Briassouli P; de Koning JP; Mao JH; Yuan J; Chan F; MacCarthy-Morrogh L; Ponder BA; Nagase H; Burn J; Ball S; Almeida M; Linardopoulos S; Balmain A		Nat Genet	34	2003	403-12	J:84842	12881723
89606	Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model.		Hesselager G; Uhrbom L; Westermark B; Nister M		Cancer Res	63	2003	4305-9	J:84848	12907595
89607	Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.		Wu Y; Cui K; Miyoshi K; Hennighausen L; Green JE; Setser J; LeRoith D; Yakar S		Cancer Res	63	2003	4384-8	J:84849	12907608
89608	Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.		Wang Y; Zhang Z; Kastens E; Lubet RA; You M		Cancer Res	63	2003	4389-95	J:84850	12907609
89609	Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.		Hoebe K; Du X; Georgel P; Janssen E; Tabeta K; Kim SO; Goode J; Lin P; Mann N; Mudd S; Crozat K; Sovath S; Han J; Beutler B		Nature	424	2003	743-8	J:84896	12872135
89610	Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma.		Rathmell JC; Elstrom RL; Cinalli RM; Thompson CB		Eur J Immunol	33	2003	2223-32	J:84935	12884297
89611	Mouse models of prostate carcinogenesis.		Abate-Shen C; Shen MM		Trends Genet	18	2002	S1-5	J:84063	12047956
89612	Calcium glucarate prevents tumor formation in mouse skin.		Singh J; Gupta KP		Biomed Environ Sci	16	2003	9-16	J:84219	12747003
89613	Telomeres in cancer and aging: lessons from the mouse.		Blasco MA		Cancer Lett	194	2003	183-8	J:84228	12757976
89614	Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma.		Ying H; Suzuki H; Furumoto H; Walker R; Meltzer P; Willingham MC; Cheng SY		Carcinogenesis	24	2003	1467-79	J:84978	12869418
89615	Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis.		Hayakawa Y; Rovero S; Forni G; Smyth MJ		Proc Natl Acad Sci U S A	100	2003	9464-9	J:84979	12867593
89616	Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.		Freie B; Li X; Ciccone SL; Nawa K; Cooper S; Vogelweid C; Schantz L; Haneline LS; Orazi A; Broxmeyer HE; Lee SH; Clapp DW		Blood	102	2003	4146-52	J:84980	12855557
89617	Absence of p53 Leads to Accelerated Neointimal Hyperplasia After Vascular Injury.		Sata M; Tanaka K; Ishizaka N; Hirata Y; Nagai R		Arterioscler Thromb Vasc Biol	23	2003	1548-52	J:84981	12893686
89618	Progressive alterations in global and GC-rich DNA methylation during tumorigenesis.		Watson RE; Curtin GM; Doolittle DJ; Goodman JI		Toxicol Sci	75	2003	289-99	J:84983	12883089
89619	The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification.		Hogarty MD		Cancer Lett	197	2003	173-9	J:85004	12880978
89620	Taenia crassiceps cysticercosis in mice does not increase the carcinogenic effect of methyl-nitrosourea.		Ordonez G; Rembao D; Sotelo J		Exp Parasitol	103	2003	169-70	J:85005	12880594
89621	Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice.		Anna CH; Iida M; Sills RC; Devereux TR		Toxicol Appl Pharmacol	190	2003	135-45	J:85007	12878043
89622	Immunization against luteinizing hormone-releasing hormone fusion proteins does not decrease prostate cancer in the transgenic adenocarcinoma mouse prostate model.		Hill RE; De Avila DM; Bertrand KP; Greenberg NM; Reeves JJ		Exp Biol Med (Maywood)	228	2003	818-22	J:85008	12876301
89623	The loss of TGF-beta signaling promotes prostate cancer metastasis.		Tu WH; Thomas TZ; Masumori N; Bhowmick NA; Gorska AE; Shyr Y; Kasper S; Case T; Roberts RL; Shappell SB; Moses HL; Matusik RJ		Neoplasia	5	2003	267-77	J:85010	12869309
89624	Energy restriction and the risk of spontaneous mammary tumors in mice: A meta-analysis.		Dirx MJ; Zeegers MP; Dagnelie PC; Van Den Bogaard T; Van Den Brandt PA		Int J Cancer	106	2003	766-70	J:85012	12866038
89625	Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice.		Pajari AM; Rajakangas J; Paivarinta E; Kosma VM; Rafter J; Mutanen M		Int J Cancer	106	2003	653-60	J:85013	12866023
89626	Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver.		Soga M; Kishimoto Y; Kawamura Y; Inagaki S; Makino S; Saibara T		Cancer Lett	196	2003	43-8	J:85014	12860288
89627	Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies.		Martiniello-Wilks R; Dane A; Mortensen E; Jeyakumar G; Wang XY; Russell PJ		Anticancer Res	23	2003	2633-42	J:84993	12894551
89628	The genetics of malignant melanoma: lessons from mouse and man.		Chin L		Nat Rev Cancer	3	2003	559-70	J:85001	12894244
89629	Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori.		Takasaki M; Konoshima T; Murata Y; Sugiura M; Nishino H; Tokuda H; Matsumoto K; Kasai R; Yamasaki K		Cancer Lett	198	2003	37-42	J:84995	12893428
89630	beta-Catenin mutations in liver tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in CDF(1) mice.		Huang H; Ushijima T; Nagao M; Sugimura T; Ohgaki H		Cancer Lett	198	2003	29-35	J:84996	12893427
89631	SU5416 Selectively Impairs Angiogenesis to Induce Prostate Cancer-specific Apoptosis.		Huss WJ; Barrios RJ; Greenberg NM		Mol Cancer Ther	2	2003	611-6	J:85002	12883033
89632	Lignan Precursors From Flaxseed or Rye Bran Do Not Protect Against the Development of Intestinal Neoplasia in ApcMin Mice.		Van Kranen HJ; Mortensen A; Sorensen IK; Van Den Berg-Wijnands J; Beems R; Nurmi T; Adlercreutz H; Van Kreijl CF		Nutr Cancer	45	2003	203-10	J:85003	12881015
89633	Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions.		Oikarinen S; Heinonen S; Karppinen S; Matto J; Adlercreutz H; Poutanen K; Mutanen M		Br J Nutr	90	2003	119-25	J:85024	12844383
89634	Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.		Miyamoto Y; Maitra A; Ghosh B; Zechner U; Argani P; Iacobuzio-Donahue CA; Sriuranpong V; Iso T; Meszoely IM; Wolfe MS; Hruban RH; Ball DW; Schmid RM; Leach SD		Cancer Cell	3	2003	565-76	J:85025	12842085
89635	Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis.		Beverly LJ; Capobianco AJ		Cancer Cell	3	2003	551-64	J:85026	12842084
89636	The use of genetically altered mice for breast cancer prevention studies.		Kavanaugh C; Green JE		J Nutr	133	2003	2404S-2409S	J:85028	12840216
89637	H-ras mutations at codon 61 or 13 in tumors initiated with a NO donor in mouse skin.		Satomi Y; Bu P; Okuda M; Tokuda H; Nishino H		Cancer Lett	196	2003	17-22	J:85015	12860284
89638	Cancer chemopreventive effects of oral feeding alpha-tocopherol on ultraviolet light B induced photocarcinogenesis of hairless mouse.		Kuchide M; Tokuda H; Takayasu J; Enjo F; Ishikawa T; Ichiishi E; Naito Y; Yoshida N; Yoshikawa T; Nishino H		Cancer Lett	196	2003	169-77	J:85016	12860275
89639	Cancer chemopreventive activity of serratane-type triterpenoids on two-stage mouse skin carcinogenesis.		Tanaka R; Minami T; Ishikawa Y; Matsunaga S; Tokuda H; Nishino H		Cancer Lett	196	2003	121-6	J:85017	12860269
89640	Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice.		Bergers G; Hanahan D		Cold Spring Harb Symp Quant Biol	67	2002	293-300	J:85018	12858552
89641	Photocarcinogenesis in the Tg.AC mouse: lomefloxacin and 8-methoxypsoralen.		Chignell CF; Haseman JK; Sik RH; Tennant RW; Trempus CS		Photochem Photobiol	77	2003	77-80	J:85019	12856886
89642	Tumour suppressors: timing will tell.		Berns A		Nature	424	2003	140-1	J:85020	12853941
89643	The role of DNA breaks in genomic instability and tumorigenesis.		Mills KD; Ferguson DO; Alt FW		Immunol Rev	194	2003	77-95	J:85021	12846809
89644	Patched 1 conditional null allele in mice.		Ellis T; Smyth I; Riley E; Graham S; Elliot K; Narang M; Kay GF; Wicking C; Wainwright B		Genesis	36	2003	158-61	J:85040	12872247
89645	Of mice and MEN1: Insulinomas in a conditional mouse knockout.		Crabtree JS; Scacheri PC; Ward JM; McNally SR; Swain GP; Montagna C; Hager JH; Hanahan D; Edlund H; Magnuson MA; Garrett-Beal L; Burns AL; Ried T; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS		Mol Cell Biol	23	2003	6075-85	J:85042	12917331
89646	Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia.		Wong JC; Alon N; Mckerlie C; Huang JR; Meyn MS; Buchwald M		Hum Mol Genet	12	2003	2063-76	J:85108	12913077
89647	Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.		Bertolino P; Tong WM; Herrera PL; Casse H; Zhang CX; Wang ZQ		Cancer Res	63	2003	4836-41	J:85133	12941803
89648	Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice.		Nagase H; Mao JH; Balmain A		Cancer Res	63	2003	4849-53	J:85134	12941805
89649	Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.		Riley RR; Duensing S; Brake T; Munger K; Lambert PF; Arbeit JM		Cancer Res	63	2003	4862-71	J:85135	12941807
89650	Measurement of genomic instability in preleukemic P190BCR/ABL transgenic mice using inter-simple sequence repeat polymerase chain reaction.		Brain JM; Goodyer N; Laneuville P		Cancer Res	63	2003	4895-8	J:85137	12941812
89651	C57BR/cdJ hepatocarcinogen susceptibility genes act cell-autonomously in C57BR/cdJ&lt;--&gt;C57BL/6J chimeras.		Chiaverotti TA; Drinkwater NR		Cancer Res	63	2003	4914-9	J:85138	12941815
89652	Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.		Kettunen HL; Kettunen AS; Rautonen NE		Cancer Res	63	2003	5136-42	J:85142	12941845
89653	Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model.		Cranston AN; Ponder BA		Cancer Res	63	2003	4777-80	J:85131	12941793
89654	Cancer susceptibility in the mouse: genetics, biology and implications for human cancer.		Demant P		Nat Rev Genet	4	2003	721-34	J:85177	12951573
89655	Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.		Jaiswal S; Traver D; Miyamoto T; Akashi K; Lagasse E; Weissman IL		Proc Natl Acad Sci U S A	100	2003	10002-7	J:85166	12890867
89656	The D4Mit12 locus on mouse chromosome 4 provides susceptibility to both gamma-ray-induced and N-methyl-N-nitrosourea-induced thymic lymphomas.		Sato H; Tamura Y; Ochiai Y; Kodama Y; Hatakeyama K; Niwa O; Kominami R		Cancer Sci	94	2003	668-71	J:85264	12901790
89657	p53 mutations increase resistance to ionizing radiation.		Lee JM; Bernstein A		Proc Natl Acad Sci U S A	90	1993	5742-6	J:85265	8516323
89658	Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.		Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A		Cancer Res	63	2003	1106-13	J:85316	12615729
89659	Abnormal prostate development in C3(1)-bcl-2 transgenic mice.		Zhang X; Chen MW; Ng A; Ng PY; Lee C; Rubin M; Olsson CA; Buttyan R		Prostate	32	1997	16-26	J:85301	9207953
89660	Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth.		Govindarajan B; Mizesko MC; Miller MS; Onda H; Nunnelly M; Casper K; Brat D; Cohen C; Arbiser JL		Clin Cancer Res	9	2003	3469-75	J:85356	12960139
89661	Persistent mammary hyperplasia in FVB/N mice.		Nieto AI; Shyamala G; Galvez JJ; Thordarson G; Wakefield LM; Cardiff RD		Comp Med	53	2003	433-8	J:85348	14524420
89662	Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling.		Wakefield LM; Thordarson G; Nieto AI; Shyamala G; Galvez JJ; Anver MR; Cardiff RD		Comp Med	53	2003	424-32	J:85349	14524419
89663	Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas.		Nilsen H; Stamp G; Andersen S; Hrivnak G; Krokan HE; Lindahl T; Barnes DE		Oncogene	22	2003	5381-6	J:85353	12934097
89664	Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues.		Berton TR; Matsumoto T; Page A; Conti CJ; Deng CX; Jorcano JL; Johnson DG		Oncogene	22	2003	5415-26	J:85354	12934101
89665	The type B leukemogenic virus truncated superantigen is dispensable for T-cell lymphomagenesis.		Mustafa F; Bhadra S; Johnston D; Lozano M; Dudley JP		J Virol	77	2003	3866-70	J:85399	12610163
89666	A PMLRARA transgene results in a retinoid-deficient phenotype associated with enhanced susceptibility to skin tumorigenesis.		Hansen LA; Brown D; Virador V; Tanaka T; Andreola F; Strain K; Dancheck B; Riley R; Arbeit JM; De Luca LM; Kogan S; Yuspa SH		Cancer Res	63	2003	5257-65	J:85510	14500356
89667	Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis.		Ying H; Suzuki H; Zhao L; Willingham MC; Meltzer P; Cheng SY		Cancer Res	63	2003	5274-80	J:85512	14500358
89668	Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.		Ma W; Tessarollo L; Hong SB; Baba M; Southon E; Back TC; Spence S; Lobe CG; Sharma N; Maher GW; Pack S; Vortmeyer AO; Guo C; Zbar B; Schmidt LS		Cancer Res	63	2003	5320-8	J:85513	14500363
89669	Evaluation of skin tumors by magnetic resonance imaging.		Rajeswari MR; Jain A; Sharma A; Singh D; Jagannathan NR; Sharma U; Degonkar MN		Lab Invest	83	2003	1279-83	J:85519	13679435
89670	Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.		Melnikova VO; Santamaria AB; Bolshakov SV; Ananthaswamy HN		Oncogene	22	2003	5958-66	J:85528	12955074
89671	Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis.		Quintanilla M; Ramirez JR; Perez-Gomez E; Romero D; Velasco B; Letarte M; Lopez-Novoa JM; Bernabeu C		Oncogene	22	2003	5976-85	J:85529	12955076
89672	Modulation by steroid receptor coactivator-1 of target-tissue responsiveness in resistance to thyroid hormone.		Kamiya Y; Zhang XY; Ying H; Kato Y; Willingham MC; Xu J; O'Malley BW; Cheng SY		Endocrinology	144	2003	4144-53	J:85597	12933689
89673	Suprabasal alpha6beta4 integrin expression in epidermis results in enhanced tumourigenesis and disruption of TGFbeta signalling.		Owens DM; Romero MR; Gardner C; Watt FM		J Cell Sci	116	2003	3783-91	J:85642	12902406
89674	Expression of Dominant Negative c-jun Inhibits Ultraviolet B-Induced Squamous Cell Carcinoma Number and Size in an SKH-1 Hairless Mouse Model.		Cooper SJ; MacGowan J; Ranger-Moore J; Young MR; Colburn NH; Bowden GT		Mol Cancer Res	1	2003	848-54	J:85672	14517347
89675	Mitochondrion-mediated apoptosis is enhanced in long-lived alphaMUPA transgenic mice and calorically restricted wild-type mice.		Tirosh O; Aronis A; Zusman I; Kossoy G; Yahav S; Shinder D; Abramovitz R; Miskin R		Exp Gerontol	38	2003	955-63	J:85675	12954482
89676	Ichthyotoxic and anticarcinogenic effects of triterpenoids from Sandoricum koetjape bark.		Ismail IS; Ito H; Mukainaka T; Higashihara H; Enjo F; Tokuda H; Nishino H; Yoshida T		Biol Pharm Bull	26	2003	1351-3	J:85677	12951486
89677	Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer.		Wilgus TA; Koki AT; Zweifel BS; Rubal PA; Oberyszyn TM		Mol Carcinog	38	2003	33-9	J:85679	12949841
89678	Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone.		Aoki K; Nakajima A; Mukasa K; Osawa E; Mori Y; Sekihara H		J Steroid Biochem Mol Biol	85	2003	469-72	J:85680	12943737
89679	Using mice to decipher the molecular genetics of brain tumors.		Hesselager G; Holland EC		Neurosurgery	53	2003	685-94; discussion 695	J:85681	12943584
89680	Bromoethane, chloroethane and ethylene oxide induced uterine neoplasms in B6C3F1 mice from 2-year NTP inhalation bioassays: pathology and incidence data revisited.		Picut CA; Aoyama H; Holder JW; Gold LS; Maronpot RR; Dixon D		Exp Toxicol Pathol	55	2003	1-9	J:85683	12940622
89681	Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias.		Andrade SG; Mesquita IM; Jambeiro JF; Santos IF; Portella RS		Rev Soc Bras Med Trop	36	2003	441-7	J:85685	12937719
89682	Mammary Tumors in HER-2/NEU Mice Are Characterized by Low Content of Estrogen Receptors-alpha and Absence of Progesterone Receptors.		Bershtein LM; Alimova IN; Tsyrlina EV; Anisimov VN		Bull Exp Biol Med	135	2003	580-1	J:85686	12937679
89683	Effect of Sapthaparna (Alstonia scholaris Linn) in modulating the benzo(a)pyrene-induced forestomach carcinogenesis in mice.		Jagetia GC; Baliga MS; Venkatesh P		Toxicol Lett	144	2003	183-93	J:85688	12927362
89684	Toxicity and carcinogenicity of riddelliine in rats and mice.		Chan PC; Haseman JK; Prejean JD; Nyska A		Toxicol Lett	144	2003	295-311	J:85689	12927348
89685	Suppression of DMBA-induced mouse skin tumor development by inositol hexaphosphate and its mode of action.		Gupta KP; Singh J; Bharathi R		Nutr Cancer	46	2003	66-72	J:85690	12925306
89686	Long-term evaluation of mice model infected with Helicobacter pylori: focus on gastric pathology including gastric cancer.		Kim DH; Kim SW; Song YJ; Oh TY; Han SU; Kim YB; Joo HJ; Cho YK; Kim DY; Cho SW; Kim MW; Kim JH; Hahm KB		Aliment Pharmacol Ther	18 Suppl 1	2003	14-23	J:85691	12925137
89687	Mouse models of gastrointestinal tumorigenesis for dietary cancer prevention studies.		Lamprecht SA; Lipkin M		Nutr Rev	61	2003	255-8	J:85692	12918879
89688	Of mice and (wo)men: genotype-phenotype correlations in BRCA1.		Hohenstein P; Fodde R		Hum Mol Genet	12 Suppl 2	2003	R271-7	J:85693	12915453
89689	Morphological and carbogen-based functional MRI of a chemically induced liver tumor model in mice.		Thomas CD; Chenu E; Walczak C; Plessis MJ; Perin F; Volk A		Magn Reson Med	50	2003	522-30	J:85684	12939760
89690	Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage.		Mohammad HP; Abbud RA; Parlow AF; Lewin JS; Nilson JH		Endocrinology	144	2003	4626-36	J:85766	12960102
89691	Expression profiling analyses of gonadotropin responses and tumor development in the absence of inhibins.		Burns KH; Owens GE; Ogbonna SC; Nilson JH; Matzuk MM		Endocrinology	144	2003	4492-507	J:85767	12959983
89692	Dissecting the roles of beta-catenin and cyclin D1 during mammary development and neoplasia.		Rowlands TM; Pechenkina IV; Hatsell SJ; Pestell RG; Cowin P		Proc Natl Acad Sci U S A	100	2003	11400-5	J:85819	13679587
89693	Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.		Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL		Am J Pathol	163	2003	1539-49	J:85799	14507660
89694	Triple basepair changes within and adjacent to the conserved YY1 motif upstream of the U3 enhancer repeats of SL3-3 murine leukemia virus cause a small but significant shortening of latency of T-lymphoma induction.		Ma SL; Lovmand J; Sorensen AB; Luz A; Schmidt J; Pedersen FS		Virology	313	2003	638-44	J:85676	12954229
89695	Pattern of secondary genomic changes in pancreatic tumors of Tgfalpha/Trp53+/- transgenic mice.		Schreiner B; Baur DM; Fingerle AA; Zechner U; Greten FR; Adler G; Sipos B; Kloppel G; Hameister H; Schmid RM		Genes Chromosomes Cancer	38	2003	240-8	J:85920	14506698
89696	Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.		Zhang Z; Wang Y; Lantry LE; Kastens E; Liu G; Hamilton AD; Sebti SM; Lubet RA; You M		Oncogene	22	2003	6257-65	J:85965	13679864
89697	Development of CD30+ lymphoproliferative disease in mice lacking interferon regulatory factor-1.		Eason DD; LeBron C; Coppola D; Moscinski LC; Livingston S; Sutton ET; Blanck G		Oncogene	22	2003	6166-76	J:85972	13679855
89698	Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo.		Lanz RB; Chua SS; Barron N; Soder BM; DeMayo F; O'Malley BW		Mol Cell Biol	23	2003	7163-76	J:85955	14517287
89699	beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.		Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ		Cancer Res	63	2003	3145-53	J:84505	12810642
89700	Recent advances in the molecular genetics of primary gliomas.		Kitange GJ; Templeton KL; Jenkins RB		Curr Opin Oncol	15	2003	197-203	J:84520	12778011
89701	Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.		Niho N; Takahashi M; Kitamura T; Shoji Y; Itoh M; Noda T; Sugimura T; Wakabayashi K		Cancer Res	63	2003	6090-5	J:86036	14522940
89702	Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis.		Kitamura T; Kawamori T; Uchiya N; Itoh M; Noda T; Matsuura M; Sugimura T; Wakabayashi K		Carcinogenesis	23	2002	1463-6	J:86037	12189188
89703	Cell Death in MMTV-c-myc Transgenic Mouse Mammary Tumors May Not Be Typical Apoptosis.		Liao DJ; Dickson RB		Lab Invest	83	2003	1437-49	J:86052	14563945
89704	Toxicological evaluation of propane expanded tobacco.		Theophilus EH; Bombick BR; Meckley DR; Higuchi MA; Borgerding MF; Morton MJ; Mosberg AT; Swauger JE		Food Chem Toxicol	41	2003	1771-80	J:86053	14563402
89705	Five new mouse susceptibility to colon cancer loci, Scc11-Scc15.		Ruivenkamp CA; Csikos T; Klous AM; Van Wezel T; Demant P		Oncogene	22	2003	7258-60	J:86054	14562056
89706	MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine.		Sansom OJ; Zabkiewicz J; Bishop SM; Guy J; Bird A; Clarke AR		Oncogene	22	2003	7130-6	J:86055	14562041
89707	Protein Kinase Cepsilon Is Linked to 12-O-tetradecanoylphorbol-13-acetate-induced Tumor Necrosis Factor-alpha Ectodomain Shedding and the Development of Metastatic Squamous Cell Carcinoma in Protein Kinase Cepsilon Transgenic Mice.		Wheeler DL; Ness KJ; Oberley TD; Verma AK		Cancer Res	63	2003	6547-55	J:86056	14559850
89708	p53 Function Is Required for Hormone-Mediated Protection of Mouse Mammary Tumorigenesis.		Medina D; Kittrell FS		Cancer Res	63	2003	6140-3	J:86057	14559792
89709	Tumor immunity in the context of autoimmunity.		Zwicker KA; Gratton KJ; Santamaria P; Bathe OF		J Surg Res	114	2003	274	J:86058	14559559
89710	Phytoestrogen-mediated suppression of Apc-associated intestinal tumorigenesis.		Javid SH; Moran AE; Carothers AM; Bertagnolli MM		J Surg Res	114	2003	269-70	J:86059	14559545
89711	Prostanoid receptor signaling relevant to tumor growth and angiogenesis.		Majima M; Amano H; Hayashi I		Trends Pharmacol Sci	24	2003	524-9	J:86060	14559404
89712	Pre-B lymphomas in SL/Kh mice: A multifactorial disease model.		Hiai H; Tsuruyama T; Yamada Y		Cancer Sci	94	2003	847-50	J:86061	14556656
89713	An updated evaluation of the carcinogenic potential of 1,4-dioxane.		Stickney JA; Sager SL; Clarkson JR; Smith LA; Locey BJ; Bock MJ; Hartung R; Olp SF		Regul Toxicol Pharmacol	38	2003	183-95	J:86062	14550759
89714	The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.		Pelengaris S; Khan M		Expert Opin Ther Targets	7	2003	623-42	J:86086	14498825
89715	The specific induction of osteosarcomas in different mouse strains after injections of 239Pu citrate.		Oghiso Y; Yamada Y		J Radiat Res (Tokyo)	44	2003	125-32	J:86088	13678341
89716	Application of sensitive fluorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool.		Kondo T; Seike M; Mori Y; Fujii K; Yamada T; Hirohashi S		Proteomics	3	2003	1758-66	J:86089	12973736
89717	Genetic susceptibility to thymic lymphomas and K-ras gene mutation in mice after exposure to X-rays and N-ethyl-N-nitrosourea.		Shimada Y; Nishimura M; Kakinuma S; Ogiu T; Fujimoto H; Kubo A; Nagai J; Kobayash K; Tano K; Yoshinaga S; Bhakat KK		Int J Radiat Biol	79	2003	423-30	J:86094	12963544
89718	Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.		Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M		Cancer Res	63	2003	5754-60	J:86075	14522896
89719	Isolation and characterization of functional mammary gland stem cells.		Welm B; Behbod F; Goodell MA; Rosen JM		Cell Prolif	36 Suppl 1	2003	17-32	J:86078	14521513
89720	Role of Rho-family proteins in cell adhesion and cancer.		Malliri A; Collard JG		Curr Opin Cell Biol	15	2003	583-9	J:86079	14519393
89721	Antigen-specific immunity does not mediate acute regression of UVB-induced p53-mutant clones.		Remenyik E; Wikonkal NM; Zhang W; Paliwal V; Brash DE		Oncogene	22	2003	6369-76	J:86081	14508517
89722	Prevention of photocarcinogenesis and UV-induced immunosuppression in mice by topical tannic acid.		Gensler HL; Gerrish KE; Williams T; Rao G; Kittelson J		Nutr Cancer	22	1994	121-30	J:86082	14502841
89723	Combined antiestrogen, antiangiogenic and anti-invasion therapy inhibits primary and metastatic tumor growth in the MMTVneu model of breast cancer.		Sacco MG; Soldati S; Indraccolo S; Cato EM; Cattaneo L; Scanziani E; Vezzoni P		Gene Ther	10	2003	1903-9	J:86083	14502219
89724	Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice.		Anisimov VN; Khavinson VKh; Popovich IG; Zabezhinski MA; Alimova IN; Rosenfeld SV; Zavarzina NY; Semenchenko AV; Yashin AI		Biogerontology	4	2003	193-202	J:86084	14501183
89725	Toxicity and carcinogenicity of Elmiron in F344/N rats and B6C3F1 mice following 2 years of gavage administration.		Abdo KM; Johnson JD; Nyska A		Arch Toxicol	77	2003	702-11	J:86111	14508637
89726	Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.		Chisari FV; Klopchin K; Moriyama T; Pasquinelli C; Dunsford HA; Sell S; Pinkert CA; Brinster RL; Palmiter RD		Cell	59	1989	1145-56	J:86165	2598264
89727	Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice.		Kim JY; Nelson AL; Algon SA; Graves O; Sturla LM; Goumnerova LC; Rowitch DH; Segal RA; Pomeroy SL		Dev Biol	263	2003	50-66	J:86153	14568546
89728	Elevated levels of polyamines alter chromatin in murine skin and tumors without global changes in nucleosome acetylation.		Hobbs CA; Paul BA; Gilmour SK		Exp Cell Res	290	2003	427-36	J:86233	14568000
89729	Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors.		de Candia P; Solit DB; Giri D; Brogi E; Siegel PM; Olshen AB; Muller WJ; Rosen N; Benezra R		Proc Natl Acad Sci U S A	100	2003	12337-42	J:86209	14526102
89730	Pten Dose Dictates Cancer Progression in the Prostate.		Trotman LC; Niki M; Dotan ZA; Koutcher JA; Cristofano AD; Xiao A; Khoo AS; Roy-Burman P; Greenberg NM; Dyke TV; Cordon-Cardo C; Pandolfi P		PLoS Biol	1	2003	385-96	J:86212	14691534
89731	Transforming growth factor-beta signaling in normal and malignant hematopoiesis.		Kim SJ; Letterio J		Leukemia	17	2003	1731-7	J:86090	12970772
89732	Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice.		Bartke A		Neuroendocrinology	78	2003	210-6	J:86298	14583653
89733	FMR2 function: insight from a mouse knockout model.		Gu Y; Nelson DL		Cytogenet Genome Res	100	2003	129-39	J:86289	14526173
89734	Positional cloning of the major quantitative trait locus underlying lung tumor susceptibility in mice.		Zhang Z; Futamura M; Vikis HG; Wang M; Li J; Wang Y; Guan KL; You M		Proc Natl Acad Sci U S A	100	2003	12642-7	J:86399	14583591
89735	Tumor reversion: correction of malignant behavior by microenvironmental cues.		Kenny PA; Bissell MJ		Int J Cancer	107	2003	688-95	J:86388	14566816
89736	Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in mice.		Lane AA; Ley TJ		Cell	115	2003	305-18	J:86458	14636558
89737	Protein 4.1B in mouse islets of Langerhans and beta-cell tumorigenesis.		Terada N; Ohno N; Yamakawa H; Baba T; Fujii Y; Christofori G; Ohara O; Ohno S		Histochem Cell Biol	120	2003	277-83	J:86504	14574582
89738	Physical activity and cancer prevention: animal-tumor models.		Hoffman-Goetz L		Med Sci Sports Exerc	35	2003	1828-33	J:86508	14600546
89739	E-cadherin controls adherens junctions in the epidermis and the renewal of hair follicles.		Young P; Boussadia O; Halfter H; Grose R; Berger P; Leone DP; Robenek H; Charnay P; Kemler R; Suter U		EMBO J	22	2003	5723-33	J:86510	14592971
89740	Overexpression of IL-7R{alpha} provides a competitive advantage during early T-cell development		Laouar Y; Crispe IN; Flavell RA		Blood	103	2004	1985-94	J:86511	 
89741	Elevated interleukin-9 receptor expression and response to interleukins-9 and -7 in thymocytes during radiation-induced T-cell lymphomagenesis in B6C3F1 mice.		Nishimura M; Kakinuma S; Yamamoto D; Kobayashi Y; Suzuki G; Sado T; Shimada Y		J Cell Physiol	198	2004	82-90	J:86493	14584047
89742	Elevated expression of inhibitor of apoptosis proteins in prostate cancer.		Krajewska M; Krajewski S; Banares S; Huang X; Turner B; Bubendorf L; Kallioniemi OP; Shabaik A; Vitiello A; Peehl D; Gao GJ; Reed JC		Clin Cancer Res	9	2003	4914-25	J:86494	14581366
89743	Absence of tumor promoting activity of Euphorbia milii latex on the mouse back skin.		Delgado IF; De-Carvalho RR; De-Oliveira AC; Kuriyama SN; Oliveira-Filho EC; Souza CA; Paumgartten FJ		Toxicol Lett	145	2003	175-80	J:86495	14581170
89744	Toxicological evaluation of dry ice expanded tobacco.		Theophilus EH; Poindexter DB; Meckley DR; Bombick BR; Borgerding MF; Higuchi MA; Ayres PH; Morton MJ; Mosberg AT; Swauger JE		Toxicol Lett	145	2003	107-19	J:86496	14581163
89745	Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer.		Moadel RM; Nguyen AV; Lin EY; Lu P; Mani J; Blaufox MD; Pollard JW; Dadachova E		Breast Cancer Res	5	2003	R199-205	J:86497	14580255
89746	p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene.		Ide F; Kitada M; Sakashita H; Kusama K; Tanaka K; Ishikawa T		Am J Pathol	163	2003	1729-33	J:86501	14578172
89747	Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.		Sharma S; Batra RK; Yang SC; Hillinger S; Zhu L; Atianzar K; Strieter RM; Riedl K; Huang M; Dubinett SM		Hum Gene Ther	14	2003	1511-24	J:86503	14577913
89748	Ahi-1, a novel gene encoding a modular protein with WD40-repeat and SH3 domains, is targeted by the Ahi-1 and Mis-2 provirus integrations.		Jiang X; Hanna Z; Kaouass M; Girard L; Jolicoeur P		J Virol	76	2002	9046-59	J:84771	12186888
89749	Isoflavone genistein: photoprotection and clinical implications in dermatology.		Wei H; Saladi R; Lu Y; Wang Y; Palep SR; Moore J; Phelps R; Shyong E; Lebwohl MG		J Nutr	133	2003	3811S-3819S	J:86580	14608119
89750	Identification of Jade1, a gene encoding a PHD zinc finger protein, in a gene trap mutagenesis screen for genes involved in anteroposterior axis development.		Tzouanacou E; Tweedie S; Wilson V		Mol Cell Biol	23	2003	8553-2	J:86562	14612400
89751	H2AX haploinsufficiency modifies genomic stability and tumor susceptibility.		Celeste A; Difilippantonio S; Difilippantonio MJ; Fernandez-Capetillo O; Pilch DR; Sedelnikova OA; Eckhaus M; Ried T; Bonner WM; Nussenzweig A		Cell	114	2003	371-83	J:86590	12914701
89752	Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism.		Libutti SK; Crabtree JS; Lorang D; Burns AL; Mazzanti C; Hewitt SM; O'Connor S; Ward JM; Emmert-Buck MR; Remaley A; Miller M; Turner E; Alexander HR; Arnold A; Marx SJ; Collins FS; Spiegel AM		Cancer Res	63	2003	8022-8	J:86642	14633735
89753	Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.		Yang X; Tang J; Rogler CE; Stanley P		Cancer Res	63	2003	7753-9	J:86643	14633700
89754	Increased formation and persistence of 1,N(6)-ethenoadenine in DNA is not associated with higher susceptibility to carcinogenesis in alkylpurine-DNA-N-glycosylase knockout mice treated with vinyl carbamate.		Barbin A; Wang R; O'Connor PJ; Elder RH		Cancer Res	63	2003	7699-703	J:86644	14633693
89755	Loss of protein phosphatase 2A expression correlates with phosphorylation of DP-1 and reversal of dysplasia through differentiation in a conditional mouse model of cancer progression.		Tilli MT; Hudgins SL; Frech MS; Halama ED; Renou JP; Furth PA		Cancer Res	63	2003	7668-73	J:86645	14633688
89756	Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice.		Takeuchi H; Saoo K; Yokohira M; Ikeda M; Maeta H; Miyazaki M; Yamazaki H; Kamataki T; Imaida K		Cancer Res	63	2003	7581-3	J:86646	14633670
89757	Mouse models to study the interaction of risk factors for human liver cancer.		Sell S		Cancer Res	63	2003	7553-62	J:86647	14633666
89758	Inducible mEDA-A1 transgene mediates sebaceous gland hyperplasia and differential formation of two types of mouse hair follicles.		Cui CY; Durmowicz M; Ottolenghi C; Hashimoto T; Griggs B; Srivastava AK; Schlessinger D		Hum Mol Genet	12	2003	2931-40	J:86628	14506134
89759	Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.		Yue W; Santen RJ; Wang JP; Li Y; Verderame MF; Bocchinfuso WP; Korach KS; Devanesan P; Todorovic R; Rogan EG; Cavalieri EL		J Steroid Biochem Mol Biol	86	2003	477-86	J:86738	14623547
89760	Phenotype characteristics of transgenic male mice expressing human aromatase under ubiquitin C promoter.		Li X; Makela S; Streng T; Santti R; Poutanen M		J Steroid Biochem Mol Biol	86	2003	469-76	J:86739	14623546
89761	Update on animal models developed for analyses of estrogen receptor biological activity.		Korach KS; Emmen JM; Walker VR; Hewitt SC; Yates M; Hall JM; Swope DL; Harrell JC; Couse JF		J Steroid Biochem Mol Biol	86	2003	387-91	J:86741	14623535
89762	Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.		Muraoka RS; Dumont N; Ritter CA; Dugger TC; Brantley DM; Chen J; Easterly E; Roebuck LR; Ryan S; Gotwals PJ; Koteliansky V; Arteaga CL		J Clin Invest	109	2002	1551-9	J:86709	12070302
89763	Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis.		Shen MM; Abate-Shen C		Dev Dyn	228	2003	767-78	J:86792	14648854
89764	Chromosome instability and tumor predisposition inversely correlate with BLM protein levels.		McDaniel LD; Chester N; Watson M; Borowsky AD; Leder P; Schultz RA		DNA Repair (Amst)	2	2003	1387-404	J:86827	14642567
89765	Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo.		Balsitis SJ; Sage J; Duensing S; Munger K; Jacks T; Lambert PF		Mol Cell Biol	23	2003	9094-103	J:86866	14645521
89766	The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.		McCormack MP; Forster A; Drynan L; Pannell R; Rabbitts TH		Mol Cell Biol	23	2003	9003-13	J:86869	14645513
89767	Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.		Bliskovsky V; Ramsay ES; Scott J; DuBois W; Shi W; Zhang S; Qian X; Lowy DR; Mock BA		Proc Natl Acad Sci U S A	100	2003	14982-7	J:86978	14634209
89768	Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor.		Yue Z; Jin S; Yang C; Levine AJ; Heintz N		Proc Natl Acad Sci U S A	100	2003	15077-82	J:86982	14657337
89769	Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.		Brown VI; Fang J; Alcorn K; Barr R; Kim JM; Wasserman R; Grupp SA		Proc Natl Acad Sci U S A	100	2003	15113-8	J:86983	14657335
89770	Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.		Qu X; Yu J; Bhagat G; Furuya N; Hibshoosh H; Troxel A; Rosen J; Eskelinen EL; Mizushima N; Ohsumi Y; Cattoretti G; Levine B		J Clin Invest	112	2003	1809-20	J:86953	14638851
89771	Extended life span is associated with insulin resistance in a transgenic mouse model of insulinoma secreting human islet amyloid polypeptide.		Andrikopoulos S; Hull RL; Verchere CB; Wang F; Wilbur SM; Wight TN; Marzban L; Kahn SE		Am J Physiol Endocrinol Metab	286	2004	E418-24	J:87038	14613923
89772	Sequestration of connexin43 in the early endosomes: An early event of Leydig cell tumor progression.		Segretain D; Decrouy X; Dompierre J; Escalier D; Rahman N; Fiorini C; Mograbi B; Siffroi JP; Huhtaniemi I; Fenichel P; Pointis G		Mol Carcinog	38	2003	179-87	J:87014	14639657
89773	A panel of repeat markers for detection of microsatellite instability in murine tumors.		Kabbarah O; Ann Mallon M; Pfeifer JD; Edelmann W; Kucherlapati R; Goodfellow PJ		Mol Carcinog	38	2003	155-9	J:87015	14639654
89774	Progesterone receptors in mammary gland development and tumorigenesis.		Conneely OM; Jericevic BM; Lydon JP		J Mammary Gland Biol Neoplasia	8	2003	205-14	J:87016	14635795
89775	Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.		Kurpios NA; Sabolic NA; Shepherd TG; Fidalgo GM; Hassell JA		J Mammary Gland Biol Neoplasia	8	2003	177-90	J:87017	14635793
89776	Beta-catenin and Tcfs in mammary development and cancer.		Hatsell S; Rowlands T; Hiremath M; Cowin P		J Mammary Gland Biol Neoplasia	8	2003	145-58	J:87018	14635791
89777	Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin.		Niwa Y; Terashima T; Sumi H		Br J Dermatol	149	2003	960-7	J:87019	14632799
89778	Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer.		Simpson PT; Shoker BS; Barraclough R; Halliwell N; Rudland PS; Sibson DR; Davies MP		Int J Exp Pathol	84	2003	173-83	J:87020	14632631
89779	Investigations on cell proliferation in B6C3F(1) mouse liver by diethanolamine.		Mellert W; Kaufmann W; Rossbacher R; van Ravenzwaay B		Food Chem Toxicol	42	2004	127-34	J:87021	14630136
89780	WT1 and glomerular function.		Menke AL; Schedl A		Semin Cell Dev Biol	14	2003	233-40	J:87022	14627122
89781	Cyclooxygenase-2 and gastric carcinogenesis.		Saukkonen K; Rintahaka J; Sivula A; Buskens CJ; Van Rees BP; Rio MC; Haglund C; Van Lanschot JJ; Offerhaus GJ; Ristimaki A		APMIS	111	2003	915-25	J:87025	14616542
89782	Animal models of ovarian cancer.		Vanderhyden BC; Shaw TJ; Ethier JF		Reprod Biol Endocrinol	1	2003	67	J:87027	14613552
89783	Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.		Belinsky SA; Klinge DM; Stidley CA; Issa JP; Herman JG; March TH; Baylin SB		Cancer Res	63	2003	7089-93	J:87028	14612500
89784	Telomere dysfunction results in enhanced organismal sensitivity to the alkylating agent N-methyl-N-nitrosourea.		Gonzalez-Suarez E; Goytisolo FA; Flores JM; Blasco MA		Cancer Res	63	2003	7047-50	J:87029	14612493
89785	Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1.		Muraoka RS; Koh Y; Roebuck LR; Sanders ME; Brantley-Sieders D; Gorska AE; Moses HL; Arteaga CL		Mol Cell Biol	23	2003	8691-703	J:87030	14612410
89786	A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate.		Tanaka T; Kohno H; Suzuki R; Yamada Y; Sugie S; Mori H		Cancer Sci	94	2003	965-73	J:87031	14611673
89787	Exposure of mouse skin to organic peroxides: subchronic effects related to carcinogenic potential.		Hanausek M; Walaszek Z; Viaje A; LaBate M; Spears E; Farrell D; Henrich R; Tveit A; Walborg EF Jr; Slaga TJ		Carcinogenesis	25	2004	431-7	J:87032	14633658
89788	Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-kappaB.		Chun KS; Cha HH; Shin JW; Na HK; Park KK; Chung WY; Surh YJ		Carcinogenesis	25	2004	445-54	J:87033	14633657
89789	Transcriptional compensation for loss of an allele of the Ini1 tumor suppressor		Guidi CJ; Veal TM; Jones SN; Imbalzano AN		J Biol Chem	279	2004	4180-5	J:87034	 
89790	High-resolution genetic map of X-linked juvenile-type granulosa cell tumor susceptibility genes in mouse.		Dorward AM; Shultz KL; Ackert-Bicknell CL; Eicher EM; Beamer WG		Cancer Res	63	2003	8197-202	J:87114	14678975
89791	Redefining tumour suppressor genes: exceptions to the two-hit hypothesis.		Paige AJ		Cell Mol Life Sci	60	2003	2147-63	J:87117	14618262
89792	Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression.		Gillgrass A; Cardiff RD; Sharan N; Kannan S; Muller WJ		Oncogene	22	2003	9151-5	J:87087	14668796
89793	Checkpoint failure and chromosomal instability without lymphomagenesis in Mre11(ATLD1/ATLD1) mice.		Theunissen JW; Kaplan MI; Hunt PA; Williams BR; Ferguson DO; Alt FW; Petrini JH		Mol Cell	12	2003	1511-23	J:87088	14690604
89794	Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis.		Qi L; Strong MA; Karim BO; Armanios M; Huso DL; Greider CW		Cancer Res	63	2003	8188-96	J:87091	14678974
89795	Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice.		Freeman KW; Welm BE; Gangula RD; Rosen JM; Ittmann M; Greenberg NM; Spencer DM		Cancer Res	63	2003	8256-63	J:87092	14678983
89796	Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin.		Rulli SB; Ahtiainen P; Makela S; Toppari J; Poutanen M; Huhtaniemi I		Endocrinology	144	2003	4980-90	J:87234	12960071
89797	Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate.		Dillner K; Kindblom J; Flores-Morales A; Shao R; Tornell J; Norstedt G; Wennbo H		Endocrinology	144	2003	4955-66	J:87236	12960074
89798	Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.		Aguirre AJ; Bardeesy N; Sinha M; Lopez L; Tuveson DA; Horner J; Redston MS; DePinho RA		Genes Dev	17	2003	3112-26	J:87196	14681207
89799	The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.		Lewis BC; Klimstra DS; Varmus HE		Genes Dev	17	2003	3127-38	J:87197	14681205
89800	STAT proteins: from normal control of cellular events to tumorigenesis.		Calo V; Migliavacca M; Bazan V; Macaluso M; Buscemi M; Gebbia N; Russo A		J Cell Physiol	197	2003	157-68	J:87269	14502555
89801	An EM algorithm for mapping binary disease loci: application to fibrosarcoma in a four-way cross mouse family.		Xu S; Yi N; Burke D; Galecki A; Miller RA		Genet Res	82	2003	127-38	J:87283	14768897
89802	Chemomodulatory effect of Moringa oleifera, Lam, on hepatic carcinogen metabolising enzymes, antioxidant parameters and skin papillomagenesis in mice.		Bharali R; Tabassum J; Azad MR		Asian Pac J Cancer Prev	4	2003	131-9	J:85009	12875626
89803	Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.		Zindy F; Williams RT; Baudino TA; Rehg JE; Skapek SX; Cleveland JL; Roussel MF; Sherr CJ		Proc Natl Acad Sci U S A	100	2003	15930-5	J:87339	14665695
89804	Decreased CD44 expression and stromal hyaluronate accumulation in myxoid dermatofibroma.		Calikoglu E; Chavaz P; Saurat JH; Kaya G		Dermatology	207	2003	104-6	J:85029	12835568
89805	The acute promyelocytic leukemia PML-RAR alpha protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice.		David G; Terris B; Marchio A; Lavau C; Dejean A		Oncogene	14	1997	1547-54	J:87302	9129145
89806	TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma.		Batten M; Fletcher C; Ng LG; Groom J; Wheway J; Laabi Y; Xin X; Schneider P; Tschopp J; Mackay CR; Mackay F		J Immunol	172	2004	812-22	J:87359	14707051
89807	Development of new prolactin analogs acting as pure prolactin receptor antagonists.		Goffin V; Bernichtein S; Kayser C; Kelly PA		Pituitary	6	2003	89-95	J:87500	14703018
89808	The Src kinase Lyn is a negative regulator of mast cell proliferation.		Hernandez-Hansen V; Mackay GA; Lowell CA; Wilson BS; Oliver JM		J Leukoc Biol	75	2004	143-51	J:87475	14525964
89809	Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.		Lee H		Exp Mol Med	35	2003	448-53	J:87529	14646599
89810	Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models.		Azuine MA; Tokuda H; Takayasu J; Enjyo F; Mukainaka T; Konoshima T; Nishino H; Kapadia GJ		Pharmacol Res	49	2004	161-9	J:87530	14643696
89811	Genetic alterations in the Catnb gene but not the H-ras gene in hepatocellular neoplasms and hepatoblastomas of B6C3F(1) mice following exposure to diethanolamine for 2 years.		Hayashi S; Ton TV; Hong HH; Irwin RD; Haseman JK; Devereux TR; Sills RC		Chem Biol Interact	146	2003	251-61	J:87531	14642737
89812	Preferential Induction of Mammary Tumors in p53 Hemizygous BALB/c Mice by Fractionated Irradiation of a Sub-lethal Dose of X-rays.		Mori N; Yamate J; Umesako SI; Hong DP; Okumoto M; Nakao R		J Radiat Res (Tokyo)	44	2003	249-254	J:87532	14646229
89813	Dietary controlled carcinogenicity study of chloral hydrate in male B6C3F1 mice.		Leakey JE; Seng JE; Latendresse JR; Hussain N; Allen LJ; Allaben WT		Toxicol Appl Pharmacol	193	2003	266-80	J:87533	14644627
89814	Body weight considerations in the B6C3F1 mouse and the use of dietary control to standardize background tumor incidence in chronic bioassays.		Leakey JE; Seng JE; Allaben WT		Toxicol Appl Pharmacol	193	2003	237-65	J:87534	14644626
89815	Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.		Philipp-Staheli J; Kim KH; Liggitt D; Gurley KE; Longton G; Kemp CJ		Oncogene	23	2004	905-13	J:87536	14647411
89816	Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging.		Van Remmen H; Ikeno Y; Hamilton M; Pahlavani M; Wolf N; Thorpe SR; Alderson NL; Baynes JW; Epstein CJ; Huang TT; Nelson J; Strong R; Richardson A		Physiol Genomics	16	2003	29-37	J:87514	14679299
89817	Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.		Brake T; Connor JP; Petereit DG; Lambert PF		Cancer Res	63	2003	8173-80	J:87516	14678972
89818	Modeling the dosage effect of oncogenes in leukemogenesis.		Ren R		Curr Opin Hematol	11	2004	25-34	J:87517	14676624
89819	Loss of heterozygosity in heavy-ion-induced murine T-cell lymphomas.		Kakinuma S; Kubo A; Amasaki Y; Nojima K; Monobe M; Majima HJ; Imakoka T; Nishimura M; Shimada Y		Biol Sci Space	17	2003	187	J:87518	14676366
89820	Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.		Li Y; Welm B; Podsypanina K; Huang S; Chamorro M; Zhang X; Rowlands T; Egeblad M; Cowin P; Werb Z; Tan LK; Rosen JM; Varmus HE		Proc Natl Acad Sci U S A	100	2003	15853-8	J:87520	14668450
89821	Physiologically based pharmacokinetic modeling of arsenic in the mouse.		Gentry PR; Covington T; Mann S; Shipp A; Yager J; Clewell H		J Toxicol Environ Health A	67	2004	43-71	J:87521	14668111
89822	Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor &quot;knockout&quot; and &quot;knockin&quot; mouse models.		Ismail PM; Amato P; Soyal SM; DeMayo FJ; Conneely OM; O'Malley BW; Lydon JP		Steroids	68	2003	779-87	J:87522	14667968
89823	Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.		Hoffman JA; Giraudo E; Singh M; Zhang L; Inoue M; Porkka K; Hanahan D; Ruoslahti E		Cancer Cell	4	2003	383-91	J:87523	14667505
89824	Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue.		Liang H; Chen Q; Coles AH; Anderson SJ; Pihan G; Bradley A; Gerstein R; Jurecic R; Jones SN		Cancer Cell	4	2003	349-60	J:87524	14667502
89825	Stem cell recruitment and liver de-differentiation in MMTV-neu (ErbB-2) transgenic mice.		Freitas I; Fracchiolla S; Baronzio G; Griffini P; Bertone R; Sitar GM; Barni S; Gerzeli G; Sacco MG		Anticancer Res	23	2003	3783-94	J:87525	14666678
89826	Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N-butyl-N-(4-hydroxybutyl)-nitrosamine.		Mitsuhashi M; Wanibuchi H; Morimura K; Doi K; Wei M; Wada S; Nakatani T; Fukushima S		Cancer Sci	94	2003	1052-8	J:87526	14662020
89827	Functional regulation of p73 and p63: development and cancer.		Melino G; Lu X; Gasco M; Crook T; Knight RA		Trends Biochem Sci	28	2003	663-70	J:87527	14659698
89828	Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.		Ko J; Shin SM; Oh YM; Lee YS; Ryoo ZY; Lee YH; Na DS; Kim JW		Oncogene	23	2004	1950-3	J:87538	14691448
89829	Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic.		Liu J; Xie Y; Ward JM; Diwan BA; Waalkes MP		Toxicol Sci	77	2004	249-57	J:87539	14691202
89830	Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha.		Moon EJ; Jeong CH; Jeong JW; Kim KR; Yu DY; Murakami S; Kim CW; Kim KW		FASEB J	18	2004	382-4	J:87540	14688211
89831	o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis.		Sills RC; Hong HL; Flake G; Moomaw C; Clayton N; Boorman GA; Dunnick J; Devereux TR		Carcinogenesis	25	2004	605-12	J:87541	14688030
89832	'Designer' tumors in mice.		Politi K; Kljuic A; Szabolcs M; Fisher P; Ludwig T; Efstratiadis A		Oncogene	23	2004	1558-65	J:87544	14661057
89833	Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.		Gurbuxani S; Vyas P; Crispino JD		Blood	103	2004	399-406	J:87699	14512321
89834	Genetic mouse models of extended lifespan.		Liang H; Masoro EJ; Nelson JF; Strong R; McMahan CA; Richardson A		Exp Gerontol	38	2003	1353-64	J:87700	14698816
89835	The retardation of aging by caloric restriction: its significance in the transgenic era.		Barger JL; Walford RL; Weindruch R		Exp Gerontol	38	2003	1343-51	J:87701	14698815
89836	The D5Mit7 locus on mouse chromosome 5 provides resistance to gamma-ray-induced but not N-methyl-N-nitrosourea-induced thymic lymphomas.		Kodama Y; Yoshikai Y; Tamura Y; Wakana S; Takagi R; Niwa O; Kominami R		Carcinogenesis	25	2004	143-8	J:87704	14514657
89837	Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.		Tang XH; Knudsen B; Bemis D; Tickoo S; Gudas LJ		Clin Cancer Res	10	2004	301-13	J:87706	14734483
89838	Elastin induces myofibrillogenesis via a specific domain, VGVAPG.		Karnik SK; Wythe JD; Sorensen L; Brooke BS; Urness LD; Li DY		Matrix Biol	22	2003	409-25	J:87748	14614988
89839	Conquering the complexity of p53.		Attardi LD; DePinho RA		Nat Genet	36	2004	7-8	J:87816	14702030
89840	Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge.		Gyetko MR; Sud S; Chensue SW		Infect Immun	72	2004	461-7	J:87817	14688127
89841	Can mouse models for brain tumors inform treatment in pediatric patients?		Weiss WA; Banerjee A		Semin Cancer Biol	14	2004	71-7	J:87818	14757537
89842	Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.		Dohan O; Carrasco N		Mol Cell Endocrinol	213	2003	59-70	J:87884	15062574
89843	Principles of tumor suppression.		Sherr CJ		Cell	116	2004	235-46	J:87895	14744434
89844	Large-scale identification of disease genes involved in acute myeloid leukemia.		Erkeland SJ; Valkhof M; Heijmans-Antonissen C; van Hoven-Beijen A; Delwel R; Hermans MH; Touw IP		J Virol	78	2004	1971-80	J:88085	14747562
89845	Mouse models of pancreatic cancer: the fur is finally flying!		Leach SD		Cancer Cell	5	2004	7-11	J:87969	14749121
89846	Focus on epithelial ovarian cancer.		Ozols RF; Bookman MA; Connolly DC; Daly MB; Godwin AK; Schilder RJ; Xu X; Hamilton TC		Cancer Cell	5	2004	19-24	J:87970	14749123
89847	An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis.		Steinman HA; Burstein E; Lengner C; Gosselin J; Pihan G; Duckett CS; Jones SN		J Biol Chem	279	2004	4877-86	J:87962	14612455
89848	Modifier genes in mice and humans.		Nadeau JH		Nat Rev Genet	2	2001	165-74	J:88013	11256068
89849	HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice.		Wang Y; Cui F; Lv Y; Li C; Xu X; Deng C; Wang D; Sun Y; Hu G; Lang Z; Huang C; Yang X		Hepatology	39	2004	318-24	J:88078	14767984
89850	Preventive Effect of Juzen-taiho-to on Endometrial Carcinogenesis in Mice Is Based on Shimotsu-to Constituent.		Tagami K; Niwa K; Lian Z; Gao J; Mori H; Tamaya T		Biol Pharm Bull	27	2004	156-61	J:88080	14758024
89851	Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer.		Giuriato S; Rabin K; Fan AC; Shachaf CM; Felsher DW		Semin Cancer Biol	14	2004	3-11	J:88081	14757531
89852	Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten.		Backman SA; Ghazarian D; So K; Sanchez O; Wagner KU; Hennighausen L; Suzuki A; Tsao MS; Chapman WB; Stambolic V; Mak TW		Proc Natl Acad Sci U S A	101	2004	1725-30	J:88084	14747659
89853	In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.		Schell TD		J Virol	78	2004	1751-62	J:88086	14747540
89854	Interaction between the immune system and tongue squamous cell carcinoma induced by 4-nitroquinoline N-oxide in mice.		Gannot G; Buchner A; Keisari Y		Oral Oncol	40	2004	287-97	J:88087	14747060
89855	Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis.		Chen CM; Behringer RR		Genes Dev	18	2004	320-32	J:88090	14744934
89856	Bacteria-Induced Intestinal Cancer in Mice with Disrupted Gpx1 and Gpx2 Genes.		Chu FF; Esworthy RS; Chu PG; Longmate JA; Huycke MM; Wilczynski S; Doroshow JH		Cancer Res	64	2004	962-968	J:88070	14871826
89857	TIMP-1 Alters Susceptibility to Carcinogenesis.		Rhee JS; Diaz R; Korets L; Hodgson JG; Coussens LM		Cancer Res	64	2004	952-61	J:88071	14871825
89858	Basal cell carcinoma and its development: insights from radiation-induced tumors in ptch1-deficient mice.		Mancuso M; Pazzaglia S; Tanori M; Hahn H; Merola P; Rebessi S; Atkinson MJ; Di Majo V; Covelli V; Saran A		Cancer Res	64	2004	934-41	J:88072	14871823
89859	c-Kit-Targeting Immunotherapy for Hereditary Melanoma in a Mouse Model.		Kato M; Takeda K; Kawamoto Y; Tsuzuki T; Hossain K; Tamakoshi A; Kunisada T; Kambayashi Y; Ogino K; Suzuki H; Takahashi M; Nakashima I		Cancer Res	64	2004	801-6	J:88074	14871802
89860	External beam radiation &quot;Salvage&quot; therapy in transgenic murine retinoblastoma.		Sobrin L; Hayden BC; Murray TG; Cicciarelli N; Scott IU; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM		Arch Ophthalmol	122	2004	251-7	J:88075	14769602
89861	Requirement for cyclin D3 in lymphocyte development and T cell leukemias.		Sicinska E; Aifantis I; Le Cam L; Swat W; Borowski C; Yu Q; Ferrando AA; Levin SD; Geng Y; von Boehmer H; Sicinski P		Cancer Cell	4	2003	451-61	J:88120	14706337
89862	Inhibitory effects of silk protein, sericin on UVB-induced acute damage and tumor promotion by reducing oxidative stress in the skin of hairless mouse.		Zhaorigetu S; Yanaka N; Sasaki M; Watanabe H; Kato N		J Photochem Photobiol B	71	2003	11-7	J:88122	14705634
89863	Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer.		Guo JY; Li X; Browning JD Jr; Rottinghaus GE; Lubahn DB; Constantinou A; Bennink M; MacDonald RS		J Nutr	134	2004	179-82	J:88123	14704314
89864	Two new anti-tumor promoting serratane-type triterpenoids from the stem bark of Picea jezoensis var. jezoensis.		Tanaka R; Ishikawa Y; Minami T; Minoura K; Tokuda H; Matsunaga S		Planta Med	69	2003	1041-7	J:88104	14735444
89865	Breast cancer: the protective effect of pregnancy.		Medina D		Clin Cancer Res	10	2004	380S-4S	J:88105	14734495
89866	Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice.		Kennedy AR; Kritchevsky D; Shen WC		Pharm Res	20	2003	1908-10	J:88108	14725352
89867	B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders.		Morse HC 3rd; McCarty T; Qi CF; Torrey TA; Naghashfar Z; Chattopadhyay SK; Fredrickson TN; Hartley JW		Adv Immunol	81	2003	97-121	J:88115	14711054
89868	Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.		Chan IT; Kutok JL; Williams IR; Cohen S; Kelly L; Shigematsu H; Johnson L; Akashi K; Tuveson DA; Jacks T; Gilliland DG		J Clin Invest	113	2004	528-38	J:88163	14966562
89869	Anion exchanger 2 is essential for spermiogenesis in mice.		Medina JF; Recalde S; Prieto J; Lecanda J; Saez E; Funk CD; Vecino P; van Roon MA; Ottenhoff R; Bosma PJ; Bakker CT; Elferink RP		Proc Natl Acad Sci U S A	100	2003	15847-52	J:88196	14673081
89870	OVCA1: emerging as a bona fide tumor suppressor.		Jensen MR; Helin K		Genes Dev	18	2004	245-8	J:88262	14871925
89871	Id2 is dispensable for Myc-induced epidermal neoplasia.		Murphy DJ; Swigart LB; Israel MA; Evan GI		Mol Cell Biol	24	2004	2083-90	J:88188	14966287
89872	Insights into the physiological role of WT1 from studies of genetically modified mice.		Discenza MT; Pelletier J		Physiol Genomics	16	2004	287-300	J:88326	14966251
89873	Modeling the cancer patient with genetically engineered mice: prediction of toxicity from molecule-targeted therapies.		Roberts RB; Arteaga CL; Threadgill DW		Cancer Cell	5	2004	115-20	J:88331	14998487
89874	Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.		Bonner AE; Lemon WJ; Devereux TR; Lubet RA; You M		Oncogene	23	2004	1166-76	J:88371	14647414
89875	Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors.		Sikder H; Huso DL; Zhang H; Wang B; Ryu B; Hwang ST; Powell JD; Alani RM		Cancer Cell	4	2003	291-9	J:88372	14585356
89876	E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice.		Schaeffer AJ; Nguyen M; Liem A; Lee D; Montagna C; Lambert PF; Ried T; Difilippantonio MJ		Cancer Res	64	2004	538-46	J:88376	14744767
89877	Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth.		Steinman HA; Sluss HK; Sands AT; Pihan G; Jones SN		Oncogene	23	2004	303-6	J:88362	14712235
89878	Caspase-3 in postnatal retinal development and degeneration.		Zeiss CJ; Neal J; Johnson EA		Invest Ophthalmol Vis Sci	45	2004	964-70	J:88367	14985318
89879	Hedgehog signalling in cancer formation and maintenance.		Pasca di Magliano M; Hebrok M		Nat Rev Cancer	3	2003	903-11	J:88369	14737121
89880	Applying the principles of stem-cell biology to cancer.		Pardal R; Clarke MF; Morrison SJ		Nat Rev Cancer	3	2003	895-902	J:88370	14737120
89881	Moderate hypermutability of a transgenic lacZ reporter gene in Myc-dependent inflammation-induced plasma cell tumors in mice.		Felix K; Polack A; Pretsch W; Jackson SH; Feigenbaum L; Bornkamm GW; Janz S		Cancer Res	64	2004	530-7	J:88429	14744766
89882	The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer.		Yang C; Ionescu-Tiba V; Burns K; Gadd M; Zukerberg L; Louis DN; Sgroi D; Schmidt EV		Am J Pathol	164	2004	1031-8	J:88435	14982856
89883	bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.		Haupt Y; Bath ML; Harris AW; Adams JM		Oncogene	8	1993	3161-4	J:88485	8414519
89884	Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia.		Kumar AR; Hudson WA; Chen W; Nishiuchi R; Yao Q; Kersey JH		Blood	103	2004	1823-8	J:88494	14615372
89885	Loss of collagenase-2 confers increased skin tumor susceptibility to male mice.		Balbin M; Fueyo A; Tester AM; Pendas AM; Pitiot AS; Astudillo A; Overall CM; Shapiro SD; Lopez-Otin C		Nat Genet	35	2003	252-7	J:86393	14517555
89886	Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo.		West KA; Linnoila IR; Belinsky SA; Harris CC; Dennis PA		Cancer Res	64	2004	446-51	J:88543	14744754
89887	Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia.		Bing C; Bao Y; Jenkins J; Sanders P; Manieri M; Cinti S; Tisdale MJ; Trayhurn P		Proc Natl Acad Sci U S A	101	2004	2500-5	J:88642	14983038
89888	Proinflammatory mediators and genetic background in oncogene mediated tumor progression.		Russell JP; Engiles JB; Rothstein JL		J Immunol	172	2004	4059-67	J:88680	15034017
89889	Reproductive system tumors in mice exposed to various types of fat perinatally.		Walker BE; Edwards SN		Anticancer Res	23	2003	4689-91	J:88753	14981914
89890	Exceptionally high protection of photocarcinogenesis by topical application of (--)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation.		Mittal A; Piyathilake C; Hara Y; Katiyar SK		Neoplasia	5	2003	555-65	J:88756	14965448
89891	Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond.		Bissonette R; Bergeron A; Liu Y		J Drugs Dermatol	3	2004	S26-31	J:88758	14964758
89892	Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice.		Oshima H; Oshima M; Inaba K; Taketo MM		EMBO J	23	2004	1669-78	J:88759	15014433
89893	A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility.		Wang Y; Zhang Z; Yan Y; Lemon WJ; LaRegina M; Morrison C; Lubet R; You M		Cancer Res	64	2004	1647-54	J:88787	14996723
89894	Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions.		Sharpless NE; Ferguson DO; O'Hagan RC; Castrillon DH; Lee C; Farazi PA; Alson S; Fleming J; Morton CC; Frank K; Chin L; Alt FW; DePinho RA		Mol Cell	8	2001	1187-96	J:88792	11779495
89895	TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.		Bhowmick NA; Chytil A; Plieth D; Gorska AE; Dumont N; Shappell S; Washington MK; Neilson EG; Moses HL		Science	303	2004	848-51	J:88881	14764882
89896	Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription.		Takai H; Naka K; Okada Y; Watanabe M; Harada N; Saito S; Anderson CW; Appella E; Nakanishi M; Suzuki H; Nagashima K; Sawa H; Ikeda K; Motoyama N		EMBO J	21	2002	5195-205	J:88888	12356735
89897	Osteopontin affects the persistence of beta-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms.		Morimoto J; Inobe M; Kimura C; Kon S; Diao H; Aoki M; Miyazaki T; Denhardt DT; Rittling S; Uede T		Int Immunol	16	2004	477-88	J:88927	14978021
89898	Genotoxicity of benzene and its metabolites.		Whysner J; Reddy MV; Ross PM; Mohan M; Lax EA		Mutat Res	566	2004	99-130	J:88934	15164977
89899	Cancer chemopreventive effects of polyunsaturated fatty acids.		Akihisa T; Tokuda H; Ogata M; Ukiya M; Iizuka M; Suzuki T; Metori K; Shimizu N; Nishino H		Cancer Lett	205	2004	9-13	J:88936	15036655
89900	RET and neuroendocrine tumors.		Ichihara M; Murakumo Y; Takahashi M		Cancer Lett	204	2004	197-211	J:88937	15013219
89901	Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancer.		Ball DW		Cancer Lett	204	2004	159-69	J:88975	15013215
89902	Hedgehog--Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer.		Ruiz i Altaba A; Stecca B; Sanchez P		Cancer Lett	204	2004	145-57	J:88976	15013214
89903	Gamma delta T cells provide an early source of interferon gamma in tumor immunity.		Gao Y; Yang W; Pan M; Scully E; Girardi M; Augenlicht LH; Craft J; Yin Z		J Exp Med	198	2003	433-42	J:88980	12900519
89904	Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero.		Waalkes MP; Liu J; Chen H; Xie Y; Achanzar WE; Zhou YS; Cheng ML; Diwan BA		J Natl Cancer Inst	96	2004	466-74	J:89009	15026472
89905	PPAR gamma signaling exacerbates mammary gland tumor development.		Saez E; Rosenfeld J; Livolsi A; Olson P; Lombardo E; Nelson M; Banayo E; Cardiff RD; Izpisua-Belmonte JC; Evans RM		Genes Dev	18	2004	528-40	J:89019	15037548
89906	Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice.		Kuefer MU; Look AT; Pulford K; Behm FG; Pattengale PK; Mason DY; Morris SW		Blood	90	1997	2901-10	J:89020	9376569
89907	Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.		So CW; Karsunky H; Wong P; Weissman IL; Cleary ML		Blood	103	2004	3192-9	J:89042	15070702
89908	Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies.		Linden M; Kirchhof N; Carlson C; Van Ness B		Blood	103	2004	2779-86	J:89049	14656874
89909	Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion markers in CD-1 mouse skin by oleandrin.		Afaq F; Saleem M; Aziz MH; Mukhtar H		Toxicol Appl Pharmacol	195	2004	361-9	J:89024	15020199
89910	Topical application of dimethylbenz[a]anthracene results in the generation of multiple melanocytic nevi in C3H/HeN mice.		Elmets CA; Yusuf N; Hamza S; Iranikakh N; Smith J; Volk AL; Skelton H; Smith K		Toxicol Appl Pharmacol	195	2004	355-60	J:89025	15020198
89911	Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice.		Klezovitch O; Fernandez TE; Tapscott SJ; Vasioukhin V		Genes Dev	18	2004	559-71	J:89028	15037549
89912	Inhibition of Mist1 homodimer formation induces pancreatic acinar-to-ductal metaplasia.		Zhu L; Tran T; Rukstalis JM; Sun P; Damsz B; Konieczny SF		Mol Cell Biol	24	2004	2673-81	J:89063	15024058
89913	Epstein-Barr virus nuclear antigen-1 and Myc cooperate in lymphomagenesis.		Drotar ME; Silva S; Barone E; Campbell D; Tsimbouri P; Jurvansu J; Bhatia P; Klein G; Wilson JB		Int J Cancer	106	2003	388-95	J:85023	12845679
89914	Enhanced malignant tumorigenesis in Cdk4 transgenic mice.		Miliani de Marval PL; Macias E; Conti CJ; Rodriguez-Puebla ML		Oncogene	23	2004	1863-73	J:89084	14647432
89915	Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.		Arnott CH; Scott KA; Moore RJ; Robinson SC; Thompson RG; Balkwill FR		Oncogene	23	2004	1902-10	J:89088	14661063
89916	Lymphotropic papovavirus early region is specifically regulated transgenic mice and efficiently induces neoplasia.		Chen JD; Neilson K; Van Dyke T		J Virol	63	1989	2204-14	J:89096	2704077
89917	Accelerated induction of bladder cancer in patched heterozygous mutant mice.		Hamed S; LaRue H; Hovington H; Girard J; Jeannotte L; Latulippe E; Fradet Y		Cancer Res	64	2004	1938-42	J:89149	15026327
89918	Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.		Cheung AM; Elia A; Tsao MS; Done S; Wagner KU; Hennighausen L; Hakem R; Mak TW		Cancer Res	64	2004	1959-65	J:89150	15026330
89919	Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.		Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A		Mutat Res	548	2004	35-45	J:89154	15063134
89920	Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways.		Mabley JG; Pacher P; Bai P; Wallace R; Goonesekera S; Virag L; Southan GJ; Szabo C		Mutat Res	548	2004	107-16	J:89155	15063141
89921	Elevated presence of retrotransposons at sites of DNA double strand break repair in mouse models of metabolic oxidative stress and MYC-induced lymphoma.		Rockwood LD; Felix K; Janz S		Mutat Res	548	2004	117-25	J:89158	15063142
89922	Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice.		Xia Y; Sidis Y; Schneyer A		Mol Endocrinol	18	2004	979-94	J:89160	14739256
89923	Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas.		Hager JH; Hodgson JG; Fridlyand J; Hariono S; Gray JW; Hanahan D		Cancer Res	64	2004	2406-10	J:89138	15059892
89924	The tyrp1-Tag/tyrp1-FGFR1-DN bigenic mouse: a model for selective inhibition of tumor development, angiogenesis, and invasion into the neural tissue by blockade of fibroblast growth factor receptor activity.		Rousseau B; Larrieu-Lahargue F; Javerzat S; Guilhem-Ducleon F; Beermann F; Bikfalvi A		Cancer Res	64	2004	2490-5	J:89139	15059903
89925	Heterozygous p53-deficient (+/-) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice.		Finnberg N; Stenius U; Hogberg J		Cancer Lett	207	2004	149-55	J:89140	15072823
89926	Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.		Shappell SB; Thomas GV; Roberts RL; Herbert R; Ittmann MM; Rubin MA; Humphrey PA; Sundberg JP; Rozengurt N; Barrios R; Ward JM; Cardiff RD		Cancer Res	64	2004	2270-305	J:89143	15026373
89927	Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers.		Kho AT; Zhao Q; Cai Z; Butte AJ; Kim JY; Pomeroy SL; Rowitch DH; Kohane IS		Genes Dev	18	2004	629-40	J:89201	15075291
89928	The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells.		Liu BY; McDermott SP; Khwaja SS; Alexander CM		Proc Natl Acad Sci U S A	101	2004	4158-63	J:89233	15020770
89929	Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition.		Lind MH; Rozell B; Wallin RP; van Hogerlinden M; Ljunggren HG; Toftgard R; Sur I		Proc Natl Acad Sci U S A	101	2004	4972-7	J:89239	15044707
89930	Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two-stage skin carcinogenesis.		Helfrich I; Chen M; Schmidt R; Furstenberger G; Kopp-Schneider A; Trick D; Grone HJ; Zur Hausen H; Rosl F		J Virol	78	2004	4797-805	J:89245	15078961
89931	Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene.		Fleischmann A; Jochum W; Eferl R; Witowsky J; Wagner EF		Cancer Cell	4	2003	477-82	J:89283	14706339
89932	Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo.		Murray NR; Jamieson L; Yu W; Zhang J; Gokmen-Polar Y; Sier D; Anastasiadis P; Gatalica Z; Thompson EA; Fields AP		J Cell Biol	164	2004	797-802	J:89285	15024028
89933	Reduced inflammatory pain in mice deficient in the differential screening-selected gene aberrative in neuroblastoma.		Ohtori S; Isogai E; Hasue F; Ozaki T; Nakamura Y; Nakagawara A; Koseki H; Yuasa S; Hanaoka E; Shinbo J; Yamamoto T; Chiba H; Yamazaki M; Moriya H; Sakiyama S		Mol Cell Neurosci	25	2004	504-14	J:89353	15033178
89934	Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.		Tuveson DA; Shaw AT; Willis NA; Silver DP; Jackson EL; Chang S; Mercer KL; Grochow R; Hock H; Crowley D; Hingorani SR; Zaks T; King C; Jacobetz MA; Wang L; Bronson RT; Orkin SH; DePinho RA; Jacks T		Cancer Cell	5	2004	375-87	J:89333	15093544
89935	Exposure to chromium (VI) in the drinking water increases susceptibility to UV-induced skin tumors in hairless mice.		Davidson T; Kluz T; Burns F; Rossman T; Zhang Q; Uddin A; Nadas A; Costa M		Toxicol Appl Pharmacol	196	2004	431-7	J:89336	15094314
89936	Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.		Kalinichenko VV; Major ML; Wang X; Petrovic V; Kuechle J; Yoder HM; Dennewitz MB; Shin B; Datta A; Raychaudhuri P; Costa RH		Genes Dev	18	2004	830-50	J:89472	15082532
89937	Chromosome segregation and genomic stability.		Draviam VM; Xie S; Sorger PK		Curr Opin Genet Dev	14	2004	120-5	J:89517	15196457
89938	IL-6 is required for glioma development in a mouse model.		Weissenberger J; Loeffler S; Kappeler A; Kopf M; Lukes A; Afanasieva TA; Aguzzi A; Weis J		Oncogene	23	2004	3308-16	J:89585	15064729
89939	Trials, tribulations, and trends in tumor modeling in mice.		Schuh JC		Toxicol Pathol	32 Suppl 1	2004	53-66	J:89557	15209404
89940	Mouse models of human familial cancer syndromes.		Ward JM; Devor-Henneman DE		Toxicol Pathol	32 Suppl 1	2004	90-8	J:89559	15209408
89941	Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene.		EL Naaman C; Grum-Schwensen B; Mansouri A; Grigorian M; Santoni-Rugiu E; Hansen T; Kriajevska M; Schafer BW; Heizmann CW; Lukanidin E; Ambartsumian N		Oncogene	23	2004	3670-80	J:89563	15116098
89942	Interaction of Nkx3.1 and p27kip1 in prostate tumor initiation.		Gary B; Azuero R; Mohanty GS; Bell WC; Eltoum IE; Abdulkadir SA		Am J Pathol	164	2004	1607-14	J:89571	15111307
89943	Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice.		Erdmann N; Liu Y; Harrington L		Proc Natl Acad Sci U S A	101	2004	6080-5	J:89591	15079066
89944	Application of gene expression profiling for validating models of human breast cancer.		Green JE; Desai KV; Ye Y; Kavanaugh C; Calvo A; Huh JI		Toxicol Pathol	32 Suppl 1	2004	84-9	J:89592	15209407
89945	Bim is a suppressor of Myc-induced mouse B cell leukemia.		Egle A; Harris AW; Bouillet P; Cory S		Proc Natl Acad Sci U S A	101	2004	6164-9	J:89600	15079075
89946	Initial stages of mammary tumor virus infection are superantigen independent.		Pobezinskaya Y; Chervonsky AV; Golovkina TV		J Immunol	172	2004	5582-7	J:89647	15100301
89947	O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis.		Nakatsuru Y; Matsukuma S; Nemoto N; Sugano H; Sekiguchi M; Ishikawa T		Proc Natl Acad Sci U S A	90	1993	6468-72	J:89748	8341657
89948	Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo.		Thomas-Tikhonenko A; Viard-Leveugle I; Dews M; Wehrli P; Sevignani C; Yu D; Ricci S; el-Deiry W; Aronow B; Kaya G; Saurat JH; French LE		Cancer Res	64	2004	3126-36	J:89749	15126350
89949	Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis.		Ming Kwan K; Li AG; Wang XJ; Wurst W; Behringer RR		Genesis	39	2004	10-25	J:89759	15124223
89950	Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability.		Guda K; Upender MB; Belinsky G; Flynn C; Nakanishi M; Marino JN; Ried T; Rosenberg DW		Oncogene	23	2004	3813-21	J:89877	15021908
89951	CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction.		Garbi N; Arnold B; Gordon S; Hammerling GJ; Ganss R		J Immunol	172	2004	5861-9	J:89861	15128765
89952	Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice.		Canela A; Martin-Caballero J; Flores JM; Blasco MA		Mol Cell Biol	24	2004	4275-93	J:89892	15121848
89953	Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models.		Zhang Z; Wang Y; Yao R; Li J; Yan Y; La Regina M; Lemon WL; Grubbs CJ; Lubet RA; You M		Oncogene	23	2004	3841-50	J:89926	15021904
89954	Establishment and characterization of mouse mammary carcinoma cell lines expressing RET with a multiple endocrine neoplasia 2A mutation.		Kawai K; Jijiwa M; Shimono Y; Kurokawa K; Murakumo Y; Ichihara M; Takahashi M		Cancer Sci	94	2003	992-7	J:89980	14611677
89955	Role of osteopontin in tumour progression.		Rittling SR; Chambers AF		Br J Cancer	90	2004	1877-81	J:89964	15138464
89956	Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis.		Joyce JA; Baruch A; Chehade K; Meyer-Morse N; Giraudo E; Tsai FY; Greenbaum DC; Hager JH; Bogyo M; Hanahan D		Cancer Cell	5	2004	443-53	J:90047	15144952
89957	Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis.		Ruiz S; Santos M; Segrelles C; Leis H; Jorcano JL; Berns A; Paramio JM; Vooijs M		Development	131	2004	2737-2748	J:90140	15148303
89958	Evidence of finely tuned expression of DNA polymerase beta in vivo using transgenic mice.		Bergoglio V; Frechet M; Philippe M; Bieth A; Mercier P; Morello D; Lacroix-Tricki M; Delsol G; Hoffmann JS; Cazaux C		FEBS Lett	566	2004	147-150	J:90141	15147885
89959	Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.		Bull RJ; Sasser LB; Lei XC		Toxicology	199	2004	169-183	J:90142	15147791
89960	Cyclin E.		Moroy T; Geisen C		Int J Biochem Cell Biol	36	2004	1424-1439	J:90143	15147722
89961	NTP technical report on the toxicity studies of 2- and 4-Methylimidazole (CAS No. 693-98-1 and 822-36-1) Administered in Feed to F344/N Rats and B6C3F1 Mice.		Chan P		Toxic Rep Ser	67	2004	1-G12	J:90144	15146214
89962	Cysteine cathepsins (proteases)-On the main stage of cancer?		Turk V; Kos J; Turk B		Cancer Cell	5	2004	409-10	J:90147	15144947
89963	The Homeodomain Protein CDP Regulates Mammary-Specific Gene Transcription and Tumorigenesis.		Zhu Q; Maitra U; Johnston D; Lozano M; Dudley JP		Mol Cell Biol	24	2004	4810-23	J:90149	15143175
89964	Disruption of CCT{beta}2 Expression Leads to Gonadal Dysfunction.		Jackowski S; Rehg JE; Zhang YM; Wang J; Miller K; Jackson P; Karim MA		Mol Cell Biol	24	2004	4720-4733	J:90150	15143167
89965	In vivo respiratory-gated micro-CT imaging in small-animal oncology models.		Cavanaugh D; Johnson E; Price RE; Kurie J; Travis EL; Cody DD		Mol Imaging	3	2004	55-62	J:90152	15142412
89966	Experimental cancer studies of chlorinated by-products.		Komulainen H		Toxicology	198	2004	239-48	J:90154	15138047
89967	Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation.		Waalkes MP; Liu J; Ward JM; Diwan BA		Toxicology	198	2004	31-8	J:90155	15138027
89968	Role of apoptosis for mouse liver growth regulation and tumor promotion: comparative analysis of mice with high (C3H/He) and low (C57Bl/6J) cancer susceptibility.		Bursch W; Grasl-Kraupp B; Wastl U; Hufnagl K; Chabicovsky M; Taper H; Schulte-Hermann R		Toxicol Lett	149	2004	25-35	J:90186	15093245
89969	Carcinogenicity and chronic toxicity in mice and rats administered vinyl acetate monomer in drinking water.		Umeda Y; Matsumoto M; Yamazaki K; Ohnishi M; Arito H; Nagano K; Yamamoto S; Matsushima T		J Occup Health	46	2004	87-99	J:90187	15090683
89970	Oxytocin and oxytocin receptors in cancer cells and proliferation.		Cassoni P; Sapino A; Marrocco T; Chini B; Bussolati G		J Neuroendocrinol	16	2004	362-4	J:90188	15089975
89971	Modulation of antioxidant potential in liver of mice by kernel oil of cashew nut (Anacardium occidentale) and its lack of tumour promoting ability in DMBA induced skin papillomagenesis.		Singh B; Kale RK; Rao AR		Indian J Exp Biol	42	2004	373-7	J:90189	15088687
89972	Chemopreventive effects of Cuminum cyminum in chemically induced forestomach and uterine cervix tumors in murine model systems.		Gagandeep; Dhanalakshmi S; Mendiz E; Rao AR; Kale RK		Nutr Cancer	47	2003	171-80	J:90190	15087270
89973	Cyclins and breast cancer.		Sutherland RL; Musgrove EA		J Mammary Gland Biol Neoplasia	9	2004	95-104	J:90193	15082921
89974	Cell cycle genes in a mouse mammary hyperplasia model.		Said TK; Medina D		J Mammary Gland Biol Neoplasia	9	2004	81-93	J:90194	15082920
89975	Role of the CDK Inhibitor p27 (Kip1) in Mammary Development and Carcinogenesis: Insights from Knockout Mice.		Musgrove EA; Davison EA; Ormandy CJ		J Mammary Gland Biol Neoplasia	9	2004	55-66	J:90195	15082918
89976	Of Mice and Myc: c-Myc and Mammary Tumorigenesis.		Jamerson MH; Johnson MD; Dickson RB		J Mammary Gland Biol Neoplasia	9	2004	27-37	J:90196	15082916
89977	Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1.		Marschang P; Brich J; Weeber EJ; Sweatt JD; Shelton JM; Richardson JA; Hammer RE; Herz J		Mol Cell Biol	24	2004	3782-93	J:90197	15082773
89978	Effects of budesonide on overall 5-methylcytosine levels and specific methylation and messenger RNA expression of the insulin-like growth factor II gene in mouse lung tumors.		Lubet R; Tao L; Wang W; Kramer P; Perreira M		Chest	125	2004	157S	J:90156	15136485
89979	Evidence that inflammation encourages pulmonary adenocarcinoma formation in mice: clinical implications.		Malkinson AM		Chest	125	2004	154S-5S	J:90157	15136480
89980	Modulation of Biomarkers During Chemoprevention of Mouse Lung Tumorigenesis by D-glucarate.		Hanausek M; Walaszek Z; Szemraj J; Zoltaszek R; Slaga TJ		Chest	125	2004	149S	J:90158	15136473
89981	Sprouty 2 gene in mouse lung tumorigenesis.		Minowada G; Miller YE		Chest	125	2004	111S	J:90159	15136453
89982	Serum levels of surfactant protein d are increased in mice with lung tumors.		Zhang F; Pao W; Umphress S; Jakowlew S; Meyer AM; Dwyer-Nield LD; Takeda K; Gelfand EW; Fisher J; Malkinson AM; Mason RJ		Chest	125	2004	109S	J:90160	15136449
89983	Development of lung tumors in mutant p53-expressing mice after inhalation exposure to asbestos.		Morris GF; Notwick AR; David O; Fermin C; Brody AR; Friedman M		Chest	125	2004	85S-6S	J:90161	15136429
89984	Cancer-associated genes can affect somatic intrachromosomal recombination early in carcinogenesis.		Hooker AM; Morley AA; Tilley WD; Sykes PJ		Mutat Res	550	2004	1-10	J:90162	15135636
89985	The roles of smad2 and smad3 in the development of chemically induced skin tumors in mice.		Tannehill-Gregg SH; Kusewitt DF; Rosol TJ; Weinstein M		Vet Pathol	41	2004	278-82	J:90163	15133179
89986	Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.		Calvisi DF; Factor VM; Ladu S; Conner EA; Thorgeirsson SS		Gastroenterology	126	2004	1374-86	J:90164	15131798
89987	In situ reduction of oxidative damage, increased cell turnover, and delay of mitochondrial injury by overexpression of manganese superoxide dismutase in a multistage skin carcinogenesis model.		Oberley TD; Xue Y; Zhao Y; Kiningham K; Szweda LI; St Clair DK		Antioxid Redox Signal	6	2004	537-48	J:90165	15130280
89988	Biological significance of the defense mechanisms against oxidative damage in nucleic acids caused by reactive oxygen species: from mitochondria to nuclei.		Nakabeppu Y; Tsuchimoto D; Ichinoe A; Ohno M; Ide Y; Hirano S; Yoshimura D; Tominaga Y; Furuichi M; Sakumi K		Ann N Y Acad Sci	1011	2004	101-11	J:90166	15126288
89989	Inhalation toxicology and carcinogenesis studies of propylene glycol mono-t-butyl ether in rats and mice.		Doi AM; Roycroft JH; Herbert RA; Haseman JK; Hailey JR; Chou BJ; Dill JA; Grumbein SL; Miller RA; Renne RA; Bucher JR		Toxicology	199	2004	1-22	J:90167	15125995
89990	Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine.		Iinuma T; Homma S; Noda T; Kufe D; Ohno T; Toda G		J Clin Invest	113	2004	1307-17	J:90168	15124022
89991	Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.		Rudnick DA; Liao Y; An JK; Muglia LJ; Perlmutter DH; Teckman JH		Hepatology	39	2004	1048-55	J:90211	15057909
89992	Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs.		Frijhoff AF; Conti CJ; Senderowicz AM		Mol Carcinog	39	2004	183-94	J:90212	15057870
89993	The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival.		Jackson DN; Foster DA		FASEB J	18	2004	627-36	J:90214	15054085
89994	Effect of O-4-ethoxyl-butyl-berbamine in combination with pegylated liposomal doxorubicin on advanced hepatoma in mice.		Fang BJ; Yu ML; Yang SG; Liao LM; Liu JW; Zhao RC		World J Gastroenterol	10	2004	950-3	J:90215	15052672
89995	Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor.		Sodhi A; Montaner S; Patel V; Gomez-Roman JJ; Li Y; Sausville EA; Sawai ET; Gutkind JS		Proc Natl Acad Sci U S A	101	2004	4821-6	J:90218	15047889
89996	Comparative study of smoke condensates from 1R4F cigarettes that burn tobacco versus ECLIPSE cigarettes that primarily heat tobacco in the SENCAR mouse dermal tumor promotion assay.		Meckley DR; Hayes JR; Van Kampen KR; Ayres PH; Mosberg AT; Swauger JE		Food Chem Toxicol	42	2004	851-63	J:90219	15046832
89997	Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia.		Castilla LH; Perrat P; Martinez NJ; Landrette SF; Keys R; Oikemus S; Flanegan J; Heilman S; Garrett L; Dutra A; Anderson S; Pihan GA; Wolff L; Liu PP		Proc Natl Acad Sci U S A	101	2004	4924-9	J:90220	15044690
89998	Dietary nucleosides and nucleotides do not affect tumor incidence but reduce amyloidosis incidence in B6C3F1 mice irradiated with californium-252.		Yokoyama H; Fujiwara H; Watanabe H		Nutrition	20	2004	383-9	J:90222	15043856
89999	Yogurt feeding inhibits promotion and progression of experimental colorectal cancer.		De Moreno De LeBlanc A; Perdigon G		Med Sci Monit	10	2004	BR96-BR104	J:90224	15039638
90000	Hypomethylation of DNA and the insulin-like growth factor-II gene in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors.		Tao L; Li Y; Kramer PM; Wang W; Pereira MA		Toxicology	196	2004	127-36	J:90225	15036762
90001	Potential of gene therapy for the treatment of pituitary tumors.		Goya RG; Sarkar DK; Brown OA; Herenu CB		Curr Gene Ther	4	2004	79-87	J:90226	15032616
90002	Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium.		Fujii S; Fujimori T; Kawamata H; Takeda J; Kitajima K; Omotehara F; Kaihara T; Kusaka T; Ichikawa K; Ohkura Y; Ono Y; Imura J; Yamaoka S; Sakamoto C; Ueda Y; Chiba T		Gut	53	2004	710-6	J:90198	15082590
90003	Review article: How useful are the rodent animal models of gastric adenocarcinoma?		Pritchard DM; Przemeck SM		Aliment Pharmacol Ther	19	2004	841-59	J:90199	15080846
90004	HER2-targeted therapy reduces incidence and progression of midlife mammary tumors in female murine mammary tumor virus huHER2-transgenic mice.		Finkle D; Quan ZR; Asghari V; Kloss J; Ghaboosi N; Mai E; Wong WL; Hollingshead P; Schwall R; Koeppen H; Erickson S		Clin Cancer Res	10	2004	2499-511	J:90202	15073130
90005	Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice.		Hata K; Yamada Y; Kuno T; Hirose Y; Hara A; Qiang SH; Mori H		Cancer Sci	95	2004	316-20	J:90203	15072589
90006	Chemomodulatory efficacy of basil leaf (Ocimum basilicum) on drug metabolizing and antioxidant enzymes, and on carcinogen-induced skin and forestomach papillomagenesis.		Dasgupta T; Rao AR; Yadava PK		Phytomedicine	11	2004	139-51	J:90204	15070164
90007	Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by topical Pycnogenol.		Sime S; Reeve VE		Photochem Photobiol	79	2004	193-8	J:90205	15068032
90008	Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin-RAS transgenic mice.		Scherl A; Li JF; Cardiff RD; Schreiber-Agus N		Prostate	59	2004	448-59	J:90206	15065094
90009	Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study.		Burns FJ; Uddin AN; Wu F; Nadas A; Rossman TG		Environ Health Perspect	112	2004	599-603	J:90208	15064167
90010	Thyroid hormone receptor mutations in cancer.		Cheng SY		Mol Cell Endocrinol	213	2003	23-30	J:90209	15062571
90011	Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).		Brent RL		Pediatrics	113	2004	984-95	J:90210	15060191
90012	Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment.		El-Hashemite N; Zhang H; Walker V; Hoffmeister KM; Kwiatkowski DJ		Cancer Res	64	2004	3436-43	J:90253	15150095
90013	Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients.		Chen LC; Hao CY; Chiu YS; Wong P; Melnick JS; Brotman M; Moretto J; Mendes F; Smith AP; Bennington JL; Moore D; Lee NM		Cancer Res	64	2004	3694-700	J:90255	15150130
90014	Comparative pathology of nerve sheath tumors in mouse models and humans.		Stemmer-Rachamimov AO; Louis DN; Nielsen GP; Antonescu CR; Borowsky AD; Bronson RT; Burns DK; Cervera P; McLaughlin ME; Reifenberger G; Schmale MC; MacCollin M; Chao RC; Cichowski K; Kalamarides M; Messerli SM; McClatchey AI; Niwa-Kawakita M; Ratner N; Re	illy KM; Zhu Y; Giovannini M	Cancer Res	64	2004	3718-24	J:90256	15150133
90015	Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene.		Teitz T; Chang JC; Kitamura M; Yen TS; Kan YW		Proc Natl Acad Sci U S A	90	1993	2910-4	J:90240	7681991
90016	The phosphoprotein StarD10 is overexpressed in breast cancer and cooperates with ErbB receptors in cellular transformation.		Olayioye MA; Hoffmann P; Pomorski T; Armes J; Simpson RJ; Kemp BE; Lindeman GJ; Visvader JE		Cancer Res	64	2004	3538-44	J:90244	15150109
90017	Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.		Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY		Cancer Res	64	2004	3525-32	J:90247	15150107
90018	Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation.		Rossiter H; Barresi C; Pammer J; Rendl M; Haigh J; Wagner EF; Tschachler E		Cancer Res	64	2004	3508-16	J:90248	15150105
90019	The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia.		Xu Y; Sumter TF; Bhattacharya R; Tesfaye A; Fuchs EJ; Wood LJ; Huso DL; Resar LM		Cancer Res	64	2004	3371-5	J:90252	15150086
90020	Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis.		Quintanilla M; Brown K; Ramsden M; Balmain A		Nature	322	1986	78-80	J:90312	3014349
90021	Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice.		Arbeit JM; Olson DC; Hanahan D		Oncogene	13	1996	1847-57	J:90314	8934530
90022	E6 and E7 expression from the HPV 18 LCR: development of genital hyperplasia and neoplasia in transgenic mice.		Comerford SA; Maika SD; Laimins LA; Messing A; Elsasser HP; Hammer RE		Oncogene	10	1995	587-97	J:90315	7845684
90023	An in vivo model for receptor tyrosine kinase autocrine/paracrine activation: auto-stimulated KIT receptor acts as a tumor promoting factor in papillomavirus-induced tumorigenesis.		Kondoh G; Hayasaka N; Li Q; Nishimune Y; Hakura A		Oncogene	10	1995	341-7	J:90316	7530826
90024	Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter.		Bailleul B; Surani MA; White S; Barton SC; Brown K; Blessing M; Jorcano J; Balmain A		Cell	62	1990	697-708	J:90317	1696852
90025	v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis.		Brown K; Quintanilla M; Ramsden M; Kerr IB; Young S; Balmain A		Cell	46	1986	447-56	J:90318	3015415
90026	Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs.		Arbeit JM; Munger K; Howley PM; Hanahan D		Am J Pathol	142	1993	1187-97	J:90319	8386443
90027	Potential therapeutic applications of recombinant, invasive E. coli.		Critchley RJ; Jezzard S; Radford KJ; Goussard S; Lemoine NR; Grillot-Courvalin C; Vassaux G		Gene Ther	11	2004	1224-33	J:90341	15141160
90028	Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice.		Wu X; Chen L; Brown CA; Yan C; Matzuk MM		Mol Endocrinol	18	2004	1509-19	J:90339	15016837
90029	In Vivo Tumor Co-Transfection with Superantigen and CD80 Induces Systemic Immunity without Tolerance and Prolongs Survival in Mice with Hepatocellular Carcinoma.		Li ZS; Yang XW; Chen Z; Dong HL; Ye J; Qu P; Lu SY; Zhang XM; Sui YF		Cancer Biol Ther	3	2004	660-6	J:90342	15136758
90030	p53 designer genes for the modern mouse.		Hergenhahn M; Luo JL; Hollstein M		Cell Cycle	3	2004	738-41	J:90343	15118408
90031	Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation.		Imado T; Iwasaki T; Kataoka Y; Kuroiwa T; Hara H; Fujimoto J; Sano H		Blood	104	2004	1542-9	J:90346	15100150
90032	Life, death and tax:  role of HTLV-I oncoprotein in genetic instability and cellular transformation		Jeang KT; Giam CZ; Majone F; Aboud M		J Biol Chem	279	2004	31991-4	J:90347	15090550
90033	Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models.		Corthay A; Lundin KU; Munthe LA; Froyland M; Gedde-Dahl T; Dembic Z; Bogen B		Cancer Immunol Immunother	53	2004	759-69	J:90349	15088126
90034	Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis.		Sata M; Nishimatsu H; Osuga J; Tanaka K; Ishizaka N; Ishibashi S; Hirata Y; Nagai R		Hypertension	43	2004	1214-20	J:90350	15166180
90035	Identification and characterization of potential human carcinogens using B6.129tmlTrp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus		French JE		IARC Sci Publ		2004	271-87	J:90351	15055301
90036	Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformation.		Chen J; Williams IR; Kutok JL; Duclos N; Anastasiadou E; Masters SC; Fu H; Gilliland DG		Blood	104	2004	535-42	J:90352	15054045
90037	Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.		Rosenbauer F; Wagner K; Kutok JL; Iwasaki H; Le Beau MM; Okuno Y; Akashi K; Fiering S; Tenen DG		Nat Genet	36	2004	624-30	J:90331	15146183
90038	Unraveling Human Tumor Suppressor Pathways: A Tale of the INK4A Locus.		Voorhoeve PM; Agami R		Cell Cycle	3	2004	616-20	J:90332	15044859
90039	Beyond the Metabolic Function of PTP1B.		Dube N; Tremblay ML		Cell Cycle	3	2004	550-3	J:90333	15044856
90040	Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia.		Williams TM; Lee H; Cheung MW; Cohen AW; Razani B; Iyengar P; Scherer PE; Pestell RG; Lisanti MP		J Biol Chem	279	2004	24745-56	J:90334	15044451
90041	Oncogenic Tyrosine Kinases, DNA Repair and Survival: The Role of Bcl-x(L) Deamidation in Transformation and Genotoxic Therapies.		Alexander DR		Cell Cycle	3	2004	584-7	J:90335	15034307
90042	Double strand break metabolism and cancer susceptibility: lessons from the mre11 complex.		Petrini JH; Theunissen JW		Cell Cycle	3	2004	541-2	J:90336	15034299
90043	Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis.		Kim DJ; Akiyama TE; Harman FS; Burns AM; Shan W; Ward JM; Kennett MJ; Gonzalez FJ; Peters JM		J Biol Chem	279	2004	23719-27	J:90337	15033975
90044	Oncogenic K-ras in Mouse Models of Myeloproliferative Disease and Acute Myeloid Leukemia.		Chan IT; Gilliland DG		Cell Cycle	3	2004	536-7	J:90338	15020845
90045	Green tea protects against psoralen plus ultraviolet A-induced photochemical damage to skin.		Zhao JF; Zhang YJ; Jin XH; Athar M; Santella RM; Bickers DR; Wang ZY		J Invest Dermatol	113	1999	1070-5	J:90451	10594754
90046	Collaboration of homologous recombination and nonhomologous end-joining factors for the survival and integrity of mice and cells.		Couedel C; Mills KD; Marco B; Shen L; Olshen A; Johnson RD; Nussenzweig A; Essers J; Kanaar R; Li GC; Alt FW; Jasin M		Genes Dev	18	2004	1293-304	J:90441	15175261
90047	Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis.		D'Armiento J; DiColandrea T; Dalal SS; Okada Y; Huang MT; Conney AH; Chada K		Mol Cell Biol	15	1995	5732-9	J:90446	7565725
90048	Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and {gamma}{delta} T Cells.		Street SE; Hayakawa Y; Zhan Y; Lew AM; MacGregor D; Jamieson AM; Diefenbach A; Yagita H; Godfrey DI; Smyth MJ		J Exp Med	199	2004	879-884	J:90480	15007091
90049	A spontaneously arising pancreatic tumor does not promote the differentiation of naive CD8+ T lymphocytes into effector CTL.		Lyman MA; Aung S; Biggs JA; Sherman LA		J Immunol	172	2004	6558-67	J:90532	15153470
90050	XPA Gene-Deficient, SCF-Transgenic Mice with Epidermal Melanin Are Resistant to UV-Induced Carcinogenesis.		Yamazaki F; Okamoto H; Miyauchi-Hashimoto H; Matsumura Y; Itoh T; Tanaka K; Kunisada T; Horio T		J Invest Dermatol	123	2004	220-8	J:90498	15191564
90051	Characterization of the progressive skin disease and inflammatory cell infiltrate in mice with inhibited NF-kappaB signaling.		Van Hogerlinden M; Rozell BL; Toftgard R; Sundberg JP		J Invest Dermatol	123	2004	101-8	J:90507	15191549
90052	Skp2-mediated degradation of p27 regulates progression into mitosis.		Nakayama K; Nagahama H; Minamishima YA; Miyake S; Ishida N; Hatakeyama S; Kitagawa M; Iemura S; Natsume T; Nakayama KI		Dev Cell	6	2004	661-72	J:90569	15130491
90053	Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer.		Chu FF; Esworthy RS; Doroshow JH		Free Radic Biol Med	36	2004	1481-95	J:90711	15182851
90054	Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration.		Sansom OJ; Reed KR; Hayes AJ; Ireland H; Brinkmann H; Newton IP; Batlle E; Simon-Assmann P; Clevers H; Nathke IS; Clarke AR; Winton DJ		Genes Dev	18	2004	1385-90	J:90759	15198980
90055	Involvement of V(D)J recombinase in the generation of intragenic deletions in the Rit1/Bcl11b tumor suppressor gene in gamma-ray-induced thymic lymphomas and in normal thymus of the mouse.		Sakata J; Inoue J; Ohi H; Kosugi-Okano H; Mishima Y; Hatakeyama K; Niwa O; Kominami R		Carcinogenesis	25	2004	1069-75	J:90764	14754877
90056	Anthony Dipple Carcinogenesis Award. p53 from pathway to therapy.		Lane D		Carcinogenesis	25	2004	1077-81	J:90746	15205365
90057	Defective expression of Notch1 and Notch2 in connection to alterations of c-Myc and Ikaros in gamma-radiation-induced mouse thymic lymphomas.		Lopez-Nieva P; Santos J; Fernandez-Piqueras J		Carcinogenesis	25	2004	1299-304	J:90747	14976135
90058	Leukemia-like syndrome in Balb/c mice infected with the lymphotropic gamma herpesvirus MHV-Sumava: an analogy to EBV infection.		Mistrikova J; Mrmusova-Supolikova M; Rajcani J		Neoplasma	51	2004	71-6	J:90786	15190414
90059	EXPLANT-CELL CULTURE OF PRIMARY MAMMARY TUMORS FROM MMTV-c-Myc TRANSGENIC MICE.		Pei XF; Noble MS; Davoli MA; Rosfjord E; Tilli MT; Furth PA; Russell R; Johnson MD; Dickson RB		In Vitro Cell Dev Biol Anim	40	2004	14-21	J:90794	15180438
90060	Liver-specific expression of the agouti gene in transgenic mice promotes liver carcinogenesis in the absence of obesity and diabetes.		Kuklin AI; Mynatt RL; Klebig ML; Kiefer LL; Wilkison WO; Woychik RP; Michaud EJ		Mol Cancer	3	2004	17	J:90795	15175105
90061	Generation and analysis of brca1 conditional knockout mice.		Deng CX; Xu X		Methods Mol Biol	280	2004	185-200	J:90788	15187254
90062	Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice.		Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Wu Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Tsujinoue H; Masaki T; Fukui H		Hepatology	39	2004	1517-24	J:90789	15185292
90063	Chemopreventive effect of piperine on modulating lipid peroxidation and membrane bound enzymes in benzo(a)pyrene induced lung carcinogenesis.		Selvendiran K; Sakthisekaran D		Biomed Pharmacother	58	2004	264-7	J:90790	15183854
90064	Novel mouse model for carcinoembryonic antigen-based therapy.		Chan CH; Stanners CP		Mol Ther	9	2004	775-85	J:90783	15194045
90065	Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma.		Chen D; Livne-Bar I; Vanderluit JL; Slack RS; Agochiya M; Bremner R		Cancer Cell	5	2004	539-551	J:90785	15193257
90066	Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice.		Wei M; Wanibuchi H; Morimura K; Salim EI; Moku M; Doi K; Mitsuhashi M; Masuda C; Shen J; Kinoshita A; Fukushima S		Anticancer Res	24	2004	785-90	J:90807	15161027
90067	Cyclin D1 in human neuroendocrine: tumorigenesis.		Chung DC		Ann N Y Acad Sci	1014	2004	209-17	J:90808	 
90068	Molecular pathology of the MEN1 gene.		Agarwal SK; Lee Burns A; Sukhodolets KE; Kennedy PA; Obungu VH; Hickman AB; Mullendore ME; Whitten I; Skarulis MC; Simonds WF; Mateo C; Crabtree JS; Scacheri PC; Ji Y; Novotny EA; Garrett-Beal L; Ward JM; Libutti SK; Richard Alexander H; Cerrato A; Parisi	 MJ; Santa Anna-A S; Oliver B; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ	Ann N Y Acad Sci	1014	2004	189-98	J:90809	15153434
90069	Growth regulation of gastric epithelial cells by Runx3.		Fukamachi H; Ito K		Oncogene	23	2004	4330-5	J:90850	15156189
90070	Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors.		Schreiber K; Cannon RE; Karrison T; Beck-Engeser G; Huo D; Tennant RW; Jensen H; Kast WM; Krausz T; Meredith SC; Chen L; Schreiber H		Oncogene	23	2004	3972-9	J:90857	15077191
90071	CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors.		Han SY; Iliopoulos D; Druck T; Guler G; Grubbs CJ; Pereira M; Zhang Z; You M; Lubet RA; Fong LY; Huebner K		Oncogene	23	2004	3990-8	J:90858	15007387
90072	p300/CBP and cancer.		Iyer NG; Ozdag H; Caldas C		Oncogene	23	2004	4225-31	J:90860	15156177
90073	Loss of tyrosinase activity confers increased skin tumor susceptibility in mice.		Saran A; Spinola M; Pazzaglia S; Peissel B; Tiveron C; Tatangelo L; Mancuso M; Covelli V; Giovannelli L; Pitozzi V; Pignatiello C; Milani S; Dolara P; Dragani TA		Oncogene	23	2004	4130-5	J:90844	15007389
90074	Characterization of double transgenic mice expressing hepatocye growth factor and transforming growth factor alpha.		Shiota G; Kawasaki H; Nakamura T; Schmidt EV		Res Commun Mol Pathol Pharmacol	90	1995	17-24	J:90882	8581343
90075	Lymphomagenesis, hydronephrosis, and autoantibodies result from dysregulation of IL-9 and are differentially dependent on Th2 cytokines.		Lauder AJ; Jolin HE; Smith P; van den Berg JG; Jones A; Wisden W; Smith KG; Dasvarma A; Fallon PG; McKenzie AN		J Immunol	173	2004	113-22	J:90927	15210765
90076	Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16alpha-fluoro-5-androsten-17-one.		Perkins SN; Hursting SD; Haines DC; James SJ; Miller BJ; Phang JM		Carcinogenesis	18	1997	989-94	J:90934	9163685
90077	Protective effects of silymarin against photocarcinogenesis in a mouse skin model.		Katiyar SK; Korman NJ; Mukhtar H; Agarwal R		J Natl Cancer Inst	89	1997	556-66	J:90935	9106644
90078	Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice.		Honda H; Fujii T; Takatoku M; Mano H; Witte ON; Yazaki Y; Hirai H		Blood	85	1995	2853-61	J:90936	7537982
90079	Anemia, thrombocytopenia, leukocytosis, extramedullary hematopoiesis, and impaired progenitor function in Pten+/-SHIP-/- mice: a novel model of myelodysplasia.		Moody JL; Xu L; Helgason CD; Jirik FR		Blood	103	2004	4503-10	J:90968	15001465
90080	Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice.		Voncken JW; Morris C; Pattengale P; Dennert G; Kikly C; Groffen J; Heisterkamp N		Blood	79	1992	1029-36	J:90937	1737087
90081	Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice.		Manenti G; Galbiati F; Gianni-Barrera R; Pettinicchio A; Acevedo A; Dragani TA		Oncogene	23	2004	4495-504	J:90940	15064703
90082	Loss of Rad52 partially rescues tumorigenesis and T-cell maturation in Atm-deficient mice.		Treuner K; Helton R; Barlow C		Oncogene	23	2004	4655-61	J:90941	15122331
90083	Uropathic observations in mice expressing a constitutively active point mutation in the 5-HT3A receptor subunit.		Bhattacharya A; Dang H; Zhu QM; Schnegelsberg B; Rozengurt N; Cain G; Prantil R; Vorp DA; Guy N; Julius D; Ford AP; Lester HA; Cockayne DA		J Neurosci	24	2004	5537-48	J:90942	15201326
90084	Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis.		Bagheri-Yarmand R; Talukder AH; Wang RA; Vadlamudi RK; Kumar R		Development	131	2004	3469-79	J:90989	15226262
90085	Dual role of interleukin-4 (IL-4) in pulmonary paracoccidioidomycosis: endogenous IL-4 can induce protection or exacerbation of disease depending on the host genetic pattern.		Arruda C; Valente-Ferreira RC; Pina A; Kashino SS; Fazioli RA; Vaz CA; Franco MF; Keller AC; Calich VL		Infect Immun	72	2004	3932-40	J:90995	15213137
90086	Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.		Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR		Cancer Res	64	2004	4162-70	J:91072	15205327
90087	Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons.		Bizub D; Wood AW; Skalka AM		Proc Natl Acad Sci U S A	83	1986	6048-52	J:91086	3016738
90088	Combinatorial chemoprevention of intestinal neoplasia.		Torrance CJ; Jackson PE; Montgomery E; Kinzler KW; Vogelstein B; Wissner A; Nunes M; Frost P; Discafani CM		Nat Med	6	2000	1024-8	J:91147	10973323
90089	Heart and bone tumors in transgenic mice.		Behringer RR; Peschon JJ; Messing A; Gartside CL; Hauschka SD; Palmiter RD; Brinster RL		Proc Natl Acad Sci U S A	85	1988	2648-52	J:91117	2833748
90090	Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice.		Anisimov VN; Baturin DA; Popovich IG; Zabezhinski MA; Manton KG; Semenchenko AV; Yashin AI		Int J Cancer	111	2004	475-9	J:91123	15239122
90091	In utero effects of chemicals on reproductive tissues in females.		Miller KP; Borgeest C; Greenfeld C; Tomic D; Flaws JA		Toxicol Appl Pharmacol	198	2004	111-31	J:91192	15236949
90092	Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation.		Lu SL; Reh D; Li AG; Woods J; Corless CL; Kulesz-Martin M; Wang XJ		Cancer Res	64	2004	4405-10	J:91201	15231647
90093	Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice.		Saleem M; Afaq F; Adhami VM; Mukhtar H		Oncogene	23	2004	5203-14	J:91202	15122342
90094	Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice.		Dunnick JK; Hardisty JF; Herbert RA; Seely JC; Furedi-Machacek EM; Foley JF; Lacks GD; Stasiewicz S; French JE		Toxicol Pathol	25	1997	533-40	J:91169	9437796
90095	Carcinogenicity studies of oxazepam in mice.		Bucher JR; Shackelford CC; Haseman JK; Johnson JD; Kurtz PJ; Persing RL		Fundam Appl Toxicol	23	1994	280-97	J:91170	7982536
90096	Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence.		Weindruch R; Walford RL		Science	215	1982	1415-8	J:91171	7063854
90097	High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas.		Shin MS; Fredrickson TN; Hartley JW; Suzuki T; Agaki K; Morse HC rd		Cancer Res	64	2004	4419-27	J:91250	15231650
90098	Transplacental lung carcinogenesis: molecular mechanisms and pathogenesis.		Miller MS		Toxicol Appl Pharmacol	198	2004	95-110	J:91251	15236948
90099	Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin.		Reagan-Shaw S; Afaq F; Aziz MH; Ahmad N		Oncogene	23	2004	5151-60	J:91203	15122319
90100	Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation.		So PL; Lee K; Hebert J; Walker P; Lu Y; Hwang J; Kopelovich L; Athar M; Bickers D; Aszterbaum M; Epstein EH Jr		Cancer Res	64	2004	4385-9	J:91209	15231643
90101	Targeted oncogenesis reveals a distinct tissue-specific utilization of alternative promoters of the human mineralocorticoid receptor gene in transgenic mice.		Le Menuet D; Viengchareun S; Penfornis P; Walker F; Zennaro MC; Lombes M		J Biol Chem	275	2000	7878-86	J:91287	10713103
90102	Pertubation of B and T cell development and predisposition to lymphomagenesis in Emu Bmi1 transgenic mice require the Bmi1 RING finger.		Alkema MJ; Jacobs H; van Lohuizen M; Berns A		Oncogene	15	1997	899-910	J:91254	9285685
90103	Body weight is not always a good predictor of longevity in mice.		Anisimov VN; Arbeev KG; Popovich IG; Zabezhinksi MA; Rosenfeld SV; Piskunova TS; Arbeeva LS; Semenchenko AV; Yashin AI		Exp Gerontol	39	2004	305-19	J:91261	15036390
90104	Chk1 is haploinsufficient for multiple functions critical to tumor suppression.		Lam MH; Liu Q; Elledge SJ; Rosen JM		Cancer Cell	6	2004	45-59	J:91266	15261141
90105	Runx3-/- gastric epithelial cells differentiate into intestinal type cells.		Fukamachi H; Ito K; Ito Y		Biochem Biophys Res Commun	321	2004	58-64	J:91300	15358215
90106	Expression of SV-40 T antigen in the small intestinal epithelium of transgenic mice results in proliferative changes in the crypt and reentry of villus-associated enterocytes into the cell cycle but has no apparent effect on cellular differentiation progr	ams and does not cause neoplastic transformation.	Hauft SM; Kim SH; Schmidt GH; Pease S; Rees S; Harris S; Roth KA; Hansbrough JR; Cohn SM; Ahnen DJ; et al.		J Cell Biol	117	1992	825-39	J:91360	1349609
90107	Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types.		Lopez MJ; Upchurch BH; Rindi G; Leiter AB		J Biol Chem	270	1995	885-91	J:91365	7822327
90108	The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms.		Gugasyan R; Voss A; Varigos G; Thomas T; Grumont RJ; Kaur P; Grigoriadis G; Gerondakis S		Mol Cell Biol	24	2004	5733-45	J:91366	15199130
90109	Mouse models of human cancers (part 3).		Borowsky AD; Munn RJ; Galvez JJ; Cardiff RD; Ward JM; Morse HC rd; Kogan SC; Aldape KD; Louis DN; Bosenberg MW		Comp Med	54	2004	258-70	J:91416	15253271
90110	Mammary tumor heterogeneity in wt-ErbB-2 transgenic mice.		Kosanke S; Edgerton SM; Moore D nd; Yang X; Mason T; Alvarez K; Jones L; Kim A; Thor AD		Comp Med	54	2004	280-7	J:91417	15253274
90111	MBD4 deficiency does not increase mutation or accelerate tumorigenesis in mice lacking MMR.		Sansom OJ; Bishop SM; Bird A; Clarke AR		Oncogene	23	2004	5693-6	J:91458	15184874
90112	JCV T-antigen interacts with the neurofibromatosis type 2 gene product in a transgenic mouse model of malignant peripheral nerve sheath tumors.		Shollar D; Del Valle L; Khalili K; Otte J; Gordon J		Oncogene	23	2004	5459-67	J:91460	15133494
90113	Development of a cancer DNA phenotype prior to tumor formation.		Malins DC; Anderson KM; Gilman NK; Green VM; Barker EA; Hellstrom KE		Proc Natl Acad Sci U S A	101	2004	10721-5	J:91488	15249662
90114	Glucagon gene 5'-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice.		Lee YC; Asa SL; Drucker DJ		J Biol Chem	267	1992	10705-8	J:91490	1587847
90115	Transgenerational transmission of radiation- and chemically induced tumors and congenital anomalies in mice: studies of their possible relationship to induced chromosomal and molecular changes.		Nomura T; Nakajima H; Ryo H; Li LY; Fukudome Y; Adachi S; Gotoh H; Tanaka H		Cytogenet Genome Res	104	2004	252-60	J:91493	15162048
90116	Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium.		Kiaris H; Politi K; Grimm LM; Szabolcs M; Fisher P; Efstratiadis A; Artavanis-Tsakonas S		Am J Pathol	165	2004	695-705	J:91518	15277242
90117	Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases.		Lim CE; Matthaei KI; Blackburn AC; Davis RP; Dahlstrom JE; Koina ME; Anders MW; Board PG		Am J Pathol	165	2004	679-93	J:91519	15277241
90118	Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.		Won YK; Ong CN; Shi X; Shen HM		Carcinogenesis	25	2004	1449-1458	J:91524	15033901
90119	Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2.		Meyer AM; Dwyer-Nield LD; Hurteau GJ; Keith RL; O'Leary E; You M; Bonventre JV; Nemenoff RA; Malkinson AM		Carcinogenesis	25	2004	1517-1524	J:91526	15033900
90120	Expression in a recombinant murid herpesvirus 4 reveals the in vivo transforming potential of the K1 open reading frame of Kaposi's sarcoma-associated herpesvirus.		Douglas J; Dutia B; Rhind S; Stewart JP; Talbot SJ		J Virol	78	2004	8878-84	J:91557	15280496
90121	Lymphomagenesis and female-specific lethality in p53-deficient mice occur independently of E2f1.		Wloga EH; Criniti V; Yamasaki L; Bronson RT		Nat Cell Biol	6	2004	565-7; author reply 567-8	J:91560	15232580
90122	Characterization of mice lacking the tetraspanin superfamily member CD151.		Wright MD; Geary SM; Fitter S; Moseley GW; Lau LM; Sheng KC; Apostolopoulos V; Stanley EG; Jackson DE; Ashman LK		Mol Cell Biol	24	2004	5978-88	J:91605	15199151
90123	Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.		Araki T; Mohi MG; Ismat FA; Bronson RT; Williams IR; Kutok JL; Yang W; Pao LI; Gilliland DG; Epstein JA; Neel BG		Nat Med	10	2004	849-57	J:91609	15273746
90124	The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer.		Schuendeln MM; Piekorz RP; Wichmann C; Lee Y; McKinnon PJ; Boyd K; Takahashi Y; Ihle JN		Mol Cell Biol	24	2004	6403-9	J:91577	15226440
90125	Molecular mechanisms guiding late stages of B-cell development.		Rolink AG; Andersson J; Melchers F		Immunol Rev	197	2004	41-50	J:91585	14962185
90126	Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in a/j mice by oral administration of green tea.		Liao J; Yang GY; Park ES; Meng X; Sun Y; Jia D; Seril DN; Yang CS		Nutr Cancer	48	2004	44-53	J:91646	15203377
90127	The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse.		Hulboy DL; Gautam S; Fingleton B; Matrisian LM		Oncol Rep	12	2004	13-7	J:91647	15201952
90128	Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.		Kasper S; Smith JA Jr		J Urol	172	2004	12-9	J:91648	15201729
90129	Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.		Podsypanina K; Li Y; Varmus HE		BMC Med	2	2004	24	J:91649	15198801
90130	SOCS1 Is a Suppressor of Liver Fibrosis and Hepatitis-induced Carcinogenesis.		Yoshida T; Ogata H; Kamio M; Joo A; Shiraishi H; Tokunaga Y; Sata M; Nagai H; Yoshimura A		J Exp Med	199	2004	1701-7	J:91651	15197228
90131	TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.		O'Neil J; Shank J; Cusson N; Murre C; Kelliher M		Cancer Cell	5	2004	587-96	J:91652	15193261
90132	Disregulation of E-cadherin in transgenic mouse models of liver cancer.		Calvisi DF; Ladu S; Conner EA; Factor VM; Thorgeirsson SS		Lab Invest	84	2004	1137-47	J:91632	15220935
90133	Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice.		Schubert R; Erker L; Barlow C; Yakushiji H; Larson D; Russo A; Mitchell JB; Wynshaw-Boris A		Hum Mol Genet	13	2004	1793-802	J:91634	15213104
90134	Epidermal growth factor receptor and epidermal growth factor receptor therapies in renal cell carcinoma: do we need a better mouse trap?		Dancey JE		J Clin Oncol	22	2004	2975-7	J:91640	15210735
90135	Cancer preventive potential of Momordica charantia L. against benzo(a)pyrene induced fore-stomach tumourigenesis in murine model system.		Deep G; Dasgupta T; Rao AR; Kale RK		Indian J Exp Biol	42	2004	319-22	J:91626	15233304
90136	Cancer Chemopreventive Activity of Rotenoids from Derris trifoliata.		Ito C; Itoigawa M; Kojima N; Tan HT; Takayasu J; Tokuda H; Nishino H; Furukawa H		Planta Med	70	2004	585-8	J:91627	15229812
90137	Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression.		Mao JH; To MD; Perez-Losada J; Wu D; Del Rosario R; Balmain A		Genes Dev	18	2004	1800-5	J:91661	15289454
90138	Reprogramming of a melanoma genome by nuclear transplantation.		Hochedlinger K; Blelloch R; Brennan C; Yamada Y; Kim M; Chin L; Jaenisch R		Genes Dev	18	2004	1875-85	J:91662	15289459
90139	Essential role of limiting telomeres in the pathogenesis of Werner syndrome.		Chang S; Multani AS; Cabrera NG; Naylor ML; Laud P; Lombard D; Pathak S; Guarente L; DePinho RA		Nat Genet	36	2004	877-82	J:91715	15235603
90140	Notch in lung development and lung cancer.		Collins BJ; Kleeberger W; Ball DW		Semin Cancer Biol	14	2004	357-64	J:91818	15288261
90141	Chemokines and Kaposi's sarcoma.		Jensen KK; Lira SA		Semin Cancer Biol	14	2004	187-94	J:91824	15246054
90142	Development of UV-Induced Squamous Cell Carcinomas Is Suppressed in the Absence of SPARC.		Aycock RL; Bradshaw AC; Sage EH; Starcher B		J Invest Dermatol	123	2004	592-9	J:91793	15304102
90143	Loss of a single allele of SHIP exacerbates the immunopathology of Pten heterozygous mice.		Moody JL; Pereira CG; Magil A; Fritzler MJ; Jirik FR		Genes Immun	4	2003	60-6	J:91864	12595903
90144	Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.		Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J		Oncogene	23	2004	6047-55	J:91868	15208658
90145	Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice.		Rao G; Pedone CA; Valle LD; Reiss K; Holland EC; Fults DW		Oncogene	23	2004	6156-62	J:91870	15195141
90146	Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.		Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ		Cancer Res	64	2004	5140-7	J:91874	15289317
90147	p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.		Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H		Cancer Res	64	2004	5118-26	J:91875	15289314
90148	Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy.		Lu Y; Bellgrau D; Dwyer-Nield LD; Malkinson AM; Duke RC; Rodell TC; Franzusoff A		Cancer Res	64	2004	5084-8	J:91876	15289309
90149	Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity.		Caulin C; Nguyen T; Longley MA; Zhou Z; Wang XJ; Roop DR		Cancer Res	64	2004	5054-8	J:91877	15289303
90150	Antioxidants block prostate cancer in lady transgenic mice.		Venkateswaran V; Fleshner NE; Sugar LM; Klotz LH		Cancer Res	64	2004	5891-6	J:91953	15313934
90151	Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.		Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP		Carcinogenesis	25	2004	1735-46	J:91956	15166086
90152	Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte.		Woodworth CD; Michael E; Smith L; Vijayachandra K; Glick A; Hennings H; Yuspa SH		Carcinogenesis	25	2004	1771-8	J:91957	15105299
90153	PPAR{gamma} influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.		Nicol CJ; Yoon M; Ward JM; Yamashita M; Fukamachi K; Peters JM; Gonzalez FJ		Carcinogenesis	25	2004	1747-1755	J:91958	15073042
90154	Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.		Keith RL; Miller YE; Hudish TM; Girod CE; Sotto-Santiago S; Franklin WA; Nemenoff RA; March TH; Nana-Sinkam SP; Geraci MW		Cancer Res	64	2004	5897-904	J:91952	15313935
90155	The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together.		Stracker TH; Theunissen JW; Morales M; Petrini JH		DNA Repair (Amst)	3	2004	845-54	J:91984	15279769
90156	p63 and p73: roles in development and tumor formation.		Moll UM; Slade N		Mol Cancer Res	2	2004	371-86	J:91990	15280445
90157	Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice.		Waalkes MP; Liu J; Ward JM; Diwan BA		Toxicol Appl Pharmacol	198	2004	377-84	J:91991	15276417
90158	Arsenic and urinary bladder cell proliferation.		Luster MI; Simeonova PP		Toxicol Appl Pharmacol	198	2004	419-23	J:92005	15276422
90159	Evidence that arsenite acts as a cocarcinogen in skin cancer.		Rossman TG; Uddin AN; Burns FJ		Toxicol Appl Pharmacol	198	2004	394-404	J:92006	15276419
90160	Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs.		Poirier MC; Olivero OA; Walker DM; Walker VE		Toxicol Appl Pharmacol	199	2004	151-61	J:92009	15313587
90161	Lessons learned from perinatal exposure to diethylstilbestrol.		Newbold RR		Toxicol Appl Pharmacol	199	2004	142-50	J:92010	15313586
90162	Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.		Drosten M; Hilken G; Bockmann M; Rodicker F; Mise N; Cranston AN; Dahmen U; Ponder BA; Putzer BM		J Natl Cancer Inst	96	2004	1231-9	J:92103	15316058
90163	Expression of collagen XVIII and MMP-20 in developing teeth and odontogenic tumors.		Vaananen A; Tjaderhane L; Eklund L; Heljasvaara R; Pihlajaniemi T; Herva R; Ding Y; Bartlett JD; Salo T		Matrix Biol	23	2004	153-61	J:92108	15296943
90164	Cancer risk assessment of toxaphene.		Buranatrevedh S		Ind Health	42	2004	321-7	J:92109	15295903
90165	Loss of Smad3 in acute T-cell lymphoblastic leukemia.		Wolfraim LA; Fernandez TM; Mamura M; Fuller WL; Kumar R; Cole DE; Byfield S; Felici A; Flanders KC; Walz TM; Roberts AB; Aplan PD; Balis FM; Letterio JJ		N Engl J Med	351	2004	552-9	J:92110	15295048
90166	Immunoprevention of Mammary Carcinoma in HER-2/neu Transgenic Mice Is IFN-{gamma} and B Cell Dependent.		Nanni P; Landuzzi L; Nicoletti G; De Giovanni C; Rossi I; Croci S; Astolfi A; Iezzi M; Di Carlo E; Musiani P; Forni G; Lollini PL		J Immunol	173	2004	2288-2296	J:92111	15294941
90167	Investigation of the effect of lignans on murine mammary gland differentiation in TG.NK mice.		Mortensen A; Kramer F; Lindecrona RH; Sorensen IK		Asia Pac J Clin Nutr	13	2004	S172	J:92112	15294749
90168	The defense mechanisms in mammalian cells against oxidative damage in nucleic acids and their involvement in the suppression of mutagenesis and cell death.		Nakabeppu Y; Tsuchimoto D; Furuichi M; Sakumi K		Free Radic Res	38	2004	423-9	J:92113	15293549
90169	CD44 overexpression by oligodendrocytes: A novel mouse model of inflammation-independent demyelination and dysmyelination.		Tuohy TM; Wallingford N; Liu Y; Chan FH; Rizvi T; Xing R; Bebo B; Rao MS; Sherman LS		Glia	47	2004	335-45	J:92115	15293231
90170	Chemoprevention of melanoma.		Demierre MF; Merlino G		Curr Oncol Rep	6	2004	406-13	J:92116	15291986
90171	Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information.		Lock EA; Hard GC		Crit Rev Toxicol	34	2004	211-99	J:92155	15239388
90172	Survival after gamma interferon intratumoral injections in a model of hepatocarcinoma.		Peyregne V; Quash G; Isaac S; Chantepie J; Akiba H; Scoazec JY; Gilly FN		Hepatogastroenterology	51	2004	1115-20	J:92156	15239257
90173	Manipulating mouse telomeres: models of tumorigenesis and aging.		Xin Z; Broccoli D		Cytogenet Genome Res	105	2004	471-8	J:92158	15237236
90174	Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis.		Wulf G; Garg P; Liou YC; Iglehart D; Lu KP		EMBO J	23	2004	3397-407	J:92164	15257284
90175	Tumor Profile of Novel p53 Heterozygous Tg.AC (v-Ha-ras) Bitransgenic Mice Treated with Benzo(a)pyrene and Fed Dietary N-acetyl-L-cysteine (NAC).		Martin KR; Jokinen MP; Honeycutt HP; Quinn A; Kari FW; Barrett JC; French JE		Toxicol Sci	81	2004	293-301	J:92165	15254344
90176	Transgenic mice as an in vivo model of lymphomagenesis.		Tarantul VZ		Int Rev Cytol	236	2004	123-80	J:92140	15261738
90177	High-resolution X-ray microtomography for the detection of lung tumors in living mice.		De Clerck NM; Meurrens K; Weiler H; Van Dyck D; Van Houtte G; Terpstra P; Postnov AA		Neoplasia	6	2004	374-9	J:92141	15256059
90178	Alpha 2-HS glycoprotein (fetuin-A) modulates murine skin tumorigenesis.		Leite-Browning ML; McCawley LJ; Jahnen-Dechent W; King LE Jr; Matrisian LM; Ochieng J		Int J Oncol	25	2004	319-24	J:92142	15254728
90179	Nivalenol, a main Fusarium toxin in dietary foods from high-risk areas of cancer of esophagus and gastric cardia in China, induced benign and malignant tumors in mice.		Hsia CC; Wu ZY; Li YS; Zhang F; Sun ZT		Oncol Rep	12	2004	449-56	J:92143	15254715
90180	Cisplatin enhances the p53-independent apoptosis induced by a topoisomerase I inhibitor (CPT-11) in the lens epithelial tumors in transgenic mice.		Nakamura T; Nakajima Y; Enomoto T; Hori S; Hidaka T; Murata Y; Saito S		Oncol Rep	12	2004	253-8	J:92144	15254685
90181	Effect of high fat diet on body weight and mammary tumor latency in MMTV-TGF-alpha mice.		Cleary MP; Grande JP; Maihle NJ		Int J Obes Relat Metab Disord	28	2004	956-62	J:92145	15254485
90182	Genetic evidence for functional dependency of p18Ink4c on Cdk4.		Pei XH; Bai F; Tsutsui T; Kiyokawa H; Xiong Y		Mol Cell Biol	24	2004	6653-64	J:92146	15254233
90183	Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice.		Thulesen J; Hartmann B; Hare KJ; Kissow H; Orskov C; Holst JJ; Poulsen SS		Gut	53	2004	1145-50	J:92148	15247183
90184	Long-lived alpha MUPA transgenic mice exhibit increased mitochondrion-mediated apoptotic capacity.		Tirosh O; Schwartz B; Zusman I; Kossoy G; Yahav S; Miskin R		Ann N Y Acad Sci	1019	2004	439-42	J:92149	15247062
90185	Insights into aging obtained from p53 mutant mouse models.		Dumble M; Gatza C; Tyner S; Venkatachalam S; Donehower LA		Ann N Y Acad Sci	1019	2004	171-7	J:92150	15247009
90186	Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.		Reuter T; Heldmann M; Schimmer S; Schepers K; Dittmer U		Vaccine	22	2004	2686-9	J:92151	15246598
90187	Inhibition of DMBA-croton oil two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate through modulation of cutaneous oxidative stress and inhibition of nitric oxide production.		Das RK; Bhattacharya S		Asian Pac J Cancer Prev	5	2004	151-8	J:92152	15244517
90188	Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.		Fottner Ch; Hoeflich A; Wolf E; Weber MM		Horm Metab Res	36	2004	397-405	J:92153	15241731
90189	Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants.		Mitra-Kaushik S; Harding JC; Hess JL; Ratner L		Blood	104	2004	802-9	J:92261	15090453
90190	Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditis.		Morita M; Stamp G; Robins P; Dulic A; Rosewell I; Hrivnak G; Daly G; Lindahl T; Barnes DE		Mol Cell Biol	24	2004	6719-27	J:92264	15254239
90191	The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice.		Mizoguchi A; Mizoguchi E; Bhan AK		Gastroenterology	116	1999	320-6	J:92347	9922312
90192	Resistance of CD1d-/- mice to ultraviolet-induced skin cancer is associated with increased apoptosis.		Matsumura Y; Moodycliffe AM; Nghiem DX; Ullrich SE; Ananthaswamy HN		Am J Pathol	165	2004	879-87	J:92422	15331412
90193	Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis.		Iskander K; Paquet M; Brayton C; Jaiswal AK		Cancer Res	64	2004	5925-8	J:92400	15342368
90194	Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.		Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET		Cancer Res	64	2004	5973-81	J:92401	15342376
90195	Conditional deletion of Rb causes early stage prostate cancer.		Maddison LA; Sutherland BW; Barrios RJ; Greenberg NM		Cancer Res	64	2004	6018-25	J:92406	15342382
90196	Mek1 alters epidermal growth and differentiation.		Scholl FA; Dumesic PA; Khavari PA		Cancer Res	64	2004	6035-40	J:92407	15342384
90197	The Rgr oncogene induces tumorigenesis in transgenic mice.		Jimenez M; Perez de Castro I; Benet M; Garcia JF; Inghirami G; Pellicer A		Cancer Res	64	2004	6041-9	J:92408	15342385
90198	Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.		Li H; Gerald WL; Benezra R		Cancer Res	64	2004	6137-43	J:92409	15342397
90199	AID is required for c-myc/IgH chromosome translocations in vivo.		Ramiro AR; Jankovic M; Eisenreich T; Difilippantonio S; Chen-Kiang S; Muramatsu M; Honjo T; Nussenzweig A; Nussenzweig MC		Cell	118	2004	431-8	J:92464	15315756
90200	The genetic immunodeficiency disease, leukocyte adhesion deficiency, in humans, dogs, cattle, and mice.		Gu YC; Bauer TR Jr; Ackermann MR; Smith CW; Kehrli ME Jr; Starost MF; Hickstein DD		Comp Med	54	2004	363-72	J:92465	15357315
90201	Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification.		Hansford LM; Thomas WD; Keating JM; Burkhart CA; Peaston AE; Norris MD; Haber M; Armati PJ; Weiss WA; Marshall GM		Proc Natl Acad Sci U S A	101	2004	12664-9	J:92436	15314226
90202	Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome.		Shim GJ; Warner M; Kim HJ; Andersson S; Liu L; Ekman J; Imamov O; Jones ME; Simpson ER; Gustafsson JA		Proc Natl Acad Sci U S A	101	2004	12628-33	J:92438	15314222
90203	Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects.		Reilly KM; Tuskan RG; Christy E; Loisel DA; Ledger J; Bronson RT; Smith CD; Tsang S; Munroe DJ; Jacks T		Proc Natl Acad Sci U S A	101	2004	13008-13	J:92444	15319471
90204	Ahnak/Desmoyokin is dispensable for proliferation, differentiation, and maintenance of integrity in mouse epidermis.		Kouno M; Kondoh G; Horie K; Komazawa N; Ishii N; Takahashi Y; Takeda J; Hashimoto T		J Invest Dermatol	123	2004	700-7	J:92500	15373775
90205	Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction.		White DE; Kurpios NA; Zuo D; Hassell JA; Blaess S; Mueller U; Muller WJ		Cancer Cell	6	2004	159-70	J:92547	15324699
90206	Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice.		Iavnilovitch E; Cardiff RD; Groner B; Barash I		Int J Cancer	112	2004	607	J:92536	15382041
90207	Hepsin promotes prostate cancer progression and metastasis.		Klezovitch O; Chevillet J; Mirosevich J; Roberts RL; Matusik RJ; Vasioukhin V		Cancer Cell	6	2004	185-95	J:92562	15324701
90208	Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility.		Yang G; Scherer SJ; Shell SS; Yang K; Kim M; Lipkin M; Kucherlapati R; Kolodner RD; Edelmann W		Cancer Cell	6	2004	139-50	J:92555	15324697
90209	Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis.		Chan KS; Sano S; Kiguchi K; Anders J; Komazawa N; Takeda J; DiGiovanni J		J Clin Invest	114	2004	720-8	J:92593	15343391
90210	An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.		Giraudo E; Inoue M; Hanahan D		J Clin Invest	114	2004	623-33	J:92599	15343380
90211	Stat3 is required for the development of skin cancer.		Pedranzini L; Leitch A; Bromberg J		J Clin Invest	114	2004	619-22	J:92600	15343379
90212	Formation of cystic ovarian follicles associated with elevated luteinizing hormone requires estrogen receptor-beta.		Couse JF; Yates MM; Sanford R; Nyska A; Nilson JH; Korach KS		Endocrinology	145	2004	4693-702	J:92628	15231698
90213	A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.		Kato Y; Ying H; Willingham MC; Cheng SY		Endocrinology	145	2004	4430-8	J:92629	15231697
90214	Netrin-1 controls colorectal tumorigenesis by regulating apoptosis.		Mazelin L; Bernet A; Bonod-Bidaud C; Pays L; Arnaud S; Gespach C; Bredesen DE; Scoazec JY; Mehlen P		Nature	431	2004	80-4	J:92659	15343335
90215	Cancer: cell survival guide.		Fearon ER; Cho KR		Nature	431	2004	35-6	J:92660	15343320
90216	Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia.		Kunstfeld R; Hirakawa S; Hong YK; Schacht V; Lange-Asschenfeldt B; Velasco P; Lin C; Fiebiger E; Wei X; Wu Y; Hicklin D; Bohlen P; Detmar M		Blood	104	2004	1048-57	J:92643	15100155
90217	Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. (Erratum: v 25(1):523)		Hulit J; Wang C; Li Z; Albanese C; Rao M; Di Vizio D; Shah S; Byers SW; Mahmood R; Augenlicht LH; Russell R; Pestell RG		Mol Cell Biol	24	2004	7598-611	J:92787	15314168
90218	PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance.		Kulkarni RN; Jhala US; Winnay JN; Krajewski S; Montminy M; Kahn CR		J Clin Invest	114	2004	828-36	J:92861	15372107
90219	Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4.		Rahman NA; Kiiveri S; Rivero-Muller A; Levallet J; Vierre S; Kero J; Wilson DB; Heikinheimo M; Huhtaniemi I		Mol Endocrinol	18	2004	2553-69	J:92851	15256532
90220	Rap1 and SPA-1 in hematologic malignancy.		Kometani K; Ishida D; Hattori M; Minato N		Trends Mol Med	10	2004	401-8	J:92899	15310461
90221	Wip1-deficient mice are resistant to common cancer genes.		Harrison M; Li J; Degenhardt Y; Hoey T; Powers S		Trends Mol Med	10	2004	359-61	J:92900	15310454
90222	Ticking fast or ticking slow, through Shc must you go?		Martin FM; Friedman JS		Sci Aging Knowledge Environ	2004	2004	pe32	J:92901	15308771
90223	Prediction of rodent carcinogenesis: an evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies.		Allen DG; Pearse G; Haseman JK; Maronpot RR		Toxicol Pathol	32	2004	393-401	J:92902	15307212
90224	Early occurrence of spontaneous tumors in CD-1 mice and Sprague-Dawley rats.		Son WC; Gopinath C		Toxicol Pathol	32	2004	371-4	J:92903	15307208
90225	Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase.		Nam KT; Oh SY; Ahn B; Kim YB; Jang DD; Yang KH; Hahm KB; Kim DY		Gut	53	2004	1250-5	J:92904	15306579
90226	The effects of styrene on lung cells in female mice and rats.		Gamer AO; Leibold E; Deckardt K; Kittel B; Kaufmann W; Tennekes HA; van Ravenzwaay B		Food Chem Toxicol	42	2004	1655-67	J:92905	15304312
90227	Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions.		Hobbs RM; Silva-Vargas V; Groves R; Watt FM		J Invest Dermatol	123	2004	503-15	J:92906	15304090
90228	Inhibitory effect of topical applications of nondenatured soymilk on the formation and growth of UVB-induced skin tumors.		Huang MT; Xie JG; Lin CB; Kizoulis M; Seiberg M; Shapiro S; Conney AH		Oncol Res	14	2004	387-97	J:92908	15301430
90229	Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice.		Nomura S; Baxter T; Yamaguchi H; Leys C; Vartapetian AB; Fox JG; Lee JR; Wang TC; Goldenring JR		Gastroenterology	127	2004	582-94	J:92909	15300590
90230	Notch signaling in mammary development and oncogenesis.		Callahan R; Egan SE		J Mammary Gland Biol Neoplasia	9	2004	145-63	J:92910	15300010
90231	Nodal and cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.		Kenney NJ; Adkins HB; Sanicola M		J Mammary Gland Biol Neoplasia	9	2004	133-44	J:92911	15300009
90232	Wnt proteins in mammary development and cancer.		Brennan KR; Brown AM		J Mammary Gland Biol Neoplasia	9	2004	119-31	J:92912	15300008
90233	The role of tbx2 and tbx3 in mammary development and tumorigenesis.		Rowley M; Grothey E; Couch FJ		J Mammary Gland Biol Neoplasia	9	2004	109-18	J:92913	15300007
90234	Tumorigenesis facilitated by Pten deficiency in the skin: Evidence of p53-Pten complex formation on the initiation phase.		Komazawa N; Suzuki A; Sano S; Horie K; Matsuura N; Mak TW; Nakano T; Takeda J; Kondoh G		Cancer Sci	95	2004	639-43	J:92914	15298725
90235	Role of gammadelta T lymphocytes in tumor defense.		Zocchi MR; Poggi A		Front Biosci	9	2004	2588-604	J:92873	15358583
90236	Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities.		Bauer AK; Malkinson AM; Kleeberger SR		Am J Physiol Lung Cell Mol Physiol	287	2004	L685-703	J:92874	15355860
90237	Comparative evaluation of cancer chemopreventive efficacy of alpha-tocopherol and quercetin in a murine model.		De S; Chakraborty RN; Ghosh S; Sengupta A; Das S		J Exp Clin Cancer Res	23	2004	251-8	J:92875	15354409
90238	Multiple functions of maspin in tumor progression and mouse development.		Zhang M		Front Biosci	9	2004	2218-26	J:92876	15353283
90239	Increased apoptosis of periprostatic adipose tissue in VDR null mice.		Guzey M; Jukic D; Arlotti J; Acquafondata M; Dhir R; Getzenberg RH		J Cell Biochem	93	2004	133-41	J:92877	15352170
90240	Increased DNA methylation in the HoxA5 promoter region correlates with decreased expression of the gene during tumor promotion.		Watson RE; Curtin GM; Hellmann GM; Doolittle DJ; Goodman JI		Mol Carcinog	41	2004	54-66	J:92878	15352125
90241	Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice.		Jamerson MH; Johnson MD; Korsmeyer SJ; Furth PA; Dickson RB		Br J Cancer	91	2004	1372-9	J:92916	15354213
90242	Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23.		MacPherson D; Kim J; Kim T; Rhee BK; Van Oostrom CT; DiTullio RA; Venere M; Halazonetis TD; Bronson R; De Vries A; Fleming M; Jacks T		EMBO J	23	2004	3689-99	J:92917	15343266
90243	Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8-expressing transgenic mice.		Casanova ML; Bravo A; Martinez-Palacio J; Fernandez-Acenero MJ; Villanueva C; Larcher F; Conti CJ; Jorcano JL		FASEB J	18	2004	1556-8	J:92918	15319370
90244	Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene.		Berge G; OVrebo S; Eilertsen E; Haugen A; Mollerup S		Br J Cancer	91	2004	1380-3	J:92919	15316568
90245	Targeted expression of human O(6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis.		Becker K; Dosch J; Gregel CM; Martin BA; Kaina B		Cancer Res	56	1996	3244-9	J:92925	8764116
90246	Separately expressed T cell receptor alpha and beta chain transgenes exert opposite effects on T cell differentiation and neoplastic transformation.		Brabb T; Rubicz R; Mannikko V; Goverman J		Eur J Immunol	27	1997	3039-48	J:92992	9394835
90247	Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis.		Astrof S; Crowley D; George EL; Fukuda T; Sekiguchi K; Hanahan D; Hynes RO		Mol Cell Biol	24	2004	8662-70	J:93027	15367684
90248	Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice.		Strasser A; Harris AW; Vaux DL; Webb E; Bath ML; Adams JM; Cory S		Curr Top Microbiol Immunol	166	1990	175-81	J:93111	2073796
90249	Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice.		Fujishita T; Doi Y; Sonoshita M; Hiai H; Oshima M; Huebner K; Croce CM; Taketo MM		Br J Cancer	91	2004	1571-4	J:93269	15467769
90250	Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage.		Lee D; Pearsall RS; Das S; Dey SK; Godfrey VL; Threadgill DW		Mol Cell Biol	24	2004	8907-16	J:93327	15456865
90251	p19( Arf) Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways.		Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ		PLoS Biol	2	2004	E242	J:93298	15314658
90252	HSF4 is required for normal cell growth and differentiation during mouse lens development.		Fujimoto M; Izu H; Seki K; Fukuda K; Nishida T; Yamada S; Kato K; Yonemura S; Inouye S; Nakai A		EMBO J	23	2004	4297-306	J:93301	15483628
90253	The Rb tumor suppressor is required for stress erythropoiesis.		Spike BT; Dirlam A; Dibling BC; Marvin J; Williams BO; Jacks T; Macleod KF		EMBO J	23	2004	4319-29	J:93304	15457215
90254	Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members.		Herms J; Anliker B; Heber S; Ring S; Fuhrmann M; Kretzschmar H; Sisodia S; Muller U		EMBO J	23	2004	4106-15	J:93306	15385965
90255	Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP mice.		Kee K; Foster BA; Merali S; Kramer DL; Hensen ML; Diegelman P; Kisiel N; Vujcic S; Mazurchuk RV; Porter CW		J Biol Chem	279	2004	40076-83	J:93350	15252047
90256	Increased Sensitivity to UV Radiation in Mice with a p53 Point Mutation at Ser389.		Bruins W; Zwart E; Attardi LD; Iwakuma T; Hoogervorst EM; Beems RB; Miranda B; Van Oostrom CT; Van Den Berg J; Van Den Aardweg GJ; Lozano G; Van Steeg H; Jacks T; De Vries A		Mol Cell Biol	24	2004	8884-94	J:93328	15456863
90257	Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.		Martin AC; Thornton JD; Liu J; Wang X; Zuo J; Jablonski MM; Chaum E; Zindy F; Skapek SX		Invest Ophthalmol Vis Sci	45	2004	3387-96	J:93377	15452040
90258	The implausibility of leukemia induction by formaldehyde: a critical review of the biological evidence on distant-site toxicity.		Heck Hd H; Casanova M		Regul Toxicol Pharmacol	40	2004	92-106	J:93378	15450713
90259	The risk of lymphoma in AKR/J mice does not rise with chronic exposure to 50 Hz magnetic fields (1 microT and 100 microT).		Sommer AM; Lerchl A		Radiat Res	162	2004	194-200	J:93379	15387147
90260	Cancer: an inflammatory link.		Balkwill F; Coussens LM		Nature	431	2004	405-6	J:93380	15385993
90261	Granuloma necrosis during Mycobacterium avium infection does not require tumor necrosis factor.		Florido M; Appelberg R		Infect Immun	72	2004	6139-41	J:93381	15385519
90262	Pathology of Ovarian Neoplasms in Genetically Modified Mice.		Nikitin AY; Connolly DC; Hamilton TC		Comp Med	54	2004	26-8	J:93382	15382342
90263	Pathology of Mouse Models of Human Lung Cancer.		Shmidt EN; Nitkin AY		Comp Med	54	2004	23-6	J:93383	15382341
90264	Endocrine Tumors of the Pancreas in Transgenic Mice.		Longnecker DS		Comp Med	54	2004	21-2	J:93384	15382338
90265	Models of Exocrine Pancreatic Neoplasms in Transgenic Mice.		Longnecker DS		Comp Med	54	2004	18-21	J:93385	15382335
90266	Mouse Models of Intestinal Cancer.		Boivin GP; Groden J		Comp Med	54	2004	15-8	J:93386	15382328
90267	Viral mediated gene therapy for the management of metastatic thyroid carcinoma.		DeGroot LJ; Zhang R		Curr Drug Targets Immune Endocr Metabol Disord	4	2004	235-44	J:93387	15379725
90268	A novel mouse model for colitis-associated colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sulfate sodium.		Wang JG; Wang DF; Lv BJ; Si JM		World J Gastroenterol	10	2004	2958-62	J:93388	15378773
90269	TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration?		Scott KA; Arnott CH; Robinson SC; Moore RJ; Thompson RG; Marshall JF; Balkwill FR		Oncogene	23	2004	6954-66	J:93774	15273742
90270	Human keratin 14 driven HPV 16 E6/E7 transgenic mice exhibit hyperkeratinosis.		Kim SH; Kim KS; Lee EJ; Kim MO; Park JH; Cho KI; Imakawa K; Hyun BH; Chang KT; Taek Lee H; Ryoo ZY		Life Sci	75	2004	3035-42	J:93367	15474555
90271	Application of Benzo(a)pyrene and Coal Tar Tumor Dose-Response Data to a Modified Benchmark Dose Method of Guideline Development.		Fitzgerald DJ; Robinson NI; Pester BA		Environ Health Perspect	112	2004	1341-6	J:93368	15471723
90272	Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate.		Suzuki R; Kohno H; Sugie S; Tanaka T		Cancer Sci	95	2004	721-7	J:93369	15471557
90273	The wrickkened pathways of fgf23, mepe and phex.		Rowe PS		Crit Rev Oral Biol Med	15	2004	264-81	J:93370	15470265
90274	Inactivation mechanism of tyrosinase in mouse melanoma.		Tomita Y; Seiji M		J Dermatol	4	1977	245-9	J:93371	15461355
90275	Developmental Context Determines Latency of MYC-Induced Tumorigenesis.		Beer S; Zetterberg A; Ihrie RA; McTaggart RA; Yang Q; Bradon N; Arvanitis C; Attardi LD; Feng S; Ruebner B; Cardiff RD; Felsher DW		PLoS Biol	2	2004	E332	J:93372	15455033
90276	Minimal influence of metallothionein over-expression on nickel carcinogenesis in mice.		Waalkes MP; Liu J; Kasprzak KS; Diwan BA		Toxicol Lett	153	2004	357-64	J:93373	15454311
90277	Targeting the p53-MDM2 interaction to treat cancer.		Klein C; Vassilev LT		Br J Cancer	91	2004	1415-9	J:93374	15452548
90278	Inhibition of DMBA/croton oil-induced two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate.		Das RK; Ghosh S; Sengupta A; Das S; Bhattacharya S		Eur J Cancer Prev	13	2004	411-417	J:93375	15452454
90279	The Loss of PTEN Allows TCR {alpha}{beta} Lineage Thymocytes to Bypass IL-7 and Pre-TCR-mediated Signaling.		Hagenbeek TJ; Naspetti M; Malergue F; Garcon F; Nunes JA; Cleutjens KB; Trapman J; Krimpenfort P; Spits H		J Exp Med	200	2004	883-894	J:93376	15452180
90280	Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis.		Jacoby RF; Cole CE; Hawk ET; Lubet RA		Gastroenterology	127	2004	838-44	J:93405	15362039
90281	Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice.		Mutoh H; Sakurai S; Satoh K; Osawa H; Hakamata Y; Takeuchi T; Sugano K		Gut	53	2004	1416-23	J:93406	15361487
90282	The immunopathology of experimental visceral leishmaniasis.		Kaye PM; Svensson M; Ato M; Maroof A; Polley R; Stager S; Zubairi S; Engwerda CR		Immunol Rev	201	2004	239-53	J:93407	15361245
90283	Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice.		Fenske TS; Pengue G; Mathews V; Hanson PT; Hamm SE; Riaz N; Graubert TA		Proc Natl Acad Sci U S A	101	2004	15184-9	J:93408	15477599
90284	Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: Implications for pre-mRNA processing.		Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM		Mol Carcinog	41	2004	187-96	J:93409	15390079
90285	Requirement of the forkhead gene Foxe1, a target of sonic hedgehog signaling, in hair follicle morphogenesis.		Brancaccio A; Minichiello A; Grachtchouk M; Antonini D; Sheng H; Parlato R; Dathan N; Dlugosz AA; Missero C		Hum Mol Genet	13	2004	2595-606	J:93410	15367491
90286	Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.		Keller C; Hansen MS; Coffin CM; Capecchi MR		Genes Dev	18	2004	2608-13	J:93443	15520281
90287	Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.		Keller C; Arenkiel BR; Coffin CM; El-Bardeesy N; DePinho RA; Capecchi MR		Genes Dev	18	2004	2614-26	J:93444	15489287
90288	Genomic instability in mouse Burkitt lymphoma is dominated by illegitimate genetic recombinations, not point mutations.		Rockwood LD; Torrey TA; Kim JS; Coleman AE; Kovalchuk AL; Xiang S; Ried T; Morse HC rd; Janz S		Oncogene	21	2002	7235-40	J:93497	12370814
90289	Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis.		Channavajhala P; Seldin DC		Oncogene	21	2002	5280-8	J:93498	12149649
90290	Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.		Aguilar S; Corominas JM; Malats N; Pereira JA; Dufresne M; Real FX; Navarro P		Am J Pathol	165	2004	1129-39	J:93505	15466380
90291	Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53.		Grossman D; Kim PJ; Blanc-Brude OP; Brash DE; Tognin S; Marchisio PC; Altieri DC		J Clin Invest	108	2001	991-9	J:93483	11581300
90292	Tumors in hepatobiliary tract and pancreatic islet tissues of transgenic mice harboring gastrin simian virus 40 large tumor antigen fusion gene.		Montag AG; Oka T; Baek KH; Choi CS; Jay G; Agarwal K		Proc Natl Acad Sci U S A	90	1993	6696-700	J:93491	8393573
90293	The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089.		Perez-Stable CM; Schwartz GG; Farinas A; Finegold M; Binderup L; Howard GA; Roos BA		Cancer Epidemiol Biomarkers Prev	11	2002	555-63	J:93494	12050097
90294	Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage (Version 6).		Friedberg EC; Meira LB		DNA Repair (Amst)	3	2004	1617-38	J:93496	15474422
90295	High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.		Torres-Arzayus MI; De Mora JF; Yuan J; Vazquez F; Bronson R; Rue M; Sellers WR; Brown M		Cancer Cell	6	2004	263-74	J:93548	15380517
90296	Antiapoptotic BCL-2 is required for maintenance of a model leukemia.		Letai A; Sorcinelli MD; Beard C; Korsmeyer SJ		Cancer Cell	6	2004	241-9	J:93549	15380515
90297	Mice expressing SV40 T antigen directed by the intestinal trefoil factor promoter develop tumors resembling human small cell carcinoma of the colon.		Gum JR Jr; Hicks JW; Crawley SC; Yang SC; Borowsky AD; Dahl CM; Kakar S; Kim DH; Cardiff RD; Kim YS		Mol Cancer Res	2	2004	504-13	J:93550	15383629
90298	Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta.		Wang D; Wang H; Shi Q; Katkuri S; Walhi W; Desvergne B; Das SK; Dey SK; DuBois RN		Cancer Cell	6	2004	285-95	J:93551	15380519
90299	The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event.		Stoler AB; Stenback F; Balmain A		J Cell Biol	122	1993	1103-17	J:93506	7689080
90300	The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.		Curtis DJ; Robb L; Strasser A; Begley CG		Oncogene	15	1997	2975-83	J:93511	9416841
90301	Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.		Mustacich D; Wagner A; Williams R; Bair W; Barbercheck L; Stratton SP; Bhattacharyya AK; Powis G		Carcinogenesis	25	2004	1983-9	J:93627	15166090
90302	Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43.		Avanzo JL; Mesnil M; Hernandez-Blazquez FJ; Mackowiak II; Mori CM; da Silva TC; Oloris SC; Garate AP; Massironi SM; Yamasaki H; Dagli ML		Carcinogenesis	25	2004	1973-82	J:93628	15166089
90303	DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study.		Young LC; Thulien KJ; Campbell MR; Tron VA; Andrew SE		Carcinogenesis	25	2004	1821-7	J:93629	15166087
90304	Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations.		Plummer NW; Gallione CJ; Srinivasan S; Zawistowski JS; Louis DN; Marchuk DA		Am J Pathol	165	2004	1509-18	J:93631	15509522
90305	Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity.		Holst PJ; Rosenkilde MM; Manfra D; Chen SC; Wiekowski MT; Holst B; Cifire F; Lipp M; Schwartz TW; Lira SA		J Clin Invest	108	2001	1789-96	J:93671	11748262
90306	Hyaluronan participates in the epidermal response to disruption of the permeability barrier in vivo.		Maytin EV; Chung HH; Seetharaman VM		Am J Pathol	165	2004	1331-41	J:93678	15466397
90307	Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.		Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C		Endocrinology	137	1996	375-8	J:93679	8536638
90308	Anti-HER-2/neu immune responses are induced before the development of clinical tumors but declined following tumorigenesis in HER-2/neu transgenic mice.		Takeuchi N; Hiraoka S; Zhou XY; Nagafuku M; Ono S; Tsujimura T; Nakazawa M; Yura Y; Hamaoka T; Fujiwara H		Cancer Res	64	2004	7588-95	J:93643	15492286
90309	Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis.		Athar M; Li C; Tang X; Chi S; Zhang X; Kim AL; Tyring SK; Kopelovich L; Hebert J; Epstein EH Jr; Bickers DR; Xie J		Cancer Res	64	2004	7545-52	J:93644	15492281
90310	Id2 is dispensable for myc-induced lymphomagenesis.		Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL		Cancer Res	64	2004	7296-301	J:93645	15492249
90311	Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.		Cavin LG; Venkatraman M; Factor VM; Kaur S; Schroeder I; Mercurio F; Beg AA; Thorgeirsson SS; Arsura M		Cancer Res	64	2004	7030-8	J:93646	15466196
90312	A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors.		Wyckoff J; Wang W; Lin EY; Wang Y; Pixley F; Stanley ER; Graf T; Pollard JW; Segall J; Condeelis J		Cancer Res	64	2004	7022-9	J:93647	15466195
90313	A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.		McCawley LJ; Crawford HC; King LE Jr; Mudgett J; Matrisian LM		Cancer Res	64	2004	6965-72	J:93648	15466188
90314	COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas.		Dornan D; Bheddah S; Newton K; Ince W; Frantz GD; Dowd P; Koeppen H; Dixit VM; French DM		Cancer Res	64	2004	7226-30	J:93649	15492238
90315	Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium.		Russell RG; Lasorella A; Dettin LE; Iavarone A		Cancer Res	64	2004	7220-5	J:93650	15492237
90316	The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice.		Yamamoto Y; Moore R; Goldsworthy TL; Negishi M; Maronpot RR		Cancer Res	64	2004	7197-200	J:93651	15492232
90317	The gap junction protein connexin32 is a mouse lung tumor suppressor.		King TJ; Lampe PD		Cancer Res	64	2004	7191-6	J:93652	15492231
90318	Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary t	umorigenesis in mice.	Zhang H; Kuang SQ; Liao L; Zhou S; Xu J		Cancer Res	64	2004	7169-77	J:93653	15466215
90319	Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice.		Li CK; Pender SL; Pickard KM; Chance V; Holloway JA; Huett A; Goncalves NS; Mudgett JS; Dougan G; Frankel G; MacDonald TT		J Immunol	173	2004	5171-9	J:93706	15470062
90320	Haploinsufficiency of Anx7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the Anx7(+/-) mouse.		Srivastava M; Montagna C; Leighton X; Glasman M; Naga S; Eidelman O; Ried T; Pollard HB		Proc Natl Acad Sci U S A	100	2003	14287-92	J:93685	14608035
90321	Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia.		Stepanova L; Yang G; DeMayo F; Wheeler TM; Finegold M; Thompson TC; Harper JW		Oncogene	19	2000	2186-93	J:93695	10822368
90322	Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice.		Hwang KW; Sweatt WB; Mashayekhi M; Palucki DA; Sattar H; Chuang E; Alegre ML		J Immunol	173	2004	5415-24	J:93742	15494488
90323	Cancer chemopreventive activity of 3beta-methoxyserrat-14-en-21beta-ol and several serratane analogs on two-stage mouse skin carcinogenesis.		Tanaka R; Shanmugasundaram K; Yamaguchi C; Ishikawa Y; Tokuda H; Nishide K; Node M		Cancer Lett	214	2004	149-56	J:93751	15363540
90324	The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity.		Artis D; Villarino A; Silverman M; He W; Thornton EM; Mu S; Summer S; Covey TM; Huang E; Yoshida H; Koretzky G; Goldschmidt M; Wu GD; de Sauvage F; Miller HR; Saris CJ; Scott P; Hunter CA		J Immunol	173	2004	5626-34	J:93739	15494513
90325	Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR/ABL-induced chronic myeloid leukemia-like myeloproliferative disease in mice.		Pelletier SD; Hong DS; Hu Y; Liu Y; Li S		Blood	104	2004	2163-71	J:93772	15213099
90326	Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice.		Henry MD; Triplett AA; Oh KB; Smith GH; Wagner KU		Oncogene	23	2004	6980-5	J:93776	15286714
90327	The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.		Caporali A; Davalli P; Astancolle S; D'Arca D; Brausi M; Bettuzzi S; Corti A		Carcinogenesis	25	2004	2217-24	J:93777	15358631
90328	Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?		Baxter EW; Blyth K; Donehower LA; Cameron ER; Onions DE; Neil JC		J Virol	70	1996	2095-100	J:93778	8642629
90329	The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.		Marin MC; Hsu B; Stephens LC; Brisbay S; McDonnell TJ		Exp Cell Res	217	1995	240-7	J:93779	7698223
90330	Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: role of inclusion body formation.		Waalkes MP; Liu J; Goyer RA; Diwan BA		Cancer Res	64	2004	7766-72	J:93863	15520181
90331	Protein kinase C epsilon is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas.		Wheeler DL; Martin KE; Ness KJ; Li Y; Dreckschmidt NE; Wartman M; Ananthaswamy HN; Mitchell DL; Verma AK		Cancer Res	64	2004	7756-65	J:93804	15520180
90332	Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions.		Yao R; Wang Y; Lemon WJ; Lubet RA; You M		Oncogene	23	2004	7746-52	J:93805	15361829
90333	Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice.		Mutoh H; Sakurai S; Satoh K; Tamada K; Kita H; Osawa H; Tomiyama T; Sato Y; Yamamoto H; Isoda N; Yoshida T; Ido K; Sugano K		Cancer Res	64	2004	7740-7	J:93806	15520178
90334	Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth.		Bajou K; Maillard C; Jost M; Lijnen RH; Gils A; Declerck P; Carmeliet P; Foidart JM; Noel A		Oncogene	23	2004	6986-90	J:93782	15286708
90335	Polyethylene glycol inhibits intestinal neoplasia and induces epithelial apoptosis in Apc(min) mice.		Roy HK; Gulizia J; DiBaise JK; Karolski WJ; Ansari S; Madugula M; Hart J; Bissonnette M; Wali RK		Cancer Lett	215	2004	35-42	J:93789	15374630
90336	Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells.		Shinohara S; Rothstein JL		Oncogene	23	2004	7571-9	J:93839	15326486
90337	Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.		Malek SN; Dordai DI; Reim J; Dintzis H; Desiderio S		Proc Natl Acad Sci U S A	95	1998	7351-6	J:93840	9636152
90338	Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.		Schmidt EV; Pattengale PK; Weir L; Leder P		Proc Natl Acad Sci U S A	85	1988	6047-51	J:93841	3261863
90339	Forty years of cancer modelling in the mouse.		Hirst GL; Balmain A		Eur J Cancer	40	2004	1974-80	J:93849	15315806
90340	Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice.		Kondoh G; Murata Y; Aozasa K; Yutsudo M; Hakura A		J Virol	65	1991	3335-9	J:93826	1851881
90341	Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis.		Li AG; Lu SL; Zhang MX; Deng C; Wang XJ		Cancer Res	64	2004	7836-45	J:93860	15520189
90342	The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas.		Hallahan AR; Pritchard JI; Hansen S; Benson M; Stoeck J; Hatton BA; Russell TL; Ellenbogen RG; Bernstein ID; Beachy PA; Olson JM		Cancer Res	64	2004	7794-800	J:93861	15520185
90343	Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo.		Fraser MM; Zhu X; Kwon CH; Uhlmann EJ; Gutmann DH; Baker SJ		Cancer Res	64	2004	7773-9	J:93862	15520182
90344	Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.		Kawakubo H; Carey JL; Brachtel E; Gupta V; Green JE; Walden PD; Maheswaran S		Oncogene	23	2004	8310-9	J:93855	15378000
90345	Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice.		Martin-Caballero J; Flores JM; Garcia-Palencia P; Collado M; Serrano M		Oncogene	23	2004	8231-7	J:93856	15378017
90346	Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon.		Poole AJ; Heap D; Carroll RE; Tyner AL		Oncogene	23	2004	8128-34	J:93857	15377995
90347	Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.		Sakai Y; Morrison BJ; Burke JD; Park JM; Terabe M; Janik JE; Forni G; Berzofsky JA; Morris JC		Cancer Res	64	2004	8022-8	J:93858	15520211
90348	Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.		Wang S; Gao J; Lei Q; Rozengurt N; Pritchard C; Jiao J; Thomas GV; Li G; Roy-Burman P; Nelson PS; Liu X; Wu H		Cancer Cell	4	2003	209-21	J:93902	14522255
90349	Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.		Matheu A; Pantoja C; Efeyan A; Criado LM; Martin-Caballero J; Flores JM; Klatt P; Serrano M		Genes Dev	18	2004	2736-46	J:93879	15520276
90350	Living with or without cyclins and cyclin-dependent kinases.		Sherr CJ; Roberts JM		Genes Dev	18	2004	2699-711	J:93880	15545627
90351	Act1, a negative regulator in CD40- and BAFF-mediated B cell survival.		Qian Y; Qin J; Cui G; Naramura M; Snow EC; Ware CF; Fairchild RL; Omori SA; Rickert RC; Scott M; Kotzin BL; Li X		Immunity	21	2004	575-87	J:93923	15485634
90352	Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach.		Cui G; Koh TJ; Chen D; Zhao CM; Takaishi S; Dockray GJ; Varro A; Rogers AB; Fox JG; Wang TC		Cancer Res	64	2004	8160-6	J:94009	15548680
90353	Evaluation of the antitumor effects of Herpes simplex virus lacking ribonucleotide reductase in a murine retinoblastoma model.		Cullinan A; Lindstrom M; Sabet S; Albert D; Brandt C		Curr Eye Res	29	2004	167-72	J:94106	15512963
90354	Involvement of insulin receptor substrate 2 in mammary tumor metastasis.		Nagle JA; Ma Z; Byrne MA; White MF; Shaw LM		Mol Cell Biol	24	2004	9726-35	J:94107	15509777
90355	Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers.		Colnot S; Niwa-Kawakita M; Hamard G; Godard C; Le Plenier S; Houbron C; Romagnolo B; Berrebi D; Giovannini M; Perret C		Lab Invest	84	2004	1619-30	J:94108	15502862
90356	Lymphocyte changes in peripheral blood, spleen, and liver in DMBA-induced squamous cell carcinoma of mouse cheek skin.		Sakai Y; Tanaka M; Shirakawa M		Odontology	92	2004	36-42	J:94110	15490303
90357	Dietary iron promotes azoxymethane-induced colon tumors in mice.		Ilsley JN; Leung SF; Belinsky GS; Guda K; Zhang Q; Huang X; Blumberg JB; Milbury PE; Roberts LJ nd; Stevens RG; Rosenberg DW		Nutr Cancer	49	2004	162-9	J:94112	15489209
90358	Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1.		Kim SS; Cao L; Li C; Xu X; Huber LJ; Chodosh LA; Deng CX		Mol Cell Biol	24	2004	9498-507	J:94114	15485917
90359	TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice.		Zapata JM; Krajewska M; Morse HC rd; Choi Y; Reed JC		Proc Natl Acad Sci U S A	101	2004	16600-5	J:94116	15545599
90360	Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs.		Espejel S; Klatt P; Menissier-de Murcia J; Martin-Caballero J; Flores JM; Taccioli G; de Murcia G; Blasco MA		J Cell Biol	167	2004	627-38	J:94117	15545322
90361	Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice.		Yue HH; Diehl GE; Winoto A		Cell Death Differ	12	2005	94-7	J:94118	15514675
90362	The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia.		Montaner S; Sodhi A; Servitja JM; Ramsdell AK; Barac A; Sawai ET; Gutkind JS		Blood	104	2004	2903-11	J:94078	15231571
90363	Bmx tyrosine kinase transgene induces skin hyperplasia, inflammatory angiogenesis, and accelerated wound healing.		Paavonen K; Ekman N; Wirzenius M; Rajantie I; Poutanen M; Alitalo K		Mol Biol Cell	15	2004	4226-33	J:94080	15229285
90364	PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain.		Cook WD; McCaw BJ; Herring C; John DL; Foote SJ; Nutt SL; Adams JM		Blood	104	2004	3437-44	J:94081	15304397
90365	Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea.		Tsujimura K; Obata Y; Matsudaira Y; Ozeki S; Taguchi O; Nishida K; Okanami Y; Akatsuka Y; Kuzushima K; Takahashi T		Cancer Sci	95	2004	914-919	J:94084	15546510
90366	Modeling pancreatic cancer in animals to address specific hypotheses.		Grippo PJ; Sandgren EP		Methods Mol Med	103	2004	217-44	J:94086	15542910
90367	Genetic Interaction between Rb and K-ras in the Control of Differentiation and Tumor Suppression.		Takahashi C; Contreras B; Bronson RT; Loda M; Ewen ME		Mol Cell Biol	24	2004	10406-15	J:94087	15542848
90368	The Mouse Genomic Instability Mutation chaos1 Is an Allele of Polq That Exhibits Genetic Interaction with Atm.		Shima N; Munroe RJ; Schimenti JC		Mol Cell Biol	24	2004	10381-9	J:94088	15542845
90369	Modulation of p53 in 7,12-dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice.		Arora A; Siddiqui IA; Shukla Y		Mol Cancer Ther	3	2004	1459-66	J:94089	15542785
90370	No effects of GSM-modulated 900 MHz electromagnetic fields on survival rate and spontaneous development of lymphoma in female AKR/J mice.		Sommer AM; Streckert J; Bitz AK; Hansen VW; Lerchl A		BMC Cancer	4	2004	77	J:94091	15538947
90371	During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities.		DiLorenzo TP; Lieberman SM; Takaki T; Honda S; Chapman HD; Santamaria P; Serreze DV; Nathenson SG		Clin Immunol	105	2002	332-41	J:94192	12498815
90372	Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus.		Islas-Ohlmayer M; Padgett-Thomas A; Domiati-Saad R; Melkus MW; Cravens PD; Martin Mdel P; Netto G; Garcia JV		J Virol	78	2004	13891-900	J:94210	15564497
90373	Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.		Sorensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS		J Virol	78	2004	13216-31	J:94217	15542674
90374	Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.		Dannenberg JH; Schuijff L; Dekker M; van der Valk M; te Riele H		Genes Dev	18	2004	2952-62	J:94277	15574596
90375	Effect of neuronol on lifespan and development of spontaneous tumors in SAMP-1 mice with genetically accelerated aging.		Popovich IG; Zabezhinskii MA; Anisimov VN; Kovalenko AL; Petrov AY; Semenchenko AV; Yashin AI		Bull Exp Biol Med	136	2003	595-8	J:94109	15500082
90376	Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.		Moriya K; Yotsuyanagi H; Shintani Y; Fujie H; Ishibashi K; Matsuura Y; Miyamura T; Koike K		J Gen Virol	78	1997	1527-31	J:94426	9225025
90377	Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.		Zinser GM; Welsh J		Carcinogenesis	25	2004	2361-72	J:94402	15333467
90378	Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice.		Chisari FV; Filippi P; Buras J; McLachlan A; Popper H; Pinkert CA; Palmiter RD; Brinster RL		Proc Natl Acad Sci U S A	84	1987	6909-13	J:94462	3477814
90379	DNA damage-induced apoptosis: insights from the mouse.		Zabkiewicz J; Clarke AR		Biochim Biophys Acta	1705	2004	17-25	J:94438	15585170
90380	Influence of glutathione S-transferase pi and p53 expression on tumor frequency and spectrum in mice.		Gate L; Majumdar RS; Lunk A; Tew KD		Int J Cancer	113	2005	29-35	J:94440	15386426
90381	Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector.		Gallo P; Dharmapuri S; Nuzzo M; Maldini D; Iezzi M; Cavallo F; Musiani P; Forni G; Monaci P		Int J Cancer	113	2005	67-77	J:94441	15386429
90382	Smad1, {beta}-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription.		Hu MC; Rosenblum ND		Development	132	2005	215-225	J:94513	15576399
90383	Transgenic expression of hepatitis C virus structural proteins in the mouse.		Kawamura T; Furusaka A; Koziel MJ; Chung RT; Wang TC; Schmidt EV; Liang TJ		Hepatology	25	1997	1014-21	J:94902	9096613
90384	Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms.		Sunday ME; Haley KJ; Sikorski K; Graham SA; Emanuel RL; Zhang F; Mu Q; Shahsafaei A; Hatzis D		Oncogene	18	1999	4336-47	J:94544	10439041
90385	Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice.		Michiels FM; Caillou B; Talbot M; Dessarps-Freichey F; Maunoury MT; Schlumberger M; Mercken L; Monier R; Feunteun J		Proc Natl Acad Sci U S A	91	1994	10488-92	J:94546	7937980
90386	The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner.		McFadden DG; Barbosa AC; Richardson JA; Schneider MD; Srivastava D; Olson EN		Development	132	2005	189-201	J:94514	15576406
90387	Costimulation of adenylyl cyclase and phospholipase C by a mutant alpha 1B-adrenergic receptor transgene promotes malignant transformation of thyroid follicular cells.		Ledent C; Denef JF; Cottecchia S; Lefkowitz R; Dumont J; Vassart G; Parmentier M		Endocrinology	138	1997	369-78	J:94522	8977426
90388	Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice.		Zeiger MA; Saji M; Gusev Y; Westra WH; Takiyama Y; Dooley WC; Kohn LD; Levine MA		Endocrinology	138	1997	3133-40	J:94523	9231760
90389	The role of gelatinases in colorectal cancer progression and metastasis.		Mook OR; Frederiks WM; Van Noorden CJ		Biochim Biophys Acta	1705	2004	69-89	J:94439	15588763
90390	Expression of Bcl-2 extends the survival of olfactory receptor neurons in the absence of an olfactory bulb.		Hayward MD; Bocchiaro CM; Morgan JI		Brain Res Mol Brain Res	132	2004	221-34	J:94654	15582160
90391	Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.		Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P		Mol Cancer Res	2	2004	632-42	J:94659	15561779
90392	Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.		Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM		Mol Cancer Res	2	2004	620-31	J:94660	15561778
90393	Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice.		Almholt K; Lund LR; Rygaard J; Nielsen BS; Dano K; Romer J; Johnsen M		Int J Cancer	113	2005	525-32	J:94645	15472905
90394	Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice.		Afaq F; Saleem M; Krueger CG; Reed JD; Mukhtar H		Int J Cancer	113	2005	423-33	J:94646	15455341
90395	Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma.		Kappler R; Bauer R; Calzada-Wack J; Rosemann M; Hemmerlein B; Hahn H		Oncogene	23	2004	8785-95	J:94710	15480423
90396	PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine.		Reed KR; Sansom OJ; Hayes AJ; Gescher AJ; Winton DJ; Peters JM; Clarke AR		Oncogene	23	2004	8992-6	J:94711	15480419
90397	Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl.		Zhang JQ; Okumura C; McCarty T; Shin MS; Mukhopadhyay P; Hori M; Torrey TA; Naghashfar Z; Zhou JX; Lee CH; Roopenian DC; Morse HC rd; Davidson WF		J Exp Med	200	2004	1467-78	J:94696	15583018
90398	Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.		Eischen CM; Alt JR; Wang P		Oncogene	23	2004	8931-40	J:94714	15467748
90399	A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis.		Gao H; Ouyang X; Banach-Petrosky W; Borowsky AD; Lin Y; Kim M; Lee H; Shih WJ; Cardiff RD; Shen MM; Abate-Shen C		Proc Natl Acad Sci U S A	101	2004	17204-9	J:94720	15569926
90400	Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.		Colnot S; Decaens T; Niwa-Kawakita M; Godard C; Hamard G; Kahn A; Giovannini M; Perret C		Proc Natl Acad Sci U S A	101	2004	17216-21	J:94721	15563600
90401	Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele.		Graveel C; Su Y; Koeman J; Wang LM; Tessarollo L; Fiscella M; Birchmeier C; Swiatek P; Bronson R; Vande Woude G		Proc Natl Acad Sci U S A	101	2004	17198-203	J:94722	15557554
90402	JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.		Passegue E; Wagner EF; Weissman IL		Cell	119	2004	431-43	J:94778	15507213
90403	Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer.		Duan W; Gao L; Druhan LJ; Zhu WG; Morrison C; Otterson GA; Villalona-Calero MA		J Natl Cancer Inst	96	2004	1718-21	J:94800	15547185
90404	Progressive glomerulonephritis and histiocytic sarcoma associated with macrophage functional defects in CYP1B1-deficient mice.		Ward JM; Nikolov NP; Tschetter JR; Kopp JB; Gonzalez FJ; Kimura S; Siegel RM		Toxicol Pathol	32	2004	710-8	J:94877	15580705
90405	Ameloblastin is a cell adhesion molecule required for maintaining the differentiation state of ameloblasts.		Fukumoto S; Kiba T; Hall B; Iehara N; Nakamura T; Longenecker G; Krebsbach PH; Nanci A; Kulkarni AB; Yamada Y		J Cell Biol	167	2004	973-83	J:94844	15583034
90406	Enhanced tumorigenesis in HTLV-1 tax-transgenic mice deficient in interferon-gamma.		Mitra-Kaushik S; Harding J; Hess J; Schreiber R; Ratner L		Blood	104	2004	3305-11	J:94890	15292059
90407	Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.		Engwerda CR; Ato M; Stager S; Alexander CE; Stanley AC; Kaye PM		Am J Pathol	165	2004	2123-33	J:94946	15579454
90408	Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo.		Bierkamp C; Bonhoure S; Mathieu A; Clerc P; Fourmy D; Pradayrol L; Seva C; Dufresne M		Am J Pathol	165	2004	2135-45	J:94947	15579455
90409	Directed mutagenesis reveals that two histidines in tissue inhibitor of metalloproteinase-1 are each essential for the suppression of cell migration, invasion, and tumorigenicity.		Walther SE; Denhardt DT		Cell Growth Differ	7	1996	1579-88	J:39703	8930408
90410	DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.		Rovero S; Amici A; Carlo ED; Bei R; Nanni P; Quaglino E; Porcedda P; Boggio K; Smorlesi A; Lollini PL; Landuzzi L; Colombo MP; Giovarelli M; Musiani P; Forni G		J Immunol	165	2000	5133-42	J:95045	11046045
90411	alphaMUPA mice: a transgenic model for longevity induced by caloric restriction.		Miskin R; Tirosh O; Pardo M; Zusman I; Schwartz B; Yahav S; Dubnov G; Kohen R		Mech Ageing Dev	126	2005	255-61	J:95046	15621205
90412	Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.		Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L		Liver Int	24	2004	637-45	J:95067	15566516
90413	Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation.		Reneker LW; Xie L; Xu L; Govindarajan V; Overbeek PA		Int J Dev Biol	48	2004	879-88	J:95070	15558479
90414	Impact of p53-based immunization on primary chemically-induced tumors.		Cicinnati VR; Dworacki G; Albers A; Beckebaum S; Tuting T; Kaczmarek E; Deleo AB		Int J Cancer	113	2005	961-70	J:95100	15514940
90415	Protection against prenatal irradiation-induced genomic instability and its consequences in adult mice by Ocimum flavonoids, orientin and vicenin.		Uma Devi P; Satyamitra M		Int J Radiat Biol	80	2004	653-62	J:95103	15586885
90416	Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function.		Kissenpfennig A; Ait-Yahia S; Clair-Moninot V; Stossel H; Badell E; Bordat Y; Pooley JL; Lang T; Prina E; Coste I; Gresser O; Renno T; Winter N; Milon G; Shortman K; Romani N; Lebecque S; Malissen B; Saeland S; Douillard P		Mol Cell Biol	25	2005	88-99	J:95147	15601833
90417	Cdk4 is indispensable for postnatal proliferation of the anterior pituitary.		Jirawatnotai S; Aziyu A; Osmundson EC; Moons DS; Zou X; Kineman RD; Kiyokawa H		J Biol Chem	279	2004	51100-6	J:95201	15456744
90418	Overexpression of protein kinase C-{epsilon} in the mouse epidermis leads to a spontaneous myeloproliferative-like disease.		Wheeler DL; Reddig PJ; Ness KJ; Leith CP; Oberley TD; Verma AK		Am J Pathol	166	2005	117-26	J:95241	15632005
90419	The nonsteroidal anti-inflammatory drug, nabumetone, differentially inhibits beta-catenin signaling in the MIN mouse and azoxymethane-treated rat models of colon carcinogenesis.		Roy HK; Karolski WJ; Wali RK; Ratashak A; Hart J; Smyrk TC		Cancer Lett	217	2005	161-9	J:95217	15617833
90420	Lack of elevated liver carcinogenicity of aminophenylnorharman in p53-deficient mice.		Iidaka T; Tsukamoto T; Totsuka Y; Hirata A; Sakai H; Shirai N; Yamamoto M; Wakabayashi K; Yanai T; Masegi T; Donehower LA; Tatematsu M		Cancer Lett	217	2005	149-59	J:95218	15617832
90421	Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice.		Marchetto MC; Muotri AR; Burns DK; Friedberg EC; Menck CF		Proc Natl Acad Sci U S A	101	2004	17759-64	J:95281	15598745
90422	Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.		Alli PM; Pinn ML; Jaffee EM; McFadden JM; Kuhajda FP		Oncogene	24	2005	39-46	J:95289	15489885
90423	Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1.		Harder KW; Quilici C; Naik E; Inglese M; Kountouri N; Turner A; Zlatic K; Tarlinton DM; Hibbs ML		Blood	104	2004	3901-10	J:95291	15339845
90424	Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).		Lepourcelet M; Tou L; Cai L; Sawada J; Lazar AJ; Glickman JN; Williamson JA; Everett AD; Redston M; Fox EA; Nakatani Y; Shivdasani RA		Development	132	2005	415-27	J:95310	15604097
90425	Role of Dok-1 and Dok-2 in leukemia suppression.		Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP		J Exp Med	200	2004	1689-95	J:95334	15611295
90426	Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.		Olive KP; Tuveson DA; Ruhe ZC; Yin B; Willis NA; Bronson RT; Crowley D; Jacks T		Cell	119	2004	847-60	J:95316	15607980
90427	Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.		Lang GA; Iwakuma T; Suh YA; Liu G; Rao VA; Parant JM; Valentin-Vega YA; Terzian T; Caldwell LC; Strong LC; El-Naggar AK; Lozano G		Cell	119	2004	861-72	J:95318	15607981
90428	Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia.		Bohlooly M; Olsson B; Bruder CE; Linden D; Sjogren K; Bjursell M; Egecioglu E; Svensson L; Brodin P; Waterton JC; Isaksson OG; Sundler F; Ahren B; Ohlsson C; Oscarsson J; Tornell J		Diabetes	54	2005	51-62	J:95367	15616010
90429	Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle.		Hutchin ME; Kariapper MS; Grachtchouk M; Wang A; Wei L; Cummings D; Liu J; Michael LE; Glick A; Dlugosz AA		Genes Dev	19	2005	214-23	J:95373	15625189
90430	Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.		Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y		J Exp Med	200	2004	1681-7	J:95335	15611294
90431	Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation.		Griep AE; Herber R; Jeon S; Lohse JK; Dubielzig RR; Lambert PF		J Virol	67	1993	1373-84	J:95339	8382301
90432	Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.		Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A		Nature	432	2004	775-9	J:95108	15592418
90433	Anti-rejection drug treatment increases Basal cell carcinoma burden in ptch1+/- mice.		Vogt A; Hebert J; Hwang J; Lu Y; Epstein EH		J Invest Dermatol	124	2005	263-7	J:95379	15654983
90434	What have animal models taught us about the p53 pathway?		Lozano G; Zambetti GP		J Pathol	205	2005	206-20	J:95381	15643668
90435	New approaches for modelling cancer mechanisms in the mouse.		Maddison K; Clarke AR		J Pathol	205	2005	181-93	J:95382	15641017
90436	The pathophysiology of HOX genes and their role in cancer.		Grier DG; Thompson A; Kwasniewska A; McGonigle GJ; Halliday HL; Lappin TR		J Pathol	205	2005	154-71	J:95383	15643670
90437	Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway.		Insinga A; Monestiroli S; Ronzoni S; Gelmetti V; Marchesi F; Viale A; Altucci L; Nervi C; Minucci S; Pelicci PG		Nat Med	11	2005	71-6	J:95455	15619634
90438	Transgenic complementation of leptin receptor deficiency. II. Increased leptin receptor transgene dose effects on obesity/diabetes and fertility/lactation in lepr-db/db mice.		Chua SC Jr; Liu SM; Li Q; Sun A; DeNino WF; Heymsfield SB; Guo XE		Am J Physiol Endocrinol Metab	286	2004	E384-92	J:95415	14600075
90439	Activation of c-myb by 5' retrovirus promoter insertion in myeloid neoplasms is dependent upon an intact alternative splice donor site (SD') in gag.		Ramirez JM; Houzet L; Koller R; Bies J; Wolff L; Mougel M		Virology	330	2004	398-407	J:95484	15567434
90440	Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.		Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U		Virology	330	2004	365-74	J:95485	15567431
90441	Ultrasound detection of spontaneous hepato-cellular carcinomas in X/myc bitransgenic mice.		Mai W; Barraud L; Lefrancois L; Scoazec JY; Guerret S; Vray D; Merle P; Vitvitski-Trepo L; Trepo C; Janier MF		Liver Int	24	2004	651-7	J:95487	15566518
90442	Expression of SV40 T antigen gene in the oligodendroglia induced primitive neuroectodermal tumor-like tumors in the mouse brain.		Konishi S; Naora H; Kimura M; Sato M; Nagasaki M; Yokoyama M; Otani H; Moritake K; Katsuki M		Congenit Anom (Kyoto)	44	2004	215-24	J:95488	15566412
90443	Application of comparative functional genomics to identify best-fit mouse models to study human cancer.		Lee JS; Chu IS; Mikaelyan A; Calvisi DF; Heo J; Reddy JK; Thorgeirsson SS		Nat Genet	36	2004	1306-11	J:95489	15565109
90444	Mouse models of tuberous sclerosis complex.		Scheidenhelm DK; Gutmann DH		J Child Neurol	19	2004	726-33	J:95490	15563020
90445	BAG-1 haplo-insufficiency impairs lung tumorigenesis.		Gotz R; Kramer BW; Camarero G; Rapp UR		BMC Cancer	4	2004	85	J:95491	15560850
90446	Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine.		Yao R; Lemon WJ; Wang Y; Grubbs CJ; Lubet RA; You M		Neoplasia	6	2004	569-77	J:95493	15548366
90447	Constitutional Rearrangement of the Architectural Factor HMGA2: A Novel Human Phenotype Including Overgrowth and Lipomas.		Ligon AH; Moore SD; Parisi MA; Mealiffe ME; Harris DJ; Ferguson HL; Quade BJ; Morton CC		Am J Hum Genet	76	2005	340-8	J:95495	15593017
90448	Tumorigenesis in p27/p53- and p18/p53-double null mice: Functional collaboration between the pRb and p53 pathways.		Damo LA; Snyder PW; Franklin DS		Mol Carcinog	42	2005	109-20	J:95497	15584024
90449	Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.		Kasper S		J Cell Biochem	94	2005	279-97	J:95499	15565647
90450	A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.		Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA		J Med Genet	41	2004	923-31	J:95465	15591278
90451	Role of MMTV integration locus cellular genes in breast cancer.		Tekmal RR; Keshava N		Front Biosci	2	1997	d519-26	J:95467	9334290
90452	Vitamin D and breast cancer: insights from animal models.		Welsh J		Am J Clin Nutr	80	2004	1721S-4S	J:95468	15585794
90453	Hepatocarcinogenic potential of the glucocorticoid antagonist RU486 in B6C3F1 mice: effect on apoptosis, expression of oncogenes and the tumor suppressor gene p53.		Youssef JA; Badr MZ		Mol Cancer	2	2003	3	J:95466	12605714
90454	Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.		Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M		Cancer Res	65	2005	85-91	J:95530	15665282
90455	Carcinogenic activity of cigarette smoke gas phase and its modulation by Beta-carotene and N-acetylcysteine.		Witschi H		Toxicol Sci	84	2005	81-7	J:95500	15564316
90456	A Multitargeted, Metronomic, and Maximum-Tolerated Dose 'Chemo-Switch' Regimen is Antiangiogenic, Producing Objective Responses and Survival Benefit in a Mouse Model of Cancer.		Pietras K; Hanahan D		J Clin Oncol	23	2005	939-52	J:95501	15557593
90457	Cystic Renal Neoplasia Following Conditional Inactivation of Apc in Mouse Renal Tubular Epithelium.		Qian CN; Knol J; Igarashi P; Lin F; Zylstra U; Teh BT; Williams BO		J Biol Chem	280	2005	3938-3945	J:95502	15550389
90458	Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice.		Teufelhofer O; Parzefall W; Kainzbauer E; Ferk F; Freiler C; Knasmuller S; Elbling L; Thurman R; Schulte-Hermann R		Carcinogenesis	26	2005	319-29	J:95506	15513930
90459	Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.		Dasgupta B; Li W; Perry A; Gutmann DH		Cancer Res	65	2005	236-45	J:95509	15665300
90460	Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.		Reichling T; Goss KH; Carson DJ; Holdcraft RW; Ley-Ebert C; Witte D; Aronow BJ; Groden J		Cancer Res	65	2005	166-76	J:95511	15665292
90461	Predisposition to mouse thymic lymphomas in response to ionizing radiation depends on variant alleles encoding metal-responsive transcription factor-1 (Mtf-1).		Tamura Y; Maruyama M; Mishima Y; Fujisawa H; Obata M; Kodama Y; Yoshikai Y; Aoyagi Y; Niwa O; Schaffner W; Kominami R		Oncogene	24	2005	399-406	J:95547	15516976
90462	p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).		Di Cristofano A; Niki M; Zhao M; Karnell FG; Clarkson B; Pear WS; Van Aelst L; Pandolfi PP		J Exp Med	194	2001	275-84	J:95640	11489947
90463	New and unexpected: forkhead meets ARF.		Costa RH; Kalinichenko VV; Major ML; Raychaudhuri P		Curr Opin Genet Dev	15	2005	42-8	J:95658	15661532
90464	Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development.		Cunha GR; Ricke W; Thomson A; Marker PC; Risbridger G; Hayward SW; Wang YZ; Donjacour AA; Kurita T		J Steroid Biochem Mol Biol	92	2004	221-36	J:95951	15663986
90465	Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.		Muller-Decker K; Berger I; Ackermann K; Ehemann V; Zoubova S; Aulmann S; Pyerin W; Furstenberger G		Am J Pathol	166	2005	575-84	J:95970	15681840
90466	High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.		Bijl J; Sauvageau M; Thompson A; Sauvageau G		Genes Dev	19	2005	224-33	J:95693	15655112
90467	OVCA1: tumor suppressor gene.		Chen CM; Behringer RR		Curr Opin Genet Dev	15	2005	49-54	J:95659	15661533
90468	Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly.		Hartmann D; De Strooper B; Saftig P		Curr Biol	9	1999	719-27	J:95663	10421573
90469	CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life.		Elchuri S; Oberley TD; Qi W; Eisenstein RS; Jackson Roberts L; Van Remmen H; Epstein CJ; Huang TT		Oncogene	24	2005	367-80	J:95667	15531919
90470	Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors.		Blackman B; Russell T; Nordeen SK; Medina D; Neville MC		Breast Cancer Res	7	2005	R248-55	J:95792	15743505
90471	The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines.		Montagna C; Lyu MS; Hunter K; Lukes L; Lowther W; Reppert T; Hissong B; Weaver Z; Ried T		Cancer Res	63	2003	2179-87	J:95797	12727837
90472	Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate.		Shaffer DR; Viale A; Ishiwata R; Leversha M; Olgac S; Manova K; Satagopan J; Scher H; Koff A		Proc Natl Acad Sci U S A	102	2005	210-5	J:95751	15615849
90473	Role of the proto-oncogene Pokemon in cellular transformation and ARF repression.		Maeda T; Hobbs RM; Merghoub T; Guernah I; Zelent A; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP		Nature	433	2005	278-85	J:95884	15662416
90474	PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature.		Makinen T; Adams RH; Bailey J; Lu Q; Ziemiecki A; Alitalo K; Klein R; Wilkinson GA		Genes Dev	19	2005	397-410	J:95885	15687262
90475	Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.		Wang J; Iwasaki H; Krivtsov A; Febbo PG; Thorner AR; Ernst P; Anastasiadou E; Kutok JL; Kogan SC; Zinkel SS; Fisher JK; Hess JL; Golub TR; Armstrong SA; Akashi K; Korsmeyer SJ		EMBO J	24	2005	368-81	J:95914	15635450
90476	Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon.		Perreault N; Sackett SD; Katz JP; Furth EE; Kaestner KH		Genes Dev	19	2005	311-5	J:95893	15650110
90477	Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice.		Moorehead RA; Fata JE; Johnson MB; Khokha R		Cell Death Differ	8	2001	16-29	J:95899	11313699
90478	A sumoylation site in PML/RARA is essential for leukemic transformation.		Zhu J; Zhou J; Peres L; Riaucoux F; Honore N; Kogan S; de The H		Cancer Cell	7	2005	143-153	J:95945	15710327
90479	P53 and prognosis: new insights and further complexity.		Vousden KH; Prives C		Cell	120	2005	7-10	J:95926	15652475
90480	Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis.		Feith DJ; Bol DK; Carboni JM; Lynch MJ; Sass-Kuhn S; Shoop PL; Shantz LM		Cancer Res	65	2005	572-8	J:95977	15695401
90481	Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.		Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y		Mol Cell Biol	25	2005	661-70	J:96007	15632067
90482	Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.		Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE		Oncogene	24	2005	790-800	J:96009	15592523
90483	PKC theta mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia.		Felli MP; Vacca A; Calce A; Bellavia D; Campese AF; Grillo R; Di Giovine M; Checquolo S; Talora C; Palermo R; Di Mario G; Frati L; Gulino A; Screpanti I		Oncogene	24	2005	992-1000	J:96010	15592506
90484	Met proto-oncogene juxtamembrane rare variations in mouse and humans: differential effects of Arg and Cys alleles on mouse lung tumorigenesis.		Zaffaroni D; Spinola M; Galvan A; Falvella FS; Pazzaglia S; Saran A; Mancuso MT; Galbiati F; Pignatiello C; Cabrera W; Ibanez O; Manenti G; Dragani TA		Oncogene	24	2005	1084-90	J:96012	15592501
90485	Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS.		Agger K; Santoni-Rugiu E; Holmberg C; Karlstrom O; Helin K		Oncogene	24	2005	780-9	J:96015	15531911
90486	Mutations in Apc and p53 synergize to promote mammary neoplasia.		Meniel V; Hay T; Douglas-Jones A; Sansom OJ; Clarke AR		Cancer Res	65	2005	410-6	J:96023	15695381
90487	Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.		Shaked Y; Bertolini F; Man S; Rogers MS; Cervi D; Foutz T; Rawn K; Voskas D; Dumont DJ; Ben-David Y; Lawler J; Henkin J; Huber J; Hicklin DJ; D'Amato RJ; Kerbel RS		Cancer Cell	7	2005	101-11	J:96033	15652753
90488	An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesis.		Kim E; Rundhaug JE; Benavides F; Yang P; Newman RA; Fischer SM		Oncogene	24	2005	1174-87	J:96098	15558016
90489	The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma.		Lewis BC; Klimstra DS; Socci ND; Xu S; Koutcher JA; Varmus HE		Mol Cell Biol	25	2005	1228-37	J:96090	15684377
90490	c-myc-induced hepatocarcinogenesis in the absence of IGF-I receptor.		Cadoret A; Desbois-Mouthon C; Wendum D; Leneuve P; Perret C; Tronche F; Housset C; Holzenberger M		Int J Cancer	114	2005	668-72	J:96173	15609331
90491	B-raf and Ha-ras mutations in chemically induced mouse liver tumors.		Jaworski M; Buchmann A; Bauer P; Riess O; Schwarz M		Oncogene	24	2005	1290-5	J:96134	15592514
90492	Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia.		Hentges KE; Weiser KC; Schountz T; Woodward LS; Morse HC; Justice MJ		Oncogene	24	2005	1220-30	J:96135	15580294
90493	Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.		Huang H; Regan KM; Wang F; Wang D; Smith DI; van Deursen JM; Tindall DJ		Proc Natl Acad Sci U S A	102	2005	1649-54	J:96136	15668399
90494	A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes.		Meikle L; McMullen JR; Sherwood MC; Lader AS; Walker V; Chan JA; Kwiatkowski DJ		Hum Mol Genet	14	2005	429-35	J:96138	15601645
90495	Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice.		Nomura S; Yamaguchi H; Ogawa M; Wang TC; Lee JR; Goldenring JR		Am J Physiol Gastrointest Liver Physiol	288	2005	G362-75	J:96139	15647607
90496	DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development.		Durkin ME; Avner MR; Huh CG; Yuan BZ; Thorgeirsson SS; Popescu NC		FEBS Lett	579	2005	1191-6	J:96194	15710412
90497	Antitumor-promoting activity of coumarins from citrus plants.		Ito C; Itoigawa M; Ju-Ichi M; Sakamoto N; Tokuda H; Nishino H; Furukawa H		Planta Med	71	2005	84-7	J:96268	15678381
90498	Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.	 	Saito A; Hayashi T; Okuno S; Nishi T; Chan PH	 	J Cereb Blood Flow Metab	25	2005	267-80	J:96269	15678128
90499	A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice.		Lambertsen KL; Meldgaard M; Ladeby R; Finsen B		J Cereb Blood Flow Metab	25	2005	119-35	J:96270	15678118
90500	Therapeutic Effect of the Immunomodulator Glatiramer Acetate on Trinitrobenzene Sulfonic Acid-induced Experimental Colitis.	 	Aharoni R; Kayhan B; Arnon R	 	Inflamm Bowel Dis	11	2005	106-15	J:96271	 
90501	Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1.		Scacheri PC; Crabtree JS; Kennedy AL; Swain GP; Ward JM; Marx SJ; Spiegel AM; Collins FS		Mamm Genome	15	2004	872-7	J:96272	15672591
90502	Prognostic Significance of Metastasis-Associated Protein S100A4 (Mts1) in Prostate Cancer Progression and Chemoprevention Regimens in an Autochthonous Mouse Model.		Saleem M; Adhami VM; Ahmad N; Gupta S; Mukhtar H		Clin Cancer Res	11	2005	147-53	J:96273	15671539
90503	Cancer preventive agents. Part 1: Chemopreventive potential of cimigenol, cimigenol-3,15-dione, and related compounds.		Sakurai N; Kozuka M; Tokuda H; Mukainaka T; Enjo F; Nishino H; Nagai M; Sakurai Y; Lee KH		Bioorg Med Chem	13	2005	1403-8	J:96274	15670948
90504	Effects of soy oil on murine salivary tumorigenesis.		Actis AB; Cremonezzi DC; King IB; Joekes S; Eynard AR; Valentich MA		Prostaglandins Leukot Essent Fatty Acids	72	2005	187-94	J:96276	15664303
90505	Differential expression of Hyaluronic Acid Binding Protein 1 (HABP1)/P32/C1QBP during progression of epidermal carcinoma.		Ghosh I; Chowdhury AR; Rajeswari MR; Datta K		Mol Cell Biochem	267	2004	133-9	J:96278	15663194
90506	Comparison of properties of spontaneous and radiation-induced mouse thymic lymphomas: role of Trp53 and radiation.		Kubota T; Yoshikai Y; Tamura Y; Mishima Y; Aoyagi Y; Niwa O; Kominami R		Radiat Res	163	2005	159-64	J:96279	15658891
90507	Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.		Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT		Mol Endocrinol	19	2005	644-56	J:96247	15550471
90508	Relationship between tumour growth rate and carbogen-based functional MRI for a chemically induced HCC in mice.		Thomas CD; Chenu E; Walczak C; Plessis MJ; Perin F; Volk A		MAGMA	17	2004	271-80	J:96310	15614512
90509	Suppression of thymic lymphoma induction by life-long low-dose-rate irradiation accompanied by immune activation in C57BL/6 mice.		Ina Y; Tanooka H; Yamada T; Sakai K		Radiat Res	163	2005	153-8	J:96280	15658890
90510	Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.		Lee J; Hargest R; Wasan H; Phillips RK		Dis Colon Rectum	47	2004	2105-13	J:96281	15657662
90511	Single UVB Overexposure Stimulates Melanocyte Proliferation in Murine Skin, in Contrast to Fractionated or UVA-1 Exposure.		van Schanke A; Jongsma MJ; Bisschop R; van Venrooij GM; Rebel H; de Gruijl FR		J Invest Dermatol	124	2005	241-7	J:96282	15654980
90512	Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas.		Okada H; Kimura MT; Tan D; Fujiwara K; Igarashi J; Makuuchi M; Hui AM; Tsurumaru M; Nagase H		Int J Oncol	26	2005	369-77	J:96284	15645121
90513	Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.		Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M		Breast Cancer Res	7	2005	R164-70	J:96285	15642165
90514	Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis.		Wang X; Wang JP; Maughan MF; Lachman LB		Breast Cancer Res	7	2005	R145-55	J:96286	15642163
90515	Inhibitory effects of polysaccharides isolated from Phellinus gilvus on benzo(a)pyrene-induced forestomach carcinogenesis in mice.		Bae JS; Jang KH; Yim H; Park SC; Jin HK		World J Gastroenterol	11	2005	577-9	J:96287	15641149
90516	Influence of diet containing lyophilized Enterococcus faecium M-74 with organic selenium on tumor incidence in Apc1638N mice.		Hlubinova K; Rychly B; Altanerova V; Ebringer L; Altaner C		Neoplasma	51	2004	341-4	J:96288	15640937
90517	Cancer prevention by antioxidants.		Nishino H; Tokuda H; Satomi Y; Masuda M; Osaka Y; Yogosawa S; Wada S; Mou XY; Takayasu J; Murakoshi M; Jinnno K; Yano M		Biofactors	22	2004	57-61	J:96289	15630252
90518	Combretastatin a-4 prodrug in the treatment of a murine model of retinoblastoma.		Escalona-Benz E; Jockovich ME; Murray TG; Hayden B; Hernandez E; Feuer W; Windle JJ		Invest Ophthalmol Vis Sci	46	2005	8-11	J:96291	15623747
90519	Diet-Induced Obesity and Mammary Tumor Development in MMTV-neu Female Mice.		Cleary MP; Grande JP; Juneja SC; Maihle NJ		Nutr Cancer	50	2004	174-80	J:96292	15623464
90520	Natural history of neurofibromatosis 1-associated optic nerve glioma in mice.		Bajenaru ML; Garbow JR; Perry A; Hernandez MR; Gutmann DH		Ann Neurol	57	2005	119-27	J:96293	15622533
90521	Animal models for prostate cancer.		Pollard M		Prostate	1	1980	207-13	J:96295	15619920
90522	4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.		Lubet RA; Huebner K; Fong LY; Altieri DC; Steele VE; Kopelovich L; Kavanaugh C; Juliana MM; Soong SJ; Grubbs CJ		Carcinogenesis	26	2005	571-8	J:96327	15591090
90523	Suprabasal induction of ornithine decarboxylase in adult mouse skin is sufficient to activate keratinocytes.		Lan L; Hayes CS; Laury-Kleintop L; Gilmour SK		J Invest Dermatol	124	2005	602-14	J:96330	15737202
90524	Location of inclusion cysts in mouse ovaries in relation to age, pregnancy, and total ovulation number: implications for ovarian cancer?		Tan OL; Hurst PR; Fleming JS		J Pathol	205	2005	483-90	J:96333	15685692
90525	Decreased susceptibility of mast cell-deficient Kit(W)/Kit(W-v) mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors.		Wedemeyer J; Galli SJ		Lab Invest	85	2005	388-96	J:96368	15696191
90526	Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model.		Iwasaki M; Kuwata T; Yamazaki Y; Jenkins NA; Copeland NG; Osato M; Ito Y; Kroon E; Sauvageau G; Nakamura T		Blood	105	2005	784-93	J:96544	15454493
90527	Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse.		Moran AE; Carothers AM; Weyant MJ; Redston M; Bertagnolli MM		Cancer Res	65	2005	1097-104	J:96568	15705912
90528	Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.		Pupa SM; Iezzi M; Di Carlo E; Invernizzi A; Cavallo F; Meazza R; Comes A; Ferrini S; Musiani P; Menard S		Cancer Res	65	2005	1071-8	J:96572	15705909
90529	Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization.		Berger M; Bergers G; Arnold B; Hammerling GJ; Ganss R		Blood	105	2005	1094-101	J:96610	15459006
90530	The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis.		Kolluri SK; Corr M; James SY; Bernasconi M; Lu D; Liu W; Cottam HB; Leoni LM; Carson DA; Zhang XK		Proc Natl Acad Sci U S A	102	2005	2525-30	J:96631	15699354
90531	B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression.		Raykov Z; Savelyeva L; Balboni G; Giese T; Rommelaere J; Giese NA		J Virol	79	2005	3517-24	J:96692	15731246
90532	Essential role of RSK2 in c-Fos-dependent osteosarcoma development.		David JP; Mehic D; Bakiri L; Schilling AF; Mandic V; Priemel M; Idarraga MH; Reschke MO; Hoffmann O; Amling M; Wagner EF		J Clin Invest	115	2005	664-72	J:96755	15719069
90533	Mouse models for human lung cancer.		Meuwissen R; Berns A		Genes Dev	19	2005	643-64	J:96751	15769940
90534	Haploinsufficiency for odc modifies mouse skin tumor susceptibility.		Guo Y; Cleveland JL; O'Brien TG		Cancer Res	65	2005	1146-9	J:96790	15734996
90535	Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.		Provinciali M; Re F; Donnini A; Orlando F; Bartozzi B; Di Stasio G; Smorlesi A		Int J Cancer	115	2005	36-45	J:96793	15688416
90536	Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation.		Mathieu A; Clerc P; Portolan G; Bierkamp C; Lulka H; Pradayrol L; Seva C; Fourmy D; Dufresne M		Int J Cancer	115	2005	46-54	J:96794	15688412
90537	Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.		Sale S; Tunstall RG; Ruparelia KC; Potter GA; Steward WP; Gescher AJ		Int J Cancer	115	2005	194-201	J:96796	15688382
90538	A mechanism-based antioxidant approach for the reduction of skin carcinogenesis.		Zhao Y; Chaiswing L; Oberley TD; Batinic-Haberle I; St Clair W; Epstein CJ; St Clair D		Cancer Res	65	2005	1401-5	J:96783	15735027
90539	Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.		Schaper ID; Marcuzzi GP; Weissenborn SJ; Kasper HU; Dries V; Smyth N; Fuchs P; Pfister H		Cancer Res	65	2005	1394-400	J:96784	15735026
90540	Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.		Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC rd; Janz S		Cancer Res	65	2005	1306-15	J:96785	15735016
90541	Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer.		Peace BE; Toney-Earley K; Collins MH; Waltz SE		Cancer Res	65	2005	1285-93	J:96786	15735014
90542	Distal Chr 4 harbors a genetic locus (Gct1) fundamental for spontaneous ovarian granulosa cell tumorigenesis in a mouse model.		Dorward AM; Shultz KL; Horton LG; Li R; Churchill GA; Beamer WG		Cancer Res	65	2005	1259-64	J:96787	15735010
90543	A novel transgenic mouse model reveals humanlike regulation of an 8-kbp human TERT gene promoter fragment in normal and tumor tissues.		Ritz JM; Kuhle O; Riethdorf S; Sipos B; Deppert W; Englert C; Gunes C		Cancer Res	65	2005	1187-96	J:96788	15735002
90544	Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.		Garcia-Espana A; Salazar E; Sun TT; Wu XR; Pellicer A		Cancer Res	65	2005	1150-7	J:96789	15734997
90545	Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice.		Niho N; Mutoh M; Takahashi M; Tsutsumi K; Sugimura T; Wakabayashi K		Proc Natl Acad Sci U S A	102	2005	2970-4	J:96832	15710887
90546	Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice.		Haines J; Johnson V; Pack K; Suraweera N; Slijepcevic P; Cabuy E; Coster M; Ilyas M; Wilding J; Sieber O; Bodmer W; Tomlinson I; Silver A		Proc Natl Acad Sci U S A	102	2005	2868-73	J:96833	15710876
90547	Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.		Drake CG; Doody AD; Mihalyo MA; Huang CT; Kelleher E; Ravi S; Hipkiss EL; Flies DB; Kennedy EP; Long M; McGary PW; Coryell L; Nelson WG; Pardoll DM; Adler AJ		Cancer Cell	7	2005	239-49	J:96922	15766662
90548	RalGDS is required for tumor formation in a model of skin carcinogenesis.		Gonzalez-Garcia A; Pritchard CA; Paterson HF; Mavria G; Stamp G; Marshall CJ		Cancer Cell	7	2005	219-26	J:96936	15766660
90549	Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain.		Govindarajan B; Brat DJ; Csete M; Martin WD; Murad E; Litani K; Cohen C; Cerimele F; Nunnelley M; Lefkove B; Yamamoto T; Lee C; Arbiser JL		J Biol Chem	280	2005	5870-4	J:96943	15576369
90550	The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression.		Cayuela ML; Flores JM; Blasco MA		EMBO Rep	6	2005	268-74	J:96945	15731767
90551	Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro.		Scherberich A; Tucker RP; Degen M; Brown-Luedi M; Andres AC; Chiquet-Ehrismann R		Oncogene	24	2005	1525-32	J:96989	15592496
90552	Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor).		Fen Li C; Kandel C; Baliko F; Nadesan P; Brunner N; Alman BA		Oncogene	24	2005	1615-24	J:96994	15674349
90553	Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression.		Klein RD; Van Pelt CS; Sabichi AL; Dela Cerda J; Fischer SM; Furstenberger G; Muller-Decker K		Cancer Res	65	2005	1808-13	J:96997	15753378
90554	Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade.		Wang D; Buchanan FG; Wang H; Dey SK; DuBois RN		Cancer Res	65	2005	1822-9	J:96998	15753380
90555	DNA repair, genome stability, and aging.		Lombard DB; Chua KF; Mostoslavsky R; Franco S; Gostissa M; Alt FW		Cell	120	2005	497-512	J:96973	15734682
90556	Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.		Campbell JS; Hughes SD; Gilbertson DG; Palmer TE; Holdren MS; Haran AC; Odell MM; Bauer RL; Ren HP; Haugen HS; Yeh MM; Fausto N		Proc Natl Acad Sci U S A	102	2005	3389-94	J:96979	15728360
90557	Microcomputed tomography colonography for polyp detection in an in vivo mouse tumor model.		Pickhardt PJ; Halberg RB; Taylor AJ; Durkee BY; Fine J; Lee FT Jr; Weichert JP		Proc Natl Acad Sci U S A	102	2005	3419-22	J:96981	15728368
90558	Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation.		Hui DJ; Terenzi F; Merrick WC; Sen GC		J Biol Chem	280	2005	3433-40	J:96982	15561726
90559	Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice.		Liu R; Varghese S; Rabkin SD		Cancer Res	65	2005	1532-40	J:97030	15735042
90560	MET and MYC cooperate in mammary tumorigenesis.		Welm AL; Kim S; Welm BE; Bishop JM		Proc Natl Acad Sci U S A	102	2005	4324-9	J:97033	15738393
90561	Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability.		Rao CV; Yang YM; Swamy MV; Liu T; Fang Y; Mahmood R; Jhanwar-Uniyal M; Dai W		Proc Natl Acad Sci U S A	102	2005	4365-70	J:97036	15767571
90562	CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.		Daniel D; Chiu C; Giraudo E; Inoue M; Mizzen LA; Chu NR; Hanahan D		Cancer Res	65	2005	2018-25	J:97006	15753402
90563	Inactivation of p21WAF1/cip1 Enhances Intestinal Tumor Formation in Muc2-/- Mice.		Yang W; Velcich A; Lozonschi I; Liang J; Nicholas C; Zhuang M; Bancroft L; Augenlicht LH		Am J Pathol	166	2005	1239-46	J:97073	15793302
90564	Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice.		Gonzalez-Suarez E; Geserick C; Flores JM; Blasco MA		Oncogene	24	2005	2256-70	J:97040	15688016
90565	Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.		Muller AJ; Duhadaway JB; Donover PS; Sutanto-Ward E; Prendergast GC		Nat Med	11	2005	312-9	J:97114	15711557
90566	Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome.		Mann MB; Hodges CA; Barnes E; Vogel H; Hassold TJ; Luo G		Hum Mol Genet	14	2005	813-25	J:97101	15703196
90581	Inbred Strains of Mice (Updated July 30, 1996)		Festing MFW		Mouse Genome	94	1996	523-677	J:97121	 
90596	Overexpression of human beta TrCP1 deleted of its F box induces tumorigenesis in transgenic mice.		Belaidouni N; Peuchmaur M; Perret C; Florentin A; Benarous R; Besnard-Guerin C		Oncogene	24	2005	2271-6	J:97165	15735746
90597	Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.		El-Hashemite N; Walker V; Kwiatkowski DJ		Cancer Res	65	2005	2474-81	J:97168	15781664
90598	Methylation in the p21WAF1/cip1 promoter of Apc+/-, p21+/- mice and lack of response to sulindac.		Yang W; Bancroft L; Augenlicht LH		Oncogene	24	2005	2104-9	J:97205	15688007
90599	Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours.		Borlak J; Meier T; Halter R; Spanel R; Spanel-Borowski K		Oncogene	24	2005	1809-19	J:97210	15674348
90600	Deficiency in the gap junction protein connexin32 alters p27Kip1 tumor suppression and MAPK activation in a tissue-specific manner.		King TJ; Gurley KE; Prunty J; Shin JL; Kemp CJ; Lampe PD		Oncogene	24	2005	1718-26	J:97211	15608667
90601	Flavopiridol reduces malignant transformation of the esophageal mucosa in p27 knockout mice.		Lechpammer M; Xu X; Ellis FH; Bhattacharaya N; Shapiro GI; Loda M		Oncogene	24	2005	1683-8	J:97212	15674336
90602	The protooncogene MYC can break B cell tolerance.		Refaeli Y; Field KA; Turner BC; Trumpp A; Bishop JM		Proc Natl Acad Sci U S A	102	2005	4097-102	J:97189	15753301
90603	Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.		Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R		Toxicol Sci	85	2005	515-29	J:97233	15728704
90604	Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice.		Ishida D; Kometani K; Yang H; Kakugawa K; Masuda K; Iwai K; Suzuki M; Itohara S; Nakahata T; Hiai H; Kawamoto H; Hattori M; Minato N		Cancer Cell	4	2003	55-65	J:97239	12892713
90605	Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice.		Jin L; Qi M; Chen DZ; Anderson A; Yang GY; Arbeit JM; Auborn KJ		Cancer Res	59	1999	3991-7	J:97240	10463597
90606	Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice.		Petrik MB; McEntee MF; Johnson BT; Obukowicz MG; Whelan J		J Nutr	130	2000	2434-43	J:97277	11015469
90607	Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection.		Golovkina TV; Prescott JA; Ross SR		J Virol	67	1993	7690-4	J:97279	8230492
90608	Polyomavirus tumor induction in mice: influences of viral coding and noncoding sequences on tumor profiles.		Freund R; Mandel G; Carmichael GG; Barncastle JP; Dawe CJ; Benjamin TL		J Virol	61	1987	2232-9	J:97280	3035223
90609	Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice.		Rogler CE; Yang D; Rossetti L; Donohoe J; Alt E; Chang CJ; Rosenfeld R; Neely K; Hintz R		J Biol Chem	269	1994	13779-84	J:97259	7514593
90610	Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity.		Ikeno Y; Bronson RT; Hubbard GB; Lee S; Bartke A		J Gerontol A Biol Sci Med Sci	58	2003	291-6	J:97260	12663691
90611	Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.		McNeil N; Kim JS; Ried T; Janz S		Genes Chromosomes Cancer	43	2005	137-46	J:97311	15751044
90612	Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach.		Katz JP; Perreault N; Goldstein BG; Actman L; McNally SR; Silberg DG; Furth EE; Kaestner KH		Gastroenterology	128	2005	935-45	J:97350	15825076
90613	Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis.		Ilsley JN; Nakanishi M; Flynn C; Belinsky GS; De Guise S; Adib JN; Dobrowsky RT; Bonventre JV; Rosenberg DW		Cancer Res	65	2005	2636-43	J:97356	15805260
90614	A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.		Campbell MR; Nation PN; Andrew SE		Cancer Res	65	2005	2626-35	J:97357	15805259
90615	Altered immunity accompanies disease progression in a mouse model of prostate dysplasia.		Tien AH; Xu L; Helgason CD		Cancer Res	65	2005	2947-55	J:97358	15805298
90616	Signaling pathways associated with colonic mucosa hyperproliferation in mice overexpressing gastrin precursors.		Ferrand A; Bertrand C; Portolan G; Cui G; Carlson J; Pradayrol L; Fourmy D; Dufresne M; Wang TC; Seva C		Cancer Res	65	2005	2770-7	J:97359	15805277
90617	Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.		Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH		Cancer Res	65	2005	2755-60	J:97360	15805275
90618	Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels.		Magnussen A; Kasman IM; Norberg S; Baluk P; Murray R; McDonald DM		Cancer Res	65	2005	2712-21	J:97361	15805270
90619	Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.		Parangi S; O'Reilly M; Christofori G; Holmgren L; Grosfeld J; Folkman J; Hanahan D		Proc Natl Acad Sci U S A	93	1996	2002-7	J:97343	8700875
90620	CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells.		Kammertoens T; Willebrand R; Erdmann B; Li L; Li Y; Engels B; Uckert W; Blankenstein T		Cancer Res	65	2005	2560-4	J:97347	15805249
90621	Chfr is required for tumor suppression and Aurora A regulation.		Yu X; Minter-Dykhouse K; Malureanu L; Zhao WM; Zhang D; Merkle CJ; Ward IM; Saya H; Fang G; van Deursen J; Chen J		Nat Genet	37	2005	401-6	J:97428	15793587
90622	Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls-iron interaction: Absence in the Cyp1a2(-/-) knockout mouse.		Greaves P; Clothier B; Davies R; Higginson FM; Edwards RE; Dalton TP; Nebert DW; Smith AG		Biochem Biophys Res Commun	331	2005	147-52	J:97596	15845371
90623	Normal thyroid structure and function in rhophilin 2-deficient mice.		Behrends J; Clement S; Pajak B; Pohl V; Maenhaut C; Dumont JE; Schurmans S		Mol Cell Biol	25	2005	2846-52	J:97638	15767687
90624	Inactivation of CtIP Leads to Early Embryonic Lethality Mediated by G1 Restraint and to Tumorigenesis by Haploid Insufficiency.		Chen PL; Liu F; Cai S; Lin X; Li A; Chen Y; Gu B; Lee EY; Lee WH		Mol Cell Biol	25	2005	3535-42	J:97648	15831459
90625	Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.		Rankin EB; Higgins DF; Walisser JA; Johnson RS; Bradfield CA; Haase VH		Mol Cell Biol	25	2005	3163-72	J:97652	15798202
90626	Id2 mediates tumor initiation, proliferation, and angiogenesis in rb mutant mice.		Lasorella A; Rothschild G; Yokota Y; Russell RG; Iavarone A		Mol Cell Biol	25	2005	3563-74	J:97629	15831462
90627	Scaffold attachment factor B1 functions in development, growth, and reproduction.		Ivanova M; Dobrzycka KM; Jiang S; Michaelis K; Meyer R; Kang K; Adkins B; Barski OA; Zubairy S; Divisova J; Lee AV; Oesterreich S		Mol Cell Biol	25	2005	2995-3006	J:97633	15798188
90628	Modifiers of mammary tumor progression and metastasis on mouse chromosomes 7, 9, and 17.		Lancaster M; Rouse J; Hunter KW		Mamm Genome	16	2005	120-6	J:97671	15859357
90629	Abnormal V(D)J recombination of T cell receptor beta locus in SMAR1 transgenic mice.		Kaul-Ghanekar R; Majumdar S; Jalota A; Gulati N; Dubey N; Saha B; Chattopadhyay S		J Biol Chem	280	2005	9450-9	J:97769	15623522
90630	Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity.		Kim DJ; Murray IA; Burns AM; Gonzalez FJ; Perdew GH; Peters JM		J Biol Chem	280	2005	9519-27	J:97778	15632134
90631	The fate of low affinity tumor-specific CD8+ T cells in tumor-bearing mice.		Lyman MA; Nugent CT; Marquardt KL; Biggs JA; Pamer EG; Sherman LA		J Immunol	174	2005	2563-72	J:97745	15728462
90632	Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice.		Abbud RA; Takumi I; Barker EM; Ren SG; Chen DY; Wawrowsky K; Melmed S		Mol Endocrinol	19	2005	1383-91	J:97799	15677710
90633	Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene.		Le Tissier PR; Carmignac DF; Lilley S; Sesay AK; Phelps CJ; Houston P; Mathers K; Magoulas C; Ogden D; Robinson IC		Mol Endocrinol	19	2005	1251-62	J:97826	15661833
90634	Cyclins and cdks in development and cancer: a perspective.		Deshpande A; Sicinski P; Hinds PW		Oncogene	24	2005	2909-15	J:97828	15838524
90635	Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.		Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM		Cancer Res	65	2005	3226-35	J:97830	15833854
90636	The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.		Kong G; Kim HT; Wu K; DeNardo D; Hilsenbeck SG; Xu XC; Lamph WW; Bissonnette R; Dannenberg AJ; Brown PH		Cancer Res	65	2005	3462-9	J:97832	15833882
90637	Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.		Astolfi A; Rolla S; Nanni P; Quaglino E; De Giovanni C; Iezzi M; Musiani P; Forni G; Lollini PL; Cavallo F; Calogero RA		Cancer Immunol Immunother	54	2005	599-610	J:97899	15690207
90638	The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.		Sekine I; Sato M; Sunaga N; Toyooka S; Peyton M; Parsons R; Wang W; Gazdar AF; Minna JD		Oncogene	24	2005	2735-8	J:97943	15735765
90639	Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas.		Park JM; Terabe M; Sakai Y; Munasinghe J; Forni G; Morris JC; Berzofsky JA		J Immunol	174	2005	4228-36	J:97963	15778385
90640	Seasonal effects of rotational stress on Lewis lung carcinoma metastasis and T-lymphocyte subsets in mice.		Perissin L; Zorzet S; Rapozzi V; Carignola R; Angeli A; Giraldi T		Life Sci	63	1998	711-9	J:50731	9740308
90641	Sp1 and Sp3 regulate transcriptional activity of the facilitative glucose transporter isoform-3 gene in mammalian neuroblasts and trophoblasts.		Rajakumar RA; Thamotharan S; Menon RK; Devaskar SU		J Biol Chem	273	1998	27474-83	J:50345	9765277
90642	Limited importance of CD40/CD40L interaction in the B7-dependent generation of anti- MOPC-315 cytotoxic T lymphocyte activity by tumor bearer splenic cells stimulated in vitro in the presence of tumor necrosis factor.		Kalinichenko TV; Mokyr MB		Cancer Immunol Immunother	46	1998	293-303	J:50973	9756413
90643	Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38.		Sadzuka Y; Hirotsu S; Hirota S		Jpn J Cancer Res	90	1999	226-32	J:53537	10189894
90644	Tissue folate binding protein levels in transgenic mice with tumors and in non-transgenic controls.		Au TV; SoLui MC; Zhang Y; Arjomand A; Lin YM; Dueker SR; Ho YK; Clifford AJ		Comp Biochem Physiol C Pharmacol Toxicol Endocrinol	123	1999	45-52	J:55313	10390055
90645	Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to various kinase inhibitors.		Somerville L; Cory JG		Anticancer Res	19	1999	1021-6	J:55753	10368649
90646	Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction.		Imaizumi K; Kawabe T; Ichiyama S; Kikutani H; Yagita H; Shimokata K; Hasegawa Y		Am J Physiol	277	1999	L49-57	J:56448	10409230
90647	Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo.		Sugimoto C; Fujieda S; Seki M; Sunaga H; Fan GK; Tsuzuki H; Borner C; Saito H; Matsukawa S		Int J Cancer	82	1999	860-7	J:56960	10446454
90648	Effective treatment of murine leukemia with antisense poly-2'O-(2,4-dinitrophenyl)-oligoribonucleotides.		Wang A; Wang JH		Antisense Nucleic Acid Drug Dev	9	1999	43-51	J:53838	10192288
90649	Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.		Matsumoto-Taniura N; Matsumoto K; Nakamura T		Br J Cancer	81	1999	194-202	J:57539	10496342
90650	Bcr-Abl with an SH3 deletion retains the ability To induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy.		Gross AW; Zhang X; Ren R		Mol Cell Biol	19	1999	6918-28	J:59441	10490629
90651	Inhibitory effect of a gastrin receptor antagonist, CR2945, on 1, 2-dimethylhydrazine-induced colorectal cancer in mice.		Fontana MG; Donato F; Villanacci V; Ghirardi M; Moneghini D; Di Betta E; Salerni B		Eur Surg Res	31	1999	406-11	J:59518	10529554
90652	Long-term carcinogenicity of pan masala in Swiss mice.		Bhisey RA; Ramchandani AG; D'Souza AV; Borges AM; Notani PN		Int J Cancer	83	1999	679-84	J:59526	10521807
90653	Isolation and characterization of mouse probasin: An androgen-regulated protein specifically expressed in the differentiated prostate		Johnson MA; Hernandez I; Wei Y; Greenberg N		Prostate	43	2000	255-62	J:62973	10861744
90654	Identification and quantification of aberrant crypt foci in the colon of Min mice--a murine model of familial adenomatous polyposis		Paulsen JE; Namork E; Steffensen IL; Eide TJ; Alexander J		Scand J Gastroenterol	35	2000	534-9	J:62966	10868458
90655	Mice, mutations and mammary glands.		Tennent BJ; Cardiff RD		Mol Med Today	6	2000	143-4	J:62967	10866490
90656	Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.		Nasu Y; Bangma CH; Hull GW; Lee HM; Hu J; Wang J; McCurdy MA; Shimura S; Yang G; Timme TL; Thompson TC		Gene Ther	6	1999	338-49	J:53796	10435084
90657	Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.		Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW		Mol Cell Biol	22	2002	6521-32	J:78491	12192050
90658	Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination.		Hecht SS; Upadhyaya P; Wang M; Bliss RL; McIntee EJ; Kenney PM		Carcinogenesis	23	2002	1455-61	J:78495	12189187
90659	Modulation of Epidermal Tumor Development Caused by Targeted Overexpression of Epidermis-type 12S-Lipoxygenase.		Muller K; Siebert M; Heidt M; Marks F; Krieg P; Furstenberger G		Cancer Res	62	2002	4610-6	J:78499	12183416
90660	Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice.		Lund AH; Turner G; Trubetskoy A; Verhoeven E; Wientjens E; Hulsman D; Russell R; DePinho RA; Lenz J; van Lohuizen M		Nat Genet	32	2002	160-5	J:78529	12185367
90661	WNT and FGF gene clusters (Review).		Katoh M		Int J Oncol	21	2002	1269-73	J:80304	12429977
90662	Mechanisms of tumor-induced immunosuppression: evidence for contact-dependent T cell suppression by monocytes.		Jaffe ML; Arai H; Nabel GJ		Mol Med	2	1996	692-701	J:39692	8972484
90663	Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.		Mandelboim O; Vadai E; Feldman M; Eisenbach L		Gene Ther	2	1995	757-65	J:39676	8750016
90664	Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models.		Nielsen LL; Shi B; Hajian G; Yaremko B; Lipari P; Ferrari E; Gurnani M; Malkowski M; Chen J; Bishop WR; Liu M		Cancer Res	59	1999	5896-901	J:59101	10606231
90665	Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.		Andrechek ER; Laing MA; Girgis-Gabardo AA; Siegel PM; Cardiff RD; Muller WJ		Cancer Res	63	2003	4920-6	J:85139	12941816
90666	Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption.		Sakumi K; Tominaga Y; Furuichi M; Xu P; Tsuzuki T; Sekiguchi M; Nakabeppu Y		Cancer Res	63	2003	902-5	J:82287	12615700
90667	Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.		Silva S; Wiener F; Klein G; Janz S		Genes Chromosomes Cancer	42	2005	416-26	J:95921	15645495
90668	Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis.		Matsumoto T; Jiang J; Kiguchi K; Ruffino L; Carbajal S; Beltran L; Bol DK; Rosenberg MP; DiGiovanni J		Cancer Res	63	2003	4819-28	J:85132	12941801
90669	Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.		Farazi PA; Glickman J; Jiang S; Yu A; Rudolph KL; DePinho RA		Cancer Res	63	2003	5021-7	J:85141	12941829
90670	beta-catenin-dependent and -independent effects of DeltaN-plakoglobin on epidermal growth and differentiation.		Teuliere J; Faraldo MM; Shtutman M; Birchmeier W; Huelsken J; Thiery JP; Glukhova MA		Mol Cell Biol	24	2004	8649-61	J:93018	15367683
90671	The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis.		Ruggero D; Montanaro L; Ma L; Xu W; Londei P; Cordon-Cardo C; Pandolfi PP		Nat Med	10	2004	484-6	J:89878	15098029
90672	Evaluation of toxicity of beta-tethymustine, a new anticancer compound, in mice.		Ghosh M; Sadhu U; Bhattacharya S; Dutta S; Bhattacharya B; Sanyal U		Cancer Lett	138	1999	107-14	J:55308	10378781
90673	Transgenic mouse models for tumors of melanocytes and retinal pigment epithelium.		Beermann F; Hunziker A; Foletti A		Pigment Cell Res	12	1999	71-80	J:54879	10231194
90674	Four P-like elements are required for optimal transcription of the mouse IL-4 gene: involvement of a distinct set of nuclear factor of activated T cells and activator protein-1 family proteins.		Takemoto N; Koyano-Nakagawa N; Arai N; Arai K; Yokota T		Int Immunol	9	1997	1329-38	J:43360	9310836
90675	A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.		Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M		Oncogene	18	1999	7124-34	J:59021	10597314
90676	Two polysialic acid synthases, mouse ST8Sia II and IV, synthesize different degrees of polysialic acids on different substrate glycoproteins in mouse neuroblastoma Neuro2a cells		Kojima N; Tachida Y; Tsuji S		J Biochem (Tokyo)	122	1997	1265-73	J:44973	9498575
90677	Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.		Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM		Cancer Res	50	1990	227-34	J:46457	2136804
90678	Passive but not active CD8+ T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse model.		Romieu R; Baratin M; Kayibanda M; Lacabanne V; Ziol M; Guillet JG; Viguier M		J Immunol	161	1998	5133-7	J:50908	9820481
90679	Immunopotentiation with low-dose cyclophosphamide in the active specific immunotherapy of cancer.		Bass KK; Mastrangelo MJ		Cancer Immunol Immunother	47	1998	1-12	J:52547	9755873
90680	Inhibitory effect of Cordyceps sinensis on spontaneous liver metastasis of Lewis lung carcinoma and B16 melanoma cells in syngeneic mice.		Nakamura K; Yamaguchi Y; Kagota S; Kwon YM; Shinozuka K; Kunitomo M		Jpn J Pharmacol	79	1999	335-41	J:54412	10230862
90681	Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells.		Satoh K; Narumi K; Abe T; Sakai T; Kikuchi T; Tanaka M; Shimo-Oka T; Uchida M; Tezuka F; Isemura M; Nukiwa T		Br J Cancer	80	1999	1115-22	J:55547	10376960
90682	Farnesyltransferase inhibitors: targeting the molecular basis of cancer.		Oliff A		Biochim Biophys Acta	1423	1999	C19-30	J:55707	10382537
90683	Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network.		Foley KP; Eisenman RN		Biochim Biophys Acta	1423	1999	M37-47	J:55708	10382539
90684	Gamma-globulin inhibits tumor spread in mice.		Shoenfeld Y; Fishman P		Int Immunol	11	1999	1247-52	J:56801	10421782
90685	Specificity of loss of heterozygosity in radiation-induced mouse myeloid and lymphoid leukaemias.		Cleary HJ; Wright E; Plumb M		Int J Radiat Biol	75	1999	1223-30	J:59546	10549598
90686	Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted.		Yamakage K; Omori Y; Zaidan-Dagli ML; Cros MP; Yamasaki H		J Invest Dermatol	114	2000	289-94	J:60012	10651988
90687	Tumor cells utilize multiple pathways to down-modulate apoptosis. Lessons from a mouse model of islet cell carcinogenesis		Hager JH; Hanahan D		Ann N Y Acad Sci	887	1999	150-63	J:60812	10668471
90688	N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts.		Shoemaker AR; Moser AR; Dove WF		Cancer Res	55	1995	4479-85	J:29099	7671263
90689	Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.		Ghebranious N; Sell S		Hepatology	27	1998	383-91	J:47062	9462635
90690	Restriction landmark genomic scanning of mouse liver tumors for gene amplification: overexpression of cyclin A2		Haddad R; Morrow AD; Plass C; Held WA		Biochem Biophys Res Commun	274	2000	188-96	J:63571	10903917
90691	Inhibition of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin ornithine decarboxylase and protein kinase C by polyphenolics from grapes.		Bomser J; Singletary K; Meline B		Chem Biol Interact	127	2000	45-59	J:63572	10903418
90692	K6/ODC transgenic mice as a sensitive model for carcinogen identification.		Chen Y; Megosh LC; Gilmour SK; Sawicki JA; O'Brien TG		Toxicol Lett	116	2000	27-35	J:63568	10906419
90693	Preventive effects of sulphasalazine on colorectal carcinogenesis in mice with ulcerative colitis		Suzuki S; Sakamoto S; Mitamura T; Sassa S; Kudo H; Yamashita Y		In Vivo	14	2000	463-6	J:63569	10904883
90694	Effect of intragastric application of N-methylnitrosourea in p53 knockout mice.		Ohgaki H; Fukuda M; Tohma Y; Huang H; Stoica G; Tatematsu M; Donehower LA		Mol Carcinog	28	2000	97-101	J:63574	10900466
90695	Mouse keratinocytes immortalized with large T antigen acquire alpha3beta1 integrin-dependent secretion of MMP-9/gelatinase B.		DiPersio CM; Shao M; Di Costanzo L; Kreidberg JA; Hynes RO		J Cell Sci	113	2000	2909-21	J:63565	10910775
90696	HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice		Reilly RT; Gottlieb MB; Ercolini AM; Machiels JP; Kane CE; Okoye FI; Muller WJ; Dixon KH; Jaffee EM		Cancer Res	60	2000	3569-76	J:63566	10910070
90697	Detection and cloning of unique integration sites of retrotransposon, intracisternal A-particle element in the genome of acute myeloid leukemia cells in mice.		Ishihara H; Tanaka I		FEBS Lett	418	1997	205-9	J:44395	9414127
90698	SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells.		Sumi-Ichinose C; Ichinose H; Metzger D; Chambon P		Mol Cell Biol	17	1997	5976-86	J:42997	9315656
90699	Characterization of the integrin alpha(v) gene promoter in mice.		Kambe M; Miyamoto Y; Hayashi M		Biochim Biophys Acta	1395	1998	209-19	J:45789	9473675
90700	IRF-1: the transcription factor linking the interferon response and oncogenesis.		Taniguchi T; Lamphier MS; Tanaka N		Biochim Biophys Acta	1333	1997	M9-17	J:42960	9294015
90701	Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.		Feldman BJ; Reid TR; Cleary ML		Oncogene	15	1997	2735-42	J:44682	9401000
90702	Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma.		Petersen J; Dandri M; Gupta S; Rogler CE		Proc Natl Acad Sci U S A	95	1998	310-5	J:45624	9419372
90703	WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice.		Moennikes O; Stahl S; Bannasch P; Buchmann A; Schwarz M		Carcinogenesis	24	2003	1561-5	J:85508	12819187
90704	Osteopontin expression in mammary gland development and tumorigenesis.		Rittling SR; Novick KE		Cell Growth Differ	8	1997	1061-9	J:44569	9342184
90705	Inflammation and Cancer I. Rodent models of infectious gastrointestinal and liver cancer.		Rogers AB; Fox JG		Am J Physiol Gastrointest Liver Physiol	286	2004	G361-6	J:88079	14766534
90706	Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance.		Blankenstein T; Qin Z		Adv Cancer Res	90	2003	179-207	J:88116	14710951
90707	Rhabdomyosarcomagenesis-Novel pathway found.		Asakura A; Rudnicki MA		Cancer Cell	4	2003	421-2	J:88121	14706332
90708	IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.		Greten FR; Eckmann L; Greten TF; Park JM; Li ZW; Egan LJ; Kagnoff MF; Karin M		Cell	118	2004	285-96	J:91947	15294155
90709	The mitochondrial SDHD gene is required for early embryogenesis, and its partial deficiency results in persistent carotid body glomus cell activation with full responsiveness to hypoxia.		Piruat JI; Pintado CO; Ortega-Saenz P; Roche M; Lopez-Barneo J		Mol Cell Biol	24	2004	10933-40	J:95252	15572694
90710	IL-18 UV-induced melanocyte proliferation and nevi in mice.		van Schanke A; Heppener DF; Kranen HJ; Mullenders LH; Gruijl FR		Pigment Cell Res	16	2003	579-80	J:85678	12950763
90711	Modifier genes and protective alleles in humans and mice.		Nadeau JH		Curr Opin Genet Dev	13	2003	290-5	J:88012	12787792
90712	Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence.		Rane SG; Cosenza SC; Mettus RV; Reddy EP		Mol Cell Biol	22	2002	644-56	J:95126	11756559
90713	Corticotropin-releasing hormone stimulates the expression of the steroidogenic acute regulatory protein in MA-10 mouse cells.		Huang BM; Stocco DM; Li PH; Yang HY; Wu CM; Norman RL		Biol Reprod	57	1997	547-51	J:42712	9282989
90714	Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).		Howroyd P; Swanson C; Dunn C; Cattley RC; Corton JC		Toxicol Pathol	32	2004	591-9	J:93792	15603543
90715	An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP).		He B; Bai S; Hnat AT; Kalman RI; Minges JT; Patterson C; Wilson EM		J Biol Chem	279	2004	30643-53	J:90344	15107424
90716	Shorter telomeres, accelerated ageing and increased lymphoma in DNA-PKcs-deficient mice.		Espejel S; Martin M; Klatt P; Martin-Caballero J; Flores JM; Blasco MA		EMBO Rep	5	2004	503-9	J:90345	15105825
90717	B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis.		Ruddell A; Mezquita P; Brandvold KA; Farr A; Iritani BM		Am J Pathol	163	2003	2233-45	J:86614	14633598
90718	Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization.		Degl'innocenti E; Grioni M; Boni A; Camporeale A; Bertilaccio MT; Freschi M; Monno A; Arcelloni C; Greenberg NM; Bellone M		Eur J Immunol	35	2004	66-75	J:95463	15597325
90719	Pericryptal fibroblast sheath in intestinal metaplasia and gastric carcinoma.		Mutoh H; Sakurai S; Satoh K; Osawa H; Tomiyama T; Kita H; Yoshida T; Tamada K; Yamamoto H; Isoda N; Ido K; Sugano K		Gut	54	2005	33-9	J:95464	15591501
90720	Mechanisms leading to chromosomal instability.		Gollin SM		Semin Cancer Biol	15	2005	33-42	J:95460	15613286
90721	Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization.		Degl'Innocenti E; Grioni M; Boni A; Camporeale A; Bertilaccio MT; Freschi M; Monno A; Arcelloni C; Greenberg NM; Bellone M		Eur J Immunol	35	2005	66-75	J:95264	 
90722	The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models.		Attardi LD		Mutat Res	569	2005	145-57	J:95220	15603759
90723	Study on prevention of two-stage skin carcinogenesis by Hibiscus rosa sinensis extract and the role of its chemical constituent, gentisic acid, in the inhibition of tumour promotion response and oxidative stress in mice.		Sharma S; Khan N; Sultana S		Eur J Cancer Prev	13	2004	53-63	J:90200	15075789
90724	Saffron can prevent chemically induced skin carcinogenesis in Swiss albino mice.		Das I; Chakrabarty RN; Das S		Asian Pac J Cancer Prev	5	2004	70-6	J:90201	15075009
90725	Genetically engineered mouse models for lung cancer.		Kwak I; Tsai SY; DeMayo FJ		Annu Rev Physiol	66	2004	647-63	J:88754	14977417
90726	The preneoplastic phenotype in murine mammary tumorigenesis.		Medina D		J Mammary Gland Biol Neoplasia	5	2000	393-407	J:88755	14973384
90727	WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice.		Kutz WE; Gong Y; Warman ML		Mol Cell Biol	25	2005	414-21	J:94500	15601861
90728	DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen.		Itoh T; Cado D; Kamide R; Linn S		Proc Natl Acad Sci U S A	101	2004	2052-7	J:88125	14769931
90729	The mutagenic action of N-ethyl-N-nitrosourea in the mouse.		Noveroske JK; Weber JS; Justice MJ		Mamm Genome	11	2000	478-83	J:63664	10886009
90730	Human papillomavirus-induced carcinogenesis with p53 deficiency in mouse: novel lymphomagenesis in HPV16E6E7 transgenic mice mimicking p53 defect.		Li Q; Yoshioka N; Yutsudo M; Inafuku S; Aozasa K; Kitamura Y; Aizawa S; Nishimune Y; Hakura A; Kondoh G		Virology	252	1998	28-33	J:89022	9875313
90731	Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia.		Wang F; McKeehan K; Yu C; Ittmann M; McKeehan WL		Prostate	58	2004	1-12	J:87519	14673947
90732	Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer.		Mukherjee P; Madsen CS; Ginardi AR; Tinder TL; Jacobs F; Parker J; Agrawal B; Longenecker BM; Gendler SJ		J Immunother	26	2003	47-62	J:81059	12514429
90733	The effect of 6-methylthiohexyl isothiocyanate isolated from Wasabia japonica (wasabi) on 4-(methylnitrosamino)-1-(3-pyridyl)-1-buatnone-induced lung tumorigenesis in mice.		Yano T; Yajima S; Virgona N; Yano Y; Otani S; Kumagai H; Sakurai H; Kishimoto M; Ichikawa T		Cancer Lett	155	2000	115-20	J:62468	10822125
90734	Anticarcinogenicity potential of spinasterol isolated from squash flowers		Villasenor IM; Domingo AP		Teratog Carcinog Mutagen	20	2000	99-105	J:62469	10820420
90735	MDM2 and its splice variant messenger RNAs: expression in tumors and down-regulation using antisense oligonucleotides.		Bartel F; Harris LC; Wurl P; Taubert H		Mol Cancer Res	2	2004	29-35	J:88006	14757843
90736	Tumor promotion by Mdm2 splice variants unable to bind p53.		Fridman JS; Hernando E; Hemann MT; de Stanchina E; Cordon-Cardo C; Lowe SW		Cancer Res	63	2003	5703-6	J:86076	14522887
90737	Transcriptional repression of catalase in mouse skin tumor progression.		Kwei KA; Finch JS; Thompson EJ; Bowden GT		Neoplasia	6	2004	440-8	J:95494	15548352
90738	Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.		Lu C; Speers C; Zhang Y; Xu X; Hill J; Steinbis E; Celestino J; Shen Q; Kim H; Hilsenbeck S; Mohsin SK; Wakeling A; Osborne CK; Brown PH		J Natl Cancer Inst	95	2003	1825-33	J:87515	14679152
90739	Crosstalk between PARP-1 and NF-kappaB modulates the promotion of skin neoplasia.		Martin-Oliva D; O'Valle F; Munoz-Gamez JA; Valenzuela MT; Nunez MI; Aguilar M; Ruiz de Almodovar JM; Garcia del Moral R; Oliver FJ		Oncogene	23	2004	5275-83	J:91204	15077172
90740	Characterization of mouse fibroblast (NIH3T3) and fibrosarcoma cell lines (WEHI-164 and MFS 8) using PMRS.		Jayashree B; Visalakshi V; Rajalakshmi KR; Sukumaran MS; Moni MS; Rajkumar T; Deshmukh S		Indian J Biochem Biophys	35	1998	108-14	J:49614	9753870
90741	Loss of Brca2 and p53 Synergistically Promotes Genomic Instability and Deregulation of T-cell Apoptosis.		Cheung AM; Hande MP; Jalali F; Tsao MS; Skinnider B; Hirao A; McPherson JP; Karaskova J; Suzuki A; Wakeham A; You-Ten A; Elia A; Squire J; Bristow R; Hakem R; Mak TW		Cancer Res	62	2002	6194-204	J:79697	12414647
90742	Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide.		Kundu N; Dorsey R; Jackson MJ; Guiterrez P; Wilson K; Fu S; Ramanujam K; Thomas E; Fulton AM		Int J Cancer	76	1998	713-9	J:47767	9610731
90743	Preleukemia in long-term plasmacytoma-regressor mice.		Sagi-Assif O; Trakhtenbrot L; Douer D; Witz IP		Int J Cancer	76	1998	689-93	J:47768	9610727
90744	Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane.		Altavilla G; Caputo A; Trabanelli C; Brocca Cofano E; Sabbioni S; Menegatti MA; Barbanti-Brodano G; Corallini A		Eur J Cancer	40	2004	275-83	J:88106	14728943
90745	PPARalpha agonist-induced rodent tumors: modes of action and human relevance.		Klaunig JE; Babich MA; Baetcke KP; Cook JC; Corton JC; David RM; DeLuca JG; Lai DY; McKee RH; Peters JM; Roberts RA; Fenner-Crisp PA		Crit Rev Toxicol	33	2003	655-780	J:88107	14727734
90746	The antitumor effects of levamisole in mice are mediated by NC-1.1+ cells.		Clarke GR; Burton RC; Smart YC		Cancer Immunol Immunother	45	1997	115-8	J:44325	9390203
90747	A novel retrovirus provides the cooperating oncogenic event(s) required to demonstrate the tumor suppressor activity of p15(Ink4b) in myeloid cells in vivo.		Wolff L; Garin MT; Koller R; Bies J; Tessarollo L; Anver MR; Powell D; Perella C		Blood Cells Mol Dis	32	2004	226-31	J:87853	14757439
90748	DNA repair and repair fidelity in metastatic variants of the B16 murine melanoma.		Usmani BA; Lunec J; Sherbet GV		J Cell Biochem	51	1993	336-44	J:45526	7684740
90749	Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer.		Jackson L; Wahli W; Michalik L; Watson SA; Morris T; Anderton K; Bell DR; Smith JA; Hawkey CJ; Bennett AJ		Gut	52	2003	1317-22	J:85694	12912864
90750	A mouse model for breast cancer induced by amplification and overexpression of the neu promoter and transgene		Weinstein EJ; Kitsberg DI; Leder P		Mol Med	6	2000	4-16	J:62441	10803404
90751	The role of p53 in suppression of KSHV cyclin-induced lymphomagenesis.		Verschuren EW; Hodgson JG; Gray JW; Kogan S; Jones N; Evan GI		Cancer Res	64	2004	581-9	J:88091	14744772
90752	Deletion of functional gastrin gene markedly increases colon carcinogenesis in response to azoxymethane in mice.		Cobb S; Wood T; Tessarollo L; Velasco M; Given R; Varro A; Tarasova N; Singh P		Gastroenterology	123	2002	516-30	J:77985	12145805
90753	Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease.		Ostrand-Rosenberg S; Sinha P; Clements V; Dissanayake SI; Miller S; Davis C; Danna E		Cancer Immunol Immunother	53	2004	86-91	J:86509	14593499
90754	Epigenetic gene silencing by Runx proteins.		Taniuchi I; Littman DR		Oncogene	23	2004	4341-5	J:92283	15156191
90755	IgG1 plasmacytosis in interleukin 6 transgenic mice.		Suematsu S; Matsuda T; Aozasa K; Akira S; Nakano N; Ohno S; Miyazaki J; Yamamura K; Hirano T; Kishimoto T		Proc Natl Acad Sci U S A	86	1989	7547-51	J:40124	2798426
90756	Different procarcinogenic potentials of lymphocyte subsets in a transgenic mouse model of chronic hepatitis B.		Nakamoto Y; Suda T; Momoi T; Kaneko S		Cancer Res	64	2004	3326-33	J:89587	15126377
90757	Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice.		Buettner VL; Hill KA; Nishino H; Schaid DJ; Frisk CS; Sommer SS		Oncogene	13	1996	2407-13	J:90313	8957082
90758	Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation.		Kaneko K; Zulianello L; Scott M; Cooper CM; Wallace AC; James TL ; Cohen FE ; Prusiner SB		Proc Natl Acad Sci U S A	94	1997	10069-74	J:42936	9294164
90759	Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.		Pierce AM; Gimenez-Conti IB; Schneider-Broussard R; Martinez LA; Conti CJ; Johnson DG		Proc Natl Acad Sci U S A	95	1998	8858-63	J:48935	9671769
90760	Genomic approaches to understanding mammary tumor progression in transgenic mice and responses to therapy.		Green JE; Desai K; Ye Y; Kavanaugh C; Calvo A; Huh JI		Clin Cancer Res	10	2004	385S-90S	J:87738	14734496
90761	Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells.		Granot-Attas S; Elson A		Exp Cell Res	294	2004	236-43	J:88345	14980517
90762	Articular Chondromatosis and Chrondroid Metaplasia in Transgenic TAg Mice.		Verschoyle RD; Edwards R; Nolan B; Greaves P		Toxicol Pathol	32	2004	22-5	J:88112	14713544
90763	Predominant K-ras Codon 12 G --&gt; A Transition in Chemically Induced Lung Neoplasms in B6C3F1 Mice.		Ton TV; Hong HH; Anna CH; Dunnick JK; Devereux TR; Sills RC; Kim Y		Toxicol Pathol	32	2004	16-21	J:88113	14713543
90764	Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.		Thurston G; McLean JW; Rizen M; Baluk P; Haskell A; Murphy TJ; Hanahan D; McDonald DM		J Clin Invest	101	1998	1401-13	J:46826	9525983
90765	TSH-activated signaling pathways in thyroid tumorigenesis.		Rivas M; Santisteban P		Mol Cell Endocrinol	213	2003	31-45	J:87885	15062572
90766	New murine model for hepatocellular carcinoma: transgenic mice expressing metallothionein-ovine growth hormone fusion gene.		Orian JM; Tamakoshi K; Mackay IR; Brandon MR		J Natl Cancer Inst	82	1990	393-8	J:78231	2154583
90767	Long-term overexpression of human granulocyte colony-stimulating factor in transgenic mice: persistent neutrophilia with no increased mortality for more than one year		Serizawa I; Amano K; Ishii H; Ichikawa T; Kusaka M; Taguchi T; Kiyokawa N; Fujimoto J		Cytokine	12	2000	630-5	J:62975	10843738
90768	Apc(Min) (/+) mouse model of colon cancer: Gene expression profiling in tumors.		Leclerc D; Deng L; Trasler J; Rozen R		J Cell Biochem	93	2004	1242-1254	J:94113	15486983
90769	Glutathione conjugation of perchloroethylene in rats and mice in vitro: sex-, species-, and tissue-dependent differences.		Lash LH; Qian W; Putt DA; Desai K; Elfarra AA; Sicuri AR; Parker JC		Toxicol Appl Pharmacol	150	1998	49-57	J:49451	9630452
90770	Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.		Walter MJ; Park JS; Lau SK; Li X; Lane AA; Nagarajan R; Shannon WD; Ley TJ		Mol Cell Biol	24	2004	10882-93	J:95255	15572690
90771	Phenotypic characteristics of mouse lung adenoma induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.		Okubo C; Morishita Y; Minami Y; Ishiyama T; Kano J; Iijima T; Noguchi M		Mol Carcinog	42	2005	121-6	J:95498	15584020
90772	Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.		Kobzdej M; Matuszyk J; Strzadala L		Leuk Res	24	2000	33-8	J:93684	10634643
90773	Cytogenetic studies on abelson-virus-induced mouse leukemias.		Klein G; Ohno S; Rosenberg N; Wiener F; Spira J; Baltimore D		Int J Cancer	25	1980	805-11	J:88076	14768711
90774	Restricted expression of endogenous N-tropic XC-positive leukemia virus in hybrids between G and AKR mice: an effect of the Fv-4r gene.		Odaka T; Ikeda H; Akatsuka T		Int J Cancer	25	1980	757-62	J:88077	14768705
90775	SAGE profiling of UV-induced mouse skin squamous cell carcinomas, comparison with acute UV irradiation effects.		Rundhaug JE; Hawkins KA; Pavone A; Gaddis S; Kil H; Klein RD; Berton TR; McCauley E; Johnson DG; Lubet RA; Fischer SM; Aldaz CM		Mol Carcinog	42	2005	40-52	J:94115	15547921
90776	Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis.		Zhu P; Martin E; Mengwasser J; Schlag P; Janssen KP; Gottlicher M		Cancer Cell	5	2004	455-63	J:90019	15144953
90777	Sustained hepatic expression of FoxM1B in transgenic mice has minimal effects on hepatocellular carcinoma development but increases cell proliferation rates in preneoplastic and early neoplastic lesions.		Kalinina OA; Kalinin SA; Polack EW; Mikaelian I; Panda S; Costa RH; Adami GR		Oncogene	22	2003	6266-76	J:85966	13679865
90778	Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.		Jhappan C; Takayama H; Dickson RB; Merlino G		Cell Growth Differ	5	1994	385-94	J:81426	8043512
90779	Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.		Cheung WC; Kim JS; Linden M; Peng L; Van Ness B; Polakiewicz RD; Janz S		J Clin Invest	113	2004	1763-73	J:90901	15199411
90780	Recent advances in stress signaling in cancer.		Morin CI; Huot J		Cancer Res	64	2004	1893-8	J:88788	14996754
90781	AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.		Kuang SQ; Liao L; Zhang H; Lee AV; O'Malley BW; Xu J		Cancer Res	64	2004	1875-85	J:88789	14996752
90782	Mice with genetically determined high susceptibility to ultraviolet (UV)-induced immunosuppression show enhanced UV carcinogenesis.		Noonan FP; Muller HK; Fears TR; Kusewitt DF; Johnson TM; De Fabo EC		J Invest Dermatol	121	2003	1175-81	J:88118	14708623
90783	VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40T antigen mice.		Moody TW; Dudek J; Zakowicz H; Walters J; Jensen RT; Petricoin E; Couldrey C; Green JE		Life Sci	74	2004	1345-57	J:88119	14706566
90784	Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis.		Kong Y; Poon R; Nadesan P; Di Muccio T; Fodde R; Khokha R; Alman BA		Cancer Res	64	2004	5795-803	J:91954	15313922
90785	Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors.		Pentland AP; Scott G; VanBuskirk J; Tanck C; LaRossa G; Brouxhon S		Cancer Res	64	2004	5587-91	J:91955	15313895
90786	Cancer-inducible transgene expression by the Grp94 promoter: spontaneous activation in tumors of various origins and cancer-associated macrophages.		Reddy RK; Dubeau L; Kleiner H; Parr T; Nichols P; Ko B; Dong D; Ko H; Mao C; DiGiovanni J; Lee AS		Cancer Res	62	2002	7207-12	J:80830	12499260
90787	Overexpression of Sonic Hedgehog suppresses embryonic hair follicle morphogenesis.		Ellis T; Smyth I; Riley E; Bowles J; Adolphe C; Rothnagel JA; Wicking C; Wainwright BJ		Dev Biol	263	2003	203-15	J:86444	14597196
90788	Critical stages of tumor growth regulation in transgenic mice harboring a hepatocellular carcinoma revealed by distinct patterns of tumor necrosis factor-alpha and transforming growth factor-beta mRNA production.		Romieu R; Lacabanne V; Kayibanda M; Antoine B; Bennoun M; Chouaib S; Guillet JG; Viguier M		Int Immunol	9	1997	1405-13	J:43614	9352345
90789	Allelic loss analysis of lymphomas induced in fas-heterozygous deficient mice.		Ogawa S; Hong DP; Mori N; Umesako S; Song CW; Okumoto M		J Vet Med Sci	66	2004	97-102	J:88067	14960823
90790	DNA rearrangement causes hepatocarcinogenesis in albumin-plasminogen activator transgenic mice.		Sandgren EP; Palmiter RD; Heckel JL; Brinster RL; Degen JL		Proc Natl Acad Sci U S A	89	1992	11523-7	J:94743	1454842
90791	Mammary tumor induction in transgenic mice expressing an RNA-binding protein.		Tessier CR; Doyle GA; Clark BA; Pitot HC; Ross J		Cancer Res	64	2004	209-14	J:87477	14729626
90792	Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.		Hingorani SR; Petricoin EF; Maitra A; Rajapakse V; King C; Jacobetz MA; Ross S; Conrads TP; Veenstra TD; Hitt BA; Kawaguchi Y; Johann D; Liotta LA; Crawford HC; Putt ME; Jacks T; Wright CV; Hruban RH; Lowy AM; Tuveson DA		Cancer Cell	4	2003	437-50	J:87973	14706336
90793	Selected nuclear LINE elements with mitochondrial-DNA-like inserts are more plentiful and mobile in tumor than in normal tissue of mouse and rat.		Hadler HI; Devadas K; Mahalingam R		J Cell Biochem	68	1998	100-9	J:44809	9407318
90794	Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.		Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA		Oncogene	19	2000	2678-86	J:62688	10851067
90795	Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours.		Celso CL; Prowse DM; Watt FM		Development	131	2004	1787-99	J:90191	15084463
90796	Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice.		Branda CS; Dymecki SM		Dev Cell	6	2004	7-28	J:87967	14723844
90797	Svi3: A provirus common integration site in c-myc in SL/Kh pre-B lymphomas.		Jin G; Tsuruyama T; Yamada Y; Hiai H		Cancer Sci	94	2003	791-5	J:86092	12967477
90798	Effects of topical L-selenomethionine with topical and oral vitamin E on pigmentation and skin cancer induced by ultraviolet irradiation in Skh:2 hairless mice.		Burke KE; Clive J; Combs GF Jr; Nakamura RM		J Am Acad Dermatol	49	2003	458-72	J:86093	12963910
90799	Nuclear morphology during the S phase.		Mazzotti G; Gobbi P; Manzoli L; Falconi M		Microsc Res Tech	40	1998	418-31	J:46775	9527051
90800	Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.		Miliani de Marval PL; Macias E; Rounbehler R; Sicinski P; Kiyokawa H; Johnson DG; Conti CJ; Rodriguez-Puebla ML		Mol Cell Biol	24	2004	7538-47	J:92784	15314163
90801	Mice deficient in the nucleotide excision repair gene XPA have elevated sensitivity to benzo[a]pyrene induction of lung tumors.		Ide F; Iida N; Nakatsuru Y; Oda H; Tanaka K; Ishikawa T		Carcinogenesis	21	2000	1263-5	J:62877	10837020
90802	XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.		de Vries A; Berg RJ; Wijnhoven S; Westerman A; Wester PW; van Kreijl CF; Capel PJ; de Gruijl FR; van Kranen HJ; van Steeg H		Oncogene	16	1998	2205-12	J:47450	9619829
90803	Establishment and characterization of two cell lines from N-methyl-N-nitrosourea-induced mouse glandular stomach carcinomas.		Ichinose M; Nakanishi H; Fujino S; Tatematsu M		Jpn J Cancer Res	89	1998	516-24	J:48674	9685855
90804	Early steps of a thymic tumor in SV40 transgenic mice: hyperplasia of medullary epithelial cells and increased mature thymocyte numbers disturb thymic export.		Nabarra B; Martinon C; Godard C; Vasseur F; de Ribains G; Miquerol L; Kahn A; Ezine S		Dev Immunol	9	2002	223-31	J:90148	15144019
90805	Helicobacter pylori Does Not Promote N-Methyl-N-nitrosourea-induced Gastric Carcinogenesis in SPF C57BL / 6 Mice.		Nakamura Y; Sakagami T; Yamamoto N; Yokota Y; Koizuka H; Hori K; Fukuda Y; Tanida N; Kobayashi T; Shimoyama T		Jpn J Cancer Res	93	2002	111-6	J:75254	11856473
90806	Isolation and characterization of apoptosis-resistant mutants from a radiosensitive mouse lymphoma cell line.		Kawai H; Kitamura Y; Nikaido O; Tatsuka M; Hama-Inaba H; Muto M ; Ohyama H ; Suzuki F		Radiat Res	149	1998	41-51	J:44824	9421153
90807	Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation.		Packham G; Brimmell M; Cleveland JL		Biochem J	328	1997	807-13	J:45057	9396724
90808	Consequences of chromosomal abnormalities in tumor development.		Sanchez-Garcia I		Annu Rev Genet	31	1997	429-53	J:45346	9442903
90809	Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.		Karasaki H; Obata M; Ogawa K; Lee GH		Oncogene	15	1997	1833-40	J:43610	9362450
90810	Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7.		Akagi J; Hodge JW; McLaughlin JP; Gritz L; Mazzara G; Kufe D ; Schlom J ; Kantor JA		J Immunother	20	1997	38-47	J:41537	9101412
90811	Lymphoblastic lymphoma in a colony of N:NIH(S)-bg-nu-xid mice.		Waggie KS; Wu-Owens J; Hollifield V; Hansen CT		Lab Anim Sci	42	1992	375-7	J:2184	1434498
90812	Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter.		He Y; Huang L		Cancer Res	57	1997	3993-9	J:42734	9307284
90813	An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy.		Henderson BW; Bellnier DA; Greco WR; Sharma A; Pandey RK; Vaughan LA ; Weishaupt KR ; Dougherty TJ		Cancer Res	57	1997	4000-7	J:42735	9307285
90814	Lymphomas and plasmacytomas in transgenic mice involving bcl2, myc and v-abl.		Harris AW; Strasser A; Bath ML; Elefanty AG; Cory S		Curr Top Microbiol Immunol	224	1997	221-30	J:46020	9308245
90815	Genetic recombinations between c-myc and Igh mu as precursors for recombinations between c-myc and Igh alpha in BALB/c plasmacytomas.		Janz S; Kovalchuk AL; Muller JR; Potter M		Curr Top Microbiol Immunol	224	1997	241-50	J:46021	9308247
90816	Prevention of mouse lung tumors by budesonide and its modulation of biomarkers.		Pereira MA; Li Y; Gunning WT; Kramer PM; Al-Yaqoub F; Lubet RA; Steele VE; Szabo E; Tao L		Carcinogenesis	23	2002	1185-92	J:77758	12117777
90817	Cancer modeling in the modern era: progress and challenges.		Van Dyke T; Jacks T		Cell	108	2002	135-44	J:76944	11832204
90818	Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma		Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG		Clin Cancer Res	3	1997	1661-7	J:45315	9815857
90819	Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity		Foster BJ; Wiegand RA; Pugh S; LoRusso PM; Rake J; Corbett TH		Clin Cancer Res	3	1997	2047-53	J:45316	9815596
90820	DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus.		Jhappan C; Morse HC 3rd; Fleischmann RD; Gottesman MM; Merlino G		Nat Genet	17	1997	483-6	J:44390	9398856
90821	Inhibition of UV-induced p53 mutations by sunscreens: implications for skin cancer prevention.		Ananthaswamy HN; Loughlin SM; Ullrich SE; Kripke ML		J Invest Dermatol Symp Proc	3	1998	52-6	J:49628	9732059
90822	Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.		Cavallo F; Signorelli P; Giovarelli M; Musiani P; Modesti A; Brunda MJ ; Colombo MP ; Forni G		J Natl Cancer Inst	89	1997	1049-58	J:41661	9230887
90823	Chronic stress accelerates ultraviolet-induced cutaneous carcinogenesis.		Parker J; Klein SL; McClintock MK; Morison WL; Ye X; Conti CJ; Peterson N; Nousari CH; Tausk FA		J Am Acad Dermatol	51	2004	919-22	J:95469	15583583
90824	Perspectives on reproductive senescence and biological aging: studies in genetically altered follitropin receptor knockout [FORKO] mice.		Danilovich N; Maysinger D; Sairam MR		Exp Gerontol	39	2004	1669-78	J:95470	15582283
90825	A dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion.		Thompson EJ; MacGowan J; Young MR; Colburn N; Bowden GT		Cancer Res	62	2002	3044-7	J:77031	12036911
90826	Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency.		Kang-Decker N; Tong C; Boussouar F; Baker DJ; Xu W; Leontovich AA; Taylor WR; Brindle PK; van Deursen JM		Cancer Cell	5	2004	177-89	J:88323	14998493
90827	Focus on gastric cancer.		Ushijima T; Sasako M		Cancer Cell	5	2004	121-5	J:88332	14998488
90828	Refined histopathologic scoring system improves power to detect colitis QTL in mice.		Bleich A; Mahler M; Most C; Leiter EH; Liebler-Tenorio E; Elson CO; Hedrich HJ; Schlegelberger B; Sundberg JP		Mamm Genome	15	2004	865-71	J:94027	15672590
90829	Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [see comments]		Boehm T; Folkman J; Browder T; O'Reilly MS		Nature	390	1997	404-7	J:44308	9389480
90830	Suppression of lymphoma and epithelial malignancies effected by interferon gamma.		Street SE; Trapani JA; MacGregor D; Smyth MJ		J Exp Med	196	2002	129-34	J:77491	12093877
90831	Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression.		Wang XJ; Greenhalgh DA; Eckhardt JN; Rothnagel JA; Roop DR		Mol Carcinog	10	1994	15-22	J:81467	8185825
90832	A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.		Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA		Photochem Photobiol	67	1998	332-6	J:46778	9523532
90833	The detection of chemically initiated cells having the mutation of K-ras gene at an early stage of lung carcinogenesis in mice.		Yano T; Yuasa M; Murakami A; Ichikawa T; Hagiwara K		Anal Biochem	244	1997	187-9	J:38419	9025932
90834	Effects of 1,4-phenylenebis(methylene)selenocyanate and selenomethionine on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mouse lung.		Prokopczyk B; Amin S; Desai DH; Kurtzke C; Upadhyaya P; El-Bayoumy K		Carcinogenesis	18	1997	1855-7	J:43002	9328187
90835	Haptoglobin, inflammation, and tumorigenesis in the MIN mouse.		Barbour K W; Davis T; White A; Baumann H; Berger F G		Redox Rep	6	2001	366-8	J:75249	11865977
90836	Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.		Iwahara T; Fujimoto J; Wen D; Cupples R; Bucay N; Arakawa T ; Mori S ; Ratzkin B ; Yamamoto T		Oncogene	14	1997	439-49	J:38743	9053841
90837	Deregulated expression of TCL1 causes T cell leukemia in mice.		Virgilio L; Lazzeri C; Bichi R; Nibu K; Narducci MG; Russo G; Rothstein JL; Croce CM		Proc Natl Acad Sci U S A	95	1998	3885-9	J:46821	9520462
90838	T cell lymphoma in transgenic mice expressing the human Hsp70 gene.		Seo JS; Park YM; Kim JI; Shim EH; Kim CW; Jang JJ; Kim SH; Lee WH		Biochem Biophys Res Commun	218	1996	582-7	J:93922	8561799
90839	Inactivation of 11 beta-hydroxysteroid dehydrogenase type 1 by gene targeting in mice.		Kotelevtsev YV; Jamieson PM; Best R; Stewart F; Edwards CRW; Seckl JR; Mullins JJ		Endocr Res	22	1996	791-792	J:37960	 
90840	Long-term, low-level exposure of mice prone to mammary tumors to 435 MHz radiofrequency radiation.		Toler JC; Shelton WW; Frei MR; Merritt JH; Stedham MA		Radiat Res	148	1997	227-34	J:42610	9291353
90841	Sensitivity to radiation treatment and changes in metallothionein synthesis in a transplanted murine tumor.		Shibuya K; Cherian MG; Satoh M		Radiat Res	148	1997	235-9	J:42611	9291354
90842	Effect of Hibiscus rosa sinensis Extract on Hyperproliferation and Oxidative Damage Caused by Benzoyl Peroxide and Ultraviolet Radiations in Mouse Skin.		Sharma S; Sultana S		Basic Clin Pharmacol Toxicol	95	2004	220-225	J:94085	15546476
90843	Increasing metastatic potential is associated with induced chromosome 14 translocations in a previously nonmetastatic murine melanoma cell line.		Nemeth MA; Wilson MR; Fidler IJ; Pathak S		Cancer Genet Cytogenet	98	1997	119-25	J:43633	9332476
90844	Earlier onset of melanotroph carcinogenesis in mice with inherited mutant paternal allele of the retinoblastoma gene.		Nikitin AY; Riley DJ; Lee WH		Cancer Res	57	1997	4274-8	J:43634	9331088
90845	Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.		Vierboom MP; Nijman HW; Offringa R; van der Voort EI; van Hall T ; van den Broek L ; Fleuren GJ ; Kenemans P ; Kast WM ; Melief CJ		J Exp Med	186	1997	695-704	J:42596	9271585
90846	Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation.		Nakayama E; von Hoegen I; Parnes JR		Proc Natl Acad Sci U S A	86	1989	1352-6	J:43413	2645579
90847	Mouse models for human familial adenomatous polyposis.		Kucherlapati R; Lin DP; Edelmann W		Semin Cancer Biol	11	2001	219-25	J:78289	11407946
90848	Transplacental effects of 1-ethyl-1-nitrosourea in inbred strains of mice. IV. Rapid tumor induction in strain crosses.		Diwan BA; Meier H; Huebner RJ		J Natl Cancer Inst	52	1974	893-5	J:24683	4363693
90849	Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice.		Tsuruyama T; Nakamura T; Jin G; Ozeki M; Yamada Y; Hiai H		Proc Natl Acad Sci U S A	99	2002	8253-8	J:77108	12048235
90850	Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models.		Zhang D; Hirota T; Marumoto T; Shimizu M; Kunitoku N; Sasayama T; Arima Y; Feng L; Suzuki M; Takeya M; Saya H		Oncogene	23	2004	8720-30	J:94713	15480417
90851	Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice		Cipriano SC; Chen L; Kumar TR; Matzuk MM		Endocrinology	141	2000	2319-27	J:62951	10875231
90852	Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice.		Morikawa T; Wanibuchi H; Morimura K; Ogawa M; Fukushima S		Jpn J Cancer Res	91	2000	579-81	J:62952	10874208
90853	Possible mechanism on enhanced carcinogenesis of genotoxic carcinogens and unsolved mechanisms on lesser carcinogenic susceptibility to some carcinogens in rasH2 mice.		Mitsumori K		J Toxicol Sci	28	2003	371-83	J:88088	14746341
90854	Triterpene Acids from the Leaves of Perilla frutescens and Their Anti-inflammatory and Antitumor-promoting Effects.		Banno N; Akihisa T; Tokuda H; Yasukawa K; Higashihara H; Ukiya M; Watanabe K; Kimura Y; Hasegawa J; Nishino H		Biosci Biotechnol Biochem	68	2004	85-90	J:88089	14745168
90855	A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone.		Udaka K; Tsomides TJ; Walden P; Fukusen N; Eisen HN		Proc Natl Acad Sci U S A	90	1993	11272-6	J:43415	8248240
90856	Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge.		Hermans IF; Daish A; Moroni-Rawson P; Ronchese F		Cancer Immunol Immunother	44	1997	341-7	J:42583	9298937
90857	Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years.		Hong HL; Ton TV; Devereux TR; Moomaw C; Clayton N; Chan P; Dunnick JK; Sills RC		Toxicol Appl Pharmacol	191	2003	227-34	J:86087	13678655
90858	Expression of Superantigen-Like specificities on murine SJL/J-B lymphomas - Anti-Tumor v beta 17a+ T-Lymphocytes use a diverse set of T-Cell receptor v alpha-Chain gene sequences.		Katz J; Bonavida B		Int J Oncol	4	1994	839-847	J:20725	 
90859	Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.		Fedele M; Battista S; Kenyon L; Baldassarre G; Fidanza V; Klein-Szanto AJ; Parlow AF; Visone R; Pierantoni GM; Outwater E; Santoro M; Croce CM; Fusco A		Oncogene	21	2002	3190-8	J:76679	12082634
90860	BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl.		Hemmeryckx B; Reichert A; Watanabe M; Kaartinen V; de Jong R; Pattengale PK; Groffen J; Heisterkamp N		Oncogene	21	2002	3225-31	J:76680	12082638
90861	Breast and lung carcinoma in "A" stock mice		Bittner JJ		Public Health Rep	54	1939	380-92	J:2402	 
90862	A new strain of the mouse mammary tumor virus		Blair PB		Science	127	1957	518	J:2403	 
90863	The relation of coat color to the spontaneous incidence of mammary tumors in mice		Little CC		J Exp Med	59	1934	229-250	J:2446	 
90864	The genetics of non-epithelial tumor formation in mice		Little CC; Murray WS; Cloudman AM		Am Naturalist	73	1939	467-469	J:2449	 
90865	Differences between high and low breast tumor strains of mice when ovariectomized at birth		Woolley G; Fekete E; Little CC		Proc Soc Exp Biol Med	45	1940	796-798	J:2493	 
90866	Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.		Imamoto A; Beltran LM; Fujiki H; Chenicek KJ; DiGiovanni J		Carcinogenesis	13	1992	177-82	J:2743	1740006
90867	Cellular aspects of radiation-induced leukaemia.		Wright E		Leukemia	5	1991	825	J:3083	1943236
90868	Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations.		Potter M; Wiener F		Carcinogenesis	13	1992	1681-97	J:3176	1423827
90869	Search for Ha-ras codon 61 mutations in liver tumours caused by hexachlorobenzene and Aroclor 1254 in C57BL/10ScSn mice with iron overload.		Rumsby PC; Evans JG; Phillimore HE; Carthew P; Smith AG		Carcinogenesis	13	1992	1917-20	J:3179	1423854
90870	Cytogenetic damage and tumor incidence in mouse skin after single, topical applications of 7,12-dimethylbenz[a]anthracene.		Steinel HH; Bonin AM; He S; Baker RS		Mutat Res	285	1993	19-26	J:3851	7678128
90871	C57BL/6 mice are resistant to tumor promotion by full thickness skin wounding.		DiGiovanni J; Bhatt TS; Walker SE		Carcinogenesis	14	1993	319-21	J:3931	8435875
90872	Inhibition of skin tumor promotion by restriction of fat and carbohydrate calories in SENCAR mice.		Birt DF; Pinch HJ; Barnett T; Phan A; Dimitroff K		Cancer Res	53	1993	27-31	J:4514	8416746
90873	Analysis of Ly-1+ B-cell populations and IgH rearrangements in normal spleens and in lymphomas of AKR/J and AKR Fv-1b mice.		Rosner A; Peled A; Haran-Ghera N; Canaani E		Cancer Res	53	1993	2147-53	J:4757	7683252
90874	Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells.		Azumi JI; Sachs L		Proc Natl Acad Sci U S A	74	1977	253-7	J:5764	264678
90875	Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex.		Chesebro B; Wehrly K		Proc Natl Acad Sci U S A	76	1979	425-9	J:6107	284359
90876	Fragilitas ossium: a new autosomal recessive mutation in the mouse.		Guenet JL; Stanescu R; Maroteaux P; Stanescu V		J Hered	72	1981	440-1	J:6711	6801109
90877	The c-myc oncogene is translocated to the involved chromosome 12 in mouse plasmacytoma.		Erikson J; Miller DA; Miller OJ; Abcarian PW; Skurla RM; Mushinski JF; Croce CM		Proc Natl Acad Sci U S A	82	1985	4212-6	J:7886	3923490
90878	Suggestive evidence that genes controlling invasion and metastasis of T-cell lymphomas are located on mouse chromosome 3.		Verschaeve L; Verschueren H; VandenDriessche T; van Hecke D; Verhaegen S; de Baetselier P		Genes Chromosomes Cancer	1	1989	119-30	J:10969	2487151
90879	Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging [see comments]		van Lohuizen M; Verbeek S; Scheijen B; Wientjens E; van der Gulden H; Berns A		Cell	65	1991	737-52	J:11213	1904008
90880	Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice [see comments]		Haupt Y; Alexander WS; Barri G; Klinken SP; Adams JM		Cell	65	1991	753-63	J:11214	1904009
90881	An animal model of Kaposi's sarcoma. II. Pathogenesis of dimethyl hydrazine induced angiosarcoma and colorectal cancer in three mouse strains.		Madarnas P; Dube M; Rola-Pleszczynski M; Nigam VN		Anticancer Res	12	1992	113-7	J:11667	1567155
90882	Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung.		Pepin P; Bouchard L; Nicole P; Castonguay A		Carcinogenesis	13	1992	341-8	J:12685	1547522
90883	Accelerated appearance of skin tumors in hairless mice by repeated UV irradiation with initial intense exposure and characterization of the tumors.		Nishigori C; Tanaka M; Moriwaki S; Imamura S; Takebe H		Jpn J Cancer Res	83	1992	1172-8	J:12864	1483932
90884	Ethanol calories do not enhance breast cancer in isocalorically fed C3H/Ou mice.		Hackney JF; Engelman RW; Good RA		Nutr Cancer	18	1992	245-53	J:13330	1296198
90885	Lymphomagenesis in AKR.Fv-1b congenic mice.		Haran-Ghera N; Peled A; Brightman BK; Fan H		Cancer Res	53	1993	3433-8	J:13735	8324753
90886	Pyvs: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus.		Lukacher AE; Freund R; Carroll JP; Bronson RT; Benjamin TL		Virology	196	1993	241-8	J:14044	8395116
90887	Study of natural lipocortin I. A potent mediator for macrophage-mediated immunosuppression in tumor-bearing mice.		Sakata T; Iwagami S; Tsuruta Y; Suzuki S; Suzuki R		J Immunol	151	1993	4964-72	J:15213	8409450
90888	Spontaneous ovarian choriocarcinoma, yolk sac carcinoma, and teratoma in B6C3F1 mice: a case report.		Frith CH; Evans MG		Toxicol Pathol	21	1993	91-8	J:15588	8378711
90889	Somatically acquired recombinant murine leukemia proviruses in thymic leukemias of AKR/J mice.		Herr W; Gilbert W		J Virol	46	1983	70-82	J:15761	6298471
90890	Oxidative stress as a modulating factor of pulmonary tumorigenesis in mice; comparative study on two different strains.		Yano T; Ishikawa G; Ichikawa T		Comp Biochem Physiol C	104	1993	407-10	J:15792	8103432
90891	Caraway oil inhibits skin tumors in female BALB/c mice.		Shwaireb MH		Nutr Cancer	19	1993	321-5	J:16108	8346080
90892	Ki-ras oncogene mutations in tumors and DNA adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice.		Mass MJ; Jeffers AJ; Ross JA; Nelson G; Galati AJ; Stoner GD; Nesnow S		Mol Carcinog	8	1993	186-92	J:16251	8216737
90893	FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.		Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH		Carcinogenesis	14	1993	2353-8	J:16333	8242866
90894	Pregnancy dependence of mammary tumours in DDD mice congenic for Mtv-2, DDD/1-Mtv-2/Mtv-2.		Sayama K; Kaneko T; Matsuzawa A		Lab Anim	28	1994	44-9	J:16782	8158968
90895	Age-related changes of the prostate gland in the senescence-accelerated mouse.		Sugimura Y; Sakurai M; Hayashi N; Yamashita A; Kawamura J		Prostate	24	1994	24-32	J:17463	7507239
90896	Cyclopenta[cd]pyrene-induced tumorigenicity, Ki-ras codon 12 mutations and DNA adducts in strain A/J mouse lung [published erratum appears in Carcinogenesis 1994 Jul;15(7):1471]		Nesnow S; Ross JA; Nelson G; Wilson K; Roop BC; Jeffers AJ; Galati AJ; Stoner GD; Sangaiah R; Gold A; Mass MJ		Carcinogenesis	15	1994	601-6	J:17781	8149468
90897	Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone.		Rumsby PC; Davies MJ; Evans JG		Mol Carcinog	9	1994	71-5	J:18360	8142011
90898	Promotion of hepatocellular foci and adenomas by di(2-ethylhexyl) phthalate and phenobarbital in C3H/HeNCr mice following exposure to N-nitrosodiethylamine at 15 days of age.		Weghorst CM; Devor DE; Henneman JR; Ward JM		Exp Toxicol Pathol	45	1994	423-31	J:18361	8167465
90899	Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice.		Fattori E; Della Rocca C; Costa P; Giorgio M; Dente B; Pozzi L; Ciliberto G		Blood	83	1994	2570-9	J:18424	7513204
90900	Calcium and protein kinase C regulation of the glucocorticoid receptor in mouse corticotrope tumor cells.		Sheppard KE		J Steroid Biochem Mol Biol	48	1994	337-45	J:28542	7511409
90901	Influence of iron on the induction of hepatic tumors and porphyria by octachlorostyrene in C57BL/10ScSn mice.		Smith AG; Carthew P; Francis JE; Ingebrigtsen K		Cancer Lett	81	1994	145-50	J:19336	8012931
90902	Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.		Ward JM; Fox JG; Anver MR; Haines DC; George CV; Collins MJ Jr; Gorelick PL; Nagashima K; Gonda MA; Gilden RV; Tully JG; Russell RJ; Benveniste RE; Paster BJ; Dewhirst FE; Donovan JC; Anderson LM; Rice JM.		J Natl Cancer Inst	86	1994	1222-7	J:19662	8040890
90903	Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice.		Jiao D; Eklind KI; Choi CI; Desai DH; Amin SG; Chung FL		Cancer Res	54	1994	4327-33	J:19793	8044780
90904	5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors.		Srivastava PK; Chen YT; Old LJ		Proc Natl Acad Sci U S A	84	1987	3807-11	J:20303	2438686
90905	Renal cysts in transgenic mice expressing transforming growth factor-alpha [see comments]		Lowden DA; Lindemann GW; Merlino G; Barash BD; Calvet JP; Gattone VH 2nd		J Lab Clin Med	124	1994	386-94	J:20315	8083581
90906	T cell tumours of disparate phenotype in mice transgenic for Rbtn-2.		Larson RC; Fisch P; Larson TA; Lavenir I; Langford T; King G; Rabbitts TH		Oncogene	9	1994	3675-81	J:22065	7970726
90907	Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene: a potentially useful model for evaluation of chemopreventive agents.		Hecht SS; Isaacs S; Trushin N		Carcinogenesis	15	1994	2721-5	J:22203	8001227
90908	Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice.		Sharp R; Babyatsky MW; Takagi H; Tagerud S; Wang TC; Bockman DE; Brand SJ; Merlino G		Development	121	1995	149-61	J:22557	7867496
90909	Radiation-induced lymphomas in MSM, (BALB/cHeA x MSM) F1 and (BALB/cHeA x STS/A) F1 hybrid mice.		Okumoto M; Mori N; Miyashita N; Moriwaki K; Imai S; Haga S; Hiroishi S; Takamori Y; Esaki K		Jikken Dobutsu	44	1995	43-8	J:22782	7705478
90910	CD5 positive b cell leukaemia in old CBA mice.		Brohee D; Neve P		Med Sci Res	22	1994	841-842	J:23020	 
90911	Bioassay of alkyl halides and nucleotide base analogs by pulmonary tumor response in strain A mice.		Poirier LA; Stoner GD; Shimkin MB		Cancer Res	35	1975	1411-5	J:23524	124206
90912	Susceptibility to follicular hormone and disposition to mammary cancer in female mice		van Gulik PJ; Korteweg R		Am J Cancer	38	1940	506-15	J:24295	 
90913	[Two inbred strains of mice (SHN and SLN) with different mammary tumorigenesis established from the same basal stock of Swiss albino mice (author's transl)]		Nagasawa H		Jikken Dobutsu	28	1979	561-75	J:25409	527677
90914	Origin of pathogenic determinants of recombinant murine leukemia viruses: analysis of Bxv-1-related xenotropic viruses from CWD mice.		Massey AC; Coppola MA; Thomas CY		J Virol	64	1990	5491-9	J:24693	2170683
90915	Lifespan, age changes and tumour incidence in an ageing C57BL mouse colony.		Rowlatt C; Chesterman FC; Sheriff MU		Lab Anim	10	1976	419-42	J:24696	979138
90916	The hereditary factor in induced skin tumours in mice: establishment of a strain specially sensitive to carcinogenic agents applied to the skin		Bonser GM		J Pathol	46	1938	581-602	J:24714	 
90917	Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development.		Said TK; Medina D		Carcinogenesis	16	1995	823-30	J:24913	7728962
90918	Lactational performances of high (C3H/He) and low (C57BL/6) mammary tumor strains of mice (II)		Nagasawa H; Yanai R; Kosugiyama M; Fujimoto M; Kuretani K		Jikken Dobutsu	18	1969	23-7	J:24862	 
90919	Induction of tumours of connective tissue by repeated applications of 4-nitroquinoline N-oxide to mouse skin.		Searle CE; Spencer AT		Br J Cancer	20	1966	877-85	J:25337	5964618
90920	Carcinogenesis in naturally tumour-resistant mice. X-irradiation versus urethane as a carcinogenic agent.		Goldfeder A; Kauffman SL; Ghosh AK		Br J Cancer	20	1966	361-74	J:25339	5944278
90921	Inherited resistance to N- and B-tropic murine leukemia viruses in vitro: evidence that congenic mouse strains SIM and SIM.R differ at the Fv-1 locus.		Ware LM; Axelrad AA		Virology	50	1972	339-48	J:25416	4344190
90922	Atypical immunoglobulins associated with spontaneous lymphomas in an inbred strain of mice.		Schrohenloher RE; Bailey PC		J Natl Cancer Inst	49	1972	1027-37	J:25848	4628466
90923	Genetic analysis of the induction of tumors by methylcholanthrene. IX. Induced and spontaneous adenocarcinomas of the stomach in mice		Strong LC		J Natl Cancer Inst	5	1945	339-62	J:25855	 
90924	The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.		MacPhee M; Chepenik KP; Liddell RA; Nelson KK; Siracusa LD; Buchberg AM		Cell	81	1995	957-66	J:26137	7781071
90925	Mutations of the Ki-ras protooncogene in 3-methylcholanthrene and urethan-induced and butylated hydroxytoluene-promoted lung tumors of strain A/J and SWR mice.		Wang X; Witschi H		Cancer Lett	91	1995	33-9	J:26588	7750092
90926	Failure of dietary oltipraz to inhibit benzo[a]pyrene-induced lung tumorigenesis in strain a mice.		Morse MA; Zu H; Kresty LA; Stoner GD		Cancer Lett	91	1995	133-8	J:26589	7750088
90927	Protection by coffee cherry against spontaneous mammary tumour development in mice.		Nagasawa H; Yasuda M; Sakamoto S; Inatomi H		Anticancer Res	15	1995	141-6	J:26556	7733624
90928	Experimental model of upper intestinal adenocarcinoma induced by N-methyl-N'-nitro-N-nitrosoguanidine in C57BL/6 mice.		Ho SB; Lyftogt CT; Shekels LL; Niehans GA		Cancer Lett	91	1995	177-83	J:26684	7767907
90929	Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo[a]pyrene.		Mitsunaga SI; Zhang SY; Ruggeri BA; Gimenez-Conti I; Robles AI; Conti CJ; Klein-Szanto AJ		Carcinogenesis	16	1995	1629-35	J:26836	7542177
90930	Differential induction of bone and hematopoietic tumors in C3H mice after the injection of 239Pu citrate.		Oghiso Y; Yamada Y; Iida H		J Radiat Res (Tokyo)	35	1994	236-47	J:25034	7752107
90931	Six-month exposure of strain A/J mice to cigarette sidestream smoke: cell kinetics and lung tumor data.		Witschi H; Oreffo VI; Pinkerton KE		Fundam Appl Toxicol	26	1995	32-40	J:26918	7657060
90932	Mouse mammary tumor virus (MMTV) infection in SWISS and RIII mice. Correlation between resistance to exogenous infection and anti-MMTV serum response.		Hainaut P; Vaira D; Francois C; Calberg-Bacq CM		Arch Virol	113	1990	35-52	J:27029	2167058
90933	Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors.		Marchetti A; Robbins J; Campbell G; Buttitta F; Squartini F; Bistocchi M; Callahan R		J Virol	65	1991	4550-4	J:26996	1712864
90934	Resistance of STS/A mice to lymphoma induction by X-irradiation.		Okumoto M; Nishikawa R; Imai S; Hilgers J		J Radiat Res (Tokyo)	30	1989	135-9	J:27073	2769623
90935	Morphologic classification and correlation of incidence of hyperplastic and neoplastic hematopoietic lesions in mice with age.		Frith CH; Wiley LD		J Gerontol	36	1981	534-45	J:27153	7264236
90936	The different activation of int genes in mammary carcinomas developed in three mouse strains harboring mouse mammary tumor viruses derived from DD/Tbr.		Okumoto M; Nishikawa R; Iwai M; Iwai Y; Imai S; Mori N; Takamori Y; Yagasaki O		Jikken Dobutsu	40	1991	431-8	J:27299	1660818
90937	Observations on three fuctional tests in a high-tumor and a low-tumor strain of mice		Fekete E		Am J Cancer	38	1940	234-8	J:26268	 
90938	The relationship between inhalation of nitrogen dioxide, the immune system, and progression of a spontaneously occurring lymphoma in AKR mice.		Richters A; Damji KS		J Environ Pathol Toxicol Oncol	10	1990	225-30	J:27491	2262886
90939	Role of the AKR gene locus AKv-1 in susceptibility to chemical induction of thymic lymphomas.		Becker FF		Cancer Res	50	1990	6235-7	J:27594	2169341
90940	Effect of pulsed magnetic fields on leukemia-prone AKR mice. No-effect on mortality through five generations.		Bellossi A		Leuk Res	15	1991	899-902	J:27674	1921450
90941	The effects of passive antiviral immunotherapy in AKR mice: I. The susceptibility of AKR mice to spontaneous and induced T cell lymphomagenesis.		Haran-Ghera N; Peled A; Wu L; Shortman K; Brightman BK; Fan H		Leukemia	9	1995	1199-206	J:27742	7630195
90942	Pulmonary tumors in mice. IV. Lung tumors induced by subcutaneous injection of 1:2:5:6-dibenzanthracene in different media and by its direct contact with lung tissues		Andervont HB		Public Health Rep	52	1937	1584-9	J:26361	 
90943	Pulmonary tumors in mice. I. The susceptibility of the lungs of albino mice to the carcinogenic action of 1, 2, 5, 6-dibenzanthracene		Andervont HB		Public Health Rep	52	1937	212-21	J:26364	 
90944	Changes in the incidence of mammary carcinoma in mice of the A stock		Bittner JJ		Cancer Res	1	1941	113-4	J:26322	 
90945	Ecotropic virus involvement in spontaneous B-cell lymphomas of CWD/LeAgl mice.		Angel JM; Bedigian HG		Leuk Res	13	1989	417-25	J:27894	2545977
90946	Changes of lipid-bound sialic acid in the plasma of mice bearing benzpyrene-induced tumors.		Polivkova J; Vosmikova K; Pospisil J		Neoplasma	36	1989	667-71	J:27902	2615870
90947	Oral administration of tritiated water (HTO) in mouse. II. Tumour development.		Yamamoto O; Seyama T; Jo T; Terato H; Saito T; Kinomura A		Int J Radiat Biol	68	1995	47-54	J:28654	7629437
90948	Inhibition of 12-O-tetradecanoylphorbol-13-acetate and other skin tumor-promoter-caused induction of epidermal interleukin-1 alpha mRNA and protein expression in SENCAR mice by green tea polyphenols.		Katiyar SK; Rupp CO; Korman NJ; Agarwal R; Mukhtar H		J Invest Dermatol	105	1995	394-8	J:28767	7665919
90949	Ectopic expression of rhombotin-2 causes selective expansion of CD4-CD8- lymphocytes in the thymus and T-cell tumors in transgenic mice.		Neale GA; Rehg JE; Goorha RM		Blood	86	1995	3060-71	J:29260	7579400
90950	Role of point mutation of the K-ras gene in tumorigenesis of B6C3F1 mouse lung lesions induced by urethane.		Kawano R; Nishisaka T; Takeshima Y; Yonehara S; Inai K		Jpn J Cancer Res	86	1995	802-10	J:29422	7591956
90951	Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin.		Hermiston ML; Gordon JI		Science	270	1995	1203-7	J:29749	7502046
90952	The effects of passive anti-viral immunotherapy in AKR mice: II. Susceptibility to B cell lymphomagenesis.		Haran-Ghera N; Peled A; Canaani E; Caspi Y; Haimovich J; Shaft D; Resnitzky P; Brightman BK; Fan H		Leukemia	9	1995	1940-7	J:29969	7475287
90953	Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.		Tivol EA; Borriello F; Schweitzer AN; Lynch WP; Bluestone JA; Sharpe AH		Immunity	3	1995	541-7	J:30393	7584144
90954	Qa2 expression in BALB/c sublines and a BALB/cLAC tumor.		Rogers MJ; Galetto G; Matthai R; Potter M		Curr Top Microbiol Immunol	122	1985	43-9	J:30480	2994957
90955	Dietary fat: gene expression and mammary tumorigenesis.		Etkind PR; Qiu L; Lumb K		Nutr Cancer	24	1995	13-21	J:31391	7491294
90956	Chemoprevention of diethylnitrosamine-induced liver foci and hepatocellular adenomas in C3H mice.		Pereira MA		Anticancer Res	15	1995	1953-6	J:31687	8572583
90957	Mutations involving the endogenous ecotropic murine leukemia virus in primary mammary carcinomas of BALB/c mice.		Natoli F; Crowley MR; Asch HL; Stoler DL; Asch BB		Cancer Lett	99	1996	121-7	J:31689	8564923
90958	Influence of paternal (252) Cf neutron exposure on abnormal sperm, embryonal lethality, and liver tumorigenesis in the F(1) offspring of mice.		Watanabe H; Takahashi T; Lee JY; Ohtaki M; Roy G; Ando Y; Yamada K; Gotoh T; Kurisu K; Fujimoto N; Satow Y; Ito A		Jpn J Cancer Res	87	1996	51-7	J:31884	8609049
90959	Tenfold increased incidence of spontaneous multiple myeloma in long-term immunosuppressed aging C57BL/KaLwRij mice.		Radl J; Van Arkel C; Hopstaken CM; HogenEsch H		Clin Immunol Immunopathol	79	1996	155-62	J:32802	8620621
90960	A quantitative trait locus in major histocompatibility complex determining latent period of mouse lymphomas.		Kamoto T; Shisa H; Pataer A; Lu L; Yoshida O; Yamada Y; Hiai H		Jpn J Cancer Res	87	1996	401-4	J:33016	8641972
90961	Alterations in expression of CYP1A1 and NADPH-cytochrome P450 reductase during lung tumor development in SWR/J mice.		Forkert PG; Lord JA; Parkinson A		Carcinogenesis	17	1996	127-32	J:32979	8565121
90962	Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.		Lasky JL; Thorbecke GJ		Eur J Immunol	19	1989	365-71	J:33209	2495224
90963	Promotion by dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice.		Pereira MA; Phelps JB		Cancer Lett	102	1996	133-41	J:33530	8603361
90964	Common sites of viral integration in lymphomas arising in AKXD recombinant inbred mouse strains.		Mucenski ML; Gilbert DJ; Taylor BA; Jenkins NA; Copeland NG		Oncogene Res	2	1987	33-48	J:34583	3505665
90965	Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis.		Girard L; Hanna Z; Beaulieu N; Hoemann CD; Simard C; Kozak CA; Jolicoeur P		Genes Dev	10	1996	1930-44	J:34764	8756350
90966	Microsatellite analysis of recurrent chromosome 2 deletions in acute myeloid leukaemia induced by radiation in F1 hybrid mice.		Clark DJ; Meijne EI; Bouffler SD; Huiskamp R; Skidmore CJ; Cox R ; Silver AR		Genes Chromosomes Cancer	16	1996	238-46	J:35175	8875237
90967	Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein [see comments]		Lefebvre O; Chenard MP; Masson R; Linares J; Dierich A; LeMeur M; Wendling C; Tomasetto C; Chambon P; Rio MC		Science	274	1996	259-62	J:35923	8824193
90968	Spontaneous tumors of the prostate gland in inbred strains of mice.		Waymouth C; Coman DR; Ward-Bailey PF		J Natl Cancer Inst	70	1983	199-208	J:35930	6571915
90969	Transplacental transmission of a leukemogenic murine leukemia virus.		Bedigian HG; Shepel LA; Hoppe PC		J Virol	67	1993	6105-9	J:36190	8396671
90970	Resistance of AKR mice to lymphoid leukemia associated with a chronic protozoan infection, Besnoitia jellisoni.		Lunde MN; Gelderman AH		J Natl Cancer Inst	47	1971	485-8	J:36194	5559245
90971	Expression of murine renin genes in subcutaneous connective tissue.		Sigmund CD; Jones CA; Mullins JJ; Kim U; Gross KW		Proc Natl Acad Sci U S A	87	1990	7993-7	J:36423	2172970
90972	Decreased tumor surveillance in perforin-deficient mice.		van den Broek ME; Kagi D; Ossendorp F; Toes R; Vamvakas S; Lutz WK ; Melief CJ ; Zinkernagel RM ; Hengartner H		J Exp Med	184	1996	1781-90	J:36584	8920866
90973	Genetic predisposition to lymphomas in mice.		Hiai H		Pathol Int	46	1996	707-18	J:36697	8916139
90974	Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice.		Gould KA; Luongo C; Moser AR; McNeley MK; Borenstein N; Shedlovsky A; Dove WF; Hong K; Dietrich WF; Lander ES		Genetics	144	1996	1777-85	J:37223	8978063
90975	Mutagenic responses of L5178Y mouse cells at the tk and hprt loci.		McGregor DB; Riach C; Cattanach P; Edwards I; Shepherd W; Caspary WJ		Toxicol In Vitro	10	1996	643-647	J:38009	 
90976	Mapping of a major osteomagenic determinant of murine leukemia virus RFB-14 to non-long terminal repeat sequences.		Ostergaard M; Pedersen L; Schmidt J; Luz A; Lovmand J; Erfle V; Pedersen FS; Strauss PG		J Virol	71	1997	645-9	J:37972	8985395
90977	Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.		Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL		Cell Mol Biol (Noisy-le-grand)	42	1996	769-78	J:38187	8832108
90978	Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice: the difference is as clear as black and white.		Ponnaiya B; Cornforth MN; Ullrich RL		Radiat Res	147	1997	121-5	J:38126	9008202
90979	Phosphatidyl serine is involved in the reduced rate of transcription of the inducible nitric oxide synthase gene in macrophages from tumor-bearing mice.		DiNapoli MR; Calderon CL; Lopez DM		J Immunol	158	1997	1810-7	J:38255	9029120
90980	Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model		Hanania EG; Deisseroth AB		Clin Cancer Res	3	1997	281-6	J:38355	9815684
90981	Strain differences in the cytotoxic activity and TNF production of murine macrophages stimulated by lentinan.		Kerekgyarto C; Virag L; Tanko L; Chihara G; Fachet J		Int J Immunopharmacol	18	1996	347-53	J:38452	9024935
90982	Animal models and the molecular pathology of cancer.		Lovejoy EA; Clarke AR; Harrison DJ		J Pathol	181	1997	130-5	J:38594	9120714
90983	Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.		Jonkers J; Korswagen HC; Acton D; Breuer M; Berns A		EMBO J	16	1997	441-50	J:38606	9034327
90984	Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle [see comments]		Seldin DC; Leder P		Science	267	1995	894-7	J:38552	7846532
90985	Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation.		Bernardin F; Collyn-d'Hooghe M; Quief S; Bastard C; Leprince D ; Kerckaert JP		Oncogene	14	1997	849-55	J:38632	9047392
90986	Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor.		Ishii S; Nagase T; Tashiro F; Ikuta K; Sato S; Waga I; Kume K ; Miyazaki J ; Shimizu T		EMBO J	16	1997	133-42	J:38639	9009274
90987	The S3a ribosomal protein gene is identical to the Fte-1 (v-fos transformation effector) gene and the TNF-alpha-induced TU-11 gene, and its transcript level is altered in transformed and tumor cells.		Lecomte F; Szpirer J; Szpirer C		Gene	186	1997	271-7	J:38783	9074506
90988	Molecular cloning of a functional murine arginine-specific mono-ADP-ribosyltransferase and its expression in lymphoid cells.		Yu Y; Okamoto S; Nemoto E; Dennert G		DNA Cell Biol	16	1997	235-44	J:38788	9052744
90989	A water-soluble antitumor glycoprotein from Chlorella vulgaris.		Noda K; Ohno N; Tanaka K; Kamiya N; Okuda M; Yadomae T; Nomoto K; Shoyama Y		Planta Med	62	1996	423-6	J:38881	8923807
90990	Fgr expression restricted to subpopulation of monocyte/macrophage lineage in resting conditions is induced in various hematopoietic cells after activation or transformation.		Hatakeyama S; Iwabuchi K; Ato M; Iwabuchi C; Kajino K; Takami K; Katoh M; Ogasawara K; Good RA; Onoe K		Microbiol Immunol	40	1996	223-31	J:38882	8934677
90991	Mechanism of the anti-tumour effect of 2,3,5-trimethyl-6-(3-pyridylmethyl) 1,4-benzoquinone (CV-6504).		Hussey HJ; Tisdale MJ		Br J Cancer	75	1997	845-9	J:38933	9062405
90992	Multiple promoter elements differentially regulate the expression of the mouse tenascin gene.		Copertino DW; Edelman GM; Jones FS		Proc Natl Acad Sci U S A	94	1997	1846-51	J:39011	9050867
90993	Regulation of ribosomal RNA gene transcription during retinoic acid-induced differentiation of mouse teratocarcinoma cells.		Datta PK; Budhiraja S; Reichel RR; Jacob ST		Exp Cell Res	231	1997	198-205	J:39142	9056427
90994	Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice.		Smith-McCune K; Zhu YH; Hanahan D; Arbeit J		Cancer Res	57	1997	1294-300	J:39289	9102216
90995	Low incidence of p53 mutations in UVA (365-nm)-induced skin tumors in hairless mice.		van Kranen HJ; de Laat A; van de Ven J; Wester PW; de Vries A; Berg RJ; van Kreijl CF; de Gruijl FR		Cancer Res	57	1997	1238-40	J:39290	9102205
90996	A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis.		Helbing CC; Veillette C; Riabowol K; Johnston RN; Garkavtsev I		Cancer Res	57	1997	1255-8	J:39291	9102209
90997	Spontaneous development of plasmacytomas in a selected subline of BALB/cJ mice.		Silva S; Wang Y; Babonits M; Imreh S; Wiener F; Klein G		Eur J Cancer	33	1997	479-85	J:39292	9155535
90998	The thyrotrope-restricted isoform of the retinoid-X receptor-gamma1 mediates 9-cis-retinoic acid suppression of thyrotropin-beta promoter activity.		Haugen BR; Brown NS; Wood WM; Gordon DF; Ridgway EC		Mol Endocrinol	11	1997	481-9	J:39371	9092800
90999	Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury.		Ichimiya S; Davis JG; O'Rourke DM; Katsumata M; Greene MI		DNA Cell Biol	16	1997	311-21	J:39372	9115640
91000	Calorie restriction reduces the incidence of myeloid leukemia induced by a single whole-body radiation in C3H/He mice.		Yoshida K; Inoue T; Nojima K; Hirabayashi Y; Sado T		Proc Natl Acad Sci U S A	94	1997	2615-9	J:39326	9122244
91001	Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation.		Ceci JD; Patriotis CP; Tsatsanis C; Makris AM; Kovatch R; Swing DA ; Jenkins NA ; Tsichlis PN ; Copeland NG		Genes Dev	11	1997	688-700	J:39450	9087424
91002	Ras involvement in signal transduction by the serotonin 5-HT2B receptor.		Launay JM; Birraux G; Bondoux D; Callebert J; Choi DS; Loric S; Maroteaux L		J Biol Chem	271	1996	3141-7	J:39559	8621713
91003	Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice.		Lander JK; Fan H		J Virol	71	1997	3940-52	J:39477	9094671
91004	Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses.		Golovkina TV; Piazzon I; Nepomnaschy I; Buggiano V; de Olano Vela M ; Ross SR		J Virol	71	1997	3895-903	J:39479	9094666
91005	The Pax-5 gene is alternatively spliced during B-cell development.		Zwollo P; Arrieta H; Ede K; Molinder K; Desiderio S; Pollock R		J Biol Chem	272	1997	10160-8	J:39638	9092562
91006	Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.		Abe A; Emi N; Taji H; Kasai M; Kohno A; Saito H		Gene Ther	3	1996	988-93	J:39695	8940639
91007	Gene therapy for hepatocellular carcinoma: long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vivo.		Huang H; Chen SH; Kosai K; Finegold MJ; Woo SL		Gene Ther	3	1996	980-7	J:39696	8940638
91008	Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression.		Aruga A; Aruga E; Cameron MJ; Chang AE		J Leukoc Biol	61	1997	507-16	J:39669	9103238
91009	Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts.		Ciana P; Neri A; Cappellini C; Cavallo F; Pomati M; Chang CC; Maiolo AT; Lombardi L		Oncogene	14	1997	1805-10	J:39766	9150386
91010	Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYAC.		Butzler C; Zou X; Popov AV; Bruggemann M		Oncogene	14	1997	1383-8	J:39733	9178899
91011	Induced melanin reduces mutations and cell killing in mouse melanoma.		Li W; Hill HZ		Photochem Photobiol	65	1997	480-5	J:39734	9077136
91012	Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity.		Celluzzi CM; Falo LD Jr		J Invest Dermatol	108	1997	716-20	J:39959	9129221
91013	A comparative review of the immunobiology of murine neuroblastoma and human neuroblastoma.		Ziegler MM; Ishizu H; Nagabuchi E; Takada N; Arya G		Cancer	79	1997	1757-66	J:39897	9128993
91014	Analysis of the ability of 12-O-tetradecanoylphorbol-13-acetate to induce epidermal hyperplasia, transforming growth factor-alpha, and skin tumor promotion in wa-1 mice.		Kiguchi K; Beltran L; Dubowski A; DiGiovanni J		J Invest Dermatol	108	1997	784-91	J:40006	9129233
91015	Manipulation of the mouse germline in the study of Min-induced neoplasia.		Bilger A; Shoemaker AR; Gould KA; Dove WF		Semin Cancer Biol	7	1996	249-60	J:40100	9110402
91016	The p53-deficient mouse: a model for basic and applied cancer studies.		Donehower LA		Semin Cancer Biol	7	1996	269-78	J:40101	9110404
91017	Gender-dependent differences in hepatic tumor promotion in diethylnitrosamine initiated infant B6C3F1 mice by alpha-hexachlorocyclohexane.		Siglin JC; Weghorst CM; Rodwell DE; Klaunig JE		J Toxicol Environ Health	44	1995	235-45	J:40170	7531777
91018	Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis.		Watanabe M; McCormick KL; Volker K; Ortaldo JR; Wigginton JM ; Brunda MJ ; Wiltrout RH ; Fogler WE		Am J Pathol	150	1997	1869-80	J:40138	9137109
91019	Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition.		van der Horst GT; van Steeg H; Berg RJ; van Gool AJ; de Wit J; Weeda G; Morreau H; Beems RB; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH		Cell	89	1997	425-35	J:40211	9150142
91020	Detection of mouse tyrosinase with a monoclonal antibody MAT-1 against human tyrosinase.		Suzuki S; Takimoto H; Masui S; Kato T; Shibata K; Tomita Y; Shibahara S; Nakano H		Pigment Cell Res	9	1996	298-303	J:40291	9125753
91021	Ganglioside GD1alpha functions in the adhesion of metastatic tumor cells to endothelial cells of the target tissue.		Taki T; Ishikawa D; Ogura M; Nakajima M; Handa S		Cancer Res	57	1997	1882-8	J:40424	9157980
91022	Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.		Ahmad I; Filep JJ; Franklin JC; Janoff AS; Masters GR; Pattassery J ; Peters A ; Schupsky JJ ; Zha Y ; Mayhew E		Cancer Res	57	1997	1915-21	J:40426	9157985
91023	Modulation of alpha 6/beta 1 integrin expression during differentiation of F9 murine embryonal carcinoma cells to parietal endoderm.		Morini M; Piccini D; Barbieri O; Astigiano S		Exp Cell Res	232	1997	304-12	J:40525	9168806
91024	Hrp12, a novel heat-responsive, tissue-specific, phosphorylated protein isolated from mouse liver.		Samuel SJ; Tzung SP; Cohen SA		Hepatology	25	1997	1213-22	J:40528	9141440
91025	Cytogenetic analyses of a murine carcinoma cell line and six metastatic derivatives with different degrees of radioresistability.		Jamasbi RJ; Ye MQ; Norvell TM		In Vitro Cell Dev Biol Anim	33	1997	137-44	J:40685	9081221
91026	Fre2, a proviral integration site of Friend murine leukemia virus that is closely linked to Fv2.		Friedrich RW; Veit M; Eisel D; Friedrich U; Pass M; Kozak CA		Leukemia	11	1997	619-23	J:40755	9180281
91027	Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential.		Di Carlo E; Modesti A; Castrilli G; Landuzzi L; Allione A; de Giovanni C ; Musso T ; Musiani P		J Pathol	182	1997	76-85	J:40758	9227345
91028	CD44v10 expression in the mouse and functional activity in delayed type hypersensitivity.		Rosel M; Seiter S; Zoller M		J Cell Physiol	171	1997	305-17	J:40760	9180900
91029	Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.		Yamamoto N; Naraparaju VR		Cancer Res	57	1997	2187-92	J:40806	9187119
91030	Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.		Yan Y; Frisen J; Lee MH; Massague J; Barbacid M		Genes Dev	11	1997	973-83	J:40142	9136926
91031	Gene expression in skin tumors induced in hairless mice by chronic exposure to ultraviolet B irradiation.		Sato H; Suzuki JS; Tanaka M; Ogiso M; Tohyama C; Kobayashi S		Photochem Photobiol	65	1997	908-14	J:40850	9155265
91032	The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.		Majlessi L; Bordenave G		Eur J Immunol	27	1997	1346-52	J:40938	9209483
91033	TAP-dependent major histocompatibility complex class I presentation of soluble proteins using listeriolysin.		Darji A; Chakraborty T; Wehland J; Weiss S		Eur J Immunol	27	1997	1353-9	J:40939	9209484
91034	Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.		Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J ; Starling GC ; Siadak AW ; Aruffo A		Eur J Immunol	27	1997	1469-78	J:40942	9209500
91035	The defined attenuated Listeria monocytogenes delta mp12 mutant is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma.		Paglia P; Arioli I; Frahm N; Chakraborty T; Colombo MP; Guzman CA		Eur J Immunol	27	1997	1570-5	J:40945	9209512
91036	Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein.		Bouillet P; Sapin V; Chazaud C; Messaddeq N; Decimo D; Dolle P ; Chambon P		Mech Dev	63	1997	173-86	J:40904	9203140
91037	Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established.		Vitetta ES; Tucker TF; Racila E; Huang YW; Marches R; Lane N ; Scheuermann RH ; Street NE ; Watanabe T ; Uhr JW		Blood	89	1997	4425-36	J:40906	9192767
91038	A heart segmental defect in the anterior-posterior axis of a transgenic mutant mouse.		Yamamura H; Zhang M; Markwald RR; Mjaatvedt CH		Dev Biol	186	1997	58-72	J:41016	9188753
91039	Analysis of phosphofructokinase subunits and isozymes in ascites tumor cells and its original tissue, murine mammary gland.		Sanchez-Martinez C; Aragon JJ		FEBS Lett	409	1997	86-90	J:40993	9199509
91040	The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells.		Murata Y; Kudoh T; Sugiyama H; Toyoshima K; Akiyama T		FEBS Lett	409	1997	41-5	J:40994	9199500
91041	Increased transcription of the E mu-myc transgene and mRNA stabilisation produce only a modest elevation in Myc protein.		Colley SM; Tilbrook PA; Klinken SP		Oncogene	14	1997	2735-9	J:40998	9178772
91042	Differential involvement of caspases in apoptosis of myeloid leukemic cells induced by chemotherapy versus growth factor withdrawal.		Barge RM; Willemze R; Vandenabeele P; Fiers W; Beyaert R		FEBS Lett	409	1997	207-10	J:41093	9202146
91043	APC binds to the novel protein EB1.		Su LK; Burrell M; Hill DE; Gyuris J; Brent R; Wiltshire R; Trent J ; Vogelstein B ; Kinzler KW		Cancer Res	55	1995	2972-7	J:41064	7606712
91044	Contribution of oncogenes and tumor suppressor genes to myeloid leukemia.		Wolff L		Biochim Biophys Acta	1332	1997	F67-104	J:41073	9196020
91045	p94fer facilitates cellular recovery of gamma irradiated pre-T cells.		Halachmy S; Bern O; Schreiber L; Carmel M; Sharabi Y; Shoham J ; Nir U		Oncogene	14	1997	2871-80	J:41166	9205095
91046	Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair [news]		Brugarolas J; Jacks T		Nat Med	3	1997	721-2	J:41377	9212093
91047	Identification of a T-cell receptor from a therapeutic murine T-cell clone.		Shilyansky J; Yang JC; Custer MC; Spiess P; Mixon A; Cole DJ; Mule JJ; Rosenberg SA; Nishimura MI		J Immunother	20	1997	247-55	J:41451	9220314
91048	T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6.		Kubo M; Ransom J; Webb D; Hashimoto Y; Tada T; Nakayama T		EMBO J	16	1997	4007-20	J:41611	9233810
91049	Detection of endothelial cells by MEC 13.3 monoclonal antibody in mice mammary tumors.		Vanzulli S; Gazzaniga S; Braidot MF; Vecchi A; Mantovani A; Wainstok de Calmanovici R		Biocell	21	1997	39-46	J:41562	9212717
91050	Effect of c-Fos overexpression on the murine macrophage cell line P388DI.		Mirahmadi R; Le Garrec Y; Rouer E; Michel P; Pompidou A		C R Acad Sci III	320	1997	13-8	J:41568	9099259
91051	Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell.		Takeda T; Kurachi H; Yamamoto T; Homma H; Adachi K; Morishige K ; Miyake A ; Murata Y		Endocrinology	138	1997	2689-96	J:41571	9202205
91052	Targeting an anti-viral CD8+ T cell response to a growing tumor facilitates its rejection.		Bohm W; Schirmbeck R; Reimann J		Cancer Immunol Immunother	44	1997	230-8	J:41689	9222282
91053	Priming of the antitumor response promotes efficacy of interleukin-2 therapy.		Everse LA; Bernsen MR; Dullens HF; Den Otter W		Cancer Immunol Immunother	44	1997	221-9	J:41690	9222281
91054	Mouse CD1 is mainly expressed on hemopoietic-derived cells.		Brossay L; Jullien D; Cardell S; Sydora BC; Burdin N; Modlin RL ; Kronenberg M		J Immunol	159	1997	1216-24	J:41641	9233616
91055	Cross-linking of the IgM receptor induces rapid translocation of IgM-associated Ig alpha, Lyn, and Syk tyrosine kinases to the membrane skeleton.		Jugloff LS; Jongstra-Bilen J		J Immunol	159	1997	1096-106	J:41647	9233602
91056	Cytokine expression and tumorigenicity of large granular lymphocytic leukemia cells from mice transgenic for the tax gene of human T-cell leukemia virus type I.		Grossman WJ; Ratner L		Blood	90	1997	783-94	J:41777	9226179
91057			Hirouchi Y		J Toxicol Pathol	7	1994	153-177	J:41781	 
91058	Host-tumor interactions in the SJL lymphoma model.		Ponzio NM; Brown PH; Thorbecke GJ		Int Rev Immunol	1	1986	273-301	J:41782	3334050
91059	Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia.		Saiardi A; Bozzi Y; Baik JH; Borrelli E		Neuron	19	1997	115-26	J:41857	9247268
91060	Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice.		Kelly MA; Rubinstein M; Asa SL; Zhang G; Saez C; Bunzow JR; Allen RG ; Hnasko R ; Ben-Jonathan N ; Grandy DK ; Low MJ		Neuron	19	1997	103-13	J:41858	9247267
91061	Molecular aberrations in the MHC class I-restricted pathway for antigen presentation in methylcholanthrene sarcomas from nude mice: discrepancies between MHC mRNA and surface protein.		Engel AM; Svane IM; Madsen MW; Pedersen M; Werdelin O		Clin Exp Immunol	109	1997	323-31	J:42024	9276529
91062	The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development.		Hoyt PR; Bartholomew C; Davis AJ; Yutzey K; Gamer LW; Potter SS ; Ihle JN ; Mucenski ML		Mech Dev	65	1997	55-70	J:42030	9256345
91063	Members of the family of IL-6-type cytokines activate Stat5a in various cell types.		Piekorz RP; Nemetz C; Hocke GM		Biochem Biophys Res Commun	236	1997	438-43	J:41984	9240457
91064	Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors.		Germolec DR; Spalding J; Boorman GA; Wilmer JL; Yoshida T; Simeonova PP ; Bruccoleri A ; Kayama F ; Gaido K ; Tennant R ; Burleson F ; Dong W ; Lang RW ; Luster MI		Mutat Res	386	1997	209-18	J:42204	9219559
91065	Relative genotoxic potency of arsenic and its methylated metabolites.		Moore MM; Harrington-Brock K; Doerr CL		Mutat Res	386	1997	279-90	J:42205	9219565
91066	A possible correlation between growth-factor sensitivity and response to mitoxantrone treatment in a murine myeloid leukaemia (SA7HD) cell line.		Abubakar AA; Riches AC		Acta Oncol	36	1997	421-7	J:42209	9247104
91067	The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11.		Valk PJ; Hol S; Vankan Y; Ihle JN; Askew D; Jenkins NA; Gilbert DJ ; Copeland NG ; de Both NJ ; Lowenberg B ; Delwel R		J Virol	71	1997	6796-804	J:42241	9261404
91068	Specific transcription of the unrearranged TCR V beta 8.2 gene in lymphoid tissues occurs independently of V(D)J rearrangement.		Jolly CJ; O'Neill HC		Immunol Cell Biol	75	1997	13-20	J:42246	9046429
91069	Identification of mouse histone deacetylase 1 as a growth factor-inducible gene.		Bartl S; Taplick J; Lagger G; Khier H; Kuchler K; Seiser C		Mol Cell Biol	17	1997	5033-43	J:42359	9271381
91070	Molecular cloning and expression of mouse homologue of SFA-1/PETA-3 (CD151), a member of the transmembrane 4 superfamily.		Hasegawa H; Watanabe H; Nomura T; Utsunomiya Y; Yanagisawa K ; Fujita S		Biochim Biophys Acta	1353	1997	125-30	J:42363	9294006
91071	Organization of the murine reduced folate carrier gene and identification of variant splice forms.		Brigle KE; Spinella MJ; Sierra EE; Goldman ID		Biochim Biophys Acta	1353	1997	191-8	J:42364	9294013
91072	Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells.		Zhao R; Seither R; Brigle KE; Sharina IG; Wang PJ; Goldman ID		J Biol Chem	272	1997	21207-12	J:42365	9261128
91073	The mouse extracellular signal-regulated kinase 2 gene. Gene structure and characterization of the promoter.		Sugiura N; Suga T; Ozeki Y; Mamiya G; Takishima K		J Biol Chem	272	1997	21575-81	J:42367	9261178
91074	fau cDNA encodes a ubiquitin-like-S30 fusion protein and is expressed as an antisense sequence in the Finkel-Biskis-Reilly murine sarcoma virus.		Michiels L; Van der Rauwelaert E; Van Hasselt F; Kas K; Merregaert J		Oncogene	8	1993	2537-46	J:42311	8395683
91075	Expression of the parathyroid hormone-related peptide gene in retinoic acid-induced differentiation: involvement of ETS and Sp1.		Karperien M; Farih-Sips H; Lowik CW; de Laat SW; Boonstra J ; Defize LH		Mol Endocrinol	11	1997	1435-48	J:42449	9280059
91076	The oncologic and genetic characterization of C3H/He mice.		Kharkovskaya NA; Klepikov NN; Krasnova TA; Hrustalev SA		Exp Oncol	19	1997	118-123	J:42414	 
91077	Chromosome 2 hypersensitivity and clonal development in murine radiation acute myeloid leukaemia.		Bouffler SD; Meijne EI; Morris DJ; Papworth D		Int J Radiat Biol	72	1997	181-9	J:42665	9269311
91078	Lymphocyte-specific genomic instability and risk of lymphoid malignancy.		Kirsch IR; Lista F		Semin Immunol	9	1997	207-15	J:42638	9200332
91079	Stages in the development of radiation-induced thymic lymphomas in C57 BL/Ka mice: preleukemic cells become progressively resistant to the tumor preventing effects of a bone marrow graft.		Humblet C; Greimers R; Boniver J; Defrense MP		Exp Hematol	25	1997	109-13	J:38304	9015210
91080	Preferential loss of heterozygosity of chromosome 7 loci in simian virus 40 t/T antigen-induced mouse hepatocellular carcinomas does not involve H-ras mutations.		Casola S; Vernucci M; Ungaro P; Bruni CB; Riccio A		Acta Genet Med Gemellol (Roma)	45	1996	221-5	J:37932	8872035
91081	Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.		Bradley MB; Fernandez JM; Ungers G; Diaz-Barrientos T; Steimle V ; Mach B ; O'Reilly R ; Lee JS		J Immunol	159	1997	1086-95	J:41648	9233601
91082	1,2-Dimethylhydrazine carcinogenesis in C3HA and CBA female mice prenatally treated with diethylstilbestrol.		Turusov VS; Trukhanova LS; Lanko NS; Morozova OV; Gorbacheva EV ; Politova SN		Teratog Carcinog Mutagen	17	1997	19-28	J:42423	9249927
91083	Immunoglobulin/Myc recombinations in murine Peyer's patch follicles.		Muller JR; Mushinski EB; Williams JA; Hausner PF		Genes Chromosomes Cancer	20	1997	1-8	J:42598	9290947
91084	Eradication of tumor growth via biolistic transformation with allogeneic MHC genes.		Hui KM; Chia TF		Gene Ther	4	1997	762-7	J:42535	9338003
91085	Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.		Pattengale PK; Taylor CR		Am J Pathol	113	1983	237-65	J:27146	6605691
91086	Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).		Lowsky R; DeCoteau JF; Reitmair AH; Ichinohasama R; Dong WF; Xu Y ; Mak TW ; Kadin ME ; Minden MD		Blood	89	1997	2276-82	J:39216	9116269
91087	Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.		Moser GJ; Wolf DC; Goldsworthy TL		Toxicol Pathol	25	1997	275-83	J:42639	9210259
91088	Body weight-tumor incidence correlations in long-term rodent carcinogenicity studies.		Haseman JK; Young E; Eustis SL; Hailey JR		Toxicol Pathol	25	1997	256-63	J:42640	9210256
91089	Family-specific differences in transcription efficiency of Ig heavy chain promoters.		Buchanan KL; Smith EA; Dou S; Corcoran LM; Webb CF		J Immunol	159	1997	1247-54	J:41639	9233620
91090	Isolation of murine and human homologues of the fission-yeast dis3+ gene encoding a mitotic-control protein and its overexpression in cancer cells with progressive phenotype.		Lim J; Kuroki T; Ozaki K; Kohsaki H; Yamori T; Tsuruo T; Nakamori S ; Imaoka S ; Endo M ; Nakamura Y		Cancer Res	57	1997	921-5	J:38776	9041195
91091	Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.		Nazarov V; Hilbert D; Wolff L		Virology	205	1994	479-85	J:21604	7975249
91092	Susceptibility to polyomavirus-induced tumors in inbred mice: role of innate immune responses.		Velupillai P; Carroll JP; Benjamin TL		J Virol	76	2002	9657-63	J:78911	12208944
91093	A transplantable mast-cell neoplasm in the mouse		Dunn TB; Potter M		J Natl Cancer Inst	18	1957	587-601	J:48381	13416911
91094	Observations on the effect of a folic-acid antagonist on transplantable lymphoid leukemias in mice		Law LW; Dunn TB; Boyle PJ; Miller JH		J Natl Cancer Inst	10	1949	179-192	J:48408	 
91095	Immunological prevention of a multigene cancer syndrome.		Croci S; Nicoletti G; Landuzzi L; De Giovanni C; Astolfi A; Marini C; Di Carlo E; Musiani P; Forni G; Nanni P; Lollini PL		Cancer Res	64	2004	8428-34	J:93904	15548714
91096	Reversible lymphomagenesis in conditionally c-MYC expressing mice.		Marinkovic D; Marinkovic T; Mahr B; Hess J; Wirth T		Int J Cancer	110	2004	336-42	J:89331	15095297
91097	c-fos is required for malignant progression of skin tumors.		Saez E; Rutberg SE; Mueller E; Oppenheim H; Smoluk J; Yuspa SH; Spiegelman BM		Cell	82	1995	721-32	J:78834	7545543
91098	Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice.		Symons RC; Daly MJ; Fridlyand J; Speed TP; Cook WD; Gerondakis S; Harris AW; Foote SJ		Proc Natl Acad Sci U S A	99	2002	11299-304	J:78523	12149518
91099	Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.		de Guzman CG; Warren AJ; Zhang Z; Gartland L; Erickson P; Drabkin H; Hiebert SW; Klug CA		Mol Cell Biol	22	2002	5506-17	J:77906	12101243
91100	Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.		Le DT; Kong N; Zhu Y; Lauchle JO; Aiyigari A; Braun BS; Wang E; Kogan SC; Le Beau MM; Parada L; Shannon KM		Blood	103	2004	4243-50	J:90973	14982883
91101	Replication failure, genome instability, and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene.		Harrison C; Ketchen AM; Redhead NJ; O'Sullivan MJ; Melton DW		Cancer Res	62	2002	4065-74	J:77902	12124343
91102	A new transplantable mouse liver tumor of spontaneous origin.		Taper HS; Woolley GW; Teller MN; Lardis MP		Cancer Res	26	1966	143-8	J:49296	5901739
91103	Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum.		Weiss WA; Israel M; Cobbs C; Holland E; James CD; Louis DN; Marks C; McClatchey AI; Roberts T; Van Dyke T; Wetmore C; Chiu IM; Giovannini M; Guha A; Higgins RJ; Marino S; Radovanovic I; Reilly K; Aldape K		Oncogene	21	2002	7453-63	J:79667	12386807
91104	Expression of v-Ha-ras driven by the calcitonin/calcitonin gene-related peptide promoter: a novel transgenic murine model for medullary thyroid carcinoma.		Johnston D; Hatzis D; Sunday ME		Oncogene	16	1998	167-77	J:45621	9464534
91105	Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.		Portella G; Cumming SA; Liddell J; Cui W; Ireland H; Akhurst RJ; Balmain A		Cell Growth Differ	9	1998	393-404	J:47607	9607560
91106	Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice.		Haddad R; Held WA		Cancer Res	57	1997	4615-23	J:43450	9377577
91107	Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.		Coleman AE; Schrock E; Weaver Z; du Manoir S; Yang F; Ferguson-Smith MA ; Ried T ; Janz S		Cancer Res	57	1997	4585-92	J:43451	9377573
91108	Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death.		Sandig V; Brand K; Herwig S; Lukas J; Bartek J; Strauss M		Nat Med	3	1997	313-9	J:38864	9055859
91109	Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay.		Olive PL; Horsman MR; Grau C; Overgaard J		Br J Cancer	76	1997	694-9	J:42876	9310232
91110	Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.		Bottinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM		Cancer Res	57	1997	5564-70	J:45231	9407968
91111	Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.		Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR		Cancer Cell	1	2002	63-74	J:77129	12086889
91112	Of mice and women.		Foulkes WD		Cancer Cell	1	2002	11-2	J:77130	12086881
91113	Cell adhesion molecules and cancer metastasis.		Saiki I		Jpn J Pharmacol	75	1997	215-42	J:44668	9434254
91114	Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.		Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS		J Virol	71	1997	7273-80	J:42954	9311802
91115	Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice.		Estensen RD; Jordan MM; Wiedmann TS; Galbraith AR; Steele VE; Wattenberg LW		Carcinogenesis	25	2004	197-201	J:88491	14578161
91116	Involvement of EGF in medroxyprogesterone acetate (MPA)-induced mammary gland hyperplasia and its role in MPA-induced mammary tumors in BALB/c mice.		Molinolo A; Simian M; Vanzulli S; Pazos P; Lamb C; Montecchia F; Lanari C		Cancer Lett	126	1998	49-57	J:47076	9563648
91117	Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.		Duncan LM; Deeds J; Hunter J; Shao J; Holmgren LM; Woolf EA; Tepper RI; Shyjan AW		Cancer Res	58	1998	1515-20	J:47077	9537257
91118	PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia.		Padua RA; Larghero J; Robin M; Pogam Cl C; Schlageter MH; Muszlak S; Fric J; West R; Rousselot P; Phan TH; Mudde L; Teisserenc H; Carpentier AF; Kogan S; Degos L; Pla M; Bishop JM; Stevenson F; Charron D; Chomienne C		Nat Med	9	2003	1413-7	J:86505	14566333
91119	Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma.		Talora C; Campese AF; Bellavia D; Pascucci M; Checquolo S; Groppioni M; Frati L; Von Boehmer H; Gulino A; Screpanti I		EMBO Rep	4	2003	1067-71	J:86506	14566327
91120	Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia.		Masunaga S; Ono K; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Takagaki M		Jpn J Cancer Res	88	1997	770-7	J:43036	9330609
91121	Gene expression profile of normal lungs predicts genetic predisposition to lung cancer in mice.		Gariboldi M; Spinola M; Milani S; Pignatiello C; Kadota K; Bono H; Hayashizaki Y; Dragani TA; Okazaki Y		Carcinogenesis	24	2003	1819-1826	J:85734	12919955
91122	Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.		Crawford HC; Scoggins CR; Washington MK; Matrisian LM; Leach SD		J Clin Invest	109	2002	1437-44	J:76811	12045257
91123	NF-Y binds to the CCAAT box motif of the FGF-4 gene and promotes FGF-4 expression in embryonal carcinoma cells.		Lamb KA; Johnson LR; Rizzino A		Mol Reprod Dev	48	1997	301-9	J:43321	9322240
91124	Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.		Kitamura T; Itoh M; Noda T; Matsuura M; Wakabayashi K		Int J Cancer	109	2004	576-80	J:88631	14991580
91125	Early tumor effect on splenic Th lymphocytes in mice.		Segura JA; Barbero LG; Marquez J		FEBS Lett	414	1997	1-6	J:42873	9305721
91126	Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice [see comments]		Lattanzio G; Libert C; Aquilina M; Cappelletti M; Ciliberto G ; Musiani P ; Poli V		Am J Pathol	151	1997	689-96	J:42869	9284817
91127	Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.		Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS		Cancer Res	57	1997	3759-64	J:42807	9288784
91128	Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro.		Record IR; Broadbent JL; King RA; Dreosti IE; Head RJ; Tonkin AL		Int J Cancer	72	1997	860-4	J:42798	9311605
91129	Characterization of C57BL/6 plasmacytomas lacking a c-myc translocation.		Pumphrey JG; Hausner P; Rudikoff S		Int J Cancer	72	1997	892-7	J:42799	9311610
91130	Isolation of a novel gene showing reduced expression in metastatic colorectal carcinoma cell lines and carcinomas.		Fukuda S; Kuroki T; Kohsaki H; Hayashi S; Ozaki K; Yamori T ; Tsuruo T ; Nakamori S ; Imaoka S ; Nakamura Y		Jpn J Cancer Res	88	1997	725-31	J:43038	9330603
91131	Epidermal proliferation but not quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis.		Berton TR; Mitchell DL; Fischer SM; Locniskar MF		J Invest Dermatol	109	1997	340-7	J:42793	9284102
91132	Female embryonic lethality in mice nullizygous for both Msh2 and p53.		Cranston A; Bocker T; Reitmair A; Palazzo J; Wilson T; Mak T ; Fishel R		Nat Genet	17	1997	114-8	J:42723	9288110
91133	The mouse 5-HT2B receptor: possible involvement in trophic functions of serotonin.		Choi DS; Colas JF; Kellermann O; Loric S; Launay JM; Rosay P; Maroteaux L		Cell Mol Biol (Noisy-le-grand)	40	1994	403-11	J:38874	7920184
91134	IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.		Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM		J Immunol	158	1997	1284-92	J:38370	9013971
91135	Opposite effect of stable transfection of bioactive transforming growth factor-beta 1 (TGF beta 1) versus exogenous TGF beta 1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells.		Rundhaug JE; Park J; Pavone A; Opdenakker G; Fischer SM		Mol Carcinog	19	1997	122-36	J:41908	9210959
91136	Meeting report: genetic environmental interactions in cancer susceptibility in animal models.		Knudson AG; Hino O		J Natl Cancer Inst	89	1997	1669-72	J:44671	9390535
91137	Genetic mapping of cancer susceptibility/resistance loci in the mouse.		Manenti G; De Gregorio L; Gariboldi M; Falvella FS; Zanesi N; Pierotti MA; Dragani TA		Recent Results Cancer Res	154	1998	292-7	J:54731	10027009
91138	The Ras family of GTPases in cancer cell invasion		Hernandez-Alcoceba R; del Peso L; Lacal JC		Cell Mol Life Sci	57	2000	65-76	J:60900	10949581
91139	Modulatory effect of henna leaf (Lawsonia inermis) on drug metabolising phase I and phase II enzymes, antioxidant enzymes, lipid peroxidation and chemically induced skin and forestomach papillomagenesis in mice.		Dasgupta T; Rao AR; Yadava PK		Mol Cell Biochem	245	2003	11-22	J:83065	12708740
91140	Causation of nervous system tumors in children: insights from traditional and genetically engineered animal models.		Rice JM		Toxicol Appl Pharmacol	199	2004	175-91	J:92008	15313589
91141	The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.		Sternlicht MD; Bissell MJ; Werb Z		Oncogene	19	2000	1102-13	J:61020	10713697
91142	Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.		Onizuka S; Tawara I; Shimizu J; Sakaguchi S; Fujita T; Nakayama E		Cancer Res	59	1999	3128-33	J:56458	10397255
91143	Sequence analysis of a novel cDNA which is overexpressed in testicular tumors from polyomavirus large T-antigen transgenic mice.		Lebel M; Mes-Masson AM		DNA Seq	5	1994	31-9	J:55995	7894057
91144	Involvement of Notch1 in the development of mouse mammary tumors.		Dievart A; Beaulieu N; Jolicoeur P		Oncogene	18	1999	5973-81	J:58363	10557086
91145	High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression.		Westervelt P; Lane AA; Pollock JL; Oldfather K; Holt MS; Zimonjic DB; Popescu NC; DiPersio JF; Ley TJ		Blood	102	2003	1857-65	J:84230	12750176
91146	Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule		Hayden BH; Murray TG; Scott IU; Cicciarelli N; Hernandez E; Feuer W; Fulton L; O'Brien JM		Arch Ophthalmol	118	2000	1549-54	J:66203	11074812
91147	Multidrug resistance modifies polyamines uptake in P388 murine lymphoma cells: experimental and modeling approach.		Berlaimont V; Bogaerts P; Dubois J; Hanus R; Hanocq M		Biophys Chem	77	1999	161-71	J:55209	10326249
91148	Modification of membrane currents in mouse neuroblastoma cells following infection with rabies virus.		Iwata M; Komori S; Unno T; Minamoto N; Ohashi H		Br J Pharmacol	126	1999	1691-8	J:55210	10372810
91149	The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase		Roumiantsev S; de Aos IE; Varticovski L; Ilaria RL; Van Etten RA		Blood	97	2001	4-13	J:67117	11133737
91150	Hemopoietic damage and induction of leukemia in offspring due to preconception paternal irradiation from incorporated plutonium-239.		Lord BI; Hoyes KP		Radiat Res	152	1999	S34-7	J:59551	10564933
91151	Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice.		Diwan BA; Riggs CW; Logsdon D; Haines DC; Olivero OA; Rice JM; Yuspa SH; Poirier MC; Anderson LM		Toxicol Appl Pharmacol	161	1999	82-99	J:59552	10558926
91152	Local hypertrophic/hyperplastic changes of keratinizing squamous epithelium of pinna induced by concanavalin A and other immunomodulators in mice.		Wlodarski K; Luczak M; Galus R; Wlodarski P		Folia Biol (Praha)	45	1999	217-23	J:58878	10730890
91153	Effects of mobile phone radiation on UV-induced skin tumourigenesis in ornithine decarboxylase transgenic and non-transgenic mice.		Heikkinen P; Kosma VM; Alhonen L; Huuskonen H; Komulainen H; Kumlin T; Laitinen JT; Lang S; Puranen L; Juutilainen J		Int J Radiat Biol	79	2003	221-33	J:84196	12775446
91154	Astrocytomas in an inbred mouse strain.		Fraser H		J Pathol	103	1971	266-70	J:58166	5563880
91155	CDK-independent activities of D type cyclins.		Bernards R		Biochim Biophys Acta	1424	1999	M17-22	J:58429	10528151
91156	DNA repair and cancer: lessons from mutant mouse models.		Ishikawa T; Zhang SS; Qin X; Takahashi Y; Oda H; Nakatsuru Y; Ide F		Cancer Sci	95	2004	112-7	J:88757	14965359
91157	Suppression of UV Carcinogenesis by Difluoromethylornithine in Nucleotide Excision Repair-deficient Xpa Knockout Mice.		Rebel H; van Steeg H; Beems RB; Schouten R; de Gruijl FR; Terleth C		Cancer Res	62	2002	1338-42	J:75229	11888902
91158	Induction of preferential cytotoxicity against allogeneic mouse lymphoma cells: in vitro and in vivo studies.		Leshem B; Dorfman Y; Kedar E		Cancer Immunol Immunother	48	1999	179-88	J:56575	10431687
91159	Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells.		He AW; Cory JG		Oncol Res	10	1998	455-64	J:54297	10223621
91160	Role of gene knockout mice in understanding the mechanisms of chemical toxicity and carcinogenesis.		Gonzalez FJ; Kimura S		Cancer Lett	143	1999	199-204	J:59457	10503904
91161	Y-700, a novel inhibitor of xanthine oxidase, suppresses the development of colon aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine-treated mice.		Hashimoto T; Fukunari A; Yamada I; Yanaka N; Chen D; Kato N		Biosci Biotechnol Biochem	69	2005	209-11	J:96275	15665488
91162	Specific methylation events contribute to the transcriptional repression of the mouse tissue inhibitor of metalloproteinases-3 gene in neoplastic cells.		Pennie WD; Hegamyer GA; Young MR; Colburn NH		Cell Growth Differ	10	1999	279-86	J:54839	10319998
91163	Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.		Asai M; Kato M; Asai N; Iwashita T; Murakami H; Kawai K; Nakashima I; Takahashi M		Jpn J Cancer Res	90	1999	86-92	J:53156	10076570
91164	DNA methylation regulates p27kip1 expression in rodent pituitary cell lines.		Qian X; Jin L; Kulig E; Lloyd RV		Am J Pathol	153	1998	1475-82	J:51457	9811339
91165	Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors.		Hermans IF; Daish A; Yang J; Ritchie DS; Ronchese F		Cancer Res	58	1998	3909-17	J:52667	9731502
91166	Experimental induction of rhabdomyosarcoma in mice with fractionated doses of beta-irradiation.		Gupta A; Andrews KL; McDaniel KM; Nagle RB; Bowden GT		J Cancer Res Clin Oncol	125	1999	257-67	J:55193	10359130
91167	Immunogenetic analysis of gastric MALT lymphoma-like lesions induced by Helicobacter pylori infection in neonatally thymectomized mice.		Fukui T; Okazaki K; Tamaki H; Kawasaki K; Matsuura M; Asada M; Nishi T; Uchida K; Iwano M; Ohana M; Hiai H; Chiba T		Lab Invest	84	2004	485-92	J:88761	14968120
91168	Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.		Toura I; Kawano T; Akutsu Y; Nakayama T; Ochiai T; Taniguchi M		J Immunol	163	1999	2387-91	J:57102	10452972
91169	Cell-cell interaction modulates myoD-induced skeletal myogenesis of pluripotent P19 cells in vitro.		Armour C; Garson K; McBurney MW		Exp Cell Res	251	1999	79-91	J:56943	10438573
91170	Melanoma cell autonomous growth: the Rb/E2F pathway.		Halaban R		Cancer Metastasis Rev	18	1999	333-43	J:61195	10721488
91171	Study of the antitumor effect of Ukrain: the role of macrophage secretion of alpha-1-proteinase inhibitor.		Korolenko TA; Kaledin VI; Svechnikova IG; Li XV; Stashko JF; Ilnitskaya SI; Nikolin VP		Drugs Exp Clin Res	24	1998	271-6	J:55075	10190086
91172	Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity.		Park CB; Kim DJ; Uehara N; Takasuka N; Hiroyasu BT; Tsuda H		Cancer Lett	139	1999	177-82	J:55772	10395176
91173	Decrease of metastatic ability after selection for intravasating ability in Lewis lung carcinoma (3LL) cell line.		Ota T; Maeda M; Tatsuka M; Matsui T; Tanino M; Tanaka T		Cancer Lett	139	1999	105-8	J:55773	10408901
91174	Identification and characterization of collaborating oncogenes in compound mutant mice.		Berns A; Mikkers H; Krimpenfort P; Allen J; Scheijen B; Jonkers J		Cancer Res	59	1999	1773s-1777s	J:54359	10197595
91175	Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine.		Anderson LD Jr; Petropoulos D; Everse LA; Mullen CA		Cancer Res	59	1999	1525-30	J:54360	10197624
91176	Upregulation of endogenous p53 and induction of in vivo apoptosis in B-lineage lymphomas of E(mu)-myc transgenic mice by deregulated c-myc transgene.		Prasad VS; LaFond RE; Zhou M; Jacobsen KA; Osmond DG; Sidman CL		Mol Carcinog	18	1997	66-77	J:39684	9049182
91177	Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.		Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC		J Immunol	161	1998	5164-70	J:52779	9820486
91178	Role of the transcription factor Sox-2 in the expression of the FGF-4 gene in embryonal carcinoma cells.		Johnson LR; Lamb KA; Gao Q; Nowling TK; Rizzino A		Mol Reprod Dev	50	1998	377-86	J:48465	9669521
91179	Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.		Bronte V; Kasic T; Gri G; Gallana K; Borsellino G; Marigo I; Battistini L; Iafrate M; Prayer-Galetti T; Pagano F; Viola A		J Exp Med	201	2005	1257-68	J:98050	15824085
91180	Mutation frequencies and AID activation state in B-cell lymphomas from Ung-deficient mice.		Nilsen H; An Q; Lindahl T		Oncogene	24	2005	3063-6	J:98053	15735713
91181	Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.		Wang Y; Zhang Z; Lubet R; You M		Oncogene	24	2005	3042-9	J:98054	15846305
91182	Occurrence of tumors in agent-free strain C3H male mice implanted with estrogen-cholesterol pellets		Heston WE; Deringer MK		Proc Soc Exp Biol Med	82	1953	731-4	J:24782	13055984
91183	Cotylenin A, a plant-growth regulator, induces the differentiation in murine and human myeloid leukemia cells.		Asahi K; Honma Y; Hazeki K; Sassa T; Kubohara Y; Sakurai A; Takahashi N		Biochem Biophys Res Commun	238	1997	758-63	J:43251	9325163
91184	Regulation of the replication of the murine immunoglobulin heavy chain gene locus: evaluation of the role of the 3' regulatory region.		Michaelson JS; Ermakova O; Birshtein BK; Ashouian N; Chevillard C ; Riblet R ; Schildkraut CL		Mol Cell Biol	17	1997	6167-74	J:43370	9315677
91185	Lipid metabolism in tumour-bearing mice: studies with knockout mice for tumour necrosis factor receptor 1 protein.		Lopez-Soriano J; Llovera M; Carbo N; Garcia-Martinez C; Lopez-Soriano FJ; Argiles JM		Mol Cell Endocrinol	132	1997	93-9	J:42776	9324050
91186	Cobalamin analogues modulate the growth of leukemia cells in vitro.		McLean GR; Pathare PM; Wilbur DS; Morgan AC; Woodhouse CS; Schrader JW ; Ziltener HJ		Cancer Res	57	1997	4015-22	J:42736	9307287
91187	Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.		Yang YF; Zou JP; Mu J; Wijesuriya R; Ono S; Walunas T; Bluestone J ; Fujiwara H ; Hamaoka T		Cancer Res	57	1997	4036-41	J:42737	9307290
91188	Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1alpha on metastasis and the location of B16F1 melanoma cell arrest.		Scherbarth S; Orr FW		Cancer Res	57	1997	4105-10	J:42739	9307300
91189	Retinoblastoma gene deficiency has mitogenic but not tumorigenic effects on erythropoiesis.		Hu N; Gulley ML; Kung JT; Lee EY		Cancer Res	57	1997	4123-9	J:42740	9307303
91190	p53-independent apoptosis induced by paclitaxel through an indirect mechanism.		Lanni JS; Lowe SW; Licitra EJ; Liu JO; Jacks T		Proc Natl Acad Sci U S A	94	1997	9679-83	J:42820	9275183
91191	Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.		Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A ; Adachi N ; Kohno K ; Higashi K ; Kuwano M		Oncol Res	8	1996	197-206	J:42780	8884812
91192	Post-translational processing of human procorticotrophin-releasing factor in transfected mouse neuroblastoma and Chinese hamster ovary cell lines.		Brar B; Sanderson T; Wang N; Lowry PJ		J Endocrinol	154	1997	431-40	J:42781	9379120
91193	A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product.		Castellanos A; Pintado B; Weruaga E; Arevalo R; Lopez A; Orfao A ; Sanchez-Garcia I		Blood	90	1997	2168-74	J:42895	9310467
91194	Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12.		Rakhmilevich AL; Janssen K; Turner J; Culp J; Yang NS		Hum Gene Ther	8	1997	1303-11	J:42852	9295125
91195	CD4 T cell anergy in murine AIDS: costimulation via CD28 and the addition of IL-12 are not sufficient to rescue anergic CD4 T cells.		Andrews C; Swain SL; Muralidhar G		J Immunol	159	1997	2132-8	J:42854	9278299
91196	Growth of P511 mastocytoma cells in BALB/c mouse brain elicits CTL response without tumor elimination: a new tumor model for regional central nervous system immunity.		Gordon LB; Nolan SC; Cserr HF; Knopf PM; Harling-Berg CJ		J Immunol	159	1997	2399-408	J:42855	9278331
91197	In vitro properties of the first ORF protein from mouse LINE-1 support its role in ribonucleoprotein particle formation during retrotransposition.		Kolosha VO; Martin SL		Proc Natl Acad Sci U S A	94	1997	10155-60	J:42973	9294179
91198	Genomic instability and apoptosis are frequent in p53 deficient young mice.		Fukasawa K; Wiener F; Vande Woude GF; Mai S		Oncogene	15	1997	1295-302	J:43057	9315097
91199	Effects of protein kinase C activators on phorbol ester-sensitive and -resistant EL4 thymoma cells.		Sansbury HM; Wisehart-Johnson AE; Qi C; Fulwood S; Meier KE		Carcinogenesis	18	1997	1817-24	J:43004	9328180
91200	Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.		Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR ; Ambrose CM ; Hession C ; Miatkowski K ; Griffiths DA ; Ngam-ek A ; Meier W ; Benjamin CD ; Hochman PS		J Immunol	159	1997	3288-98	J:43091	9317127
91201	Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.		Salazar-Onfray F; Charo J; Petersson M; Freland S; Noffz G; Qin Z ; Blankenstein T ; Ljunggren HG ; Kiessling R		J Immunol	159	1997	3195-202	J:43092	9317117
91202	Multigenerational effects of dietary fat carcinogenesis in mice.		Walker BE; Kurth LA		Cancer Res	57	1997	4162-3	J:43177	9331066
91203	Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLlpr/lpr mice.		Piredda L; Amendola A; Colizzi V; Davies PJA; Farrace MG; Fraziano M; Gentile V; Uray I; Piacentini M; Fesus L		Cell Death Differ	4	1997	463-472	J:43229	16465267
91204	Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.		Douglas RS; Woo EY; Capocasale RJ; Tarshis AD; Nowell PC; Moore JS		Cell Immunol	179	1997	126-37	J:43231	9268496
91205	Hyperthermia and incorporation of halogenated pyrimidines: radiosensitization in cultured rodent and human tumor cells.		Van Bree C; Franken NA; Bakker PJ; Klomp-Tukker LJ; Barendsen GW ; Kipp JB		Int J Radiat Oncol Biol Phys	39	1997	489-96	J:43234	9308955
91206	Multiple cDNAs encoding the esk kinase predict transmembrane and intracellular enzyme isoforms.		Douville EM; Afar DE; Howell BW; Letwin K; Tannock L; Ben-David Y ; Pawson T ; Bell JC		Mol Cell Biol	12	1992	2681-9	J:43402	1375325
91207	Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain. Its possible role in plasmacytomagenesis.		Sugita T; Totsuka T; Saito M; Yamasaki K; Taga T; Hirano T; Kishimoto T		J Exp Med	171	1990	2001-9	J:43406	2112585
91208	[Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors]		Lanari C; Montecchia MF; Pazos P; Simian M; Vanzulli S; Lamb C; Molinolo AA		Medicina (B Aires)	57 Suppl 2	1997	55-69	J:43368	9567344
91209	[Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxy- progesterone acetate in BALB/c mice]		Elizalde PV; Balana ME; Charreau EH		Medicina (B Aires)	57 Suppl 2	1997	70-4	J:43369	9580484
91210	Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model.		Ma D; Gerard RD; Li XY; Alizadeh H; Niederkorn JY		Blood	90	1997	2738-46	J:43526	9326241
91211	Molecular mechanisms of mutagen hypersensitivity in adenine phosphoribosyl transferase-deficient Friend mouse erythroleukaemia cells		Yadollahi-Farsani M; McKenna PG; McKelvey-Martin VJ		Br J Biomed Sci	54	1997	174-80	J:43527	9499594
91212	Expression of the brain creatine kinase gene is low in neuroblastoma cell lines.		Wilson CD; Shen W; Molloy GR		Dev Neurosci	19	1997	375-83	J:43529	9323458
91213	Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma.		Glick RP; Lichtor T; Mogharbel A; Taylor CA; Cohen EP		Neurosurgery	41	1997	898-906; discussion 906-7	J:43554	9316052
91214	Dissimilar characteristics of N-methyl-N-nitrosourea-initiated foci and tumors promoted by dichloroacetic acid or trichloroacetic acid in the liver of female B6C3F1 mice.		Latendresse JR; Pereira MA		Toxicol Pathol	25	1997	433-40	J:43557	9323830
91215	Secondary polycythemia in male B6C3F1 mice with spontaneously occurring hepatocellular carcinomas.		Horinouchi A; Hayashi S; Ando T; Nonoyama T		Toxicol Pathol	25	1997	511-5	J:43558	9323843
91216	The insulin receptor content is increased in breast cancers initiated by three different oncogenes in transgenic mice.		Frittitta L; Cerrato A; Sacco MG; Weidner N; Goldfine ID; Vigneri R		Breast Cancer Res Treat	45	1997	141-7	J:43630	9342439
91217	A regulatory element within a coding exon modulates keratin 18 gene expression in transgenic mice.		Neznanov N; Umezawa A; Oshima RG		J Biol Chem	272	1997	27549-57	J:43714	9346889
91218	Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.		Jager R; Herzer U; Schenkel J; Weiher H		Oncogene	15	1997	1787-95	J:43653	9362445
91219	Evidence of a dominant transcriptional pathway which regulates an undifferentiated and complete metastatic phenotype.		Barsky SH; Sternlicht MD; Safarians S; Nguyen M; Chin K; Stewart SD ; Hiti AL ; Gray JW		Oncogene	15	1997	2077-91	J:43816	9366525
91220	Mammary tumour incidence in relation to age and number of litters in C3H and RIII mice		Pullinger BD; Iversen S		Br J Cancer	14	1960	267-78	J:43819	13738461
91221	Effect of parity regimen on the rate of occurrence of mammary tumors in A, C3H, and RIII mice.		Moore DH; Holben JA		Int J Cancer	24	1979	161-4	J:43822	489162
91222	Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells.		Chiba H; Clifford J; Metzger D; Chambon P		J Cell Biol	139	1997	735-47	J:43755	9348290
91223	Inhibition of transcription affects synthesis of steroidogenic acute regulatory protein and steroidogenesis in MA-10 mouse Leydig tumor cells.		Clark BJ; Combs R; Hales KH; Hales DB; Stocco DM		Endocrinology	138	1997	4893-901	J:43856	9348220
91224	Transcriptional behavior of LCR enhancer elements integrated at the same chromosomal locus by recombinase-mediated cassette exchange.		Bouhassira EE; Westerman K; Leboulch P		Blood	90	1997	3332-44	J:43863	9345015
91225	Folate deficiency delays the onset but increases the incidence of leukemia in Friend virus-infected mice.		Koury MJ; Park DJ; Martincic D; Horne DW; Kravtsov V; Whitlock JA ; del Pilar Aguinaga M ; Kopsombut P		Blood	90	1997	4054-61	J:43993	9354675
91226	Selective potentiation of lometrexol growth inhibition by dipyridamole through cell-specific inhibition of hypoxanthine salvage.		Turner RN; Aherne GW; Curtin NJ		Br J Cancer	76	1997	1300-7	J:43995	9374375
91227	Free radical-derived quinone methide mediates skin tumor promotion by butylated hydroxytoluene hydroperoxide: expanded role for electrophiles in multistage carcinogenesis.		Guyton KZ; Bhan P; Kuppusamy P; Zweier JL; Trush MA; Kensler TW		Proc Natl Acad Sci U S A	88	1991	946-50	J:44002	1846971
91228	Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice.		Lala PK; Al-Mutter N; Orucevic A		Int J Cancer	73	1997	371-80	J:44007	9359485
91229	Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA.		Tokuyama S; Moriya S; Taniguchi S; Yasui A; Miyazaki J; Orikasa S ; Miyagi T		Int J Cancer	73	1997	410-5	J:44008	9359489
91230	Delays in malignant tumor development in transgenic mice by forced epidermal keratin 10 expression in mouse skin carcinomas.		Santos M; Ballestin C; Garcia-Martin R; Jorcano JL		Mol Carcinog	20	1997	3-9	J:43946	9328431
91231	Analysis of the E-cadherin and P-cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis.		Faraldo ML; Rodrigo I; Behrens J; Birchmeier W; Cano A		Mol Carcinog	20	1997	33-47	J:43947	9328434
91232	Retinoic acid signaling cascade in differentiating murine epidermal keratinocytes: alterations in papilloma- and carcinoma-derived cell lines.		Vettermann O; Siegenthaler G; Winter H; Schweizer J		Mol Carcinog	20	1997	58-67	J:43948	9328436
91233	Identification of differentially expressed genes in chemically induced skin tumors.		Rutberg SE; Lee EJ; Hansen LH; Glick AB; Yuspa SH		Mol Carcinog	20	1997	88-98	J:43949	9328439
91234	Increased apoptosis during papilloma development in mice susceptible to tumor progression.		Stern MC; Duran HA; McKenna EA; Conti CJ		Mol Carcinog	20	1997	137-42	J:43950	9328444
91235	New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.		Hennings H; Lowry DT; Yuspa SH; Mock B; Potter M		Mol Carcinog	20	1997	143-50	J:43951	9328445
91236	Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells.		Sinal CJ; Bend JR		Mol Pharmacol	52	1997	590-9	J:43953	9380021
91237	Interferon-gamma-induced MHC class I expression and defects in Jak/Stat signalling in methylcholanthrene-induced sarcomas.		Svane IM; Engel AM; Nielsen M; Werdelin O		Scand J Immunol	46	1997	379-87	J:43956	9350289
91238	Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo.		Baker A; Payne CM; Briehl MM; Powis G		Cancer Res	57	1997	5162-7	J:44091	9371519
91239	Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase.		Ueno T; Ohtawa K; Mitsui K; Kodera Y; Hiroto M; Matsushima A ; Inada Y ; Nishimura H		Leukemia	11	1997	1858-61	J:44098	9369418
91240	Unmasking a growth-promoting effect of the adrenocorticotropic hormone in Y1 mouse adrenocortical tumor cells.		Lotfi CF; Todorovic Z; Armelin HA; Schimmer BP		J Biol Chem	272	1997	29886-91	J:44167	9368063
91241	Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability		Hubbard FC; Goodrow TL; Liu SC; Brilliant MH; Basset P; Mains RE; Klein-Szanto AJ		Cancer Res	57	1997	5226-31	J:44300	9393739
91242	Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo		Lannutti BJ; Gately ST; Quevedo ME; Soff GA; Paller AS		Cancer Res	57	1997	5277-80	J:44303	9393749
91243	Intratumoral heterogeneity for and epigenetic modulation of mdr-1 expression in murine melanoma.		Yoon SS; Fidler IJ; Beltran PJ; Bucana CD; Wang YF; Fan D		Melanoma Res	7	1997	275-87	J:44370	9293477
91244	Overexpression of manganese superoxide dismutase selectively modulates the activity of Jun-associated transcription factors in fibrosarcoma cells		Kiningham KK; St. Clair DK		Cancer Res	57	1997	5265-71	J:44304	9393747
91245	An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo.		Ethelberg S; Sorensen AB; Schmidt J; Luz A; Pedersen FS		J Virol	71	1997	9796-9	J:44516	9371648
91246	Expression of the SIL gene is correlated with growth induction and cellular proliferation.		Izraeli S; Colaizzo-Anas T; Bertness VL; Mani K; Aplan PD; Kirsch IR		Cell Growth Differ	8	1997	1171-9	J:44527	9372240
91247	Innate resistance to Listeria monocytogenes in tumor-bearing mice.		Gahan CG; Barrett JR; O'Brien MG; O'Sullivan GC; Shanahan F; Collins JK		J Leukoc Biol	62	1997	726-32	J:44477	9400813
91248	Mutagenicity of photodynamic therapy as compared to UVC and ionizing radiation in human and murine lymphoblast cell lines.		Evans HH; Horng MF; Ricanati M; Deahl JT; Oleinick NL		Photochem Photobiol	66	1997	690-6	J:44683	9383992
91249	Chloroform mode of action: implications for cancer risk assessment.		Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA		Regul Toxicol Pharmacol	26	1997	142-55	J:44687	9356278
91250	Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.		Flammang TJ; Tungeln LSV; Kadlubar FF; Fu PP		Regul Toxicol Pharmacol	26	1997	230-40	J:44688	9356286
91251	In situ hybridization demonstration of albumin mRNA in B6C3F1 murine liver and hepatocellular neoplasms.		Pilling AM; Endersby-Wood HJ; Jones SA; Williams TC		Vet Pathol	34	1997	585-91	J:44689	9396139
91252	Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene.		Morris DW; Dutra JC		Virology	238	1997	161-5	J:44691	9375020
91253	Mouse lung epithelial cell lines--tools for the study of differentiation and the neoplastic phenotype.		Malkinson AM; Dwyer-Nield LD; Rice PL; Dinsdale D		Toxicology	123	1997	53-100	J:44692	9347924
91254	Wig-1, a new p53-induced gene encoding a zinc finger protein.		Varmeh-Ziaie S; Okan I; Wang Y; Magnusson KP; Warthoe P; Strauss M; Wiman KG		Oncogene	15	1997	2699-704	J:44645	9400996
91255	The carcinogenic potential of the gas phase of environmental tobacco smoke.		Witschi H; Espiritu I; Maronpot RR; Pinkerton KE; Jones AD		Carcinogenesis	18	1997	2035-42	J:44654	9395199
91256	Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver.		Leavitt SA; DeAngelo AB; George MH; Ross JA		Carcinogenesis	18	1997	2101-6	J:44655	9395208
91257	Induction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to a mucin-1 tumour antigen.		Lofthouse SA; Apostolopoulos V; Pietersz GA; Li W; McKenzie IF		Vaccine	15	1997	1586-93	J:44771	9330472
91258	Identification of cell binding sequences in mouse laminin gamma1 chain by systematic peptide screening.		Nomizu M; Kuratomi Y; Song SY; Ponce ML; Hoffman MP; Powell SK; Miyoshi K; Otaka A; Kleinman HK; Yamada Y		J Biol Chem	272	1997	32198-205	J:44736	9405421
91259	Roles of the imprinted gene Igf2 and paternal duplication of distal chromosome 7 in the perinatal abnormalities of androgenetic mouse chimeras.		McLaughlin KJ; Kochanowski H; Solter D; Schwarzkopf G; Szabo PE; Mann JR		Development	124	1997	4897-904	J:44840	9428426
91260	Photodynamic effect of polyethylene glycol-modified fullerene on tumor.		Tabata Y; Murakami Y; Ikada Y		Jpn J Cancer Res	88	1997	1108-16	J:44845	9439687
91261	Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase.		Yu CL; Jove R; Burakoff SJ		J Immunol	159	1997	5206-10	J:44275	9548458
91262	Polyamines regulate both transcription and translation of the gene encoding ornithine decarboxylase antizyme in mouse.		Nilsson J; Koskiniemi S; Persson K; Grahn B; Holm I		Eur J Biochem	250	1997	223-31	J:44893	9428668
91263	p53-based immunotherapy of cancer.		DeLeo AB		Crit Rev Immunol	18	1998	29-35	J:44954	9419445
91264	Co-expression of immunogenic determinants by the same cellular immunogen is required for the optimum immunotherapeutic benefit in mice with melanoma.		Xu W; de Zoeten E; Carr-Brendel V; Cohen EP		Cancer Immunol Immunother	45	1998	217-24	J:45010	9439644
91265	A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [see comments]		Enari M; Sakahira H; Yokoyama H; Okawa K; Iwamatsu A; Nagata S		Nature	391	1998	43-50	J:45015	9422506
91266	Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.		Santoni-Rugiu E; Jensen MR; Thorgeirsson SS		Cancer Res	58	1998	123-34	J:45016	9426068
91267	Thiazolidinyl- and perhydrothiazinylphosphamidesters: toxicity and preliminary antitumour evaluation.		Voelcker G; Bielicki L; Hohorst HJ		J Cancer Res Clin Oncol	123	1997	623-31	J:45021	9620221
91268			Cao X		J Cancer Res Clin Oncol	123	1997	602-608	J:45022	9620217
91269	Overexpression of mouse follistatin causes reproductive defects in transgenic mice.		Guo Q; Kumar TR; Woodruff T; Hadsell LA; DeMayo FJ; Matzuk MM		Mol Endocrinol	12	1998	96-106	J:45065	9440814
91270	Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity.		Morgan DJ; Kreuwel HT; Fleck S; Levitsky HI; Pardoll DM; Sherman LA		J Immunol	160	1998	643-51	J:45169	9551898
91271	MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytes.		Armstrong TD; Clements VK; Ostrand-Rosenberg S		J Immunol	160	1998	661-6	J:45171	9551900
91272	NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.		Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG		J Immunol	160	1998	674-80	J:45172	9551902
91273	Processing of exogenous hepatitis B surface antigen particles for Ld-restricted epitope presentation depends on exogenous beta2-microglobulin.		Schirmbeck R; Thoma S; Reimann J		Eur J Immunol	27	1997	3471-84	J:45132	9464837
91274	Fetal and neonatal NK1.1+ Ly-49- cells can distinguish between major histocompatibility complex class I(hi) and class I(lo) target cells: evidence for a Ly-49-independent negative signaling receptor.		Sivakumar PV; Bennett M; Kumar V		Eur J Immunol	27	1997	3100-4	J:45135	9464793
91275	Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.		Rajnavolgyi E; Horvath A; Gogolak P; Toth GK; Fazekas G; Fridkin M; Pecht I		Eur J Immunol	27	1997	3105-14	J:45136	9464794
91276	An evolutionary conserved element is essential for somite and adjacent mesenchymal expression of the Hoxa1 gene.		Thompson JR; Chen SW; Ho L; Langston AW; Gudas LJ		Dev Dyn	211	1998	97-108	J:45210	9438427
91277	Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha.		Abu-Abed SS; Beckett BR; Chiba H; Chithalen JV; Jones G; Metzger D; Chambon P; Petkovich M		J Biol Chem	273	1998	2409-15	J:45401	9442090
91278	Instability of the D4Mit12 microsatellite marker in C57BL/6J x BALB/cJF1 hybrid mice is independent of the tumor phenotype		Herranz M; Santos J; Perez de Castro I; Melendez B; Fernandez-Piqueras J		Cytogenet Cell Genet	78	1997	221-3	J:45402	9465892
91279	Polyenzyme preparation Wobe-Mugos inhibits growth of solid tumors and development of experimental metastases in mice.		Wald M; Zavadova E; Pouckova P; Zadinova M; Boubelik M		Life Sci	62	1998	PL43-8	J:45368	9488106
91280	Transforming growth factor-alpha mRNA and epidermal growth factor receptor mRNA expression in normal and neoplastic mammary glands of four strains of mice with different mammary tumor potentials.		Tsunoda S; Ikezaki Y; Nagasawa H		Zoolog Sci	14	1997	803-7	J:45373	9450392
91281			Moiseeva EV; Vodovozova EL; Mikhalyov II; Molotkovsky JG		Mouse Genome	95	1997	895-97	J:45475	 
91282	Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.		Ashley DM; Kong FM; Bigner DD; Hale LP		Cancer Res	58	1998	302-9	J:45434	9443409
91283	Interferon-gamma-inducing factor elicits antitumor immunity in association with interferon-gamma production.		Tan J; Crucian BE; Chang AE; Aruga E; Aruga A; Dovhey SE; Tanigawa K; Yu H		J Immunother	21	1998	48-55	J:45439	9456436
91284	Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [see comments]		Arap W; Pasqualini R; Ruoslahti E		Science	279	1998	377-80	J:45442	9430587
91285	Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation.		Kim JM; Araki S; Kim DJ; Park CB; Takasuka N; Baba-Toriyama H; Ota T; Nir Z; Khachik F; Shimidzu N; Tanaka Y; Osawa T; Uraji T; Murakoshi M; Nishino H; Tsuda H		Carcinogenesis	19	1998	81-5	J:45637	9472697
91286	Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression.		Stern MC; Gimenez-Conti IB; Budunova I; Coghlan L; Fischer SM; DiGiovanni J; Slaga TJ; Conti CJ		Carcinogenesis	19	1998	125-32	J:45639	9472703
91287	Comparative mouse skin tumorigenicity and induction of Ha-ras mutations by bay region diol epoxides of 5-methylchrysene and 5,6-dimethylchrysene.		Hecht SS; Ronai ZA; Dolan L; Desai D; Amin S		Carcinogenesis	19	1998	157-60	J:45640	9472707
91288	Overexpression of phosphoinositide-specific phospholipase Cgamma in NIH 3T3 cells promotes transformation and tumorigenicity.		Smith MR; Court DW; Kim HK; Park JB; Rhee SG; Rhim JS; Kung HF		Carcinogenesis	19	1998	177-85	J:45641	9472710
91289	Patterns of chloroform-induced regenerative cell proliferation in BDF1 mice correlate with organ specificity and dose-response of tumor formation.		Templin MV; Constan AA; Wolf DC; Wong BA; Butterworth BE		Carcinogenesis	19	1998	187-93	J:45642	9472711
91290	Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen.		Shibata MA; Jorcyk CL; Devor DE; Yoshidome K; Rulong S; Resau J; Roche N; Roberts AB; Ward JM; Green JE		Carcinogenesis	19	1998	195-205	J:45643	9472712
91291	Effects of long-term feeding with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in C57BL/ByA and E mu-pim-1 mice.		Kristiansen E; Mortensen A; Sorensen IK		Cancer Lett	122	1998	215-20	J:45597	9464513
91292	Distinct functions of protein kinase Calpha and protein kinase Cbeta during retinoic acid-induced differentiation of F9 cells.		Cho Y; Klein MG; Talmage DA		Cell Growth Differ	9	1998	147-54	J:45811	9486851
91293	Immunoglobulin VH gene sequence analysis of spontaneous murine immunoglobulin-secreting B-cell tumours with clinical features of human disease.		Zhu D; van Arkel C; King CA; Meirvenne SV; de Greef C; Thielemans K; Radl J; Stevenson FK		Immunology	93	1998	162-70	J:45812	9616364
91294	Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 mice.		Ehrke MJ; Verstovsek S; Ujhazy P; Meer JM; Eppolito C; Maccubbin DL; Mihich E		Cancer Immunol Immunother	45	1998	287-98	J:45966	9490198
91295	Superiority of the ear pinna over a subcutaneous tumour inoculation site for induction of a Th1-type cytokine response.		Jurianz K; von Hoegen P; Schirrmacher V		Cancer Immunol Immunother	45	1998	327-33	J:45967	9490203
91296	Suppression of tubulin tyrosine ligase during tumor growth.		Lafanechere L; Courtay-Cahen C; Kawakami T; Jacrot M; Rudiger M; Wehland J; Job D; Margolis RL		J Cell Sci	111	1998	171-81	J:45930	9405300
91297	The neurofibromatosis type 1 (NF1) tumor suppressor gene and myeloid leukemia.		Largaespada DA; Brannan CI; Shaughnessy JD; Jenkins NA; Copeland NG		Curr Top Microbiol Immunol	211	1996	233-9	J:46032	8585954
91298	Genotypic differences in host immunoreactivity and their effect on the development of polycyclic hydrocarbon- induced tumors.		Elmets CA; Anderson CY; Mukhtar H		Environ Toxicol Pharmacol	4	1997	289-293	J:46069	 
91299	Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases.		Cao Y; O'Reilly MS; Marshall B; Flynn E; Ji RW; Folkman J		J Clin Invest	101	1998	1055-63	J:46184	9486976
91300	Topoisomerase II inhibitor-induced apoptosis in thymocytes and lymphoma cells.		Kizaki H; Onishi Y		Adv Enzyme Regul	37	1997	403-23	J:44770	9381984
91301	Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells.		Zhang ZC; Nechushtan H; Jacob-Hirsch J; Avni D; Meyuhas O; Razin E		Oncogene	16	1998	763-9	J:46151	9488040
91302	Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.		Amundadottir LT; Leder P		Oncogene	16	1998	737-46	J:46152	9488037
91303	Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO.		Ahn MY; Huang G; Bae SC; Wee HJ; Kim WY; Ito Y		Proc Natl Acad Sci U S A	95	1998	1812-7	J:46154	9465099
91304	Elevated expression of PDI family proteins during differentiation of mouse F9 teratocarcinoma cells.		Miyaishi O; Kozaki K; Iida K; Isobe K; Hashizume Y; Saga S		J Cell Biochem	68	1998	436-45	J:46305	9493907
91305	Atm-dependent interactions of a mammalian chk1 homolog with meiotic chromosomes.		Flaggs G; Plug AW; Dunks KM; Mundt KE; Ford JC; Quiggle MR; Taylor EM; Westphal CH; Ashley T; Hoekstra MF; Carr AM		Curr Biol	7	1997	977-86	J:46333	9382850
91306	Regulation of retinoblastoma gene expression in a mouse mammary tumor model.		Hanania EG; Au WW; Ullrich RL; Papaconstantinou J		Cancer Gene Ther	2	1995	251-61	J:46440	8548579
91307	Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors.		Kallman RF; Silini G; van Putten LM		J Natl Cancer Inst	39	1967	539-549	J:46442	6053718
91308	Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer.		Ren C; Yang G; Timme TL; Wheeler TM; Thompson TC		Cancer Res	58	1998	1285-90	J:46413	9515817
91309	Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.		Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF		Cancer Res	58	1998	1278-84	J:46414	9515816
91310	Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.		Mangues R; Corral T; Kohl NE; Symmans WF; Lu S; Malumbres M; Gibbs JB; Oliff A; Pellicer A		Cancer Res	58	1998	1253-9	J:46415	9515813
91311	Interleukin 12 gene therapy of MHC-negative murine melanoma metastases.		Nanni P; Rossi I; De Giovanni C; Landuzzi L; Nicoletti G; Stoppacciaro A; Parenza M; Colombo MP; Lollini PL		Cancer Res	58	1998	1225-30	J:46416	9515809
91312	Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosyl-ceramide, KRN7000.		Nakagawa R; Motoki K; Ueno H; Iijima R; Nakamura H; Kobayashi E; Shimosaka A; Koezuka Y		Cancer Res	58	1998	1202-7	J:46417	9515806
91313	Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo.		McSheehy PM; Robinson SP; Ojugo AS; Aboagye EO; Cannell MB; Leach MO; Judson IR; Griffiths JR		Cancer Res	58	1998	1185-94	J:46418	9515804
91314	Interaction between a semisynthetic diet and indole-3-carbinol on mammary tumor incidence in Balb/cfC3H mice.		Malloy VL; Bradlow HL; Orentreich N		Anticancer Res	17	1997	4333-7	J:46468	9494529
91315	Molecular identification and expression of erythroid K:Cl cotransporter in human and mouse erythroleukemic cells.		Pellegrino CM; Rybicki AC; Musto S; Nagel RL; Schwartz RS		Blood Cells Mol Dis	24	1998	31-40	J:46469	9516379
91316	Nucleolar localization of mouse mammary tumor virus proteins in T-cell lymphomas.		Hoch-Marchaim H; Hasson T; Rorman E; Cohen S; Hochman J		Virology	242	1998	246-54	J:46577	9514962
91317	Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma.		Lode HN; Dreier T; Xiang R; Varki NM; Kang AS; Reisfeld RA		Proc Natl Acad Sci U S A	95	1998	2475-80	J:46708	9482910
91318	The radiosensitivity of recurrent clones of an irradiated murine squamous cell carcinoma in the in vitro megacolony system.		Tarnawski R; Kummermehr J; Trott KR		Radiother Oncol	46	1998	209-14	J:46709	9510049
91319	Testicular teratocarcinogenesis in mice--a review.		Matin A; Collin GB; Varnum DS; Nadeau JH		APMIS	106	1998	174-82	J:46683	9524576
91320	Genomic imprinting in testicular germ cell tumours.		Looijenga LH; Verkerk AJ; Dekker MC; van Gurp RJ; Gillis AJ; Oosterhuis JW		APMIS	106	1998	187-95; discussion 196-7	J:46684	9524578
91321	Are estrogens carcinogenic during development of the testes?		McLachlan JA; Newbold RR; Li S; Negishi M		APMIS	106	1998	240-2; discussion 243-4	J:46685	9524585
91322	Posttranscriptional regulation of thyrotropin beta-subunit messenger ribonucleic acid by thyroid hormone in murine thyrotrope tumor cells: a conserved mechanism across species.		Staton JM; Leedman PJ		Endocrinology	139	1998	1093-100	J:46690	9492042
91323	Spleen peptides (Polyerga(TM)) inhibit development of artificial lung metastases of murine mammary carcinoma and increase efficiency of chemotherapy in mice.		Zarkovic N; Hartleb M; Zarkovic K; Borovic S; Golubic J; Kalisnik T; Frech S; Klingmuller M; Loncaric I; Bosnjak B; Jurin M; Kuhlmey J		Cancer Biother Radiopharm	13	1998	25-32	J:46741	10850339
91324	cDNA cloning of a 8-lipoxygenase and a novel epidermis-type lipoxygenase from phorbol ester-treated mouse skin.		Krieg P; Kinzig A; Heidt M; Marks F; Furstenberger G		Biochim Biophys Acta	1391	1998	7-12	J:46809	9518531
91325	Contribution of the T cell receptor BJ gene to recognition of the P91A tumor antigen in DBA/2 mice.		Suzuki S; Masuko-Hongo K; Hoger TA; Hong NM; Sasakawa H; Kurokawa M; Miura M; Kurimoto F; Hata K; Mizushima Y; Kobata T; Nishioka K; Yamamoto K; Kato T		Cancer Immunol Immunother	46	1998	93-103	J:47005	9558005
91326	The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation.		Tong B; Grimes HL; Yang TY; Bear SE; Qin Z; Du K; El-Deiry WS; Tsichlis PN		Mol Cell Biol	18	1998	2462-73	J:47010	9566867
91327	Oct-1 promoter region contains octamer sites and TAAT motifs recognized by Oct proteins [published erratum appears in FEBS Lett 1998 Aug 21;433(3):335]		Pankratova EV; Polanovsky OL; Polanovasky OL$[corrected to Polanovsky OL]		FEBS Lett	426	1998	81-5	J:47146	9598983
91328	Expression of Hras-p21 and keratin K13 in UVR-induced skin tumors in Sencar mice.		Tong Y; Tucker SB; Smith MA		J Toxicol Environ Health	53	1998	439-53	J:47102	9537281
91329	Serum deprivation and protein synthesis inhibition induce two different apoptotic processes in N18 neuroblastoma cells.		Boix J; Fibla J; Yuste V; Piulats JM; Llecha N; Comella JX		Exp Cell Res	238	1998	422-9	J:45991	9473351
91330	Biodistribution of 14C-misonidazole as a probe for hypoxic cells in a murine tumor model.		Ikeda H; Takahashi I; Yonome I; Mitsuhashi N; Niibe H		Anticancer Res	18	1998	241-5	J:47219	9568084
91331	Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.		Xie W; Wu X; Chow LT; Chin E; Paterson AJ; Kudlow JE		Cell Growth Differ	9	1998	313-25	J:47225	9563851
91332	DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors.		Chen Y; Hu D; Eling DJ; Robbins J; Kipps TJ		Cancer Res	58	1998	1965-71	J:47343	9581840
91333	Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.		Manki A; Ono T; Uenaka A; Seino Y; Nakayama E		Cancer Res	58	1998	1960-4	J:47344	9581839
91334	Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells.		Lee AH; Tannock IF		Cancer Res	58	1998	1901-8	J:47345	9581831
91335	Potentiating effect of dietary vitamin A on photocarcinogenesis in hairless mice.		Mikkelsen S; Berne B; Staberg B; Vahlquist A		Carcinogenesis	19	1998	663-6	J:47404	9600352
91336	Lectin intravital perfusion studies in tumor-bearing mice: micrometer-resolution, wide-area mapping of microvascular labeling, distinguishing efficiently and inefficiently perfused microregions in the tumor.		Debbage PL; Griebel J; Ried M; Gneiting T; DeVries A; Hutzler P		J Histochem Cytochem	46	1998	627-39	J:47372	9562571
91337	Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor.		Vercammen D; Beyaert R; Denecker G; Goossens V; Van Loo G; Declercq W; Grooten J; Fiers W; Vandenabeele P		J Exp Med	187	1998	1477-85	J:47469	9565639
91338	Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-alpha therapy: phenotypic and functional characterization up to 20 months after initial tumor inoculation.		Ehrke MJ; Verstovsek S; Pocchiari SK; Krawczyk CM; Ujhazy P; Zaleskis G; Maccubbin DL; Meer JM; Mihich E		Int J Cancer	76	1998	579-86	J:47474	9590137
91339	Down-regulation of c-myc and bcl-2 gene expression in PU.1-induced apoptosis in murine erythroleukemia cells.		Kihara-Negishi F; Yamada T; Kubota Y; Kondoh N; Yamamoto H; Abe M; Shirai T; Hashimoto Y; Oikawa T		Int J Cancer	76	1998	523-30	J:47475	9590129
91340	Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor.		Kong HL; Hecht D; Song W; Kovesdi I; Hackett NR; Yayon A; Crystal RG		Hum Gene Ther	9	1998	823-33	J:47561	9581905
91341	Cloning and chromosomal mapping of an orphan chemokine receptor: mouse RDC1		Heesen M; Berman MA; Charest A; Housman D; Gerard C; Dorf ME		Immunogenetics	47	1998	364-70	J:47562	9510554
91342	Impaired tumorigenicity of IL-4-producing murine neuroblastoma cells in immunodeficient nude mice.		Yoshida H; Enomoto H; Miyauchi M; Takenaga K; Tanabe M; Ohnuma N; Sakiyama S; Tagawa M		Int J Oncol	12	1998	1067-71	J:47566	9538130
91343	Comparison of methods of identifying Helicobacter hepaticus in B6C3F1 mice used in a carcinogenesis bioassay.		Fox JG; MacGregor JA; Shen Z; Li X; Lewis R; Dangler CA		J Clin Microbiol	36	1998	1382-7	J:47567	9574710
91344	Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases.		Henderson CJ; Smith AG; Ure J; Brown K; Bacon EJ; Wolf CR		Proc Natl Acad Sci U S A	95	1998	5275-80	J:47638	9560266
91345	Activation of bcl-2 suppressible 40 and 44 kDa p38-like kinases during apoptosis of early and late B lymphocytic cell lines.		Maucher C; Weissinger EM; Kremmer E; Baccarini M; Procyk K; Henderson DW; Wolff L; Kolch W; Kaspers B; Mushinski JF; Mischak H		FEBS Lett	427	1998	29-35	J:47600	9613594
91346	Differential effects of somatostatin and its analog on protein tyrosine kinases activity in the rat pituitary and the murine colonic tumors.		Pawlikowski M; Lachowicz L; Kunert-Radek J; Winczyk K; Janiszewska G; Szkudlarek J		Biochem Biophys Res Commun	246	1998	375-7	J:47708	9610366
91347	Assembled IgG molecules are exported from the endoplasmic reticulum in myeloma cells despite the retention signal SEKDEL.		Biocca S; Tafani M; Cattaneo A		Biochem Biophys Res Commun	246	1998	518-23	J:47709	9610394
91348	Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site.		Wenger RH; Kvietikova I; Rolfs A; Camenisch G; Gassmann M		Eur J Biochem	253	1998	771-7	J:47710	9654078
91349	X-ray-induced lymphomagenesis in E mu-pim-1 transgenic mice: an investigation of the co-operating molecular events.		van der Houven van Oordt CW; Schouten TG; van Krieken JH; van Dierendonck JH; van der Eb AJ; Breuer ML		Carcinogenesis	19	1998	847-53	J:47712	9635873
91350	No requirement for V(D)J recombination in p53-deficient thymic lymphoma.		Liao MJ; Zhang XX; Hill R; Gao J; Qumsiyeh MB; Nichols W; Van Dyke T		Mol Cell Biol	18	1998	3495-501	J:47667	9584189
91351	2-Mercapto-propylamine: radiopharmacology in mice, pharmacokinetic studies in mice and in rats, mutagenicity and differential distribution between tissues and EMT6 tumour in mice.		Schumacher CP; Robbe Y; Sicart MT; Subra G; Delard R; Dubois JB		Farmaco	53	1998	118-24	J:47829	9604319
91352	p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells.		Zamble DB; Jacks T; Lippard SJ		Proc Natl Acad Sci U S A	95	1998	6163-8	J:47905	9600935
91353	B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.		Zheng P; Wu Y; Guo Y; Lee C; Liu Y		Proc Natl Acad Sci U S A	95	1998	6284-9	J:47908	9600957
91354	p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.		Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC		Oncogene	16	1998	2965-74	J:48164	9662328
91355	Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.		Jakowlew SB; Moody TW; You L; Mariano JM		Mol Carcinog	22	1998	46-56	J:48235	9609100
91356	p107 is a suppressor of retinoblastoma development in pRb-deficient mice.		Robanus-Maandag E; Dekker M; van der Valk M; Carrozza ML; Jeanny JC; Dannenberg JH; Berns A; te Riele H		Genes Dev	12	1998	1599-609	J:48194	9620848
91357	Transplantable mouse tumors		Fekete E; Kent EL		Transplant Bull	2	1955	61-62	J:47052	 
91358	Resistance of various inbred strains of mice to tumor homoiotransplants, and its relation to the H-2 allele which each carries		Snell GD; Russell E; Fekete E; Smith P		J Natl Cancer Inst	14	1953	485-491	J:47054	13233807
91359	The effect of phosphoramides on the growth of a variety of mouse and rat tumors		Sugiura K; Stock CC		Cancer Res	15	1955	38-51	J:47492	13231073
91360	A survey of transplantable and transmissible animal tumors		Dunham LJ; Stewart HL		J Natl Cancer Inst	13	1952	1299-1377	J:47514	 
91361	Chemoprevention by N-acetylcysteine of urethane-induced clastogenicity and lung tumors in mice.		Balansky RM; De Flora S		Int J Cancer	77	1998	302-5	J:48259	9650568
91362	12(S)-hydroxyeicosatetraenoic acid increases the actin microfilament content in B16a melanoma cells: a protein kinase-dependent process.		Rice RL; Tang DG; Haddad M; Honn KV; Taylor JD		Int J Cancer	77	1998	271-8	J:48260	9650564
91363	Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress.		Treister A; Sagi-Assif O; Meer M; Smorodinsky NI; Anavi R; Golan I; Meshel T; Kahana O; Eshel R; Katz BZ; Shevach E; Witz IP		Int J Cancer	77	1998	306-13	J:48261	9650569
91364	Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation.		Sunters A; McCluskey J; Grigoriadis AE		Dev Genet	22	1998	386-97	J:48539	9664690
91365	Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.		Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P		J Immunol	161	1998	563-70	J:48544	9670928
91366	Skin tumor development and keratin expression in different experimental models. Relation to inducing agent and target tissue structure.		Makinen M; Stenback F		Exp Toxicol Pathol	50	1998	199-208	J:48611	9681650
91367	Increase of adenylate kinase isozyme 1 protein during neuronal differentiation in mouse embryonal carcinoma P19 cells and in rat brain primary cultured cells.		Inouye S; Seo M; Yamada Y; Nakazawa A		J Neurochem	71	1998	125-33	J:48619	9648858
91368	Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.		Qian X; Balestra ME; Yamanaka S; Boren J; Lee I; Innerarity TL		Arterioscler Thromb Vasc Biol	18	1998	1013-20	J:48744	9633945
91369	Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors.		Luo JC; Yamaguchi S; Shinkai A; Shitara K; Shibuya M		Cancer Res	58	1998	2652-60	J:48747	9635593
91370	Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells.		Maurer-Gebhard M; Schmidt M; Azemar M; Altenschmidt U; Stocklin E; Wels W; Groner B		Cancer Res	58	1998	2661-6	J:48748	9635594
91371	Fibroblast growth factor receptor 4, implicated in progression of islet cell carcinogenesis by its expression profile, does not contribute functionally.		Olson DC; Deng C; Hanahan D		Cell Growth Differ	9	1998	557-64	J:48719	9690623
91372	Genes differentially expressed with malignant transformation and metastatic tumor progression of murine squamous cell carcinoma.		Dong G; Loukinova E; Smith CW; Chen Z; Van Waes C		J Cell Biochem Suppl	28-29	1997	90-100	J:48886	9589353
91373	Lung-specific expression in mice of a dominant negative mutant form of the p53 tumor suppressor protein.		Morris GF; Hoyle GW; Athas GB; Lei WH; Xu J; Morris CB; Friedman M		J La State Med Soc	150	1998	179-85	J:48898	9610073
91374	Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia.		Traver D; Akashi K; Weissman IL; Lagasse E		Immunity	9	1998	47-57	J:48838	9697835
91375	A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.		Zhao R; Assaraf YG; Goldman ID		J Biol Chem	273	1998	19065-71	J:48840	9668089
91376	Idiotype-specific inhibition of LFA-1-mediated cell adhesion by anti-idiotype x anti-LFA-1 bispecific antibodies.		Kollet O; Haimovich J; Hollander N		Immunol Lett	62	1998	171-6	J:48843	9698116
91377	Function and expression of CD44 during spreading, migration, and invasion of murine carcinoma cells.		Ladeda V; Aguirre Ghiso JA; Bal de Kier Joffe E		Exp Cell Res	242	1998	515-27	J:48959	9683538
91378	Regulatory role of T cells in a murine model of lymphoproliferative disease.		Raveche E; Fernandes H; Ong H; Peng B		Cell Immunol	187	1998	67-75	J:48960	9682005
91379	Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue [see comments]		Basak S; Speicher D; Eck S; Wunner W; Maul G; Simmons MS; Herlyn D		J Natl Cancer Inst	90	1998	691-7	J:48961	9586666
91380	LFA-1-dependent tumoricidal activity of cisplatin-treated macrophages.		Singh RA; Sodhi A		Immunol Cell Biol	76	1998	343-9	J:49206	9723775
91381	Murine tumor suppressor models.		Venkatachalam S; Donehower LA		Mutat Res	400	1998	391-407	J:49209	9685699
91382	Investigation of lung tumour induction in C3H/HeH mice, with and without tumour promotion with urethane, following paternal X-irradiation.		Cattanach BM; Papworth D; Patrick G; Goodhead DT; Hacker T; Cobb L ; Whitehill E		Mutat Res	403	1998	1-12	J:49145	9726000
91383	Inbreeding abolishes the effect of parental origin of a mutant Rb-1 allele on pituitary tumorigenesis in mice.		Armstrong JF; Hooper ML		Br J Cancer	78	1998	484-5	J:49159	9716031
91384	Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system.		Kishima H; Shimizu K; Miyao Y; Mabuchi E; Tamura K; Tamura M; Sasaki M; Hakakawa T		Br J Cancer	78	1998	446-53	J:49160	9716025
91385	Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.		Ahmad N; Gali H; Javed S; Agarwal R		Biochem Biophys Res Commun	247	1998	294-301	J:49254	9642119
91386	Evaluation of lactate as a 1H nuclear magnetic resonance spectroscopy index for noninvasive prediction and early detection of tumor response to radiation therapy in EMT6 tumors.		Aboagye EO; Bhujwalla ZM; He Q; Glickson JD		Radiat Res	150	1998	38-42	J:49257	9650600
91387	Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice.		D'Agostini F; Bagnasco M; Giunciuglio D; Albini A; De Flora S		Int J Oncol	13	1998	217-24	J:49381	9664114
91388	Screening of N-acylneuraminic acids in serum and tissue specimens of mouse C57BI with Lewis' lung cancer by high-performance liquid chromatography.		Makatsori E; Fermani K; Aletras A; Karamanos NK; Tsegenidis T		J Chromatogr B Biomed Appl	712	1998	23-9	J:49382	9698225
91389	Putative tumor suppressor gene region within 0.85 cM on chromosome 12 in radiation-induced murine lymphomas.		Okumoto M; Song CW; Tabata K; Ishibashi M; Mori N; Park YG; Kominami R ; Matsumoto Y ; Takamori Y ; Esaki K		Mol Carcinog	22	1998	175-81	J:49336	9688143
91390	Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model.		Lefor AT; Fabian DF		J Surg Res	75	1998	49-53	J:49445	9614856
91391	A novel angiotensin II binding site in murine tissues.		Herblin WF; Barbera F; Diamond S; Gibson RE; Timmermans P		Life Sci	63	1998	223-34	J:49446	9698052
91392	Tamoxifen inhibits colorectal cancer metastases in the liver: a study in a murine model.		Kuruppu D; Christophi C; Bertram JF; O'Brien PE		J Gastroenterol Hepatol	13	1998	521-7	J:49447	9641652
91393	Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.		Battershill JM; Fielder RJ		Hum Exp Toxicol	17	1998	193-205	J:49448	9617631
91394	Increased induction of Ca2+-mediated differentiation by gamma ray is mediated by endogenous activation of the protein kinase C signaling pathways in mouse epidermal cells.		Song HJ; Cho CK; Yoo SY; Park KS; Lee YS		Int J Radiat Oncol Biol Phys	41	1998	897-904	J:49449	9652855
91395	Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells.		Picard V; Epsztejn S; Santambrogio P; Cabantchik ZI; Beaumont C		J Biol Chem	273	1998	15382-6	J:49408	9624120
91396	Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein.		Ji H; Chang EY; Lin KY; Kurman RJ; Pardoll DM; Wu TC		Int J Cancer	78	1998	41-5	J:49409	9724092
91397	p53 expression in skin carcinogenesis and its relationship to cell proliferation and tumour growth.		Stenback F; Makinen M; Jussila T		Eur J Cancer	34	1998	1415-24	J:49490	9849426
91398	VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development.		Larcher F; Murillas R; Bolontrade M; Conti CJ; Jorcano JL		Oncogene	17	1998	303-11	J:49104	9690512
91399	Differential induction of Cyp1a1, Cyp1b1, Ahd4, and Nmo1 in murine skin tumors and adjacent normal epidermis by ligands of the aryl hydrocarbon receptor.		Reiners JJ Jr; Jones CL; Hong N; Myrand SP		Mol Carcinog	21	1998	135-46	J:46703	9496914
91400	Antitumor activity of tricyclic pyrone analogs, a new synthetic class of microtubule de-stabilizing agents, in the murine EMT-6 mammary tumor cell line in vitro.		Perchellet EM; Ladesich JB; Chen Y; Sin HS; Hua DH; Kraft SL; Perchellet JP		Anticancer Drugs	9	1998	565-76	J:49515	9877246
91401	Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.		Molnar J; Szabo D; Mandi Y; Mucsi I; Fischer J; Varga A; Konig S; Motohashi N		Anticancer Res	18	1998	3033-8	J:49516	9713505
91402	Induction of endogenous mammary tumor virus in lymphocytes infected with murine acquired immunodeficiency syndrome virus.		Gayama S; Doyon L; Vaupel B; Sekaly RP; Kanagawa O		Cell Immunol	187	1998	124-30	J:49638	9732700
91403	Time-course of hypericin phototoxicity and effect on mitochondrial energies in EMT6 mouse mammary carcinoma cells		Johnson SA; Dalton AE; Pardini RS		Free Radic Biol Med	25	1998	144-52	J:49589	9667489
91404	Docetaxel chronopharmacology in mice.		Tampellini M; Filipski E; Liu XH; Lemaigre G; Li XM; Vrignaud P; Francois E; Bissery MC; Levi F		Cancer Res	58	1998	3896-904	J:49596	9731500
91405	Allogeneic cell therapy for a murine mammary carcinoma.		Morecki S; Yacovlev E; Diab A; Slavin S		Cancer Res	58	1998	3891-5	J:49597	9731499
91406	Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases.		Xiang R; Lode HN; Dreier T; Gillies SD; Reisfeld RA		Cancer Res	58	1998	3918-25	J:49598	9731503
91407	Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors.		Onishi Y; Kizaki H		Biochem Biophys Res Commun	228	1996	7-13	J:49527	8912629
91408	Pigmented uveal tumours in a transgenic mouse model.		Kramer TR; Powell MB; Wilson MM; Salvatore J; Grossniklaus HE		Br J Ophthalmol	82	1998	953-60	J:49678	9828784
91409	Induction of bone tumors in transgenic mice by C-FOS depends on the presence of a retroviral long terminal repeat.		Ruther U		Cancer Genet Cytogenet	105	1998	123-7	J:49679	9723028
91410	Effect of promoter and intron 2 polymorphisms on murine lung K-ras gene expression.		Jones-Bolin SE; Johansson E; Palmisano WA; Anderson MW; Wiest JS ; Belinsky SA		Carcinogenesis	19	1998	1503-8	J:49680	9744549
91411	Deregulated expression of the retinoid X receptor alpha prevents muscle differentiation in P19 embryonal carcinoma cells.		Pratt MA; Crippen C; Hubbard K; Menard M		Cell Growth Differ	9	1998	713-22	J:49794	9751115
91412	Sodium butyrate suppresses apoptosis in human Burkitt lymphomas and murine plasmacytomas bearing c-myc translocations.		Alexandrov I; Romanova L; Mushinski F; Nordan R		FEBS Lett	434	1998	209-14	J:49795	9738480
91413	p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment.		Guerra B; Issinger OG		FEBS Lett	434	1998	115-20	J:49797	9738462
91414	Quantitative selectivity of contact-mediated intercellular communication in a metastatic mouse mammary tumor line.		Miller BE; Roi LD; Howard LM; Miller FR		Cancer Res	43	1983	4102-7	J:48394	6871851
91415	Metastatic cutaneous melanoma promoted by ultraviolet radiation in mice with transgene-initiated low melanoma susceptibility.		Kelsall SR; Mintz B		Cancer Res	58	1998	4061-5	J:49907	9751610
91416	Tissue-specific expression and activation of N-methylpurine-DNA glycosylase in thymic carcinomas of transgenic mice expressing the SV40 large T-antigen gene.		Kim NK; Lee SH; Cha KY; Seo JS		Mol Cells	8	1998	383-7	J:49953	9749523
91417	Inhibition of IgG2ab production by Ig allotype-specific T cells can Be mediated without T-B cell contact.		Rujithamkul N; Majlessi L; Denoyelle C; Bordenave G		Cell Immunol	188	1998	41-8	J:50038	9743556
91418	Reduced susceptibility of electroporated tumor cell lines to killing by cytotoxic lymphocytes.		Dressel R; Baraki H; Langer F; Gunther E		Biochem Biophys Res Commun	250	1998	259-63	J:50041	9753617
91419	Enhancement of antigen-specific IFN-gamma production from CD8(+) T cells by a single amino acid-substituted peptide derived from bovine alphas1-casein.		Totsuka M; Kakehi M; Kohyama M; Hachimura S; Hisatsune T; Kaminogawa S		Clin Immunol Immunopathol	88	1998	277-86	J:50008	9743615
91420	Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms.		Okada H; Tahara H; Shurin MR; Attanucci J; Giezeman-Smits KM; Fellows WK; Lotze MT; Chambers WH; Bozik ME		Int J Cancer	78	1998	196-201	J:50009	9754652
91421	Clonal deletion of thymocytes as a tumor escape mechanism.		Lauritzsen GF; Hofgaard PO; Schenck K; Bogen B		Int J Cancer	78	1998	216-22	J:50010	9754655
91422	Expression of RGD minus fibronectin that does not form extracellular matrix fibrils is sufficient to decrease tumor metastasis.		Urtreger A; Porro F; Puricelli L; Werbajh S; Baralle FE; Bal de Kier Joffe E; Kornblihtt AR; Muro AF		Int J Cancer	78	1998	233-41	J:50011	9754657
91423	Sequence, linkage to H2-K, and function of mouse tapasin in MHC class I assembly.		Grandea AG 3rd; Comber PG; Wenderfer SE; Schoenhals G; Fruh K ; Monaco JJ ; Spies T		Immunogenetics	48	1998	260-5	J:50012	9716645
91424	Expression of the H2-Ea gene is modulated by a polymorphic transcriptional enhancer.		Janitz M; Reiners-Schramm L; Lauster R		Immunogenetics	48	1998	266-72	J:50013	9716646
91425	CIITA B-cell-specific promoter suppression in MHC class II-silenced cell hybrids.		Lennon AM; Ottone C; Rosemblatt M; Fellous M; Bono MR; Alcaide-Loridan C		Immunogenetics	48	1998	283-91	J:50014	9716648
91426	A method to score micronuclei in vivo using cytochalasin B-induced cytokinesis block.		Uma Devi P; Satish Rao BS; Kamath R		Mutat Res	401	1998	33-7	J:50072	9639669
91427	Expression of two different endogenous galactoside-binding lectins sharing sequence homology.		Raz A; Carmi P; Pazerini G		Cancer Res	48	1988	645-9	J:50230	3335026
91428	Dietary lutein from marigold extract inhibits mammary tumor development in BALB/c mice.		Park JS; Chew BP; Wong TS		J Nutr	128	1998	1650-6	J:50209	9772131
91429	Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.		Mackey JR; Mani RS; Selner M; Mowles D; Young JD; Belt JA; Crawford CR; Cass CE		Cancer Res	58	1998	4349-57	J:50211	9766663
91430	Distinct regulatory mechanisms for interferon-alpha/beta (IFN-alpha/beta)- and IFN-gamma-mediated induction of Ly-6E gene in B cells.		Khodadoust MM; Khan KD; Park EH; Bothwell AL		Blood	92	1998	2399-409	J:50213	9746780
91431	19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.		Asou H; Koike M; Elstner E; Cambell M; Le J; Uskokovic MR; Kamada N; Koeffler HP		Blood	92	1998	2441-9	J:50214	9746784
91432	Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase.		Burgess GS; Williamson EA; Cripe LD; Litz-Jackson S; Bhatt JA; Stanley K; Stewart MJ; Kraft AS; Nakshatri H; Boswell HS		Blood	92	1998	2450-60	J:50215	9746785
91433	Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzo-thiopyranoindazole derivatives.		Perni RB; Wentland MP; Huang JI; Powles RG; Aldous S; Klingbeil KM; Peverly AD; Robinson RG; Corbett TH; Jones JL; Mattes KC; Rake JB; Coughlin SA		J Med Chem	41	1998	3645-54	J:50291	9733489
91434	Interaction of 2',2'-difluorodeoxycytidine (gemcitabine) and formycin B with the Na+-dependent and -independent nucleoside transporters of Ehrlich ascites tumor cells.		Burke T; Lee S; Ferguson PJ; Hammond JR		J Pharmacol Exp Ther	286	1998	1333-40	J:50293	9732397
91435	Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice.		Hsu CX; Ross BD; Chrisp CE; Derrow SZ; Charles LG; Pienta KJ; Greenberg NM; Zeng Z; Sanda MG		J Urol	160	1998	1500-5	J:50294	9751403
91436	Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice.		Llovera M; Garcia-Martinez C; Lopez-Soriano J; Carbo N; Agell N; Lopez-Soriano FJ; Argiles JM		Mol Cell Endocrinol	142	1998	183-9	J:50298	9783914
91437	Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide.		Lin TS; Ishiguro K; Sartorelli AC		Oncol Res	10	1998	175-84	J:50299	9778688
91438	Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer.		Rancourt C; Rogers BE; Sosnowski BA; Wang M; Piche A; Pierce GF; Alvarez RD; Siegal GP; Douglas JT; Curiel DT		Clin Cancer Res	4	1998	2455-61	J:50256	9796978
91439	Transforming growth factor-beta expression in mouse lung carcinogenesis.		Jakowlew SB; Moody TW; You L; Mariano JM		Exp Lung Res	24	1998	579-93	J:50427	9659584
91440	c-Myc-associated genomic instability of the dihydrofolate reductase locus in vivo.		Taylor C; Mai S		Cancer Detect Prev	22	1998	350-6	J:50429	9674878
91441	Oxytocin receptor within the breast: biological function and distribution.		Sapino A; Cassoni P; Stella A; Bussolati G		Anticancer Res	18	1998	2181-6	J:50430	9703781
91442	Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis.		Goss KJ; Brown PD; Matrisian LM		Int J Cancer	78	1998	629-35	J:50603	9808534
91443	Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.		Takahashi C; Sheng Z; Horan TP; Kitayama H; Maki M; Hitomi K; Kitaura Y; Takai S; Sasahara RM; Horimoto A; Ikawa Y; Ratzkin BJ; Arakawa T; Noda M		Proc Natl Acad Sci U S A	95	1998	13221-6	J:50571	9789069
91444	Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues.		Kim Y; Fischer SM		J Biol Chem	273	1998	27686-94	J:50691	9765305
91445	E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families.		Keirsebilck A; Bonne S; Bruyneel E; Vermassen P; Lukanidin E; Mareel M; van Roy F		Cancer Res	58	1998	4587-91	J:50670	9788607
91446	Endotoxin-induced protein phosphorylation in macrophages is modulated by tumor cells.		Kumar A; Singh SM; Sodhi A		Int J Immunopharmacol	20	1998	99-110	J:50720	9717085
91447	Differential expression of Galalpha1,3Gal epitope in polymeric and monomeric IgM secreted by mouse myeloma cells deficient in alpha2, 6-sialyltransferase.		Smilovich D; Malagolini N; Fagioli C; de Lalla C; Sitia R; Serafini-Cessi F		Glycobiology	8	1998	841-8	J:50721	9637816
91448	Association of ceramide accumulation with photodynamic treatment-induced cell death.		Separovic D; Mann KJ; Oleinick NL		Photochem Photobiol	68	1998	101-9	J:50722	9679455
91449	Cancer chemopreventive activity of synthetic colorants used in foods, pharmaceuticals and cosmetic preparations.		Kapadia GJ; Tokuda H; Sridhar R; Balasubramanian V; Takayasu J; Bu P; Enjo F; Takasaki M; Konoshima T; Nishino H		Cancer Lett	129	1998	87-95	J:50723	9714339
91450	The field bean protease inhibitor has the potential to suppress B16F10 melanoma cell lung metastasis in mice.		Banerji A; Fernandes A; Bane S; Ahire S		Cancer Lett	129	1998	15-20	J:50724	9714330
91451	Recombinant immunocytokines targeting the mouse transferrin receptor: construction and biological activities.		Dreier T; Lode HN; Xiang R; Dolman CS; Reisfeld RA; Kang AS		Bioconjug Chem	9	1998	482-9	J:50725	9667950
91452	Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11.		Liu P; Zhang H; McLellan A; Vogel H; Bradley A		Genetics	150	1998	1155-68	J:50799	9799267
91453	Heteroclitic immunization induces tumor immunity.		Dyall R; Bowne WB; Weber LW; LeMaoult J; Szabo P; Moroi Y; Piskun G; Lewis JJ; Houghton AN; Nikolic-Zugic J		J Exp Med	188	1998	1553-61	J:50774	9802967
91454	Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand.		Miwa K; Asano M; Horai R; Iwakura Y; Nagata S; Suda T		Nat Med	4	1998	1287-92	J:50775	9809553
91455	Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.		Gill RM; Slack R; Kiess M; Hamel PA		Exp Cell Res	244	1998	157-70	J:50820	9770359
91456	Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.		Rodriguez-Puebla ML; LaCava M; Gimenez-Conti IB; Johnson DG; Conti CJ		Oncogene	17	1998	2251-8	J:50890	9811455
91457	Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo.		Deng J; Xia W; Hung MC		Oncogene	17	1998	2167-75	J:50892	9811448
91458	Murine DEP-1, a receptor protein tyrosine phosphatase, is expressed in macrophages and is regulated by CSF-1 and LPS.		Osborne JM; den Elzen N; Lichanska AM; Costelloe EO; Yamada T; Cassady AI; Hume DA		J Leukoc Biol	64	1998	692-701	J:50896	9823776
91459	Tumor specific boosting of IL-2 induced NK activation by paraformaldehyde fixed tumor cells.		Dhillon S; Saxena RK		Immunol Lett	63	1998	153-8	J:50979	9840684
91460	Susceptibility alleles for aberrant B-1 cell proliferation involved in spontaneously occurring B-cell chronic lymphocytic leukemia in a model of New Zealand white mice.		Hamano Y; Hirose S; Ida A; Abe M; Zhang D; Kodera S; Jiang Y ; Shirai J ; Miura Y ; Nishimura H ; Shirai T		Blood	92	1998	3772-9	J:50981	9808571
91461	Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells.		Matteucci A; Faenza I; Gilmour RS; Manzoli L; Billi AM; Peruzzi D; Bavelloni A; Rhee SG; Cocco L		Cancer Res	58	1998	5057-60	J:50946	9823310
91462	Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo.		Crawford HC; Matrisian LM; Liaw L		Cancer Res	58	1998	5206-15	J:50948	9823334
91463	Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.		Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK		Cancer Res	58	1998	5231-8	J:50949	9823337
91464	Regulation of luteinizing hormone receptor gene expression by insulin- like growth factor-I in an immortalized murine Leydig tumor cell line (BLT-1).		Zhang FP; El-Hafnawy T; Huhtaniemi I		Biol Reprod	59	1998	1116-23	J:51006	9780317
91465	Genetic background influences timing, morphology and dissemination of lymphomas in p53-deficient mice.		van Meyel DJ; Sanchez-Sweatman OH; Kerkvliet N; Stitt L; Ramsay DA; Khokha R; Chambers AF; Cairncross JG		Int J Oncol	13	1998	917-22	J:51144	9772279
91466	Effect of mutations of murine lens alphaB crystallin on transfected neural cell viability and cellular translocation in response to stress.		Wiesmann KE; Coop A; Goode D; Hepburne-Scott HW; Crabbe MJ		FEBS Lett	438	1998	25-31	J:51180	9821953
91467	MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats.		Kam JL; Regimbald LH; Hilgers JH; Hoffman P; Krantz MJ; Longenecker BM; Hugh JC		Cancer Res	58	1998	5577-81	J:51365	9850097
91468	The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.		Powell DJ Jr; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL		Cancer Res	58	1998	5523-8	J:51366	9850089
91469	The low molecular weight Dextran 40 inhibits the adhesion of T lymphocytes to endothelial cells.		Termeer CC; Weiss JM; Schopf E; Vanscheidt W; Simon JC		Clin Exp Immunol	114	1998	422-6	J:51331	9844053
91470	PTHrP regulates epidermal differentiation in adult mice.		Foley J; Longely BJ; Wysolmerski JJ; Dreyer BE; Broadus AE; Philbrick WM		J Invest Dermatol	111	1998	1122-8	J:51409	9856827
91471	Spontaneous and chemically induced proliferative lesions in Tg.AC transgenic and p53-heterozygous mice.		Mahler JF; Flagler ND; Malarkey DE; Mann PC; Haseman JK; Eastin W		Toxicol Pathol	26	1998	501-11	J:51448	9715509
91472	Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.		de La Coste A; Romagnolo B; Billuart P; Renard CA; Buendia MA; Soubrane O; Fabre M; Chelly J; Beldjord C; Kahn A; Perret C		Proc Natl Acad Sci U S A	95	1998	8847-51	J:51428	9671767
91473	Growth and differentiation of bone marrow hematopoietic cells in mice bearing Ehrlich ascite tumor and treated with Dicyclopentadienildichlorotitanium (IV).		Valadares MC; Klein SI; Zyngier S; Queiroz ML		Int J Immunopharmacol	20	1998	573-81	J:51476	9839661
91474	Protection by black tea and green tea against UVB and UVA + B induced skin cancer in hairless mice.		Record IR; Dreosti IE		Mutat Res	422	1998	191-9	J:51532	9920445
91475	Tumour suppressor gene mutations in humans and mice: parallels and contrasts.		Hooper ML		EMBO J	17	1998	6783-9	J:51534	9843483
91476	Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.		Starck J; Doubeikovski A; Sarrazin S; Gonnet C; Rao G; Skoultchi A; Godet J; Dusanter-Fourt I; Morle F		Mol Cell Biol	19	1999	121-35	J:51643	9858537
91477	Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells.		Yoshiji H; Kuriyama S; Yoshii J; Yamazaki M; Kikukawa M; Tsujinoue H; Nakatani T; Fukui H		Hepatology	28	1998	1489-96	J:51781	9828211
91478	GM-CSF-transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages and poorly tumorigenic in immune-compromised mice.		Kumar R; Yoneda J; Fidler IJ; Dong Z		J Leukoc Biol	65	1999	102-8	J:51946	9886252
91479	Enhancement of tumor radioresponse in vivo by gemcitabine.		Milas L; Fujii T; Hunter N; Elshaikh M; Mason K; Plunkett W; Ang KK; Hittelman W		Cancer Res	59	1999	107-14	J:51981	9892194
91480	In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.		Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G		Cancer Res	59	1999	122-7	J:51982	9892196
91481	Host genes affecting survival period of chemically induced bladder cancer in mice.		Higashi S; Murai T; Mori S; Kamoto T; Yoshitomi M; Arakawa Y; Makino S; Fukushima S; Yoshida O; Hiai H		J Cancer Res Clin Oncol	124	1998	670-6	J:51984	9879827
91482	Mannosylerythritol lipid is a potent inducer of apoptosis and differentiation of mouse melanoma cells in culture.		Zhao X; Wakamatsu Y; Shibahara M; Nomura N; Geltinger C; Nakahara T; Murata T; Yokoyama KK		Cancer Res	59	1999	482-6	J:52036	9927066
91483	Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12.		Cavallo F; Di Carlo E; Butera M; Verrua R; Colombo MP; Musiani P; Forni G		Cancer Res	59	1999	414-21	J:52037	9927056
91484	Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.		Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R		J Immunol	161	1998	6977-84	J:52130	9862733
91485	Effects of hydroxyapatite on spontaneous mammary tumourigenesis and related parameters in SHN virgin mice.		Nagasawa H; Kawamura Y; Kanamaru Y		Anticancer Res	18	1998	3251-6	J:52097	9858891
91486	High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.		Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G		Anticancer Res	18	1998	3571-8	J:52098	9858941
91487	Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.		Yu Q; Stamenkovic I		Genes Dev	13	1999	35-48	J:52215	9887098
91488	Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.		Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Petein M; Budel V; Schoofs A; Pourrias B; Kiss R		Breast Cancer Res Treat	51	1998	39-55	J:52327	9877028
91489	Genetic immunization against neu/erbB2 transgenic breast cancer.		Amici A; Venanzi FM; Concetti A		Cancer Immunol Immunother	47	1998	183-90	J:52328	9875670
91490	Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo [see comments]		Walczak H; Miller RE; Ariail K; Gliniak B; Griffith TS; Kubin M; Chin W; Jones J; Woodward A; Le T; Smith C; Smolak P; Goodwin RG; Rauch CT; Schuh JC; Lynch DH		Nat Med	5	1999	157-63	J:52388	9930862
91491	Epigenetic modulation of differentiation in CE44 teratocarcinoma.		Alvarez A; Lacalle J; Garcia-Sanz M; Simon J; Arechaga J; Hilario E		Histol Histopathol	14	1999	1-9	J:52500	9987644
91492	Radiation-resistant and radiation-sensitive forms of host resistance to polyomavirus.		Carroll JP; Fung JS; Bronson RT; Razvi E; Benjamin TL		J Virol	73	1999	1213-8	J:52505	9882323
91493	Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia.		Salomon DS; Bianco C; De Santis M		Bioessays	21	1999	61-70	J:52449	10070255
91494	Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.		Kozin SV; Kozina LV		Radiat Res	151	1999	79-84	J:52456	9973088
91495	A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model.		Lahiri-Chatterjee M; Katiyar SK; Mohan RR; Agarwal R		Cancer Res	59	1999	622-32	J:52543	9973210
91496	Pharmacological modulation of cisplatin toxicity rhythms with buthionine sulfoximine in mice bearing pancreatic adenocarcinoma (PO3).		Li XM; Filipski E; Levi F		Chronobiol Int	15	1998	323-35	J:52618	9706410
91497	Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer.		Engelman JA; Lee RJ; Karnezis A; Bearss DJ; Webster M; Siegel P; Muller WJ; Windle JJ; Pestell RG; Lisanti MP		J Biol Chem	273	1998	20448-55	J:52621	9685399
91498	Regulatory volume decrease and intracellular Ca2+ in murine neuroblastoma cells studied with fluorescent probes.		Altamirano J; Brodwick MS; Alvarez-Leefmans FJ		J Gen Physiol	112	1998	145-60	J:52622	9689024
91499	Relative contributions of apoptosis and random necrosis in tumour response to photodynamic therapy: effect of the chemical structure of Zn(II)-phthalocyanines.		Jori G; Fabris C		J Photochem Photobiol B	43	1998	181-5	J:52623	9718718
91500	Analgesics in mice used in cancer research: reduction of discomfort?		van Loo PL; Everse LA; Bernsen MR; Baumans V; Hellebrekers LJ; Kruitwagen CL; den Otter W		Lab Anim	31	1997	318-25	J:52624	9350703
91501	CD45 partially mediates heterotypic adhesion between murine leukemia/lymphoma cell line L5178Y and marrow stromal cells.		Juneja HS; Schmalstieg FC; Lee S; Chen J		Leuk Res	22	1998	805-15	J:52625	9716012
91502	Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.		Coppee F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE		Oncogene	17	1998	631-41	J:52626	9704929
91503	Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors.		Tutt AL; French RR; Illidge TM; Honeychurch J; McBride HM; Penfold CA; Fearon DT; Parkhouse RM; Klaus GG; Glennie MJ		J Immunol	161	1998	3176-85	J:52682	9743386
91504	Immunobiology of lipid-modulated UV-carcinogenesis.		Black HS; Okotie-Eboh G; Gerguis J		J Photochem Photobiol B	44	1998	124-9	J:52683	9757594
91505	Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment.		Korbelik M; Cecic I		J Photochem Photobiol B	44	1998	151-8	J:52684	9757597
91506	Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells [see comments]		Nasu Y; Timme TL; Yang G; Bangma CH; Li L; Ren C; Park SH; DeLeon M; Wang J; Thompson TC		Nat Med	4	1998	1062-4	J:52685	9734401
91507	The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.		Moriya K; Fujie H; Shintani Y; Yotsuyanagi H; Tsutsumi T; Ishibashi K; Matsuura Y; Kimura S; Miyamura T; Koike K		Nat Med	4	1998	1065-7	J:52686	9734402
91508	Inhibition of skin carcinomas but not papillomas by sphingosine, N-methylsphingosine, and N-acetylsphingosine.		Birt DF; Merrill AH Jr; Barnett T; Enkvetchakul B; Pour PM; Liotta DC; Geisler V; Menaldino DS; Schwartzbauer J		Nutr Cancer	31	1998	119-26	J:52688	9770723
91509	Starvation-induced autophagocytosis paradoxically decreases the susceptibility to oxidative stress of the extremely oxidative stress-sensitive NIT insulinoma cells.		Olejnicka BT; Dalen H; Baranowski MM; Brunk UT		Redox Rep	3	1997	311-8	J:52690	9754330
91510	Structure, tumorigenicity, microsomal metabolism, and DNA binding of 7-Nitrodibenz [a,h]anthracene.		Fu PP; Von Tungeln LS; Chiu LH; Zhan DJ; Deck J; Bucci T; Wang JC		Chem Res Toxicol	11	1998	937-45	J:52648	9705756
91511	Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor.		Dong Z; Yoneda J; Kumar R; Fidler IJ		J Exp Med	188	1998	755-63	J:52652	9705957
91512	Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1.		Petersson M; Charo J; Salazar-Onfray F; Noffz G; Mohaupt M; Qin Z; Klein G; Blankenstein T; Kiessling R		J Immunol	161	1998	2099-105	J:52653	9725200
91513	Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.		Prevost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H		J Immunol	161	1998	2187-94	J:52654	9725210
91514	Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model.		Fernando GJ; Stewart TJ; Tindle RW; Frazer IH		J Immunol	161	1998	2421-7	J:52655	9725239
91515	The oncogene heregulin induces apoptosis in breast epithelial cells and tumors.		Weinstein EJ; Grimm S; Leder P		Oncogene	17	1998	2107-13	J:52750	9798682
91516	Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.		Hilbert DM; Theisen PW; Rudikoff EK; Bauer SR		Oncogene	17	1998	2125-35	J:52752	9798684
91517	Isolation and characterization of mouse ovarian surface epithelial cell lines.		Kido M; Shibuya M		Pathol Res Pract	194	1998	725-30	J:52753	9820870
91518	In situ molecular dosimetry and tumor risk: UV-induced DNA damage and tumor latency time.		de Gruijl FR; Berg RJ		Photochem Photobiol	68	1998	555-60	J:52754	9796438
91519	Tumor induction in F344/N rats and B6C3F1 mice following inhalation exposure to ethylbenzene.		Chan PC; Hasemani JK; Mahleri J; Aranyi C		Toxicol Lett	99	1998	23-32	J:52755	9801027
91520	Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation?		Magnusson KP; Satalino R; Qian W; Klein G; Wiman KG		Oncogene	17	1998	2333-7	J:52759	9811464
91521	Tumours derived from HTLV-I tax transgenic mice are characterized by enhanced levels of apoptosis and oncogene expression.		Hall AP; Irvine J; Blyth K; Cameron ER; Onions DE; Campbell ME		J Pathol	186	1998	209-14	J:52715	9924438
91522	Melatonin decreases bone marrow and lymphatic toxicity of adriamycin in mice bearing TLX5 lymphoma.		Rapozzi V; Zorzet S; Comelli M; Mavelli I; Perissin L; Giraldi T		Life Sci	63	1998	1701-13	J:52716	9806226
91523	Active signaling by Neu in transgenic mice.		DiGiovanna MP; Lerman MA; Coffey RJ; Muller WJ; Cardiff RD; Stern DF		Oncogene	17	1998	1877-84	J:52718	9778054
91524	Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies.		Hailey JR; Haseman JK; Bucher JR; Radovsky AE; Malarkey DE; Miller RT; Nyska A; Maronpot RR		Toxicol Pathol	26	1998	602-11	J:52719	9789946
91525	Frequency of ras mutations in liver neoplasms from B6C3F1 mice exposed to tetrafluoro-ethylene for two years.		Hong HH; Devereux TR; Roycroft JH; Boorman GA; Sills RC		Toxicol Pathol	26	1998	646-50	J:52720	9789951
91526	Erythropoietin mRNA in hepatocellular carcinomas and kidney in male B6C3F1 mice with secondary polycythemia.		Horinouchi A; Miyamoto S; Sekiguchi M; Doi H; Okazaki S; Ando T		Toxicol Pathol	26	1998	682-6	J:52721	9789956
91527	Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.		Fujimoto S; Chikazawa H		Jpn J Cancer Res	89	1998	1343-51	J:52796	10081496
91528	Aryl hydrocarbon receptor regulation of ceramide-induced apoptosis in murine hepatoma 1c1c7 cells. A function independent of aryl hydrocarbon receptor nuclear translocator.		Reiners JJ Jr; Clift RE		J Biol Chem	274	1999	2502-10	J:52937	9891021
91529	Construction and characterization of murine neuroblastoma cell clones allowing inducible and high expression of the prion protein.		Windl O; Lorenz H; Behrens C; Romer A; Kretzschmar HA		J Gen Virol	80	1999	15-21	J:52942	9934678
91530	Low frequency of Ras gene mutation in spontaneous and gamma-ray-induced thymic lymphomas of scid mice.		Nishimura M; Wakana S; Kakinuma S; Mita K; Ishii H; Kobayashi S; Ogiu T; Sado T; Shimada Y		Radiat Res	151	1999	142-9	J:52541	9952298
91531	Prophylactic effect of Korean mistletoe (Viscum album coloratum) extract on tumor metastasis is mediated by enhancement of NK cell activity.		Yoon TJ; Yoo YC; Kang TB; Baek YJ; Huh CS; Song SK; Lee KH; Azuma I; Kim JB		Int J Immunopharmacol	20	1998	163-72	J:52620	9730252
91532	alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression.		Lochter A; Navre M; Werb Z; Bissell MJ		Mol Biol Cell	10	1999	271-82	J:53052	9950676
91533	Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.		Bogler O; Nagane M; Gillis J; Huang HJ; Cavenee WK		Cell Growth Differ	10	1999	73-86	J:53089	10074901
91534	A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes.		Schneider TJ; Fischer GM; Donohoe TJ; Colarusso TP; Rothstein TL		J Exp Med	189	1999	949-56	J:53509	10075978
91535	Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum.		Kavarana MJ; Kovaleva EG; Creighton DJ; Wollman MB; Eiseman JL		J Med Chem	42	1999	221-8	J:53689	9925727
91536	Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells.		Han SH; Yea SS; Jeon YJ; Yang KH; Kaminski NE		J Pharmacol Exp Ther	287	1998	1105-12	J:53170	9864299
91537	Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice.		Doki Y; Murakami K; Yamaura T; Sugiyama S; Misaki T; Saiki I		Br J Cancer	79	1999	1121-6	J:53274	10098745
91538	Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation.		Janssens MY; Verovski VN; Van den Berge DL; Monsaert C; Storme GA		Br J Cancer	79	1999	1085-9	J:53275	10098740
91539	Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases.		Quintieri L; Rosato A; Amboldi N; Vizler C; Ballinari D; Zanovello P; Collavo D		Br J Cancer	79	1999	1067-73	J:53276	10098738
91540	Search for oncogenic regulators in an autocrine tumor model using differential display PCR: identification of novel candidate genes including the calcium channel mtrp6.		Buess M; Engler O; Hirsch HH; Moroni C		Oncogene	18	1999	1487-94	J:53278	10050885
91541	Gap junction blockage interferes with neuronal and astroglial differentiation of mouse P19 embryonal carcinoma cells.		Bani-Yaghoub M; Underhill TM; Naus CC		Dev Genet	24	1999	69-81	J:53374	10079512
91542	Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease.		Dallas SL; Garrett IR; Oyajobi BO; Dallas MR; Boyce BF; Bauss F; Radl J; Mundy GR		Blood	93	1999	1697-706	J:53331	10029599
91543	TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor.		Tomasson MH; Williams IR; Hasserjian R; Udomsakdi C; McGrath SM; Schwaller J; Druker B; Gilliland DG		Blood	93	1999	1707-14	J:53332	10029600
91544	Study of an Argentine mistletoe, the hemiparasite Ligaria cuneifolia (R. et P.) Tiegh. (Loranthaceae).		Fernandez T; Wagner ML; Varela BG; Ricco RA; Hajos SE; Gurni AA; Alvarez E		J Ethnopharmacol	62	1998	25-34	J:53394	9720608
91545	The Big Blue(R) transgenic mouse mutation detection assay: the mutation pattern of sectored mutant plaques.		Hill KA; Nishino H; Buettner VL; Halangoda A; Li W; Sommer SS		Mutat Res	425	1999	47-54	J:53544	10082915
91546	Genomic instability in silica- and cadmium chloride-transformed BALB/c-3T3 and tumor cell lines by random amplified polymorphic DNA analysis.		Keshava C; Keshava N; Zhou G; Whong WZ; Ong TM		Mutat Res	425	1999	117-23	J:53545	10082922
91547	Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo.		Kim JJ; Tsai A; Nottingham LK; Morrison L; Cunning DM; Oh J; Lee DJ; Dang K; Dentchev T; Chalian AA; Agadjanyan MG; Weiner DB		J Clin Invest	103	1999	869-77	J:53610	10079108
91548	A syngeneic mouse glioma model for study of glioblastoma therapy.		Weiner NE; Pyles RB; Chalk CL; Balko MG; Miller MA; Dyer CA; Warnick RE; Parysek LM		J Neuropathol Exp Neurol	58	1999	54-60	J:53692	10068314
91549	The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1alpha, IL-6, GM-CSF, and KC.		Smith CW; Chen Z; Dong G; Loukinova E; Pegram MY; Nicholas-Figueroa L; Van Waes C		Clin Exp Metastasis	16	1998	655-64	J:53669	9932612
91550	Diminution of the development of experimental metastases produced by murine metastatic lines in essential fatty acid-deficient host mice.		Mannini A; Calorini L; Mugnai G; Ruggieri S		Clin Exp Metastasis	16	1998	407-14	J:53671	10091936
91551	Multiple effects of transfection with interleukin 2 and/or interferon gamma on the behavior of mouse T lymphoma cells.		Geldhof AB; Van Ginderachter J; Vandersteen P; Raes G; De Baetselier P		Clin Exp Metastasis	16	1998	447-59	J:53673	10091940
91552	Cell adhesion activity for murine carcinoma cells of a wheat germ 55-kDa protein with binding affinity for animal extracellular matrix proteins.		Shoji Y; Aoyagi Y; Kawakami T; Isemura S; Isemura M		Biochim Biophys Acta	1426	1999	498-504	J:53770	10076067
91553	Effects of protocatechuic acid, S-methylmethanethiosulfonate or 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone(KYN-54) on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in mice [published erratum appears in Cancer Lett 1	999 Nov 1;146(1):113]	Mori H; Matsunaga K; Tanakamaru Y; Kawabata K; Yamada Y; Sugie S; Nishikawa A		Cancer Lett	135	1999	123-7	J:53774	10096419
91554	Frequent loss of heterozygosity on chromosomes 4, 12 and 19 in radiation-induced lymphomas in mice.		Okumoto M; Park YG; Song CW; Mori N		Cancer Lett	135	1999	223-8	J:53775	10096432
91555	A comprehensive evaluation of the carcinogenic potential of middle distillate fuels.		Nessel CS		Drug Chem Toxicol	22	1999	165-80	J:53852	10189577
91556	Analysis of Tax-expressing cell lines generated from HTLV-I tax-transgenic mice: correlation between c-myc overexpression and neoplastic potential.		Saggioro D; D'agostino DM; Chieco-Bianchi L		Exp Cell Res	247	1999	525-33	J:53853	10066380
91557	Paclitaxel vs cyclophosphamide in peripheral blood stem cell mobilization:,comparative studies in a murine model.		Verma UN; van den Blink B; Pillai R; Chawla J; Mazumder A; Herscowitz HB; Meehan KR		Exp Hematol	27	1999	553-60	J:53854	10089919
91558	Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines.		Lauring J; Schlissel MS		Mol Cell Biol	19	1999	2601-12	J:53951	10082526
91559	Matrix metalloproteinases and oral cancer		Thomas GT; Lewis MP; Speight PM		Oral Oncol	35	1999	227-33	J:54039	10621841
91560	Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer.		Siegel PM; Ryan ED; Cardiff RD; Muller WJ		EMBO J	18	1999	2149-64	J:54661	10205169
91561	Mouse models dissect the role of p53 in cancer and development.		Lozano G; Liu G		Semin Cancer Biol	8	1998	337-44	J:54171	10101799
91562	Inhibition of mouse mammary adenocarcinoma (EMT6) growth and metastases in mice by a modified form of C-reactive protein.		Kresl JJ; Potempa LA; Anderson B; Radosevich JA		Tumour Biol	20	1999	72-87	J:54174	10050106
91563	Effects of tumor cell-derived interleukin 1 alpha on invasiveness of metastatic clones of murine RCT sarcoma through endothelial cells.		Yasuda T; Matsui H; Kanamori M; Yudoh K; Ohmori K; Aoki M; Tsuji H		Tumour Biol	20	1999	105-16	J:54175	10050109
91564	Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.		Fernandez NC; Lozier A; Flament C; Ricciardi-Castagnoli P; Bellet D; Suter M; Perricaudet M; Tursz T; Maraskovsky E; Zitvogel L		Nat Med	5	1999	405-11	J:54135	10202929
91565	B16LS9 melanoma cells spread to the liver from the murine ocular posterior compartment (PC).		Diaz CE; Rusciano D; Dithmar S; Grossniklaus HE		Curr Eye Res	18	1999	125-9	J:54255	10223656
91566	Functional assessment of the calcium messenger system in cultured mouse Leydig tumor cells: regulation of human chorionic gonadotropin-induced expression of the steroidogenic acute regulatory protein.		Manna PR; Pakarinen P; El-Hefnawy T; Huhtaniemi IT		Endocrinology	140	1999	1739-51	J:54257	10098511
91567	BCL-2 gene family and the regulation of programmed cell death.		Korsmeyer SJ		Cancer Res	59	1999	1693s-1700s	J:54356	10197582
91568	Effect induced by interleukin-1 on the behaviour of B16F10 melanoma cells.		De Galdeano AG; Boyano D; Canavate L		Oncol Rep	6	1999	225-8	J:54755	9864433
91569	Effect of epidermal growth factor administration on the development of mouse salivary gland carcinomas.		Tsujimoto H; Yura Y; Yoshioka Y; Kusaka J; Yoshida H; Sato M		J Oral Pathol Med	28	1999	30-6	J:54758	9890455
91570	Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells.		Choi S; Okada F; Kobayashi M; Habelhah H; Nakae D; Konishi Y; Totsuka Y; Hosokawa M		Anticancer Drugs	10	1999	235-43	J:54832	10211555
91571	Role of connexin (gap junction) genes in cell growth control and carcinogenesis.		Yamasaki H; Krutovskikh V; Mesnil M; Tanaka T; Zaidan-Dagli ML; Omori Y		C R Acad Sci III	322	1999	151-9	J:54804	10196667
91572	Time sequence of cancer occurrence. Implications in low level radiation risk assessment.		Mewissen DJ; Rust JH; Ugarte A; Haren DJ		C R Acad Sci III	322	1999	183-96	J:54805	10196672
91573	HNPCC: the Msh2-null mouse model.		Cranston A		Eurocancer 98		1998	103-104	J:54807	 
91574	Mouse models for cancer.		Wagner EF		Eurocancer 98		1998	251-252	J:54808	 
91575	Hyperthermia enhances the response of paclitaxel and radiation in a mouse adenocarcinoma.		Cividalli A; Cruciani G; Livdi E; Pasqualetti P; Tirindelli Danesi D		Int J Radiat Oncol Biol Phys	44	1999	407-12	J:54864	10760437
91576	Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein.		Akimoto T; Seong J; Hunter NR; Buchmiller L; Mason K; Milas L		Int J Radiat Oncol Biol Phys	44	1999	413-419	J:54865	10760438
91577	Mechanisms of downregulation of transfected E-cadherin cDNA during formation of invasive tumors in syngeneic mice.		Keirsebilck A; Van Hoorde L; Gao Y; De Bruyne G; Bruyneel E; Vermassen P; Mareel M; van Roy F		Invasion Metastasis	18	1998	44-56	J:54866	10207250
91578	Rodent fibroblast model for studies of response of malignant cells to exogenous 5-aminolevulinic acid.		Li G; Szewczuk MR; Raptis L; Johnson JG; Weagle GE; Pottier RH; Kennedy JC		Br J Cancer	80	1999	676-84	J:54586	10360643
91579	Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma.		Ristevski S; Purcell DF; Marshall J; Campagna D; Nouri S; Fenton SP; McPhee DA; Kannourakis G		J Virol	73	1999	4662-9	J:54945	10233925
91580	Tumor antigens are constitutively presented in the draining lymph nodes.		Marzo AL; Lake RA; Lo D; Sherman L; McWilliam A; Nelson D; Robinson BW; Scott B		J Immunol	162	1999	5838-45	J:54976	10229818
91581	1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo.		Hershberger PA; Modzelewski RA; Shurin ZR; Rueger RM; Trump DL; Johnson CS		Cancer Res	59	1999	2644-9	J:55362	10363987
91582	Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice.		Gu DL; Gonzalez AM; Printz MA; Doukas J; Ying W; D'Andrea M; Hoganson DK; Curiel DT; Douglas JT; Sosnowski BA; Baird A; Aukerman SL; Pierce GF		Cancer Res	59	1999	2608-14	J:55363	10363982
91583	Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis.		Murray NR; Davidson LA; Chapkin RS; Clay Gustafson W; Schattenberg DG; Fields AP		J Cell Biol	145	1999	699-711	J:55331	10330400
91584	Murine interferon-alpha1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-alpha/beta therapy.		Rozera C; Mecchia M; Gresser I; Bandu MT; Proietti E; Venditti M; Sestili P; Santini SM; Fais S; Belardelli F; Ferrantini M		Cancer Gene Ther	6	1999	246-53	J:55445	10359210
91585	Myeloid malignancies induced by alkylating agents in Nf1 mice.		Mahgoub N; Taylor BR; Le Beau MM; Gratiot M; Carlson KM; Atwater SK ; Jacks T ; Shannon KM		Blood	93	1999	3617-23	J:55413	10339466
91586	Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.		Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ		J Immunol	162	1999	7343-9	J:55524	10358185
91587	Chemopreventive effect of 4'-demethyl epipodophyllotoxin on DMBA/TPA-induced mouse skin carcinogenesis.		Dhawan D; Balasubramanian S; Amonkar AJ; Singh N		Carcinogenesis	20	1999	997-1003	J:55568	10357779
91588	Metabolic proficiency and benzo[a]pyrene DNA adduct formation in APCMin mouse adenomas and uninvolved mucosa.		Sattar A; Hewer A; Phillips DH; Campbell FC		Carcinogenesis	20	1999	1097-101	J:55569	10357794
91589	Pentachlorophenol (PCP) produces liver oxidative stress and promotes but does not initiate hepatocarcinogenesis in B6C3F1 mice.		Umemura T; Kai S; Hasegawa R; Sai K; Kurokawa Y; Williams GM		Carcinogenesis	20	1999	1115-20	J:55570	10357797
91590	Comparative tumorigenicity of the cyclopenta-fused polycyclic aromatic hydrocarbons aceanthrylene, dihydroaceanthrylene and acephenanthrylene in preweanling CD-1 and BLU:Ha mouse bioassays.		Wang JS; He X; Mulder PP; Boere BB; Cornelisse J; Lugtenburg J; Busby WF Jr		Carcinogenesis	20	1999	1137-41	J:55571	10357801
91591	Constitutive nuclear translocation of NF-kappa B in B cells in the absence of I kappa B degradation.		Doerre S; Corley RB		J Immunol	163	1999	269-77	J:55640	10384125
91592	A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.		Peng LS; Penichet ML; Morrison SL		J Immunol	163	1999	250-8	J:55641	10384123
91593	Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.		Seo N; Tokura Y; Takigawa M; Egawa K		J Immunol	163	1999	242-9	J:55642	10384122
91594	A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL.		Matsui S; Ahlers JD; Vortmeyer AO; Terabe M; Tsukui T; Carbone DP; Liotta LA; Berzofsky JA		J Immunol	163	1999	184-93	J:55644	10384115
91595	Sialoadhesin-positive host macrophages play an essential role in graft-versus-leukemia reactivity in mice.		Muerkoster S; Rocha M; Crocker PR; Schirrmacher V; Umansky V		Blood	93	1999	4375-86	J:55730	10361136
91596	Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease.		Pan L; Teshima T; Hill GR; Bungard D; Brinson YS; Reddy VS; Cooke KR; Ferrara JL		Blood	93	1999	4071-8	J:55736	10361103
91597	Ultraviolet radiation-induced suppression of natural killer cell activity is enhanced in xeroderma pigmentosum group A (XPA) model mice.		Miyauchi-Hashimoto H; Okamoto H; Tanaka K; Horio T		J Invest Dermatol	112	1999	965-70	J:55739	10383746
91598	Mycoplasma arginini enhances cytotoxicity of thioglycollate-elicited murine macrophages toward YAC-1 tumor cells through production of NO.		Ribeiro-Dias F; Russo M; Marzagao Barbuto JA; Fernandes do Nascimento FR; Timenetsky J; Jancar S		J Leukoc Biol	65	1999	808-14	J:55699	10380903
91599	Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion.		Pelengaris S; Littlewood T; Khan M; Elia G; Evan G		Mol Cell	3	1999	565-77	J:55801	10360173
91600	Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.		Kumar TR; Palapattu G; Wang P; Woodruff TK; Boime I; Byrne MC ; Matzuk MM		Mol Endocrinol	13	1999	851-65	J:55802	10379885
91601	Effect of dietary conjugated linoleic acid on phorbol ester-induced PGE2 production and hyperplasia in mouse epidermis.		Kavanaugh CJ; Liu KL; Belury MA		Nutr Cancer	33	1999	132-8	J:55806	10368807
91602	Effects of oral administration of tea, decaffeinated tea, and caffeine on the formation and growth of tumors in high-risk SKH-1 mice previously treated with ultraviolet B light.		Lou YR; Lu YP; Xie JG; Huang MT; Conney AH		Nutr Cancer	33	1999	146-53	J:55807	10368809
91603	Content and structure of ceramide and sphingomyelin and sphingomyelinase activity in mouse hepatoma-22.		Rylova SN; Somova OG; Zubova ES; Dudnik LB; Kogtev LS; Kozlov AM; Alesenko AV; Dyatlovitskaya EV		Biochemistry (Mosc)	64	1999	437-41	J:55765	10231598
91604	Reversal of estrogen-resistance in murine mammary adenocarcinomas.		Montecchia MF; Molinolo A; Lanari C		Breast Cancer Res Treat	54	1999	93-9	J:55768	10424399
91605	A combination of dietary protein depletion and PHA-induced gut growth reduce the mass of a murine non-Hodgkin lymphoma.		Pryme IF; Pusztai A; Bardocz S; Ewen SW		Cancer Lett	139	1999	145-52	J:55770	10395171
91606	Frequent Ha-ras mutations in murine skin and liver tumors induced by 7H-dibenzo[c,g]carbazole.		Mitchell KR; Warshawsky D		Mol Carcinog	25	1999	107-12	J:55838	10365912
91607	DNA vaccines as cancer treatment.		Cohen EP; deZoeten EE; Schatzman M		Am Sci	87	1999	328-335	J:55940	 
91608	The hairless gene in mouse and man [letter]		Sundberg JP; Price VH; King LE Jr		Arch Dermatol	135	1999	718-20	J:55941	10376709
91609	Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice.		Xie W; Chow LT; Paterson AJ; Chin E; Kudlow JE		Oncogene	18	1999	3593-607	J:55970	10380881
91610	Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT.		Qin X; Liu L; Gerson SL		Oncogene	18	1999	4394-400	J:56767	10439048
91611	The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression.		Li F; Altieri DC		Cancer Res	59	1999	3143-51	J:56094	10397257
91612	Interferon gamma and antisense transforming growth factor beta transgenes synergize to enhance the immunogenicity of a murine mammary carcinoma.		McEarchern JA; Besselsen DG; Akporiaye ET		Cancer Immunol Immunother	48	1999	63-70	J:56052	10414459
91613	Signaling through CD40 enhances cytotoxic T lymphocyte generation by CD8+ T cells from mice bearing large tumors.		Donepudi M; Quach DD; Mokyr MB		Cancer Immunol Immunother	48	1999	153-64	J:56053	10414470
91614	Reactivation of mutant p53: a new strategy for cancer therapy.		Selivanova G; Kawasaki T; Ryabchenko L; Wiman KG		Semin Cancer Biol	8	1998	369-78	J:56234	10101802
91615	Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.		Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC		Cancer Res	55	1995	3915-27	J:56318	7641211
91616	Genetics of skin tumor promotion.		Angel JM; DiGiovanni J		Prog Exp Tumor Res	35	1999	143-57	J:56380	10377758
91617	Genetic and hormonal regulation of murine hepatocarcinogenesis.		Chiaverotti T; Carabeo R; Drinkwater N		Prog Exp Tumor Res	35	1999	131-42	J:56381	10377757
91618	A rat model system for predisposition to stomach cancer.		Ushijima T; Nagao M		Prog Exp Tumor Res	35	1999	120-30	J:56382	10377756
91619	Genetic and epigenetic susceptibility to endogenous retrovirus-induced lymphomas in SL mice.		Hiai H; Yamada Y; Abujiang P; Lu L; Kamoto T; Tsuruyama T		Prog Exp Tumor Res	35	1999	64-77	J:56385	10377752
91620	Myeloid leukemia: disease genes and mouse models.		Copeland NG; Jenkins NA		Prog Exp Tumor Res	35	1999	53-63	J:56386	10377751
91621	Cancer predisposition in mutant mice defective in the XPC DNA repair gene.		Friedberg EC; Cheo DL; Meira LB; Reis AM		Prog Exp Tumor Res	35	1999	37-52	J:56387	10377750
91622	Alkylation carcinogenesis in mice with altered levels of DNA repair methyltransferase.		Sekiguchi M; Sanada M		Prog Exp Tumor Res	35	1999	25-36	J:56388	10377749
91623	Overview of transgenic and gene knockout mice.		Yamamura K		Prog Exp Tumor Res	35	1999	13-24	J:56389	10377748
91624	Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice.		Hauser W; Knobeloch KP; Eigenthaler M; Gambaryan S; Krenn V; Geiger J; Glazova M; Rohde E; Horak I; Walter U; Zimmer M		Proc Natl Acad Sci U S A	96	1999	8120-5	J:56356	10393958
91625	Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis.		Wang XJ; Liefer KM; Tsai S; O'Malley BW; Roop DR		Proc Natl Acad Sci U S A	96	1999	8483-8	J:56432	10411901
91626	Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis.		Bortner DM; Rosenberg MP		Cell Growth Differ	6	1995	1579-89	J:56434	9019163
91627	Upregulation of E2F transcription factors in chemically induced mouse skin tumors.		Balasubramanian S; Ahmad N; Mukhtar H		Int J Oncol	15	1999	387-90	J:56588	10402252
91628	Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response.		Chiodoni C; Paglia P; Stoppacciaro A; Rodolfo M; Parenza M; Colombo MP		J Exp Med	190	1999	125-33	J:56589	10429676
91629	BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis.		Potter M; Wax JS; Hansen CT; Kenny JJ		Int Immunol	11	1999	1059-64	J:56726	10383938
91630	Erythroblasts from friend virus infected- and phenylhydrazine-treated mice accurately model erythroid differentiation.		Hodges VM; Winter PC; Lappin TR		Br J Haematol	106	1999	325-34	J:56793	10460588
91631	Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone.		Elkin M; Ariel I; Miao HQ; Nagler A; Pines M; de-Groot N; Hochberg A; Vlodavsky I		Cancer Res	59	1999	4111-8	J:56923	10463616
91632	UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.		Yonekura K; Basaki Y; Chikahisa L; Okabe S; Hashimoto A; Miyadera K; Wierzba K; Yamada Y		Clin Cancer Res	5	1999	2185-91	J:56873	10473104
91633	A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway.		Lazarus DD; Destree AT; Mazzola LM; McCormack TA; Dick LR; Xu B; Huang JQ; Pierce JW; Read MA; Coggins MB; Solomon V; Goldberg AL; Brand SJ; Elliott PJ		Am J Physiol	277	1999	E332-41	J:56874	10444430
91634	Thymoma classification. A siren's song of simplicity [editorial] [see comments]		Harris NL; Muller-Hermelink HK		Am J Clin Pathol	112	1999	299-303	J:57078	10478132
91635	Thymoma classification: my opinion [editorial] [see comments]		Kornstein MJ		Am J Clin Pathol	112	1999	304-7	J:57079	10478133
91636	Thymoma classification. The ride of the valkyries? [editorial; comment]		Suster S; Moran CA		Am J Clin Pathol	112	1999	308-10	J:57080	10478134
91637	Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment.		Ito D; Back TC; Shakhov AN; Wiltrout RH; Nedospasov SA		J Immunol	163	1999	2809-15	J:57087	10453025
91638	Increase in histidine decarboxylase activity in tissues of mice bearing Colon-26 tumor cells.		Takeuchi Y; Nishibori M; Uomoto M; Iwagaki H; Nakaya N; Tanaka N; Saeki K		Naunyn Schmiedebergs Arch Pharmacol	360	1999	92-8	J:57160	10463338
91639	Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function.		Lydon JP; Ge G; Kittrell FS; Medina D; O'Malley BW		Cancer Res	59	1999	4276-84	J:57273	10485472
91640	Natural killer T cell ligand alpha-galactosylceramide inhibited lymph node metastasis of highly metastatic melanoma cells.		Nakui M; Iwakabe K; Ohta A; Sekimoto M; Sato M; Makuuchi H; Kawano T; Taniguchi M; Nishimura T		Jpn J Cancer Res	90	1999	801-4	J:57823	10543249
91641	Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice.		Yao Y; Slosberg ED; Wang L; Hibshoosh H; Zhang YJ; Xing WQ; Santella RM; Weinstein IB		Oncogene	18	1999	5159-66	J:57824	10498865
91642	Is increased IL-1 beta mRNA expression in spleen of tumor-bearing mice relevant to cancer cachexia?		Nakatani S; Iwagaki H; Okabayashi T; Isozaki H; Takakura N; Tanaka N		Res Commun Mol Pathol Pharmacol	102	1998	241-9	J:57186	10342911
91643	Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1.		Martin DC; Fowlkes JL; Babic B; Khokha R		J Cell Biol	146	1999	881-92	J:57334	10459021
91644	Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule.		Beer S; Oleszewski M; Gutwein P; Geiger C; Altevogt P		J Cell Sci	112	1999	2667-75	J:57335	10413675
91645	The adaptive response modifies latency for radiation-induced myeloid leukemia in CBA/H mice.		Mitchel RE; Jackson JS; McCann RA; Boreham DR		Radiat Res	152	1999	273-9	J:57336	10453088
91646	The UVA light used during the fluorescence microscopy assay affects the level of intracellular calcium being measured in experiments with electric-field exposure.		Ihrig I; Schubert F; Habel B; Haberland L; Glaser R		Radiat Res	152	1999	303-11	J:57337	10453091
91647	Increased resistance of the radiosensitive M10 mutant cells of the L5178Y mouse lymphoma cell line to heat-induced apoptosis.		Ostapenko VV; Wang X; Ohnishi K; Takahashi A; Yamamoto I; Tanaka Y; Ohnishi T		Radiat Res	152	1999	321-7	J:57338	10453093
91648	Evidence that irradiation of far-infrared rays inhibits mammary tumour growth in SHN mice.		Nagasawa H; Udagawa Y; Kiyokawa S		Anticancer Res	19	1999	1797-800	J:57400	10470118
91649	Inhibitory potential of Chlorella vulgaris (E-25) on mouse skin papillomagenesis and xenobiotic detoxication system.		Singh A; Singh SP; Bamezai R		Anticancer Res	19	1999	1887-91	J:57402	10470132
91650	Cancer therapy based on p53.		McCormick F		Cancer J Sci Am	5	1999	139-44	J:57366	10367167
91651	Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice.		Gensler HL; Williams T; Huang AC; Jacobson EL		Nutr Cancer	34	1999	36-41	J:57439	10453439
91652	Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in thei	r expression by breast and colorectal carcinomas with/without metastatic propensity.	Andre S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ		J Cancer Res Clin Oncol	125	1999	461-74	J:57522	10480338
91653	Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis.		Waikel RL; Wang XJ; Roop DR		Oncogene	18	1999	4870-8	J:57526	10490820
91654	Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiological approach.		Sylla A; Diallo MS; Castegnaro J; Wild CP		Mutat Res	428	1999	187-96	J:57528	10517992
91655	Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.		King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE		Am J Pathol	155	1999	731-8	J:57499	10487831
91656	Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model.		Yamanaka K; Hara I; Nagai H; Miyake H; Gohji K; Micallef MJ; Kurimoto M; Arakawa S; Kamidono S		Cancer Immunol Immunother	48	1999	297-302	J:57640	10473804
91657	Genetic profile of insertion mutations in mouse leukemias and lymphomas.		Hansen GM; Skapura D; Justice MJ		Genome Res	10	2000	237-43	J:57749	10673281
91658	Antiangiogenic activity of the cleaved conformation of the serpin antithrombin [see comments]		O'Reilly MS; Pirie-Shepherd S; Lane WS; Folkman J		Science	285	1999	1926-8	J:57720	10489375
91659	Neuron-specific splicing of zinc finger transcription factor REST/NRSF/XBR is frequent in neuroblastomas and conserved in human, mouse and rat.		Palm K; Metsis M; Timmusk T		Brain Res Mol Brain Res	72	1999	30-9	J:57888	10521596
91660	Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain.		Matin A; Collin GB; Asada Y; Varnum D; Nadeau JH		Nat Genet	23	1999	237-40	J:57892	10508525
91661	Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition.		Pentland AP; Schoggins JW; Scott GA; Khan KN; Han R		Carcinogenesis	20	1999	1939-44	J:58034	10506108
91662	Cytogenetic analysis of the bipotential murine pre-B cell lymphoma, P388, and its derivative macrophage-like tumor, P388D1, using SKY and CGH.		Coleman AE; Forest ST; McNeil N; Kovalchuk AL; Ried T; Janz S		Leukemia	13	1999	1592-600	J:58004	10516761
91663	Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.		Golub TR; Slonim DK; Tamayo P; Huard C; Gaasenbeek M; Mesirov JP; Coller H; Loh ML; Downing JR; Caligiuri MA; Bloomfield CD; Lander ES		Science	286	1999	531-7	J:58100	10521349
91664	Developmental defects and tumor predisposition in Rb mutant mice.		Vooijs M; Berns A		Oncogene	18	1999	5293-303	J:58235	10498881
91665	Modeling malignant melanoma in mice: pathogenesis and maintenance.		Chin L		Oncogene	18	1999	5304-10	J:58236	10498882
91666	The INK4 family of cell cycle inhibitors in cancer.		Roussel MF		Oncogene	18	1999	5311-7	J:58237	10498883
91667	Modeling human lung cancer in mice: similarities and shortcomings.		Tuveson DA; Jacks T		Oncogene	18	1999	5318-24	J:58238	10498884
91668	Mechanisms of APC-driven tumorigenesis: lessons from mouse models.		Fodde R; Smits R; Hofland N; Kielman M; Meera Khan P		Cytogenet Cell Genet	86	1999	105-11	J:58313	10545699
91669	Gain of chromosomes 15 and 19 is frequent in both mouse hepatocellular carcinoma cell lines and primary tumors, but loss of chromosomes 4 and 12 is detected only in the cell lines.		Ogawa K; Osanai M; Obata M; Ishizaki K; Kamiya K		Carcinogenesis	20	1999	2083-8	J:58424	10545409
91670	Resistance to skin tumorigenesis in DNAPK-deficient SCID mice is not due to immunodeficiency but results from hypersensitivity to TPA-induced apoptosis.		Kemp CJ; Vo K; Gurley KE		Carcinogenesis	20	1999	2051-6	J:58425	10545405
91671	The IGF-I receptor in cancer research.		Baserga R		Exp Cell Res	253	1999	1-6	J:58736	10579905
91672	The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis.		Kim H; Muller WJ		Exp Cell Res	253	1999	78-87	J:58739	10579913
91673	The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis.		de Martin R; Schmid JA; Hofer-Warbinek R		Mutat Res	437	1999	231-43	J:58891	10592330
91674	IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile.		Horton HM; Dorigo O; Hernandez P; Anderson D; Berek JS; Parker SE		J Immunol	163	1999	6378-85	J:58975	10586027
91675	The tenascin-C knockout revisited.		Mackie EJ; Tucker RP		J Cell Sci	112	1999	3847-53	J:59038	10547346
91676	Induction of melanogenic abnormalities in NF1+/- mutant mice by DMBA [letter]		Mashour GA; Martuza RL; Kurtz A		J Invest Dermatol	113	1999	1133-4	J:59045	10594763
91677	Regulated genomic instability and neoplasia in the lymphoid lineage.		Vanasse GJ; Concannon P; Willerford DM		Blood	94	1999	3997-4010	J:59009	10590043
91678	Persistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis.		Ananthaswamy HN; Ouhtit A; Evans RL; Gorny A; Khaskina P; Sands AT; Conti CJ		Oncogene	18	1999	7395-8	J:59014	10602497
91679	A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia		Pollock JL; Westervelt P; Kurichety AK; Pelicci PG; Grisolano JL; Ley TJ		Proc Natl Acad Sci U S A	96	1999	15103-8	J:59080	10611345
91680	Mixed phenotype lymphomas in thymectomized (SL/KhxAKR/Ms)F1 mice.		Lu LM; Hiai H		Jpn J Cancer Res	90	1999	1218-23	J:59209	10622532
91681	Ras gene mutations in vinyl chloride-induced liver tumours are carcinogen-specific but vary with cell type and species.		Boivin-Angele S; Lefrancois L; Froment O; Spiethoff A; Bogdanffy MS; Wegener K; Wesch H; Barbin A; Bancel B; Trepo C; Bartsch H; Swenberg J; Marion MJ		Int J Cancer	85	2000	223-7	J:59263	10629081
91682	The retinoblastoma gene family: cousins with overlapping interests.		Mulligan G; Jacks T		Trends Genet	14	1998	223-9	J:59266	9635405
91683	Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter.		al-Ubaidi MR; Font RL; Quiambao AB; Keener MJ; Liou GI; Overbeek PA; Baehr W		J Cell Biol	119	1992	1681-7	J:59267	1334963
91684	Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.		Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Moroy T		Oncogene	18	1999	7816-24	J:59355	10618723
91685	Extragonadal teratocarcinoma in chimeric mice.		Blackshear P; Mahler J; Bennett LM; McAllister KA; Forsythe D; Davis BJ		Vet Pathol	36	1999	457-60	J:59442	10490215
91686	The drinking water chlorination by-products 3,4-dichloro-5-hydroxy-2[5H]-furanone(mucochloric acid) and 3-chloro-4-(dichloromethyl)-5-hydroxy-2[5H]-furanone do not induce preneoplastic or neoplastic intestinal lesions in F344 rats, balb/ca mice or C57bl/6		Steffensen IL; Paulsen JE; Engeset D; Kronberg L; Alexander J		Pharmacol Toxicol	85	1999	56-64	J:59443	10488686
91687	Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression.		Guo Y; Zhao J; Sawicki J; Peralta Soler A; O'Brien TG		Mol Carcinog	26	1999	32-6	J:59445	10487519
91688	Nitrobenzene carcinogenicity in animals and human hazard evaluation.		Holder JW		Toxicol Ind Health	15	1999	445-57	J:59447	10487355
91689	The extracellular matrix in skin tumor development-a morphological study.		Stenback F; Makinen MJ; Jussila T; Kauppila S; Risteli J; Talve L; Risteli L		J Cutan Pathol	26	1999	327-38	J:59448	10487290
91690	Duodenal adenomas in Balb/-c mice monoinfected with Clostridium perfringens.		Rozengurt N; Sanchez S		J Comp Pathol	121	1999	217-25	J:59449	10486158
91691	Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.		de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C		Cancer Res	59	1999	5017-22	J:59528	10519417
91692	Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease.		Fausto N		Semin Liver Dis	19	1999	243-52	J:59530	10518304
91693	No complementation between TP53 or RB-1 and v-src in astrocytomas of GFAP-v-src transgenic mice.		Maddalena AS; Hainfellner JA; Hegi ME; Glatzel M; Aguzzi A		Brain Pathol	9	1999	627-37	J:59531	10517501
91694	Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.		Chou D; Matsuki J; Saitou Y; Kosugi SI; Shinbo T; Gejyo F; Niwa O; Kominami R		Mol Carcinog	26	1999	157-62	J:59553	10559790
91695	Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression.		Jonkers J; Weening JJ; van der Valk M; Bobeldijk R; Berns A		Oncogene	18	1999	5982-90	J:59555	10557087
91696	Anti-carcinogenic activity of the roots of Panax notoginseng. II.		Konoshima T; Takasaki M; Tokuda H		Biol Pharm Bull	22	1999	1150-2	J:59556	10549877
91697	Sandalwood oil prevents skin tumour development in CD1 mice.		Dwivedi C; Zhang Y		Eur J Cancer Prev	8	1999	449-55	J:59557	10548401
91698	Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone.		Badary OA; Al-Shabanah OA; Nagi MN; Al-Rikabi AC; Elmazar MM		Eur J Cancer Prev	8	1999	435-40	J:59558	10548399
91699	Organization of chromatin in cancer cells: role of signalling pathways.		Davie JR; Samuel SK; Spencer VA; Holth LT; Chadee DN; Peltier CP; Sun JM; Chen HY; Wright JA		Biochem Cell Biol	77	1999	265-75	J:59559	10546890
91700	Signaling mismatch repair in cancer [news]		Fishel R		Nat Med	5	1999	1239-41	J:59560	10545986
91701	Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions.		Austin SC; Funk CD		Prostaglandins Other Lipid Mediat	58	1999	231-52	J:59822	10593166
91702	Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor		Shimizu Y; Nakatsuru Y; Ichinose M; Takahashi Y; Kume H; Mimura J; Fujii-Kuriyama Y; Ishikawa T		Proc Natl Acad Sci U S A	97	2000	779-82	J:59890	10639156
91703	IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.		Vidal-Vanaclocha F; Fantuzzi G; Mendoza L; Fuentes AM; Anasagasti MJ; Martin J; Carrascal T; Walsh P; Reznikov LL; Kim SH; Novick D; Rubinstein M; Dinarello CA		Proc Natl Acad Sci U S A	97	2000	734-9	J:59893	10639148
91704	HGF: a multifunctional growth factor controlling cell scattering.		Stella MC; Comoglio PM		Int J Biochem Cell Biol	31	1999	1357-62	J:60021	10641789
91705	Dose-response relationship for induction of solid tumors in female B6C3F1 mice irradiated neonatally with a single dose of gamma rays.		Sasaki S; Fukuda N		J Radiat Res (Tokyo)	40	1999	229-41	J:60022	10641485
91706	Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action.		DeAngelo AB; George MH; House DE		J Toxicol Environ Health	58	1999	485-507	J:60025	10632141
91707	DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis.		Dasika GK; Lin SC; Zhao S; Sung P; Tomkinson A; Lee EY		Oncogene	18	1999	7883-99	J:60026	10630641
91708	Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans		Kobaek-Larsen M; Thorup I; Diederichsen A; Fenger C; Hoitinga MR		Comp Med	50	2000	16-26	J:60321	10987662
91709	Regulation of beta-catenin signaling in the Wnt pathway.		Kikuchi A		Biochem Biophys Res Commun	268	2000	243-8	J:60324	10679188
91710	XRCC1 keeps DNA from getting stranded.		Thompson LH; West MG		Mutat Res	459	2000	1-18	J:60325	10677679
91711	The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas		Rajan L; Broussard D; Lozano M; Lee CG; Kozak CA; Dudley JP		J Virol	74	2000	2466-71	J:60327	10666282
91712	Biochemical interactions in the wnt pathway.		Seidensticker MJ; Behrens J		Biochim Biophys Acta	1495	2000	168-82	J:60281	10656974
91713	A mouse model for glioma: biology, pathology, and therapeutic opportunities		Holland EC		Toxicol Pathol	28	2000	171-7	J:60497	10669005
91714	Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis		Langenbach R; Loftin CD; Lee C; Tiano H		Ann N Y Acad Sci	889	1999	52-61	J:60499	10668482
91715	A paradigm for cancer treatment using the retinoblastoma gene in a mouse model		Nikitin AY; Riley DJ; Lee WH		Ann N Y Acad Sci	886	1999	12-22	J:60502	10667199
91716	A novel mechanism of resistance to mouse mammary tumor virus infection.		Golovkina TV		J Virol	74	2000	2752-9	J:60602	10684291
91717	C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B.		Smith-Hicks CL; Sizer KC; Powers JF; Tischler AS; Costantini F		EMBO J	19	2000	612-22	J:60659	10675330
91718	Farnesyltransferase inhibitor-induced regression of mammary tumors in TGF alpha and TGF alpha/neu transgenic mice correlates with inhibition of map kinase and p70s6 kinase phosphorylation.		Norgaard P; Law BK; Plovisson HS; Moses HL		Ann N Y Acad Sci	886	1999	265-8	J:60816	10667235
91719	Microdistribution and localized dosimetry of the alpha-emitting radionuclides 239Pu, 241Am and 233U in mouse femoral shaft.		Austin AL; Ellender M; Haines JW; Harrison JD; Lord BI		Int J Radiat Biol	76	2000	101-11	J:60818	10665963
91720	Induction of solid tumours in the Swiss albino mouse by low-dose foetal irradiation.		Uma Devi P; Hossain M		Int J Radiat Biol	76	2000	95-9	J:60819	10665962
91721	Modification of murine adult haemopoiesis and response to methyl nitrosourea following exposure to radiation at different developmental stages.		Hoyes KP; Hendry JH; Lord BI		Int J Radiat Biol	76	2000	77-85	J:60820	10665960
91722	Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis		Song S; Liem A; Miller JA; Lambert PF		Virology	267	2000	141-50	J:60821	10662610
91723	Primary brain tumor incidence in mice exposed to split-dose ionizing radiation and circularly polarized 60 Hz magnetic fields		Kharazi AI; Babbitt JT; Hahn TJ		Cancer Lett	147	1999	149-56	J:60822	10660100
91724	Cancer chemopreventive activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis		Konoshima T; Takasaki M; Ichiishi E; Murakami T; Tokuda H; Nishino H; Duc NM; Kasai R; Yamasaki K		Cancer Lett	147	1999	11-6	J:60823	10660083
91725	Leukemic cells from murine myeloid leukemia display an intrinsic ability for autonomous proliferation.		Curtis DJ; Metcalf D; Alexander B; Begley CG		Exp Hematol	28	2000	36-45	J:60824	10658675
91726	Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model.		Factor VM; Laskowska D; Jensen MR; Woitach JT; Popescu NC; Thorgeirsson SS		Proc Natl Acad Sci U S A	97	2000	2196-201	J:60792	10681450
91727	Analysis of highly frequent allelic loss region on distal chromosome 12 in murine radiation-induced lymphomas.		Park YG; Song CW; Mori N; Sugimoto K; Hong DP; Okumoto M		Cancer Lett	148	2000	95-103	J:60793	10680598
91728	Trans-4-hydroxy-2-nonenal, an aldehydic lipid peroxidation product, lacks genotoxicity in lacI transgenic mice		Nishikawa A; Furukawa F; Kasahara K; Ikezaki S; Itoh T; Suzuki T; Uchida K; Kurihara M; Hayashi M; Miyata N; Hirose M		Cancer Lett	148	2000	81-6	J:60794	10680596
91729	Evaluation of carcinogenic and co-carcinogenic potential Quinalphos in mouse skin		Shukla Y; Singh A; Mehrotra NK		Cancer Lett	148	2000	1-7	J:60795	10680586
91730	Treatment and survival study in the C57BL/6J-APC(Min)/+(Min) mouse with R-flurbiprofen.		Wechter WJ; Murray ED Jr; Kantoci D; Quiggle DD; Leipold DD; Gibson KM; McCracken JD		Life Sci	66	2000	745-53	J:60796	10680582
91731	Action of Myc in vivo - proliferation and apoptosis.		Pelengaris S; Rudolph B; Littlewood T		Curr Opin Genet Dev	10	2000	100-5	J:60797	10679391
91732	Tumor suppressor genes.		Macleod K		Curr Opin Genet Dev	10	2000	81-93	J:60798	10679386
91733	Mice bearing late-stage tumors have normal functional systemic T cell responses In vitro and In vivo		Radoja S; Rao TD; Hillman D; Frey AB		J Immunol	164	2000	2619-28	J:60799	10679101
91734	NOD/LtSz-Rag1null mice: An immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells		Shultz LD; Lang PA; Christianson SW; Gott B; Lyons B; Umeda S; Leiter E; Hesselton R; Wagar EJ; Leif JH; Kollet O; Lapidot T; Greiner DL		J Immunol	164	2000	2496-507	J:60800	10679087
91735	Matrix metalloproteinases in tumor invasion		Johansson N; Ahonen M; Kahari VM		Cell Mol Life Sci	57	2000	5-15	J:60901	10949577
91736	Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view.		Wells AD; Malkovsky M		Immunol Today	21	2000	129-32	J:60906	10689300
91737	Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis.		Hadsell DL; Murphy KL; Bonnette SG; Reece N; Laucirica R; Rosen JM		Oncogene	19	2000	889-98	J:61037	10702797
91738	Mutagenic activity of 4-nitroquinoline-N-oxide in upper aerodigestive tissue in lacZ mice (MutaMouse) and the effects of 1, 4-phenylenebis(methylene)selenocyanate.		von Pressentin MM; El-Bayoumy K; Guttenplan JB		Mutat Res	466	2000	71-8	J:61044	10751728
91739	Comparison of the mutational spectra of the lacZ transgene in four organs of the MutaMouse treated with benzo[a]pyrene: target organ specificity		Hakura A; Tsutsui Y; Sonoda J; Tsukidate K; Mikami T; Sagami F		Mutat Res	447	2000	239-47	J:61046	10751607
91740	Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators.		Corton JC; Lapinskas PJ; Gonzalez FJ		Mutat Res	448	2000	139-51	J:61121	10725468
91741	The interactive Web-based histology atlas system.		Evans JA; Wagner U; Santos CM; Hennighausen L		Oncogene	19	2000	989-91	J:61207	10713681
91742	Tissue-specific activities of methylated dibenzo[c,g]carbazoles in mice: carcinogenicity, DNA adduct formation, and CYP1A induction in liver and skin		Taras-Valero D; Perin-Roussel O; Plessis MJ; Zajdela F; Perin F		Environ Mol Mutagen	35	2000	139-49	J:61209	10712748
91743	Mutations in cancer genes of UV-induced skin tumors of hairless mice.		van Kranen HJ; de Gruijl FR		J Epidemiol	9	1999	S58-65	J:61210	10709351
91744	Gastro-intestinal tumorigenesis in Smad4 mutant mice.		Taketo MM; Takaku K		Cytokine Growth Factor Rev	11	2000	147-57	J:61211	10708962
91745	Cancer chemoprevention through interruption of multistage carcinogenesis. The lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer.		Marks F; Furstenberger G		Eur J Cancer	36	2000	314-29	J:61212	10708932
91746	Azoxymethane induces KI-ras activation in the tumor resistant AKR/J mouse colon.		Bolt AB; Papanikolaou A; Delker DA; Wang QS; Rosenberg DW		Mol Carcinog	27	2000	210-8	J:61213	10708483
91747	Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.		Hassan AB; Howell JA		Cancer Res	60	2000	1070-6	J:61216	10706126
91748	Phenotyping of evi1, Evi11/Cb2, and evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice		Joosten M; Valk PJ; Vankan Y; de Both N; Lowenberg B; Delwel R		Virology	268	2000	308-18	J:61218	10704339
91749	Modulation by dietary factors in murine FAP models.		Paulsen JE		Toxicol Lett	112-113	2000	403-9	J:61259	10720759
91750	Predisposition to lung tumorigenesis.		Manenti G; Nomoto T; De Gregorio L; Gariboldi M; Stefania Falvella F; Nagao M; Dragani TA		Toxicol Lett	112-113	2000	257-63	J:61260	10720740
91751	Acceleration of lymphomagenesis in mismatch-repair deficient mice by exposure to genotoxic agents.		Jansen L; Claij N; Dekker M; van Klink Y; van der Valk M; van 't Wout K; te Riele H		Toxicol Lett	112-113	2000	245-50	J:61261	10720738
91752	Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors		Cheo DL; Meira LB; Burns DK; Reis AM; Issac T; Friedberg EC		Cancer Res	60	2000	1580-4	J:61421	10749126
91753	Genotype-specific Trp53 mutational analysis in ultraviolet B radiation-induced skin cancers in Xpc and Xpc Trp53 mutant mice		Reis AM; Cheo DL; Meira LB; Greenblatt MS; Bond JP; Nahari D; Friedberg EC		Cancer Res	60	2000	1571-9	J:61422	10749125
91754	The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas.		Feng SL; Guo Y; Factor VM; Thorgeirsson SS; Bell DW; Testa JR; Peifley KA; Winkles JA		Am J Pathol	156	2000	1253-61	J:61543	10751351
91755	Anti-tumor-promoting activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis Ha et Grushv. (I).		Konoshima T; Takasaki M; Tokuda H; Nishino H; Duc NM; Kasai R; Yamasaki K		Biol Pharm Bull	21	1998	834-8	J:60791	9743252
91756	Flt3-ligand induces transient tumor regression in an ectopic treatment model of major histocompatibility complex-negative prostate cancer.		Ciavarra RP; Somers KD; Brown RR; Glass WF; Consolvo PJ; Wright GL; Schellhammer PF		Cancer Res	60	2000	2081-4	J:61730	10786663
91757	E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.		Wang D; Russell JL; Johnson DG		Mol Cell Biol	20	2000	3417-24	J:61792	10779331
91758	Role of transforming growth factor beta in human disease.		Blobe GC; Schiemann WP; Lodish HF		N Engl J Med	342	2000	1350-8	J:61877	10793168
91759	Mutation analysis of the pRb pathway in 2',3'-dideoxycytidine- and 1, 3-butadiene-induced mouse lymphomas.		Zhuang SM; Wiseman RW; Soderkvist P		Cancer Lett	152	2000	129-34	J:61991	10773403
91760	Topical retinoic acid enhances, and a dark tan protects, from subedemal solar-simulated photocarcinogenesis.		Halliday GM; Robertson BO; Barnetson RS		J Invest Dermatol	114	2000	923-7	J:61993	10771472
91761	In vivo MRI measurements of tumor growth induced by dichloroacetate: implications for mode of action.		Miller JH; Minard K; Wind RA; Orner GA; Sasser LB; Bull RJ		Toxicology	145	2000	115-25	J:61994	10771136
91762	The effects of Brassica oleraceae var capitata on epidermal glutathione and lipid peroxides in DMBA-initiated-TPA-promoted mice		Isbir T; Yaylim I; Aydin M; Ozturk O; Koyuncu H; Zeybek U; Agachan B; Yilmaz H		Anticancer Res	20	2000	219-24	J:61995	10769658
91763	The p53/p63/p73 family of transcription factors: overlapping and distinct functions.		Levrero M; De Laurenzi V; Costanzo A; Gong J; Wang JY; Melino G		J Cell Sci	113	2000	1661-70	J:61996	10769197
91764	Esophagogastric adenocarcinoma in an E1A/E1B transgenic model involves p53 disruption.		Duncan MD; Tihan T; Donovan DM; Phung QH; Rowley DL; Harmon JW; Gearhart PJ; Duncan KL		J Gastrointest Surg	4	2000	290-7	J:61997	10769092
91765	Diabetes and pancreatic tumours in transgenic mice expressing Pa x 6		Yamaoka T; Yano M; Yamada T; Matsushita T; Moritani M; Ii S; Yoshimoto K; Hata J; Itakura M		Diabetologia	43	2000	332-9	J:61998	10768094
91766	Experimental prostate carcinogenesis - rodent models.		Shirai T; Takahashi S; Cui L; Futakuchi M; Kato K; Tamano S; Imaida K		Mutat Res	462	2000	219-26	J:61999	10767633
91767	Effects of lentinan on colorectal carcinogenesis in mice with ulcerative colitis		Mitamura T; Sakamoto S; Suzuki S; Yoshimura S; Maemura M; Kudo H		Oncol Rep	7	2000	599-601	J:62000	10767375
91768	Accelerated development of polyoma tumors and embryonic lethality: different effects of p53 loss on related mouse backgrounds		Dey DC; Bronson RP; Dahl J; Carroll JP; Benjamin TL		Cell Growth Differ	11	2000	231-7	J:62235	10845423
91769	Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies.		Feo F; Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi D		Crit Rev Oncog	11	2000	19-62	J:62494	10795626
91770	Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor.		Kundu SD; Kim IY; Yang T; Doglio L; Lang S; Zhang X; Buttyan R; Kim SJ; Chang J; Cai X; Wang Z; Lee C		Prostate	43	2000	118-24	J:62393	10754527
91771	Correlations among tumor types in mouse cancer bioassays: liver adenomas, liver carcinomas, leukemias and lymphomas		Linkov I; Polkanov M; Shagiakhmetov A; Wilson R; Gray GM		Toxicol Ind Health	16	2000	16-40	J:62493	10798383
91772	Cancer risk estimation for mixtures of coal tars and benzo(a)pyrene.		Gaylor DW; Culp SJ; Goldstein LS; Beland FA		Risk Anal	20	2000	81-5	J:62495	10795341
91773	Leukemia and lymphoma incidence in rodents exposed to low-frequency magnetic fields		Boorman GA; Rafferty CN; Ward JM; Sills RC		Radiat Res	153	2000	627-36	J:62496	10790285
91774	Magnetic fields and mammary cancer in rodents: A critical review and evaluation of published literature		Boorman GA; McCormick DL; Ward JM; Haseman JK; Sills RC		Radiat Res	153	2000	617-26	J:62497	10790284
91775	Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy		Bossu E; Padilla-Ybarra JJ; Notter D; Vigneron C; Guillemin F		Anticancer Drugs	11	2000	85-91	J:62498	10789590
91776	Reevaluation of the cancer potency factor of toxaphene: recommendations from a peer review panel		Goodman JI; Brusick DJ; Busey WM; Cohen SM; Lamb JC; Starr TB		Toxicol Sci	55	2000	3-16	J:62499	10788554
91777	Mammary gland neoplasia: insights from transgenic mouse models		Siegel PM; Hardy WR; Muller WJ		Bioessays	22	2000	554-63	J:62598	10842309
91778	Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination.		Boley SE; Anderson EE; French JE; Donehower LA; Walker DB; Recio L		Cancer Res	60	2000	2831-5	J:62604	10850423
91779	Impact of global genome repair versus transcription-coupled repair on ultraviolet carcinogenesis in hairless mice.		Berg RJ; Rebel H; van der Horst GT; van Kranen HJ; Mullenders LH; van Vloten WA; de Gruijl FR		Cancer Res	60	2000	2858-63	J:62605	10850428
91780	DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene		Culp SJ; Warbritton AR; Smith BA; Li EE; Beland FA		Carcinogenesis	21	2000	1433-40	J:62954	10874023
91781	Hematopoietic neoplasia in C57BL/6 mice exposed to split-dose ionizing radiation and circularly polarized 60 Hz magnetic fields		Babbitt JT; Kharazi AI; Taylor JM; Bonds CB; Mirell SG; Frumkin E; Zhuang D; Hahn TJ		Carcinogenesis	21	2000	1379-89	J:62955	10874017
91782	Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis.		Kensler TW; Dolan PM; Gange SJ; Lee JK; Wang Q; Posner GH		Carcinogenesis	21	2000	1341-5	J:62957	10874012
91783	Allelotype analysis of chemically induced squamous cell carcinomas in F(1) hybrids of two inbred mouse strains with different susceptibility to tumor progression		C Stern M; Benavides F; A Klingelberger E; J Conti C		Carcinogenesis	21	2000	1297-301	J:62958	10874006
91784	Tumor promotion of N-nitroso-N-(3-keto-1, 2-butanediol)-3'-nitrotyramine derived from nitrosation of maillard reaction product in CD-1 mice		Chang WC; Chen CC; Tseng TH; Huang HP; Hsu JD; Wang CJ		Toxicol Appl Pharmacol	166	2000	51-8	J:62959	10873718
91785	Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action.		Waalkes MP; Keefer LK; Diwan BA		Toxicol Appl Pharmacol	166	2000	24-35	J:62960	10873715
91786	Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice		Acton DS; Velthuyzen D; Lips CJ; Hoppener JW		Oncogene	19	2000	3121-5	J:62961	10871866
91787	Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis		Ise K; Nakamura K; Nakao K; Shimizu S; Harada H; Ichise T; Miyoshi J; Gondo Y; Ishikawa T; Aiba A; Katsuki M		Oncogene	19	2000	2951-6	J:62962	10871846
91788	Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?		Shall S; de Murcia G		Mutat Res	460	2000	1-15	J:63068	10856830
91789	Syndecan-1 is required for wnt-1-induced mammary tumorigenesis in mice		Alexander CM; Reichsman F; Hinkes MT; Lincecum J; Becker KA; Cumberledge S; Bernfield M		Nat Genet	25	2000	329-32	J:63122	10888884
91790	Lymphomas and high-level expression of murine leukemia viruses in CFW mice.		Taddesse-Heath L; Chattopadhyay SK; Dillehay DL; Lander MR; Nagashfar Z; Morse HC 3rd; Hartley JW		J Virol	74	2000	6832-7	J:63292	10888622
91791	A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13.		Muller AJ; Teresky AK; Levine AJ		Proc Natl Acad Sci U S A	97	2000	8421-6	J:63413	10890890
91792	Epithelial defect in prostates of Stat5a-null mice.		Nevalainen MT; Ahonen TJ; Yamashita H; Chandrashekar V; Bartke A; Grimley PM; Robinson GW; Hennighausen L; Rui H		Lab Invest	80	2000	993-1006	J:63495	10908145
91793	Decreased expression of the gut-enriched Kruppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients		Dang DT; Bachman KE; Mahatan CS; Dang LH; Giardiello FM; Yang VW		FEBS Lett	476	2000	203-7	J:63496	10913614
91794	Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen.		Singh P; Velasco M; Given R; Varro A; Wang TC		Gastroenterology	119	2000	162-71	J:63579	10889165
91795	The biology of mammary transgenes: five rules.		Cardiff RD		J Mammary Gland Biol Neoplasia	1	1996	61-73	J:63580	10887481
91796	Tumor viruses and endogenous retrotransposons in mammary tumorigenesis.		Asch BB		J Mammary Gland Biol Neoplasia	1	1996	49-60	J:63581	10887480
91797	Calorie restriction and spontaneous hepatic tumors in C3H/He mice.		Yoshida K; Inoue T; Hirabayashi Y; Nojima K; Sado T		J Nutr Health Aging	3	1999	121-6	J:63582	10885807
91798	Development of early melanocytic lesions in transgenic mice predisposed to melanoma		Zhu H; Reuhl K; Botha R; Ryan K; Wei J; Chen S		Pigment Cell Res	13	2000	158-64	J:63583	10885674
91799	Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc(Min/+)mice		Chiu CH; McEntee MF; Whelan J		Prostaglandins Leukot Essent Fatty Acids	62	2000	269-75	J:63584	10883057
91800	The state-of-the-art in chemoprevention of skin cancer.		Stratton SP; Dorr RT; Alberts DS		Eur J Cancer	36	2000	1292-7	J:63585	10882869
91801	A carcinogenicity study of sucralose in the CD-1 mouse.		Mann SW; Yuschak MM; Amyes SJ; Aughton P; Finn JP		Food Chem Toxicol	38 Suppl 2	2000	S91-8	J:63586	10882820
91802	Inhibition of radiation-induced lymphatic leukemia in C57BL mice by 19S alpha-2-globulin (alpha 2-MG) from human blood serum.		Berenblum I; Burger M; Knyszynski A		Radiat Res	60	1974	501-5	J:63587	10881727
91803	Recovery from radiation-carcinogenic injury to the mouse ovary.		Yuhas JM		Radiat Res	60	1974	321-32	J:63588	10881715
91804	A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans		Lemon SM; Lerat H; Weinman SA; Honda M		Trans Am Clin Climatol Assoc	111	2000	146-56; discussion 156-7	J:63590	10881339
91805	Inhibitory effect of melatonin on 7, 12-dimethylbenz[a]anthracene-induced carcinogenesis of the uterine cervix and vagina in mice and mutagenesis in vitro.		Anisimov VN; Zabezhinski MA; Popovich IG; Zaripova EA; Musatov SA; Andre V; Vigreux C; Godard T; Sichel F		Cancer Lett	156	2000	199-205	J:63591	10880770
91806	Outbred mice with long-term helicobacter felis infection develop both gastric lymphoid tissue and glandular hyperplastic lesions		Ferrero RL; Ave P; Radcliff FJ; Labigne A; Huerre MR		J Pathol	191	2000	333-40	J:63592	10878557
91807	Mouse strain susceptibility to diethylnitrosamine induced hepatocarcinogenesis is cell autonomous whereas sex-susceptibility Is due to the micro-environment: analysis with C3H <--> BALB / c sexually chimeric mice.		Tsukamoto T; Inada K; Fukami H; Yamamoto M; Tanaka H; Kusakabe M; Bishop CE; Tatematsu M		Jpn J Cancer Res	91	2000	665-73	J:63672	10920272
91808	Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.		Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM		Cancer	89	2000	488-99	J:63724	10931447
91809	Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study		Dahl AR; Grossi IM; Houchens DP; Scovell LJ; Placke ME; Imondi AR; Stoner GD; De Luca LM; Wang D; Mulshine JL		Clin Cancer Res	6	2000	3015-24	J:63840	10955779
91810	The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.		Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V		Oncogene	19	2000	3498-507	J:63788	10918608
91811	Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure.		Oda H; Zhang S; Tsurutani N; Shimizu S; Nakatsuru Y; Aizawa S; Ishikawa T		Cancer Res	57	1997	646-50	J:63938	9044841
91812	Retinoids and ovarian cancer		Zhang D; Holmes WF; Wu S; Soprano DR; Soprano KJ		J Cell Physiol	185	2000	1-20	J:64130	10942515
91813	Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.		Grippo PJ; Sandgren EP		Am J Pathol	157	2000	805-13	J:64395	10980120
91814	Rous-Whipple Award Lecture. Nucleotide excision repair and cancer predisposition: A journey from man to yeast to mice.		Friedberg EC		Am J Pathol	157	2000	693-701	J:64397	10980107
91815	9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice		Wu K; Kim HT; Rodriquez JL; Munoz-Medellin D; Mohsin SK; Hilsenbeck SG; Lamph WW; Gottardis MM; Shirley MA; Kuhn JG; Green JE; Brown PH		Clin Cancer Res	6	2000	3696-704	J:64491	10999763
91816	Genetic analysis of chemoresistance in primary murine lymphomas.		Schmitt CA; Rosenthal CT; Lowe SW		Nat Med	6	2000	1029-35	J:64496	10973324
91817	Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred.		Mukherjee P; Ginardi AR; Madsen CS; Sterner CJ; Adriance MC; Tevethia MJ; Gendler SJ		J Immunol	165	2000	3451-60	J:64570	10975866
91818	1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.		Recio L; Saranko CJ; Steen AM		Res Rep Health Eff Inst	91	2000	49-87; discussion 141-9	J:64674	10925839
91819	1,3-butadiene: cancer, mutations, and adducts. Part I: Carcinogenicity of 1,2,3,4-diepoxybutane.		Henderson RF; Barr EB; Belinsky SA; Benson JM; Hahn FF; Menache MG		Res Rep Health Eff Inst	84	2000	11-43; discussion 45-8	J:64675	10925838
91820	Silk protein, sericin, suppresses colon carcinogenesis induced by 1, 2-dimethylhydrazine in mice		Sasaki M; Kato N; Watanabe H; Yamada H		Oncol Rep	7	2000	1049-52	J:64628	10948337
91821	Different cellular basis for the resistance of C3H and STS strain mice to the development of thymic lymphomas following fractionated whole-body irradiation: analysis using radiation bone marrow chimeras.		Kamisaku H; Aizawa S; Tanaka K; Watanabe K; Sado T		Int J Radiat Biol	76	2000	1105-11	J:64629	10947123
91822	Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.		Raghow S; Kuliyev E; Steakley M; Greenberg N; Steiner MS		Cancer Res	60	2000	4093-7	J:64630	10945615
91823	Chronic inhalation toxicity and carcinogenicity studies of 3-chloro-2-methylpropene in BDF1 mice.		Katagiri T; Takeuchi T; Mine T; Noguchi T; Nishizawa T; Yamamoto S; Okudaira M; Matsushima T		Ind Health	38	2000	309-18	J:64632	10943079
91824	Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.		Sanders S; Thorgeirsson SS		Mol Carcinog	28	2000	168-73	J:64633	10942533
91825	Ki-ras and the characteristics of mouse lung tumors.		Ramakrishna G; Bialkowska A; Perella C; Birely L; Fornwald LW; Diwan BA; Shiao YH; Anderson LM		Mol Carcinog	28	2000	156-67	J:64634	10942532
91826	Differential expression of p16(INK4a) in azoxymethane-induced mouse colon tumorigenesis.		Wang QS; Papanikolaou A; Nambiar PR; Rosenberg DW		Mol Carcinog	28	2000	139-47	J:64635	10942530
91827	Anti-tumor-promoting activity of lignans from the aerial part of saussurea medusa		Takasaki M; Konoshima T; Komatsu K; Tokuda H; Nishino H		Cancer Lett	158	2000	53-9	J:64636	10940509
91828	Protective effect of isoflavone derivative against photocarcinogenesis in a mouse model		Widyarini S; Spinks N; Reeve VE		Redox Rep	5	2000	156-8	J:64637	10939302
91829	Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane		Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW		Int J Oncol	17	2000	551-8	J:64638	10938397
91830	B cell lymphomas of C57L/J mice; the role of natural killer cells and T helper cells in lymphoma development and growth.		Erianne GS; Wajchman J; Yauch R; Tsiagbe VK; Kim BS; Ponzio NM		Leuk Res	24	2000	705-18	J:64640	10936423
91831	Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice		Lavau C; Luo RT; Du C; Thirman MJ		Proc Natl Acad Sci U S A	97	2000	10984-9	J:64740	10995463
91832	Genetics of chemical carcinogenesis: analysis of bidirectional selective breeding inducing maximal resistance or maximal susceptibility to 2-stage skin tumorigenesis in the mouse.		Saran A; Neveu T; Covelli V; Mouton D; Pazzaglia S; Rebessi S; Doria G; Biozzi G		Int J Cancer	88	2000	424-31	J:65010	11054672
91833	Skin-specific expression of a truncated E1a oncoprotein binding to p105-Rb leads to abnormal hair follicle maturation without increased epidermal proliferation.		Missero C; Serra C; Stenn K; Dotto GP		J Cell Biol	121	1993	1109-20	J:65047	7684738
91834	A simple phenolic antioxidant protocatechuic acid enhances tumor promotion and oxidative stress in female ICR mouse skin: dose- and timing-dependent enhancement and involvement of bioactivation by tyrosinase		Nakamura Y; Torikai K; Ohto Y; Murakami A; Tanaka T; Ohigashi H		Carcinogenesis	21	2000	1899-907	J:65255	11023549
91835	Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice		Gordon J; Del Valle L; Otte J; Khalili K		Oncogene	19	2000	4840-6	J:65177	11039901
91836	Bradykinin B2 null mice are prone to renal dysplasia: gene-environment interactions in kidney development		El-Dahr SS; Harrison-Bernard LM; Dipp S; Yosipiv IV; Meleg-Smith S		Physiol Genomics	3	2000	121-31	J:65386	11015607
91837	Linkage disequilibrium and haplotype mapping of a skin cancer susceptibility locus in outbred mice.		Peissel B; Zaffaroni D; Zanesi N; Zedda I; Manenti G; Rebessi S; Pazzaglia S; Doria G; Covelli V; Dragani TA; Saran A		Mamm Genome	11	2000	979-81	J:65393	11063253
91838	Suppression of intestinal polyposis in ApcDelta 716 knockout mice by an additional mutation in the cytosolic phospholipase A2 gene		Takaku K; Sonoshita M; Sasaki N; Uozumi N; Doi Y; Shimizu T; Taketo MM		J Biol Chem	275	2000	34013-6	J:65510	10969066
91839	Variant form of diffuse corporal gastritis in NHE2 knockout mice		Boivin GP; Schultheis PJ; Shull GE; Stemmermann GN		Comp Med	50	2000	511-5	J:65754	11099134
91840	Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis		De Vree JM; Ottenhoff R; Bosma PJ; Smith AJ; Aten J; Elferink RP		Gastroenterology	119	2000	1720-30	J:66180	11113093
91841	Inhibitory effect of apple pectin and culture condensate of Bifidobacterium longum on colorectal tumors induced by 1,2-dimethylhydrazine in transgenic mice harboring human prototype c-Ha-ras genes.		Ohno K; Narushima S; Takeuchi S; Itoh K; Mitsuoka T; Nakayama H; Itoh T; Hioki K; Nomura T		Exp Anim	49	2000	305-7	J:66181	11109558
91842	Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model		Adnane J; Jackson RJ; Nicosia SV; Cantor AB; Pledger WJ; Sebti SM		Oncogene	19	2000	5338-47	J:66183	11103935
91843	Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant		Klein MA; Ruedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME		Oncogene	19	2000	5329-37	J:66184	11103934
91844	A cancer modifier role for parathyroid hormone-related protein		Manenti G; Peissel B; Gariboldi M; Falvella FS; Zaffaroni D; Allaria B; Pazzaglia S; Rebessi S; Covelli V; Saran A; Dragani TA		Oncogene	19	2000	5324-8	J:66185	11103933
91845	Requirement for reverse immune surveillance for the growth of germinal center-derived murine lymphomas		Ponzio NM; Thorbecke GJ		Semin Cancer Biol	10	2000	331-40	J:66187	11100880
91846	Chronic toxicity of Di(2-ethylhexyl)phthalate in mice		David RM; Moore MR; Finney DC; Guest D		Toxicol Sci	58	2000	377-85	J:66188	11099649
91847	Submandibular gland adenocarcinoma of intercalated duct origin in Smgb-Tag mice		Dardick I; Ho J; Paulus M; Mellon PL; Mirels L		Lab Invest	80	2000	1657-70	J:66189	11092526
91848	Chemopreventive activity of crude hydroxsymatairesinol (HMR) extract in Apc(Min) mice		Oikarinen SI; Pajari A; Mutanen M		Cancer Lett	161	2000	253-8	J:66190	11090976
91849	Anti-tumor-promoting effects of glycoglycerolipid analogues on two-stage mouse skin carcinogenesis		Colombo D; Compostella F; Ronchetti F; Scala A; Toma L; Kuchide M; Tokuda H; Nishino H		Cancer Lett	161	2000	201-5	J:66191	11090970
91850	Cancer chemopreventive agents, labdane diterpenoids from the stem bark of thuja standishii (Gord.) carr		Tanaka R; Ohtsu H; Iwamoto M; Minami T; Tokuda H; Nishino H; Matsunaga S; Yoshitake A		Cancer Lett	161	2000	165-70	J:66192	11090965
91851	Mesenchymal proliferation with decidual-like morphology in seminal vesicles of aging mice.		Karbe E; Schaetti P; Hartmann E; Wadsworth P; Weber PB; Zeller G		Exp Toxicol Pathol	52	2000	465-72	J:66193	11089898
91852	Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing		Elson DA; Ryan HE; Snow JW; Johnson R; Arbeit JM		Cancer Res	60	2000	6189-95	J:66194	11085544
91853	Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue		Wang Y; Hayward SW; Donjacour AA; Young P; Jacks T; Sage J; Dahiya R; Cardiff RD; Day ML; Cunha GR		Cancer Res	60	2000	6008-17	J:66195	11085521
91854	NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis		Long DJ 2nd; Waikel RL; Wang XJ; Perlaky L; Roop DR; Jaiswal AK		Cancer Res	60	2000	5913-5	J:66196	11085502
91855	Transgenic mouse models and hepatocellular carcinoma: future prospects [editorial]		Lakhtakia R; Panda SK		Trop Gastroenterol	21	2000	91-4	J:66197	11084827
91856	Studies of the immortalizing activity of HTLV type 1 tax, using an infectious molecular clone and transgenic mice		Ratner L; Portis T; Robek M; Harding J; Grossman W		AIDS Res Hum Retroviruses	16	2000	1647-51	J:66198	11080805
91857	Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency.		Feng F; Rittling SR		Breast Cancer Res Treat	63	2000	71-9	J:66199	11079161
91858	Oncogenes and angiogenesis: signaling three-dimensional tumor growth.		Rak J; Yu JL; Klement G; Kerbel RS		J Investig Dermatol Symp Proc	5	2000	24-33	J:66572	11147671
91859	Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse		Jeffery EW; Hjerrild KA; Paeper B; Clark LB; Yasayko SA; Wilkinson JE; Galas D; Ziegler SF; Ramsdell F; Brunkow ME		Nat Genet	27	2001	68-73	J:66695	11138001
91860	Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice.		Geng Y; Yu Q; Sicinska E; Das M; Bronson RT; Sicinski P		Proc Natl Acad Sci U S A	98	2001	194-9	J:66707	11134518
91861	A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.		Bultman S; Gebuhr T; Yee D; La Mantia C; Nicholson J; Gilliam A; Randazzo F; Metzger D; Chambon P; Crabtree G; Magnuson T		Mol Cell	6	2000	1287-95	J:66861	11163203
91862	Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.		Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE		Cancer Res	60	2000	6901-10	J:66915	11156389
91863	Derivation and initial characterization of a mouse mammary tumor cell line carrying the polyomavirus middle T antigen: utility in the development of novel cancer therapeutics.		Nielsen LL; Gurnani M; Shi B; Terracina G; Johnson RC; Carroll J; Mathis JM; Hajian G		Cancer Res	60	2000	7066-74	J:66916	11156413
91864	Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter.		Chiu IM; Touhalisky K; Liu Y; Yates A; Frostholm A		Oncogene	19	2000	6229-39	J:66917	11175337
91865	The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis.		Vernucci M; Cerrato F; Besnard N; Casola S; Pedone PV; Bruni CB; Riccio A		Oncogene	19	2000	6376-85	J:66918	11175353
91866	Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice.		Tong W; Pollard JW		Mol Cell Biol	21	2001	1319-28	J:67129	11158317
91867	Regulation of neoplastic angiogenesis		Fidler IJ		J Natl Cancer Inst Monogr	28	2000	10-4	J:67130	 
91868	NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.		Kroon E; Thorsteinsdottir U; Mayotte N; Nakamura T; Sauvageau G		EMBO J	20	2001	350-61	J:67131	11157742
91869	Role of 'platelet-type' 12-lipoxygenase in skin carcinogenesis.		Virmani J; Johnson EN; Klein-Szanto AJ; Funk CD		Cancer Lett	162	2001	161-5	J:67133	11146221
91870	Effects of dichloroacetate (DCA) on serum insulin levels and insulin-controlled signaling proteins in livers of male B6C3F1 mice.		Lingohr MK; Thrall BD; Bull RJ		Toxicol Sci	59	2001	178-84	J:67135	11134557
91871	Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice.		Dedera DA; Waller EK; LeBrun DP; Sen-Majumdar A; Stevens ME; Barsh GS; Cleary ML		Cell	74	1993	833-43	J:67185	8104101
91872	Breast cancer in mice: effect of murine muc-1 immunization on tumor incidence in C3H/HeOuj mice.		Xing PX; Poulos G; McKenzie IF		J Immunother	24	2001	10-8	J:67187	11211144
91873	Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters.		Miller MS; Gressani KM; Leone-Kabler S; Townsend AJ; Malkinson AM; O'Sullivan MG		Exp Lung Res	26	2000	709-30	J:67463	11195466
91874	Mechanisms of aflatoxin B1 lung tumorigenesis.		Massey TE; Smith GB; Tam AS		Exp Lung Res	26	2000	673-83	J:67464	11195464
91875	K-ras p21 expression and activity in lung and lung tumors.		Ramakrishna G; Sithanandam G; Cheng RY; Fornwald LW; Smith GT; Diwan BA; Anderson LM		Exp Lung Res	26	2000	659-71	J:67465	11195463
91876	Fine mapping and characterization of candidate lung tumor resistance genes for the Par2 locus on mouse chromosome 18.		Zhang Z; Lin L; Liu G; Wang M; Hill J; Wang Y; You M; Devereux TR		Exp Lung Res	26	2000	627-39	J:67467	11195460
91877	Polygenic resistance to mouse pulmonary adenomas.		Hiai H; Abujiang P; Nishimura M		Exp Lung Res	26	2000	617-25	J:67468	11195459
91878	Morphometric analysis of CC10-hASH1 transgenic mouse lung: a model for bronchiolization of alveoli and neuroendocrine carcinoma.		Linnoila RI; Sahu A; Miki M; Ball DW; DeMayo FJ		Exp Lung Res	26	2000	595-615	J:67469	11195458
91879	Use of p53 transgenic mice in the development of cancer models for multiple purposes.		Lubet RA; Zhang Z; Wiseman RW; You M		Exp Lung Res	26	2000	581-93	J:67470	11195457
91880	An inducible melanoma model implicates a role for RAS in tumor maintenance and angiogenesis.		Wong AK; Chin L		Cancer Metastasis Rev	19	2000	121-9	J:67471	11191050
91881	Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models.		Rego EM; Pandolfi PP		Semin Hematol	38	2001	54-70	J:67472	11172540
91882	Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.		Zhang SL; DuBois W; Ramsay ES; Bliskovski V; Morse HC; Taddesse-Heath L; Vass WC; DePinho RA; Mock BA		Mol Cell Biol	21	2001	310-8	J:67572	11113205
91883	Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study.		Athar M; An KP; Morel KD; Kim AL; Aszterbaum M; Longley J; Epstein EH; Bickers DR		Biochem Biophys Res Commun	280	2001	1042-7	J:67519	11162632
91884	Does the GH-IGF axis play a role in cancer pathogenesis?		Cohen P; Clemmons DR; Rosenfeld RG		Growth Horm IGF Res	10	2000	297-305	J:67520	11161960
91885	Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice.		Fischer SM; Lee M; Lubet RA		Carcinogenesis	22	2001	83-8	J:67522	11159745
91886	Herpesvirus saimiri Tip gene causes T-cell lymphomas in transgenic mice.		Wehner LE; Schroder N; Kamino K; Friedrich U; Biesinger B; Ruther U		DNA Cell Biol	20	2001	81-8	J:67734	11244565
91887	p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.		Philipp-Staheli J; Payne SR; Kemp CJ		Exp Cell Res	264	2001	148-68	J:68005	11237531
91888	FHIT gene therapy prevents tumor development in Fhit-deficient mice.		Dumon KR; Ishii H; Fong LY; Zanesi N; Fidanza V; Mancini R; Vecchione A; Baffa R; Trapasso F; During MJ; Huebner K; Croce CM		Proc Natl Acad Sci U S A	98	2001	3346-51	J:68073	11248081
91889	Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.		Madden CR; Finegold MJ; Slagle BL		J Virol	75	2001	3851-8	J:68432	11264374
91890	Potentiation of docetaxel antitumor activity by batimastat against mouse forestomach carcinoma.		Gu B; Wu D; Li M; Lu H		J Environ Pathol Toxicol Oncol	19	2000	375-82	J:68529	11213020
91891	The effect of humoral immunity against adducted benzo[a]pyrene on DNA damage elicited by acute carcinogen exposure in Swiss mice.		Galati R; Crebelli R; Zijno A; Conti L; Falasca G; Verdina A		In Vivo	14	2000	747-51	J:68531	11204493
91892	Transgenic mouse models for lung cancer.		Zhao B; Magdaleno S; Chua S; Wang YL; Burcin M; Elberg D; Finegold M; Tsai S; DeMayo FJ		Exp Lung Res	26	2000	567-79	J:68532	11195456
91893	The role of CC10 in pulmonary carcinogenesis: from a marker to tumor suppression.		Linnoila RI; Szabo E; DeMayo F; Witschi H; Sabourin C; Malkinson A		Ann N Y Acad Sci	923	2000	249-67	J:68533	11193761
91894	Telomerase, immortality and cancer.		Krupp G; Bonatz G; Parwaresch R		Biotechnol Annu Rev	6	2000	103-40	J:68534	11193292
91895	Resistance to melanoma metastases in mice selected for high acute inflammatory response.		Maria DA; Ribeiro OG; Pizzocaro KF; De Franco M; Cabrera WK; Starobinas N; Gallois V; Siqueira M; Seman M; Ibanez OM		Carcinogenesis	22	2001	337-42	J:68537	11181457
91896	Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models.		Fenton BM		Int J Radiat Oncol Biol Phys	49	2001	799-808	J:68538	11172963
91897	Mechanisms of cell cycle arrest in response to tgf-beta in progestin-dependent and -independent growth of mammary tumors.		Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV		Exp Cell Res	265	2001	152-66	J:68481	11281653
91898	Effects of oral administration of Echinacea purpurea (American herb) on incidence of spontaneous leukemia caused by recombinant leukemia viruses in AKR/J mice.		Hayashi I; Ohotsuki M; Suzuki I; Watanabe T		Nihon Rinsho Meneki Gakkai Kaishi	24	2001	10-20	J:68482	11280896
91899	Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.		Calvisi DF; Factor VM; Loi R; Thorgeirsson SS		Cancer Res	61	2001	2085-91	J:68485	11280770
91900	Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.		Kirma N; Gill K; Mandava U; Tekmal RR		Cancer Res	61	2001	1910-8	J:68486	11280746
91901	Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene.		Yu Y; Okayasu R; Weil MM; Silver A; McCarthy M; Zabriskie R; Long S; Cox R; Ullrich RL		Cancer Res	61	2001	1820-4	J:68487	11280730
91902	Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells.		Smahel M; Sima P; Ludvikova V; Vonka V		Virology	281	2001	231-8	J:68490	11277695
91903	A fresh look at tumor immunosurveillance and immunotherapy.		Smyth MJ; Godfrey DI; Trapani JA		Nat Immunol	2	2001	293-9	J:68491	11276199
91904	Time-dependent promotion activity of 17beta-estradiol on uterine carcinogenesis in mice initiated with N-ethyl-N-nitrosourea.		Takahashi M; Nishimura S; Miyajima K; Sasahara K; Yoshida M; Ando J; Maekawa A		Cancer Lett	165	2001	123-30	J:68492	11275360
91905	Double producers of kappa and lambda define a subset of B cells in mouse plasmacytomas.		Diaw L; Siwarski D; DuBois W; Jones G; Huppi K		Mol Immunol	37	2000	775-81	J:68493	11275262
91906	L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis.		Qian F; Hanahan D; Weissman IL		Proc Natl Acad Sci U S A	98	2001	3976-81	J:68494	11274419
91907	Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis.		Hong KH; Bonventre JC; O'Leary E; Bonventre JV; Lander ES		Proc Natl Acad Sci U S A	98	2001	3935-9	J:68495	11274413
91908	Methylnitrosourea induction of thymomas in AKR mice requires one or two 'hits' only.		Frei JV		Carcinogenesis	1	1980	721-3	J:68496	11272126
91909	Up- and down-regulation of granulocyte/macrophage-colony stimulating factor activity in murine skin increase susceptibility to skin carcinogenesis by independent mechanisms.		Mann A; Breuhahn K; Schirmacher P; Wilhelmi A; Beyer C; Rosenau A; Ozbek S; Rose-John S; Blessing M		Cancer Res	61	2001	2311-9	J:68923	11280804
91910	META-controlled env-initiated transcripts encoding superantigens of murine Mtv29 and Mtv7 and their possible role in B cell lymphomagenesis.		Sen N; Simmons WJ; Thomas RM; Erianne G; Zhang DJ; Jaeggli NS; Huang C; Xiong X; Tsiagbe VK; Ponzio NM; Thorbecke GJ		J Immunol	166	2001	5422-9	J:69025	11313379
91911	Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in gamma-radiation-induced thymic lymphomas.		Santos J; Herranz M; Fernandez M; Vaquero C; Lopez P; Fernandez-Piqueras J		Oncogene	20	2001	2186-9	J:69119	11360203
91912	TGFbeta signaling and cancer.		Hata A		Exp Cell Res	264	2001	111-6	J:69241	11237527
91913	Interactions between BRCA proteins and DNA structure.		Scully R		Exp Cell Res	264	2001	67-73	J:69242	11237524
91914	Regulation of p53 function.		Woods DB; Vousden KH		Exp Cell Res	264	2001	56-66	J:69243	11237523
91915	PTEN: life as a tumor suppressor.		Simpson L; Parsons R		Exp Cell Res	264	2001	29-41	J:69244	11237521
91916	Models for gain-of-function and loss-of-function of MMPs. Transgenic and gene targeted mice.		Coussens LM; Shapiro SD; Soloway PD; Werb Z		Methods Mol Biol	151	2001	149-79	J:69247	11217297
91917	COX-2 and iNOS, good targets for chemoprevention of colon cancer.		Watanabe K; Kawamori T; Nakatsugi S; Wakabayashi K		Biofactors	12	2000	129-33	J:69249	11216473
91918	Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.		Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE		Oncogene	20	2001	2044-9	J:69250	11360188
91919	Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.		Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR		Oncogene	20	2001	1973-80	J:69251	11360181
91920	DNA strand break-sensing molecule poly(ADP-Ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression.		Tong WM; Hande MP; Lansdorp PM; Wang ZQ		Mol Cell Biol	21	2001	4046-54	J:69252	11359911
91921	Dose-response study of myo-inositol as an inhibitor of lung tumorigenesis induced in A/J mice by benzo.		Hecht SS; Kenney PM; Wang M; Upadhyaya P		Cancer Lett	167	2001	1-6	J:69253	11323092
91922	Cancer chemopreventive activities of S-3-1, a synthetic derivative of danshinone.		Chen XG; Li Y; Yan CH; Li LN; Han R		J Asian Nat Prod Res	3	2001	63-75	J:69199	11355772
91923	Changes of E-cadherin and beta-catenin in human and mouse intestinal tumours.		Sloncova E; Fric P; Kucerova D; Lojda Z; Tuhackova Z; Sovova V		Histochem J	33	2001	13-7	J:69200	11352396
91924	Chemopreventive activity ofWithania somnifera in experimentally induced fibrosarcoma tumours in Swiss albino mice.		Prakash J; Gupta SK; Kochupillai V; Singh N; Gupta YK; Joshi S		Phytother Res	15	2001	240-4	J:69201	11351360
91925	Green tea polyphenolic antioxidants and skin photoprotection (Review).		Katiyar SK; Elmets CA		Int J Oncol	18	2001	1307-13	J:69202	11351267
91926	The effect of dietary carotenoids on lung tumorigenesis induced by intratracheally instillated diesel exhaust particles.		Yamanushi TT; Ichinose T; Seto H; Sagai M; Torii MI; Igarashi O		J Nutr Sci Vitaminol (Tokyo)	47	2001	32-9	J:69203	11349888
91927	Caloric restriction and cancer.		Kritchevsky D		J Nutr Sci Vitaminol (Tokyo)	47	2001	13-9	J:69204	11349885
91928	Nine cases of granular cell tumors in B6C3F1 mice.		Miyajima R; Hasegawa K; Yasui Y; Kihara T; Hosoi M; Yamakawa S; Iwata H; Enomoto M		J Vet Med Sci	63	2001	449-52	J:69205	11346182
91929	Combined treatment of a murine breast cancer model with type 5 adenovirus vectors expressing murine angiostatin and il-12: a role for combined anti-angiogenesis and immunotherapy.		Gyorffy S; Palmer K; Podor TJ; Hitt M; Gauldie J		J Immunol	166	2001	6212-7	J:69206	11342643
91930	Mouse models of neurofibromatosis.		McClatchey AI; Cichowski K		Biochim Biophys Acta	1471	2001	M73-80	J:69207	11342186
91931	Effects of topical and oral vitamin E on pigmentation and skin cancer induced by ultraviolet irradiation in Skh:2 hairless mice.		Burke KE; Clive J; Combs GF; Commisso J; Keen CL; Nakamura RM		Nutr Cancer	38	2000	87-97	J:69208	11341050
91932	Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-gamma delivery is associated with macrophages recruitment and nitric oxide production.		Baratin M; Ziol M; Romieu R; Kayibanda M; Gouilleux F; Briand P; Leroy P; Haddada H; Renia L; Viguier M; Guillet JG		Cancer Gene Ther	8	2001	193-202	J:69209	11332990
91933	Phenotypic consequences of lung-specific inducible expression of FGF-3.		Zhao B; Chua SS; Burcin MM; Reynolds SD; Stripp BR; Edwards RA; Finegold MJ; Tsai SY; DeMayo FJ		Proc Natl Acad Sci U S A	98	2001	5898-903	J:69401	11331772
91934	Relation of skin polyamines to the hairless phenotype in transgenic mice overexpressing spermidine/spermine N-acetyltransferase.		Pietila M; Parkkinen JJ; Alhonen L; Janne J		J Invest Dermatol	116	2001	801-5	J:69462	11348473
91935	Suppressed apoptosis of pre-B cells in bone marrow of pre-leukemic p190bcr/abl transgenic mice.		Yu Q; Brain J; Laneuville P; Osmond DG		Leukemia	15	2001	819-27	J:69587	11368444
91936	The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy.		McLaughlin PM; Harmsen MC; Dokter WH; Kroesen BJ; van der Molen H; Brinker MG; Hollema H; Ruiters MH; Buys CH; de Leij LF		Cancer Res	61	2001	4105-11	J:69638	11358833
91937	Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter.		Yamanaka K; Mizol M; Kato K; Hasegawa A; Nakano M; Okada S		Biol Pharm Bull	24	2001	510-4	J:69732	11379771
91938	Tumourigenic studies on deltamethrin in Swiss albino mice.		Shukla Y; Arora A; Singh A		Toxicology	163	2001	1-9	J:69733	11376860
91939	Involvement of gap junctions in tumor suppression: analysis of genetically-manipulated mice.		Omori Y; Zaidan Dagli ML; Yamakage K; Yamasaki H		Mutat Res	477	2001	191-6	J:69734	11376700
91940	Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.		Deng C		Mutat Res	477	2001	183-9	J:69735	11376699
91941	Possible involvement of O(6)-methylguanine formation and p53 dysfunction in mouse urinary bladder carcinogenesis.		Fukushima S		Mutat Res	477	2001	125-30	J:69736	11376694
91942	Analysis of MTH1 gene function in mice with targeted mutagenesis.		Tsuzuki T; Egashira A; Kura S		Mutat Res	477	2001	71-8	J:69737	11376688
91943	Cancer predisposition in mutant mice defective in multiple genetic pathways: uncovering important genetic interactions.		Meira LB; Reis AM; Cheo DL; Nahari D; Burns DK; Friedberg EC		Mutat Res	477	2001	51-8	J:69738	11376686
91944	Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies.		Ishikawa T; Ide F; Qin X; Zhang S; Takahashi Y; Sekiguchi M; Tanaka K; Nakatsuru Y		Mutat Res	477	2001	41-9	J:69739	11376685
91945	Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility.		Cushman LJ; Watkins-Chow DE; Brinkmeier ML; Raetzman LT; Radak AL; Lloyd RV; Camper SA		Hum Mol Genet	10	2001	1141-53	J:69741	11371507
91946	Effect of bacterial metabolism in the intestine on colorectal tumors induced by 1,2-dimethylhydrazine in transgenic mice harboring human prototype c-Ha-ras genes.		Ohno K; Narushima S; Takeuchi S; Itoh K; Itoh T; Hioki K; Nomura T		J Exp Clin Cancer Res	20	2001	51-6	J:69742	11370830
91947	Acceleration of mammary neoplasia in aromatase transgenic mice by 7,12-dimethylbenz.		Keshava N; Mandava U; Kirma N; Tekmal RR		Cancer Lett	167	2001	125-33	J:69745	11369132
91948	Helicobacter-induced expression of Bcl-X(L) in B lymphocytes in the mouse model: a possible step in the development of gastric mucosa-associated lymphoid tissue (MALT) lymphoma.		Morgner A; Sutton P; O'Rourke JL; Enno A; Dixon MF; Lee A		Int J Cancer	92	2001	634-40	J:69747	11340565
91949	Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice.		Gonzalez FJ; Kimura S		Mutat Res	477	2001	79-87	J:69988	11376689
91950	LacI transgenic animal study: relationships among DNA-adduct levels, mutant frequencies and cancer incidences.		Nagao M; Ochiai M; Okochi E; Ushijima T; Sugimura T		Mutat Res	477	2001	119-24	J:69994	11376693
91951	Changes of tumor susceptibility arising concomitantly with a reversal of polydactylism in mice		Isherwood VC; Strong LC		Cancer Res	21	1961	796-8	J:69996	13717983
91952	Further investigations on the origin of tumors in mice.  I. Tumor incidence and tumor age in various strains of mice.		Lathrop AE; Loeb L		J Exp Med	22	1915	646-673	J:70093	 
91953	Transgenic models for study of pulmonary development and disease.		Glasser SW; Korfhagen TR; Wert SE; Whitsett JA		Am J Physiol	267	1994	L489-97	J:70094	7977760
91954	Three loci modify growth of a transgene-induced mammary tumor: suppression of proliferation associated with decreased microvessel density.		Le Voyer T; Rouse J; Lu Z; Lifsted T; Williams M; Hunter KW		Genomics	74	2001	253-61	J:70229	11414753
91955	Preconception urethane or chromium(III) treatment of male mice: multiple neoplastic and non-neoplastic changes in offspring.		Yu W; Sipowicz MA; Haines DC; Birely L; Diwan BA; Riggs CW; Kasprzak KS; Anderson LM		Toxicol Appl Pharmacol	158	1999	161-76	J:70184	10406931
91956	Specific protection against breast cancers by cyclin D1 ablation.		Yu Q; Geng Y; Sicinski P		Nature	411	2001	1017-21	J:70276	11429595
91957	Analysis of loss of heterozygosity in lymphoma and leukaemia arising in F1 hybrid mice locates a common region of chromosome 4 loss.		Meijne E; Huiskamp R; Haines J; Moody J; Finnon R; Wilding J; Spanjer S; Bouffler S; Edwards A; Cox R; Silver A		Genes Chromosomes Cancer	31	2001	373-81	J:70425	11433528
91958	Inhibiting effect of reserpine and female sensitivity in hepatic tumor induction with 2,7-diacetamidofluorene in SMA-Ms strain mice.		Kozuka S		Cancer Res	30	1970	1384-6	J:70524	5426940
91959	In silico mapping of complex disease-related traits in mice.		Grupe A; Germer S; Usuka J; Aud D; Belknap JK; Klein RF; Ahluwalia MK; Higuchi R; Peltz G		Science	292	2001	1915-8	J:70452	11397946
91960	p53 Family Update: p73 and p63 Develop Their Own Identities.		Irwin MS; Kaelin WG		Cell Growth Differ	12	2001	337-49	J:70460	11457731
91961	A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice.		Kobayashi T; Minowa O; Sugitani Y; Takai S; Mitani H; Kobayashi E; Noda T; Hino O		Proc Natl Acad Sci U S A	98	2001	8762-7	J:70463	11438694
91962	The helper virus envelope glycoprotein affects the disease specificity of a recombinant murine leukemia virus carrying a v-myc oncogene.		Granger SW; Fan H		Virus Genes	22	2001	311-9	J:70624	11450949
91963	Pharmacokinetic studies in tg.ac and fvb mice administered.		Hoffmann MJ; Sinko PJ; Lee YH; Meeker RJ; Snyder R		Toxicol Appl Pharmacol	174	2001	139-45	J:70625	11446829
91964	Melatonin increases both life span and tumor incidence in female CBA mice.		Anisimov VN; Zavarzina NY; Zabezhinski MA; Popovich IG; Zimina OA; Shtylick AV; Arutjunyan AV; Oparina TI; Prokopenko VM; Mikhalski AI; Yashin AI		J Gerontol A Biol Sci Med Sci	56	2001	B311-23	J:70181	11445596
91965	Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.		Wang TC; Cardiff RD; Zukerberg L; Lees E; Arnold A; Schmidt EV		Nature	369	1994	669-71	J:70571	8208295
91966	Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse.		Shannon KM; Le Beau MM; Largaespada DA; Killeen N		Semin Cancer Biol	11	2001	191-200	J:70651	11407944
91967	Genetically engineered mouse models of astrocytoma: GEMs in the rough?		Reilly KM; Jacks T		Semin Cancer Biol	11	2001	177-91	J:70652	11407943
91968	Animal models of cell cycle dysregulation and the pathogenesis of gliomas.		Holland EC		J Neurooncol	51	2001	265-76	J:70653	11407597
91969	Protective effect of Picroliv, the active constituent of Picrorhiza kurroa, against chemical carcinogenesis in mice.		Rajeshkumar NV; Kuttan R		Teratog Carcinog Mutagen	21	2001	303-13	J:70654	11406836
91970	Molecular clones of hepatitis C virus: applications to animal models.		Gale M Jr; Beard MR		ILAR J	42	2001	139-51	J:70655	11406716
91971	New animal models of hepatitis B and C.		Feitelson MA; Larkin JD		ILAR J	42	2001	127-38	J:70656	11406715
91972	Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice.		Sacco MG; Cato EM; Ceruti R; Soldati S; Indraccolo S; Caniatti M; Scanziani E; Vezzoni P		Gene Ther	8	2001	67-70	J:70657	11402303
91973	Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice.		Yang D; Holt GE; Velders MP; Kwon ED; Kast WM		Cancer Res	61	2001	5857-60	J:70659	11479226
91974	Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist.		Pollak M; Blouin MJ; Zhang JC; Kopchick JJ		Br J Cancer	85	2001	428-30	J:70871	11487276
91975	The ROSA26 LacZ-neoR insertion confers resistance to mammary tumors in ApcMin/+ mice.		Kohlhepp RL; Hegge LF; Moser AR		Mamm Genome	12	2001	606-11	J:70825	11471054
91976	Delayed-type hypersensitivity and humoral immunity modulation by dietary lipids in a murine model of pulmonary tumorigenesis induced by urethan.		Piegari M; Salvador AF; Munoz SE; Valentich MA; Eynard AR		Exp Toxicol Pathol	53	2001	181-6	J:70913	11484837
91977	UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53.		Jiang W; Ananthaswamy HN; Muller HK; Ouhtit A; Bolshakov S; Ullrich SE; El-Naggar AK; Kripke ML		Proc Natl Acad Sci U S A	98	2001	9790-5	J:70914	11481437
91978	Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation.		Komatsu SI; Watanabe H; Oka T; Tsuge H; Nii H; Kato N		J Nutr	131	2001	2204-7	J:70915	11481418
91979	NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin.		Long DJ 2nd; Waikel RL; Wang XJ; Roop DR; Jaiswal AK		J Natl Cancer Inst	93	2001	1166-70	J:70916	11481389
91980	Inhibitory effect of glycolic acid on ultraviolet-induced skin tumorigenesis in SKH-1 hairless mice and its mechanism of action.		Hong JT; Kim EJ; Ahn KS; Jung KM; Yun YP; Park YK; Lee SH		Mol Carcinog	31	2001	152-60	J:70917	11479924
91981	Melanoma induction in a hairless mouse with short-term application of dimethylbenz.		Kligman LH; Elenitsas R		Melanoma Res	11	2001	319-24	J:70918	11479419
91982	Interactions between methylating and pyridyloxobutylating agents in A/J mouse lungs: implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis.		Peterson LA; Thomson NM; Crankshaw DL; Donaldson EE; Kenney PJ		Cancer Res	61	2001	5757-63	J:70919	11479212
91983	Differential dietary effects on colonic and small bowel neoplasia in C57BL/6J Apc Min/+ mice.		Yu CF; Whiteley L; Carryl O; Basson MD		Dig Dis Sci	46	2001	1367-80	J:70920	11478486
91984	Use of historical control data in carcinogenicity studies in rodents.		Haseman JK; Huff J; Boorman GA		Toxicol Pathol	12	1984	126-35	J:70921	11478313
91985	Intravascular HBO(2) saturations, perfusion and hypoxia in spontaneous and transplanted tumor models.		Fenton BM; Lord EM; Paoni SF		Int J Cancer	93	2001	693-8	J:70922	11477580
91986	Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice.		Jansen AP; Dreckschmidt NE; Verwiebe EG; Wheeler DL; Oberley TD; Verma AK		Int J Cancer	93	2001	635-43	J:70923	11477572
91987	Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice.		Lian Z; Niwa K; Tagami K; Hashimoto M; Gao J; Yokoyama Y; Mori H; Tamaya T		Jpn J Cancer Res	92	2001	726-34	J:70924	11473722
91988	In vivo expansion of the endogenous B-cell compartment stimulated by radiation and serial bone marrow transplantation induces B-cell leukaemia in mice.		Holyoake TL; Freshney MG; Samuel K; Ansell J; Watson GE; Wright EG; Graham GJ; Pragnell IB		Br J Haematol	114	2001	49-56	J:70925	11472344
91989	Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice.		O'Mahony L; Feeney M; O'Halloran S; Murphy L; Kiely B; Fitzgibbon J; Lee G; O'Sullivan G; Shanahan F; Collins JK		Aliment Pharmacol Ther	15	2001	1219-25	J:70926	11472326
91990	Detection of early gene expression changes by differential display in the livers of mice exposed to dichloroacetic acid.		Thai SF; Allen JW; DeAngelo AB; George MH; Fuscoe JC		Carcinogenesis	22	2001	1317-22	J:70927	11470764
91991	Nitroglycerin: a NO donor inhibits TPA-mediated tumor promotion in murine skin.		Trikha P; Sharma N; Athar M		Carcinogenesis	22	2001	1207-11	J:70928	11470751
91992	Sox8 gene expression identifies immature glial cells in developing cerebellum and cerebellar tumours.		Cheng Y; Lee C; Badge RM; Orme AT; Scotting PJ		Brain Res Mol Brain Res	92	2001	193-200	J:71400	11483257
91993	Keratinocyte-specific onset of serine protease BSSP expression in experimental carcinogenesis.		Breitenbach U; Tuckermann JP; Gebhardt C; Richter KH; Furstenberger G; Christofori G; Angel P		J Invest Dermatol	117	2001	634-40	J:71512	11564170
91994	T-cell-immunity-based inhibitory effects of orally administered herbal medicine juzen-taiho-to on the growth of primarily developed melanocytic tumors in RET-transgenic mice.		Dai Y; Kato M; Takeda K; Kawamoto Y; Akhand AA; Hossain K; Suzuki H; Nakashima I		J Invest Dermatol	117	2001	694-701	J:71513	11564179
91995	Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium.		Stanbrough M; Leav I; Kwan PW; Bubley GJ; Balk SP		Proc Natl Acad Sci U S A	98	2001	10823-8	J:71472	11535819
91996	Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis.		Xia X; Qian S; Soriano S; Wu Y; Fletcher AM; Wang XJ; Koo EH; Wu X; Zheng H		Proc Natl Acad Sci U S A	98	2001	10863-8	J:71473	11517342
91997	Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts.		Scolan EL; Wendling F; Barnache S; Denis N; Tulliez M; Vainchenker W; Moreau-Gachelin F		Oncogene	20	2001	5484-92	J:71641	11571646
91998	Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models.		Van Etten RA		Curr Opin Hematol	8	2001	224-30	J:71713	11561160
91999	Retroviral transduction model of mixed lineage leukemia fused to CREB binding protein.		Liedman D; Zeleznik-Le N		Curr Opin Hematol	8	2001	218-23	J:71714	11561159
92000	Mouse models of acute promyelocytic leukemia.		Pollock JL; Westervelt P; Walter MJ; Lane AA; Ley TJ		Curr Opin Hematol	8	2001	206-11	J:71715	11561157
92001	Greater expression of transforming growth factor alpha and proliferating cell nuclear antigen staining in mouse hepatoblastomas than hepatocellular carcinomas induced by a diethylnitrosamine-sodium phenobarbital regimen.		Sakairi T; Kobayashi K; Goto K; Okada M; Kusakabe M; Tsuchiya T; Sugimoto J; Sano F; Mutai M		Toxicol Pathol	29	2001	479-82	J:71716	11560253
92002	Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study.		Toyosawa K; Okimoto K; Kobayashi I; Kijima K; Kikawa E; Kohchi M; Koujitani T; Tanaka K; Matsuoka N		Toxicol Pathol	29	2001	458-66	J:71717	11560251
92003	High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.		Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC		Toxicol Pathol	29	2001	422-9	J:71718	11560247
92004	Mouse models of metastatic pancreatic adenocarcinoma.		Xie K; Wang B; Shi Q; Abbruzzese JL; Xiong Q; Le X		Int J Pancreatol	29	2001	25-35	J:71719	11558630
92005	Lack of modifying effects of eugenol on development of lung proliferative lesions induced by urethane in transgenic mice carrying the human prototype c-Ha-ras gene.		Koujitani T; Yasuhara K; Tamura T; Onodera H; Takagi H; Takizawa T; Hirose M; Hayashi Y; Mitsumori K		J Toxicol Sci	26	2001	129-39	J:71720	11552296
92006	Protection against ultraviolet B- and C-induced DNA damage and skin carcinogenesis by the flowers of Prunus persica extract.		Heo MY; Kim SH; Yang HE; Lee SH; Jo BK; Kim HP		Mutat Res	496	2001	47-59	J:71721	11551480
92007	A definitive role of ornithine decarboxylase in photocarcinogenesis.		Ahmad N; Gilliam AC; Katiyar SK; O'Brien TG; Mukhtar H		Am J Pathol	159	2001	885-92	J:71722	11549581
92008	High-LET radiation carcinogenesis.		Fry RJ; Powers-Risius P; Alpen EL; Ainsworth EJ; Ullrich RL		Adv Space Res	3	1983	241-8	J:71723	11542751
92009	Fluence-based relative biological effectiveness for charged particle carcinogenesis in mouse Harderian gland.		Alpen EL; Powers-Risius P; Curtis SB; DeGuzman R; Fry RJ		Adv Space Res	14	1994	573-81	J:71724	11539994
92010	Analysis of ovarian gene expression in follicle-stimulating hormone beta knockout mice.		Burns KH; Yan C; Kumar TR; Matzuk MM		Endocrinology	142	2001	2742-51	J:71936	11415992
92011	Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the apc(min/+) mouse.		Scott DJ; Hull MA; Cartwright EJ; Lam WK; Tisbury A; Poulsom R; Markham AF; Bonifer C; Coletta PL		Gastroenterology	121	2001	889-99	J:72030	11606502
92012	Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome.		Tripodis N; Hart AA; Fijneman RJ; Demant P		J Natl Cancer Inst	93	2001	1484-91	J:71973	11584065
92013	Induction of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice.		Tornell J; Rymo L; Isaksson OG		Int J Cancer	49	1991	114-7	J:72118	1874564
92014	High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice.		Tornell J; Carlsson B; Pohjanen P; Wennbo H; Rymo L; Isaksson O		J Steroid Biochem Mol Biol	43	1992	237-42	J:72119	1525063
92015	Epidermal growth factor-like growth factors. I. Breast malignancies and other epithelial proliferations in transgenic mice.		Strayer DS; Yang S; Schwartz MS		Lab Invest	69	1993	660-73	J:72120	8264229
92016	Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.		Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S		Oncogene	20	2001	6538-43	J:72205	11641778
92017	Apoptosis regulators and their role in tumorigenesis.		Zornig M; Hueber A; Baum W; Evan G		Biochim Biophys Acta	1551	2001	F1-F37	J:72163	11591448
92018	Whey acidic protein extrinsically expressed from the mouse mammary tumor virus long terminal repeat results in hyperplasia of the coagulation gland epithelium and impaired mammary development.		Hennighausen L; McKnight R; Burdon T; Baik M; Wall RJ; Smith GH		Cell Growth Differ	5	1994	607-13	J:72254	7522033
92019	Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors.		Stamp G; Fantl V; Poulsom R; Jamieson S; Smith R; Peters G; Dickson C		Cell Growth Differ	3	1992	929-38	J:72255	1335281
92020	Estradiol dependence of the specific mammary tissue targeting of polyoma virus oncogenicity in nude mice.		Berebbi M; Martin PM; Berthois Y; Bernard AM; Blangy D		Oncogene	5	1990	505-9	J:72256	1970153
92021	Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.		Kumar R; Medina D; Sukumar S		Oncogene	5	1990	1271-7	J:72257	2118247
92022	Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene.		Mangues R; Seidman I; Pellicer A; Gordon JW		Oncogene	5	1990	1491-7	J:72258	2174525
92023	Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice.		Mangues R; Seidman I; Gordon JW; Pellicer A		Oncogene	7	1992	2073-6	J:72259	1328989
92024	Reversibility of acute B-cell leukaemia induced by BCR-ABL1.		Huettner CS; Zhang P; Van Etten RA; Tenen DG		Nat Genet	24	2000	57-60	J:72377	10615128
92025	In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.		Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A		Transgenic Res	10	2001	471-8	J:72382	11708657
92026	The theory of APL.		Piazza F; Gurrieri C; Pandolfi PP		Oncogene	20	2001	7216-22	J:72631	11704849
92027	Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice.		Nanni P; Nicoletti G; De Giovanni C; Landuzzi L; Di Carlo E; Cavallo F; Pupa SM; Rossi I; Colombo MP; Ricci C; Astolfi A; Musiani P; Forni G; Lollini PL		J Exp Med	194	2001	1195-205	J:73011	11696586
92028	Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.		He LZ; Tolentino T; Grayson P; Zhong S; Warrell RP Jr; Rifkind RA; Marks PA; Richon VM; Pandolfi PP		J Clin Invest	108	2001	1321-30	J:73012	11696577
92029	The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice.		Bauer AK; Dwyer-Nield LD; Hankin JA; Murphy RC; Malkinson AM		Toxicology	169	2001	1-15	J:73013	11696405
92030	Dermal carcinogenicity in transgenic mice: effect of vehicle on responsiveness of hemizygous Tg.AC mice to phorbol 12-myristate 13-acetate (TPA).		Stoll RE; Furst SM; Stoltz JH; Lilly PD; Mennear JH		Toxicol Pathol	29	2001	535-40	J:73014	11695570
92031	The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis.		Tamaoki N		Toxicol Pathol	29 Suppl	2001	81-9	J:73016	11695564
92032	Tg.AC genetically altered mouse: assay working group overview of available data.		Eastin WC; Mennear JH; Tennant RW; Stoll RE; Branstetter DG; Bucher JR; McCullough B; Binder RL; Spalding JW; Mahler JF		Toxicol Pathol	29 Suppl	2001	60-80	J:73017	11695563
92033	The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model.		Tennant RW; Stasiewicz S; Eastin WC; Mennear JH; Spalding JW		Toxicol Pathol	29 Suppl	2001	51-9	J:73018	11695562
92034	P53+/- hemizygous knockout mouse: overview of available data.		Storer RD; French JE; Haseman J; Hajian G; LeGrand EK; Long GG; Mixson LA; Ochoa R; Sagartz JE; Soper KA		Toxicol Pathol	29 Suppl	2001	30-50	J:73019	11695560
92035	The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.		French J; Storer RD; Donehower LA		Toxicol Pathol	29 Suppl	2001	24-9	J:73020	11695559
92036	Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing.		Venkatachalam S; Tyner SD; Pickering CR; Boley S; Recio L; French JE; Donehower LA		Toxicol Pathol	29 Suppl	2001	147-54	J:73022	11695551
92037	Neonatal mouse model: review of methods and results.		McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J		Toxicol Pathol	29 Suppl	2001	128-37	J:73023	11695548
92038	Xpa and Xpa/p53+/- knockout mice: overview of available data.		van Kreijl CF; McAnulty PA; Beems RB; Vynckier A; van Steeg H; Fransson-Steen R; Alden CL; Forster R; van der Laan JW; Vandenberghe J		Toxicol Pathol	29 Suppl	2001	117-27	J:73024	11695547
92039	DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.		van Steeg H; de Vries A; van Oostrom CTh; van Benthem J; Beems RB; van Kreijl CF		Toxicol Pathol	29 Suppl	2001	109-16	J:73025	11695546
92040	Relationship between incidence and onset age of mammary tumours and uterine adenomyosis in four strains of mice: comparison with the findings of 40 generations previously.		Nagasawa H; Kusakawa S		In Vivo	15	2001	345-50	J:73026	11695228
92041	Increased activity of MAP, p70S6 and p90rs kinases is associated with AP-1 activation in spontaneous liver tumours, but not in adjacent tissue in mice.		Ostrowski J; Woszczynski M; Kowalczyk P; Wocial T; Hennig E; Trzeciak L; Janik P; Bomsztyk K		Br J Cancer	82	2000	1041-50	J:60905	10737387
92042	Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members.		Wach S; Schirmacher P; Protschka M; Blessing M		Oncogene	20	2001	7761-9	J:73149	11753654
92043	Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.		Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M		Oncogene	20	2001	7812-6	J:73150	11753661
92044	Transforming functions of Simian Virus 40.		Saenz-Robles MT; Sullivan CS; Pipas JM		Oncogene	20	2001	7899-907	J:73151	11753672
92045	Decreased Focal Adhesion Kinase Suppresses Papilloma Formation during Experimental Mouse Skin Carcinogenesis.		McLean GW; Brown K; Arbuckle MI; Wyke AW; Pikkarainen T; Ruoslahti E; Frame MC		Cancer Res	61	2001	8385-9	J:73153	11731413
92046	Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.		Guo Z; Yikang S; Yoshida H; Mak TW; Zacksenhaus E		Cancer Res	61	2001	8395-400	J:73154	11731416
92047	Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.		Hunter KW; Broman KW; Voyer TL; Lukes L; Cozma D; Debies MT; Rouse J; Welch DR		Cancer Res	61	2001	8866-72	J:73358	11751410
92048	Inhibition of poly(ADP-ribose) polymerase activity accelerates T-cell lymphomagenesis in p53 deficient mice.		Beneke R; Moroy T		Oncogene	20	2001	8136-41	J:73364	11781827
92049	Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.		Fisher GH; Wellen SL; Klimstra D; Lenczowski JM; Tichelaar JW; Lizak MJ; Whitsett JA; Koretsky A; Varmus HE		Genes Dev	15	2001	3249-62	J:73468	11751631
92050	The effects of aromatase overexpression on mammary growth and gene expression in the aromatase x transforming growth factor alpha double transgenic mice.		Kirma N; Mandava U; Wuichet K; Tekmal RR		J Steroid Biochem Mol Biol	78	2001	419-26	J:73478	11738552
92051	Studies of methionine cycle intermediates (SAM, SAH), DNA methylation and the impact of folate deficiency on tumor numbers in Min mice.		Sibani S; Melnyk S; Pogribny IP; Wang W; Hiou-Tim F; Deng L; Trasler J; James SJ; Rozen R		Carcinogenesis	23	2002	61-5	J:73559	11756224
92052	Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter.		Watabe T; Lin M; Ide H; Donjacour AA; Cunha GR; Witte ON; Reiter RE		Proc Natl Acad Sci U S A	99	2002	401-6	J:73560	11752398
92053	Tumour reducing and anticarcinogenic activity of Acanthus ilicifolius in mice.		Babu BH; Shylesh BS; Padikkala J		J Ethnopharmacol	79	2002	27-33	J:73561	11744292
92054	p16INK4A and p14ARF tumour suppressors in melanoma: lessons from the mouse.		Walker GJ; Hayward NK		Lancet	359	2002	7-8	J:73725	11809177
92055	Inhibition of both skin and lung tumorigenesis by Car-R mouse-derived cancer modifier loci.		Saran A; Zaffaroni D; Pazzaglia S; Peissel B; Galbiati F; Spinola M; Manenti G; Zanesi N; Rebessi S; Mancuso MT; Covelli V; Dragani TA		Int J Cancer	97	2002	580-3	J:74019	11807781
92056	The H-2 locus and viral leukemogenesis as studied in congenic strains of mice.		Tennant JR; Snell GD		J Natl Cancer Inst	41	1968	597-604	J:74027	4299544
92057	p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.		Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T		Mol Cell Biol	22	2002	370-7	J:73975	11739748
92058	Cripto: A tumor growth factor and more.		Adamson ED; Minchiotti G; Salomon DS		J Cell Physiol	190	2002	267-78	J:74309	11857442
92059	Neural precursor cell apoptosis and glial tumorigenesis following transplacental ethyl-nitrosourea exposure.		Leonard JR; D'Sa C; Klocke BJ; Roth KA		Oncogene	20	2001	8281-6	J:74394	11781843
92060	Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.		Cuenco GM; Ren R		Oncogene	20	2001	8236-48	J:74395	11781838
92061	The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression.		Baturin DA; Alimova IN; Anisimov VN; Popovich IG; Zabezhinski MA; Provinciali M; Mancini R; Franceschi C		Neuroendocrinol Lett	22	2001	441-7	J:74396	11781542
92062	The price of tumour suppression?		Ferbeyre G; Lowe SW		Nature	415	2002	26-7	J:74398	11780097
92063	Near real-time in vivo confocal imaging of mouse mammary tumors.		Lacy AA; Collier T; Price JE; Dharmawardhane S; Richards-Kortum R		Front Biosci	7	2002	F1-7	J:74399	11779701
92064	RET(Men2B)-transgene produces sympathoadrenal tumors but does not prevent intestinal aganglionosis in gdnf-/- or gfr alpha-1(-/-) mice.		Rajan I; Gestblom C; Kapur RP		Pediatr Dev Pathol	4	2001	446-53	J:74400	11779046
92065	Activation of clg, a novel dbl family guanine nucleotide exchange factor gene, by proviral insertion at evi24, a common integration site in B cell and myeloid leukemias.		Himmel KL; Bi F; Shen H; Jenkins NA; Copeland NG; Zheng Y; Largaespada DA		J Biol Chem	277	2002	13463-72	J:74401	11839748
92066	Spectrum of Znfn1a1 (Ikaros) inactivation and its association with loss of heterozygosity in radiogenic T-cell lymphomas in susceptible B6C3F1 mice.		Kakinuma S; Nishimura M; Sasanuma S; Mita K; Suzuki G; Katsura Y; Sado T; Shimada Y		Radiat Res	157	2002	331-40	J:74402	11839096
92067	Role of the multidrug resistance protein 1 gene in the carcinogenicity of aflatoxin B1: investigations using mrp1-null mice.		Lorico A; Nesland J; Emilsen E; Fodstad O; Rappa G		Toxicology	171	2002	201-5	J:74403	11836025
92068	Effect of Bcl-2 expression on hepatic preneoplasia in mice.		Gillet R; Grimber G; Cavard C; Bennoun M; Mignon A; Briand P; Joulin V		Cancer Lett	177	2002	189-95	J:74404	11825666
92069	Conditional loss of nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.		Abdulkadir SA; Magee JA; Peters TJ; Kaleem Z; Naughton CK; Humphrey PA; Milbrandt J		Mol Cell Biol	22	2002	1495-503	J:74350	11839815
92070	Stage-specific alterations of cyclin expression during UVB-induced murine skin tumor development.		Kim AL; Athar M; Bickers DR; Gautier J		Photochem Photobiol	75	2002	58-67	J:74351	11837328
92071	Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice.		Stromnes IM; Dittmer U; Schumacher TN; Schepers K; Messer RJ; Evans LH; Peterson KE; Race B; Hasenkrug KJ		J Virol	76	2002	2225-32	J:74353	11836400
92072	Telomere shortening and cell fates in mouse models of neoplasia.		Artandi SE		Trends Mol Med	8	2002	44-7	J:74354	11796266
92073	Impaired antioxidant defense system of colonic tissue and cancer development in dextran sulfate sodium-induced colitis in mice.		Korenaga D; Takesue F; Kido K; Yasuda M; Inutsuka S; Honda M; Nagahama S		J Surg Res	102	2002	144-9	J:74355	11796011
92074	Selection for c-myc Integration Sites in Polyclonal T-Cell Lymphomas.		Broussard DR; Mertz JA; Lozano M; Dudley JP		J Virol	76	2002	2087-99	J:74356	11836386
92075	Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia.		Clerc P; Leung-Theung-Long S; Wang TC; Dockray GJ; Bouisson M; Delisle MB; Vaysse N; Pradayrol L; Fourmy D; Dufresne M		Gastroenterology	122	2002	428-37	J:74357	11832457
92076	Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice.		Marten K; Bremer C; Khazaie K; Sameni M; Sloane B; Tung CH; Weissleder R		Gastroenterology	122	2002	406-14	J:74358	11832455
92077	Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.		Lerat H; Honda M; Beard MR; Loesch K; Sun J; Yang Y; Okuda M; Gosert R; Xiao SY; Weinman SA; Lemon SM		Gastroenterology	122	2002	352-65	J:74359	11832450
92078	Cancer as a complex genetic trait. Tumor susceptibility in humans and mouse models.		Balmain A		Cell	108	2002	145-52	J:74360	11832205
92079	Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer.		Keith RL; Miller YE; Hoshikawa Y; Moore MD; Gesell TL; Gao B; Malkinson AM; Golpon HA; Nemenoff RA; Geraci MW		Cancer Res	62	2002	734-40	J:74362	11830527
92080	Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses.		Fox JG; Sheppard BJ; Dangler CA; Whary MT; Ihrig M; Wang TC		Cancer Res	62	2002	696-702	J:74363	11830522
92081	Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.		Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Rocca CD; Lozupone F; Piacentini M; Buendia MA; Tripodi M		Oncogene	21	2002	1335-45	J:75077	11857077
92082	Independent variation in susceptibilities of six different mouse strains to induction of pepsinogen-altered pyloric glands and gastric tumor intestinalization by N-methyl-N-nitrosourea.		Yamamoto M; Furihata C; Ogiu T; Tsukamoto T; Inada K; Hirano K; Tatematsu M		Cancer Lett	179	2002	121-32	J:75233	11888666
92083	NHEJ deficiency and disease.		Pierce AJ; Jasin M		Mol Cell	8	2001	1160-1	J:75234	11885597
92084	ErbB2/Neu-Induced, Cyclin D1-Dependent Transformation Is Accelerated in p27-Haploinsufficient Mammary Epithelial Cells but Impaired in p27-Null Cells.		Muraoka RS; Lenferink AE; Law B; Hamilton E; Brantley DM; Roebuck LR; Arteaga CL		Mol Cell Biol	22	2002	2204-19	J:75235	11884607
92085	Decrease in K-ras p21 and Increase in Raf1 and Activated Erk 1 and 2 in Murine Lung Tumors Initiated by N-Nitrosodimethylamine and Promoted by 2,3,7,8-Tetrachlorodibenzo-p-dioxin.		Ramakrishna G; Perella C; Birely L; Diwan BA; Fornwald LW; Anderson LM		Toxicol Appl Pharmacol	179	2002	21-34	J:75236	11884234
92086	The Mus cervicolor MuLV isolate M813 is highly fusogenic and induces a T-cell lymphoma associated with large multinucleated cells.		Prassolov V; Ivanov D; Hein S; Rutter G; Munk C; Lohler J; Stocking C		Virology	290	2001	39-49	J:75237	11883004
92087	Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate.		Lamartiniere CA; Cotroneo MS; Fritz WA; Wang J; Mentor-Marcel R; Elgavish A		J Nutr	132	2002	552S-8S	J:75238	11880592
92088	Perinatal selenium exposure decreases spontaneous liver tumorogenesis in CBA mice.		Popova NV		Cancer Lett	179	2002	39-42	J:75239	11880180
92089	Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?		McAllister KA; Wiseman RW		Breast Cancer Res	4	2002	54-7	J:75240	11879563
92090	Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models.		Sutherland RL; Musgrove EA		Breast Cancer Res	4	2002	14-7	J:75241	11879554
92091	Hyperfractionated external beam radiation therapy in the treatment of murine transgenic retinoblastoma.		Hayden BC; Murray TG; Cicciarelli N; Scott IU; Alexandridou A; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM		Arch Ophthalmol	120	2002	353-9	J:75242	11879140
92092	A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.		Kwiatkowski DJ; Zhang H; Bandura JL; Heiberger KM; Glogauer M; el-Hashemite N; Onda H		Hum Mol Genet	11	2002	525-34	J:75243	11875047
92093	Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo.		Nguyen A; Burack WR; Stock JL; Kortum R; Chaika OV; Afkarian M; Muller WJ; Murphy KM; Morrison DK; Lewis RE; McNeish J; Shaw AS		Mol Cell Biol	22	2002	3035-45	J:75739	11940661
92094	Presence of mouse mammary tumor virus specifically alters the body odor of mice.		Yamazaki K; Boyse EA; Bard J; Curran M; Kim D; Ross SR; Beauchamp GK		Proc Natl Acad Sci U S A	99	2002	5612-5	J:75740	11929982
92095	Spontaneous lesions in control B6C3F1 mice and recommended sectioning of male accessory sex organs.		Suwa T; Nyska A; Haseman JK; Mahler JF; Maronpot RR		Toxicol Pathol	30	2002	228-34	J:75741	11950166
92096	Assessment of carcinogenicity of di(2-ethylhexyl)phthalate in a short-term assay using Xpa-/- and Xpa-/-/p53+/- mice.		Mortensen A; Bertram M; Aarup V; Sorensen IK		Toxicol Pathol	30	2002	188-99	J:75742	11950162
92097	Genetic control of polyamine-dependent susceptibility to skin tumorigenesis.		Megosh LC; Hu J; George K; O'Brien TG		Genomics	79	2002	505-12	J:75743	11944982
92098	DNA mismatch repair deficiency accelerates endometrial tumorigenesis in pten heterozygous mice.		Wang H; Douglas W; Lia M; Edelmann W; Kucherlapati R; Podsypanina K; Parsons R; Ellenson LH		Am J Pathol	160	2002	1481-6	J:75744	11943731
92099	An Analysis of T Cell Intrinsic Roles of E2A by Conditional Gene Disruption in the Thymus.		Pan L; Hanrahan J; Li J; Hale LP; Zhuang Y		J Immunol	168	2002	3923-32	J:75746	11937548
92100	Evaluation of the Tg.AC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals--practical pointers, mechanistic clues, and new questions.		Sistare FD; Thompson KL; Honchel R; DeGeorge J		Int J Toxicol	21	2002	65-79	J:75747	11936901
92101	Induction of stem cell cycling in mice increases their sensitivity to a chemical leukaemogen: implications for inherited genomic instability and the bystander effect.		Lord BI; Woolford LB		Mutat Res	501	2002	13-7	J:75749	11934433
92102	A murine model of nijmegen breakage syndrome.		Williams BR; Mirzoeva OK; Morgan WF; Lin J; Dunnick W; Petrini JH		Curr Biol	12	2002	648-53	J:75956	11967151
92103	An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes.		Corral J; Lavenir I; Impey H; Warren AJ; Forster A; Larson TA; Bell S; McKenzie AN; King G; Rabbitts TH		Cell	85	1996	853-61	J:75959	8681380
92104	The common retroviral insertion locus dsi1 maps 30 kilobases upstream of the p1 promoter of the murine runx3/cbfa3/aml2 gene.		Stewart M; MacKay N; Cameron ER; Neil JC		J Virol	76	2002	4364-9	J:75971	11932403
92105	Absence of Post-translational Aspartyl beta -Hydroxylation of Epidermal Growth Factor Domains in Mice Leads to Developmental Defects and an Increased Incidence of Intestinal Neoplasia.		Dinchuk JE; Focht RJ; Kelley JA; Henderson NL; Zolotarjova NI; Wynn R; Neff NT; Link J; Huber RM; Burn TC; Rupar MJ; Cunningham MR; Selling BH; Ma J; Stern AA; Hollis GF; Stein RB; Friedman PA		J Biol Chem	277	2002	12970-7	J:75888	11773073
92106	Abdominal malignant mesothelioma in a mouse.		Yener Z; Karaca T; Yuksel H		Aust Vet J	80	2002	301-2	J:77151	12074314
92107	Ectopic expression of the ets transcription factor ER81 in transgenic mouse mammary gland enhances both urokinase plasminogen activator and stromelysin-1 transcription.		Netzer S; Leenders F; Dumont P; Baert JL; de Launoit Y		Transgenic Res	11	2002	123-31	J:76676	12054346
92108	Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice.		Berrigan D; Perkins SN; Haines DC; Hursting SD		Carcinogenesis	23	2002	817-22	J:76613	12016155
92109	The proto-oncogene c-myc in hematopoietic development and leukemogenesis.		Hoffman B; Amanullah A; Shafarenko M; Liebermann DA		Oncogene	21	2002	3414-21	J:76752	12032779
92110	Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease.		Scheijen B; Griffin JD		Oncogene	21	2002	3314-33	J:76753	12032772
92111	Radiation-induced genetic instability in vivo depends on p53 status.		Liang L; Shao C; Deng L; Mendonca MS; Stambrook PJ; Tischfield JA		Mutat Res	502	2002	69-80	J:76754	11996974
92112	Cancer susceptibility and the functions of BRCA1 and BRCA2.		Venkitaraman AR		Cell	108	2002	171-82	J:76921	11832208
92113	The role of PML in tumor suppression.		Salomoni P; Pandolfi PP		Cell	108	2002	165-70	J:76927	11832207
92114	Apoptosis: a link between cancer genetics and chemotherapy.		Johnstone RW; Ruefli AA; Lowe SW		Cell	108	2002	153-64	J:76928	11832206
92115	Ovulatory Surges of Human CG Prevent Hormone-Induced Granulosa Cell Tumor Formation Leading to the Identification of Tumor-Associated Changes in the Transcriptome.		Owens GE; Keri RA; Nilson JH		Mol Endocrinol	16	2002	1230-42	J:76875	12040011
92116	Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations.		Schaeffer BK; Terhune PG; Longnecker DS		Am J Pathol	145	1994	696-701	J:76994	8080049
92117	Characterization of the ELSV transgenic mouse model of pancreatic carcinoma. Histologic type of large and small tumors.		Glasner S; Memoli V; Longnecker DS		Am J Pathol	140	1992	1237-45	J:76995	1316086
92118	Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver.		Sandgren EP; Luetteke NC; Qiu TH; Palmiter RD; Brinster RL; Lee DC		Mol Cell Biol	13	1993	320-30	J:76996	8417334
92119	The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.		Naik P; Karrim J; Hanahan D		Genes Dev	10	1996	2105-16	J:76998	8804306
92120	Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia.		Long DJ nd; Gaikwad A; Multani A; Pathak S; Montgomery CA; Gonzalez FJ; Jaiswal AK		Cancer Res	62	2002	3030-6	J:77032	12036909
92121	p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas.		Zhang Z; Li J; Lantry LE; Wang Y; Wiseman RW; Lubet RA; You M		Cancer Res	62	2002	3024-9	J:77033	12036908
92122	Role of endogenous oxidative DNA damage in carcinogenesis: what can we learn from repair-deficient mice?		Epe B		Biol Chem	383	2002	467-75	J:77185	12033436
92123	Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model.		Zhao Y; Oberley TD; Chaiswing L; Lin SM; Epstein CJ; Huang TT; St Clair D		Oncogene	21	2002	3836-46	J:77186	12032821
92124	Outbreak of hind limb paralysis in young CFW Swiss Webster mice.		Ceccarelli AV; Rozengurt N		Comp Med	52	2002	171-5	J:77189	12022398
92125	Cancer chemopreventive effects of a Brazilian folk medicine, Juca, on in vivo two-stage skin carcinogenesis.		Nakamura ES; Kurosaki F; Arisawa M; Mukainaka T; Takayasu J; Okuda M; Tokuda H; Nishino H; Pastore F		J Ethnopharmacol	81	2002	135-7	J:77191	12020938
92126	Recent advances in cancer research: mouse models of tumorigenesis.		Herzig M; Christofori G		Biochim Biophys Acta	1602	2002	97-113	J:77192	12020798
92127	Cancare-a herbal formulation inhibits chemically induced tumours in experimental animals.		Rajeshkumar NV; Kuttan R		Indian J Exp Biol	39	2001	654-9	J:77193	12019758
92128	The effect of a water-dispersible beta-carotene formulation on the prevention of age-related lymphoid neoplasms in mice.		Riondel J; Wong HK; Glise D; Ducros V; Favier A		Anticancer Res	22	2002	883-8	J:77196	12014666
92129	Growth inhibition of mouse autochthonous skin cancer by oral administration of new serine protease inhibitor ONO-3403.		Ohkoshi M; Okuda S		Anticancer Res	22	2002	821-3	J:77197	12014657
92130	Initiating oncogenic event determines gene-expression patterns of human breast cancer models.		Desai KV; Xiao N; Wang W; Gangi L; Greene J; Powell JI; Dickson R; Furth P; Hunter K; Kucherlapati R; Simon R; Liu ET; Green JE		Proc Natl Acad Sci U S A	99	2002	6967-72	J:77198	12011455
92131	Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.		Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH		Cancer Epidemiol Biomarkers Prev	11	2002	467-74	J:77199	12010861
92132	A head holder for magnetic resonance imaging that allows the stereotaxic alignment of spontaneously occurring intracranial mouse tumors.		Tada T; Wendland M; Watson N; Kuriyama N; Kuriyama H; Roberts T; Burns M; Weiss W; Israel MA		J Neurosci Methods	116	2002	1-7	J:77200	12007978
92133	Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester.		Juzenas P; Sharfaei S; Moan J; Bissonnette R		J Photochem Photobiol B	67	2002	11-7	J:77201	12007462
92134	Age distribution of cancer in mice: the incidence turnover at old age.		Pompei F; Polkanov M; Wilson R		Toxicol Ind Health	17	2001	7-16	J:77202	12004924
92135	Conditional mouse models of sporadic cancer.		Jonkers J; Berns A		Nat Rev Cancer	2	2002	251-65	J:77203	12001987
92136	Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci.		Pierce RH; Vail ME; Ralph L; Campbell JS; Fausto N		Am J Pathol	160	2002	1555-60	J:77204	12000706
92137	Improved Survival Rates in Mice that Received Prophylactic Fluids After Carcinogen Treatment.		Smith DE; Blumberg JB; Lipman RD		Contemp Top Lab Anim Sci	38	1999	84-86	J:77205	12086460
92138	Epidermotropic Lymphoma (Mycosis Fungoides) in an ICR Mouse.		Lohmiller JJ; Swing SP; Valli VE; Li X		Contemp Top Lab Anim Sci	38	1999	47-49	J:77206	12086417
92139	Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak.		Chandrasekharan S; Qiu TH; Alkharouf N; Brantley K; Mitchell JB; Liu ET		Mol Cell Biol	22	2002	5235-47	J:77207	12077350
92140	Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.		Bajenaru ML; Zhu Y; Hedrick NM; Donahoe J; Parada LF; Gutmann DH		Mol Cell Biol	22	2002	5100-13	J:77208	12077339
92141	Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia.		Westervelt P; Pollock JL; Oldfather KM; Walter MJ; Ma MK; Williams A; DiPersio JF; Ley TJ		Proc Natl Acad Sci U S A	99	2002	9468-73	J:77209	12077315
92142	Bethesda proposals for classification of lymphoid neoplasms in mice.		Morse HC 3rd; Anver MR; Fredrickson TN; Haines DC; Harris AW; Harris NL; Jaffe ES; Kogan SC; MacLennan IC; Pattengale PK; Ward JM		Blood	100	2002	246-58	J:77210	12070034
92143	Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.		Kogan SC; Ward JM; Anver MR; Berman JJ; Brayton C; Cardiff RD; Carter JS; de Coronado S; Downing JR; Fredrickson TN; Haines DC; Harris AW; Harris NL; Hiai H; Jaffe ES; MacLennan IC; Pandolfi PP; Pattengale PK; Perkins AS; Simpson RM; Tuttle MS; Wong JF; M	orse HC rd	Blood	100	2002	238-45	J:77211	12070033
92144	Iron augments stage-I and stage-II tumor promotion in murine skin.		Bhasin G; Kauser H; Athar M		Cancer Lett	183	2002	113-22	J:77212	12065085
92145	Senescence: a companion in chemotherapy?		Berns A		Cancer Cell	1	2002	309-11	J:77137	12086843
92146	Loss of Stat5a delays mammary cancer progression in a mouse model.		Ren S; Cai HR; Li M; Furth PA		Oncogene	21	2002	4335-9	J:77139	12082622
92147	Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis.		Gebhardt C; Breitenbach U; Tuckermann JP; Dittrich BT; Richter KH; Angel P		Oncogene	21	2002	4266-76	J:77140	12082614
92148	A review of animal models for the study of arsenic carcinogenesis.		Wang JP; Qi L; Moore MR; Ng JC		Toxicol Lett	133	2002	17-31	J:77147	12076507
92149	Mouse models of neurofibromatosis 1 and 2.		Gutmann DH; Giovannini M		Neoplasia	4	2002	279-90	J:77141	12082543
92150	Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse.		Boulton E; Cleary H; Plumb M		Carcinogenesis	23	2002	1079-85	J:77142	12082032
92151	Occurrence of H-ras codon 61 CAA to AAA mutation during mouse liver tumor progression.		Parsons BL; Culp SJ; Manjanatha MG; Heflich RH		Carcinogenesis	23	2002	943-8	J:77144	12082015
92152	Inhibitory Effects of Toremifene on N-Methyl-N-nitrosourea and Estradiol-17beta-induced Endometrial Carcinogenesis in Mice.		Niwa K; Hashimoto M; Lian Z; Gao J; Tagami K; Yokoyama Y; Mori H; Tamaya T		Jpn J Cancer Res	93	2002	626-35	J:77146	12079510
92153	Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazone.		Herman JR; Dethloff LA; McGuire EJ; Parker RF; Walsh KM; Gough AW; Masuda H; De La Iglesia FA		Toxicol Sci	68	2002	226-36	J:77149	12075125
92154	Acrylonitrile Is a Multisite Carcinogen in Male and Female B6C3F1 Mice.		Ghanayem BI; Nyska A; Haseman JK; Bucher JR		Toxicol Sci	68	2002	59-68	J:77150	12075111
92155	TGF-beta antagonists: why suppress a tumor suppressor?		Akhurst RJ		J Clin Invest	109	2002	1533-6	J:77300	12070299
92156	Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor.		Omer CA; Chen Z; Diehl RE; Conner MW; Chen HY; Trumbauer ME; Gopal-Truter S; Seeburger G; Bhimnathwala H; Abrams MT; Davide JP; Ellis MS; Gibbs JB; Greenberg I; Koblan KS; Kral AM; Liu D; Lobell RB; Miller PJ; Mosser SD; O'Neill TJ; Rands E; Schaber MD; S	enderak ET; Oliff A; Kohl NE	Cancer Res	60	2000	2680-8	J:77272	10825141
92157	Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer.		Leman ES; Arlotti JA; Dhir R; Greenberg N; Getzenberg RH		J Cell Biochem	86	2002	203-12	J:77969	12111990
92158	SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival.		Liu Q; Sasaki T; Kozieradzki I; Wakeham A; Itie A; Dumont DJ; Penninger JM		Genes Dev	13	1999	786-91	J:77739	10197978
92159	Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled.		Chapellier B; Mark M; Messaddeq N; Calleja C; Warot X; Brocard J; Gerard C; Li M; Metzger D; Ghyselinck NB; Chambon P		EMBO J	21	2002	3402-13	J:77763	12093741
92160	E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model.		Pierce AM; Schneider-Broussard R; Gimenez-Conti IB; Russell JL; Conti CJ; Johnson DG		Mol Cell Biol	19	1999	6408-14	J:77880	10454586
92161	Malignant melanoma in transgenic mice.		Bradl M; Klein-Szanto A; Porter S; Mintz B		Proc Natl Acad Sci U S A	88	1991	164-8	J:77882	1846036
92162	Normal ras genes: Their onco-suppressor and pro-apoptotic functions (Review).		Spandidos DA; Sourvinos G; Tsatsanis C; Zafiropoulos A		Int J Oncol	21	2002	237-41	J:77964	12118316
92163	Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice.		Sharfaei S; Juzenas P; Moan J; Bissonnette R		Arch Dermatol Res	294	2002	237-42	J:77966	12115027
92164	Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun.		Young MR; Farrell L; Lambert P; Awasthi P; Colburn NH		Mol Carcinog	34	2002	72-7	J:77967	12112313
92165	A major breakpoint cluster domain in murine radiation-induced acute myeloid leukemia.		Finnon R; Moody J; Meijne E; Haines J; Clark D; Edwards A; Cox R; Silver A		Mol Carcinog	34	2002	64-71	J:77968	12112312
92166	Protective effect of tenuazonic acid against dimethyl benz(a)antracene-induced skin carcinogenesis in mice.		Antony M; Shukla Y; Janardhanan KK		Teratog Carcinog Mutagen	22	2002	309-14	J:77970	12111715
92167	Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis.		Martins CP; Berns A		EMBO J	21	2002	3739-48	J:77971	12110586
92168	Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies.		Koike K		J Gastroenterol	37 Suppl 13	2002	55-64	J:77973	12109667
92169	Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs).		Brand K		Curr Gene Ther	2	2002	255-71	J:77974	12109221
92170	Oncolytic viruses: programmable tumour hunters.		Bell JC; Garson KA; Lichty BD; Stojdl DF		Curr Gene Ther	2	2002	243-54	J:77975	12109220
92171	Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.		King D; Yang G; Thompson MA; Hiebert SW		Oncogene	21	2002	4978-82	J:78079	12118376
92172	The food mutagen 2-amino-9H-pyrido[2,3-b]indole (AalphaC) but not its methylated form (MeAalphaC) increases intestinal tumorigenesis in neonatally exposed multiple intestinal neoplasia mice.		Steffensen IL; Paulsen JE; Alexander J		Carcinogenesis	23	2002	1373-8	J:78063	12151357
92173	Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.		He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP		Nat Genet	18	1998	126-35	J:78201	9462740
92174	Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations.		Oshima M; Oshima H; Kobayashi M; Tsutsumi M; Taketo MM		Cancer Res	55	1995	2719-22	J:78202	7796392
92175	Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53.		Howes KA; Ransom N; Papermaster DS; Lasudry JG; Albert DM; Windle JJ		Genes Dev	8	1994	1300-10	J:78203	7986270
92176	An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.		Rosenbaum H; Harris AW; Bath ML; McNeall J; Webb E; Adams JM; Cory S		EMBO J	9	1990	897-905	J:78204	2155783
92177	Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice.		Quaife CJ; Pinkert CA; Ornitz DM; Palmiter RD; Brinster RL		Cell	48	1987	1023-34	J:78205	3470144
92178	beta-catenin mutations are absent in hepatocellular carcinomas of SV40 T-antigen transgenic mice.		Umeda T; Yamamoto T; Kajino K; Hino O		Int J Oncol	16	2000	1133-6	J:78280	10811985
92179	Mouse transgenic for murine oviduct-specific glycoprotein promoter-driven simian virus 40 large T-antigen: Tumor formation and its hormonal regulation.		Miyoshi I; Takahashi K; Kon Y; Okamura T; Mototani Y; Araki Y; Kasai N		Mol Reprod Dev	63	2002	168-76	J:78481	12203826
92180	Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.		Stern MC; Benavides F; LaCava M; Conti CJ		Mol Carcinog	35	2002	13-20	J:78482	12203363
92181	Aloe arborescens extract inhibits TPA-induced ear oedema, putrescine increase and tumour promotion in mouse skin.		Shimpo K; Ida C; Chihara T; Beppu H; Kaneko T; Kuzuya H		Phytother Res	16	2002	491-3	J:78483	12203274
92182	Antitumor vaccines: is it possible to prevent a tumor?		Lollini PL; Forni G		Cancer Immunol Immunother	51	2002	409-16	J:78484	12202901
92183	Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model.		Okayasu I; Yamada M; Mikami T; Yoshida T; Kanno J; Ohkusa T		J Gastroenterol Hepatol	17	2002	1078-83	J:78485	12201867
92184	Inhibition of mouse skin tumor promotion by anti-inflammatory diarylheptanoids derived from Alpinia oxyphylla Miquel (Zingiberaceae).		Chun KS; Park KK; Lee J; Kang M; Surh YJ		Oncol Res	13	2002	37-45	J:78486	12201673
92185	Carcinogenic and cocarcinogenic potential of cypermethrin on mouse skin.		Shukla Y; Yadav A; Arora A		Cancer Lett	182	2002	33-41	J:78505	12175521
92186	Long-term exposure of E micro-Pim1 transgenic mice to 898.4 MHz microwaves does not increase lymphoma icidence.		Utteridge TD; Gebski V; Finnie JW; Vernon-Roberts B; Kuchel TR		Radiat Res	158	2002	357-64	J:78507	12175314
92187	Differentially expressed genes associated with mouse lung tumor progression.		Yao R; Wang Y; Lubet RA; You M		Oncogene	21	2002	5814-21	J:78508	12173053
92188	Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice.		Engel I; Murre C		Proc Natl Acad Sci U S A	99	2002	11322-7	J:78509	12172006
92189	Therapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis.		Reuter BK; Zhang XJ; Miller MJ		BMC Cancer	2	2002	19	J:78510	12171603
92190	Effect of myelopeptide-2 on the development of spontaneous and urethane-induced tumors in mice.		Mikhailova AA; Kirilina EA; Morozova OV; Turusov VS		Bull Exp Biol Med	133	2002	68-70	J:78511	12170311
92191	Inducible expression of FGF-3 in mouse mammary gland.		Ngan ES; Ma ZQ; Chua SS; DeMayo FJ; Tsai SY		Proc Natl Acad Sci U S A	99	2002	11187-92	J:78512	12169667
92192	Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.		Zhuang SM; Wiseman RW; Soderkvist P		Oncogene	21	2002	5643-8	J:78513	12165863
92193	Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.		Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L		Oncogene	21	2002	5548-56	J:78514	12165853
92194	A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis.		Barrington RE; Subler MA; Rands E; Omer CA; Miller PJ; Hundley JE; Koester SK; Troyer DA; Bearss DJ; Conner MW; Gibbs JB; Hamilton K; Koblan KS; Mosser SD; O'Neill TJ; Schaber MD; Senderak ET; Windle JJ; Oliff A; Kohl NE		Mol Cell Biol	18	1998	85-92	J:78608	9418856
92195	Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody.		Vicari AP; Chiodoni C; Vaure C; Ait-Yahia S; Dercamp C; Matsos F; Reynard O; Taverne C; Merle P; Colombo MP; O'Garra A; Trinchieri G; Caux C		J Exp Med	196	2002	541-9	J:78644	12186845
92196	Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.		Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE		Int J Cancer	101	2002	224-34	J:78871	12209972
92197	Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.		Rosner A; Miyoshi K; Landesman-Bollag E; Xu X; Seldin DC; Moser AR; MacLeod CL; Shyamala G; Gillgrass AE; Cardiff RD		Am J Pathol	161	2002	1087-97	J:78873	12213737
92198	Cancer predisposition and hematopoietic failure in Rad50(S/S) mice.		Bender CF; Sikes ML; Sullivan R; Huye LE; Le Beau MM; Roth DB; Mirzoeva OK; Oltz EM; Petrini JH		Genes Dev	16	2002	2237-51	J:78820	12208847
92199	Lung tumor development in mice exposed to tobacco smoke and fed beta-carotene diets.		Obermueller-Jevic UC; Espiritu I; Corbacho AM; Cross CE; Witschi H		Toxicol Sci	69	2002	23-9	J:79078	12215657
92200	Regulation of gene expression by WT1 in development and tumorigenesis.		Ellisen LW		Int J Hematol	76	2002	110-6	J:79079	12215008
92201	A mouse model of human oral-esophageal cancer.		Opitz OG; Harada H; Suliman Y; Rhoades B; Sharpless NE; Kent R; Kopelovich L; Nakagawa H; Rustgi AK		J Clin Invest	110	2002	761-9	J:79110	12235107
92202	Combined effects on tumor growth and metastasis by anti-estrogenic and antiangiogenic therapies in MMTV-neu mice.		Sacco MG; Soldati S; Mira Cato E; Cattaneo L; Pratesi G; Scanziani E; Vezzoni P		Gene Ther	9	2002	1338-41	J:79069	12224018
92203	Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice.		Cleary MP; Jacobson MK; Phillips FC; Getzin SC; Grande JP; Maihle NJ		Cancer Epidemiol Biomarkers Prev	11	2002	836-43	J:79070	12223427
92204	Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.		Muller-Decker K; Neufang G; Berger I; Neumann M; Marks F; Furstenberger G		Proc Natl Acad Sci U S A	99	2002	12483-8	J:79071	12221288
92205	A survey of EPA/OPP and open literature on selected pesticide chemicals. III. Mutagenicity and carcinogenicity of benomyl and carbendazim.		McCarroll N; Protzel A; Ioannou Y; Frank Stack H; Jackson M; Waters M; Dearfield K		Mutat Res	512	2002	1-35	J:79072	12220588
92206	Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis.		Rossi DJ; Ylikorkala A; Korsisaari N; Salovaara R; Luukko K; Launonen V; Henkemeyer M; Ristimaki A; Aaltonen LA; Makela TP		Proc Natl Acad Sci U S A	99	2002	12327-32	J:79074	12218179
92207	Isotype switch-mediated CH deletions are a recurrent feature of Myc/CH translocations in peritoneal plasmacytomas in mice.		Kovalchuk AL; Janz S		Int J Cancer	101	2002	423-6	J:79076	12216069
92208	17beta-estradiol is a hormonal regulator of mirex tumor promotion sensitivity in mice.		Porter KL; Chanda S; Wang HQ; Gaido KW; Smart RC; Robinette CL		Toxicol Sci	69	2002	42-8	J:79077	12215659
92209	Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors.		Okuda T; Cai Z; Yang S; Lenny N; Lyu CJ; van Deursen JM; Harada H; Downing JR		Blood	91	1998	3134-43	J:79160	9558367
92210	Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors.		Lagutina I; Conway SJ; Sublett J; Grosveld GC		Mol Cell Biol	22	2002	7204-16	J:79365	12242297
92211	Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development.		Gonzalez-Suarez E; Flores JM; Blasco MA		Mol Cell Biol	22	2002	7291-301	J:79366	12242304
92212	Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18).		McDonnell TJ; Korsmeyer SJ		Nature	349	1991	254-6	J:79443	1987477
92213	In Vivo Plasmid Electroporation Induces Tumor Antigen-specific CD8+ T-Cell Responses and Delays Tumor Growth in a Syngeneic Mouse Melanoma Model.		Kalat M; Kupcu Z; Schuller S; Zalusky D; Zehetner M; Paster W; Schweighoffer T		Cancer Res	62	2002	5489-94	J:79444	12359758
92214	Photosensitizing effect of protoporphyrin IX in pigmented melanoma of mice.		Juzenas P; Juzeniene A; Stakland S; Iani V; Moan J		Biochem Biophys Res Commun	297	2002	468	J:79445	12270116
92215	Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis.		Blasco MA; Rizen M; Greider CW; Hanahan D		Nat Genet	12	1996	200-4	J:79417	8563761
92216	Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice.		Khare SD; Sarosi I; Xia XZ; McCabe S; Miner K; Solovyev I; Hawkins N; Kelley M; Chang D; Van G; Ross L; Delaney J; Wang L; Lacey D; Boyle WJ; Hsu H		Proc Natl Acad Sci U S A	97	2000	3370-5	J:79421	10716715
92217	Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA.		Sfondrini L; Besusso D; Rumio C; Rodolfo M; Menard S; Balsari A		FASEB J	16	2002	1749-54	J:79699	12409317
92218	Survival characteristics and age-adjusted disease incidences in C57BL/6 mice fed a commonly used cereal-based diet modulated by dietary restriction.		Turturro A; Duffy P; Hass B; Kodell R; Hart R		J Gerontol A Biol Sci Med Sci	57	2002	B379-89	J:79701	12403793
92219	Lymphoproliferative defects in mice lacking the expression of neurofibromin: functional and biochemical consequences of Nf1 deficiency in T-cell development and function.		Ingram DA; Zhang L; McCarthy J; Wenning MJ; Fisher L; Yang FC; Clapp DW; Kapur R		Blood	100	2002	3656-62	J:79702	12393709
92220	Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma.		Hoyer KK; French SW; Turner DE; Nguyen MT; Renard M; Malone CS; Knoetig S; Qi CF; Su TT; Cheroutre H; Wall R; Rawlings DJ; Morse HC rd; Teitell MA		Proc Natl Acad Sci U S A	99	2002	14392-7	J:79703	12381789
92221	Benzyl isothiocyanate: an effective inhibitor of polycyclic aromatic hydrocarbon tumorigenesis in A/J mouse lung.		Hecht SS; Kenney PM; Wang M; Upadhyaya P		Cancer Lett	187	2002	87-94	J:79705	12359355
92222	Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.		Brantley DM; Cheng N; Thompson EJ; Lin Q; Brekken RA; Thorpe PE; Muraoka RS; Cerretti DP; Pozzi A; Jackson D; Lin C; Chen J		Oncogene	21	2002	7011-26	J:79653	12370823
92223	Molecular pathogenesis of primary hyperparathyroidism.		Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K		J Bone Miner Res	17 Suppl 2	2002	N30-6	J:79654	12412775
92224	Rapid induction of uterine endometrial proliferative lesions in transgenic mice carrying a human prototype c-Ha-ras gene (rasH2 mice) given a single intraperitoneal injection of N-ethyl-N-nitrosourea.		Watanabe T; Kashida Y; Yasuhara K; Koujitani T; Hirose M; Mitsumori K		Cancer Lett	188	2002	39-46	J:79656	12406546
92225	Pathways to melanoma development: lessons from the mouse.		Walker GJ; Hayward NK		J Invest Dermatol	119	2002	783-92	J:79657	12406321
92226	Epididymal dysfunction initiated by the expression of simian virus 40 T-antigen leads to angulated sperm flagella and infertility in transgenic mice.		Sipila P; Cooper TG; Yeung CH; Mustonen M; Penttinen J; Drevet J; Huhtaniemi I; Poutanen M		Mol Endocrinol	16	2002	2603-17	J:79658	12403849
92227	The genetics of radiation-induced and sporadic osteosarcoma: a unifying theory?		Rosemann M; Kuosaite V; Nathrath M; Atkinson MJ		J Radiol Prot	22	2002	A113-6	J:79659	12400958
92228	Mechanistic and genetic studies of radiation tumorigenesis in the mouse--implications for low dose risk estimation.		Bouffler S; Silver A; Cox R		J Radiol Prot	22	2002	A11-6	J:79660	12400940
92229	Pituitary tumorigenesis in prolactin gene-disrupted mice.		Cruz-Soto ME; Scheiber MD; Gregerson KA; Boivin GP; Horseman ND		Endocrinology	143	2002	4429-36	J:79661	12399440
92230	High vascular endothelial growth factor (VEGF) expression in chemically-induced hepatic microcancers in mice.		Turlin B; Le Quilleuc D; Leroyer P; Brissot P; Deugnier Y; Loreal O		J Hepatol	37	2002	620-4	J:79662	12399228
92231	Mice defective in the mismatch repair gene Msh2 show increased predisposition to UVB radiation-induced skin cancer.		Meira LB; Cheo DL; Reis AM; Claij N; Burns DK; Riele H; Friedberg EC		DNA Repair (Amst)	1	2002	929-34	J:79733	12531020
92232	Additive roles of XPA and MSH2 genes in UVB-induced skin tumorigenesis in mice.		Yoshino M; Nakatsu Y; Riele H; Hirota S; Kitamura Y; Tanaka K		DNA Repair (Amst)	1	2002	935-40	J:79734	12531021
92233	Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites.		Joosten M; Vankan-Berkhoudt Y; Tas M; Lunghi M; Jenniskens Y; Parganas E; Valk PJ; Lowenberg B; van den Akker E; Delwel R		Oncogene	21	2002	7247-55	J:79868	12370816
92234	Apoptosis and carcinogenesis.		Lyons SK; Clarke AR		Br Med Bull	53	1997	554-69	J:47223	9374037
92235	Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats.		Falvella FS; Pascale RM; Gariboldi M; Manenti G; De Miglio MR; Simile MM; Dragani TA; Feo F		Carcinogenesis	23	2002	1933-6	J:80006	12419843
92236	Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase. Recepteur d'origine nantais.		Chen YQ; Zhou YQ; Fu LH; Wang D; Wang MH		Carcinogenesis	23	2002	1811-9	J:80007	12419829
92237	IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.		Shankaran V; Ikeda H; Bruce AT; White JM; Swanson PE; Old LJ; Schreiber RD		Nature	410	2001	1107-11	J:80176	11323675
92238	Photocarcinogenesis: measuring the reproducibility of a biologic response to ultraviolet radiation exposure in mice.		Sambuco CP; Forbes PD; Davies RE; Learn DB; Arocena M; Hoberman AM		Front Biosci	8	2003	A26-33	J:80282	12456327
92239	Tumorigenic potential of carbaryl in the heterozygous p53 knockout mouse model.		Bigot-Lasserre D; Chuzel F; Debruyne EL; Bars R; Carmichael NG		Food Chem Toxicol	41	2003	99-106	J:80284	12453734
92240	A comparative review of melanocytic neoplasms.		Smith SH; Goldschmidt MH; McManus PM		Vet Pathol	39	2002	651-78	J:80285	12450197
92241	Inhibition by ajoene of skin-tumor promotion in mice.		Nishikawa T; Yamada N; Hattori A; Fukuda H; Fujino T		Biosci Biotechnol Biochem	66	2002	2221-3	J:80286	12450136
92242	Ovarian dependence for pituitary tumorigenesis in d2 dopamine receptor-deficient mice.		Hentges ST; Low MJ		Endocrinology	143	2002	4536-43	J:80287	12446580
92243	Animal models of papillomavirus pathogenesis.		Campo MS		Virus Res	89	2002	249-61	J:80288	12445664
92244	Inhibition of UV-induced p53 mutations and skin cancers by sunscreens: implication for skin cancer prevention.		Ananthaswamy HN; Ullrich SE; Kripke ML		Exp Dermatol	11 Suppl 1	2002	40-3	J:80289	12444959
92245	p53 mutations as a marker of skin cancer risk: comparison of UVA and UVB effects.		De Gruijl FR		Exp Dermatol	11 Suppl 1	2002	37-9	J:80290	12444958
92246	The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation.		Buckwalter TL; Venkateswaran A; Lavender M; La Perle KM; Cho JY; Robinson ML; Jhiang SM		Oncogene	21	2002	8166-72	J:80291	12444552
92247	A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention.		Cohen LA		Exp Biol Med (Maywood)	227	2002	864-8	J:80314	12424327
92248	DNA alkylation and repair in the large bowel: animal and human studies.		Povey AC; Badawi AF; Cooper DP; Hall CN; Harrison KL; Jackson PE; Lees NP; O'Connor PJ; Margison GP		J Nutr	132	2002	3518S-3521S	J:80315	12421880
92249	A glycomic approach to hepatic tumors in N-acetylglucosaminyltransferase III (GnT-III) transgenic mice induced by diethylnitrosamine (DEN): identification of haptoglobin as a target molecule of GnT-III.		Ekuni A; Miyoshi E; Ko JH; Noda K; Kitada T; Ihara S; Endo T; Hino A; Honke K; Taniguchi N		Free Radic Res	36	2002	827-33	J:80316	12420740
92250	Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice.		Duan W; Ding H; Subler MA; Zhu WG; Zhang H; Stoner GD; Windle JJ; Otterson GA; Villalona-Calero MA		Oncogene	21	2002	7831-8	J:80317	12420220
92251	Inhibitory effect of stevioside on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin.		Yasukawa K; Kitanaka S; Seo S		Biol Pharm Bull	25	2002	1488-90	J:80318	12419967
92252	Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes.		Bajenaru ML; Donahoe J; Corral T; Reilly KM; Brophy S; Pellicer A; Gutmann DH		Glia	33	2001	314-23	J:80411	11246230
92253	Early death of mice cloned from somatic cells.		Ogonuki N; Inoue K; Yamamoto Y; Noguchi Y; Tanemura K; Suzuki O; Nakayama H; Doi K; Ohtomo Y; Satoh M; Nishida A; Ogura A		Nat Genet	30	2002	253-4	J:80414	11836501
92254	T-antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus.		Chen J; Tobin GJ; Pipas JM; Van Dyke T		Oncogene	7	1992	1167-75	J:80499	1317542
92255	Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice.		Haliotis T; Ball JK; Dexter D; Roder JC		Int J Cancer	35	1985	505-13	J:80649	2985510
92256	Pituitary adenomas in mice transgenic for growth hormone-releasing hormone.		Asa SL; Kovacs K; Stefaneanu L; Horvath E; Billestrup N; Gonzalez-Manchon C; Vale W		Endocrinology	131	1992	2083-9	J:80650	1425411
92257	Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas.		McAndrew J; Paterson AJ; Asa SL; McCarthy KJ; Kudlow JE		Endocrinology	136	1995	4479-88	J:80651	7664668
92258	Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas.		Kim R; Trubetskoy A; Suzuki T; Jenkins NA; Copeland NG; Lenz J		J Virol	77	2003	2056-62	J:81051	12525640
92259	The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.		Harris AW; Pinkert CA; Crawford M; Langdon WY; Brinster RL; Adams JM		J Exp Med	167	1988	353-71	J:81130	3258007
92260	The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.		Langdon WY; Harris AW; Cory S; Adams JM		Cell	47	1986	11-8	J:81131	3093082
92261	Common sites of retroviral integration in mouse hematopoietic tumors identified by high-throughput, single nucleotide polymorphism-based mapping and bacterial artificial chromosome hybridization.		Shen H; Suzuki T; Munroe DJ; Stewart C; Rasmussen L; Gilbert DJ; Jenkins NA; Copeland NG		J Virol	77	2003	1584-8	J:81077	12502872
92262	The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development.		Finke D; Luther SA; Acha-Orbea H		Proc Natl Acad Sci U S A	100	2003	199-204	J:81078	12502785
92263	An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice.		Terazaki Y; Yano S; Yuge K; Nagano S; Fukunaga M; Guo ZS; Komiya S; Shirouzu K; Kosai K		Hepatology	37	2003	155-63	J:81079	12500200
92264	Gadd45a Protects against UV Irradiation-induced Skin Tumors, and Promotes Apoptosis and Stress Signaling via MAPK and p53.		Hildesheim J; Bulavin DV; Anver MR; Alvord WG; Hollander MC; Vardanian L; Fornace AJ Jr		Cancer Res	62	2002	7305-15	J:81080	12499274
92265	A low molecular weight antioxidant decreases weight and lowers tumor incidence.		Mitchell JB; Xavier S; DeLuca AM; Sowers AL; Cook JA; Krishna MC; Hahn SM; Russo A		Free Radic Biol Med	34	2003	93-102	J:81081	12498984
92266	E2F4 loss suppresses tumorigenesis in Rb mutant mice.		Lee EY; Cam H; Ziebold U; Rayman JB; Lees JA; Dynlacht BD		Cancer Cell	2	2002	463-72	J:81082	12498715
92267	Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.		Moody SE; Sarkisian CJ; Hahn KT; Gunther EJ; Pickup S; Dugan KD; Innocent N; Cardiff RD; Schnall MD; Chodosh LA		Cancer Cell	2	2002	451-61	J:81083	12498714
92268	p53: Regular or super?		Roussel MF		Cancer Cell	2	2002	434-5	J:81084	12498711
92269	Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis.		Bair WB 3rd; Hart N; Einspahr J; Liu G; Dong Z; Alberts D; Bowden GT		Cancer Epidemiol Biomarkers Prev	11	2002	1645-52	J:81085	12496056
92270	Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice.		Ishikawa T; Shibuya K; Yasui K; Mitamura K; Ueda S		Comp Immunol Microbiol Infect Dis	26	2003	115-24	J:81086	12493492
92271	Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment.		Van Kempen LC; Rhee JS; Dehne K; Lee J; Edwards DR; Coussens LM		Differentiation	70	2002	610-23	J:81087	12492502
92272	Carcinogenesis in laboratory mice after low doses of ionizing radiation.		Di Majo V; Rebessi S; Pazzaglia S; Saran A; Covelli V		Radiat Res	159	2003	102-8	J:81088	12492373
92273	Mice with a mutation in the thyroid hormone receptor Beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.		Suzuki H; Willingham MC; Cheng SY		Thyroid	12	2002	963-9	J:81089	12490073
92274	Effects of hydroxyapatite in combination with far-infrared rays on spontaneous mammary tumorigenesis in SHN mice.		Udagawa Y; Ishigame H; Nagasawa H		Am J Chin Med	30	2002	495-505	J:81528	12568277
92275	Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.		Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D		Cancer Res	63	2003	567-72	J:81530	12566297
92276	Circadian rhythm of tumor promotion in the two-stage model of mouse tumorigenesis.		Wille JJ		Cancer Lett	190	2003	143-9	J:81531	12565168
92277	Toxicology and carcinogenesis studies of microencapsulated citral in rats and mice.		Ress NB; Hailey JR; Maronpot RR; Bucher JR; Travlos GS; Haseman JK; Orzech DP; Johnson JD; Hejtmancik MR		Toxicol Sci	71	2003	198-206	J:81532	12563105
92278	Carcinogenicity and mechanistic insights on the behavior of epoxides and epoxide-forming chemicals.		Melnick RL		Ann N Y Acad Sci	982	2002	177-89	J:81534	12562636
92279	Carcinogenicity of methyl-tertiary butyl ether in gasoline.		Mehlman MA		Ann N Y Acad Sci	982	2002	149-59	J:81535	12562634
92280	Carcinogenic effects of benzene: Cesare Maltoni's contributions.		Mehlman MA		Ann N Y Acad Sci	982	2002	137-48	J:81536	12562633
92281	Targeting mature T cell leukemia: new understanding of molecular pathways.		Pekarsky Y; Hallas C; Croce CM		Am J Pharmacogenomics	3	2003	31-6	J:81537	12562214
92282	The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice.		Gladdy RA; Taylor MD; Williams CJ; Grandal I; Karaskova J; Squire JA; Rutka JT; Guidos CJ; Danska JS		Cancer Cell	3	2003	37-50	J:81538	12559174
92283	Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.		Osawa E; Nakajima A; Wada K; Ishimine S; Fujisawa N; Kawamori T; Matsuhashi N; Kadowaki T; Ochiai M; Sekihara H; Nakagama H		Gastroenterology	124	2003	361-7	J:81539	12557142
92284	Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter.		Bol D; Kiguchi K; Beltran L; Rupp T; Moats S; Gimenez-Conti I; Jorcano J; DiGiovanni J		Mol Carcinog	21	1998	2-12	J:81468	9473766
92285	Identification of a putative intestinal stem cell and early lineage marker; musashi-1.		Potten CS; Booth C; Tudor GL; Booth D; Brady G; Hurley P; Ashton G; Clarke R; Sakakibara S; Okano H		Differentiation	71	2003	28-41	J:81476	12558601
92286	Oral mucosal carcinogenesis in SENCAR mice.		Kim TW; Chen Q; Shen X; Regezi JA; Ramos DM; Tanaka H; Jordan RC; Kramer RH		Anticancer Res	22	2002	2733-40	J:81560	12529989
92287	Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.		Gelling RW; Du XQ; Dichmann DS; Romer J; Huang H; Cui L; Obici S; Tang B; Holst JJ; Fledelius C; Johansen PB; Rossetti L; Jelicks LA; Serup P; Nishimura E; Charron MJ		Proc Natl Acad Sci U S A	100	2003	1438-43	J:81772	12552113
92288	Exclusion of Madh2, Madh4, and Madh7 as candidates for the modifier of Min 2 ( Mom2) locus.		Silverman KA; Koratkar RA; Siracusa LD; Buchberg AM		Mamm Genome	14	2003	119-29	J:81868	12584607
92289	Expression profiling of mouse endometrial cancers microdissected from ethanol-fixed, paraffin-embedded tissues.		Kabbarah O; Pinto K; Mutch DG; Goodfellow PJ		Am J Pathol	162	2003	755-62	J:81936	12598310
92290	Role of connexin32 and beta-catenin in tumor promotion in mouse liver.		Schwarz M; Wanke I; Wulbrand U; Moennikes O; Buchmann A		Toxicol Pathol	31	2003	99-102	J:81937	12597453
92291	A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model.		Suttie A; Nyska A; Haseman JK; Moser GJ; Hackett TR; Goldsworthy TL		Toxicol Pathol	31	2003	31-8	J:81938	12597447
92292	Pentachlorophenol (but not phenobarbital) promotes intrahepatic biliary cysts induced by diethylnitrosamine to cholangio cystic neoplasms in B6C3F1 mice possibly due to oxidative stress.		Umemura T; Kodama Y; Kanki K; Iatropoulos MJ; Nishikawa A; Hirose M; Williams GM		Toxicol Pathol	31	2003	10-3	J:81939	12597444
92293	Molecular Alterations and Lung Tumors in p53 Mutant Mice Exposed to Cigarette Smoke.		De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M		Cancer Res	63	2003	793-800	J:81941	12591728
92294	p53-independent Response to Cisplatin and Oxaliplatin in MMTV-ras Mouse Salivary Tumors.		Petit T; Bearss DJ; Troyer DA; Munoz RM; Windle JJ		Mol Cancer Ther	2	2003	165-71	J:81944	12589033
92295	1,3-Butadiene: exposure estimation, hazard characterization, and exposure-response analysis.		Hughes K; Meek ME; Walker M; Beauchamp R		J Toxicol Environ Health B Crit Rev	6	2003	55-83	J:81945	12587254
92296	Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.		Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H		Cancer Res	63	2003	1583-8	J:82650	12670908
92297	Coordinated regulation of life and death by RB.		Chau BN; Wang JY		Nat Rev Cancer	3	2003	130-8	J:82690	12563312
92298	Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis.		Geisen C; Karsunky H; Yucel R; Moroy T		Oncogene	22	2003	1724-9	J:82785	12642875
92299	Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models.		Seril DN; Liao J; Yang GY; Yang CS		Carcinogenesis	24	2003	353-62	J:82854	12663492
92300	Fragments of the simian virus 40 transforming gene facilitate transformation of rat embryo cells.		Colby WW; Shenk T		Proc Natl Acad Sci U S A	79	1982	5189-93	J:82816	6291029
92301	Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells.		Daniel D; Meyer-Morse N; Bergsland EK; Dehne K; Coussens LM; Hanahan D		J Exp Med	197	2003	1017-28	J:82978	12695493
92302	Induction of tumors in mice by genomic hypomethylation.		Gaudet F; Hodgson JG; Eden A; Jackson-Grusby L; Dausman J; Gray JW; Leonhardt H; Jaenisch R		Science	300	2003	489-92	J:82979	12702876
92303	Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms.		Mai V; Colbert LH; Berrigan D; Perkins SN; Pfeiffer R; Lavigne JA; Lanza E; Haines DC; Schatzkin A; Hursting SD		Cancer Res	63	2003	1752-5	J:82980	12702556
92304	Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.		Johnson JJ; Chen W; Hudson W; Yao Q; Taylor M; Rabbitts TH; Kersey JH		Blood	101	2003	3229-35	J:82943	12515728
92305	Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth.		Pegg AE; Feith DJ; Fong LY; Coleman CS; O'Brien TG; Shantz LM		Biochem Soc Trans	31	2003	356-60	J:82944	12653638
92306	Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant kras in transgenic mice.		Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP		Cancer Res	63	2003	2016-9	J:83055	12727811
92307	Analyzing tumor suppressor activities in the murine small intestine.		Clarke AR; Sansom OJ		Oncol Res	13	2003	333-7	J:83056	12725522
92308	Chemoprevention for colorectal tumorigenesis associated with chronic colitis in mice via apoptosis.		Orii S; Yamaguchi T; Anzai H; Saito S; Chiba T; Suzuki K		J Exp Clin Cancer Res	22	2003	41-6	J:83057	12725321
92309	Mice Lacking the Giant Protocadherin mFAT1 Exhibit Renal Slit Junction Abnormalities and a Partially Penetrant Cyclopia and Anophthalmia Phenotype.		Ciani L; Patel A; Allen ND; Ffrench-Constant C		Mol Cell Biol	23	2003	3575-82	J:83058	12724416
92310	Inhibition of papilloma formation by analogues of 7,8-dihydroretinoic Acid.		Shealy YF; Riordan JM; Frye JL; Simpson-Herren L; Sani BP; Hill DL		J Med Chem	46	2003	1931-9	J:83059	12723955
92311	Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.		Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW		Mol Carcinog	37	2003	51-9	J:83060	12720300
92312	Genetic engineering to study testicular tumorigenesis.		Yan W; Burns KH; Matzuk MM		APMIS	111	2003	174-81; discussion 182-3	J:83018	12760377
92313	Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.		Bergers G; Song S; Meyer-Morse N; Bergsland E; Hanahan D		J Clin Invest	111	2003	1287-95	J:83089	12727920
92314	Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.		Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ		Cancer Res	63	2003	2256-67	J:83091	12727848
92315	The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.		Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK		Cancer Res	63	2003	2005-9	J:83092	12727809
92316	Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.		Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL		Mol Cell	11	2003	905-14	J:83093	12718877
92317	Protective Effects of Tomato Juice on Mouse Skin Carcinogenesis.		De S; Das S		Asian Pac J Cancer Prev	2	2001	43-47	J:83094	12718653
92318	Lack of Carcinogenic Sensitivity of the Glandular Stomach in Heterozygous p53 Knockout Mice Given N-Methyl-N-Nitrosourea in their Drinking Water for 26 Weeks.		Takagi H; Mitsumori K; Nishikawa A; Onodera H; Furukawa F; Kasahara KI; Hirose M		Asian Pac J Cancer Prev	1	2000	299-303	J:83095	12716304
92319	Inhibition of N-ethyl-N'-nitro-N-nitrosoguanidine-induced Duodenal Tumorigenesis in Mice by Whole-leaf Aloe arborescens Miller var. natalensis Berger.		Shimpo K; Chikako T; Shinzato M; Beppu H; Kaneko T; Ida C; Kawai K; Hirono I; Shamoto M; Nagatsu T; Kuzuya H		Asian Pac J Cancer Prev	1	2000	283-288	J:83096	12716301
92320	Inhibitory Effects of Heated Garlic on N-Ethyl-N'-nitro-N-nitrosoguanidine-induced Carcinogenesis in the Duodenum and Jejunum of C57BL/6 Mice.		Shimpo K; Chihara T; Kaneko T; Shinzato M; Beppu H; Hoshino M; Ida C; Shamoto M; Kuzuya H		Asian Pac J Cancer Prev	3	2002	339-344	J:83097	12716292
92321	Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage. Version 5.		Friedberg EC; Meira LB		DNA Repair (Amst)	2	2003	501-30	J:83229	12713810
92322	Characterization and chromosomal instability of novel derived cell lines from a wt-erbB-2 transgenic mouse model.		Jeruss JS; Liu NX; Chung Y; Magrane G; Waldman F; Edgerton S; Yang X; Thor AD		Carcinogenesis	24	2003	659-64	J:83359	12727793
92323	Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643.		Iida M; Anna CH; Hartis J; Bruno M; Wetmore B; Dubin JR; Sieber S; Bennett L; Cunningham ML; Paules RS; Tomer KB; Houle CD; Merrick AB; Sills RC; Devereux TR		Carcinogenesis	24	2003	757-70	J:83360	12727805
92324	Subversion of the innate immune system by a retrovirus.		Jude BA; Pobezinskaya Y; Bishop J; Parke S; Medzhitov RM; Chervonsky AV; Golovkina TV		Nat Immunol	4	2003	573-8	J:83088	12730691
92325	LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice.		Cappello P; Triebel F; Iezzi M; Caorsi C; Quaglino E; Lollini PL; Amici A; Di Carlo E; Musiani P; Giovarelli M; Forni G		Cancer Res	63	2003	2518-25	J:83494	12750275
92326	Hormonal and Dietary Modulation of Mammary Carcinogenesis in Mouse Mammary Tumor Virus-c-erbB-2 Transgenic Mice.		Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD		Cancer Res	63	2003	2425-33	J:83495	12750262
92327	Adenoma multiplicity in irradiated apc(min) mice is modified by chromosome 16 segments from BALB/c.		Degg NL; Weil MM; Edwards A; Haines J; Coster M; Moody J; Ellender M; Cox R; Silver A		Cancer Res	63	2003	2361-3	J:83497	12750251
92328	Disruption of protein kinase ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis.		Chida K; Hara T; Hirai T; Konishi C; Nakamura K; Nakao K; Aiba A; Katsuki M; Kuroki T		Cancer Res	63	2003	2404-8	J:83498	12750259
92329	IL-1alpha, Innate Immunity, and Skin Carcinogenesis: The Effect of Constitutive Expression of IL-1alpha in Epidermis on Chemical Carcinogenesis.		Murphy JE; Morales RE; Scott J; Kupper TS		J Immunol	170	2003	5697-703	J:83467	12759452
92330	Long-term high-dose interferon-alpha therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice.		Merle P; Barraud L; Lefrancois L; Chevallier M; Guerret S; Maisonnas M; Bordes I; Savre-Train I; Trepo C; Vitvitski-Trepo L		Oncogene	22	2003	2762-71	J:83468	12743599
92331	Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase.		Sommer G; Agosti V; Ehlers I; Rossi F; Corbacioglu S; Farkas J; Moore M; Manova K; Antonescu CR; Besmer P		Proc Natl Acad Sci U S A	100	2003	6706-11	J:83616	12754375
92332	Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis.		Shim GJ; Wang L; Andersson S; Nagy N; Kis LL; Zhang Q; Makela S; Warner M; Gustafsson JA		Proc Natl Acad Sci U S A	100	2003	6694-9	J:83617	12740446
92333	Alterations in fas expression are characteristic of, but not solely responsible for, enhanced metastatic competence.		Liu K; Abrams SI		J Immunol	170	2003	5973-80	J:83715	12794124
92334	HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.		Klein A; Guhl E; Tzeng YJ; Fuhrhop J; Levrero M; Graessmann M; Graessmann A		Oncogene	22	2003	2910-9	J:83717	12771941
92335	Adenoma growth stimulation by the trans-10, cis-12 isomer of conjugated linoleic acid (CLA) is associated with changes in mucosal NF-kappaB and cyclin D1 protein levels in the Min mouse.		Rajakangas J; Basu S; Salminen I; Mutanen M		J Nutr	133	2003	1943-8	J:83718	12771343
92336	Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells.		Chen D; Xia J; Tanaka Y; Chen H; Koido S; Wernet O; Mukherjee P; Gendler SJ; Kufe D; Gong J		Immunology	109	2003	300-7	J:83723	12757626
92337	Engineering cancer resistance in mice.		Klatt P; Serrano M		Carcinogenesis	24	2003	817-26	J:83797	12771024
92338	Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.		Meyer K; Lee JS; Dyck PA; Cao WQ; Rao MS; Thorgeirsson SS; Reddy JK		Carcinogenesis	24	2003	975-84	J:83798	12771043
92339	Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas.		Doll JA; Stellmach VM; Bouck NP; Bergh AR; Lee C; Abramson LP; Cornwell ML; Pins MR; Borensztajn J; Crawford SE		Nat Med	9	2003	774-80	J:83748	12740569
92340	Angiogenesis: Tumorigenesis and the angiogenic switch.		Bergers G; Benjamin LE		Nat Rev Cancer	3	2003	401-10	J:83837	12778130
92341	Induction of angiogenesis during the transition from hyperplasia to neoplasia.		Folkman J; Watson K; Ingber D; Hanahan D		Nature	339	1989	58-61	J:83939	2469964
92342	Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis.		Elson DA; Riley RR; Lacey A; Thordarson G; Talamantes FJ; Arbeit JM		Cancer Res	60	2000	1267-75	J:83941	10728686
92343	Phospholipase Cdelta1 is required for skin stem cell lineage commitment.		Nakamura Y; Fukami K; Yu H; Takenaka K; Kataoka Y; Shirakata Y; Nishikawa S; Hashimoto K; Yoshida N; Takenawa T		EMBO J	22	2003	2981-91	J:83948	12805213
92344	Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase.		Ellies LG; Fishman M; Hardison J; Kleeman J; Maglione JE; Manner CK; Cardiff RD; MacLeod CL		Int J Cancer	106	2003	1-7	J:84004	12794750
92345	10 years of mouse cancer modifier Loci: human relevance.		Dragani TA		Cancer Res	63	2003	3011-8	J:83966	12810618
92346	Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.		Saukkonen K; Tomasetto C; Narko K; Rio MC; Ristimaki A		Cancer Res	63	2003	3032-6	J:83968	12810622
92347	Inhibition of the Development of Metastatic Squamous Cell Carcinoma in Protein Kinase C epsilon Transgenic Mice by alpha-Difluoromethylornithine Accompanied by Marked Hair Follicle Degeneration and Hair Loss.		Wheeler DL; Ness KJ; Oberley TD; Verma AK		Cancer Res	63	2003	3037-42	J:83969	12810623
92348	Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines.		Wang M; Lemon WJ; Liu G; Wang Y; Iraqi FA; Malkinson AM; You M		Cancer Res	63	2003	3317-24	J:83970	12810665
92349	The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis.		Xue C; Plieth D; Venkov C; Xu C; Neilson EG		Cancer Res	63	2003	3386-94	J:83971	12810675
92350	Molecular genetics of prostate cancer.		Abate-Shen C; Shen MM		Genes Dev	14	2000	2410-34	J:84064	11018010
92351	Distinct signaling requirements for Dmu selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression in B cell progenitors.		Hayashi K; Yamamoto M; Nojima T; Goitsuka R; Kitamura D		Immunity	18	2003	825-36	J:84040	12818163
92352	Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis.		Ding W; Beissert S; Deng L; Miranda E; Cassetty C; Seiffert K; Campton KL; Yan Z; Murphy GF; Bluestone JA; Granstein RD		J Clin Invest	111	2003	1923-31	J:84044	12813028
92353	Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant mice.		Gould TD; Gray NA; Manji HK		Pharmacol Res	48	2003	49-53	J:84200	12770514
92354	Magnetic resonance imaging of gastric cancer in Tff1 knock-out mice.		Berr SS; Roche JK; El-Rifai W; Smith MF Jr; Powell SM		Magn Reson Med	49	2003	1033-6	J:84201	12768581
92355	Mutation analysis of vinyl carbamate or urethane induced lung tumors in rasH2 transgenic mice.		Tomisawa M; Suemizu H; Ohnishi Y; Maruyama C; Urano K; Usui T; Yasuhara K; Tamaoki N; Mitsumori K		Toxicol Lett	142	2003	111-7	J:84202	12765245
92356	Expression of matrix metalloproteinase, tissue inhibitors of metalloproteinase and adhesion molecules in silicotic mice with lung tumor metastasis.		Ishihara Y; Nishikawa T; Iijima H; Matsunaga K		Toxicol Lett	142	2003	71-5	J:84203	12765241
92357	Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model.		Dupuy E; Hainaud P; Villemain A; Bodevin-Phedre E; Brouland JP; Briand P; Tobelem G		J Hepatol	38	2003	793-802	J:84204	12763373
92358	Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.		Luke JJ; Van De Wetering CI; Knudson CM		Cell Death Differ	10	2003	740-8	J:84205	12761582
92359	Natural History of Helicobacter hepaticus Infection in Conventional A/J Mice, with Special Reference to Liver Involvement.		Avenaud P; Le Bail B; Mayo K; Marais A; Fawaz R; Bioulac-Sage P; Megraud F		Infect Immun	71	2003	3667-72	J:84206	12761159
92360	DNA damage responses and chemosensitivity in the E mu-myc mouse lymphoma model.		Schmitt CA; Wallace-Brodeur RR; Rosenthal CT; McCurrach ME; Lowe SW		Cold Spring Harb Symp Quant Biol	65	2000	499-510	J:84207	12760067
92361	Generation of tumors in transgenic mice expressing the SV40 T antigen under the control of ovarian-specific promoter 1.		Garson K; Macdonald E; Dube M; Bao R; Hamilton TC; Vanderhyden BC		J Soc Gynecol Investig	10	2003	244-50	J:84208	12759154
92362	Cancer preventive potential of trichothecenes from Trichothecium roseum.		Konishi K; Iida A; Kaneko M; Tomioka K; Tokuda H; Nishino H; Kumeda Y		Bioorg Med Chem	11	2003	2511-8	J:84209	12757719
92363	Genetic differences in aryl hydrocarbon hydroxylase induction and benzo(a)pyrene-produced tumorigenesis in the mouse.		Benedict WF; Considine N; Nebert DW		Mol Pharmacol	9	1973	266-77	J:84312	4123113
92364	2,3,7,8-tetrachlorodibenzo-p-dioxin as cocarcinogen causing 3-methylcholanthrene-initiated subcutaneous tumors in mice genetically 'nonresponsive' at Ah locus.		Kouri RE; Rude TH; Joglekar R; Dansette PM; Jerina DM; Atlas SA; Owens IS; Nebert DW		Cancer Res	38	1978	2777-83	J:84318	679184
92365	Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.		Sage J; Miller AL; Perez-Mancera PA; Wysocki JM; Jacks T		Nature	424	2003	223-8	J:84407	12853964
92366	BALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- mice.		Blackburn AC; Brown JS; Naber SP; Otis CN; Wood JT; Jerry DJ		Cancer Res	63	2003	2364-8	J:83496	12750252
92367	Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma.		Kelly JA; Spolski R; Kovanen PE; Suzuki T; Bollenbacher J; Pise-Masison CA; Radonovich MF; Lee S; Jenkins NA; Copeland NG; Morse HC rd; Leonard WJ		J Exp Med	198	2003	79-89	J:84460	12835478
92368	Bruton's Tyrosine Kinase Cooperates with the B Cell Linker Protein SLP-65 as a Tumor Suppressor in Pre-B Cells.		Kersseboom R; Middendorp S; Dingjan GM; Dahlenborg K; Reth M; Jumaa H; Hendriks RW		J Exp Med	198	2003	91-8	J:84461	12835482
92369	Functional analysis of tumor suppressor genes in mice.		Jones S; Donehower L		Methods Mol Biol	223	2003	283-314	J:84521	12777738
92370	Role of tumor suppressors in DNA damage response.		Zhou BB; Mattern M; Khanna K		Methods Mol Biol	223	2003	39-50	J:84522	12777719
92371	Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis.		Zoumpourlis V; Solakidi S; Papathoma A; Papaevangeliou D		Carcinogenesis	24	2003	1159-65	J:84488	12807763
92372	Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation.		Mittal A; Elmets CA; Katiyar SK		Carcinogenesis	24	2003	1379-88	J:84489	12807737
92373	Radiation-induced deletions in the 5' end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas.		Tsuji H; Ishii-Ohba H; Ukai H; Katsube T; Ogiu T		Carcinogenesis	24	2003	1257-68	J:84492	12807718
92374	The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo.		Macdiarmid J; Stevenson D; Campbell DH; Wilson JB		Carcinogenesis	24	2003	1209-18	J:84493	12807717
92375	Renal and blood pressure phenotype in 18-mo-old bradykinin B2R(-/-)CRD mice.		Harrison-Bernard LM; Dipp S; El-Dahr SS		Am J Physiol Regul Integr Comp Physiol	285	2003	R782-90	J:84494	12805091
92376	Chemical peeling with salicylic acid in polyethylene glycol vehicle suppresses skin tumour development in hairless mice.		Dainichi T; Ueda S; Isoda M; Koga T; Kinukawa N; Nose Y; Ishii K; Amano S; Horii I; Furue M		Br J Dermatol	148	2003	906-12	J:84495	12786820
92377	Neoplastic development in plasma cells.		Potter M		Immunol Rev	194	2003	177-95	J:84565	12846815
92378	Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo.		Baron V; De Gregorio G; Krones-Herzig A; Virolle T; Calogero A; Urcis R; Mercola D		Oncogene	22	2003	4194-204	J:84566	12833142
92379	Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice.		Gutmann DH; Winkeler E; Kabbarah O; Hedrick N; Dudley S; Goodfellow PJ; Liskay RM		Oncogene	22	2003	4581-5	J:84658	12881715
92380	Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.		Pirkmaier A; Dow R; Ganiatsas S; Waring P; Warren K; Thompson A; Hendley J; Germain D		Oncogene	22	2003	4425-33	J:84631	12853979
92381	Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice.		Almholt K; Nielsen BS; Frandsen TL; Brunner N; Dano K; Johnsen M		Oncogene	22	2003	4389-97	J:84633	12853975
92382	Hypertrophic neuropathies and malignant peripheral nerve sheath tumors in transgenic mice overexpressing glial growth factor beta3 in myelinating Schwann cells.		Huijbregts RP; Roth KA; Schmidt RE; Carroll SL		J Neurosci	23	2003	7269-80	J:84874	12917360
92383	Pulmonary expression of leukemia inhibitory factor induces B cell hyperplasia and confers protection in hyperoxia.		Wang J; Chen Q; Corne J; Zhu Z; Lee CG; Bhandari V; Homer RJ; Elias JA		J Biol Chem	278	2003	31226-32	J:84881	12782633
92384	Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX.		Bassing CH; Chua KF; Sekiguchi J; Suh H; Whitlow SR; Fleming JC; Monroe BC; Ciccone DN; Yan C; Vlasakova K; Livingston DM; Ferguson DO; Scully R; Alt FW		Proc Natl Acad Sci U S A	99	2002	8173-8	J:84909	12034884
92385	Forestomach tumor induction by 2,4-hexadienal in F344N rats and B6C3F1 mice.		Chan PC; Mahler J; Peddada S; Lomnitski L; Nyska A		Arch Toxicol	77	2003	511-20	J:84985	12879212
92386	Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice.		Rose-Hellekant TA; Arendt LM; Schroeder MD; Gilchrist K; Sandgren EP; Schuler LA		Oncogene	22	2003	4664-74	J:84986	12879011
92387	Variations in Prkdc and susceptibility to benzene-induced toxicity in mice.		Faiola B; Bauer AK; Fuller ES; Wong VA; Pluta LJ; Abernethy DJ; Mangum JB; Everitt JI; Recio L		Toxicol Sci	75	2003	321-32	J:84988	12857942
92388	Sexually dimorphic roles of steroid hormone receptor signaling in gonadal tumorigenesis.		Burns KH; Agno JE; Chen L; Haupt B; Ogbonna SC; Korach KS; Matzuk MM		Mol Endocrinol	17	2003	2039-52	J:84989	12855748
92389	Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.		Burns KH; Agno JE; Sicinski P; Matzuk MM		Mol Endocrinol	17	2003	2053-69	J:84990	12855747
92390	Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-alpha-stimulated STAT2-independent production of IFN-gamma in the brain.		Wang J; Pham-Mitchell N; Schindler C; Campbell IL		J Clin Invest	112	2003	535-43	J:85154	12925694
92391	Mouse models for genetic dissection of polygenic gastrointestinal diseases.		Hillebrandt S; Matern S; Lammert F		Eur J Clin Invest	33	2003	155-60	J:85237	12588290
92392	The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer.		Girardi M; Glusac E; Filler RB; Roberts SJ; Propperova I; Lewis J; Tigelaar RE; Hayday AC		J Exp Med	198	2003	747-55	J:85334	12953094
92393	E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas.		Ziebold U; Lee EY; Bronson RT; Lees JA		Mol Cell Biol	23	2003	6542-52	J:85441	12944480
92394	Inappropriate P-cadherin expression in the mouse mammary epithelium is compatible with normal mammary gland function.		Radice GL; Sauer CL; Kostetskii I; Peralta Soler A; Knudsen KA		Differentiation	71	2003	361-73	J:85551	12919105
92395	Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis.		Hurlin PJ; Zhou ZQ; Toyo-oka K; Ota S; Walker WL; Hirotsune S; Wynshaw-Boris A		EMBO J	22	2003	4584-96	J:85481	12970171
92396	Preinfection treatment of resistant mice with CpG oligodeoxynucleotides renders them susceptible to friend retrovirus-induced leukemia.		Olbrich AR; Schimmer S; Dittmer U		J Virol	77	2003	10658-62	J:85584	12970451
92397	Mouse strain susceptibility to gonadectomy-induced adrenocortical tumor formation correlates with the expression of GATA-4 and luteinizing hormone receptor.		Bielinska M; Parviainen H; Porter-Tinge SB; Kiiveri S; Genova E; Rahman N; Huhtaniemi IT; Muglia LJ; Heikinheimo M; Wilson DB		Endocrinology	144	2003	4123-33	J:85587	12933687
92398	Driving the cell cycle to cancer.		Malumbres M; Hunt SL; Sotillo R; Martin J; Odajima J; Martin A; Dubus P; Ortega S; Barbacid M		Adv Exp Med Biol	532	2003	1-11	J:85695	12908544
92399	Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.		McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH		Cancer Res	63	2003	4594-601	J:85696	12907637
92400	Opposite effects of modifiers of the ApcMin mutation in intestine and mammary gland.		Czarnomska A; Krysiak E; Piskorowska J; Sitarz M; Pysniak K; Pilcik T; Demant P		Cancer Res	63	2003	4533-7	J:85697	12907628
92401	Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.		Vax VV; Bibi R; Diaz-Cano S; Gueorguiev M; Kola B; Borboli N; Bressac-de Paillerets B; Walker GJ; Dedov II; Grossman AB; Korbonits M		J Endocrinol	178	2003	301-10	J:85698	12904177
92402	Mouse skin as a model for cancer chemoprevention by nonsteroidal anti-inflammatory drugs.		Marks F; Furstenberger G; Neufang G; Muller-Decker K		Recent Results Cancer Res	163	2003	46-57; discussion 264-6	J:85699	12903842
92403	Novel approaches to identify low-penetrance cancer susceptibility genes using mouse models.		de Koning JP; Mao JH; Balmain A		Recent Results Cancer Res	163	2003	19-27; discussion 264-6	J:85700	12903840
92404	Rofecoxib (vioxx), a specific cyclooxygenase-2 inhibitor, is chemopreventive in a mouse model of colon cancer.		Evans JF		Am J Clin Oncol	26	2003	S62-5	J:85701	12902858
92405	HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augment CD8+ T cell effector function and tumor-free survival in Her-2/neu-transgenic mice.		Wolpoe ME; Lutz ER; Ercolini AM; Murata S; Ivie SE; Garrett ES; Emens LA; Jaffee EM; Reilly RT		J Immunol	171	2003	2161-9	J:85703	12902523
92406	Indian hedgehog and beta-catenin signaling: role in the sebaceous lineage of normal and neoplastic mammalian epidermis.		Niemann C; Unden AB; Lyle S; Zouboulis ChC; Toftgard R; Watt FM		Proc Natl Acad Sci U S A	100 Suppl 1	2003	11873-80	J:85704	12917489
92407	Gene expression analysis on small numbers of invasive cells collected by chemotaxis from primary mammary tumors of the mouse.		Wang W; Wyckoff JB; Wang Y; Bottinger EP; Segall JE; Condeelis JS		BMC Biotechnol	3	2003	13	J:85705	12914671
92408	Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-beta1.		Chabicovsky M; Wastl U; Taper H; Grasl-Kraupp B; Schulte-Hermann R; Bursch W		J Cancer Res Clin Oncol	129	2003	536-42	J:85706	12905009
92409	Mouse mammary tumor viruses expressed by RIII/Sa mice with a high incidence of mammary tumors interact with the V beta-2- and V beta-8-specific T cells during viral infection.		Uz-Zaman T; Ignatowicz L; Sarkar NH		Virology	314	2003	294-304	J:85844	14517082
92410	HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice.		Manjili MH; Wang XY; Chen X; Martin T; Repasky EA; Henderson R; Subjeck JR		J Immunol	171	2003	4054-61	J:85932	14530326
92411	Transgenic tumor models for carcinogen identification: the heterozygous Trp53-deficient and RasH2 mouse lines.		Storer RD; French JE; Donehower LA; Gulezian D; Mitsumori K; Recio L; Schiestl RH; Sistare FD; Tamaoki N; Usui T; van Steeg H		Mutat Res	540	2003	165-76	J:86063	14550500
92412	Expression of hepatoma-derived growth factor in hepatocarcinogenesis.		Yoshida K; Nakamura H; Okuda Y; Enomoto H; Kishima Y; Uyama H; Ito H; Hirasawa T; Inagaki S; Kawase I		J Gastroenterol Hepatol	18	2003	1293-1301	J:86064	14535987
92413	Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).		Tolg C; Poon R; Fodde R; Turley EA; Alman BA		Oncogene	22	2003	6873-82	J:86065	14534534
92414	Development of T-cell lymphomas in Emu-IEX-1 mice.		Zhang Y; Finegold MJ; Porteu F; Kanteti P; Wu MX		Oncogene	22	2003	6845-6851	J:86066	14534530
92415	Teratogenic effect of broad-band electromagnetic field on neonatal mice (Mus musculus).		Gagnon ZE; Newkirk C; Conetta JA; Sama MA; Sisselman S		J Environ Sci Health Part A Tox Hazard Subst Environ Eng	38	2003	2465-81	J:86067	14533916
92416	Carcinogenicity of bisphenol-A in Fischer rats and B6C3F1 mice.		Huff J		Odontology	89	2001	12-20	J:86068	14530916
92417	Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis.		Yu S; Rao S; Reddy JK		Curr Mol Med	3	2003	561-72	J:86069	14527087
92418	CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice.		Erdman SE; Rao VP; Poutahidis T; Ihrig MM; Ge Z; Feng Y; Tomczak M; Rogers AB; Horwitz BH; Fox JG		Cancer Res	63	2003	6042-50	J:86071	14522933
92419	Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu mice.		Cuadros C; Dominguez AL; Frost GI; Borgstrom P; Lustgarten J		Cancer Res	63	2003	5895-901	J:86072	14522915
92420	Serum levels of surfactant protein D are increased in mice with lung tumors.		Zhang F; Pao W; Umphress SM; Jakowlew SB; Meyer AM; Dwyer-Nield LD; Nielsen LD; Takeda K; Gelfand EW; Fisher JH; Zhang L; Malkinson AM; Mason RJ		Cancer Res	63	2003	5889-94	J:86073	14522914
92421	Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.		Andarawewa KL; Boulay A; Masson R; Mathelin C; Stoll I; Tomasetto C; Chenard MP; Gintz M; Bellocq JP; Rio MC		Cancer Res	63	2003	5844-9	J:86074	14522908
92422	Identification and characterization of CRG-L2, a new marker for liver tumor development.		Graveel CR; Harkins-Perry SR; Acevedo LG; Farnham PJ		Oncogene	22	2003	1730-6	J:86019	12642876
92423	Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.		Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH		Oncogene	21	2002	1325-34	J:86020	11857076
92424	Factors contributory to early death of young CD-1 mice in carcinogenicity studies.		Son WC		Toxicol Lett	145	2003	88-98	J:86095	12962977
92425	Genetic deficiency in Pparg does not alter development of experimental prostate cancer.		Saez E; Olson P; Evans RM		Nat Med	9	2003	1265-1266	J:86096	12960963
92426	Regression of upper gastric cancer in mice by FHIT gene delivery.		Ishii H; Zanesi N; Vecchione A; Trapasso F; Yendamuri S; Sarti M; Baffa R; During MJ; Huebner K; Fong LY; Croce CM		FASEB J	17	2003	1768-70	J:86098	12958204
92427	Aging and cancer in transgenic and mutant mice.		Anisimov VN		Front Biosci	8	2003	s883-902	J:86099	12957819
92428	Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections.		Miller YE; Dwyer-Nield LD; Keith RL; Le M; Franklin WA; Malkinson AM		Cancer Lett	198	2003	139-44	J:86100	12957351
92429	Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context.		Guerra C; Mijimolle N; Dhawahir A; Dubus P; Barradas M; Serrano M; Campuzano V; Barbacid M		Cancer Cell	4	2003	111-20	J:86101	12957286
92430	Mutations and aneuploidy: co-conspirators in cancer?		Pihan G; Doxsey SJ		Cancer Cell	4	2003	89-94	J:86102	12957283
92431	Life and death decisions by E2F-1.		Bell LA; Ryan KM		Cell Death Differ	11	2004	137-42	J:86105	14526389
92432	Inducible expression of BCR/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome.		Huettner CS; Koschmieder S; Iwasaki H; Iwasaki-Arai J; Radomska HS; Akashi K; Tenen DG		Blood	102	2003	3363-70	J:86227	12855552
92433	Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease.		Do Y; Rafi-Janajreh AQ; McKallip RJ; Nagarkatti PS; Nagarkatti M		Int Immunol	15	2003	1327-40	J:86310	14565931
92434	Tumor chemopreventive activity of 3-O-acylated (-)-epigallocatechins.		Kumagai A; Nagaoka Y; Obayashi T; Terashima Y; Tokuda H; Hara Y; Mukainaka T; Nishino H; Kuwajima H; Uesato S		Bioorg Med Chem	11	2003	5143-8	J:86482	14604677
92435	Transgenic and knockout mice for DNA repair functions in carcinogenesis and mutagenesis.		Wijnhoven SW; van Steeg H		Toxicology	193	2003	171-87	J:86483	14599776
92436	Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice.		Li W; Qiao W; Chen L; Xu X; Yang X; Li D; Li C; Brodie SG; Meguid MM; Hennighausen L; Deng CX		Development	130	2003	6143-53	J:86484	14597578
92437	mRNA expression and phenotype of odontogenic tumours in the v-Ha-ras transgenic mouse.		Dodds AP; Cannon RE; Suggs CA; Wright JT		Arch Oral Biol	48	2003	843-50	J:86485	14596874
92438	Transgenic mice over-expressing galanin exhibit pituitary adenomas and increased secretion of galanin, prolactin and growth hormone.		Perumal P; Vrontakis ME		J Endocrinol	179	2003	145-54	J:86486	14596666
92439	Dietary energy restriction in breast cancer prevention.		Thompson HJ; Zhu Z; Jiang W		J Mammary Gland Biol Neoplasia	8	2003	133-42	J:86488	14587868
92440	Tnfa and Il-10 deficiencies have contrasting effects on lung tumor susceptibility: Gender-dependent modulation of IL-10 haploinsufficiency.		Bernert H; Sekikawa K; Radcliffe RA; Iraqi F; You M; Malkinson AM		Mol Carcinog	38	2003	117-23	J:86489	14587096
92441	Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase.		Turner SD; Tooze R; Maclennan K; Alexander DR		Oncogene	22	2003	7750-61	J:86490	14586401
92442	Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice.		Hora JJ; Maydew ER; Lansky EP; Dwivedi C		J Med Food	6	2003	157-61	J:86491	14585180
92443	The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice.		Lyons SK; Meuwissen R; Krimpenfort P; Berns A		Cancer Res	63	2003	7042-6	J:86565	14612492
92444	Targeted expression of activated Rac3 in mammary epithelium leads to defective postlactational involution and benign mammary gland lesions.		Leung K; Nagy A; Gonzalez-Gomez I; Groffen J; Heisterkamp N; Kaartinen V		Cells Tissues Organs	175	2003	72-83	J:86529	14605486
92445	Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.		Terabe M; Matsui S; Park JM; Mamura M; Noben-Trauth N; Donaldson DD; Chen W; Wahl SM; Ledbetter S; Pratt B; Letterio JJ; Paul WE; Berzofsky JA		J Exp Med	198	2003	1741-52	J:86808	14657224
92446	Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.		Bajenaru ML; Hernandez MR; Perry A; Zhu Y; Parada LF; Garbow JR; Gutmann DH		Cancer Res	63	2003	8573-7	J:87063	14695164
92447	BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.		Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S		Cancer Res	63	2003	8656-63	J:87064	14695177
92448	TIP30 deficiency increases susceptibility to tumorigenesis.		Ito M; Jiang C; Krumm K; Zhang X; Pecha J; Zhao J; Guo Y; Roeder RG; Xiao H		Cancer Res	63	2003	8763-7	J:87066	14695192
92449	Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.		Jin C; McKeehan K; Guo W; Jauma S; Ittmann MM; Foster B; Greenberg NM; McKeehan WL; Wang F		Cancer Res	63	2003	8784-90	J:87067	14695195
92450	Geranylgeranyltransferase I inhibitor GGTI-2154 induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice.		Sun J; Ohkanda J; Coppola D; Yin H; Kothare M; Busciglio B; Hamilton AD; Sebti SM		Cancer Res	63	2003	8922-9	J:87068	14695209
92451	Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors.		Ruzinova MB; Schoer RA; Gerald W; Egan JE; Pandolfi PP; Rafii S; Manova K; Mittal V; Benezra R		Cancer Cell	4	2003	277-89	J:87303	14585355
92452	Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis.		Thayer SP; di Magliano MP; Heiser PW; Nielsen CM; Roberts DJ; Lauwers GY; Qi YP; Gysin S; Fernandez-del Castillo C; Yajnik V; Antoniu B; McMahon M; Warshaw AL; Hebrok M		Nature	425	2003	851-6	J:87305	14520413
92453	Activating Smoothened mutations in sporadic basal-cell carcinoma.		Xie J; Murone M; Luoh SM; Ryan A; Gu Q; Zhang C; Bonifas JM; Lam CW; Hynes M; Goddard A; Rosenthal A; Epstein EH Jr; de Sauvage FJ		Nature	391	1998	90-2	J:87306	9422511
92454	p53-independent functions of MDM2.		Ganguli G; Wasylyk B		Mol Cancer Res	1	2003	1027-35	J:87254	14707286
92455	Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival.		Hernandez I; Maddison LA; Wei Y; DeMayo F; Petras T; Li B; Gingrich JR; Rosen JM; Greenberg NM		Mol Cancer Res	1	2003	1036-47	J:87255	14707287
92456	Early parity significantly elevates mammary tumor incidence in MMTV-c-myc transgenic mice.		Jamerson MH; Johnson MD; Furth PA; Dickson RB		Transgenic Res	12	2003	747-50	J:87257	14713205
92457	Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.		Braun BS; Tuveson DA; Kong N; Le DT; Kogan SC; Rozmus J; Le Beau MM; Jacks TE; Shannon KM		Proc Natl Acad Sci U S A	101	2004	597-602	J:87429	14699048
92458	Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.		Chang SH; Liu CH; Conway R; Han DK; Nithipatikom K; Trifan OC; Lane TF; Hla T		Proc Natl Acad Sci U S A	101	2004	591-6	J:87430	14688410
92459	Caloric restriction and insulin-like growth factors in aging and cancer.		Sell CH		Horm Metab Res	35	2003	705-11	J:87383	14710349
92460	Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule.		Ali O; Cohen P; Lee KW		Horm Metab Res	35	2003	726-33	J:87384	14710351
92461	Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice.		Liu G; Parant JM; Lang G; Chau P; Chavez-Reyes A; El-Naggar AK; Multani A; Chang S; Lozano G		Nat Genet	36	2004	63-68	J:87501	14702042
92462	RIII/Sa Mice with a High Incidence of Mammary Tumors Express Two Exogenous Strains and One Potential Endogenous Strain of Mouse Mammary Tumor Virus. (Erratum v 78(7):3803)		Sarkar NH; Golovkina T; Uz-Zaman T		J Virol	78	2004	1055-62	J:87504	14694140
92463	The Cyclooxygenase-2 Inhibitor, Celecoxib, Prevents the Development of Mammary Tumors in HER-2/neu Mice.		Lanza-Jacoby S; Miller S; Flynn J; Gallatig K; Daskalakis C; Masferrer JL; Zweifel BS; Sembhi H; Russo IH		Cancer Epidemiol Biomarkers Prev	12	2003	1486-1491	J:87505	14693742
92464	Stage-dependent expression of an angiogenic agent and vascular organization in experimental skin tumor development.		Nayha V; Laitakari J; Stenback F		Toxicol Pathol	31	2003	539-48	J:87506	14692622
92465	Inhibition by ethinylestradiol of N-ethyl-N-nitrosourea-initiated uterine carcinogenesis in transgenic mice carrying a human prototype C-Ha-ras gene (rasH2 mice).		Watanabe T; Kashida Y; Ueda M; Onodera H; Takizawa T; Hirose M; Mitsumori K		Toxicol Pathol	31	2003	496-505	J:87507	14692618
92466	Mutation and overexpression of the transgene in ethylnitrosourea-induced tumors in mice carrying a human prototype c-Ha-ras gene.		Toyosawa K; Tanaka K; Imai T; Yasuhara K; Koujitani T; Hirose M; Mitsumori K		Toxicol Pathol	31	2003	491-5	J:87508	14692617
92467	Spontaneous acute tumor lysis syndrome in a DBA/1J mouse: a case report and review.		Lovelace K; vanGessel Y; Asher LV; Vogel P		Toxicol Pathol	31	2003	486-90	J:87509	14692616
92468	Comparison of the Chemopreventive Efficacies of 1,4-phenylenebis(methylene)selenocyanate and Selenium-Enriched Yeast on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Induced Lung Tumorigenesis in A/J Mouse.		Das A; Desai D; Pittman B; Amin S; El-Bayoumy K		Nutr Cancer	46	2003	179-85	J:87511	14690794
92469	Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer.		Zukerberg LR; DeBernardo RL; Kirley SD; D'Apuzzo M; Lynch MP; Littell RD; Duska LR; Boring L; Rueda BR		Cancer Res	64	2004	202-8	J:87478	14729625
92470	Glycine-extended gastrin promotes the growth of lung cancer.		Koh TJ; Field JK; Varro A; Liloglou T; Fielding P; Cui G; Houghton J; Dockray GJ; Wang TC		Cancer Res	64	2004	196-201	J:87479	14729624
92471	Angiogenic acceleration of Neu induced mammary tumor progression and metastasis.		Oshima RG; Lesperance J; Munoz V; Hebbard L; Ranscht B; Sharan N; Muller WJ; Hauser CA; Cardiff RD		Cancer Res	64	2004	169-79	J:87480	14729621
92472	Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.		Harada N; Oshima H; Katoh M; Tamai Y; Oshima M; Taketo MM		Cancer Res	64	2004	48-54	J:87481	14729607
92473	Prevention by methionine of dichloroacetic acid-induced liver cancer and DNA hypomethylation in mice.		Pereira MA; Wang W; Kramer PM; Tao L		Toxicol Sci	77	2004	243-8	J:87545	14657517
92474	Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.		Bhasin G; Kauser H; Athar M		Arch Toxicol	78	2004	283-9	J:87547	14997284
92475	Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis.		Coletta PL; Muller AM; Jones EA; Muhl B; Holwell S; Clarke D; Meade JL; Cook GP; Hawcroft G; Ponchel F; Lam WK; MacLennan KA; Hull MA; Bonifer C; Markham AF		Blood	103	2004	1050-8	J:87640	14525778
92476	Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice.		Wolff L; Garin MT; Koller R; Bies J; Liao W; Malumbres M; Tessarollo L; Powell D; Perella C		Oncogene	22	2003	9265-74	J:87722	14681685
92477	Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele.		Karray S; Kress C; Cuvellier S; Hue-Beauvais C; Damotte D; Babinet C; Levi-Strauss M		J Immunol	172	2004	2118-25	J:87990	14764677
92478	Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation.		King TJ; Lampe PD		Carcinogenesis	25	2004	669-80	J:88130	14742325
92479	Wnt signaling and breast cancer.		Howe LR; Brown AM		Cancer Biol Ther	3	2004	36-41	J:88132	14739782
92480	Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia.		Gitler AD; Kong Y; Choi JK; Zhu Y; Pear WS; Epstein JA		Pediatr Res	55	2004	581-4	J:88133	14739366
92481	Immunological inhibition of carcinogenesis.		Spadaro M; Lanzardo S; Curcio C; Forni G; Cavallo F		Cancer Immunol Immunother	53	2004	204-16	J:88135	14722672
92482	Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma.		Czarneski J; Lin YC; Chong S; McCarthy B; Fernandes H; Parker G; Mansour A; Huppi K; Marti GE; Raveche E		Leukemia	18	2004	597-606	J:88136	14712288
92483	T-bet regulates metastasis rate in a murine model of primary prostate cancer.		Peng SL; Townsend MJ; Hecht JL; White IA; Glimcher LH		Cancer Res	64	2004	452-5	J:88093	14744755
92484	Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency.		Dai W; Wang Q; Liu T; Swamy M; Fang Y; Xie S; Mahmood R; Yang YM; Xu M; Rao CV		Cancer Res	64	2004	440-5	J:88094	14744753
92485	Lung tumor response in strain a mice exposed to tobacco smoke: some dose-effect relationships.		Witschi H; Espiritu I; Uyeminami D; Suffia M; Pinkerton KE		Inhal Toxicol	16	2004	27-32	J:88095	14744662
92486	Identification of molecular targets for dietary energy restriction prevention of skin carcinogenesis: An idea cultivated by Edward Bresnick.		Birt DF; Przybyszewski J; Wang W; Stewart J; Liu Y		J Cell Biochem	91	2004	258-64	J:88096	14743386
92487	Effect of interferon alpha and cell cycle progression on translation mediated by the hepatitis C virus 5' untranslated region: a study using a transgenic mouse model.		Takeda Y; Okoshi S; Suzuki K; Yano M; Gangemi JD; Jay G; Asakura H; Aoyagi Y		J Viral Hepat	11	2004	33-44	J:88098	14738556
92488	Hematopoiesis and retinoids: development and disease.		Oren T; Sher JA; Evans T		Leuk Lymphoma	44	2003	1881-91	J:88099	14738139
92489	Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis.		Zhu H; Wang Y; Chen J; Cheng G; Xue J		Exp Mol Pathol	76	2004	44-50	J:88097	14738868
92490	p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis.		Gao J; Huang HY; Pak J; Cheng J; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR		Oncogene	23	2004	687-96	J:88102	14737103
92491	RTCGD: retroviral tagged cancer gene database.		Akagi K; Suzuki T; Stephens RM; Jenkins NA; Copeland NG		Nucleic Acids Res	32	2004	D523-7	J:87513	14681473
92492	The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases.		Yang XJ		Nucleic Acids Res	32	2004	959-76	J:88392	14960713
92493	Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells.		Lengagne R; Le Gal FA; Garcette M; Fiette L; Ave P; Kato M; Briand JP; Massot C; Nakashima I; Renia L; Guillet JG; Prevost-Blondel A		Cancer Res	64	2004	1496-501	J:88453	14973052
92494	Enhanced tumor formation in cyclin D1 x transforming growth factor beta1 double transgenic mice with characterization by magnetic resonance imaging.		Deane NG; Lee H; Hamaamen J; Ruley A; Washington MK; LaFleur B; Thorgeirsson SS; Price R; Beauchamp RD		Cancer Res	64	2004	1315-22	J:88454	14973059
92495	Mutations in the Trp53 gene of UV-irradiated Xpc mutant mice suggest a novel Xpc-dependent DNA repair process.		Nahari D; McDaniel LD; Task LB; Daniel RL; Velasco-Miguel S; Friedberg EC		DNA Repair (Amst)	3	2004	379-86	J:88558	15010313
92496	Genetic control of myeloproliferation in BXH-2 mice.		Turcotte K; Gauthier S; Mitsos LM; Shustik C; Copeland NG; Jenkins NA; Fournet JC; Jolicoeur P; Gros P		Blood	103	2004	2343-50	J:88564	14630819
92497	VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.		Egle A; Harris AW; Bath ML; O'Reilly L; Cory S		Blood	103	2004	2276-83	J:88565	14630790
92498	Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.		Quaglino E; Rolla S; Iezzi M; Spadaro M; Musiani P; De Giovanni C; Lollini PL; Lanzardo S; Forni G; Sanges R; Crispi S; De Luca P; Calogero R; Cavallo F		J Clin Invest	113	2004	709-17	J:88661	14991069
92499	Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells.		Rooney S; Sekiguchi J; Whitlow S; Eckersdorff M; Manis JP; Lee C; Ferguson DO; Alt FW		Proc Natl Acad Sci U S A	101	2004	2410-5	J:88663	14983023
92500	TGFbeta and Wnt pathway cross-talk.		Attisano L; Labbe E		Cancer Metastasis Rev	23	2004	53-61	J:88745	15000149
92501	Discovery of an innate cancer resistance gene?		Smyth MJ; Kershaw MH		Mol Interv	3	2003	186-9	J:88746	14993445
92502	Detection of murine intestinal adenomas using targeted molecular autofluorescence.		Banerjee B; Henderson JO; Chaney TC; Davidson NO		Dig Dis Sci	49	2004	54-9	J:88747	14992435
92503	Ethanol and aloe emodin alter the p53 mutational spectrum in ultraviolet radiation-induced murine skin tumors.		Badgwell DB; Walker CM; Baker WT; Strickland FM		Mol Carcinog	39	2004	127-38	J:88748	14991742
92504	Carcinogenic potential of commonly used hernia repair prostheses in an experimental model.		Witherspoon P; Bryson G; Wright DM; Reid R; O'Dwyer PJ		Br J Surg	91	2004	368-72	J:88749	14991641
92505	Wnt-cadherin connections in normal and neoplastic mammary epithelium.		Meniel V; Clarke AR		J Mammary Gland Biol Neoplasia	8	2003	435-47	J:88751	14985639
92506	Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.		Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T		Anticancer Res	23	2003	4897-900	J:88752	14981942
92507	High incidence of thymic epithelial tumors in E2F2 transgenic mice.		Scheijen B; Bronk M; van der Meer T; De Jong D; Bernards R		J Biol Chem	279	2004	10476-83	J:88864	14684733
92508	Id proteins in neural cancer.		Iavarone A; Lasorella A		Cancer Lett	204	2004	189-96	J:88940	15013218
92509	Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors.		Galang CK; Muller WJ; Foos G; Oshima RG; Hauser CA		J Biol Chem	279	2004	11281-92	J:88947	14662758
92510	Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion.		Young MR; Li JJ; Rincon M; Flavell RA; Sathyanarayana BK; Hunziker R; Colburn N		Proc Natl Acad Sci U S A	96	1999	9827-32	J:89032	10449779
92511	Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist.		Shepherd J; Little MC; Nicklin MJ		J Invest Dermatol	122	2004	665-9	J:89034	15086551
92512	Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation.		Barthelman M; Chen W; Gensler HL; Huang C; Dong Z; Bowden GT		Cancer Res	58	1998	711-6	J:89040	9485025
92513	Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc(Min) mouse.		Ushida Y; Sekine K; Kuhara T; Takasuka N; Iigo M; Tsuda H		Cancer Lett	134	1998	141-5	J:88991	10025873
92514	Lack of effect of a 60 Hz magnetic field on biomarkers of tumor promotion in the skin of SENCAR mice.		DiGiovanni J; Johnston DA; Rupp T; Sasser LB; Anderson LE; Morris JE; Miller DL; Kavet R; Walborg EF Jr		Carcinogenesis	20	1999	685-9	J:88992	10223200
92515	SNPs in cancer research and treatment.		Erichsen HC; Chanock SJ		Br J Cancer	90	2004	747-51	J:88993	14970847
92516	Host genetics and tumour metastasis.		Hunter KW		Br J Cancer	90	2004	752-5	J:88994	14970848
92517	ALL-1/MLL1, a homologue of Drosophila TRITHORAX, modifies chromatin and is directly involved in infant acute leukaemia.		Canaani E; Nakamura T; Rozovskaia T; Smith ST; Mori T; Croce CM; Mazo A		Br J Cancer	90	2004	756-60	J:88995	14970849
92518	Proteases, extracellular matrix, and cancer: a workshop of the path B study section.		DeClerck YA; Mercurio AM; Stack MS; Chapman HA; Zutter MM; Muschel RJ; Raz A; Matrisian LM; Sloane BF; Noel A; Hendrix MJ; Coussens L; Padarathsingh M		Am J Pathol	164	2004	1131-9	J:89123	15039201
92519	Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.		Song S; Gulliver GA; Lambert PF		Proc Natl Acad Sci U S A	95	1998	2290-5	J:89127	9482878
92520	A delayed chemically induced tumorigenesis in Brca2 mutant mice.		Yan DH; Wen Y; Su LK; Xia W; Wang SC; Zhang S; Gan L; Lee DF; Spohn B; Frey JA; Hortobagyi GN; Hung MC		Oncogene	23	2004	1896-901	J:89083	14981540
92521	Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice.		Tang X; Kim AL; Feith DJ; Pegg AE; Russo J; Zhang H; Aszterbaum M; Kopelovich L; Epstein EH Jr; Bickers DR; Athar M		J Clin Invest	113	2004	867-75	J:89218	15067319
92522	Reduction of Smad3 accelerates re-epithelialization in a murine model of colitis.		Tokumasa A; Katsuno T; Tanaga TS; Yokote K; Saito Y; Suzuki Y		Biochem Biophys Res Commun	317	2004	377-83	J:89177	15063768
92523	Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. (Erratum: Cancer Res 2004;64(10):3725)		Nikitin AY; Alcaraz A; Anver MR; Bronson RT; Cardiff RD; Dixon D; Fraire AE; Gabrielson EW; Gunning WT; Haines DC; Kaufman MH; Linnoila RI; Maronpot RR; Rabson AS; Reddick RL; Rehm S; Rozengurt N; Schuller HM; Shmidt EN; Travis WD; Ward JM; Jacks T		Cancer Res	64	2004	2307-16	J:89179	15059877
92524	Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.		Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J		Cancer Res	64	2004	2382-9	J:89180	15059889
92525	Rorgamma (Rorc) is a common integration site in type B leukemogenic virus-induced T-cell lymphomas.		Broussard DR; Lozano MM; Dudley JP		J Virol	78	2004	4943-6	J:89248	15078980
92526	Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis.		Andrechek ER; Hardy WR; Laing MA; Muller WJ		Proc Natl Acad Sci U S A	101	2004	4984-9	J:89255	15051890
92527	Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver.		Dagli ML; Yamasaki H; Krutovskikh V; Omori Y		Carcinogenesis	25	2004	483-92	J:89347	14688024
92528	Complex effects of Ras proto-oncogenes in tumorigenesis.		Diaz R; Lopez-Barcons L; Ahn D; Garcia-Espana A; Yoon A; Matthews J; Mangues R; Perez-Soler R; Pellicer A		Carcinogenesis	25	2004	535-9	J:89348	14633661
92529	Changes in protein expression in p53 deleted spontaneous thymic lymphomas.		Honore B; Vorum H; Pedersen AE; Buus S; Claesson MH		Exp Cell Res	295	2004	91-101	J:89352	15051493
92530	Use of transgenic mice in carcinogenicity hazard assessment.		Jacobson-Kram D; Sistare FD; Jacobs AC		Toxicol Pathol	32 Suppl 1	2004	49-52	J:89555	15209403
92531	Relevance of Animal Carcinogenesis Findings to Human Cancer Predictions and Prevention.		Maronpot RR; Flake G; Huff J		Toxicol Pathol	32	2004	40-48	J:89556	15204987
92532	Reduced lung tumorigenesis in human methylguanine DNA--methyltransferase transgenic mice achieved by expression of transgene within the target cell.		Liu L; Qin X; Gerson SL		Carcinogenesis	20	1999	279-84	J:89446	10069465
92533	Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis.		Vuillemenot BR; Pulling LC; Palmisano WA; Hutt JA; Belinsky SA		Carcinogenesis	25	2004	623-9	J:89449	14656941
92534	Apoptosis as a novel target for cancer chemoprevention.		Sun SY; Hail N Jr; Lotan R		J Natl Cancer Inst	96	2004	662-72	J:89450	15126603
92535	Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent.		Kobayashi H; Kawamoto S; Sakai Y; Choyke PL; Star RA; Brechbiel MW; Sato N; Tagaya Y; Morris JC; Waldmann TA		J Natl Cancer Inst	96	2004	703-8	J:89455	15126607
92536	Enhancers and suppressors of testicular cancer susceptibility in single- and double-mutant mice.		Lam MY; Youngren KK; Nadeau JH		Genetics	166	2004	925-33	J:89604	15020477
92537	Transgenic overexpression of Reg protein caused gastric cell proliferation and differentiation along parietal cell and chief cell lineages.		Miyaoka Y; Kadowaki Y; Ishihara S; Ose T; Fukuhara H; Kazumori H; Takasawa S; Okamoto H; Chiba T; Kinoshita Y		Oncogene	23	2004	3572-9	J:89606	15116092
92538	Association of liver hemangiosarcoma and secondary iron overload in B6C3F1 mice--the National Toxicology Program experience.		Nyska A; Haseman JK; Kohen R; Maronpot RR		Toxicol Pathol	32	2004	222-8	J:89609	15200160
92539	Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.		Hirose Y; Hata K; Kuno T; Yoshida K; Sakata K; Yamada Y; Tanaka T; Reddy BS; Mori H		Carcinogenesis	25	2004	821-5	J:89550	14729596
92540	Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.		Hansen K; Khanna C		Eur J Cancer	40	2004	858-80	J:89551	15120042
92541	Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.		Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H		Cancer Res	64	2004	3334-43	J:89552	15126378
92542	Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein.		Vogt A; Chuang PT; Hebert J; Hwang J; Lu Y; Kopelovich L; Athar M; Bickers DR; Epstein EH Jr		J Exp Med	199	2004	753-61	J:89553	15024045
92543	Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.		Lina BA; Woutersen RA; Bruijntjes JP; van Benthem J; van den Berg JA; Monbaliu J; Thoolen BJ; Beems RB; van Kreijl CF		Toxicol Pathol	32	2004	192-201	J:89554	15200157
92544	Early B-cell factor-associated zinc-finger gene is a frequent target of retroviral integration in murine B-cell lymphomas.		Warming S; Suzuki T; Yamaguchi TP; Jenkins NA; Copeland NG		Oncogene	23	2004	2727-31	J:89735	15048087
92545	Detection of primary lung tumors in rodents by magnetic resonance imaging.		Garbow JR; Zhang Z; You M		Cancer Res	64	2004	2740-2	J:89736	15087388
92546	Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice.		Felix K; Gerstmeier S; Kyriakopoulos A; Howard OM; Dong HF; Eckhaus M; Behne D; Bornkamm GW; Janz S		Cancer Res	64	2004	2910-7	J:89737	15087411
92547	Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: implications for chromosome instability and tumor progression.		Herzog CR; Bodon N; Pittman B; Maronpot RR; Massey TE; Anderson MW; You M; Devereux TR		Oncogene	23	2004	3033-9	J:89738	14755239
92548	A dynamic switch in Rb+/- mediated neuroendocrine tumorigenesis.		Leung SW; Wloga EH; Castro AF; Nguyen T; Bronson RT; Yamasaki L		Oncogene	23	2004	3296-307	J:89741	15021915
92549	Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors.		Xie Y; Yang H; Cunanan C; Okamoto K; Shibata D; Pan J; Barnes DE; Lindahl T; McIlhatton M; Fishel R; Miller JH		Cancer Res	64	2004	3096-102	J:89742	15126346
92550	Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.		Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ		Cancer Res	64	2004	3171-8	J:89743	15126356
92551	Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferase.		Allay E; Reese JS; McGuire EA; Koc ON; Sedransk N; Gerson SL		Oncogene	15	1997	2127-32	J:89744	9366529
92552	Restricted oncogenicity of BCR/ABL p190 in transgenic mice.		Voncken JW; Griffiths S; Greaves MF; Pattengale PK; Heisterkamp N; Groffen J		Cancer Res	52	1992	4534-9	J:89786	1643646
92553	Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues.		Biondi CA; Gartside MG; Waring P; Loffler KA; Stark MS; Magnuson MA; Kay GF; Hayward NK		Mol Cell Biol	24	2004	3125-31	J:89898	15060136
92554	Generation and characterization of LANP/pp32 null mice.		Opal P; Garcia JJ; McCall AE; Xu B; Weeber EJ; Sweatt JD; Orr HT; Zoghbi HY		Mol Cell Biol	24	2004	3140-9	J:89899	15060138
92555	Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.		Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F		Cancer Res	64	2004	2858-64	J:89875	15087404
92556	p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro.		Terradillos O; Pollicino T; Lecoeur H; Tripodi M; Gougeon ML; Tiollais P; Buendia MA		Oncogene	17	1998	2115-23	J:90064	9798683
92557	Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis.		Koike K; Moriya K; Yotsuyanagi H; Shintani Y; Fujie H; Tsutsumi T; Kimura S		Cancer Lett	134	1998	181-6	J:90065	10025879
92558	Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis.		Potter M; Wax JS		J Immunol	127	1981	1591-5	J:90066	7276572
92559	Anti-mu induces lymphoma in germfree congenitally athymic (nude) but not in heterozygous (nu/+) mice.		Gershwin ME; Ohsugi Y; Castles JJ; Ikeda RM; Ruebner B		J Immunol	131	1983	2069-73	J:90067	6413585
92560	Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia.		Lallemand-Breitenbach V; Guillemin MC; Janin A; Daniel MT; Degos L; Kogan SC; Bishop JM; de The H		J Exp Med	189	1999	1043-52	J:90069	10190895
92561	De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine.		Haramis AP; Begthel H; van den Born M; van Es J; Jonkheer S; Offerhaus GJ; Clevers H		Science	303	2004	1684-6	J:90023	15017003
92562	Inhibin/activin and ovarian cancer.		Robertson DM; Burger HG; Fuller PJ		Endocr Relat Cancer	11	2004	35-49	J:90227	15027884
92563	Macrophages: modulators of breast cancer progression.		Lin EY; Pollard JW		Novartis Found Symp	256	2004	158-68; discussion 168-72, 259	J:90229	15027489
92564	Lymphangiogenesis and tumour metastasis.		Tille JC; Nisato R; Pepper MS		Novartis Found Symp	256	2004	112-31; discussion 132-6, 259-	J:90230	15027486
92565	Proinflammatory cytokines, immune response and tumour progression.		Spadaro M; Forni G		Novartis Found Symp	256	2004	92-9; discussion 99-111, 266-9	J:90231	15027485
92566	Animal models of tumor immunity, immunotherapy and cancer vaccines.		Ostrand-Rosenberg S		Curr Opin Immunol	16	2004	143-50	J:90233	15023405
92567	Intestinal expression of mutant and wild-type progastrin significantly increases colon carcinogenesis in response to azoxymethane in transgenic mice.		Cobb S; Wood T; Ceci J; Varro A; Velasco M; Singh P		Cancer	100	2004	1311-23	J:90234	15022301
92568	Hepatocarcinogenesis by peroxisome proliferators.		Suga T		J Toxicol Sci	29	2004	1-12	J:90237	15018150
92569	Angiogenesis in transgenic models of multistep angiogenesis.		Radovanovic I; D'Angelo MG; Aguzzi A		Cancer Treat Res	117	2004	97-114	J:90238	15015554
92570	Salix caprea inhibits skin carcinogenesis in murine skin: inhibition of oxidative stress, ornithine decarboxylase activity and DNA synthesis.		Sultana S; Saleem M		J Ethnopharmacol	91	2004	267-76	J:90171	15120450
92571	Dietary Soy Sphingolipids Suppress Tumorigenesis and Gene Expression in 1,2-Dimethylhydrazine-Treated CF1 Mice and Apc(Min/+) Mice.		Symolon H; Schmelz EM; Dillehay DL; Merrill AH Jr		J Nutr	134	2004	1157-1161	J:90172	15113963
92572	Dietary depletion of vitamin e and vitamin a inhibits mammary tumor growth and metastasis in transgenic mice.		Albright CD; Salganik RI; Van Dyke T		J Nutr	134	2004	1139-44	J:90173	15113960
92573	In vivo mapping of spontaneous mammary tumors in transgenic mice using MRI and ultrasonography.		Galie M; D'Onofrio M; Calderan L; Nicolato E; Amici A; Crescimanno C; Marzola P; Sbarbati A		J Magn Reson Imaging	19	2004	570-9	J:90174	15112306
92574	VEGF-DT385 Toxin Conjugate Inhibits Mammary Adenocarcinoma Development in a Transgenic Mouse Model of Spontaneous Tumorigenesis.		Wild R; Yokoyama Y; Dings RP; Ramakrishnan S		Breast Cancer Res Treat	85	2004	161-71	J:90175	15111774
92575	Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles.		Javelaud D; Mauviel A		Int J Biochem Cell Biol	36	2004	1161-5	J:90176	15109563
92576	DNA damage tumor suppressor genes and genomic instability.		Motoyama N; Naka K		Curr Opin Genet Dev	14	2004	11-6	J:90177	15108799
92577	Epigenetic and gene expression changes related to transgenerational carcinogenesis.		Cheng RY; Hockman T; Crawford E; Anderson LM; Shiao YH		Mol Carcinog	40	2004	1-11	J:90178	15108325
92578	Chemopreventive potential of Azadirachta indica (Neem) leaf extract in murine carcinogenesis model systems.		Dasgupta T; Banerjee S; Yadava PK; Rao AR		J Ethnopharmacol	92	2004	23-36	J:90180	15099843
92579	Modulation of patched-associated susceptibility to radiation induced tumorigenesis by genetic background.		Pazzaglia S; Mancuso M; Tanori M; Atkinson MJ; Merola P; Rebessi S; Di Majo V; Covelli V; Hahn H; Saran A		Cancer Res	64	2004	3798-806	J:90301	15172986
92580	Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens.		Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA		Cancer Res	64	2004	3844-8	J:90302	15172992
92581	Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.		Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ		Cancer Res	64	2004	3849-54	J:90303	15172993
92582	Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine.		De Giovanni C; Nicoletti G; Landuzzi L; Astolfi A; Croci S; Comes A; Ferrini S; Meazza R; Iezzi M; Di Carlo E; Musiani P; Cavallo F; Nanni P; Lollini PL		Cancer Res	64	2004	4001-9	J:90304	15173014
92583	Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice.		Lee TH; Finegold MJ; Shen RF; DeMayo JL; Woo SL; Butel JS		J Virol	64	1990	5939-47	J:90305	2243380
92584	Inhibition of plasmacytoma development in BALB/c mice by indomethacin.		Potter M; Wax JS; Anderson AO; Nordan RP		J Exp Med	161	1985	996-1012	J:90309	3989472
92585	Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.		Yukawa K; Kikutani H; Inomoto T; Uehira M; Bin SH; Akagi K; Yamamura K; Kishimoto T		J Exp Med	170	1989	711-26	J:90310	2504875
92586	Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.		Esumi H; Ohgaki H; Kohzen E; Takayama S; Sugimura T		Jpn J Cancer Res	80	1989	1176-8	J:90311	2516847
92587	The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.		Terradillos O; Billet O; Renard CA; Levy R; Molina T; Briand P; Buendia MA		Oncogene	14	1997	395-404	J:90270	9053836
92588	Complete remission of TEL-PDGFRB-induced myeloproliferative disease in mice by receptor tyrosine kinase inhibitor SU11657.		Cain JA; Grisolano JL; Laird AD; Tomasson MH		Blood	104	2004	561-4	J:90354	15044254
92589	The roles of transcription factors in B lymphocyte commitment, development, and transformation.		Smith E; Sigvardsson M		J Leukoc Biol	75	2004	973-81	J:90464	14982952
92590	Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA.		Barlow C; Meister B; Lardelli M; Lendahl U; Vennstrom B		EMBO J	13	1994	4241-50	J:90554	7925269
92591	Collaboration of Brca1 and Chk2 in tumorigenesis.		McPherson JP; Lemmers B; Hirao A; Hakem A; Abraham J; Migon E; Matysiak-Zablocki E; Tamblyn L; Sanchez-Sweatman O; Khokha R; Squire J; Hande MP; Mak TW; Hakem R		Genes Dev	18	2004	1144-53	J:90512	15131084
92592	Fatal acute lymphoblastic leukemia in mice transgenic for B cell-restricted bcl-xL and c-myc.		Swanson PJ; Kuslak SL; Fang W; Tze L; Gaffney P; Selby S; Hippen KL; Nunez G; Sidman CL; Behrens TW		J Immunol	172	2004	6684-91	J:90515	15153484
92593	mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.		Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR		Nat Med	10	2004	594-601	J:90631	15156201
92594	Investigating gene function using mouse models.		Lee D; Threadgill DW		Curr Opin Genet Dev	14	2004	246-52	J:90728	15172666
92595	Osteosarcomas in transgenic mice expressing an alpha-amylase-SV40 T-antigen hybrid gene.		Knowles BB; McCarrick J; Fox N; Solter D; Damjanov I		Am J Pathol	137	1990	259-62	J:90730	2386195
92596	Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer.		Nebert DW; Dalton TP; Okey AB; Gonzalez FJ		J Biol Chem	279	2004	23847-50	J:90676	15028720
92597	Effects of estrogens and metabolites on endometrial carcinogenesis in young adult mice initiated with N-ethyl-N'-nitro-N-nitrosoguanidine.		Takahashi M; Shimomoto T; Miyajima K; Yoshida M; Katashima S; Uematsu F; Maekawa A; Nakae D		Cancer Lett	211	2004	1-9	J:90677	15194211
92598	The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.		Suckow MA; Gutierrez LS; Risatti CA; Wolter WR; Taylor RE; Pollard M; Navari RM; Castellino FJ; Paoni NF		Cancer Lett	209	2004	165-9	J:90679	15159018
92599	Therapy of murine squamous cell carcinomas with 2-difluoromethylornithine.		Chen Y; Hu J; Boorman D; Klein-Szanto A; O'Brien TG		J Carcinog	3	2004	10	J:90796	15175104
92600	Treatment with 5-Fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors.		Wilgus TA; Breza TS Jr; Tober KL; Oberyszyn TM		J Invest Dermatol	122	2004	1488-94	J:90797	15175041
92601	Evaluation of the anticarcinogenic activity of Swertia chirata Buch.Ham, an Indian medicinal plant, on DMBA-induced mouse skin carcinogenesis model.		Saha P; Mandal S; Das A; Das PC; Das S		Phytother Res	18	2004	373-8	J:90798	15173996
92602	Use of mitogenic cascade blockers for treatment of C-Raf induced lung adenoma in vivo: CI-1040 strongly reduces growth and improves lung structure.		Kramer BW; Goetz R; Rapp UR		BMC Cancer	4	2004	24	J:90799	15171791
92603	Technical note: A toy as tool: a low-cost image analysis system for the evaluation of tumor size in experimental small animal models.		Brockmann MA; Ulmer S; Lamszus K; Giese A; Petersen D		Microsc Res Tech	63	2004	306-9	J:90800	15170761
92604	Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice.		Pendas AM; Folgueras AR; Llano E; Caterina J; Frerard F; Rodriguez F; Astudillo A; Noel A; Birkedal-Hansen H; Lopez-Otin C		Mol Cell Biol	24	2004	5304-13	J:90802	15169894
92605	Mouse models of childhood cancer of the nervous system.		Dyer MA		J Clin Pathol	57	2004	561-76	J:90803	15166259
92606	Genetically defined mouse models that mimic natural aspects of human prostate cancer development.		Roy-Burman P; Wu H; Powell WC; Hagenkord J; Cohen MB		Endocr Relat Cancer	11	2004	225-54	J:90804	15163300
92607	Increased Susceptibility of Mice Lacking Clara Cell 10-kDa Protein to Lung Tumorigenesis by 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a Potent Carcinogen in Cigarette Smoke.		Yang Y; Zhang Z; Mukherjee AB; Linnoila RI		J Biol Chem	279	2004	29336-40	J:90868	15148323
92608	Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo.		Yin L; Ghebranious N; Chakraborty S; Sheehan CE; Ilic Z; Sell S		Hepatology	27	1998	73-80	J:90869	9425920
92609	Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.		Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D		Hepatology	25	1997	874-83	J:90870	9096591
92610	Abnormalities of epidermal differentiation associated with expression of the human papillomavirus type 1 early region in transgenic mice.		Tinsley JM; Fisher C; Searle PF		J Gen Virol	73	1992	1251-60	J:90871	1375281
92611	Cervical/vaginal dysplasias of transgenic mice harbouring human papillomavirus type 16 E6-E7 genes.		Sasagawa T; Kondoh G; Inoue M; Yutsudo M; Hakura A		J Gen Virol	75	1994	3057-65	J:90872	7964615
92612	Stomach cancer in transgenic mice expressing human papillomavirus type 16 early region genes from a keratin promoter.		Searle PF; Thomas DP; Faulkner KB; Tinsley JM		J Gen Virol	75	1994	1125-37	J:90873	8176373
92613	Microsatellite instability, chemosensitivity and mutant frequency in a series of 1,2-dimethylhydrazine induced murine colon adenocarcinoma models.		Thompson MJ; Slack R; Double JA; Bibby MC		Int J Oncol	13	1998	531-6	J:90874	9683789
92614	Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols.		Wang ZY; Khan WA; Bickers DR; Mukhtar H		Carcinogenesis	10	1989	411-5	J:90875	2912593
92615	Inhibition of the skin tumorigenicity of (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice.		Khan WA; Wang ZY; Athar M; Bickers DR; Mukhtar H		Cancer Lett	42	1988	7-12	J:90876	3141040
92616	Hyperpigmentation and melanocytic hyperplasia in transgenic mice expressing the human T24 Ha-ras gene regulated by a mouse tyrosinase promoter.		Powell MB; Hyman P; Bell OD; Balmain A; Brown K; Alberts D; Bowden GT		Mol Carcinog	12	1995	82-90	J:90877	7662120
92617	Effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on intestinal polyp development in Apc delta 716 knockout mice.		Oshima M; Oshima H; Tsutsumi M; Nishimura S; Sugimura T; Nagao M; Taketo MM		Mol Carcinog	15	1996	11-7	J:90878	8561861
92618	Plasmacytoma induction in specific pathogen-free (SPF) bcl-2 transgenic BALB/c mice.		Silva S; Klein G		Curr Top Microbiol Immunol	246	1999	379-85	J:90879	10396078
92619	Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice.		Huang SN; Chisari FV		Hepatology	21	1995	620-6	J:90880	7875658
92620	High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice.		Koike K; Moriya K; Iino S; Yotsuyanagi H; Endo Y; Miyamura T; Kurokawa K		Hepatology	19	1994	810-9	J:90881	8138251
92621	Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.		Horie Y; Suzuki A; Kataoka E; Sasaki T; Hamada K; Sasaki J; Mizuno K; Hasegawa G; Kishimoto H; Iizuka M; Naito M; Enomoto K; Watanabe S; Mak TW; Nakano T		J Clin Invest	113	2004	1774-83	J:90905	15199412
92622	BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice.		Voncken JW; Kaartinen V; Pattengale PK; Germeraad WT; Groffen J; Heisterkamp N		Blood	86	1995	4603-11	J:90914	8541551
92623	BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice.		Baker DJ; Jeganathan KB; Cameron JD; Thompson M; Juneja S; Kopecka A; Kumar R; Jenkins RB; de Groen PC; Roche P; van Deursen JM		Nat Genet	36	2004	744-9	J:91128	15208629
92624	A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of congenic lines.		Bilger A; Bennett LM; Carabeo RA; Chiaverotti TA; Dvorak C; Liss KM; Schadewald SA; Pitot HC; Drinkwater NR		Genetics	167	2004	859-66	J:91132	15238534
92625	Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.		Mall M; Grubb BR; Harkema JR; O'Neal WK; Boucher RC		Nat Med	10	2004	487-93	J:91139	15077107
92626	Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts.		Inai T; Mancuso M; Hashizume H; Baffert F; Haskell A; Baluk P; Hu-Lowe DD; Shalinsky DR; Thurston G; Yancopoulos GD; McDonald DM		Am J Pathol	165	2004	35-52	J:91234	15215160
92627	Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice.		Tournoy J; Bossuyt X; Snellinx A; Regent M; Garmyn M; Serneels L; Saftig P; Craessaerts K; De Strooper B; Hartmann D		Hum Mol Genet	13	2004	1321-31	J:91235	15128703
92628	Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone.		Asa SL; Kovacs K; Stefaneanu L; Horvath E; Billestrup N; Gonzalez-Manchon C; Vale W		Proc Soc Exp Biol Med	193	1990	232-5	J:91172	2106141
92629	Inducible formation of liver tumors in transgenic mice.		Ruther U; Woodroofe C; Fattori E; Ciliberto G		Oncogene	8	1993	87-93	J:91173	8423999
92630	Acute leukaemia in bcr/abl transgenic mice.		Heisterkamp N; Jenster G; ten Hoeve J; Zovich D; Pattengale PK; Groffen J		Nature	344	1990	251-3	J:91174	2179728
92631	Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: lessons from transgenic animal models.		Wolf E; Kahnt E; Ehrlein J; Hermanns W; Brem G; Wanke R		Mech Ageing Dev	68	1993	71-87	J:91175	8350664
92632	Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice.		Doi ST; Kimura M; Katsuki M		Jpn J Cancer Res	85	1994	801-7	J:91176	7928625
92633	Accelerating effect of nude gene heterozygosity on spontaneous AKR thymic lymphomagenesis.		Shisa H; Kojima A; Hiai H		Jpn J Cancer Res	77	1986	568-71	J:91177	3089990
92634	Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.		Kemp CJ; Donehower LA; Bradley A; Balmain A		Cell	74	1993	813-22	J:91178	8374952
92635	Reversal of food restriction-induced inhibition of mouse skin tumor promotion by adrenalectomy.		Pashko LL; Schwartz AG		Carcinogenesis	13	1992	1925-8	J:91179	1423856
92636	Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems.		Dunnick JK; Hailey JR		Cancer Res	56	1996	4922-6	J:91180	8895745
92637	Chemoprevention of spontaneous tumorigenesis in p53-knockout mice.		Hursting SD; Perkins SN; Haines DC; Ward JM; Phang JM		Cancer Res	55	1995	3949-53	J:91181	7664260
92638	Inhibitory effect of green tea on the growth of established skin papillomas in mice.		Wang ZY; Huang MT; Ho CT; Chang R; Ma W; Ferraro T; Reuhl KR; Yang CS; Conney AH		Cancer Res	52	1992	6657-65	J:91182	1423310
92639	Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice.		Wang ZY; Huang MT; Ferraro T; Wong CQ; Lou YR; Reuhl K; Iatropoulos M; Yang CS; Conney AH		Cancer Res	52	1992	1162-70	J:91183	1737375
92640	Incidence and pathological features of spontaneous tumors in athymic nude mice.		Sharkey FE; Fogh J		Cancer Res	39	1979	833-9	J:91184	427772
92641	Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea.		Gensler HL; Timmermann BN; Valcic S; Wachter GA; Dorr R; Dvorakova K; Alberts DS		Nutr Cancer	26	1996	325-35	J:91185	8910914
92642	The transgenic Tg.AC mouse model for identification of chemical carcinogens.		Tennant RW; Tice RR; Spalding JW		Toxicol Lett	102-103	1998	465-71	J:91186	10022297
92643	Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains.		Kripke ML		Cancer Res	37	1977	1395-400	J:91187	851959
92644	The effects of dietary myoinositol on lung tumor development in tobacco smoke-exposed mice.		Witschi H; Espiritu I; Ly M; Uyeminami D		Inhal Toxicol	16	2004	195-201	J:91644	15204766
92645	Animal models for the study of childhood leukemia: considerations for model identification and optimization to identify potential risk factors.		McCormick DL; Kavet R		Int J Toxicol	23	2004	149-61	J:91645	15204718
92646	Cell type-specific effects of Rb deletion in the murine retina.		MacPherson D; Sage J; Kim T; Ho D; McLaughlin ME; Jacks T		Genes Dev	18	2004	1681-94	J:91406	15231717
92647	Tumor regionality in the mouse intestine reflects the mechanism of loss of Apc function.		Haigis KM; Hoff PD; White A; Shoemaker AR; Halberg RB; Dove WF		Proc Natl Acad Sci U S A	101	2004	9769-73	J:91411	15210940
92648	Multiple endocrine neoplasia induced by the promiscuous expression of a viral oncogene.		Reynolds RK; Hoekzema GS; Vogel J; Hinrichs SH; Jay G		Proc Natl Acad Sci U S A	85	1988	3135-9	J:91413	2452444
92649	Mouse models of human cancers (Part 2).		Galvez JJ; Cardiff RD; Munn RJ; Borowsky AD; Boivin GP; Groden J; Longnecker DS; Shmidt EN; Nikitin AY; Connolly DC; Hamilton TC		Comp Med	54	2004	13-15	J:91415	15027614
92650	Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.		Shih AH; Dai C; Hu X; Rosenblum MK; Koutcher JA; Holland EC		Cancer Res	64	2004	4783-9	J:91507	15256447
92651	Involvement of mammalian Mus81 in genome integrity and tumor suppression.		McPherson JP; Lemmers B; Chahwan R; Pamidi A; Migon E; Matysiak-Zablocki E; Moynahan ME; Essers J; Hanada K; Poonepalli A; Sanchez-Sweatman O; Khokha R; Kanaar R; Jasin M; Hande MP; Hakem R		Science	304	2004	1822-6	J:91570	15205536
92652	Carcinogenic Susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 Mice.		Okamura M; Moto M; Kashida Y; Machida N; Mitsumori K		Toxicol Pathol	32	2004	474-81	J:91628	15223773
92653	Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol.		Platt KL; Dienes HP; Tommasone M; Luch A		Chem Biol Interact	148	2004	27-36	J:91629	15223354
92654	Upper Dose Thresholds for Radiation-Induced Adaptive Response against Cancer in High-Dose-Exposed, Cancer-Prone, Radiation-Sensitive Trp53 Heterozygous Mice.		Mitchel RE; Jackson JS; Carlisle SM		Radiat Res	162	2004	20-30	J:91630	15222780
92655	Validation: the new challenge for pathology.		Cardiff RD; Rosner A; Hogarth MA; Galvez JJ; Borowsky AD; Gregg JP		Toxicol Pathol	32 Suppl 1	2004	31-9	J:91635	15209401
92656	The genetics of cancer susceptibility: from mouse to man.		Ewart-Toland A; Balmain A		Toxicol Pathol	32 Suppl 1	2004	26-30	J:91636	15209400
92657	Experimental study to test the potential tumor promotion effect of a tooth bleaching agent.		Collet AM; Palmieri M; Molinari B; Schwint AE; Itoiz ME		Acta Odontol Latinoam	14	2001	30-4	J:91637	15208934
92658	Insights into the viral G protein-coupled receptor encoded by human herpesvirus type 8 (HHV-8).		Couty JP; Gershengorn MC		Biol Cell	96	2004	349-54	J:91638	15207903
92659	The topical application of 2,3,7,8-tetrachlorodibenzo- [Formula: see text] -dioxin lacks skin tumor-promoting potency but induces hepatic injury and tumor necrosis factor-alpha expression in ICR male mice.		Wu CH; Chen HL; Su HJ; Lee CC; Shen KT; Ho WL; Ho SY; Ho YS; Wang YJ		Food Chem Toxicol	42	2004	1217-25	J:91639	15207371
92660	Tumor Spectrum in the p53 Heterozygous Zeta Globin-Promoted Tg.AC (v-Ha-ras) Bitransgenic Mouse Model.		Martin KR; Jokinen MP; Honeycutt HP; Quinn A; Kari FW; Barrett JC; French JE		Toxicol Pathol	32	2004	418-25	J:91642	15204965
92661	Effect of Oral Gavage Dosing Regimens in Female Tg rasH2 Transgenic Mice.		Morton D; Sellers RS; Furst SM; Hawley KD; May JR		Toxicol Pathol	32	2004	413-7	J:91643	15204964
92662	Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia.		Flores I; Murphy DJ; Swigart LB; Knies U; Evan GI		Oncogene	23	2004	5923-30	J:91726	15208685
92663	MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation.		Schroeder JA; Masri AA; Adriance MC; Tessier JC; Kotlarczyk KL; Thompson MC; Gendler SJ		Oncogene	23	2004	5739-47	J:91736	15221004
92664	Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis.		Kurita T; Mills AA; Cunha GR		Development	131	2004	1639-49	J:91853	14998922
92665	Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging.		Johansson FK; Brodd J; Eklof C; Ferletta M; Hesselager G; Tiger CF; Uhrbom L; Westermark B		Proc Natl Acad Sci U S A	101	2004	11334-7	J:91806	15273287
92666	Role of IFN regulatory factor-1 and IL-12 in immunological resistance to pathogenesis of N-methyl-N-nitrosourea-induced T lymphoma.		Liu J; Xiang Z; Ma X		J Immunol	173	2004	1184-93	J:91927	15240709
92667	Understanding arsenic carcinogenicity by the use of animal models.		Wanibuchi H; Salim EI; Kinoshita A; Shen J; Wei M; Morimura K; Yoshida K; Kuroda K; Endo G; Fukushima S		Toxicol Appl Pharmacol	198	2004	366-76	J:92019	15276416
92668	The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis.		Yamanaka K; Kato K; Mizoi M; An Y; Takabayashi F; Nakano M; Hoshino M; Okada S		Toxicol Appl Pharmacol	198	2004	385-93	J:91978	15276418
92669	Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression.		Lefort K; Dotto GP		Semin Cancer Biol	14	2004	374-86	J:92119	15288263
92670	Notch in mammary gland development and breast cancer.		Politi K; Feirt N; Kitajewski J		Semin Cancer Biol	14	2004	341-7	J:92120	15288259
92671	Transgenic mouse with human mutant p53 expression in the prostate epithelium.		Elgavish A; Wood PA; Pinkert CA; Eltoum IE; Cartee T; Wilbanks J; Mentor-Marcel R; Tian L; Scroggins SE		Prostate	61	2004	26-34	J:92122	15287091
92672	Array comparative genomic hybridization with cyanin cis-platinum-labeled DNAs.		Raap AK; van der Burg MJ; Knijnenburg J; Meershoek E; Rosenberg C; Gray JW; Wiegant J; Hodgson JG; Tanke HJ		Biotechniques	37	2004	130-4	J:92124	15283211
92673	Pituitary tumor transforming gene: an update.		Yu R; Melmed S		Front Horm Res	32	2004	175-85	J:92125	15281346
92674	CO(2) laser resurfacing and photocarcinogenesis: An experimental study.		Hedelund L; Haedersdal M; Egekvist H; Heidenheim M; Wulf HC; Poulsen T		Lasers Surg Med	35	2004	58-61	J:92126	15278929
92675	Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors.		Jevremovic D; Gulati R; Hennig I; Diaz RM; Cole C; Kleppe L; Cosset FL; Simari RD; Vile RG		Am J Physiol Heart Circ Physiol	287	2004	H494-500	J:92128	15277193
92676	Inherited disorders of the skin in human and mouse: from development to differentiation.		O'Shaughnessy RF; Christiano AM		Int J Dev Biol	48	2004	171-9	J:92129	15272382
92677	Chemical Constituents of Millettia taiwaniana: Structure Elucidation of Five New Isoflavonoids and Their Cancer Chemopreventive Activity(1).		Ito C; Itoigawa M; Kojima N; Tokuda H; Hirata T; Nishino H; Furukawa H		J Nat Prod	67	2004	1125-30	J:92130	15270565
92678	Chemopreventive action of Boerhaavia diffusa on DMBA-induced skin carcinogenesis in mice.		Bharali R; Azad MR; Tabassum J		Indian J Physiol Pharmacol	47	2003	459-64	J:92132	15266960
92679	The rate of the CD8-dependent initial reduction in tumor volume is not limited by contact-dependent perforin, Fas ligand, or TNF-mediated cytolysis.		Hollenbaugh JA; Reome J; Dobrzanski M; Dutton RW		J Immunol	173	2004	1738-43	J:92134	15265903
92680	Loss of DNA mismatch repair function and cancer predisposition in the mouse: Animal models for human hereditary nonpolyposis colorectal cancer.		Edelmann L; Edelmann W		Am J Med Genet	129C	2004	91-9	J:92136	15264277
92681	Nkx2.1 transcription factor in lung cells and a transforming growth factor-beta1 heterozygous mouse model of lung carcinogenesis.		Kang Y; Hebron H; Ozbun L; Mariano J; Minoo P; Jakowlew SB		Mol Carcinog	40	2004	212-31	J:92138	15264213
92682	Development of transgenic mice that inducibly express an active form of c-Src in the epidermis.		Matsumoto T; Kiguchi K; Jiang J; Carbajal S; Ruffino L; Beltran L; Wang XJ; Roop DR; DiGiovanni J		Mol Carcinog	40	2004	189-200	J:92139	15264211
92683	Bad-deficient mice develop diffuse large B cell lymphoma.		Ranger AM; Zha J; Harada H; Datta SR; Danial NN; Gilmore AP; Kutok JL; Le Beau MM; Greenberg ME; Korsmeyer SJ		Proc Natl Acad Sci U S A	100	2003	9324-9	J:84987	12876200
92684	Bone marrow transplantation restores immune system function and prevents lymphoma in Atm-deficient mice.		Bagley J; Cortes ML; Breakefield XO; Iacomini J		Blood	104	2004	572-8	J:92237	15044255
92685	Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.		Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S		Eur J Immunol	34	2004	2740	J:92335	15368290
92686	ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background.		Fang Y; Tsao CC; Goodman BK; Furumai R; Tirado CA; Abraham RT; Wang XF		EMBO J	23	2004	3164-74	J:92291	15282542
92687	Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.		Mallikarjuna G; Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R		Cancer Res	64	2004	6349-56	J:92412	15342425
92688	Inhibitory effects of 7-hydroxy-3-methoxy-cadalene on 4-(methylinitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice.		Kim JH; Lee HJ; Kim GS; Choi DH; Lee SS; Kang JK; Chae C; Paik NW; Cho MH		Cancer Lett	213	2004	139-45	J:92415	15327828
92689	Skin and salivary gland carcinogenicity of 7,12-dimethylbenz[a]anthracene is equivalent in the presence or absence of aryl hydrocarbon receptor.		Ide F; Suka N; Kitada M; Sakashita H; Kusama K; Ishikawa T		Cancer Lett	214	2004	35-41	J:92416	15331171
92690	Phenotypes of SERCA and PMCA knockout mice.		Prasad V; Okunade GW; Miller ML; Shull GE		Biochem Biophys Res Commun	322	2004	1192-203	J:92485	15336967
92691	Annexins and disease.		Hayes MJ; Moss SE		Biochem Biophys Res Commun	322	2004	1166-70	J:92486	15336964
92692	NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse.		Hamaguchi K; Gaskins HR; Leiter EH		Diabetes	40	1991	842-9	J:92449	1647994
92693	Dibenzo[A,L]pyrene-induced genotoxic and carcinogenic responses are dramatically suppressed in aryl hydrocarbon receptor-deficient mice.		Nakatsuru Y; Wakabayashi K; Fujii-Kuriyama Y; Ishikawa T; Kusama K; Ide F		Int J Cancer	112	2004	179-83	J:92561	15352028
92694	Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration.		Hahn P; Qian Y; Dentchev T; Chen L; Beard J; Harris ZL; Dunaief JL		Proc Natl Acad Sci U S A	101	2004	13850-5	J:92620	15365174
92695	Guard your master: thyroid hormone receptors protect their gland of origin from thyroid cancer.		Kohrle J		Endocrinology	145	2004	4427-9	J:92625	15375080
92696	IL-15Ralpha is a negative regulator of TCR-activated proliferation in CD4+ T cells.		Lee JM; Chung CY; Chiang WW; Liou YH; Chen CF; Liao NS		J Immunol	173	2004	3155-64	J:92705	15322176
92697	p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness.		Wolfraim LA; Walz TM; James Z; Fernandez T; Letterio JJ		J Immunol	173	2004	3093-102	J:92713	15322169
92698	NF-kappaB functions as a tumour promoter in inflammation-associated cancer.		Pikarsky E; Porat RM; Stein I; Abramovitch R; Amit S; Kasem S; Gutkovich-Pyest E; Urieli-Shoval S; Galun E; Ben-Neriah Y		Nature	431	2004	461-6	J:92668	15329734
92699	TIRC7 deficiency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response.		Utku N; Boerner A; Tomschegg A; Bennai-Sanfourche F; Bulwin GC; Heinemann T; Loehler J; Blumberg RS; Volk HD		J Immunol	173	2004	2342-52	J:92730	15294947
92700	PML nuclear bodies: dynamic sensors of DNA damage and cellular stress.		Dellaire G; Bazett-Jones DP		Bioessays	26	2004	963-77	J:92879	15351967
92701	Effect of Onosma echioides on DMBA/croton oil mediated carcinogenic response, hyperproliferation and oxidative damage in murine skin.		Sharma S; Khan N; Sultana S		Life Sci	75	2004	2391-410	J:92880	15350816
92702	Liver carcinogenesis and formation of 8-hydroxy-deoxyguanosine in C3H/HeN mice by oxidized dietary oils containing carcinogenic dicarbonyl compounds.		Ichinose T; Nobuyuki S; Takano H; Abe M; Sadakane K; Yanagisawa R; Ochi H; Fujioka K; Lee KG; Shibamoto T		Food Chem Toxicol	42	2004	1795-803	J:92881	15350677
92703	Toxicology and carcinogenesis studies of microencapsulated trans-cinnamaldehyde in rats and mice.		Hooth MJ; Sills RC; Burka LT; Haseman JK; Witt KL; Orzech DP; Fuciarelli AF; Graves SW; Johnson JD; Bucher JR		Food Chem Toxicol	42	2004	1757-68	J:92882	15350673
92704	APC dosage effects in tumorigenesis and stem cell differentiation.		Gaspar C; Fodde R		Int J Dev Biol	48	2004	377-86	J:92883	15349813
92705	Advanced molecular cytogenetics in human and mouse.		Dorritie K; Montagna C; Difilippantonio MJ; Ried T		Expert Rev Mol Diagn	4	2004	663-76	J:92884	 
92706	Role of F-Box Protein {beta}Trcp1 in Mammary Gland Development and Tumorigenesis.		Kudo Y; Guardavaccaro D; Santamaria PG; Koyama-Nasu R; Latres E; Bronson R; Yamasaki L; Pagano M		Mol Cell Biol	24	2004	8184-8194	J:92886	15340078
92707	Evaluation of protective potentials of a potentized homeopathic drug, Chelidonium majus, during azo dye induced hepatocarcinogenesis in mice.		Biswas SJ; Khuda-Bukhsh AR		Indian J Exp Biol	42	2004	698-714	J:92887	15339035
92708	Telomere biology and the molecular basis of aging.		Parwaresch R; Krupp G		Arkh Patol	64	2002	37-9	J:92888	 
92709	Detection and volume determination of colonic tumors in Min mice by magnetic resonance micro-imaging.		Hensley HH; Chang WC; Clapper ML		Magn Reson Med	52	2004	524-9	J:92889	15334570
92710	Diet-Gene Interactions in p53-Deficient Mice: Insulin-like Growth Factor-1 as a Mechanistic Target.		Hursting SD; Lavigne JA; Berrigan D; Donehower LA; Davis BJ; Phang JM; Barrett JC; Perkins SN		J Nutr	134	2004	2482S-6S	J:92891	15333746
92711	Chemopreventive action of Phyllanthus urinaria Linn on DMBA-induced skin carcinogenesis in mice.		Bharali R; Tabassum J; Azad MR		Indian J Exp Biol	41	2003	1325-8	J:92892	15332506
92712	Inhibition of cutaneous oxidative stress and two-stage skin carcinogenesis by Hemidesmus indicus (L.) in Swiss albino mice.		Sultana S; Alam A; Khan N; Sharma S		Indian J Exp Biol	41	2003	1416-23	J:92893	15320495
92713	Experimental manipulation of radiographic density in mouse mammary gland.		Hariri M; Wood GA; DiGrappa MA; MacPherson M; Backman SA; Yaffe MJ; Mak TW; Boyd NF; Khokha R		Breast Cancer Res	6	2004	R540-5	J:92894	15318935
92714	Age and gender differences in antioxidant enzyme activity: potential relationship to liver carcinogenesis in male mice.		Sverko V; Sobocanec S; Balog T; Marotti T		Biogerontology	5	2004	235-42	J:92895	15314273
92715	Distribution of oval cells and c-myc mRNA expression in mouse hepatocarcinogenesis.		Fang CH; Zhang GQ; Zhu XY; Gong JQ		Hepatobiliary Pancreat Dis Int	3	2004	433-9	J:92897	15313684
92716	Immunohistochemical analysis of heme oxygenase-1 in preneoplastic and neoplastic lesions during chemical hepatocarcinogenesis.		Caballero F; Meiss R; Gimenez A; Batlle A; Vazquez E		Int J Exp Pathol	85	2004	213-22	J:92898	15312126
92717	Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes.		Swartz JM; Bystrom J; Dyer KD; Nitto T; Wynn TA; Rosenberg HF		J Leukoc Biol	76	2004	812-9	J:92977	15277569
92718	Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice.		Hu Y; Ippolito JE; Garabedian EM; Humphrey PA; Gordon JI		J Biol Chem	277	2002	44462-74	J:93042	12228243
92719	Loss of Keratin 10 Leads to Mitogen-activated Protein Kinase (MAPK) Activation, Increased Keratinocyte Turnover, and Decreased Tumor Formation in Mice.		Reichelt J; Furstenberger G; Magin TM		J Invest Dermatol	123	2004	973-81	J:93045	15482487
92720	Tooth patterning and enamel formation can be manipulated by misexpression of TNF receptor Edar.		Pispa J; Mustonen T; Mikkola ML; Kangas AT; Koppinen P; Lukinmaa PL; Jernvall J; Thesleff I		Dev Dyn	231	2004	432-40	J:93098	15366021
92721	Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia.		Brenner O; Levanon D; Negreanu V; Golubkov O; Fainaru O; Woolf E; Groner Y		Proc Natl Acad Sci U S A	101	2004	16016-21	J:93240	15514019
92722	Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2.		Udd L; Katajisto P; Rossi DJ; Lepisto A; Lahesmaa AM; Ylikorkala A; Jarvinen HJ; Ristimaki AP; Makela TP		Gastroenterology	127	2004	1030-7	J:93361	15480979
92723	Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers.		Kwak MK; Wakabayashi N; Kensler TW		Mutat Res	555	2004	133-48	J:93363	15476857
92724	Genetic mapping of a Ptch1-associated rhabdomyosarcoma susceptibility locus on mouse chromosome 2.		Hahn H; Nitzki F; Schorban T; Hemmerlein B; Threadgill D; Rosemann M		Genomics	84	2004	853-8	J:93364	15475264
92725	Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to Apc(Min) intestinal tumorigenesis.		Koratkar R; Silverman KA; Pequignot E; Hauck WW; Buchberg AM; Siracusa LD		Genomics	84	2004	844-52	J:93365	15475263
92726	Pathological changes in the liver of a senescence accelerated mouse strain (SAMP8): A mouse model for the study of liver diseases.		Ye X; Meeker HC; Kozlowski PB; Wegiel J; Wang KC; Imaki H; Carp RI		Histol Histopathol	19	2004	1141-51	J:93389	15375757
92727	The human BCL6 transgene promotes the development of lymphomas in the mouse.		Baron BW; Anastasi J; Montag A; Huo D; Baron RM; Karrison T; Thirman MJ; Subudhi SK; Chin RK; Felsher DW; Fu YX; McKeithan TW; Baron JM		Proc Natl Acad Sci U S A	101	2004	14198-203	J:93391	15375218
92728	Tissue plasminogen activator is a potent activator of PDGF-CC.		Fredriksson L; Li H; Fieber C; Li X; Eriksson U		EMBO J	23	2004	3793-802	J:93392	15372073
92729	Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice.		Veugelers M; Wilkes D; Burton K; McDermott DA; Song Y; Goldstein MM; La Perle K; Vaughan CJ; O'Hagan A; Bennett KR; Meyer BJ; Legius E; Karttunen M; Norio R; Kaariainen H; Lavyne M; Neau JP; Richter G; Kirali K; Farnsworth A; Stapleton K; Morelli P; Takan	ashi Y; Bamforth JS; Eitelberger F; Noszian I; Manfroi W; Powers J; Mochizuki Y; Imai T; Ko GT; Driscoll DA; Goldmuntz E; Edelberg JM; Collins A; Eccles D; Irvine AD; McKnight GS; Basson CT	Proc Natl Acad Sci U S A	101	2004	14222-7	J:93393	15371594
92730	An in vivo comparative study of sonic, desert and Indian hedgehog reveals that hedgehog pathway activity regulates epidermal stem cell homeostasis.		Adolphe C; Narang M; Ellis T; Wicking C; Kaur P; Wainwright B		Development	131	2004	5009-19	J:93394	15371305
92731	Review of studies concerning the tumorigenicity of 2-butoxyethanol in B6C3F1 mice and its relevance for human risk assessment.		Boatman R; Corley R; Green T; Klaunig J; Udden M		J Toxicol Environ Health B Crit Rev	7	2004	385-98	J:93395	15371241
92732	Retinoic acid receptor alpha dominant negative form causes steatohepatitis and liver tumors in transgenic mice.		Yanagitani A; Yamada S; Yasui S; Shimomura T; Murai R; Murawaki Y; Hashiguchi K; Kanbe T; Saeki T; Ichiba M; Tanabe Y; Yoshida Y; Morino S; Kurimasa A; Usuda N; Yamazaki H; Kunisada T; Ito H; Murawaki Y; Shiota G		Hepatology	40	2004	366-75	J:93397	15368441
92733	Telomeres and telomerase: a dual role in hepatocarcinogenesis.		Satyanarayana A; Manns MP; Rudolph KL		Hepatology	40	2004	276-83	J:93398	15368430
92734	Mini-review: Overcoming tumor-intrinsic resistance to immune effector function.		Ganss R; Arnold B; Hammerling GJ		Eur J Immunol	34	2004	2635	J:93399	15368278
92735	Down-regulation of SNAIL suppresses MIN mouse tumorigenesis: modulation of apoptosis, proliferation, and fractal dimension.		Roy HK; Iversen P; Hart J; Liu Y; Koetsier JL; Kim Y; Kunte DP; Madugula M; Backman V; Wali RK		Mol Cancer Ther	3	2004	1159-65	J:93400	15367710
92736	A conjugate of a tumor-targeting ligand and a T cell costimulatory antibody to treat brain tumors.		Gawlick U; Kranz DM; Schepkin VD; Roy EJ		Bioconjug Chem	15	2004	1137-45	J:93401	15366970
92737	Transforming variant of Met receptor confers serum independence and anti-apoptotic property and could be involved in the mouse thymic lymphomagenesis.		Baek CM; Jeon SH; Jang JJ; Lee BS; Lee JH		Exp Mol Med	36	2004	283-91	J:93402	15365247
92738	Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model.		Albert DM; Kumar A; Strugnell SA; Darjatmoko SR; Lokken JM; Lindstrom MJ; Damico CM; Patel S		Arch Ophthalmol	122	2004	1365-9	J:93403	15364717
92739	Abrogation of hepatocyte apoptosis and early appearance of liver dysplasia in ethanol-fed p53-deficient mice.		Pani G; Fusco S; Colavitti R; Borrello S; Maggiano N; Cravero AA; Farre SM; Galeotti T; Koch OR		Biochem Biophys Res Commun	325	2004	97-100	J:93527	15522206
92740	Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice.		Romer JT; Kimura H; Magdaleno S; Sasai K; Fuller C; Baines H; Connelly M; Stewart CF; Gould S; Rubin LL; Curran T		Cancer Cell	6	2004	229-40	J:93535	15380514
92741	Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.		Alexander WS; Schrader JW; Adams JM		Mol Cell Biol	7	1987	1436-44	J:93657	3037318
92742	Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.		Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS		Cancer Res	64	2004	7039-44	J:93661	15466197
92743	Nitric oxide, a mediator of inflammation, suppresses tumorigenesis.		Hussain SP; Trivers GE; Hofseth LJ; He P; Shaikh I; Mechanic LE; Doja S; Jiang W; Subleski J; Shorts L; Haines D; Laubach VE; Wiltrout RH; Djurickovic D; Harris CC		Cancer Res	64	2004	6849-53	J:93662	15466171
92744	c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism.		Knies-Bamforth UE; Fox SB; Poulsom R; Evan GI; Harris AL		Cancer Res	64	2004	6563-70	J:93664	15374969
92745	Transforming growth factor-beta pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis.		Lucas PJ; McNeil N; Hilgenfeld E; Choudhury B; Kim SJ; Eckhaus MA; Ried T; Gress RE		Cancer Res	64	2004	6524-9	J:93665	15374963
92746	Targeted disruption of the 3p12 gene, Dutt1/Robo1, predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter.		Xian J; Aitchison A; Bobrow L; Corbett G; Pannell R; Rabbitts T; Rabbitts P		Cancer Res	64	2004	6432-7	J:93666	15374951
92747	Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.		Iida K; Itoh K; Kumagai Y; Oyasu R; Hattori K; Kawai K; Shimazui T; Akaza H; Yamamoto M		Cancer Res	64	2004	6424-31	J:93667	15374950
92748	alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.		Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW		Cancer Res	64	2004	6402-9	J:93668	15374947
92749	Ultraviolet B but not ultraviolet A radiation initiates melanoma.		De Fabo EC; Noonan FP; Fears T; Merlino G		Cancer Res	64	2004	6372-6	J:93669	15374941
92750	Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.		Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW		Cancer Res	64	2004	6394-401	J:93670	15374946
92751	Dissection of BXSB lupus phenotype using mice congenic for chromosome 1 demonstrates that separate intervals direct different aspects of disease.		Haywood ME; Rogers NJ; Rose SJ; Boyle J; McDermott A; Rankin JM; Thiruudaian V; Lewis MR; Fossati-Jimack L; Izui S; Walport MJ; Morley BJ		J Immunol	173	2004	4277-85	J:93760	15383556
92752	Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3.		Takaoka M; Harada H; Andl CD; Oyama K; Naomoto Y; Dempsey KL; Klein-Szanto AJ; El-Deiry WS; Grimberg A; Nakagawa H		Cancer Res	64	2004	7711-23	J:93836	15520175
92753	Mechanism of endogenous myc gene down-regulation in E mu-N-myc tumors.		Ma A; Smith RK; Tesfaye A; Achacoso P; Dildrop R; Rosenberg N; Alt FW		Mol Cell Biol	11	1991	440-4	J:93929	1986238
92754	TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.		Becker C; Fantini MC; Schramm C; Lehr HA; Wirtz S; Nikolaev A; Burg J; Strand S; Kiesslich R; Huber S; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Galle PR; Blessing M; Rose-John S; Neurath MF		Immunity	21	2004	491-501	J:93937	15485627
92755	MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.		Shachaf CM; Kopelman AM; Arvanitis C; Karlsson A; Beer S; Mandl S; Bachmann MH; Borowsky AD; Ruebner B; Cardiff RD; Yang Q; Bishop JM; Contag CH; Felsher DW		Nature	431	2004	1112-7	J:93899	15475948
92756	Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model.		Uhrbom L; Nerio E; Holland EC		Nat Med	10	2004	1257-1260	J:93965	15502845
92757	Interferon-gamma induced medulloblastoma in the developing cerebellum.		Lin W; Kemper A; McCarthy KD; Pytel P; Wang JP; Campbell IL; Utset MF; Popko B		J Neurosci	24	2004	10074-83	J:94092	15537876
92758	Proteotypic classification of spontaneous and transgenic mammary neoplasms.		Mikaelian I; Blades N; Churchill GA; Fancher K; Knowles BB; Eppig JT; Sundberg JP		Breast Cancer Res	6	2004	R668-79	J:94093	15535849
92759	The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis.		Carrick DM; Lai WS; Blackshear PJ		Arthritis Res Ther	6	2004	248-64	J:94094	15535838
92760	Genetic Loci that influence cause of death in a heterogeneous mouse stock.		Lipman R; Galecki A; Burke DT; Miller RA		J Gerontol A Biol Sci Med Sci	59	2004	B977-83	J:94096	15528770
92761	Hot-water extracts from adzuki beans (Vigna angularis) suppress not only the proliferation of KATO III cells in culture but also benzo(a)pyrene-induced tumorigenesis in mouse forestomatch.		Itoh T; Itoh Y; Mizutani M; Fujishiro K; Furuichi Y; Komiya T; Hibasami H		J Nutr Sci Vitaminol (Tokyo)	50	2004	295-9	J:94097	15527074
92762	Loss of heterozygosity and nonsense mutation in Apc in azoxymethane-induced colonic tumours in min mice.		Mollersen L; Paulsen JE; Alexander J		Anticancer Res	24	2004	2595-9	J:94102	15517863
92763	Hepatic Temporal Gene Expression Profiling in Helicobacter hepaticus-Infected A/JCr Mice.		Boutin S; Rogers A; Shen Z; Fry R; Love J; Nambiar P; Suerbaum S; Fox J		Toxicol Pathol	32	2004	678-93	J:94104	15513911
92764	Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis.		Crnic I; Strittmatter K; Cavallaro U; Kopfstein L; Jussila L; Alitalo K; Christofori G		Cancer Res	64	2004	8630-8	J:94451	15574770
92765	Heightened susceptibility to chronic gastritis, hyperplasia and metaplasia in Kcnq1 mutant mice.		Elso CM; Lu X; Culiat CT; Rutledge JC; Cacheiro NL; Generoso WM; Stubbs LJ		Hum Mol Genet	13	2004	2813-21	J:94410	15385447
92766	cAMP-dependent oncogenic action of Rap1b in the thyroid gland.		Ribeiro-Neto F; Leon A; Urbani-Brocard J; Lou L; Nyska A; Altschuler DL		J Biol Chem	279	2004	46868-75	J:94485	15331589
92767	Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts.		Direkze NC; Hodivala-Dilke K; Jeffery R; Hunt T; Poulsom R; Oukrif D; Alison MR; Wright NA		Cancer Res	64	2004	8492-5	J:94454	15574751
92768	An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice.		Stocklin E; Botteri F; Groner B		J Cell Biol	122	1993	199-208	J:94528	8100231
92769	Directed expression of an oncogene to the olfactory neuronal lineage in transgenic mice.		Largent BL; Sosnowski RG; Reed RR		J Neurosci	13	1993	300-12	J:94538	8423476
92770	Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.		Adhami VM; Siddiqui IA; Ahmad N; Gupta S; Mukhtar H		Cancer Res	64	2004	8715-22	J:94677	15574782
92771	Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression.		McLean GW; Komiyama NH; Serrels B; Asano H; Reynolds L; Conti F; Hodivala-Dilke K; Metzger D; Chambon P; Grant SG; Frame MC		Genes Dev	18	2004	2998-3003	J:94680	15601818
92772	Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha.		Zhang P; Iwasaki-Arai J; Iwasaki H; Fenyus ML; Dayaram T; Owens BM; Shigematsu H; Levantini E; Huettner CS; Lekstrom-Himes JA; Akashi K; Tenen DG		Immunity	21	2004	853-63	J:94682	15589173
92773	APRIL promotes B-1 cell-associated neoplasm.		Planelles L; Carvalho-Pinto CE; Hardenberg G; Smaniotto S; Savino W; Gomez-Caro R; Alvarez-Mon M; de Jong J; Eldering E; Martinez-A C; Medema JP; Hahne M		Cancer Cell	6	2004	399-408	J:94628	15488762
92774	Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.		Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB		Cancer Cell	6	2004	387-98	J:94629	15488761
92775	Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity.		Middendorp S; Zijlstra AJ; Kersseboom R; Dingjan GM; Jumaa H; Hendriks RW		Blood	105	2005	259-65	J:94768	15331445
92776	Developmental timing of activated erbB2 expression plays a critical role in the induction of mammary tumors.		Andrechek ER; Muller WJ		Cell Cycle	3	2004	1111-3	J:94769	15326381
92777	Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.		Argilla D; Chin K; Singh M; Hodgson JG; Bosenberg M; de Solorzano CO; Lockett S; DePinho RA; Gray J; Hanahan D		Cancer Cell	6	2004	373-85	J:94774	15488760
92778	2-AAF-induced tumor development in nucleotide excision repair-deficient mice is associated with a defect in global genome repair but not with transcription coupled repair.		Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; van den Berg J; van Kreijl CF; Vos JG; de Vries A; van Steeg H		DNA Repair (Amst)	4	2005	3-9	J:94445	15533832
92779	Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.		Nielsen AA; Sorensen AB; Schmidt J; Pedersen FS		J Virol	79	2005	67-78	J:94815	15596802
92780	Deregulated expression of the Myc cellular oncogene drives development of mouse 'Burkitt-like' lymphomas from naive B cells.		Zhu D; Qi CF; Morse HC rd; Janz S; Stevenson FK		Blood	105	2005	2135-7	J:95904	15522957
92781	Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin.		Rodriguez-Puebla ML; LaCava M; Bolontrade MF; Russell J; Conti CJ		Mol Carcinog	26	1999	150-6	J:59554	10559789
92782	Loss of palindromic symmetry in Tg.AC mice with a nonresponder phenotype.		Honchel R; Rosenzweig BA; Thompson KL; Blanchard KT; Furst SM; Stoll RE; Sistare FD		Mol Carcinog	30	2001	99-110	J:94915	11241757
92783	Strain-specific of alachlor on murine olfactory mucosal responses.		Genter MB; Goss KH; Groden J		Toxicol Pathol	32	2004	719-25	J:94917	15580706
92784	UVB-induced apoptosis drives clonal expansion during skin tumor development.		Zhang W; Hanks AN; Boucher K; Florell SR; Allen SM; Alexander A; Brash DE; Grossman D		Carcinogenesis	26	2005	249-57	J:95011	15498793
92785	Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.		Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM		Carcinogenesis	26	2005	219-27	J:95013	15447978
92786	Targeted over-expression of mPGES-1 and elevated PGE2 production is not sufficient for lung tumorigenesis in mice.		Blaine SA; Meyer AM; Hurteau G; Wick M; Hankin JA; Murphy RC; Dannenberg AJ; Geraci MW; Subbaramaiah K; Nemenoff RA		Carcinogenesis	26	2005	209-17	J:95014	15471895
92787	Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice.		Paul B; Hayes CS; Kim A; Athar M; Gilmour SK		Carcinogenesis	26	2005	119-24	J:95015	15375010
92788	Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development.		Bai Y; Edamatsu H; Maeda S; Saito H; Suzuki N; Satoh T; Kataoka T		Cancer Res	64	2004	8808-10	J:94952	15604236
92789	Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors.		Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos S; Robinson-White A; Lenherr S; Weinberg FD; Claflin E; Meoli E; Cho-Chung YS; Stratakis CA		Cancer Res	64	2004	8811-5	J:94953	15604237
92790	Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis.		Vitale-Cross L; Amornphimoltham P; Fisher G; Molinolo AA; Gutkind JS		Cancer Res	64	2004	8804-7	J:94955	15604235
92791	Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.		Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP		Cancer Res	64	2004	8876-81	J:94956	15604247
92792	Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.		Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T		Cancer Res	64	2004	8882-90	J:94957	15604248
92793	Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors.		Muraoka-Cook RS; Kurokawa H; Koh Y; Forbes JT; Roebuck LR; Barcellos-Hoff MH; Moody SE; Chodosh LA; Arteaga CL		Cancer Res	64	2004	9002-11	J:94958	15604265
92794	Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics.		Reyzer ML; Caldwell RL; Dugger TC; Forbes JT; Ritter CA; Guix M; Arteaga CL; Caprioli RM		Cancer Res	64	2004	9093-100	J:94959	15604278
92795	Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh).		Raafat A; Bargo S; Anver MR; Callahan R		Oncogene	23	2004	9401-7	J:94961	15531924
92796	The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice.		Greer P; Haigh J; Mbamalu G; Khoo W; Bernstein A; Pawson T		Mol Cell Biol	14	1994	6755-63	J:95056	7523858
92797	Transgenic mouse model of malignant skin melanoma.		Mintz B; Silvers WK		Proc Natl Acad Sci U S A	90	1993	8817-21	J:95063	8415613
92798	Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.		Lee L; Sudentas P; Donohue B; Asrican K; Worku A; Walker V; Sun Y; Schmidt K; Albert MS; El-Hashemite N; Lader AS; Onda H; Zhang H; Kwiatkowski DJ; Dabora SL		Genes Chromosomes Cancer	42	2005	213-27	J:95229	15578690
92799	Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation.		Boxer RB; Jang JW; Sintasath L; Chodosh LA		Cancer Cell	6	2004	577-86	J:95304	15607962
92800	Sak/Plk4 and mitotic fidelity.		Swallow CJ; Ko MA; Siddiqui NU; Hudson JW; Dennis JW		Oncogene	24	2005	306-12	J:95395	15640847
92801	Leukemogenesis caused by incapacitated GATA-1 function.		Shimizu R; Kuroha T; Ohneda O; Pan X; Ohneda K; Takahashi S; Philipsen S; Yamamoto M		Mol Cell Biol	24	2004	10814-25	J:95112	15572684
92802	Poly(ADP-ribosyl)ation and aging.		Burkle A; Beneke S; Muiras ML		Exp Gerontol	39	2004	1599-1601	J:95471	15582275
92803	Effect of ethanol on the tumorigenicity of urethane (ethyl carbamate) in B6C3F(1) mice.		Beland FA; Benson RW; Mellick PW; Kovatch RM; Roberts DW; Fang JL; Doerge DR		Food Chem Toxicol	43	2005	1-19	J:95472	15582191
92804	Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations.		Carroll SL; Stonecypher MS		J Neuropathol Exp Neurol	63	2004	1115-23	J:95473	15581179
92805	TYK2 is a key regulator of the surveillance of B lymphoid tumors.		Stoiber D; Kovacic B; Schuster C; Schellack C; Karaghiosoff M; Kreibich R; Weisz E; Artwohl M; Kleine OC; Muller M; Baumgartner-Parzer S; Ghysdael J; Freissmuth M; Sexl V		J Clin Invest	114	2004	1650-8	J:95477	15578097
92806	Effects of soy-derived isoflavones and a high-fat diet on spontaneous mammary tumor development in Tg.NK (MMTV/c-neu) mice.		Luijten M; Thomsen AR; van den Berg JA; Wester PW; Verhoef A; Nagelkerke NJ; Adlercreutz H; van Kranen HJ; Piersma AH; Sorensen IK; Rao GN; van Kreijl CF		Nutr Cancer	50	2004	46-54	J:95478	15572297
92807	6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity.		Balzarini J; Pannecouque C; Naesens L; Andrei G; Snoeck R; De Clercq E; Hockova D; Holy A		Nucleosides Nucleotides Nucleic Acids	23	2004	1321-7	J:95479	15571252
92808	Effects of energy balance on cancer in genetically altered mice.		Patel AC; Nunez NP; Perkins SN; Barrett JC; Hursting SD		J Nutr	134	2004	3394S-8S	J:95481	15570044
92809	Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.		Narayanan BA; Narayanan NK; Pittman B; Reddy BS		Clin Cancer Res	10	2004	7727-37	J:95483	15570007
92810	Inactivation of imprinted genes induced by cellular stress and tumorigenesis.		Pantoja C; de Los Rios L; Matheu A; Antequera F; Serrano M		Cancer Res	65	2005	26-33	J:95440	15665276
92811	Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.		Kawamori T; Kitamura T; Watanabe K; Uchiya N; Maruyama T; Narumiya S; Sugimura T; Wakabayashi K		Carcinogenesis	26	2005	353-7	J:95533	15564292
92812	Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin.		Lee JY; Shin JW; Chun KS; Park KK; Chung WY; Bang YJ; Sung JH; Surh YJ		Carcinogenesis	26	2005	359-67	J:95534	15498788
92813	Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.		Gulliver GA; Herber RL; Liem A; Lambert PF		J Virol	71	1997	5905-14	J:95537	9223480
92814	Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma.		O'Hagan RC; Brennan CW; Strahs A; Zhang X; Kannan K; Donovan M; Cauwels C; Sharpless NE; Wong WH; Chin L		Cancer Res	63	2003	5352-6	J:95538	14500367
92815	Tumor susceptibility of Rassf1a knockout mice.		Tommasi S; Dammann R; Zhang Z; Wang Y; Liu L; Tsark WM; Wilczynski SP; Li J; You M; Pfeifer GP		Cancer Res	65	2005	92-8	J:95683	15665283
92816	Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulator.		Keegan CE; Hutz JE; Else T; Adamska M; Shah SP; Kent AE; Howes JM; Beamer WG; Hammer GD		Hum Mol Genet	14	2005	113-23	J:95686	15537664
92817	Ron tyrosine kinase receptor regulates papilloma growth and malignant conversion in a murine model of skin carcinogenesis.		Chan EL; Peace BE; Collins MH; Toney-Earley K; Waltz SE		Oncogene	24	2005	479-88	J:95632	15531916
92818	Tumor-prone phenotype of the DDB2-deficient mice.		Yoon T; Chakrabortty A; Franks R; Valli T; Kiyokawa H; Raychaudhuri P		Oncogene	24	2005	469-78	J:95633	15558025
92819	Malignancy of eye melanomas originating in the retinal pigment epithelium of transgenic mice after genetic ablation of choroidal melanocytes.		Mintz B; Klein-Szanto AJ		Proc Natl Acad Sci U S A	89	1992	11421-5	J:95743	1454829
92820	Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling.		Carroll SL; Stonecypher MS		J Neuropathol Exp Neurol	64	2005	1-9	J:95869	15715079
92821	Modulation of liver tumorigenesis in Connexin32-deficient mouse.		Luebeck EG; Buchmann A; Schneider D; Moolgavkar SH; Schwarz M		Mutat Res	570	2005	33-47	J:95870	15680401
92822	Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.		Ling BC; Wu J; Miller SJ; Monk KR; Shamekh R; Rizvi TA; Decourten-Myers G; Vogel KS; DeClue JE; Ratner N		Cancer Cell	7	2005	65-75	J:95933	15652750
92823	Powerful skin cancer protection by a CPD-photolyase transgene.		Jans J; Schul W; Sert YG; Rijksen Y; Rebel H; Eker AP; Nakajima S; van Steeg H; de Gruijl FR; Yasui A; Hoeijmakers JH; van der Horst GT		Curr Biol	15	2005	105-15	J:95934	15668165
92824	Role of estrogens in development of prostate cancer.		Harkonen PL; Makela SI		J Steroid Biochem Mol Biol	92	2004	297-305	J:95939	15663993
92825	A targeted mutation of Nkd1 impairs mouse spermatogenesis.		Li Q; Ishikawa TO; Miyoshi H; Oshima M; Taketo MM		J Biol Chem	280	2005	2831-9	J:95901	15546883
92826	WNT and Cyclooxygenase-2 Cross-talk Accelerates Adenoma Growth.		Wang D; Mann JR; Dubois RN		Cell Cycle	3	2004	1512-5	J:95903	15539957
92827	Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium.		Ohno N; Terada N; Murata S; Yamakawa H; Newsham IF; Katoh R; Ohara O; Ohno S		Histochem Cell Biol	122	2004	579-86	J:95905	15517334
92828	COOH-terminal 26-amino acid residues of progastrin are sufficient for stimulation of mitosis in murine colonic epithelium in vivo.		Ottewell PD; Varro A; Dockray GJ; Kirton CM; Watson AJ; Wang TC; Dimaline R; Pritchard DM		Am J Physiol Gastrointest Liver Physiol	288	2005	G541-9	J:95906	15486344
92829	Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability.		Criscuoli ML; Nguyen M; Eliceiri BP		Blood	105	2005	1508-14	J:95907	15486073
92830	Muscle-specific Pten deletion protects against insulin resistance and diabetes.		Wijesekara N; Konrad D; Eweida M; Jefferies C; Liadis N; Giacca A; Crackower M; Suzuki A; Mak TW; Kahn CR; Klip A; Woo M		Mol Cell Biol	25	2005	1135-45	J:95993	15657439
92831	Mutation of the androgen receptor causes oncogenic transformation of the prostate.		Han G; Buchanan G; Ittmann M; Harris JM; Yu X; Demayo FJ; Tilley W; Greenberg NM		Proc Natl Acad Sci U S A	102	2005	1151-6	J:96117	15657128
92832	Directing oncogenic fusion genes into stem cells via an SCL enhancer.		Eguchi M; Eguchi-Ishimae M; Green A; Enver T; Greaves M		Proc Natl Acad Sci U S A	102	2005	1133-8	J:96118	15650051
92833	Increase of smooth muscle cell migration and of intimal hyperplasia in mice lacking the alpha/beta hydrolase domain containing 2 gene.		Miyata K; Oike Y; Hoshii T; Maekawa H; Ogawa H; Suda T; Araki K; Yamamura KI		Biochem Biophys Res Commun	329	2005	296-304	J:96209	15721306
92834	Lack of histamine alters gastric mucosal morphology: comparison of histidine decarboxylase-deficient and mast cell-deficient mice.		Nakamura E; Kataoka T; Furutani K; Jimbo K; Aihara T; Tanaka S; Ichikawa A; Ohtsu H; Okabe S		Am J Physiol Gastrointest Liver Physiol	287	2004	G1053-61	J:96160	15271653
92835	Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/+) mouse model of colorectal cancer.		Javid SH; Moran AE; Carothers AM; Redston M; Bertagnolli MM		Carcinogenesis	26	2005	587-95	J:96347	15579483
92836	Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.		Dinulescu DM; Ince TA; Quade BJ; Shafer SA; Crowley D; Jacks T		Nat Med	11	2005	63-70	J:96296	15619626
92837	Carcinogenicity and chronic toxicity after inhalation exposure of rats and mice to N,N-dimethylformamide.		Senoh H; Aiso S; Arito H; Nishizawa T; Nagano K; Yamamoto S; Matsushima T		J Occup Health	46	2004	429-39	J:96298	15613765
92838	Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis.		Pelengaris S; Abouna S; Cheung L; Ifandi V; Zervou S; Khan M		BMC Biol	2	2004	26	J:96299	15613240
92839	Orofacial and gastrointestinal hyperplasia and neoplasia in smad4 and elf/smad4 mutant mice.		Redman RS; Katuri V; Tang Y; Dillner A; Mishra B; Mishra L		J Oral Pathol Med	34	2005	23-9	J:96300	15610403
92840	Development of a conditional mouse model for head and neck squamous cell carcinoma.		Bindels EM; van den Brekel MW		Adv Otorhinolaryngol	62	2005	1-11	J:96301	15608413
92841	Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.		Mirsalis JC; Shimon JA; Johnson A; Fairchild D; Kanazawa N; Nguyen T; de Boer J; Glickman B; Winegar RA		Environ Mol Mutagen	45	2005	17-35	J:96303	15605353
92842	Wnt1 is epistatic to Id2 in inducing mammary hyperplasia, ductal side-branching, and tumors in the mouse.		Marino S; Romelfanger C; Yokota Y; Nusse R		BMC Cancer	4	2004	91	J:96305	15601467
92843	Antiangiogenic gene therapy of myeloproliferative disease developed in transgenic mice expressing P230 bcr/abl.		Miyake K; Inokuchi K; Miyake N; Dan K; Shimada T		Gene Ther	12	2005	541-5	J:96309	15616602
92844	Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity.		Descargues P; Deraison C; Bonnart C; Kreft M; Kishibe M; Ishida-Yamamoto A; Elias P; Barrandon Y; Zambruno G; Sonnenberg A; Hovnanian A		Nat Genet	37	2005	56-65	J:96435	15619623
92845	An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.		Sweet-Cordero A; Mukherjee S; Subramanian A; You H; Roix JJ; Ladd-Acosta C; Mesirov J; Golub TR; Jacks T		Nat Genet	37	2005	48-55	J:96436	15608639
92846	Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis.		Ma DW; Finnell RH; Davidson LA; Callaway ES; Spiegelstein O; Piedrahita JA; Salbaum JM; Kappen C; Weeks BR; James J; Bozinov D; Lupton JR; Chapkin RS		Cancer Res	65	2005	887-97	J:96380	15705887
92847	Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention.		Liu B; Edgerton S; Yang X; Kim A; Ordonez-Ercan D; Mason T; Alvarez K; McKimmey C; Liu N; Thor A		Cancer Res	65	2005	879-86	J:96381	15705886
92848	Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice.		Zhou Z; Flesken-Nikitin A; Levine CG; Shmidt EN; Eng JP; Nikitina EY; Spencer DM; Nikitin AY		Cancer Res	65	2005	787-96	J:96382	15705875
92849	Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens.		Iida M; Anna CH; Holliday WM; Collins JB; Cunningham ML; Sills RC; Devereux TR		Carcinogenesis	26	2005	689-99	J:96384	15618236
92850	Modulation of light-induced skin tumors by N-acetylcysteine and/or ascorbic acid in hairless mice.		D'Agostini F; Balansky RM; Camoirano A; De Flora S		Carcinogenesis	26	2005	657-64	J:96385	15618233
92851	Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis.		Koschmieder S; Gottgens B; Zhang P; Iwasaki-Arai J; Akashi K; Kutok JL; Dayaram T; Geary K; Green AR; Tenen DG; Huettner CS		Blood	105	2005	324-34	J:96511	15331442
92852	In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice.		Sanchez P; Ruiz i Altaba A		Mech Dev	122	2005	223-30	J:96475	15652709
92853	Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation.		Schoonjans K; Dubuquoy L; Mebis J; Fayard E; Wendling O; Haby C; Geboes K; Auwerx J		Proc Natl Acad Sci U S A	102	2005	2058-62	J:96476	15684064
92854	VDUP1 is required for the development of natural killer cells.		Lee KN; Kang HS; Jeon JH; Kim EM; Yoon SR; Song H; Lyu CY; Piao ZH; Kim SU; Han YH; Song SS; Lee YH; Song KS; Kim YM; Yu DY; Choi I		Immunity	22	2005	195-208	J:96677	15723808
92855	Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model.		Brake T; Lambert PF		Proc Natl Acad Sci U S A	102	2005	2490-5	J:96639	15699322
92856	Modeling variation in tumors in vivo.		Stringer JR; Larson JS; Fischer JM; Medvedovic M; Hersh MN; Boivin GP; Stringer SL		Proc Natl Acad Sci U S A	102	2005	2408-13	J:96640	15695337
92857	Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout mice.		van Kranen HJ; Westerman A; Berg RJ; Kram N; van Kreijl CF; Wester PW; de Gruijl FR		Mutat Res	571	2005	81-90	J:96767	15748640
92858	Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia.		Kim SH; Roth KA; Moser AR; Gordon JI		J Cell Biol	123	1993	877-93	J:96717	8227147
92859	Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma.		von Felbert V; Cordoba F; Weissenberger J; Vallan C; Kato M; Nakashima I; Braathen LR; Weis J		Am J Pathol	166	2005	831-41	J:96719	15743795
92860	The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR.		Park BJ; Kang JW; Lee SW; Choi SJ; Shin YK; Ahn YH; Choi YH; Choi D; Lee KS; Kim S		Cell	120	2005	209-21	J:96923	15680327
92861	Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model.		Duan W; Gabril MY; Moussa M; Chan FL; Sakai H; Fong G; Xuan JW		Oncogene	24	2005	1510-24	J:96884	15674347
92862	Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage.		Wiemann SU; Satyanarayana A; Buer J; Kamino K; Manns MP; Rudolph KL		Oncogene	24	2005	1501-9	J:96885	15608677
92863	Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model.		Gupta V; Carey JL; Kawakubo H; Muzikansky A; Green JE; Donahoe PK; MacLaughlin DT; Maheswaran S		Proc Natl Acad Sci U S A	102	2005	3219-24	J:97014	15728372
92864	Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice.		Sakatani T; Kaneda A; Iacobuzio-Donahue CA; Carter MG; de Boom Witzel S; Okano H; Ko MS; Ohlsson R; Longo DL; Feinberg AP		Science	307	2005	1976-8	J:97083	15731405
92865	Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.		Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y		Mutat Res	572	2005	132-41	J:97087	15790496
92866	Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional brca1 in ovarian granulosa cells.		Chodankar R; Kwang S; Sangiorgi F; Hong H; Yen HY; Deng C; Pike MC; Shuler CF; Maxson R; Dubeau L		Curr Biol	15	2005	561-5	J:97090	15797026
92867	PHOX2B Genotype Allows for Prediction of Tumor Risk in Congenital Central Hypoventilation Syndrome.		Trochet D; O'brien LM; Gozal D; Trang H; Nordenskjold A; Laudier B; Svensson PJ; Uhrig S; Cole T; Munnich A; Gaultier C; Lyonnet S; Amiel J		Am J Hum Genet	76	2005	421-6	J:96308	15657873
92868	Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.		Webb M; Emberley ED; Lizardo M; Alowami S; Qing G; Alfia'ar A; Snell-Curtis LJ; Niu Y; Civetta A; Myal Y; Shiu R; Murphy LC; Watson PH		BMC Cancer	5	2005	17	J:97056	15717926
92869	Gene Expression Analysis of Immune-Mediated Arrest of Tumorigenesis in a Transgenic Mouse Model of HER-2/neu-Positive Basal-Like Mammary Carcinoma.		Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL		Am J Pathol	166	2005	1205-16	J:97061	15793299
92870	Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.		Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC		Cancer Res	65	2005	2065-9	J:97154	15781613
92871	Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis.		Iskander K; Gaikwad A; Paquet M; Long DJ nd; Brayton C; Barrios R; Jaiswal AK		Cancer Res	65	2005	2054-8	J:97155	15781611
92872	Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.		Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL		Cancer Res	65	2005	2296-302	J:97162	15781643
92873	Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth.		Cha TL; Qiu L; Chen CT; Wen Y; Hung MC		Cancer Res	65	2005	2287-95	J:97163	15781642
92888	Pathology image and annotation source		Mikaelian I; Sundberg JP		Personal Communication		2004		J:97123	 
92890	Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia.		Xu Z; Chen L; Leung L; Yen TS; Lee C; Chan JY		Proc Natl Acad Sci U S A	102	2005	4120-5	J:97188	15738389
92891	Melanoma genetics and the development of rational therapeutics.		Chudnovsky Y; Khavari PA; Adams AE		J Clin Invest	115	2005	813-24	J:97325	15841168
92892	Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.		Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T		J Clin Invest	115	2005	910-918	J:97328	15761494
92893	UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency.		Tanaka K; Kamiuchi S; Ren Y; Yonemasu R; Ichikawa M; Murai H; Yoshino M; Takeuchi S; Saijo M; Nakatsu Y; Miyauchi-Hashimoto H; Horio T		Mutat Res	477	2001	31-40	J:97333	11376684
92894	A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.		Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T		Proc Natl Acad Sci U S A	102	2005	4506-11	J:97285	15767564
92895	Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice.		Hursting SD; Perkins SN; Phang JM		Proc Natl Acad Sci U S A	91	1994	7036-40	J:97286	8041741
92896	Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes.		Wiseman RW; Cochran C; Dietrich W; Lander ES; Soderkvist P		Proc Natl Acad Sci U S A	91	1994	3759-63	J:97287	8170984
92897	Expression profiling of murine intestinal adenomas reveals early deregulation of multiple matrix metalloproteinase (Mmp) genes.		Martinez C; Bhattacharya S; Freeman T; Churchman M; Ilyas M		J Pathol	206	2005	100-10	J:97518	15809971
92898	Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor.		Lucas PJ; Kim SJ; Melby SJ; Gress RE		J Exp Med	191	2000	1187-96	J:97523	10748236
92899	Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation.		Berton TR; Mitchell DL; Guo R; Johnson DG		Oncogene	24	2005	2449-60	J:97525	15735727
92900	MBD2 deficiency does not accelerate p53 mediated lymphomagenesis.		Sansom OJ; Bishop SM; Bird A; Clarke AR		Oncogene	24	2005	2430-2	J:97526	15735763
92901	Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma.		Zavros Y; Eaton KA; Kang W; Rathinavelu S; Katukuri V; Kao JY; Samuelson LC; Merchant JL		Oncogene	24	2005	2354-66	J:97527	15735748
92902	The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.		Cardone M; Kandilci A; Carella C; Nilsson JA; Brennan JA; Sirma S; Ozbek U; Boyd K; Cleveland JL; Grosveld GC		Mol Cell Biol	25	2005	2395-405	J:97664	15743832
92903	Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland.		Denchi EL; Attwooll C; Pasini D; Helin K		Mol Cell Biol	25	2005	2660-72	J:97665	15767672
92904	Real time in vivo non-invasive optical imaging using near-infrared fluorescent quantum dots(1).	 	Morgan NY; English S; Chen W; Chernomordik V; Russo A; Smith PD; Gandjbakhche A	 	Acad Radiol	12	2005	313-23	J:97843	 
92905	PU.1 silencing leads to terminal differentiation of erythroleukemia cells.		Atar O; Levi BZ		Biochem Biophys Res Commun	329	2005	1288-92	J:97844	15766566
92906	Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues.		Pei XH; Xiong Y		Oncogene	24	2005	2787-95	J:97979	15838515
92907	A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice.		Turcotte K; Gauthier S; Tuite A; Mullick A; Malo D; Gros P		J Exp Med	201	2005	881-90	J:97931	15781580
92908	An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse.		Suttie AW; Dinse GE; Nyska A; Moser GJ; Goldsworthy TL; Maronpot RR		Toxicol Pathol	33	2005	386-97	J:97938	15805078
92909	Cyclin E in normal and neoplastic cell cycles.		Hwang HC; Clurman BE		Oncogene	24	2005	2776-86	J:97941	15838514
92910	Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice.		Kim Y; Hong HH; Lachat Y; Clayton NP; Devereux TR; Melnick RL; Hegi ME; Sills RC		Toxicol Pathol	33	2005	307-12	J:97942	15814359
92911	Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I.		Griffiths E; Ong H; Soloski MJ; Bachmann MF; Ohashi PS; Speiser DE		Cancer Res	58	1998	4682-7	J:50671	9788622
92912	Using EC and ES cell culture to study early development: recent observations on Indian hedgehog and Bmps.		Grabel L; Becker S; Lock L; Maye P; Zanders T		Int J Dev Biol	42	1998	917-25	J:51143	9853822
92913	Influence of aromatic hydrocarbon receptor-mediated events on the genotoxicity of cigarette smoke condensate.		Dertinger SD; Silverstone AE; Gasiewicz TA		Carcinogenesis	19	1998	2037-42	J:51246	9855021
92914	Verapamil inhibits tumor protease production, local invasion and metastasis development in murine carcinoma cells.		Farias EF; Aguirre Ghiso JA; Ladeda V; Bal de Kier Joffe E		Int J Cancer	78	1998	727-34	J:51475	9833766
92915	Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre.		Bojic U; Ehlers K; Ellerbeck U; Bacon CL; O'Driscoll E; O'Connell C; Berezin V; Kawa A; Lepekhin E; Bock E; Regan CM; Nau H		Eur J Pharmacol	354	1998	289-99	J:52649	9754931
92916	Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice.		Naoe Y; Kawamura I; Inami M; Matsumoto S; Nishigaki F; Tsujimoto S; Manda T; Shimomura K		Jpn J Cancer Res	89	1998	1318-25	J:52797	10081493
92917	Impact of 9-(2-phosphonylmethoxyethyl)adenine on (deoxy)ribonucleotide metabolism and nucleic acid synthesis in tumor cells.		Hatse S; De Clercq E; Balzarini J		FEBS Lett	445	1999	92-7	J:53245	10069380
92918	Tli1, a resistance locus for carcinogen-induced T-lymphoma.		Wielowieyski A; Brennan LA; Jongstra J		Mamm Genome	10	1999	623-7	J:55012	10341098
92919	Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied	by autoimmune depigmentation.	van Elsas A; Hurwitz AA; Allison JP		J Exp Med	190	1999	355-66	J:56799	10430624
92920	Differential sensitivity of double minute chromosomes to hydroxyurea treatment in cultured methotrexate-resistant mouse cells.		Nevaldine BH; Rizwana R; Hahn PJ		Mutat Res	406	1999	55-62	J:57523	10479722
92921	Evidence for a hsp25-specific mechanism involved in transcriptional activation by heat shock.		Neininger A; Gaestel M		Exp Cell Res	242	1998	285-93	J:50800	9665826
92922	The effect of hypergravity on carcinogenesis in mice.		Volegov VI; Ilyin EA		J Gravit Physiol	9	2002	P297-8	J:88744	15002589
92923	Spontaneous and radiation-induced leukemogenesis of the mouse small eye mutant, Pax6(Sey3H).		Nitta Y; Yoshida K; Satoh K; Senba K; Nakagata N; Peters J; Cattanach BM		J Radiat Res (Tokyo)	45	2004	245-51	J:92585	15304967
92924	Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis.		Yamasaki H; Omori Y; Zaidan-Dagli ML; Mironov N; Mesnil M; Krutovskikh V		Cancer Detect Prev	23	1999	273-9	J:57367	10403898
92925	Mouse models for colorectal cancer.		Heyer J; Yang K; Lipkin M; Edelmann W; Kucherlapati R		Oncogene	18	1999	5325-33	J:58239	10498885
92926	Prostate development and carcinogenesis in prolactin receptor knockout mice.		Robertson FG; Harris J; Naylor MJ; Oakes SR; Kindblom J; Dillner K; Wennbo H; Tornell J; Kelly PA; Green J; Ormandy CJ		Endocrinology	144	2003	3196-205	J:84352	12810576
92927	Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia.		Lee CR; Cervi D; Truong AH; Li YJ; Sarkar A; Ben-David Y		Anticancer Res	23	2003	2159-66	J:84992	12894591
92928	Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia.		Foster KW; Liu Z; Nail CD; Li X; Fitzgerald TJ; Bailey SK; Frost AR; Louro ID; Townes TM; Paterson AJ; Kudlow JE; Lobo-Ruppert SM; Ruppert JM		Oncogene	24	2005	1491-500	J:96886	15674344
92929	Activated dendritic cells from bone marrow cells of mice receiving cytokine-expressing tumor cells are associated with the enhanced survival of mice bearing syngeneic tumors.		Fujii S; Hamada H; Fujimoto K; Shimomura T; Kawakita M		Blood	93	1999	4328-35	J:55731	10361131
92930	Use of the glucose starvation-inducible glucose-regulated protein 78 promoter in suicide gene therapy of murine fibrosarcoma.		Gazit G; Hung G; Chen X; Anderson WF; Lee AS		Cancer Res	59	1999	3100-6	J:56098	10397251
92931	Preferential overexpression of a 172Arg-->Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development.		Li B; Greenberg N; Stephens LC; Meyn R; Medina D; Rosen JM		Cell Growth Differ	5	1994	711-21	J:56433	7947386
92932	Nitrobenzene potential human cancer risk based on animal studies.		Holder JW		Toxicol Ind Health	15	1999	458-63	J:59446	10487356
92933	Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin.		Robanus-Maandag E; Giovannini M; van der Valk M; Niwa-Kawakita M; Abramowski V; Antonescu C; Thomas G; Berns A		Oncogene	23	2004	6541-7	J:92413	15221010
92934	Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids.		Spiegelman VS; Budunova IV; Carbajal S; Slaga TJ		Mol Carcinog	20	1997	99-107	J:44371	9328440
92935	Tumour susceptibility to innate and adaptive immunotherapy changes during tumour maturation.		Stewart TJ; Fernando GJ; Frazer IH; Leggatt GR		Immunol Cell Biol	82	2004	455-61	J:93362	15479430
92936	Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cycloox	ygenase-2 and inducible nitric oxide synthase.	Tanaka T; Suzuki R; Kohno H; Sugie S; Takahashi M; Wakabayashi K		Carcinogenesis	26	2005	229-38	J:95012	15459021
92937	An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.		Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY		Mol Cell Biol	25	2005	124-35	J:95391	15601836
92938	EVI1 induces myelodysplastic syndrome in mice. (Correction 115:2296)		Buonamici S; Li D; Chi Y; Zhao R; Wang X; Brace L; Ni H; Saunthararajah Y; Nucifora G		J Clin Invest	114	2004	713-9	J:92885	15343390
92939	Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice.		Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y		Carcinogenesis	17	1996	2455-61	J:90307	8968063
92940	Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols.		Wang ZY; Agarwal R; Bickers DR; Mukhtar H		Carcinogenesis	12	1991	1527-30	J:90308	1860173
92941	Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.		Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS		Carcinogenesis	25	2004	901-8	J:88131	14742323
92942	Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16.		Melero I; Singhal MC; McGowan P; Haugen HS; Blake J; Hellstrom KE; Yang G; Clegg CH; Chen L		J Virol	71	1997	3998-4004	J:94539	9094677
92943	Cloning and chromosome assignment of the human CDX2 gene		Drummond F; Putt W; Fox M; Edwards YH		Ann Hum Genet	61	1997	393-400	J:45377	9459001
92944	Follicular origin of epidermal papillomas in v-Ha-ras transgenic TG.AC mouse skin.		Hansen LA; Tennant RW		Proc Natl Acad Sci U S A	91	1994	7822-6	J:95062	8052666
92945	Sasa health exerts a protective effect on Her2/NeuN mammary tumorigenesis.		Ren M; Reilly RT; Sacchi N		Anticancer Res	24	2004	2879-84	J:94101	15517891
92946	grb2 heterozygosity rescues embryonic lethality but not tumorigenesis in pten+/- mice.		Cully M; Elia A; Ong SH; Stambolic V; Pawson T; Tsao MS; Mak TW		Proc Natl Acad Sci U S A	101	2004	15358-63	J:93530	15492213
92947	Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands.		Shyamala G; Yang X; Silberstein G; Barcellos-Hoff MH; Dale E		Proc Natl Acad Sci U S A	95	1998	696-701	J:45538	9435255
92948	Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking.		Ye YN; Liu ES; Shin VY; Wu WK; Cho CH		Toxicology	203	2004	179-88	J:93404	15363593
92949	Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.		Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ		Oncol Rep	12	2004	709-16	J:93390	15375489
92950	Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene.		Ruggeri B; DiRado M; Zhang SY; Bauer B; Goodrow T; Klein-Szanto AJ		Proc Natl Acad Sci U S A	90	1993	1013-7	J:94916	8430068
92951	Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: implication for prevention against inflammation-related carcinogenesis.		Miyoshi N; Takabayashi S; Osawa T; Nakamura Y		Carcinogenesis	25	2004	567-75	J:89448	14688023
92952	Targeted expression of spermidine/spermine N1-acetyltransferase increases susceptibility to chemically induced skin carcinogenesis.		Coleman CS; Pegg AE; Megosh LC; Guo Y; Sawicki JA; O'Brien TG		Carcinogenesis	23	2002	359-64	J:75245	11872645
92953	Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha.		Sukhai MA; Wu X; Xuan Y; Zhang T; Reis PP; Dube K; Rego EM; Bhaumik M; Bailey DJ; Wells RA; Kamel-Reid S; Pandolfi PP		Oncogene	23	2004	665-78	J:88103	14737102
92954	Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms.		Akbulut H; Tang Y; Maynard J; Zhang L; Pizzorno G; Deisseroth A		Clin Cancer Res	10	2004	7738-46	J:95482	15570008
92955	Characterization of mice doubly transgenic for parathyroid hormone-related protein and murine placental lactogen: a novel role for placental lactogen in pancreatic beta-cell survival.		Fujinaka Y; Sipula D; Garcia-Ocana A; Vasavada RC		Diabetes	53	2004	3120-30	J:94579	15561942
92956	Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells.		Cesen-Cummings K; Fernstrom MJ; Malkinson AM; Ruch RJ		Carcinogenesis	19	1998	61-7	J:45636	9472694
92957	B-cell deficiency does not abrogate development of cutaneous hyperplasia in mice inheriting the defective fibrillin-1 gene		Kasturi KN; Hatakeyama A; Murai C; Gordon R; Phelps RG; Bona CA		J Autoimmun	10	1997	505-17	J:45060	9451590
92958	A role for id proteins in mammary gland physiology and tumorigenesis.		Candia P; Benera R; Solit DB		Adv Cancer Res	92	2004	81-94	J:94095	15530557
92959	Progression of Chronic Hepatitis and Preneoplasia in Helicobacter hepaticus-Infected A/JCr Mice.		Rogers A; Boutin S; Whary M; Sundina N; Ge Z; Cormier K; Fox J		Toxicol Pathol	32	2004	668-77	J:94105	15513910
92960	V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression		Jiang BH; Agani F; Passaniti A; Semenza GL		Cancer Res	57	1997	5328-35	J:44301	9393757
92961	Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences.		Grisolano JL; Wesselschmidt RL; Pelicci PG; Ley TJ		Blood	89	1997	376-87	J:77881	9002938
92962	Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model.		Osakabe N; Yasuda A; Natsume M; Yoshikawa T		Carcinogenesis	25	2004	549-57	J:88134	14729597
92963	Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.		Moran AE; Hunt DH; Javid SH; Redston M; Carothers AM; Bertagnolli MM		J Biol Chem	279	2004	43261-72	J:94014	15294912
92964	Stem cell factor enhances interleukin-2-mediated expansion of murine natural killer cells in vivo.		Fehniger TA; Carson WE; Mrozek E; Caligiuri MA		Blood	90	1997	3647-53	J:44566	9345049
92965	A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model.		Emtage PC; Wan Y; Bramson JL; Graham FL; Gauldie J		J Immunol	160	1998	2531-8	J:45926	9498799
92966	Amplification and novel locations of endogenous mouse mammary tumor virus genomes in mouse T-cell lymphomas.		Dudley J; Risser R		J Virol	49	1984	92-101	J:46438	6317898
92967	Effect of hepatoma H22 on lymphatic endothelium in vitro.		Yu H; Zhou HZ; Wang CM; Gu XM; Pan BR		World J Gastroenterol	10	2004	3428-32	J:94098	15526361
92968	V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.		Nacht M; Jacks T		Cell Growth Differ	9	1998	131-8	J:45810	9486849
92969	Diversity of epitopes recognized by cytotoxic T lymphocytes that are specific for rejection antigen peptide pRL1a presented on BALB/c leukemia RL Male 1.		Yokoi T; Uenaka A; Ono T; Onizuka S; Inoue H; Nakayama E		Int Immunol	9	1997	1195-201	J:44376	9263017
92970	Mapping of genetic modifiers of thymic lymphoma development in p53-knockout mice.		Ochiai Y; Tamura Y; Saito Y; Matsuki A; Wakabayashi Y; Aizawa Y; Niwa O; Kominami R		Oncogene	22	2003	1098-102	J:81940	12592396
92971	A minireview of chronic animal inhalation studies with mainstream cigarette smoke.		Coggins CR		Inhal Toxicol	14	2002	991-1002	J:79663	12396407
92972	Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice.		Rangarajan A; Weinberg RA		Nat Rev Cancer	3	2003	952-9	J:88100	14737125
92973	Downregulation of Muc1 in MMTV-c-Neu tumors.		Adriance MC; Gendler SJ		Oncogene	23	2004	697-705	J:88101	14737104
92974	Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly.		Wagner KU; Claudio E; Rucker EB rd; Riedlinger G; Broussard C; Schwartzberg PL; Siebenlist U; Hennighausen L		Development	127	2000	4949-58	J:75416	11044408
92975	E mu-RD2 transgenic mice develop B-cell lymphoma and leukemia.		Greenwald RJ; Tumang JR; Sinha A; Currier N; Cardiff RD; Rothstein TL; Faller DV; Denis GV		Blood	103	2004	1475-84	J:88243	14563639
92976	Apoptosis, cell proliferation and in vivo biological behaviour of primary and metastatic tumour cells of an AKR lymphoma variant.		Donin N; Katzenelson D; Ravia J; Hiss J; Schiby G; Kay S; Sinai J; Michowitz M; Leibovici J		Apoptosis	2	1997	214-220	J:44563	14646557
92977	Immunoregulation by interleukin-12 in MB49.1 tumor-bearing mice: cellular and cytokine-mediated effector mechanisms		Hunter SE; Waldburger KE; Thibodeaux DK; Schaub RG; Goldman SJ; Leonard JP		Eur J Immunol	27	1997	3438-46	J:45130	9464833
92978	Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization.		Buhl AM; Pleiman CM; Rickert RC; Cambier JC		J Exp Med	186	1997	1897-910	J:44404	9382888
92979	Expression of wild-type and mutant simian virus 40 large tumor antigens in villus-associated enterocytes of transgenic mice.		Kim SH; Roth KA; Coopersmith CM; Pipas JM; Gordon JI		Proc Natl Acad Sci U S A	91	1994	6914-8	J:91409	8041720
92980	Recent developments in the biology and therapy of T-cell and natural killer-cell lymphomas.		Porcu P; Baiocchi RA; Magro C		Curr Opin Oncol	15	2003	353-62	J:86097	12960516
92981	Characterization of the molecules involved in the hematopoietic microenvironment provided by mouse stromal cell line MC3T3-G2/PA6 using a unique reporter system that analyzes the direct cell-to-cell interaction.		Satoh M; Mioh H; Konishi N; Takahashi I; Tamaoki T		Acta Haematol	98	1997	95-103	J:44373	9286306
92982	Exacerbation of benzene pneumotoxicity in connexin 32 knockout mice: enhanced proliferation of CYP2E1-immunoreactive alveolar epithelial cells.		Yoon BI; Hirabayashi Y; Kawasaki Y; Tsuboi I; Ott T; Kodama Y; Kanno J; Kim DY; Willecke K; Inoue T		Toxicology	195	2004	19-29	J:87502	14698565
92983	A mouse model of uterine leiomyosarcoma.		Politi K; Szabolcs M; Fisher P; Kljuic A; Ludwig T; Efstratiadis A		Am J Pathol	164	2004	325-36	J:87503	14695345
92984	Frequent p53 mutations and occasional loss of chromosome 4 in invasive bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in B6D2F1 mice.		Ogawa K; Uzvolgyi E; St John MK; de Oliveira ML; Arnold L; Cohen SM		Mol Carcinog	21	1998	70-9	J:47069	9473773
92985	Systemic polyomavirus genome increase and dissemination of capsid-defective genomes in mammary gland tumor-bearing mice.		Wirth JJ; Chen L; Fluck MM		J Virol	74	2000	6975-83	J:63294	10888636
92986	Absence of p53-dependent cell cycle regulation in pluripotent mouse cell lines.		Schmidt-Kastner PK; Jardine K; Cormier M; McBurney MW		Oncogene	16	1998	3003-11	J:48165	9662333
92987	How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein.		Goodrich DW		J Cell Physiol	197	2003	169-80	J:85622	14502556
92988	RecQ helicases: suppressors of tumorigenesis and premature aging.		Bachrati CZ; Hickson ID		Biochem J	374	2003	577-606	J:85650	12803543
92989	Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity.		De Giovanni C; Landuzzi L; Nicoletti G; Astolfi A; Croci S; Micaroni M; Nanni P; Lollini PL		Int J Cancer	109	2004	200-6	J:88314	14750170
92990	pRb Inactivation in Mammary Cells Reveals Common Mechanisms for Tumor Initiation and Progression in Divergent Epithelia.		Simin K; Wu H; Lu L; Pinkel D; Albertson D; Cardiff RD; Dyke TV		PLoS Biol	2	2004	E22	J:88315	14966529
92991	Differential sensitivity of the tyrosyl radical of mouse ribonucleotide reductase to nitric oxide and peroxynitrite.		Guittet O; Ducastel B; Salem JS; Henry Y; Rubin H; Lemaire G; Lepoivre M		J Biol Chem	273	1998	22136-44	J:49250	9705359
92992	Targeted activation of {beta}-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.		Teuliere J; Faraldo MM; Deugnier MA; Shtutman M; Ben-Ze'ev A; Thiery JP; Glukhova MA		Development	132	2005	267-277	J:95360	15590737
92993	The metastatic characteristics of murine lymphoma cell lines in vivo are manifested after target organ invasion.		Aoudjit F; Potworowski EF; St-Pierre Y		Blood	91	1998	623-9	J:45595	9427718
92994	Vitamin d and colon carcinogenesis.		Harris DM; Go VL		J Nutr	134	2004	3463S-71S	J:95480	15570055
92995	Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.		Coughlin CM; Salhany KE; Wysocka M; Aruga E; Kurzawa H; Chang AE; Hunter CA; Fox JC; Trinchieri G; Lee WMF		J Clin Invest	101	1998	1441-52	J:46548	9502787
92996	Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice.		Tebbutt NC; Giraud AS; Inglese M; Jenkins B; Waring P; Clay FJ; Malki S; Alderman BM; Grail D; Hollande F; Heath JK; Ernst M		Nat Med	8	2002	1089-97	J:79073	12219085
92997	Enhanced antitumor effects of tumor antigen-pulsed dendritic cells by their transfection with GM-CSF gene		Cao X; Zhang W; Ma S; Zhang M; Wang J; Ye T		Sci China Ser C	40	1997	539-545	J:47636	 
92998	Simian virus 40 T antigen-induced gonadotroph adenomas: a model of human null cell adenomas.		Kumar TR; Graham KE; Asa SL; Low MJ		Endocrinology	139	1998	3342-51	J:49256	9645710
92999	Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis.		Greten FR; Weber CK; Greten TF; Schneider G; Wagner M; Adler G; Schmid RM		Gastroenterology	123	2002	2052-63	J:80283	12454861
93000	Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine.		Seril DN; Liao J; Ho KL; Yang CS; Yang GY		Carcinogenesis	23	2002	993-1001	J:77143	12082021
93001	The role of IL-4 and IL-10 cytokines in controlling an anti-tumor response in vivo.		Terres G; Coffman RL		Int Immunol	10	1998	823-32	J:48264	9678764
93002	VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.		Hirakawa S; Kodama S; Kunstfeld R; Kajiya K; Brown LF; Detmar M		J Exp Med	201	2005	1089-99	J:98045	15809353
93003	A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.		Yu L; Liu C; Bennett K; Wu YZ; Dai Z; Vandeusen J; Opavsky R; Raval A; Trikha P; Rodriguez B; Becknell B; Mao C; Lee S; Davuluri RV; Leone G; Van den Veyver IB; Caligiuri MA; Plass C		Genomics	84	2004	647-60	J:93366	15475242
93004	In vivo effects of activated H-ras oncogene expressed in the liver and in urogenital tissues.		Gilbert E; Morel A; Tulliez M; Maunoury R; Terzi F; Miquerol L; Kahn A		Int J Cancer	73	1997	749-56	J:44803	9398057
93005	Mutant herpes simplex virus-mediated suppression of retinoblastoma.		Kogishi J; Miyatake S; Hangai M; Akimoto M; Okazaki K; Honda Y		Curr Eye Res	18	1999	321-6	J:57194	10372992
93006	Apc gene knockout mice as a model for familial adenomatous polyposis.		Taketo MM		Prog Exp Tumor Res	35	1999	109-19	J:56383	10377755
93007	Inheritance of pulmonary adenoma susceptibility in mice.		Malkinson AM		Prog Exp Tumor Res	35	1999	78-94	J:56384	10377753
93008	Immunotherapy for lung metastases of murine renal cell carcinoma: synergy between radiation and cytokine-producing tumor vaccines.		Nishisaka N; Maini A; Kinoshita Y; Yasumoto R; Kishimoto T; Jones RF; Morse P; Hillman GG; Wang CY; Haas GP		J Immunother	22	1999	308-14	J:56473	10404432
93009	Tumor's other immune targets: dendritic cells.		Esche C; Lokshin A; Shurin GV; Gastman BR; Rabinowich H; Watkins SC; Lotze MT; Shurin MR		J Leukoc Biol	66	1999	336-44	J:56688	10449178
93010	Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.		Wang XJ; Greenhalgh DA; Roop DR		Mol Carcinog	27	2000	200-9	J:61214	10708482
93011	The paradox of E2F1: oncogene and tumor suppressor gene.		Johnson DG		Mol Carcinog	27	2000	151-7	J:61215	10708476
93012	Mutagenesis induced by oral carcinogens in lacZ mouse (MutaMouse) tongue and other oral tissues.		von Pressentin MM; Kosinska W; Guttenplan JB		Carcinogenesis	20	1999	2167-70	J:58422	10545421
93013	Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene.		Gressani KM; Leone-Kabler S; O'Sullivan MG; Case LD; Malkinson AM; Miller MS		Carcinogenesis	20	1999	2159-65	J:58423	10545420
93014	The MYC dualism in growth and death.		Fuhrmann G; Rosenberger G; Grusch M; Klein N; Hofmann J; Krupitza G		Mutat Res	437	1999	205-17	J:58890	10592328
93015	Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1.		Lewis MT; Ross S; Strickland PA; Sugnet CW; Jimenez E; Scott MP; Daniel CW		Development	126	1999	5181-93	J:42408	10529434
93016	Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ.		Frech MS; Halama ED; Tilli MT; Singh B; Gunther EJ; Chodosh LA; Flaws JA; Furth PA		Cancer Res	65	2005	681-5	J:96383	15705859
93017			Yamaguchi H		Genes Cells	1	1996	253-68	J:97838	9140068
93019	Genetic selection for high acute inflammatory response confers resistance to lung carcinogenesis in the mouse.		Ribeiro OG; Cabrera WH; Maria DA; De Franco M; Massa S; Di Pace RF; de Souza VR; Starobinas N; Semen M; Ibanez OM		Exp Lung Res	31	2005	105-16	J:97847	15765921
93020	Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity.		Spadaro M; Ambrosino E; Iezzi M; Di Carlo E; Sacchetti P; Curcio C; Amici A; Wei WZ; Musiani P; Lollini PL; Cavallo F; Forni G		Clin Cancer Res	11	2005	1941-52	J:97855	15756020
93021	The immunogenicity of dendritic cell-based vaccines is not hampered by Doxorubicin and melphalan administration.		Casati A; Zimmermann VS; Benigni F; Bertilaccio MT; Bellone M; Mondino A		J Immunol	174	2005	3317-25	J:97858	15749863
93022	Chemoprevention by Hippophae rhamnoides: Effects on Tumorigenesis, Phase II and Antioxidant Enzymes, and IRF-1 Transcription Factor.		Padmavathi B; Upreti M; Singh V; Rao AR; Singh RP; Rath PC		Nutr Cancer	51	2005	59-67	J:97859	15749631
93023	Insulin in aging and cancer: antidiabetic drug diabenol as geroprotector and anticarcinogen.		Popovich IG; Zabezhinski MA; Egormin PA; Tyndyk ML; Anikin IV; Spasov AA; Semenchenko AV; Yashin AI; Anisimov VN		Int J Biochem Cell Biol	37	2005	1117-29	J:97862	15743682
93024	Differential Roles of E-Type Cyclins During Transformation of Murine E2F-1-Deficient Cells.		Ishii H; Mimori K; Yoshikawa Y; Mori M; Furukawa Y; Vecchione A		DNA Cell Biol	24	2005	173-9	J:97842	15767783
93025	Mouse models incorporating alterations in the major tumor suppressor genes P53 and P16: their use in screening for potential carcinogens, developing further relevant mouse models, and screening for potential chemopreventive and chemotherapetutic agents.		Lubet R; Wang Y; Zhang Z; You M		Exp Lung Res	31	2005	117-33	J:97846	15765922
93026	Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice.		Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y		Oncol Rep	13	2005	491-5	J:97879	15706423
93027	New toxicity data for the propylene glycol ethers - a commitment to public health and safety.		Spencer PJ		Toxicol Lett	156	2005	181-8	J:97880	15705495
93028	U.S. EPA's IRIS assessment of 2-butoxyethanol: the relationship of noncancer to cancer effects.		Gift JS		Toxicol Lett	156	2005	163-78	J:97881	15705494
93029	Mode of action of butoxyethanol-induced mouse liver hemangiosarcomas and hepatocellular carcinomas.		Klaunig JE; Kamendulis LM		Toxicol Lett	156	2005	107-15	J:97882	15705491
93030	INRS activities on risk assessment of glycol ethers.		Fastier A; Herve-Bazin B; McGregor DB		Toxicol Lett	156	2005	59-76	J:97883	15705488
93031	Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.		Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR		BMC Cancer	5	2005	15	J:97885	15703070
93032	Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.		Dunois-Larde C; Levrel O; Brams A; Thiery JP; Radvanyi F		Mol Carcinog	42	2005	142-9	J:97886	15690367
93033	A mouse model of Werner Syndrome: what can it tell us about aging and cancer?		Chang S		Int J Biochem Cell Biol	37	2005	991-9	J:97864	15743673
93034	Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor-1 knock-out mice.		Mannick EE; Cote RL; Schurr JR; Krowicka HS; Sloop GD; Zapata-Velandia A; Correa H; Ruiz B; Horswell R; Lentz JJ; Byrne P; Gastanaduy MM; Hornick CA; Liu Z		J Gastroenterol Hepatol	20	2005	371-80	J:97866	15740479
93035	Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane.		Suzuki R; Kohno H; Sugie S; Tanaka T		Histol Histopathol	20	2005	483-92	J:97867	15736053
93036	Overexpression of Cyclin D1 in Pancreatic {beta}-Cells In Vivo Results in Islet Hyperplasia Without Hypoglycemia.		Zhang X; Gaspard JP; Mizukami Y; Li J; Graeme-Cook F; Chung DC		Diabetes	54	2005	712-9	J:97869	15734847
93037	Therapeutic efficacy of MUC1-specific cytotoxic T lymphocytes and CD137 co-stimulation in a spontaneous breast cancer model.		Mukherjee P; Tinder TL; Basu GD; Pathangey LB; Chen L; Gendler SJ		Breast Dis	20	2004	53-63	J:97888	15687707
93038	Immunobiology of her-2/neu transgenic mice.		Pannellini T; Forni G; Musiani P		Breast Dis	20	2004	33-42	J:97889	15687705
93039	Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling.		Ye Y; Qiu TH; Kavanaugh C; Green JE		Breast Dis	19	2004	69-82	J:97890	15687699
93040	Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-exposed hairless mice.		Liu Y; Viau G; Bissonnette R		J Cutan Med Surg	8	2004	131-9	J:97892	15685390
93041	Levels of 4-aminobiphenyl-induced somatic H-ras mutation in mouse liver DNA correlate with potential for liver tumor development.		Parsons BL; Beland FA; Von Tungeln LS; Delongchamp RR; Fu PP; Heflich RH		Mol Carcinog	42	2005	193-201	J:97894	15761837
93042	Gadd45a acts as a modifier locus for lymphoblastic lymphoma.		Hollander MC; Patterson AD; Salvador JM; Anver MR; Hunger SP; Fornace AJ		Leukemia	19	2005	847-50	J:97896	15744335
93043	An unusual gene dosage effect of p27kip1 in a mouse model of prostate cancer.		Abate-Shen C; Shen MM		Cell Cycle	4	2005	e45-7	J:97898	15701964
93044	Wnt signalling in stem cells and cancer.		Reya T; Clevers H		Nature	434	2005	843-50	J:98117	15829953
93045	Sheep retrovirus structural protein induces lung tumours.		Wootton SK; Halbert CL; Miller AD		Nature	434	2005	904-7	J:98116	15829964
93046	Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter.		Sugaya M; Watanabe T; Yang A; Starost MF; Kobayashi H; Atkins AM; Borris DL; Hanan EA; Schimel D; Bryant MA; Roberts N; Skobe M; Staskus KA; Kaldis P; Blauvelt A		Blood	105	2005	2356-63	J:98130	15536152
93047	Frizzled 9 knock-out mice have abnormal B-cell development.		Ranheim EA; Kwan HC; Reya T; Wang YK; Weissman IL; Francke U		Blood	105	2005	2487-94	J:98133	15572594
93048	C-Abl as a modulator of p53.		Levav-Cohen Y; Goldberg Z; Zuckerman V; Grossman T; Haupt S; Haupt Y		Biochem Biophys Res Commun	331	2005	737-49	J:98174	15865930
93049	Death squads enlisted by the tumour suppressor p53.		Michalak E; Villunger A; Erlacher M; Strasser A		Biochem Biophys Res Commun	331	2005	786-98	J:98175	15865934
93050	p53 mutation heterogeneity in cancer.		Soussi T; Lozano G		Biochem Biophys Res Commun	331	2005	834-842	J:98177	15865939
93051	Mdmx as an essential regulator of p53 activity.		Marine JC; Jochemsen AG		Biochem Biophys Res Commun	331	2005	750-60	J:98176	15865931
93052	T cell-mediated delay of spontaneous mammary tumor onset: increased efficacy with in vivo versus in vitro activation.		O'Mara LA; Norian LA; Kreamalmeyer D; White JM; Allen PM		J Immunol	174	2005	4662-9	J:98157	15814690
93053	Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment.		Iyengar P; Espina V; Williams TW; Lin Y; Berry D; Jelicks LA; Lee H; Temple K; Graves R; Pollard J; Chopra N; Russell RG; Sasisekharan R; Trock BJ; Lippman M; Calvert VS; Petricoin EF; Liotta L; Dadachova E; Pestell RG; Lisanti MP; Bonaldo P; Scherer PE		J Clin Invest	115	2005	1163-1176	J:98091	15841211
93054			Schoeffner DJ		Lab Invest	85	2005	608-623	J:98204	15765121
93055			Matsuda M		Lab Invest	85	2005	655-663	J:98206	15765122
93056	Animal models of acute myelogenous leukaemia - development, application and future perspectives.		McCormack E; Bruserud O; Gjertsen BT		Leukemia	19	2005	687-706	J:98112	15759039
93057	SLUG in cancer development.		Perez-Mancera PA; Gonzalez-Herrero I; Perez-Caro M; Gutierrez-Cianca N; Flores T; Gutierrez-Adan A; Pintado B; Sanchez-Martin M; Sanchez-Garcia I		Oncogene	24	2005	3073-82	J:98295	15735690
93058	Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors.		Galli UM; Sauter M; Lecher B; Maurer S; Herbst H; Roemer K; Mueller-Lantzsch N		Oncogene	24	2005	3223-8	J:98279	15735668
93059	Chemoprevention of UV light-induced skin tumorigenesis by inhibition of the epidermal growth factor receptor.		El-Abaseri TB; Fuhrman J; Trempus C; Shendrik I; Tennant RW; Hansen LA		Cancer Res	65	2005	3958-65	J:98332	15867397
93060	A survivin gene signature predicts aggressive tumor behavior.		Salz W; Eisenberg D; Plescia J; Garlick DS; Weiss RM; Wu XR; Sun TT; Altieri DC		Cancer Res	65	2005	3531-4	J:98361	15867343
93061	Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.		Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S		Oncogene	24	2005	3141-53	J:98342	15735679
93062	Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma.		Oliver TG; Read TA; Kessler JD; Mehmeti A; Wells JF; Huynh TT; Lin SM; Wechsler-Reya RJ		Development	132	2005	2425-39	J:98381	15843415
93063	Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.		Fedele M; Pentimalli F; Baldassarre G; Battista S; Klein-Szanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A		Oncogene	24	2005	3427-35	J:98383	15735694
93064	Mouse skin tumor promotion by sodium arsenate is associated with enhanced PCNA expression.		Motiwale L; Ingle AD; Rao KV		Cancer Lett	223	2005	27-35	J:98388	15890234
93065	Deletion of bid impedes cell proliferation and hepatic carcinogenesis.		Bai L; Ni HM; Chen X; Difrancesca D; Yin XM		Am J Pathol	166	2005	1523-32	J:98464	15855651
93066	Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival.		Hammerman PS; Fox CJ; Birnbaum MJ; Thompson CB		Blood	105	2005	4477-83	J:98472	15705789
93067	The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cells.		Shaked Y; Cervi D; Neuman M; Chen L; Klement G; Michaud CR; Haeri M; Pak BJ; Kerbel RS; Ben-David Y		Blood	105	2005	4500-7	J:98473	15701719
93068	The retinoblastoma gene pathway regulates the postmitotic state of hair cells of the mouse inner ear.		Mantela J; Jiang Z; Ylikoski J; Fritzsch B; Zacksenhaus E; Pirvola U		Development	132	2005	2377-88	J:98518	15843406
93069	Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.		Ackermann J; Frutschi M; Kaloulis K; McKee T; Trumpp A; Beermann F		Cancer Res	65	2005	4005-11	J:98545	15899789
93070	CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.		Erdman SE; Sohn JJ; Rao VP; Nambiar PR; Ge Z; Fox JG; Schauer DB		Cancer Res	65	2005	3998-4004	J:98546	15899788
93071	Versatile prostate cancer treatment with inducible caspase and interleukin-12.		Nikitina EY; Desai SA; Zhao X; Song W; Luo AZ; Gangula RD; Slawin KM; Spencer DM		Cancer Res	65	2005	4309-19	J:98548	15899823
93072	Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.		Knauf JA; Ma X; Smith EP; Zhang L; Mitsutake N; Liao XH; Refetoff S; Nikiforov YE; Fagin JA		Cancer Res	65	2005	4238-45	J:98550	15899815
93073	Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer.		Bradley SV; Oravecz-Wilson KI; Bougeard G; Mizukami I; Li L; Munaco AJ; Sreekumar A; Corradetti MN; Chinnaiyan AM; Sanda MG; Ross TS		Cancer Res	65	2005	4126-33	J:98551	15899803
93074	The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours.		Youngren KK; Coveney D; Peng X; Bhattacharya C; Schmidt LS; Nickerson ML; Lamb BT; Deng JM; Behringer RR; Capel B; Rubin EM; Nadeau JH; Matin A		Nature	435	2005	360-4	J:98580	15902260
93075	Dietary Genistein Improves Survival and Reduces Expression of Osteopontin in the Prostate of Transgenic Mice with Prostatic Adenocarcinoma (TRAMP).		Mentor-Marcel R; Lamartiniere CA; Eltoum IA; Greenberg NM; Elgavish A		J Nutr	135	2005	989-95	J:98642	15867270
93076	Direct single gene mutational events account for radiation-induced intestinal adenoma yields in apc(min/+) mice.		Ellender M; Harrison JD; Edwards AA; Bouffler SD; Cox R		Radiat Res	163	2005	552-6	J:98647	15850417
93077	Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet.		Seril DN; Liao J; Yang CS; Yang GY		Dig Dis Sci	50	2005	696-707	J:98648	15844705
93078	Roots of Withania somnifera Inhibit Forestomach and Skin Carcinogenesis in Mice.		Padmavathi B; Rath PC; Rao AR; Singh RP		Evid Based Complement Alternat Med	2	2005	99-105	J:98649	15841284
93079	De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent.		de Visser KE; Korets LV; Coussens LM		Cancer Cell	7	2005	411-23	J:98942	15894262
93080	Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis.		Tang Y; Katuri V; Srinivasan R; Fogt F; Redman R; Anand G; Said A; Fishbein T; Zasloff M; Reddy EP; Mishra B; Mishra L		Cancer Res	65	2005	4228-37	J:98549	15899814
93081	Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma.		Boissan M; Wendum D; Arnaud-Dabernat S; Munier A; Debray M; Lascu I; Daniel JY; Lacombe ML		J Natl Cancer Inst	97	2005	836-45	J:98838	15928304
93082	Temporal variation of excess mortality rate from solid tumors in mice irradiated at various ages with gamma rays.		Sasaki S; Fukuda N		J Radiat Res (Tokyo)	46	2005	1-19	J:98671	15802854
93083	Evaluation of chemopreventive action and antimutagenic effect of the standardized Panax ginseng extract, EFLA400, in Swiss albino mice.		Panwar M; Kumar M; Samarth R; Kumar A		Phytother Res	19	2005	65-71	J:98673	15799001
93084	Quantitation of apoptosis induction by etoposide or hydroxyurea in mouse interleukin 3-dependent lymphoma cells.		Olmos G; Prieto A; Herraez A; Tejedor MC; Alvarez-Mon M; Diez JC		In Vivo	19	2005	455-64	J:98675	15796210
93085	Large liver cell dysplasia in hepatitis B virus x transgenic mouse liver and human chronic hepatitis B virus-infected liver.		Koo JS; Seong JK; Park C; Yu DY; Oh BK; Oh SH; Park YN		Intervirology	48	2005	16-22	J:98678	15785085
93086	The invertor knock-in conditional chromosomal translocation mimic.		Forster A; Pannell R; Drynan LF; Codrington R; Daser A; Metzler M; Lobato MN; Rabbitts TH		Nat Methods	2	2005	27-30	J:98679	15782166
93087	Wnt signalling induces maturation of Paneth cells in intestinal crypts.		van Es JH; Jay P; Gregorieff A; van Gijn ME; Jonkheer S; Hatzis P; Thiele A; van den Born M; Begthel H; Brabletz T; Taketo MM; Clevers H		Nat Cell Biol	7	2005	381-6	J:98680	15778706
93088	Mouse Models of Colorectal Cancer and Liver Metastases.		Heijstek MW; Kranenburg O; Borel Rinkes IH		Dig Surg	22	2005	16-25	J:98650	15838167
93089	Multiple sites of tumorigenesis in transgenic mice overproducing hCG.		Huhtaniemi I; Rulli S; Ahtiainen P; Poutanen M		Mol Cell Endocrinol	234	2005	117-26	J:98652	15836960
93090	Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.		Jager R; Friedrichs N; Heim I; Buttner R; Schorle H		Breast Cancer Res Treat	90	2005	273-80	J:98654	15830141
93091	Murine Lung Tumor Measurement Using Respiratory-Gated Micro-Computed Tomography.		Cody DD; Nelson CL; Bradley WM; Wislez M; Juroske D; Price RE; Zhou X; Bekele BN; Kurie JM		Invest Radiol	40	2005	263-269	J:98655	15829823
93092	K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.		Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S		Exp Lung Res	31	2005	271-81	J:98657	15824025
93093	Chemoprevention: mouse colon and lung tumor bioassay and modulation of DNA methylation as a biomarker.		Pereira MA; Tao LH; Wang W; Gunning WT; Lubet R		Exp Lung Res	31	2005	145-63	J:98659	15824018
93094	Tumour-suppression activity of the proapoptotic regulator Par4.		Garcia-Cao I; Duran A; Collado M; Carrascosa MJ; Martin-Caballero J; Flores JM; Diaz-Meco MT; Moscat J; Serrano M		EMBO Rep	6	2005	577-83	J:98835	15877079
93095	Analysis of the Par2 modifier of pulmonary adenoma formation in mice		Wang M; Wang Y; You M; Devereux TR		Exp Lung Res	31	2005	193-204	J:98656	15828125
93096	Effect of D-limonene on immune response in BALB/c mice with lymphoma.		Del Toro-Arreola S; Flores-Torales E; Torres-Lozano C; Del Toro-Arreola A; Tostado-Pelayo K; Guadalupe Ramirez-Duenas M; Daneri-Navarro A		Int Immunopharmacol	5	2005	829-38	J:98681	15778119
93097	Bone cancer risk in mice exposed to 224Ra: protraction effects from promotion.		Heidenreich WF; Muller WA; Paretzke HG; Rosemann M		Radiat Environ Biophys	44	2005	61-7	J:98683	15864614
93098	c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.		Christensen JG; Burrows J; Salgia R		Cancer Lett	225	2005	1-26	J:98768	15922853
93099	Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor.		Huang W; Zhang J; Washington M; Liu J; Parant JM; Lozano G; Moore DD		Mol Endocrinol	19	2005	1646-53	J:98536	15831521
93100	Nucleotide excision repair- and p53-deficient mouse models in cancer research.		Hoogervorst EM; van Steeg H; de Vries A		Mutat Res	574	2005	3-21	J:98769	15914203
93101	Inhibition of tumour promotion in mouse skin by extracts of rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia), unique South African herbal teas.		Marnewick J; Joubert E; Joseph S; Swanevelder S; Swart P; Gelderblom W		Cancer Lett	224	2005	193-202	J:98777	15914270
93102	A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues.		Kirschner LS; Kusewitt DF; Matyakhina L; Towns WH nd; Carney JA; Westphal H; Stratakis CA		Cancer Res	65	2005	4506-14	J:98799	15930266
93103	The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.		Chang SH; Ai Y; Breyer RM; Lane TF; Hla T		Cancer Res	65	2005	4496-9	J:98801	15930264
93104	Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas.		Hoogervorst EM; Bruins W; Zwart E; van Oostrom CT; van den Aardweg GJ; Beems RB; van den Berg J; Jacks T; van Steeg H; de Vries A		Cancer Res	65	2005	3610-6	J:98840	15867355
93105	Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice.		Johansson FK; Goransson H; Westermark B		Oncogene	24	2005	3896-905	J:98841	15750623
93106	A new murine tumor model for studying HLA-A2-restricted anti-tumor immunity.		Kaplan BL; Moore TV; Schreiber K; Callender GG; Schreiber H; Nishimura MI		Cancer Lett	224	2005	153-66	J:98829	15911111
93107	Chromosomal instability in mouse metastatic pancreatic cancer--it's Kras and Tp53 after all.		Siveke JT; Schmid RM		Cancer Cell	7	2005	405-7	J:98833	15894260
93108	A Novel Nonsense Mutation and Polymorphisms in the Mouse Hairless Gene.		Zhang JT; Fang SG; Wang CY		J Invest Dermatol	124	2005	1200-1205	J:98859	15955095
93109	Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skin.		Wang Y; Gao D; Atencio DP; Perez E; Saladi R; Moore J; Guevara D; Rosenstein BS; Lebwohl M; Wei H		Int J Cancer	116	2005	193-9	J:98931	15800929
93110	Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.		Hingorani SR; Wang L; Multani AS; Combs C; Deramaudt TB; Hruban RH; Rustgi AK; Chang S; Tuveson DA		Cancer Cell	7	2005	469-83	J:98936	15894267
93111	Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.		Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL		Cancer Cell	7	2005	433-44	J:98939	15894264
93112	Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.		Hochedlinger K; Yamada Y; Beard C; Jaenisch R		Cell	121	2005	465-77	J:98920	15882627
93113	Intestinal tumorigenesis in Min mice is enhanced by X-irradiation in an age-dependent manner.		Okamoto M; Yonekawa H		J Radiat Res (Tokyo)	46	2005	83-91	J:98670	15802863
93114	Connexin43 is overexpressed in Apc(Min/+)-mice adenomas and colocalises with COX-2 in myofibroblasts.		Husoy T; Knutsen HK; Cruciani V; Olstorn HB; Mikalsen SO; Loberg EM; Alexander J		Int J Cancer	116	2005	351-8	J:98957	15800939
93115	Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.		Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T		Cancer Cell	7	2005	363-73	J:98958	15837625
93116	Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.		Meester-Smoor MA; Vermeij M; van Helmond MJ; Molijn AC; van Wely KH; Hekman AC; Vermey-Keers C; Riegman PH; Zwarthoff EC		Mol Cell Biol	25	2005	4229-36	J:98889	15870292
93117	The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.		Shankar DB; Cheng JC; Kinjo K; Federman N; Moore TB; Gill A; Rao NP; Landaw EM; Sakamoto KM		Cancer Cell	7	2005	351-62	J:98943	15837624
93118	Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).		Martin A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M		Cancer Cell	7	2005	591-8	J:98948	15950907
93119	Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis.		Hao Z; Duncan GS; Chang CC; Elia A; Fang M; Wakeham A; Okada H; Calzascia T; Jang Y; You-Ten A; Yeh WC; Ohashi P; Wang X; Mak TW		Cell	121	2005	579-91	J:98949	15907471
93120	Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development.		Mijimolle N; Velasco J; Dubus P; Guerra C; Weinbaum CA; Casey PJ; Campuzano V; Barbacid M		Cancer Cell	7	2005	313-24	J:98944	15837621
93121	A critical function for type I interferons in cancer immunoediting.		Dunn GP; Bruce AT; Sheehan KC; Shankaran V; Uppaluri R; Bui JD; Diamond MS; Koebel CM; Arthur C; White JM; Schreiber RD		Nat Immunol	6	2005	722-9	J:99146	15951814
93122	Role of epidermal growth factor receptor signaling in RAS-driven melanoma.		Bardeesy N; Kim M; Xu J; Kim RS; Shen Q; Bosenberg MW; Wong WH; Chin L		Mol Cell Biol	25	2005	4176-88	J:99136	15870287
93123	The Lsc RhoGEF mediates signaling from thromboxane A(2) to actin polymerization and apoptosis in thymocytes.		Harenberg A; Girkontaite I; Giehl K; Fischer KD		Eur J Immunol	35	2005	1977-1986	J:99190	15884057
93124	Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene.		Faulkin LJ Jr		J Natl Cancer Inst	36	1966	289-97	J:99255	4286277
93125	Interaction of Bcr/Abl with C3G, an exchange factor for the small GTPase Rap1, through the adapter protein Crkl.		Cho YJ; Hemmeryckx B; Groffen J; Heisterkamp N		Biochem Biophys Res Commun	333	2005	1276-1283	J:99259	15982636
93126	Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?		Aziz MH; Reagan-Shaw S; Wu J; Longley BJ; Ahmad N		FASEB J	19	2005	1193-5	J:99249	15837718
93127	Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.		Chen J; Williams IR; Lee BH; Duclos N; Huntly BJ; Donoghue DJ; Gilliland DG		Blood	106	2005	328-37	J:99251	15784730
93128	Ultraviolet radiation-induced malignant skin melanoma in melanoma-susceptible transgenic mice.		Klein-Szanto AJ; Silvers WK; Mintz B		Cancer Res	54	1994	4569-72	J:99252	8062242
93129	Oncogene cooperation and B-lymphoid tumorigenesis in Emu-myc transgenic mice.		Alexander WS; Bernard O; Langdon WY; Harris AW; Adams JM; Cory S		Haematol Blood Transfus	32	1989	423-7	J:99253	2696688
93130	Expression of differentiation-specific proteins in preneoplastic mammary tissues in BALB/c mice.		Medina D; Schwartz M; Taha M; Oborn CJ; Smith GH		Cancer Res	47	1987	4686-93	J:99254	3621162
93131	Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.		Smyth MJ; Wallace ME; Nutt SL; Yagita H; Godfrey DI; Hayakawa Y		J Exp Med	201	2005	1973-85	J:99284	15967825
93132	EphB receptor activity suppresses colorectal cancer progression.		Batlle E; Bacani J; Begthel H; Jonkeer S; Gregorieff A; van de Born M; Malats N; Sancho E; Boon E; Pawson T; Gallinger S; Pals S; Clevers H		Nature	435	2005	1126-30	J:99366	15973414
93133	Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells.		van Es JH; van Gijn ME; Riccio O; van den Born M; Vooijs M; Begthel H; Cozijnsen M; Robine S; Winton DJ; Radtke F; Clevers H		Nature	435	2005	959-63	J:99348	15959515
93134	Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer.		Liu M; Howes A; Lesperance J; Stallcup WB; Hauser CA; Kadoya K; Oshima RG; Abraham RT		Cancer Res	65	2005	5325-36	J:99382	15958580
93135	Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.		Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM		Cancer Res	65	2005	5211-20	J:99383	15958566
93136	Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation.		Xiao A; Yin C; Yang C; Di Cristofano A; Pandolfi PP; Van Dyke T		Cancer Res	65	2005	5172-80	J:99385	15958561
93137	Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53.		Krones-Herzig A; Mittal S; Yule K; Liang H; English C; Urcis R; Soni T; Adamson ED; Mercola D		Cancer Res	65	2005	5133-43	J:99386	15958557
93138	Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics.		Romer J; Curran T		Cancer Res	65	2005	4975-8	J:99387	15958535
93139	The p53 story: layers of complexity.		Braithwaite AW; Royds JA; Jackson P		Carcinogenesis	26	2005	1161-9	J:99388	15817608
93140	Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas.		Pedersen TX; Pennington CJ; Almholt K; Christensen IJ; Nielsen BS; Edwards DR; Romer J; Dano K; Johnsen M		Carcinogenesis	26	2005	1233-40	J:99389	15760918
93141	Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines.		Dwyer-Nield LD; Srebernak MC; Barrett BS; Ahn J; Cosper P; Meyer AM; Kisley LR; Bauer AK; Thompson DC; Malkinson AM		Carcinogenesis	26	2005	1196-206	J:99390	15746162
93142	Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors.		Parsons-Wingerter P; Kasman IM; Norberg S; Magnussen A; Zanivan S; Rissone A; Baluk P; Favre CJ; Jeffry U; Murray R; McDonald DM		Am J Pathol	167	2005	193-211	J:99505	15972964
93143	A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors.		Tegerstedt K; Lindencrona JA; Curcio C; Andreasson K; Tullus C; Forni G; Dalianis T; Kiessling R; Ramqvist T		Cancer Res	65	2005	5953-7	J:99521	15994974
93144	Increased expression of germinal center-associated nuclear protein RNA-primase is associated with lymphomagenesis.		Fujimura S; Xing Y; Takeya M; Yamashita Y; Ohshima K; Kuwahara K; Sakaguchi N		Cancer Res	65	2005	5925-34	J:99522	15994971
93145	Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis.		Farago M; Dominguez I; Landesman-Bollag E; Xu X; Rosner A; Cardiff RD; Seldin DC		Cancer Res	65	2005	5792-801	J:99523	15994955
93146	Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation.		Sano S; Chan KS; Kira M; Kataoka K; Takagi S; Tarutani M; Itami S; Kiguchi K; Yokoi M; Sugasawa K; Mori T; Hanaoka F; Takeda J; DiGiovanni J		Cancer Res	65	2005	5720-9	J:99525	15994947
93147	The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo.		Osthus RC; Karim B; Prescott JE; Smith BD; McDevitt M; Huso DL; Dang CV		Cancer Res	65	2005	5620-7	J:99526	15994934
93148	Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.		Wechselberger C; Strizzi L; Kenney N; Hirota M; Sun Y; Ebert A; Orozco O; Bianco C; Khan NI; Wallace-Jones B; Normanno N; Adkins H; Sanicola M; Salomon DS		Oncogene	24	2005	4094-105	J:99542	15897912
93149	Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice.		Krepulat F; Lohler J; Heinlein C; Hermannstadter A; Tolstonog GV; Deppert W		Oncogene	24	2005	4645-59	J:99543	15870706
93150	Increased chromosome instability but not cancer predisposition in haploinsufficient Bub3 mice.		Kalitsis P; Fowler KJ; Griffiths B; Earle E; Chow CW; Jamsen K; Choo KH		Genes Chromosomes Cancer	44	2005	29-36	J:99580	15898111
93151	Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability.		Oda S; Maehara Y; Ikeda Y; Oki E; Egashira A; Okamura Y; Takahashi I; Kakeji Y; Sumiyoshi Y; Miyashita K; Yamada Y; Zhao Y; Hattori H; Taguchi K; Ikeuchi T; Tsuzuki T; Sekiguchi M; Karran P; Yoshida MA		Nucleic Acids Res	33	2005	1628-36	J:99674	15778432
93152	E2F1 is crucial for E2F-dependent apoptosis.		Denchi EL; Helin K		EMBO Rep	6	2005	661-8	J:99576	15976820
93153	Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.		Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ		J Clin Invest	115	2005	1714-23	J:99647	15937546
93154	Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy.		Curino AC; Engelholm LH; Yamada SS; Holmbeck K; Lund LR; Molinolo AA; Behrendt N; Nielsen BS; Bugge TH		J Cell Biol	169	2005	977-85	J:99636	15967816
93155	Maintained rules of development in a mouse B-cell tumor.		Robbiani DF; Colon K; Affer M; Chesi M; Bergsagel PL		Leukemia	19	2005	1278-80	J:99667	15843816
93156	Lack of guanylyl cyclase C, the receptor for Escherichia coli heat-stable enterotoxin, results in reduced polyp formation and increased apoptosis in the multiple intestinal neoplasia (Min) mouse model.		Mann EA; Steinbrecher KA; Stroup C; Witte DP; Cohen MB; Giannella RA		Int J Cancer	116	2005	500-5	J:99670	15825168
93157	Peroxisome proliferator-activated receptor gamma agonist troglitazone induces colon tumors in normal C57BL/6J mice and enhances colonic carcinogenesis in Apc(1638 N/+) Mlh1(+/-) double mutant mice.		Yang K; Fan KH; Lamprecht SA; Edelmann W; Kopelovich L; Kucherlapati R; Lipkin M		Int J Cancer	116	2005	495-9	J:99671	15818612
93158	Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.		Nishikawa H; Kato T; Tawara I; Takemitsu T; Saito K; Wang L; Ikarashi Y; Wakasugi H; Nakayama T; Taniguchi M; Kuribayashi K; Old LJ; Shiku H		Proc Natl Acad Sci U S A	102	2005	9253-7	J:99871	15961541
93159	A mouse model for cyclin E-dependent genetic instability and tumorigenesis.		Loeb KR; Kostner H; Firpo E; Norwood T; D Tsuchiya K; Clurman BE; Roberts JM		Cancer Cell	8	2005	35-47	J:99695	16023597
93160	A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma.		Wilson C; Idziaszczyk S; Parry L; Guy C; Griffiths DF; Lazda E; Bayne RA; Smith AJ; Sampson JR; Cheadle JP		Hum Mol Genet	14	2005	1839-50	J:99796	15888477
93161	Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling.		Regier DS; Higbee J; Lund KM; Sakane F; Prescott SM; Topham MK		Proc Natl Acad Sci U S A	102	2005	7595-600	J:99817	15894621
93162	Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer.		Sum EY; Segara D; Duscio B; Bath ML; Field AS; Sutherland RL; Lindeman GJ; Visvader JE		Proc Natl Acad Sci U S A	102	2005	7659-64	J:99878	15897450
93163	Inhibitory effects of Pfaffia paniculata (Brazilian ginseng) on preneoplastic and neoplastic lesions in a mouse hepatocarcinogenesis model.		da Silva TC; Paula da Silva A; Akisue G; Luis Avanzo J; Kazumi Nagamine M; Fukumasu H; Matsuzaki P; Cesar Raspantini P; Haraguchi M; Lima Gorniak S; Dagli ML		Cancer Lett	226	2005	107-13	J:99959	16039950
93164	Conditionally MYC:insights from novel transgenic models.		Arvanitis C; Felsher DW		Cancer Lett	226	2005	95-9	J:99960	16039948
93165	Overexpression of human cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.		Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS		Am J Pathol	167	2005	585-97	J:99942	16049342
93166	Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis.		Johnson AH; Frierson HF; Zaika A; Powell SM; Roche J; Crowe S; Moskaluk CA; El-Rifai W		Am J Pathol	167	2005	577-84	J:99943	16049341
93167	Prostate cancer and the genomic revolution: Advances using microarray analyses.		Calvo A; Gonzalez-Moreno O; Yoon CY; Huh JI; Desai K; Nguyen QT; Green JE		Mutat Res	576	2005	66-79	J:99985	15950992
93168	Disruption of the TGF-beta pathway and modeling human cancer in mice.		Letterio JJ		Mutat Res	576	2005	120-31	J:99986	15935406
93169	Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse.		Collier LS; Carlson CM; Ravimohan S; Dupuy AJ; Largaespada DA		Nature	436	2005	272-6	J:99991	16015333
93170	Applications of mouse glioma models in preclinical trials.		Hu X; Holland EC		Mutat Res	576	2005	54-65	J:99983	16011838
93171	Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice.		Sinclair AM; Lee JA; Goldstein A; Xing D; Liu S; Ju R; Tucker PW; Neufeld EJ; Scheuermann RH		Blood	98	2001	3658-67	J:100055	11739170
93172	Radiofrequency-induced carcinogenesis: cellular calcium homeostasis changes as a triggering factor.		Anghileri LJ; Mayayo E; Domingo JL; Thouvenot P		Int J Radiat Biol	81	2005	205-9	J:100047	16019929
93173	Human coxsackie adenovirus receptor (CAR) expression in transgenic mouse prostate tumors enhances adenoviral delivery of genes.		Bao Y; Peng W; Verbitsky A; Chen J; Wu L; Rauen KA; Sawicki JA		Prostate	64	2005	401-7	J:100079	15761871
93174	Gelatinase-mediated migration and invasion of cancer cells.		Bjorklund M; Koivunen E		Biochim Biophys Acta	1755	2005	37-69	J:100082	15907591
93175	Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon.		Donnelly ET; Bardwell H; Thomas GA; Williams ED; Hoper M; Crowe P; McCluggage WG; Stevenson M; Phillips DH; Hewer A; Osborne MR; Campbell FC		Br J Cancer	92	2005	2160-5	J:100068	15928667
93176	Helicobacter felis-induced gastritis was suppressed in mice overexpressing thioredoxin-1.		Kawasaki K; Nishio A; Nakamura H; Uchida K; Fukui T; Ohana M; Yoshizawa H; Ohashi S; Tamaki H; Matsuura M; Asada M; Nishi T; Nakase H; Toyokuni S; Liu W; Yodoi J; Okazaki K; Chiba T		Lab Invest	85	2005	1104-17	J:100105	15965489
93177	Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression.		Ma L; Teruya-Feldstein J; Behrendt N; Chen Z; Noda T; Hino O; Cordon-Cardo C; Pandolfi PP		Genes Dev	19	2005	1779-86	J:100094	16027168
93178	Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.		Manning BD; Logsdon MN; Lipovsky AI; Abbott D; Kwiatkowski DJ; Cantley LC		Genes Dev	19	2005	1773-8	J:100095	16027169
93179	Beta-carotene interaction with NNK in the AJ-mouse model: effects on cell proliferation, tumor formation and retinoic acid responsive genes.		Goralczyk R; Wertz K; Lenz B; Riss G; Buchwald Hunziker P; Geatrix B; Aebischer CP; Bachmann H		Biochim Biophys Acta	1740	2005	179-88	J:100126	15949685
93180	Oncogene-induced senescence as an initial barrier in lymphoma development.		Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dorken B; Jenuwein T; Schmitt CA		Nature	436	2005	660-5	J:100109	16079837
93181	Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis.		Ko MA; Rosario CO; Hudson JW; Kulkarni S; Pollett A; Dennis JW; Swallow CJ		Nat Genet	37	2005	883-8	J:100110	16025114
93182	Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention.		Xu Y; Sette A; Sidney J; Gendler SJ; Franco A		Immunol Cell Biol	83	2005	440-8	J:100138	16033540
93183	Characterization of integrin beta6 and thrombospondin-1 double-null mice.		Ludlow A; Yee KO; Lipman R; Bronson R; Weinreb P; Huang X; Sheppard D; Lawler J		J Cell Mol Med	9	2005	421-37	J:100142	15963261
93184	Long-term effects of neonatal exposure to hydroxylated polychlorinated biphenyls in the BALB/cCrgl mouse.		Martinez JM; Stephens LC; Jones LA		Environ Health Perspect	113	2005	1022-6	J:100133	16079073
93185	The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats.		Dai C; Lyustikman Y; Shih A; Hu X; Fuller GN; Rosenblum M; Holland EC		Neoplasia	7	2005	397-406	J:100162	15967117
93186	mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.		Hu X; Pandolfi PP; Li Y; Koutcher JA; Rosenblum M; Holland EC		Neoplasia	7	2005	356-68	J:100163	15967113
93187	Tumor induction in mice locally irradiated with carbon ions: a retrospective analysis.		Ando K; Koike S; Oohira C; Ogiu T; Yatagai F		J Radiat Res (Tokyo)	46	2005	185-90	J:100149	15988136
93188	Molecular targets of nitric-oxide-donating aspirin in cancer.		Kashfi K; Rigas B		Biochem Soc Trans	33	2005	701-4	J:100151	16042578
93189	Knockout mice reveal a tumor suppressor function for Testin.		Drusco A; Zanesi N; Roldo C; Trapasso F; Farber JL; Fong LY; Croce CM		Proc Natl Acad Sci U S A	102	2005	10947-51	J:100181	16033868
93190	Chemopreventive and therapeutic efficacy of orally active tyrosine kinase inhibitors in a transgenic mouse model of gallbladder carcinoma.		Kiguchi K; Ruffino L; Kawamoto T; Ajiki T; Digiovanni J		Clin Cancer Res	11	2005	5572-80	J:100183	16061875
93191	The retinoid anticancer signal: mechanisms of target gene regulation.		Liu T; Bohlken A; Kuljaca S; Lee M; Nguyen T; Smith S; Cheung B; Norris MD; Haber M; Holloway AJ; Bowtell DD; Marshall GM		Br J Cancer	93	2005	310-8	J:100284	16012519
93192	Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.		List K; Szabo R; Molinolo A; Sriuranpong V; Redeye V; Murdock T; Burke B; Nielsen BS; Gutkind JS; Bugge TH		Genes Dev	19	2005	1934-50	J:100345	16103220
93193	Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis.		Dendouga N; Gao H; Moechars D; Janicot M; Vialard J; McGowan CH		Mol Cell Biol	25	2005	7569-79	J:100407	16107704
93194	Nonclinical toxicology studies with zidovudine: genetic toxicity tests and carcinogenicity bioassays in mice and rats.		Ayers KM; Clive D; Tucker WE Jr; Hajian G; de Miranda P		Fundam Appl Toxicol	32	1996	148-58	J:100398	8921318
93195	A transplacental carcinogenicity bioassay in CD-1 mice with zidovudine.		Ayers KM; Torrey CE; Reynolds DJ		Fundam Appl Toxicol	38	1997	195-8	J:100399	9299194
93196	RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.		Hakem A; Sanchez-Sweatman O; You-Ten A; Duncan G; Wakeham A; Khokha R; Mak TW		Genes Dev	19	2005	1974-9	J:100482	16107613
93197	A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.		Cowley DO; Muse GW; Van Dyke T		Mol Cell Biol	25	2005	7796-802	J:100551	16107724
93198	Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model.		Bok RA; Hansell EJ; Nguyen TP; Greenberg NM; McKerrow JH; Shuman MA		Prostate Cancer Prostatic Dis	6	2003	272-80	J:100578	14663466
93199	MDM2 as MYCN transcriptional target: Implications for neuroblastoma pathogenesis.		Slack A; Lozano G; Shohet JM		Cancer Lett	228	2005	21-7	J:100601	15927364
93200	Low-dose-dependent carcinogenic potential of 2-amino-3-methylimidazo[4,5-f]quinoline in the immunodeficient (SCID) mouse colon.		Salim EI; Wanibuchi H; Yamamoto S; Morimura K; Mori S; Makino S; Nomura T; Fukushima S		Nutr Cancer	34	1999	220-8	J:100585	10578491
93201	The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.		Klein RD		Mutat Res	576	2005	111-9	J:100619	15885713
93202	Molecular mechanism of HMGA1 deregulation in human neuroblastoma.		Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Gulino A		Cancer Lett	228	2005	97-104	J:100622	15923078
93203	Transgenic mouse models for the prevention of breast cancer.		Shen Q; Brown PH		Mutat Res	576	2005	93-110	J:100623	15888345
93204	Development of a new mouse model (xeroderma pigmentosum a-deficient, stem cell factor-transgenic) of ultraviolet B-induced melanoma.		Yamazaki F; Okamoto H; Matsumura Y; Tanaka K; Kunisada T; Horio T		J Invest Dermatol	125	2005	521-5	J:100608	16117793
93205	Prospects for therapeutic inhibition of neuroblastoma angiogenesis.		Shusterman S; Maris JM		Cancer Lett	228	2005	171-9	J:100609	15927358
93206	Transcription-coupled repair: impact on UV-induced mutagenesis in cultured rodent cells and mouse skin tumors.		van Zeeland AA; Vreeswijk MP; de Gruijl FR; van Kranen HJ; Vrieling H; Mullenders LF		Mutat Res	577	2005	170-8	J:100610	15949822
93207	Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines.		Hance KW; Zeytin HE; Greiner JW		Mutat Res	576	2005	132-54	J:100615	15888344
93208	Pathological and Molecular Progression of Astrocytomas in a GFAP:12V-Ha-Ras Mouse Astrocytoma Model.		Shannon P; Sabha N; Lau N; Kamnasaran D; Gutmann DH; Guha A		Am J Pathol	167	2005	859-67	J:100679	16127163
93209	The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice.		Dumaz N; van Kranen HJ; de Vries A; Berg RJ; Wester PW; van Kreijl CF; Sarasin A; Daya-Grosjean L; de Gruijl FR		Carcinogenesis	18	1997	897-904	J:100680	9163673
93210	Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma.		Boissan M; Beurel E; Wendum D; Rey C; Lecluse Y; Housset C; Lacombe ML; Desbois-Mouthon C		Am J Pathol	167	2005	869-77	J:100681	16127164
93211	The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of helicobacter-induced mucosa-associated lymphoid tissue lymphoma.		Mueller A; O'rourke J; Chu P; Chu A; Dixon MF; Bouley DM; Lee A; Falkow S		Am J Pathol	167	2005	797-812	J:100682	16127158
93212	Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.		Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP		Nature	436	2005	725-30	J:100683	16079851
93213	NKG2D function protects the host from tumor initiation.		Smyth MJ; Swann J; Cretney E; Zerafa N; Yokoyama WM; Hayakawa Y		J Exp Med	202	2005	583-8	J:100684	16129707
93214	The photocarcinogenesis of antibiotic lomefloxacin and UVA radiation is enhanced in xeroderma pigmentosum group A gene-deficient mice.		Itoh T; Miyauchi-Hashimoto H; Sugihara A; Tanaka K; Horio T		J Invest Dermatol	125	2005	554-9	J:100666	16117798
93215	Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice.		Goldsby RE; Lawrence NA; Hays LE; Olmsted EA; Chen X; Singh M; Preston BD		Nat Med	7	2001	638-9	J:100685	11385474
93216	Mechanisms and preclinical efficacy of silibinin in preventing skin cancer.		Singh RP; Agarwal R		Eur J Cancer	41	2005	1969-79	J:100739	16084079
93217	The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: An overview.		Crowell JA		Eur J Cancer	41	2005	1889-910	J:100741	16005206
93218	G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.		Doumont G; Martoriati A; Beekman C; Bogaerts S; Mee PJ; Bureau F; Colombo E; Alcalay M; Bellefroid E; Marchesi F; Scanziani E; Pelicci PG; Marine JC		EMBO J	24	2005	3093-103	J:100764	16107883
93219	The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.		Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD		Leukemia	13	1999	1790-803	J:100742	10557054
93220	CD44 attenuates metastatic invasion during breast cancer progression.		Lopez JI; Camenisch TD; Stevens MV; Sands BJ; McDonald J; Schroeder JA		Cancer Res	65	2005	6755-63	J:100774	16061657
93221	Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.		Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C		Cancer Res	65	2005	6773-9	J:100775	16061659
93222	Mice lacking the p53/p63 target gene Perp are resistant to papilloma development.		Marques MR; Horner JS; Ihrie RA; Bronson RT; Attardi LD		Cancer Res	65	2005	6551-6	J:100776	16061634
93223	Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.		Zanesi N; Mancini R; Sevignani C; Vecchione A; Kaou M; Valtieri M; Calin GA; Pekarsky Y; Gnarra JR; Croce CM; Huebner K		Cancer Res	65	2005	6576-82	J:100777	16061637
93224	A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E.		Rubin BP; Antonescu CR; Scott-Browne JP; Comstock ML; Gu Y; Tanas MR; Ware CB; Woodell J		Cancer Res	65	2005	6631-9	J:100778	16061643
93225	Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells.		Huss WJ; Gray DR; Greenberg NM; Mohler JL; Smith GJ		Cancer Res	65	2005	6640-50	J:100779	16061644
93226	Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene.		Genther Williams SM; Disbrow GL; Schlegel R; Lee D; Threadgill DW; Lambert PF		Cancer Res	65	2005	6534-42	J:100781	16061632
93227	Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo.		Momota H; Nerio E; Holland EC		Cancer Res	65	2005	7429-35	J:100766	16103096
93228	Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer.		Gauger MA; Sancar A		Cancer Res	65	2005	6828-34	J:100767	16061665
93229	Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.		Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S		Cancer Res	65	2005	6864-73	J:100768	16061670
93230	Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression.		Beverly LJ; Felsher DW; Capobianco AJ		Cancer Res	65	2005	7159-68	J:100770	16103066
93231	PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression.		Bassi DE; Lopez De Cicco R; Cenna J; Litwin S; Cukierman E; Klein-Szanto AJ		Cancer Res	65	2005	7310-9	J:100771	16103082
93232	beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.		Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR		Cancer Res	65	2005	6692-700	J:100772	16061650
93233	Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1.		Birger Y; Catez F; Furusawa T; Lim JH; Prymakowska-Bosak M; West KL; Postnikov YV; Haines DC; Bustin M		Cancer Res	65	2005	6711-8	J:100773	16061652
93234	Control of genomic instability and epithelial tumor development by the p53-Fbxw7/Cdc4 pathway.		Perez-Losada J; Mao JH; Balmain A		Cancer Res	65	2005	6488-92	J:100782	16061623
93235	p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.		Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH		Oncogene	24	2005	5521-4	J:100784	16007185
93236	Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma.		Ishii K; Shappell SB; Matusik RJ; Hayward SW		Lab Invest	85	2005	1086-103	J:100901	15980886
93237			Sugie S		Int J Cancer	117	2005	524-530	J:100931	15929075
93238	Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes.		Bremer C; Ntziachristos V; Weitkamp B; Theilmeier G; Heindel W; Weissleder R		Invest Radiol	40	2005	321-7	J:101113	15905717
93239	Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.		Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM Jr; Grossniklaus HE; Edelhauser HF; O'Brien JM		Ophthalmology	112	2005	1151-8	J:101127	15885791
93240	New target antigens for cancer immunoprevention.		Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Nanni P		Curr Cancer Drug Targets	5	2005	221-8	J:101122	15892621
93241	Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.		Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ		Proc Natl Acad Sci U S A	102	2005	12513-8	J:101159	16113082
93242	Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.		Tsikitis M; Zhang Z; Edelman W; Zagzag D; Kalpana GV		Proc Natl Acad Sci U S A	102	2005	12129-34	J:101185	16099835
93243	Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms.		Futterer A; Campanero MR; Leonardo E; Criado LM; Flores JM; Hernandez JM; San Miguel JF; Martinez-A C		J Clin Invest	115	2005	2351-2362	J:101201	16127461
93244	Failure of cigarette smoke to induce or promote lung cancer in the A/J mouse.		Finch GL; Nikula KJ; Belinsky SA; Barr EB; Stoner GD; Lechner JF		Cancer Lett	99	1996	161-7	J:101386	8616820
93245	Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis.		Yamada Y; Jackson-Grusby L; Linhart H; Meissner A; Eden A; Lin H; Jaenisch R		Proc Natl Acad Sci U S A	102	2005	13580-5	J:101415	16174748
93246	Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice.		Chugh P; Matta H; Schamus S; Zachariah S; Kumar A; Richardson JA; Smith AL; Chaudhary PM		Proc Natl Acad Sci U S A	102	2005	12885-90	J:101429	16120683
93247	Short-term in vitro and in vivo analyses for assessing the tumor-promoting potentials of cigarette smoke condensates.		Curtin GM; Hanausek M; Walaszek Z; Mosberg AT; Slaga TJ		Toxicol Sci	81	2004	14-25	J:101433	15159522
93248	Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.		Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD		Breast Cancer Res	7	2005	R708-18	J:101435	16168116
93249	Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis.		Hollander MC; Philburn RT; Patterson AD; Velasco-Miguel S; Friedberg EC; Linnoila RI; Fornace AJ Jr		Proc Natl Acad Sci U S A	102	2005	13200-5	J:101421	16141330
93250	Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model.		de Moreno de LeBlanc A; Perdigon G		Biocell	29	2005	15-24	J:101445	15954463
93251	Lung tumorigenicity in A/J and rasH2 transgenic mice following mainstream tobacco smoke inhalation.		Curtin GM; Higuchi MA; Ayres PH; Swauger JE; Mosberg AT		Toxicol Sci	81	2004	26-34	J:101446	15159525
93252	Use of gene expression profiling to direct in vivo molecular imaging of lung cancer.		Grimm J; Kirsch DG; Windsor SD; Kim CF; Santiago PM; Ntziachristos V; Jacks T; Weissleder R		Proc Natl Acad Sci U S A	102	2005	14404-9	J:101448	16183744
93253	Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice.		Jorgenson TA; Meierhenry EF; Rushbrook CJ; Bull RJ; Robinson M		Fundam Appl Toxicol	5	1985	760-9	J:101451	4043598
93254	Exercise and intestinal polyp development in APCMin mice.		Colbert LH; Mai V; Perkins SN; Berrigan D; Lavigne JA; Wimbrow HH; Alvord WG; Haines DC; Srinivas P; Hursting SD		Med Sci Sports Exerc	35	2003	1662-9	J:101440	14523302
93255	Intestinal metaplasia with a high salt diet induces epithelial proliferation and alters cell composition in the gastric mucosa of mice.		Xiao F; Crissey MA; Lynch JP; Kaestner KH; Silberg DG; Suh E		Cancer Biol Ther	4	2005	669-75	J:101441	15970710
93256	Chemopreventive effects of mustard (Brassica compestris) on chemically induced tumorigenesis in murine forestomach and uterine cervix.		Gagandeep; Dhiman M; Mendiz E; Rao AR; Kale RK		Hum Exp Toxicol	24	2005	303-12	J:101442	16004197
93257	Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis.		Yang H; Rouse J; Lukes L; Lancaster M; Veenstra T; Zhou M; Shi Y; Park YG; Hunter K		Clin Exp Metastasis	21	2004	719-35	J:101443	16035617
93258	Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.		Tegerstedt K; Franzen AV; Andreasson K; Joneberg J; Heidari S; Ramqvist T; Dalianis T		Anticancer Res	25	2005	2601-8	J:101444	16080500
93259	Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8(+) T cells in tumors.		Mantena SK; Roy AM; Katiyar SK		Photochem Photobiol	81	2005	1174-9	J:101475	15938647
93260	Induction of different genetic changes by different classes of chemical carcinogens during progression of mouse skin tumors.		Bremner R; Kemp CJ; Balmain A		Mol Carcinog	11	1994	90-7	J:101507	7916997
93261	Necrotizing arterial lesions in mice-bearing tumors induced by polyoma virus.		Dawe CJ; Freund R; Barncastle JP; Dubensky TW; Mandel G; Benjamin TL		J Exp Pathol	3	1987	177-201	J:101508	2826731
93262	Peripheral neuropathy associated with functional islet cell adenomas in SV40 transgenic mice.		Dyer KR; Messing A		J Neuropathol Exp Neurol	48	1989	399-412	J:101509	2543797
93263	Effect of deguelin on UVB-induced skin carcinogenesis.		Gills JJ; Kosmeder J nd; Moon RC; Lantvit DD; Pezzuto JM		J Chemother	17	2005	297-301	J:101510	16041863
93264	Strain A/J mouse lung adenoma growth patterns vary when induced by different carcinogens.		Gunning WT; Castonguay A; Goldblatt PJ; Stoner GD		Toxicol Pathol	19	1991	168-75	J:101511	1771369
93265	Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.		Asa SL; Lee YC; Drucker DJ		Virchows Arch	427	1996	595-606	J:101537	8605571
93266	In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy.		Becker C; Fantini MC; Wirtz S; Nikolaev A; Kiesslich R; Lehr HA; Galle PR; Neurath MF		Gut	54	2005	950-4	J:101538	15951540
93267	The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress.		Mizoi M; Takabayashi F; Nakano M; An Y; Sagesaka Y; Kato K; Okada S; Yamanaka K		Toxicol Lett	158	2005	87-94	J:101549	16039397
93268	Promotion of colorectal neoplasia in experimental murine ulcerative colitis.		Okayasu I; Ohkusa T; Kajiura K; Kanno J; Sakamoto S		Gut	39	1996	87-92	J:101550	8881816
93269	Arsenic and cancer: effects of joint administration of arsenite and selenite on the genesis of mammary adenocarcinoma in inbred female C3H/St mice.		Schrauzer GN; White DA; McGinness JE; Schneider CJ; Bell LJ		Bioinorg Chem	9	1978	245-53	J:101551	698283
93270	Spontaneous tumors in nude mice: effect of the viable yellow gene.		Stutman O		Exp Cell Biol	47	1979	129-35	J:101552	446837
93271	Chemoprevention of tobacco smoke-induced lung tumors by inhalation of an epigallocatechin gallate (EGCG) aerosol: a pilot study.		Witschi H; Espiritu I; Ly M; Uyeminami D; Morin D; Raabe OG		Inhal Toxicol	16	2004	763-70	J:101553	16036746
93272	Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.		Marchlik E; Kalman R; Rosenberg N		J Virol	79	2005	11618-26	J:101770	16140739
93273	Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Apc Min/+ tumorigenesis.		Markova M; Koratkar RA; Silverman KA; Sollars VE; MacPhee-Pellini M; Walters R; Palazzo JP; Buchberg AM; Siracusa LD; Farber SA		Oncogene	24	2005	6450-8	J:101761	16007193
93274	Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma.		Bascom JL; Fata JE; Hirai Y; Sternlicht MD; Bissell MJ		Cancer Res	65	2005	8617-21	J:101605	16204027
93275	Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.		Stevenson D; Charalambous C; Wilson JB		Cancer Res	65	2005	8826-35	J:101600	16204053
93276	Targeted disruption of Smad4 in mouse epidermis results in failure of hair follicle cycling and formation of skin tumors.		Yang L; Mao C; Teng Y; Li W; Zhang J; Cheng X; Li X; Han X; Xia Z; Deng H; Yang X		Cancer Res	65	2005	8671-8	J:101602	16204035
93277	Haploinsufficiency of Atp2a2, encoding the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 Ca2+ pump, predisposes mice to squamous cell tumors via a novel mode of cancer susceptibility.		Prasad V; Boivin GP; Miller ML; Liu LH; Erwin CR; Warner BW; Shull GE		Cancer Res	65	2005	8655-61	J:101603	16204033
93278	The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.		Li Q; Ishikawa TO; Oshima M; Taketo MM		Cancer Res	65	2005	8622-7	J:101604	16204028
93279	The transcription factor Pokemon: a new key player in cancer pathogenesis.		Maeda T; Hobbs RM; Pandolfi PP		Cancer Res	65	2005	8575-8	J:101607	16204018
93280	Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.		Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS		Cancer Res	51	1991	4528-34	J:101591	1831401
93281	Chemoprevention of colon carcinogenesis by dietary perillyl alcohol.		Reddy BS; Wang CX; Samaha H; Lubet R; Steele VE; Kelloff GJ; Rao CV		Cancer Res	57	1997	420-5	J:101592	9012468
93282	Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.		Spalding JW; Momma J; Elwell MR; Tennant RW		Carcinogenesis	14	1993	1335-41	J:101593	8330346
93283	Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice.		Yamanaka K; Ohtsubo K; Hasegawa A; Hayashi H; Ohji H; Kanisawa M; Okada S		Carcinogenesis	17	1996	767-70	J:101594	8625489
93284	Genetic alterations of p53 and ras genes in 1,3-butadiene- and 2',3'-dideoxycytidine-induced lymphomas.		Zhuang SM; Cochran C; Goodrow T; Wiseman RW; Soderkvist P		Cancer Res	57	1997	2710-4	J:101595	9205081
93285	Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis.		Raval-Fernandes S; Kickhoefer VA; Kitchen C; Rome LH		Cancer Res	65	2005	8846-52	J:101599	16204055
93286	Transforming growth factor beta 1 induction is associated with transforming growth factors beta 2 and beta 3 down-modulation in 12-O-tetradecanoylphorbol-13-acetate-induced skin hyperplasia.		Escherick JS; DiCunto F; Flanders KC; Missero C; Dotto GP		Cancer Res	53	1993	5517-22	J:101627	7693343
93287	Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes.		Ando K; Saitoh A; Hino O; Takahashi R; Kimura M; Katsuki M		Cancer Res	52	1992	978-82	J:101628	1737360
93288	Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.		Breuer M; Wientjens E; Verbeek S; Slebos R; Berns A		Cancer Res	51	1991	958-63	J:101629	1988138
93289	Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis.		Newbold RR; Bullock BC; McLachlan JA		Cancer Res	50	1990	7677-81	J:101630	2174729
93290	Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.		Dunsford HA; Sell S; Chisari FV		Cancer Res	50	1990	3400-7	J:101631	1692259
93291	Expression of the retrotransposons, intracisternal A-particles, during neoplastic progression of mouse mammary epithelium analyzed with a monoclonal antibody.		Asch BB; Asch HL		Cancer Res	50	1990	2404-10	J:101632	2156618
93292	Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.		Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS		Cancer Res	49	1989	6108-17	J:101633	2551499
93293	Chromosomal aberrations observed in 52 mouse myeloid leukemias.		Hayata I; Seki M; Yoshida K; Hirashima K; Sado T; Yamagiwa J; Ishihara T		Cancer Res	43	1983	367-73	J:101634	6571708
93294	Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol.		McLachlan JA; Newbold RR; Bullock BC		Cancer Res	40	1980	3988-99	J:101635	7193511
93295	Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development.		Wijnhoven SW; Zwart E; Speksnijder EN; Beems RB; Olive KP; Tuveson DA; Jonkers J; Schaap MM; van den Berg J; Jacks T; van Steeg H; de Vries A		Cancer Res	65	2005	8166-73	J:101617	16166291
93296	Mitochondrial production of reactive oxygen species and incidence of age-associated lymphoma in OF1 mice: Effect of alternate-day fasting.		Descamps O; Riondel J; Ducros V; Roussel AM		Mech Ageing Dev	126	2005	1185-91	J:101678	16126250
93297	Five loci, SLT1 to SLT5, controlling the susceptibility to spontaneously occurring lung cancer in mice.		Wang D; You M		Cancer Res	65	2005	8158-65	J:101722	16166290
93298	A mouse model recapitulating molecular features of human mesothelioma.		Altomare DA; Vaslet CA; Skele KL; De Rienzo A; Devarajan K; Jhanwar SC; McClatchey AI; Kane AB; Testa JR		Cancer Res	65	2005	8090-5	J:101723	16166281
93299	Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.		Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J		Cancer Res	65	2005	7993-8002	J:101724	16140972
93300	Correlation of DNA damage in epidemic dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice.		Das M; Ansari KM; Dhawan A; Shukla Y; Khanna SK		Int J Cancer	117	2005	709-17	J:101690	15981203
93301	Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia.		Ziv S; Brenner O; Amariglio N; Smorodinsky NI; Galron R; Carrion DV; Zhang W; Sharma GG; Pandita RK; Agarwal M; Elkon R; Katzin N; Bar-Am I; Pandita TK; Kucherlapati R; Rechavi G; Shiloh Y; Barzilai A		Hum Mol Genet	14	2005	2929-43	J:101745	16150740
93302	Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: involvement of transforming growth factor-beta-dependent cell growth attenuation.		Kanehira T; Tani T; Takagi T; Nakano Y; Howard EF; Tamura M		Cancer Res	65	2005	7660-5	J:101726	16140932
93303	New genetic tactics to model alveolar rhabdomyosarcoma in the mouse.		Keller C; Capecchi MR		Cancer Res	65	2005	7530-2	J:101727	16140913
93304	Cardiac and CNS defects in a mouse with targeted disruption of suppressor of fused.		Cooper AF; Yu KP; Brueckner M; Brailey LL; Johnson L; McGrath JM; Bale AE		Development	132	2005	4407-17	J:101731	16155214
93305	Diethylstilbestrol (DES): carcinogenic potential in Xpa-/-, Xpa-/- / p53+/-, and wild-type mice during 9 months' dietary exposure.		McAnulty PA; Skydsgaard M		Toxicol Pathol	33	2005	609-20	J:101774	16178126
93306	Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesis.		Casanovas O; Hager JH; Chun MG; Hanahan D		Oncogene	24	2005	6597-604	J:101759	16007165
93307	Nfkb 1 is dispensable for Myc-induced lymphomagenesis.		Keller U; Nilsson JA; Maclean KH; Old JB; Cleveland JL		Oncogene	24	2005	6231-40	J:101764	15940251
93308	Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.		Al Masri A; Gendler SJ		Oncogene	24	2005	5799-808	J:101766	15897873
93309	T antigen expression and tumorigenesis in transgenic mice containing a mouse major urinary protein/SV40 T antigen hybrid gene.		Held WA; Mullins JJ; Kuhn NJ; Gallagher JF; Gu GD; Gross KW		EMBO J	8	1989	183-91	J:101807	2714250
93310	Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: Inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms.		Tanaka T; Kohno H; Suzuki R; Hata K; Sugie S; Niho N; Sakano K; Takahashi M; Wakabayashi K		Int J Cancer	118	2006	25-34	J:101781	16049979
93311	Nuclear factor-kappaB and liver carcinogenesis.		Arsura M; Cavin LG		Cancer Lett	229	2005	157-69	J:101908	16125305
93312	EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer.		Milliken EL; Zhang X; Flask C; Duerk JL; Macdonald PN; Keri RA		Cancer Lett	229	2005	205-15	J:101899	16115727
93313	ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development.		Shen KC; Heng H; Wang Y; Lu S; Liu G; Deng CX; Brooks SC; Wang YA		Cancer Res	65	2005	8747-53	J:101601	16204044
93314	Omomyc expression in skin prevents Myc-induced papillomatosis.		Soucek L; Nasi S; Evan GI		Cell Death Differ	11	2004	1038-45	J:101692	15143346
93315	Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS.		Campbell IL		Brain Res Brain Res Rev	48	2005	166-77	J:98646	15850655
93316	Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice.		Cattoretti G; Pasqualucci L; Ballon G; Tam W; Nandula SV; Shen Q; Mo T; Murty VV; Dalla-Favera R		Cancer Cell	7	2005	445-55	J:98937	15894265
93317	Different susceptibility to lung tumorigenesis in mice with an identical Kras2 intron 2.		Manenti G; Falvella FS; Gariboldi M; Dragani TA; Pierotti MA		Genomics	29	1995	438-44	J:29218	8666392
93318	Chromosome mechanisms and INI1 inactivation in human and mouse rhabdoid tumors.		Rousseau-Merck MF; Fiette L; Klochendler-Yeivin A; Delattre O; Aurias A		Cancer Genet Cytogenet	157	2005	127-33	J:97874	15721633
93319	ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.		Linden M; Kirchhof N; Kvitrud M; Ness BV		Leuk Res	29	2005	435-44	J:97871	15725478
93320	Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia.		Yu L; Liu C; Vandeusen J; Becknell B; Dai Z; Wu YZ; Raval A; Liu TH; Ding W; Mao C; Liu S; Smith LT; Lee S; Rassenti L; Marcucci G; Byrd J; Caligiuri MA; Plass C		Nat Genet	37	2005	265-74	J:97873	15723065
93321	beta-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate.		Kohno H; Suzuki R; Sugie S; Tanaka T		Cancer Sci	96	2005	69-76	J:97872	15723650
93322	Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.		Kelavkar UP; Glasgow W; Olson SJ; Foster BA; Shappell SB		Neoplasia	6	2004	821-30	J:97875	15720809
93323	Early neoplastic progression is complement independent.		de Visser KE; Korets LV; Coussens LM		Neoplasia	6	2004	768-76	J:97876	15720803
93324	Revealing progesterone's role in uterine and mammary gland biology: insights from the mouse.		Fernandez-Valdivia R; Mukherjee A; Mulac-Jericevic B; Conneely OM; DeMayo FJ; Amato P; Lydon JP		Semin Reprod Med	23	2005	22-37	J:97877	 
93325	Role of inflammation in mouse lung tumorigenesis: a review.		Malkinson AM		Exp Lung Res	31	2005	57-82	J:97848	15765919
93326	Mouse lung neuroendocrine carcinomas: distinct morphologies, same transcription factors.		Linnoila RI; Naizhen X; Meuwissen R; Berns A; DeMayo FJ		Exp Lung Res	31	2005	37-55	J:97849	15765918
93327	Induction and modulation of lung tumors: genomic and transcriptional alterations in cigarette smoke-exposed mice.		De Flora S; Izzotti A; D'Agostini F; Bennicelli C; You M; Lubet RA; Balansky RM		Exp Lung Res	31	2005	19-35	J:97850	15765917
93328	A/J mouse as a model for lung tumorigenesis caused by tobacco smoke: strengths and weaknesses.		Witschi H		Exp Lung Res	31	2005	3-18	J:97851	15765916
93329	The chemopreventive effects of orally administered dexamethasone in strain a/j mice following cessation of smoke exposure.		Witschi H; Espiritu I; Ly M; Uyeminami D		Inhal Toxicol	17	2005	119-22	J:97852	15764489
93330	NF-kappaB: a signal for cancer.		Mann DA; Oakley F		J Hepatol	42	2005	610-1	J:97853	15763352
93331	Transgenic and knock out mice in skeletal research. Towards a molecular understanding of the mammalian skeleton.		Schilling AF; Priemel M; Timo Beil F; Haberland M; Holzmann T; Catala-Lehnen P; Pogoda P; Blicharski D; Muldner C; Locherbach C; Rueger JM; Amling M		J Musculoskelet Neuronal Interact	1	2001	275-89	J:97854	15758501
93332	Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.		Wang J; Boxer LM		J Biol Chem	280	2005	12766-73	J:97900	15687498
93333	Hematopoietic malignancies associated with increased Stat5 and Bcl-x(L) expressions in Ink4a/Arf-deficient mice.		Sung YH; Park J; Choi B; Kim J; Cheong C; Choi YS; Yang EY; Lee M; Han JS; Park SC; Han TH; Kim TJ; Song J; Rhee K; Lee HW		Mech Ageing Dev	126	2005	732-739	J:98234	15888328
93334	CpG oligodeoxynucleotides prevent the development of scleroderma-like syndrome in tight-skin mice by stimulating a Th1 immune response.		Shen Y; Ichino M; Nakazawa M; Minami M		J Invest Dermatol	124	2005	1141-8	J:98858	15955088
93335	Patches of mutant p53-immunoreactive epidermal cells induced by chronic UVB Irradiation harbor the same p53 mutations as squamous cell carcinomas in the skin of hairless SKH-1 mice.		Kramata P; Lu YP; Lou YR; Singh RN; Kwon SM; Conney AH		Cancer Res	65	2005	3577-85	J:98346	15867351
93336	Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor.		Carboni JM; Lee AV; Hadsell DL; Rowley BR; Lee FY; Bol DK; Camuso AE; Gottardis M; Greer AF; Ho CP; Hurlburt W; Li A; Saulnier M; Velaparthi U; Wang C; Wen ML; Westhouse RA; Wittman M; Zimmermann K; Rupnow BA; Wong TW		Cancer Res	65	2005	3781-7	J:98350	15867374
93337	Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.		Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martin-Caballero J; Barbacid M; Carnero A; Malumbres M		Cancer Res	65	2005	3846-52	J:98351	15867383
93338	Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.		Landrette SF; Kuo YH; Hensen K; Barjesteh van Waalwijk van Doorn-Khosrovani S; Perrat PN; Van de Ven WJ; Delwel R; Castilla LH		Blood	105	2005	2900-7	J:98443	15585652
93339	An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.		Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S		J Immunol	174	2005	5298-305	J:98420	15843526
93340	Overexpression of pituitary adenylate cyclase-activating polypeptide in islets inhibits hyperinsulinemia and islet hyperplasia in agouti yellow mice.		Tomimoto S; Hashimoto H; Shintani N; Yamamoto K; Kawabata Y; Hamagami K; Yamagata K; Miyagawa J; Baba A		J Pharmacol Exp Ther	309	2004	796-803	J:98575	14742740
93341	Influence of functional group substitutions on the carcinogenicity of anthraquinone in rats and mice: analysis of long-term bioassays by the National Cancer Institute and the National Toxicology Program.		Doi AM; Irwin RD; Bucher JR		J Toxicol Environ Health B Crit Rev	8	2005	109-26	J:98668	15804751
93342	Early molecular changes in endometrial cancer.		Ellenson LH		Int J Gynecol Cancer	15	2005	399-400	J:98660	15823134
93343	The circadian clock and tumor suppression by Mammalian period genes.		Lee CC		Methods Enzymol	393	2005	852-61	J:98662	15817328
93344	Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer.		Green AR; Styles JA; Parrott EL; Gray D; Edwards RE; Smith AG; Gant TW; Greaves P; Al-Azzawi F; White IN		Exp Toxicol Pathol	56	2005	255-63	J:98663	15816354
93345	Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.		Calvisi DF; Thorgeirsson SS		Toxicol Pathol	33	2005	181-4	J:98665	15805070
93346	Microarray data analysis of mouse neoplasia.		Malarkey DE; Parker JS; Turman CA; Scott AM; Paules RS; Collins J; Maronpot RR		Toxicol Pathol	33	2005	127-35	J:98667	15805064
93347	Prevention of mouse skin tumor promotion by dietary energy restriction requires an intact adrenal gland and glucocorticoid supplementation restores inhibition.		Stewart JW; Koehler K; Jackson W; Hawley J; Wang W; Au A; Myers R; Birt DF		Carcinogenesis	26	2005	1077-84	J:98821	15746164
93348	Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice.		Lu J; Imamura K; Nomura S; Mafune K; Nakajima A; Kadowaki T; Kubota N; Terauchi Y; Ishii G; Ochiai A; Esumi H; Kaminishi M		Cancer Res	65	2005	4769-74	J:98823	15930296
93349			Declercq J		Cancer Res	65	2005	4544-53	J:98825	15930271
93350			Maggio-Price L		Am J Pathol	166	2005	1793-1806	J:98826	15920164
93351	Absence of acute apoptotic response to genotoxic carcinogens in p53-deficient mice is associated with increased susceptibility to azoxymethane-induced colon tumours.		Hu Y; Le Leu RK; Young GP		Int J Cancer	115	2005	561-7	J:98930	15700305
93352	Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).		Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC		Toxicol Pathol	33	2005	292-9	J:98987	15902973
93353	Susceptibilities of p53 knockout and rasH2 transgenic mice to urethane-induced lung carcinogenesis are inherited from their original strains.		Ozaki M; Ozaki K; Watanabe T; Uwagawa S; Okuno Y; Shirai T		Toxicol Pathol	33	2005	267-71	J:98988	15902970
93354	A role for ADAM12 in breast tumor progression and stromal cell apoptosis.		Kveiborg M; Frohlich C; Albrechtsen R; Tischler V; Dietrich N; Holck P; Kronqvist P; Rank F; Mercurio AM; Wewer UM		Cancer Res	65	2005	4754-61	J:98962	15930294
93355	WHO-EORTC classification for cutaneous lymphomas.		Willemze R; Jaffe ES; Burg G; Cerroni L; Berti E; Swerdlow SH; Ralfkiaer E; Chimenti S; Diaz-Perez JL; Duncan LM; Grange F; Harris NL; Kempf W; Kerl H; Kurrer M; Knobler R; Pimpinelli N; Sander C; Santucci M; Sterry W; Vermeer MH; Wechsler J; Whittaker S;	 Meijer CJ	Blood	105	2005	3768-85	J:98969	15692063
93356	Diethylstilbestrol effects and lymphomagenesis in Mlh1-deficient mice.		Kabbarah O; Sotelo AK; Mallon MA; Winkeler EL; Fan MY; Pfeifer JD; Shibata D; Gutmann DH; Goodfellow PJ		Int J Cancer	115	2005	666-9	J:98929	15700306
93357	Converging pathways in leukemogenesis and stem cell self-renewal.		Moore MA		Exp Hematol	33	2005	719-37	J:99030	15963848
93358	Mechanisms involved in A/J mouse lung tumorigenesis induced by inhalation of an environmental tobacco smoke surrogate.		Stinn W; Teredesai A; Kuhl P; Knorr-Wittmann C; Kindt R; Coggins C; Haussmann HJ		Inhal Toxicol	17	2005	263-76	J:98664	15814487
93359	Polyclonality of familial murine adenomas: analyses of mouse chimeras with low tumor multiplicity suggest short-range interactions.		Thliveris AT; Halberg RB; Clipson L; Dove WF; Sullivan R; Washington MK; Stanhope S; Newton MA		Proc Natl Acad Sci U S A	102	2005	6960-5	J:99067	15870186
93360	Proteolytic processing of TGFalpha redirects its mitogenic activity: the membrane-anchored form is autocrine, the secreted form is paracrine.		Roh M; Paterson AJ; Liu K; McAndrew J; Chin E; Kudlow JE		Biochim Biophys Acta	1743	2005	231-42	J:99073	15843037
93361	Generation of rac3 Null Mutant Mice: Role of Rac3 in Bcr/Abl-Caused Lymphoblastic Leukemia.		Cho YJ; Zhang B; Kaartinen V; Haataja L; de Curtis I; Groffen J; Heisterkamp N		Mol Cell Biol	25	2005	5777-85	J:99168	15964830
93362	Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.		Glinsky GV; Berezovska O; Glinskii AB		J Clin Invest	115	2005	1503-21	J:99201	15931389
93363	Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice.		Greer P; Maltby V; Rossant J; Bernstein A; Pawson T		Mol Cell Biol	10	1990	2521-7	J:99299	2188092
93364	Models of ovarian cancer-Are we there yet?		Garson K; Shaw TJ; Clark KV; Yao DS; Vanderhyden BC		Mol Cell Endocrinol	239	2005	15-26	J:99301	15955618
93365	Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice.		Wang Y; Putnam CD; Kane MF; Zhang W; Edelmann L; Russell R; Carrion DV; Chin L; Kucherlapati R; Kolodner RD; Edelmann W		Nat Genet	37	2005	750-5	J:99303	15965476
93366	Temporal dissection of p53 function in vitro and in vivo.		Christophorou MA; Martin-Zanca D; Soucek L; Lawlor ER; Brown-Swigart L; Verschuren EW; Evan GI		Nat Genet	37	2005	718-26	J:99305	15924142
93367	mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival.		Dannenberg JH; David G; Zhong S; van der Torre J; Wong WH; Depinho RA		Genes Dev	19	2005	1581-95	J:99406	15998811
93368	c-Fos-Dependent Induction of the Small Ras-Related GTPase Rab11a in Skin Carcinogenesis.		Gebhardt C; Breitenbach U; Richter KH; Furstenberger G; Mauch C; Angel P; Hess J		Am J Pathol	167	2005	243-53	J:99378	15972968
93369	Potent modulation of intestinal tumorigenesis in Apcmin/+ mice by the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase.		Tucker JM; Murphy JT; Kisiel N; Diegelman P; Barbour KW; Davis C; Medda M; Alhonen L; Janne J; Kramer DL; Porter CW; Berger FG		Cancer Res	65	2005	5390-8	J:99381	15958588
93370	A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.		Majeed N; Blouin MJ; Kaplan-Lefko PJ; Barry-Shaw J; Greenberg NM; Gaudreau P; Bismar TA; Pollak M		Oncogene	24	2005	4736-40	J:99544	15870705
93371	Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.		Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y		Oncogene	24	2005	4477-85	J:99545	15856017
93372	Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations.		Zhang X; Podsypanina K; Huang S; Mohsin SK; Chamness GC; Hatsell S; Cowin P; Schiff R; Li Y		Oncogene	24	2005	4220-31	J:99546	15824740
93373	Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo.		Helmrich A; Lee S; O'Brien P; Dorken B; Lowe SW; Schrock E; Schmitt CA		Oncogene	24	2005	4174-82	J:99547	15824738
93374	Gli1 is important for medulloblastoma formation in Ptc1+/- mice.		Kimura H; Stephen D; Joyner A; Curran T		Oncogene	24	2005	4026-36	J:99548	15806168
93375	A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.		Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D		Oncogene	24	2005	4037-51	J:99549	15806157
93376	Characterization of murine S-endoglin isoform and its effects on tumor development.		Perez-Gomez E; Eleno N; Lopez-Novoa JM; Ramirez JR; Velasco B; Letarte M; Bernabeu C; Quintanilla M		Oncogene	24	2005	4450-61	J:99551	15806144
93377	Spectral karyotyping of sarcomas and fibroblasts derived from Ink4a/Arf-deficient mice reveals chromosomal instability in vitro.		Robertson SA; Schoumans J; Looyenga BD; Yuhas JA; Zylstra CR; Koeman JM; Swiatek PJ; Teh BT; Williams BO		Int J Oncol	26	2005	629-34	J:99590	15703817
93378	Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1).		Kondo S; Lu Y; Debbas M; Lin AW; Sarosi I; Itie A; Wakeham A; Tuan J; Saris C; Elliott G; Ma W; Benchimol S; Lowe SW; Mak TW; Thukral SK		Proc Natl Acad Sci U S A	100	2003	5431-6	J:99823	12702766
93379	Transgenic over-expression of GATA-1 mutant lacking N-finger domain causes hemolytic syndrome in mouse erythroid cells.		Nakano M; Ohneda K; Yamamoto-Mukai H; Shimizu R; Ohneda O; Ohmura S; Suzuki M; Tsukamoto S; Yanagawa T; Yoshida H; Takakuwa Y; Yamamoto M		Genes Cells	10	2005	47-62	J:99964	15670213
93380	Comparisons of thresholds for carcinogenicity on linear and logarithmic dosage scales.		Waddell WJ		Hum Exp Toxicol	24	2005	325-32	J:99966	16004200
93381	Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor.		Hamdi HK; Castellon R		Biochem Biophys Res Commun	334	2005	769-78	J:100031	16024000
93382	5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions.		Hennig R; Grippo P; Ding XZ; Rao SM; Buchler MW; Friess H; Talamonti MS; Bell RH; Adrian TE		Cancer Res	65	2005	6011-6	J:100088	16024599
93383	8-Oxoguanine formation induced by chronic UVB exposure makes Ogg1 knockout mice susceptible to skin carcinogenesis.		Kunisada M; Sakumi K; Tominaga Y; Budiyanto A; Ueda M; Ichihashi M; Nakabeppu Y; Nishigori C		Cancer Res	65	2005	6006-10	J:100089	16024598
93384	Sulindac corrects defective apoptosis and suppresses azoxymethane-induced colonic oncogenesis in p53 knockout mice.		Hu Y; Le Leu RK; Young GP		Int J Cancer	116	2005	870-5	J:100059	15849741
93385	Cdc2-cyclin E complexes regulate the G1/S phase transition.		Aleem E; Kiyokawa H; Kaldis P		Nat Cell Biol	7	2005	831-6	J:100155	16007079
93386	Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation.		Qi L; Strong MA; Karim BO; Huso DL; Greider CW		Nat Cell Biol	7	2005	706-11	J:100156	15965466
93387	Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling.		Jenkins BJ; Grail D; Nheu T; Najdovska M; Wang B; Waring P; Inglese M; McLoughlin RM; Jones SA; Topley N; Baumann H; Judd LM; Giraud AS; Boussioutas A; Zhu HJ; Ernst M		Nat Med	11	2005	845-52	J:100160	16041381
93388	A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.		Bodek G; Vierre S; Rivero-Muller A; Huhtaniemi I; Ziecik AJ; Rahman NA		Neoplasia	7	2005	497-508	J:100161	15967102
93389	The Ews-ERG fusion protein can initiate neoplasia from lineage-committed haematopoietic cells.		Codrington R; Pannell R; Forster A; Drynan LF; Daser A; Lobato N; Metzler M; Rabbitts TH		PLoS Biol	3	2005	e242	J:100116	15974803
93390	COX-2 inhibitors and genetic background reduce mammary tumorigenesis in cyclooxygenase-2 transgenic mice.		Narko K; Zweifel B; Trifan O; Ristimaki A; Lane TF; Hla T		Prostaglandins Other Lipid Mediat	76	2005	86-94	J:100120	15967164
93391	Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas.		Abraham N; Ma MC; Snow JW; Miners MJ; Herndier BG; Goldsmith MA		Oncogene	24	2005	5252-7	J:100190	15870688
93392	Administration of green tea or caffeine enhances the disappearance of UVB-induced patches of mutant p53 positive epidermal cells in SKH-1 mice.		Lu YP; Lou YR; Liao J; Xie JG; Peng QY; Yang CS; Conney AH		Carcinogenesis	26	2005	1465-72	J:100090	15817611
93393	Menin molecular interactions: insights into normal functions and tumorigenesis.		Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ		Horm Metab Res	37	2005	369-74	J:100388	16001329
93394	Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.		Oppenheim DE; Roberts SJ; Clarke SL; Filler R; Lewis JM; Tigelaar RE; Girardi M; Hayday AC		Nat Immunol	6	2005	928-37	J:100454	16116470
93395	Cellular UV damage responses--functions of tumor suppressor p53.		Latonen L; Laiho M		Biochim Biophys Acta	1755	2005	71-89	J:100531	15921859
93396	Abnormalities caused by carbohydrate alterations in Ibeta6-N-acetylglucosaminyltransferase-deficient mice.		Chen GY; Muramatsu H; Kondo M; Kurosawa N; Miyake Y; Takeda N; Muramatsu T		Mol Cell Biol	25	2005	7828-38	J:100533	16107727
93397	Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.		Bourdeaut F; Trochet D; Janoueix-Lerosey I; Ribeiro A; Deville A; Coz C; Michiels JF; Lyonnet S; Amiel J; Delattre O		Cancer Lett	228	2005	51-8	J:100596	15949893
93398	INK4a/ARF: a multifunctional tumor suppressor locus.		Sharpless NE		Mutat Res	576	2005	22-38	J:100600	15878778
93399	Mechanism of skin tumorigenesis by contact sensitizers: the effect of the corticosteroid fluocinolone acetonide on inflammation and tumor induction by 2,4 dinitro-1-fluorobenzene in the skin of the TG.AC (v-Ha-ras) mouse.		Albert RE; French JE; Maronpot R; Spalding J; Tennant R		Environ Health Perspect	104	1996	1062-8	J:100677	8930547
93400	Deficiency of protein kinase Calpha in mice results in impairment of epidermal hyperplasia and enhancement of tumor formation in two-stage skin carcinogenesis.		Hara T; Saito Y; Hirai T; Nakamura K; Nakao K; Katsuki M; Chida K		Cancer Res	65	2005	7356-62	J:100793	16103087
93401	Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.		Drynan LF; Pannell R; Forster A; Chan NM; Cano F; Daser A; Rabbitts TH		EMBO J	24	2005	3136-46	J:100794	16096649
93402	Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new.		Hecht SS		Carcinogenesis	26	2005	1488-92	J:100753	15930027
93403	MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice.		Alkhalaf M; Ganguli G; Messaddeq N; Le Meur M; Wasylyk B		Oncogene	18	1999	1419-34	J:100754	10050879
93404	Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine.		Sansom OJ; Reed KR; van de Wetering M; Muncan V; Winton DJ; Clevers H; Clarke AR		J Biol Chem	280	2005	28463-7	J:100825	15946945
93405	Ovarian cancer metastasis: integrating insights from disparate model organisms.		Naora H; Montell DJ		Nat Rev Cancer	5	2005	355-66	J:100829	15864277
93406	The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.		He G; Muga S; Thuillier P; Lubet RA; Fischer SM		Mol Carcinog	43	2005	198-206	J:101139	15864802
93407	Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity.		Iskander K; Jaiswal AK		Chem Biol Interact	153-154	2005	147-57	J:101105	15935811
93408	Search for testicular cancer gene hits dead-end.		Matin A; Nadeau JH		Cell Cycle	4	2005	1136-8	J:101387	16082220
93409	Lung tumor location and lymphocyte infiltration in mice are genetically determined.		Horlings H; Demant P		Exp Lung Res	31	2005	513-25	J:101388	16019985
93410	1,2,3-Trichloropropane: a multisite carcinogen in rats and mice.		Irwin RD; Haseman JK; Eustis SL		Fundam Appl Toxicol	25	1995	241-52	J:101389	7665008
93411	The contribution of hepatic steroid metabolism to serum estradiol and estriol concentrations in nonylphenol treated MMTVneu mice and its potential effects on breast cancer incidence and latency.		Acevedo R; Parnell PG; Villanueva H; Chapman LM; Gimenez T; Gray SL; Baldwin WS		J Appl Toxicol	25	2005	339-53	J:101390	16013040
93412	Estrogen-induced Leydig cell tumor in the mouse: a model system for the study of carcinogenesis and hormone dependency.		Huseby RA		J Toxicol Environ Health Suppl	1	1976	177-92	J:101391	11351
93413	Dermal carcinogenicity in transgenic mice: relative responsiveness of male and female hemizygous and homozygous Tg.AC mice to 12-O-tetradecanoylphorbol 13-acetate (TPA) and benzene.		Blanchard KT; Ball DJ; Holden HE; Furst SM; Stoltz JH; Stoll RE		Toxicol Pathol	26	1998	541-7	J:101392	9715513
93414	Directed expression of simian virus 40 T-antigen in transgenic mice using the epidermal growth factor gene promoter.		Pascall IC; Surani MA; Barton SC; Vaughan TJ; Brown KD		J Mol Endocrinol	12	1994	313-25	J:101459	7916970
93415	Testicular tumors in mice exposed in utero to diethylstilbestrol.		Newbold RR; Bullock BC; McLachlan JA		J Urol	138	1987	1446-50	J:101460	3682076
93416	Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol.		Couse JF; Davis VL; Hanson RB; Jefferson WN; McLachlan JA; Bullock BC; Newbold RR; Korach KS		Mol Carcinog	19	1997	236-42	J:101461	9290700
93417	Safety evaluation of toothpaste containing chloroform. I. Long-term studies in mice.		Roe FJ; Palmer AK; Worden AN; Van Abbe NJ		J Environ Pathol Toxicol	2	1979	799-819	J:101462	422936
93418	Insulin-like growth factor binding protein-1 over-expression in transgenic mice inhibits hepatic preneoplasia.		Lu S; Archer MC		Mol Carcinog	36	2003	142-6	J:101463	12619036
93419	Increased tumor cell proliferation in murine tumors with decreasing dosage of wild-type p53.		Tyner SD; Choi J; Laucirica R; Ford RJ; Donehower LA		Mol Carcinog	24	1999	197-208	J:101464	10204804
93420	Production of the long and short forms of MFG-E8 by epidermal keratinocytes.		Watanabe T; Totsuka R; Miyatani S; Kurata S; Sato S; Katoh I; Kobayashi S; Ikawa Y		Cell Tissue Res	321	2005	185-93	J:101465	15951990
93421	Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update.		Haseman JK; Hailey JR; Morris RW		Toxicol Pathol	26	1998	428-41	J:101512	9608650
93422	S-antigen and rod-opsin immunoreactions in midline brain neoplasms of transgenic mice: similarities to pineal cell tumors and certain medulloblastomas in man.		Korf HW; Gotz W; Herken R; Theuring F; Gruss P; Schachenmayr W		J Neuropathol Exp Neurol	49	1990	424-37	J:101513	2141872
93423	Spontaneous nephroblastoma in a strain CE/J mouse. A case report.		Liebelt AG; Sass B; Sobel HJ; Werner RM		Toxicol Pathol	17	1989	57-61	J:101514	2546252
93424	Transplacental induction of mouse lung tumors: stage of fetal organogenesis in relation to frequency, morphology, size, and neoplastic progression of N-nitrosoethylurea-induced tumors.		Rehm S; Ward JM; Anderson LM; Riggs CW; Rice JM		Toxicol Pathol	19	1991	35-46	J:101515	2047706
93425	Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice.		Reifenberg K; Lohler J; Pudollek HP; Schmitteckert E; Spindler G; Kock J; Schlicht HJ		J Hepatol	26	1997	119-30	J:101516	9148002
93426	High incidence of acute myeloid leukemia in SJL/J mice after X-irradiation and corticosteroids.		Resnitzky P; Estrov Z; Haran-Ghera N		Leuk Res	9	1985	1519-28	J:101517	3866124
93427	Role of nucleophosmin in embryonic development and tumorigenesis.		Grisendi S; Bernardi R; Rossi M; Cheng K; Khandker L; Manova K; Pandolfi PP		Nature	437	2005	147-53	J:101494	16007073
93428	Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.		Nateri AS; Spencer-Dene B; Behrens A		Nature	437	2005	281-5	J:101496	16007074
93429	Sulindac suppresses tumorigenesis in the Min mouse.		Beazer-Barclay Y; Levy DB; Moser AR; Dove WF; Hamilton SR; Vogelstein B; Kinzler KW		Carcinogenesis	17	1996	1757-60	J:101582	8761438
93430	T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.		Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM		Cancer Res	56	1996	5113-9	J:101583	8912842
93431	Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes.		Corallini A; Altavilla G; Pozzi L; Bignozzi F; Negrini M; Rimessi P; Gualandi F; Barbanti-Brodano G		Cancer Res	53	1993	5569-75	J:101584	8221699
93432	Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.		Greenhalgh DA; Wang XJ; Donehower LA; Roop DR		Cancer Res	56	1996	4413-23	J:101585	8813135
93433	Histochemical profile of mouse hepatocellular adenomas and carcinomas induced by a single dose of diethylnitrosamine.		Hacker HJ; Mtiro H; Bannasch P; Vesselinovitch SD		Cancer Res	51	1991	1952-8	J:101586	1848480
93434	Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7,12-dimethylbenz(a)anthracene application and ultraviolet irradiation.		Husain Z; Pathak MA; Flotte T; Wick MM		Cancer Res	51	1991	4964-70	J:101587	1909931
93435	Allelotype analysis of mouse skin tumors using polymorphic microsatellites: sequential genetic alterations on chromosomes 6, 7, and 11.		Kemp CJ; Fee F; Balmain A		Cancer Res	53	1993	6022-7	J:101588	7903201
93436	Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.		Kennedy AR; Beazer-Barclay Y; Kinzler KW; Newberne PM		Cancer Res	56	1996	679-82	J:101589	8630994
93437	Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant forms of the human c-Ha-ras transgene.		Ogawa K; Imaida K; Masui T; Kawabe M; Hasegawa R; Kato K; Ito N; Shirai T		Carcinogenesis	17	1996	341-5	J:101590	8625461
93438	Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.		Bell RH Jr; Memoli VA; Longnecker DS		Carcinogenesis	11	1990	1393-8	J:101539	2167183
93439	Insulin-like growth factor II (IGF-II) mRNA expression during hepatocarcinogenesis in transgenic mice.		Cariani E; Dubois N; Lasserre C; Briand P; Brechot C		J Hepatol	13	1991	220-6	J:101540	1720799
93440	Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice.		Dubois N; Bennoun M; Allemand I; Molina T; Grimber G; Daudet-Monsac M; Abelanet R; Briand P		J Hepatol	13	1991	227-39	J:101541	1660504
93441	Carcinogenic responses of transgenic heterozygous p53 knockout mice to inhaled 239PuO2 or metallic beryllium.		Finch GL; March TH; Hahn FF; Barr EB; Belinsky SA; Hoover MD; Lechner JF; Nikula KJ; Hobbs CH		Toxicol Pathol	26	1998	484-91	J:101542	9715507
93442	Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic TG.AC mice.		Hansen LA; Tennant R		Mol Carcinog	9	1994	143-54	J:101543	7908201
93443	Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin.		Hennings H; Blumberg PM; Pettit GR; Herald CL; Shores R; Yuspa SH		Carcinogenesis	8	1987	1343-6	J:101544	3621472
93444	Carcinogenicity of dermally administered 1,2-dihydro-2,2,4-trimethylquinoline monomer in F344 rats and B6C3F1 mice.		Irwin RD; French JE; Elwell M; Haseman J; Braun AG; Voelker FA		J Appl Toxicol	19	1999	125-32	J:101545	10215184
93445	Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. I. Induction of brain tumors in adult mice with Rous chicken sarcoma cells.		Kumanishi T		Jpn J Exp Med	37	1967	461-74	J:101546	4301953
93446	Delay of dimethylbenz[a]anthracene-induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein.		Li B; Kittrell FS; Medina D; Rosen JM		Mol Carcinog	14	1995	75-83	J:101547	7576102
93447	Chemoprevention of colon cancer carcinogenesis by balsalazide: inhibition of azoxymethane-induced aberrant crypt formation in the rat colon and intestinal tumor formation in the B6-Min/+ mouse.		MacGregor DJ; Kim YS; Sleisenger MH; Johnson LK		Int J Oncol	17	2000	173-9	J:101548	10853036
93448	Effect of 5-fluorouracil on early teratomas in mice.		Aldrich JT; Stevens LC		Cancer Res	27	1967	945-9	J:101636	6025258
93449	Mouse bronchiolar cell carcinogenesis. Histologic characterization and expression of Clara cell antigen in lesions induced by N-nitrosobis-(2-chloroethyl) ureas.		Rehm S; Lijinsky W; Singh G; Katyal SL		Am J Pathol	139	1991	413-22	J:101637	1651059
93450	Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large tag transgenic mice.		Schirmacher P; Held WA; Yang D; Biempica L; Rogler CE		Am J Pathol	139	1991	231-41	J:101638	1649555
93451	Dynamics of cell proliferation and cell death during the emergence of primitive neuroectodermal tumors of the immature central nervous system in transgenic mice.		Fung KM; Lee VM; Trojanowski JQ		Am J Pathol	146	1995	1376-87	J:101639	7778677
93452	Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene.		Tehranian A; Morris DW; Min BH; Bird DJ; Cardiff RD; Barry PA		Am J Pathol	149	1996	1177-91	J:101640	8863667
93453	Metal-inducible pathology in the liver, pancreas, and kidney of transgenic mice expressing SV40 early region genes.		Dyer KR; Messing A		Am J Pathol	135	1989	401-10	J:101641	2782379
93454	Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles.		Dawe CJ; Freund R; Mandel G; Ballmer-Hofer K; Talmage DA; Benjamin TL		Am J Pathol	127	1987	243-61	J:101642	2437801
93455	Adenocarcinoma of the rete testis. Diethylstilbestrol-induced lesions of the mouse rete testis.		Newbold RR; Bullock BC; McLachlan JA		Am J Pathol	125	1986	625-8	J:101643	3799821
93456	Immunocytochemical localization of the surfactant apoprotein and Clara cell antigen in chemically induced and naturally occurring pulmonary neoplasms of mice.		Ward JM; Singh G; Katyal SL; Anderson LM; Kovatch RM		Am J Pathol	118	1985	493-9	J:101644	3883798
93457	Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice.		Conaway CC; Wang CX; Pittman B; Yang YM; Schwartz JE; Tian D; McIntee EJ; Hecht SS; Chung FL		Cancer Res	65	2005	8548-57	J:101608	16166336
93458	Medullary thyroid carcinoma arises in the absence of prolactin signaling.		Kedzia C; Lacroix L; Ameur N; Ragot T; Kelly PA; Caillou B; Binart N		Cancer Res	65	2005	8497-503	J:101609	16166330
93459	Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung.		Wilderman MJ; Sun J; Jassar AS; Kapoor V; Khan M; Vachani A; Suzuki E; Kinniry PA; Sterman DH; Kaiser LR; Albelda SM		Cancer Res	65	2005	8379-87	J:101611	16166316
93460	In vivo assessment of RAS-dependent maintenance of tumor angiogenesis by real-time magnetic resonance imaging.		Tang Y; Kim M; Carrasco D; Kung AL; Chin L; Weissleder R		Cancer Res	65	2005	8324-30	J:101613	16166309
93461	Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential.		Simonson SJ; Difilippantonio MJ; Lambert PF		Cancer Res	65	2005	8266-73	J:101614	16166303
93462	Essential role for Ras signaling in glioblastoma maintenance.		Holmen SL; Williams BO		Cancer Res	65	2005	8250-5	J:101615	16166301
93463	Magnetic resonance angiography visualization of abnormal tumor vasculature in genetically engineered mice.		Brubaker LM; Bullitt E; Yin C; Van Dyke T; Lin W		Cancer Res	65	2005	8218-23	J:101616	16166297
93464	Non-melanoma skin cancer: what drives tumor development and progression?		Boukamp P		Carcinogenesis	26	2005	1657-67	J:101709	15905207
93465	Human p53 knock-in (hupki) mice do not differ in liver tumor response from their counterparts with murine p53.		Jaworski M; Hailfinger S; Buchmann A; Hergenhahn M; Hollstein M; Ittrich C; Schwarz M		Carcinogenesis	26	2005	1829-34	J:101711	15917304
93466	A Herpes saimiri oncogene causing peripheral T-cell lymphoma in transgenic mice.		Kretschmer C; Murphy C; Biesinger B; Beckers J; Fickenscher H; Kirchner T; Fleckenstein B; Ruther U		Oncogene	12	1996	1609-16	J:101796	8622880
93467	Overexpressed max is not oncogenic and attenuates myc-induced lymphoproliferation and lymphomagenesis in transgenic mice.		Lindeman GJ; Harris AW; Bath ML; Eisenman RN; Adams JM		Oncogene	10	1995	1013-7	J:101799	7898919
93468	Moloney virus induction of T-cell lymphomas in a plasmacytomagenic strain of E mu-v-abl transgenic mice.		Haupt Y; Harris AW; Adams JM		Int J Cancer	55	1993	623-9	J:101802	8406991
93469	De-regulation of endogenous retrotransposons in mouse mammary carcinomas of diverse etiologies.		Asch BB; Asch HL; Stoler DL; Anderson GR		Int J Cancer	54	1993	813-9	J:101804	8392034
93470	Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis.		Prakash O; Swamy OR; Peng X; Tang ZY; Li L; Larson JE; Cohen JC; Gill J; Farr G; Wang S; Samaniego F		Blood	105	2005	3987-94	J:98973	15665117
93471	The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice.		Quaglino E; Mastini C; Iezzi M; Forni G; Musiani P; Klapper LN; Hardy B; Cavallo F		Vaccine	23	2005	3280-7	J:98651	15837233
93472	YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification.		Bergmann S; Royer-Pokora B; Fietze E; Jurchott K; Hildebrandt B; Trost D; Leenders F; Claude JC; Theuring F; Bargou R; Dietel M; Royer HD		Cancer Res	65	2005	4078-87	J:98552	15899797
93473	The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.		Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M		Dev Neurosci	26	2004	417-34	J:98644	15855771
93474	Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.		Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW		J Urol	173	2005	1778-83	J:98661	15821586
93475	Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer.		Artandi SE; Attardi LD		Biochem Biophys Res Commun	331	2005	881-90	J:98173	15865944
93476	The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis.		Jenkins BJ; Roberts AW; Najdovska M; Grail D; Ernst M		Blood	105	2005	3512-20	J:98977	15650055
93477	Genetic toxicity and carcinogenicity studies of glutaraldehyde-a review.		Zeiger E; Gollapudi B; Spencer P		Mutat Res	589	2005	136-51	J:98676	15795166
93478	An identity crisis for fps/fes: oncogene or tumor suppressor?		Sangrar W; Zirgnibl RA; Gao Y; Muller WJ; Jia Z; Greer PA		Cancer Res	65	2005	3518-22	J:98281	15867340
93479	Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.		Logie A; Dunois-Larde C; Rosty C; Levrel O; Blanche M; Ribeiro A; Gasc JM; Jorcano J; Werner S; Sastre-Garau X; Thiery JP; Radvanyi F		Hum Mol Genet	14	2005	1153-60	J:98682	15772091
93480	Radiation leukemia virus common integration at the Kis2 locus: simultaneous overexpression of a novel noncoding RNA and of the proximal Phf6 gene.		Landais S; Quantin R; Rassart E		J Virol	79	2005	11443-56	J:101772	16103195
93481	Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998.		Gold LS; Manley NB; Slone TH; Rohrbach L; Garfinkel GB		Toxicol Sci	85	2005	747-808	J:98685	15800034
93482	Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.		Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopleovich L; Glazer RI		Cancer Res	65	2005	3950-7	J:98331	15867396
93483	p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow.		Vidal A; Zacharoulis S; Guo W; Shaffer D; Giancotti F; Bramley AH; de la Hoz C; Jensen KK; Kato D; MacDonald DD; Knowles J; Yeh N; Frohman LA; Rafii S; Lyden D; Koff A		Proc Natl Acad Sci U S A	102	2005	6890-5	J:99064	15867156
93484	Intestinal dysplasia induced by simian virus 40 T antigen is independent of p53.		Markovics JA; Carroll PA; Robles MT; Pope H; Coopersmith CM; Pipas JM		J Virol	79	2005	7492-502	J:98855	15919904
93485	Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.		Kim Y; Sills RC; Houle CD		Toxicol Pathol	33	2005	175-80	J:98666	15805069
93486	bHLH-zip transcription factor Spz1 mediates mitogen-activated protein kinase cell proliferation, transformation, and tumorigenesis.		Hsu SH; Hsieh-Li HM; Huang HY; Huang PH; Li H		Cancer Res	65	2005	4041-50	J:98544	15899793
93487	p63 deficiency activates a program of cellular senescence and leads to accelerated aging.		Keyes WM; Wu Y; Vogel H; Guo X; Lowe SW; Mills AA		Genes Dev	19	2005	1986-99	J:100483	16107615
93488	A new common integration site, Int7, for the mouse mammary tumor virus in mouse mammary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences.		Lowther W; Wiley K; Smith GH; Callahan R		J Virol	79	2005	10093-6	J:100100	16014973
93489	A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies.		Gabril MY; Duan W; Wu G; Moussa M; Izawa JI; Panchal CJ; Sakai H; Xuan JW		Mol Ther	11	2005	348-62	J:97870	15727931
93490	Probing p53 biological functions through the use of genetically engineered mouse models.		Attardi LD; Donehower LA		Mutat Res	576	2005	4-21	J:100060	16038709
93491	Inhibition of lung tumorigenesis by tea.		Yang CS; Liao J; Yang GY; Lu G		Exp Lung Res	31	2005	135-44	J:97845	15765923
93492	The Peroxisome Proliferator-Activated Receptor gamma Ligand Rosiglitazone Delays the Onset of Inflammatory Bowel Disease in Mice with Interleukin 10 Deficiency.		Lytle C; Tod TJ; Vo KT; Lee JW; Atkinson RD; Straus DS		Inflamm Bowel Dis	11	2005	231-43	J:97868	15735429
93493	No evidence for tumorigenesis of AAV vectors in a large-scale study in mice.		Bell P; Wang L; Lebherz C; Flieder DB; Bove MS; Wu D; Gao GP; Wilson JM; Wivel NA		Mol Ther	12	2005	299-306	J:100154	16043099
93494	Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.		Bhatia N; Spiegelman VS		Mol Carcinog	42	2005	213-21	J:97893	15765534
93495	Sonic hedgehog signaling in basal cell carcinomas.		Daya-Grosjean L; Couve-Privat S		Cancer Lett	225	2005	181-92	J:99520	15978322
93496	Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice.		Tekmal RR; Liu YG; Nair HB; Jones J; Perla RP; Lubahn DB; Korach KS; Kirma N		J Steroid Biochem Mol Biol	95	2005	9-15	J:100292	15955696
93497	Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis.		O'Brien ML; Spear BT; Glauert HP		Crit Rev Toxicol	35	2005	61-88	J:97865	15742903
93498	Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.		Ma X; Ziel-van der Made AC; Autar B; van der Korput HA; Vermeij M; van Duijn P; Cleutjens KB; de Krijger R; Krimpenfort P; Berns A; van der Kwast TH; Trapman J		Cancer Res	65	2005	5730-9	J:99524	15994948
93499	Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas.		Casola S; Ungaro P; Pedone PV; Lazzaro D; Fattori E; Ciliberto G; Zarrilli R; Bruni CB; Riccio A		Oncogene	11	1995	711-21	J:101797	7651735
93500	Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus.		Press RD; Wisner TW; Ewert DL		Oncogene	11	1995	525-35	J:101798	7630637
93501	First-generation offspring of male mice exposed to (239)Pu-citrate show no evidence of leukaemia or life shortening.		Selby P; Priest N		Int J Radiat Biol	81	2005	273-91	J:100048	16019937
93502	Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase.		Luo J; Sobkiw CL; Logsdon NM; Watt JM; Signoretti S; O'Connell F; Shin E; Shim Y; Pao L; Neel BG; Depinho RA; Loda M; Cantley LC		Proc Natl Acad Sci U S A	102	2005	10238-43	J:100184	16006513
93503	T-cell lymphomas in v-Myb transgenic mice.		Badiani PA; Kioussis D; Swirsky DM; Lampert IA; Weston K		Oncogene	13	1996	2205-12	J:101775	8950988
93504	Cancer in rodents: does it tell us about cancer in humans?		Anisimov VN; Ukraintseva SV; Yashin AI		Nat Rev Cancer	5	2005	807-19	J:101780	16195752
93505	Lesions of the rete testis in mice exposed prenatally to diethylstilbestrol.		Newbold RR; Bullock BC; McLachlan JA		Cancer Res	45	1985	5145-50	J:101800	4027990
93506	Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.		Wilson JB; Bell JL; Levine AJ		EMBO J	15	1996	3117-26	J:101801	8670812
93507	Hepatic tumors induced by carbon tetrachloride in transgenic mice carrying a human c-H-ras proto-oncogene without mutations.		Tsunematsu S; Saito H; Kagawa T; Morizane T; Hata J; Nakamura T; Ishii H; Tsuchiya M; Nomura T; Katsuki M		Int J Cancer	59	1994	554-9	J:101803	7960226
93508	Expression pattern of the cell adhesion molecules. E-cadherin, P-cadherin and alpha 6 beta 4 intergrin is altered in pre-malignant skin tumors of p53-deficient mice.		Cano A; Gamallo C; Kemp CJ; Benito N; Palacios J; Quintanilla M; Balmain A		Int J Cancer	65	1996	254-62	J:101805	8567126
93509	Tissue-specific expression of kallikrein family transgenes in mice and rats.		Smith MS; Lechago J; Wines DR; MacDonald RJ; Hammer RE		DNA Cell Biol	11	1992	345-58	J:101806	1605858
93510	Life-long over-expression of ornithine decarboxylase (ODC) gene in transgenic mice does not lead to generally enhanced tumorigenesis or neuronal degeneration.		Alhonen L; Halmekyto M; Kosma VM; Wahlfors J; Kauppinen R; Janne J		Int J Cancer	63	1995	402-4	J:101808	7591239
93511	Skin morphology of the mutant hairless USP mouse.		Massironi SM; Giacoia MR; Maiorka PC; Kipnis TL; Dagli ML		Braz J Med Biol Res	38	2005	33-9	J:101827	15665986
93512	Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.		Zhu Y; Guignard F; Zhao D; Liu L; Burns DK; Mason RP; Messing A; Parada LF		Cancer Cell	8	2005	119-30	J:101868	16098465
93513	The utility of genetically altered mouse models for nutrition and cancer chemoprevention research.		Hursting SD; Nunez NP; Patel AC; Perkins SN; Lubet RA; Barrett JC		Mutat Res	576	2005	80-92	J:99984	15990122
93514	Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models.		Difilippantonio S; Celeste A; Fernandez-Capetillo O; Chen HT; Reina San Martin B; Van Laethem F; Yang YP; Petukhova GV; Eckhaus M; Feigenbaum L; Manova K; Kruhlak M; Camerini-Otero RD; Sharan S; Nussenzweig M; Nussenzweig A		Nat Cell Biol	7	2005	675-85	J:100798	15965469
93515	Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between.		Jura N; Archer H; Bar-Sagi D		Cell Res	15	2005	72-7	J:97891	15686632
93516	Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis.		Halliday GM		Mutat Res	571	2005	107-20	J:97861	15748642
93517	Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.		Jansen AP; Camalier CE; Colburn NH		Cancer Res	65	2005	6034-41	J:100086	16024603
93518	Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma.		Kundu RK; Sangiorgi F; Wu LY; Pattengale PK; Hinton DR; Gill PS; Maxson R		Blood	94	1999	275-82	J:100577	10381523
93519	Antagonists of tumor-specific immunity: tumor-induced immune suppression and host genes that co-opt the anti-tumor immune response.		Ostrand-Rosenberg S; Sinha P; Danna EA; Miller S; Davis C; Dissanayake SK		Breast Dis	20	2004	127-35	J:97887	15687713
93520	How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men.		Corpet DE; Pierre F		Eur J Cancer	41	2005	1911-22	J:100740	16084718
93521	Tumor suppressive effects of tocotrienol in vivo and in vitro.		Wada S; Satomi Y; Murakoshi M; Noguchi N; Yoshikawa T; Nishino H		Cancer Lett	229	2005	181-91	J:101897	16098658
93524	Strain Clarification		Beamer WG		Personal Communication		1998		J:101431	 
93525	Information obtained from The Jackson Laboratory's JAX Mice and Services, Bar Harbor, ME (http://jaxmice.jax.org/)		Mouse Genome Informatics (MGI)				2005		J:101977	 
93526	Strain Synonym Annotation by the Mouse Tumor Biology (MTB) Database Curatorial Staff		Mouse Tumor Biology Database Scientific Curators				2005		J:101978	 
93527	Linkage mapping of norepinephrine transporter protein and serotonin transporter protein genes		Gelernter J; Kruger S; Pakstis AJ; Amara S; Kidd KK		Am J Hum Genet	53 Suppl	1993	A1003 (Abstr.)	J:36186	 
93528	Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse.		Carlson CM; Frandsen JL; Kirchhof N; McIvor RS; Largaespada DA		Proc Natl Acad Sci U S A	102	2005	17059-64	J:103838	16286660
93529	Cutting edge: TRAIL deficiency accelerates hematological malignancies.		Zerafa N; Westwood JA; Cretney E; Mitchell S; Waring P; Iezzi M; Smyth MJ		J Immunol	175	2005	5586-90	J:103779	16237043
93530	Pathology Image source		Ward JM		Personal Communication		2004		J:107304	 
93531	Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.		Kelliher MA; Seldin DC; Leder P		EMBO J	15	1996	5160-6	J:36076	8895560
93532	Pathology image source		Churchill GA		Personal Communication		2004		J:112750	 
93533	Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.		Herber R; Liem A; Pitot H; Lambert PF		J Virol	70	1996	1873-81	J:86018	8627712
93534	Jackson Aging Center		Sundberg J		MGI Direct Data Submission		2007		J:122261	 
93535	Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice.		Iwanaga Y; Chi YH; Miyazato A; Sheleg S; Haller K; Peloponese JM Jr; Li Y; Ward JM; Benezra R; Jeang KT		Cancer Res	67	2007	160-6	J:117337	17210695
93536	Genetic background controls tumor development in PTEN-deficient mice.		Freeman D; Lesche R; Kertesz N; Wang S; Li G; Gao J; Groszer M; Martinez-Diaz H; Rozengurt N; Thomas G; Liu X; Wu H		Cancer Res	66	2006	6492-6	J:110567	16818619
93537	Genetic mapping of a putative tumor suppressor locus that influences tumorigenesis and metastasis in mice.		Ayanga B; Price R; Gu X; Lozano G; Evans SC		Genes Chromosomes Cancer	45	2006	668-75	J:108788	16586494
93538	Evidence that MIG-6 is a tumor-suppressor gene.		Zhang YW; Staal B; Su Y; Swiatek P; Zhao P; Cao B; Resau J; Sigler R; Bronson R; Vande Woude GF		Oncogene	26	2007	269-76	J:117840	16819504
93539	Therapy-induced malignant neoplasms in Nf1 mutant mice.		Chao RC; Pyzel U; Fridlyand J; Kuo YM; Teel L; Haaga J; Borowsky A; Horvai A; Kogan SC; Bonifas J; Huey B; Jacks TE; Albertson DG; Shannon KM		Cancer Cell	8	2005	337-48	J:103509	16226708
93540	Genotype-phenotype relationships in a mouse model for human small-cell lung cancer.		Calbo J; Meuwissen R; van Montfort E; van Tellingen O; Berns A		Cold Spring Harb Symp Quant Biol	70	2005	225-32	J:115156	16869758
93541	The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.		Zhang L; Anglesio MS; O'sullivan M; Zhang F; Yang G; Sarao R; Nghiem MP; Cronin S; Hara H; Melnyk N; Li L; Wada T; Liu PP; Farrar J; Arceci RJ; Sorensen PH; Penninger JM		Nat Med	13	2007	1060-1069	J:125183	17694067
93542	Inactivation of conditional Rb by Villin-Cre leads to aggressive tumors outside the gastrointestinal tract.		Kucherlapati MH; Nguyen AA; Bronson RT; Kucherlapati RS		Cancer Res	66	2006	3576-83	J:108215	16585182
93543	Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.		Liu X; Holstege H; van der Gulden H; Treur-Mulder M; Zevenhoven J; Velds A; Kerkhoven RM; van Vliet MH; Wessels LF; Peterse JL; Berns A; Jonkers J		Proc Natl Acad Sci U S A	104	2007	12111-6	J:126551	17626182
93544	Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.		Bowen TJ; Yakushiji H; Montagna C; Jain S; Ried T; Wynshaw-Boris A		Cancer Res	65	2005	8736-46	J:102687	16204043
93545	Retroviral insertions in the VISION database identify molecular pathways in mouse lymphoid leukemia and lymphoma.		Weiser KC; Liu B; Hansen GM; Skapura D; Hentges KE; Yarlagadda S; Morse Iii HC; Justice MJ		Mamm Genome	18	2007	709-22	J:126376	17926094
93546	The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.		Uziel T; Zindy F; Xie S; Lee Y; Forget A; Magdaleno S; Rehg JE; Calabrese C; Solecki D; Eberhart CG; Sherr SE; Plimmer S; Clifford SC; Hatten ME; McKinnon PJ; Gilbertson RJ; Curran T; Sherr CJ; Roussel MF		Genes Dev	19	2005	2656-67	J:102702	16260494
93547	Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.		Derksen PW; Liu X; Saridin F; van der Gulden H; Zevenhoven J; Evers B; van Beijnum JR; Griffioen AW; Vink J; Krimpenfort P; Peterse JL; Cardiff RD; Berns A; Jonkers J		Cancer Cell	10	2006	437-49	J:116152	17097565
93548	A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.		Besson A; Gurian-West M; Chen X; Kelly-Spratt KS; Kemp CJ; Roberts JM		Genes Dev	20	2006	47-64	J:103819	16391232
93549	Induction of renal tumorigenesis with elevated levels of somatic loss of heterozygosity in Tsc1+/- mice on a Blm-deficient background.		Wilson C; Idziaszczyk S; Colley J; Humphreys V; Guy C; Maynard J; Sampson JR; Cheadle JP		Cancer Res	65	2005	10179-82	J:103410	16288003
93550	Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors.		Politi K; Zakowski MF; Fan PD; Schonfeld EA; Pao W; Varmus HE		Genes Dev	20	2006	1496-510	J:109092	16705038
93551	XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice.		Yan CT; Kaushal D; Murphy M; Zhang Y; Datta A; Chen C; Monroe B; Mostoslavsky G; Coakley K; Gao Y; Mills KD; Fazeli AP; Tepsuporn S; Hall G; Mulligan R; Fox E; Bronson R; De Girolami U; Lee C; Alt FW		Proc Natl Acad Sci U S A	103	2006	7378-83	J:109585	16670198
93552	Patched2 modulates tumorigenesis in patched1 heterozygous mice.		Lee Y; Miller HL; Russell HR; Boyd K; Curran T; McKinnon PJ		Cancer Res	66	2006	6964-71	J:112118	16849540
93553	A mouse model of basal-like breast carcinoma with metaplastic elements.		McCarthy A; Savage K; Gabriel A; Naceur C; Reis-Filho JS; Ashworth A		J Pathol	211	2007	389-98	J:119996	17212342
93554	Murine bilateral retinoblastoma exhibiting rapid-onset, metastatic progression and N-myc gene amplification.		MacPherson D; Conkrite K; Tam M; Mukai S; Mu D; Jacks T		EMBO J	26	2007	784-94	J:119919	17235288
93555	Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice.		Pangas SA; Li X; Umans L; Zwijsen A; Huylebroeck D; Gutierrez C; Wang D; Martin JF; Jamin SP; Behringer RR; Robertson EJ; Matzuk MM		Mol Cell Biol	28	2008	248-57	J:128934	17967875
93556	Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model.		Hill R; Song Y; Cardiff RD; Van Dyke T		Cancer Res	65	2005	10243-54	J:103408	16288012
93557	Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma.		Ryschich E; Lizdenis P; Ittrich C; Benner A; Stahl S; Hamann A; Schmidt J; Knolle P; Arnold B; Hammerling GJ; Ganss R		Cancer Res	66	2006	198-211	J:105110	16397233
93558	Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling.		Hodgson JG; Malek T; Bornstein S; Hariono S; Ginzinger DG; Muller WJ; Gray JW		Cancer Res	65	2005	9695-704	J:102690	16266989
93559	A conditional mouse model for malignant mesothelioma.		Jongsma J; van Montfort E; Vooijs M; Zevenhoven J; Krimpenfort P; van der Valk M; van de Vijver M; Berns A		Cancer Cell	13	2008	261-71	J:132943	18328429
93560	A genetic mouse model for metastatic lung cancer with gender differences in survival.		Zheng S; El-Naggar AK; Kim ES; Kurie JM; Lozano G		Oncogene	26	2007	6896-904	J:129627	17486075
93561	A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent.		Robinson C; van Bruggen I; Segal A; Dunham M; Sherwood A; Koentgen F; Robinson BW; Lake RA		Cancer Res	66	2006	10786-94	J:116125	17108115
93562	The differential effects of mutant p53 alleles on advanced murine lung cancer.		Jackson EL; Olive KP; Tuveson DA; Bronson R; Crowley D; Brown M; Jacks T		Cancer Res	65	2005	10280-8	J:103407	16288016
93563	A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.		Wang Y; Zhang Z; Lubet RA; You M		Oncogene	25	2006	1277-80	J:107333	16247444
93564	Tumor spectrum, tumor latency and tumor incidence of the pten-deficient mice.		Lu TL; Chang JL; Liang CC; You LR; Chen CM		PLoS ONE	2	2007	e1237	J:130367	18043744
93565	Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.		Floyd HS; Farnsworth CL; Kock ND; Mizesko MC; Little JL; Dance ST; Everitt J; Tichelaar J; Whitsett JA; Miller MS		Carcinogenesis	26	2005	2196-206	J:102839	16051643
93566	Existence of a threshold-like dose for gamma-ray induction of thymic lymphomas and no susceptibility to radiation-induced solid tumors in SCID mice.		Ishii-Ohba H; Kobayashi S; Nishimura M; Shimada Y; Tsuji H; Sado T; Ogiu T		Mutat Res	619	2007	124-33	J:120953	17397880
93567	p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.		Bai F; Pei XH; Nishikawa T; Smith MD; Xiong Y		Mol Cell Biol	27	2007	1495-504	J:118265	17145768
93568	Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.		Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF		Int J Cancer	120	2007	259-67	J:116086	17044021
93569	Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.		Huang X; Wullschleger S; Shpiro N; McGuire VA; Sakamoto K; Woods YL; McBurnie W; Fleming S; Alessi DR		Biochem J	412	2008	211-21	J:136150	18387000
93570	Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.		Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R		J Natl Cancer Inst	99	2007	1668-82	J:127821	18000218
93571	Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice.		Loffler KA; Biondi CA; Gartside MG; Serewko-Auret MM; Duncan R; Tonks ID; Mould AW; Waring P; Muller HK; Kay GF; Hayward NK		Oncogene	26	2007	4009-17	J:122890	17173065
93572	Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice.		Zhang QS; Eaton L; Snyder ER; Houghtaling S; Mitchell JB; Finegold M; Van Waes C; Grompe M		Cancer Res	68	2008	1601-8	J:132758	18316625
93573	The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.		Terzian T; Suh YA; Iwakuma T; Post SM; Neumann M; Lang GA; Van Pelt CS; Lozano G		Genes Dev	22	2008	1337-44	J:134767	18483220
93574	Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage response and tumorigenesis.		Minter-Dykhouse K; Ward I; Huen MS; Chen J; Lou Z		J Cell Biol	181	2008	727-35	J:137023	18504301
93575	p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice.		Ward IM; Minn K; van Deursen J; Chen J		Mol Cell Biol	23	2003	2556-63	J:82512	12640136
93576	Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia.		Matoso A; Zhou Z; Hayama R; Flesken-Nikitin A; Nikitin AY		Carcinogenesis	29	2008	620-8	J:133299	17893233
93577	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.		Dawlaty MM; Malureanu L; Jeganathan KB; Kao E; Sustmann C; Tahk S; Shuai K; Grosschedl R; van Deursen JM		Cell	133	2008	103-15	J:137482	18394993
93578	Tumor suppression by p53 in the absence of Atm.		Bailey SL; Gurley KE; Hoon-Kim K; Kelly-Spratt KS; Kemp CJ		Mol Cancer Res	6	2008	1185-92	J:139874	18583527
93579	Mtbp haploinsufficiency in mice increases tumor metastasis.		Iwakuma T; Tochigi Y; Van Pelt CS; Caldwell LC; Terzian T; Parant JM; Chau GP; Koch JG; Eischen CM; Lozano G		Oncogene	27	2008	1813-20	J:135509	17906694
93580	Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease.		Walkley CR; Qudsi R; Sankaran VG; Perry JA; Gostissa M; Roth SI; Rodda SJ; Snay E; Dunning P; Fahey FH; Alt FW; McMahon AP; Orkin SH		Genes Dev	22	2008	1662-76	J:136693	18559481
93581	Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.		Wang RH; Sengupta K; Li C; Kim HS; Cao L; Xiao C; Kim S; Xu X; Zheng Y; Chilton B; Jia R; Zheng ZM; Appella E; Wang XW; Ried T; Deng CX		Cancer Cell	14	2008	312-23	J:140089	18835033
93582	PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma.		Tanori M; Mancuso M; Pasquali E; Leonardi S; Rebessi S; Di Majo V; Guilly MN; Giangaspero F; Covelli V; Pazzaglia S; Saran A		Carcinogenesis	29	2008	1911-9	J:139958	18660545
93583	The nonhomologous end joining factor Artemis suppresses multi-tissue tumor formation and prevents loss of heterozygosity.		Woo Y; Wright SM; Maas SA; Alley TL; Caddle LB; Kamdar S; Affourtit J; Foreman O; Akeson EC; Shaffer D; Bronson RT; Morse HC rd; Roopenian D; Mills KD		Oncogene	26	2007	6010-20	J:130286	17384673
93584	A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma.		Boylan KL; Gosse MA; Staggs SE; Janz S; Grindle S; Kansas GS; Van Ness BG		Cancer Res	67	2007	4069-78	J:121329	17483317
93585	Synergy of p53 and Rb Deficiency in a Conditional Mouse Model for Metastatic Prostate Cancer.		Zhou Z; Flesken-Nikitin A; Corney DC; Wang W; Goodrich DW; Roy-Burman P; Nikitin AY		Cancer Res	66	2006	7889-98	J:112104	16912162
93586	On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed.		Lang RB; Stanton LW; Marcu KB		Nucleic Acids Res	10	1982	611-30	J:6721	6278424
93587	53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.		Morales JC; Franco S; Murphy MM; Bassing CH; Mills KD; Adams MM; Walsh NC; Manis JP; Rassidakis GZ; Alt FW; Carpenter PB		Proc Natl Acad Sci U S A	103	2006	3310-5	J:107173	16492765
93588	The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression.		Shakya R; Szabolcs M; McCarthy E; Ospina E; Basso K; Nandula S; Murty V; Baer R; Ludwig T		Proc Natl Acad Sci U S A	105	2008	7040-5	J:134977	18443292
93589	Tnk1/Kos1 knockout mice develop spontaneous tumors.		Hoare S; Hoare K; Reinhard MK; Lee YJ; Oh SP; May WS Jr		Cancer Res	68	2008	8723-32	J:140639	18974114
93590	MIF loss impairs Myc-induced lymphomagenesis.		Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O		Cell Death Differ	12	2005	1319-28	J:101099	15947793
93591	Maternal effects and cancer risk in the progeny of mice exposed to X-rays before conception.		Dasenbrock C; Tillmann T; Ernst H; Behnke W; Kellner R; Hagemann G; Kaever V; Kohler M; Rittinghausen S; Mohr U; Tomatis L		Exp Toxicol Pathol	56	2005	351-60	J:101100	15945274
93592	Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice.		Cai X; Carlson J; Stoicov C; Li H; Wang TC; Houghton J		Gastroenterology	128	2005	1937-52	J:101102	15940628
93593	Generation of a unique strain of multiple intestinal neoplasia (Apc(+/Min-FCCC)) mice with significantly increased numbers of colorectal adenomas.		Cooper HS; Chang WC; Coudry R; Gary MA; Everley L; Spittle CS; Wang H; Litwin S; Clapper ML		Mol Carcinog	44	2005	31-41	J:101103	15937958
93594	Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus.		Rasmussen MH; Sorensen AB; Morris DW; Dutra JC; Engelhard EK; Wang CL; Schmidt J; Pedersen FS		Virology	337	2005	353-64	J:101111	15913695
93595	Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.		Chiarle R; Simmons WJ; Cai H; Dhall G; Zamo A; Raz R; Karras JG; Levy DE; Inghirami G		Nat Med	11	2005	623-9	J:101120	15895073
93596	Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response.		Ercolini AM; Ladle BH; Manning EA; Pfannenstiel LW; Armstrong TD; Machiels JP; Bieler JG; Emens LA; Reilly RT; Jaffee EM		J Exp Med	201	2005	1591-602	J:101130	15883172
93597	Molecular characterization of salivary gland malignancy using the Smgb-Tag transgenic mouse model.		Makitie AA; Pintor Dos Reis P; Arora S; Macmillan C; Warner GC; Sukhai M; Dardick I; Perez-Ordonez B; Wells R; Brown D; Gilbert R; Freeman J; Gullane P; Irish J; Kamel-Reid S		Lab Invest	85	2005	947-61	J:101133	15880136
93598	Epithelial-stromal tumor of the seminal vesicles in the transgenic adenocarcinoma mouse prostate model.		Tani Y; Suttie A; Flake GP; Nyska A; Maronpot RR		Vet Pathol	42	2005	306-14	J:101136	15872376
93599	Effect of N-cadherin misexpression by the mammary epithelium in mice.		Knudsen KA; Sauer C; Johnson KR; Wheelock MJ		J Cell Biochem	95	2005	1093-107	J:101141	15838877
93600	A mutation in stratifin is responsible for the repeated epilation (Er) phenotype in mice.		Herron BJ; Liddell RA; Parker A; Grant S; Kinne J; Fisher JK; Siracusa LD		Nat Genet	37	2005	1210-2	J:101891	16200063
93601	Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors.		Cleary MP; Juneja SC; Phillips FC; Hu X; Grande JP; Maihle NJ		Exp Biol Med (Maywood)	229	2004	182-93	J:102011	14734797
93602	Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression.		Cowey SL; Quast M; Belalcazar LM; Wei J; Deng X; Given R; Singh P		Cancer	103	2005	2643-53	J:102108	15864814
93603	Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice.		Themis M; Waddington SN; Schmidt M; von Kalle C; Wang Y; Al-Allaf F; Gregory LG; Nivsarkar M; Themis M; Holder MV; Buckley SM; Dighe N; Ruthe AT; Mistry A; Bigger B; Rahim A; Nguyen TH; Trono D; Thrasher AJ; Coutelle C		Mol Ther	12	2005	763-71	J:102125	16084128
93604	Absence of pathogenic mitochondrial DNA mutations in mouse brain tumors.		Kiebish MA; Seyfried TN		BMC Cancer	5	2005	102	J:102140	16105171
93605	Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.		Park SS; Shaffer AL; Kim JS; duBois W; Potter M; Staudt LM; Janz S		Cancer Res	65	2005	7644-52	J:102146	16140930
93606	Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN(+/-) mice.		Bayascas JR; Leslie NR; Parsons R; Fleming S; Alessi DR		Curr Biol	15	2005	1839-46	J:102216	16243031
93607	Pten constrains centroacinar cell expansion and malignant transformation in the pancreas.		Stanger BZ; Stiles B; Lauwers GY; Bardeesy N; Mendoza M; Wang Y; Greenwood A; Cheng KH; McLaughlin M; Brown D; Depinho RA; Wu H; Melton DA; Dor Y		Cancer Cell	8	2005	185-95	J:102226	16169464
93608	The transcriptional repressor Snail promotes mammary tumor recurrence.		Moody SE; Perez D; Pan TC; Sarkisian CJ; Portocarrero CP; Sterner CJ; Notorfrancesco KL; Cardiff RD; Chodosh LA		Cancer Cell	8	2005	197-209	J:102242	16169465
93609	Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences.		Lou DQ; Molina T; Bennoun M; Porteu A; Briand P; Joulin V; Vasseur-Cognet M; Cavard C		Cancer Lett	229	2005	107-14	J:102246	16157222
93610	High incidence, early onset of histiocytic sarcomas in mice with Hertwig's anemia.		Barker JE; Deveau SA; Compton ST; Fancher K; Eppig JT		Exp Hematol	33	2005	1118-29	J:102334	16219534
93611	53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice.		Ward IM; Difilippantonio S; Minn K; Mueller MD; Molina JR; Yu X; Frisk CS; Ried T; Nussenzweig A; Chen J		Mol Cell Biol	25	2005	10079-86	J:102355	16260621
93612	RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.		Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE		Mol Cell Biol	25	2005	10136-47	J:102359	16260626
93613	Ets2-dependent microenvironmental support of mouse mammary tumors.		Tynan JA; Wen F; Muller WJ; Oshima RG		Oncogene	24	2005	6870-6	J:102368	16007139
93614	Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development.		Formisano P; Perruolo G; Libertini S; Santopietro S; Troncone G; Raciti GA; Oriente F; Portella G; Miele C; Beguinot F		Oncogene	24	2005	7012-21	J:102369	16044159
93615	Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development.		Melnikova VO; Pacifico A; Chimenti S; Peris K; Ananthaswamy HN		Oncogene	24	2005	7055-63	J:102370	16007135
93616	A moderate reduction of Bcl-x(L) expression protects against tumorigenesis; however, it also increases susceptibility to tissue injury.		Henderson CC; Zhang Z; Manson SR; Riehm JJ; Kataoka M; Flye MW; Garbow JR; You M; Weintraub SJ		Oncogene	24	2005	7120-4	J:102371	16007126
93617	Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice.		Oshima M; Oshima H; Matsunaga A; Taketo MM		Cancer Res	65	2005	9147-51	J:102372	16230370
93618	Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.		Sung YM; He G; Fischer SM		Cancer Res	65	2005	9304-11	J:102373	16230392
93619	Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development.		Boerboom D; Paquet M; Hsieh M; Liu J; Jamin SP; Behringer RR; Sirois J; Taketo MM; Richards JS		Cancer Res	65	2005	9206-15	J:102374	16230381
93620	Critical function for ADAM9 in mouse prostate cancer.		Peduto L; Reuter VE; Shaffer DR; Scher HI; Blobel CP		Cancer Res	65	2005	9312-9	J:102376	16230393
93621	p27kip1 in intestinal tumorigenesis and chemoprevention in the mouse.		Yang W; Bancroft L; Liang J; Zhuang M; Augenlicht LH		Cancer Res	65	2005	9363-8	J:102377	16230399
93622	Snm1-deficient mice exhibit accelerated tumorigenesis and susceptibility to infection.		Ahkter S; Richie CT; Zhang N; Behringer RR; Zhu C; Legerski RJ		Mol Cell Biol	25	2005	10071-8	J:102381	16260620
93623	Tumor promotion by caspase-resistant retinoblastoma protein.		Borges HL; Bird J; Wasson K; Cardiff RD; Varki N; Eckmann L; Wang JY		Proc Natl Acad Sci U S A	102	2005	15587-92	J:102483	16227443
93624	Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways.		Hutt JA; Vuillemenot BR; Barr EB; Grimes MJ; Hahn FF; Hobbs CH; March TH; Gigliotti AP; Seilkop SK; Finch GL; Mauderly JL; Belinsky SA		Carcinogenesis	26	2005	1999-2009	J:102522	15944214
93625	XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer.		Munoz P; Blanco R; Flores JM; Blasco MA		Nat Genet	37	2005	1063-71	J:102653	16142233
93626	Unexpected roles for pRb in mouse skin carcinogenesis.		Ruiz S; Santos M; Lara MF; Segrelles C; Ballestin C; Paramio JM		Cancer Res	65	2005	9678-86	J:102689	16266987
93627	Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development.		Dube N; Bourdeau A; Heinonen KM; Cheng A; Loy AL; Tremblay ML		Cancer Res	65	2005	10088-95	J:102693	16267035
93628	HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.		Howe LR; Chang SH; Tolle KC; Dillon R; Young LJ; Cardiff RD; Newman RA; Yang P; Thaler HT; Muller WJ; Hudis C; Brown AM; Hla T; Subbaramaiah K; Dannenberg AJ		Cancer Res	65	2005	10113-9	J:102694	16267038
93629	Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.		Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM		Cancer Res	65	2005	8662-70	J:102704	16204034
93630	Relationship between UV-induced mutant p53 patches and skin tumours, analysed by mutation spectra and by induction kinetics in various DNA-repair-deficient mice.		Rebel H; Kram N; Westerman A; Banus S; van Kranen HJ; de Gruijl FR		Carcinogenesis	26	2005	2123-30	J:102840	16051635
93631	Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis.		Shoji Y; Takahashi M; Takasuka N; Niho N; Kitamura T; Sato H; Maruyama T; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K		Carcinogenesis	26	2005	2116-22	J:102841	16051640
93632	Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.		Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M		Mol Cancer Res	3	2005	563-74	J:102874	16254190
93633	Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: a study on hCG overexpressing transgenic mice.		Ahtiainen P; Rulli SB; Shariatmadari R; Pelliniemi LJ; Toppari J; Poutanen M; Huhtaniemi IT		Oncogene	24	2005	7301-9	J:102880	16007123
93634	Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice.		Tarakanova VL; Suarez F; Tibbetts SA; Jacoby MA; Weck KE; Hess JL; Speck SH; Virgin HW th		J Virol	79	2005	14668-79	J:102883	16282467
93635	Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues.		Zinser GM; Suckow M; Welsh J		J Steroid Biochem Mol Biol	97	2005	153-64	J:102891	16111884
93636	Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.		Dong W; Kloz U; Accardi R; Caldeira S; Tong WM; Wang ZQ; Jansen L; Durst M; Sylla BS; Gissmann L; Tommasino M		J Virol	79	2005	14899-908	J:102913	16282489
93637	Immunohistochemical and genetic analysis of mandibular cysts in heterozygous ptc knockout mice.		Kimi K; Ohki K; Kumamoto H; Kondo M; Taniguchi Y; Tanigami A; Ooya K		J Oral Pathol Med	32	2003	108-13	J:102978	12542834
93638	Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis.		Cully M; Shiu J; Piekorz RP; Muller WJ; Done SJ; Mak TW		Cancer Res	65	2005	10363-70	J:103403	16288026
93639	CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma.		Tan EH; Hooi SC; Laban M; Wong E; Ponniah S; Wee A; Wang ND		Cancer Res	65	2005	10330-7	J:103404	16288022
93640	A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas.		Taverna D; Crowley D; Connolly M; Bronson RT; Hynes RO		Cancer Res	65	2005	10324-9	J:103405	16288021
93641	Enhanced DDB2 expression protects mice from carcinogenic effects of chronic UV-B irradiation.		Alekseev S; Kool H; Rebel H; Fousteri M; Moser J; Backendorf C; de Gruijl FR; Vrieling H; Mullenders LH		Cancer Res	65	2005	10298-306	J:103406	16288018
93642	Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis.		Reddy HK; Mettus RV; Rane SG; Grana X; Litvin J; Reddy EP		Cancer Res	65	2005	10174-8	J:103411	16288002
93643	Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development.		Steinman HA; Hoover KM; Keeler ML; Sands AT; Jones SN		Oncogene	24	2005	7935-40	J:103425	16027727
93644	Genomic instability in radiation-induced mouse lymphoma from p53 heterozygous mice.		Mao JH; Li J; Jiang T; Li Q; Wu D; Perez-Losada J; DelRosario R; Peterson L; Balmain A; Cai WW		Oncogene	24	2005	7924-34	J:103426	16116484
93645	FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model.		Lee BH; Williams IR; Anastasiadou E; Boulton CL; Joseph SW; Amaral SM; Curley DP; Duclos N; Huntly BJ; Fabbro D; Griffin JD; Gilliland DG		Oncogene	24	2005	7882-92	J:103427	16116483
93646	Fine allelotyping of Erbb2-induced mammary tumors in mice reveals multiple discontinuous candidate regions of tumor-suppressor loci.		Cool M; Depault F; Jolicoeur P		Genes Chromosomes Cancer	45	2006	191-202	J:103450	16258954
93647	Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.		Willimsky G; Blankenstein T		Nature	437	2005	141-6	J:103546	16136144
93648	Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.		Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS		Gastroenterology	129	2005	1005-18	J:103565	16143138
93649	Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice.		Yamashita N; Osato M; Huang L; Yanagida M; Kogan SC; Iwasaki M; Nakamura T; Shigesada K; Asou N; Ito Y		Br J Haematol	131	2005	495-507	J:103596	16281942
93650	Frequent harderian gland adenocarcinomas in inbred white-footed mice (Peromyscus leucopus).		Parnell PG; Crossland JP; Beattie RM; Dewey MJ		Comp Med	55	2005	382-6	J:103613	16158914
93651	Squamous cell carcinomas of the skin at ear tag sites in aged FVB/N mice.		Baron BW; Langan G; Huo D; Baron JM; Montag A		Comp Med	55	2005	231-5	J:103615	16089170
93652	Recurrent non-reciprocal translocations of chromosome 5 in primary T(12;15)-positive BALB/c plasmacytomas.		Coleman AE; Ried T; Janz S		Curr Top Microbiol Immunol	246	1999	175-80; discussion 181	J:103623	10396054
93653	Analysis of Orthologous Gene Expression between Human Pulmonary Adenocarcinoma and a Carcinogen-Induced Murine Model.		Stearman RS; Dwyer-Nield L; Zerbe L; Blaine SA; Chan Z; Bunn PA Jr; Johnson GL; Hirsch FR; Merrick DT; Franklin WA; Baron AE; Keith RL; Nemenoff RA; Malkinson AM; Geraci MW		Am J Pathol	167	2005	1763-75	J:103641	16314486
93654	Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis.		Lee HY; Oh SH; Woo JK; Kim WY; Van Pelt CS; Price RE; Cody D; Tran H; Pezzuto JM; Moriarty RM; Hong WK		J Natl Cancer Inst	97	2005	1695-9	J:103647	16288123
93655	p27kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice.		Kuzushita N; Rogers AB; Monti NA; Whary MT; Park MJ; Aswad BI; Shirin H; Koff A; Eguchi H; Moss SF		Gastroenterology	129	2005	1544-56	J:103656	16285954
93656	Monoclonal B-cell hyperplasia and leukocyte imbalance precede development of B-cell malignancies in uracil-DNA glycosylase deficient mice.		Andersen S; Ericsson M; Dai HY; Pena-Diaz J; Slupphaug G; Nilsen H; Aarset H; Krokan HE		DNA Repair (Amst)	4	2005	1432-41	J:103664	16174566
93657	Transgenic expression of Helios in B lineage cells alters B cell properties and promotes lymphomagenesis.		Dovat S; Montecino-Rodriguez E; Schuman V; Teitell MA; Dorshkind K; Smale ST		J Immunol	175	2005	3508-15	J:103729	16148093
93658	Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease.		Yazawa N; Hamaguchi Y; Poe JC; Tedder TF		Proc Natl Acad Sci U S A	102	2005	15178-83	J:103745	16217038
93659	VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.		Kaplan RN; Riba RD; Zacharoulis S; Bramley AH; Vincent L; Costa C; MacDonald DD; Jin DK; Shido K; Kerns SA; Zhu Z; Hicklin D; Wu Y; Port JL; Altorki N; Port ER; Ruggero D; Shmelkov SV; Jensen KK; Rafii S; Lyden D		Nature	438	2005	820-7	J:103807	16341007
93660	Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.		Huang S; Li Y; Chen Y; Podsypanina K; Chamorro M; Olshen AB; Desai KV; Tann A; Petersen D; Green JE; Varmus HE		Genome Biol	6	2005	R84	J:103821	16207355
93661	Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors.		Currier N; Solomon SE; Demicco EG; Chang DL; Farago M; Ying H; Dominguez I; Sonenshein GE; Cardiff RD; Xiao ZX; Sherr DH; Seldin DC		Toxicol Pathol	33	2005	726-37	J:103858	16263698
93662	Mice transgenic for NPM-ALK develop non-Hodgkin lymphomas.		Jager R; Hahne J; Jacob A; Egert A; Schenkel J; Wernert N; Schorle H; Wellmann A		Anticancer Res	25	2005	3191-6	J:103860	16101126
93663	Early epidermal destruction with subsequent epidermal hyperplasia is a unique feature of the papilloma-independent squamous cell carcinoma phenotype in PKCepsilon overexpressing transgenic mice.		Li Y; Wheeler DL; Alters W; Chaiswing L; Verma AK; Oberley TD		Toxicol Pathol	33	2005	684-94	J:103872	16243773
93664	Cancer stem cell characteristics in retinoblastoma.		Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F		Mol Vis	11	2005	729-37	J:103973	16179903
93665	Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice.		Suzuki R; Kohno H; Sugie S; Nakagama H; Tanaka T		Carcinogenesis	27	2006	162-9	J:104028	16081511
93666	Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice.		Rogers AB; Taylor NS; Whary MT; Stefanich ED; Wang TC; Fox JG		Cancer Res	65	2005	10709-15	J:104073	16322215
93667	Overcoming Fas-mediated apoptosis accelerates Helicobacter-induced gastric cancer in mice.		Cai X; Stoicov C; Li H; Carlson J; Whary M; Fox JG; Houghton J		Cancer Res	65	2005	10912-20	J:104087	16322238
93668	Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice.		Thierbach R; Schulz TJ; Isken F; Voigt A; Mietzner B; Drewes G; von Kleist-Retzow JC; Wiesner RJ; Magnuson MA; Puccio H; Pfeiffer AF; Steinberg P; Ristow M		Hum Mol Genet	14	2005	3857-64	J:104119	16278235
93669	Cancer development induced by graded expression of Snail in mice.		Perez-Mancera PA; Perez-Caro M; Gonzalez-Herrero I; Flores T; Orfao A; de Herreros AG; Gutierrez-Adan A; Pintado B; Sagrera A; Sanchez-Martin M; Sanchez-Garcia I		Hum Mol Genet	14	2005	3449-61	J:104124	16207734
93670	Kaiso-deficient mice show resistance to intestinal cancer.		Prokhortchouk A; Sansom O; Selfridge J; Caballero IM; Salozhin S; Aithozhina D; Cerchietti L; Meng FG; Augenlicht LH; Mariadason JM; Hendrich B; Melnick A; Prokhortchouk E; Clarke A; Bird A		Mol Cell Biol	26	2006	199-208	J:104155	16354691
93671	Tumor suppression and normal aging in mice with constitutively high p53 activity.		Mendrysa SM; O'leary KA; McElwee MK; Michalowski J; Eisenman RN; Powell DA; Perry ME		Genes Dev	20	2006	16-21	J:104174	16391230
93672	Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet.		Bissahoyo A; Pearsall RS; Hanlon K; Amann V; Hicks D; Godfrey VL; Threadgill DW		Toxicol Sci	88	2005	340-5	J:104177	16150884
93673	The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice.		Tomblyn S; Langenheim JF; Jacquemart IC; Holle E; Chen WY		Int J Oncol	27	2005	1381-9	J:104184	16211235
93674	The Cables gene on chromosome 18Q regulates colon cancer progression in vivo		Kirley SD; D'Apuzzo M; Lauwers GY; Graeme-Cook F; Chung DC; Zukerberg LR		Cancer Biol Ther	4	2005	861-3	J:104191	16210915
93675	Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse.		Wang Z; Prins GS; Coschigano KT; Kopchick JJ; Green JE; Ray VH; Hedayat S; Christov KT; Unterman TG; Swanson SM		Endocrinology	146	2005	5188-96	J:104208	16141391
93676	Vitamin E and organoselenium prevent the cocarcinogenic activity of arsenite with solar UVR in mouse skin.		Uddin AN; Burns FJ; Rossman TG		Carcinogenesis	26	2005	2179-86	J:104230	16014701
93677	Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.		Zhu Y; Harada T; Liu L; Lush ME; Guignard F; Harada C; Burns DK; Bajenaru ML; Gutmann DH; Parada LF		Development	132	2005	5577-88	J:104342	16314489
93678	Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development.		Hummerich L; Muller R; Hess J; Kokocinski F; Hahn M; Furstenberger G; Mauch C; Lichter P; Angel P		Oncogene	25	2006	111-21	J:104343	16247483
93679	Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis.		Wei C; Amos CI; Stephens LC; Campos I; Deng JM; Behringer RR; Rashid A; Frazier ML		Cancer Res	65	2005	11297-303	J:104347	16357136
93680	Apc deficiency predisposes to renal carcinoma in the mouse.		Sansom OJ; Griffiths DF; Reed KR; Winton DJ; Clarke AR		Oncogene	24	2005	8205-10	J:104413	16116480
93681	Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53.		Seo J; Chung YS; Sharma GG; Moon E; Burack WR; Pandita TK; Choi K		Oncogene	24	2005	8176-86	J:104414	16261166
93682	Nine-week detection of six genotoxic lung carcinogens using the rasH2/BHT mouse model.		Umemura T; Kodama Y; Nishikawa A; Hioki K; Nomura T; Kanki K; Kuroiwa Y; Ishii Y; Kurokawa Y; Hirose M		Cancer Lett	231	2006	314-8	J:104435	16399233
93683	Differential sensitivity of mouse epithelial tissues to the polyomavirus middle T oncogene.		Cecena G; Wen F; Cardiff RD; Oshima RG		Am J Pathol	168	2006	310-20	J:104437	16400032
93684	The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth.		Shen H; Schuster R; Stringer KF; Waltz SE; Lentsch AB		FASEB J	20	2006	59-64	J:104574	16394268
93685	Chronic stress and susceptibility to skin cancer.		Saul AN; Oberyszyn TM; Daugherty C; Kusewitt D; Jones S; Jewell S; Malarkey WB; Lehman A; Lemeshow S; Dhabhar FS		J Natl Cancer Inst	97	2005	1760-7	J:104631	16333031
93686	Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis.		Bauer AK; Dixon D; DeGraff LM; Cho HY; Walker CR; Malkinson AM; Kleeberger SR		J Natl Cancer Inst	97	2005	1778-81	J:104658	16333033
93687	Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.		Casanovas O; Hicklin DJ; Bergers G; Hanahan D		Cancer Cell	8	2005	299-309	J:104853	16226705
93688	Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice.		Kosmider O; Denis N; Lacout C; Vainchenker W; Dubreuil P; Moreau-Gachelin F		Cancer Cell	8	2005	467-78	J:104970	16338660
93689	Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice.		Lin Q; Clark AB; McCulloch SD; Yuan T; Bronson RT; Kunkel TA; Kucherlapati R		Cancer Res	66	2006	87-94	J:105034	16397220
93690	An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model.		Reilly KM; Broman KW; Bronson RT; Tsang S; Loisel DA; Christy ES; Sun Z; Diehl J; Munroe DJ; Tuskan RG		Cancer Res	66	2006	62-8	J:105038	16397217
93691	Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice.		Rao VP; Poutahidis T; Ge Z; Nambiar PR; Horwitz BH; Fox JG; Erdman SE		Cancer Res	66	2006	57-61	J:105039	16397216
93692	Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia.		Kuo YH; Landrette SF; Heilman SA; Perrat PN; Garrett L; Liu PP; Le Beau MM; Kogan SC; Castilla LH		Cancer Cell	9	2006	57-68	J:105040	16413472
93693	Requirement for CDK4 kinase function in breast cancer.		Yu Q; Sicinska E; Geng Y; Ahnstrom M; Zagozdzon A; Kong Y; Gardner H; Kiyokawa H; Harris LN; Stal O; Sicinski P		Cancer Cell	9	2006	23-32	J:105043	16413469
93694	Dual degradation signals control Gli protein stability and tumor formation.		Huntzicker EG; Estay IS; Zhen H; Lokteva LA; Jackson PK; Oro AE		Genes Dev	20	2006	276-81	J:105048	16421275
93695	Evidence for complex multigenic inheritance of radiation AML susceptibility in mice revealed using a surrogate phenotypic assay.		Darakhshan F; Badie C; Moody J; Coster M; Finnon R; Finnon P; Edwards AA; Szluinska M; Skidmore CJ; Yoshida K; Ullrich R; Cox R; Bouffler SD		Carcinogenesis	27	2006	311-8	J:105074	16093251
93696	Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma.		Tuveson DA; Zhu L; Gopinathan A; Willis NA; Kachatrian L; Grochow R; Pin CL; Mitin NY; Taparowsky EJ; Gimotty PA; Hruban RH; Jacks T; Konieczny SF		Cancer Res	66	2006	242-7	J:105076	16397237
93697	Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.		Garbe AI; Vermeer B; Gamrekelashvili J; von Wasielewski R; Greten FR; Westendorf AM; Buer J; Schmid RM; Manns MP; Korangy F; Greten TF		Cancer Res	66	2006	508-16	J:105147	16397267
93698	Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer.		McCabe MT; Low JA; Daignault S; Imperiale MJ; Wojno KJ; Day ML		Cancer Res	66	2006	385-92	J:105165	16397253
93699	Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland.		Davis MA; Reynolds AB		Dev Cell	10	2006	21-31	J:105283	16399075
93700	Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis.		Suizu F; Ryo A; Wulf G; Lim J; Lu KP		Mol Cell Biol	26	2006	1463-79	J:105549	16449657
93701	E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.		Russell JL; Weaks RL; Berton TR; Johnson DG		Oncogene	25	2006	867-76	J:105657	16205640
93702	Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas.		Kichina JV; Zeremski M; Aris L; Gurova KV; Walker E; Franks R; Nikitin AY; Kiyokawa H; Gudkov AV		Oncogene	25	2006	857-66	J:105658	16170338
93703	Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.		Qiao W; Li AG; Owens P; Xu X; Wang XJ; Deng CX		Oncogene	25	2006	207-17	J:105673	16170355
93704	Hint1 is a haplo-insufficient tumor suppressor in mice.		Li H; Zhang Y; Su T; Santella RM; Weinstein IB		Oncogene	25	2006	713-21	J:105674	16186798
93705	Notch3 signaling initiates choroid plexus tumor formation.		Dang L; Fan X; Chaudhry A; Wang M; Gaiano N; Eberhart CG		Oncogene	25	2006	487-91	J:105676	16186803
93706	LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.		Thornburg NJ; Kulwichit W; Edwards RH; Shair KH; Bendt KM; Raab-Traub N		Oncogene	25	2006	288-97	J:105677	16247482
93707	Locations of mouse DNA damage response and repair loci, and cancer risk modifiers.		Bulman RA; Dragani TA; Bouffler SD; Cox R		DNA Repair (Amst)	5	2006	274-7	J:105678	16290248
93708	AML1 deletion in adult mice causes splenomegaly and lymphomas.		Putz G; Rosner A; Nuesslein I; Schmitz N; Buchholz F		Oncogene	25	2006	929-39	J:105709	16247465
93709	The rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development.		Malliri A; Rygiel TP; van der Kammen RA; Song JY; Engers R; Hurlstone AF; Clevers H; Collard JG		J Biol Chem	281	2006	543-8	J:105716	16249175
93710	Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice.		Baker DJ; Jeganathan KB; Malureanu L; Perez-Terzic C; Terzic A; van Deursen JM		J Cell Biol	172	2006	529-40	J:105717	16476774
93711	Comparison of gene expression and DNA copy number changes in a murine model of lung cancer.		Sweet-Cordero A; Tseng GC; You H; Douglass M; Huey B; Albertson D; Jacks T		Genes Chromosomes Cancer	45	2006	338-48	J:105735	16323170
93712	Assessment of F-MuLV-induced tumorigenesis reveals new candidate tumor genes including Pecam1, St7, and Prim2		Yatsula B; Galvao C; McCrann M; Perkins AS		Leukemia	20	2006	162-165	J:105807	16307020
93713	A transgenic mouse model for TEL-JAK2-induced B-cell lymphoma/leukemia		dos Santos NR; Ghysdael J		Leukemia	20	2006	182-5	J:105808	16281066
93714	Array CGH analysis reveals chromosomal aberrations in mouse lung adenocarcinomas induced by the human lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.		Herzog CR; Desai D; Amin S		Biochem Biophys Res Commun	341	2006	856-63	J:105867	16455056
93715	Distinct roles for cysteine cathepsin genes in multistage tumorigenesis.		Gocheva V; Zeng W; Ke D; Klimstra D; Reinheckel T; Peters C; Hanahan D; Joyce JA		Genes Dev	20	2006	543-56	J:105935	16481467
93716	Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia.		Metcalf D; Dakic A; Mifsud S; Di Rago L; Wu L; Nutt S		Proc Natl Acad Sci U S A	103	2006	1486-91	J:105994	16432184
93717	Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.		Wang S; Garcia AJ; Wu M; Lawson DA; Witte ON; Wu H		Proc Natl Acad Sci U S A	103	2006	1480-5	J:105995	16432235
93718	ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.		Pusapati RV; Rounbehler RJ; Hong S; Powers JT; Yan M; Kiguchi K; McArthur MJ; Wong PK; Johnson DG		Proc Natl Acad Sci U S A	103	2006	1446-51	J:105997	16432227
93719	Involvement of cyclooxygenase-2 in gastric mucosal hypertrophy in gastrin transgenic mice.		Kanda N; Seno H; Kawada M; Sawabu T; Uenoyoma Y; Nakajima T; Konda Y; Fukui H; Takeuchi T; Chiba T		Am J Physiol Gastrointest Liver Physiol	290	2006	G519-27	J:106047	16254046
93720	In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas.		Kuang C; Xiao Y; Liu X; Stringfield TM; Zhang S; Wang Z; Chen Y		Proc Natl Acad Sci U S A	103	2006	1858-63	J:106078	16443684
93721	Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice.		Begum M; Tashiro H; Katabuchi H; Suzuki A; Kurman RJ; Okamura H		Lab Invest	86	2006	286-96	J:106131	16402032
93722	Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor.		Takahashi C; Contreras B; Iwanaga T; Takegami Y; Bakker A; Bronson RT; Noda M; Loda M; Hunt JL; Ewen ME		Nat Genet	38	2006	118-23	J:106133	16369533
93723	Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.		Haines BB; Ryu CJ; Chang S; Protopopov A; Luch A; Kang YH; Draganov DD; Fragoso MF; Paik SG; Hong HJ; DePinho RA; Chen J		Cancer Cell	9	2006	109-20	J:106246	16473278
93724	Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia.		Sternsdorf T; Phan VT; Maunakea ML; Ocampo CB; Sohal J; Silletto A; Galimi F; Le Beau MM; Evans RM; Kogan SC		Cancer Cell	9	2006	81-94	J:106252	16473276
93725	Efficacy of deguelin and silibinin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice.		Yan Y; Wang Y; Tan Q; Lubet RA; You M		Neoplasia	7	2005	1053-7	J:106425	16354587
93726	Protein kinase C delta overexpressing transgenic mice are resistant to chemically but not to UV radiation-induced development of squamous cell carcinomas: a possible link to specific cytokines and cyclooxygenase-2.		Aziz MH; Wheeler DL; Bhamb B; Verma AK		Cancer Res	66	2006	713-22	J:106470	16424000
93727	In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor.		Yu Z; Loehr CV; Fischer KA; Louderback MA; Krueger SK; Dashwood RH; Kerkvliet NI; Pereira CB; Jennings-Gee JE; Dance ST; Miller MS; Bailey GS; Williams DE		Cancer Res	66	2006	755-62	J:106476	16424006
93728	Pericytes limit tumor cell metastasis.		Xian X; Hakansson J; Stahlberg A; Lindblom P; Betsholtz C; Gerhardt H; Semb H		J Clin Invest	116	2006	642-51	J:106508	16470244
93729	Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human.		Morito N; Yoh K; Fujioka Y; Nakano T; Shimohata H; Hashimoto Y; Yamada A; Maeda A; Matsuno F; Hata H; Suzuki A; Imagawa S; Mitsuya H; Esumi H; Koyama A; Yamamoto M; Mori N; Takahashi S		Cancer Res	66	2006	812-9	J:106513	16424013
93730	Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.		Hu C; Dievart A; Lupien M; Calvo E; Tremblay G; Jolicoeur P		Am J Pathol	168	2006	973-90	J:106552	16507912
93731	Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.		Zanesi N; Aqeilan R; Drusco A; Kaou M; Sevignani C; Costinean S; Bortesi L; La Rocca G; Koldovsky P; Volinia S; Mancini R; Calin G; Scott CP; Pekarsky Y; Croce CM		Cancer Res	66	2006	915-20	J:106561	16424025
93732	Increased expression of osteopontin contributes to the progression of prostate cancer.		Khodavirdi AC; Song Z; Yang S; Zhong C; Wang S; Wu H; Pritchard C; Nelson PS; Roy-Burman P		Cancer Res	66	2006	883-8	J:106566	16424021
93733	Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice.		Maggio-Price L; Treuting P; Zeng W; Tsang M; Bielefeldt-Ohmann H; Iritani BM		Cancer Res	66	2006	828-38	J:106572	16424015
93734	Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.		Blyth K; Vaillant F; Hanlon L; Mackay N; Bell M; Jenkins A; Neil JC; Cameron ER		Cancer Res	66	2006	2195-201	J:106649	16489021
93735	Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.		Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P		Cancer Res	66	2006	2188-94	J:106650	16489020
93736	The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.		Kim IM; Ackerson T; Ramakrishna S; Tretiakova M; Wang IC; Kalin TV; Major ML; Gusarova GA; Yoder HM; Costa RH; Kalinichenko VV		Cancer Res	66	2006	2153-61	J:106651	16489016
93737	A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice.		Lu Y; Yao R; Yan Y; Wang Y; Hara Y; Lubet RA; You M		Cancer Res	66	2006	1956-63	J:106659	16488994
93738	Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting.		Harper J; Burns JL; Foulstone EJ; Pignatelli M; Zaina S; Hassan AB		Cancer Res	66	2006	1940-8	J:106661	16488992
93739	Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner.		Yoo LI; Liu DW; Le Vu S; Bronson RT; Wu H; Yuan J		Cancer Res	66	2006	1929-39	J:106662	16488991
93740	Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant.		Kwak EL; Kim S; Zhang J; Cardiff RD; Schmidt EV; Haber DA		Cancer Res	66	2006	1923-8	J:106663	16488990
93741	Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.		Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH		Cancer Res	66	2006	1712-20	J:106668	16452231
93742	Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.		Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL		Cancer Res	66	2006	1481-90	J:106673	16452204
93743	Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment.		Waalkes MP; Liu J; Ward JM; Powell DA; Diwan BA		Cancer Res	66	2006	1337-45	J:106681	16452187
93744	Delayed onset of Igf2-induced mammary tumors in Igf2r transgenic mice.		Wise TL; Pravtcheva DD		Cancer Res	66	2006	1327-36	J:106682	16452186
93745	PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.		Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA		Cancer Res	66	2006	1302-12	J:106683	16452183
93746	Grg1 acts as a lung-specific oncogene in a transgenic mouse model.		Allen T; van Tuyl M; Iyengar P; Jothy S; Post M; Tsao MS; Lobe CG		Cancer Res	66	2006	1294-301	J:106684	16452182
93747	p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis.		Bourcier C; Jacquel A; Hess J; Peyrottes I; Angel P; Hofman P; Auberger P; Pouyssegur J; Pages G		Cancer Res	66	2006	2700-7	J:106698	16510590
93748	Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.		Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA		Cancer Res	66	2006	2691-9	J:106700	16510589
93749	N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma.		Browd SR; Kenney AM; Gottfried ON; Yoon JW; Walterhouse D; Pedone CA; Fults DW		Cancer Res	66	2006	2666-72	J:106701	16510586
93750	Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice.		Fedele M; Fidanza V; Battista S; Pentimalli F; Klein-Szanto AJ; Visone R; De Martino I; Curcio A; Morisco C; Del Vecchio L; Baldassarre G; Arra C; Viglietto G; Indolfi C; Croce CM; Fusco A		Cancer Res	66	2006	2536-43	J:106702	16510570
93751	Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer.		Daikoku T; Tranguch S; Trofimova IN; Dinulescu DM; Jacks T; Nikitin AY; Connolly DC; Dey SK		Cancer Res	66	2006	2527-31	J:106703	16510568
93752	Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.		van Schanke A; van Venrooij GM; Jongsma MJ; Banus HA; Mullenders LH; van Kranen HJ; de Gruijl FR		Cancer Res	66	2006	2608-15	J:106704	16510579
93753	Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.		Rankin EB; Tomaszewski JE; Haase VH		Cancer Res	66	2006	2576-83	J:106705	16510575
93754	Histologic and molecular characterizations of megakaryocytic leukemia in mice.		Hao X; Shin MS; Zhou JX; Lee CH; Qi CF; Naghashfar Z; Hartley JW; Fredrickson TN; Ward JM; Morse HC rd		Leuk Res	30	2006	397-406	J:106749	16219351
93755	A role for Brca1 in chromosome end maintenance.		McPherson JP; Hande MP; Poonepalli A; Lemmers B; Zablocki E; Migon E; Shehabeldin A; Porras A; Karaskova J; Vukovic B; Squire J; Hakem R		Hum Mol Genet	15	2006	831-8	J:106759	16446310
93756	Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy.		Airoldi I; Di Carlo E; Cocco C; Sorrentino C; Fais F; Cilli M; D'Antuono T; Colombo MP; Pistoia V		Blood	106	2005	3846-53	J:106805	16081683
93757	Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma.		Kundu M; Compton S; Garrett-Beal L; Stacy T; Starost MF; Eckhaus M; Speck NA; Liu PP		Blood	106	2005	3621-4	J:106809	16051740
93758	A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus.		Glud SZ; Sorensen AB; Andrulis M; Wang B; Kondo E; Jessen R; Krenacs L; Stelkovics E; Wabl M; Serfling E; Palmetshofer A; Pedersen FS		Blood	106	2005	3546-52	J:106810	16051745
93759	Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.		Dezfouli S; Bakke A; Huang J; Wynshaw-Boris A; Hurlin PJ		Mol Cell Biol	26	2006	2080-92	J:106916	16507988
93760	Genomic and proteomic analysis of mammary tumors arising in transgenic mice.		Xie L; Xu BJ; Gorska AE; Shyr Y; Schwartz SA; Cheng N; Levy S; Bierie B; Caprioli RM; Moses HL		J Proteome Res	4	2005	2088-98	J:106939	16335954
93761	Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgene.		Dudgeon C; Kek C; Demidov ON; Saito S; Fernandes K; Diot A; Bourdon JC; Lane DP; Appella E; Fornace AJ Jr; Bulavin DV		Cancer Res	66	2006	2928-36	J:107053	16540640
93762	Enhanced photocarcinogenesis in interleukin-12-deficient mice.		Maeda A; Schneider SW; Kojima M; Beissert S; Schwarz T; Schwarz A		Cancer Res	66	2006	2962-9	J:107060	16540644
93763	Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice.		Hacker E; Muller HK; Irwin N; Gabrielli B; Lincoln D; Pavey S; Powell MB; Malumbres M; Barbacid M; Hayward N; Walker G		Cancer Res	66	2006	2946-52	J:107061	16540642
93764	The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis.		Yerushalmi HF; Besselsen DG; Ignatenko NA; Blohm-Mangone KA; Padilla-Torres JL; Stringer DE; Cui H; Holubec H; Payne CM; Gerner EW		Mol Carcinog	45	2006	93-105	J:107079	16329147
93765	Induction of murine leukemia and lymphoma by dominant negative retinoic acid receptor alpha.		Wang YA; Shen K; Ishida Y; Wang Y; Kakizuka A; Brooks SC		Mol Carcinog	44	2005	252-61	J:107085	16273555
93766	Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors.		Nanda A; Karim B; Peng Z; Liu G; Qiu W; Gan C; Vogelstein B; St Croix B; Kinzler KW; Huso DL		Proc Natl Acad Sci U S A	103	2006	3351-6	J:107172	16492758
93767	An inducible mouse model of melanoma expressing a defined tumor antigen.		Huijbers IJ; Krimpenfort P; Chomez P; van der Valk MA; Song JY; Inderberg-Suso EM; Schmitt-Verhulst AM; Berns A; Van den Eynde BJ		Cancer Res	66	2006	3278-86	J:107175	16540681
93768	K-ras activation generates an inflammatory response in lung tumors.		Ji H; Houghton AM; Mariani TJ; Perera S; Kim CB; Padera R; Tonon G; McNamara K; Marconcini LA; Hezel A; El-Bardeesy N; Bronson RT; Sugarbaker D; Maser RS; Shapiro SD; Wong KK		Oncogene	25	2006	2105-12	J:107260	16288213
93769	Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma.		Villa-Morales M; Santos J; Fernandez-Piqueras J		Oncogene	25	2006	2022-9	J:107261	16301997
93770	Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.		Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP		Oncogene	25	2006	1974-9	J:107263	16331271
93771	Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.		Katuri V; Tang Y; Li C; Jogunoori W; Deng CX; Rashid A; Sidawy AN; Evans S; Reddy EP; Mishra B; Mishra L		Oncogene	25	2006	1871-86	J:107271	16288220
93772	Smad4 haploinsufficiency in mouse models for intestinal cancer.		Alberici P; Jagmohan-Changur S; De Pater E; Van Der Valk M; Smits R; Hohenstein P; Fodde R		Oncogene	25	2006	1841-51	J:107273	16288217
93773	Accelerated onsets of gastric hamartomas and hepatic adenomas/carcinomas in Lkb1+/-p53-/- compound mutant mice.		Takeda H; Miyoshi H; Kojima Y; Oshima M; Taketo MM		Oncogene	25	2006	1816-20	J:107275	16278673
93774	A mouse prostate cancer model induced by Hedgehog overexpression		Chen BY; Lin DP; Liu JY; Chang H; Huang PH; Chen YL; Chang HH.		J Biomed Sci	13	2006	373-84	J:107303	16374524
93775	Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic mice.		Arendt LM; Rose-Hellekant TA; Sandgren EP; Schuler LA		Am J Pathol	168	2006	1365-74	J:107327	16565509
93776	Prevention of lung cancer progression by bexarotene in mouse models.		Wang Y; Zhang Z; Yao R; Jia D; Wang D; Lubet RA; You M		Oncogene	25	2006	1320-9	J:107330	16247446
93777	Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis.		Sterneck E; Zhu S; Ramirez A; Jorcano JL; Smart RC		Oncogene	25	2006	1272-6	J:107334	16205634
93778	Sequences within the gag gene of mouse mammary tumor virus needed for mammary gland cell transformation.		Swanson I; Jude BA; Zhang AR; Pucker A; Smith ZE; Golovkina TV		J Virol	80	2006	3215-24	J:107375	16537589
93779	Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus.		Voisin V; Barat C; Hoang T; Rassart E		J Virol	80	2006	4026-37	J:107383	16571819
93780	Suppression of intestinal neoplasia by deletion of Dnmt3b.		Lin H; Yamada Y; Nguyen S; Linhart H; Jackson-Grusby L; Meissner A; Meletis K; Lo G; Jaenisch R		Mol Cell Biol	26	2006	2976-83	J:107386	16581773
93781	Application of Gleason analogous grading system and flow cytometry DNA analysis in a novel knock-in mouse prostate cancer model.		Wu G; Yu L; Wang L; Wang H; Xuan JW		Postgrad Med J	82	2006	40-5	J:107433	16397079
93782	NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.		Lin YW; Slape C; Zhang Z; Aplan PD		Blood	106	2005	287-95	J:107446	15755899
93783	Genetic mosaics reveal both cell-autonomous and cell-nonautonomous function of murine p27Kip1.		Chien WM; Rabin S; Macias E; Miliani de Marval PL; Garrison K; Orthel J; Rodriguez-Puebla M; Fero ML		Proc Natl Acad Sci U S A	103	2006	4122-7	J:107588	16537495
93784	2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with Apc(Min) mutation.		Andreassen A; Vikse R; Mikalsen A; Adamovic T; Steffensen IL; Hjertholm H; Levan G; Alexander J		Mutat Res	604	2006	60-70	J:107714	16574467
93785	Plasma cell tumour progression in iMyc(Emicro) gene-insertion mice.		Kim J; Han S; Park S; McNeil N; Janz S		J Pathol	209	2006	44-55	J:107719	16482495
93786	Multilocus inheritance determines predisposition to alpha-radiation induced bone tumourigenesis in mice.		Rosemann M; Kuosaite V; Kremer M; Favor J; Quintanilla-Martinez L; Atkinson MJ		Int J Cancer	118	2006	2132-8	J:107725	16331598
93787	Ganglioneuromas and renal anomalies are induced by activated RET(MEN2B) in transgenic mice.		Sweetser DA; Froelick GJ; Matsumoto AM; Kafer KE; Marck B; Palmiter RD; Kapur RP		Oncogene	18	1999	877-86	J:108163	10023663
93788	Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis.		Hagendoorn J; Tong R; Fukumura D; Lin Q; Lobo J; Padera TP; Xu L; Kucherlapati R; Jain RK		Cancer Res	66	2006	3360-4	J:108222	16585153
93789	Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.		Bardeesy N; Aguirre AJ; Chu GC; Cheng KH; Lopez LV; Hezel AF; Feng B; Brennan C; Weissleder R; Mahmood U; Hanahan D; Redston MS; Chin L; Depinho RA		Proc Natl Acad Sci U S A	103	2006	5947-52	J:108298	16585505
93790	Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.		Marin HE; Peraza MA; Billin AN; Willson TM; Ward JM; Kennett MJ; Gonzalez FJ; Peters JM		Cancer Res	66	2006	4394-401	J:108304	16618765
93791	Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.		Katzenellenbogen M; Pappo O; Barash H; Klopstock N; Mizrahi L; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Mitchell LA; Kohen R; Domany E; Galun E; Goldenberg D		Cancer Res	66	2006	4001-10	J:108307	16618719
93792	Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression.		Koster MI; Lu SL; White LD; Wang XJ; Roop DR		Cancer Res	66	2006	3981-6	J:108308	16618715
93793	Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms.		Reschly EJ; Spaulding C; Vilimas T; Graham WV; Brumbaugh RL; Aifantis I; Pear WS; Kee BL		Blood	107	2006	4115-21	J:108314	16449526
93794	Gene therapy: therapeutic gene causing lymphoma.		Woods NB; Bottero V; Schmidt M; von Kalle C; Verma IM		Nature	440	2006	1123	J:108380	16641981
93795	Murine model for mantle cell lymphoma.		Smith MR; Joshi I; Jin F; Al-Saleem T		Leukemia	20	2006	891-3	J:108532	16525491
93796	Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.		Lu SL; Herrington H; Reh D; Weber S; Bornstein S; Wang D; Li AG; Tang CF; Siddiqui Y; Nord J; Andersen P; Corless CL; Wang XJ		Genes Dev	20	2006	1331-42	J:108711	16702406
93797	p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.		Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA		Oncogene	25	2006	3023-31	J:108774	16407836
93798	PAK1 hyperactivation is sufficient for mammary gland tumor formation.		Wang RA; Zhang H; Balasenthil S; Medina D; Kumar R		Oncogene	25	2006	2931-6	J:108776	16331248
93799	Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.		Giles RH; Lolkema MP; Snijckers CM; Belderbos M; van der Groep P; Mans DA; van Beest M; van Noort M; Goldschmeding R; van Diest PJ; Clevers H; Voest EE		Oncogene	25	2006	3065-70	J:108778	16407833
93800	PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway.		Kato Y; Ying H; Zhao L; Furuya F; Araki O; Willingham MC; Cheng SY		Oncogene	25	2006	2736-47	J:108779	16314832
93801	Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice.		Chen E; Lim MS; Rosic-Kablar S; Liu J; Jolicoeur P; Dube ID; Hough MR		Oncogene	25	2006	2575-87	J:108780	16407851
93802	ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency.		Cao L; Kim S; Xiao C; Wang RH; Coumoul X; Wang X; Li WM; Xu XL; De Soto JA; Takai H; Mai S; Elledge SJ; Motoyama N; Deng CX		EMBO J	25	2006	2167-77	J:108783	16675955
93803	Gene promoter hypermethylation in mouse lung tumors.		Vuillemenot BR; Hutt JA; Belinsky SA		Mol Cancer Res	4	2006	267-73	J:108790	16603640
93804	Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice.		Albertelli MA; Scheller A; Brogley M; Robins DM		Mol Endocrinol	20	2006	1248-60	J:108849	16601069
93805	The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans.		Carrasco DR; Fenton T; Sukhdeo K; Protopopova M; Enos M; You MJ; Divicio D; Nogueira C; Stommel J; Pinkus GS; Fletcher C; Hornick JL; Cavenee WK; Furnari FB; Depinho RA		Cancer Cell	9	2006	379-90	J:108872	16697958
93806	Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.		Farazi PA; Glickman J; Horner J; Depinho RA		Cancer Res	66	2006	4766-73	J:108914	16651430
93807	p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.		Cabodi S; Tinnirello A; Di Stefano P; Bisaro B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P		Cancer Res	66	2006	4672-80	J:108916	16651418
93808	Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation.		Nunez NP; Oh WJ; Rozenberg J; Perella C; Anver M; Barrett JC; Perkins SN; Berrigan D; Moitra J; Varticovski L; Hursting SD; Vinson C		Cancer Res	66	2006	5469-76	J:109048	16707476
93809	Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.		Tormo D; Ferrer A; Bosch P; Gaffal E; Basner-Tschakarjan E; Wenzel J; Tuting T		Cancer Res	66	2006	5427-35	J:109052	16707471
93810	Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.		Vasiljeva O; Papazoglou A; Kruger A; Brodoefel H; Korovin M; Deussing J; Augustin N; Nielsen BS; Almholt K; Bogyo M; Peters C; Reinheckel T		Cancer Res	66	2006	5242-50	J:109056	16707449
93811	Lack of Rb and p53 delays cerebellar development and predisposes to large cell anaplastic medulloblastoma through amplification of N-Myc and Ptch2.		Shakhova O; Leung C; van Montfort E; Berns A; Marino S		Cancer Res	66	2006	5190-200	J:109060	16707443
93812	Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice.		Fenske TS; McMahon C; Edwin D; Jarvis JC; Cheverud JM; Minn M; Mathews V; Bogue MA; Province MA; McLeod HL; Graubert TA		Cancer Res	66	2006	5029-38	J:109061	16707424
93813	Identification of a tumour suppressor network opposing nuclear Akt function.		Trotman LC; Alimonti A; Scaglioni PP; Koutcher JA; Cordon-Cardo C; Pandolfi PP		Nature	441	2006	523-7	J:109082	16680151
93814	Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.		Yilmaz OH; Valdez R; Theisen BK; Guo W; Ferguson DO; Wu H; Morrison SJ		Nature	441	2006	475-82	J:109085	16598206
93815	SLUG (SNAI2) overexpression in embryonic development.		Perez-Mancera PA; Gonzalez-Herrero I; Maclean K; Turner AM; Yip MY; Sanchez-Martin M; Garcia JL; Robledo C; Flores T; Gutierrez-Adan A; Pintado B; Sanchez-Garcia I		Cytogenet Genome Res	114	2006	24-9	J:109188	16717446
93816	Spontaneous and irradiation-induced tumor susceptibility in BRCA2 germline mutant mice and cooperative effects with a p53 germline mutation.		McAllister KA; Houle CD; Malphurs J; Ward T; Collins NK; Gersch W; Wharey L; Seely JC; Betz L; Bennett LM; Wiseman RW; Davis BJ		Toxicol Pathol	34	2006	187-98	J:109193	16546942
93817	Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.		Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP		Am J Pathol	161	2002	1357-69	J:109251	12368209
93818	Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression.		Chao C; Herr D; Chun J; Xu Y		EMBO J	25	2006	2615-22	J:109354	16757976
93819	Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.		Coste A; Antal MC; Chan S; Kastner P; Mark M; O'Malley BW; Auwerx J		EMBO J	25	2006	2453-64	J:109522	16675958
93820	Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation.		Ferby I; Reschke M; Kudlacek O; Knyazev P; Pante G; Amann K; Sommergruber W; Kraut N; Ullrich A; Fassler R; Klein R		Nat Med	12	2006	568-73	J:109556	16648858
93821	Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.		Costinean S; Zanesi N; Pekarsky Y; Tili E; Volinia S; Heerema N; Croce CM		Proc Natl Acad Sci U S A	103	2006	7024-9	J:109591	16641092
93822	The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice.		Chen ML; Xu PZ; Peng XD; Chen WS; Guzman G; Yang X; Di Cristofano A; Pandolfi PP; Hay N		Genes Dev	20	2006	1569-74	J:109600	16778075
93823	p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control.		Bai F; Pei XH; Pandolfi PP; Xiong Y		Mol Cell Biol	26	2006	4564-76	J:109606	16738322
93824	Smad4 signalling in T cells is required for suppression of gastrointestinal cancer.		Kim BG; Li C; Qiao W; Mamura M; Kasperczak B; Anver M; Wolfraim L; Hong S; Mushinski E; Potter M; Kim SJ; Fu XY; Deng C; Letterio JJ		Nature	441	2006	1015-9	J:110041	16791201
93825	Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine.		Balansky R; D'Agostini F; Ganchev G; Izzotti A; Di Marco B; Lubet RA; Zanesi N; Croce CM; De Flora S		Proc Natl Acad Sci U S A	103	2006	7823-8	J:110096	16672365
93826	Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors.		Ji H; Zhao X; Yuza Y; Shimamura T; Li D; Protopopov A; Jung BL; McNamara K; Xia H; Glatt KA; Thomas RK; Sasaki H; Horner JW; Eck M; Mitchell A; Sun Y; Al-Hashem R; Bronson RT; Rabindran SK; Discafani CM; Maher E; Shapiro GI; Meyerson M; Wong KK		Proc Natl Acad Sci U S A	103	2006	7817-22	J:110098	16672372
93827	Role of SRC kinases in Neu-induced tumorigenesis: challenging the paradigm using Csk homologous kinase transgenic mice.		Kaminski R; Zagozdzon R; Fu Y; Mroz P; Fu W; Seng S; Avraham S; Avraham HK		Cancer Res	66	2006	5757-62	J:110109	16740714
93828	Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.		Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X		Cancer Res	66	2006	5707-15	J:110111	16740708
93829	Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.		Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Lozach LE; Bassett IG; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A		Cancer Res	66	2006	5565-73	J:110115	16740691
93830	The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.		Ji H; Li D; Chen L; Shimamura T; Kobayashi S; McNamara K; Mahmood U; Mitchell A; Sun Y; Al-Hashem R; Chirieac LR; Padera R; Bronson RT; Kim W; Janne PA; Shapiro GI; Tenen D; Johnson BE; Weissleder R; Sharpless NE; Wong KK		Cancer Cell	9	2006	485-95	J:110131	16730237
93831	HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.		Fedele M; Visone R; De Martino I; Troncone G; Palmieri D; Battista S; Ciarmiello A; Pallante P; Arra C; Melillo RM; Helin K; Croce CM; Fusco A		Cancer Cell	9	2006	459-71	J:110132	16766265
93832	Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2.		Yang YA; Zhang GM; Feigenbaum L; Zhang YE		Cancer Cell	9	2006	445-57	J:110133	16766264
93833	Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.		van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E		BMC Cancer	6	2006	58	J:110164	16536875
93834	Separate Origins of Hepatitis B Virus Surface Antigen-Negative Foci and Hepatocellular Carcinomas in Transgenic HBsAg (alb/psx) Mice.		Crawford DR; Ostrowski S; Vakharia D; Ilic Z; Sell S		Am J Pathol	169	2006	223-32	J:110171	16816375
93835	Disabled-2 Heterozygous Mice Are Predisposed to Endometrial and Ovarian Tumorigenesis and Exhibit Sex-Biased Embryonic Lethality in a p53-Null Background.		Yang DH; Fazili Z; Smith ER; Cai KQ; Klein-Szanto A; Cohen C; Horowitz IR; Xu XX		Am J Pathol	169	2006	258-67	J:110173	16816378
93836	Organ-specific susceptibility of p53 knockout mice to N-bis(2-hydroxypropyl)nitrosamine carcinogenesis.		Hirata A; Tsukamoto T; Yamamoto M; Sakai H; Yanai T; Masegi T; Donehower LA; Tatematsu M		Cancer Lett	238	2006	271-83	J:110174	16150539
93837	Dominant negative retinoic acid receptor initiates tumor formation in mice.		Kupumbati TS; Cattoretti G; Marzan C; Farias EF; Taneja R; Mira-y-Lopez R		Mol Cancer	5	2006	12	J:110176	16563162
93838	p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors.		Keyes WM; Vogel H; Koster MI; Guo X; Qi Y; Petherbridge KM; Roop DR; Bradley A; Mills AA		Proc Natl Acad Sci U S A	103	2006	8435-40	J:110204	16714381
93839	Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model.		Diwadkar-Navsariwala V; Prins GS; Swanson SM; Birch LA; Ray VH; Hedayat S; Lantvit DL; Diamond AM		Proc Natl Acad Sci U S A	103	2006	8179-84	J:110207	16690748
93840	Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility.		Mao JH; Saunier EF; de Koning JP; McKinnon MM; Higgins MN; Nicklas K; Yang HT; Balmain A; Akhurst RJ		Proc Natl Acad Sci U S A	103	2006	8125-30	J:110209	16702541
93841	In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia.		Matsushita H; Scaglioni PP; Bhaumik M; Rego EM; Cai LF; Majid SM; Miyachi H; Kakizuka A; Miller WH Jr; Pandolfi PP		J Exp Med	203	2006	821-8	J:110240	16549595
93842	A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy.		Chen W; Li Q; Hudson WA; Kumar A; Kirchhof N; Kersey JH		Blood	108	2006	669-77	J:110241	16551973
93843	MYC levels govern hematopoietic tumor type and latency in transgenic mice.		Smith DP; Bath ML; Metcalf D; Harris AW; Cory S		Blood	108	2006	653-61	J:110242	16537801
93844	Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.		Floyd HS; Jennings-Gee JE; Kock ND; Miller MS		Mol Carcinog	45	2006	506-17	J:110395	16482519
93845	Differential susceptibility to chemically induced thymic lymphomas in SENCARB and SSIN inbred mice.		Benavides F; Gomez G; Venables-Griffith A; Lambertz I; Flores M; Angel JM; Fuchs-Young R; Richie ER; Conti CJ		Mol Carcinog	45	2006	543-8	J:110396	16479612
93846	Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice.		Caty V; Liu Y; Viau G; Bissonnette R		Br J Dermatol	154	2006	740-2	J:110402	16536820
93847	Skin tumorigenic potential of aflatoxin B1 in mice.		Rastogi S; Dogra RK; Khanna SK; Das M		Food Chem Toxicol	44	2006	670-7	J:110411	16298033
93848	Hair cycle-dependent basal cell carcinoma tumorigenesis in Ptc1neo67/+ mice exposed to radiation.		Mancuso M; Leonardi S; Tanori M; Pasquali E; Pierdomenico M; Rebessi S; Di Majo V; Covelli V; Pazzaglia S; Saran A		Cancer Res	66	2006	6606-14	J:110565	16818633
93849	Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase.		Gautam A; Bepler G		Cancer Res	66	2006	6497-502	J:110566	16818620
93850	Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.		Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA		Cancer Res	66	2006	6622-7	J:110575	16818635
93851	Gonadectomy in mice of the inbred strain CE/J induces proliferation of sub-capsular adrenal cells expressing gonadal marker genes.		Johnsen IK; Slawik M; Shapiro I; Hartmann MF; Wudy SA; Looyenga BD; Hammer GD; Reincke M; Beuschlein F		J Endocrinol	190	2006	47-57	J:110711	16837610
93852	Influence of genetic background on RBE of carbon ions for tumor induction.		Kakinuma S; Shang Y; Amasaki Y; Nojima K; Monobe M; Imaoka T; Nishimura M; Shimada Y		Biol Sci Space	19	2005	106	J:110882	16551046
93853	STAT1 acts as a tumor promoter for leukemia development.		Kovacic B; Stoiber D; Moriggl R; Weisz E; Ott RG; Kreibich R; Levy DE; Beug H; Freissmuth M; Sexl V		Cancer Cell	10	2006	77-87	J:110949	16843267
93854	Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice.		Klinakis A; Szabolcs M; Politi K; Kiaris H; Artavanis-Tsakonas S; Efstratiadis A		Proc Natl Acad Sci U S A	103	2006	9262-7	J:111038	16751266
93855	Selective utilization of nonhomologous end-joining and homologous recombination DNA repair pathways during nervous system development.		Orii KE; Lee Y; Kondo N; McKinnon PJ		Proc Natl Acad Sci U S A	103	2006	10017-22	J:111068	16777961
93856	Skin epidermis lacking the c-myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.		Oskarsson T; Essers MA; Dubois N; Offner S; Dubey C; Roger C; Metzger D; Chambon P; Hummler E; Beard P; Trumpp A		Genes Dev	20	2006	2024-9	J:111139	16882980
93857	Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice.		Suzuki T; Minehata K; Akagi K; Jenkins NA; Copeland NG		EMBO J	25	2006	3422-31	J:111171	16858412
93858	Genetic analysis of myc and telomerase interactions in vivo.		Flores I; Evan G; Blasco MA		Mol Cell Biol	26	2006	6130-8	J:111405	16880523
93859	Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.		Manhes C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V		J Endocrinol	190	2006	271-85	J:111563	16899561
93860	Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice.		Liu P; Wang Y; Vikis H; Maciag A; Wang D; Lu Y; Liu Y; You M		Nat Genet	38	2006	888-95	J:111629	16862160
93861	A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice.		To MD; Perez-Losada J; Mao JH; Hsu J; Jacks T; Balmain A		Nat Genet	38	2006	926-30	J:111642	16823377
93862	Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.		Xu X; Kobayashi S; Qiao W; Li C; Xiao C; Radaeva S; Stiles B; Wang RH; Ohara N; Yoshino T; LeRoith D; Torbenson MS; Gores GJ; Wu H; Gao B; Deng CX		J Clin Invest	116	2006	1843-52	J:111718	16767220
93863	Loss of hepatic NF-kappaB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.		Sakurai T; Maeda S; Chang L; Karin M		Proc Natl Acad Sci U S A	103	2006	10544-51	J:111806	16807293
93864	Mouse genomic representational oligonucleotide microarray analysis: detection of copy number variations in normal and tumor specimens.		Lakshmi B; Hall IM; Egan C; Alexander J; Leotta A; Healy J; Zender L; Spector MS; Xue W; Lowe SW; Wigler M; Lucito R		Proc Natl Acad Sci U S A	103	2006	11234-9	J:111823	16844783
93865	Comparison of the effectiveness of high and low let radiations for the proportion of survivals with liver tumors at every age in (C57BL/6N x C3H/HeN) F1 mice.		Nitta Y; Satoh K; Suga S; Endo S; Nitta K		J Vet Med Sci	68	2006	647-53	J:111922	16891775
93866	Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer.		Stabile LP; Lyker JS; Land SR; Dacic S; Zamboni BA; Siegfried JM		Carcinogenesis	27	2006	1547-55	J:112055	16513678
93867	Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient mice.		Fong LY; Jiang Y; Farber JL		Carcinogenesis	27	2006	1489-96	J:112059	16543248
93868	Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice.		Rao VP; Poutahidis T; Ge Z; Nambiar PR; Boussahmain C; Wang YY; Horwitz BH; Fox JG; Erdman SE		Cancer Res	66	2006	7395-400	J:112089	16885333
93869	High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.		Wei Q; Clarke L; Scheidenhelm DK; Qian B; Tong A; Sabha N; Karim Z; Bock NA; Reti R; Swoboda R; Purev E; Lavoie JF; Bajenaru ML; Shannon P; Herlyn D; Kaplan D; Henkelman RM; Gutmann DH; Guha A		Cancer Res	66	2006	7429-37	J:112090	16885338
93870	Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice.		Zaidi MR; Okada Y; Chada KK		Cancer Res	66	2006	7453-9	J:112091	16885341
93871	Haploinsufficiency in DNA polymerase beta increases cancer risk with age and alters mortality rate.		Cabelof DC; Ikeno Y; Nyska A; Busuttil RA; Anyangwe N; Vijg J; Matherly LH; Tucker JD; Wilson SH; Richardson A; Heydari AR		Cancer Res	66	2006	7460-5	J:112092	16885342
93872	Impaired notch signaling promotes de novo squamous cell carcinoma formation.		Proweller A; Tu L; Lepore JJ; Cheng L; Lu MM; Seykora J; Millar SE; Pear WS; Parmacek MS		Cancer Res	66	2006	7438-44	J:112093	16885339
93873	ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.		Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D		Cancer Res	66	2006	7473-81	J:112094	16885344
93874	Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo.		Wendel HG; Malina A; Zhao Z; Zender L; Kogan SC; Cordon-Cardo C; Pelletier J; Lowe SW		Cancer Res	66	2006	7639-46	J:112099	16885364
93875	Emergence of androgen independence at early stages of prostate cancer progression in nkx3.1; pten mice.		Gao H; Ouyang X; Banach-Petrosky WA; Shen MM; Abate-Shen C		Cancer Res	66	2006	7929-33	J:112106	16912166
93876	Tsc1 Haploinsufficiency without Mammalian Target of Rapamycin Activation Is Sufficient for Renal Cyst Formation in Tsc1+/- Mice.		Wilson C; Bonnet C; Guy C; Idziaszczyk S; Colley J; Humphreys V; Maynard J; Sampson JR; Cheadle JP		Cancer Res	66	2006	7934-8	J:112107	16912167
93877	Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin/+ mice.		Oster H; Leitges M		Cancer Res	66	2006	6955-63	J:112117	16849539
93878	Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse.		Teng Y; Sun AN; Pan XC; Yang G; Yang LL; Wang MR; Yang X		Cancer Res	66	2006	6972-81	J:112119	16849541
93879	Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.		Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B		Cancer Res	66	2006	7050-8	J:112120	16849550
93880	Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.		Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL		Cancer Res	66	2006	7119-27	J:112122	16849558
93881	Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma.		Chesler L; Schlieve C; Goldenberg DD; Kenney A; Kim G; McMillan A; Matthay KK; Rowitch D; Weiss WA		Cancer Res	66	2006	8139-8146	J:112163	16912192
93882	Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen.		Waalkes MP; Liu J; Ward JM; Diwan BA		Toxicol Appl Pharmacol	215	2006	295-305	J:112186	16712894
93883	p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer.		Zhang Z; Wang Y; Yao R; Li J; Lubet RA; You M		Mol Cancer Res	4	2006	401-10	J:112187	16778087
93884	Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.		Kim M; Gans JD; Nogueira C; Wang A; Paik JH; Feng B; Brennan C; Hahn WC; Cordon-Cardo C; Wagner SN; Flotte TJ; Duncan LM; Granter SR; Chin L		Cell	125	2006	1269-81	J:112205	16814714
93885	P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells.		Ridgeway AG; McMenamin J; Leder P		Oncogene	25	2006	3518-27	J:112291	16434961
93886	Hepatocellular carcinoma in Txnip-deficient mice.		Sheth SS; Bodnar JS; Ghazalpour A; Thipphavong CK; Tsutsumi S; Tward AD; Demant P; Kodama T; Aburatani H; Lusis AJ		Oncogene	25	2006	3528-36	J:112292	16607285
93887	Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.		Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM		Oncogene	25	2006	4027-32	J:112293	16518415
93888	Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.		De la Cueva E; Garcia-Cao I; Herranz M; Lopez P; Garcia-Palencia P; Flores JM; Serrano M; Fernandez-Piqueras J; Martin-Caballero J		Oncogene	25	2006	4128-32	J:112294	16462758
93889	Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis.		Ma W; Xia X; Stafford LJ; Yu C; Wang F; LeSage G; Liu M		Oncogene	25	2006	4207-16	J:112295	16501603
93890	MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer.		Cuevas BD; Winter-Vann AM; Johnson NL; Johnson GL		Oncogene	25	2006	4998-5010	J:112298	16568086
93891	Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform.		Kim SS; Cao L; Lim SC; Li C; Wang RH; Xu X; Bachelier R; Deng CX		Mol Cell Biol	26	2006	6983-92	J:112308	16943438
93892	Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.		Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA		Oncogene	25	2006	3325-34	J:112325	16434967
93893	Activated type I TGFbeta receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression.		Muraoka-Cook RS; Shin I; Yi JY; Easterly E; Barcellos-Hoff MH; Yingling JM; Zent R; Arteaga CL		Oncogene	25	2006	3408-23	J:112326	16186809
93894	Decreased Mdm2 expression inhibits tumor development induced by loss of ARF.		Wang P; Greiner TC; Lushnikova T; Eischen CM		Oncogene	25	2006	3708-18	J:112330	16491126
93895	Interferon-gamma induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors.		Egwuagu CE; Li W; Yu CR; Che Mei Lin M; Chan CC; Nakamura T; Chepelinsky AB		Oncogene	25	2006	3670-9	J:112331	16462767
93896	Smad3 Deficiency Promotes Tumorigenesis in the Distal Colon of ApcMin/+ Mice.		Sodir NM; Chen X; Park R; Nickel AE; Conti PS; Moats R; Bading JR; Shibata D; Laird PW		Cancer Res	66	2006	8430-8	J:112366	16951153
93897	Envelope proteins of Jaagsiekte sheep retrovirus and enzootic nasal tumor virus induce similar bronchioalveolar tumors in lungs of mice.		Wootton SK; Halbert CL; Miller AD		J Virol	80	2006	9322-5	J:112384	16940543
93898	Gadd45a Suppresses Ras-Driven Mammary Tumorigenesis by Activation of c-Jun NH2-Terminal Kinase and p38 Stress Signaling Resulting in Apoptosis and Senescence.		Tront JS; Hoffman B; Liebermann DA		Cancer Res	66	2006	8448-54	J:112408	16951155
93899	N-myc Is an Essential Downstream Effector of Shh Signaling during both Normal and Neoplastic Cerebellar Growth.		Hatton BA; Knoepfler PS; Kenney AM; Rowitch DH; de Alboran IM; Olson JM; Eisenman RN		Cancer Res	66	2006	8655-61	J:112411	16951180
93900	Susceptibility to Induced and Spontaneous Carcinogenesis Is Increased in Fatless A-ZIP/F-1 but not in Obese ob/ob Mice.		Ablamunits V; Cohen Y; Brazee IB; Gaetz HP; Vinson C; Klebanov S		Cancer Res	66	2006	8897-902	J:112412	16951207
93901	Mouse lymphomas caused by an intron-splicing donor site deletion of the FasL gene.		Wang CC; Zeng Q; Hwang LA; Guo K; Li J; Liew HC; Hong W		Biochem Biophys Res Commun	349	2006	50-8	J:112563	16935260
93902	An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.		Mangues R; Kahn JM; Seidman I; Pellicer A		Cancer Res	54	1994	6395-401	J:112637	7987834
93903	An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria.		Andressoo JO; Mitchell JR; de Wit J; Hoogstraten D; Volker M; Toussaint W; Speksnijder E; Beems RB; van Steeg H; Jans J; de Zeeuw CI; Jaspers NG; Raams A; Lehmann AR; Vermeulen W; Hoeijmakers JH; van der Horst GT		Cancer Cell	10	2006	121-32	J:112689	16904611
93904	Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling.		Wang Y; Liu Y; Wu C; Zhang H; Zheng X; Zheng Z; Geiger TL; Nuovo GJ; Liu Y; Zheng P		Cancer Cell	10	2006	179-90	J:112696	16959610
93905	Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis.		Trapasso F; Drusco A; Costinean S; Alder H; Aqeilan RI; Iuliano R; Gaudio E; Raso C; Zanesi N; Croce CM; Fusco A		DNA Cell Biol	25	2006	376-82	J:112807	16792508
93906	Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.		Aghi M; Cohen KS; Klein RJ; Scadden DT; Chiocca EA		Cancer Res	66	2006	9054-64	J:112935	16982747
93907	Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning.		D'Orazio JA; Nobuhisa T; Cui R; Arya M; Spry M; Wakamatsu K; Igras V; Kunisada T; Granter SR; Nishimura EK; Ito S; Fisher DE		Nature	443	2006	340-4	J:112959	16988713
93908	Moderate overexpression of AIB1 triggers pre-neoplastic changes in mammary epithelium.		Avivar A; Garcia-Macias MC; Ascaso E; Herrera G; O'Connor JE; de Mora JF		FEBS Lett	580	2006	5222-6	J:112967	16963027
93909	Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms.		Finch A; Prescott J; Shchors K; Hunt A; Soucek L; Dansen TB; Swigart LB; Evan GI		Cancer Cell	10	2006	113-20	J:112704	16904610
93910	Most spontaneous tumors in a mouse model of Li-Fraumeni syndrome do not have a mutator phenotype.		Hill KA; Buettner VL; Heidt A; Chen LL; Li W; Gonzalez KD; Wang JC; Scaringe WA; Sommer SS		Carcinogenesis	27	2006	1860-6	J:113346	16597646
93911	Critical Roles for Non-pRb Targets of Human Papillomavirus Type 16 E7 in Cervical Carcinogenesis.		Balsitis S; Dick F; Dyson N; Lambert PF		Cancer Res	66	2006	9393-400	J:113382	17018593
93912	Tip60 Protein Isoforms and Altered Function in Skin and Tumors that Overexpress Ornithine Decarboxylase.		Hobbs CA; Wei G; Defeo K; Paul B; Hayes CS; Gilmour SK		Cancer Res	66	2006	8116-22	J:113386	16912189
93913	Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients.		Tsuruta H; Kishimoto H; Sasaki T; Horie Y; Natsui M; Shibata Y; Hamada K; Yajima N; Kawahara K; Sasaki M; Tsuchiya N; Enomoto K; Mak TW; Nakano T; Habuchi T; Suzuki A		Cancer Res	66	2006	8389-96	J:113388	16951148
93914	p27Kip1 Repression of ErbB2-Induced Mammary Tumor Growth in Transgenic Mice Involves Skp2 and Wnt/{beta}-Catenin Signaling.		Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG		Cancer Res	66	2006	8529-41	J:113389	16951165
93915	Transgenic Mice Expressing the p75 CCAAT-Displacement Protein/Cut Homeobox Isoform Develop a Myeloproliferative Disease-Like Myeloid Leukemia.		Cadieux C; Fournier S; Peterson AC; Bedard C; Bedell BJ; Nepveu A		Cancer Res	66	2006	9492-501	J:113393	17018605
93916	Pituitary tumor transforming gene overexpression facilitates pituitary tumor development.		Donangelo I; Gutman S; Horvath E; Kovacs K; Wawrowsky K; Mount M; Melmed S		Endocrinology	147	2006	4781-91	J:113662	16809444
93917	Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer.		Gao H; Ouyang X; Banach-Petrosky WA; Gerald WL; Shen MM; Abate-Shen C		Proc Natl Acad Sci U S A	103	2006	14477-82	J:114539	16973750
93918	9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2.		Mernitz H; Smith DE; Zhu AX; Wang XD		Cancer Lett	244	2006	101-8	J:114593	16413115
93919	Impact of genetic background on spontaneous or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumorigenesis in Min/+ mice.		Steffensen IL; Alexander J		Cancer Lett	240	2006	289-96	J:114594	16343741
93920	Parp-1 deficiency does not increase the frequency of tumors in the oral cavity and esophagus of ICR/129Sv mice by 4-nitroquinoline 1-oxide, a carcinogen producing bulky adducts.		Gunji A; Uemura A; Tsutsumi M; Nozaki T; Kusuoka O; Omura K; Suzuki H; Nakagama H; Sugimura T; Masutani M		Cancer Lett	241	2006	87-92	J:114595	16338061
93921	Quantitative analysis of early chemically-induced pulmonary lesions in mice of varying susceptibilities to lung tumorigenesis.		O'Donnell EP; Zerbe LK; Dwyer-Nield LD; Kisley LR; Malkinson AM		Cancer Lett	241	2006	197-202	J:114596	16337739
93922	Lung tumors in 2 year old strain A/J mice exposed for 6 months to tobacco smoke.		Witschi H; Espiritu I; Maronpot RR		Cancer Lett	241	2006	64-8	J:114597	16290922
93923	Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis.		Jang JW; Boxer RB; Chodosh LA		Mol Cell Biol	26	2006	8109-21	J:114642	16908535
93924	The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice.		Kong CT; Sham MH; So CW; Cheah KS; Chen SJ; Chan LC		Leukemia	20	2006	1829-39	J:114902	16888613
93925	Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.		Kelavkar UP; Parwani AV; Shappell SB; Martin WD		Neoplasia	8	2006	510-22	J:114903	16820097
93926	DNA copy number alterations and expression of relevant genes in mouse thymic lymphomas induced by gamma-irradiation and N-methyl-N-nitrosourea.		Kang HM; Jang JJ; Langford C; Shin SH; Park SY; Chung YJ		Cancer Genet Cytogenet	166	2006	27-35	J:114912	16616109
93927	Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.		Shyamala G; Chou YC; Cardiff RD; Vargis E		Cancer Res	66	2006	10391-8	J:114913	17079459
93928	Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis.		Chesnokova V; Kovacs K; Castro AV; Zonis S; Melmed S		Mol Endocrinol	19	2005	2371-9	J:114916	15919720
93929	Low dietary folate initiates intestinal tumors in mice, with altered expression of G2-M checkpoint regulators polo-like kinase 1 and cell division cycle 25c.		Knock E; Deng L; Wu Q; Leclerc D; Wang XL; Rozen R		Cancer Res	66	2006	10349-56	J:114921	17079455
93930	Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications.		Yang H; Yu LR; Yi M; Lucas DA; Lukes L; Lancaster M; Chan KC; Issaq HJ; Stephens RM; Conrads TP; Veenstra TD; Hunter KW		J Proteome Res	5	2006	1555-67	J:114932	16823962
93931	Characterization of pancreatic lesions from MT-tgfalpha, Ela-myc and MT-tgfalpha/Ela-myc single and double transgenic mice.		Liao DJ; Wang Y; Wu J; Adsay NV; Grignon D; Khanani F; Sarkar FH		J Carcinog	5	2006	19	J:114933	16822304
93932	In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met.		Moshitch-Moshkovitz S; Tsarfaty G; Kaufman DW; Stein GY; Shichrur K; Solomon E; Sigler RH; Resau JH; Vande Woude GY; Tsarfaty I		Neoplasia	8	2006	353-63	J:114940	16790084
93933	A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway.		Mao J; Ligon KL; Rakhlin EY; Thayer SP; Bronson RT; Rowitch D; McMahon AP		Cancer Res	66	2006	10171-8	J:114992	17047082
93934	UV-B radiation induces epithelial tumors in mice lacking DNA polymerase eta and mesenchymal tumors in mice deficient for DNA polymerase iota.		Ohkumo T; Kondo Y; Yokoi M; Tsukamoto T; Yamada A; Sugimoto T; Kanao R; Higashi Y; Kondoh H; Tatematsu M; Masutani C; Hanaoka F		Mol Cell Biol	26	2006	7696-706	J:115000	17015482
93935	Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.		Guo W; Pylayeva Y; Pepe A; Yoshioka T; Muller WJ; Inghirami G; Giancotti FG		Cell	126	2006	489-502	J:115020	16901783
93936	SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.		Ma Y; Cui W; Yang J; Qu J; Di C; Amin HM; Lai R; Ritz J; Krause DS; Chai L		Blood	108	2006	2726-35	J:115037	16763212
93937	Development of megakaryoblastic leukaemia in Runx1-Evi1 knock-in chimaeric mouse.		Maki K; Yamagata T; Yamazaki I; Oda H; Mitani K		Leukemia	20	2006	1458-60	J:115038	16761014
93938	Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression.		Pannellini T; Spadaro M; Di Carlo E; Ambrosino E; Iezzi M; Amici A; Lollini PL; Forni G; Cavallo F; Musiani P		J Immunol	176	2006	7695-703	J:115041	16751417
93939	Intestinal overexpression of ZNF148 suppresses ApcMin/+ neoplasia.		Law DJ; Labut EM; Merchant JL		Mamm Genome	17	2006	999-1004	J:115045	17019648
93940	Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor.		Semba S; Han SY; Qin HR; McCorkell KA; Iliopoulos D; Pekarsky Y; Druck T; Trapasso F; Croce CM; Huebner K		J Biol Chem	281	2006	28244-53	J:115052	16864578
93941	PPARdelta status and mismatch repair mediated neoplasia in the mouse intestine.		Reed KR; Sansom OJ; Hayes AJ; Gescher AJ; Peters JM; Clarke AR		BMC Cancer	6	2006	113	J:115062	16672050
93942	Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease.		Chan IT; Kutok JL; Williams IR; Cohen S; Moore S; Shigematsu H; Ley TJ; Akashi K; Le Beau MM; Gilliland DG		Blood	108	2006	1708-15	J:115068	16675706
93943	Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.		Shen RR; Ferguson DO; Renard M; Hoyer KK; Kim U; Hao X; Alt FW; Roeder RG; Morse HC rd; Teitell MA		Blood	108	2006	1991-8	J:115070	16728701
93944	Generation and characterization of a transgenic mouse model for pancreatic cancer.		Sun Q; Feng J; Wei XL; Zhang R; Dong SZ; Shen Q; Dong J; Li HD; Hu YH		World J Gastroenterol	12	2006	2785-8	J:115073	16718771
93945	IFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice.		Hanada T; Kobayashi T; Chinen T; Saeki K; Takaki H; Koga K; Minoda Y; Sanada T; Yoshioka T; Mimata H; Kato S; Yoshimura A		J Exp Med	203	2006	1391-7	J:115075	16717119
93946	Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma.		Hassler S; Ramsey C; Karlsson MC; Larsson D; Herrmann B; Rozell B; Backheden M; Peltonen L; Kampe O; Winqvist O		Blood	108	2006	1941-8	J:115076	16709926
93947	IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.		Maeda S; Kamata H; Luo JL; Leffert H; Karin M		Cell	121	2005	977-90	J:115107	15989949
93948	Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.		Bissell MJ; Kenny PA; Radisky DC		Cold Spring Harb Symp Quant Biol	70	2005	343-56	J:115151	16869771
93949	Induction of complete regressions of oncogene-induced breast tumors in mice.		Benezra R; Henke E; Ciarrocchi A; Ruzinova M; Solit D; Rosen N; Nolan D; Mittal V; de Candia P		Cold Spring Harb Symp Quant Biol	70	2005	375-81	J:115183	16869774
93950	Inactivation of the p53 pathway in retinoblastoma.		Laurie NA; Donovan SL; Shih CS; Zhang J; Mills N; Fuller C; Teunisse A; Lam S; Ramos Y; Mohan A; Johnson D; Wilson M; Rodriguez-Galindo C; Quarto M; Francoz S; Mendrysa SM; Guy RK; Marine JC; Jochemsen AG; Dyer MA		Nature	444	2006	61-6	J:115580	17080083
93951	Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.		Giuriato S; Ryeom S; Fan AC; Bachireddy P; Lynch RC; Rioth MJ; van Riggelen J; Kopelman AM; Passegue E; Tang F; Folkman J; Felsher DW		Proc Natl Acad Sci U S A	103	2006	16266-71	J:115637	17056717
93952	Recombination activating genes (RAG) in lymphoma development.		Haines BB; Ryu CJ; Chen J		Cell Cycle	5	2006	913-6	J:115811	16687916
93953	Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis.		Leung N; Turbide C; Olson M; Marcus V; Jothy S; Beauchemin N		Oncogene	25	2006	5527-36	J:115838	16619040
93954	Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.		Sung YM; He G; Hwang DH; Fischer SM		Oncogene	25	2006	5507-16	J:115840	16607275
93955	Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase.		Keating AK; Salzberg DB; Sather S; Liang X; Nickoloff S; Anwar A; Deryckere D; Hill K; Joung D; Sawczyn KK; Park J; Curran-Everett D; McGavran L; Meltesen L; Gore L; Johnson GL; Graham DK		Oncogene	25	2006	6092-100	J:115843	16652142
93956	Interleukin-12-deficient mice are at greater risk of UV radiation-induced skin tumors and malignant transformation of papillomas to carcinomas.		Meeran SM; Mantena SK; Meleth S; Elmets CA; Katiyar SK		Mol Cancer Ther	5	2006	825-32	J:115844	16648552
93957	Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice.		Pazzaglia S; Tanori M; Mancuso M; Gessi M; Pasquali E; Leonardi S; Oliva MA; Rebessi S; Di Majo V; Covelli V; Giangaspero F; Saran A		Oncogene	25	2006	5575-80	J:115846	16636673
93958	Mice with skin-specific DNA repair gene (Ercc1) inactivation are hypersensitive to ultraviolet irradiation-induced skin cancer and show more rapid actinic progression.		Doig J; Anderson C; Lawrence NJ; Selfridge J; Brownstein DG; Melton DW		Oncogene	25	2006	6229-38	J:115849	16682947
93959	Strain-specific induction of murine lung tumors following in utero exposure to 3-methylcholanthrene.		Jennings-Gee JE; Moore JE; Xu M; Dance ST; Kock ND; McCoy TP; Carr JJ; Miller MS		Mol Carcinog	45	2006	676-84	J:115855	16652375
93960	The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis.		Lindvall C; Evans NC; Zylstra CR; Li Y; Alexander CM; Williams BO		J Biol Chem	281	2006	35081-7	J:115934	16973609
93961	Tumour biology: Policing of oncogene activity by p53.		Efeyan A; Garcia-Cao I; Herranz D; Velasco-Miguel S; Serrano M		Nature	443	2006	159	J:115936	16971940
93962	E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice.		Michel A; Kopp-Schneider A; Zentgraf H; Gruber AD; de Villiers EM		J Virol	80	2006	11153-64	J:115955	16971438
93963	Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation.		Pogoriler J; Millen K; Utset M; Du W		Development	133	2006	3929-37	J:115956	16943274
93964	Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth.		Shen H; Schuster R; Lu B; Waltz SE; Lentsch AB		Prostate	66	2006	1721-8	J:115957	16941672
93965	Proopiomelanocortin heterozygous and homozygous null mutant mice develop pituitary adenomas.		Karpac J; Ostwald D; Li GY; Bui S; Hunnewell P; Brennan MB; Hochgeschwender U		Cell Mol Biol (Noisy-le-grand)	52	2006	47-52	J:115999	16914086
93966	Germ line insertions of moloney murine leukemia virus in the TLL mouse causes site-specific differences in lymphoma/leukemia frequency and tumor immunophenotype.		Johansson AS; Eriksson M; Noren-Nystrom U; Larefalk A; Eriksson B; Holmberg D		Anticancer Res	26	2006	2873-8	J:116014	16886607
93967	Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis.		Keith RL; Geraci MW; Nana-Sinkam SP; Breyer RM; Hudish TM; Meyer AM; Malkinson AM; Dwyer-Nield LD		Anticancer Res	26	2006	2857-61	J:116015	16886605
93968	Hedgehog/Ras interactions regulate early stages of pancreatic cancer.		Pasca di Magliano M; Sekine S; Ermilov A; Ferris J; Dlugosz AA; Hebrok M		Genes Dev	20	2006	3161-73	J:116111	17114586
93969	Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.		Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL		Genes Dev	20	2006	3147-60	J:116129	17114585
93970	Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.		Bardeesy N; Cheng KH; Berger JH; Chu GC; Pahler J; Olson P; Hezel AF; Horner J; Lauwers GY; Hanahan D; DePinho RA		Genes Dev	20	2006	3130-46	J:116130	17114584
93971	Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.		Strizzi L; Bianco C; Hirota M; Watanabe K; Mancino M; Hamada S; Raafat A; Lawson S; Ebert A; D'Antonio A; Losito S; Normanno N; Salomon D		J Pathol	211	2007	36-44	J:116138	17072826
93972	Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.		Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY		Science	314	2006	1467-70	J:116190	17138902
93973	Cbfbeta reduces Cbfbeta-SMMHC-associated acute myeloid leukemia in mice.		Heilman SA; Kuo YH; Goudswaard CS; Valk PJ; Castilla LH		Cancer Res	66	2006	11214-8	J:116203	17145866
93974	Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine.		Lu G; Liao J; Yang G; Reuhl KR; Hao X; Yang CS		Cancer Res	66	2006	11494-501	J:116211	17145898
93975	Thioredoxin overexpression in mice, model of attenuation of oxidative stress, prevents benzene-induced hemato-lymphoid toxicity and thymic lymphoma.		Li GX; Hirabayashi Y; Yoon BI; Kawasaki Y; Tsuboi I; Kodama Y; Kurokawa Y; Yodoi J; Kanno J; Inoue T		Exp Hematol	34	2006	1687-97	J:116394	17157166
93976	Caffeine and caffeine sodium benzoate have a sunscreen effect, enhance UVB-induced apoptosis, and inhibit UVB-induced skin carcinogenesis in SKH-1 mice.		Lu YP; Lou YR; Xie JG; Peng QY; Zhou S; Lin Y; Shih WJ; Conney AH		Carcinogenesis	28	2007	199-206	J:116512	16864596
93977	Oxidative and nitrative stress caused by subcutaneous implantation of a foreign body accelerates sarcoma development in Trp53+/- mice.		Tazawa H; Tatemichi M; Sawa T; Gilibert I; Ma N; Hiraku Y; Donehower LA; Ohgaki H; Kawanishi S; Ohshima H		Carcinogenesis	28	2007	191-8	J:116514	16857722
93978	Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling.		Zhang X; Mehta RG; Lantvit DD; Coschigano KT; Kopchick JJ; Green JE; Hedayat S; Christov KT; Ray VH; Unterman TG; Swanson SM		Carcinogenesis	28	2007	143-50	J:116587	16916863
93979	Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation.		Zinser GM; Leonis MA; Toney K; Pathrose P; Thobe M; Kader SA; Peace BE; Beauman SR; Collins MH; Waltz SE		Cancer Res	66	2006	11967-74	J:116687	17178895
93980	Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.		Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV		Cancer Res	66	2006	11649-58	J:116753	17178859
93981	Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.		Oshima H; Matsunaga A; Fujimura T; Tsukamoto T; Taketo MM; Oshima M		Gastroenterology	131	2006	1086-95	J:116782	17030179
93982	Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.		Ogata H; Kobayashi T; Chinen T; Takaki H; Sanada T; Minoda Y; Koga K; Takaesu G; Maehara Y; Iida M; Yoshimura A		Gastroenterology	131	2006	179-93	J:116784	16831601
93983	Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice.		Lassman AB; Dai C; Fuller GN; Vickers AJ; Holland EC		Neuron Glia Biol	1	2004	157-163	J:117003	17047730
93984	DNA methylation during mouse hemopoietic differentiation and radiation-induced leukemia.		Giotopoulos G; McCormick C; Cole C; Zanker A; Jawad M; Brown R; Plumb M		Exp Hematol	34	2006	1462-70	J:117005	17046565
93985	Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis.		Wen R; Chen Y; Bai L; Fu G; Schuman J; Dai X; Zeng H; Yang C; Stephan RP; Cleveland JL; Wang D		Mol Cell Biol	26	2006	9364-76	J:117023	17030619
93986	Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.		Ma Z; Gibson SL; Byrne MA; Zhang J; White MF; Shaw LM		Mol Cell Biol	26	2006	9338-51	J:117024	17030605
93987	Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer.		Dumstorf CA; Clark AB; Lin Q; Kissling GE; Yuan T; Kucherlapati R; McGregor WG; Kunkel TA		Proc Natl Acad Sci U S A	103	2006	18083-8	J:117079	17114294
93988	A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas.		Liu B; Park E; Zhu F; Bustos T; Liu J; Shen J; Fischer SM; Hu Y		Proc Natl Acad Sci U S A	103	2006	17202-7	J:117109	17079494
93989	Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.		Du Z; Podsypanina K; Huang S; McGrath A; Toneff MJ; Bogoslovskaia E; Zhang X; Moraes RC; Fluck M; Allred DC; Lewis MT; Varmus HE; Li Y		Proc Natl Acad Sci U S A	103	2006	17396-401	J:117125	17090666
93990	High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: Comparison to C3H and C57 mice.		Iwai S; Murai T; Makino S; Min W; Morimura K; Mori S; Hagihara A; Seki S; Fukushima S		Cancer Lett	246	2007	115-21	J:117176	16569478
93991	Transgenic overexpression of RasGRP1 in mouse epidermis results in spontaneous tumors of the skin.		Oki-Idouchi CE; Lorenzo PS		Cancer Res	67	2007	276-80	J:117325	17210708
93992	Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression.		Chang MY; Boulden J; Sutanto-Ward E; Duhadaway JB; Soler AP; Muller AJ; Prendergast GC		Cancer Res	67	2007	100-7	J:117330	17210688
93993	Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.		Maroulakou IG; Oemler W; Naber SP; Tsichlis PN		Cancer Res	67	2007	167-77	J:117336	17210696
93994	Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis.		Blanco R; Munoz P; Flores JM; Klatt P; Blasco MA		Genes Dev	21	2007	206-20	J:117418	17234886
93995	A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice.		Shima N; Alcaraz A; Liachko I; Buske TR; Andrews CA; Munroe RJ; Hartford SA; Tye BK; Schimenti JC		Nat Genet	39	2007	93-8	J:117494	17143284
93996	Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness.		Brouxhon S; Konger RL; VanBuskirk J; Sheu TJ; Ryan J; Erdle B; Almudevar A; Breyer RM; Scott G; Pentland AP		J Invest Dermatol	127	2007	439-46	J:117581	16977324
93997	Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2.		Dearth RK; Cui X; Kim HJ; Kuiatse I; Lawrence NA; Zhang X; Divisova J; Britton OL; Mohsin S; Allred DC; Hadsell DL; Lee AV		Mol Cell Biol	26	2006	9302-14	J:117647	17030631
93998	Effect of an epidermal growth factor receptor inhibitor in mouse models of lung cancer.		Yan Y; Lu Y; Wang M; Vikis H; Yao R; Wang Y; Lubet RA; You M		Mol Cancer Res	4	2006	971-81	J:117804	17189387
93999	TGFbeta1 and TGFalpha contrarily affect alveolar survival and tumorigenesis in mouse mammary epithelium.		Booth BW; Jhappan C; Merlino G; Smith GH		Int J Cancer	120	2007	493-9	J:117812	17096338
94000	Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival.		Zell JA; Ignatenko NA; Yerushalmi HF; Ziogas A; Besselsen DG; Gerner EW; Anton-Culver H		Int J Cancer	120	2007	459-68	J:117825	17096347
94001	Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice.		Tsumura H; Yoshida T; Saito H; Imanaka-Yoshida K; Suzuki N		Oncogene	25	2006	7673-9	J:117828	16785989
94002	Haploinsufficiency of the mSds3 chromatin regulator promotes chromosomal instability and cancer only upon complete neutralization of p53.		David G; Dannenberg JH; Simpson N; Finnerty PM; Miao L; Turner GM; Ding Z; Carrasco R; Depinho RA		Oncogene	25	2006	7354-60	J:117829	16767157
94003	Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions.		Oakes SR; Robertson FG; Kench JG; Gardiner-Garden M; Wand MP; Green JE; Ormandy CJ		Oncogene	26	2007	543-53	J:117839	16862169
94004	PRAK is essential for ras-induced senescence and tumor suppression.		Sun P; Yoshizuka N; New L; Moser BA; Li Y; Liao R; Xie C; Chen J; Deng Q; Yamout M; Dong MQ; Frangou CG; Yates JR rd; Wright PE; Han J		Cell	128	2007	295-308	J:117893	17254968
94005	Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.		Huang X; Yu C; Jin C; Yang C; Xie R; Cao D; Wang F; McKeehan WL		Mol Carcinog	45	2006	934-42	J:117979	16929488
94006	Hepatocyte-specific Pten-deficient mice as a novel model for nonalcoholic steatohepatitis and hepatocellular carcinoma.		Watanabe S; Horie Y; Suzuki A		Hepatol Res	33	2005	161-6	J:118074	16214396
94007	Relative toxicity of chronic irradiation by 45Ca beta particles and 242Cm alpha particles with respect to the production of lung tumors in CBA/Ca mice.		Priest ND; Hoel DG; Brooks PN		Radiat Res	166	2006	782-93	J:118127	17067209
94008	The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice.		Fritz WA; Lin TM; Cardiff RD; Peterson RE		Carcinogenesis	28	2007	497-505	J:118152	17052998
94009	Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.		Yang F; Huang X; Yi T; Yen Y; Moore DD; Huang W		Cancer Res	67	2007	863-7	J:118204	17283114
94010	Deregulated CDC25A expression promotes mammary tumorigenesis with genomic instability.		Ray D; Terao Y; Fuhrken PG; Ma ZQ; DeMayo FJ; Christov K; Heerema NA; Franks R; Tsai SY; Papoutsakis ET; Kiyokawa H		Cancer Res	67	2007	984-91	J:118218	17283130
94011	Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis.		Yeager N; Klein-Szanto A; Kimura S; Di Cristofano A		Cancer Res	67	2007	959-66	J:118219	17283127
94012	p21 delays tumor onset by preservation of chromosomal stability.		Barboza JA; Liu G; Ju Z; El-Naggar AK; Lozano G		Proc Natl Acad Sci U S A	103	2006	19842-7	J:118255	17170138
94013	Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression.		Wang D; Wang H; Guo Y; Ning W; Katkuri S; Wahli W; Desvergne B; Dey SK; DuBois RN		Proc Natl Acad Sci U S A	103	2006	19069-74	J:118285	17148604
94014	Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.		Luedde T; Beraza N; Kotsikoris V; van Loo G; Nenci A; De Vos R; Roskams T; Trautwein C; Pasparakis M		Cancer Cell	11	2007	119-32	J:118336	17292824
94015	Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice.		Cho NL; Javid SH; Carothers AM; Redston M; Bertagnolli MM		Cancer Res	67	2007	2366-72	J:118600	17332369
94016	Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis.		Coles AH; Liang H; Zhu Z; Marfella CG; Kang J; Imbalzano AN; Jones SN		Cancer Res	67	2007	2054-61	J:118602	17332334
94017	Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice.		Wakabayashi Y; Mao JH; Brown K; Girardi M; Balmain A		Nature	445	2007	761-5	J:118622	17230190
94018	The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.		Shai A; Brake T; Somoza C; Lambert PF		Cancer Res	67	2007	1626-35	J:118649	17308103
94019	Hyperproduction of Hyaluronan in Neu-Induced Mammary Tumor Accelerates Angiogenesis through Stromal Cell Recruitment: Possible Involvement of Versican/PG-M.		Koyama H; Hibi T; Isogai Z; Yoneda M; Fujimori M; Amano J; Kawakubo M; Kannagi R; Kimata K; Taniguchi S; Itano N		Am J Pathol	170	2007	1086-99	J:118655	17322391
94020	Inhibition of CCAAT/enhancer binding protein family DNA binding in mouse epidermis prevents and regresses papillomas.		Oh WJ; Rishi V; Orosz A; Gerdes MJ; Vinson C		Cancer Res	67	2007	1867-76	J:118666	17308129
94021	Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis.		Shaw AT; Meissner A; Dowdle JA; Crowley D; Magendantz M; Ouyang C; Parisi T; Rajagopal J; Blank LJ; Bronson RT; Stone JR; Tuveson DA; Jaenisch R; Jacks T		Genes Dev	21	2007	694-707	J:119477	17369402
94022	Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.		Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM		J Clin Invest	103	1999	1669-75	J:119609	10377173
94023	The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development.		Grose R; Fantl V; Werner S; Chioni AM; Jarosz M; Rudling R; Cross B; Hart IR; Dickson C		EMBO J	26	2007	1268-78	J:119723	17304214
94024	Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.		Guerra C; Schuhmacher AJ; Canamero M; Grippo PJ; Verdaguer L; Perez-Gallego L; Dubus P; Sandgren EP; Barbacid M		Cancer Cell	11	2007	291-302	J:119988	17349585
94025	Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.		Vecchione A; Baldassarre G; Ishii H; Nicoloso MS; Belletti B; Petrocca F; Zanesi N; Fong LY; Battista S; Guarnieri D; Baffa R; Alder H; Farber JL; Donovan PJ; Croce CM		Cancer Cell	11	2007	275-89	J:119989	17349584
94026	Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.		Izeradjene K; Combs C; Best M; Gopinathan A; Wagner A; Grady WM; Deng CX; Hruban RH; Adsay NV; Tuveson DA; Hingorani SR		Cancer Cell	11	2007	229-43	J:119990	17349581
94027	Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs.		Tambe Y; Yoshioka-Yamashita A; Mukaisho K; Haraguchi S; Chano T; Isono T; Kawai T; Suzuki Y; Kushima R; Hattori T; Goto M; Yamada S; Kiso M; Saga Y; Inoue H		Carcinogenesis	28	2007	777-84	J:119999	17088259
94028	Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer.		Blanco-Aparicio C; Perez-Gallego L; Pequeno B; Leal JF; Renner O; Carnero A		Carcinogenesis	28	2007	584-94	J:120002	17050554
94029	The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia.		Carriere C; Seeley ES; Goetze T; Longnecker DS; Korc M		Proc Natl Acad Sci U S A	104	2007	4437-42	J:120054	17360542
94030	Targeted deletion of Wwox reveals a tumor suppressor function.		Aqeilan RI; Trapasso F; Hussain S; Costinean S; Marshall D; Pekarsky Y; Hagan JP; Zanesi N; Kaou M; Stein GS; Lian JB; Croce CM		Proc Natl Acad Sci U S A	104	2007	3949-54	J:120064	17360458
94031	Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.		Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA		Proc Natl Acad Sci U S A	104	2007	3931-6	J:120065	17360455
94032	A reduction of cyclooxygenase 2 gene dosage counters the ovarian morphological aging and tumor phenotype in Wv mice.		Yang WL; Cai KQ; Smedberg JL; Smith ER; Klein-Szanto A; Hamilton TC; Xu XX		Am J Pathol	170	2007	1325-36	J:120134	17392171
94033	Lung cancer induced in mice by the envelope protein of jaagsiekte sheep retrovirus (JSRV) closely resembles lung cancer in sheep infected with JSRV.		Wootton SK; Metzger MJ; Hudkins KL; Alpers CE; York D; DeMartini JC; Miller AD		Retrovirology	3	2006	94	J:120256	17177996
94034	Wnt-1 is dominant over neu in specifying mammary tumor expression profiles.		Huang S; Podsypanina K; Chen Y; Cai W; Tsimelzon A; Hilsenbeck S; Li Y		Technol Cancer Res Treat	5	2006	565-71	J:120262	17121432
94035	'Candidatus Helicobacter heilmannii' from a cynomolgus monkey induces gastric mucosa-associated lymphoid tissue lymphomas in C57BL/6 mice.		Nakamura M; Murayama SY; Serizawa H; Sekiya Y; Eguchi M; Takahashi S; Nishikawa K; Takahashi T; Matsumoto T; Yamada H; Hibi T; Tsuchimoto K; Matsui H		Infect Immun	75	2007	1214-22	J:120263	17194807
94036	Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction.		Erlacher M; Labi V; Manzl C; Bock G; Tzankov A; Hacker G; Michalak E; Strasser A; Villunger A		J Exp Med	203	2006	2939-51	J:120274	17178918
94037	Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.		Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ Jr; Anderson CW; Appella E; Bulavin DV		J Exp Med	203	2006	2793-9	J:120284	17158963
94038	Endogenous MMTV Proviruses Induce Susceptibility to Both Viral and Bacterial Pathogens.		Bhadra S; Lozano MM; Payne SM; Dudley JP		PLoS Pathog	2	2006	e128	J:120299	17140288
94039	Inactivation of Apc in the mouse prostate causes prostate carcinoma.		Bruxvoort KJ; Charbonneau HM; Giambernardi TA; Goolsby JC; Qian CN; Zylstra CR; Robinson DR; Roy-Burman P; Shaw AK; Buckner-Berghuis BD; Sigler RE; Resau JH; Sullivan R; Bushman W; Williams BO		Cancer Res	67	2007	2490-6	J:120308	17363566
94040	Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.		Zindy F; Uziel T; Ayrault O; Calabrese C; Valentine M; Rehg JE; Gilbertson RJ; Sherr CJ; Roussel MF		Cancer Res	67	2007	2676-84	J:120317	17363588
94041	Fine mapping and candidate gene analyses of pulmonary adenoma resistance 1, a major genetic determinant of mouse lung adenoma resistance.		Wang M; Zhang Z; Zhang Z; Vikis H; Yan Y; Wang Y; You M		Cancer Res	67	2007	2508-16	J:120319	17363568
94042	The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.		Liby K; Royce DB; Williams CR; Risingsong R; Yore MM; Honda T; Gribble GW; Dmitrovsky E; Sporn TA; Sporn MB		Cancer Res	67	2007	2414-9	J:120335	17363558
94043	Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.		Bentires-Alj M; Neel BG		Cancer Res	67	2007	2420-4	J:120339	17347513
94044	Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.		Julien SG; Dube N; Read M; Penney J; Paquet M; Han Y; Kennedy BP; Muller WJ; Tremblay ML		Nat Genet	39	2007	338-46	J:120342	17259984
94045	VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites.		Hirakawa S; Brown LF; Kodama S; Paavonen K; Alitalo K; Detmar M		Blood	109	2007	1010-7	J:120617	17032920
94046	Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse.		Ignatenko NA; Holubec H; Besselsen DG; Blohm-Mangone KA; Padilla-Torres JL; Nagle RB; de Alboranc IM; Guillen-R JM; Gerner EW		Cancer Biol Ther	5	2006	1658-64	J:120790	17106247
94047	Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice.		Osvaldt AB; Wendt LR; Bersch VP; Backes AN; de Cassia A Schumacher R; Edelweiss MI; Rohde L		Surgery	140	2006	803-9	J:120792	17084724
94048	Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation.		Chai J; Lu X; Godfrey V; Fletcher C; Roberts CW; Van Dyke T; Weissman BE		Cancer Res	67	2007	3002-9	J:120820	17409406
94049	Dual role of inactivating Lef1 mutations in epidermis: tumor promotion and specification of tumor type.		Niemann C; Owens DM; Schettina P; Watt FM		Cancer Res	67	2007	2916-21	J:120821	17409394
94050	Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice.		Zheng Y; Chen WL; Louie SG; Yen TS; Ou JH		Hepatology	45	2007	16-21	J:120827	17187428
94051	Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.		Corsino P; Davis B; Law M; Chytil A; Forrester E; Norgaard P; Teoh N; Law B		Cancer Res	67	2007	3135-44	J:120831	17409420
94052	N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.		Hulit J; Suyama K; Chung S; Keren R; Agiostratidou G; Shan W; Dong X; Williams TM; Lisanti MP; Knudsen K; Hazan RB		Cancer Res	67	2007	3106-16	J:120832	17409417
94053	Gender differences in UVB-induced skin carcinogenesis, inflammation, and DNA damage.		Thomas-Ahner JM; Wulff BC; Tober KL; Kusewitt DF; Riggenbach JA; Oberyszyn TM		Cancer Res	67	2007	3468-74	J:120836	17389759
94054	Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis.		Roberts SJ; Ng BY; Filler RB; Lewis J; Glusac EJ; Hayday AC; Tigelaar RE; Girardi M		Proc Natl Acad Sci U S A	104	2007	6770-5	J:120942	17412837
94055	Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model.		Wu Q; Kiguchi K; Kawamoto T; Ajiki T; Traag J; Carbajal S; Ruffino L; Thames H; Wistuba I; Thomas M; Vasquez KM; DiGiovanni J		Cancer Res	67	2007	3794-800	J:120947	17440093
94056	Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors.		Meeran SM; Katiyar S; Elmets CA; Katiyar SK		Cancer Res	67	2007	3785-93	J:120948	17440092
94057	Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor.		Sasai K; Romer JT; Kimura H; Eberhart DE; Rice DS; Curran T		Cancer Res	67	2007	3871-7	J:120952	17413002
94058	Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.		Wu R; Hendrix-Lucas N; Kuick R; Zhai Y; Schwartz DR; Akyol A; Hanash S; Misek DE; Katabuchi H; Williams BO; Fearon ER; Cho KR		Cancer Cell	11	2007	321-33	J:120955	17418409
94059	A conditional mouse model of synovial sarcoma: insights into a myogenic origin.		Haldar M; Hancock JD; Coffin CM; Lessnick SL; Capecchi MR		Cancer Cell	11	2007	375-88	J:120967	17418413
94060	The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.		Carrasco DR; Sukhdeo K; Protopopova M; Sinha R; Enos M; Carrasco DE; Zheng M; Mani M; Henderson J; Pinkus GS; Munshi N; Horner J; Ivanova EV; Protopopov A; Anderson KC; Tonon G; DePinho RA		Cancer Cell	11	2007	349-60	J:120968	17418411
94061	Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.		Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC		Environ Mol Mutagen	48	2007	299-306	J:120980	16395694
94062	Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia.		Baek SJ; Okazaki R; Lee SH; Martinez J; Kim JS; Yamaguchi K; Mishina Y; Martin DW; Shoieb A; McEntee MF; Eling TE		Gastroenterology	131	2006	1553-60	J:120981	17101328
94063	The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.		Kim CS; Ying H; Willingham MC; Cheng SY		Carcinogenesis	28	2007	932-9	J:121055	17127711
94064	Induction of inducible nitric oxide synthase: a protective mechanism in colitis-induced adenocarcinoma.		Zhang R; Ma A; Urbanski SJ; McCafferty DM		Carcinogenesis	28	2007	1122-30	J:121056	17116728
94065	Ikaros is a mutational target for lymphomagenesis in Mlh1-deficient mice.		Kakinuma S; Kodama Y; Amasaki Y; Yi S; Tokairin Y; Arai M; Nishimura M; Monobe M; Kojima S; Shimada Y		Oncogene	26	2007	2945-9	J:121058	17086208
94066	Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice.		Perez-Caro M; Gutierrez-Cianca N; Gonzalez-Herrero I; Lopez-Hernandez I; Flores T; Orfao A; Sanchez-Martin M; Gutierrez-Adan A; Pintado B; Sanchez-Garcia I		Oncogene	26	2007	1702-13	J:121061	16983340
94067	Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis.		Rojas P; Cadenas MB; Lin PC; Benavides F; Conti CJ; Rodriguez-Puebla ML		Oncogene	26	2007	1723-30	J:121062	16983339
94068	Genetic dissection of the role of p21Cip1/Waf1 in p53-mediated tumour suppression.		Efeyan A; Collado M; Velasco-Miguel S; Serrano M		Oncogene	26	2007	1645-9	J:121066	16964282
94069	Normal cellular senescence and cancer susceptibility in mice genetically deficient in Ras-induced senescence-1 (Ris1).		Nieto M; Barradas M; Criado LM; Flores JM; Serrano M; Llano E		Oncogene	26	2007	1673-80	J:121067	16964279
94070	Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.		McDermott SP; Ranheim EA; Leatherberry VS; Khwaja SS; Klos KS; Alexander CM		Oncogene	26	2007	1407-16	J:121068	16953225
94071	Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation.		Jones RA; Campbell CI; Gunther EJ; Chodosh LA; Petrik JJ; Khokha R; Moorehead RA		Oncogene	26	2007	1636-44	J:121069	16953219
94072	Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.		Kim I; Morimura K; Shah Y; Yang Q; Ward JM; Gonzalez FJ		Carcinogenesis	28	2007	940-6	J:121075	17183066
94073	CD34 expression by hair follicle stem cells is required for skin tumor development in mice.		Trempus CS; Morris RJ; Ehinger M; Elmore A; Bortner CD; Ito M; Cotsarelis G; Nijhof JG; Peckham J; Flagler N; Kissling G; Humble MM; King LC; Adams LD; Desai D; Amin S; Tennant RW		Cancer Res	67	2007	4173-81	J:121305	17483328
94074	Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors.		Olson MV; Johnson DG; Jiang H; Xu J; Alonso MM; Aldape KD; Fuller GN; Bekele BN; Yung WK; Gomez-Manzano C; Fueyo J		Cancer Res	67	2007	4005-9	J:121307	17483310
94075	The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.		Tesfaye A; Di Cello F; Hillion J; Ronnett BM; Elbahloul O; Ashfaq R; Dhara S; Prochownik E; Tworkoski K; Reeves R; Roden R; Ellenson LH; Huso DL; Resar LM		Cancer Res	67	2007	3998-4004	J:121308	17483309
94076	Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.		Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H		Cancer Res	67	2007	4079-87	J:121347	17483318
94077	Short telomeres limit tumor progression in vivo by inducing senescence.		Feldser DM; Greider CW		Cancer Cell	11	2007	461-9	J:121351	17433785
94078	Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice.		Davie SA; Maglione JE; Manner CK; Young D; Cardiff RD; MacLeod CL; Ellies LG		Transgenic Res	16	2007	193-201	J:121391	17206489
94079	Myc deletion rescues Apc deficiency in the small intestine.		Sansom OJ; Meniel VS; Muncan V; Phesse TJ; Wilkins JA; Reed KR; Vass JK; Athineos D; Clevers H; Clarke AR		Nature	446	2007	676-9	J:121434	17377531
94080	Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.		Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU		Oncogene	26	2007	5950-9	J:121475	17369844
94081	Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.		Sorensen KD; Kunder S; Quintanilla-Martinez L; Sorensen J; Schmidt J; Pedersen FS		Virology	362	2007	179-91	J:121483	17258785
94082	Genetic and nutritional deficiencies in folate metabolism influence tumorigenicity in Apcmin/+ mice.		Lawrance AK; Deng L; Brody LC; Finnell RH; Shane B; Rozen R		J Nutr Biochem	18	2007	305-12	J:121499	16963246
94083	Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues.		Parisi T; Yuan TL; Faust AM; Caron AM; Bronson R; Lees JA		Mol Cell Biol	27	2007	2283-93	J:121512	17210634
94084	Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.		Bulavin DV; Phillips C; Nannenga B; Timofeev O; Donehower LA; Anderson CW; Appella E; Fornace AJ Jr		Nat Genet	36	2004	343-50	J:121570	14991053
94085	p63, cellular senescence and tumor development.		Guo X; Mills AA		Cell Cycle	6	2007	305-11	J:121627	17224650
94086	Development of a murine model for blastoid variant mantle-cell lymphoma.		Ford RJ; Shen L; Lin-Lee YC; Pham LV; Multani A; Zhou HJ; Tamayo AT; Zhang C; Hawthorn L; Cowell JK; Ambrus JL Jr		Blood	109	2007	4899-906	J:121701	17311992
94087	A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors.		Dankort D; Filenova E; Collado M; Serrano M; Jones K; McMahon M		Genes Dev	21	2007	379-84	J:121715	17299132
94088	Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer.		Souders NC; Sewell DA; Pan ZK; Hussain SF; Rodriguez A; Wallecha A; Paterson Y		Cancer Immun	7	2007	2	J:121727	17279610
94089	Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.		Fingleton B; Carter KJ; Matrisian LM		Cancer Res	67	2007	4800-6	J:121728	17510409
94090	Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma formation.		Walshe J; Serewko-Auret MM; Teakle N; Cameron S; Minto K; Smith L; Burcham PC; Russell T; Strutton G; Griffin A; Chu FF; Esworthy S; Reeve V; Saunders NA		Cancer Res	67	2007	4751-8	J:121730	17510403
94091	Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.		Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE		Cancer Res	67	2007	4732-41	J:121732	17510401
94092	Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models.		Ji H; Wang Z; Perera SA; Li D; Liang MC; Zaghlul S; McNamara K; Chen L; Albert M; Sun Y; Al-Hashem R; Chirieac LR; Padera R; Bronson RT; Thomas RK; Garraway LA; Janne PA; Johnson BE; Chin L; Wong KK		Cancer Res	67	2007	4933-9	J:121738	17510423
94093	Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells.		Wang A; Arantes S; Conti C; McArthur M; Aldaz CM; Macleod MC		Mol Carcinog	46	2007	476-87	J:121782	17295236
94094	Loss of nuclear p21(Cip1/WAF1) during neoplastic progression to metastasis in gamma-irradiated p21 hemizygous mice.		Engelman RW; Jackson RJ; Coppola D; Wharton W; Cantor AB; Pledger WJ		Exp Mol Pathol	82	2007	234-44	J:121797	17207793
94095	The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.		Hernando E; Charytonowicz E; Dudas ME; Menendez S; Matushansky I; Mills J; Socci ND; Behrendt N; Ma L; Maki RG; Pandolfi PP; Cordon-Cardo C		Nat Med	13	2007	748-753	J:121901	17496901
94096	Abrogation of nuclear receptors Nr4a3 andNr4a1 leads to development of acute myeloid leukemia.		Mullican SE; Zhang S; Konopleva M; Ruvolo V; Andreeff M; Milbrandt J; Conneely OM		Nat Med	13	2007	730-5	J:121903	17515897
94097	Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk.		Blackburn AC; Hill LZ; Roberts AL; Wang J; Aud D; Jung J; Nikolcheva T; Allard J; Peltz G; Otis CN; Cao QJ; Ricketts RS; Naber SP; Mollenhauer J; Poustka A; Malamud D; Jerry DJ		Am J Pathol	170	2007	2030-41	J:122161	17525270
94098	Prostate Cancer Associated with p53 and Rb Deficiency Arises from the Stem/Progenitor Cell-Enriched Proximal Region of Prostatic Ducts.		Zhou Z; Flesken-Nikitin A; Nikitin AY		Cancer Res	67	2007	5683-90	J:122263	17553900
94099	SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion.		Kitamura T; Kometani K; Hashida H; Matsunaga A; Miyoshi H; Hosogi H; Aoki M; Oshima M; Hattori M; Takabayashi A; Minato N; Taketo MM		Nat Genet	39	2007	467-75	J:122308	17369830
94100	Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo.		Aqeilan RI; Hagan JP; Aqeilan HA; Pichiorri F; Fong LY; Croce CM		Cancer Res	67	2007	5606-10	J:122364	17575124
94101	Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice.		El-Naggar SM; Malik MT; Martin A; Moore JP; Proctor M; Hamid T; Kakar SS		J Endocrinol	194	2007	179-91	J:122411	17592032
94102	Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice.		Yang G; Curley D; Bosenberg MW; Tsao H		Cancer Res	67	2007	5649-57	J:122413	17575131
94103	BRCA2 is required for neurogenesis and suppression of medulloblastoma.		Frappart PO; Lee Y; Lamont J; McKinnon PJ		EMBO J	26	2007	2732-42	J:122559	17476307
94104	Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment.		Chang Y; Zuka M; Perez-Pinera P; Astudillo A; Mortimer J; Berenson JR; Deuel TF		Proc Natl Acad Sci U S A	104	2007	10888-93	J:122589	17578909
94105	ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence.		Ha L; Ichikawa T; Anver M; Dickins R; Lowe S; Sharpless NE; Krimpenfort P; Depinho RA; Bennett DC; Sviderskaya EV; Merlino G		Proc Natl Acad Sci U S A	104	2007	10968-73	J:122592	17576930
94106	Evidence for clustered tumour suppressor gene loci on mouse chromosomes 2 and 4 in radiation-induced acute myeloid leukaemia.		Jawad M; Cole C; Zanker A; Lo P; Fitch S; Plumb M		Int J Radiat Biol	82	2006	383-91	J:122640	16846973
94107	Understanding genetic progression of squamous cell carcinoma to spindle cell carcinoma in a mouse model of head and neck cancer.		Chuang R; Crowe DL		Int J Oncol	30	2007	1279-87	J:122642	17390032
94108	Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3.		Farioli-Vecchioli S; Tanori M; Micheli L; Mancuso M; Leonardi L; Saran A; Ciotti MT; Ferretti E; Gulino A; Pazzaglia S; Tirone F		FASEB J	21	2007	2215-25	J:122681	17371797
94109	Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas.		Ma Y; Fiering S; Black C; Liu X; Yuan Z; Memoli VA; Robbins DJ; Bentley HA; Tsongalis GJ; Demidenko E; Freemantle SJ; Dmitrovsky E		Proc Natl Acad Sci U S A	104	2007	4089-94	J:122698	17360482
94110	Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.		Chamberlain JS; Metzger J; Reyes M; Townsend D; Faulkner JA		FASEB J	21	2007	2195-204	J:122706	17360850
94111	Distinct pattern of allelic loss and inactivation of cadherin 1 and 5 genes in mammary carcinomas arising in p53(+/-) mice.		Umesako S; Iiga S; Takahashi M; Imura K; Mori N; Hong DP; Song CW; Niwa O; Okumoto M		J Radiat Res (Tokyo)	48	2007	143-52	J:122711	17327688
94112	Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers.		Maser RS; Choudhury B; Campbell PJ; Feng B; Wong KK; Protopopov A; O'Neil J; Gutierrez A; Ivanova E; Perna I; Lin E; Mani V; Jiang S; McNamara K; Zaghlul S; Edkins S; Stevens C; Brennan C; Martin ES; Wiedemeyer R; Kabbarah O; Nogueira C; Histen G; Aster J	; Mansour M; Duke V; Foroni L; Fielding AK; Goldstone AH; Rowe JM; Wang YA; Look AT; Stratton MR; Chin L; Futreal PA; DePinho RA	Nature	447	2007	966-71	J:122751	17515920
94113	RINT-1 serves as a tumor suppressor and maintains Golgi dynamics and centrosome integrity for cell survival.		Lin X; Liu CC; Gao Q; Zhang X; Wu G; Lee WH		Mol Cell Biol	27	2007	4905-16	J:122805	17470549
94114	Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.		Naugler WE; Sakurai T; Kim S; Maeda S; Kim K; Elsharkawy AM; Karin M		Science	317	2007	121-4	J:122816	17615358
94115	c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression.		Tong C; Yin Z; Song Z; Dockendorff A; Huang C; Mariadason J; Flavell RA; Davis RJ; Augenlicht LH; Yang W		Am J Pathol	171	2007	297-303	J:122824	17591974
94116	Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia.		Zhu L; Shi G; Schmidt CM; Hruban RH; Konieczny SF		Am J Pathol	171	2007	263-73	J:122825	17591971
94117	Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family.		Garlanda C; Riva F; Veliz T; Polentarutti N; Pasqualini F; Radaelli E; Sironi M; Nebuloni M; Zorini EO; Scanziani E; Mantovani A		Cancer Res	67	2007	6017-21	J:122829	17616656
94118	Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy.		Li D; Shimamura T; Ji H; Chen L; Haringsma HJ; McNamara K; Liang MC; Perera SA; Zaghlul S; Borgman CL; Kubo S; Takahashi M; Sun Y; Chirieac LR; Padera RF; Lindeman NI; Janne PA; Thomas RK; Meyerson ML; Eck MJ; Engelman JA; Shapiro GI; Wong KK		Cancer Cell	12	2007	81-93	J:122849	17613438
94119	FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.		Zuo T; Wang L; Morrison C; Chang X; Zhang H; Li W; Liu Y; Wang Y; Liu X; Chan MW; Liu JQ; Love R; Liu CG; Godfrey V; Shen R; Huang TH; Yang T; Park BK; Wang CY; Zheng P; Liu Y		Cell	129	2007	1275-86	J:122865	17570480
94120	Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.		Gupta S; Ramjaun AR; Haiko P; Wang Y; Warne PH; Nicke B; Nye E; Stamp G; Alitalo K; Downward J		Cell	129	2007	957-68	J:122866	17540175
94121	Loss of the maternal imprint in Dnmt3Lmat-/- mice leads to a differentiation defect in the extraembryonic tissue.		Arima T; Hata K; Tanaka S; Kusumi M; Li E; Kato K; Shiota K; Sasaki H; Wake N		Dev Biol	297	2006	361-73	J:112884	16920095
94122	HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP.		Shai A; Nguyen ML; Wagstaff J; Jiang YH; Lambert PF		Oncogene	26	2007	3321-8	J:122885	17130828
94123	Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.		Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF		Oncogene	26	2007	2833-9	J:122886	17099725
94124	Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1.		Takahashi K; Akiyama H; Shimazaki K; Uchida C; Akiyama-Okunuki H; Tomita M; Fukumoto M; Uchida T		Oncogene	26	2007	3835-45	J:122891	17160015
94125	Poly(ADP-ribose) polymerase-1 plays a role in suppressing mammary tumourigenesis in mice.		Tong WM; Yang YG; Cao WH; Galendo D; Frappart L; Shen Y; Wang ZQ		Oncogene	26	2007	3857-67	J:122892	17160013
94126	Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo.		Lian F; Smith DE; Ernst H; Russell RM; Wang XD		Carcinogenesis	28	2007	1567-74	J:122897	17420169
94127	Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach.		Cao L; Xu X; Cao LL; Wang RH; Coumoul X; Kim SS; Deng CX		Carcinogenesis	28	2007	1401-7	J:122899	17363841
94128	Convergence of congenic mapping and allele-specific alterations in tumors for the resolution of the Skts1 skin tumor susceptibility locus.		de Koning JP; Wakabayashi Y; Nagase H; Mao JH; Balmain A		Oncogene	26	2007	4171-8	J:122902	17311004
94129	Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.		Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ		Oncogene	26	2007	4415-27	J:122904	17297472
94130	Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities.		Andujar P; Lecomte C; Renier A; Fleury-Feith J; Kheuang L; Daubriac J; Janin A; Jaurand MC		Carcinogenesis	28	2007	1599-605	J:122906	17272307
94131	Conditional N-rasG12V expression promotes manifestations of neurofibromatosis in a mouse model.		Saito H; Yoshida T; Yamazaki H; Suzuki N		Oncogene	26	2007	4714-9	J:122909	17237809
94132	Transgenic mice that express normal and mutated amelogenins.		Gibson CW; Yuan ZA; Li Y; Daly B; Suggs C; Aragon MA; Alawi F; Kulkarni AB; Wright JT		J Dent Res	86	2007	331-5	J:122914	17384027
94133	Tissue-specific and reversible RNA interference in transgenic mice.		Dickins RA; McJunkin K; Hernando E; Premsrirut PK; Krizhanovsky V; Burgess DJ; Kim SY; Cordon-Cardo C; Zender L; Hannon GJ; Lowe SW		Nat Genet	39	2007	914-21	J:123006	17572676
94134	MFG-E8/lactadherin promotes tumor growth in an angiogenesis-dependent transgenic mouse model of multistage carcinogenesis.		Neutzner M; Lopez T; Feng X; Bergmann-Leitner ES; Leitner WW; Udey MC		Cancer Res	67	2007	6777-85	J:123138	17638889
94135	Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis.		Loomis KD; Zhu S; Yoon K; Johnson PF; Smart RC		Cancer Res	67	2007	6768-76	J:123139	17638888
94136	Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice.		Ray D; Terao Y; Nimbalkar D; Hirai H; Osmundson EC; Zou X; Franks R; Christov K; Kiyokawa H		Cancer Res	67	2007	6605-11	J:123144	17638870
94137	MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis.		Sakamoto K; Tominaga Y; Yamauchi K; Nakatsu Y; Sakumi K; Yoshiyama K; Egashira A; Kura S; Yao T; Tsuneyoshi M; Maki H; Nakabeppu Y; Tsuzuki T		Cancer Res	67	2007	6599-604	J:123145	17638869
94138	Transforming growth factor alpha dependent cancer progression is modulated by Muc1.		Pochampalli MR; Bitler BG; Schroeder JA		Cancer Res	67	2007	6591-8	J:123146	17638868
94139	Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.		Ancrile B; Lim KH; Counter CM		Genes Dev	21	2007	1714-9	J:123152	17639077
94140	Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype.		Besson A; Hwang HC; Cicero S; Donovan SL; Gurian-West M; Johnson D; Clurman BE; Dyer MA; Roberts JM		Genes Dev	21	2007	1731-46	J:123168	17626791
94141	Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.		Terzian T; Wang Y; Van Pelt CS; Box NF; Travis EL; Lozano G		Mol Cell Biol	27	2007	5479-85	J:123661	17526734
94142	HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis.		Wei G; Ku S; Ma GK; Saito S; Tang AA; Zhang J; Mao JH; Appella E; Balmain A; Huang EJ		Proc Natl Acad Sci U S A	104	2007	13040-5	J:123698	17666529
94143	Precancerous lesions upon sporadic activation of beta-catenin in mice.		Coste I; Freund JN; Spaderna S; Brabletz T; Renno T		Gastroenterology	132	2007	1299-308	J:123704	17408631
94144	Clusterin is associated with spontaneous breast cancer in TA2 mice.		Sun B; Zhang S; Zhang D; Liu Y; Li Y; Rong Z; Zhu Y; Jia X		FEBS Lett	581	2007	3277-82	J:123731	17597618
94145	Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans.		An G; Wei B; Xia B; McDaniel JM; Ju T; Cummings RD; Braun J; Xia L		J Exp Med	204	2007	1417-29	J:123826	17517967
94146	Impaired microRNA processing enhances cellular transformation and tumorigenesis.		Kumar MS; Lu J; Mercer KL; Golub TR; Jacks T		Nat Genet	39	2007	673-7	J:123829	17401365
94147	Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia.		Hoshino A; Yee CJ; Campbell M; Woltjer RL; Townsend RL; van der Meer R; Shyr Y; Holt JT; Moses HL; Jensen RA		Int J Biol Sci	3	2007	281-91	J:123858	17505536
94148	Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.		Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA		Nat Cell Biol	9	2007	493-505	J:123861	17450133
94149	NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis.		Zhang B; Wang Z; Li T; Tsitsikov EN; Ding HF		Blood	110	2007	743-51	J:123872	17405906
94150	Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.		Liao CP; Zhong C; Saribekyan G; Bading J; Park R; Conti PS; Moats R; Berns A; Shi W; Zhou Z; Nikitin AY; Roy-Burman P		Cancer Res	67	2007	7525-33	J:123911	17671224
94151	Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.		Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K		Cancer Res	67	2007	7212-22	J:123914	17671189
94152	Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.		Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW		Cancer Res	67	2007	7147-54	J:123915	17671182
94153	IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.		Tjandra SS; Hsu C; Goh I; Gurung A; Poon R; Nadesan P; Alman BA		Cancer Res	67	2007	7124-31	J:123917	17671179
94154	Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas.		Bagheri-Yarmand R; Balasenthil S; Gururaj AE; Talukder AH; Wang YH; Lee JH; Kim YS; Zhang X; Jones DM; Medeiros LJ; Stephens LC; Liu YJ; Lee N; Kim I; Kumar R		Cancer Res	67	2007	7062-7	J:123918	17671172
94155	Hypoxia-inducible factor-1 facilitates cervical cancer progression in human papillomavirus type 16 transgenic mice.		Lu ZH; Wright JD; Belt B; Cardiff RD; Arbeit JM		Am J Pathol	171	2007	667-81	J:123929	17600126
94156	Mammary tumor modifiers in BALB/cJ mice heterozygous for p53.		Koch JG; Gu X; Han Y; El-Naggar AK; Olson MV; Medina D; Jerry DJ; Blackburn AC; Peltz G; Amos CI; Lozano G		Mamm Genome	18	2007	300-9	J:123935	17557176
94157	DNA damage-induced cellular senescence is sufficient to suppress tumorigenesis: a mouse model.		Van Nguyen T; Puebla-Osorio N; Pang H; Dujka ME; Zhu C		J Exp Med	204	2007	1453-61	J:123936	17535972
94158	The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.		Hosen N; Shirakata T; Nishida S; Yanagihara M; Tsuboi A; Kawakami M; Oji Y; Oka Y; Okabe M; Tan B; Sugiyama H; Weissman IL		Leukemia	21	2007	1783-91	J:123972	17525726
94159	The TFIID subunit TAF4 regulates keratinocyte proliferation and has cell-autonomous and non-cell-autonomous tumour suppressor activity in mouse epidermis.		Fadloun A; Kobi D; Pointud JC; Indra AK; Teletin M; Bole-Feysot C; Testoni B; Mantovani R; Metzger D; Mengus G; Davidson I		Development	134	2007	2947-58	J:124111	17626060
94160	Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas.		Strom A; Bonal C; Ashery-Padan R; Hashimoto N; Campos ML; Trumpp A; Noda T; Kido Y; Real FX; Thorel F; Herrera PL		Development	134	2007	2719-25	J:124123	17596282
94161	An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations.		Caulin C; Nguyen T; Lang GA; Goepfert TM; Brinkley BR; Cai WW; Lozano G; Roop DR		J Clin Invest	117	2007	1893-901	J:124222	17607363
94162	p53 protects against skin cancer induction by UV-B radiation.		Jiang W; Ananthaswamy HN; Muller HK; Kripke ML		Oncogene	18	1999	4247-53	J:124236	10435637
94163	Intestinal tumorigenicity of mice carrying hemizygous Pax6, Pax6(Sey-4H).		Nitta Y; Yoshida K; Nakagata N; Nitta K; Harada T; Ishizaki F		Exp Anim	56	2007	289-94	J:124276	17660683
94164	Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice.		Weng Y; Fang C; Turesky RJ; Behr M; Kaminsky LS; Ding X		Cancer Res	67	2007	7825-32	J:124316	17699788
94165	Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer.		Chang MY; Boulden J; Katz JB; Wang L; Meyer TJ; Soler AP; Muller AJ; Prendergast GC		Cancer Res	67	2007	7605-12	J:124317	17699764
94166	Distinct ErbB-2 coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles.		Schade B; Lam SH; Cernea D; Sanguin-Gendreau V; Cardiff RD; Jung BL; Hallett M; Muller WJ		Cancer Res	67	2007	7579-88	J:124318	17699761
94167	Disruption of Tumor Cell Adhesion Promotes Angiogenic Switch and Progression to Micrometastasis in RAF-Driven Murine Lung Cancer.		Ceteci F; Ceteci S; Karreman C; Kramer BW; Asan E; Gotz R; Rapp UR		Cancer Cell	12	2007	145-159	J:124321	17692806
94168	Snail family transcription factors are implicated in thyroid carcinogenesis.		Hardy RG; Vicente-Duenas C; Gonzalez-Herrero I; Anderson C; Flores T; Hughes S; Tselepis C; Ross JA; Sanchez-Garcia I		Am J Pathol	171	2007	1037-46	J:124326	17724139
94169	Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.		Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP		Cancer Res	67	2007	7654-64	J:124339	17699770
94170	Loss of p53 and Ink4a/Arf cooperate in a cell autonomous fashion to induce metastasis of hepatocellular carcinoma cells.		Chen YW; Klimstra DS; Mongeau ME; Tatem JL; Boyartchuk V; Lewis BC		Cancer Res	67	2007	7589-96	J:124361	17699762
94171	Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.		Prasher JM; Elenitoba-Johnson KS; Kelley LL		Oncogene	20	2001	2946-55	J:124424	11420707
94172	Loss of the Atp2c1 Secretory Pathway Ca2+-ATPase (SPCA1) in Mice Causes Golgi Stress, Apoptosis, and Midgestational Death in Homozygous Embryos and Squamous Cell Tumors in Adult Heterozygotes.		Okunade GW; Miller ML; Azhar M; Andringa A; Sanford LP; Doetschman T; Prasad V; Shull GE		J Biol Chem	282	2007	26517-27	J:124662	17597066
94173	LKB1 modulates lung cancer differentiation and metastasis.		Ji H; Ramsey MR; Hayes DN; Fan C; McNamara K; Kozlowski P; Torrice C; Wu MC; Shimamura T; Perera SA; Liang MC; Cai D; Naumov GN; Bao L; Contreras CM; Li D; Chen L; Krishnamurthy J; Koivunen J; Chirieac LR; Padera RF; Bronson RT; Lindeman NI; Christiani DC	; Lin X; Shapiro GI; Janne PA; Johnson BE; Meyerson M; Kwiatkowski DJ; Castrillon DH; Bardeesy N; Sharpless NE; Wong KK	Nature	448	2007	807-10	J:124682	17676035
94174	Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung.		Li Y; Du H; Qin Y; Roberts J; Cummings OW; Yan C		Cancer Res	67	2007	8494-503	J:124864	17875688
94175	Deletion of the AU-Rich RNA Binding Protein Apobec-1 Reduces Intestinal Tumor Burden in Apcmin Mice.		Blanc V; Henderson JO; Newberry RD; Xie Y; Cho SJ; Newberry EP; Kennedy S; Rubin DC; Wang HL; Luo J; Davidson NO		Cancer Res	67	2007	8565-73	J:124876	17875695
94176	Functional Interplay of p53 and Mus81 in DNA Damage Responses and Cancer.		Pamidi A; Cardoso R; Hakem A; Matysiak-Zablocki E; Poonepalli A; Tamblyn L; Perez-Ordonez B; Hande MP; Sanchez O; Hakem R		Cancer Res	67	2007	8527-35	J:124877	17875692
94177	Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice.		Bleuming SA; He XC; Kodach LL; Hardwick JC; Koopman FA; Ten Kate FJ; van Deventer SJ; Hommes DW; Peppelenbosch MP; Offerhaus GJ; Li L; van den Brink GR		Cancer Res	67	2007	8149-55	J:124881	17804727
94178	Inactivation of Smad4 Accelerates KrasG12D-Mediated Pancreatic Neoplasia.		Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA		Cancer Res	67	2007	8121-30	J:124882	17804724
94179	Requirement for Rac1 in a K-ras Induced Lung Cancer in the Mouse.		Kissil JL; Walmsley MJ; Hanlon L; Haigis KM; Bender Kim CF; Sweet-Cordero A; Eckman MS; Tuveson DA; Capobianco AJ; Tybulewicz VL; Jacks T		Cancer Res	67	2007	8089-94	J:124883	17804720
94180	Chromosomal instability and supernumerary centrosomes represent precursor defects in a mouse model of T-cell lymphoma.		van de Wetering CI; Knudson CM		Cancer Res	67	2007	8081-8	J:124884	17804719
94181	Identification of an Integrated SV40 T/t-Antigen Cancer Signature in Aggressive Human Breast, Prostate, and Lung Carcinomas with Poor Prognosis.		Deeb KK; Michalowska AM; Yoon CY; Krummey SM; Hoenerhoff MJ; Kavanaugh C; Li MC; Demayo FJ; Linnoila I; Deng CX; Lee EY; Medina D; Shih JH; Green JE		Cancer Res	67	2007	8065-8080	J:124885	17804718
94182	Expression of a CALM-AF10 Fusion Gene Leads to Hoxa Cluster Overexpression and Acute Leukemia in Transgenic Mice.		Caudell D; Zhang Z; Chung YJ; Aplan PD		Cancer Res	67	2007	8022-31	J:124888	17804713
94183	Distinct pathways of genomic progression to benign and malignant tumors of the liver.		Tward AD; Jones KD; Yant S; Cheung ST; Fan ST; Chen X; Kay MA; Wang R; Bishop JM		Proc Natl Acad Sci U S A	104	2007	14771-14776	J:124960	17785413
94184	Aberrant huntingtin interacting protein 1 in lymphoid malignancies.		Bradley SV; Smith MR; Hyun TS; Lucas PC; Li L; Antonuk D; Joshi I; Jin F; Ross TS		Cancer Res	67	2007	8923-31	J:125099	17875735
94185	A spatially and temporally restricted mouse model of soft tissue sarcoma.		Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T		Nat Med	13	2007	992-7	J:125101	17676052
94186	Ddb2 is a haploinsufficient tumor suppressor and controls spontaneous germ cell apoptosis.		Itoh T; Iwashita S; Cohen MB; Meyerholz DK; Linn S		Hum Mol Genet	16	2007	1578-86	J:125108	17468495
94187	Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response.		Gorrini C; Squatrito M; Luise C; Syed N; Perna D; Wark L; Martinato F; Sardella D; Verrecchia A; Bennett S; Confalonieri S; Cesaroni M; Marchesi F; Gasco M; Scanziani E; Capra M; Mai S; Nuciforo P; Crook T; Lough J; Amati B		Nature	448	2007	1063-7	J:125164	17728759
94188	p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.		Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A		Nature	448	2007	943-6	J:125189	17713536
94189	New chemically induced skin tumour susceptibility loci identified in a mouse backcross between FVB and dominant resistant PWK.		Fujiwara K; Igarashi J; Irahara N; Kimura M; Nagase H		BMC Genet	8	2007	39	J:125337	17598916
94190	Comparison of gene expression data from human and mouse breast cancers: identification of a conserved breast tumor gene set.		Klein A; Wessel R; Graessmann M; Jurgens M; Petersen I; Schmutzler R; Niederacher D; Arnold N; Meindl A; Scherneck S; Seitz S; Graessmann A		Int J Cancer	121	2007	683-8	J:125401	17410534
94191	Global gene expression in Ha-ras and B-raf mutated mouse liver tumors.		Jaworski M; Ittrich C; Hailfinger S; Bonin M; Buchmann A; Schwarz M; Kohle C		Int J Cancer	121	2007	1382-5	J:125411	17514646
94192	Loss of p27Kip1 enhances tumor progression in chronic hepatocyte injury-induced liver tumorigenesis with widely ranging effects on Cdk2 or Cdc2 activation.		Sun D; Ren H; Oertel M; Sellers RS; Zhu L		Carcinogenesis	28	2007	1859-66	J:125423	17434927
94193	Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice.		Chandramouli A; Shi J; Feng Y; Holubec H; M Shanas R; Bhattacharyya AK; Zheng W; Nelson MA		Carcinogenesis	28	2007	2028-35	J:125424	17389615
94194	Multi-step lymphomagenesis deduced from DNA changes in thymic lymphomas and atrophic thymuses at various times after gamma-irradiation.		Ohi H; Mishima Y; Kamimura K; Maruyama M; Sasai K; Kominami R		Oncogene	26	2007	5280-9	J:125502	17325664
94195	Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice.		Banach-Petrosky W; Jessen WJ; Ouyang X; Gao H; Rao J; Quinn J; Aronow BJ; Abate-Shen C		Cancer Res	67	2007	9089-96	J:125506	17909013
94196	Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies.		Kucherlapati M; Nguyen A; Kuraguchi M; Yang K; Fan K; Bronson R; Wei K; Lipkin M; Edelmann W; Kucherlapati R		Oncogene	26	2007	6297-306	J:125533	17452984
94197	Loss of suppressor-of-fused function promotes tumorigenesis.		Lee Y; Kawagoe R; Sasai K; Li Y; Russell HR; Curran T; McKinnon PJ		Oncogene	26	2007	6442-7	J:125534	17452975
94198	Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.		Tchougounova E; Kastemar M; Brasater D; Holland EC; Westermark B; Uhrbom L		Oncogene	26	2007	6289-96	J:125535	17438529
94199	Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.		Jeng YM; Cai-Ng S; Li A; Furuta S; Chew H; Chen PL; Lee EY; Lee WH		Oncogene	26	2007	6160-6	J:125539	17420720
94200	Role of Gab2 in mammary tumorigenesis and metastasis.		Ke Y; Wu D; Princen F; Nguyen T; Pang Y; Lesperance J; Muller WJ; Oshima RG; Feng GS		Oncogene	26	2007	4951-60	J:125541	17310989
94201	Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors.		Min JN; Huang L; Zimonjic DB; Moskophidis D; Mivechi NF		Oncogene	26	2007	5086-97	J:125542	17310987
94202	Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas.		Chen M; Rahman L; Voeller D; Kastanos E; Yang SX; Feigenbaum L; Allegra C; Kaye FJ; Steeg P; Zajac-Kaye M		Oncogene	26	2007	4817-24	J:125543	17297449
94203	Akt activation induces epidermal hyperplasia and proliferation of epidermal progenitors.		Murayama K; Kimura T; Tarutani M; Tomooka M; Hayashi R; Okabe M; Nishida K; Itami S; Katayama I; Nakano T		Oncogene	26	2007	4882-8	J:125544	17297448
94204	IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells.		Cao Y; Luo JL; Karin M		Proc Natl Acad Sci U S A	104	2007	15852-7	J:125555	17890319
94205	Dynamics of the immune reaction to pancreatic cancer from inception to invasion.		Clark CE; Hingorani SR; Mick R; Combs C; Tuveson DA; Vonderheide RH		Cancer Res	67	2007	9518-27	J:125575	17909062
94206	Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas.		Park E; Zhu F; Liu B; Xia X; Shen J; Bustos T; Fischer SM; Hu Y		Cancer Res	67	2007	9158-68	J:125636	17909021
94207	Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.		Chesler L; Goldenberg DD; Seales IT; Satchi-Fainaro R; Grimmer M; Collins R; Struett C; Nguyen KN; Kim G; Tihan T; Bao Y; Brekken RA; Bergers G; Folkman J; Weiss WA		Cancer Res	67	2007	9435-42	J:125649	17909053
94208	Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strain.		Zhu R; Ji Y; Xiao L; Matin A		Mamm Genome	18	2007	584-95	J:125712	17671812
94209	IL-10 controls ultraviolet-induced carcinogenesis in mice.		Loser K; Apelt J; Voskort M; Mohaupt M; Balkow S; Schwarz T; Grabbe S; Beissert S		J Immunol	179	2007	365-71	J:125760	17579057
94210	From the Cover: Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.		Azarova AM; Lyu YL; Lin CP; Tsai YC; Lau JY; Wang JC; Liu LF		Proc Natl Acad Sci U S A	104	2007	11014-9	J:125761	17578914
94211	Neurokinin-1 receptor blockade and murine lung tumorigenesis.		Lucattelli M; Fineschi S; Geppetti P; Gerard NP; Lungarella G		Am J Respir Crit Care Med	174	2006	674-83	J:125777	16799078
94212	p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis.		Fasseu M; Aplan PD; Chopin M; Boissel N; Bories JC; Soulier J; von Boehmer H; Sigaux F; Regnault A		Blood	110	2007	2610-9	J:125789	17507663
94213	Epidermal hyperplasia and papillomatosis in mice with a keratinocyte-restricted deletion of csk.		Honda K; Sakaguchi T; Sakai K; Schmedt C; Ramirez A; Jorcano JL; Tarakhovsky A; Kamisoyama H; Sakai T		Carcinogenesis	28	2007	2074-81	J:125790	17494055
94214	The associated contributions of p53 and the DNA mismatch repair protein Msh6 to spontaneous tumorigenesis.		Young LC; Keuling AM; Lai R; Nation PN; Tron VA; Andrew SE		Carcinogenesis	28	2007	2131-8	J:125800	17615258
94215	Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC.		Goga A; Yang D; Tward AD; Morgan DO; Bishop JM		Nat Med	13	2007	820-7	J:125802	17589519
94216	The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.		Reimann M; Loddenkemper C; Rudolph C; Schildhauer I; Teichmann B; Stein H; Schlegelberger B; Dorken B; Schmitt CA		Blood	110	2007	2996-3004	J:125810	17562874
94217	Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.		Mallakin A; Sugiyama T; Taneja P; Matise LA; Frazier DP; Choudhary M; Hawkins GA; D'Agostino RB Jr; Willingham MC; Inoue K		Cancer Cell	12	2007	381-94	J:126002	17936562
94218	FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia.		Lee BH; Tothova Z; Levine RL; Anderson K; Buza-Vidas N; Cullen DE; McDowell EP; Adelsperger J; Frohling S; Huntly BJ; Beran M; Jacobsen SE; Gilliland DG		Cancer Cell	12	2007	367-80	J:126003	17936561
94219	Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.		Takami T; Kaposi-Novak P; Uchida K; Gomez-Quiroz LE; Conner EA; Factor VM; Thorgeirsson SS		Cancer Res	67	2007	9844-51	J:126015	17942915
94220	Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.		Hinoi T; Akyol A; Theisen BK; Ferguson DO; Greenson JK; Williams BO; Cho KR; Fearon ER		Cancer Res	67	2007	9721-30	J:126018	17942902
94221	Activating Notch1 mutations in mouse models of T-ALL.		O'Neil J; Calvo J; McKenna K; Krishnamoorthy V; Aster JC; Bassing CH; Alt FW; Kelliher M; Look AT		Blood	107	2006	781-5	J:126197	16166587
94222	Adult mice lacking the p53/p63 target gene Perp are not predisposed to spontaneous tumorigenesis but display features of ectodermal dysplasia syndromes.		Ihrie RA; Bronson RT; Attardi LD		Cell Death Differ	13	2006	1614-8	J:126293	16485031
94223	Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+/- mice.		Vaslet CA; Messier NJ; Kane AB		Toxicol Sci	68	2002	331-8	J:126303	12151629
94224	Broad, ectopic expression of the sperm protein PLCZ1 induces parthenogenesis and ovarian tumours in mice.		Yoshida N; Amanai M; Fukui T; Kajikawa E; Brahmajosyula M; Iwahori A; Nakano Y; Shoji S; Diebold J; Hessel H; Huss R; Perry AC		Development	134	2007	3941-52	J:126315	17933795
94225	Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors.		Cobaleda C; Jochum W; Busslinger M		Nature	449	2007	473-7	J:126362	17851532
94226	p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.		Song H; Hollstein M; Xu Y		Nat Cell Biol	9	2007	573-80	J:126497	17417627
94227	Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium.		Chang WC; Coudry RA; Clapper ML; Zhang X; Williams KL; Spittle CS; Li T; Cooper HS		Carcinogenesis	28	2007	2375-81	J:126538	17557903
94228	Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.		Taylor JA rd; Kuchel GA; Hegde P; Voznesensky OS; Claffey K; Tsimikas J; Leng L; Bucala R; Pilbeam C		BMC Cancer	7	2007	135	J:126543	17650334
94229	AAV vector integration sites in mouse hepatocellular carcinoma.		Donsante A; Miller DG; Li Y; Vogler C; Brunt EM; Russell DW; Sands MS		Science	317	2007	477	J:126554	17656716
94230	Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer.		Rottenberg S; Nygren AO; Pajic M; van Leeuwen FW; van der Heijden I; van de Wetering K; Liu X; de Visser KE; Gilhuijs KG; van Tellingen O; Schouten JP; Jonkers J; Borst P		Proc Natl Acad Sci U S A	104	2007	12117-22	J:126564	17626183
94231	Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.		Iida K; Itoh K; Maher JM; Kumagai Y; Oyasu R; Mori Y; Shimazui T; Akaza H; Yamamoto M		Carcinogenesis	28	2007	2398-403	J:126703	17602169
94232	Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis.		Wang X; Feith DJ; Welsh P; Coleman CS; Lopez C; Woster PM; O'Brien TG; Pegg AE		Carcinogenesis	28	2007	2404-11	J:126716	17675337
94233	Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase.		Li T; Wen H; Brayton C; Das P; Smithson LA; Fauq A; Fan X; Crain BJ; Price DL; Golde TE; Eberhart CG; Wong PC		J Biol Chem	282	2007	32264-73	J:126817	17827153
94234	A urokinase-type plasminogen activator deficiency diminishes the frequency of intestinal adenomas in ApcMin/+ mice.		Ploplis VA; Tipton H; Menchen H; Castellino FJ		J Pathol	213	2007	266-74	J:126931	17893885
94235	Snai2 expression enhances ultraviolet radiation-induced skin carcinogenesis.		Newkirk KM; Parent AE; Fossey SL; Choi C; Chandler HL; Rajala-Schultz PJ; Kusewitt DF		Am J Pathol	171	2007	1629-39	J:126938	17916597
94236	Overexpression of Eg5 causes genomic instability and tumor formation in mice.		Castillo A; Morse HC rd; Godfrey VL; Naeem R; Justice MJ		Cancer Res	67	2007	10138-47	J:127104	17974955
94237	RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis.		Luke CT; Oki-Idouchi CE; Cline JM; Lorenzo PS		Cancer Res	67	2007	10190-7	J:127144	17974959
94238	Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.		Zeisberg EM; Potenta S; Xie L; Zeisberg M; Kalluri R		Cancer Res	67	2007	10123-8	J:127148	17974953
94239	Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis.		Segrelles C; Lu J; Hammann B; Santos M; Moral M; Cascallana JL; Lara MF; Rho O; Carbajal S; Traag J; Beltran L; Martinez-Cruz AB; Garcia-Escudero R; Lorz C; Ruiz S; Bravo A; Paramio JM; DiGiovanni J		Cancer Res	67	2007	10879-88	J:127302	18006833
94240	Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.		Schomber T; Kopfstein L; Djonov V; Albrecht I; Baeriswyl V; Strittmatter K; Christofori G		Cancer Res	67	2007	10840-8	J:127304	18006829
94241	Narrow-band UVB induces more carcinogenic skin tumors than broad-band UVB through the formation of cyclobutane pyrimidine dimer.		Kunisada M; Kumimoto H; Ishizaki K; Sakumi K; Nakabeppu Y; Nishigori C		J Invest Dermatol	127	2007	2865-71	J:127312	17687389
94242	Influence of a nonfragile FHIT transgene on murine tumor susceptibility.		McCorkell KA; Mancini R; Siprashvili Z; Barnoski BL; Iliopoulos D; Siracusa LD; Zanesi N; Croce CM; Fong LY; Druck T; Huebner K		Cytogenet Genome Res	118	2007	196-203	J:127365	18000371
94243	Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer.		Doghman M; Karpova T; Rodrigues GA; Arhatte M; De Moura J; Cavalli LR; Virolle V; Barbry P; Zambetti GP; Figueiredo BC; Heckert LL; Lalli E		Mol Endocrinol	21	2007	2968-87	J:127369	17761949
94244	Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.		Yanagi S; Kishimoto H; Kawahara K; Sasaki T; Sasaki M; Nishio M; Yajima N; Hamada K; Horie Y; Kubo H; Whitsett JA; Mak TW; Nakano T; Nakazato M; Suzuki A		J Clin Invest	117	2007	2929-40	J:127405	17909629
94245	Alpha-catenin is essential in intestinal adenoma formation.		Shibata H; Takano H; Ito M; Shioya H; Hirota M; Matsumoto H; Kakudo Y; Ishioka C; Akiyama T; Kanegae Y; Saito I; Noda T		Proc Natl Acad Sci U S A	104	2007	18199-204	J:127452	17989230
94246	Epithelial NF-{kappa}B activation promotes urethane-induced lung carcinogenesis.		Stathopoulos GT; Sherrill TP; Cheng DS; Scoggins RM; Han W; Polosukhin VV; Connelly L; Yull FE; Fingleton B; Blackwell TS		Proc Natl Acad Sci U S A	104	2007	18514-9	J:127598	18000061
94247	RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments.		Hu Y; Raynard S; Sehorn MG; Lu X; Bussen W; Zheng L; Stark JM; Barnes EL; Chi P; Janscak P; Jasin M; Vogel H; Sung P; Luo G		Genes Dev	21	2007	3073-84	J:127650	18003859
94248	Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin.		Shao J; Washington MK; Saxena R; Sheng H		Carcinogenesis	28	2007	2476-83	J:127726	17693663
94249	Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- 1 haploinsufficiency.		Pandey J; Umphress SM; Kang Y; Angdisen J; Naumova A; Mercer KL; Jacks T; Jakowlew SB		Carcinogenesis	28	2007	2589-96	J:127727	17690114
94250	Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.		Furuya F; Lu C; Willingham MC; Cheng SY		Carcinogenesis	28	2007	2451-8	J:127728	17660507
94251	Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing.		Linhart HG; Lin H; Yamada Y; Moran E; Steine EJ; Gokhale S; Lo G; Cantu E; Ehrich M; He T; Meissner A; Jaenisch R		Genes Dev	21	2007	3110-22	J:127808	18056424
94252	Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice.		Tolleson WH; Doss JC; Latendresse J; Warbritton AR; Melchior WB Jr; Chin L; Dubielzig RR; Albert DM		Arch Ophthalmol	123	2005	1088-94	J:128245	16087843
94253	Assessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasion.		Du YC; Lewis BC; Hanahan D; Varmus H		PLoS Biol	5	2007	2255-69	J:128448	17941720
94254	Identification of novel modifier loci of Apc Min affecting mammary tumor development.		Wang H; Teske D; Tess A; Kohlhepp R; Choi Y; Kendziorski C; Moser AR		Cancer Res	67	2007	11226-33	J:128481	18056448
94255	Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo.		Kang JS; Wanibuchi H; Morimura K; Gonzalez FJ; Fukushima S		Cancer Res	67	2007	11141-6	J:128482	18056438
94256	Dissecting eIF4E action in tumorigenesis.		Wendel HG; Silva RL; Malina A; Mills JR; Zhu H; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Teruya-Feldstein J; Pelletier J; Lowe SW		Genes Dev	21	2007	3232-7	J:128485	18055695
94257	Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma.		Melani C; Sangaletti S; Barazzetta FM; Werb Z; Colombo MP		Cancer Res	67	2007	11438-46	J:128492	18056472
94258	Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease.		Li KJ; Shiau AL; Chiou YY; Yo YT; Wu CL		Kidney Int	67	2005	1710-22	J:128557	15840017
94259	Increased Rac activity is required for the progression of T-lymphomas induced by Pten-deficiency.		Strumane K; Song JY; Baas I; Collard JG		Leuk Res	32	2008	113-20	J:128628	17521720
94260	Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.		Fontaniere S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX		Endocr Relat Cancer	13	2006	1223-36	J:128679	17158767
94261	The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.		Chakravarti D; Venugopal D; Mailander PC; Meza JL; Higginbotham S; Cavalieri EL; Rogan EG		Mutat Res	649	2008	161-78	J:128695	17931959
94262	Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors.		Regales L; Balak MN; Gong Y; Politi K; Sawai A; Le C; Koutcher JA; Solit DB; Rosen N; Zakowski MF; Pao W		PLoS ONE	2	2007	e810	J:128700	17726540
94263	Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.		Park ES; Shaughnessy JD Jr; Gupta S; Wang H; Lee JS; Woo HG; Zhan F; Owens JD Jr; Potter M; Janz S; Mushinski JF		BMC Genomics	8	2007	302	J:128718	17764563
94264	Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas.		Akporiaye ET; Bradley-Dunlop D; Gendler SJ; Mukherjee P; Madsen CS; Hahn T; Besselsen DG; Dial SM; Cui H; Trevor K		Vaccine	25	2007	6965-74	J:128727	17707958
94265	Generation and characterization of islet cell tumor in pTet-on/pTRE-SV40Tag double-transgenic mice model.		Shen Q; Sun Q; Wei X; Dong J; Zhang R; Wu P; Jin Y; Feng J; Li H; Hu Y		J Biosci Bioeng	104	2007	14-21	J:128729	17697978
94266	An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer.		Dillon RL; Brown ST; Ling C; Shioda T; Muller WJ		Mol Cell Biol	27	2007	8648-57	J:128960	17938205
94267	Deletion of Ku70, Ku80, or both causes early aging without substantially increased cancer.		Li H; Vogel H; Holcomb VB; Gu Y; Hasty P		Mol Cell Biol	27	2007	8205-14	J:129043	17875923
94268	Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis.		Venkatesan RN; Treuting PM; Fuller ED; Goldsby RE; Norwood TH; Gooley TA; Ladiges WC; Preston BD; Loeb LA		Mol Cell Biol	27	2007	7669-82	J:129046	17785453
94269	Skp2B stimulates mammary gland development by inhibiting REA, the repressor of the estrogen receptor.		Umanskaya K; Radke S; Chander H; Monardo R; Xu X; Pan ZQ; O'Connell MJ; Germain D		Mol Cell Biol	27	2007	7615-22	J:129069	17785450
94270	Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.		Kress CL; Konopleva M; Martinez-Garcia V; Krajewska M; Lefebvre S; Hyer ML; McQueen T; Andreeff M; Reed JC; Zapata JM		PLoS ONE	2	2007	e559	J:129306	17593960
94271	K-ras mutations in lung tumors and tumors from other organs are consistent with a common mechanism of ethylene oxide tumorigenesis in the B6C3F1 mouse.		Hong HH; Houle CD; Ton TV; Sills RC		Toxicol Pathol	35	2007	81-5	J:129340	17325976
94272	Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.		Ferletta M; Uhrbom L; Olofsson T; Ponten F; Westermark B		Mol Cancer Res	5	2007	891-7	J:129378	17855658
94273	Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.		Dai C; Whitesell L; Rogers AB; Lindquist S		Cell	130	2007	1005-18	J:129386	17889646
94274	Complex lymphoid and epithelial thymic tumours in Thy1-myc transgenic mice.		Spanopoulou E; Early A; Elliott J; Crispe N; Ladyman H; Ritter M; Watt S; Grosveld F; Kioussis D		Nature	342	1989	185-9	J:129440	2572968
94275	Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I.		Grossman WJ; Kimata JT; Wong FH; Zutter M; Ley TJ; Ratner L		Proc Natl Acad Sci U S A	92	1995	1057-61	J:129466	7862633
94276	Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice.		Howard G; Eiges R; Gaudet F; Jaenisch R; Eden A		Oncogene	27	2008	404-8	J:129471	17621273
94277	Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression.		Quereda V; Martinalbo J; Dubus P; Carnero A; Malumbres M		Oncogene	26	2007	7665-74	J:129474	17599058
94278	Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion.		Darwiche N; Ryscavage A; Perez-Lorenzo R; Wright L; Bae DS; Hennings H; Yuspa SH; Glick AB		Oncogene	26	2007	6885-95	J:129489	17525749
94279	Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.		Hasegawa H; Sawa H; Lewis MJ; Orba Y; Sheehy N; Yamamoto Y; Ichinohe T; Tsunetsugu-Yokota Y; Katano H; Takahashi H; Matsuda J; Sata T; Kurata T; Nagashima K; Hall WW		Nat Med	12	2006	466-72	J:129531	16550188
94280	A role of estrogen/ERalpha signaling in BRCA1-associated tissue-specific tumor formation.		Li W; Xiao C; Vonderhaar BK; Deng CX		Oncogene	26	2007	7204-12	J:129624	17496925
94281	Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.		Zhong Y; Jiang L; Hiai H; Toyokuni S; Yamada Y		Oncogene	26	2007	6937-47	J:129628	17486074
94282	Gonadotropin-induced adrenocortical neoplasia in NU/J nude mice.		Bielinska M; Genova E; Boime I; Parviainen H; Kiiveri S; Leppaluoto J; Rahman N; Heikinheimo M; Wilson DB		Endocrinology	146	2005	3975-84	J:129792	15919738
94283	STAT1 expression is not required for polyp formation in Min mice.		Liddle FJ; Frank DA		Mol Carcinog	47	2008	75-9	J:129797	17683066
94284	Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice.		Schaetzlein S; Kodandaramireddy NR; Ju Z; Lechel A; Stepczynska A; Lilli DR; Clark AB; Rudolph C; Kuhnel F; Wei K; Schlegelberger B; Schirmacher P; Kunkel TA; Greenberg RA; Edelmann W; Rudolph KL		Cell	130	2007	863-77	J:129929	17803909
94285	Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis.		Takahashi Y; Coppola D; Matsushita N; Cualing HD; Sun M; Sato Y; Liang C; Jung JU; Cheng JQ; Mul JJ; Pledger WJ; Wang HG		Nat Cell Biol	9	2007	1142-51	J:129990	17891140
94286	A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.		Bessette K; Lang ML; Fava RA; Grundy M; Heinen J; Horne L; Spolski R; Al-Shami A; Morse HC rd; Leonard WJ; Kelly JA		Blood	111	2008	344-50	J:129993	17890450
94287	CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells.		Opavsky R; Wang SH; Trikha P; Raval A; Huang Y; Wu YZ; Rodriguez B; Keller B; Liyanarachchi S; Wei G; Davuluri RV; Weinstein M; Felsher D; Ostrowski M; Leone G; Plass C		PLoS Genet	3	2007	1757-69	J:130029	17907813
94288	Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors.		Soucek L; Lawlor ER; Soto D; Shchors K; Swigart LB; Evan GI		Nat Med	13	2007	1211-8	J:130030	17906636
94289	EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells.		Cortina C; Palomo-Ponce S; Iglesias M; Fernandez-Masip JL; Vivancos A; Whissell G; Huma M; Peiro N; Gallego L; Jonkheer S; Davy A; Lloreta J; Sancho E; Batlle E		Nat Genet	39	2007	1376-83	J:130035	17906625
94290	Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type specific cancer genes in leukemia.		Sauvageau M; Miller M; Lemieux S; Lessard J; Hebert J; Sauvageau G		Blood	111	2008	790-9	J:130038	17906077
94291	Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.		Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD		Blood	111	2008	767-75	J:130041	17901249
94292	Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice.		Ajioka I; Martins RA; Bayazitov IT; Donovan S; Johnson DA; Frase S; Cicero SA; Boyd K; Zakharenko SS; Dyer MA		Cell	131	2007	378-90	J:130181	17956737
94293	Inducibility of cytochrome P450 1A1 and chemical carcinogenesis by benzo[a]pyrene in AhR repressor-deficient mice.		Hosoya T; Harada N; Mimura J; Motohashi H; Takahashi S; Nakajima O; Morita M; Kawauchi S; Yamamoto M; Fujii-Kuriyama Y		Biochem Biophys Res Commun	365	2008	562-7	J:130214	18022386
94294	Pituitary-specific knockout of the carney complex gene prkar1a leads to pituitary tumorigenesis.		Yin Z; Williams-Simons L; Parlow AF; Asa S; Kirschner LS		Mol Endocrinol	22	2008	380-7	J:130264	17975024
94295	ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex.		Li Z; Tognon CE; Godinho FJ; Yasaitis L; Hock H; Herschkowitz JI; Lannon CL; Cho E; Kim SJ; Bronson RT; Perou CM; Sorensen PH; Orkin SH		Cancer Cell	12	2007	542-58	J:130323	18068631
94296	Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition.		Acevedo VD; Gangula RD; Freeman KW; Li R; Zhang Y; Wang F; Ayala GE; Peterson LE; Ittmann M; Spencer DM		Cancer Cell	12	2007	559-71	J:130340	18068632
94297	Common activation of canonical wnt signaling in pancreatic adenocarcinoma.		Pasca di Magliano M; Biankin AV; Heiser PW; Cano DA; Gutierrez PJ; Deramaudt T; Segara D; Dawson AC; Kench JG; Henshall SM; Sutherland RL; Dlugosz A; Rustgi AK; Hebrok M		PLoS ONE	2	2007	e1155	J:130408	17982507
94298	Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.		Shing DC; Trubia M; Marchesi F; Radaelli E; Belloni E; Tapinassi C; Scanziani E; Mecucci C; Crescenzi B; Lahortiga I; Odero MD; Zardo G; Gruszka A; Minucci S; Di Fiore PP; Pelicci PG		J Clin Invest	117	2007	3696-707	J:130740	18037989
94299	Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype.		Belguise K; Guo S; Yang S; Rogers AE; Seldin DC; Sherr DH; Sonenshein GE		Cancer Res	67	2007	11742-50	J:130797	18089804
94300	BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.		Omidvar N; Kogan S; Beurlet S; le Pogam C; Janin A; West R; Noguera ME; Reboul M; Soulie A; Leboeuf C; Setterblad N; Felsher D; Lagasse E; Mohamedali A; Thomas NS; Fenaux P; Fontenay M; Pla M; Mufti GJ; Weissman I; Chomienne C; Padua RA		Cancer Res	67	2007	11657-67	J:130798	18089795
94301	Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage.		Uronis JM; Herfarth HH; Rubinas TC; Bissahoyo AC; Hanlon K; Threadgill DW		Cancer Res	67	2007	11594-600	J:130799	18089788
94302	Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer.		Strati K; Lambert PF		Cancer Res	67	2007	11585-93	J:130800	18089787
94303	Hepatocellular carcinoma associated with liver-gender disruption in male mice.		Rogers AB; Theve EJ; Feng Y; Fry RC; Taghizadeh K; Clapp KM; Boussahmain C; Cormier KS; Fox JG		Cancer Res	67	2007	11536-46	J:130801	18089782
94304	Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.		Debies MT; Gestl SA; Mathers JL; Mikse OR; Leonard TL; Moody SE; Chodosh LA; Cardiff RD; Gunther EJ		J Clin Invest	118	2008	51-63	J:130828	18060046
94305	The development of duodenal microadenomas in FAP patients: the human correlate of the Min mouse.		Preston SL; Leedham SJ; Oukrif D; Deheregoda M; Goodlad RA; Poulsom R; Alison MR; Wright NA; Novelli M		J Pathol	214	2008	294-301	J:130833	18085615
94306	TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis.		Finnberg N; Klein-Szanto AJ; El-Deiry WS		J Clin Invest	118	2008	111-23	J:130845	18079962
94307	The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression.		Armata HL; Garlick DS; Sluss HK		Cancer Res	67	2007	11696-703	J:130855	18089799
94308	Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.		Maclean KH; Dorsey FC; Cleveland JL; Kastan MB		J Clin Invest	118	2008	79-88	J:130876	18097482
94309	Hmga1 null mice are less susceptible to chemically induced skin carcinogenesis.		Visone R; Iuliano R; Palmieri D; Server IN; Chiappetta G; De Martino I; Fedele M; Costinean S; Oberyszyn TM; Kusewitt DF; Croce CM; Fusco A		Eur J Cancer	44	2008	318-325	J:130889	18155899
94310	Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.		Chiaverotti T; Couto SS; Donjacour A; Mao JH; Nagase H; Cardiff RD; Cunha GR; Balmain A		Am J Pathol	172	2008	236-46	J:130924	18156212
94311	Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.		Arendt LM; Schuler LA		Am J Pathol	172	2008	194-202	J:130926	18156207
94312	A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.		Yang S; Pham LK; Liao CP; Frenkel B; Reddi AH; Roy-Burman P		Cancer Res	68	2008	198-205	J:131034	18172312
94313	Expression of CDK4 or CDK2 in mouse oral cavity is retained in adult pituitary with distinct effects on tumorigenesis.		Macias E; de Marval PL; Senderowicz A; Cullen J; Rodriguez-Puebla ML		Cancer Res	68	2008	162-71	J:131035	18172308
94314	LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis.		Gurumurthy S; Hezel AF; Berger JH; Bosenberg MW; Bardeesy N		Cancer Res	68	2008	55-63	J:131037	18172296
94315	Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome.		Sussan TE; Yang A; Li F; Ostrowski MC; Reeves RH		Nature	451	2008	73-5	J:131046	18172498
94316	Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9.		Ramocki NM; Wilkins HR; Magness ST; Simmons JG; Scull BP; Lee GH; McNaughton KK; Lund PK		Endocrinology	149	2008	261-7	J:131133	17916629
94317	Natural History of Meningioma Development in Mice Reveals: A Synergy of Nf2 and p16(Ink4a) Mutations.		Kalamarides M; Stemmer-Rachamimov AO; Takahashi M; Han ZY; Chareyre F; Niwa-Kawakita M; Black PM; Carroll RS; Giovannini M		Brain Pathol	18	2008	62-70	J:131179	17924978
94318	The resistance to the tumor suppressive effects of COX inhibitors and COX-2 gene disruption in TRAMP mice is associated with the loss of COX expression in prostate tissue.		Wang X; Colby JK; Yang P; Fischer SM; Newman RA; Klein RD		Carcinogenesis	29	2008	120-8	J:131198	17942462
94319	N-acetylcysteine protects melanocytes against oxidative stress/damage and delays onset of ultraviolet-induced melanoma in mice.		Cotter MA; Thomas J; Cassidy P; Robinette K; Jenkins N; Florell SR; Leachman S; Samlowski WE; Grossman D		Clin Cancer Res	13	2007	5952-8	J:131200	17908992
94320	Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.		Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW		Blood	111	2008	2163-9	J:131202	17855626
94321	Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73.		Tannapfel A; John K; Mise N; Schmidt A; Buhlmann S; Ibrahim SM; Putzer BM		Carcinogenesis	29	2008	211-8	J:131219	17984115
94322	PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.		Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T		J Clin Invest	118	2008	683-94	J:131298	18188449
94323	AID is required for germinal center-derived lymphomagenesis.		Pasqualucci L; Bhagat G; Jankovic M; Compagno M; Smith P; Muramatsu M; Honjo T; Morse HC rd; Nussenzweig MC; Dalla-Favera R		Nat Genet	40	2008	108-12	J:131307	18066064
94324	Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia.		Le Toriellec E; Despouy G; Pierron G; Gaye N; Joiner M; Bellanger D; Vincent-Salomon A; Stern MH		Blood	111	2008	2321-8	J:131389	18073348
94325	Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.		Yusuf N; Nasti TH; Long JA; Naseemuddin M; Lucas AP; Xu H; Elmets CA		Cancer Res	68	2008	615-22	J:131415	18199559
94326	Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development.		Dong D; Ni M; Li J; Xiong S; Ye W; Virrey JJ; Mao C; Ye R; Wang M; Pen L; Dubeau L; Groshen S; Hofman FM; Lee AS		Cancer Res	68	2008	498-505	J:131417	18199545
94327	Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling.		Li L; Abdel Fattah E; Cao G; Ren C; Yang G; Goltsov AA; Chinault AC; Cai WW; Timme TL; Thompson TC		Cancer Res	68	2008	434-43	J:131419	18199537
94328	alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.		Hedlund M; Ng E; Varki A; Varki NM		Cancer Res	68	2008	388-94	J:131420	18199532
94329	The Vitamin D Receptor Is a Wnt Effector that Controls Hair Follicle Differentiation and Specifies Tumor Type in Adult Epidermis.		Palmer HG; Anjos-Afonso F; Carmeliet G; Takeda H; Watt FM		PLoS ONE	3	2008	e1483	J:131616	18213391
94330	Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies.		Bernet A; Mazelin L; Coissieux MM; Gadot N; Ackerman SL; Scoazec JY; Mehlen P		Gastroenterology	133	2007	1840-8	J:131645	17967459
94331	The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.		Truffinet V; Pinaud E; Cogne N; Petit B; Guglielmi L; Cogne M; Denizot Y		J Immunol	179	2007	6033-42	J:131646	17947677
94332	Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.		Graves CW; Philips ST; Bradley SV; Oravecz-Wilson KI; Li L; Gauvin A; Ross TS		Cancer Res	68	2008	1064-73	J:131697	18281481
94333	PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.		Hambardzumyan D; Becher OJ; Rosenblum MK; Pandolfi PP; Manova-Todorova K; Holland EC		Genes Dev	22	2008	436-48	J:131700	18281460
94334	Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.		Iwanaga K; Yang Y; Raso MG; Ma L; Hanna AE; Thilaganathan N; Moghaddam S; Evans CM; Li H; Cai WW; Sato M; Minna JD; Wu H; Creighton CJ; Demayo FJ; Wistuba II; Kurie JM		Cancer Res	68	2008	1119-27	J:131721	18281487
94335	T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus.		Hagenbeek TJ; Spits H		Leukemia	22	2008	608-19	J:131742	18046443
94336	EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.		Shair KH; Bendt KM; Edwards RH; Bedford EC; Nielsen JN; Raab-Traub N		PLoS Pathog	3	2007	e166	J:131745	17997602
94337	Distinct structural abnormalities of chromosomes 11 and 12 associated with loss of heterozygosity in X-ray-induced mouse thymic lymphomas.		Yoshida MA; Nakata A; Akiyama M; Kakinuma S; Sado T; Nishimura M; Shimada Y		Cancer Genet Cytogenet	179	2007	1-10	J:131747	17981208
94338	Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci.		Bernichtein S; Petretto E; Jamieson S; Goel A; Aitman TJ; Mangion JM; Huhtaniemi IT		Endocrinology	149	2008	651-61	J:131752	18006632
94339	Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis.		Wunderlich FT; Luedde T; Singer S; Schmidt-Supprian M; Baumgartl J; Schirmacher P; Pasparakis M; Bruning JC		Proc Natl Acad Sci U S A	105	2008	1297-302	J:131857	18216263
94340	Direct evidence for epithelial-mesenchymal transitions in breast cancer.		Trimboli AJ; Fukino K; de Bruin A; Wei G; Shen L; Tanner SM; Creasap N; Rosol TJ; Robinson ML; Eng C; Ostrowski MC; Leone G		Cancer Res	68	2008	937-45	J:131862	18245497
94341	Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas.		Contreras CM; Gurumurthy S; Haynie JM; Shirley LJ; Akbay EA; Wingo SN; Schorge JO; Broaddus RR; Wong KK; Bardeesy N; Castrillon DH		Cancer Res	68	2008	759-66	J:131865	18245476
94342	Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.		Martinez-Cruz AB; Santos M; Lara MF; Segrelles C; Ruiz S; Moral M; Lorz C; Garcia-Escudero R; Paramio JM		Cancer Res	68	2008	683-92	J:131867	18245467
94343	Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.		Popivanova BK; Kitamura K; Wu Y; Kondo T; Kagaya T; Kaneko S; Oshima M; Fujii C; Mukaida N		J Clin Invest	118	2008	560-70	J:131872	18219394
94344	AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies.		Chesi M; Robbiani DF; Sebag M; Chng WJ; Affer M; Tiedemann R; Valdez R; Palmer SE; Haas SS; Stewart AK; Fonseca R; Kremer R; Cattoretti G; Bergsagel PL		Cancer Cell	13	2008	167-80	J:131912	18242516
94345	GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model.		Kouros-Mehr H; Bechis SK; Slorach EM; Littlepage LE; Egeblad M; Ewald AJ; Pai SY; Ho IC; Werb Z		Cancer Cell	13	2008	141-52	J:131913	18242514
94346	Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.		Zheng H; Chang L; Patel N; Yang J; Lowe L; Burns DK; Zhu Y		Cancer Cell	13	2008	117-28	J:131915	18242512
94347	Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.		Wu J; Williams JP; Rizvi TA; Kordich JJ; Witte D; Meijer D; Stemmer-Rachamimov AO; Cancelas JA; Ratner N		Cancer Cell	13	2008	105-16	J:131916	18242511
94348	Chromosome X modulates incidence of testicular germ cell tumors in Ter mice.		Hammond S; Zhu R; Youngren KK; Lam J; Anderson P; Matin A		Mamm Genome	18	2007	832-8	J:132029	18049836
94349	Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice.		Albertelli MA; O'Mahony OA; Brogley M; Tosoian J; Steinkamp M; Daignault S; Wojno K; Robins DM		Hum Mol Genet	17	2008	98-110	J:132039	17906287
94350	WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy.		Ludes-Meyers JH; Kil H; Nunez MI; Conti CJ; Parker-Thornburg J; Bedford MT; Aldaz CM		Genes Chromosomes Cancer	46	2007	1129-36	J:132078	17823927
94351	Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis.		Lin DI; Lessie MD; Gladden AB; Bassing CH; Wagner KU; Diehl JA		Oncogene	27	2008	1231-42	J:132085	17724472
94352	Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.		Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J		Oncogene	27	2008	1087-94	J:132087	17700521
94353	Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.		Jones LP; Tilli MT; Assefnia S; Torre K; Halama ED; Parrish A; Rosen EM; Furth PA		Oncogene	27	2008	794-802	J:132088	17653086
94354	The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer.		Ying H; Willingham MC; Cheng SY		Oncogene	27	2008	823-30	J:132089	17653082
94355	Characterization of mammary tumors from Brg1 heterozygous mice.		Bultman SJ; Herschkowitz JI; Godfrey V; Gebuhr TC; Yaniv M; Perou CM; Magnuson T		Oncogene	27	2008	460-8	J:132091	17637742
94356	Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis.		Richard S; Vogel G; Huot ME; Guo T; Muller WJ; Lukong KE		Oncogene	27	2008	548-56	J:132092	17621265
94357	ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.		Maekawa T; Sano Y; Shinagawa T; Rahman Z; Sakuma T; Nomura S; Licht JD; Ishii S		Oncogene	27	2008	1045-54	J:132120	17700520
94358	Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling.		Tang Y; Kitisin K; Jogunoori W; Li C; Deng CX; Mueller SC; Ressom HW; Rashid A; He AR; Mendelson JS; Jessup JM; Shetty K; Zasloff M; Mishra B; Reddy EP; Johnson L; Mishra L		Proc Natl Acad Sci U S A	105	2008	2445-50	J:132133	18263735
94359	Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma.		Ratnacaram CK; Teletin M; Jiang M; Meng X; Chambon P; Metzger D		Proc Natl Acad Sci U S A	105	2008	2521-6	J:132170	18268330
94360	Failure of catalase to protect against aflatoxin B1-induced mouse lung tumorigenicity.		Guindon KA; Foley JF; Maronpot RR; Massey TE		Toxicol Appl Pharmacol	227	2008	179-83	J:132194	18155117
94361	Excess FGF-7 in Corneal Epithelium Causes Corneal Intraepithelial Neoplasia in Young Mice and Epithelium Hyperplasia in Adult Mice.		Chikama T; Liu CY; Meij JT; Hayashi Y; Wang IJ; Yang L; Nishida T; Kao WW		Am J Pathol	172	2008	638-49	J:132274	18276784
94362	Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice.		Williams TM; Cheung MW; Park DS; Razani B; Cohen AW; Muller WJ; Di Vizio D; Chopra NG; Pestell RG; Lisanti MP		Mol Biol Cell	14	2003	1027-42	J:132472	12631721
94363	MdmX promotes bipolar mitosis to suppress transformation and tumorigenesis in p53-deficient cells and mice.		Matijasevic Z; Steinman HA; Hoover K; Jones SN		Mol Cell Biol	28	2008	1265-73	J:132640	18039860
94364	Beta-catenin expression results in p53-independent DNA damage and oncogene-induced senescence in prelymphomagenic thymocytes in vivo.		Xu M; Yu Q; Subrahmanyam R; Difilippantonio MJ; Ried T; Sen JM		Mol Cell Biol	28	2008	1713-23	J:132650	18160717
94365	Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent.		Schmidt VA; Chiariello CS; Capilla E; Miller F; Bahou WF		Mol Cell Biol	28	2008	1489-502	J:132670	18180285
94366	T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model.		Hebbard LW; Garlatti M; Young LJ; Cardiff RD; Oshima RG; Ranscht B		Cancer Res	68	2008	1407-16	J:132759	18316604
94367	Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.		Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H		Cancer Res	68	2008	1347-53	J:132760	18316597
94368	Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.		van Veelen W; van Gasteren CJ; Acton DS; Franklin DS; Berger R; Lips CJ; Hoppener JW		Cancer Res	68	2008	1329-37	J:132761	18316595
94369	A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice.		Tan Y; Timakhov RA; Rao M; Altomare DA; Xu J; Liu Z; Gao Q; Jhanwar SC; Di Cristofano A; Wiest DL; Knepper JE; Testa JR		Cancer Res	68	2008	1296-302	J:132762	18316591
94370	Genotype x diet interactions in mice predisposed to mammary cancer. I. Body weight and fat.		Gordon RR; Hunter KW; Sorensen P; Pomp D		Mamm Genome	19	2008	163-78	J:132804	18286334
94371	Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells.		Tsatsanis C; Vaporidi K; Zacharioudaki V; Androulidaki A; Sykulev Y; Margioris AN; Tsichlis PN		Proc Natl Acad Sci U S A	105	2008	2987-92	J:132817	18287049
94372	Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.		Hegedus B; Banerjee D; Yeh TH; Rothermich S; Perry A; Rubin JB; Garbow JR; Gutmann DH		Cancer Res	68	2008	1520-8	J:132860	18316617
94373	Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma.		Briggs KJ; Corcoran-Schwartz IM; Zhang W; Harcke T; Devereux WL; Baylin SB; Eberhart CG; Watkins DN		Genes Dev	22	2008	770-85	J:132980	18347096
94374	Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development.		Zhao H; Ayrault O; Zindy F; Kim JH; Roussel MF		Genes Dev	22	2008	722-727	J:132983	18347090
94375	Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development.		Labi V; Erlacher M; Kiessling S; Manzl C; Frenzel A; O'Reilly L; Strasser A; Villunger A		J Exp Med	205	2008	641-55	J:133084	18299399
94376	Ovarian granulosa cell tumors express a functional membrane receptor for anti-Mullerian hormone in transgenic mice.		Dutertre M; Gouedard L; Xavier F; Long WQ; di Clemente N; Picard JY; Rey R		Endocrinology	142	2001	4040-6	J:133090	11517183
94377	Trp53 deletion stimulates the formation of metastatic pancreatic tumors.		Morton JP; Klimstra DS; Mongeau ME; Lewis BC		Am J Pathol	172	2008	1081-7	J:133144	18310506
94378	Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors.		Klinger MB; Guilbault B; Goulding RE; Kay RJ		Oncogene	24	2005	2695-704	J:133229	15829980
94379	Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis.		Dourdin N; Schade B; Lesurf R; Hallett M; Munn RJ; Cardiff RD; Muller WJ		Cancer Res	68	2008	2122-31	J:133305	18381417
94380	Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.		Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL		Cancer Res	68	2008	1809-19	J:133311	18339861
94381	The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.		Hatton BA; Villavicencio EH; Tsuchiya KD; Pritchard JI; Ditzler S; Pullar B; Hansen S; Knoblaugh SE; Lee D; Eberhart CG; Hallahan AR; Olson JM		Cancer Res	68	2008	1768-76	J:133312	18339857
94382	Bin3 deletion causes cataracts and increased susceptibility to lymphoma during aging.		Ramalingam A; Duhadaway JB; Sutanto-Ward E; Wang Y; Dinchuk J; Huang M; Donover PS; Boulden J; McNally LM; Soler AP; Muller AJ; Duncan MK; Prendergast GC		Cancer Res	68	2008	1683-90	J:133313	18339847
94383	Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer.		Perera SA; Maser RS; Xia H; McNamara K; Protopopov A; Chen L; Hezel AF; Kim CF; Bronson RT; Castrillon DH; Chin L; Bardeesy N; Depinho RA; Wong KK		Carcinogenesis	29	2008	747-53	J:133322	18283039
94384	ShcA signalling is essential for tumour progression in mouse models of human breast cancer.		Ursini-Siegel J; Hardy WR; Zuo D; Lam SH; Sanguin-Gendreau V; Cardiff RD; Pawson T; Muller WJ		EMBO J	27	2008	910-20	J:133325	18273058
94385	Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas.		Becher OJ; Hambardzumyan D; Fomchenko EI; Momota H; Mainwaring L; Bleau AM; Katz AM; Edgar M; Kenney AM; Cordon-Cardo C; Blasberg RG; Holland EC		Cancer Res	68	2008	2241-9	J:133329	18381430
94386	Lkb1 deficiency causes prostate neoplasia in the mouse.		Pearson HB; McCarthy A; Collins CM; Ashworth A; Clarke AR		Cancer Res	68	2008	2223-32	J:133330	18381428
94387	Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis.		Croci S; Landuzzi L; Nicoletti G; Palladini A; Antognoli A; De Giovanni C; Nanni P; Lollini PL		Pathol Oncol Res	13	2007	336-9	J:133412	18158569
94388	A mechanism misregulating p27 in tumors discovered in a functional genomic screen.		Garrett-Engele CM; Tasch MA; Hwang HC; Fero ML; Perlmutter RM; Clurman BE; Roberts JM		PLoS Genet	3	2007	e219	J:133427	18069898
94389	Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.		Saal LH; Gruvberger-Saal SK; Persson C; Lovgren K; Jumppanen M; Staaf J; Jonsson G; Pires MM; Maurer M; Holm K; Koujak S; Subramaniyam S; Vallon-Christersson J; Olsson H; Su T; Memeo L; Ludwig T; Ethier SP; Krogh M; Szabolcs M; Murty VV; Isola J; Hibshoos	h H; Parsons R; Borg A	Nat Genet	40	2008	102-7	J:133430	18066063
94390	Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis.		Patek CE; Arends MJ; Wallace WA; Luo F; Hagan S; Brownstein DG; Rose L; Devenney PS; Walker M; Plowman SJ; Berry RL; Kolch W; Sansom OJ; Harrison DJ; Hooper ML		Exp Cell Res	314	2008	1105-14	J:133431	18062963
94391	Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse.		Sportoletti P; Grisendi S; Majid SM; Cheng K; Clohessy JG; Viale A; Teruya-Feldstein J; Pandolfi PP		Blood	111	2008	3859-62	J:133435	18212245
94392	A protective role of mast cells in intestinal tumorigenesis.		Sinnamon MJ; Carter KJ; Sims LP; Lafleur B; Fingleton B; Matrisian LM		Carcinogenesis	29	2008	880-6	J:133499	18258601
94393	Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model.		Li L; Piloto O; Nguyen HB; Greenberg K; Takamiya K; Racke F; Huso D; Small D		Blood	111	2008	3849-58	J:133528	18245664
94394	Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression.		Knostman KA; Venkateswaran A; Zimmerman B; Capen CC; Jhiang SM		Thyroid	17	2007	1181-8	J:133544	18004977
94395	Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras.		Podsypanina K; Politi K; Beverly LJ; Varmus HE		Proc Natl Acad Sci U S A	105	2008	5242-7	J:133578	18356293
94396	Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.		Matsuoka S; Oike Y; Onoyama I; Iwama A; Arai F; Takubo K; Mashimo Y; Oguro H; Nitta E; Ito K; Miyamoto K; Yoshiwara H; Hosokawa K; Nakamura Y; Gomei Y; Iwasaki H; Hayashi Y; Matsuzaki Y; Nakayama K; Ikeda Y; Hata A; Chiba S; Nakayama KI; Suda T		Genes Dev	22	2008	986-91	J:133773	18367647
94397	Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling.		Malanchi I; Peinado H; Kassen D; Hussenet T; Metzger D; Chambon P; Huber M; Hohl D; Cano A; Birchmeier W; Huelsken J		Nature	452	2008	650-3	J:133779	18385740
94398	Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response.		Swarbrick A; Roy E; Allen T; Bishop JM		Proc Natl Acad Sci U S A	105	2008	5402-7	J:133783	18378907
94399	Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response.		Girirajan S; Hauck PM; Williams S; Vlangos CN; Szomju BB; Solaymani-Kohal S; Mosier PD; White KL Jr; McCoy K; Elsea SH		Mamm Genome	19	2008	246-62	J:133892	18343975
94400	Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms.		Xu X; Page JL; Surtees JA; Liu H; Lagedrost S; Lu Y; Bronson R; Alani E; Nikitin AY; Weiss RS		Cancer Res	68	2008	2652-60	J:133963	18413732
94401	p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.		Shai A; Pitot HC; Lambert PF		Cancer Res	68	2008	2622-31	J:133964	18413729
94402	Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis.		Zimmers TA; Jin X; Gutierrez JC; Acosta C; McKillop IH; Pierce RH; Koniaris LG		J Cancer Res Clin Oncol	134	2008	753-9	J:134049	18210153
94403	RAGE signaling sustains inflammation and promotes tumor development.		Gebhardt C; Riehl A; Durchdewald M; Nemeth J; Furstenberger G; Muller-Decker K; Enk A; Arnold B; Bierhaus A; Nawroth PP; Hess J; Angel P		J Exp Med	205	2008	275-85	J:134050	18208974
94404	Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse.		Ohnishi N; Yuasa H; Tanaka S; Sawa H; Miura M; Matsui A; Higashi H; Musashi M; Iwabuchi K; Suzuki M; Yamada G; Azuma T; Hatakeyama M		Proc Natl Acad Sci U S A	105	2008	1003-8	J:134055	18192401
94405	The homeodomain transcription factor Cdx1 does not behave as an oncogene in normal mouse intestine.		Crissey MA; Guo RJ; Fogt F; Li H; Katz JP; Silberg DG; Suh ER; Lynch JP		Neoplasia	10	2008	8-19	J:134076	18231635
94406	Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms.		Hezel AF; Gurumurthy S; Granot Z; Swisa A; Chu GC; Bailey G; Dor Y; Bardeesy N; Depinho RA		Mol Cell Biol	28	2008	2414-25	J:134078	18227155
94407	Mutation of C/EBPalpha predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen.		Hasemann MS; Damgaard I; Schuster MB; Theilgaard-Monch K; Sorensen AB; Mrsic A; Krugers T; Ylstra B; Pedersen FS; Nerlov C; Porse BT		Blood	111	2008	4309-21	J:134083	18212247
94408	Cellular expression patterns of genes upregulated in murine and human colonic neoplasms.		Chen X; Ehrhardt WM; Halberg RB; Aronow BJ; Dove WF		J Histochem Cytochem	56	2008	433-41	J:134084	18180384
94409	Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.		Yekkala K; Baudino TA		Mol Cancer Res	5	2007	1296-303	J:134087	18171987
94410	Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer.		Korpi JT; Kervinen V; Maklin H; Vaananen A; Lahtinen M; Laara E; Ristimaki A; Thomas G; Ylipalosaari M; Astrom P; Lopez-Otin C; Sorsa T; Kantola S; Pirila E; Salo T		Br J Cancer	98	2008	766-75	J:134226	18253113
94411	p27 deficiency cooperates with Bcl-2 but not Bax to promote T-cell lymphoma.		Cheng N; van de Wetering CI; Knudson CM		PLoS ONE	3	2008	e1911	J:134259	18382684
94412	The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.		Firestein R; Blander G; Michan S; Oberdoerffer P; Ogino S; Campbell J; Bhimavarapu A; Luikenhuis S; de Cabo R; Fuchs C; Hahn WC; Guarente LP; Sinclair DA		PLoS ONE	3	2008	e2020	J:134301	18414679
94413	LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis.		Katajisto P; Vaahtomeri K; Ekman N; Ventela E; Ristimaki A; Bardeesy N; Feil R; DePinho RA; Makela TP		Nat Genet	40	2008	455-9	J:134476	18311138
94414	NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.		Guerra N; Tan YX; Joncker NT; Choy A; Gallardo F; Xiong N; Knoblaugh S; Cado D; Greenberg NR; Raulet DH		Immunity	28	2008	571-80	J:134509	18394936
94415	Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis.		Nakanishi M; Montrose DC; Clark P; Nambiar PR; Belinsky GS; Claffey KP; Xu D; Rosenberg DW		Cancer Res	68	2008	3251-9	J:134592	18451151
94416	Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.		Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM		Cancer Res	68	2008	3495-504	J:134608	18451178
94417	Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression.		Anzo M; Cobb LJ; Hwang DL; Mehta H; Said JW; Yakar S; LeRoith D; Cohen P		Cancer Res	68	2008	3342-9	J:134610	18451161
94419	Pten haploinsufficiency accelerates formation of high-grade astrocytomas.		Kwon CH; Zhao D; Chen J; Alcantara S; Li Y; Burns DK; Mason RP; Lee EY; Wu H; Parada LF		Cancer Res	68	2008	3286-94	J:134611	18451155
94420	Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.		Shafee N; Smith CR; Wei S; Kim Y; Mills GB; Hortobagyi GN; Stanbridge EJ; Lee EY		Cancer Res	68	2008	3243-50	J:134612	18451150
94421	Frequent p53 and H-ras mutations in benzene- and ethylene oxide-induced mammary gland carcinomas from B6C3F1 mice.		Houle CD; Ton TV; Clayton N; Huff J; Hong HH; Sills RC		Toxicol Pathol	34	2006	752-62	J:134714	17162533
94422	Carcinogenicity evaluation: comparison of tumor data from dual control groups in the CD-1 mouse.		Baldrick P; Reeve L		Toxicol Pathol	35	2007	562-9	J:134840	17562489
94423	N-ethyl-N-nitrosourea (ENU)-induced meningiomatosis and meningioma in p16(INK4a)/p19(ARF) tumor suppressor gene-deficient mice.		Morrison JP; Satoh H; Foley J; Horton JL; Dunnick JK; Kissling GE; Malarkey DE		Toxicol Pathol	35	2007	780-7	J:134886	17943659
94424	The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.		Fereshteh MP; Tilli MT; Kim SE; Xu J; O'Malley BW; Wellstein A; Furth PA; Riegel AT		Cancer Res	68	2008	3697-706	J:135022	18483252
94425	Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.		Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST		Cancer Res	68	2008	3655-61	J:135025	18483247
94426	Targeted knockout of BRG1 potentiates lung cancer development.		Glaros S; Cirrincione GM; Palanca A; Metzger D; Reisman D		Cancer Res	68	2008	3689-96	J:135031	18483251
94427	Inactivation of gadd45a sensitizes epithelial cancer cells to ionizing radiation in vivo resulting in prolonged survival.		Lu X; Yang C; Hill R; Yin C; Hollander MC; Fornace AJ Jr; Van Dyke T		Cancer Res	68	2008	3579-83	J:135074	18483238
94428	Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis.		Chen H; Lee JS; Liang X; Zhang H; Zhu T; Zhang Z; Taylor ME; Zahnow C; Feigenbaum L; Rein A; Sukumar S		Cancer Res	68	2008	3637-44	J:135075	18463397
94429	Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia.		Raufman JP; Samimi R; Shah N; Khurana S; Shant J; Drachenberg C; Xie G; Wess J; Cheng K		Cancer Res	68	2008	3573-8	J:135076	18483237
94430	Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis.		Jeganathan K; Malureanu L; Baker DJ; Abraham SC; van Deursen JM		J Cell Biol	179	2007	255-67	J:135093	17938250
94431	Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation.		Guo W; Lasky JL; Chang CJ; Mosessian S; Lewis X; Xiao Y; Yeh JE; Chen JY; Iruela-Arispe ML; Varella-Garcia M; Wu H		Nature	453	2008	529-33	J:135172	18463637
94432	STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.		Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ		J Clin Invest	118	2008	1727-38	J:135184	18431520
94433	Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma.		Tilli MT; Frech MS; Steed ME; Hruska KS; Johnson MD; Flaws JA; Furth PA		Am J Pathol	163	2003	1713-9	J:135395	14578170
94434	Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.		Cano F; Drynan LF; Pannell R; Rabbitts TH		Oncogene	27	2008	1945-50	J:135508	17906700
94435	Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer.		Milliken EL; Lozada KL; Johnson E; Landis MD; Seachrist DD; Whitten I; Sutton AL; Abdul-Karim FW; Keri RA		Oncogene	27	2008	1759-66	J:135510	17891171
94436	Role of the Notch ligand Delta1 in embryonic and adult mouse epidermis.		Estrach S; Cordes R; Hozumi K; Gossler A; Watt FM		J Invest Dermatol	128	2008	825-32	J:135515	17960184
94437	Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.		Heinlein C; Krepulat F; Lohler J; Speidel D; Deppert W; Tolstonog GV		Int J Cancer	122	2008	1701-9	J:135540	18092324
94438	Tumors caused by overexpression and forced activation of Stat5 in mammary epithelial cells of transgenic mice are parity-dependent and developed in aged, postestropausal females.		Eilon T; Groner B; Barash I		Int J Cancer	121	2007	1892-902	J:135547	17640063
94439	Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon.		Calcagno SR; Li S; Colon M; Kreinest PA; Thompson EA; Fields AP; Murray NR		Int J Cancer	122	2008	2462-70	J:135568	18271008
94440	Ephrin-A1 promotes the malignant progression of intestinal tumors in Apc(min/+) mice.		Shi L; Itoh F; Itoh S; Takahashi S; Yamamoto M; Kato M		Oncogene	27	2008	3265-73	J:135593	18246128
94441	Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.		Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H		Oncogene	27	2008	3465-74	J:135601	18193087
94442	p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.		Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ		Oncogene	27	2008	3145-55	J:135611	18059331
94443	Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.		van Hengel J; D'Hooge P; Hooghe B; Wu X; Libbrecht L; De Vos R; Quondamatteo F; Klempt M; Brakebusch C; van Roy F		Gastroenterology	134	2008	781-92	J:135821	18325391
94444	Genotype X diet interactions in mice predisposed to mammary cancer: II. Tumors and metastasis.		Gordon RR; Hunter KW; La Merrill M; Sorensen P; Threadgill DW; Pomp D		Mamm Genome	19	2008	179-89	J:136011	18288525
94445	Enhanced susceptibility to chemical induction of ovarian tumors in mice with a germ line p53 mutation.		Wang Y; Zhang Z; Lu Y; Yao R; Jia D; Wen W; LaRegina M; Crist K; Lubet R; You M		Mol Cancer Res	6	2008	99-109	J:136024	18234966
94446	Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells.		Kirstetter P; Schuster MB; Bereshchenko O; Moore S; Dvinge H; Kurz E; Theilgaard-Monch K; Mansson R; Pedersen TA; Pabst T; Schrock E; Porse BT; Jacobsen SE; Bertone P; Tenen DG; Nerlov C		Cancer Cell	13	2008	299-310	J:136134	18394553
94447	Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.		van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW		Mol Immunol	45	2008	3085-95	J:136203	18471881
94448	Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.		Tran TP; Fan AC; Bendapudi PK; Koh S; Komatsubara K; Chen J; Horng G; Bellovin DI; Giuriato S; Wang CS; Whitsett JA; Felsher DW		PLoS ONE	3	2008	e2125	J:136212	18461184
94449	Genetic ablation of alphav integrins in epithelial cells of the eyelid skin and conjunctiva leads to squamous cell carcinoma.		McCarty JH; Barry M; Crowley D; Bronson RT; Lacy-Hulbert A; Hynes RO		Am J Pathol	172	2008	1740-7	J:136231	18467691
94450	Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer.		Yang Y; Iwanaga K; Raso MG; Wislez M; Hanna AE; Wieder ED; Molldrem JJ; Wistuba II; Powis G; Demayo FJ; Kim CF; Kurie JM		PLoS ONE	3	2008	e2220	J:136369	18493606
94451	Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions.		Yang Y; Bai J; Shen R; Brown SA; Komissarova E; Huang Y; Jiang N; Alberts GF; Costa M; Lu L; Winkles JA; Dai W		Cancer Res	68	2008	4077-85	J:136425	18519666
94452	Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC(Min/+) mice.		Elander N; Ungerback J; Olsson H; Uematsu S; Akira S; Soderkvist P		Biochem Biophys Res Commun	372	2008	249-53	J:136951	18485889
94453	Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells.		Oguma K; Oshima H; Aoki M; Uchio R; Naka K; Nakamura S; Hirao A; Saya H; Taketo MM; Oshima M		EMBO J	27	2008	1671-81	J:137013	18511911
94454	Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis.		Homig-Holzel C; Hojer C; Rastelli J; Casola S; Strobl LJ; Muller W; Quintanilla-Martinez L; Gewies A; Ruland J; Rajewsky K; Zimber-Strobl U		J Exp Med	205	2008	1317-29	J:137122	18490492
94455	Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression.		Chen PC; Kuraguchi M; Velasquez J; Wang Y; Yang K; Edwards R; Gillen D; Edelmann W; Kucherlapati R; Lipkin SM		PLoS Genet	4	2008	e1000092	J:137189	18551179
94456	Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia.		Frew IJ; Minola A; Georgiev S; Hitz M; Moch H; Richard S; Vortmeyer AO; Krek W		Mol Cell Biol	28	2008	4536-48	J:137442	18474617
94457	Attenuation of UVB-induced sunburn reaction and oxidative DNA damage with no alterations in UVB-induced skin carcinogenesis in Nrf2 gene-deficient mice.		Kawachi Y; Xu X; Taguchi S; Sakurai H; Nakamura Y; Ishii Y; Fujisawa Y; Furuta J; Takahashi T; Itoh K; Yamamoto M; Yamazaki F; Otsuka F		J Invest Dermatol	128	2008	1773-9	J:137535	18200051
94458	Impaired anti-leukemic immune response in PKCtheta-deficient mice.		Garaude J; Kaminski S; Charni S; Aguilo JI; Jacquet C; Plays M; Hernandez J; Rodriguez F; Hipskind RA; Anel A; Villalba M		Mol Immunol	45	2008	3463-9	J:137698	18462800
94459	DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice.		Meira LB; Bugni JM; Green SL; Lee CW; Pang B; Borenshtein D; Rickman BH; Rogers AB; Moroski-Erkul CA; McFaline JL; Schauer DB; Dedon PC; Fox JG; Samson LD		J Clin Invest	118	2008	2516-25	J:137708	18521188
94460	CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.		Shmelkov SV; Butler JM; Hooper AT; Hormigo A; Kushner J; Milde T; St Clair R; Baljevic M; White I; Jin DK; Chadburn A; Murphy AJ; Valenzuela DM; Gale NW; Thurston G; Yancopoulos GD; D'Angelica M; Kemeny N; Lyden D; Rafii S		J Clin Invest	118	2008	2111-20	J:137714	18497886
94461	A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition.		Schuhmacher AJ; Guerra C; Sauzeau V; Canamero M; Bustelo XR; Barbacid M		J Clin Invest	118	2008	2169-79	J:137729	18483625
94462	Estrogen receptor-positive mammary tumorigenesis in TGFalpha transgenic mice progresses with progesterone receptor loss.		Rose-Hellekant TA; Schroeder MD; Brockman JL; Zhdankin O; Bolstad R; Chen KS; Gould MN; Schuler LA; Sandgren EP		Oncogene	26	2007	5238-46	J:137737	17334393
94463	Effect of Bcl11b genotypes and gamma-radiation on the development of mouse thymic lymphomas.		Yoshikai Y; Sato T; Morita S; Kohara Y; Takagi R; Mishima Y; Kominami R		Biochem Biophys Res Commun	373	2008	282-5	J:137956	18558082
94464	RelB-dependent stromal cells promote T-cell leukemogenesis.		dos Santos NR; Williame M; Gachet S; Cormier F; Janin A; Weih D; Weih F; Ghysdael J		PLoS ONE	3	2008	e2555	J:137965	18596915
94465	FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C/EBPalpha and activating eIF4E.		Perez-Mancera PA; Bermejo-Rodriguez C; Sanchez-Martin M; Abollo-Jimenez F; Pintado B; Sanchez-Garcia I		PLoS ONE	3	2008	e2569	J:138016	18596980
94466	Enhanced lung tumor development in tobacco smoke-exposed p53 transgenic and Kras2 heterozygous deficient mice.		Yan Y; Tan Q; Wang Y; Wang D; Jin M; Gordon T; Lubet RA; You M		Inhal Toxicol	19 Suppl 1	2007	183-7	J:138096	17886066
94467	In vivo potential effects of adenovirus type 5 E1A and E1B on lung carcinogenesis and lymphoproliferative inflammation.		Yang Y; McKerlie C; Lu Z; Wang L; Buchwald M		J Virol	82	2008	8105-11	J:138162	18524829
94468	Mouse strain differences in inflammatory responses of colonic mucosa induced by dextran sulfate sodium cause differential susceptibility to PhIP-induced large bowel carcinogenesis.		Nakanishi M; Tazawa H; Tsuchiya N; Sugimura T; Tanaka T; Nakagama H		Cancer Sci	98	2007	1157-63	J:138489	17573895
94469	AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.		Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A		Oncogene	27	2008	4752-6	J:138509	18408759
94470	Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response.		Pahler JC; Tazzyman S; Erez N; Chen YY; Murdoch C; Nozawa H; Lewis CE; Hanahan D		Neoplasia	10	2008	329-40	J:138514	18392134
94471	Loss of Rassf1a cooperates with Apc(Min) to accelerate intestinal tumourigenesis.		van der Weyden L; Arends MJ; Dovey OM; Harrison HL; Lefebvre G; Conte N; Gergely FV; Bradley A; Adams DJ		Oncogene	27	2008	4503-8	J:138515	18391979
94472	Aurora A overexpression induces cellular senescence in mammary gland hyperplastic tumors developed in p53-deficient mice.		Zhang D; Shimizu T; Araki N; Hirota T; Yoshie M; Ogawa K; Nakagata N; Takeya M; Saya H		Oncogene	27	2008	4305-14	J:138521	18372918
94473	Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1-/- mice.		Leung N; Turbide C; Balachandra B; Marcus V; Beauchemin N		Oncogene	27	2008	4943-53	J:138528	18454175
94474	Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis.		Kataoka K; Kim DJ; Carbajal S; Clifford JL; DiGiovanni J		Carcinogenesis	29	2008	1108-14	J:138529	18453544
94475	Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21 WAF-induced differentiation triggered by GSK3beta inactivation and reduced AKT activity.		Yao D; Alexander CL; Quinn JA; Chan WC; Wu H; Greenhalgh DA		J Cell Sci	121	2008	1758-69	J:138532	18445683
94476	Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.		Jia S; Liu Z; Zhang S; Liu P; Zhang L; Lee SH; Zhang J; Signoretti S; Loda M; Roberts TM; Zhao JJ		Nature	454	2008	776-9	J:138565	18594509
94477	TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.		Muller-Hermelink N; Braumuller H; Pichler B; Wieder T; Mailhammer R; Schaak K; Ghoreschi K; Yazdi A; Haubner R; Sander CA; Mocikat R; Schwaiger M; Forster I; Huss R; Weber WA; Kneilling M; Rocken M		Cancer Cell	13	2008	507-18	J:138631	18538734
94478	VEGF Restores Delayed Tumor Progression in Tumors Depleted of Macrophages.		Lin EY; Li JF; Bricard G; Wang W; Deng Y; Sellers R; Porcelli SA; Pollard JW		Mol Oncol	1	2007	288-302	J:138643	18509509
94479	B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic beta-cell carcinogenesis.		Sobczak I; Galabova-Kovacs G; Sadzak I; Kren A; Christofori G; Baccarini M		Oncogene	27	2008	4779-87	J:138656	18490924
94480	Divergent effects of castration on prostate cancer in TRAMP mice: possible implications for therapy.		Tang Y; Wang L; Goloubeva O; Khan MA; Zhang B; Hussain A		Clin Cancer Res	14	2008	2936-43	J:138663	18483360
94481	Constitutive activation of Raf-1 induces glioma formation in mice.		Lyustikman Y; Momota H; Pao W; Holland EC		Neoplasia	10	2008	501-10	J:138670	18472967
94482	Estrogen receptor beta deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice.		Giroux V; Lemay F; Bernatchez G; Robitaille Y; Carrier JC		Int J Cancer	123	2008	303-11	J:138676	18464259
94483	Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis.		Willenbring H; Sharma AD; Vogel A; Lee AY; Rothfuss A; Wang Z; Finegold M; Grompe M		Cancer Cell	14	2008	59-67	J:138701	18598944
94484	Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl.		Slape C; Liu LY; Beachy S; Aplan PD		Blood	112	2008	2017-9	J:138720	18566322
94485	The H19 locus acts in vivo as a tumor suppressor.		Yoshimizu T; Miroglio A; Ripoche MA; Gabory A; Vernucci M; Riccio A; Colnot S; Godard C; Terris B; Jammes H; Dandolo L		Proc Natl Acad Sci U S A	105	2008	12417-22	J:138826	18719115
94486	PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma.		He X; Zhu Z; Johnson C; Stoops J; Eaker AE; Bowen W; DeFrances MC		Cancer Res	68	2008	5591-8	J:138844	18632611
94487	Targeted deletion of Rad9 in mouse skin keratinocytes enhances genotoxin-induced tumor development.		Hu Z; Liu Y; Zhang C; Zhao Y; He W; Han L; Yang L; Hopkins KM; Yang X; Lieberman HB; Hang H		Cancer Res	68	2008	5552-61	J:138845	18632607
94488	Loss of the transmembrane but not the soluble kit ligand isoform increases testicular germ cell tumor susceptibility in mice.		Heaney JD; Lam MY; Michelson MV; Nadeau JH		Cancer Res	68	2008	5193-7	J:138878	18593919
94489	Haploinsufficiency of the maspin tumor suppressor gene leads to hyperplastic lesions in prostate.		Shao LJ; Shi HY; Ayala G; Rowley D; Zhang M		Cancer Res	68	2008	5143-51	J:138880	18593913
94490	Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia.		Akakura S; Huang C; Nelson PJ; Foster B; Gelman IH		Cancer Res	68	2008	5096-103	J:138882	18593908
94491	c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice.		Shibata W; Maeda S; Hikiba Y; Yanai A; Sakamoto K; Nakagawa H; Ogura K; Karin M; Omata M		Cancer Res	68	2008	5031-9	J:138883	18593901
94492	Suppression of colorectal oncogenesis by selenium-enriched milk proteins: apoptosis and K-ras mutations.		Hu Y; McIntosh GH; Le Leu RK; Woodman R; Young GP		Cancer Res	68	2008	4936-44	J:138896	18559541
94493	Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.		Zhang M; Behbod F; Atkinson RL; Landis MD; Kittrell F; Edwards D; Medina D; Tsimelzon A; Hilsenbeck S; Green JE; Michalowska AM; Rosen JM		Cancer Res	68	2008	4674-82	J:138898	18559513
94494	Early-onset lymphoma and extensive embryonic apoptosis in two domain-specific Fen1 mice mutants.		Larsen E; Kleppa L; Meza TJ; Meza-Zepeda LA; Rada C; Castellanos CG; Lien GF; Nesse GJ; Neuberger MS; Laerdahl JK; William Doughty R; Klungland A		Cancer Res	68	2008	4571-9	J:138901	18559501
94495	Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice.		Kuprash DV; Qin Z; Ito D; Grivennikov SI; Abe K; Drutskaya LN; Blankenstein T; Nedospasov SA		Cancer Lett	268	2008	70-5	J:138907	18442881
94496	Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.		Versteeg HH; Schaffner F; Kerver M; Ellies LG; Andrade-Gordon P; Mueller BM; Ruf W		Cancer Res	68	2008	7219-27	J:138924	18757438
94497	Nitric oxide is a key component in inflammation-accelerated tumorigenesis.		Hussain SP; He P; Subleski J; Hofseth LJ; Trivers GE; Mechanic L; Hofseth AB; Bernard M; Schwank J; Nguyen G; Mathe E; Djurickovic D; Haines D; Weiss J; Back T; Gruys E; Laubach VE; Wiltrout RH; Harris CC		Cancer Res	68	2008	7130-6	J:138926	18757428
94498	Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin.		Squarize CH; Castilho RM; Gutkind JS		Cancer Res	68	2008	7066-72	J:138927	18757421
94499	Podoplanin is a novel fos target gene in skin carcinogenesis.		Durchdewald M; Guinea-Viniegra J; Haag D; Riehl A; Lichter P; Hahn M; Wagner EF; Angel P; Hess J		Cancer Res	68	2008	6877-83	J:138930	18757399
94500	MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.		Tinder TL; Subramani DB; Basu GD; Bradley JM; Schettini J; Million A; Skaar T; Mukherjee P		J Immunol	181	2008	3116-25	J:138959	18713982
94501	Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis.		Joshi J; Fernandez-Marcos PJ; Galvez A; Amanchy R; Linares JF; Duran A; Pathrose P; Leitges M; Canamero M; Collado M; Salas C; Serrano M; Moscat J; Diaz-Meco MT		EMBO J	27	2008	2181-93	J:139014	18650932
94502	Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis.		Inoue-Narita T; Hamada K; Sasaki T; Hatakeyama S; Fujita S; Kawahara K; Sasaki M; Kishimoto H; Eguchi S; Kojima I; Beermann F; Kimura T; Osawa M; Itami S; Mak TW; Nakano T; Manabe M; Suzuki A		Cancer Res	68	2008	5760-8	J:139051	18632629
94503	Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice.		Daikoku T; Hirota Y; Tranguch S; Joshi AR; DeMayo FJ; Lydon JP; Ellenson LH; Dey SK		Cancer Res	68	2008	5619-27	J:139053	18632614
94504	Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice.		Leung WK; Wu KC; Wong CY; Cheng AS; Ching AK; Chan AW; Chong WW; Go MY; Yu J; To KF; Wang X; Chui YL; Fan DM; Sung JJ		Carcinogenesis	29	2008	1648-54	J:139054	18611916
94505	The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice.		Pfefferle R; Marcuzzi GP; Akgul B; Kasper HU; Schulze F; Haase I; Wickenhauser C; Pfister H		J Invest Dermatol	128	2008	2310-5	J:139066	18401427
94506	Clarification of data used in three studies on MCA-induction of sarcoma in mice.		Smyth MJ		Blood	111	2008	4419	J:139067	18398063
94507	Overexpression of Separase induces aneuploidy and mammary tumorigenesis.		Zhang N; Ge G; Meyer R; Sethi S; Basu D; Pradhan S; Zhao YJ; Li XN; Cai WW; El-Naggar AK; Baladandayuthapani V; Kittrell FS; Rao PH; Medina D; Pati D		Proc Natl Acad Sci U S A	105	2008	13033-8	J:139128	18728194
94508	AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27.		Short JD; Houston KD; Dere R; Cai SL; Kim J; Johnson CL; Broaddus RR; Shen J; Miyamoto S; Tamanoi F; Kwiatkowski D; Mills GB; Walker CL		Cancer Res	68	2008	6496-506	J:139145	18701472
94509	The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas.		Refaeli Y; Young RM; Turner BC; Duda J; Field KA; Bishop JM		PLoS Biol	6	2008	e152	J:139351	18578569
94510	Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice.		Roy JS; Van Themsche C; Demers M; Opdenakker G; Arnold B; St-Pierre Y		Leukemia	21	2007	2506-11	J:139419	17805326
94511	Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells.		Yang ZJ; Ellis T; Markant SL; Read TA; Kessler JD; Bourboulas M; Schuller U; Machold R; Fishell G; Rowitch DH; Wainwright BJ; Wechsler-Reya RJ		Cancer Cell	14	2008	135-45	J:139573	18691548
94512	Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo.		de Ostrovich KK; Lambertz I; Colby JK; Tian J; Rundhaug JE; Johnston D; Conti CJ; DiGiovanni J; Fuchs-Young R		Am J Pathol	173	2008	824-34	J:139583	18688034
94513	Susceptibility of Snark-deficient mice to azoxymethane-induced colorectal tumorigenesis and the formation of aberrant crypt foci.		Tsuchihara K; Ogura T; Fujioka R; Fujii S; Kuga W; Saito M; Ochiya T; Ochiai A; Esumi H		Cancer Sci	99	2008	677-82	J:139603	18307533
94514	The pleiotropic phenotype of apc mutations in the mouse: allele specificity and effects of the genetic background.		Halberg RB; Chen X; Amos-Landgraf JM; White A; Rasmussen K; Clipson L; Pasch C; Sullivan R; Pitot HC; Dove WF		Genetics	180	2008	601-9	J:139675	18723878
94515	Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.		Berman SD; Calo E; Landman AS; Danielian PS; Miller ES; West JC; Fonhoue BD; Caron A; Bronson R; Bouxsein ML; Mukherjee S; Lees JA		Proc Natl Acad Sci U S A	105	2008	11851-6	J:139697	18697945
94516	Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion.		Dovey JS; Zacharek SJ; Kim CF; Lees JA		Proc Natl Acad Sci U S A	105	2008	11857-62	J:139699	18697930
94517	Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis.		Garrison SP; Jeffers JR; Yang C; Nilsson JA; Hall MA; Rehg JE; Yue W; Yu J; Zhang L; Onciu M; Sample JT; Cleveland JL; Zambetti GP		Mol Cell Biol	28	2008	5391-402	J:139744	18573879
94518	Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice.		Dunphy KA; Blackburn AC; Yan H; O'Connell LR; Jerry DJ		Breast Cancer Res	10	2008	R43	J:139811	18471300
94519	Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice.		Sansom OJ; Mansergh FC; Evans MJ; Wilkins JA; Clarke AR		Gut	56	2007	1410-4	J:139856	17299058
94520	Expression of a bcr-1 isoform of RARalpha-PML does not affect the penetrance of acute promyelocytic leukemia or the acquisition of an interstitial deletion on mouse chromosome 2.		Walter MJ; Ries RE; Armstrong JR; Park JS; Mardis ER; Ley TJ		Blood	109	2007	1237-40	J:139857	17008533
94521	Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.		Le Beau MM; Davis EM; Patel B; Phan VT; Sohal J; Kogan SC		Blood	102	2003	1072-4	J:139858	12689927
94522	Multicolour spectral karyotyping of mouse chromosomes.		Liyanage M; Coleman A; du Manoir S; Veldman T; McCormack S; Dickson RB; Barlow C; Wynshaw-Boris A; Janz S; Wienberg J; Ferguson-Smith MA; Schrock E; Ried T		Nat Genet	14	1996	312-5	J:139861	8896561
94523	Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers.		Burniat A; Jin L; Detours V; Driessens N; Goffard JC; Santoro M; Rothstein J; Dumont JE; Miot F; Corvilain B		Endocrinology	149	2008	5107-17	J:139875	18583418
94524	Mdm2 and Mdm4 loss regulates distinct p53 activities.		Barboza JA; Iwakuma T; Terzian T; El-Naggar AK; Lozano G		Mol Cancer Res	6	2008	947-54	J:139880	18567799
94525	Induction of lung adenocarcinoma in transgenic mice expressing activated EGFR driven by the SP-C promoter.		Ohashi K; Rai K; Fujiwara Y; Osawa M; Hirano S; Takata K; Kondo E; Yoshino T; Takata M; Tanimoto M; Kiura K		Cancer Sci	99	2008	1747-53	J:139882	18564139
94526	A case report of a renal mixed epithelial and stromal tumor in a heterozygous S1P2 receptor deficient mouse.		Takabatake M; Takuwa Y; Takuwa N; Yasuno H; Matsumoto S; Shibutani M; Mitsumori K		J Vet Med Sci	70	2008	483-5	J:139899	18525171
94527	DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development.		Fan T; Schmidtmann A; Xi S; Briones V; Zhu H; Suh HC; Gooya J; Keller JR; Xu H; Roayaei J; Anver M; Ruscetti S; Muegge K		Epigenetics	3	2008	134-42	J:139913	18487951
94528	Widespread hyperplasia induced by transgenic TGFalpha in ApcMin mice is associated with only regional effects on tumorigenesis.		Bilger A; Sullivan R; Prunuske AJ; Clipson L; Drinkwater NR; Dove WF		Carcinogenesis	29	2008	1825-30	J:139925	18310091
94529	Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.		Wang D; Wang H; Ning W; Backlund MG; Dey SK; DuBois RN		Cancer Res	68	2008	6468-76	J:140031	18676872
94530	Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer.		Liu Y; Mo JQ; Hu Q; Boivin G; Levin L; Lu S; Yang D; Dong Z; Lu S		Cancer Res	68	2008	6396-406	J:140032	18676865
94531	Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.		Martin MD; Carter KJ; Jean-Philippe SR; Chang M; Mobashery S; Thiolloy S; Lynch CC; Matrisian LM; Fingleton B		Cancer Res	68	2008	6251-9	J:140033	18676849
94532	Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer.		Macias-Perez I; Borza C; Chen X; Yan X; Ibanez R; Mernaugh G; Matrisian LM; Zent R; Pozzi A		Cancer Res	68	2008	6127-35	J:140034	18676835
94533	Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression.		Declercq J; Skaland I; Van Dyck F; Janssen EA; Baak JP; Drijkoningen M; Van de Ven WJ		Int J Cancer	123	2008	1593-600	J:140057	18649356
94534	Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors.		Manenti G; Trincucci G; Pettinicchio A; Amendola E; Scarfo M; Dragani TA		Oncogene	27	2008	5753-8	J:140066	18560355
94535	The role of the transcription factor AP-1 in colitis-associated and beta-catenin-dependent intestinal tumorigenesis in mice.		Hasselblatt P; Gresh L; Kudo H; Guinea-Viniegra J; Wagner EF		Oncogene	27	2008	6102-9	J:140139	18679426
94536	K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors.		Kindler T; Cornejo MG; Scholl C; Liu J; Leeman DS; Haydu JE; Frohling S; Lee BH; Gilliland DG		Blood	112	2008	3373-82	J:140221	18663146
94537	Luteinizing hormone promotes gonadal tumorigenesis in inhibin-deficient mice.		Nagaraja AK; Agno JE; Kumar TR; Matzuk MM		Mol Cell Endocrinol	294	2008	19-28	J:140408	18657590
94538	Murine Neonatal Melanocytes Exhibit a Heightened Proliferative Response to Ultraviolet Radiation and Migrate to the Epidermal Basal Layer.		Walker GJ; G Kimlin M; Hacker E; Ravishankar S; Muller HK; Beermann F; Hayward NK		J Invest Dermatol		2008		J:140418	18633434
94539	A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors.		Seidler B; Schmidt A; Mayr U; Nakhai H; Schmid RM; Schneider G; Saur D		Proc Natl Acad Sci U S A	105	2008	10137-42	J:140423	18621715
94540	Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression.		Hoot KE; Lighthall J; Han G; Lu SL; Li A; Ju W; Kulesz-Martin M; Bottinger E; Wang XJ		J Clin Invest	118	2008	2722-32	J:140425	18618014
94541	Lentivirus-mediated oncogene introduction into mammary cells in vivo induces tumors.		Siwko SK; Bu W; Gutierrez C; Lewis B; Jechlinger M; Schaffhausen B; Li Y		Neoplasia	10	2008	653-62, 1 p following 662	J:140428	18592025
94542	Spontaneous vulvar papillomas in a colony of mice used for pancreatic cancer research.		Gades NM; Ohash A; Mills LD; Rowley MA; Predmore KS; Marler RJ; Couch FJ		Comp Med	58	2008	271-5	J:140431	18589869
94543	Development of thymic lymphomas in mice disrupted of Brca2 allele in the thymus.		Park PG; Lee H		Exp Mol Med	40	2008	339-44	J:140433	18587272
94544	Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.		Nielsen BS; Egeblad M; Rank F; Askautrud HA; Pennington CJ; Pedersen TX; Christensen IJ; Edwards DR; Werb Z; Lund LR		PLoS ONE	3	2008	e2959	J:140590	18698413
94545	Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth.		Gounaris E; Tung CH; Restaino C; Maehr R; Kohler R; Joyce JA; Plough HL; Barrett TA; Weissleder R; Khazaie K		PLoS ONE	3	2008	e2916	J:140593	18698347
94546	EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model.		Lin PP; Pandey MK; Jin F; Xiong S; Deavers M; Parant JM; Lozano G		Cancer Res	68	2008	8968-75	J:140636	18974141
94547	Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice.		Corcoran RB; Bachar Raveh T; Barakat MT; Lee EY; Scott MP		Cancer Res	68	2008	8788-95	J:140638	18974121
94548	p37Ing1b regulates B-cell proliferation and cooperates with p53 to suppress diffuse large B-cell lymphomagenesis.		Coles AH; Marfella CG; Imbalzano AN; Steinman HA; Garlick DS; Gerstein RM; Jones SN		Cancer Res	68	2008	8705-14	J:140640	18974112
94549	Spinal glioma: platelet-derived growth factor B-mediated oncogenesis in the spinal cord.		Hitoshi Y; Harris BT; Liu H; Popko B; Israel MA		Cancer Res	68	2008	8507-15	J:140662	18922925
94550	Two cases of uveal amelanotic melanoma in transgenic Tyr-HRAS+ Ink4a/Arf heterozygous mice.		Latendresse JR; Muskhelishvili L; Warbritton A; Tolleson WH		Toxicol Pathol	35	2007	827-32	J:140820	17987514
94551	Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.		Tu S; Bhagat G; Cui G; Takaishi S; Kurt-Jones EA; Rickman B; Betz KS; Penz-Oesterreicher M; Bjorkdahl O; Fox JG; Wang TC		Cancer Cell	14	2008	408-19	J:140955	18977329
94552	Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genes.		Wu MY; Eldin KW; Beaudet AL		J Natl Cancer Inst	100	2008	1247-59	J:141004	18728284
94553	Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.		Kinkade CW; Castillo-Martin M; Puzio-Kuter A; Yan J; Foster TH; Gao H; Sun Y; Ouyang X; Gerald WL; Cordon-Cardo C; Abate-Shen C		J Clin Invest	118	2008	3051-64	J:141005	18725989
94554	Modelling Myc inhibition as a cancer therapy.		Soucek L; Whitfield J; Martins CP; Finch AJ; Murphy DJ; Sodir NM; Karnezis AN; Swigart LB; Nasi S; Evan GI		Nature	455	2008	679-83	J:141029	18716624
94555	Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer.		Provenzano PP; Inman DR; Eliceiri KW; Beggs HE; Keely PJ		Am J Pathol	173	2008	1551-65	J:141117	18845837
94556	RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.		Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y		Cancer Cell	14	2008	226-37	J:141161	18772112
94557	IKKalpha is required to maintain skin homeostasis and prevent skin cancer.		Liu B; Xia X; Zhu F; Park E; Carbajal S; Kiguchi K; DiGiovanni J; Fischer SM; Hu Y		Cancer Cell	14	2008	212-25	J:141162	18772111
94558	Cyp1b1 exerts opposing effects on intestinal tumorigenesis via exogenous and endogenous substrates.		Halberg RB; Larsen MC; Elmergreen TL; Ko AY; Irving AA; Clipson L; Jefcoate CR		Cancer Res	68	2008	7394-402	J:141215	18794127
94559	Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation.		Yang K; Popova NV; Yang WC; Lozonschi I; Tadesse S; Kent S; Bancroft L; Matise I; Cormier RT; Scherer SJ; Edelmann W; Lipkin M; Augenlicht L; Velcich A		Cancer Res	68	2008	7313-22	J:141219	18794118
94560	Impaired spermatogenesis and elevated spontaneous tumorigenesis in xeroderma pigmentosum group A gene (Xpa)-deficient mice.		Nakane H; Hirota S; Brooks PJ; Nakabeppu Y; Nakatsu Y; Nishimune Y; Iino A; Tanaka K		DNA Repair (Amst)	7	2008	1938-1950	J:141237	18790090
94561	Ku80 deletion suppresses spontaneous tumors and induces a p53-mediated DNA damage response.		Holcomb VB; Rodier F; Choi Y; Busuttil RA; Vogel H; Vijg J; Campisi J; Hasty P		Cancer Res	68	2008	9497-502	J:141382	19010925
94562	Regulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer.		Cheung AF; Dupage MJ; Dong HK; Chen J; Jacks T		Cancer Res	68	2008	9459-68	J:141383	19010921
94563	Reduced Mcm2 expression results in severe stem/progenitor cell deficiency and cancer.		Pruitt SC; Bailey KJ; Freeland A		Stem Cells	25	2007	3121-32	J:141493	17717065
94564	Ku80 and p53 suppress medulloblastoma that arise independent of Rag-1-induced DSBs.		Holcomb VB; Vogel H; Marple T; Kornegay RW; Hasty P		Oncogene	25	2006	7159-65	J:141515	16751807
94565	Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression.		Lahlou H; Sanguin-Gendreau V; Zuo D; Cardiff RD; McLean GW; Frame MC; Muller WJ		Proc Natl Acad Sci U S A	104	2007	20302-7	J:141541	18056629
94566	Involvement of insulin-like growth factor-insulin receptor signal pathway in the transgenic mouse model of medulloblastoma.		Sun Q; Wei X; Feng J; Zhang R; Shen Q; Dong J; Jin Y; Dong S; Li H; Hu Y		Cancer Sci	99	2008	234-40	J:141623	18271920
94567	C620R mutation of the murine ret proto-oncogene: loss of function effect in homozygotes and possible gain of function effect in heterozygotes.		Yin L; Puliti A; Bonora E; Evangelisti C; Conti V; Tong WM; Medard JJ; Lavoue MF; Forey N; Wang LC; Manie S; Morel G; Raccurt M; Wang ZQ; Romeo G		Int J Cancer	121	2007	292-300	J:141658	17372903
94568	IL-12 deficiency exacerbates inflammatory responses in UV-irradiated skin and skin tumors.		Meeran SM; Punathil T; Katiyar SK		J Invest Dermatol	128	2008	2716-27	J:141810	18509359
94569	Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice.		Hollander MC; Balogh AR; Liwanag J; Han W; Linnoila RI; Anver MR; Dennis PA		Neoplasia	10	2008	866-72	J:142154	18683321
94570	Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.		Strumane K; Rygiel T; van der Valk M; Collard JG		J Cancer Res Clin Oncol	135	2009	69-80	J:142164	18592271
94571	Evaluation of cancer tests of 1,3-butadiene using internal dose, genotoxic potency, and a multiplicative risk model.		Fred C; Tornqvist M; Granath F		Cancer Res	68	2008	8014-21	J:141819	18829559
94572	Degradation of BRCA2 in alkyltransferase-mediated DNA repair and its clinical implications.		Philip S; Swaminathan S; Kuznetsov SG; Kanugula S; Biswas K; Chang S; Loktionova NA; Haines DC; Kaldis P; Pegg AE; Sharan SK		Cancer Res	68	2008	9973-81	J:142088	19047179
94573	Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.	 	Zhu L; Gibson P; Currle DS; Tong Y; Richardson RJ; Bayazitov IT; Poppleton H; Zakharenko S; Ellison DW; Gilbertson RJ	 	Nature	457	2009	603-7	J:144215	19092805
94574	Crypt stem cells as the cells-of-origin of intestinal cancer.		Barker N; Ridgway RA; van Es JH; van de Wetering M; Begthel H; van den Born M; Danenberg E; Clarke AR; Sansom OJ; Clevers H		Nature	457	2009	608-11	J:144216	19092804
94575	European mutant mouse pathology database (Pathbase)		Pathbase web site, University of Cambridge		MGI Direct Data Submission		2009		J:144924	 
94576	Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency.		Frappart PO; Lee Y; Russell HR; Chalhoub N; Wang YD; Orii KE; Zhao J; Kondo N; Baker SJ; McKinnon PJ		Proc Natl Acad Sci U S A		2009		J:144617	19164512
94577	SKY/M-FISH and CGH Database		SKY/M-FISH and CGH web site, NCBI and NCI		MGI Direct Data Submission		2009		J:145690	 
94578	Strain-dependent differences in susceptibility to lung cancer in inbred mice exposed to mainstream cigarette smoke.		Gordon T; Bosland M		Cancer Lett	275	2009	213-20	J:145754	19118942
94579	Conditional Pten knock-out mice: a model for metastatic phaeochromocytoma.		Korpershoek E; Loonen AJ; Corvers S; van Nederveen FH; Jonkers J; Ma X; Ziel-van der Made A; Korsten H; Trapman J; Dinjens WN; de Krijger RR		J Pathol	217	2009	597-604	J:145860	19142977
94580	Cancer stem cells are enriched in the side population cells in a mouse model of glioma.		Harris MA; Yang H; Low BE; Mukherje J; Guha A; Bronson RT; Shultz LD; Israel MA; Yun K		Cancer Res	68	2008	10051-9	J:142242	19074870
